Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AATF "BFR2, CHE-1, CHE1, DED" ENSG00000275700 "Apoptosis antagonizing transcription factor" Q9NY61 17 36948875-37056871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 137.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004940, HPA075963" Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA004940: AB_1078075, HPA075963: " "unprognostic (1.10e-1)" "unprognostic (5.46e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-3)" "unprognostic (5.54e-2)" "unprognostic (1.94e-2)" "prognostic unfavorable (6.62e-5)" "unprognostic (3.06e-2)" "unprognostic (4.10e-2)" "unprognostic (2.84e-1)" "unprognostic (2.48e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.14e-5)" "unprognostic (2.18e-2)" "unprognostic (1.51e-1)" "unprognostic (7.53e-3)" "unprognostic (3.21e-3)" 8.2 6.8 5.7 11.4 9.8 14.4 7.1 7.5 6.9 7.5 8.8 9.2 7.5 6.2 9.7 6.3 7.6 8.2 7.5 9.8 5.9 7.6 8.7 6.8 11.0 10.1 4.5 11.1 8.8 8.5 5.2 11.1 8.3 7.1 8.6 4.6 6.7 9.2 13.0 8.3 8.5 8.5 7.9 11.2 7.0 8.7 10.2 18.5 9.5 7.2 13.1 10.4 13.5 19.4 18.8 32.1 27.3 20.5 27.2 19.0 20.8 33.7 7.3 14.7 9.9 11.5 13.5 13.4 9.8 15.3 13.6 23.1 14.6 37.7 17.1 11.6 24.6 18.4 27.7 15.4 20.7 19.1 20.7 17.5 13.3 16.1 12.1 28.1 14.9 10.1 27.7 19.7 17.6 13.6 11.0 18.4 24.2 11.3 13.2 15.2 30.9 21.3 9.3 12.0 12.9 20.0 22.1 20.2 12.7 18.4 15.9 6.9 19.7 8.1 18.0 16.8 14.1 14.5 12.3 11.8 20.0 25.0 42.0 12.8 18.2 28.4 14.7 21.0 20.8 14.2 20.2 32.1 23.9 27.3 23.5 18.0 21.5 25.0 18.8 19.4 19.6 19.6 26.1 20.5 25.9 17.4 27.2 19.0 20.8 28.8 32.8 36.7 38.8 12.4 16.1 28.1 36.1 40.9 24.4 21.6 62.0 8.3 31.9 21.4 24.3 32.8 23.3 41.6 49.6 22.2 22.9 46.2 13.9 41.7 17.5 15.4 8.6 24.5 50.0 21.9 36.5 27.0 64.9 22.6 26.9 40.2 25.9 21.9 36.9 22.5 32.3 37.3 47.2 30.2 38.3 137.1 42.4 29.3 33.1 ABCA12 "DKFZP434G232, ICR2B, LI2" ENSG00000144452 "ATP binding cassette subfamily A member 12" Q86UK0 2 214931542-215138428 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 23.1;tongue: 29.3" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 11.4;Suprabasal keratinocytes: 33.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 28.7;SK-BR-3: 13.4;T-47d: 7.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "cerebral cortex: 1.6;hippocampal formation: 1.8" HPA078239 Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoli, Cytosol" "HPA078239: AB_2732373" "unprognostic (6.12e-2)" "unprognostic (4.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.03e-1)" "unprognostic (2.49e-1)" "unprognostic (2.13e-1)" "unprognostic (2.09e-4)" "unprognostic (6.52e-3)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (2.50e-2)" "unprognostic (7.69e-2)" "unprognostic (5.92e-2)" "unprognostic (2.64e-2)" "unprognostic (2.36e-1)" "unprognostic (5.08e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 6.9 0.1 0.1 6.2 0.3 0.0 1.4 0.0 0.0 4.4 8.4 0.1 0.0 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 6.1 4.9 0.0 0.1 0.4 0.0 0.3 0.0 0.1 23.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.1 0.0 29.3 6.1 0.1 3.7 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.7 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 2.0 0.0 13.4 0.0 0.1 7.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 11.4 0.0 0.4 0.0 0.0 3.4 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.1 0.3 0.4 0.0 0.0 0.3 1.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.7 0.0 0.0 0.0 0.2 0.5 0.2 33.8 2.9 0.0 0.0 2.2 ABCC4 "EST170205, MOAT-B, MOATB, MRP4" ENSG00000125257 "ATP binding cassette subfamily C member 4" O15439 13 95019829-95301475 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 35.0" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 38.5;granulocytes: 53.1;Proximal tubular cells: 32.7" "Cancer enriched" "Detected in all" 8 "prostate cancer: 90.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "HEL: 61.8;HMC-1: 67.7;RPTEC TERT1: 18.2" "Low region specificity" "Detected in all" HPA002476 Enhanced Approved "Nucleoli,Golgi apparatus,Plasma membrane" NA NA "Nucleoli, Plasma membrane" "Golgi apparatus" "HPA002476: AB_1844434" "unprognostic (8.77e-2)" "unprognostic (1.94e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.89e-4)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (7.45e-3)" "unprognostic (2.40e-2)" "unprognostic (9.96e-2)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.55e-2)" "prognostic favorable (2.25e-10)" "unprognostic (7.44e-3)" "unprognostic (1.67e-1)" "unprognostic (5.55e-2)" "unprognostic (2.35e-2)" 3.2 1.7 3.8 11.8 4.7 2.9 6.2 1.0 4.6 4.4 11.6 10.3 3.9 4.1 5.8 16.4 3.0 8.6 10.3 3.5 5.7 3.9 19.6 1.9 13.8 7.4 6.6 2.2 7.2 3.5 7.0 2.8 1.8 7.4 35.0 7.3 6.0 3.3 5.2 7.6 4.5 7.4 11.1 6.5 3.8 8.2 3.8 7.0 3.4 6.6 3.1 5.8 25.6 13.4 3.6 4.1 1.0 4.8 4.1 3.6 3.4 4.5 8.0 1.3 2.4 2.5 3.3 0.3 3.6 3.7 3.3 2.8 11.1 3.4 2.5 2.4 4.9 2.4 6.2 2.0 1.8 4.1 7.5 3.1 61.8 2.5 2.2 5.1 7.0 67.7 2.5 0.8 2.3 4.8 4.7 4.2 2.8 6.4 0.1 4.4 1.4 1.3 1.1 1.5 5.5 1.9 1.9 3.7 6.6 18.2 10.3 3.3 2.4 1.2 0.2 2.5 1.5 0.0 3.8 6.9 3.5 2.2 2.9 4.3 0.0 0.0 1.0 6.6 4.0 1.7 0.6 1.2 0.4 3.2 1.2 2.7 3.6 2.6 3.6 4.1 2.7 1.6 3.5 1.0 4.1 4.8 0.7 3.3 3.4 3.8 4.7 1.0 4.6 5.7 3.9 6.6 2.2 7.4 7.0 8.9 28.3 3.7 6.2 3.8 0.0 3.1 5.1 6.7 11.4 22.7 21.6 0.1 0.0 5.2 3.2 11.3 1.4 0.0 2.6 0.4 3.9 38.5 53.1 0.0 3.8 0.0 0.0 2.5 1.0 1.7 6.4 6.3 1.7 19.0 3.2 0.3 4.1 9.3 1.8 32.7 0.7 0.0 3.9 0.6 9.1 6.6 0.2 2.2 7.8 3.7 ABCC8 "ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2" ENSG00000006071 "ATP binding cassette subfamily C member 8" Q09428 11 17392498-17476879 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport Receptor "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0;pancreas: 25.5;pituitary gland: 26.6" "Group enriched" "Detected in some" 8 "Bipolar cells: 39.2;Intestinal endocrine cells: 21.0" "Cancer enriched" "Detected in some" 9 "pancreatic cancer: 16.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A549: 4.7;AN3-CA: 3.8;SCLC-21H: 6.7" "Low region specificity" "Detected in all" "CAB011451, HPA042318" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" No NA Nucleoli "Golgi apparatus, Cytosol" "CAB011451: , HPA042318: AB_2677947" "unprognostic (4.30e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (4.73e-2)" "unprognostic (9.48e-3)" "unprognostic (2.23e-1)" "unprognostic (4.46e-3)" "unprognostic (2.53e-3)" "unprognostic (6.04e-2)" "unprognostic (2.34e-2)" "unprognostic (8.72e-3)" "unprognostic (1.13e-1)" "unprognostic (2.22e-2)" "unprognostic (1.96e-2)" "unprognostic (6.88e-5)" "unprognostic (2.72e-2)" "unprognostic (1.85e-1)" 1.3 6.7 4.4 0.8 6.1 0.9 4.0 28.0 12.3 3.0 1.3 2.6 7.7 1.9 3.1 3.7 0.8 1.2 0.9 2.9 5.1 4.8 1.0 0.8 2.9 0.8 3.6 7.2 0.9 25.5 1.0 26.6 1.6 8.5 2.8 1.3 0.7 0.9 8.5 2.3 1.1 1.5 1.3 4.0 0.9 3.5 1.1 2.3 0.0 6.2 0.0 0.8 0.7 0.8 0.1 0.0 0.5 0.0 0.1 0.2 0.0 0.0 4.7 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 4.4 6.1 28.0 12.3 5.1 4.8 3.6 7.2 8.5 2.3 0.0 0.0 0.0 0.0 0.0 39.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 21.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.0 0.0 0.0 1.2 0.0 1.6 0.0 0.2 0.1 0.0 0.0 0.0 0.1 ABCF3 EST201864 ENSG00000161204 "ATP binding cassette subfamily F member 3" Q9NUQ8 3 184186023-184194012 "Predicted intracellular proteins" "Antiviral defense" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036332 Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA036332: AB_10603571" "unprognostic (1.70e-2)" "unprognostic (1.16e-1)" "unprognostic (3.10e-2)" "unprognostic (3.81e-2)" "unprognostic (4.11e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.16e-5)" "unprognostic (5.18e-2)" "unprognostic (5.97e-2)" "unprognostic (2.67e-1)" "unprognostic (1.01e-1)" "unprognostic (5.52e-2)" "unprognostic (1.85e-2)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.94e-2)" "unprognostic (6.53e-2)" 13.0 47.0 18.9 10.6 19.7 12.4 12.7 23.0 27.2 15.3 12.1 15.4 33.8 13.1 13.5 11.1 16.1 15.0 10.8 22.9 15.4 16.8 16.5 22.3 12.1 12.7 15.4 15.1 17.8 19.7 41.6 17.9 16.0 19.8 13.3 11.8 15.5 21.4 30.1 33.8 15.2 12.8 10.8 12.3 14.9 13.3 12.6 18.6 8.8 15.4 14.4 14.2 12.5 13.8 16.1 16.4 13.9 19.4 14.5 25.4 21.5 21.9 13.6 7.8 15.0 22.8 12.8 15.4 16.0 17.9 21.7 17.1 23.2 8.8 13.3 32.4 17.1 25.5 21.1 12.1 16.8 11.3 16.9 11.6 11.4 11.9 13.6 19.2 12.8 11.7 18.8 15.5 15.3 15.3 12.8 15.5 11.7 10.5 16.1 15.3 26.5 12.5 8.2 11.8 22.8 18.9 12.6 13.0 22.3 11.9 13.3 13.5 7.8 16.5 31.8 14.7 8.9 43.0 11.3 15.1 11.7 12.7 18.2 23.6 18.2 17.5 17.1 18.1 12.8 14.3 5.3 18.6 13.9 22.7 19.4 23.5 16.0 20.1 18.7 16.4 16.1 25.4 20.5 9.3 14.5 19.1 10.1 17.2 21.5 18.9 19.7 23.0 27.2 15.4 16.8 15.4 15.1 19.8 18.6 8.9 1.3 14.9 9.2 12.9 15.7 10.5 12.7 4.0 4.5 14.0 13.7 32.3 24.9 18.7 6.1 9.2 19.0 0.0 19.5 21.8 10.8 7.8 9.2 18.1 18.8 19.1 10.9 14.1 10.3 7.6 11.5 8.1 15.1 28.9 12.7 13.7 17.3 10.2 11.0 23.7 20.6 6.5 7.3 10.7 14.7 8.9 36.6 15.4 13.1 11.5 ABHD14B "CIB, MGC15429" ENSG00000114779 "Abhydrolase domain containing 14B" Q96IU4 3 51968510-51983409 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 216.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036444, HPA036642" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA 2600000 Nucleoli "Nucleoplasm, Cytosol" "HPA036444: AB_10672221, HPA036642: AB_10672225" "unprognostic (8.97e-2)" "prognostic favorable (6.92e-5)" "unprognostic (1.84e-1)" "prognostic favorable (5.42e-5)" "unprognostic (1.07e-1)" "unprognostic (2.21e-2)" "unprognostic (2.06e-3)" "unprognostic (1.35e-3)" "unprognostic (3.95e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-1)" "unprognostic (2.95e-2)" "prognostic favorable (2.93e-5)" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (9.70e-2)" "unprognostic (3.70e-2)" 40.0 34.2 6.2 19.8 7.5 11.4 25.2 10.7 7.0 21.9 33.6 8.6 32.1 30.3 19.6 21.7 27.7 22.0 32.9 12.2 6.2 5.8 42.6 78.4 21.5 35.1 7.8 7.3 29.5 45.0 14.2 15.2 11.4 6.7 30.9 20.2 29.1 39.4 35.0 11.7 16.0 58.7 22.6 8.9 23.3 18.7 11.2 6.2 26.0 35.3 15.2 32.5 24.6 16.9 24.9 15.5 12.5 9.4 9.9 27.2 14.0 10.3 8.8 0.7 10.4 28.8 25.7 2.7 4.1 4.8 7.6 8.9 6.5 20.5 11.6 3.3 14.3 3.5 5.2 6.4 5.9 5.8 15.8 6.9 18.3 7.7 25.5 15.5 10.2 18.9 33.2 20.4 7.7 10.5 11.7 9.2 17.7 10.6 18.6 14.7 10.1 4.5 7.8 1.0 11.3 22.6 11.6 1.4 52.4 13.8 4.2 4.4 4.7 10.4 19.4 33.0 1.6 27.9 7.0 8.7 4.0 19.1 9.1 2.4 23.7 11.1 4.8 8.8 32.8 7.0 12.5 9.4 4.2 18.3 7.6 27.2 24.9 23.0 22.4 15.5 18.7 23.4 21.3 0.8 9.9 4.8 11.3 16.3 14.0 6.2 7.5 10.7 7.0 6.2 5.8 7.8 7.3 6.7 6.2 6.0 25.8 75.9 43.7 26.9 12.4 3.2 56.0 24.1 9.1 66.3 13.7 13.4 124.3 28.2 1.4 33.6 100.6 0.0 40.7 15.9 35.2 36.3 50.7 104.1 49.3 7.9 72.9 30.7 50.2 0.5 60.1 36.2 52.3 32.5 83.5 7.7 25.4 66.2 43.9 216.2 37.1 38.8 41.0 0.5 3.4 26.6 9.8 59.8 107.0 52.8 ABTB1 "BPOZ, Btb3, BTBD21, EF1ABP" ENSG00000114626 "Ankyrin repeat and BTB domain containing 1" Q969K4 3 127672935-127680920 "Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 107.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 107.3" "Lineage enriched" "Detected in all" 12 "granulocytes: 107.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035022, HPA035023" Uncertain Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA035022: AB_10669998, HPA035023: AB_10602104" "unprognostic (6.76e-2)" "unprognostic (9.18e-3)" "unprognostic (2.11e-2)" "unprognostic (6.34e-2)" "unprognostic (6.51e-2)" "unprognostic (2.00e-3)" "unprognostic (4.43e-2)" "unprognostic (2.12e-2)" "unprognostic (9.81e-2)" "unprognostic (4.48e-3)" "unprognostic (4.55e-3)" "unprognostic (2.86e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.88e-1)" "unprognostic (1.81e-2)" "unprognostic (3.98e-2)" "unprognostic (7.92e-3)" 20.4 13.7 11.7 17.7 20.1 42.3 14.2 43.4 27.2 15.4 14.3 13.8 12.9 12.3 15.6 10.9 9.6 13.1 17.6 20.4 10.9 8.2 11.4 8.3 15.5 22.1 9.7 15.8 15.8 11.2 7.8 15.3 12.0 11.4 13.5 4.9 12.4 15.2 14.5 25.1 11.6 13.0 13.3 7.5 41.4 11.7 5.9 12.5 17.8 10.2 9.1 10.4 14.6 17.4 2.9 3.8 107.3 8.6 3.2 5.8 5.1 3.1 7.6 0.7 1.5 7.2 6.9 5.8 5.0 8.7 3.5 4.8 0.2 6.7 1.4 9.0 3.8 4.3 1.4 0.0 3.8 0.8 14.7 2.1 2.3 13.5 1.8 5.8 0.3 7.1 8.6 4.1 3.5 0.9 11.3 3.6 5.9 0.1 10.3 3.7 5.0 3.5 9.9 0.6 3.6 8.4 2.2 4.2 9.8 5.2 2.0 7.0 4.7 3.6 4.4 18.2 1.9 1.1 2.6 6.6 3.6 3.1 6.5 1.6 8.4 2.7 0.4 8.5 2.9 5.7 4.5 8.6 20.5 2.4 6.2 2.3 2.5 2.6 2.3 3.8 2.9 2.2 1.9 107.3 3.2 5.4 2.4 5.8 5.1 11.7 20.1 43.4 27.2 10.9 8.2 9.7 15.8 11.4 12.5 17.9 18.3 15.2 14.1 10.4 9.9 6.2 10.2 4.0 2.3 7.0 17.7 6.5 13.3 12.2 0.4 13.5 12.4 0.0 15.1 20.9 14.5 11.3 14.9 8.5 19.9 3.2 23.0 23.4 52.6 1.9 31.4 20.7 10.1 45.9 16.6 16.2 19.1 23.0 21.2 17.0 30.1 64.7 31.9 0.7 6.8 8.2 13.3 46.5 11.2 8.4 AC008560.1 ENSG00000253251 "Uncharacterized protein FLJ26957 " Q6ZNX1 5 65624765-65630891 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 28 "Alveolar cells type 2: 1.4;Ciliated cells: 1.4;Club cells: 2.3;Cytotrophoblasts: 3.3;Extravillous trophoblasts: 3.7;Hofbauer cells: 3.1;Syncytiotrophoblasts: 4.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA066071, HPA068764" Approved Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA066071: AB_2685609, HPA068764: AB_2686028" "unprognostic (7.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.34e-1)" "unprognostic (1.82e-1)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.38e-2)" "unprognostic (7.24e-3)" "unprognostic (5.09e-4)" "unprognostic (2.12e-2)" "unprognostic (1.68e-2)" "unprognostic (1.49e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "prognostic favorable (1.17e-4)" 5.8 7.1 7.3 6.5 13.1 31.5 10.0 8.7 13.3 5.4 6.6 7.1 5.5 7.0 5.9 7.4 6.3 5.3 6.1 4.9 8.2 7.9 11.6 9.7 6.2 9.9 9.9 8.0 5.9 8.7 3.8 13.1 6.5 11.3 10.7 7.6 5.7 6.4 6.6 6.6 7.0 7.6 7.8 9.1 8.9 6.0 7.5 8.6 10.4 6.9 6.4 8.3 5.3 5.0 5.0 4.4 13.4 4.1 6.3 8.8 2.9 2.7 3.7 5.7 11.9 3.3 3.8 6.8 4.3 3.8 6.0 7.7 6.4 8.7 5.0 4.9 5.0 7.1 3.6 5.5 5.2 9.2 6.7 6.9 4.6 9.6 8.5 2.6 5.0 7.9 2.3 7.3 6.4 6.8 1.8 4.1 8.5 6.5 11.9 5.0 7.1 7.1 7.3 4.5 1.6 2.2 4.9 5.4 7.9 5.0 6.0 7.7 5.8 3.8 3.5 10.8 3.9 4.2 4.5 3.1 5.7 7.5 4.4 6.8 7.5 13.8 11.2 4.2 6.2 5.2 13.4 4.1 7.5 5.4 3.7 5.7 5.0 6.5 5.6 3.7 4.9 8.8 8.1 4.3 6.3 4.1 4.4 7.9 2.9 7.3 13.1 8.7 13.3 8.2 7.9 9.9 8.0 11.3 8.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 AC118549.1 ENSG00000036549 "ZZ-type zinc finger-containing protein 3 " Q8IYH5 1 77562416-77683419 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 19.0;Proximal tubular cells: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053663, HPA054913, HPA066197" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA053663: AB_2682222, HPA054913: AB_2682640, HPA066197: AB_2685635" "unprognostic (1.30e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-2)" "unprognostic (2.13e-3)" "unprognostic (5.38e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (6.96e-5)" "unprognostic (2.91e-1)" "unprognostic (9.67e-2)" "unprognostic (1.35e-1)" "unprognostic (2.83e-1)" "unprognostic (1.91e-1)" "unprognostic (1.71e-1)" "unprognostic (3.96e-1)" "unprognostic (1.95e-1)" "unprognostic (3.05e-2)" "unprognostic (1.43e-1)" 17.8 17.4 20.8 14.1 23.6 11.6 21.6 20.4 20.3 18.1 16.2 16.1 18.3 12.1 18.3 14.3 14.5 15.3 12.1 13.7 16.9 11.7 18.8 20.0 12.3 15.8 24.1 17.8 24.1 14.5 19.0 28.2 13.9 14.4 16.0 13.0 10.5 15.2 16.8 19.0 16.9 12.4 17.0 16.2 11.5 13.5 9.9 23.6 17.9 26.5 8.6 16.0 20.1 14.9 7.9 7.4 5.6 5.1 7.4 10.4 5.0 13.4 6.9 12.7 9.7 11.1 17.7 13.4 17.2 15.9 15.9 17.5 7.7 7.2 17.6 15.5 14.4 18.0 12.4 16.7 11.1 24.1 13.8 13.2 21.8 13.9 9.5 17.1 22.5 6.2 13.5 17.2 17.6 34.4 15.4 16.1 12.2 21.1 13.7 15.4 6.3 11.2 7.0 18.8 7.4 15.7 13.2 21.7 9.0 11.1 14.3 15.9 13.4 10.3 11.8 30.3 9.1 7.1 12.4 13.2 13.8 17.0 22.3 22.1 10.3 14.4 18.7 13.6 19.7 10.5 0.1 4.6 5.6 6.9 5.1 10.4 7.9 8.2 8.1 7.4 7.9 10.2 9.2 0.9 7.4 4.7 5.0 10.4 5.0 20.8 23.6 20.4 20.3 16.9 11.7 24.1 17.8 14.4 23.6 11.9 19.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 12.5 10.4 0.0 11.4 10.0 13.1 0.0 0.0 0.0 0.0 11.1 10.1 0.0 0.0 5.8 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 13.6 0.0 0.0 11.8 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 AC138696.1 ENSG00000264668 8 143247110-143276403 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 4.8" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: AB_2683082" "unprognostic (2.24e-2)" "unprognostic (2.10e-1)" "unprognostic (3.56e-3)" "unprognostic (1.87e-1)" "unprognostic (8.68e-3)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (9.80e-2)" "unprognostic (4.20e-1)" "unprognostic (3.27e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-2)" "unprognostic (2.20e-2)" "unprognostic (3.99e-1)" "unprognostic (2.59e-2)" "unprognostic (4.06e-1)" 3.6 4.8 6.2 2.5 4.4 1.5 2.5 5.8 7.3 3.3 3.8 4.7 2.5 2.6 5.7 2.7 2.8 7.8 2.0 2.7 6.2 4.8 2.6 1.9 2.7 2.5 4.8 3.0 5.8 6.8 4.6 4.5 2.2 4.2 3.0 2.2 3.8 3.6 3.9 4.7 1.8 3.1 3.2 3.7 2.7 2.7 3.5 3.6 1.5 2.7 1.5 2.6 3.6 4.4 0.6 0.6 0.0 0.2 0.9 2.1 0.1 1.4 0.0 0.0 0.8 4.8 0.3 0.5 1.4 3.0 1.6 0.6 0.0 1.9 0.2 0.8 0.3 0.3 0.7 0.0 0.6 0.5 0.0 1.4 0.3 0.0 0.0 0.0 0.3 0.7 2.8 1.3 0.0 1.0 0.5 0.9 1.1 0.0 0.1 0.0 0.0 3.3 0.0 3.0 0.4 0.9 1.6 2.8 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.7 0.0 1.0 0.9 0.0 0.0 0.7 3.0 0.1 2.3 0.8 1.6 1.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 2.1 0.2 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.9 0.2 0.6 0.3 0.1 6.2 4.4 5.8 7.3 6.2 4.8 4.8 3.0 4.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC245033.1 ENSG00000260836 15 82536788-82573194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 11.3" "Group enriched" "Detected in some" 240 "Alveolar cells type 1: 29.8;Alveolar cells type 2: 42.6;Ciliated cells: 20.1;Club cells: 15.9;granulocytes: 11.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 19.0" HPA055060 Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoli, Cytosol" "HPA055060: AB_2682686" "unprognostic (2.91e-2)" 1.5 0.9 5.3 0.9 7.1 0.9 1.3 6.1 11.3 0.9 1.0 1.4 0.0 0.9 0.9 0.9 1.5 0.9 0.9 1.3 3.9 1.6 0.9 1.0 1.1 0.9 3.2 6.1 0.9 1.0 0.9 2.0 1.0 7.3 1.1 1.1 1.9 0.9 0.9 2.0 0.9 1.4 0.9 2.4 1.1 0.9 1.4 1.7 0.0 1.0 0.0 1.0 1.7 0.8 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.7 0.7 19.0 0.3 0.0 0.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.1 6.1 11.3 3.9 1.6 3.2 6.1 7.3 1.7 29.8 42.6 0.0 0.0 0.0 0.0 0.0 0.0 20.1 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACADVL "ACAD6, LCACD, VLCAD" ENSG00000072778 "Acyl-CoA dehydrogenase very long chain" P49748 17 7217125-7225273 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019006, HPA020595" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria NA NA 19000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA019006: AB_1844478, HPA020595: AB_1844479" "unprognostic (4.81e-2)" "unprognostic (2.86e-1)" "unprognostic (2.21e-2)" "unprognostic (1.09e-2)" "unprognostic (6.63e-3)" "unprognostic (1.51e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (6.87e-4)" "unprognostic (3.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (4.01e-1)" "unprognostic (2.84e-3)" 32.7 69.2 22.8 18.2 21.1 15.1 24.1 19.8 18.4 21.1 44.0 16.5 26.7 51.7 17.4 19.7 31.5 14.2 24.4 118.2 20.2 12.2 35.2 90.0 17.3 9.8 18.5 16.8 15.5 67.8 31.5 32.3 40.2 20.9 22.1 24.2 20.0 27.4 29.0 132.3 20.3 51.2 25.0 15.7 21.9 28.7 11.5 18.6 14.6 29.6 36.9 21.2 22.4 31.8 8.3 32.0 37.9 29.0 11.6 14.9 20.0 33.5 32.1 13.2 18.1 57.0 21.0 25.0 24.7 34.4 28.1 17.5 12.9 30.3 18.0 20.6 51.7 10.1 25.9 8.8 27.0 24.9 56.9 9.1 9.6 22.8 19.7 27.4 9.1 25.0 23.3 24.7 23.5 37.1 43.6 25.3 22.1 12.3 21.9 45.1 12.7 9.4 11.0 6.2 35.2 12.7 13.2 14.6 42.6 62.6 30.6 3.5 8.7 34.8 44.3 20.2 12.9 20.3 14.0 25.1 24.9 18.7 12.6 24.1 20.6 9.6 0.9 45.9 16.1 18.1 6.8 29.0 37.9 13.5 18.0 12.4 8.3 10.9 14.9 32.0 7.6 8.3 10.2 6.3 11.6 12.0 26.0 9.7 20.0 22.8 21.1 19.8 18.4 20.2 12.2 18.5 16.8 20.9 18.6 56.6 73.4 64.0 249.7 77.5 39.6 397.7 150.3 17.4 43.3 191.9 58.9 369.3 157.5 241.9 107.0 71.4 453.8 23.3 66.5 164.5 100.7 311.9 89.7 297.9 171.6 31.8 172.2 51.5 68.0 184.1 115.3 93.1 77.6 423.8 144.6 37.1 129.2 196.4 124.8 276.8 38.8 103.5 102.3 100.5 34.7 76.5 554.7 68.2 215.2 275.4 ACOX1 PALMCOX ENSG00000161533 "Acyl-CoA oxidase 1" Q15067 17 75941507-75979363 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 95.6" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 185.5;Hepatocytes: 244.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 22.9;neutrophil: 38.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 38.6" "Cell line enhanced" "Detected in all" "BEWO: 35.3;RT4: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021094, HPA021192, HPA021195, HPA028759" Approved Approved Nucleoli,Peroxisomes NA NA 160000 Peroxisomes Nucleoli "CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352" "unprognostic (7.47e-2)" "unprognostic (3.69e-1)" "unprognostic (1.25e-3)" "unprognostic (1.36e-1)" "unprognostic (7.49e-2)" "unprognostic (8.14e-2)" "unprognostic (3.75e-2)" "unprognostic (4.95e-2)" "unprognostic (1.61e-1)" "unprognostic (5.33e-2)" "unprognostic (1.25e-1)" "unprognostic (3.38e-2)" "prognostic favorable (5.25e-7)" "unprognostic (3.39e-1)" "unprognostic (2.41e-2)" "unprognostic (1.72e-1)" "unprognostic (4.46e-2)" 21.8 12.9 8.8 8.3 10.2 4.2 13.6 6.4 9.8 6.4 26.5 8.2 9.6 31.0 6.6 6.7 19.5 6.0 12.3 16.0 8.3 7.9 20.8 95.6 9.2 7.5 8.2 8.3 7.6 28.7 9.8 8.9 13.6 7.8 9.5 14.3 11.3 9.5 9.1 18.3 13.4 53.1 7.9 6.7 7.2 13.6 6.2 6.3 7.1 9.1 11.4 10.6 10.6 7.9 1.6 3.3 38.6 5.8 2.1 2.7 2.2 5.4 7.7 2.5 3.8 13.3 5.6 35.3 4.0 4.0 4.8 5.5 5.4 9.0 3.1 4.3 6.8 4.5 3.3 10.7 4.2 7.6 2.8 3.2 4.0 4.4 17.7 7.2 3.4 2.6 9.3 3.3 5.4 3.6 5.1 12.0 4.3 4.1 3.1 5.3 16.1 7.6 2.5 1.9 13.5 6.7 4.2 7.7 3.6 8.1 47.5 3.1 4.6 11.4 17.8 3.8 8.7 10.9 3.9 7.9 6.7 4.9 5.4 3.8 5.1 3.5 1.2 3.9 3.2 3.9 22.9 5.8 1.6 2.1 4.5 2.7 1.6 2.0 2.7 3.3 1.6 2.4 2.3 38.6 2.1 2.8 2.9 2.6 2.2 8.8 10.2 6.4 9.8 8.3 7.9 8.2 8.3 7.8 6.3 26.8 20.6 3.0 13.1 11.9 23.8 38.6 48.4 14.7 18.2 22.7 21.6 32.5 18.3 19.8 8.4 14.6 185.5 23.3 35.6 39.3 17.0 27.2 16.2 244.8 23.1 17.5 33.1 22.1 31.8 6.5 27.6 19.9 13.5 25.2 35.0 64.2 31.5 87.7 44.2 74.6 28.4 0.0 16.4 5.6 10.7 26.5 36.2 10.2 32.4 22.6 ACOXL FLJ11042 ENSG00000153093 "Acyl-CoA oxidase like" Q9NUZ1 2 110732573-111118222 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 29.7;lung: 20.8;placenta: 23.8" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 2: 27.4" "Group enriched" "Detected in some" 6 "lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "A-431: 9.1;RPMI-8226: 16.5;RT4: 21.3;U-266/70: 14.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035392, HPA035393" Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA035392: AB_2674604, HPA035393: AB_2674605" "unprognostic (1.62e-1)" "unprognostic (7.30e-2)" "unprognostic (6.77e-4)" "unprognostic (2.93e-7)" "unprognostic (1.32e-2)" "unprognostic (7.84e-5)" "unprognostic (1.28e-1)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (7.31e-2)" "unprognostic (7.24e-2)" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (2.73e-1)" "unprognostic (1.72e-1)" "prognostic favorable (6.48e-4)" 0.3 0.3 0.2 0.5 0.4 1.6 0.3 0.2 0.4 0.4 0.4 0.2 2.3 0.0 0.3 29.7 0.2 0.5 0.4 0.3 0.2 0.2 0.6 0.2 20.8 0.6 0.2 0.2 0.2 0.4 4.9 0.7 23.8 0.4 4.1 0.1 0.2 0.5 0.2 0.3 0.4 0.3 2.6 0.2 1.3 0.4 4.6 0.2 0.6 1.5 0.2 0.9 8.5 5.2 1.0 0.6 4.1 1.1 0.7 0.6 0.3 9.1 0.0 0.2 0.3 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.6 0.6 0.2 0.2 0.1 0.2 1.0 0.0 0.0 0.0 0.2 3.2 0.2 0.4 0.2 0.0 0.1 0.2 0.1 1.0 0.0 0.1 0.3 0.0 0.4 1.4 1.4 0.1 3.3 0.7 0.4 3.1 0.1 0.4 0.1 0.2 16.5 0.0 21.3 2.0 0.4 0.1 0.4 0.1 0.7 0.2 1.0 0.3 0.2 0.4 0.2 0.1 14.4 3.7 0.5 0.1 0.2 0.2 2.2 1.1 0.5 0.4 0.7 0.2 1.0 0.4 0.6 0.2 0.8 0.5 0.4 4.1 0.7 0.4 0.6 0.4 0.3 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 0.0 27.4 0.0 0.2 0.2 0.6 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.1 0.0 1.2 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.3 0.9 2.2 0.3 0.0 0.0 0.0 0.7 ACSL3 "ACS3, FACL3, PRO2194" ENSG00000123983 "Acyl-CoA synthetase long chain family member 3" O95573 2 222860934-222944639 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 206.1" "Cell type enhanced" "Detected in all" 9 "Horizontal cells: 494.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 94.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011315, HPA071021" Approved Approved "Nucleoli,Nucleoli rim,Lipid droplets" NA NA "Nucleoli, Nucleoli rim" "Lipid droplets" "HPA011315: AB_1848344, HPA071021: AB_2686335" "unprognostic (1.87e-1)" "unprognostic (5.64e-2)" "unprognostic (2.36e-1)" "unprognostic (9.35e-3)" "unprognostic (7.53e-2)" "unprognostic (2.07e-2)" "prognostic unfavorable (2.75e-4)" "prognostic unfavorable (8.78e-4)" "unprognostic (3.90e-2)" "unprognostic (2.50e-1)" "unprognostic (2.64e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-1)" "unprognostic (2.72e-1)" "unprognostic (2.65e-1)" "unprognostic (1.60e-1)" 14.7 17.0 22.8 9.9 26.0 16.3 51.5 19.4 45.9 15.3 16.5 16.1 11.6 12.7 10.9 18.4 28.3 9.0 11.8 22.7 20.9 22.8 17.9 22.3 15.6 10.5 19.6 21.2 11.7 10.3 206.1 8.8 19.1 24.4 44.4 16.7 14.4 34.2 15.5 19.1 11.4 12.7 12.2 22.2 9.7 28.3 13.7 14.2 13.5 17.3 11.2 8.7 14.6 15.4 15.0 22.5 21.8 16.8 16.6 20.1 16.5 10.1 17.9 27.4 29.8 12.0 29.8 7.6 12.9 33.6 15.5 32.7 16.1 26.1 4.8 7.5 12.3 33.5 29.9 5.9 28.7 20.1 8.7 11.2 11.4 14.5 17.9 26.5 7.5 5.6 15.3 40.8 25.6 44.7 11.9 16.8 8.5 21.5 18.6 21.8 21.5 14.6 8.8 13.9 23.0 9.3 8.0 23.2 8.2 22.3 41.6 14.5 10.7 7.6 20.6 94.2 22.1 10.3 18.4 11.6 10.4 16.6 8.9 9.4 6.6 3.2 16.8 11.1 7.1 31.4 16.6 14.6 21.8 20.1 16.8 19.3 11.6 12.8 14.6 15.7 15.0 18.7 16.7 21.8 16.6 15.9 22.5 9.5 16.5 22.8 26.0 19.4 45.9 20.9 22.8 19.6 21.2 24.4 14.2 32.8 58.5 16.4 65.8 41.3 91.7 51.2 40.8 37.5 44.3 34.9 72.6 32.9 6.6 28.6 31.0 38.3 33.1 23.3 27.3 8.4 36.3 113.5 26.5 47.9 33.5 494.2 20.1 36.2 50.2 18.9 24.2 42.9 45.5 32.5 32.3 205.8 32.5 38.6 33.6 12.5 51.8 45.3 51.8 50.2 49.9 42.7 50.7 27.7 46.5 102.1 ACVR1 "ACVR1A, ACVRLK2, ALK2, SKR1" ENSG00000115170 "Activin A receptor type 1" Q04771 2 157736444-157875862 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007505, HPA046514" Approved Uncertain Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA007505: AB_1844752, HPA046514: AB_2732526" "unprognostic (6.99e-2)" "unprognostic (3.32e-2)" "unprognostic (3.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.73e-1)" "unprognostic (6.09e-2)" "unprognostic (3.66e-3)" "unprognostic (1.08e-1)" "unprognostic (3.99e-1)" "unprognostic (3.20e-1)" "unprognostic (2.65e-2)" "unprognostic (4.29e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-3)" "unprognostic (3.17e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (5.17e-4)" 18.9 9.2 18.0 10.0 12.7 1.6 38.7 15.3 12.2 25.2 14.4 7.4 8.4 8.9 24.8 26.8 11.0 16.6 20.5 18.8 18.7 8.6 21.7 18.9 22.5 15.1 10.4 7.9 18.5 12.3 11.3 17.0 14.2 12.3 16.8 10.5 14.3 18.1 13.6 15.6 12.8 11.5 29.2 12.3 9.2 11.8 8.8 10.9 7.5 34.0 14.6 6.9 16.1 32.5 1.4 2.4 3.8 2.6 1.9 10.0 1.6 2.1 4.3 5.0 6.5 25.4 26.5 7.0 15.4 25.6 12.4 13.2 3.4 4.8 0.0 7.1 16.6 12.0 6.0 3.6 8.3 13.3 14.7 3.1 8.7 2.5 4.9 20.1 0.6 10.4 33.2 15.8 25.3 32.3 16.2 13.4 2.4 3.2 2.4 15.5 3.8 0.1 0.2 7.5 3.0 7.8 1.4 6.7 1.8 16.0 8.1 4.4 5.5 5.9 3.4 21.1 8.2 1.8 2.3 19.3 18.8 6.2 9.2 5.8 1.6 1.2 0.1 19.3 0.5 20.2 3.8 2.6 0.2 1.1 1.7 1.2 1.4 7.8 2.5 1.8 0.8 3.1 1.5 0.8 1.9 2.3 2.4 10.0 1.6 18.0 12.7 15.3 12.2 18.7 8.6 10.4 7.9 12.3 10.9 8.9 7.0 0.8 6.8 8.8 7.5 9.2 12.7 6.7 9.1 7.0 0.0 7.0 5.0 8.4 0.5 13.5 3.1 0.0 15.5 4.4 11.6 8.9 4.7 12.1 6.5 3.2 4.1 17.2 11.6 1.1 18.7 7.7 3.3 3.6 5.2 6.1 14.7 3.5 14.9 15.3 1.5 12.9 15.5 0.5 2.5 6.6 8.8 1.0 3.5 7.6 ADAMTS12 ENSG00000151388 "ADAM metallopeptidase with thrombospondin type 1 motif 12" P58397 5 33523535-33892192 "Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 16 "Ito cells: 17.8;Leydig cells: 20.4;Peritubular cells: 16.6;Sertoli cells: 51.8;Smooth muscle cells: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 20.2;hTERT-RPE1: 36.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA035973, HPA075079" Uncertain Approved Nucleoli,Mitochondria "Secreted to extracellular matrix" NA NA Nucleoli Mitochondria "HPA035973: AB_10669663, HPA075079: AB_2732278" "unprognostic (6.18e-3)" "unprognostic (3.12e-4)" "unprognostic (1.05e-1)" "unprognostic (8.37e-2)" "unprognostic (1.65e-1)" "unprognostic (3.52e-1)" "unprognostic (2.60e-2)" "unprognostic (3.49e-3)" "unprognostic (3.78e-3)" "unprognostic (3.39e-2)" "unprognostic (5.63e-3)" "unprognostic (1.45e-1)" "unprognostic (4.27e-7)" "unprognostic (4.45e-3)" "unprognostic (1.47e-1)" "unprognostic (5.85e-2)" "prognostic unfavorable (6.78e-4)" 13.7 5.4 0.2 2.5 0.8 0.0 17.6 0.3 1.0 6.0 3.0 2.3 2.6 0.6 13.0 4.4 1.4 3.1 5.9 1.4 0.3 0.6 2.0 2.1 9.4 4.2 1.2 0.2 4.9 8.7 1.2 0.9 5.5 2.1 6.7 1.4 2.7 4.4 4.2 4.1 2.0 1.6 9.4 6.5 0.6 1.8 5.0 0.3 0.1 2.6 4.1 1.6 4.3 7.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 11.4 0.3 10.4 0.0 15.4 7.3 0.0 5.4 13.9 7.1 8.8 0.0 0.0 0.0 0.0 3.7 12.6 0.3 0.2 7.0 10.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 5.8 0.0 20.2 5.3 36.2 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 12.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 12.2 15.6 0.1 3.2 1.8 1.3 0.0 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.3 1.0 0.3 0.6 1.2 0.2 2.1 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.2 3.3 0.4 0.0 0.0 0.2 0.2 12.8 0.1 0.0 0.0 0.5 0.0 0.0 17.8 0.3 2.5 20.4 0.0 6.8 0.0 0.0 6.7 0.2 0.0 16.6 2.2 0.2 51.8 14.2 0.2 1.7 0.6 0.7 0.0 0.0 0.1 ADAR "ADAR1, G1P1, IFI4" ENSG00000160710 "Adenosine deaminase, RNA specific" P55265 1 154582062-154627999 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing" "DNA-binding, Hydrolase, RNA-binding" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003890, HPA051519, CAB056157" Enhanced Enhanced Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520" "unprognostic (3.46e-1)" "unprognostic (8.11e-2)" "unprognostic (1.42e-1)" "unprognostic (1.83e-2)" "unprognostic (2.38e-1)" "unprognostic (9.37e-2)" "unprognostic (2.07e-2)" "unprognostic (6.97e-2)" "unprognostic (2.03e-1)" "unprognostic (2.90e-1)" "unprognostic (4.13e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.30e-5)" "unprognostic (3.44e-1)" "unprognostic (1.49e-1)" "unprognostic (9.00e-2)" "unprognostic (3.94e-2)" 36.1 33.1 30.3 36.6 44.4 43.1 29.7 41.4 50.8 30.7 28.2 33.3 19.9 31.4 38.0 26.5 27.7 32.9 28.9 24.0 25.7 38.1 31.5 36.0 34.7 41.3 27.3 32.6 39.2 29.5 46.2 38.4 33.9 39.8 28.8 31.1 32.2 36.7 30.2 14.0 27.0 40.6 36.3 24.4 47.7 29.1 21.9 26.9 57.6 32.8 16.7 41.9 29.7 27.6 7.8 6.1 25.1 8.6 6.4 9.7 5.6 26.6 30.9 26.5 32.6 26.8 27.8 31.5 18.4 36.9 61.6 53.5 26.6 26.2 48.0 29.7 29.3 34.2 25.9 33.8 34.9 31.4 46.6 16.9 25.0 21.9 15.0 29.2 35.3 27.8 27.0 25.5 31.5 32.3 25.2 31.5 34.7 23.6 37.0 21.5 32.5 42.6 18.2 43.7 35.7 23.3 40.8 21.8 38.6 21.1 29.7 26.4 31.5 31.7 51.3 37.6 41.3 34.5 43.5 28.7 22.1 21.8 18.2 21.2 43.8 48.0 51.6 21.5 23.3 24.9 6.9 6.6 12.0 9.4 8.3 8.8 7.8 9.4 9.7 6.1 6.2 8.8 8.6 25.1 6.4 8.6 5.5 7.1 5.6 30.3 44.4 41.4 50.8 25.7 38.1 27.3 32.6 39.8 26.9 77.4 46.4 72.2 33.2 29.7 90.3 15.5 33.1 41.5 43.3 45.4 90.3 33.7 8.3 43.8 3.6 83.1 68.1 23.3 58.0 42.0 39.5 47.9 61.1 78.8 46.9 158.9 60.6 78.0 80.2 9.5 68.1 57.4 18.6 68.5 54.5 46.8 58.0 53.7 55.5 36.0 81.7 51.8 36.9 11.7 23.2 35.3 26.3 58.3 48.2 41.3 ADTRP "AIG1L, C6orf105, dJ413H6.1" ENSG00000111863 "Androgen dependent TFPI regulating protein" Q96IZ2 6 11712054-11807046 "Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 109.7;Enterocytes: 113.2;Late spermatids: 127.1;Paneth cells: 73.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "pons and medulla: 12.4" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 10.5;T-reg: 9.8" "Lineage enriched" "Detected in many" 7 "T-cells: 10.5" "Cell line enhanced" "Detected in some" "hTERT-HME1: 10.5;HUVEC TERT2: 35.9;RPMI-8226: 13.5;TIME: 19.4;U-138 MG: 12.9;U-266/84: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA048113 Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA048113: AB_2680268" "unprognostic (6.82e-3)" "unprognostic (1.41e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-3)" "unprognostic (3.04e-3)" "unprognostic (1.41e-2)" "unprognostic (4.00e-2)" "unprognostic (1.77e-1)" "unprognostic (1.85e-2)" "unprognostic (2.72e-1)" "unprognostic (5.41e-3)" "unprognostic (2.90e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (2.61e-2)" "unprognostic (1.40e-1)" "unprognostic (1.95e-2)" "unprognostic (1.26e-1)" 0.8 0.4 0.6 10.6 0.8 0.0 0.9 0.3 2.1 0.4 21.8 1.5 48.3 22.4 0.4 4.0 0.9 0.5 0.3 0.5 1.2 0.4 3.8 1.0 3.9 2.0 0.4 1.1 0.4 0.6 0.8 0.3 0.3 12.4 1.7 16.2 38.0 0.7 48.0 0.4 12.7 61.2 0.5 0.4 1.0 11.4 14.1 0.1 0.8 0.7 0.6 3.2 2.7 0.5 0.2 0.2 1.4 0.3 0.1 10.5 1.5 1.7 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.3 0.5 0.3 1.6 0.8 0.0 0.7 0.3 1.1 0.7 0.0 4.8 0.6 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 8.9 3.6 10.5 7.5 35.9 0.2 8.6 0.0 1.2 0.0 0.0 0.2 0.1 0.0 2.5 0.0 0.1 13.5 0.7 0.1 0.0 0.1 0.6 0.0 0.3 1.3 0.0 0.3 19.4 12.9 0.9 0.3 1.0 0.5 15.2 0.0 2.7 0.5 0.1 1.4 0.1 0.0 0.0 0.3 2.3 0.2 2.8 0.2 0.1 0.1 10.5 0.8 0.2 0.1 0.2 0.2 9.8 1.5 0.6 0.8 0.3 2.1 1.2 0.4 0.4 1.1 12.4 0.1 0.0 1.4 1.5 0.2 4.5 0.0 0.0 0.0 0.0 3.4 5.2 0.0 0.1 44.7 0.7 109.7 0.1 113.2 23.3 2.2 0.1 1.0 0.5 5.7 0.0 8.9 0.0 5.2 0.0 0.3 127.1 1.7 1.3 1.7 47.7 36.6 0.0 5.0 73.7 0.7 0.0 0.0 0.0 1.0 1.5 0.8 5.0 0.1 5.7 46.8 0.4 AEN "FLJ12484, FLJ12562, ISG20L1" ENSG00000181026 "Apoptosis enhancing nuclease" Q8WTP8 15 88621296-88632282 "Predicted intracellular proteins" "Apoptosis, DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048599 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nucleoli" "Nuclear membrane" "HPA048599: AB_2756313" "unprognostic (8.64e-2)" "unprognostic (1.94e-1)" "unprognostic (2.16e-2)" "prognostic favorable (1.72e-4)" "unprognostic (1.52e-2)" "unprognostic (4.40e-2)" "unprognostic (4.08e-2)" "unprognostic (9.42e-2)" "unprognostic (4.28e-2)" "unprognostic (1.17e-2)" "unprognostic (9.00e-2)" "unprognostic (7.88e-2)" "unprognostic (8.58e-3)" "unprognostic (3.39e-2)" "unprognostic (2.73e-1)" "unprognostic (8.71e-2)" "unprognostic (6.10e-2)" 9.4 10.4 6.5 10.2 7.2 14.8 11.2 2.8 5.0 8.0 7.8 4.9 13.4 5.0 9.3 10.2 8.9 7.0 23.0 8.2 4.7 8.5 7.9 17.4 9.1 15.4 13.1 3.1 11.2 18.8 6.7 21.3 11.0 7.8 11.6 9.1 4.3 14.5 9.1 18.8 5.9 8.0 10.6 9.3 14.2 11.1 14.3 4.6 14.0 16.6 10.9 13.7 12.5 5.4 9.3 4.1 0.6 3.6 3.0 15.0 7.6 4.9 22.1 13.8 11.8 6.1 7.4 29.3 17.7 16.2 13.6 16.8 18.1 9.7 21.3 5.7 9.6 12.3 7.1 50.8 14.3 11.5 5.2 20.0 11.4 8.9 29.9 15.1 9.4 11.5 9.1 12.7 17.0 14.0 4.9 11.4 7.1 17.9 12.1 16.6 11.5 11.6 7.9 33.3 10.3 12.8 15.3 9.8 15.7 5.7 10.7 10.9 10.0 7.1 8.2 13.6 33.0 6.8 10.9 10.3 13.9 19.4 5.6 23.8 23.5 15.7 18.2 12.8 10.6 27.2 0.0 1.8 0.6 5.3 3.1 10.0 9.3 9.1 6.9 4.1 9.3 10.0 8.8 0.4 3.0 3.6 2.4 15.0 7.6 6.5 7.2 2.8 5.0 4.7 8.5 13.1 3.1 7.8 4.6 6.0 7.2 11.2 18.2 16.6 0.4 3.4 10.2 2.7 12.5 1.8 0.0 3.4 3.3 12.4 19.8 4.4 2.9 0.0 6.4 13.5 6.7 23.7 2.3 5.0 4.1 1.6 8.6 1.8 5.9 39.3 4.0 5.1 13.5 20.8 5.8 2.3 9.5 5.8 2.5 5.0 0.8 12.9 17.0 6.3 15.0 24.7 5.1 7.2 6.0 24.5 AGPAT4 "dJ473J16.2, LPAAT-delta" ENSG00000026652 "1-acylglycerol-3-phosphate O-acyltransferase 4" Q9NRZ5 6 161129979-161274061 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.0" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 51.8;Late spermatids: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 19.8;HEL: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053287, HPA060525" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoli, Vesicles" "HPA053287: AB_2682101, HPA060525: AB_2684306" "unprognostic (5.69e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.73e-1)" "unprognostic (3.43e-2)" "unprognostic (4.14e-2)" "unprognostic (6.67e-3)" "unprognostic (1.94e-4)" "unprognostic (1.05e-1)" "unprognostic (3.42e-2)" "unprognostic (2.77e-2)" "unprognostic (1.76e-3)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.08e-4)" "unprognostic (1.82e-2)" "unprognostic (8.87e-2)" "unprognostic (3.63e-4)" "unprognostic (5.51e-2)" 5.6 4.2 10.5 3.5 19.1 8.0 4.5 9.6 26.6 5.3 4.2 35.6 1.0 2.6 10.7 4.5 5.2 7.2 8.0 2.9 14.2 11.8 5.2 2.0 6.1 2.0 25.8 12.4 10.0 2.3 1.3 9.8 14.6 27.4 3.7 4.4 0.7 2.7 4.9 2.1 1.9 2.5 8.5 49.0 5.2 3.0 4.2 19.8 0.6 4.8 2.0 2.2 4.0 3.8 1.1 1.9 0.6 3.5 5.8 7.0 2.1 0.3 0.8 19.8 3.9 3.7 7.6 0.8 0.7 0.2 1.5 2.5 1.1 3.5 0.5 1.4 3.1 9.2 0.3 3.6 3.0 1.4 2.2 6.2 14.8 3.5 0.0 2.9 0.1 2.1 9.1 1.5 4.0 2.1 7.1 4.6 2.3 7.3 6.8 1.8 0.0 1.0 1.6 4.7 0.0 7.5 0.0 0.9 0.4 4.3 0.3 11.5 4.4 3.0 1.6 0.8 8.1 0.8 1.0 5.1 2.1 2.6 1.4 3.3 0.5 0.7 0.0 7.8 0.8 1.3 0.0 3.5 0.0 7.0 2.8 2.3 0.4 3.3 4.1 1.9 1.1 1.7 2.7 0.6 5.8 2.5 1.5 2.9 2.1 10.5 19.1 9.6 15.8 14.2 11.8 25.8 12.4 27.4 19.8 3.0 5.6 5.2 4.6 2.9 1.0 4.0 2.5 10.7 5.7 5.2 0.0 16.0 0.0 4.3 51.8 12.2 0.0 0.0 7.0 10.7 11.3 0.8 10.5 0.4 16.7 0.0 1.7 9.8 7.6 44.8 5.5 15.4 3.3 11.8 0.0 4.0 5.9 0.0 8.1 0.3 0.9 19.4 6.2 3.6 2.9 2.3 18.5 7.4 0.0 3.2 AGTPBP1 "CCP1, KIAA1035, Nna1" ENSG00000135049 "ATP/GTP binding protein 1" Q9UPW5 9 85546539-85742029 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.2" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 96.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057208, HPA071094" Approved Approved Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "HPA057208: AB_2683370, HPA071094: " "unprognostic (2.15e-1)" "unprognostic (3.78e-2)" "unprognostic (4.93e-3)" "unprognostic (6.12e-2)" "unprognostic (1.42e-1)" "unprognostic (8.95e-3)" "unprognostic (1.86e-2)" "unprognostic (1.65e-1)" "unprognostic (1.71e-1)" "unprognostic (8.26e-3)" "unprognostic (5.69e-3)" "unprognostic (6.31e-2)" "unprognostic (3.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (9.60e-3)" "unprognostic (1.25e-1)" 7.9 5.7 13.1 8.6 14.6 48.2 6.0 14.2 21.4 5.1 5.0 21.6 1.8 3.8 5.0 4.2 5.4 4.2 5.3 11.2 17.3 13.5 6.8 4.5 11.9 16.0 18.8 14.5 3.5 6.4 8.0 4.8 6.0 23.5 4.9 5.9 7.4 3.9 3.4 13.6 6.0 4.3 6.4 24.1 12.8 5.3 12.5 14.4 8.8 5.8 4.3 7.8 5.7 3.8 1.6 10.7 20.3 9.5 4.5 6.6 5.7 2.9 5.7 16.9 6.7 3.5 3.8 6.4 4.4 3.8 4.5 5.2 3.0 5.1 18.4 3.8 4.6 8.0 1.7 7.8 5.6 4.3 19.5 6.9 3.1 6.9 5.4 7.3 14.1 3.7 3.6 6.6 4.2 14.5 2.9 7.2 9.5 3.9 14.8 2.0 4.6 11.0 8.4 11.7 10.6 4.0 10.1 6.2 5.6 7.9 3.2 20.4 14.5 5.0 5.5 9.1 16.8 2.1 4.6 7.1 2.9 5.2 18.5 5.2 10.1 8.4 8.4 6.2 13.9 5.9 20.3 9.5 8.3 6.6 5.7 6.4 1.6 3.3 5.1 10.7 1.2 2.7 5.2 14.0 4.5 4.3 1.7 3.4 5.7 13.1 14.6 14.2 21.4 17.3 13.5 18.8 14.5 23.5 14.4 59.6 13.8 5.4 2.3 7.0 29.1 39.1 0.0 18.7 21.6 3.5 96.2 3.7 6.6 4.8 44.2 7.5 2.7 0.0 3.5 3.5 4.5 3.7 25.5 3.6 7.2 33.4 7.5 10.4 38.6 49.1 1.7 22.6 3.3 9.0 4.9 16.0 4.6 0.0 2.5 6.1 56.8 12.9 7.2 25.0 27.2 9.4 2.4 20.8 3.8 1.6 AKAP11 "AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11" ENSG00000023516 "A-kinase anchoring protein 11" Q9UKA4 13 42272153-42323267 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039089 Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Nucleoli, Plasma membrane, Cytosol" "HPA039089: AB_10674279" "unprognostic (6.43e-2)" "prognostic unfavorable (9.26e-4)" "unprognostic (4.91e-1)" "unprognostic (6.89e-2)" "unprognostic (1.92e-1)" "unprognostic (7.34e-2)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (7.91e-2)" "unprognostic (2.15e-3)" "unprognostic (3.02e-2)" "unprognostic (1.35e-1)" "unprognostic (7.49e-3)" "unprognostic (7.44e-2)" "unprognostic (1.49e-1)" "unprognostic (6.02e-2)" "unprognostic (1.10e-1)" 11.2 13.6 21.7 10.0 42.3 3.0 11.0 19.9 30.7 17.1 9.1 9.0 5.9 6.9 13.0 15.2 10.2 10.2 9.7 10.4 18.3 17.9 12.9 9.9 10.2 13.4 16.4 22.8 14.6 6.4 11.6 14.5 7.2 20.3 11.1 10.1 6.7 7.6 12.4 5.7 9.1 8.1 13.4 21.4 11.7 9.5 18.1 16.0 5.6 13.3 4.6 12.6 10.4 9.4 3.0 1.6 4.2 1.4 4.8 2.7 0.7 9.4 9.7 11.9 7.0 15.6 19.2 5.2 12.8 10.7 7.8 7.3 10.6 7.9 19.5 5.0 14.3 8.2 11.3 10.3 10.7 14.9 20.7 4.8 5.5 6.7 5.2 12.3 13.6 13.5 14.0 11.1 15.8 13.9 11.4 11.3 9.8 18.0 7.9 15.6 7.1 7.9 4.4 7.0 13.9 4.5 6.6 8.4 9.4 7.7 7.0 5.1 7.4 9.8 6.5 4.5 5.7 5.6 7.4 15.7 13.2 6.9 19.8 9.6 3.0 3.8 10.1 16.8 7.0 9.2 4.2 0.9 1.2 1.7 1.1 2.1 2.7 2.4 1.6 1.0 3.0 2.1 2.1 0.3 4.8 1.4 1.6 2.7 0.7 21.7 42.3 19.9 24.6 18.3 17.9 16.4 22.8 20.3 16.0 23.8 23.3 15.9 13.0 10.9 54.0 42.5 15.3 30.8 40.9 27.9 35.3 3.6 1.7 10.1 7.6 19.9 8.4 23.3 8.1 3.1 16.4 11.4 33.5 19.7 10.7 39.7 20.2 27.6 23.5 9.4 20.1 21.2 8.5 11.8 14.2 66.5 10.8 15.8 31.5 17.7 36.7 19.4 17.9 31.7 33.9 14.8 2.1 15.9 11.2 11.3 AL121900.2 ENSG00000284776 20 18567453-18744216 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9;Ciliated cells: 5.3" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBF TERT88: 22.9" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA040981: AB_10673268" 4.0 5.7 4.0 4.4 5.8 5.8 6.0 4.5 14.1 3.6 6.2 2.0 6.0 5.2 7.4 5.9 4.5 5.4 5.4 7.8 4.4 15.4 6.3 4.7 6.9 4.5 5.4 7.7 16.1 8.3 5.3 4.4 7.6 4.6 6.4 3.1 8.8 8.2 12.2 1.1 5.5 5.9 4.3 5.8 0.9 6.8 5.4 3.6 5.1 9.9 6.8 5.7 6.4 4.9 6.9 2.9 4.8 3.9 5.9 1.7 3.7 1.8 7.9 3.9 2.6 9.1 0.5 2.4 6.5 6.2 0.7 0.9 5.6 0.5 1.9 7.8 3.5 3.5 4.9 15.1 22.9 0.9 0.3 5.1 2.0 2.0 3.1 10.0 6.0 0.0 14.4 4.5 7.4 3.6 8.0 1.5 0.9 7.9 5.3 2.8 1.7 0.8 2.1 3.2 0.0 0.3 4.1 5.5 4.9 4.7 7.8 2.0 0.2 6.4 3.1 6.6 5.0 6.5 0.0 8.5 0.4 7.1 5.3 1.7 8.5 1.5 5.1 1.6 5.6 2.9 3.2 2.7 4.8 4.8 5.9 4.9 5.4 3.6 6.9 2.9 1.7 3.4 1.9 3.9 2.8 1.2 4.5 1.7 8.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL136454.1 ENSG00000231767 1 192716132-192716653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Ciliated cells: 13.4;Club cells: 30.7;Distal tubular cells: 36.5;granulocytes: 33.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 7.5;SK-MEL-30: 6.6;THP-1: 7.8" "HPA041344, HPA049132, HPA054087" Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373" "unprognostic (2.56e-1)" "unprognostic (1.02e-2)" "unprognostic (1.90e-2)" "unprognostic (8.64e-2)" "unprognostic (3.78e-1)" "unprognostic (5.09e-2)" "unprognostic (7.80e-3)" "prognostic favorable (5.72e-4)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.48e-4)" "unprognostic (3.07e-2)" "unprognostic (6.43e-2)" "unprognostic (5.80e-2)" "unprognostic (7.99e-2)" "unprognostic (2.58e-2)" "unprognostic (2.10e-2)" "unprognostic (3.62e-2)" 1.7 0.9 0.3 2.3 0.6 1.9 2.6 0.9 0.9 1.3 0.7 0.0 3.9 2.8 1.8 2.5 0.8 0.7 1.8 0.8 0.5 1.2 0.4 1.3 3.3 1.7 0.2 2.6 7.3 0.0 0.0 0.6 0.8 1.5 0.0 0.4 5.9 4.2 3.4 0.1 1.6 0.6 0.7 3.0 1.2 0.4 1.0 0.2 0.6 2.5 0.8 3.0 2.3 6.1 2.6 1.3 1.9 4.5 7.4 6.4 1.7 0.7 0.5 1.1 0.5 0.0 4.4 0.2 1.0 0.0 0.6 0.0 1.3 0.4 4.4 0.0 0.3 1.8 0.3 0.5 0.0 1.4 0.9 0.8 0.9 3.3 0.4 1.2 2.3 0.5 0.8 0.3 0.0 0.1 0.3 0.4 0.2 1.3 0.0 0.9 1.5 7.5 1.9 0.2 0.4 1.7 0.5 1.0 0.6 2.2 1.4 2.7 0.3 2.7 6.6 0.2 1.7 7.8 0.9 1.1 2.1 1.4 4.0 2.6 1.8 1.5 1.4 1.2 0.2 1.3 1.4 0.7 3.2 1.9 4.6 6.1 5.7 3.5 2.6 5.8 7.4 7.0 0.4 4.5 1.4 2.4 3.6 6.4 8.9 8.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 30.7 1.8 0.0 0.0 36.5 1.4 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 2.8 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL162231.1 ENSG00000187186 9 34664163-34666112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 68.6" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 34.9;Distal tubular cells: 21.6;Proximal tubular cells: 30.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 28.3" "Low region specificity" "Detected in all" HPA069617 Enhanced Approved "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA Vesicles "Nucleoli, Endoplasmic reticulum" "HPA069617: AB_2686161" "unprognostic (8.20e-3)" "unprognostic (3.13e-1)" "unprognostic (1.17e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (6.63e-5)" "unprognostic (2.30e-1)" "unprognostic (2.46e-2)" "unprognostic (9.22e-2)" "unprognostic (2.11e-1)" "unprognostic (2.55e-2)" "unprognostic (5.99e-4)" "unprognostic (8.02e-2)" "unprognostic (1.39e-5)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (7.08e-3)" "unprognostic (2.00e-2)" 3.0 6.9 12.1 2.1 21.6 1.8 2.9 6.9 20.2 2.3 1.8 1.9 1.1 2.8 4.0 13.9 1.8 1.8 2.2 9.1 11.8 9.5 4.9 2.5 2.2 1.4 9.6 12.2 7.8 6.2 3.4 13.1 2.3 7.0 3.7 1.2 1.8 4.6 2.1 21.9 2.2 2.0 3.8 5.0 1.0 1.4 68.6 5.3 0.6 3.5 2.0 0.7 1.5 2.5 4.0 11.8 12.0 2.5 3.5 2.9 1.6 0.3 6.0 5.6 7.2 4.6 2.3 5.0 4.8 1.4 3.0 3.5 1.0 2.4 0.0 0.6 3.2 6.0 1.4 3.6 1.7 0.5 12.9 0.6 0.0 28.3 1.7 1.1 2.6 4.5 2.4 2.0 1.8 1.9 4.2 0.8 7.4 3.2 7.4 2.2 0.0 0.5 2.6 4.6 5.3 1.6 0.0 5.3 0.9 5.4 0.0 5.8 9.3 3.4 1.1 8.0 3.3 2.8 7.4 1.1 10.7 14.8 3.4 1.1 7.9 2.6 1.0 13.2 1.5 14.6 12.0 2.5 2.6 1.8 1.3 1.7 4.0 2.3 1.0 0.8 1.6 2.9 1.5 3.5 3.5 0.8 11.8 2.0 1.6 12.1 21.6 6.9 20.2 11.8 9.5 9.6 12.2 7.0 5.3 8.9 9.5 0.0 0.0 0.0 0.0 0.0 0.0 6.7 4.5 34.9 0.0 11.6 21.6 12.0 0.0 0.0 0.0 0.0 9.4 10.4 0.0 0.0 2.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 9.0 0.0 0.0 10.8 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 ALG14 MGC19780 ENSG00000172339 "ALG14, UDP-N-acetylglucosaminyltransferase subunit" Q96F25 1 94974407-95072945 "Disease related genes, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031829 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA031829: AB_2674062" "unprognostic (7.79e-2)" "unprognostic (3.59e-2)" "unprognostic (1.51e-3)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "unprognostic (6.56e-2)" "unprognostic (4.00e-1)" "unprognostic (2.17e-2)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "unprognostic (7.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (9.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.99e-2)" "unprognostic (1.93e-1)" 5.8 13.2 6.8 4.1 8.5 4.6 6.8 5.6 8.0 5.5 7.5 8.5 7.0 8.5 5.4 11.3 5.7 4.8 6.1 6.3 7.0 7.2 8.9 15.1 5.3 7.5 8.2 4.7 5.3 12.6 5.8 6.6 6.3 8.4 5.1 8.7 6.9 14.5 9.8 7.2 5.0 9.2 4.4 9.4 5.8 6.0 10.0 4.2 3.7 8.5 6.2 5.3 4.8 4.2 4.9 5.8 3.1 3.9 2.8 3.8 1.9 5.2 3.3 2.8 2.5 2.2 3.8 2.5 3.8 4.1 3.9 3.3 3.9 1.8 2.7 4.0 4.7 4.7 3.6 3.2 3.6 4.7 5.7 5.5 1.5 3.6 5.9 3.6 3.6 1.0 4.1 3.7 2.9 2.9 3.2 3.3 3.6 2.9 3.6 3.7 2.5 3.8 2.3 1.7 5.2 4.8 2.4 5.7 2.9 4.4 3.0 2.5 3.2 2.1 7.2 6.3 2.2 3.2 3.1 2.6 2.5 2.8 4.4 7.9 2.3 2.2 2.4 1.8 1.8 2.0 3.1 3.2 1.1 2.5 3.9 2.4 4.9 3.1 3.1 4.5 4.4 2.9 3.0 2.7 2.8 1.9 5.8 3.8 1.9 6.8 8.5 5.6 8.0 7.0 7.2 8.2 4.7 8.4 4.2 0.0 12.6 5.2 10.9 10.4 14.8 7.3 10.2 8.1 11.4 15.7 5.9 28.7 16.6 21.4 5.4 8.0 19.2 23.3 46.6 23.6 21.1 9.2 1.1 30.6 17.2 7.9 4.1 14.7 6.3 6.5 13.3 10.8 30.4 11.8 11.1 28.5 21.0 25.9 9.6 34.3 12.9 32.3 12.5 33.6 22.6 7.5 21.1 4.4 24.9 9.1 AMDHD2 CGI-14 ENSG00000162066 "Amidohydrolase domain containing 2" Q9Y303 16 2520357-2531422 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 104.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA041184, HPA041321" Enhanced Approved Nucleoli,Cytosol No No 69000 "Nucleoli, Cytosol" "HPA041184: AB_10803998, HPA041321: AB_10795588" "unprognostic (1.20e-1)" "prognostic favorable (5.19e-4)" "unprognostic (7.86e-3)" "unprognostic (2.39e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.48e-2)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-2)" "unprognostic (8.68e-2)" "unprognostic (1.30e-1)" "unprognostic (8.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" 12.8 16.9 8.6 11.4 10.1 12.7 10.9 7.3 16.0 9.4 8.8 11.1 11.3 19.5 10.4 11.9 8.4 9.0 14.6 11.8 7.1 4.8 15.3 10.5 20.0 15.8 9.8 11.3 8.1 10.1 6.5 7.5 10.7 8.9 8.6 2.4 10.9 16.1 9.6 10.2 15.0 19.1 7.2 8.3 22.2 11.5 25.7 7.9 7.3 9.9 11.0 8.9 9.3 8.0 9.8 17.1 16.6 15.8 4.9 8.1 4.8 6.5 8.8 1.9 4.0 2.1 1.7 14.3 5.9 2.5 4.7 5.9 6.3 11.6 3.0 4.2 1.1 10.1 6.0 1.1 1.6 0.1 3.8 5.3 4.3 7.9 8.2 8.0 3.1 14.1 4.0 1.7 3.4 0.5 1.2 2.9 8.5 9.8 7.2 1.9 15.6 5.1 8.6 4.1 0.5 6.8 19.7 3.0 11.0 1.3 3.6 7.3 7.2 3.8 9.2 15.5 0.3 9.5 0.8 4.0 5.3 8.1 10.5 3.0 15.2 9.7 5.9 5.9 5.9 6.6 9.9 6.1 16.5 7.4 15.8 5.5 9.8 5.9 5.3 2.3 7.4 5.0 4.2 16.6 4.9 15.2 17.1 8.1 4.8 8.6 10.1 7.3 16.0 7.1 4.8 9.8 11.3 8.9 7.9 3.0 12.3 13.1 4.6 7.9 9.0 2.0 7.6 5.3 2.3 5.2 5.9 14.1 5.0 24.6 45.6 7.1 18.1 0.0 14.7 23.4 8.0 6.0 6.9 10.4 104.3 22.3 12.1 18.4 33.6 16.0 9.8 15.9 18.6 34.3 9.0 10.8 16.8 14.4 6.0 38.1 12.0 0.0 4.4 7.7 17.2 7.9 23.3 15.3 7.0 3.8 ANAPC11 "APC11, Apc11p, HSPC214, MGC882" ENSG00000141552 "Anaphase promoting complex subunit 11" Q9NYG5 17 81890790-81900991 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 944.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA021989, HPA027838" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA021989: AB_1844915, HPA027838: AB_10600978" "unprognostic (9.00e-3)" "unprognostic (1.24e-2)" "unprognostic (3.76e-1)" "unprognostic (4.93e-2)" "unprognostic (8.76e-2)" "unprognostic (1.67e-1)" "unprognostic (5.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.65e-1)" "unprognostic (2.17e-3)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (8.07e-2)" "unprognostic (9.08e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-1)" 29.3 26.1 44.9 21.9 34.1 39.6 27.2 19.5 31.8 19.4 26.3 14.8 30.3 26.1 19.2 27.5 31.7 24.6 26.0 63.6 32.9 26.7 25.9 38.4 18.5 26.7 35.2 31.8 17.2 40.3 12.6 20.6 25.7 29.8 25.4 12.2 18.1 48.8 24.0 94.2 21.6 24.8 25.4 27.6 18.9 25.9 42.2 27.3 18.5 32.5 45.7 17.0 23.5 25.5 54.9 107.5 74.0 80.1 43.1 52.8 80.4 41.4 97.5 23.2 34.3 18.5 21.1 26.6 20.1 15.8 18.3 20.9 40.0 36.6 13.1 22.5 17.7 20.2 24.2 9.3 25.7 6.6 19.2 70.6 19.6 43.3 60.3 20.8 14.6 17.4 23.4 23.5 18.7 15.3 11.9 29.3 17.9 26.7 38.2 18.9 74.7 35.5 24.2 21.9 40.3 72.8 14.8 22.1 26.3 16.7 37.3 29.2 47.4 21.7 34.3 39.4 16.7 41.9 35.6 17.4 35.6 28.5 38.1 37.7 18.7 7.8 16.5 37.4 22.3 28.4 70.1 80.1 74.0 45.3 63.7 42.8 54.9 46.4 49.5 64.6 51.6 45.2 43.5 40.5 43.1 59.3 107.5 52.8 80.4 44.9 34.1 19.5 31.8 32.9 26.7 35.2 31.8 29.8 27.3 119.1 121.6 108.7 168.5 132.0 55.6 277.3 203.8 155.2 153.6 188.5 19.6 436.4 442.7 236.1 329.1 152.3 247.2 186.9 293.4 435.1 217.2 291.4 105.2 427.2 386.6 31.8 182.7 139.3 155.4 944.1 168.2 179.2 248.0 315.6 205.6 112.3 274.1 235.0 154.9 400.2 53.7 103.5 220.7 379.1 245.5 163.2 425.4 121.6 237.2 254.5 ANG "RAA1, RNASE5" ENSG00000214274 Angiogenin P03950 14 20684177-20698971 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Stress response" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 371.4" "Cell type enriched" "Detected in many" 21 "Hepatocytes: 4646.2" "Cancer enriched" "Detected in all" 17 "liver cancer: 279.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "classical monocyte: 18.1;myeloid DC: 10.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Hep G2: 52.5;OE19: 40.2" "Low region specificity" "Detected in many" HPA055896 Approved "Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments" "Secreted to blood" Yes No 308000000 230000000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "Actin filaments" "HPA055896: " "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.77e-2)" "prognostic favorable (6.85e-4)" "unprognostic (5.71e-3)" "unprognostic (6.99e-2)" "prognostic favorable (7.83e-5)" "unprognostic (1.16e-1)" "unprognostic (3.20e-3)" "unprognostic (9.19e-3)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (6.65e-2)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (2.00e-1)" "unprognostic (3.09e-1)" 17.0 0.9 0.7 2.6 0.7 0.7 16.4 0.5 0.7 14.4 9.0 0.7 6.6 3.5 10.7 10.3 8.0 3.8 13.3 3.8 0.8 0.7 10.6 371.4 6.9 2.3 1.0 0.1 17.7 9.0 1.3 1.1 1.9 0.8 17.5 6.5 5.5 20.2 7.7 3.5 4.0 7.4 9.7 1.5 1.5 7.9 7.1 0.4 0.0 4.2 5.5 3.6 14.3 15.0 4.5 10.4 0.3 18.1 0.0 0.9 4.8 1.3 3.4 0.8 0.0 8.6 10.3 0.1 1.4 3.0 0.4 1.4 2.0 1.8 0.1 0.4 4.2 2.9 1.3 0.9 1.0 0.4 5.8 1.3 0.3 1.9 52.5 1.8 1.3 0.1 8.3 0.8 0.5 1.8 4.3 2.0 1.5 0.0 9.6 1.2 0.2 0.2 0.4 0.2 40.2 3.8 0.2 1.3 3.9 0.8 1.0 0.0 0.1 1.5 0.6 2.3 1.9 1.4 0.2 1.7 0.5 1.0 0.5 0.2 2.0 1.6 0.2 1.1 0.6 1.6 0.0 18.1 0.0 0.3 2.1 0.2 4.5 0.9 0.8 10.4 2.4 0.2 0.2 0.3 0.0 0.1 1.6 0.4 4.8 0.7 0.7 0.5 0.6 0.8 0.7 1.0 0.1 0.8 0.4 26.8 12.4 18.0 36.0 24.2 0.0 0.6 219.1 60.2 18.2 10.4 0.0 1.5 10.0 27.6 0.7 12.2 37.1 23.3 27.7 3.3 31.0 52.1 0.0 4646.2 15.9 0.0 68.2 70.0 110.5 1.1 65.9 16.0 21.9 1.0 138.3 9.1 26.8 17.3 22.6 45.5 0.6 12.9 18.6 0.7 1.0 45.8 7.8 12.1 44.2 29.8 ANKRD18A "FLJ35740, KIAA2015" ENSG00000180071 "Ankyrin repeat domain 18A" Q8IVF6 9 38571358-38620660 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "bone marrow: 24.4;brain: 11.1;testis: 19.1" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 17.4;Muller glia cells: 13.3;Rod photoreceptor cells: 33.7;Spermatocytes: 25.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 16.6" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Supported "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.38e-2)" "unprognostic (1.26e-1)" "unprognostic (2.37e-1)" "unprognostic (4.34e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-2)" "unprognostic (1.94e-5)" "unprognostic (2.31e-2)" "unprognostic (1.63e-2)" "unprognostic (1.58e-2)" "unprognostic (7.03e-2)" "unprognostic (2.14e-1)" 0.5 0.7 1.4 0.8 9.1 24.4 1.1 0.4 4.1 1.0 2.1 8.5 2.4 0.9 0.7 1.1 1.4 1.2 2.7 1.1 3.0 2.2 1.5 1.2 1.5 0.8 4.8 2.3 0.4 4.1 2.5 3.2 0.7 8.7 1.6 1.5 0.4 0.9 3.9 0.4 2.4 1.5 0.7 11.1 0.5 2.0 19.1 6.9 0.0 3.8 0.0 0.5 0.7 0.8 0.4 0.0 1.1 0.0 0.1 1.7 0.1 4.5 3.5 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 1.9 0.0 0.0 0.9 3.4 3.2 0.0 0.0 4.8 0.0 4.8 2.8 0.0 16.6 0.4 0.0 2.3 0.0 3.1 1.7 0.0 7.0 1.6 0.3 0.3 4.3 0.1 0.8 3.6 5.8 2.0 0.0 6.3 6.3 2.1 1.9 1.5 3.0 2.3 0.5 0.1 7.4 2.5 7.9 4.3 0.0 1.3 0.1 0.0 0.3 0.5 0.0 0.0 0.0 2.0 0.0 0.0 1.1 0.5 0.0 0.7 0.0 1.3 0.8 0.0 0.4 0.7 1.7 0.5 0.1 0.0 0.0 1.0 0.1 1.4 9.1 0.4 4.1 3.0 2.2 4.8 2.3 8.7 6.9 0.0 1.0 0.0 1.8 0.6 3.9 6.5 0.0 17.4 5.7 1.8 2.0 0.0 1.7 4.4 4.9 0.0 0.7 0.0 2.0 0.1 0.0 2.0 0.0 0.5 0.1 0.0 4.1 0.0 0.0 1.3 0.6 0.0 0.0 0.0 3.6 13.3 3.7 2.9 0.4 0.1 33.7 0.0 0.1 25.6 2.0 1.5 0.0 0.0 2.3 0.7 ANKRD18B bA255A11.3 ENSG00000230453 "Ankyrin repeat domain 18B" A2A2Z9 9 33524394-33573009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.9;testis: 26.9" "Group enriched" "Detected in many" 6 "Ciliated cells: 16.0;Early spermatids: 23.8;Muller glia cells: 23.4;Spermatocytes: 37.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 20.8" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Approved "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.71e-2)" "unprognostic (1.85e-1)" "unprognostic (4.85e-3)" "unprognostic (1.00e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.29e-4)" "unprognostic (1.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.65e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-2)" "unprognostic (6.43e-5)" "unprognostic (4.89e-2)" "unprognostic (9.75e-4)" "unprognostic (8.25e-2)" "unprognostic (5.18e-2)" 1.5 0.9 4.3 0.1 0.4 0.2 1.3 12.9 3.9 0.3 0.2 0.2 0.1 0.0 0.5 1.0 2.1 1.0 0.9 0.3 2.1 1.3 0.1 0.4 0.7 0.1 1.0 1.4 0.1 0.1 0.1 1.6 1.3 2.6 2.0 0.3 0.2 0.2 0.1 1.4 5.5 0.2 0.1 1.0 0.9 0.0 26.9 0.1 0.1 0.9 1.6 0.7 1.2 1.1 0.5 0.8 0.1 0.2 0.0 0.8 0.1 7.5 8.5 0.7 0.2 0.3 1.4 0.7 1.6 1.7 2.1 2.3 1.6 0.2 0.2 0.4 0.2 2.3 1.7 4.6 1.6 2.9 0.1 4.6 8.2 9.9 3.1 0.0 2.7 0.6 1.1 4.5 2.9 7.6 0.9 3.9 0.0 4.5 2.1 2.6 1.3 0.2 20.8 7.3 0.3 3.7 0.0 10.5 1.5 1.2 1.8 0.2 7.3 3.5 0.4 0.6 6.8 6.0 10.1 3.9 1.7 7.6 3.5 3.0 1.2 0.8 0.1 0.8 0.1 1.2 0.0 0.1 0.1 0.3 0.1 0.7 0.4 0.2 0.6 0.0 0.5 0.4 0.8 0.1 0.0 0.2 0.8 0.1 0.1 4.3 0.4 12.9 3.9 2.1 1.3 1.0 1.4 2.6 0.1 0.0 0.0 0.0 4.4 1.8 2.6 2.4 2.5 16.0 3.4 1.8 0.0 0.0 0.0 0.6 23.8 0.0 0.3 0.0 0.4 0.2 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.6 0.6 0.1 0.0 0.0 1.6 23.4 0.3 1.4 0.7 0.0 4.3 0.0 0.0 37.6 1.7 2.9 0.0 0.0 1.0 3.5 ANKRD30A NY-BR-1 ENSG00000148513 "Ankyrin repeat domain 30A" Q9BXX3 10 37125788-37384111 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 38 "breast: 31.7;testis: 17.8" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 12.3;Late spermatids: 4.8;Spermatocytes: 23.6" "Cancer enriched" "Detected in single" 37 "breast cancer: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "A549: 3.9;U-266/70: 15.6" HPA071849 Uncertain Nucleoli NA NA Nucleoli "HPA071849: " "unprognostic (2.79e-1)" "unprognostic (2.81e-1)" "unprognostic (1.01e-7)" "unprognostic (1.41e-1)" "unprognostic (5.93e-1)" 0.6 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 23.6 1.7 0.0 0.2 0.0 0.0 0.0 ANKRD30B NY-BR-1.1 ENSG00000180777 "Ankyrin repeat domain 30B" Q9BXX2 18 14728272-14852738 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "testis: 42.2" "Group enriched" "Detected in some" 8 "Early spermatids: 10.7;Late spermatids: 11.2;Spermatocytes: 17.0" "Cancer enhanced" "Detected in single" "breast cancer: 2.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 31.8" "HPA060455, HPA071849" Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA060455: AB_2684282, HPA071849: " "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" "unprognostic (1.65e-1)" "unprognostic (1.86e-1)" "unprognostic (9.74e-2)" "unprognostic (2.84e-1)" "unprognostic (1.55e-9)" "unprognostic (1.38e-2)" "unprognostic (1.53e-1)" "unprognostic (7.98e-2)" 0.3 0.2 1.2 0.1 2.5 0.1 2.3 0.0 1.8 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.9 0.1 0.1 0.1 0.1 0.4 1.2 0.1 0.6 0.1 0.0 0.1 1.0 0.1 0.2 2.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 42.2 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.8 2.6 0.1 31.8 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.5 0.0 1.8 0.9 0.9 0.4 1.2 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.0 10.7 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.8 11.2 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.4 0.3 0.5 0.0 0.6 0.1 ANKRD49 "FGIF, FLJ20189, GBIF" ENSG00000168876 "Ankyrin repeat domain 49" Q8WVL7 11 94493629-94499583 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040273, HPA048137" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA040273: AB_10674991, HPA048137: AB_2680279" "unprognostic (1.52e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "unprognostic (5.22e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-3)" "unprognostic (1.46e-2)" "unprognostic (7.21e-3)" "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (4.21e-3)" "prognostic unfavorable (9.96e-4)" "unprognostic (6.32e-3)" "unprognostic (2.82e-1)" "unprognostic (3.40e-2)" "prognostic favorable (6.16e-4)" 9.8 9.0 10.2 10.7 10.8 19.6 12.7 18.6 10.9 15.6 14.8 4.5 9.5 11.2 15.1 19.6 13.2 8.2 7.9 5.7 9.5 6.9 13.3 11.0 10.4 17.5 7.2 8.5 12.3 15.6 9.1 27.9 16.3 7.7 12.6 13.1 7.7 12.1 10.7 7.9 8.8 19.2 9.6 12.5 21.3 12.1 5.3 8.5 22.6 18.0 9.9 19.2 11.9 9.3 20.5 17.7 34.7 15.1 17.3 19.6 10.5 6.4 2.9 7.6 6.5 7.5 9.6 9.2 10.2 9.1 10.7 12.7 14.2 12.7 17.0 15.7 7.2 9.3 14.1 9.2 6.9 8.6 13.3 7.4 14.7 11.4 4.8 8.6 12.9 11.8 6.7 17.4 8.2 11.5 7.9 8.4 15.1 13.9 10.1 7.0 4.4 13.7 23.4 4.4 12.2 7.3 11.1 8.5 8.5 10.1 6.8 7.5 7.8 7.0 7.0 6.3 14.2 14.2 8.7 5.2 9.7 6.8 10.6 5.1 5.9 13.6 18.1 3.2 15.6 5.5 34.7 15.1 12.6 14.9 12.5 16.3 20.5 15.9 13.1 11.4 19.6 19.6 17.9 27.1 17.3 9.3 17.7 19.1 10.5 10.2 10.8 18.6 10.9 9.5 6.9 7.2 8.5 7.7 8.5 11.9 9.4 31.8 9.7 4.9 15.9 5.3 17.8 8.1 17.0 24.4 13.7 25.3 18.3 16.9 4.4 13.5 27.1 46.7 20.0 13.5 13.3 9.6 19.8 16.6 12.2 11.1 12.9 16.0 28.9 1.5 33.1 17.8 10.1 13.6 20.3 20.2 18.8 30.3 22.3 12.6 14.5 25.8 11.8 22.3 18.8 5.9 23.5 35.0 21.1 5.1 ANKS6 "ANKRD14, FLJ36928, NPHP16, SAMD6" ENSG00000165138 "Ankyrin repeat and sterile alpha motif domain containing 6" Q68DC2 9 98731329-98796965 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA008355 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA008355: AB_2058277" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (9.31e-2)" "unprognostic (9.15e-3)" "unprognostic (6.90e-3)" "unprognostic (1.22e-1)" "unprognostic (4.29e-3)" "unprognostic (4.10e-2)" "unprognostic (1.48e-1)" "unprognostic (3.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.94e-2)" "prognostic favorable (3.44e-5)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (3.95e-2)" "unprognostic (2.68e-1)" 5.0 3.7 5.8 4.3 9.9 1.8 4.8 31.2 9.5 7.3 6.5 9.4 2.6 5.9 6.0 7.4 7.5 7.8 7.7 2.9 6.9 6.1 7.7 1.8 7.2 3.4 10.1 4.4 9.6 18.1 10.0 2.8 2.8 11.4 3.6 7.3 4.2 3.1 3.5 3.3 4.4 5.4 8.9 6.1 2.5 7.7 6.1 9.2 1.8 13.4 2.4 4.5 5.4 6.4 0.9 0.0 0.0 0.1 0.0 2.1 0.2 5.2 7.9 7.3 12.8 6.1 5.0 4.9 3.8 6.6 4.3 5.2 4.3 3.8 9.7 2.9 5.4 6.2 15.6 5.3 6.4 2.3 13.5 5.5 2.3 4.7 1.8 6.0 1.2 1.6 6.1 8.1 5.9 6.0 5.3 4.9 9.0 16.3 2.3 3.3 8.7 0.5 2.5 11.5 23.5 8.6 6.5 18.1 0.7 7.7 3.3 4.7 5.4 1.6 9.4 4.3 6.2 0.0 2.7 4.9 4.5 4.9 12.2 3.7 4.5 7.6 1.6 6.3 4.4 6.4 0.0 0.1 0.0 1.3 0.0 0.7 0.9 0.7 2.1 0.0 0.6 1.8 0.9 0.0 0.0 0.0 0.0 1.1 0.2 5.8 9.9 31.2 9.5 6.9 6.1 10.1 4.4 11.4 9.2 6.0 8.0 2.4 0.7 1.5 6.1 4.4 12.7 5.3 4.5 12.2 7.9 2.3 3.3 3.6 2.9 3.1 4.2 0.0 7.7 2.5 3.4 3.4 1.1 1.5 1.6 0.0 4.7 1.8 1.5 4.9 2.6 1.1 0.0 1.0 6.8 1.4 7.0 3.5 4.2 5.0 0.6 0.0 2.3 4.2 4.9 1.0 0.9 2.1 7.6 2.4 ANXA10 ANX14 ENSG00000109511 "Annexin A10" Q9UJ72 4 168092515-168187690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 33.5;stomach 1: 105.3" "Group enriched" "Detected in some" 14 "Exocrine glandular cells: 153.7;Hepatocytes: 62.3;Pancreatic endocrine cells: 198.3" "Group enriched" "Detected in many" 5 "pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "OE19: 72.5;PC-3: 32.8;RT4: 44.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA005469, HPA074650" Enhanced Approved Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Nucleoli" Vesicles "HPA005469: AB_1844849, HPA074650: " "unprognostic (2.29e-2)" "unprognostic (8.71e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (4.69e-1)" "unprognostic (2.29e-2)" "prognostic favorable (3.64e-6)" "unprognostic (1.18e-3)" "unprognostic (2.88e-1)" "unprognostic (8.61e-4)" "unprognostic (3.43e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-3)" "unprognostic (8.41e-2)" "unprognostic (4.01e-1)" "unprognostic (2.04e-1)" "unprognostic (8.89e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 1.4 0.1 4.2 0.1 0.1 0.5 0.0 33.5 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 1.5 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 105.3 0.1 0.1 0.1 0.1 0.1 0.1 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.5 32.8 0.0 0.1 0.0 0.0 44.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 10.2 0.0 2.3 0.0 2.0 0.0 0.0 3.5 7.3 0.0 0.0 0.0 153.7 0.0 0.0 0.6 0.0 62.3 0.0 0.0 0.0 1.3 2.7 0.0 0.0 0.0 0.0 1.0 0.4 0.0 198.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 AP002495.1 ENSG00000254469 "Putative short transient receptor potential channel 2-like protein " Q6ZNB5 11 71865509-71928654 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 2.7;Cytotrophoblasts: 4.7;Extravillous trophoblasts: 2.1;Hofbauer cells: 1.8;Syncytiotrophoblasts: 2.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA051121, HPA051124" Uncertain Enhanced "Nucleoli,Mitotic chromosome" NA NA Nucleoli "Mitotic chromosome" "HPA051121: AB_2681349, HPA051124: " "unprognostic (1.66e-1)" "unprognostic (1.19e-2)" "unprognostic (2.23e-1)" "unprognostic (1.73e-2)" "unprognostic (2.39e-1)" "unprognostic (2.42e-1)" "unprognostic (2.32e-3)" "unprognostic (9.79e-4)" "unprognostic (5.91e-3)" "unprognostic (5.04e-3)" "unprognostic (7.21e-2)" "unprognostic (2.23e-1)" "unprognostic (1.92e-2)" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (3.60e-1)" "unprognostic (3.12e-3)" 5.8 6.9 8.2 7.7 7.3 9.1 7.3 7.4 8.7 7.5 6.3 11.6 21.7 6.1 9.2 13.2 6.2 7.2 5.0 4.8 6.4 4.9 7.6 5.1 5.4 8.9 6.8 5.4 12.1 7.2 7.4 12.7 4.8 6.6 7.2 8.5 10.4 7.9 15.7 5.9 8.8 7.5 6.4 6.5 7.9 6.9 9.7 11.9 11.6 8.7 3.6 12.2 7.1 6.8 6.0 7.5 3.4 4.5 1.8 8.5 3.2 2.8 6.4 5.1 4.8 1.9 2.0 3.2 3.3 2.5 3.5 3.3 7.6 7.3 6.2 3.0 2.1 4.2 9.2 5.4 3.4 3.9 9.0 4.7 10.0 7.2 4.5 1.4 4.8 3.4 2.6 1.6 5.7 4.6 2.8 5.2 8.8 6.7 9.2 3.5 5.8 4.8 3.5 5.6 9.8 4.7 4.0 18.7 4.3 3.7 3.6 7.6 7.8 4.8 4.5 10.1 3.9 6.5 2.4 4.9 2.7 4.8 5.2 2.0 5.7 9.1 7.7 4.7 5.1 4.4 3.4 3.0 2.5 4.6 4.5 2.9 4.2 8.5 6.3 3.5 6.0 8.2 6.8 2.6 1.8 2.7 7.5 7.1 3.2 8.2 7.3 7.4 8.7 6.4 4.9 6.8 5.4 6.6 11.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 APOC3 ENSG00000110245 "Apolipoprotein C3" P02656 11 116829706-116833072 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 714.1" "Cell type enriched" "Detected in some" 60 "Hepatocytes: 64257.6" "Cancer enriched" "Detected in many" 643 "liver cancer: 4021.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "CACO-2: 28.5;Hep G2: 77.0" "Not detected" "Not detected" "HPA065365, HPA073918" Supported Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Secreted to blood" NA NA 106000000000 97000000000 Nucleoplasm "Nucleoli, Cell Junctions" "HPA065365: AB_2732733, HPA073918: " "prognostic favorable (3.77e-4)" "unprognostic (2.33e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.60e-2)" "unprognostic (5.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 38.7 0.1 0.1 31.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.4 714.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 91.3 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 28.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 77.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.3 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 100.1 0.0 0.0 0.0 0.0 858.6 0.0 0.0 0.0 0.0 0.0 3.3 0.0 3.8 0.0 0.0 1074.6 0.4 0.3 0.0 0.0 0.0 64257.6 1.0 0.0 0.0 825.6 1072.7 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 3.2 0.0 0.0 APTX "AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157" ENSG00000137074 Aprataxin Q7Z2E3 9 32972606-33025168 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064930 Supported Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA064930: AB_2685386" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (4.04e-1)" "unprognostic (8.16e-2)" "unprognostic (2.26e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-3)" "unprognostic (3.48e-3)" "unprognostic (3.49e-2)" "prognostic favorable (6.01e-5)" "unprognostic (7.87e-2)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.50e-2)" 12.9 20.3 17.5 11.2 18.4 19.9 16.5 15.1 21.7 12.0 15.2 19.3 9.3 11.7 14.7 12.9 19.1 14.7 8.0 11.9 13.3 13.9 17.9 23.4 12.6 11.8 16.4 16.5 11.8 14.3 15.8 14.3 12.1 20.2 12.1 18.1 14.6 12.5 11.9 14.1 20.6 13.8 14.6 15.7 11.7 12.5 18.2 14.5 8.8 10.5 12.6 16.1 13.4 12.1 17.1 18.4 16.1 20.8 26.4 19.4 15.0 21.6 16.4 12.5 10.8 12.8 11.2 16.6 14.5 15.1 17.7 19.6 21.8 7.7 16.9 8.7 12.1 11.0 11.5 20.3 19.4 22.0 22.8 8.3 10.0 23.5 22.2 14.8 16.1 9.6 15.0 23.8 20.3 26.4 11.3 16.9 13.1 15.1 16.9 16.5 9.3 14.4 23.7 19.1 14.2 17.7 13.1 8.7 12.0 14.5 13.2 8.7 7.3 13.3 11.9 9.7 12.1 13.5 6.6 10.4 9.9 13.2 17.1 14.9 7.3 12.0 16.9 14.7 13.2 7.9 9.1 17.7 14.9 13.4 16.3 17.6 17.0 15.2 15.5 18.4 17.1 18.0 14.6 16.1 26.4 20.8 17.9 19.4 15.0 17.5 18.4 15.1 21.7 13.3 13.9 16.4 16.5 20.2 14.5 17.9 31.9 15.7 18.7 14.8 13.6 12.9 28.1 25.4 19.4 8.7 9.8 23.7 24.9 20.4 49.1 11.9 11.6 0.0 24.6 22.8 12.6 16.4 16.1 17.4 16.5 12.7 16.1 6.7 15.2 35.4 12.4 14.5 13.5 20.8 12.6 17.8 24.5 3.5 9.9 24.1 16.2 12.9 12.2 35.9 27.0 18.4 23.3 14.1 15.1 20.4 ARHGAP11A KIAA0013 ENSG00000198826 "Rho GTPase activating protein 11A" Q6P4F7 15 32615144-32639949 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.4;lymphoid tissue: 35.0" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 20.0;Spermatocytes: 24.4;Spermatogonia: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040830, HPA066481" Enhanced Approved Nucleoli,Cytosol No Yes Cytosol Nucleoli "HPA040830: AB_10805830, HPA066481: " "unprognostic (5.00e-2)" "unprognostic (5.57e-2)" "unprognostic (6.10e-2)" "unprognostic (1.97e-1)" "unprognostic (2.93e-1)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.05e-4)" "prognostic unfavorable (8.69e-4)" "unprognostic (4.87e-2)" "unprognostic (7.71e-2)" "prognostic unfavorable (2.92e-5)" "unprognostic (3.43e-2)" "unprognostic (1.07e-12)" "unprognostic (7.37e-2)" "unprognostic (5.23e-1)" "unprognostic (1.54e-2)" "unprognostic (9.64e-2)" 1.9 1.5 2.0 17.2 2.9 16.4 3.3 1.1 3.9 1.6 5.4 1.6 0.5 4.3 2.3 0.5 7.5 0.5 4.1 1.4 2.2 1.9 0.8 1.2 2.0 9.4 4.4 0.8 0.8 3.1 0.9 1.0 4.7 2.0 1.2 6.7 0.8 2.0 0.5 1.7 3.2 9.6 3.3 8.9 5.0 2.6 6.4 1.9 35.0 1.0 5.3 10.3 2.6 2.7 0.9 1.7 2.6 1.8 0.5 3.8 1.1 23.5 25.4 20.3 13.4 1.4 3.8 12.2 23.9 13.8 22.8 17.6 17.5 12.0 13.7 7.6 14.0 26.1 17.5 14.3 12.5 30.8 26.9 8.3 43.4 22.9 8.9 0.5 32.3 17.4 1.2 1.5 18.3 14.5 4.3 16.8 27.0 30.0 32.6 26.4 9.6 16.9 10.8 12.7 19.7 14.9 20.1 45.5 10.7 8.1 12.5 19.6 13.5 25.1 13.0 5.4 11.0 18.5 31.0 12.9 30.8 22.8 12.9 25.4 11.9 18.8 37.8 13.2 38.4 26.9 0.1 1.1 2.6 2.3 1.8 0.9 0.9 3.8 3.3 1.7 0.7 1.5 2.0 0.0 0.5 0.3 0.6 2.8 1.1 2.0 2.9 1.1 3.9 2.2 1.9 4.4 0.8 2.0 1.9 0.0 2.9 1.5 0.9 4.2 0.0 0.8 5.1 1.4 2.3 1.8 0.0 2.5 0.0 0.8 2.9 1.1 0.5 0.0 0.7 20.0 1.1 1.0 0.0 1.0 8.0 0.0 0.0 2.5 4.1 3.4 0.6 3.2 0.0 3.6 3.7 0.0 0.5 1.1 0.4 0.2 0.9 6.5 0.9 24.4 18.6 1.9 2.6 3.2 5.1 1.4 ARID5A "MRF-1, RP11-363D14" ENSG00000196843 "AT-rich interaction domain 5A" Q03989 2 96536743-96552638 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Smooth muscle cells: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "HDLM-2: 73.1;RPMI-8226: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002860, HPA023879" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA002860: , HPA023879: AB_1845014" "prognostic favorable (2.05e-6)" "unprognostic (1.08e-3)" "unprognostic (1.69e-2)" "unprognostic (3.89e-3)" "unprognostic (1.90e-2)" "unprognostic (3.38e-2)" "unprognostic (3.03e-1)" "unprognostic (1.17e-1)" "unprognostic (1.24e-3)" "unprognostic (2.46e-1)" "unprognostic (1.56e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.24e-8)" "unprognostic (2.74e-2)" "unprognostic (9.79e-2)" "unprognostic (1.06e-1)" "unprognostic (5.13e-2)" 20.1 4.1 6.8 24.5 8.7 14.6 26.2 3.1 8.8 10.5 14.6 4.9 4.1 7.2 17.5 16.1 9.1 11.5 16.8 17.8 7.0 5.5 5.4 7.2 26.0 29.0 10.7 3.1 11.4 9.8 3.8 6.6 13.0 17.4 14.7 3.7 11.4 8.2 5.1 26.1 7.3 12.3 33.1 13.6 14.9 10.1 5.4 6.2 12.4 8.2 7.7 15.7 19.5 12.0 5.2 12.8 21.4 5.3 17.7 11.5 8.8 0.8 0.3 0.4 1.5 0.8 0.9 2.2 1.4 4.9 1.7 1.5 0.8 0.2 0.2 1.0 0.8 2.6 1.3 0.4 0.0 0.5 73.1 1.1 1.8 0.3 1.7 1.0 1.2 1.4 0.6 1.6 1.4 0.2 1.5 1.5 2.2 1.5 11.1 0.6 0.8 2.4 4.3 0.9 0.4 0.0 3.3 3.0 32.2 0.2 0.7 0.6 0.3 0.1 0.1 1.1 0.4 0.0 2.7 1.4 1.5 1.9 1.7 1.2 6.8 5.3 0.9 0.8 3.0 1.4 7.2 5.3 21.4 11.5 4.8 11.1 4.4 9.7 10.7 7.1 5.2 10.8 10.5 15.3 17.7 3.3 12.8 11.0 8.8 6.8 8.7 3.1 8.8 7.0 5.5 10.7 3.1 17.4 6.2 3.0 28.9 11.8 34.4 46.5 17.4 12.2 5.1 10.7 11.4 3.5 29.5 3.6 3.3 29.9 14.9 43.6 3.2 0.0 27.0 7.0 17.5 22.9 58.0 22.2 62.8 0.0 0.0 22.1 29.8 23.3 3.4 64.4 55.6 95.6 5.4 6.2 24.8 5.3 6.0 5.0 24.7 45.3 294.5 2.7 17.6 28.4 3.3 91.4 2.6 17.8 ARL2 ARFL2 ENSG00000213465 "ADP ribosylation factor like GTPase 2" P36404 11 65014113-65022184 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 847.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044610 Supported Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol" NA NA Nucleoplasm "Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol" "HPA044610: AB_10964207" "unprognostic (9.23e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (4.58e-4)" "unprognostic (1.61e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-3)" "unprognostic (2.34e-1)" "unprognostic (9.85e-3)" "unprognostic (6.43e-2)" "unprognostic (6.87e-3)" "prognostic favorable (7.70e-4)" "unprognostic (2.15e-2)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (1.24e-2)" 39.6 32.0 37.3 17.7 78.7 19.8 26.8 16.1 46.5 21.2 23.5 34.7 13.4 23.9 26.8 20.2 23.7 35.2 22.4 52.6 34.8 32.7 33.8 6.6 23.1 14.8 36.1 38.2 27.2 29.9 22.5 15.4 25.5 32.7 25.3 15.5 30.3 26.9 33.1 78.3 19.6 23.4 28.2 44.9 16.7 18.9 31.4 28.7 7.9 26.3 23.6 12.9 24.7 22.8 43.7 37.8 18.7 21.8 21.0 40.7 34.7 36.1 57.7 17.9 26.4 48.6 36.9 16.3 17.8 41.3 25.6 25.3 16.3 25.0 14.0 34.1 25.1 39.0 23.3 18.8 31.4 12.2 14.6 29.5 14.1 26.0 24.6 37.2 17.1 12.8 29.0 26.3 21.3 47.8 37.4 34.0 16.9 33.2 26.1 17.2 42.8 14.1 38.5 28.0 17.2 47.1 7.5 19.6 33.6 27.5 15.8 33.3 18.8 15.3 15.9 50.2 17.6 16.6 21.0 25.6 48.3 16.3 38.3 18.4 9.0 12.6 8.6 22.8 24.7 39.2 10.2 21.8 18.7 34.8 21.2 37.6 43.7 32.2 33.6 27.6 37.3 36.8 40.7 2.8 21.0 12.4 37.8 20.6 34.7 37.3 78.7 16.1 46.5 34.8 32.7 36.1 38.2 32.7 28.7 20.8 35.8 37.0 78.1 72.4 72.3 89.8 50.9 32.1 52.4 78.5 27.5 165.9 227.1 118.2 362.1 147.4 126.8 46.7 66.9 164.2 116.5 55.8 93.5 17.1 87.0 65.2 80.0 119.1 47.3 847.8 66.4 70.8 168.7 138.9 56.4 119.5 81.6 95.1 66.8 340.4 40.2 64.7 111.8 98.4 65.3 72.4 89.7 39.2 87.9 60.9 ARL9 ENSG00000196503 "ADP ribosylation factor like GTPase 9" Q6T311 4 56505209-56525481 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.7;testis: 12.6" "Group enriched" "Detected in some" 11 "Early spermatids: 81.2;Late spermatids: 192.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 4.4;REH: 8.7;SCLC-21H: 9.2" "Low region specificity" "Detected in all" HPA072942 Enhanced Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA072942: AB_2686561" "unprognostic (9.91e-2)" "unprognostic (2.19e-1)" "unprognostic (2.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.24e-3)" "unprognostic (6.86e-3)" "unprognostic (3.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (4.46e-2)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (6.79e-6)" "unprognostic (1.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" 1.3 1.1 4.4 0.8 4.9 3.4 2.0 1.5 7.1 1.3 1.3 0.6 2.4 1.0 2.0 1.1 1.1 1.2 2.4 0.8 3.9 3.2 0.5 0.5 0.6 1.0 1.3 2.9 3.0 0.4 0.4 1.6 0.3 8.7 2.2 1.0 1.9 0.9 3.8 0.4 4.1 1.0 3.7 2.5 0.8 1.0 12.6 0.6 0.1 1.1 1.2 0.7 1.5 2.5 2.1 2.2 1.6 0.4 1.4 1.4 0.1 0.0 0.5 0.6 0.5 1.2 2.9 0.1 0.9 0.5 2.1 2.1 0.5 0.7 0.7 0.0 1.5 0.1 0.2 0.4 0.2 1.2 0.1 0.1 0.3 0.0 0.1 2.8 0.3 0.7 4.4 0.7 1.9 0.4 0.4 2.1 0.2 0.2 0.9 2.0 0.0 0.3 0.1 2.2 0.1 1.3 8.7 0.0 0.1 0.1 0.3 9.2 0.1 0.3 0.4 0.2 0.2 0.2 0.1 0.4 0.3 0.4 0.0 0.1 0.4 0.4 0.4 0.1 0.0 0.3 0.8 0.4 0.4 0.7 0.4 0.4 1.0 1.2 1.0 0.3 2.1 1.4 0.6 1.6 1.4 0.4 2.2 1.0 0.1 4.4 4.9 1.5 7.1 3.9 3.2 1.3 2.9 8.7 0.6 0.0 1.4 0.0 0.8 5.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.4 81.2 0.2 0.0 0.0 0.2 0.1 1.2 0.7 0.0 0.0 0.1 0.0 0.0 0.6 0.3 192.4 1.4 0.0 5.0 0.0 0.3 1.0 0.6 0.0 1.1 0.3 0.0 0.0 0.2 12.2 0.9 1.4 0.0 0.0 0.4 0.3 ARNTL2 "bHLHe6, BMAL2, CLIF, MOP9, PASD9" ENSG00000029153 "Aryl hydrocarbon receptor nuclear translocator like 2" Q8WYA1 12 27332854-27425289 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.0" "Cell type enhanced" "Detected in many" 15 "Glandular cells: 33.6;Pancreatic endocrine cells: 57.8;Urothelial cells: 126.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 35.3;U-2197: 48.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059074 Uncertain Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA059074: AB_2683897" "unprognostic (6.86e-2)" "unprognostic (6.16e-2)" "unprognostic (5.88e-3)" "unprognostic (1.01e-2)" "unprognostic (3.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.84e-3)" "unprognostic (2.97e-3)" "unprognostic (1.49e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (5.29e-6)" "unprognostic (5.26e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (7.81e-3)" "unprognostic (2.77e-1)" "unprognostic (1.21e-1)" "unprognostic (2.79e-1)" 3.5 1.3 5.7 9.8 5.9 2.2 3.3 3.6 10.6 6.8 3.1 1.1 0.0 2.9 1.5 0.5 30.0 1.5 3.9 1.9 9.1 2.8 1.6 10.3 2.7 5.0 2.1 6.8 0.9 2.3 2.4 1.5 14.7 2.6 1.9 3.5 0.0 9.2 0.9 1.0 7.7 2.8 4.7 2.0 1.2 10.9 2.8 1.3 3.8 1.2 15.4 21.1 5.9 12.5 0.6 1.4 4.5 0.5 0.5 1.5 0.2 21.9 5.6 1.2 0.4 1.1 3.4 17.7 7.8 10.3 5.1 8.0 5.3 17.1 0.2 4.4 3.7 15.8 9.1 3.6 27.4 13.1 35.3 4.7 4.2 3.7 4.4 1.5 8.5 1.8 1.2 2.4 17.8 14.0 8.8 23.9 5.3 2.1 9.0 5.8 2.6 4.6 4.6 9.7 7.5 19.7 8.6 20.7 1.3 4.3 12.6 4.1 0.7 4.0 0.6 0.1 3.1 0.8 2.8 16.2 16.6 9.6 48.3 32.2 1.3 2.4 0.0 14.3 6.9 3.2 4.5 0.5 0.5 0.2 0.3 0.2 0.5 0.2 0.2 1.4 0.6 0.2 0.3 2.4 0.5 0.2 0.3 1.5 0.2 5.7 5.9 3.6 10.6 9.1 2.8 2.1 6.8 2.6 1.3 3.0 2.2 0.0 32.7 0.7 1.1 0.8 17.8 0.0 7.9 8.7 0.0 1.3 0.0 22.0 3.3 4.2 0.7 0.0 23.8 3.5 2.3 33.6 0.0 4.2 1.3 0.0 1.2 3.1 2.8 3.0 0.0 5.0 1.7 26.2 2.7 0.0 57.8 0.0 0.0 0.6 0.0 0.0 2.1 3.4 4.9 1.9 3.5 0.0 0.6 126.8 ARPP21 "ARPP-21, R3HDM3, TARPP" ENSG00000172995 "CAMP regulated phosphoprotein 21" Q9UBL0 3 35638945-35794496 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 146.9;lymphoid tissue: 41.2;skeletal muscle: 43.6" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 2.8;Cardiomyocytes: 3.4;Early spermatids: 1.6;Late spermatids: 2.2" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Region enriched" "Detected in all" 5 "basal ganglia: 146.9" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 12.1" "Lineage enriched" "Detected in single" 30 "dendritic cells: 12.1" "Cell line enhanced" "Detected in some" "JURKAT: 46.2;MOLT-4: 27.1;REH: 15.0;RH-30: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017303 Enhanced Supported Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA017303: AB_1845049" "unprognostic (1.72e-4)" "unprognostic (2.35e-1)" "unprognostic (1.10e-2)" "unprognostic (6.61e-2)" "unprognostic (6.30e-3)" "unprognostic (8.90e-2)" "unprognostic (2.42e-3)" "unprognostic (1.27e-1)" "unprognostic (7.42e-4)" "unprognostic (1.32e-1)" "unprognostic (2.35e-1)" "unprognostic (1.52e-1)" 1.2 1.3 12.3 1.5 146.9 4.6 1.1 27.8 67.9 1.1 1.4 0.3 0.0 1.3 1.1 1.1 3.2 1.1 1.1 1.1 6.8 2.8 2.0 2.9 1.2 1.2 3.9 11.5 1.1 1.1 1.1 1.9 1.1 6.7 2.0 1.5 0.0 1.1 1.3 43.6 1.1 1.4 1.1 0.8 1.2 1.1 1.1 14.8 41.2 1.5 3.5 1.5 1.1 0.1 0.1 12.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.2 0.0 46.2 0.0 0.1 1.1 0.0 27.1 0.0 0.0 0.0 1.1 15.0 8.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 12.1 0.0 0.0 12.3 146.9 27.8 14.7 6.8 2.8 3.9 11.5 6.7 14.8 0.0 0.0 0.0 0.0 0.0 2.8 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 ASNA1 "ARSA-I, GET3, TRC40" ENSG00000198356 "ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)" O43681 19 12737139-12748323 "Predicted intracellular proteins, Transporters" Transport Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045951, HPA048087" Approved Enhanced Nucleoplasm,Nucleoli NA NA 52000 Nucleoli Nucleoplasm "HPA045951: AB_2679511, HPA048087: AB_2680258" "unprognostic (2.87e-1)" "prognostic favorable (9.53e-4)" "unprognostic (1.01e-1)" "unprognostic (2.16e-1)" "unprognostic (2.05e-2)" "unprognostic (5.70e-2)" "unprognostic (2.01e-2)" "unprognostic (1.33e-2)" "unprognostic (3.34e-1)" "unprognostic (3.08e-2)" "unprognostic (1.85e-1)" "unprognostic (4.39e-2)" "prognostic favorable (4.27e-5)" "unprognostic (6.11e-2)" "unprognostic (5.77e-2)" "unprognostic (2.32e-3)" "prognostic unfavorable (8.47e-4)" 22.3 33.9 32.3 23.1 32.8 35.1 22.2 28.2 51.9 23.5 27.2 26.1 23.6 24.7 24.8 30.3 33.3 30.7 28.9 48.0 30.5 27.9 46.9 28.5 21.2 26.6 29.2 26.5 24.2 30.3 23.8 25.2 32.0 27.3 21.8 18.3 30.9 26.7 21.5 35.7 28.9 24.7 21.3 24.5 26.5 24.2 30.9 18.5 25.8 40.7 28.0 23.5 28.7 20.6 12.5 27.1 16.0 26.9 9.3 20.2 19.4 33.6 27.8 14.9 32.1 29.7 18.3 18.4 17.5 24.2 34.0 26.8 21.7 16.8 15.5 27.4 22.7 39.0 18.1 20.6 23.4 16.3 23.8 32.3 13.4 21.0 24.6 31.8 19.8 26.1 21.1 20.6 27.4 16.3 22.0 24.0 18.4 16.6 21.1 26.5 75.3 26.1 15.9 37.7 21.7 52.4 19.4 23.2 30.3 31.7 28.8 27.7 23.5 23.7 31.9 28.0 13.3 26.3 19.1 20.4 48.1 16.3 53.2 40.6 38.0 63.9 14.3 33.7 32.4 26.4 16.0 26.9 15.0 16.1 20.4 13.7 12.5 14.4 14.2 27.1 10.6 10.4 12.8 9.6 9.3 23.7 17.8 20.2 19.4 32.3 32.8 28.2 51.9 30.5 27.9 29.2 26.5 27.3 18.5 3.0 6.5 44.7 52.5 61.4 33.5 7.4 66.2 9.4 5.7 52.4 15.7 89.1 112.7 135.7 88.0 42.9 87.6 46.7 116.1 66.8 58.1 46.3 34.5 24.5 125.2 27.0 53.9 36.8 50.0 143.9 44.5 54.1 77.6 138.9 56.6 59.9 93.6 94.7 53.0 177.7 23.1 32.3 54.5 52.9 128.0 69.5 92.6 59.8 57.4 54.0 ASXL1 KIAA0978 ENSG00000171456 "Additional sex combs like 1, transcriptional regulator" Q8IXJ9 20 32358330-32439319 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor" "Cancer-related genes, Craniosynostosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064156 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA064156: AB_2685200" "unprognostic (1.49e-1)" "unprognostic (5.97e-2)" "unprognostic (8.36e-2)" "prognostic unfavorable (2.86e-4)" "unprognostic (6.69e-2)" "prognostic favorable (9.16e-4)" "unprognostic (2.01e-3)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (1.38e-1)" "unprognostic (4.32e-2)" "unprognostic (3.21e-2)" "unprognostic (1.84e-3)" "unprognostic (5.47e-2)" "unprognostic (1.90e-1)" "unprognostic (4.82e-2)" "unprognostic (1.06e-1)" 24.3 19.6 19.0 35.0 18.2 39.0 24.7 28.3 23.8 32.4 22.7 17.7 16.9 15.6 32.4 22.2 14.3 20.5 21.6 17.9 19.7 10.7 21.2 25.2 27.3 26.7 20.3 14.7 28.1 27.1 21.2 16.3 19.8 18.2 20.6 16.4 16.6 17.4 23.3 25.5 18.2 21.8 21.8 12.2 28.2 19.7 32.1 23.0 47.4 26.8 15.8 29.0 23.2 35.3 9.8 3.1 1.3 0.8 1.7 14.6 1.9 22.9 13.3 20.9 11.6 9.6 12.0 18.2 15.4 13.2 26.9 19.9 39.6 14.8 21.7 9.9 19.0 25.6 16.0 17.6 14.8 22.0 32.5 9.6 34.6 21.1 21.6 8.6 14.4 14.4 13.3 9.9 18.7 14.1 13.3 14.8 17.9 16.7 11.8 12.5 7.0 19.7 11.6 5.0 10.7 15.4 11.5 25.1 9.4 11.0 11.1 9.6 15.1 27.9 9.3 12.2 11.6 13.3 10.2 15.3 28.6 25.0 13.2 17.1 13.8 14.7 16.0 14.5 38.4 10.9 0.0 0.8 1.3 4.4 0.7 3.5 9.8 5.2 5.6 0.7 5.8 5.8 5.9 0.9 1.7 0.7 3.1 14.6 1.9 19.0 18.2 28.3 23.8 19.7 10.7 20.3 14.7 18.2 23.0 47.6 38.1 41.7 41.8 35.5 18.7 18.5 15.3 21.4 25.0 26.2 49.1 16.2 21.6 12.4 73.4 61.8 21.2 0.0 10.8 12.8 37.0 40.7 17.4 29.3 18.3 17.5 6.9 34.4 16.8 61.5 23.6 23.6 74.2 10.0 12.1 12.6 14.1 11.5 13.8 22.1 30.4 6.5 44.0 25.6 13.5 26.7 4.9 41.5 15.5 32.6 ATF3 ENSG00000162772 "Activating transcription factor 3" P18847 1 212565334-212620777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 138.4" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 644.1;Intestinal endocrine cells: 855.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 6.1;intermediate monocyte: 5.5;myeloid DC: 2.2;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 12 "dendritic cells: 2.2;granulocytes: 6.1;monocytes: 8.1" "Cell line enhanced" "Detected in many" "BEWO: 39.9;SuSa: 49.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA001562 Approved Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA001562: AB_1078233" "unprognostic (2.66e-2)" "unprognostic (1.52e-2)" "unprognostic (2.80e-1)" "unprognostic (4.27e-3)" "unprognostic (3.29e-1)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" "unprognostic (9.31e-2)" "unprognostic (8.65e-3)" "unprognostic (8.75e-2)" "unprognostic (1.52e-1)" "unprognostic (6.97e-2)" "unprognostic (3.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-2)" "unprognostic (2.08e-2)" 41.5 21.5 9.5 41.0 7.1 9.4 30.2 3.0 8.0 30.0 16.2 15.3 36.4 5.0 34.9 28.6 31.4 38.1 33.4 31.8 6.5 6.9 19.4 36.1 42.8 4.6 13.5 6.5 23.1 16.0 15.1 12.4 65.1 9.4 30.4 15.0 8.1 12.1 138.4 13.2 39.5 11.4 76.1 13.0 5.4 31.6 10.7 12.4 1.5 45.5 37.3 7.4 38.3 33.8 0.3 2.2 6.1 8.1 0.0 0.4 0.8 6.1 0.3 12.3 2.6 1.2 3.2 39.9 4.4 3.5 3.8 9.1 8.1 4.6 0.1 2.0 0.2 20.8 3.4 7.3 1.1 6.3 29.1 7.1 0.4 3.6 2.9 22.6 2.6 6.9 5.5 19.8 10.6 24.7 0.7 0.7 7.1 2.8 23.2 0.5 0.8 7.9 1.6 8.8 3.3 2.6 2.3 8.2 5.2 0.5 0.9 5.5 5.6 5.7 10.3 17.3 49.4 6.0 1.9 0.7 1.1 5.9 3.7 2.0 18.3 7.7 2.1 3.6 1.4 3.2 6.1 0.9 0.0 0.4 5.5 0.4 0.1 0.1 0.0 2.2 0.3 0.0 0.0 0.3 0.0 8.1 1.1 0.0 0.8 9.5 7.1 3.0 8.0 6.5 6.9 13.5 6.5 9.4 12.4 393.1 144.2 7.7 234.8 180.1 3.7 604.8 73.9 128.5 135.4 52.4 0.0 136.7 1.7 158.3 2.8 136.2 500.9 0.0 108.1 256.8 236.1 644.1 77.3 21.2 99.6 1.6 855.0 28.8 13.4 2.5 16.1 211.8 165.4 55.1 427.3 12.1 155.6 312.1 1.1 1.2 2.5 97.0 421.2 0.3 2.1 177.2 351.7 6.9 216.0 169.1 ATF6B "CREBL1, G13" ENSG00000213676 "Activating transcription factor 6 beta" Q99941 6 32115264-32128253 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046871 Uncertain Approved Nucleoplasm,Nucleoli NA NA 31000000 Nucleoplasm Nucleoli "HPA046871: AB_10963542" "unprognostic (2.93e-3)" "unprognostic (1.56e-1)" "unprognostic (5.50e-2)" "unprognostic (1.82e-2)" "unprognostic (1.13e-1)" "unprognostic (4.37e-2)" "unprognostic (9.80e-3)" "unprognostic (1.55e-1)" "unprognostic (3.15e-1)" "unprognostic (3.68e-2)" "unprognostic (9.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.04e-3)" "unprognostic (1.75e-2)" "unprognostic (1.76e-1)" "unprognostic (3.86e-1)" "unprognostic (1.10e-2)" 11.7 19.4 23.1 13.7 29.4 24.9 14.3 20.2 19.1 17.8 20.2 15.4 9.8 11.2 19.2 32.7 20.0 27.7 15.4 11.0 19.4 11.4 13.5 14.0 15.6 17.0 20.6 16.5 22.6 18.4 38.1 16.1 21.1 16.9 16.8 18.8 14.1 16.2 14.0 7.1 17.8 15.9 9.4 12.8 22.8 20.2 19.5 17.0 21.7 21.2 11.8 21.0 18.0 16.4 4.4 5.7 6.6 4.1 5.6 4.9 4.4 0.7 2.9 8.1 3.0 6.0 6.8 2.9 3.3 3.1 7.3 9.1 9.4 15.7 14.3 11.5 29.1 10.5 4.6 10.9 21.8 5.3 2.9 12.0 1.0 15.1 10.0 19.9 1.1 17.4 11.4 9.7 1.3 20.2 18.4 19.7 26.9 18.9 19.0 18.5 7.4 10.0 7.0 2.4 14.0 0.5 0.7 3.5 6.4 6.5 1.4 0.5 0.8 14.2 7.7 19.2 3.7 24.2 1.8 8.5 4.0 4.4 6.4 9.8 19.1 8.2 6.7 9.2 6.6 9.8 6.6 2.2 1.9 4.9 4.1 4.7 4.4 2.8 2.3 5.7 3.4 1.8 3.5 2.5 5.6 3.7 3.8 4.5 4.4 23.1 29.4 20.2 19.1 19.4 11.4 20.6 16.5 16.9 17.0 11.9 14.6 95.8 29.3 22.0 84.7 1.7 45.9 28.1 10.3 52.4 90.3 71.4 5.0 39.2 2.4 30.3 49.8 0.0 37.3 41.1 28.7 30.1 16.1 18.3 46.0 41.3 51.5 37.4 39.0 3.2 65.6 45.4 30.4 53.3 48.7 43.1 31.4 49.1 48.8 11.3 83.5 58.2 28.4 71.1 55.1 22.1 74.6 74.8 52.7 35.4 ATG10 "APG10L, DKFZP586I0418, FLJ13954" ENSG00000152348 "Autophagy related 10" Q9H0Y0 5 81972025-82276857 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044163 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA044163: AB_2678842" "unprognostic (1.20e-1)" "unprognostic (7.96e-2)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" "unprognostic (3.18e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (3.22e-5)" "unprognostic (5.60e-3)" "unprognostic (2.96e-2)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.21e-1)" "unprognostic (9.62e-2)" "unprognostic (1.67e-1)" "unprognostic (2.10e-1)" "unprognostic (1.30e-3)" "unprognostic (4.43e-1)" 8.2 9.2 8.4 6.3 13.6 8.4 11.7 11.3 15.4 7.2 8.9 14.7 7.5 5.5 12.0 13.7 10.9 7.2 7.3 8.0 8.4 7.9 9.3 10.4 7.1 8.3 10.3 13.5 5.8 9.9 23.0 9.5 7.9 11.3 9.6 10.2 12.4 8.6 9.6 10.3 10.9 6.0 9.1 10.4 6.7 7.1 27.0 8.9 22.8 11.7 4.6 9.9 9.2 8.2 7.6 11.4 12.2 9.3 9.2 8.9 6.0 3.4 9.2 6.0 17.0 4.0 7.7 15.3 4.0 3.2 2.9 4.5 2.7 12.5 6.0 3.4 6.4 22.4 2.0 4.3 8.9 3.9 10.2 3.1 6.6 8.7 2.8 3.9 3.4 5.5 7.1 6.1 4.3 3.6 4.5 5.5 13.0 7.9 5.2 10.6 6.9 7.8 4.0 8.5 2.5 6.0 5.9 8.6 14.4 7.5 4.8 8.9 12.8 6.5 3.6 7.4 10.7 7.0 6.5 4.3 5.6 5.2 2.8 8.3 7.0 11.7 8.3 7.4 8.3 8.9 3.3 9.3 12.2 8.4 8.8 7.9 5.9 7.5 7.7 11.4 7.6 7.2 8.9 12.1 9.2 6.5 8.8 7.4 6.0 8.4 13.6 11.3 15.4 8.4 7.9 10.3 13.5 11.3 8.9 14.9 14.1 6.0 15.3 22.0 16.1 7.0 12.7 9.4 18.2 12.2 9.8 22.1 13.3 13.4 56.8 11.3 7.8 0.0 16.0 38.5 13.5 10.0 10.5 11.9 15.9 17.5 9.2 9.2 11.9 69.6 6.4 17.8 30.4 20.8 7.6 11.4 14.5 9.9 9.6 13.5 14.7 0.0 13.4 45.1 18.1 28.0 17.6 15.2 10.9 11.2 ATP13A3 AFURS1 ENSG00000133657 "ATPase 13A3" Q9H7F0 3 194402672-194498364 "Predicted membrane proteins" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029471 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA Nucleoli "Plasma membrane, Cytosol" "HPA029471: AB_10600784" "unprognostic (5.07e-2)" "unprognostic (3.53e-2)" "unprognostic (2.94e-1)" "unprognostic (5.31e-2)" "unprognostic (3.20e-2)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (9.87e-2)" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (1.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.34e-2)" "unprognostic (3.77e-1)" 27.1 14.4 9.0 20.8 12.7 17.5 22.8 15.3 13.8 12.1 13.4 10.8 17.2 11.4 16.2 13.2 12.4 11.3 17.1 37.8 9.6 8.1 29.7 56.9 22.1 11.6 10.1 8.3 13.2 11.4 37.6 10.6 28.9 10.6 11.8 12.6 12.9 16.7 15.9 11.8 7.7 15.0 12.1 9.0 17.1 16.3 8.8 8.4 18.9 37.1 12.0 12.7 17.8 16.1 1.9 2.4 2.3 2.3 2.2 4.7 1.0 49.1 5.6 10.0 9.5 11.4 17.8 24.4 16.9 18.4 18.4 33.5 30.8 12.0 19.4 50.3 24.3 61.0 16.7 9.6 16.8 42.8 64.7 8.3 10.7 7.4 6.5 19.8 34.8 28.1 8.1 7.5 38.2 24.9 30.2 9.5 12.0 12.3 39.3 22.3 8.4 14.0 6.9 9.5 16.1 9.7 12.8 21.6 11.6 15.6 15.7 15.4 8.1 17.9 18.6 12.5 8.8 35.7 24.4 12.4 22.5 18.7 44.6 31.5 25.9 46.7 34.5 44.6 20.7 15.5 1.8 1.7 2.3 1.8 2.3 2.2 1.9 1.7 2.8 2.4 1.1 2.5 2.5 0.3 2.2 0.9 1.6 4.7 1.0 9.0 12.7 15.3 13.8 9.6 8.1 10.1 8.3 10.6 8.4 47.6 35.1 27.9 35.7 73.3 24.1 34.6 96.8 24.1 37.5 47.1 19.6 25.7 3.3 56.7 1.9 46.6 20.8 0.0 60.7 16.3 46.0 62.6 8.1 112.9 37.1 14.3 29.4 49.1 35.1 1.1 9.5 48.5 59.1 8.2 21.5 10.3 76.7 20.4 12.4 39.8 13.3 12.9 36.0 14.0 7.0 62.2 54.0 20.1 19.9 58.3 ATP6AP1L ENSG00000205464 "ATPase H+ transporting accessory protein 1 like" Q52LC2 5 82279462-82386977 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 27.5;Early spermatids: 20.6" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 8 "dendritic cells: 1.3;NK-cells: 1.5;T-cells: 1.2" "Cell line enriched" "Detected in some" 5 "MOLT-4: 15.7" HPA053771 Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA053771: AB_2682257" "unprognostic (1.64e-1)" "unprognostic (8.15e-2)" "unprognostic (5.10e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-1)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (5.09e-1)" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (1.94e-1)" "unprognostic (2.22e-3)" "unprognostic (2.92e-1)" "unprognostic (1.46e-1)" "unprognostic (2.14e-2)" "unprognostic (2.43e-2)" 1.6 1.0 2.6 0.2 2.4 0.6 0.7 2.5 2.1 1.8 1.2 0.1 1.5 0.1 1.4 2.4 1.7 2.0 2.7 1.8 0.8 1.4 1.5 0.7 2.5 4.4 2.4 0.1 2.0 0.7 1.4 0.6 2.6 2.5 3.3 5.1 0.2 0.6 2.7 0.8 1.8 3.8 1.5 0.4 0.9 0.5 0.1 1.3 0.0 0.1 1.5 1.2 0.0 0.1 0.0 0.1 1.0 0.6 0.3 0.0 0.1 0.3 0.4 0.9 0.1 0.0 0.0 0.0 0.9 1.3 0.0 0.3 2.9 0.0 1.3 0.6 0.5 0.2 0.3 2.3 0.2 0.0 2.1 1.1 0.0 2.6 0.2 0.5 0.2 0.7 1.2 0.0 0.2 15.7 0.5 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.2 0.4 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 1.2 0.1 0.7 1.2 0.0 1.5 0.0 1.3 0.0 0.0 0.0 1.6 0.5 2.3 1.9 12.1 2.4 0.0 14.7 1.2 5.2 27.5 6.1 1.7 2.6 20.6 1.8 1.3 0.0 2.9 2.7 3.8 1.2 2.3 1.6 1.2 1.6 1.2 4.9 1.5 16.6 4.4 1.3 0.0 1.0 1.8 10.6 2.6 0.0 2.8 1.1 14.2 0.0 1.4 14.0 5.5 1.3 2.9 1.9 1.1 1.3 ATP6V1G1 "ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10" ENSG00000136888 "ATPase H+ transporting V1 subunit G1" O75348 9 114587746-114598373 "Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004615, HPA042898" Supported Approved Nucleoplasm,Nucleoli NA NA 150000 Nucleoli Nucleoplasm "CAB004615: AB_2258908, HPA042898: AB_2678217" "unprognostic (3.85e-1)" "unprognostic (1.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (1.84e-3)" "unprognostic (2.49e-1)" "unprognostic (1.51e-1)" "unprognostic (2.28e-1)" "unprognostic (3.47e-3)" "unprognostic (9.40e-3)" "unprognostic (4.13e-2)" "prognostic favorable (1.73e-7)" "unprognostic (2.44e-2)" "unprognostic (1.50e-1)" "unprognostic (9.11e-2)" "unprognostic (3.92e-2)" 34.8 66.4 41.5 36.7 38.0 56.6 56.6 37.5 49.4 45.2 34.2 23.4 42.3 26.7 43.7 91.0 57.5 32.3 39.2 45.4 40.8 52.5 84.9 65.9 45.3 50.0 52.2 39.5 49.2 55.9 39.5 79.4 77.8 44.7 65.3 33.2 49.2 63.2 45.1 54.9 40.8 33.2 31.7 35.6 66.5 52.7 58.3 25.6 51.7 65.2 53.5 53.4 45.8 40.1 99.9 81.6 96.6 67.9 50.0 85.1 121.6 18.2 17.6 36.2 8.8 30.1 21.8 33.6 28.5 22.6 23.6 17.0 23.6 22.0 17.7 24.9 20.3 44.1 41.4 27.0 21.5 19.9 14.0 18.6 17.0 22.3 34.2 42.1 37.8 31.5 27.9 57.9 18.9 23.6 24.8 22.3 28.7 32.5 37.6 32.2 39.6 36.4 23.9 42.8 52.2 33.2 35.4 23.2 28.3 48.4 31.4 27.3 34.9 38.4 67.2 101.2 36.5 54.4 44.9 29.7 19.3 15.3 30.0 31.9 50.7 99.4 30.9 24.8 22.7 26.4 78.3 67.9 96.6 46.7 63.9 57.9 99.9 65.6 56.0 50.9 94.2 85.1 67.1 87.3 50.0 65.8 81.6 76.5 121.6 41.5 38.0 37.5 49.4 40.8 52.5 52.2 39.5 44.7 25.6 148.9 142.4 298.6 409.4 461.0 169.7 124.8 155.4 207.5 149.0 314.0 39.3 304.8 822.3 322.2 78.2 218.7 155.2 93.5 229.3 273.5 294.0 644.3 261.0 292.4 487.8 155.7 346.4 198.9 353.7 42.3 283.3 376.1 469.0 820.6 271.3 242.1 355.1 164.9 235.8 828.3 125.3 232.8 269.9 334.2 301.9 504.0 633.4 276.3 162.4 656.9 ATXN1 "ATX1, D6S504E, SCA1" ENSG00000124788 "Ataxin 1" P54253 6 16299112-16761491 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008335, HPA070756" Approved Supported Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoplasm "Nucleoli, Cytosol" "HPA008335: AB_1845129, HPA070756: AB_2686306" "unprognostic (1.01e-1)" "unprognostic (4.77e-2)" "unprognostic (1.23e-1)" "unprognostic (5.64e-3)" "unprognostic (4.54e-1)" "unprognostic (1.95e-2)" "unprognostic (7.74e-2)" "unprognostic (4.51e-2)" "unprognostic (4.06e-1)" "unprognostic (1.11e-2)" "unprognostic (3.87e-2)" "unprognostic (2.69e-2)" "unprognostic (1.41e-3)" "unprognostic (1.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (3.29e-3)" 8.1 9.1 17.7 11.9 25.1 5.5 9.1 33.7 29.5 14.8 13.5 12.9 10.3 8.2 20.5 9.8 11.1 11.0 12.1 11.8 18.0 11.0 9.1 10.1 14.8 11.6 21.1 17.7 10.7 10.3 18.4 11.6 10.3 16.4 14.2 8.5 9.8 8.4 14.0 26.3 12.0 8.3 19.1 16.1 11.4 10.3 8.1 25.6 4.6 11.8 12.5 7.4 11.7 11.3 0.4 0.8 4.4 1.7 0.1 2.5 0.8 3.4 2.0 0.7 0.0 3.5 4.8 4.6 3.7 8.7 2.3 2.7 2.1 2.2 0.1 5.0 7.1 3.0 3.2 0.2 2.3 3.3 1.9 3.6 0.5 3.2 6.7 5.7 3.2 5.6 3.7 4.5 4.8 4.1 8.9 4.6 0.7 0.0 4.1 1.9 1.7 0.2 3.6 0.7 1.1 3.3 0.2 4.6 3.0 3.1 5.8 0.2 2.0 3.4 4.3 7.0 7.0 2.8 5.5 7.0 3.2 4.9 3.7 3.3 24.3 13.9 0.1 2.0 3.3 7.8 0.7 1.7 0.4 2.5 1.3 1.9 0.4 1.7 2.4 0.8 0.1 0.2 1.5 4.4 0.1 0.7 0.4 1.3 0.8 17.7 25.1 33.7 29.5 18.0 11.0 21.1 17.7 16.4 25.6 44.7 20.4 14.9 54.4 81.3 39.6 30.2 25.5 22.7 26.1 10.4 94.2 0.3 6.6 15.9 3.6 15.7 12.5 0.0 7.4 3.0 26.7 57.3 38.1 25.3 20.8 36.5 1.2 20.3 33.9 1.8 9.8 33.2 30.4 28.9 12.3 24.2 22.2 13.5 26.5 7.7 108.3 51.8 35.3 0.9 1.3 42.7 0.3 44.9 6.8 52.7 ATXN3 "ATX3, JOS, MJD, SCA3" ENSG00000066427 "Ataxin 3" P54252 14 92044496-92106625 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB021976, HPA024123, HPA069338" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124" "unprognostic (1.06e-2)" "unprognostic (2.93e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-2)" "unprognostic (5.76e-2)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (9.85e-3)" "unprognostic (1.69e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-2)" "unprognostic (3.06e-2)" "unprognostic (2.03e-2)" "unprognostic (8.94e-3)" "unprognostic (4.22e-1)" "unprognostic (1.64e-1)" "unprognostic (1.11e-1)" 17.8 10.3 10.2 9.1 11.6 14.3 12.8 18.7 12.1 16.0 11.8 12.2 11.9 6.4 17.9 12.4 17.7 9.5 11.2 10.4 9.0 9.9 9.9 16.0 12.3 11.6 16.3 9.5 14.0 10.3 11.9 17.2 11.7 13.8 15.8 11.7 8.6 11.4 10.2 6.1 21.0 8.7 20.6 16.5 12.6 9.0 14.8 14.3 16.2 11.5 12.0 15.6 15.4 13.6 9.8 14.5 11.4 18.8 7.0 8.5 5.3 5.6 11.1 10.1 9.3 14.7 14.4 19.7 6.4 10.5 8.2 11.5 8.1 15.7 11.5 12.8 10.5 9.7 9.9 7.7 14.1 18.2 13.1 2.3 4.9 5.4 11.8 12.1 8.6 8.8 11.6 12.6 14.3 15.0 11.0 12.6 12.9 6.5 8.6 12.4 22.0 9.0 7.8 7.1 18.8 9.2 7.2 18.5 6.5 10.5 12.8 3.4 6.0 15.6 6.6 8.8 14.1 12.3 6.1 6.7 8.1 11.9 5.2 3.4 7.5 12.5 10.6 6.0 8.5 4.7 11.4 13.4 9.4 5.9 14.5 7.0 7.1 6.9 6.5 14.5 9.8 7.6 8.5 11.3 7.0 18.8 8.4 6.8 5.3 10.2 11.6 18.7 12.1 9.0 9.9 16.3 9.5 13.8 14.3 14.9 14.3 18.1 26.1 22.6 32.4 17.3 17.8 12.0 12.5 40.1 47.1 17.4 13.3 17.7 18.3 43.4 11.7 0.0 15.0 23.8 25.4 29.1 23.2 19.1 20.8 25.4 15.4 39.3 27.2 18.5 62.7 31.8 21.9 30.7 16.0 20.6 17.6 17.5 61.2 14.6 45.6 45.3 35.8 30.5 60.9 26.5 21.2 23.0 19.4 25.1 AXIN1 PPP1R49 ENSG00000103126 "Axin 1" O15169 16 287440-352673 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012987 Approved Supported Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "CAB012987: AB_2533178" "unprognostic (3.81e-2)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (7.64e-2)" "unprognostic (1.90e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (3.38e-5)" "unprognostic (1.23e-1)" "unprognostic (3.58e-1)" "unprognostic (1.56e-1)" "unprognostic (4.58e-2)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" "unprognostic (4.41e-2)" "unprognostic (1.94e-1)" "unprognostic (1.23e-2)" "unprognostic (1.03e-1)" 10.8 8.3 13.7 18.9 17.1 28.1 21.0 26.4 13.6 10.4 15.8 12.7 9.4 17.3 12.6 8.5 14.1 10.7 12.7 11.0 11.5 7.7 9.8 9.6 13.6 13.4 15.6 10.6 13.3 17.7 11.1 11.9 8.4 13.9 11.4 10.2 9.6 13.9 9.5 17.7 16.9 17.6 18.9 9.6 15.1 15.2 9.6 14.6 17.5 12.7 7.5 14.5 11.9 22.9 1.8 1.4 5.5 1.1 3.6 10.4 2.4 9.6 14.0 7.5 13.2 5.6 5.2 15.8 6.5 6.0 9.1 7.8 20.6 11.3 15.0 10.1 6.7 10.9 13.9 11.7 10.2 4.1 14.7 19.2 9.7 11.8 14.9 9.6 11.1 10.8 5.1 17.8 9.3 11.5 8.0 6.0 11.0 24.1 8.3 4.1 25.8 12.0 7.7 17.1 11.7 8.6 22.7 6.8 20.8 6.8 5.7 17.1 10.5 12.4 13.9 20.5 5.9 9.2 14.2 6.7 9.0 9.7 10.3 9.4 9.6 9.3 18.3 4.3 7.4 8.8 1.4 1.1 5.5 10.4 0.9 9.5 1.8 3.0 7.0 0.8 1.6 3.2 4.3 3.2 3.6 0.7 1.4 3.0 2.4 13.7 17.1 26.4 13.6 11.5 7.7 15.6 10.6 13.9 14.6 3.0 11.3 5.2 5.3 16.4 4.9 5.0 5.1 6.7 6.8 3.5 0.0 3.1 0.0 6.1 1.0 6.7 18.6 0.0 6.1 20.3 5.9 9.4 10.4 4.7 6.5 4.8 10.4 4.3 7.5 1.3 4.9 5.9 10.1 3.6 14.5 3.7 8.8 11.9 4.6 2.1 5.4 12.9 5.3 4.4 7.6 13.2 3.1 7.7 11.8 8.7 B3GNT4 "B3GN-T4, beta3Gn-T4" ENSG00000176383 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4" Q9C0J1 12 122203543-122208952 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3;skin 1: 8.5" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 2.6;Proximal tubular cells: 6.1;Spermatogonia: 2.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 8.2;hTCEpi: 9.9;T-47d: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055261 Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA055261: AB_2682765" "unprognostic (1.67e-1)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.60e-2)" "unprognostic (1.32e-3)" "unprognostic (1.98e-1)" "unprognostic (3.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.82e-2)" "unprognostic (3.69e-1)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.24e-1)" "unprognostic (2.79e-1)" "unprognostic (8.97e-2)" "unprognostic (9.47e-2)" 0.7 3.2 7.3 0.8 6.8 4.6 0.8 16.3 9.1 0.5 0.7 0.5 0.0 1.0 0.6 0.7 1.8 1.1 1.1 0.8 4.9 4.0 6.1 0.6 1.1 0.9 1.5 7.3 0.8 0.8 0.8 1.9 0.8 4.0 0.7 0.6 1.0 1.7 0.7 1.1 8.5 1.0 0.6 0.6 1.0 0.7 2.0 0.3 0.0 0.8 0.3 0.8 0.6 0.5 0.8 1.0 0.8 1.7 0.4 1.9 0.4 5.5 1.0 0.4 2.2 0.2 0.1 1.0 0.1 0.0 0.3 0.7 3.5 0.5 0.5 1.0 0.0 0.4 2.0 2.7 2.2 0.2 8.2 2.8 0.2 1.5 0.3 0.6 0.7 1.1 0.7 9.9 0.1 0.5 0.8 0.0 2.0 1.6 0.7 0.2 4.9 0.0 0.7 0.6 0.2 2.0 0.4 0.6 1.0 1.4 0.6 1.4 1.8 1.6 1.0 0.5 0.9 7.6 0.1 0.1 0.5 2.8 0.5 0.3 0.6 5.0 1.2 0.5 0.8 0.3 0.8 0.4 0.2 0.8 0.1 0.4 0.8 1.3 0.2 0.2 0.5 1.9 0.2 0.5 0.4 1.7 1.0 0.6 0.4 7.3 6.8 16.3 8.1 4.9 4.0 1.5 7.3 4.0 0.3 0.0 2.6 0.0 0.7 1.1 0.1 0.4 0.0 1.4 1.2 0.0 0.0 0.4 1.7 1.0 0.2 0.0 0.0 0.0 0.2 0.4 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.6 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.4 0.6 0.0 6.1 0.1 0.0 0.2 0.5 2.6 1.3 0.5 0.5 0.3 0.4 B3GNT5 "B3GN-T5, beta3Gn-T5" ENSG00000176597 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5" Q9BYG0 3 183253244-183298504 "Enzymes, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 80.2" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 101.7;Syncytiotrophoblasts: 132.0;Urothelial cells: 125.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "GAMG: 30.4;HBEC3-KT: 25.2;hTCEpi: 30.7" "Region enriched" "Detected in single" 12 "cerebellum: 16.5" "Low region specificity" "Detected in all" HPA017292 Uncertain Approved Nucleoli NA NA Nucleoli "HPA017292: AB_1845237" "unprognostic (2.17e-1)" "unprognostic (5.73e-2)" "unprognostic (1.07e-2)" "unprognostic (4.83e-3)" "unprognostic (1.89e-1)" "unprognostic (3.08e-2)" "prognostic unfavorable (5.09e-4)" "unprognostic (7.10e-3)" "unprognostic (7.78e-2)" "unprognostic (8.48e-2)" "prognostic unfavorable (7.23e-6)" "unprognostic (4.20e-1)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.18e-2)" "unprognostic (2.71e-1)" "unprognostic (3.53e-2)" "unprognostic (8.10e-3)" 8.6 1.4 2.2 6.1 2.3 31.6 4.3 1.2 2.5 6.4 29.8 5.4 2.1 17.5 3.2 5.4 23.5 5.4 10.1 3.3 3.0 2.9 3.5 3.0 11.2 5.1 4.0 0.7 4.2 3.5 1.8 5.1 19.8 4.5 3.9 9.2 3.2 8.7 2.5 6.6 8.0 80.2 2.9 6.3 2.3 5.1 2.9 2.3 1.0 4.6 18.9 8.9 5.0 10.6 0.1 1.1 9.0 1.5 0.0 0.3 0.4 16.1 1.5 8.7 5.3 7.3 21.6 7.9 0.2 0.4 1.7 1.4 3.2 8.5 0.0 1.0 0.0 30.4 7.4 8.9 25.2 1.4 0.0 5.5 0.8 0.7 0.0 9.3 8.1 4.0 10.1 30.7 1.3 23.0 2.3 15.7 0.0 9.2 0.0 13.8 0.0 0.0 2.6 3.6 9.5 14.0 2.5 4.4 0.0 5.3 4.5 0.4 8.3 4.5 0.0 1.9 4.1 0.0 9.9 23.1 0.4 3.4 0.5 3.9 0.0 0.0 0.0 3.3 19.2 8.6 0.0 1.5 1.5 0.0 0.3 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.3 0.4 2.2 2.3 1.2 2.5 3.0 2.9 4.0 0.7 4.5 2.3 6.0 17.4 0.0 55.5 57.9 7.1 2.0 12.7 101.7 27.3 5.2 21.6 24.4 1.7 15.7 9.9 10.0 77.7 0.0 10.5 9.4 7.4 42.6 13.9 0.4 25.3 3.2 36.7 3.1 9.7 19.2 1.4 50.1 11.8 11.8 73.1 3.2 25.3 42.1 0.4 4.3 12.7 0.0 3.4 0.9 0.4 74.2 132.0 0.7 26.9 125.2 B3GNTL1 B3GNT8 ENSG00000175711 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1" Q67FW5 17 82942155-83051810 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 17.4;Late spermatids: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.9;HL-60: 18.6;THP-1: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023585, HPA024547" Supported Approved "Nucleoli,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli, Nucleoli fibrillar center" Vesicles "HPA023585: AB_2061075, HPA024547: AB_1845240" "unprognostic (1.51e-2)" "unprognostic (9.84e-2)" "unprognostic (4.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.38e-1)" "unprognostic (8.11e-2)" "unprognostic (2.61e-7)" "unprognostic (9.95e-2)" "unprognostic (2.62e-1)" "unprognostic (1.62e-1)" "unprognostic (8.74e-2)" "unprognostic (2.80e-2)" "unprognostic (4.17e-9)" "unprognostic (2.02e-1)" "unprognostic (1.47e-1)" "unprognostic (1.88e-1)" "unprognostic (3.39e-3)" 3.7 4.3 6.5 7.2 13.9 17.7 4.0 6.4 10.7 4.7 3.6 4.2 1.7 4.7 6.3 6.1 3.7 8.3 3.9 6.2 6.9 4.7 2.9 3.4 4.4 5.6 3.8 7.1 6.6 7.6 1.7 6.1 3.9 7.1 4.6 2.8 3.7 5.6 4.5 5.0 4.4 3.3 5.1 4.4 6.6 4.9 4.0 3.7 6.9 4.4 4.8 3.3 4.3 3.8 3.7 8.8 16.9 5.7 2.4 11.2 3.3 8.2 5.5 0.1 2.7 1.5 4.9 3.4 3.0 2.7 3.5 2.7 3.3 17.9 4.0 5.9 3.7 8.5 1.6 1.4 0.0 3.0 6.2 3.6 8.5 8.2 11.0 5.6 18.6 0.3 1.8 1.5 2.1 3.5 1.7 4.2 6.4 3.7 3.9 2.8 1.8 5.2 7.1 1.3 5.6 4.0 6.8 0.7 0.3 2.0 1.8 1.7 0.6 2.5 1.9 2.5 2.6 0.0 17.9 6.9 6.8 4.6 1.0 5.3 0.8 1.9 3.0 7.5 2.4 0.9 2.6 5.7 0.9 2.7 5.0 4.1 2.8 4.3 3.0 8.8 3.7 3.8 4.6 16.9 2.4 2.5 3.5 11.2 3.3 6.5 13.9 6.4 10.7 6.9 4.7 3.8 7.1 7.1 3.7 3.0 5.0 1.3 1.7 0.9 3.9 1.7 2.5 17.4 6.8 5.2 3.9 5.1 1.7 1.6 11.7 1.5 0.3 0.0 0.8 2.1 3.0 1.5 6.9 1.0 7.2 3.2 1.2 1.8 8.1 15.2 2.8 6.7 1.7 3.6 1.2 1.1 1.9 2.9 4.6 2.2 3.4 0.0 1.2 0.7 4.3 1.5 1.6 6.4 2.7 2.0 BAHCC1 "BAHD2, KIAA1447" ENSG00000266074 "BAH domain and coiled-coil containing 1" 17 81395475-81466332 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 22.2" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 47.8;Cone photoreceptor cells: 21.6;Horizontal cells: 31.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 1.4;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 8 "dendritic cells: 1.1;granulocytes: 1.4" "Cell line enhanced" "Detected in many" "HL-60: 11.0;MOLT-4: 13.6;NB-4: 46.8;REH: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023386, HPA076910" Approved Approved Nucleoli NA NA Nucleoli "HPA023386: AB_1859537, HPA076910: AB_2732325" "unprognostic (2.04e-1)" "unprognostic (2.23e-1)" "unprognostic (2.28e-1)" "unprognostic (1.52e-1)" "unprognostic (1.85e-2)" "unprognostic (1.08e-1)" "unprognostic (1.16e-2)" "unprognostic (5.77e-3)" "unprognostic (1.94e-1)" "unprognostic (2.05e-2)" "prognostic favorable (7.38e-4)" "unprognostic (1.43e-1)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (1.18e-1)" "unprognostic (2.18e-1)" "unprognostic (3.78e-2)" 5.9 4.8 5.0 3.0 8.3 8.1 3.6 22.2 7.4 5.1 3.1 10.6 1.1 6.0 4.5 2.3 2.5 3.8 5.6 2.2 4.8 2.8 1.1 4.4 1.1 8.5 5.7 6.0 4.3 5.3 3.2 1.6 4.9 4.4 1.5 9.5 6.1 3.8 6.2 4.4 5.5 4.0 3.2 4.9 3.6 4.4 10.4 9.6 2.5 1.6 0.5 3.7 4.4 0.0 1.1 1.4 0.1 0.0 0.0 0.0 1.7 3.0 2.2 7.3 0.8 1.2 1.0 1.3 1.1 0.7 0.4 0.5 0.8 0.0 2.0 1.5 1.0 1.8 1.0 0.8 0.1 0.0 3.3 2.4 0.7 0.9 0.7 11.0 2.3 2.0 0.3 0.6 0.6 1.1 0.8 2.8 1.7 0.0 0.3 1.0 13.6 46.8 0.1 1.1 2.0 14.3 1.5 0.0 0.9 0.1 10.2 1.6 1.6 0.0 5.8 0.2 0.3 8.8 1.0 4.0 0.5 2.1 0.6 0.0 0.0 0.0 0.0 5.1 0.7 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 6.0 9.6 0.0 1.4 0.0 47.8 5.8 15.3 4.0 6.8 3.5 21.6 0.1 1.7 2.8 0.5 4.7 3.2 0.0 3.7 0.1 4.3 1.3 0.0 3.0 0.5 31.8 8.1 4.9 5.1 0.0 6.9 1.3 0.0 1.0 4.2 7.5 1.6 0.0 5.3 0.8 16.8 0.0 2.0 1.5 7.8 0.0 0.0 0.0 4.5 0.7 BATF2 MGC20410 ENSG00000168062 "Basic leucine zipper ATF-like transcription factor 2" Q8N1L9 11 64987943-64997045 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 8.4;Mucus-secreting cells: 8.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 6.6;neutrophil: 9.6" "Group enriched" "Detected in many" 6 "granulocytes: 9.6;monocytes: 6.6" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 11.4;BJ hTERT+ SV40 Large T+ RasG12V: 17.5;GAMG: 15.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA062496 Approved Approved Nucleoli NA NA Nucleoli "HPA062496: AB_2684783" "unprognostic (5.29e-2)" "unprognostic (3.36e-2)" "unprognostic (1.44e-1)" "unprognostic (4.59e-2)" "unprognostic (2.31e-2)" "unprognostic (6.11e-2)" "unprognostic (5.08e-2)" "unprognostic (6.92e-3)" "unprognostic (1.03e-1)" "prognostic favorable (9.39e-5)" "prognostic unfavorable (2.12e-4)" "unprognostic (1.28e-1)" "unprognostic (9.09e-3)" "unprognostic (2.34e-3)" "unprognostic (3.17e-2)" "unprognostic (3.82e-2)" "unprognostic (1.12e-2)" 2.8 5.3 2.4 8.3 3.3 0.4 3.2 1.0 3.4 2.0 8.9 1.9 7.2 8.8 2.1 2.8 2.3 2.9 9.3 2.2 1.9 1.7 10.0 5.4 7.8 2.7 2.2 2.4 3.2 17.3 0.7 3.1 3.0 5.9 7.9 6.7 4.2 14.0 5.1 4.8 0.5 14.0 2.7 2.1 18.7 5.1 0.9 1.7 0.9 16.5 1.0 3.4 3.9 1.2 1.3 0.3 9.6 6.6 0.1 0.1 0.9 1.2 0.8 0.1 0.0 0.1 0.5 0.0 0.4 5.4 11.4 17.5 1.5 4.7 0.0 2.2 0.7 15.6 0.1 0.0 1.3 0.8 0.1 0.3 1.6 0.0 3.9 4.3 0.0 1.0 0.3 0.4 1.5 1.9 0.4 2.7 0.1 3.4 0.1 0.2 0.3 0.0 0.1 0.3 0.0 0.5 0.0 1.1 0.4 1.4 0.1 0.1 0.0 0.4 0.3 5.4 0.1 0.5 0.8 2.0 0.6 0.6 1.0 0.0 0.0 0.1 0.4 0.9 0.5 0.5 0.0 2.6 1.1 0.0 6.6 0.0 1.3 0.0 0.1 0.3 0.4 0.0 0.0 9.6 0.1 3.1 0.0 0.0 0.9 2.4 3.3 1.0 3.4 1.9 1.7 2.2 2.4 5.9 1.7 3.0 1.3 3.7 0.6 0.0 0.0 0.5 5.1 4.0 2.3 1.8 0.0 0.0 1.7 4.6 0.9 1.5 8.4 0.0 5.8 0.2 0.9 0.2 0.0 0.8 3.8 0.0 2.4 5.5 2.7 1.7 0.0 1.0 0.0 1.0 8.0 0.8 4.6 7.0 0.7 3.3 0.1 0.0 1.5 0.1 0.6 0.0 0.0 0.0 6.3 1.1 BATF3 "JDP1, JUNDM1, SNFT" ENSG00000123685 "Basic leucine zipper ATF-like transcription factor 3" Q9NR55 1 212686418-212699985 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.8" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 36.2;Macrophages: 24.9;monocytes: 98.2;Smooth muscle cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 18.0;myeloid DC: 16.5;non-classical monocyte: 26.8" "Group enriched" "Detected in many" 36 "dendritic cells: 16.5;monocytes: 26.8" "Cell line enriched" "Detected in some" 12 "HDLM-2: 93.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA075858 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA075858: " "unprognostic (3.87e-2)" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (6.85e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (3.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.08e-1)" "unprognostic (6.47e-2)" "unprognostic (1.28e-2)" "unprognostic (1.75e-1)" "unprognostic (6.43e-10)" "unprognostic (9.88e-2)" "unprognostic (5.19e-2)" "unprognostic (3.90e-1)" "unprognostic (7.08e-2)" 10.4 1.3 6.7 6.3 9.4 5.4 3.5 0.4 5.2 2.0 2.4 3.3 0.2 1.4 1.8 0.4 1.8 2.6 3.8 4.1 5.5 2.1 2.6 2.3 7.2 8.7 9.5 2.8 3.1 3.2 1.2 1.3 4.6 4.3 2.3 1.6 0.5 2.2 1.2 1.5 1.1 4.3 3.7 4.7 9.5 3.2 1.1 7.1 5.0 2.1 2.6 4.9 3.0 6.0 0.2 16.5 0.6 26.8 0.3 0.4 2.4 0.3 0.9 0.1 0.0 0.0 0.6 0.7 0.5 1.1 1.1 1.2 0.0 0.3 0.0 0.2 0.0 1.8 0.0 1.1 0.2 0.8 93.1 2.2 0.0 0.3 0.0 0.2 4.2 0.6 0.1 0.0 2.2 0.3 0.1 0.0 7.7 0.1 1.1 0.2 0.0 3.2 1.7 0.4 0.0 1.5 0.6 0.4 0.0 1.0 0.0 0.2 0.1 0.3 0.0 0.0 0.4 0.0 3.0 0.0 0.5 2.1 0.1 2.4 0.1 0.2 0.5 1.5 3.8 1.1 0.0 4.1 0.0 0.0 18.0 0.0 0.2 0.0 0.0 16.5 0.0 0.0 0.0 0.6 0.3 26.8 0.0 0.4 2.4 6.7 9.4 0.4 5.2 5.5 2.1 9.5 2.8 4.3 7.1 3.0 1.1 0.5 2.2 5.0 0.1 0.3 0.0 4.0 2.3 0.0 0.0 0.8 0.0 0.7 0.3 5.8 0.0 0.0 0.3 36.2 8.5 6.6 4.7 0.2 4.6 0.0 0.0 6.2 10.5 0.8 0.9 24.9 1.7 98.2 0.0 0.2 1.3 0.0 0.0 0.5 0.4 0.0 25.8 1.1 4.3 2.5 3.8 1.0 0.0 0.9 BCAS3 FLJ20128 ENSG00000141376 "BCAS3, microtubule associated cell migration factor" Q9H6U6 17 60677453-61392838 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Transcription, Transcription regulation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 203.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052409, HPA057289" Approved Approved Nucleoli NA NA Nucleoli "HPA052409: AB_2681821, HPA057289: AB_2683399" "unprognostic (2.84e-2)" "prognostic favorable (2.04e-4)" "unprognostic (1.20e-1)" "unprognostic (3.52e-1)" "unprognostic (5.52e-1)" "unprognostic (3.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.39e-1)" "unprognostic (1.20e-1)" "unprognostic (2.47e-1)" "prognostic favorable (1.23e-5)" "unprognostic (2.55e-1)" "prognostic favorable (1.73e-5)" "unprognostic (1.49e-1)" "unprognostic (2.54e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" 12.1 15.9 13.9 8.3 24.1 8.8 11.6 21.5 30.8 12.9 11.4 32.2 12.6 7.1 20.6 18.6 14.3 21.1 11.3 11.7 15.8 14.3 17.1 18.3 13.6 8.5 19.2 18.6 11.9 13.5 26.5 16.9 14.7 24.3 17.1 9.3 16.1 13.6 14.3 20.3 17.0 8.4 13.6 16.3 10.8 11.7 20.2 20.0 16.6 13.7 7.6 13.9 17.0 11.9 9.1 6.9 26.8 8.0 11.7 12.9 6.4 3.3 8.2 4.2 14.1 8.6 7.3 4.9 3.5 4.8 3.6 4.6 5.5 7.4 1.3 6.0 5.9 5.0 2.6 2.4 2.9 4.7 3.0 9.4 3.2 4.6 5.0 4.8 1.6 2.8 8.6 3.4 3.0 5.5 7.2 4.2 5.1 2.7 6.6 3.2 43.3 4.6 1.2 4.4 16.2 9.3 5.7 5.7 6.0 3.0 12.7 6.3 5.3 7.1 2.1 5.0 14.8 7.7 2.4 3.9 4.8 4.1 2.0 1.6 15.4 12.7 5.6 5.7 1.2 3.7 15.8 7.8 11.7 12.1 6.7 9.8 9.1 8.4 9.2 6.9 8.4 9.3 7.5 26.8 11.7 8.0 4.9 12.9 6.4 13.9 24.1 21.5 30.8 15.8 14.3 19.2 18.6 24.3 20.0 6.0 12.2 2.7 7.8 4.5 13.0 11.2 5.1 48.2 12.5 15.7 9.8 5.9 8.3 3.6 38.8 8.5 3.6 0.0 3.1 4.3 5.0 3.6 16.1 8.6 3.7 3.2 6.9 12.9 5.6 203.3 6.9 4.7 1.7 7.2 4.6 30.3 3.2 4.8 19.8 23.0 13.4 12.9 14.4 11.1 4.7 4.8 6.3 11.8 2.6 6.9 BCKDHB ENSG00000083123 "Branched chain keto acid dehydrogenase E1 subunit beta" P21953 6 80106647-80346270 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.6" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 56.4;Hepatocytes: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031580, HPA031956" Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" Yes No Mitochondria Nucleoli "HPA031580: AB_10696054, HPA031956: " "unprognostic (4.23e-1)" "unprognostic (1.61e-1)" "unprognostic (9.50e-3)" "unprognostic (9.37e-3)" "unprognostic (1.66e-1)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (2.30e-2)" "unprognostic (1.94e-1)" "unprognostic (7.32e-3)" "unprognostic (2.67e-1)" "unprognostic (4.65e-2)" "prognostic favorable (5.54e-9)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (1.49e-2)" 13.9 12.0 9.9 9.0 12.2 5.8 18.1 9.5 14.3 10.2 17.3 22.7 9.4 9.1 11.6 7.7 10.2 10.9 7.4 14.7 11.9 7.6 24.7 58.6 6.4 8.1 11.3 11.2 13.9 12.1 13.7 15.5 5.5 14.1 13.1 16.5 11.7 30.5 10.3 8.2 8.6 11.8 11.5 16.7 5.3 15.0 10.0 12.4 11.2 12.5 7.9 7.7 14.0 8.2 9.1 10.3 2.6 4.3 13.4 15.7 5.2 7.0 2.6 10.0 13.4 10.2 8.9 8.0 5.0 10.4 8.3 11.4 4.3 9.7 20.0 5.4 12.0 9.7 7.1 5.5 6.6 11.6 24.8 8.2 9.9 6.9 5.8 11.3 14.0 4.5 8.5 6.8 5.7 7.1 7.4 9.8 15.6 8.3 17.9 18.5 3.9 5.1 8.2 7.4 15.4 3.4 13.0 31.1 17.1 22.9 10.8 6.7 9.5 8.5 7.1 5.0 11.5 9.1 10.8 4.2 5.0 3.4 4.5 6.7 12.8 12.5 6.6 6.1 10.5 7.4 2.6 3.4 0.8 8.5 4.0 11.1 9.1 7.2 7.2 6.6 9.1 9.6 10.0 0.7 13.4 4.3 10.3 15.7 5.2 9.9 12.2 9.5 14.3 11.9 7.6 11.3 11.2 14.1 12.4 8.9 15.2 6.7 10.1 7.6 7.0 26.0 10.2 16.0 14.8 5.2 2.0 15.7 23.2 6.8 56.4 9.0 12.4 0.0 9.0 6.6 13.0 8.6 16.1 55.0 10.2 3.2 11.5 11.1 9.8 4.1 8.1 6.1 15.1 10.0 28.8 14.6 4.5 11.5 8.1 25.2 8.2 6.5 8.9 7.7 4.8 10.8 8.7 8.9 15.3 9.8 BLCAP BC10 ENSG00000166619 "Bladder cancer associated protein" P62952 20 37492472-37527931 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 102.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 72.5" "Low region specificity" "Detected in all" HPA047390 Approved Nucleoli NA NA Nucleoli "HPA047390: AB_2680025" "unprognostic (1.05e-2)" "unprognostic (7.91e-3)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (7.08e-2)" "unprognostic (1.27e-2)" "unprognostic (3.49e-1)" "unprognostic (3.51e-1)" "unprognostic (4.45e-1)" "unprognostic (1.91e-3)" "unprognostic (4.91e-2)" "unprognostic (6.04e-2)" "unprognostic (1.04e-3)" "unprognostic (1.96e-2)" "unprognostic (7.62e-2)" "unprognostic (1.37e-2)" "prognostic favorable (7.28e-5)" 18.9 16.7 31.6 12.9 89.5 10.7 16.4 23.2 40.1 14.3 15.6 13.3 11.4 17.6 9.8 19.9 18.5 50.5 17.9 23.5 26.5 44.4 21.3 23.8 12.2 12.5 22.5 28.3 15.1 7.9 15.4 34.4 26.1 27.6 18.9 18.8 13.4 17.7 21.1 102.5 30.3 18.9 13.4 13.4 14.2 12.4 12.2 10.6 8.5 14.0 27.3 17.8 20.2 12.7 48.0 20.5 26.6 22.2 17.0 28.4 18.7 27.0 8.0 9.4 9.7 18.2 14.0 13.3 13.0 12.6 11.6 9.5 27.8 22.1 14.1 13.0 18.0 11.1 52.5 7.0 53.9 12.1 2.9 6.3 4.6 17.8 25.7 11.7 9.1 6.1 17.8 58.1 11.1 21.1 9.6 16.1 10.3 4.4 10.6 23.3 15.2 7.5 7.2 7.5 15.3 22.5 7.2 35.1 9.4 13.3 72.5 8.6 10.4 15.6 45.3 10.5 10.1 14.9 8.7 15.3 30.1 7.7 10.5 5.5 5.8 7.2 6.8 12.5 8.4 5.3 26.6 22.2 25.9 18.7 21.5 20.4 37.5 21.4 19.8 20.5 48.0 28.4 22.0 23.2 17.0 19.3 8.8 20.6 18.7 31.6 89.5 23.2 40.1 26.5 44.4 22.5 28.3 27.6 10.6 74.5 32.3 42.7 79.2 130.6 42.3 49.4 35.7 64.3 67.1 38.4 21.6 98.9 69.6 30.6 58.8 43.9 49.9 0.0 29.8 68.6 31.1 44.2 29.9 70.6 48.4 39.7 39.3 74.3 36.4 108.7 27.6 35.6 33.7 16.2 50.0 37.9 37.4 28.1 55.9 41.1 33.0 32.3 28.8 23.1 23.8 107.4 54.3 33.2 29.7 128.8 BMI1 "PCGF4, RNF51" ENSG00000168283 "BMI1 proto-oncogene, polycomb ring finger" P35226 10 22321211-22331484 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 132.9;Late spermatids: 118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 89.1;U-937: 104.6" "CAB011120, HPA030471, HPA030472" Supported Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Nucleoli, Cytosol" "CAB011120: , HPA030471: AB_2673491, HPA030472: AB_10601090" "unprognostic (5.44e-1)" "unprognostic (2.98e-1)" "unprognostic (4.24e-2)" "unprognostic (4.37e-2)" "unprognostic (2.76e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (2.60e-8)" "unprognostic (9.43e-2)" "unprognostic (7.95e-2)" "unprognostic (7.84e-2)" "unprognostic (8.23e-2)" "unprognostic (1.56e-1)" "unprognostic (7.44e-2)" "unprognostic (9.73e-2)" "unprognostic (8.56e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-2)" 19.7 23.5 28.0 17.0 35.0 13.3 26.5 26.1 33.7 21.6 22.3 26.3 11.6 14.1 23.9 22.8 16.0 17.0 17.4 15.1 28.3 24.2 19.2 25.5 16.7 17.9 42.3 27.7 18.8 18.6 40.0 37.6 20.6 24.8 25.5 16.0 16.5 15.7 20.3 28.5 10.3 14.6 26.3 34.8 24.6 16.5 24.3 40.7 12.9 17.6 10.6 18.8 21.5 25.9 5.0 1.8 13.0 3.4 6.2 8.4 2.4 13.0 6.3 7.3 2.2 12.8 10.3 7.3 8.8 4.0 6.7 8.0 6.6 16.3 6.7 6.0 8.0 7.5 4.6 10.5 6.2 8.4 89.1 13.1 18.4 5.4 7.4 7.6 6.8 10.2 6.6 10.9 7.4 8.2 8.5 4.7 10.8 18.2 11.3 8.9 5.2 18.2 2.0 1.7 6.1 15.1 13.6 10.4 6.4 6.4 4.2 6.1 12.1 5.8 7.6 9.8 3.3 6.9 27.3 10.1 7.5 22.7 18.1 11.8 14.0 18.2 14.7 10.7 104.6 4.9 13.0 1.5 2.5 6.1 3.4 8.4 5.0 6.4 5.8 1.0 2.6 5.5 5.2 0.6 6.2 2.1 1.8 4.3 2.4 28.0 35.0 26.1 33.7 28.3 24.2 42.3 27.7 24.8 40.7 23.8 20.0 13.4 18.4 14.2 21.3 16.1 10.2 16.0 25.0 12.2 7.9 10.9 11.6 14.2 132.9 25.3 4.2 0.0 15.8 17.8 14.4 26.4 11.5 25.2 8.6 28.6 12.7 28.3 19.0 118.0 33.4 13.9 35.4 17.2 12.0 12.6 17.8 5.8 34.3 7.6 13.9 19.4 37.7 10.4 24.3 12.8 5.6 18.3 9.5 17.6 BMP7 OP-1 ENSG00000101144 "Bone morphogenetic protein 7" P18075 20 57168748-57266629 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.0;thyroid gland: 44.3" "Cell type enhanced" "Detected in many" 16 "Cytotrophoblasts: 108.5;Muller glia cells: 38.0;Syncytiotrophoblasts: 47.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.4" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "Daudi: 42.0;MCF7: 48.6;OE19: 22.8;RPMI-8226: 18.6;SK-BR-3: 31.7;U-698: 57.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057757 Approved Nucleoplasm,Nucleoli,Vesicles "Secreted to blood" NA NA 248000 Vesicles "Nucleoplasm, Nucleoli" "HPA057757: AB_2683518" "unprognostic (1.67e-1)" "unprognostic (9.72e-3)" "unprognostic (9.67e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.62e-1)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (4.63e-3)" "unprognostic (4.03e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (4.30e-2)" "unprognostic (1.21e-1)" "unprognostic (5.42e-2)" "unprognostic (1.59e-1)" 1.5 7.2 16.8 2.4 17.5 0.7 2.1 3.8 19.7 9.2 2.3 23.6 6.0 2.7 1.9 17.7 17.2 10.0 1.2 8.5 13.9 9.9 4.5 0.7 1.8 1.6 14.3 11.2 0.8 1.0 0.8 1.9 24.4 12.2 5.0 2.4 37.0 2.6 10.3 1.0 15.5 2.4 1.0 13.8 1.3 4.1 1.4 13.4 1.8 44.3 5.7 4.9 7.8 7.0 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 5.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.7 42.0 10.8 0.0 2.2 12.2 1.3 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.6 0.0 0.0 3.0 22.8 0.0 0.0 0.0 18.6 0.0 0.0 0.1 4.6 1.3 31.7 0.1 4.0 0.2 0.1 0.1 0.0 2.9 0.0 0.0 0.0 0.0 57.4 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 16.8 17.5 3.8 12.5 13.9 9.9 14.3 11.2 12.2 13.4 6.0 2.1 0.0 11.4 12.2 3.8 12.4 0.0 2.7 2.3 1.8 0.0 108.5 0.0 0.0 3.9 1.5 0.0 0.0 0.0 14.4 10.8 4.9 21.8 0.0 9.3 1.6 2.4 0.0 0.0 3.3 0.3 0.0 3.3 0.0 0.0 38.0 0.0 0.0 0.4 1.6 2.4 0.0 0.9 1.4 1.4 8.4 47.6 0.5 0.2 10.6 BMS1 "BMS1L, KIAA0187" ENSG00000165733 "BMS1, ribosome biogenesis factor" Q14692 10 42782801-42834937 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036589, HPA043081" Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli, Mitotic chromosome" "HPA036589: AB_10601460, HPA043081: AB_2678305" "unprognostic (1.46e-2)" "unprognostic (4.31e-1)" "unprognostic (7.09e-2)" "unprognostic (3.56e-2)" "unprognostic (3.11e-2)" "unprognostic (7.25e-3)" "prognostic unfavorable (1.06e-6)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (3.81e-3)" "unprognostic (1.32e-2)" "unprognostic (2.16e-3)" "unprognostic (7.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.43e-1)" "unprognostic (4.82e-2)" 17.8 15.3 10.4 15.8 19.7 17.4 16.2 22.5 20.6 15.5 12.9 13.7 11.2 11.8 23.1 13.4 17.8 14.0 10.0 14.4 10.8 13.3 17.8 16.8 14.1 17.2 12.6 15.4 17.5 16.2 24.7 28.0 15.3 22.8 14.1 15.4 12.3 18.8 14.0 29.9 18.1 13.8 14.7 15.0 18.3 13.5 14.8 13.4 20.7 14.0 17.2 19.2 14.4 15.9 9.8 8.4 3.4 9.1 6.2 11.6 5.6 16.8 14.4 14.0 15.9 10.6 8.8 13.6 14.2 15.0 16.8 14.5 19.8 13.3 9.0 10.1 12.2 9.4 14.8 22.8 18.3 22.1 13.1 16.0 12.0 11.2 16.8 9.2 32.4 11.4 7.9 9.4 18.1 17.6 9.4 12.7 10.5 21.0 9.7 11.9 14.2 18.0 10.7 17.7 11.7 15.3 16.6 14.7 9.6 9.3 14.9 10.7 11.4 12.3 13.8 11.7 15.3 16.7 9.4 15.3 7.9 28.3 15.7 23.0 7.8 9.6 26.3 11.5 24.0 6.0 3.4 5.1 2.9 8.6 9.1 10.2 9.8 10.6 9.3 8.4 7.4 11.6 10.0 0.7 6.2 7.4 4.4 7.5 5.6 10.4 19.7 22.5 20.6 10.8 13.3 12.6 15.4 22.8 13.4 29.8 24.9 24.6 24.5 20.4 21.0 41.4 22.9 68.3 44.3 22.7 9.8 24.5 18.3 25.0 12.0 26.4 7.9 0.0 30.5 25.1 21.9 17.4 20.9 17.1 17.5 20.6 16.1 23.9 18.6 8.1 21.9 21.0 32.1 41.5 10.4 11.4 29.2 7.0 15.6 23.2 25.6 19.4 20.3 35.2 53.5 22.2 20.8 20.0 16.8 36.0 BOP1 KIAA0124 ENSG00000261236 "Block of proliferation 1" Q14137 8 144262102-144291370 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 60.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 67.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047869, HPA066764" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA047869: AB_2680193, HPA066764: AB_2685716" "unprognostic (6.92e-2)" "unprognostic (5.03e-3)" "unprognostic (6.78e-2)" "unprognostic (2.06e-3)" "unprognostic (3.32e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (3.35e-5)" "unprognostic (2.25e-2)" "unprognostic (4.14e-1)" "unprognostic (3.31e-1)" "unprognostic (2.26e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (2.23e-7)" "unprognostic (7.83e-2)" "unprognostic (4.33e-1)" "unprognostic (8.49e-2)" "unprognostic (4.06e-3)" 4.8 4.3 5.7 7.7 5.9 7.8 6.4 6.3 6.9 2.0 3.9 1.6 2.0 5.1 2.7 1.5 6.8 2.6 4.8 5.1 5.5 2.8 6.2 2.3 6.6 4.1 6.7 2.7 17.5 5.1 2.2 3.2 4.3 2.9 1.5 1.5 5.8 3.0 19.0 7.4 4.5 4.9 2.0 4.8 4.4 8.3 3.3 6.3 3.9 6.7 4.5 3.5 6.9 5.2 6.4 2.5 4.7 3.5 5.7 2.5 12.5 24.6 3.4 14.5 2.0 2.3 12.6 8.7 1.8 8.8 5.5 18.6 7.3 15.3 14.9 3.3 3.3 10.1 6.2 10.3 2.0 13.4 24.8 19.2 14.9 14.1 4.6 8.5 10.6 4.5 5.1 7.4 6.7 1.7 5.5 14.2 19.3 5.1 3.4 32.0 22.8 10.9 8.3 12.9 67.8 17.5 5.1 23.3 3.6 8.4 19.1 7.6 9.3 12.1 5.9 1.7 8.9 8.1 10.3 8.1 25.0 10.9 24.9 4.9 3.1 12.8 6.0 13.8 10.6 0.0 4.7 2.5 4.4 4.7 4.8 5.2 4.9 5.7 6.4 4.5 4.4 4.1 0.2 3.5 4.0 4.1 4.2 2.5 8.9 6.1 13.4 13.8 0.5 10.2 6.7 10.2 2.7 6.8 10.4 0.0 21.5 5.0 24.4 8.9 8.7 7.0 0.0 18.7 35.1 9.3 10.0 10.3 13.1 19.1 14.3 25.8 3.7 6.4 15.5 9.8 7.5 0.0 11.8 9.2 13.7 20.3 8.6 9.2 13.6 4.2 12.9 4.3 10.4 60.5 0.1 14.9 8.7 21.6 11.6 BPGM ENSG00000172331 "Bisphosphoglycerate mutase" P07738 7 134646808-134679813 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 184.7" "Group enriched" "Detected in all" 5 "Distal tubular cells: 109.5;Erythroid cells: 303.7;Syncytiotrophoblasts: 308.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 38.0;RT4: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016493, HPA028735" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA 69000000 "Nucleoli, Nucleoli rim" Nucleoplasm "HPA016493: AB_1845414, HPA028735: AB_10600791" "unprognostic (2.56e-1)" "prognostic favorable (7.95e-4)" "unprognostic (3.19e-1)" "unprognostic (3.94e-1)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (3.81e-3)" "unprognostic (1.96e-1)" "unprognostic (7.74e-2)" "unprognostic (4.67e-3)" "unprognostic (7.42e-2)" "unprognostic (5.69e-2)" "prognostic favorable (1.54e-8)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.78e-2)" 6.1 7.3 13.6 4.5 11.1 37.7 6.9 11.7 11.6 7.1 6.9 9.1 6.1 4.3 5.4 10.2 14.6 4.7 6.9 7.3 12.5 14.2 19.1 8.1 8.0 5.2 13.9 7.8 5.7 5.4 16.5 14.4 184.7 12.4 7.5 5.4 6.7 10.6 10.3 17.7 5.5 6.0 6.6 15.9 8.6 6.8 7.4 8.8 8.5 7.5 22.2 13.3 24.9 9.5 11.6 10.2 28.2 12.8 9.8 14.5 12.8 4.5 5.5 7.4 9.9 8.5 5.0 7.4 13.7 16.6 5.3 8.0 2.2 6.1 5.5 4.1 7.6 10.6 3.7 7.8 7.5 9.4 38.0 6.8 3.2 5.1 2.5 5.8 6.0 4.2 4.9 6.9 10.0 5.5 8.2 19.3 7.0 9.2 7.0 12.6 2.2 9.8 8.4 7.6 9.3 5.3 7.5 5.3 4.0 12.1 61.1 6.3 10.7 6.3 7.7 6.8 8.2 5.1 3.9 14.7 8.5 2.0 11.4 11.1 11.5 13.2 6.9 14.7 5.8 14.5 28.2 9.8 27.6 14.5 12.8 10.4 11.6 9.5 12.7 10.2 10.5 13.2 13.4 18.0 9.8 12.5 6.7 12.0 12.8 13.6 11.1 11.7 11.6 12.5 14.2 13.9 7.8 12.4 8.8 8.9 26.7 14.4 18.4 34.7 20.3 20.5 15.3 29.4 14.8 26.2 2.0 35.3 109.5 38.4 2.2 11.9 5.1 303.7 15.9 28.0 17.1 21.1 24.3 4.3 13.3 19.1 12.6 8.0 7.3 5.1 9.5 11.3 21.9 19.8 3.8 18.6 36.1 3.5 11.3 47.1 11.6 6.5 24.7 27.9 22.5 11.5 308.5 21.5 4.5 13.7 BRF2 "BRFU, FLJ11052, TFIIIB50" ENSG00000104221 "BRF2, RNA polymerase III transcription initiation factor subunit" Q9HAW0 8 37843268-37849904 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019269, HPA023378" Supported Supported Nucleoli NA NA Nucleoli "CAB019269: , HPA023378: AB_1845446" "unprognostic (9.85e-3)" "unprognostic (2.74e-1)" "unprognostic (2.95e-2)" "unprognostic (2.00e-1)" "unprognostic (2.51e-1)" "unprognostic (1.07e-3)" "unprognostic (3.91e-2)" "unprognostic (2.35e-2)" "unprognostic (9.68e-2)" "unprognostic (3.31e-1)" "unprognostic (2.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (2.52e-3)" "unprognostic (1.33e-1)" "unprognostic (1.93e-1)" "unprognostic (7.41e-2)" 12.6 10.3 8.4 8.3 9.9 19.0 12.1 9.8 17.9 12.8 11.0 8.7 9.7 7.5 14.7 10.4 9.2 12.9 8.6 17.0 9.9 8.6 8.7 8.8 9.0 11.6 10.2 10.7 20.2 16.2 8.4 11.1 12.9 9.5 14.8 8.5 11.4 10.6 13.3 32.4 11.9 8.1 12.4 7.4 11.0 9.5 13.1 9.9 21.7 10.7 10.7 9.0 11.5 19.0 12.8 8.3 10.2 8.8 16.6 19.1 10.2 9.8 7.6 7.5 10.0 10.4 7.7 8.8 11.8 9.2 15.7 10.8 9.8 7.1 12.0 17.3 7.3 6.3 10.3 9.6 7.3 7.8 7.6 9.8 14.9 6.4 8.0 10.9 5.9 9.0 10.2 9.6 15.7 6.7 8.1 5.1 11.1 18.2 10.8 5.0 5.8 18.6 8.5 12.9 7.2 9.7 11.6 8.7 6.2 5.7 6.6 6.4 8.5 5.6 8.2 13.2 11.3 17.2 13.0 6.8 8.5 11.3 18.2 12.0 13.5 18.1 14.2 11.6 9.1 14.8 10.2 8.8 9.5 12.7 7.8 12.7 12.7 13.3 12.9 6.9 12.8 19.1 15.3 3.6 16.6 7.2 8.3 11.5 10.2 8.4 9.9 9.8 17.9 9.9 8.6 10.2 10.7 9.5 9.9 11.9 4.5 1.5 3.7 3.9 8.9 0.3 5.1 5.3 2.3 8.7 0.0 18.8 6.6 7.4 0.3 5.6 7.7 46.7 9.7 8.6 7.1 2.8 2.3 1.7 10.0 7.9 6.3 4.9 7.8 1.6 8.6 3.5 3.3 9.0 7.1 11.4 5.0 0.0 9.9 4.0 6.8 6.5 6.6 10.0 10.5 3.3 11.8 8.7 6.2 2.1 BRIX1 "BRIX, BXDC2, FLJ11100" ENSG00000113460 "BRX1, biogenesis of ribosomes" Q8TDN6 5 34915376-34925996 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039614 Enhanced "Nucleoli,Mitotic chromosome" Yes No "Nucleoli, Mitotic chromosome" "HPA039614: AB_10963698" "prognostic unfavorable (2.18e-4)" "unprognostic (2.60e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (1.10e-5)" "unprognostic (1.82e-1)" "unprognostic (5.85e-3)" "prognostic unfavorable (4.11e-8)" "unprognostic (3.37e-2)" "unprognostic (3.84e-3)" "prognostic favorable (6.34e-4)" "unprognostic (1.24e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (3.07e-9)" "unprognostic (1.95e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "unprognostic (2.09e-2)" 18.9 18.4 20.4 15.6 24.0 30.6 23.7 24.9 24.1 16.4 14.4 10.7 18.9 11.9 18.1 18.2 23.4 17.6 11.9 16.4 15.8 15.2 17.0 18.6 14.0 22.2 21.1 15.6 19.4 13.4 15.6 19.1 24.5 20.9 15.9 16.5 7.7 15.7 14.5 19.7 15.9 13.3 22.9 18.6 17.0 14.7 13.4 21.9 17.0 16.6 14.2 23.1 21.6 21.7 22.9 14.0 4.1 10.4 15.0 22.1 16.2 14.8 14.7 15.0 20.7 6.5 9.3 29.6 18.4 13.0 24.9 15.9 20.0 19.7 32.8 9.5 10.9 27.7 12.4 26.2 18.9 28.3 17.6 25.9 21.9 35.2 17.8 17.9 34.8 15.2 11.2 12.3 22.9 20.7 7.6 11.4 17.2 38.3 10.0 16.2 16.1 24.1 38.1 24.2 17.6 21.6 21.6 27.2 14.1 14.3 17.3 18.2 16.3 38.0 26.7 17.1 12.4 16.7 21.5 6.8 19.1 20.9 13.7 35.1 9.1 19.4 41.6 16.5 40.1 23.7 4.1 8.5 4.0 14.4 7.9 20.4 22.9 17.7 18.1 10.7 18.0 22.1 19.6 0.5 15.0 10.4 14.0 16.4 16.2 20.4 24.0 24.9 24.1 15.8 15.2 21.1 15.6 20.9 21.9 26.8 30.7 36.9 76.5 96.6 20.2 18.6 15.3 46.8 48.9 22.7 11.8 108.4 41.4 38.0 10.5 32.1 8.4 23.3 37.3 80.2 49.4 31.2 18.6 11.5 37.1 20.6 20.2 16.5 12.9 6.8 36.5 20.6 30.4 33.3 17.8 15.1 37.9 10.5 27.3 26.6 34.1 6.5 35.4 54.6 70.7 83.7 105.5 31.6 29.0 66.5 BRWD1 "C21orf107, DCAF19, FLJ11315, N143, WDR9" ENSG00000185658 "Bromodomain and WD repeat domain containing 1" Q9NSI6 21 39184176-39321559 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030943, HPA030944, HPA030945, CAB034184" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "CAB034184: AB_2243666, HPA030943: AB_2673666, HPA030944: AB_2673667, HPA030945: AB_10670161" "unprognostic (6.00e-2)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (1.31e-1)" "unprognostic (1.27e-1)" "unprognostic (8.39e-3)" "unprognostic (4.94e-2)" "unprognostic (5.01e-2)" "unprognostic (8.90e-2)" "unprognostic (2.26e-1)" "unprognostic (4.82e-3)" "unprognostic (5.45e-2)" "unprognostic (2.58e-3)" "unprognostic (6.48e-2)" "unprognostic (1.19e-1)" "unprognostic (3.88e-2)" "unprognostic (2.56e-2)" 10.9 16.7 33.0 15.4 36.8 13.4 16.3 15.5 40.2 12.3 12.0 14.3 10.5 8.8 13.0 21.1 10.2 11.8 9.9 12.9 29.1 32.9 13.9 21.8 10.0 12.9 24.3 17.7 16.2 17.2 12.8 12.0 15.2 13.4 13.2 11.5 13.0 9.3 11.8 14.6 11.9 9.6 13.1 16.1 9.6 9.9 17.2 10.5 22.4 17.7 9.3 13.2 12.1 11.6 8.5 7.2 11.6 6.1 10.2 11.1 3.8 10.2 4.1 10.1 5.6 6.5 9.8 10.4 5.9 6.9 4.6 5.4 3.9 7.0 32.9 6.2 8.0 5.5 5.1 9.4 6.8 7.3 7.6 7.7 22.3 7.2 7.1 8.2 12.3 6.3 6.7 11.2 6.3 16.0 10.7 6.8 21.0 16.5 16.6 6.4 7.9 8.4 14.5 10.6 12.4 5.8 14.9 7.8 10.4 5.6 6.6 8.0 10.3 12.6 15.2 8.7 3.9 12.9 17.2 7.5 6.1 2.9 3.5 4.4 18.5 12.7 16.0 7.3 13.2 4.8 4.4 5.2 11.6 10.7 6.1 8.3 8.5 9.2 11.0 7.2 6.3 11.1 9.0 5.7 10.2 3.8 6.8 10.3 3.8 33.0 36.8 15.5 40.0 29.1 32.9 24.3 17.7 13.4 10.5 44.7 40.4 19.5 36.5 56.1 63.7 54.9 17.8 49.5 39.8 17.4 110.0 50.0 38.1 24.8 41.9 37.6 30.2 23.3 30.0 38.8 37.9 51.4 31.3 31.6 22.1 69.9 34.0 33.2 35.6 16.8 40.0 27.5 28.7 23.4 35.9 35.9 32.0 28.1 42.1 28.1 103.4 25.8 37.3 85.4 77.1 61.5 83.5 38.9 34.2 55.4 BTBD16 "C10orf87, Em:AC061711.1, FLJ25359" ENSG00000138152 "BTB domain containing 16" Q32M84 10 122271306-122338162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skin 1: 9.1;testis: 27.6;urinary bladder: 17.9" "Group enriched" "Detected in some" 19 "Early spermatids: 100.4;Late spermatids: 53.9" "Cancer enriched" "Detected in many" 14 "urothelial cancer: 18.4" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 29 "T-reg: 2.8" "Lineage enriched" "Detected in single" 29 "T-cells: 2.8" "Cell line enriched" "Detected in some" 8 "RT4: 27.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA040529, HPA057638" Uncertain Uncertain Nucleoli,Cytosol Yes NA Nucleoli Cytosol "HPA040529: AB_2677022, HPA057638: " "unprognostic (1.41e-4)" "unprognostic (1.33e-1)" "unprognostic (5.97e-2)" "unprognostic (5.98e-3)" "unprognostic (2.08e-1)" "unprognostic (2.09e-3)" "unprognostic (2.88e-1)" "unprognostic (4.54e-2)" "unprognostic (1.76e-1)" "unprognostic (6.85e-2)" "unprognostic (2.48e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (9.12e-2)" "unprognostic (9.44e-3)" 0.3 0.0 0.6 0.3 0.5 0.0 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.6 0.3 0.3 0.2 0.3 0.3 0.9 0.4 0.3 4.4 0.3 0.3 1.2 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.4 0.3 0.3 9.1 0.3 0.3 2.3 0.3 0.0 27.6 0.3 0.3 0.3 0.3 0.3 17.9 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 1.3 27.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.6 0.5 0.3 0.3 0.9 0.4 1.2 0.3 0.3 0.3 0.0 0.0 0.0 0.2 2.5 0.0 0.2 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.9 100.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 53.9 0.6 0.0 0.0 0.0 0.0 0.0 1.3 2.9 0.4 0.8 0.0 0.0 0.2 3.7 0.9 2.8 0.1 0.0 0.0 0.8 BUD23 "MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22" ENSG00000071462 "BUD23, rRNA methyltransferase and ribosome maturation factor" O43709 7 73683025-73705161 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 144.6;Exocrine glandular cells: 122.2;Pancreatic endocrine cells: 97.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 113.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052185 Approved Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA052185: AB_2681753" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (2.67e-2)" "unprognostic (4.79e-2)" "unprognostic (3.62e-3)" "unprognostic (8.54e-2)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.17e-1)" "unprognostic (9.16e-2)" "unprognostic (9.20e-2)" "unprognostic (6.71e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (1.46e-1)" "unprognostic (3.13e-3)" 16.6 23.4 16.3 15.0 18.8 19.6 18.3 12.3 20.6 17.5 19.3 17.9 19.5 18.3 19.1 30.6 17.5 24.1 23.1 34.2 16.0 17.5 28.1 36.3 16.1 18.3 25.3 17.5 19.3 27.9 14.3 21.8 22.1 16.4 16.5 19.8 20.3 25.1 25.6 52.2 19.3 21.6 21.2 18.7 18.7 18.9 97.0 16.5 22.1 25.8 22.6 22.7 18.7 14.8 43.9 49.0 14.4 18.3 30.1 37.6 31.4 22.2 24.6 9.0 71.4 12.4 11.1 15.0 15.4 13.9 19.9 16.3 34.0 30.1 26.0 8.1 16.5 34.3 16.0 20.7 14.9 18.4 18.2 24.0 11.3 28.7 13.7 15.7 31.7 16.6 10.0 17.2 17.5 15.9 10.1 12.8 21.5 44.7 48.2 17.2 35.1 19.9 43.6 21.5 51.7 28.3 17.8 17.6 113.3 22.0 16.1 27.3 20.5 20.6 55.0 22.8 9.3 34.6 25.4 13.7 17.2 21.9 21.7 32.9 16.7 29.2 43.7 39.4 24.2 35.9 11.5 17.1 14.4 30.7 18.3 34.3 43.9 35.5 33.6 31.5 38.0 37.6 34.4 3.2 30.1 16.2 49.0 37.3 31.4 16.3 18.8 12.3 20.6 16.0 17.5 25.3 17.5 16.4 16.5 41.7 53.9 0.0 0.0 0.0 0.0 0.0 0.0 144.6 78.5 43.6 0.0 64.0 82.9 81.2 0.0 0.0 0.0 0.0 122.2 66.3 0.0 0.0 43.0 0.0 62.2 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 36.9 0.0 0.0 97.5 0.0 0.0 82.3 0.0 0.0 0.0 0.0 0.0 0.0 89.2 0.0 0.0 0.0 BYSL Enp1 ENSG00000112578 "Bystin like" Q13895 6 41921188-41933046 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031217, HPA031219" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA031217: AB_10599488, HPA031219: AB_10601989" "unprognostic (6.12e-3)" "unprognostic (6.97e-2)" "unprognostic (2.90e-1)" "unprognostic (2.33e-3)" "unprognostic (4.38e-2)" "unprognostic (2.73e-3)" "prognostic unfavorable (6.43e-4)" "unprognostic (2.09e-2)" "unprognostic (2.51e-1)" "unprognostic (6.38e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (2.15e-8)" "unprognostic (4.39e-2)" "unprognostic (2.18e-1)" "unprognostic (2.79e-3)" "unprognostic (5.99e-2)" 11.5 13.4 6.0 11.5 7.2 6.0 17.5 5.0 8.9 7.8 7.9 4.6 5.3 4.0 11.0 5.4 11.7 9.3 10.0 17.6 5.9 6.8 8.0 18.6 7.1 7.4 5.8 6.5 11.8 15.9 10.6 5.4 11.3 7.4 8.0 6.8 4.8 9.6 7.9 31.7 9.2 5.0 12.6 6.3 9.9 7.3 8.9 4.6 20.1 7.1 11.9 12.9 7.3 10.1 4.0 9.3 0.9 3.4 4.5 5.5 2.2 11.9 14.8 8.2 11.6 6.1 6.9 16.8 12.2 6.4 19.3 14.1 20.4 3.1 22.0 11.1 9.1 13.2 7.9 24.9 17.8 15.2 7.9 27.1 20.5 10.4 22.9 10.6 14.6 9.0 8.9 11.6 18.0 16.4 4.2 13.2 12.9 26.0 4.9 12.7 20.4 15.3 14.7 6.4 37.3 15.6 18.3 11.2 14.0 10.7 10.2 16.5 10.0 8.1 7.4 14.2 6.6 8.6 12.9 10.2 11.2 13.3 7.6 17.7 5.7 7.4 47.6 3.8 14.8 11.7 0.0 3.4 0.9 3.9 3.4 5.5 3.8 2.5 3.1 5.4 4.0 1.3 3.0 0.3 4.5 3.1 9.3 3.1 2.2 6.0 7.2 5.0 8.9 5.9 6.8 5.8 6.5 7.4 4.6 0.0 3.8 8.9 21.5 27.5 2.5 2.5 5.1 4.0 5.7 1.8 3.9 19.5 3.3 20.9 6.2 7.1 1.4 0.0 14.8 19.5 10.6 9.6 2.3 6.6 10.6 0.0 5.2 4.3 1.0 3.4 7.5 5.3 8.5 7.2 5.5 3.4 18.6 0.0 6.7 8.4 2.8 6.5 17.3 6.5 26.9 22.1 24.4 5.0 9.9 23.5 C11orf68 "BLES03, P5326" ENSG00000175573 "Chromosome 11 open reading frame 68" Q9H3H3 11 65916808-65919117 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045938 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" No Yes "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA045938: AB_10961633" "unprognostic (3.18e-1)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (1.23e-1)" "unprognostic (9.25e-2)" "unprognostic (1.15e-2)" "unprognostic (9.88e-2)" "unprognostic (5.98e-2)" "unprognostic (9.88e-2)" "unprognostic (2.73e-1)" "unprognostic (1.50e-3)" "prognostic favorable (5.02e-6)" "unprognostic (2.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.07e-2)" "unprognostic (1.18e-1)" 20.1 13.1 23.5 11.0 23.5 6.9 15.4 44.0 42.9 24.5 19.7 20.0 16.6 13.6 26.3 33.0 19.0 25.3 16.4 24.5 22.9 18.8 13.7 12.1 15.4 17.3 18.3 23.7 32.9 17.6 20.6 11.0 19.5 18.6 23.3 12.9 14.8 24.2 27.5 37.0 19.6 13.1 22.2 15.5 19.0 14.1 21.5 18.5 23.0 21.5 13.1 16.4 22.3 23.1 6.6 3.6 12.6 5.2 4.9 7.5 2.8 20.4 9.2 5.7 6.2 20.2 19.6 4.9 16.4 25.2 21.0 12.9 3.4 23.3 4.2 11.5 24.6 33.7 6.7 4.4 10.1 11.4 6.5 4.4 5.0 6.2 8.9 16.1 3.9 6.7 18.1 15.2 15.2 16.9 21.9 15.6 7.2 6.6 10.6 38.1 9.3 5.2 9.6 5.7 4.5 46.3 7.7 6.5 11.8 11.1 3.9 3.9 6.1 6.3 8.4 15.8 6.2 10.8 3.8 16.8 33.6 16.4 45.6 8.3 7.1 3.1 3.5 19.9 3.0 26.1 8.7 3.5 4.9 7.4 5.2 5.2 4.2 4.8 6.1 2.6 6.6 7.4 7.5 12.6 4.9 2.6 3.6 5.6 2.8 23.5 23.5 44.0 42.9 22.9 18.8 18.3 23.7 18.6 18.5 14.9 6.1 6.7 24.0 13.6 10.2 13.7 15.3 0.0 1.2 15.7 9.8 13.0 6.6 11.6 6.3 10.5 10.0 0.0 10.0 13.3 15.8 19.5 3.5 9.6 12.3 15.9 4.6 16.0 11.5 19.9 19.8 6.6 10.1 14.4 11.6 22.3 13.9 0.0 33.2 5.1 7.2 19.4 12.5 13.9 14.3 11.2 18.3 8.7 8.4 22.4 C12orf43 FLJ12448 ENSG00000157895 "Chromosome 12 open reading frame 43" Q96C57 12 121000486-121016502 "Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046148, HPA061739" Uncertain Supported "Nucleoli,Golgi apparatus" NA NA Nucleoli "Golgi apparatus" "HPA046148: AB_10965169, HPA061739: AB_2684597" "unprognostic (1.51e-1)" "unprognostic (5.75e-2)" "unprognostic (3.44e-1)" "unprognostic (1.75e-2)" "unprognostic (2.43e-1)" "unprognostic (3.24e-2)" "prognostic unfavorable (1.29e-6)" "prognostic unfavorable (6.44e-4)" "unprognostic (3.53e-1)" "unprognostic (5.02e-2)" "unprognostic (2.54e-1)" "unprognostic (1.95e-1)" "unprognostic (2.45e-3)" "unprognostic (9.70e-2)" "unprognostic (2.49e-1)" "unprognostic (2.28e-1)" "unprognostic (1.36e-1)" 10.0 8.6 12.1 7.5 12.9 7.5 8.7 15.2 19.6 7.4 10.2 8.5 3.1 5.7 11.4 5.3 7.2 11.2 5.8 8.7 8.4 8.5 7.2 12.0 7.8 9.2 8.3 11.1 14.3 8.8 9.3 6.8 8.3 13.1 7.3 6.4 8.0 10.0 8.0 7.2 6.4 5.8 10.0 7.1 7.3 7.2 7.1 6.7 7.5 7.6 4.0 8.4 9.6 6.9 16.2 10.7 5.8 13.7 11.0 19.9 13.4 9.8 22.3 11.7 9.1 10.4 8.2 12.9 12.2 12.6 20.6 13.0 16.0 9.3 18.3 12.6 11.8 10.9 11.2 13.7 18.7 12.4 21.9 15.3 14.6 9.5 11.8 12.3 19.3 11.8 9.6 9.9 18.9 12.0 13.1 11.8 19.3 17.3 4.9 10.8 16.2 21.1 15.2 20.8 7.7 16.7 19.0 13.8 13.8 12.6 14.8 16.0 10.2 16.4 7.2 13.2 10.2 19.4 9.1 11.2 11.4 13.7 9.2 12.8 8.9 12.8 14.3 15.0 11.6 16.8 3.7 10.3 5.8 16.9 13.7 15.4 16.2 16.7 16.4 10.7 13.0 19.9 16.9 1.6 11.0 11.4 8.6 15.1 13.4 12.1 12.9 15.2 19.6 8.4 8.5 8.3 11.1 13.1 6.7 23.8 17.8 18.3 14.4 7.8 17.3 5.9 7.6 22.7 7.9 17.4 19.6 19.3 19.9 13.9 4.8 14.4 4.9 0.0 15.9 18.1 10.8 10.6 13.9 10.2 14.6 15.9 2.4 11.1 11.0 8.2 12.7 8.1 13.5 25.2 7.7 15.4 13.1 8.6 12.0 12.9 13.6 19.4 14.4 12.6 12.8 6.8 11.4 16.6 9.5 10.6 C14orf39 SIX6OS1 ENSG00000179008 "Chromosome 14 open reading frame 39" Q8N1H7 14 60396469-60515543 "Plasma proteins, Predicted intracellular proteins" "DNA recombination, Meiosis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 70.5" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in single" "hypothalamus: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 4.7;JURKAT: 21.7;MOLT-4: 17.6;RH-30: 4.8;U-2 OS: 9.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059518 Uncertain Approved Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA059518: AB_2684049" "unprognostic (6.17e-2)" "unprognostic (1.73e-3)" "unprognostic (3.00e-6)" "unprognostic (2.78e-1)" "unprognostic (6.97e-2)" "unprognostic (7.55e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (4.35e-1)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" 1.0 2.7 0.0 0.6 0.2 0.0 0.1 0.0 0.5 0.5 0.8 0.0 0.0 0.3 0.6 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.4 1.7 0.0 0.6 16.9 0.0 0.2 1.6 0.0 1.6 6.7 0.1 3.8 0.0 0.3 0.1 0.5 0.0 0.6 14.9 0.0 0.0 0.4 1.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 4.7 0.0 0.0 0.0 0.0 0.3 3.6 0.0 0.6 0.0 0.1 0.0 21.7 0.0 0.0 1.6 0.0 17.6 0.2 2.3 0.0 1.1 0.0 4.8 0.0 0.3 1.2 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 1.4 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.6 0.0 1.4 5.7 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 3.2 0.0 0.0 0.0 5.1 0.3 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.7 0.0 1.0 0.0 0.0 70.5 6.1 0.0 0.0 0.0 0.0 0.1 C15orf61 LOC145853 ENSG00000189227 "Chromosome 15 open reading frame 61" A6NNL5 15 67521068-67530143 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062820 Approved Nucleoli,Vesicles,Cytosol "Secreted - unknown location" NA NA "Nucleoli, Vesicles" Cytosol "HPA062820: AB_2684874" "unprognostic (1.35e-1)" "unprognostic (9.42e-3)" "unprognostic (2.11e-1)" "unprognostic (5.41e-2)" "unprognostic (2.40e-1)" "unprognostic (2.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.87e-3)" "unprognostic (8.95e-2)" "unprognostic (4.01e-2)" "unprognostic (1.04e-2)" "unprognostic (8.45e-2)" "prognostic favorable (5.31e-5)" "unprognostic (2.42e-2)" "unprognostic (9.78e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" 9.9 10.0 10.8 4.7 18.1 11.0 17.9 14.5 17.2 5.5 6.0 2.4 5.6 7.5 6.3 5.9 5.5 5.2 5.1 21.0 8.7 7.2 8.4 6.4 7.2 7.5 6.9 10.9 7.9 20.7 8.8 10.9 5.8 7.3 7.2 6.4 5.9 7.0 6.4 45.8 8.4 5.0 7.0 5.8 5.0 6.6 25.2 5.5 3.6 7.7 16.9 3.7 4.6 8.0 7.2 7.2 10.7 6.6 5.1 9.8 5.0 4.2 4.6 1.2 5.1 5.4 7.8 3.3 1.9 3.4 3.5 2.8 3.5 3.0 3.6 4.1 2.1 4.1 5.0 4.6 1.3 2.9 2.1 10.9 3.8 3.5 4.6 3.5 4.7 3.2 8.1 3.5 1.1 4.3 2.5 1.6 11.1 4.3 8.0 1.1 2.4 3.8 7.7 1.9 3.4 5.8 5.2 2.6 13.1 2.5 3.0 6.8 5.1 3.3 3.2 5.8 2.3 2.8 7.2 1.6 4.7 7.2 5.9 4.8 7.6 11.0 8.7 2.0 9.2 2.4 8.6 6.6 10.7 7.0 5.2 8.0 7.2 9.2 6.9 6.9 5.6 9.8 7.9 0.8 5.1 4.4 7.2 5.6 5.0 10.8 18.1 14.5 17.2 8.7 7.2 6.9 10.9 7.3 5.5 20.8 9.1 25.1 28.7 59.6 71.3 69.8 20.4 6.7 7.9 15.7 35.3 35.6 68.0 21.1 136.1 26.6 30.6 0.0 25.8 25.7 33.5 30.2 33.5 33.8 26.4 12.7 26.0 17.2 20.2 22.0 38.0 16.0 35.4 7.2 47.0 62.2 24.4 38.6 24.1 54.0 68.8 32.3 28.3 136.2 21.8 53.2 17.2 31.9 43.0 15.6 C16orf58 FLJ13868 ENSG00000140688 "Chromosome 16 open reading frame 58" Q96GQ5 16 31489471-31509309 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024406 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol" NA NA "Nucleoli, Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA024406: AB_1845580" "unprognostic (1.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.25e-2)" "unprognostic (4.22e-1)" "unprognostic (6.21e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (9.89e-2)" "unprognostic (3.20e-1)" "unprognostic (1.58e-1)" "unprognostic (6.34e-3)" "unprognostic (1.14e-1)" "unprognostic (1.22e-1)" "unprognostic (5.69e-2)" "unprognostic (2.24e-2)" 13.5 17.7 15.9 15.3 22.3 11.0 15.7 17.9 30.8 22.6 17.5 16.6 34.2 18.6 24.2 21.4 16.8 21.0 20.0 16.7 12.9 15.3 19.1 51.0 13.9 15.7 13.8 16.4 29.5 49.1 30.7 27.6 23.1 13.1 22.0 11.6 22.9 36.9 26.7 4.8 14.1 22.2 15.6 9.1 12.9 19.7 11.9 14.3 15.1 26.4 14.2 19.3 15.9 17.4 8.9 12.0 8.8 9.8 10.8 11.3 8.4 11.6 15.4 9.7 16.8 22.5 15.0 18.0 14.0 23.9 10.9 13.0 4.6 20.5 10.0 29.7 20.6 14.1 16.3 9.6 12.9 5.1 14.5 9.6 10.1 8.8 11.6 32.7 11.9 12.2 18.2 14.1 14.3 29.5 21.5 10.5 16.1 14.9 17.3 10.6 22.0 5.5 8.0 7.5 17.1 10.1 12.7 14.5 30.2 12.4 7.3 10.6 16.3 10.5 27.7 21.8 9.6 23.9 17.6 9.1 19.1 10.7 12.2 9.1 25.2 14.7 7.5 24.4 18.4 26.2 3.8 6.9 8.8 10.3 9.8 9.6 8.9 10.7 10.2 12.0 8.5 10.8 9.3 1.2 10.8 9.6 11.0 11.3 8.4 15.9 22.3 17.9 30.8 12.9 15.3 13.8 16.4 13.1 14.3 6.0 14.2 9.0 7.9 5.5 22.6 0.8 10.2 6.7 9.1 15.7 2.0 18.1 5.0 17.5 1.5 6.3 17.7 0.0 18.6 17.9 13.1 13.9 18.4 21.9 12.9 12.7 14.3 7.4 8.4 2.5 20.1 6.4 16.9 6.4 20.7 12.4 12.0 10.5 15.2 6.8 22.3 25.8 9.2 13.4 11.7 4.1 18.7 8.3 17.8 7.9 C17orf97 "LIAT1, LOC400566" ENSG00000187624 "Chromosome 17 open reading frame 97" Q6ZQX7 17 410327-431062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.2" "Group enriched" "Detected in many" 11 "Early spermatids: 432.9;Late spermatids: 984.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 8.9;U-2197: 11.8" HPA023583 Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA023583: AB_1853122" "unprognostic (6.62e-2)" "unprognostic (9.12e-3)" "unprognostic (2.64e-1)" "unprognostic (3.07e-3)" "unprognostic (7.73e-2)" "unprognostic (6.51e-2)" "unprognostic (6.91e-2)" "unprognostic (3.17e-2)" "unprognostic (1.82e-1)" "unprognostic (1.11e-1)" "unprognostic (5.12e-2)" "unprognostic (8.07e-2)" "unprognostic (1.98e-3)" "unprognostic (7.70e-3)" "unprognostic (2.90e-1)" "unprognostic (2.84e-2)" "unprognostic (4.19e-2)" 2.1 4.9 6.0 2.4 10.6 1.9 2.7 5.2 8.7 3.9 3.6 4.2 4.4 2.2 3.5 4.5 2.4 13.6 6.6 3.8 5.2 6.1 7.6 1.9 3.8 2.8 4.0 7.6 3.8 3.8 3.4 8.2 1.4 6.2 3.3 2.9 4.2 3.5 5.8 4.3 2.5 4.7 1.9 2.8 2.1 2.4 53.2 2.9 5.0 6.9 1.8 1.9 3.1 1.8 0.4 0.9 2.7 0.4 0.8 1.4 0.2 2.6 3.8 1.8 2.2 1.0 0.8 0.9 2.0 1.3 1.5 0.9 0.1 4.0 0.7 1.5 4.3 1.2 8.9 4.8 1.0 1.4 0.3 0.6 1.9 3.3 0.3 3.4 0.4 0.8 1.0 2.5 3.3 0.4 2.2 1.5 4.4 0.3 0.1 1.0 2.2 6.4 3.4 2.8 7.9 1.2 0.7 0.4 2.4 6.2 2.2 0.6 2.1 2.4 3.4 0.5 3.2 2.0 2.9 1.4 1.8 0.9 11.8 0.8 0.2 0.2 0.0 2.3 0.9 1.1 0.4 0.4 2.7 0.3 0.2 0.0 0.2 0.2 0.8 0.5 0.4 1.4 1.3 0.2 0.8 0.4 0.9 0.0 0.2 6.0 10.6 5.2 8.7 5.2 6.1 4.0 7.6 6.2 2.9 3.0 5.1 0.0 3.8 3.0 4.3 5.3 10.2 62.9 11.4 19.2 19.6 0.9 53.0 10.2 432.9 1.8 10.5 23.3 3.1 0.2 3.7 3.9 2.3 4.7 1.7 1.6 15.4 1.8 0.0 984.3 7.8 2.5 3.3 4.6 9.3 10.0 4.7 5.8 6.0 19.3 22.2 6.5 2.1 58.4 13.3 0.9 0.7 0.0 8.5 0.9 C17orf98 LOC388381 ENSG00000275489 "Chromosome 17 open reading frame 98" A8MV24 17 38835088-38841455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 10.7" "Cell type enriched" "Detected in some" 14 "Early spermatids: 184.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "hTCEpi: 7.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051696 Uncertain Approved "Nucleoli,Intermediate filaments" NA NA "Intermediate filaments" Nucleoli "HPA051696: AB_2681576" "unprognostic (2.30e-1)" "unprognostic (3.25e-4)" "unprognostic (1.46e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-3)" "unprognostic (1.14e-2)" "unprognostic (8.69e-3)" "unprognostic (2.56e-1)" "unprognostic (7.58e-2)" "unprognostic (9.02e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 1.3 0.5 0.4 0.4 0.2 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.2 0.3 0.0 0.0 7.9 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.0 1.2 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.1 0.0 1.0 0.5 0.0 1.3 0.3 0.5 0.0 0.2 0.2 0.5 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 184.7 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 13.1 1.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.2 1.3 0.0 0.0 0.0 0.0 0.0 C18orf21 "HsT3108, PNAS-124, PNAS-131" ENSG00000141428 "Chromosome 18 open reading frame 21" Q32NC0 18 35972083-35979286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 94.7;Spermatocytes: 73.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065505, HPA067322" Uncertain Approved "Nucleoli,Plasma membrane" NA NA "Nucleoli, Plasma membrane" "HPA065505: AB_2685498, HPA067322: AB_2685822" "unprognostic (7.31e-2)" "unprognostic (2.14e-3)" "unprognostic (9.88e-2)" "unprognostic (8.66e-3)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.38e-6)" "unprognostic (2.53e-3)" "unprognostic (1.83e-2)" "prognostic favorable (1.81e-6)" "unprognostic (2.88e-2)" "unprognostic (1.24e-1)" "unprognostic (1.16e-1)" "unprognostic (1.21e-2)" "unprognostic (5.15e-3)" "unprognostic (2.35e-3)" "unprognostic (5.97e-2)" 14.1 16.1 13.4 16.7 12.5 53.0 18.4 23.1 25.8 13.0 12.8 7.9 17.6 15.2 15.0 17.7 15.0 12.9 11.7 15.2 12.4 12.5 14.0 14.5 11.3 17.1 11.7 14.7 16.4 22.0 12.9 16.9 14.8 13.0 13.4 12.3 8.1 16.5 17.8 28.7 13.6 14.1 15.8 10.6 17.2 16.7 28.7 11.7 22.9 14.8 21.4 15.7 17.8 14.8 18.5 15.1 40.6 16.5 16.5 21.7 10.6 13.3 9.1 19.8 13.6 12.7 19.4 13.3 18.4 17.5 22.1 22.5 7.7 9.1 10.7 19.7 13.5 15.3 13.7 13.8 14.1 24.6 16.2 14.1 11.2 10.8 17.3 18.4 34.0 14.0 18.7 23.0 19.5 19.8 20.6 18.0 17.2 18.1 17.4 14.5 14.9 22.4 23.6 16.6 6.2 10.0 15.2 16.9 20.8 14.9 14.7 12.7 19.0 12.3 9.9 29.4 18.9 14.4 15.3 12.8 21.8 10.4 8.0 16.2 24.4 21.7 23.5 11.1 17.7 11.4 40.6 16.5 18.3 14.6 16.5 14.6 18.5 15.9 13.7 15.1 16.1 12.3 16.0 14.9 16.5 15.3 14.6 21.7 10.6 13.4 12.5 23.1 25.8 12.4 12.5 11.7 14.7 13.0 11.7 17.9 6.7 15.9 8.2 10.5 9.1 10.8 5.1 2.7 11.4 1.8 5.9 15.8 10.0 17.5 94.7 8.7 9.3 0.0 24.9 24.6 8.9 7.3 13.9 9.4 18.9 7.9 6.9 8.6 16.8 46.0 20.8 13.1 11.8 10.8 13.0 8.4 18.6 11.5 15.9 17.0 11.1 0.0 8.6 73.2 36.1 10.8 11.0 12.8 16.6 7.1 C19orf53 "HSPC023, LYDG10" ENSG00000104979 "Chromosome 19 open reading frame 53" Q9UNZ5 19 13774168-13778462 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059928, HPA061291" Approved Approved Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA059928: AB_2684165, HPA061291: AB_2684469" "unprognostic (3.94e-2)" "unprognostic (2.70e-3)" "unprognostic (6.53e-2)" "unprognostic (3.12e-1)" "unprognostic (1.99e-2)" "unprognostic (8.93e-2)" "unprognostic (2.93e-3)" "unprognostic (2.77e-2)" "unprognostic (1.32e-1)" "unprognostic (2.96e-2)" "unprognostic (1.67e-1)" "unprognostic (6.31e-2)" "unprognostic (1.60e-3)" "unprognostic (5.21e-2)" "unprognostic (4.06e-2)" "unprognostic (2.69e-3)" "unprognostic (1.85e-2)" 37.3 41.5 55.6 31.1 53.7 42.1 33.1 22.0 41.7 40.4 35.7 27.0 34.2 28.0 33.9 55.6 43.1 44.0 39.3 67.0 46.2 44.8 42.8 68.4 35.5 42.4 47.2 34.7 49.9 46.9 27.4 41.8 27.2 37.3 39.2 26.4 30.1 45.9 35.7 90.7 31.5 29.2 39.6 37.0 34.8 31.3 34.1 30.0 59.6 53.5 47.7 41.6 43.1 43.1 67.9 63.0 57.3 49.6 36.3 75.8 92.4 35.4 50.6 25.2 21.0 35.8 40.5 16.7 33.4 29.7 41.6 41.5 46.9 17.3 18.9 41.7 40.4 30.6 19.0 23.3 50.5 21.5 22.6 73.5 17.7 54.7 50.9 37.1 27.7 23.5 49.4 36.5 38.5 21.8 26.5 35.6 28.2 27.4 32.6 32.4 79.9 39.1 28.7 32.1 27.2 89.7 21.5 19.2 32.7 36.9 44.0 23.0 27.7 23.4 27.8 33.9 19.5 25.3 28.5 23.7 47.3 18.9 50.6 45.7 36.5 46.4 28.2 28.7 31.5 25.6 48.1 48.8 57.3 49.0 49.6 55.5 67.9 63.4 57.0 44.2 63.3 75.8 68.0 23.7 36.3 43.1 63.0 69.4 92.4 55.6 53.7 22.0 41.7 46.2 44.8 47.2 34.7 37.3 30.0 107.2 86.2 241.2 221.7 258.6 46.5 224.1 198.7 117.8 97.8 254.7 21.6 202.0 532.2 215.9 134.2 206.4 254.0 163.5 291.0 335.7 214.9 274.6 125.8 284.8 320.6 33.4 218.2 154.1 231.7 499.2 202.5 228.8 219.4 359.7 182.1 129.2 247.0 245.4 171.5 582.8 48.4 90.5 205.0 94.7 135.7 304.6 178.2 221.8 197.3 276.6 C1D "LRP1, Rrp47, SUN-CoR, SUNCOR" ENSG00000197223 "C1D nuclear receptor corepressor" Q13901 2 68041130-68110948 "Predicted intracellular proteins" "Apoptosis, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037413, HPA037588" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037413: AB_2675463, HPA037588: AB_10672907" "unprognostic (1.84e-1)" "unprognostic (1.85e-1)" "unprognostic (1.06e-1)" "unprognostic (3.71e-3)" "unprognostic (2.03e-1)" "unprognostic (1.49e-2)" "unprognostic (4.01e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (1.98e-1)" "unprognostic (3.90e-2)" "unprognostic (1.29e-2)" "unprognostic (4.24e-3)" "unprognostic (6.18e-2)" "unprognostic (2.50e-1)" "unprognostic (8.80e-2)" "unprognostic (1.01e-1)" 17.1 20.1 15.9 13.3 17.9 31.5 17.2 13.9 26.5 15.4 16.3 12.4 15.4 14.7 14.9 14.6 13.8 13.9 12.4 15.8 14.9 15.6 28.4 29.8 14.4 21.0 14.8 16.8 14.9 27.3 12.5 25.3 18.6 17.0 14.8 13.9 8.6 13.5 14.0 29.4 11.7 19.2 12.2 17.2 16.4 15.1 13.8 18.6 17.4 18.0 16.4 14.7 13.2 20.0 20.0 16.1 32.1 19.6 22.6 19.7 9.4 21.9 12.3 15.4 12.9 15.6 19.8 20.5 28.5 19.7 20.0 16.5 21.5 24.7 27.7 17.4 19.0 21.2 10.8 18.1 13.3 31.2 29.5 21.8 32.5 10.5 24.6 15.8 40.3 34.5 16.3 22.4 15.0 14.3 24.4 15.3 26.2 25.8 24.2 18.3 11.1 26.8 34.9 16.5 20.4 15.3 16.9 18.3 21.8 18.1 15.9 13.5 15.5 10.4 18.2 28.2 18.6 13.3 27.4 17.0 17.3 19.9 21.1 25.0 23.2 25.8 35.0 22.0 25.1 19.6 28.1 14.3 32.1 15.9 18.5 18.7 20.0 18.0 13.2 16.1 17.2 19.6 19.7 29.0 22.6 19.6 15.0 19.0 9.4 15.9 17.9 13.9 26.5 14.9 15.6 14.8 16.8 17.0 18.6 71.5 36.3 61.4 75.3 75.6 34.8 30.5 61.1 75.0 45.5 61.1 21.6 86.5 198.9 74.3 40.6 40.9 39.1 23.3 52.1 69.0 56.7 67.4 42.8 75.7 76.6 33.4 49.7 40.5 54.7 18.1 51.5 56.0 54.0 76.7 38.4 39.8 54.5 63.3 55.5 180.4 29.5 97.0 44.0 91.4 84.7 75.4 90.2 57.5 31.5 88.7 C1orf109 FLJ20508 ENSG00000116922 "Chromosome 1 open reading frame 109" Q9NX04 1 37681570-37692249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 44.6;Suprabasal keratinocytes: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027110, HPA027127" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA027110: AB_10611813, HPA027127: AB_1845628" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (2.43e-1)" "unprognostic (3.30e-3)" "unprognostic (1.71e-2)" "unprognostic (7.13e-3)" "prognostic unfavorable (1.76e-7)" "unprognostic (1.93e-1)" "unprognostic (1.48e-2)" "unprognostic (8.38e-2)" "unprognostic (1.73e-1)" "unprognostic (3.79e-3)" "unprognostic (9.96e-2)" "unprognostic (1.66e-2)" "unprognostic (2.25e-1)" "unprognostic (7.96e-3)" "unprognostic (1.69e-1)" 13.8 15.1 12.0 9.3 15.0 9.3 14.5 17.9 20.5 12.9 11.1 11.4 16.2 11.0 15.9 14.3 13.7 13.9 10.5 11.1 13.1 12.9 12.8 12.0 8.8 14.1 13.6 15.0 19.7 19.6 20.5 10.9 14.6 15.9 15.0 7.8 12.9 20.3 14.8 15.2 14.9 8.5 11.6 9.9 10.1 11.1 11.2 12.2 13.1 15.7 9.1 12.6 13.7 12.8 11.4 27.5 3.3 5.0 12.2 16.2 7.5 8.3 9.6 8.3 13.6 7.3 5.2 18.9 10.0 7.1 15.2 11.2 14.6 10.1 11.9 12.1 4.4 7.0 12.2 15.3 10.2 15.6 18.9 17.2 13.5 9.7 9.1 14.1 14.7 8.9 7.1 12.6 14.9 19.5 6.6 7.6 10.5 26.5 14.5 8.6 5.7 14.2 6.5 25.8 8.6 18.5 14.2 17.4 32.5 8.0 7.2 25.1 12.1 8.8 13.7 20.3 8.7 7.7 6.6 5.1 15.3 9.6 12.3 20.3 11.8 13.1 24.3 7.6 14.4 16.0 1.7 5.0 3.3 10.3 3.9 16.1 11.4 12.4 9.9 5.9 10.3 16.2 13.8 0.9 12.2 4.2 27.5 6.2 7.5 12.0 15.0 17.9 20.5 13.1 12.9 13.6 15.0 15.9 12.2 6.0 6.4 16.6 16.0 44.6 9.7 4.5 7.6 6.7 15.9 3.5 9.8 11.8 11.6 8.2 1.2 10.5 4.0 23.3 6.3 11.6 13.5 9.8 11.5 4.9 4.9 15.9 4.1 5.5 4.3 0.2 9.2 4.9 11.8 7.2 4.5 10.1 8.1 7.0 13.1 6.8 12.2 0.0 10.3 10.1 26.6 54.3 6.6 13.8 7.3 9.6 C1orf210 "MGC52423, TEMP" ENSG00000253313 "Chromosome 1 open reading frame 210" Q8IVY1 1 43281883-43285617 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.0" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 105.5;Paneth cells: 49.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "basophil: 5.4" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "A-431: 7.4;BEWO: 8.3;CACO-2: 7.8;CAPAN-2: 25.2;OE19: 20.3;SK-BR-3: 8.8;T-47d: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA013788 Uncertain Uncertain "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA013788: AB_1845637" "unprognostic (1.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.06e-2)" "unprognostic (1.98e-1)" "unprognostic (3.54e-2)" "unprognostic (2.74e-1)" "unprognostic (2.01e-2)" "prognostic favorable (0.00e+0)" "unprognostic (7.57e-3)" "unprognostic (3.94e-1)" "unprognostic (1.00e-1)" "unprognostic (1.61e-2)" 0.3 0.1 0.3 6.5 0.3 0.0 7.4 0.3 0.3 3.9 28.6 0.4 7.4 20.6 1.0 10.9 11.2 2.6 20.7 0.3 0.3 0.1 25.2 3.3 13.5 0.3 0.3 0.3 1.0 29.8 3.0 9.6 6.1 0.4 4.4 14.4 0.4 25.8 7.2 0.3 10.6 64.0 0.5 0.3 0.3 14.6 1.1 0.3 1.0 32.1 7.8 7.7 3.4 5.2 0.1 0.3 5.4 0.3 0.4 0.2 0.0 7.4 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.0 0.0 7.8 25.2 0.0 0.1 0.0 0.0 5.7 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.1 0.0 20.3 0.0 0.0 0.0 0.2 0.6 4.8 3.0 0.2 0.0 8.8 0.0 1.4 9.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.3 0.4 0.3 0.2 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.4 0.3 20.8 10.7 0.8 5.9 1.0 0.0 0.0 22.9 4.0 4.5 21.0 0.0 11.1 24.9 17.9 0.1 0.0 105.5 0.0 29.5 2.9 0.2 10.4 0.0 0.9 0.6 0.0 32.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 34.2 0.0 16.3 49.1 0.0 39.3 0.0 0.0 0.2 0.1 0.0 2.3 3.9 0.0 31.2 7.8 C22orf46 "CTA-216E10.6, FLJ23584" ENSG00000184208 "Chromosome 22 open reading frame 46" C9J442 22 41688939-41698136 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 19.8" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 65.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA052741 Uncertain Approved Nucleoplasm,Nucleoli "Secreted - unknown location" NA NA Nucleoplasm Nucleoli "HPA052741: AB_2681933" "unprognostic (3.76e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-2)" "prognostic favorable (4.70e-4)" "unprognostic (1.56e-1)" "unprognostic (6.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" "unprognostic (8.38e-2)" "unprognostic (3.32e-2)" "unprognostic (7.03e-2)" "unprognostic (1.20e-1)" "unprognostic (3.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" 3.9 2.0 8.1 3.1 6.8 1.0 3.9 2.2 5.7 2.7 2.4 2.3 3.1 4.5 1.7 2.4 2.7 4.8 8.7 7.5 2.7 2.3 2.2 3.1 12.8 5.2 1.4 8.3 3.5 2.1 3.3 2.8 2.8 3.0 3.3 3.3 2.6 2.9 19.8 2.8 2.4 6.2 3.5 3.1 2.2 1.5 1.1 0.4 0.1 2.6 3.5 1.2 0.7 8.8 4.5 11.1 6.8 8.2 8.7 10.1 7.5 8.1 6.4 8.6 4.5 5.8 5.5 5.5 6.2 6.3 4.1 5.7 5.8 7.7 19.7 5.4 6.1 9.4 3.8 4.8 4.5 12.0 6.9 7.8 10.7 7.6 4.9 1.6 8.6 9.9 8.2 5.6 14.6 3.5 5.5 4.5 13.4 3.5 5.1 9.2 6.1 5.4 6.1 2.7 4.2 8.7 7.9 11.3 8.5 9.0 5.5 4.3 8.4 14.4 4.4 3.9 17.5 17.8 5.1 5.0 5.5 11.4 0.1 0.5 0.0 0.7 0.4 0.9 1.1 1.1 1.1 0.2 0.5 0.9 1.2 0.1 3.5 2.6 0.4 0.7 0.7 11.9 16.5 7.1 3.9 1.9 9.4 18.9 5.1 8.1 11.4 7.0 13.7 8.3 1.7 4.2 65.6 7.1 8.4 0.0 4.2 5.8 4.9 2.0 7.0 4.0 4.2 3.2 2.9 9.2 7.3 8.2 4.9 8.3 1.7 9.0 7.2 9.7 3.7 3.7 6.0 1.3 6.2 0.0 3.5 12.0 11.5 2.3 7.1 15.8 4.0 1.4 C2CD2L "KIAA0285, TMEM24" ENSG00000172375 "C2CD2 like" O14523 11 119102198-119118544 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.1" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011044 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Nuclear membrane, Cytosol" "HPA011044: AB_2668414" "unprognostic (3.43e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-3)" "prognostic favorable (4.92e-4)" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (2.25e-3)" "unprognostic (3.37e-3)" "unprognostic (5.28e-2)" "unprognostic (2.09e-1)" "unprognostic (3.99e-3)" "unprognostic (8.19e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (8.02e-2)" "unprognostic (8.32e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" 5.2 7.0 15.9 7.3 33.1 14.7 4.8 18.2 31.2 5.8 10.3 7.5 8.3 18.7 4.1 6.1 9.4 10.9 6.3 7.9 15.8 13.6 6.3 7.3 8.3 8.5 9.1 12.6 3.9 7.5 7.8 14.2 4.8 11.7 4.8 8.8 5.6 8.7 7.0 8.3 12.5 19.4 6.1 7.3 9.2 5.5 2.6 9.1 7.0 5.5 6.7 6.6 6.6 5.3 0.4 1.1 5.7 4.2 1.7 1.6 1.1 3.4 2.5 3.5 7.2 4.6 1.9 2.2 5.2 4.6 5.2 4.4 4.1 3.6 5.2 13.7 3.6 5.3 7.7 4.4 2.2 2.1 8.1 3.7 20.4 3.3 2.9 6.1 5.8 29.8 2.3 4.6 9.7 3.6 5.7 3.2 7.8 8.4 9.3 4.8 9.1 6.5 14.1 1.3 8.4 6.9 4.1 3.2 5.9 5.1 2.2 11.0 6.2 2.2 11.7 3.3 1.4 20.6 7.8 3.9 4.8 1.6 5.7 9.1 4.1 2.4 2.0 3.0 10.1 5.3 1.1 3.0 5.7 0.6 3.2 1.0 0.4 1.4 1.4 1.1 0.1 1.6 0.8 1.0 1.7 4.2 0.7 1.6 1.1 15.9 33.1 18.2 31.2 15.8 13.6 9.1 12.6 11.7 9.1 6.0 6.2 2.2 1.4 9.5 14.6 2.0 2.5 13.4 4.5 1.8 35.3 0.8 3.3 2.8 2.6 5.0 25.7 0.0 2.4 1.2 2.0 2.9 2.3 4.3 7.9 20.6 1.2 15.4 12.9 1.5 2.0 9.7 6.8 7.2 5.5 4.8 4.2 10.1 1.4 3.3 29.7 6.5 3.1 2.3 1.9 9.5 0.9 8.7 4.5 1.6 C2orf68 ENSG00000168887 "Chromosome 2 open reading frame 68" Q2NKX9 2 85606654-85612066 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051143 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" Nucleoli "HPA051143: AB_2681360" "unprognostic (1.71e-2)" "unprognostic (3.65e-2)" "unprognostic (1.07e-2)" "prognostic unfavorable (1.12e-6)" "unprognostic (9.34e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.76e-6)" "unprognostic (4.24e-3)" "unprognostic (8.41e-2)" "unprognostic (2.34e-1)" "unprognostic (2.88e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.11e-6)" "unprognostic (1.18e-1)" "unprognostic (1.76e-1)" "unprognostic (3.70e-2)" "unprognostic (8.81e-3)" 10.7 9.8 7.0 17.4 12.3 11.5 16.5 16.6 9.9 16.5 15.2 17.2 17.7 13.1 17.1 15.0 13.6 14.3 16.2 13.7 7.7 6.6 13.5 16.8 17.5 15.6 16.1 7.2 22.2 25.4 13.3 14.6 21.8 11.4 16.5 14.1 10.8 20.6 20.6 23.3 18.6 18.5 14.8 10.9 17.5 13.4 15.1 12.3 37.1 17.2 20.4 17.6 15.2 17.0 15.4 16.5 36.1 22.7 19.2 20.1 9.5 8.6 8.1 13.3 10.0 13.7 6.8 9.0 4.0 5.3 6.7 8.9 7.3 10.6 11.8 6.1 7.3 6.2 9.6 7.3 8.0 7.2 6.2 15.3 20.2 11.9 7.6 11.3 10.8 10.7 10.4 9.3 5.0 13.3 9.7 10.9 13.2 10.2 13.3 6.4 9.9 12.3 10.6 6.4 10.6 7.0 13.8 25.4 11.6 8.6 9.2 17.1 12.3 6.2 8.3 8.0 8.2 9.4 5.5 6.4 4.8 13.3 5.4 3.8 17.2 12.0 11.0 7.1 11.0 5.8 18.0 22.7 36.1 15.4 15.0 14.5 10.9 14.7 14.5 16.5 15.4 20.1 18.7 36.1 19.2 16.9 10.6 11.9 9.5 7.0 12.3 16.6 9.9 7.7 6.6 16.1 7.2 11.4 12.3 59.6 76.5 21.4 16.8 5.3 17.5 9.3 38.2 25.4 34.2 33.2 33.4 38.5 14.9 14.0 3.3 9.0 23.5 0.0 17.1 14.2 11.3 12.3 32.5 19.2 20.3 23.8 18.5 19.0 31.3 7.0 22.5 24.2 13.5 14.4 15.8 10.8 17.3 10.5 12.7 19.2 23.7 19.4 7.6 37.2 20.6 8.5 20.8 28.0 16.8 17.6 C5orf67 ENSG00000225940 "Chromosome 5 open reading frame 67" F2Z3F1 5 56511567-56606232 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 17.9;kidney: 9.3;retina: 16.3" "Group enriched" "Detected in some" 4 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Proximal tubular cells: 1.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.9" "Region enriched" "Detected in some" 5 "pons and medulla: 6.1" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;granulocytes: 3.3;monocytes: 1.9" "Group enriched" "Detected in some" 7 "CACO-2: 3.2;EFO-21: 9.3;U-266/70: 10.4" HPA054214 Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoli "Nucleoplasm, Vesicles" "HPA054214: " "unprognostic (7.28e-2)" "unprognostic (1.41e-1)" "unprognostic (2.55e-1)" "unprognostic (1.35e-1)" "unprognostic (1.12e-3)" "unprognostic (6.58e-2)" "unprognostic (7.93e-2)" "unprognostic (2.91e-1)" "unprognostic (2.18e-1)" "unprognostic (8.69e-2)" "unprognostic (1.35e-1)" "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" "unprognostic (3.62e-2)" 0.4 0.0 0.2 0.2 1.2 0.4 1.0 0.2 0.2 0.4 0.8 0.4 0.2 1.5 0.6 17.9 0.4 0.4 0.2 0.2 0.6 0.2 9.3 0.2 0.4 0.6 0.7 0.2 0.2 0.2 0.0 0.2 0.2 6.1 0.2 0.0 16.3 1.1 0.2 0.2 0.8 1.6 0.2 0.2 1.5 0.1 0.2 0.2 0.2 2.1 0.2 0.2 0.2 0.2 0.1 1.5 3.3 1.9 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.3 0.0 9.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.2 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.5 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 3.3 0.0 1.9 1.5 0.4 0.1 0.2 1.2 0.2 0.2 0.6 0.2 0.7 0.2 6.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C7orf26 MGC2718 ENSG00000146576 "Chromosome 7 open reading frame 26" Q96N11 7 6590017-6608726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042899, HPA052175" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Nucleoli, Intermediate filaments, Cytosol" "HPA042899: AB_2678218, HPA052175: AB_2681750" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (4.51e-2)" "unprognostic (2.50e-2)" "unprognostic (2.18e-2)" "unprognostic (5.22e-2)" "unprognostic (4.28e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "prognostic favorable (6.95e-5)" "unprognostic (4.72e-2)" "unprognostic (2.26e-3)" "unprognostic (4.41e-1)" "unprognostic (1.03e-2)" "unprognostic (3.40e-3)" "unprognostic (1.55e-1)" 19.8 17.1 13.4 21.7 17.7 29.2 20.0 20.6 26.9 19.0 17.9 21.1 21.5 19.4 23.0 15.4 14.7 19.9 15.6 12.8 14.4 14.1 15.4 18.4 19.3 24.1 18.8 20.2 20.6 23.9 17.2 16.6 14.0 15.4 21.1 11.5 16.4 21.2 16.6 18.7 21.9 16.4 19.6 13.1 27.3 18.6 16.8 16.1 31.7 18.3 18.5 20.6 17.6 19.6 4.2 6.4 4.6 3.4 3.3 6.1 1.9 11.1 9.4 6.6 15.4 10.7 6.0 8.7 6.7 5.9 9.7 6.0 8.7 4.7 13.3 8.8 5.0 18.5 12.4 8.7 6.2 4.4 5.1 12.6 4.9 5.9 9.2 12.6 11.8 15.9 6.9 9.3 5.8 6.1 5.2 10.6 14.4 12.9 10.1 5.7 18.8 10.2 24.4 13.0 5.6 12.5 20.9 5.2 11.2 6.3 9.8 8.6 16.0 6.5 21.7 9.0 7.1 9.9 17.8 7.6 8.1 26.6 8.8 14.6 12.3 12.1 12.2 5.4 13.1 23.8 1.1 3.4 4.6 4.7 3.3 6.1 4.1 5.7 6.0 2.6 4.2 5.9 4.9 3.4 3.3 3.3 6.4 5.4 1.9 13.4 17.7 20.6 26.9 14.4 14.1 18.8 20.2 15.4 16.1 8.9 7.5 6.1 8.2 13.5 6.1 5.3 10.2 4.0 5.7 1.8 5.9 10.4 0.0 7.5 5.8 9.3 8.4 0.0 8.8 9.1 9.3 8.5 1.1 6.4 11.6 4.8 12.1 14.7 10.3 3.2 7.5 9.8 6.8 4.6 12.3 6.7 9.2 10.5 8.1 6.3 6.1 6.5 13.2 11.2 13.8 11.2 8.1 14.6 10.2 6.0 C7orf50 "MGC11257, YCR016W" ENSG00000146540 "Chromosome 7 open reading frame 50" Q9BRJ6 7 996986-1138260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 250.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052281 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA052281: AB_2681784" "unprognostic (1.64e-1)" "unprognostic (1.48e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (1.79e-2)" "unprognostic (1.28e-3)" "unprognostic (2.57e-3)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "prognostic favorable (6.20e-6)" "unprognostic (1.57e-1)" "unprognostic (1.37e-2)" "unprognostic (3.37e-2)" "unprognostic (8.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" 22.5 14.2 37.7 14.9 29.4 9.7 14.9 16.4 32.8 17.0 17.5 15.5 19.4 12.8 20.1 18.8 14.8 21.0 20.3 28.7 28.1 21.4 21.7 14.2 16.1 21.2 22.4 23.0 21.6 79.5 12.3 39.3 13.9 17.3 21.7 7.9 25.9 25.1 28.8 68.4 8.2 13.8 34.5 19.1 19.5 25.1 19.5 9.8 6.0 20.8 18.0 16.6 17.2 10.9 32.3 41.5 76.3 27.0 8.1 20.6 22.7 41.6 26.7 8.9 27.2 4.8 6.9 18.9 18.7 9.3 16.7 14.2 18.8 17.9 12.5 12.4 12.0 21.2 26.5 10.7 22.6 3.3 11.9 21.6 11.4 18.9 25.5 19.7 14.5 7.9 9.8 18.1 15.5 14.3 7.3 11.4 10.6 20.3 12.0 7.4 60.2 6.7 38.9 21.9 18.8 39.7 19.8 3.3 20.7 7.8 11.6 20.6 29.5 15.4 18.3 25.2 6.2 43.9 26.8 13.1 9.7 43.2 28.9 24.5 10.3 13.8 11.4 19.5 24.2 30.6 3.2 27.0 76.3 20.6 26.2 14.6 23.6 16.9 17.4 41.5 32.3 13.2 15.3 3.0 8.1 25.0 12.0 19.7 22.7 37.7 29.4 16.4 32.8 28.1 21.4 22.4 23.0 17.3 9.8 32.8 64.7 92.5 33.2 20.6 74.8 64.4 40.8 56.2 30.7 62.8 17.7 65.3 250.4 73.5 7.0 40.5 17.6 23.3 74.9 70.2 42.1 41.1 54.3 32.5 140.0 54.0 87.1 33.7 63.1 3.4 34.2 61.3 67.4 120.8 45.0 82.9 55.6 17.3 41.8 101.0 58.5 25.8 67.4 18.1 41.5 21.3 38.9 48.4 57.1 30.7 C8orf34 "vest-1, VEST1" ENSG00000165084 "Chromosome 8 open reading frame 34" Q49A92 8 68330722-68819022 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.3;parathyroid gland: 19.9" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 16.0;Ciliated cells: 28.1;Club cells: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.5;HEK 293: 5.8;LHCN-M2: 5.1;RH-30: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044420, HPA053065" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus" No NA "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA044420: AB_10963791, HPA053065: AB_2682030" "unprognostic (1.75e-1)" "unprognostic (2.20e-1)" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (3.07e-1)" "unprognostic (2.85e-2)" "unprognostic (3.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.80e-1)" "unprognostic (1.74e-1)" "unprognostic (8.55e-2)" "unprognostic (5.86e-2)" "unprognostic (1.80e-4)" "unprognostic (5.21e-2)" "unprognostic (8.87e-2)" "unprognostic (2.84e-4)" "unprognostic (1.33e-1)" 4.2 0.9 7.4 0.8 10.6 1.1 1.5 9.6 8.4 4.0 0.7 9.6 0.2 0.7 1.5 2.5 2.1 15.3 3.2 1.6 8.9 7.0 1.0 0.7 8.3 0.8 3.7 5.0 1.4 2.1 19.9 2.7 0.9 10.4 3.9 0.9 3.5 1.4 2.2 0.9 1.8 0.8 1.7 3.2 0.8 1.7 1.4 6.7 0.0 1.0 1.1 0.7 1.2 1.1 1.8 2.0 2.9 0.7 1.3 1.8 0.5 0.3 0.0 0.8 0.4 1.2 2.3 0.2 1.4 4.5 0.7 0.6 0.3 0.4 0.2 0.9 1.2 0.2 0.3 0.3 0.8 0.2 0.1 5.8 0.7 1.0 0.4 0.3 0.1 0.5 0.1 0.6 0.8 1.6 0.3 0.1 0.7 0.3 1.0 5.1 0.6 0.1 0.5 2.6 0.0 0.1 0.2 5.4 0.1 0.6 0.4 1.1 0.2 0.3 0.3 0.0 0.6 2.6 0.2 0.1 1.0 0.6 3.4 0.2 0.8 0.0 0.1 0.4 0.3 0.8 2.1 0.7 1.2 1.4 0.3 1.1 1.0 1.2 1.1 0.3 1.8 1.5 1.8 2.9 1.3 0.5 2.0 0.8 0.5 7.4 10.6 9.6 8.4 8.9 7.0 3.7 5.0 10.4 6.7 14.9 16.0 0.0 0.6 1.4 1.2 1.2 0.0 28.1 6.8 0.0 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.2 0.9 1.2 1.1 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.6 0.0 1.0 0.2 0.2 0.6 0.3 0.0 0.0 0.4 C8orf59 ENSG00000176731 "Chromosome 8 open reading frame 59" Q8N0T1 8 85214076-85220421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044805, HPA071903" Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA044805: AB_2679095, HPA071903: AB_2686469" "unprognostic (1.61e-2)" "unprognostic (2.98e-1)" "unprognostic (4.51e-1)" "unprognostic (1.63e-3)" "unprognostic (2.19e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-3)" "unprognostic (1.63e-1)" "unprognostic (1.69e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (2.29e-1)" "unprognostic (3.84e-3)" 28.1 28.2 25.3 25.3 21.9 33.0 46.1 18.9 26.5 33.0 38.4 12.6 36.3 28.1 32.0 45.5 44.8 28.7 25.8 41.5 20.6 24.1 32.3 47.1 20.8 30.7 26.3 27.2 45.1 35.1 19.5 36.0 27.7 24.4 35.5 27.7 14.7 37.8 36.2 43.9 24.8 37.1 33.7 27.0 32.2 36.9 16.7 25.7 39.1 43.5 53.6 32.0 39.1 35.2 33.3 42.7 21.3 25.3 36.5 38.0 23.9 38.9 19.9 29.6 19.2 18.4 35.7 23.2 26.0 25.0 30.4 30.0 23.2 33.8 9.7 21.5 17.2 28.5 27.2 20.5 28.5 34.3 27.4 22.4 57.6 18.8 34.2 21.8 21.6 26.1 30.2 33.9 19.6 24.8 33.1 25.8 35.0 25.8 24.0 25.2 30.7 47.7 40.6 8.5 88.2 34.8 20.4 24.8 44.2 29.5 25.0 10.0 21.5 19.7 32.4 35.7 37.3 37.3 32.3 19.7 19.4 40.7 21.5 24.6 27.9 32.7 45.8 38.7 27.7 21.5 21.3 20.5 13.4 24.7 25.3 29.5 33.3 32.7 30.1 34.8 29.9 38.0 36.3 5.1 36.5 21.5 42.7 32.1 23.9 25.3 21.9 18.9 26.5 20.6 24.1 26.3 27.2 24.4 25.7 80.4 65.2 124.2 47.1 48.2 25.9 26.3 86.6 147.2 103.5 34.9 9.8 86.5 56.3 152.0 93.6 67.1 76.6 46.7 240.4 102.1 84.3 40.2 75.1 136.0 90.6 22.3 36.9 108.6 132.2 20.6 173.2 92.3 54.0 180.3 112.7 58.4 213.9 84.2 122.0 90.6 33.5 155.2 88.6 128.1 91.8 40.0 64.3 104.7 101.8 39.3 C9orf152 bA470J20.2 ENSG00000188959 "Chromosome 9 open reading frame 152" Q5JTZ5 9 110190048-110208189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.9;salivary gland: 34.3;stomach 1: 20.7" "Cell type enhanced" "Detected in many" 16 "Mucus-secreting cells: 113.3;Undifferentiated cells: 69.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.5" "Cell line enriched" "Detected in some" 8 "OE19: 57.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA050769 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA050769: AB_2681230" "unprognostic (1.90e-2)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "prognostic favorable (7.22e-5)" "unprognostic (2.28e-1)" "unprognostic (1.79e-3)" "unprognostic (6.86e-2)" "unprognostic (1.34e-1)" "unprognostic (4.84e-2)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (5.09e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (4.57e-1)" "unprognostic (2.49e-1)" "unprognostic (1.06e-2)" 0.4 0.0 0.4 1.7 0.4 0.0 6.1 0.4 0.4 5.3 16.1 0.5 10.5 9.1 1.0 0.4 2.4 1.5 7.1 0.4 0.4 0.0 0.4 0.5 3.6 0.4 0.4 0.4 0.4 3.9 0.0 0.8 0.4 0.4 11.6 20.9 0.4 34.3 17.0 0.4 3.8 7.0 0.4 0.4 0.4 20.7 0.4 0.4 0.4 0.4 1.6 5.2 1.3 0.4 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 57.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 3.7 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 8.9 12.3 0.0 2.5 0.2 0.0 0.2 22.9 5.3 10.3 0.0 0.0 0.0 0.0 4.3 0.0 0.0 7.7 0.0 9.9 0.0 0.2 16.2 0.0 0.9 0.1 0.0 24.9 0.0 0.0 0.0 0.0 0.2 10.1 0.0 113.3 0.0 5.3 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 69.7 4.7 C9orf85 MGC61599 ENSG00000155621 "Chromosome 9 open reading frame 85" Q96MD7 9 71911510-71986054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050767, HPA076627" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA050767: AB_2681229, HPA076627: " "unprognostic (7.81e-2)" "unprognostic (2.80e-1)" "unprognostic (6.21e-2)" "unprognostic (3.04e-1)" "unprognostic (2.89e-2)" "unprognostic (2.87e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (3.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.48e-1)" "unprognostic (1.10e-2)" "unprognostic (8.10e-2)" "unprognostic (6.60e-2)" "unprognostic (4.02e-1)" "unprognostic (6.18e-2)" 13.4 12.7 15.5 10.1 26.0 8.9 14.7 11.2 18.8 12.8 12.9 18.2 15.0 19.3 14.1 14.3 18.4 11.6 12.0 10.5 14.9 13.8 12.3 13.1 10.4 13.0 24.5 13.3 16.9 14.7 9.8 16.9 13.9 15.2 13.1 13.7 14.3 14.7 9.8 14.6 18.4 16.3 15.2 21.1 10.7 11.2 9.2 21.9 14.5 14.8 15.9 12.9 18.8 15.5 11.3 13.1 16.1 9.9 17.1 14.6 9.3 7.7 5.1 9.1 7.4 9.6 17.4 9.3 10.0 15.5 8.1 7.9 1.1 4.7 12.7 5.1 8.6 8.5 14.3 9.5 9.5 11.2 8.9 4.7 7.8 7.5 6.4 10.3 11.4 6.4 14.1 13.0 8.1 17.8 12.7 9.9 12.3 9.2 8.6 10.2 4.0 13.7 8.0 8.6 12.5 12.6 8.1 15.8 0.3 11.5 11.3 7.6 10.0 4.9 12.7 16.5 10.4 4.5 6.6 8.7 7.5 9.6 16.9 7.3 8.6 14.1 5.8 10.1 8.7 4.8 16.1 8.9 12.6 13.4 9.9 13.7 10.9 11.5 11.5 9.3 11.3 14.0 14.6 9.9 17.1 8.3 13.1 10.5 9.3 15.5 26.0 11.2 18.8 14.9 13.8 24.5 13.3 15.2 21.9 6.0 14.2 13.0 11.4 6.8 10.6 10.8 5.1 9.4 11.4 5.2 7.9 17.8 18.3 12.3 6.1 11.6 23.0 0.0 17.3 15.9 12.4 13.2 18.4 8.7 12.9 4.8 6.3 16.0 12.4 4.5 19.2 13.3 3.3 11.8 17.8 11.2 14.2 17.5 12.4 15.1 11.5 12.9 12.7 13.0 14.2 8.5 9.0 12.2 16.3 17.9 CA13 "CAXIII, FLJ37995, MGC59868" ENSG00000185015 "Carbonic anhydrase 13" Q8N1Q1 8 85220587-85284073 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.7" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 12.5;OE19: 24.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024689, CAB025567" Enhanced Approved Nucleoplasm,Nucleoli,Vesicles NA NA 100000 Nucleoli "Nucleoplasm, Vesicles" "CAB025567: , HPA024689: AB_1846004" "unprognostic (1.12e-2)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (9.16e-5)" "unprognostic (2.21e-2)" "unprognostic (2.08e-1)" "unprognostic (9.39e-2)" "unprognostic (7.90e-3)" "unprognostic (1.97e-1)" "unprognostic (1.34e-2)" "unprognostic (3.58e-2)" "unprognostic (3.13e-1)" "prognostic favorable (9.40e-4)" "unprognostic (7.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.55e-2)" "unprognostic (3.00e-1)" 2.6 2.6 2.0 1.9 3.1 0.5 2.9 2.4 2.4 3.2 18.2 0.8 0.0 14.2 1.8 1.7 6.7 1.4 25.6 5.8 1.6 1.9 10.4 17.1 9.5 2.4 2.0 0.1 2.2 1.6 9.3 6.5 1.0 5.7 2.6 3.7 1.9 7.0 1.0 1.9 7.1 56.7 1.9 5.2 2.2 7.0 0.9 0.9 0.4 10.3 3.9 5.6 2.9 5.2 0.8 2.1 3.2 2.5 0.5 0.5 1.0 0.2 0.3 0.7 0.1 0.5 0.5 0.3 0.8 0.9 0.1 2.4 5.8 4.5 0.3 0.4 1.0 5.1 1.9 1.8 2.3 0.1 1.3 0.8 12.5 1.6 5.3 1.2 0.2 0.5 1.9 0.4 0.2 1.0 1.5 1.3 0.5 3.1 2.4 2.1 0.0 0.2 0.2 0.3 24.6 0.3 0.2 1.8 0.1 6.7 0.2 0.2 0.0 0.4 0.0 1.3 0.9 0.4 0.6 1.2 2.3 3.3 0.1 1.3 1.0 0.4 1.5 4.8 1.8 2.2 3.2 2.5 1.3 0.4 0.7 0.2 0.2 0.2 0.1 2.1 0.8 0.3 0.5 0.9 0.5 0.8 0.9 0.1 1.0 2.0 3.1 2.4 2.4 1.6 1.9 2.0 0.1 5.7 0.9 3.0 7.7 1.4 2.1 1.5 1.5 5.2 5.1 10.7 12.5 12.2 31.4 0.2 8.3 3.2 9.1 2.1 16.9 0.0 1.4 0.2 3.1 2.1 0.0 4.7 0.9 0.0 4.6 9.8 3.0 10.4 0.0 2.2 5.0 0.0 3.2 2.0 3.1 4.9 0.0 16.1 5.1 0.0 1.0 1.2 2.3 2.8 0.2 1.0 3.4 1.8 CACHD1 "KIAA1573, VWCD1" ENSG00000158966 "Cache domain containing 1" 1 64470792-64693058 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 37.5;Club cells: 18.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 11 "naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Cell line enhanced" "Detected in many" "AF22: 21.4;NTERA-2: 29.3;SuSa: 19.1;U-2197: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017202 Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA017202: AB_1852423" "unprognostic (2.92e-2)" "unprognostic (2.91e-1)" "unprognostic (1.29e-2)" "unprognostic (1.02e-1)" "unprognostic (3.75e-1)" "unprognostic (1.01e-1)" "unprognostic (4.82e-2)" "unprognostic (4.32e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (8.16e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-3)" "unprognostic (2.67e-2)" "unprognostic (3.89e-1)" "unprognostic (3.65e-1)" "unprognostic (2.13e-1)" 5.4 7.6 6.5 0.5 8.4 0.0 4.7 1.2 4.3 7.3 0.8 0.2 6.1 5.2 1.6 8.5 2.1 1.2 3.5 4.2 3.3 0.4 4.7 0.4 2.3 14.2 3.7 5.5 4.5 5.5 4.0 1.0 4.4 4.3 0.8 3.0 0.9 5.3 0.6 1.7 3.3 0.5 2.4 0.2 2.1 4.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.8 21.4 3.1 8.5 3.0 0.0 3.0 3.9 5.1 4.9 12.4 0.1 0.0 8.8 4.8 3.7 1.5 11.9 2.5 5.2 2.3 6.4 4.4 1.3 0.0 0.0 1.9 0.0 2.6 1.7 0.6 3.2 2.9 2.7 3.0 0.0 0.0 0.0 0.3 0.3 0.0 29.3 0.1 2.2 2.3 2.1 0.0 0.0 0.6 0.5 11.2 6.5 0.0 2.6 19.1 0.8 0.2 1.9 0.5 3.8 15.0 2.6 0.0 0.0 0.0 0.4 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 37.5 0.0 6.1 15.3 12.7 1.4 0.0 13.4 18.2 3.5 0.0 0.0 0.0 2.0 7.7 11.8 0.0 0.0 2.5 0.1 4.1 1.2 2.3 0.9 0.2 0.0 0.0 3.1 0.3 2.3 13.3 1.8 1.7 0.0 0.0 5.2 1.3 0.0 2.8 3.1 1.1 6.5 5.7 0.4 0.4 12.9 0.0 0.0 0.1 4.8 CAMLG "CAML, GET2" ENSG00000164615 "Calcium modulating ligand" P49069 5 134738501-134752160 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 658.5;Late spermatids: 1206.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052636, HPA056472" Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA052636: AB_2681893, HPA056472: AB_2683143" "unprognostic (9.23e-2)" "unprognostic (8.54e-2)" "unprognostic (2.95e-1)" "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (3.68e-2)" "unprognostic (5.41e-3)" "unprognostic (3.07e-1)" "unprognostic (8.54e-2)" "unprognostic (5.34e-3)" "unprognostic (4.58e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (3.26e-2)" "unprognostic (1.43e-2)" "unprognostic (2.19e-1)" "unprognostic (3.16e-1)" 24.2 29.0 37.6 14.3 32.4 22.7 29.3 28.2 39.3 33.3 32.7 15.5 20.2 26.1 31.7 45.2 21.4 23.0 21.8 22.3 32.4 38.3 20.1 19.7 18.9 18.4 36.2 22.7 53.0 25.7 14.8 21.9 14.0 22.4 27.5 14.3 21.7 15.9 26.2 32.5 19.7 22.2 30.4 26.0 15.1 17.7 36.6 14.0 21.1 21.6 18.5 19.3 40.3 20.0 25.0 16.1 32.1 23.3 16.6 28.6 17.4 9.6 7.5 12.8 23.8 28.5 44.2 5.8 13.7 19.9 10.2 19.4 13.7 14.7 39.3 20.1 9.5 15.9 12.5 10.5 16.7 14.6 18.3 19.5 10.4 13.6 11.1 21.0 5.5 33.0 35.8 18.2 12.6 21.7 33.9 19.3 17.4 6.6 18.3 15.2 10.7 14.5 23.3 6.6 12.0 7.6 16.4 17.0 15.1 17.5 9.4 19.0 13.3 9.8 6.3 32.7 17.2 17.3 11.5 18.4 10.0 6.2 15.2 12.4 17.2 18.6 15.0 16.8 17.4 5.4 32.1 15.2 32.1 18.3 17.3 24.6 25.0 26.4 22.9 16.1 22.4 27.8 26.8 27.6 16.6 23.3 14.7 28.6 17.4 37.6 32.4 28.2 39.3 32.4 38.3 36.2 22.7 22.4 14.0 35.7 31.3 84.3 104.0 148.5 76.2 38.6 76.5 32.1 48.9 40.1 23.6 43.8 77.9 53.1 658.5 74.5 44.2 0.0 78.9 53.3 107.2 105.7 119.1 66.0 62.6 52.4 60.0 81.6 102.8 1206.3 155.6 92.2 91.1 124.4 64.9 79.0 61.6 59.6 124.5 149.1 63.7 97.0 161.7 114.4 74.5 176.2 61.2 108.0 83.2 90.1 CAPS2 ENSG00000180881 "Calcyphosine 2" Q9BXY5 12 75275979-75390928 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.7" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 96.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039542, HPA040004" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles,Centrosome Yes No Nucleoli "Nucleoplasm, Vesicles, Centrosome" "HPA039542: , HPA040004: AB_10794758" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" "unprognostic (7.26e-2)" "unprognostic (5.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.36e-1)" "unprognostic (9.61e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-3)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (3.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.52e-2)" "unprognostic (2.69e-1)" 2.6 4.2 8.0 1.2 5.8 1.6 3.7 15.5 11.2 3.7 2.5 5.5 2.1 1.8 5.0 8.8 3.6 21.7 3.4 5.4 6.3 6.6 6.6 4.2 5.8 1.3 5.4 5.6 4.5 2.6 7.3 15.8 0.9 7.8 5.1 2.0 4.4 5.5 3.6 3.8 2.6 1.9 2.0 8.7 2.6 3.2 8.0 9.5 1.4 9.3 2.2 1.4 2.6 2.0 0.1 0.6 0.0 0.7 1.1 1.8 0.1 1.3 3.7 1.0 0.3 1.9 1.4 0.1 0.7 0.2 2.0 2.2 0.0 1.7 0.3 3.3 0.5 0.8 0.8 0.0 1.6 1.4 1.2 0.6 1.5 0.6 0.0 0.0 0.2 0.0 0.6 1.0 1.7 0.3 12.1 0.2 1.3 0.3 0.6 2.6 0.0 1.8 1.4 0.5 0.0 0.5 0.0 0.0 0.2 2.6 0.0 2.1 1.0 0.2 0.1 1.2 0.2 1.2 0.5 0.8 1.9 0.8 0.4 0.3 0.2 0.0 0.0 1.6 0.0 1.5 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.7 0.0 0.0 0.1 0.6 0.9 0.0 1.1 0.7 0.6 1.8 0.1 8.0 5.8 15.5 11.2 6.3 6.6 5.4 5.6 7.8 9.5 8.9 3.2 0.0 2.5 1.5 0.7 7.1 2.5 96.4 17.0 5.2 3.9 1.0 5.0 0.8 21.6 1.7 0.0 0.0 1.5 0.5 1.7 1.5 0.0 1.5 0.5 1.6 0.0 2.5 1.8 11.5 5.8 0.9 0.0 0.0 1.7 5.8 0.4 0.0 6.7 2.5 20.8 0.0 1.4 9.1 0.9 0.5 0.2 0.0 0.6 0.5 CASP8AP2 "CED-4, FLASH, FLJ11208, KIAA1315, RIP25" ENSG00000118412 "Caspase 8 associated protein 2" 6 89829894-89874436 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatogonia: 89.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053573 Approved "Nucleoli,Nuclear bodies" NA NA "Nucleoli, Nuclear bodies" "HPA053573: AB_2682194" "unprognostic (7.80e-2)" "unprognostic (1.47e-1)" "unprognostic (6.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.64e-2)" "unprognostic (1.22e-2)" "unprognostic (1.75e-4)" "unprognostic (4.58e-1)" "unprognostic (4.36e-3)" "unprognostic (2.20e-2)" "unprognostic (1.11e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.88e-5)" "unprognostic (2.35e-1)" "unprognostic (1.63e-1)" "unprognostic (4.16e-2)" "unprognostic (3.53e-1)" 3.8 3.1 5.4 8.0 7.3 4.8 6.0 9.7 7.8 7.4 4.7 3.3 3.8 3.5 5.0 3.4 4.5 3.7 3.5 3.9 6.5 3.1 3.4 3.9 8.8 6.1 5.0 6.6 3.8 5.7 7.0 5.9 6.6 7.2 4.3 3.5 4.0 5.2 3.2 2.6 4.7 5.3 5.7 5.4 4.0 5.0 5.9 9.1 4.5 2.1 5.9 6.5 3.2 9.9 7.8 17.7 4.1 17.8 12.3 3.6 4.2 4.3 13.8 9.5 4.7 4.7 5.5 10.6 4.0 7.6 9.9 5.0 3.4 12.6 5.6 5.4 5.8 6.4 12.4 5.3 8.8 12.9 10.5 15.7 10.2 1.7 2.0 14.7 8.3 2.3 2.5 9.9 4.6 3.1 5.5 12.5 16.9 7.6 5.1 3.8 8.3 2.7 4.0 4.0 4.0 16.4 17.2 4.9 1.4 9.3 9.1 6.3 8.8 1.9 3.8 6.5 4.2 7.5 7.4 4.9 4.2 8.4 9.6 4.6 11.2 7.5 5.0 8.4 7.7 17.7 2.5 8.2 10.7 4.1 10.3 8.3 12.3 11.2 3.1 9.9 9.9 9.5 4.4 17.8 3.5 7.8 10.2 3.6 29.8 16.4 13.9 8.5 0.0 18.7 39.9 5.1 25.4 21.6 7.0 5.9 14.1 3.3 13.0 4.6 12.8 9.6 0.0 11.0 13.0 12.4 10.8 15.1 6.6 10.6 33.4 2.4 8.6 9.7 3.5 21.3 11.3 0.0 28.9 10.0 16.6 8.2 10.1 24.4 6.9 23.8 19.4 13.7 29.1 89.7 0.0 9.2 13.8 13.3 7.3 CATSPERG "C19orf15, DKFZp434A1022, FLJ46353" ENSG00000099338 "Cation channel sperm associated auxiliary subunit gamma" Q6ZRH7 19 38335775-38370943 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.7" "Group enriched" "Detected in many" 7 "Early spermatids: 23.9;Enterocytes: 14.0;Late spermatids: 27.8;Spermatocytes: 31.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;monocytes: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HMC-1: 5.3;MCF7: 4.3" "Low region specificity" "Detected in all" HPA052777 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in male reproductive system" NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA052777: " "unprognostic (8.50e-5)" "unprognostic (5.12e-2)" "unprognostic (3.57e-3)" "unprognostic (1.51e-1)" "unprognostic (2.63e-1)" "unprognostic (3.18e-1)" "unprognostic (2.60e-1)" "unprognostic (2.87e-3)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.50e-1)" "unprognostic (4.37e-4)" "unprognostic (9.99e-2)" "unprognostic (2.01e-1)" "unprognostic (4.61e-2)" "unprognostic (1.07e-3)" 0.9 0.8 2.9 0.8 7.7 1.1 1.3 4.3 5.8 1.2 1.1 6.5 1.9 1.2 1.2 1.8 0.9 1.4 0.9 0.8 3.9 1.0 1.0 1.0 1.1 1.0 7.4 2.2 1.3 1.0 1.0 1.2 0.8 5.2 1.3 1.0 0.4 2.0 1.1 1.0 2.0 1.1 0.9 3.2 0.9 1.0 35.7 6.5 2.2 1.3 0.0 1.0 0.9 3.3 0.1 0.6 4.8 1.8 0.2 0.5 0.2 0.2 0.5 0.2 1.8 0.8 0.0 4.2 0.2 0.0 0.0 0.0 1.3 0.8 0.3 0.0 0.0 0.7 0.6 0.5 0.1 0.0 0.9 0.2 0.1 0.2 0.0 0.1 0.3 5.3 0.0 0.8 0.0 0.5 0.5 0.1 0.8 0.0 1.4 0.0 4.3 0.0 0.0 0.0 1.1 0.8 0.1 0.0 0.8 2.0 0.1 0.4 0.6 0.4 0.9 0.2 0.7 0.4 0.0 0.3 0.0 1.0 0.7 0.0 0.8 0.9 0.0 0.2 0.2 0.0 0.3 0.8 1.8 0.4 0.9 0.2 0.0 0.1 0.2 0.6 0.1 0.5 0.2 4.8 0.2 1.8 0.4 0.3 0.2 2.9 7.7 4.3 5.8 3.9 1.0 7.4 2.2 5.2 6.5 0.0 2.4 1.7 1.9 2.3 1.1 2.4 2.5 0.0 0.0 1.8 0.0 1.0 0.0 0.8 23.9 1.5 14.0 0.0 0.6 0.2 1.5 1.8 1.1 0.5 2.8 1.6 1.7 1.8 0.8 27.8 1.7 2.6 0.0 1.8 1.5 1.9 0.5 3.5 2.1 1.1 1.1 0.0 1.0 31.9 2.7 1.6 1.1 2.5 2.0 1.4 CBS HIP4 ENSG00000160200 Cystathionine-beta-synthase P35520 21 43053191-43076943 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" "Allosteric enzyme, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 55.7;pancreas: 43.0" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 3.5;Hepatocytes: 2.6;Melanocytes: 5.0;Smooth muscle cells: 2.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 84 "neutrophil: 8.3" "Lineage enriched" "Detected in single" 84 "granulocytes: 8.3" "Cell line enhanced" "Detected in many" "BEWO: 40.8;HAP1: 38.9;HHSteC: 52.7;MCF7: 45.1;RPMI-8226: 43.1" HPA001223 Supported Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (4.86e-2)" "unprognostic (1.48e-2)" "unprognostic (6.81e-2)" "unprognostic (1.12e-3)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (9.68e-4)" "unprognostic (3.62e-1)" "unprognostic (6.76e-3)" "unprognostic (1.06e-1)" "unprognostic (6.50e-2)" "unprognostic (2.13e-1)" "unprognostic (1.61e-2)" "unprognostic (6.73e-3)" "unprognostic (2.62e-1)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" 1.3 1.5 6.5 2.4 5.1 0.4 1.0 12.3 6.7 4.8 1.3 2.0 0.8 1.6 0.9 0.8 0.8 2.0 2.1 2.0 5.6 5.5 1.3 55.7 1.7 1.4 4.8 2.8 13.9 43.0 0.3 1.4 1.4 2.3 4.0 0.7 2.8 9.3 3.4 0.8 0.6 2.9 1.4 3.7 0.8 2.7 2.2 3.3 0.8 5.0 0.8 0.9 2.6 0.8 0.0 0.0 8.3 0.0 0.0 0.0 0.0 6.4 3.9 5.1 20.0 11.5 7.4 40.8 8.0 2.0 3.3 3.4 12.0 0.3 0.0 4.3 15.0 0.0 0.4 38.9 2.8 0.6 0.0 4.9 2.7 15.6 14.4 52.7 1.6 3.8 4.5 0.4 3.6 3.2 3.0 8.8 18.9 30.1 22.7 2.5 45.1 2.8 0.0 4.8 14.6 6.8 0.0 0.0 43.1 0.1 3.6 10.6 15.6 17.4 1.0 7.5 4.3 6.2 20.4 1.2 0.2 10.0 0.1 0.8 7.9 6.3 9.0 3.7 2.4 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 6.5 5.1 12.3 5.2 5.6 5.5 4.8 2.8 2.3 3.3 0.0 0.3 0.0 0.0 0.3 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.4 0.2 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 5.0 0.0 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 2.3 0.0 0.6 0.9 0.1 0.0 0.0 0.0 CBSL ENSG00000274276 "Cystathionine-beta-synthase like" P0DN79 21 6444869-6468040 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.5;liver: 21.2;pancreas: 18.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 47 "neutrophil: 4.6" "Lineage enriched" "Detected in single" 47 "granulocytes: 4.6" "Cell line enhanced" "Detected in many" "AN3-CA: 36.5;NTERA-2: 67.6;SH-SY5Y: 21.6;U-266/70: 21.3" HPA001223 Supported Approved Nucleoli,Vesicles NA NA 190000 Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (2.39e-1)" "unprognostic (1.54e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-3)" "unprognostic (6.49e-2)" "unprognostic (1.42e-2)" "unprognostic (1.28e-2)" "unprognostic (6.62e-3)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (7.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-1)" "unprognostic (3.17e-3)" "unprognostic (8.44e-2)" "unprognostic (2.46e-1)" "unprognostic (3.61e-1)" 0.0 0.0 0.0 0.0 0.0 11.5 1.8 0.0 0.4 0.0 0.0 0.0 0.3 0.0 1.0 0.0 21.2 0.0 0.0 1.6 18.5 0.0 0.0 1.8 0.0 0.0 3.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 5.0 0.0 0.3 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 12.2 36.5 0.0 0.0 0.4 7.6 4.4 2.8 8.5 0.1 4.9 0.0 0.0 0.0 4.7 3.2 0.0 3.9 1.7 0.0 9.6 0.0 0.0 0.0 0.2 0.0 5.2 4.2 14.2 0.0 7.1 0.0 0.0 0.8 0.2 16.9 0.1 0.0 5.7 0.6 67.6 0.0 0.0 0.0 0.0 0.0 11.0 0.0 14.1 21.6 0.0 1.1 14.7 0.0 0.0 0.0 0.0 0.7 0.0 4.7 1.5 21.3 7.8 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CC2D2B "bA248J23.4, bA690P14.3, C10orf130, C10orf131" ENSG00000188649 "Coiled-coil and C2 domain containing 2B" Q6DHV5 10 95907603-96032684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.6" "Cell type enriched" "Detected in some" 6 "Early spermatids: 8.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA044091, HPA072122" Enhanced Approved "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA044091: AB_2732514, HPA072122: AB_2686489" "unprognostic (6.38e-2)" "unprognostic (5.95e-2)" "unprognostic (1.47e-1)" "unprognostic (5.00e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-2)" "unprognostic (1.04e-1)" "unprognostic (2.39e-3)" "unprognostic (1.21e-1)" "unprognostic (3.63e-1)" "unprognostic (8.18e-3)" "unprognostic (2.11e-3)" "unprognostic (9.11e-4)" "unprognostic (1.93e-2)" "unprognostic (4.34e-1)" "unprognostic (5.45e-3)" "unprognostic (1.41e-1)" 0.5 1.7 1.0 1.7 1.0 1.7 0.6 0.3 3.1 0.8 0.8 0.6 2.3 0.2 0.8 1.3 2.0 0.8 0.6 0.6 0.6 0.3 0.9 1.1 0.9 0.8 0.2 0.0 0.4 0.7 0.9 0.0 0.5 0.1 1.6 2.6 0.9 1.2 0.7 1.4 0.6 10.6 4.0 0.0 1.0 1.1 4.1 1.0 1.8 1.0 0.8 2.9 0.5 1.2 4.0 3.9 7.2 0.2 0.4 4.1 3.9 0.4 0.6 0.1 4.2 0.8 5.1 3.1 0.0 4.0 2.8 0.3 0.2 0.0 4.9 8.8 9.2 3.4 3.2 0.0 9.8 0.6 0.7 0.0 0.4 0.1 1.7 0.3 1.3 7.9 3.0 0.9 2.5 4.5 3.3 8.5 3.0 6.6 11.6 3.5 4.3 0.7 1.3 7.1 3.8 4.3 1.1 2.7 5.1 7.0 4.4 3.4 4.5 4.5 3.1 5.6 2.6 11.0 0.1 3.4 10.0 2.9 0.0 1.0 0.2 1.9 0.3 2.9 3.4 1.4 1.1 0.9 4.1 1.3 0.4 1.8 0.8 0.8 1.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CCDC137 MGC16597 ENSG00000185298 "Coiled-coil domain containing 137" Q6PK04 17 81666364-81673904 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052637, HPA053914" Uncertain Enhanced "Nucleoli,Mitotic chromosome" Yes No "Nucleoli, Mitotic chromosome" "HPA052637: AB_2681894, HPA053914: AB_2682306" "unprognostic (3.04e-1)" "unprognostic (5.82e-2)" "unprognostic (1.76e-1)" "unprognostic (3.07e-2)" "unprognostic (1.68e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (1.35e-7)" "prognostic unfavorable (8.32e-4)" "unprognostic (2.21e-2)" "unprognostic (8.33e-3)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.16e-7)" "unprognostic (4.26e-2)" "unprognostic (2.01e-1)" "unprognostic (3.93e-1)" "unprognostic (1.39e-1)" 11.3 10.9 10.9 16.0 14.1 20.2 10.2 11.3 17.0 10.3 11.5 8.0 8.9 16.2 9.1 6.4 25.2 9.2 9.1 9.1 12.1 9.0 10.6 12.1 8.7 18.8 12.4 11.9 8.4 12.0 9.4 8.4 11.2 11.8 13.1 6.4 5.7 13.0 9.9 12.7 29.8 11.8 10.3 9.1 17.7 11.4 13.4 12.4 9.8 9.2 13.1 16.6 10.6 14.7 12.8 12.6 10.2 9.2 11.9 11.2 5.9 12.4 24.7 6.7 12.0 4.9 4.9 13.5 14.3 6.8 20.6 11.4 21.8 7.5 12.9 7.6 8.5 11.6 16.4 13.9 16.1 7.7 6.6 21.4 20.0 11.0 17.3 7.5 15.3 13.1 7.2 8.7 18.9 8.5 4.5 14.5 14.0 19.0 6.9 9.6 13.6 15.2 16.6 16.1 9.5 25.0 18.2 12.7 8.3 6.5 11.4 16.5 21.3 13.1 27.0 11.7 7.9 19.5 12.7 9.9 29.8 17.4 11.9 19.7 18.2 10.5 13.0 10.7 15.0 16.9 1.9 7.8 10.2 11.2 8.4 7.0 10.3 9.7 9.6 7.4 12.8 10.7 9.6 3.5 11.9 9.2 12.6 9.5 5.9 10.9 14.1 11.3 17.0 12.1 9.0 12.4 11.9 11.8 12.4 20.8 13.4 25.0 19.6 28.2 5.7 6.2 10.2 26.8 25.0 12.2 2.0 19.0 16.6 24.5 1.0 19.6 12.7 23.3 18.6 32.2 11.4 18.3 18.5 10.9 21.5 17.5 6.9 14.1 11.0 0.9 12.7 18.2 15.1 33.3 13.4 12.9 26.4 13.6 12.7 10.2 7.1 6.5 15.6 31.2 46.5 30.1 17.4 29.9 17.0 18.6 CCDC148 MGC125588 ENSG00000153237 "Coiled-coil domain containing 148" Q8NFR7 2 158171081-158456753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 5.9;testis: 6.5" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 40.2;Cone photoreceptor cells: 53.0;Early spermatids: 22.4;Rod photoreceptor cells: 29.6" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 9 "basophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.1;HBF TERT88: 4.3;hTEC/SVTERT24-B: 2.8;RPTEC TERT1: 3.3;SCLC-21H: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042626 Uncertain Uncertain "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA042626: AB_10806244" "unprognostic (1.88e-1)" "unprognostic (5.90e-2)" "unprognostic (3.31e-2)" "unprognostic (1.94e-4)" "unprognostic (3.29e-1)" "unprognostic (7.65e-2)" "unprognostic (1.23e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (7.98e-2)" "unprognostic (1.84e-1)" "unprognostic (1.18e-1)" "unprognostic (1.42e-2)" "unprognostic (5.77e-2)" "unprognostic (3.35e-2)" "prognostic favorable (2.54e-4)" "unprognostic (6.57e-3)" 0.1 0.5 0.6 0.0 0.8 0.0 1.8 1.9 0.3 1.4 0.0 0.0 0.6 2.4 0.0 3.3 0.4 0.0 0.7 0.8 4.3 0.1 0.6 0.0 0.5 1.3 0.1 5.9 1.9 0.0 0.4 0.0 1.0 0.7 0.0 0.2 0.0 0.0 1.0 0.0 0.0 6.5 1.8 0.0 0.1 0.3 0.0 0.0 1.9 0.0 0.0 0.2 0.0 1.3 0.0 0.8 1.0 0.0 0.0 0.1 0.9 0.0 1.1 2.3 1.1 6.1 0.1 0.1 0.9 0.4 0.5 0.0 0.3 4.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.4 0.0 0.2 0.0 0.1 0.5 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 3.3 0.4 4.2 0.2 0.3 0.4 0.5 1.3 2.4 0.3 0.0 0.4 0.5 0.1 0.2 0.6 0.7 0.0 1.0 0.0 0.4 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.2 0.0 9.1 2.0 0.0 40.2 3.4 7.0 53.0 0.0 11.6 5.6 22.4 0.2 0.0 0.0 1.6 0.0 0.5 0.8 0.0 1.0 0.1 4.8 0.0 1.8 0.0 3.8 0.9 0.0 0.0 1.0 0.0 5.2 3.4 0.0 1.8 4.8 29.6 6.5 0.3 7.5 1.5 0.4 0.0 0.0 0.0 1.6 CCDC149 DKFZp761B107 ENSG00000181982 "Coiled-coil domain containing 149" Q6ZUS6 4 24806117-24980204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 4.5" "Lineage enriched" "Detected in single" 6 "monocytes: 4.5" "Cell line enhanced" "Detected in many" "U-87 MG: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044158, HPA047913" Uncertain Approved Nucleoli NA NA Nucleoli "HPA044158: AB_2678840, HPA047913: AB_2680207" "unprognostic (1.68e-1)" "unprognostic (2.43e-1)" "unprognostic (1.09e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.06e-1)" "unprognostic (4.11e-4)" "unprognostic (9.71e-5)" "unprognostic (2.68e-2)" "unprognostic (1.79e-1)" "unprognostic (7.82e-2)" "unprognostic (8.59e-3)" "unprognostic (2.25e-1)" "unprognostic (2.80e-3)" "unprognostic (8.87e-2)" "unprognostic (2.25e-1)" "unprognostic (5.03e-2)" "unprognostic (4.80e-2)" 11.7 8.3 20.1 8.2 14.7 2.8 16.7 14.8 20.6 13.2 10.8 6.9 11.1 5.3 12.9 9.2 7.9 13.9 9.9 10.9 15.9 11.5 7.5 10.3 10.0 4.4 11.5 12.7 15.9 31.7 12.8 11.2 11.6 11.3 14.3 8.6 7.5 29.8 10.1 8.6 6.9 6.4 14.5 9.9 5.8 13.8 5.4 9.4 0.9 11.9 4.6 4.3 9.6 18.3 0.0 0.8 0.8 4.5 0.2 0.0 1.2 4.1 1.6 3.3 0.5 5.2 9.6 1.0 6.0 9.1 4.8 5.6 0.0 4.6 0.0 2.9 11.4 5.4 0.7 1.0 0.7 3.1 0.0 0.0 0.0 0.3 0.3 4.4 0.0 0.0 6.6 4.3 2.7 0.0 13.5 3.8 0.0 0.0 0.8 2.9 4.4 0.0 0.1 3.8 0.4 4.6 0.0 0.0 0.2 8.6 3.0 4.6 0.0 2.5 3.8 12.3 3.7 6.4 9.2 9.3 7.0 0.8 5.2 5.1 0.1 0.0 0.0 21.5 0.9 4.8 0.0 4.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.2 1.5 0.7 0.0 1.2 20.1 14.7 14.8 20.0 15.9 11.5 11.5 12.7 11.3 9.4 0.0 7.4 0.0 6.2 5.6 11.5 5.3 5.1 4.0 3.4 7.0 9.8 4.5 0.0 5.6 0.9 13.5 1.1 0.0 8.8 1.5 5.8 10.2 0.0 6.0 9.7 4.8 1.7 6.2 11.1 1.3 10.0 3.0 8.5 0.0 10.9 9.4 7.5 3.5 11.0 2.2 11.5 6.5 11.3 1.4 1.9 2.8 8.9 0.5 4.3 5.6 CCDC168 "C13orf40, FLJ40176" ENSG00000175820 "Coiled-coil domain containing 168" Q8NDH2 13 102729369-102759070 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 23.7" "Cell type enriched" "Detected in some" 32 "Early spermatids: 828.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.6;MOLT-4: 1.3;NB-4: 1.0;THP-1: 2.0" "HPA048184, HPA058793, HPA078547" Uncertain Approved Nucleoli,Centrosome,Cytosol NA NA "Nucleoli, Centrosome" Cytosol "HPA048184: AB_2680303, HPA058793: AB_2683823, HPA078547: " "unprognostic (2.06e-1)" "unprognostic (7.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-4)" "unprognostic (2.09e-2)" "unprognostic (3.68e-2)" "unprognostic (2.74e-1)" "unprognostic (5.05e-2)" "unprognostic (3.61e-1)" "unprognostic (2.89e-3)" "unprognostic (1.73e-1)" "unprognostic (1.44e-5)" "unprognostic (2.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.85e-1)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.9 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.4 0.2 0.7 0.1 0.0 0.0 1.6 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 1.3 1.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.3 0.3 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 3.4 0.0 0.0 0.2 0.0 0.3 828.1 0.0 0.0 0.0 0.3 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.8 26.2 2.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 1.1 1.4 0.0 0.3 0.0 0.0 0.1 CCDC171 "bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740" ENSG00000164989 "Coiled-coil domain containing 171" Q6TFL3 9 15553086-16061663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 152.4;Late spermatids: 134.7;Rod photoreceptor cells: 44.6;Spermatocytes: 149.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 9.5;HEL: 14.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA019803, HPA019806, HPA024133" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848" "unprognostic (1.35e-2)" "unprognostic (2.03e-4)" "unprognostic (7.22e-3)" "unprognostic (1.16e-1)" "unprognostic (1.43e-1)" "unprognostic (1.09e-1)" "unprognostic (1.51e-2)" "unprognostic (2.05e-2)" "unprognostic (2.18e-1)" "unprognostic (6.76e-3)" "unprognostic (5.37e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-3)" "unprognostic (7.80e-2)" "unprognostic (4.90e-2)" "unprognostic (1.15e-1)" "unprognostic (6.91e-3)" 2.5 2.5 5.8 5.5 7.5 4.0 3.6 8.2 7.8 4.1 2.4 1.1 6.9 1.9 11.6 5.8 2.4 4.6 3.4 2.6 4.9 4.1 2.8 1.3 2.5 2.4 3.4 7.6 6.3 3.4 4.2 7.8 7.3 6.6 3.4 2.5 2.0 1.9 7.4 2.4 4.9 2.2 7.1 6.1 1.5 3.1 20.4 3.3 20.2 4.3 1.4 2.2 2.5 2.8 1.6 0.7 5.1 0.6 0.4 1.8 0.2 1.7 0.9 2.2 2.1 1.2 2.6 1.4 1.4 1.1 1.4 1.5 0.6 0.8 9.5 0.7 0.8 2.5 0.4 0.9 1.3 1.5 2.0 0.9 14.8 1.5 1.3 1.8 2.1 1.9 1.5 2.6 1.1 2.1 1.0 0.6 5.4 0.4 2.6 1.6 0.7 4.1 1.9 1.7 0.8 2.1 4.9 1.6 0.3 1.0 1.4 3.1 1.5 2.8 1.0 3.6 1.9 1.1 1.5 1.1 2.9 1.6 0.8 0.9 1.4 1.7 6.2 1.2 1.2 2.0 5.1 0.6 0.0 0.8 0.6 1.8 0.7 0.7 0.7 0.7 1.6 0.5 0.9 0.5 0.4 0.4 0.7 0.6 0.2 5.8 7.5 8.2 7.8 4.9 4.1 3.4 7.6 6.6 3.3 0.0 6.9 0.0 5.3 2.5 24.3 7.0 0.0 17.4 9.1 3.5 15.7 4.8 5.0 2.0 152.4 2.6 2.7 0.0 3.1 3.6 1.9 0.5 1.1 0.8 1.6 9.5 1.2 2.5 0.3 134.7 5.5 1.1 0.0 1.8 2.6 11.2 2.0 0.0 5.6 1.4 44.6 12.9 2.1 149.3 27.2 2.9 4.7 0.7 3.6 2.6 CCDC175 C14orf38 ENSG00000151838 "Coiled-coil domain containing 175" P0C221 14 59504539-59576831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.1;pituitary gland: 6.6;testis: 8.2" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 13.4;Cone photoreceptor cells: 7.9;Early spermatids: 7.0;Rod photoreceptor cells: 11.8;Spermatocytes: 16.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;SCLC-21H: 1.7" HPA004200 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA004200: AB_1078743" "unprognostic (3.64e-3)" "unprognostic (8.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (3.83e-1)" "unprognostic (2.02e-2)" "unprognostic (5.98e-2)" "unprognostic (1.27e-1)" 0.2 0.1 0.9 0.2 2.9 0.5 0.2 17.1 3.3 0.2 0.9 1.2 0.0 0.3 0.2 1.0 0.2 1.3 0.5 0.2 0.8 0.5 0.4 0.2 0.5 0.2 0.8 0.9 0.2 0.1 0.3 6.6 0.1 3.0 0.2 1.8 0.6 0.2 0.2 0.2 0.3 0.9 0.2 0.4 0.4 0.2 8.2 1.5 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.1 0.5 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.4 0.9 2.9 17.1 3.3 0.8 0.5 0.8 0.9 3.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.4 1.2 0.0 7.9 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 11.8 0.0 0.0 16.5 1.3 0.0 0.0 0.0 2.6 0.0 CCDC24 MGC45441 ENSG00000159214 "Coiled-coil domain containing 24" Q8N4L8 1 43991359-43996528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 52.2;Intestinal endocrine cells: 34.9;Spermatocytes: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 6.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035424, HPA061710" Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoli, Cytosol" "HPA035424: AB_2674619, HPA061710: AB_2684591" "prognostic favorable (3.06e-5)" "unprognostic (1.47e-1)" "unprognostic (1.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.65e-2)" "prognostic favorable (3.18e-4)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.92e-2)" "unprognostic (6.38e-2)" "unprognostic (2.81e-1)" "unprognostic (7.00e-3)" "unprognostic (3.00e-1)" "unprognostic (1.74e-2)" "unprognostic (6.91e-2)" "unprognostic (1.51e-1)" "unprognostic (7.84e-2)" "unprognostic (2.15e-3)" 1.8 5.5 9.3 2.6 9.8 1.1 5.1 3.0 9.8 7.2 5.0 3.2 18.9 3.7 4.9 6.6 2.6 20.3 13.1 1.5 6.4 8.0 8.9 3.0 3.2 2.6 5.5 9.6 3.4 6.0 9.6 14.5 2.4 5.2 7.2 4.1 6.5 8.4 14.7 1.5 0.9 3.3 3.4 3.3 3.0 4.9 15.4 1.7 0.6 8.8 1.0 2.5 4.7 2.1 6.8 0.8 1.4 4.0 0.5 0.6 0.5 5.1 3.1 1.4 1.6 1.4 1.0 3.1 0.2 2.2 1.6 2.8 2.0 15.0 4.2 5.9 0.6 4.6 5.3 0.8 7.4 1.5 4.4 1.8 2.1 1.9 0.6 1.6 0.7 3.7 0.3 0.7 5.2 0.5 5.0 1.3 1.6 0.9 1.6 2.2 4.5 0.3 1.6 3.1 4.7 2.6 1.3 0.0 0.8 6.2 2.0 3.4 3.0 4.6 2.6 2.9 3.1 7.8 0.1 0.4 2.4 7.0 1.8 0.7 0.6 2.0 0.9 6.3 0.6 2.0 0.0 0.7 1.4 0.6 4.0 0.3 6.8 0.2 0.2 0.8 3.0 0.0 0.0 0.6 0.5 3.1 0.6 0.0 0.5 9.3 9.8 3.0 9.8 6.4 8.0 5.5 9.6 5.2 1.7 3.0 7.4 0.5 8.2 1.0 8.8 0.8 12.7 52.2 19.4 8.7 5.9 4.7 18.3 7.1 16.4 0.7 6.3 0.0 6.4 1.7 3.3 6.8 2.3 2.1 2.9 3.2 34.9 1.8 3.2 8.5 2.0 1.8 3.3 4.6 12.1 9.5 5.4 8.6 2.8 8.0 14.2 0.0 2.4 48.8 19.5 0.6 2.1 0.0 13.0 8.4 CCDC58 FLJ33273 ENSG00000160124 "Coiled-coil domain containing 58" Q4VC31 3 122359591-122383231 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047777, HPA051965" Approved Approved Nucleoli,Mitochondria No No Mitochondria Nucleoli "HPA047777: AB_2680152, HPA051965: AB_2681676" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (5.64e-2)" "unprognostic (6.98e-3)" "prognostic unfavorable (2.94e-5)" "unprognostic (2.72e-2)" "unprognostic (1.03e-2)" "unprognostic (4.98e-3)" "unprognostic (5.26e-3)" "unprognostic (1.84e-2)" "unprognostic (7.11e-3)" "unprognostic (1.03e-3)" "unprognostic (2.58e-1)" "unprognostic (1.86e-1)" "prognostic favorable (7.29e-4)" 9.5 13.3 8.7 6.8 8.1 7.1 9.2 6.9 12.6 8.2 13.3 7.1 12.4 10.6 7.3 12.4 14.0 5.8 7.7 12.4 7.2 7.0 21.9 23.3 5.4 10.0 8.6 5.3 8.8 9.3 3.1 7.7 6.7 8.5 8.2 14.4 6.5 7.2 6.9 35.2 6.9 10.2 6.3 7.2 8.6 9.1 8.7 9.3 5.5 8.8 24.5 9.6 8.7 7.1 13.9 18.3 1.7 10.2 11.4 16.1 4.6 34.9 11.1 21.2 13.5 7.9 11.1 27.3 13.4 14.6 32.6 32.1 31.3 17.7 25.7 23.2 10.2 25.4 24.5 34.4 23.0 39.1 8.8 12.2 30.2 7.9 37.8 13.2 44.9 10.8 9.1 11.9 20.0 21.9 13.9 15.0 22.9 34.2 11.2 17.1 17.4 28.6 32.2 40.7 38.6 21.0 19.0 25.2 31.6 22.4 18.6 21.5 10.5 15.6 16.6 37.3 18.7 16.5 29.6 8.6 18.3 23.4 7.7 26.7 8.9 11.9 55.4 20.8 21.8 16.1 0.4 5.0 1.7 10.2 10.2 12.0 13.9 13.6 13.4 10.3 13.5 16.1 14.9 0.9 11.4 8.5 18.3 10.5 4.6 8.7 8.1 6.9 12.6 7.2 7.0 8.6 5.3 8.5 9.3 3.0 17.1 19.3 16.0 13.6 9.4 23.0 25.5 32.1 20.5 12.2 9.8 19.1 46.4 27.4 0.3 11.3 13.4 0.0 25.7 38.8 10.2 10.9 19.8 46.1 15.7 0.0 5.2 11.6 7.6 0.7 11.8 12.4 8.5 26.2 14.7 6.6 31.7 14.0 7.8 78.7 8.8 12.9 8.0 13.5 23.4 16.2 12.7 7.1 22.4 21.2 CCDC59 "BR22, HSPC128, TAP26" ENSG00000133773 "Coiled-coil domain containing 59" Q9P031 12 82223681-82358805 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038555 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Plasma membrane" "HPA038555: AB_10669543" "unprognostic (1.61e-1)" "unprognostic (6.28e-3)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (1.13e-1)" "unprognostic (6.73e-2)" "unprognostic (1.42e-3)" "unprognostic (1.50e-2)" "unprognostic (1.86e-2)" "unprognostic (1.22e-2)" "unprognostic (2.62e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (5.73e-2)" "unprognostic (2.01e-1)" "unprognostic (8.86e-2)" "unprognostic (1.02e-2)" 17.9 10.2 11.3 14.2 16.3 54.9 18.9 14.9 14.7 17.6 16.9 8.9 7.7 7.5 14.8 17.4 17.0 17.2 11.2 14.5 11.5 12.5 16.0 15.4 12.6 13.7 14.8 12.4 18.8 12.5 2.6 18.2 18.7 13.5 18.7 12.5 6.5 12.7 13.3 23.5 12.7 18.9 14.5 16.5 17.3 12.1 18.4 14.9 15.3 19.9 17.9 18.1 21.4 20.9 18.9 18.6 17.9 14.0 13.1 23.6 6.7 11.5 11.0 9.1 6.5 10.1 8.8 14.2 10.5 12.2 18.6 15.2 22.1 6.6 13.6 5.4 10.5 13.1 7.4 41.5 20.1 15.8 14.3 22.1 13.3 6.5 14.6 29.9 17.6 7.7 15.3 17.1 19.6 24.7 15.7 15.2 24.7 25.2 7.0 11.4 20.9 16.2 24.1 14.4 11.0 25.5 12.3 13.6 11.1 9.8 11.6 15.5 7.5 12.1 6.5 15.3 10.6 14.0 23.4 7.1 9.3 7.1 6.5 19.2 11.2 12.5 26.1 6.6 14.1 12.4 12.7 9.3 16.8 11.6 9.6 19.8 15.2 18.6 16.9 9.6 18.9 22.1 17.6 17.9 13.1 14.0 18.6 23.6 6.7 11.3 16.3 14.9 14.7 11.5 12.5 14.8 12.4 13.5 14.9 62.5 48.8 69.0 103.9 76.2 31.5 38.7 38.2 61.6 62.6 41.8 21.6 67.1 109.5 41.0 58.5 55.4 25.5 23.3 49.8 74.4 49.4 61.8 76.2 47.2 50.6 41.3 34.3 57.1 55.3 15.9 49.5 60.8 45.5 44.1 52.3 38.3 47.8 48.0 50.5 57.2 38.9 19.4 54.7 185.8 116.5 78.5 122.8 77.6 53.2 81.7 CCDC7 "BIOT2, C10orf68, FLJ13031, FLJ32762" ENSG00000216937 "Coiled-coil domain containing 7" Q96M83 10 32446140-32882874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 65.5" "Group enriched" "Detected in many" 8 "Early spermatids: 397.3;Late spermatids: 669.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA075536 Approved "Nucleoli,Mitotic spindle,Cytosol" Yes No Nucleoli "Mitotic spindle, Cytosol" "HPA075536: AB_2686755" "unprognostic (3.43e-3)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "unprognostic (1.01e-2)" "unprognostic (2.69e-2)" "unprognostic (3.75e-3)" "unprognostic (2.65e-5)" "unprognostic (6.95e-2)" "unprognostic (7.57e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-3)" "unprognostic (2.84e-2)" "unprognostic (2.95e-5)" "unprognostic (7.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" 2.1 2.1 3.2 3.8 3.6 2.8 2.2 4.8 3.6 2.3 2.1 4.2 4.3 2.0 3.4 5.1 2.0 1.7 1.9 2.3 2.6 1.9 1.9 1.7 2.0 2.8 4.2 1.5 2.7 2.3 2.1 8.5 1.8 3.0 2.1 2.3 1.8 2.0 3.2 2.0 2.0 1.8 2.1 5.4 2.0 2.0 65.5 3.2 3.4 2.7 0.3 2.2 2.3 2.3 2.4 1.7 0.1 0.6 2.9 5.9 0.5 2.6 2.9 0.8 3.6 2.5 1.9 1.3 2.3 0.9 0.8 2.5 0.6 3.8 1.9 1.2 1.6 2.3 1.3 1.4 1.4 3.2 6.8 0.3 1.1 2.0 0.7 4.3 1.1 1.9 1.8 0.7 1.7 0.7 1.6 1.0 3.0 1.5 6.7 3.3 0.4 0.8 0.6 0.7 1.4 2.8 1.6 3.7 0.3 2.4 0.6 1.9 1.9 0.4 0.5 1.6 1.1 1.9 1.5 3.9 2.0 2.4 2.6 1.3 2.1 1.4 2.0 2.6 7.5 1.1 0.0 0.6 0.1 3.4 0.3 3.3 2.4 5.3 2.9 0.3 1.2 5.9 3.9 0.1 2.9 0.3 1.7 3.5 0.5 3.2 3.6 4.8 3.6 2.6 1.9 4.2 1.5 3.0 3.2 6.0 7.5 0.8 1.0 1.6 8.6 6.7 0.0 1.4 4.5 1.8 3.9 0.6 1.7 3.1 397.3 2.3 1.4 0.0 3.0 1.0 1.2 0.8 11.6 0.0 1.6 0.0 2.9 0.0 0.0 669.2 8.9 2.3 1.7 1.0 2.0 2.7 2.3 0.0 6.7 0.6 25.0 12.9 1.0 70.9 6.1 1.0 0.1 1.5 1.7 0.6 CCDC86 MGC2574 ENSG00000110104 "Coiled-coil domain containing 86" Q9H6F5 11 60842071-60851081 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 200.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041117, HPA041540" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA041117: AB_10794984, HPA041540: AB_10794299" "unprognostic (2.93e-1)" "unprognostic (6.59e-2)" "unprognostic (2.38e-1)" "unprognostic (1.47e-3)" "unprognostic (3.64e-1)" "prognostic unfavorable (7.36e-5)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.65e-3)" "unprognostic (9.52e-2)" "unprognostic (1.25e-2)" "unprognostic (6.12e-2)" "unprognostic (4.47e-1)" "unprognostic (3.76e-2)" "unprognostic (7.54e-3)" "unprognostic (2.90e-1)" "unprognostic (2.16e-1)" "unprognostic (6.25e-2)" 13.5 12.4 7.3 8.6 11.0 6.1 11.2 3.3 11.2 5.8 6.7 7.9 3.4 7.4 8.4 5.0 9.3 7.4 8.3 9.3 6.7 6.4 8.1 11.4 5.4 8.2 10.0 6.0 11.3 13.6 200.8 12.7 7.3 8.5 11.9 4.7 6.7 6.4 6.2 20.2 10.4 6.2 7.3 6.7 9.3 7.7 47.8 8.7 10.2 7.9 12.6 6.5 8.6 6.5 6.9 20.0 5.0 19.5 4.2 8.5 6.7 21.0 28.7 7.1 20.5 5.8 9.6 9.7 14.2 11.1 26.1 14.0 24.4 14.2 25.8 27.2 7.7 18.6 19.8 24.0 17.1 12.0 9.1 26.6 13.1 12.7 34.0 19.2 20.5 22.5 10.9 13.0 24.1 15.3 3.8 19.3 14.2 41.9 13.3 12.7 24.9 30.8 31.3 28.7 12.5 41.3 21.0 10.7 64.9 9.1 9.0 16.1 10.4 9.1 21.1 16.6 4.7 21.3 8.2 12.6 26.0 16.0 35.3 30.7 11.2 16.5 27.9 21.3 22.2 31.4 2.6 9.1 5.0 6.5 19.5 6.9 6.9 6.9 6.0 20.0 6.5 8.5 7.4 0.7 4.2 6.3 11.2 6.2 6.7 7.3 11.0 3.3 11.2 6.7 6.4 10.0 6.0 8.5 8.7 0.0 2.1 3.0 15.4 32.7 9.3 0.4 2.5 0.0 4.5 1.8 7.9 15.9 6.6 20.4 19.7 6.8 2.6 0.0 10.4 14.1 9.5 18.2 4.7 2.4 16.0 3.2 6.9 3.7 2.8 10.6 10.6 7.9 15.1 4.6 4.9 3.6 13.7 3.5 5.6 5.4 7.9 19.4 20.2 37.1 19.1 27.0 6.9 6.1 9.7 15.5 CDCA7L "JPO2, R1, RAM2" ENSG00000164649 "Cell division cycle associated 7 like" Q96GN5 7 21900900-21946084 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.9" "Cell type enhanced" "Detected in many" 7 "Spermatogonia: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 5 "olfactory region: 22.0" "HPA027169, HPA074623" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA027169: AB_1856058, HPA074623: " "unprognostic (5.13e-3)" "unprognostic (5.94e-2)" "unprognostic (1.91e-1)" "unprognostic (4.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (4.36e-6)" "unprognostic (4.09e-2)" "unprognostic (2.86e-1)" "unprognostic (3.87e-2)" "unprognostic (3.22e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.60e-1)" "unprognostic (1.73e-1)" "unprognostic (2.83e-3)" 6.2 1.2 3.7 19.9 9.6 24.2 8.0 6.5 4.2 8.4 9.0 7.8 3.9 5.2 11.1 3.6 6.0 7.0 5.4 12.5 3.9 2.5 2.7 4.5 7.3 18.7 6.2 4.0 13.9 17.4 1.0 1.6 2.2 3.7 7.6 10.2 5.8 10.5 8.0 2.7 13.6 8.7 6.6 3.0 9.3 12.7 12.6 5.3 47.9 20.0 5.1 16.5 6.0 9.4 38.5 21.8 11.8 1.3 0.8 9.7 3.3 19.7 6.8 6.4 0.1 3.5 4.5 0.0 16.2 13.9 12.6 17.9 2.5 18.0 41.3 5.3 13.9 25.1 12.2 10.1 16.6 25.5 0.0 6.7 9.9 20.1 1.6 4.5 25.9 0.1 8.3 3.0 9.7 28.5 13.0 24.8 32.3 13.6 0.0 9.7 7.4 32.7 9.3 36.5 3.9 8.4 32.9 22.9 27.5 3.5 3.7 23.5 19.2 7.3 4.5 7.4 8.5 11.0 11.7 10.5 13.8 17.0 23.9 19.5 21.3 14.6 53.4 13.2 35.0 13.5 0.3 0.6 11.8 0.6 0.9 0.1 28.6 1.9 0.9 4.3 38.5 9.7 3.9 1.1 0.8 1.3 21.8 2.7 3.3 3.7 9.6 6.5 4.2 3.9 2.5 6.2 4.0 3.7 5.3 17.9 20.3 28.9 22.5 24.2 0.2 26.3 2.5 6.7 31.8 0.0 2.0 0.5 3.3 6.7 2.6 3.7 1.5 0.0 5.3 0.2 4.3 7.7 8.1 3.4 9.6 12.7 10.3 2.5 10.2 3.6 3.7 3.5 8.5 0.0 26.4 2.4 4.9 3.5 2.5 0.0 2.1 12.9 12.3 2.7 61.1 6.8 0.2 2.5 24.4 3.9 CDCA8 "BOR, DasraB, FLJ12042, MESRGP" ENSG00000134690 "Cell division cycle associated 8" Q53HL2 1 37692418-37709719 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 20.9;Spermatocytes: 82.1;Spermatogonia: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA028120, HPA028258, HPA028783, CAB040294" Enhanced Supported "Nucleoplasm,Nucleoli,Cytokinetic bridge" Yes Yes Nucleoli "Nucleoplasm, Cytokinetic bridge" "CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092" "unprognostic (8.36e-2)" "unprognostic (2.00e-1)" "unprognostic (8.39e-2)" "unprognostic (7.75e-3)" "unprognostic (2.34e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (4.93e-10)" "unprognostic (4.30e-3)" "prognostic unfavorable (6.04e-4)" "unprognostic (3.00e-1)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.78e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.39e-3)" "unprognostic (2.99e-1)" "unprognostic (3.18e-1)" "unprognostic (1.67e-1)" 1.2 1.4 0.9 12.9 1.7 19.0 1.7 0.8 1.6 1.8 6.0 1.1 0.7 5.3 1.4 1.3 9.6 0.7 2.4 0.8 0.9 0.9 1.3 1.5 2.0 12.2 1.8 1.3 0.9 1.0 0.1 0.8 3.7 1.3 1.0 7.7 0.7 2.1 1.0 0.9 4.0 5.4 1.6 1.2 5.4 3.5 44.7 1.7 51.6 0.9 6.5 14.6 1.6 2.9 2.8 1.8 4.5 5.0 6.3 8.9 2.5 28.4 12.4 23.5 17.0 1.0 2.0 15.8 21.5 10.8 38.0 27.0 19.4 21.3 34.6 8.7 13.7 15.3 16.2 27.0 14.2 40.4 23.0 12.1 31.1 13.3 15.3 0.2 29.9 16.1 0.8 1.0 21.4 19.0 4.3 16.8 24.9 26.2 37.2 27.4 12.7 27.5 18.4 27.2 16.6 17.2 26.9 32.1 19.8 8.6 11.9 20.9 9.2 23.6 11.1 14.5 21.1 16.3 11.4 10.1 18.7 19.9 10.7 33.5 25.3 32.9 47.2 8.8 27.8 21.4 0.0 1.1 1.8 2.5 2.2 4.5 2.8 5.7 3.3 1.0 2.5 1.9 3.8 4.5 6.3 5.0 1.8 8.9 2.5 0.9 1.7 0.8 1.6 0.9 0.9 1.8 1.3 1.3 1.7 0.0 0.3 9.3 0.8 3.0 1.1 0.4 5.1 8.1 0.0 0.0 0.0 2.2 0.0 1.1 0.8 0.2 4.2 0.0 0.6 20.9 0.9 0.6 0.0 1.0 9.5 1.6 3.5 1.8 3.1 2.2 1.4 4.6 1.7 2.8 5.1 0.0 1.6 4.9 1.1 0.5 0.8 19.4 0.0 82.1 41.4 2.4 2.4 3.2 6.3 0.9 CDK4 PSK-J3 ENSG00000135446 "Cyclin dependent kinase 4" P11802 12 57747727-57756013 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 10 "HBEC3-KT: 128.1;LHCN-M2: 141.4;RH-30: 445.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006024, CAB013116, CAB069405" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear membrane, Nucleoli" "CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497" "unprognostic (8.88e-2)" "unprognostic (2.53e-1)" "unprognostic (5.27e-2)" "unprognostic (9.01e-2)" "unprognostic (2.21e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.09e-7)" "unprognostic (7.39e-2)" "unprognostic (3.23e-3)" "unprognostic (2.93e-2)" "unprognostic (3.19e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (3.15e-5)" "unprognostic (3.32e-1)" "unprognostic (1.67e-1)" "unprognostic (3.64e-1)" "unprognostic (1.57e-2)" 32.2 43.1 13.8 22.2 15.7 24.0 45.0 13.1 17.9 36.3 28.2 20.1 22.8 15.2 51.4 28.1 29.9 31.0 32.3 27.4 14.5 12.1 24.0 36.9 26.8 26.4 18.3 13.7 61.4 54.4 18.9 34.2 25.0 16.0 37.2 26.9 26.2 29.3 24.1 27.8 25.6 20.7 34.1 13.5 27.2 23.9 24.6 17.5 29.2 54.3 32.1 27.5 33.6 30.9 29.6 25.5 2.6 19.9 15.8 32.1 22.2 9.5 11.1 14.6 13.0 13.4 11.8 9.8 5.5 18.0 24.4 20.2 15.8 9.1 13.9 10.0 8.6 14.4 7.4 20.2 128.1 18.5 6.8 9.3 13.0 7.5 11.1 15.7 14.7 9.0 11.6 9.4 14.9 17.2 16.6 15.6 13.3 13.8 12.0 141.4 13.9 14.1 12.0 17.2 10.0 11.2 12.6 445.0 12.9 7.6 15.1 13.3 12.4 9.8 7.4 14.7 10.5 9.8 17.9 7.1 11.4 10.8 12.9 11.1 6.0 9.7 21.4 10.5 13.7 13.7 1.7 14.3 2.6 26.2 19.9 27.0 29.6 23.1 23.7 21.0 28.1 32.1 28.5 1.2 15.8 12.0 25.5 16.6 22.2 13.8 15.7 13.1 17.9 14.5 12.1 18.3 13.7 16.0 17.5 20.8 25.0 32.0 62.9 79.7 15.3 0.5 48.4 4.0 23.9 45.4 9.8 64.6 59.7 71.7 10.1 44.2 11.3 23.3 53.6 108.9 77.4 41.8 68.1 32.1 111.7 17.5 43.8 34.4 23.2 6.8 59.2 34.0 50.6 54.1 33.5 51.3 55.4 7.0 59.4 66.3 15.3 32.3 54.2 25.9 40.3 75.3 39.1 34.1 78.3 32.5 CDK5RAP3 "C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114" ENSG00000108465 "CDK5 regulatory subunit associated protein 3" Q96JB5 17 47967810-47981774 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022141, HPA022882, HPA027883" Supported Supported Nucleoli,Vesicles,Cytosol NA NA Cytosol "Nucleoli, Vesicles" "HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797" "unprognostic (4.27e-2)" "unprognostic (1.01e-3)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "unprognostic (5.98e-2)" "unprognostic (7.19e-3)" "unprognostic (3.84e-1)" "unprognostic (4.44e-2)" "unprognostic (7.55e-2)" "unprognostic (2.06e-1)" "unprognostic (2.59e-3)" "unprognostic (1.92e-2)" "prognostic unfavorable (3.61e-5)" "unprognostic (8.35e-3)" "unprognostic (2.30e-1)" "unprognostic (9.58e-2)" "prognostic favorable (7.31e-5)" 15.5 19.7 20.8 30.0 38.3 21.2 22.5 35.7 31.9 21.1 21.2 27.1 39.4 24.1 26.2 45.4 20.8 26.1 22.0 14.4 23.2 16.7 23.2 31.0 18.8 22.0 31.3 25.8 28.9 51.9 29.4 41.3 15.4 27.3 24.2 25.5 25.1 44.0 26.4 10.7 16.8 25.8 18.4 18.2 32.3 28.6 40.1 29.5 32.3 29.7 16.5 24.6 20.0 18.5 22.8 26.9 27.2 33.5 22.4 22.3 21.0 21.6 35.0 19.4 34.6 16.2 16.3 34.7 15.8 19.3 16.0 14.8 27.4 21.1 26.1 32.8 16.5 10.9 21.3 12.5 17.8 17.9 38.6 16.6 12.5 41.6 37.1 18.2 14.7 13.9 18.6 15.1 14.4 28.3 19.1 15.5 52.1 14.7 24.3 16.3 41.5 40.0 23.8 11.6 26.0 15.1 21.4 32.6 29.6 15.9 27.3 13.2 31.7 12.3 11.0 15.9 20.3 25.0 19.2 12.4 13.3 11.8 16.0 20.3 31.9 30.1 16.2 16.6 20.4 16.1 9.1 33.5 27.2 20.9 32.7 22.3 22.1 20.0 18.5 26.9 22.8 18.1 19.9 15.7 22.4 32.5 24.4 19.0 21.0 20.8 38.3 35.7 31.9 23.2 16.7 31.3 25.8 27.3 29.5 23.8 60.0 43.9 57.3 29.9 50.5 21.5 53.5 68.3 54.6 38.4 29.5 59.3 43.1 46.8 30.4 31.5 56.4 0.0 58.8 47.0 41.2 53.4 67.1 47.9 55.2 54.0 59.1 22.1 38.3 29.6 37.7 41.1 43.9 48.7 49.8 44.7 36.9 56.1 28.0 39.9 50.6 32.3 28.5 71.6 40.3 22.6 51.5 51.6 47.6 51.4 CDKN2A "ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf" ENSG00000147889 "Cyclin dependent kinase inhibitor 2A" "P42771, Q8N726" 9 21967753-21995301 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway" DNA-binding "Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 22.6;pituitary gland: 39.3" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 178.1;Late spermatids: 275.2;Pancreatic endocrine cells: 259.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 22.6" "Group enriched" "Detected in many" 8 "B-cells: 7.2;T-cells: 22.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 50.2;HEK 293: 56.9;HeLa: 53.2;SK-MEL-30: 53.1" "Low region specificity" "Detected in some" "CAB000093, CAB000445, CAB018232, HPA047838" Enhanced Supported Nucleoli NA NA Nucleoli "CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174" "unprognostic (3.41e-2)" "unprognostic (4.51e-2)" "unprognostic (3.00e-3)" "prognostic unfavorable (1.82e-7)" "unprognostic (5.22e-2)" "prognostic favorable (5.19e-4)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.25e-2)" "unprognostic (1.05e-1)" "unprognostic (1.04e-1)" "unprognostic (1.71e-1)" "unprognostic (1.56e-2)" "prognostic unfavorable (5.76e-7)" "unprognostic (9.41e-2)" "unprognostic (1.22e-2)" "unprognostic (3.05e-2)" "unprognostic (3.55e-1)" 5.4 8.6 2.9 4.5 3.9 1.8 5.3 1.7 3.1 1.2 2.5 4.4 0.1 1.2 1.2 1.9 6.3 3.0 2.6 0.7 1.7 1.0 0.9 1.2 3.0 3.0 3.6 1.6 1.5 1.5 8.5 39.3 6.7 5.0 1.9 1.1 1.2 2.4 2.9 0.9 1.3 3.7 1.0 3.0 8.9 6.0 13.0 1.9 3.9 1.4 3.0 14.0 2.7 1.5 7.2 0.2 0.8 1.8 0.4 22.6 2.2 2.1 0.0 0.3 14.1 0.1 0.1 6.1 2.3 0.0 19.7 35.1 3.5 50.2 7.2 32.3 1.6 0.0 6.0 5.9 36.5 15.9 31.0 56.9 0.0 53.2 2.3 1.5 3.6 3.0 3.8 0.0 19.8 11.0 42.3 2.0 0.0 0.0 33.0 18.0 0.1 0.3 0.0 0.4 4.0 29.3 0.0 13.4 26.5 4.0 0.0 33.1 2.3 38.2 6.3 53.1 1.7 7.5 0.1 6.6 0.1 0.4 0.0 0.1 14.7 8.3 29.5 0.0 9.5 0.1 0.8 1.3 0.2 6.2 0.6 9.7 7.2 8.0 11.0 0.2 7.0 0.5 4.7 0.4 0.4 1.8 0.0 22.6 2.2 2.9 3.9 1.7 3.1 1.7 1.0 3.6 1.6 5.0 1.9 0.0 0.0 1.5 0.7 1.5 0.2 4.0 0.0 14.7 1.2 10.4 0.0 20.9 0.0 32.4 178.1 2.2 6.9 0.0 22.9 52.3 3.6 10.0 4.6 0.0 6.6 0.0 68.2 0.6 8.2 275.2 2.8 1.8 8.5 26.2 6.2 0.8 259.8 10.5 1.8 0.0 0.0 0.0 1.0 5.7 4.1 0.4 7.7 12.5 2.3 34.0 CDRT1 "FBXW10B, FBXW10P1, HREP, SM25H2" ENSG00000241322 "CMT1A duplicated region transcript 1" O95170 17 15565483-15619512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 9.8;testis: 12.8" "Cell type enhanced" "Detected in some" 24 "Ciliated cells: 4.0;Early spermatids: 18.5;Late spermatids: 8.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.1" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 15.6;HaCaT: 28.6;HeLa: 9.7;OE19: 7.1" "HPA013332, HPA047457" Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA013332: AB_1848471, HPA047457: " "unprognostic (2.25e-1)" "unprognostic (2.78e-1)" "unprognostic (7.03e-2)" "unprognostic (3.95e-2)" "unprognostic (1.15e-2)" "unprognostic (1.90e-2)" "unprognostic (1.45e-2)" "unprognostic (5.93e-2)" "unprognostic (5.04e-1)" "unprognostic (1.44e-1)" "unprognostic (1.17e-1)" "unprognostic (3.38e-1)" "unprognostic (9.31e-8)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (1.86e-1)" 1.1 1.8 0.0 0.9 0.0 0.0 0.7 0.2 0.0 2.4 0.3 2.9 0.0 0.8 9.8 0.3 0.7 0.7 0.0 0.0 0.1 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.1 1.8 0.3 0.6 2.6 0.1 2.1 4.4 1.3 0.0 0.0 0.2 2.6 12.8 1.6 3.0 2.0 4.1 0.4 0.1 0.0 0.3 0.1 2.1 0.0 2.4 6.8 0.2 2.0 0.2 0.7 0.2 0.5 1.5 0.2 0.7 5.1 15.6 0.1 0.4 1.3 1.6 28.6 0.4 0.3 0.4 2.4 0.3 0.1 9.7 0.2 0.2 0.0 0.1 0.3 0.9 0.6 0.4 0.1 0.1 0.4 0.0 1.2 0.8 0.1 0.4 0.2 0.2 7.1 0.8 0.0 0.4 0.0 1.9 3.7 0.1 0.2 2.3 2.0 0.1 0.8 0.1 0.1 1.2 0.5 1.4 0.0 0.4 0.6 2.9 0.0 1.7 0.1 0.8 0.0 0.2 0.0 0.2 0.3 0.1 0.1 0.2 0.0 0.1 0.4 0.1 0.2 0.0 0.1 0.1 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.2 18.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.5 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.4 0.0 0.0 0.0 0.0 0.3 CDV3 H41 ENSG00000091527 "CDV3 homolog" Q9UKY7 3 133573730-133590261 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 485.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 153.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029761, HPA029762, HPA029763" Enhanced Enhanced "Nucleoli,Plasma membrane,Cytosol" NA NA 220000 Cytosol "Nucleoli, Plasma membrane" "HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679" "unprognostic (1.17e-2)" "unprognostic (1.22e-1)" "unprognostic (4.06e-2)" "unprognostic (4.56e-2)" "unprognostic (4.04e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.21e-6)" "unprognostic (1.20e-1)" "unprognostic (3.30e-1)" "unprognostic (8.45e-3)" "unprognostic (3.29e-3)" "unprognostic (1.13e-1)" "unprognostic (2.36e-1)" "unprognostic (7.83e-2)" "unprognostic (1.48e-2)" "unprognostic (9.87e-2)" "unprognostic (7.59e-3)" 46.4 26.5 20.7 45.7 22.4 44.9 38.1 13.2 22.3 25.6 29.5 20.2 16.2 18.5 27.0 26.1 34.1 22.0 25.4 50.5 19.0 18.3 26.2 40.2 34.3 47.6 22.5 20.6 32.8 34.4 25.6 22.5 34.8 24.4 24.6 23.9 18.7 24.6 16.7 106.6 23.1 27.7 33.1 25.4 56.6 31.4 38.2 21.5 61.1 33.9 32.5 52.1 43.8 37.2 10.6 14.2 14.7 11.1 5.3 20.8 4.5 50.8 11.8 20.9 13.8 24.2 29.9 24.8 28.1 36.6 28.2 28.0 29.3 20.5 65.0 42.7 31.4 32.6 22.0 29.9 28.1 52.8 41.5 11.3 38.4 13.0 17.9 37.7 42.7 24.7 28.3 29.5 25.1 67.9 20.0 35.5 19.3 27.6 43.7 40.7 14.6 34.9 24.7 21.1 22.1 15.2 21.3 27.8 52.1 29.6 20.7 16.6 12.5 26.7 19.9 33.4 31.3 64.3 26.2 43.9 30.1 28.4 23.8 27.8 63.8 47.8 153.1 16.8 25.9 17.4 11.5 9.6 14.7 12.2 10.7 12.8 10.6 11.7 12.4 8.5 6.5 9.4 14.4 8.7 5.3 11.1 14.2 20.8 4.5 20.7 22.4 13.2 22.3 19.0 18.3 22.5 20.6 24.4 21.5 53.6 71.1 101.7 142.6 129.7 20.9 78.7 53.5 28.1 42.1 80.3 9.8 43.1 31.5 38.9 281.1 76.6 64.9 0.0 75.3 62.7 68.5 184.4 43.9 86.4 99.8 22.3 45.3 81.0 95.3 485.8 31.7 84.0 52.3 32.5 44.7 88.5 74.6 39.3 33.6 39.1 27.1 25.8 54.6 20.4 24.7 112.0 29.4 62.3 47.8 220.3 CEACAM19 CEAL1 ENSG00000186567 "Carcinoembryonic antigen related cell adhesion molecule 19" Q7Z692 19 44662278-44684359 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 10.7;RPTEC TERT1: 13.7;TIME: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA014462, HPA052865" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA014462: AB_2669006, HPA052865: AB_2681976" "unprognostic (2.91e-1)" "unprognostic (5.29e-3)" "unprognostic (6.96e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-2)" "unprognostic (8.43e-2)" "unprognostic (5.22e-2)" "unprognostic (1.15e-2)" "unprognostic (9.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.77e-1)" "unprognostic (3.26e-9)" "unprognostic (8.01e-3)" "unprognostic (9.62e-2)" "unprognostic (1.31e-1)" "unprognostic (2.70e-1)" 1.6 2.9 1.1 0.8 1.9 1.0 2.4 4.3 1.7 3.1 2.4 2.7 2.7 1.4 2.4 4.3 2.1 4.1 1.2 1.8 3.3 4.3 3.8 0.6 0.6 4.0 4.7 1.2 3.9 1.8 4.1 3.3 2.9 3.0 12.5 10.8 2.9 3.0 0.9 1.8 2.0 3.0 3.4 1.7 1.0 4.4 1.7 0.5 1.7 1.0 1.0 0.7 0.6 4.2 8.8 1.3 0.9 3.1 3.6 3.3 2.4 3.6 0.8 1.6 0.3 1.0 0.1 0.8 3.2 0.9 5.3 2.2 0.9 0.7 1.2 5.0 0.1 4.6 1.4 3.2 0.2 0.8 1.1 8.7 2.2 5.4 10.7 2.0 0.6 0.3 0.2 1.2 1.0 0.0 0.5 0.8 1.1 1.0 0.0 1.6 0.2 13.7 1.0 1.7 0.4 0.9 0.9 0.8 1.3 1.2 0.3 17.7 0.3 6.1 1.3 0.7 0.1 0.3 0.0 0.4 1.7 1.4 1.7 1.0 0.6 0.6 0.4 0.3 0.5 0.3 0.6 0.2 1.7 0.4 0.7 1.6 1.0 0.5 0.5 0.3 0.6 3.0 2.1 0.0 0.9 1.8 2.6 4.1 2.5 1.4 2.3 0.0 0.0 0.0 0.0 1.6 0.7 3.1 1.7 0.0 2.9 0.1 0.9 1.3 0.0 1.9 0.2 0.0 1.7 4.9 1.2 0.2 2.8 0.5 0.0 0.0 2.6 0.1 3.5 3.5 2.5 0.2 0.5 0.0 2.8 3.2 0.4 5.3 0.0 0.0 2.2 0.9 CENPBD1 MGC16385 ENSG00000177946 "CENPB DNA-binding domain containing 1" B2RD01 16 89969773-89972832 "Predicted intracellular proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEK 293: 7.8;K-562: 4.7" "HPA052759, HPA060522" Uncertain Approved Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "HPA052759: AB_2681938, HPA060522: AB_2684304" "unprognostic (2.63e-2)" "unprognostic (2.22e-3)" "unprognostic (4.43e-2)" "unprognostic (3.48e-3)" "unprognostic (7.76e-2)" "unprognostic (1.03e-2)" "unprognostic (1.37e-2)" "unprognostic (1.86e-3)" "unprognostic (1.35e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-2)" "unprognostic (6.44e-2)" "prognostic favorable (5.27e-11)" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-2)" 7.2 5.9 6.6 2.6 7.3 4.5 6.3 6.1 9.5 3.3 4.0 4.9 10.5 5.9 3.6 5.0 4.0 3.6 4.6 4.2 6.6 6.1 7.6 5.6 6.7 7.1 7.9 7.0 7.6 8.9 3.9 7.1 4.4 6.2 4.9 6.0 3.8 6.0 4.8 4.2 5.1 2.9 3.8 5.6 6.6 4.7 8.2 6.3 2.5 3.5 1.8 2.5 4.8 2.7 3.7 3.6 1.4 1.6 1.4 2.7 1.3 1.2 0.0 0.2 0.4 0.5 0.9 2.1 0.8 0.3 0.0 0.0 0.6 0.0 1.3 1.2 0.9 0.3 2.0 0.0 0.0 0.3 0.0 7.8 0.0 0.3 0.5 0.4 0.4 1.3 0.0 1.4 0.0 0.0 0.2 0.0 0.6 4.7 0.9 0.0 1.1 1.4 0.6 0.7 0.4 0.5 3.2 1.6 0.0 0.0 0.0 2.7 2.0 2.9 0.3 0.1 0.3 0.7 0.0 0.0 0.2 1.9 0.3 1.2 0.8 1.3 1.0 0.5 1.2 0.5 0.6 1.6 1.4 2.4 0.7 2.1 1.2 1.9 0.8 3.6 3.7 2.7 2.3 0.5 1.4 1.4 3.1 1.1 1.3 6.6 7.3 6.1 9.5 6.6 6.1 7.9 7.0 6.2 6.3 8.9 10.7 3.7 3.1 4.1 9.6 0.4 5.1 6.7 9.1 5.2 17.7 3.7 6.6 5.6 1.5 1.6 3.4 0.0 5.1 3.6 3.5 3.4 6.9 5.8 7.4 4.8 1.2 1.3 6.3 1.3 4.4 6.9 5.0 9.0 3.2 12.6 5.2 2.9 4.9 5.0 22.5 0.0 2.8 21.8 18.8 2.8 4.2 3.2 2.6 2.1 CENPP "CENP-P, RP11-19J3.3" ENSG00000188312 "Centromere protein P" Q6IPU0 9 92325484-92620533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 30.0" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 56.2;Suprabasal keratinocytes: 88.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021787, HPA058945" Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA021787: AB_1846524, HPA058945: AB_2683860" "unprognostic (5.48e-2)" "prognostic favorable (3.91e-4)" "unprognostic (1.20e-1)" "unprognostic (2.43e-3)" "unprognostic (2.64e-2)" "prognostic favorable (3.65e-4)" "unprognostic (4.88e-5)" "unprognostic (8.06e-2)" "unprognostic (3.51e-3)" "unprognostic (1.49e-1)" "unprognostic (1.32e-1)" "unprognostic (6.68e-3)" "unprognostic (9.20e-8)" "unprognostic (1.27e-2)" "unprognostic (5.12e-2)" "unprognostic (1.11e-1)" "unprognostic (2.04e-1)" 5.0 5.1 6.8 8.9 8.8 15.5 4.9 14.9 7.4 6.0 3.8 3.5 1.4 4.5 6.4 4.1 8.4 3.6 4.6 4.3 5.4 4.6 3.5 3.2 3.5 7.8 6.1 4.5 4.6 7.5 7.8 9.4 5.3 6.8 4.8 4.5 5.5 5.0 2.8 11.8 30.0 3.2 4.8 4.4 5.4 3.0 8.7 6.5 14.8 3.0 7.4 9.1 4.4 8.0 6.7 4.8 4.1 10.3 5.1 8.2 4.0 7.9 5.0 7.1 5.1 2.9 3.2 6.7 8.4 4.7 10.5 8.4 2.3 4.6 10.1 3.9 2.7 9.7 9.6 6.8 4.6 9.8 14.4 8.0 10.3 4.5 3.3 1.5 21.1 10.0 3.4 2.6 10.2 6.6 1.4 5.3 10.0 11.1 14.7 8.0 5.0 29.6 6.4 5.7 15.0 9.5 10.0 11.6 11.3 1.6 8.0 15.8 5.5 9.5 6.1 3.0 5.3 3.2 6.5 2.5 10.3 5.1 15.5 12.0 9.8 11.4 13.3 11.5 10.5 9.3 3.0 3.2 4.1 4.9 10.3 8.2 6.7 5.3 4.1 3.6 5.7 5.0 4.8 0.8 5.1 5.1 4.8 5.7 4.0 6.8 8.8 14.9 7.4 5.4 4.6 6.1 4.5 6.8 6.5 0.0 0.3 1.5 3.6 56.2 6.4 2.0 2.5 0.0 1.2 0.0 7.9 2.7 1.7 0.9 15.3 3.1 0.7 0.0 2.0 8.2 5.6 2.1 0.0 0.8 13.9 1.6 1.2 1.3 1.3 3.6 4.0 3.0 13.5 0.0 0.6 2.5 1.2 0.0 4.6 1.1 7.5 6.5 6.7 11.1 5.7 88.2 3.2 4.3 1.7 2.4 CEP85 "CCDC21, DKFZP434L0117" ENSG00000130695 "Centrosomal protein 85" Q6P2H3 1 26234153-26279038 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 87.8" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 26.8;Spermatocytes: 43.5;Spermatogonia: 37.7;Syncytiotrophoblasts: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 15.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028252 Approved Approved "Nucleoli,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoli, Golgi apparatus" "Centrosome, Cytosol" "HPA028252: AB_1846142" "unprognostic (1.08e-1)" "unprognostic (2.59e-2)" "unprognostic (1.74e-2)" "unprognostic (4.16e-2)" "unprognostic (2.66e-1)" "unprognostic (5.30e-3)" "prognostic unfavorable (4.39e-6)" "unprognostic (3.72e-2)" "unprognostic (5.30e-2)" "unprognostic (8.24e-2)" "unprognostic (9.18e-2)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (7.33e-3)" "unprognostic (5.41e-2)" "unprognostic (1.02e-2)" "unprognostic (2.60e-2)" 2.1 2.7 4.8 3.8 11.0 12.4 3.1 7.7 8.8 2.4 3.7 15.5 4.6 3.5 2.6 3.3 5.6 2.7 2.6 19.4 5.5 4.0 3.8 3.7 3.2 5.3 20.4 4.9 2.4 3.3 4.4 4.7 3.6 7.8 3.0 4.5 4.0 3.5 2.5 87.8 8.4 3.3 2.9 10.4 4.3 3.7 26.8 13.5 12.1 5.4 5.5 6.6 3.0 3.8 2.4 3.8 15.6 5.0 2.1 3.4 2.8 13.5 6.7 10.8 11.5 3.0 2.8 21.3 6.9 3.2 9.5 10.2 8.6 12.7 12.9 9.4 2.8 5.2 12.0 12.1 5.7 9.6 9.4 10.5 18.2 13.2 9.1 3.1 16.6 20.2 1.4 5.7 8.0 5.8 4.5 4.2 17.5 24.5 18.0 7.0 4.9 15.9 20.2 10.5 6.7 11.2 16.3 12.6 12.0 4.8 2.1 18.4 8.5 9.7 8.1 8.0 6.2 7.4 11.9 4.9 7.8 13.0 9.1 10.6 14.2 20.7 16.1 4.8 29.3 14.7 3.4 4.6 15.6 3.0 4.4 2.5 2.4 2.0 2.3 3.8 1.3 1.8 3.4 0.5 2.1 5.0 1.3 3.2 2.8 4.8 11.0 7.7 8.8 5.5 4.0 20.4 4.9 7.8 13.5 0.0 2.1 0.0 4.2 6.2 9.6 26.8 2.5 1.4 4.5 5.2 11.8 2.0 6.6 1.7 0.8 1.8 3.9 0.0 1.1 3.6 2.1 2.2 2.3 2.5 4.3 0.0 1.7 1.8 5.2 2.3 1.4 4.0 1.7 4.6 3.1 1.3 2.1 3.4 0.4 0.8 10.1 0.0 1.0 43.5 37.7 5.4 34.9 3.5 4.7 3.2 CERCAM "CEECAM1, CerCAM, GLT25D3" ENSG00000167123 "Cerebral endothelial cell adhesion molecule" Q5T4B2 9 128411751-128437351 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.1" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 48.9;Fibroblasts: 70.1;Melanocytes: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 55.6;ASC TERT1: 59.3;fHDF/TERT166: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021657, HPA051595" Uncertain Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA021657: AB_1846507, HPA051595: AB_2681545" "unprognostic (2.87e-2)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" "unprognostic (2.19e-1)" "unprognostic (4.68e-3)" "unprognostic (7.79e-3)" "unprognostic (3.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (1.59e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (3.33e-16)" "unprognostic (1.34e-2)" "unprognostic (1.04e-1)" "unprognostic (6.05e-3)" "prognostic unfavorable (3.30e-5)" 12.7 5.1 40.0 7.2 65.5 1.6 9.0 10.0 62.1 19.1 6.9 61.2 5.0 4.8 11.4 10.9 8.2 6.0 17.3 8.8 72.8 34.7 4.9 1.8 5.3 2.3 59.5 28.1 14.1 18.8 15.8 21.6 27.4 31.4 11.1 5.2 3.5 13.2 13.6 4.3 8.9 6.0 27.7 78.1 3.3 5.4 5.2 62.1 0.0 6.7 2.4 2.7 15.1 6.6 0.3 2.0 0.3 1.6 1.1 5.3 2.2 9.5 6.1 6.9 7.3 55.6 59.3 5.9 30.9 29.2 8.1 6.1 2.2 0.4 0.0 12.7 50.4 6.9 6.5 3.0 4.1 3.1 2.4 4.9 0.5 5.6 3.3 17.0 1.1 17.3 32.8 2.2 8.8 2.1 33.5 9.1 0.6 2.8 7.6 10.5 18.1 0.4 11.7 0.4 0.4 4.7 0.9 4.8 1.3 3.8 3.6 1.0 1.9 6.9 8.4 3.5 2.3 6.8 2.3 10.1 21.6 5.9 29.6 4.7 8.9 6.9 0.1 20.4 3.4 4.2 0.3 1.1 0.1 3.8 1.6 0.3 0.3 0.3 4.7 1.5 0.1 0.1 5.3 0.3 1.1 0.1 2.0 0.0 2.2 40.0 65.5 10.0 24.5 72.8 34.7 59.5 28.1 31.4 62.1 6.0 13.0 0.0 6.2 7.9 1.1 3.2 0.0 6.7 21.6 10.4 0.0 14.3 0.0 10.7 2.0 7.1 0.0 0.0 2.9 48.9 70.1 3.9 8.1 0.0 5.9 6.4 0.0 18.4 0.6 1.5 22.5 4.7 38.8 1.0 0.0 0.1 6.9 0.0 24.8 0.5 0.7 6.5 15.6 1.0 19.0 3.6 16.4 2.5 0.0 2.0 CERS5 "FLJ25304, LASS5, MGC45411, Trh4" ENSG00000139624 "Ceramide synthase 5" Q8N5B7 12 50129306-50167533 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026589 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA026589: AB_1852727" "unprognostic (1.59e-2)" "unprognostic (9.83e-2)" "unprognostic (5.17e-2)" "unprognostic (3.64e-2)" "unprognostic (3.02e-1)" "unprognostic (2.49e-3)" "prognostic unfavorable (4.63e-5)" "unprognostic (5.56e-2)" "unprognostic (1.65e-2)" "unprognostic (9.26e-2)" "unprognostic (1.88e-3)" "unprognostic (5.67e-2)" "prognostic unfavorable (9.33e-11)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "prognostic favorable (5.76e-5)" "unprognostic (3.26e-1)" 18.0 13.2 18.3 13.3 21.6 10.9 18.0 38.3 19.6 21.1 15.0 17.5 8.9 6.3 22.6 20.9 14.1 17.7 14.9 9.9 16.7 11.6 16.0 7.8 14.7 15.1 13.9 19.1 22.5 13.8 23.9 22.4 19.7 14.3 15.6 11.5 14.9 14.6 16.2 5.0 21.5 12.2 21.8 10.3 15.7 13.3 11.6 14.4 12.7 15.5 7.0 14.9 18.4 18.3 21.0 26.1 33.5 35.1 29.0 26.3 22.3 9.2 10.4 23.0 6.5 12.8 10.8 19.5 20.5 17.7 19.7 18.7 24.5 14.7 14.0 17.2 29.0 10.3 8.7 10.0 7.9 19.6 22.1 10.2 11.7 8.8 14.8 25.6 11.9 16.0 18.5 12.0 16.2 15.1 25.9 17.9 12.3 8.8 13.0 24.7 16.2 10.3 32.4 14.7 5.2 10.1 13.5 15.0 10.0 25.6 12.0 7.0 11.4 17.4 8.2 27.5 15.8 11.2 13.7 17.1 17.0 11.4 12.7 8.9 12.7 12.1 11.3 13.4 8.3 7.8 24.8 19.0 28.1 26.0 25.5 22.9 17.9 22.9 22.4 18.2 21.0 17.9 24.3 33.5 29.0 35.1 26.1 26.3 22.3 18.3 21.6 38.3 19.6 16.7 11.6 13.9 19.1 14.3 14.4 17.9 17.3 12.1 17.3 15.3 41.7 5.6 15.3 9.4 14.8 14.0 19.6 27.6 6.6 19.6 0.6 14.9 9.1 0.0 12.2 48.5 20.0 10.2 15.0 3.8 17.4 30.2 15.0 15.4 17.0 1.1 15.5 16.5 11.8 30.7 7.0 21.7 14.2 7.0 16.3 6.8 36.1 32.3 17.6 8.1 7.5 12.5 28.1 20.0 6.0 11.3 CHD3 "Mi-2a, Mi2-ALPHA, ZFH" ENSG00000170004 "Chromodomain helicase DNA binding protein 3" Q12873 17 7884806-7912760 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043368, HPA076524" Supported Approved "Nucleoplasm,Nucleoli,Centriolar satellite" No No "Nucleoplasm, Nucleoli, Centriolar satellite" "HPA043368: AB_2678448, HPA076524: AB_2686804" "unprognostic (1.77e-2)" "unprognostic (8.01e-2)" "prognostic unfavorable (2.43e-4)" "prognostic favorable (7.68e-5)" "unprognostic (1.53e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (2.83e-2)" "unprognostic (5.25e-3)" "prognostic favorable (8.36e-4)" "unprognostic (9.11e-2)" "unprognostic (8.31e-2)" "unprognostic (3.98e-2)" "unprognostic (1.50e-1)" "unprognostic (8.90e-3)" "unprognostic (2.20e-3)" 10.4 12.9 31.7 24.3 26.0 18.7 12.5 12.1 28.3 41.1 21.1 4.1 22.5 8.2 46.3 16.1 15.1 25.0 20.0 8.7 30.4 14.2 15.2 2.3 13.1 19.0 8.4 28.4 27.3 15.1 28.5 21.0 8.0 10.7 32.9 11.1 20.7 19.4 23.0 3.3 16.2 14.0 23.3 6.9 14.6 15.8 11.3 5.1 40.6 19.7 7.5 17.7 20.6 28.9 1.6 4.0 4.1 3.5 2.7 7.8 3.6 12.2 30.5 17.9 23.7 21.8 18.3 9.6 14.3 19.2 12.1 13.0 5.9 10.3 34.5 10.9 21.0 9.8 16.6 33.6 15.1 15.3 17.5 19.6 16.7 39.6 0.7 11.7 4.8 32.9 24.1 8.1 16.3 10.9 32.3 22.5 15.8 11.1 0.6 11.3 12.1 13.1 5.5 2.8 12.9 11.3 38.6 21.8 5.2 12.1 29.8 12.2 16.5 35.5 13.8 6.9 5.1 15.9 7.8 28.1 26.3 20.7 6.4 20.5 2.6 0.4 19.5 13.4 13.5 22.4 0.6 2.7 4.1 7.0 1.7 5.5 1.5 6.7 6.6 2.1 1.6 7.8 5.1 2.1 2.7 3.5 4.0 3.6 3.6 31.7 26.0 12.1 28.3 30.4 14.2 8.4 28.4 10.7 5.1 29.8 57.4 11.5 44.3 32.4 61.2 9.7 17.8 24.1 37.5 76.8 7.9 15.1 14.9 21.3 8.9 17.5 12.0 0.0 20.6 16.7 30.0 67.6 38.2 2.1 8.4 42.9 54.5 18.4 21.1 13.0 41.1 14.7 8.5 54.1 12.6 11.3 23.7 7.0 53.7 7.5 15.6 25.8 27.2 12.9 50.5 17.9 13.7 34.6 25.9 53.1 CHD7 "CRG, FLJ20357, FLJ20361, KIAA1416" ENSG00000171316 "Chromodomain helicase DNA binding protein 7" Q9P2D1 8 60678778-60868028 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.1" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 227.8;Muller glia cells: 155.9;Rod photoreceptor cells: 196.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 12.2;granulocytes: 12.6;T-cells: 5.5" "Cell line enhanced" "Detected in many" "AF22: 26.3;SCLC-21H: 24.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 110.3" HPA053075 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA053075: AB_2682035" "unprognostic (3.77e-2)" "unprognostic (3.28e-3)" "unprognostic (3.17e-2)" "prognostic unfavorable (5.34e-5)" "unprognostic (9.59e-2)" "unprognostic (1.14e-1)" "unprognostic (1.86e-3)" "unprognostic (3.41e-2)" "unprognostic (3.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (9.09e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-1)" "unprognostic (8.20e-2)" "unprognostic (2.17e-1)" 3.9 2.2 7.0 7.9 11.2 25.1 4.1 47.1 9.0 2.3 5.7 13.4 3.1 5.9 2.6 3.2 5.1 3.2 3.1 4.1 8.1 4.3 3.6 3.6 4.7 7.0 8.1 3.3 1.4 6.4 12.4 9.9 5.6 9.9 2.9 5.5 6.4 5.7 2.8 10.3 5.7 6.6 2.4 7.5 6.1 4.5 4.3 12.2 1.6 5.4 2.2 7.3 2.9 5.9 12.2 0.6 12.6 0.6 0.0 5.5 0.4 3.9 2.0 26.3 4.6 0.1 0.0 8.3 0.2 0.0 0.9 0.8 4.9 3.7 7.6 0.5 0.0 1.2 2.4 13.5 3.9 0.8 2.9 7.2 17.9 3.3 6.4 1.1 5.4 3.3 0.5 3.0 0.0 4.4 1.6 3.9 6.2 1.3 6.8 0.6 4.0 8.4 6.2 18.0 3.9 0.9 17.6 6.2 2.4 2.0 4.5 24.0 11.9 0.7 3.0 7.3 9.7 5.3 5.1 4.5 0.3 4.3 0.3 2.1 7.3 4.2 11.9 1.5 0.6 6.7 10.4 0.3 12.6 2.6 0.1 3.3 8.0 2.9 0.9 0.1 12.2 5.5 2.0 7.1 0.0 0.6 0.6 0.2 0.4 7.0 11.2 47.1 6.5 8.1 4.3 8.1 3.3 9.9 12.2 29.8 17.4 46.9 22.3 27.0 32.3 30.7 30.6 20.1 23.9 15.7 227.8 7.1 1.7 15.6 11.9 29.6 17.6 0.0 9.7 5.5 7.1 31.3 38.3 9.5 11.9 66.7 83.8 27.0 12.9 7.6 0.9 10.3 20.3 19.8 30.6 155.9 13.9 22.6 0.4 4.2 196.3 0.0 4.4 4.9 3.4 28.2 5.1 13.8 21.7 25.1 CIPC KIAA1737 ENSG00000198894 "CLOCK interacting pacemaker" Q9C0C6 14 77098097-77117287 "Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.7" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA000644 Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA000644: AB_1079206" "unprognostic (3.93e-2)" "unprognostic (6.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (6.67e-3)" "unprognostic (3.73e-2)" "unprognostic (1.74e-1)" "unprognostic (2.31e-2)" "unprognostic (3.20e-1)" "prognostic favorable (1.77e-10)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "unprognostic (1.13e-1)" "unprognostic (1.21e-1)" 8.9 7.3 20.8 5.9 20.7 3.1 11.4 29.0 24.2 12.8 14.1 27.9 9.9 7.5 10.7 10.0 15.5 21.2 6.7 26.1 21.6 17.5 10.4 10.9 7.9 5.8 22.2 14.9 7.1 7.1 15.8 9.4 6.6 20.5 18.3 14.1 10.6 13.3 18.2 77.7 8.6 7.9 11.8 21.6 6.3 7.1 8.0 23.4 3.4 14.4 13.1 7.1 11.4 8.8 11.4 7.2 7.7 6.7 7.6 5.8 4.2 6.2 8.3 17.6 11.8 7.2 5.7 10.9 4.2 6.5 7.4 6.8 6.6 13.4 15.3 4.0 6.6 6.9 9.5 16.4 6.3 10.2 7.9 4.4 10.2 6.3 6.1 6.8 5.6 7.5 6.6 12.6 7.3 4.6 10.0 8.6 12.4 8.8 6.2 5.6 13.5 13.2 6.8 7.4 14.3 7.2 13.3 7.7 9.2 7.6 10.5 25.1 9.3 7.4 12.1 9.7 7.8 18.9 5.7 10.3 4.9 10.5 6.9 5.0 5.5 3.8 7.4 9.3 4.8 10.3 5.8 5.8 2.1 3.7 6.7 5.8 11.4 5.2 3.9 7.2 9.4 5.6 3.9 7.7 7.6 4.8 2.7 5.3 4.2 20.8 20.7 29.0 22.4 21.6 17.5 22.2 14.9 20.5 23.4 14.9 13.6 0.8 7.0 8.0 24.6 44.8 7.6 14.7 14.8 10.4 55.0 5.6 8.3 4.2 8.7 5.8 18.6 0.0 4.7 3.7 6.0 7.5 1.1 23.6 12.8 11.1 16.7 6.7 14.3 9.9 3.7 5.8 8.5 3.6 15.6 18.9 3.9 10.5 13.4 4.9 36.3 12.9 9.5 14.9 6.1 8.5 11.3 3.9 9.5 5.8 CKAP5 "ch-TOG, KIAA0097, TOG, TOGp" ENSG00000175216 "Cytoskeleton associated protein 5" Q14008 11 46743048-46846308 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 89.5;Spermatocytes: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039377, HPA040375" Supported Approved "Nucleoli,Nucleoli rim,Plasma membrane,Centrosome" NA Yes 460000 "Plasma membrane, Centrosome" "Nucleoli, Nucleoli rim" "HPA039377: AB_10805477, HPA040375: AB_10794739" "unprognostic (8.00e-2)" "unprognostic (7.35e-2)" "unprognostic (2.35e-1)" "unprognostic (4.12e-2)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (6.09e-2)" "unprognostic (1.12e-2)" "unprognostic (2.21e-2)" "unprognostic (4.30e-3)" "unprognostic (3.77e-2)" "unprognostic (2.03e-1)" "unprognostic (2.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (4.69e-2)" 13.7 25.5 20.6 11.5 25.7 18.6 12.5 34.6 32.9 11.3 14.6 16.5 7.3 10.2 13.7 10.4 11.7 9.5 10.1 16.6 19.2 19.3 9.7 37.7 8.5 14.1 18.8 21.1 23.8 7.9 20.0 20.8 13.8 33.0 13.5 15.0 9.1 8.7 12.0 26.3 10.7 9.9 16.1 22.5 8.8 12.9 25.4 22.2 28.6 8.0 10.8 14.7 12.6 9.7 8.6 8.4 6.0 8.7 11.7 10.0 3.6 26.4 25.6 55.0 23.5 13.0 20.5 12.8 30.4 18.5 28.9 30.8 20.8 9.0 28.9 10.7 20.4 31.0 30.1 39.4 17.2 36.4 26.0 30.1 48.2 20.5 20.0 9.7 36.7 20.2 10.4 9.2 16.2 35.2 15.1 21.8 25.4 34.0 27.1 23.9 18.2 31.2 9.5 29.5 19.7 20.6 33.1 58.5 25.3 9.3 16.3 25.6 21.8 41.3 14.8 15.1 25.4 27.3 10.0 18.7 28.1 24.9 47.7 44.8 15.4 33.2 41.6 17.6 17.4 27.5 5.4 5.7 6.0 9.0 8.7 8.8 8.6 6.7 10.0 8.4 8.0 8.2 8.5 0.9 11.7 7.8 5.4 7.5 3.6 20.6 25.7 34.6 31.2 19.2 19.3 18.8 21.1 33.0 22.2 23.8 20.5 16.4 7.9 7.6 18.2 57.6 10.2 33.5 21.6 8.7 35.3 13.2 8.3 10.6 89.5 13.5 8.1 0.0 6.6 12.2 13.2 11.2 35.9 6.2 16.0 12.7 11.6 14.1 12.9 37.9 18.1 13.5 6.8 16.2 14.1 14.9 12.6 12.4 27.3 8.7 24.2 19.4 6.6 81.4 60.7 10.2 9.6 9.6 14.9 7.8 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 75.9;brain: 227.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 14.7 12.4 61.6 10.7 76.1 11.7 14.1 11.9 77.1 14.1 10.4 100.5 3.3 10.0 16.9 12.6 22.6 10.9 14.3 15.9 85.4 52.3 11.0 14.0 12.2 13.6 133.4 28.9 19.1 5.8 7.0 6.7 20.5 72.7 14.6 13.6 4.9 6.8 15.7 9.7 17.6 9.4 18.5 227.4 11.5 7.5 28.5 95.4 4.3 11.5 4.7 14.8 14.7 11.1 19.9 19.7 28.1 18.6 49.5 75.9 28.6 17.9 7.3 22.9 14.0 27.7 21.6 12.5 14.2 19.6 20.0 27.7 14.8 18.3 9.0 19.2 13.6 38.0 24.3 17.6 10.8 35.1 21.2 7.5 18.7 5.2 13.2 22.2 16.8 18.7 25.2 58.3 15.6 16.8 21.5 21.7 17.9 9.3 27.7 28.1 9.4 12.3 11.1 19.9 7.8 15.6 8.3 30.8 11.4 18.7 8.1 8.3 22.8 19.6 6.6 28.1 32.1 6.6 14.3 20.1 26.1 24.1 17.7 18.4 36.7 15.7 14.5 43.6 16.2 33.3 28.1 18.6 19.8 21.7 10.7 40.8 19.9 40.9 39.8 19.7 16.4 16.6 16.9 13.8 49.5 10.5 12.7 75.9 28.6 61.6 76.1 11.9 38.8 85.4 52.3 133.4 28.9 72.7 95.4 32.8 39.6 30.5 103.2 128.0 19.7 48.0 12.7 16.0 23.9 26.2 23.6 44.0 24.9 18.4 58.8 63.1 19.7 46.7 14.2 132.7 70.7 85.5 35.8 18.7 31.6 14.3 27.5 54.0 25.9 62.2 47.8 38.0 108.0 43.3 18.8 28.6 24.0 11.5 43.9 18.2 31.4 51.8 126.4 168.0 50.6 171.8 80.1 103.6 17.1 110.7 CLN6 "FLJ20561, HsT18960, nclf" ENSG00000128973 "CLN6, transmembrane ER protein" Q9NWW5 15 68206992-68257211 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 161.8;Hofbauer cells: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066046, HPA066759" Approved Approved "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" "Nucleoli, Vesicles" "HPA066046: AB_2685604, HPA066759: " "unprognostic (1.01e-1)" "unprognostic (1.54e-3)" "unprognostic (7.01e-2)" "unprognostic (3.58e-2)" "unprognostic (2.71e-2)" "unprognostic (3.08e-1)" "unprognostic (2.24e-2)" "unprognostic (5.07e-2)" "unprognostic (2.40e-2)" "unprognostic (2.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.85e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-1)" "unprognostic (6.78e-2)" 21.2 17.8 11.6 16.5 11.8 29.8 13.9 14.9 20.7 14.4 20.2 13.2 11.6 17.1 11.7 14.3 16.7 12.0 17.1 10.4 11.7 10.8 22.0 29.5 18.8 27.0 11.1 12.2 12.4 19.7 11.7 11.5 18.6 14.3 13.4 18.0 28.6 16.0 17.9 16.3 17.0 18.5 12.4 11.6 26.5 15.7 13.8 9.7 27.7 14.5 18.2 21.7 11.0 10.9 2.9 4.6 9.4 13.4 1.8 4.1 2.7 11.5 28.8 7.5 10.6 4.7 3.8 18.2 11.0 5.3 13.6 11.2 22.2 18.8 18.0 5.5 6.5 10.1 21.5 21.6 10.7 5.4 11.9 26.4 25.9 21.1 16.5 9.6 29.1 18.5 6.7 3.6 10.9 7.5 2.8 9.0 10.3 17.0 36.5 10.4 31.6 13.2 20.9 18.1 20.5 12.3 12.9 23.1 24.5 11.3 30.2 15.5 6.4 12.4 19.4 10.6 5.9 10.4 29.1 5.9 15.3 18.2 11.3 38.9 26.7 29.0 14.7 9.6 35.4 14.8 0.0 7.3 0.4 2.8 11.5 3.8 2.9 2.1 4.1 4.6 2.3 2.7 1.2 9.4 1.8 13.4 3.8 1.9 2.7 11.6 11.8 14.9 20.7 11.7 10.8 11.1 12.2 14.3 9.7 8.9 5.8 12.7 17.8 17.9 161.8 19.9 0.0 0.0 4.5 5.2 15.7 29.2 0.0 3.1 0.2 12.9 13.6 23.3 1.6 44.9 15.2 12.6 9.2 17.7 76.0 20.6 14.6 14.1 18.0 1.3 8.3 11.9 18.6 7.2 15.3 16.9 3.1 20.9 7.8 1.3 31.0 6.5 8.0 0.9 16.8 12.3 18.2 10.9 30.5 14.5 CMAS ENSG00000111726 "Cytidine monophosphate N-acetylneuraminic acid synthetase" Q8NFW8 12 22046174-22065674 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Syncytiotrophoblasts: 445.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039905 Supported Uncertain Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA039905: AB_10795237" "unprognostic (5.54e-2)" "unprognostic (4.10e-2)" "unprognostic (4.25e-1)" "unprognostic (5.39e-3)" "unprognostic (1.94e-2)" "unprognostic (3.99e-2)" "unprognostic (2.30e-2)" "unprognostic (4.17e-3)" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.44e-1)" "unprognostic (7.53e-2)" "prognostic unfavorable (7.19e-4)" "unprognostic (2.27e-1)" "unprognostic (1.91e-2)" "unprognostic (3.65e-1)" "unprognostic (2.03e-1)" 8.1 28.2 28.1 9.6 31.6 17.6 14.9 16.3 39.3 12.1 34.3 14.5 17.1 29.4 12.8 32.0 33.2 10.0 11.0 18.1 28.8 33.4 12.8 31.9 7.9 9.8 33.9 27.3 11.9 18.6 14.6 14.3 20.2 34.3 17.0 33.1 10.2 14.8 12.9 18.2 12.9 32.9 13.3 18.0 8.5 12.9 30.2 14.8 6.4 10.9 11.9 12.4 11.8 17.2 12.2 19.5 19.4 18.9 22.8 19.9 15.0 19.4 15.8 19.4 9.2 15.3 19.1 28.2 13.6 15.0 14.8 15.7 35.3 22.6 17.3 13.4 11.6 27.3 15.9 11.4 18.9 20.0 22.8 14.4 52.1 12.8 17.7 14.3 13.7 27.7 12.8 18.0 18.8 28.1 20.2 19.6 18.8 32.7 8.8 26.2 25.6 15.8 32.0 46.8 21.8 21.9 11.2 20.3 16.4 17.6 21.4 7.8 13.7 10.7 19.0 15.3 40.7 26.1 18.9 14.2 16.7 13.8 14.7 24.9 6.1 7.8 23.0 27.2 10.8 16.8 10.3 17.9 19.4 13.7 18.9 17.8 12.2 18.6 18.1 19.5 12.1 16.8 17.4 1.8 22.8 16.5 12.3 19.9 15.0 28.1 31.6 16.3 39.3 28.8 33.4 33.9 27.3 34.3 14.8 11.9 13.7 19.0 62.8 26.0 35.2 62.1 28.1 46.8 28.4 22.7 3.9 144.0 64.6 44.6 10.3 38.6 126.2 116.8 73.5 117.3 40.1 92.3 22.0 56.7 56.8 33.4 40.0 38.6 32.1 12.9 23.6 27.0 42.2 49.5 94.4 20.7 65.2 133.3 26.2 64.8 17.4 19.4 37.0 79.6 93.5 38.9 445.4 22.3 85.9 97.2 CMSS1 "C3orf26, MGC4308" ENSG00000184220 "Cms1 ribosomal small subunit homolog (yeast)" Q9BQ75 3 99817834-100181732 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042820 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" NA NA Nucleoli "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA042820: AB_10795763" "unprognostic (1.50e-1)" "unprognostic (8.28e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (3.15e-6)" "unprognostic (2.13e-2)" "unprognostic (2.39e-3)" "prognostic unfavorable (5.92e-10)" "unprognostic (1.50e-1)" "unprognostic (5.92e-2)" "unprognostic (5.83e-2)" "unprognostic (6.71e-2)" "prognostic unfavorable (3.10e-4)" "unprognostic (2.18e-3)" "unprognostic (1.56e-1)" "unprognostic (2.26e-1)" "unprognostic (3.25e-1)" "unprognostic (4.04e-2)" 21.4 34.1 23.7 15.1 24.5 17.7 20.6 24.1 27.4 13.4 12.9 9.4 8.2 8.3 19.6 10.7 12.0 13.3 10.5 16.6 24.0 22.2 17.1 17.5 10.8 15.8 15.3 22.3 21.1 26.4 20.7 25.9 11.7 19.2 15.1 12.4 9.3 12.4 14.5 58.2 11.5 9.3 13.8 15.7 12.9 11.0 28.1 13.5 13.6 14.9 14.4 14.7 18.8 15.7 23.5 26.1 1.6 10.9 11.2 19.0 7.9 28.9 13.1 13.0 18.7 9.2 10.9 13.4 13.5 7.3 24.3 20.3 16.3 9.7 31.4 23.7 7.2 21.5 17.5 18.0 15.3 32.2 16.2 17.2 24.7 9.3 13.2 16.6 33.8 13.6 7.4 14.9 18.1 30.3 7.7 16.8 25.4 15.2 20.4 17.6 20.0 27.0 31.5 19.0 27.6 32.9 12.2 21.0 33.6 15.0 7.1 36.7 15.4 13.5 11.0 30.7 13.0 13.3 21.2 4.8 19.3 54.8 11.2 27.4 14.6 29.0 61.0 12.5 37.4 32.2 0.3 4.7 0.8 10.0 10.9 14.2 23.2 14.8 13.5 9.9 23.5 18.7 19.0 1.6 11.2 9.7 26.1 13.7 7.9 23.7 24.5 24.1 27.4 24.0 22.2 15.3 22.3 19.2 13.5 6.0 14.2 29.8 33.2 55.3 30.0 40.3 43.3 29.4 23.9 59.3 17.7 34.3 82.9 17.0 137.8 37.9 1.1 0.0 40.8 46.0 41.2 21.8 61.1 44.9 24.7 120.8 14.5 19.0 5.8 151.1 46.9 25.2 35.4 14.4 13.3 17.6 29.9 0.0 55.2 66.2 21.4 25.8 64.6 105.9 127.7 57.7 18.3 28.7 20.7 22.0 COIL "CLN80, p80-coilin" ENSG00000121058 Coilin P38432 17 56938187-56961054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 58.8" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 199.1;Late spermatids: 405.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017524, HPA027885, HPA057480, CAB069400" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli fibrillar center,Nuclear bodies" NA NA "Nuclear bodies" "Nucleoplasm, Nucleoli, Nucleoli fibrillar center" "CAB017524: AB_1121780, CAB069400: , HPA027885: AB_2672421, HPA057480: " "unprognostic (1.01e-2)" "unprognostic (3.05e-1)" "prognostic favorable (1.77e-4)" "unprognostic (1.90e-2)" "unprognostic (3.19e-2)" "unprognostic (4.13e-3)" "prognostic unfavorable (1.28e-4)" "unprognostic (1.64e-1)" "unprognostic (4.07e-3)" "unprognostic (3.00e-3)" "unprognostic (2.50e-2)" "unprognostic (2.25e-2)" "unprognostic (1.28e-3)" "unprognostic (2.50e-1)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (7.71e-2)" 8.7 5.6 7.3 5.5 8.1 10.9 8.2 12.6 8.9 8.9 6.4 7.6 4.9 6.7 8.1 8.1 8.5 6.8 4.9 5.3 5.8 5.7 7.0 8.5 5.3 7.7 7.1 6.5 8.6 9.1 8.5 9.7 9.5 8.2 7.8 7.3 5.8 7.5 9.1 7.9 7.8 7.0 5.9 7.2 8.1 6.4 58.8 6.0 12.3 8.7 5.3 8.5 7.7 7.3 22.5 13.7 14.0 13.4 12.7 17.8 8.6 13.2 10.1 20.8 8.0 7.1 8.6 14.4 9.5 9.0 14.6 15.6 13.8 11.5 16.0 19.4 7.6 10.9 7.8 14.1 11.0 20.9 19.2 17.8 26.1 9.7 15.6 7.7 21.9 16.0 7.9 13.8 11.0 11.9 8.7 12.4 9.5 22.5 13.4 13.7 16.8 17.2 14.0 12.2 14.7 10.2 8.2 25.6 12.8 10.0 13.4 17.7 17.5 6.4 6.4 16.0 12.5 23.1 21.5 8.7 17.0 12.9 8.2 12.3 19.9 24.8 18.8 8.9 12.2 10.3 14.0 11.5 13.9 13.9 10.4 15.6 22.5 15.4 14.6 11.3 21.6 17.8 17.2 6.8 12.7 13.4 13.7 15.2 8.6 7.3 8.1 12.6 8.9 5.8 5.7 7.1 6.5 8.2 6.0 11.9 15.2 21.2 34.1 16.7 35.0 13.4 17.8 20.1 25.0 14.0 35.3 36.2 11.6 24.9 199.1 26.3 12.6 0.0 24.1 27.5 24.2 25.8 21.9 21.5 19.3 23.8 23.0 21.5 14.0 405.7 39.1 13.9 3.3 14.4 16.2 26.1 21.4 17.5 28.7 18.7 47.6 12.9 18.4 95.4 43.3 19.8 24.4 22.3 20.7 27.1 COMMD3-BMI1 ENSG00000269897 "COMMD3-BMI1 readthrough" 10 22316388-22329542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 20.9" "HPA030471, HPA030472, HPA036584" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Nucleoli, Cytosol" "HPA030471: AB_2673491, HPA030472: AB_10601090, HPA036584: AB_10670803" "unprognostic (8.63e-2)" "unprognostic (2.36e-2)" "unprognostic (1.83e-2)" 8.5 12.4 4.5 6.6 9.1 2.8 6.9 5.1 8.5 9.7 11.9 4.7 8.3 4.9 4.0 5.9 9.4 8.3 4.3 14.3 4.7 4.1 5.5 6.9 8.0 5.0 6.6 4.7 4.3 11.4 5.7 8.7 4.7 5.7 5.0 2.8 4.2 8.3 14.6 22.8 4.8 7.6 7.0 7.3 7.3 7.6 23.4 6.6 12.3 3.7 7.6 6.4 12.0 5.4 25.0 30.3 25.7 25.8 18.8 21.6 26.6 3.6 13.1 4.6 0.5 5.3 3.6 0.7 3.7 4.1 2.0 5.2 7.2 1.4 1.8 5.5 12.4 9.8 1.7 4.9 8.0 0.6 14.5 1.6 5.0 2.7 3.2 16.3 0.4 2.3 6.4 4.5 7.2 3.8 8.0 5.1 20.9 1.0 5.1 0.6 3.5 14.9 0.5 0.5 8.6 4.1 4.2 5.1 4.0 2.0 4.5 0.4 1.6 7.1 1.7 1.5 1.4 3.2 3.6 6.7 1.6 5.1 0.3 1.0 11.1 13.4 5.9 2.5 11.1 1.6 25.7 25.8 17.2 15.1 23.5 16.6 25.0 16.1 14.7 30.3 21.9 11.0 12.2 3.8 18.8 17.8 29.2 21.6 26.6 4.5 9.1 5.1 8.5 4.7 4.1 6.6 4.7 5.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COQ5 MGC4767 ENSG00000110871 "Coenzyme Q5, methyltransferase" Q5HYK3 12 120503274-120534434 "Enzymes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049487 Approved Uncertain Nucleoli,Mitochondria NA NA Nucleoli Mitochondria "HPA049487: AB_2680789" "unprognostic (1.46e-1)" "unprognostic (1.99e-2)" "unprognostic (1.32e-1)" "unprognostic (6.30e-3)" "unprognostic (2.00e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-1)" "unprognostic (1.60e-1)" "unprognostic (2.01e-2)" "unprognostic (6.20e-2)" "unprognostic (1.62e-1)" "unprognostic (8.37e-2)" "unprognostic (3.79e-2)" "unprognostic (2.02e-1)" "unprognostic (7.73e-2)" "unprognostic (2.00e-2)" "unprognostic (3.88e-2)" 14.6 21.7 15.8 16.1 16.7 7.0 29.5 15.6 21.3 12.5 16.4 13.5 21.8 15.7 12.6 16.4 14.0 15.5 13.5 31.9 14.8 13.1 26.0 39.8 17.6 19.1 17.5 15.4 15.1 28.6 14.2 13.4 18.6 19.4 12.7 17.1 11.6 17.9 17.8 58.4 11.1 13.2 14.0 18.5 14.6 12.4 16.9 15.0 17.2 17.7 30.4 15.2 10.1 17.0 21.3 27.4 9.7 19.6 25.1 28.2 22.4 15.9 25.6 23.1 6.6 30.5 23.5 15.9 19.5 12.8 20.0 12.7 10.2 13.5 16.1 23.1 20.4 14.2 17.3 20.5 21.7 20.6 20.1 12.1 21.4 15.7 16.9 24.9 23.3 13.5 22.5 23.5 18.6 22.0 31.3 17.5 31.1 21.0 11.8 23.1 20.9 13.4 26.8 20.3 11.5 19.9 25.0 23.4 23.3 25.7 12.2 17.5 14.1 14.1 7.2 26.5 25.2 36.3 19.3 17.5 13.9 15.9 10.2 12.9 25.5 21.5 18.3 15.8 22.2 16.6 9.4 19.6 9.7 18.8 19.2 18.2 21.1 20.4 19.9 27.4 21.3 28.2 22.3 2.1 25.1 17.9 18.0 24.4 22.4 15.8 16.7 15.6 21.3 14.8 13.1 17.5 15.4 19.4 15.0 11.9 10.9 16.3 10.7 6.9 11.5 26.2 15.3 16.0 7.9 14.0 13.7 60.9 39.7 25.5 42.0 11.7 17.2 23.3 17.3 38.3 14.1 8.4 17.3 37.2 40.3 4.8 14.5 16.0 15.6 14.5 15.3 13.1 21.9 36.1 14.6 11.8 12.3 23.2 17.7 52.6 14.4 6.5 10.3 13.7 15.4 7.9 48.7 17.5 29.2 7.5 COX10 ENSG00000006695 "COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor" Q12887 17 14069496-14208677 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heme biosynthesis" Transferase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 34.9" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 89.2;Late spermatids: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032005, HPA032006" Supported Supported Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoli, Cytosol" "HPA032005: AB_10603560, HPA032006: AB_10670554" "unprognostic (6.17e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.40e-2)" "unprognostic (6.27e-3)" "unprognostic (1.07e-1)" "unprognostic (9.46e-3)" "unprognostic (6.46e-2)" "prognostic favorable (4.32e-6)" "prognostic favorable (8.73e-4)" "unprognostic (8.82e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-2)" 5.5 6.9 5.3 5.7 6.5 7.0 5.4 6.5 7.2 4.4 11.8 4.1 2.9 9.7 5.1 3.6 9.4 4.8 3.5 18.9 5.8 3.8 10.0 9.3 5.2 8.4 4.5 2.8 4.9 9.6 7.2 6.4 6.6 5.7 5.2 10.1 5.5 6.7 4.8 34.9 6.0 10.9 7.2 4.0 4.6 7.7 15.5 4.9 5.9 5.2 9.6 7.4 7.2 5.8 11.9 13.6 4.0 14.1 8.8 17.5 9.8 7.3 14.1 5.9 8.4 5.9 5.4 13.3 8.9 6.2 16.3 11.3 12.3 5.4 17.3 7.1 9.0 5.6 14.1 11.9 11.5 13.1 9.3 12.0 10.3 11.3 13.6 10.3 10.6 9.7 7.7 14.5 10.2 13.0 6.5 8.6 12.3 13.9 5.9 7.2 9.1 9.0 7.0 8.9 27.6 7.3 7.6 19.9 12.2 10.2 13.8 4.4 7.4 9.2 12.3 11.0 29.1 6.9 6.0 7.0 7.1 6.0 7.2 11.2 7.2 10.1 7.8 10.7 11.0 8.8 3.0 10.6 4.0 9.9 14.1 10.4 11.9 11.6 10.3 13.6 8.2 12.6 11.9 1.2 8.8 11.9 4.6 17.5 9.8 5.3 6.5 6.5 7.2 5.8 3.8 4.5 2.8 5.7 4.9 0.0 14.3 5.2 7.2 8.7 8.0 89.2 7.6 5.3 4.5 10.4 9.8 16.5 34.9 8.0 33.1 4.9 19.0 0.0 7.5 14.8 5.1 7.4 4.7 8.9 9.4 0.0 12.1 4.9 3.8 61.2 2.0 5.4 5.0 4.6 14.2 2.8 8.6 11.0 6.3 11.4 11.6 0.0 5.1 14.6 15.9 9.2 13.5 5.3 15.1 11.8 COX7A2L "COX7AR, COX7RP, EB1, SIG81" ENSG00000115944 "Cytochrome c oxidase subunit 7A2 like" O14548 2 42333546-42425088 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059124, CAB073545" Enhanced Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "CAB073545: , HPA059124: AB_2683912" "unprognostic (3.90e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (5.45e-2)" "unprognostic (4.60e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (4.13e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-1)" "unprognostic (1.66e-2)" "unprognostic (2.43e-1)" "unprognostic (7.07e-3)" "unprognostic (1.54e-2)" "unprognostic (2.76e-1)" "unprognostic (5.53e-2)" "unprognostic (6.19e-2)" "unprognostic (1.02e-1)" 25.1 73.3 47.3 24.4 63.3 47.7 45.4 35.2 58.2 33.4 33.8 21.0 28.8 31.7 30.2 37.9 20.9 31.2 27.1 49.8 40.4 45.3 50.9 48.9 24.0 28.1 42.6 35.6 49.8 49.3 24.9 42.7 24.0 34.9 29.5 36.2 32.3 37.0 30.3 24.4 21.5 32.1 28.4 33.1 23.1 29.4 24.8 20.5 28.0 35.8 35.8 30.9 24.5 31.1 45.1 59.7 57.2 48.7 40.5 53.7 100.9 38.3 24.6 27.3 29.6 46.9 66.9 32.7 31.8 46.5 29.1 37.2 26.9 27.8 34.0 31.9 36.4 37.3 17.2 32.5 33.7 42.6 52.2 25.0 23.0 17.6 47.7 55.3 34.5 25.6 65.6 67.9 28.4 68.8 42.2 40.9 26.7 33.4 58.4 45.0 31.2 41.1 57.4 26.8 45.4 25.6 22.5 47.4 28.8 41.6 31.1 32.5 37.1 13.3 33.6 91.2 31.7 24.1 40.3 30.8 26.4 34.6 31.9 31.0 48.0 53.6 25.5 37.4 37.5 22.4 57.2 48.7 27.2 39.0 42.0 50.0 45.1 47.9 45.3 53.1 37.6 53.7 46.1 21.6 40.5 46.3 59.7 52.8 100.9 47.3 63.3 35.2 58.2 40.4 45.3 42.6 35.6 34.9 20.5 29.8 61.2 171.1 166.3 235.9 115.5 140.5 132.5 96.4 51.2 141.3 35.3 190.2 547.2 206.3 15.8 157.6 103.8 23.3 199.6 263.9 167.1 184.8 86.4 193.0 204.8 123.9 277.2 113.5 243.6 17.7 149.8 177.9 209.2 287.7 202.3 182.8 197.6 161.4 149.2 386.1 95.5 109.9 206.0 195.8 267.6 214.7 275.6 186.4 235.2 168.4 CPNE3 ENSG00000085719 "Copine 3" O75131 8 86514427-86561498 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 66.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029552 Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol NA NA 52000 "Nucleoplasm, Cytosol" "Nucleoli, Mitochondria" "HPA029552: AB_10600703" "unprognostic (5.63e-3)" "unprognostic (1.47e-1)" "unprognostic (2.95e-2)" "unprognostic (4.22e-3)" "unprognostic (9.92e-2)" "unprognostic (6.58e-2)" "unprognostic (8.40e-2)" "unprognostic (4.76e-2)" "unprognostic (3.50e-1)" "unprognostic (1.19e-1)" "unprognostic (8.64e-3)" "unprognostic (2.77e-1)" "prognostic favorable (5.07e-4)" "unprognostic (1.15e-1)" "unprognostic (4.33e-1)" "unprognostic (1.65e-3)" "unprognostic (1.13e-2)" 26.5 16.6 21.3 9.8 18.0 35.1 20.6 18.8 13.5 26.0 16.4 20.9 13.2 15.1 28.6 12.6 40.5 15.9 14.6 24.4 17.6 19.7 29.8 25.5 16.9 22.6 19.7 10.5 26.7 24.1 25.4 28.9 16.1 17.0 22.4 16.5 21.0 20.6 15.3 10.4 18.7 19.5 20.9 18.7 18.3 16.9 9.7 14.1 30.5 33.6 21.8 29.7 25.4 20.0 14.6 31.4 28.2 24.3 15.0 18.3 14.4 34.6 12.3 8.5 11.0 32.7 25.5 6.9 16.7 24.9 14.0 15.8 7.9 11.9 9.5 11.1 20.3 8.5 26.8 18.2 17.7 25.2 10.1 14.3 1.5 9.0 9.4 11.3 0.8 0.8 17.3 19.2 15.5 20.6 22.6 17.1 4.9 8.5 18.3 17.2 13.4 16.6 0.5 3.2 28.7 17.8 7.9 7.7 44.4 18.1 24.9 18.0 14.1 14.6 66.7 10.5 10.2 25.4 2.6 18.2 12.5 12.2 16.6 12.9 13.2 15.8 2.6 18.0 3.6 11.5 10.8 16.7 26.4 18.3 19.1 14.2 14.6 14.8 12.8 30.8 14.1 13.3 14.3 28.2 15.0 24.3 31.4 10.5 14.4 21.3 18.0 18.8 13.5 17.6 19.7 19.7 10.5 17.0 14.1 128.1 76.8 40.4 87.4 72.7 16.8 108.0 79.0 77.6 69.4 66.3 13.7 59.5 84.6 63.4 1.1 55.4 37.1 23.3 72.9 45.8 62.4 110.2 8.1 86.6 42.9 42.9 48.1 57.7 74.2 2.2 79.4 49.0 50.6 32.5 53.7 70.1 62.4 52.6 82.4 99.4 16.5 58.2 55.6 3.0 10.0 79.5 65.2 47.5 69.8 73.5 CPS1 ENSG00000021826 "Carbamoyl-phosphate synthase 1" P31327 2 210477682-210679107 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Urea cycle" "Allosteric enzyme, Ligase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "liver: 298.3" "Cell type enriched" "Detected in many" 72 "Hepatocytes: 1670.2" "Cancer enriched" "Detected in many" 8 "liver cancer: 136.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 90.5;SK-BR-3: 27.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB003781, HPA021400" Enhanced Supported "Nucleoli,Nucleoli rim" NA NA 2100000 "Nucleoli, Nucleoli rim" "CAB003781: , HPA021400: AB_1847197" "unprognostic (1.67e-2)" "unprognostic (3.72e-2)" "unprognostic (4.02e-2)" "unprognostic (7.21e-7)" "unprognostic (3.81e-2)" "unprognostic (2.52e-1)" "prognostic favorable (6.93e-5)" "unprognostic (1.23e-2)" "unprognostic (2.65e-1)" "unprognostic (1.35e-2)" "unprognostic (5.38e-2)" "unprognostic (1.94e-3)" "unprognostic (2.38e-4)" "unprognostic (5.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.14e-2)" "unprognostic (3.74e-2)" 0.4 0.1 0.5 0.3 1.6 0.0 0.8 0.3 0.7 0.4 0.2 0.7 0.3 31.5 0.3 0.7 0.5 0.2 0.4 0.3 0.5 0.4 0.6 298.3 0.2 0.3 1.5 0.8 0.7 0.2 0.0 0.4 1.1 1.4 0.3 0.0 0.6 0.2 0.2 0.3 0.3 17.2 0.4 2.3 0.3 0.2 1.3 0.5 0.0 0.4 0.4 0.1 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.3 2.4 6.3 4.3 4.2 7.4 6.7 2.3 2.7 2.7 4.2 0.6 0.0 1.0 0.1 2.5 3.8 1.1 0.2 3.8 6.8 0.0 1.9 4.0 90.5 5.6 1.4 2.1 0.0 3.8 2.8 5.3 5.4 6.9 0.3 1.7 4.0 0.3 4.4 1.1 0.1 0.2 2.4 0.0 0.6 0.2 5.8 0.5 5.7 0.0 0.1 0.4 15.8 27.3 3.0 8.5 0.0 0.7 3.0 7.0 2.1 2.1 4.9 0.0 0.3 0.0 4.6 4.4 4.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.3 0.7 0.5 0.4 1.5 0.8 1.4 0.5 11.9 9.6 20.7 0.5 1.9 1.1 0.7 15.3 1.4 6.8 1.8 7.9 0.3 0.0 0.1 23.2 1.4 0.3 23.3 0.2 0.4 2.5 1.2 3.5 1670.2 0.2 0.0 0.0 16.5 22.7 3.6 2.3 1.8 1.7 0.0 0.1 1.4 0.0 0.0 1.1 0.7 2.2 0.0 2.5 0.3 1.1 1.6 17.4 5.0 0.1 0.4 CPT2 "CPT1, CPTASE" ENSG00000157184 "Carnitine palmitoyltransferase 2" P23786 1 53196429-53214197 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.0" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 64.6;Hepatocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028201, HPA028202, HPA028214" Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoplasm, Mitochondria" Nucleoli "HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958" "unprognostic (2.43e-1)" "unprognostic (2.27e-1)" "prognostic favorable (5.27e-4)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (9.34e-2)" "unprognostic (6.48e-2)" "unprognostic (1.75e-2)" "unprognostic (2.86e-1)" "unprognostic (1.67e-1)" "unprognostic (3.00e-2)" "unprognostic (8.97e-2)" "prognostic favorable (1.46e-12)" "unprognostic (4.00e-2)" "unprognostic (2.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.95e-2)" 7.5 15.5 5.3 6.8 6.1 2.3 6.5 4.0 7.2 5.1 15.4 9.4 10.7 16.6 5.1 7.6 10.5 5.4 11.3 21.4 4.3 4.5 19.8 69.0 6.9 8.3 5.7 3.7 5.3 15.9 10.7 11.5 18.1 6.4 6.0 15.6 13.8 11.8 12.2 13.6 6.0 18.9 5.5 5.2 10.3 10.1 11.2 4.7 9.7 8.3 7.2 10.3 8.0 4.9 5.9 12.4 10.0 13.1 4.8 8.0 6.5 7.7 3.2 7.5 7.3 6.5 3.8 8.5 4.8 4.9 6.9 6.4 1.6 6.5 13.2 7.3 2.2 7.8 7.7 14.0 11.0 5.9 7.3 8.2 7.5 4.3 1.3 9.5 7.1 7.3 8.2 9.4 5.0 4.2 7.7 4.7 11.7 9.6 4.7 4.2 4.5 5.5 5.8 14.0 14.4 8.6 6.4 7.2 13.9 8.6 7.2 11.2 7.6 9.6 12.2 18.1 18.1 14.2 15.2 4.5 3.9 3.1 6.8 3.9 14.5 8.9 8.1 5.0 8.2 5.7 4.1 8.4 10.0 5.1 12.6 6.2 4.5 4.9 5.9 12.4 5.9 8.0 5.5 5.1 4.8 13.1 6.4 7.0 6.5 5.3 6.1 4.0 7.2 4.3 4.5 5.7 3.7 6.4 4.7 11.9 20.8 8.9 5.1 1.5 3.1 12.4 15.3 4.0 3.4 10.4 13.7 64.6 21.6 10.7 1.1 3.6 39.8 0.0 9.3 16.0 2.8 4.8 2.3 80.0 23.6 14.3 13.9 6.7 13.5 2.1 6.4 8.2 6.8 26.2 26.9 10.5 9.8 21.0 4.9 28.3 9.9 6.5 3.2 29.8 16.3 2.3 45.7 7.1 25.3 4.6 CRAMP1 "CRAMP1L, KIAA1426" ENSG00000007545 "Cramped chromatin regulator homolog 1" Q96RY5 16 1612325-1677908 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041752 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA041752: AB_10796459" "unprognostic (3.67e-1)" "unprognostic (9.97e-2)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.41e-2)" "unprognostic (2.25e-3)" "unprognostic (5.78e-4)" "unprognostic (4.17e-2)" "unprognostic (8.53e-3)" "unprognostic (6.01e-2)" "unprognostic (1.55e-2)" "unprognostic (9.93e-2)" "unprognostic (3.86e-3)" "prognostic favorable (4.93e-4)" "unprognostic (8.57e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-2)" 8.5 6.4 9.2 10.5 9.3 13.9 11.6 24.2 11.0 8.4 8.8 11.1 5.1 7.2 11.4 8.3 8.6 9.9 6.5 7.2 8.6 5.4 6.5 4.7 9.2 8.0 9.7 10.5 12.3 9.2 10.2 10.9 8.4 9.4 9.8 7.1 9.8 8.4 9.5 8.9 13.7 8.4 8.8 7.9 9.4 8.5 21.9 9.8 18.1 11.8 4.4 7.5 10.6 11.7 0.8 2.1 0.5 0.6 2.5 1.9 0.5 5.3 8.7 11.0 10.4 7.4 7.4 12.8 6.2 5.5 8.5 6.1 8.0 9.1 5.3 6.0 7.1 5.1 9.0 13.2 6.4 7.8 6.4 13.7 8.4 10.0 4.9 5.4 11.8 13.6 6.4 8.7 10.1 8.2 8.1 8.4 12.0 11.2 4.2 4.6 8.8 7.8 7.3 8.8 3.5 5.4 30.3 5.2 9.3 5.6 5.4 11.5 8.2 9.3 7.7 4.9 8.2 6.2 16.4 9.5 8.1 7.9 6.9 7.9 7.1 10.2 13.6 2.8 7.9 7.2 0.4 0.6 0.0 1.9 0.6 0.9 0.8 0.6 0.6 0.3 0.8 0.9 0.9 0.5 2.5 0.2 2.1 0.3 0.5 9.2 9.3 24.2 11.0 8.6 5.4 9.7 10.5 9.4 9.8 14.9 13.4 0.0 4.3 0.0 7.3 0.0 7.6 5.3 15.9 8.7 17.7 3.5 1.7 4.1 21.2 4.3 3.9 0.0 1.6 2.5 3.3 6.1 4.7 3.4 4.4 3.2 2.4 8.6 6.5 7.6 4.0 2.8 0.0 1.8 8.7 4.5 5.3 3.5 6.3 1.4 17.5 6.5 0.0 13.5 19.0 0.0 4.5 6.4 6.4 4.2 CRELD1 AVSD2 ENSG00000163703 "Cysteine rich with EGF like domains 1" Q96HD1 3 9933822-9945413 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026964 Uncertain Approved Nucleoli,Cytosol "Intracellular and membrane" NA NA 16000000 Cytosol Nucleoli "HPA026964: AB_10602210" "unprognostic (3.06e-2)" "unprognostic (1.08e-1)" "unprognostic (2.69e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.07e-4)" "unprognostic (3.03e-1)" "unprognostic (3.59e-1)" "unprognostic (2.85e-2)" "unprognostic (1.24e-2)" "unprognostic (1.19e-1)" "unprognostic (1.92e-2)" "unprognostic (4.59e-2)" "unprognostic (1.14e-2)" "unprognostic (6.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.89e-1)" "unprognostic (3.78e-2)" 21.8 22.9 31.6 15.3 32.4 7.3 27.3 52.2 45.1 9.9 22.4 12.0 17.1 12.5 15.1 17.8 13.1 20.1 15.8 50.2 25.6 24.9 16.6 23.5 15.8 11.0 17.2 30.7 19.7 15.2 21.9 32.4 15.1 27.2 25.4 11.4 10.0 19.4 32.2 24.4 11.6 13.1 19.5 19.4 11.9 14.8 11.1 22.3 5.9 45.7 7.4 8.2 17.8 15.6 10.5 13.7 11.5 12.5 13.4 14.3 10.4 2.8 5.2 8.5 4.4 14.4 9.4 47.1 10.4 3.1 2.6 4.9 5.0 8.5 3.4 22.9 7.2 12.1 1.8 4.1 7.5 1.8 6.7 3.9 3.1 6.7 11.8 28.8 1.1 12.0 9.6 13.9 6.4 5.9 31.4 11.8 5.2 3.7 4.1 2.5 6.8 2.0 8.4 2.3 11.6 3.5 2.1 1.2 8.1 11.0 4.9 3.4 11.0 4.8 4.5 9.3 11.7 11.5 6.8 8.2 5.0 8.1 6.6 2.5 4.7 6.0 6.3 11.1 3.5 5.3 11.5 11.4 9.4 14.2 11.6 14.3 8.9 10.5 13.7 8.2 10.5 14.2 12.7 1.8 13.4 12.5 13.7 8.0 10.4 31.6 32.4 52.2 45.1 25.6 24.9 17.2 30.7 27.2 22.3 17.9 13.7 10.7 19.5 8.7 20.8 34.7 33.1 8.1 7.9 15.7 15.7 20.0 6.6 17.7 5.8 15.0 14.7 0.0 3.9 9.2 21.7 31.7 20.7 11.5 18.5 30.2 25.9 16.0 7.8 7.9 29.7 10.2 11.8 19.0 14.9 21.0 8.8 15.0 24.8 8.2 15.0 25.8 14.1 49.7 11.9 10.8 18.5 12.1 14.1 16.3 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "heart muscle: 180.3" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 702.6;Endothelial cells: 478.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 24.0;T-reg: 29.2" "Group enriched" "Detected in many" 19 "B-cells: 17.9;T-cells: 29.2" "Cell line enhanced" "Detected in many" "A549: 38.5;EFO-21: 39.4;HUVEC TERT2: 36.8;MCF7: 56.5;SK-BR-3: 44.3;T-47d: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA 490000 Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 22.8 11.5 27.5 9.1 24.6 1.6 16.9 3.6 30.3 20.2 10.1 9.4 33.7 7.9 15.3 30.6 25.6 29.5 24.5 180.3 22.6 18.7 20.0 6.9 28.5 9.3 13.5 16.9 12.5 12.6 4.3 20.4 29.1 10.4 14.6 3.8 8.8 18.4 28.0 10.7 28.4 9.1 24.9 10.3 13.0 11.3 10.9 7.8 1.0 17.8 23.8 13.3 23.8 17.5 17.9 0.9 0.2 0.5 1.2 29.2 3.4 0.4 38.5 5.6 15.3 0.9 4.0 1.6 1.7 0.4 0.5 0.1 1.2 7.1 0.0 39.4 12.6 0.8 22.0 0.7 9.3 0.0 0.2 0.2 0.0 24.2 14.6 4.1 0.0 3.3 1.9 0.8 0.9 5.3 7.2 36.8 0.0 0.0 0.3 5.5 56.5 0.1 0.1 1.5 7.8 23.1 0.0 0.7 1.6 25.9 0.1 8.5 21.4 2.5 44.3 0.3 0.9 37.9 0.0 14.3 12.8 6.0 0.3 7.1 0.1 0.1 0.1 3.7 0.0 25.7 0.0 0.5 0.0 2.4 0.2 2.3 14.4 24.0 5.3 0.9 17.9 5.9 1.6 0.2 1.2 0.1 0.1 29.2 3.4 27.5 24.6 3.6 30.3 22.6 18.7 13.5 16.9 10.4 7.8 145.9 41.3 6.5 66.0 136.0 2.2 702.6 96.8 105.7 131.9 179.7 3.9 0.9 131.0 90.2 30.6 478.7 0.0 0.0 80.2 15.4 145.8 41.0 7.0 27.0 2.6 89.0 24.2 229.6 13.7 62.0 25.9 11.3 148.5 2.8 0.0 55.2 33.3 0.0 13.8 9.8 3.7 271.7 208.1 5.9 44.5 172.0 26.8 6.4 0.0 77.0 CRISPLD2 "DKFZP434B044, LCRISP2, LGL1" ENSG00000103196 "Cysteine rich secretory protein LCCL domain containing 2" Q9H0B8 16 84819984-84920768 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 19 "Leydig cells: 251.5;Peritubular cells: 250.0;Smooth muscle cells: 678.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 36.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 36.0" "Cell line enhanced" "Detected in many" "ASC diff: 15.3;BEWO: 23.8;HHSteC: 56.8;HSkMC: 23.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA030054, HPA030055" Approved Approved Nucleoplasm,Nucleoli "Secreted to blood" No No 219000000000 "Nucleoplasm, Nucleoli" "HPA030054: AB_2732452, HPA030055: AB_10611821" "unprognostic (8.91e-3)" "unprognostic (3.05e-1)" "unprognostic (2.63e-2)" "unprognostic (2.02e-2)" "unprognostic (7.12e-2)" "unprognostic (2.30e-1)" "unprognostic (2.11e-2)" "unprognostic (5.58e-3)" "unprognostic (1.48e-1)" "unprognostic (5.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (1.97e-6)" "unprognostic (7.35e-3)" "unprognostic (3.38e-2)" "unprognostic (2.99e-3)" "unprognostic (5.15e-3)" 29.2 11.6 2.2 41.1 5.0 3.0 57.2 2.1 3.6 44.1 26.0 2.5 10.6 4.2 38.5 58.7 21.1 43.6 107.4 19.1 2.1 2.0 10.1 6.7 31.0 21.4 5.5 1.6 37.1 9.1 1.0 6.4 50.2 7.1 31.6 7.3 21.9 6.8 23.6 15.9 12.0 17.5 48.0 8.6 10.0 22.5 16.8 3.1 0.4 15.9 11.4 3.3 40.3 32.7 0.0 0.5 36.0 7.9 0.0 0.1 1.3 0.3 0.7 0.2 2.0 15.3 5.7 23.8 11.6 10.3 9.3 6.6 1.5 0.9 0.0 1.0 10.1 2.7 0.3 0.0 0.0 9.4 0.0 0.0 0.1 0.2 0.0 56.8 0.0 0.1 23.8 0.0 2.7 0.0 3.1 0.0 0.0 0.1 0.1 1.0 0.4 0.1 0.5 0.6 1.5 0.6 0.0 0.1 0.1 0.1 1.8 2.3 0.1 2.7 1.2 0.2 3.4 4.7 0.3 1.3 0.1 0.6 9.7 0.3 0.1 0.0 1.9 0.0 0.2 1.4 4.4 7.9 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 1.3 2.2 5.0 2.1 3.6 2.1 2.0 5.5 1.6 7.1 3.1 3.0 2.9 0.8 7.9 41.0 0.6 7.6 0.0 1.4 2.3 0.0 0.0 6.0 0.0 1.1 10.8 12.0 0.4 0.0 0.4 24.6 126.1 19.2 6.9 0.0 4.4 1.6 2.9 60.2 40.4 10.7 251.5 12.2 45.5 0.0 4.2 5.0 0.8 0.0 250.0 0.0 0.5 90.5 678.7 0.9 0.9 37.4 7.6 4.8 1.3 5.2 CRYL1 "GDH, lambda-CRY, MGC149525, MGC149526" ENSG00000165475 "Crystallin lambda 1" Q9Y2S2 13 20403666-20525873 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 104.0;liver: 80.8" "Cell type enhanced" "Detected in many" 15 "Distal tubular cells: 411.1;Hepatocytes: 272.9;Proximal tubular cells: 848.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040403 Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" NA NA 210000 "Nucleoplasm, Nucleoli" "Golgi apparatus, Plasma membrane" "HPA040403: AB_10795632" "unprognostic (1.84e-1)" "unprognostic (1.25e-1)" "unprognostic (3.25e-2)" "prognostic favorable (1.76e-5)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-3)" "unprognostic (4.75e-3)" "unprognostic (1.19e-1)" "unprognostic (4.09e-2)" "unprognostic (2.12e-2)" "unprognostic (8.80e-2)" "prognostic favorable (2.30e-9)" "unprognostic (9.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (3.11e-1)" 9.8 8.9 21.5 8.8 22.9 3.5 7.0 10.4 17.4 11.8 35.1 26.7 18.9 61.0 9.2 18.0 7.4 9.3 16.1 9.3 18.8 19.8 104.0 80.8 6.8 5.9 24.5 12.3 7.3 15.4 5.3 10.4 5.6 16.8 11.2 16.5 17.2 13.1 20.1 5.4 4.1 45.7 8.0 32.0 6.5 12.0 2.7 16.4 3.2 11.9 5.6 5.5 8.6 5.9 9.3 25.7 1.8 24.3 6.0 15.6 17.5 3.3 2.9 2.5 18.4 14.1 16.3 2.5 4.7 8.5 2.1 1.7 1.1 3.1 0.0 9.1 6.5 4.8 0.8 2.5 4.2 2.1 8.1 2.0 5.9 0.3 23.0 8.1 1.9 5.4 9.6 2.7 1.5 9.7 7.6 22.3 8.7 0.4 2.3 5.5 12.1 5.1 3.0 0.1 28.9 4.5 2.6 1.6 0.4 17.8 7.1 1.8 2.2 2.8 1.3 21.2 1.3 9.1 7.6 21.3 2.6 1.2 6.3 2.9 3.3 0.6 0.0 4.9 3.3 10.5 1.8 21.8 1.4 10.5 24.3 8.5 9.3 14.0 10.0 25.7 9.1 11.0 10.2 0.7 6.0 20.1 2.8 15.6 17.5 21.5 22.9 10.4 17.4 18.8 19.8 24.5 12.3 16.8 16.4 6.0 6.4 19.9 13.2 9.2 5.0 9.8 48.4 10.7 6.8 73.3 11.8 18.1 411.1 21.5 2.6 23.7 181.3 0.0 27.8 9.4 16.4 23.5 24.3 272.9 59.4 1.6 8.7 49.1 76.7 2.9 24.2 36.1 35.4 11.8 69.9 93.7 32.1 152.6 22.6 848.9 10.8 19.4 12.3 0.9 0.2 8.2 17.4 15.3 78.8 12.2 CSTB "CST6, EPM1, PME, STFB" ENSG00000160213 "Cystatin B" P04080 21 43772511-43776445 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8" "Cell type enhanced" "Detected in all" 7 "Hofbauer cells: 2667.6;Urothelial cells: 2153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 68.7;RT4: 87.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017380, CAB047320, HPA058557" Enhanced Supported Nucleoli,Cytosol NA NA 6100000 Cytosol Nucleoli "CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755" "unprognostic (1.69e-1)" "unprognostic (3.35e-1)" "unprognostic (2.09e-1)" "unprognostic (3.05e-2)" "unprognostic (3.05e-2)" "unprognostic (5.92e-2)" "prognostic unfavorable (6.66e-5)" "unprognostic (1.90e-1)" "unprognostic (1.32e-1)" "unprognostic (2.14e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.10e-4)" "unprognostic (3.63e-1)" "unprognostic (4.88e-1)" "unprognostic (4.24e-2)" "unprognostic (1.24e-1)" 21.1 7.5 5.6 6.1 5.9 3.2 13.6 3.0 5.3 57.8 8.8 4.4 3.9 5.6 6.1 6.4 365.3 6.0 7.2 6.5 4.6 5.0 9.6 17.3 17.2 11.2 5.3 4.9 7.8 5.0 3.2 7.6 5.2 5.8 7.1 7.2 7.8 65.2 6.2 4.8 9.4 7.5 6.3 5.1 7.4 10.4 4.1 4.1 8.6 11.6 138.8 130.6 14.0 81.5 11.4 43.2 25.4 69.1 7.7 22.3 21.3 55.9 16.9 5.6 7.1 29.8 24.5 13.9 12.1 14.1 7.7 7.6 13.0 31.4 4.5 9.4 18.8 68.7 10.0 12.9 13.5 4.8 18.8 15.3 12.6 13.0 15.0 26.7 3.1 10.6 26.0 14.1 21.0 10.5 14.4 10.6 4.3 9.3 25.0 11.2 14.1 3.9 9.7 13.5 37.6 29.2 6.5 3.1 51.3 22.0 87.3 5.3 4.8 15.9 8.5 34.0 2.8 7.9 7.8 16.3 12.7 6.6 11.9 7.6 6.1 10.8 8.4 55.4 14.7 8.9 16.8 28.2 16.9 14.5 45.9 13.3 11.4 18.6 15.0 43.2 9.7 13.2 13.0 25.4 7.7 69.1 5.3 22.3 21.3 5.6 5.9 3.0 5.3 4.6 5.0 5.3 4.9 5.8 4.1 163.8 245.7 187.7 333.5 342.3 67.2 88.0 305.8 447.0 218.4 394.3 33.4 255.6 455.9 484.2 8.1 312.8 471.8 23.3 431.0 773.3 255.1 459.8 223.9 313.1 2667.6 63.5 229.7 229.6 443.8 23.5 353.0 857.1 447.1 1223.7 177.1 98.3 684.5 378.7 310.4 313.1 54.5 116.4 179.2 37.0 105.4 520.9 336.5 191.8 261.7 2153.8 CT45A1 "CT45-1, CT45.1" ENSG00000268940 "Cancer/testis antigen family 45 member A1" Q5HYN5 X 135713453-135723539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 12.5" "Cell type enriched" "Detected in some" 5 "Spermatogonia: 5.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HMC-1: 70.1;Karpas-707: 32.4" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" "unprognostic (6.58e-3)" "unprognostic (2.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 32.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.6 0.0 0.0 0.5 6.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 5.5 0.0 0.0 0.0 0.0 0.0 CT45A10 ENSG00000269586 "Cancer/testis antigen family 45 member A10" P0DMU9 X 135881063-135889086 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 14.1" "Cell type enriched" "Detected in some" 16 "Spermatogonia: 57.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 33.3;K-562: 9.9;Karpas-707: 36.9;U-266/84: 31.0" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" "unprognostic (3.55e-1)" "unprognostic (7.08e-3)" "unprognostic (2.08e-1)" 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 36.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 7.3 31.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 57.9 0.0 0.0 0.0 0.0 0.0 CT45A2 "CT45-2, CT45.2" ENSG00000271449 "Cancer/testis antigen family 45 member A2" Q5DJT8 X 135811668-135820012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 42 "testis: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HMC-1: 32.7" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A3 "CT45-3, CT45-4, CT45.3, CT45.4, CT45A4" ENSG00000269096 "Cancer/testis antigen family 45 member A3" Q8NHU0 X 135759846-135768191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 15.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 29.9;T-47d: 17.5;U-266/84: 90.4" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.1 0.0 0.0 0.6 0.0 0.0 0.1 90.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 CT45A5 "CT45-5, CT45.5" ENSG00000228836 "Cancer/testis antigen family 45 member A5" P0DMU8 X 135777130-135785298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 10.5" "Group enriched" "Detected in some" 18 "Alveolar cells type 2: 2.2;Spermatogonia: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 18.3;Karpas-707: 12.8;RPMI-8226: 6.8;U-266/84: 66.2" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 2.5 0.0 0.0 0.9 66.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 CT45A6 "CT45-6, CT45.6" ENSG00000278289 "Cancer/testis antigen family 45 member A6" P0DMU7 X 135794706-135802656 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "U-266/84: 47.3" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A7 ENSG00000273696 "Cancer/testis antigen family 45 member A7" P0DMV0 X 135829247-135837268 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "testis: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 4.1;Karpas-707: 3.4;PC-3: 1.0;THP-1: 1.6" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.4 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A8 ENSG00000278085 "Cancer/testis antigen family 45 member A8" P0DMV1 X 135846499-135854538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 16 "testis: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AN3-CA: 14.2;HMC-1: 30.1" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A9 ENSG00000270946 "Cancer/testis antigen family 45 member A9" P0DMV2 X 135863776-135871812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 17 "testis: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "HMC-1: 55.7" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTSB ENSG00000164733 "Cathepsin B" P07858 8 11842524-11869448 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 297.0" "Cell type enhanced" "Detected in all" 11 "Hofbauer cells: 2617.6;Kupffer cells: 1392.4" "Cancer enhanced" "Detected in all" "thyroid cancer: 1446.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 53.1;classical monocyte: 127.4;intermediate monocyte: 97.0;myeloid DC: 68.0;non-classical monocyte: 54.7;plasmacytoid DC: 95.4" "Group enriched" "Detected in all" 5 "dendritic cells: 95.4;granulocytes: 53.1;monocytes: 127.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 239.8;fHDF/TERT166: 139.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000457, HPA018156, HPA048998" Enhanced Supported Nucleoli,Vesicles "Secreted to blood" NA NA 130000000 Vesicles Nucleoli "CAB000457: , HPA018156: AB_1846069, HPA048998: " "unprognostic (5.74e-2)" "unprognostic (4.32e-2)" "unprognostic (1.38e-2)" "unprognostic (2.17e-2)" "unprognostic (2.98e-3)" "unprognostic (5.96e-2)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" "unprognostic (2.82e-2)" "unprognostic (1.06e-1)" "unprognostic (7.61e-2)" "unprognostic (8.30e-2)" "unprognostic (2.85e-1)" "unprognostic (7.39e-2)" "unprognostic (4.12e-2)" "prognostic favorable (5.76e-4)" "prognostic unfavorable (9.02e-4)" 227.9 42.1 19.6 67.2 24.4 14.7 67.6 14.9 31.4 76.7 49.1 30.1 22.7 29.9 53.2 44.8 54.2 52.4 43.6 120.7 18.3 23.7 95.6 167.8 94.3 175.1 29.1 16.5 44.2 31.6 13.8 21.6 68.7 24.8 42.6 27.9 33.8 63.7 33.6 41.3 22.8 51.2 51.1 35.9 116.4 26.7 21.5 20.4 18.1 297.0 25.9 38.4 56.8 62.2 7.9 95.4 53.1 127.4 5.3 17.1 108.5 6.4 29.5 3.8 16.2 66.6 74.9 11.8 122.8 239.8 43.0 51.0 14.0 38.4 0.1 17.8 139.3 57.7 35.8 5.2 33.9 27.2 3.2 5.0 9.5 3.4 34.5 67.8 2.1 7.1 82.1 46.2 38.9 34.8 74.9 84.1 2.8 7.9 21.7 35.7 5.2 0.8 3.5 3.2 75.8 9.9 3.4 3.8 16.6 13.1 10.2 1.6 9.6 14.2 7.7 64.0 11.7 12.5 6.4 116.4 73.1 24.8 23.4 22.8 21.6 15.7 0.6 83.9 8.2 34.2 53.1 127.4 16.3 5.2 97.0 7.2 7.9 17.1 5.8 68.0 6.1 9.6 4.1 18.5 5.3 54.7 95.4 13.4 108.5 19.6 24.4 14.9 28.0 18.3 23.7 29.1 16.5 24.8 20.4 101.3 205.9 73.7 364.9 48.5 44.4 251.7 175.8 137.9 227.5 108.2 39.3 224.9 23.2 276.8 13.3 119.6 152.5 210.2 211.7 280.5 149.9 239.1 169.3 203.7 2617.6 55.6 148.7 214.9 1392.4 12.2 70.8 859.7 153.5 399.5 80.9 115.8 264.9 108.7 87.4 331.7 35.7 38.8 121.0 4.8 18.5 35.4 543.3 50.7 114.7 284.4 CUL1 ENSG00000055130 "Cullin 1" Q13616 7 148697914-148801036 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 6 "Early spermatids: 377.8;Late spermatids: 391.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002676, HPA064584" Supported Supported Nucleoplasm,Nucleoli NA NA 190000 Nucleoplasm Nucleoli "CAB002676: , HPA064584: AB_2685294" "unprognostic (3.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-1)" "unprognostic (1.19e-1)" "unprognostic (5.06e-3)" "unprognostic (9.45e-2)" "unprognostic (1.41e-2)" "unprognostic (8.23e-2)" "unprognostic (2.40e-2)" "unprognostic (3.65e-2)" "unprognostic (3.40e-2)" "unprognostic (2.84e-2)" "unprognostic (2.18e-2)" "unprognostic (3.88e-2)" "unprognostic (1.48e-1)" "unprognostic (2.40e-1)" "unprognostic (7.24e-3)" 26.0 20.9 21.2 20.4 22.4 22.3 27.5 27.5 26.2 23.9 25.8 19.5 22.5 16.7 30.2 23.7 22.7 21.2 18.7 25.7 21.1 21.8 16.9 35.2 20.5 26.5 21.7 16.7 25.0 17.9 24.9 30.7 32.0 21.0 23.9 18.8 22.7 19.6 25.0 58.9 20.5 21.2 37.7 26.3 21.9 22.4 65.6 23.7 16.9 24.5 24.6 24.5 26.1 28.8 16.8 24.1 13.4 17.1 22.1 20.8 16.1 30.8 24.0 23.6 36.5 18.6 20.9 30.0 25.5 30.2 25.8 24.7 25.5 21.6 42.4 20.5 25.2 41.8 20.9 33.7 23.8 30.5 27.7 28.6 25.0 17.0 24.8 21.8 28.4 23.8 17.1 23.4 18.9 19.2 23.4 28.1 21.4 38.6 32.7 28.1 29.5 24.6 32.5 44.2 26.3 23.0 29.9 20.8 40.8 21.2 22.6 34.0 24.9 29.8 35.5 20.1 29.0 11.6 22.6 21.6 18.5 6.4 37.4 29.3 30.7 21.3 42.0 37.6 31.7 27.2 13.4 15.2 12.0 16.1 17.1 18.6 16.8 16.7 18.6 24.1 14.4 20.8 16.7 2.1 22.1 14.5 5.5 15.9 16.1 21.2 22.4 27.5 26.2 21.1 21.8 21.7 16.7 21.0 23.7 32.8 29.7 24.2 26.3 24.7 29.4 23.2 10.2 42.8 42.1 8.7 27.5 57.0 14.9 24.9 377.8 21.8 9.5 23.3 22.9 69.2 23.6 16.6 22.0 37.5 26.1 20.6 15.0 19.0 15.2 391.5 20.1 22.4 27.0 64.1 19.5 32.1 23.7 14.4 28.7 9.3 42.8 32.3 27.8 53.2 33.0 22.2 61.2 20.8 16.5 17.9 CUTC CGI-32 ENSG00000119929 "CutC copper transporter" Q9NTM9 10 99702558-99756134 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.1" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038619, HPA058231" Enhanced Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Cytosol" Nucleoli "HPA038619: AB_10672649, HPA058231: " "unprognostic (1.25e-2)" "unprognostic (5.92e-2)" "unprognostic (2.70e-1)" "unprognostic (8.66e-2)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (3.55e-3)" "unprognostic (8.67e-2)" "unprognostic (5.36e-2)" "unprognostic (1.81e-1)" "unprognostic (5.87e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.81e-7)" "unprognostic (1.00e-1)" "unprognostic (3.42e-2)" "unprognostic (2.41e-1)" "unprognostic (3.97e-1)" 11.6 4.9 5.7 9.8 8.7 7.9 9.8 3.5 6.5 5.3 5.9 7.2 3.5 4.4 4.9 8.0 6.2 5.1 5.8 13.2 5.9 4.7 5.3 11.0 5.1 7.9 8.6 6.6 4.6 4.5 3.5 3.6 4.5 5.5 6.0 6.4 6.9 5.7 5.4 122.1 5.8 6.2 11.6 7.4 9.2 6.0 14.1 8.3 9.2 4.3 25.1 7.3 13.5 11.4 32.8 24.2 47.1 19.4 25.5 36.3 19.3 9.5 20.5 7.2 21.9 26.8 12.3 3.9 7.8 10.1 7.9 8.9 9.4 7.3 34.7 7.0 13.3 3.9 8.2 14.7 13.0 8.8 10.2 14.0 11.5 9.2 14.8 12.4 21.3 5.6 12.7 8.1 12.6 26.2 9.8 13.5 20.2 10.1 7.7 5.9 6.6 19.1 22.0 7.2 9.7 7.7 13.0 8.5 13.3 8.3 3.9 2.4 5.4 3.6 5.7 9.8 10.4 9.1 12.2 7.5 3.3 4.4 3.6 10.3 12.7 16.5 24.3 10.8 45.8 2.9 26.5 19.4 47.1 27.2 15.2 28.3 32.8 25.9 25.9 21.0 29.0 36.3 27.8 30.8 25.5 18.5 24.2 24.7 19.3 5.7 8.7 3.5 6.5 5.9 4.7 8.6 6.6 5.5 8.3 8.9 12.2 21.9 13.0 10.8 16.5 35.8 10.2 20.1 10.3 5.2 7.9 15.9 18.3 14.6 8.1 21.5 4.9 0.0 15.0 10.7 15.3 11.4 30.0 20.2 18.3 11.1 11.6 22.7 17.8 6.8 12.0 15.9 28.7 27.9 7.8 17.8 10.1 10.1 15.2 24.5 27.1 19.4 15.6 105.8 35.1 9.5 11.3 20.1 9.7 10.7 CUZD1 "ERG-1, UO-44" ENSG00000138161 "CUB and zona pellucida like domains 1" Q86UP6 10 122832149-122850793 "Predicted membrane proteins" "Cell adhesion, Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 200 "pancreas: 650.6" "Group enriched" "Detected in some" 23 "Exocrine glandular cells: 224.1;Pancreatic endocrine cells: 71.0" "Cancer enriched" "Detected in some" 54 "pancreatic cancer: 32.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 6 "B-cells: 1.1;T-cells: 3.2" "Cell line enhanced" "Detected in many" "hTERT-HME1: 7.2;LHCN-M2: 8.0" "Low region specificity" "Detected in single" "HPA068479, HPA068660, HPA074117" Enhanced Approved Nucleoli,Vesicles No No Nucleoli Vesicles "HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663" "unprognostic (4.68e-2)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "unprognostic (1.52e-5)" "unprognostic (8.08e-2)" "unprognostic (5.20e-3)" "unprognostic (1.16e-4)" "unprognostic (4.19e-2)" "unprognostic (3.03e-2)" "unprognostic (5.15e-2)" "unprognostic (8.46e-2)" "unprognostic (6.64e-3)" "unprognostic (2.75e-3)" "unprognostic (4.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.56e-1)" "unprognostic (4.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 650.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.3 0.2 0.0 3.2 0.2 1.6 1.7 1.7 0.0 0.5 0.8 1.0 2.5 0.7 0.3 1.7 1.8 3.7 0.9 0.7 1.1 0.0 1.7 0.0 1.5 2.6 2.3 2.2 3.6 4.7 0.8 0.3 0.0 3.8 1.2 0.3 1.5 7.2 0.2 1.8 1.5 1.3 1.5 8.0 0.4 2.0 2.7 1.7 0.9 1.3 0.0 4.0 0.6 1.4 1.3 1.9 0.7 0.9 0.4 1.1 2.0 1.3 1.9 3.6 0.0 2.4 0.9 0.0 1.9 1.4 3.2 1.3 5.9 0.0 0.0 0.1 0.3 0.8 0.1 1.3 0.6 0.9 1.1 0.1 1.1 1.4 0.7 0.0 0.0 0.2 0.2 3.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.1 0.0 0.0 0.0 224.1 0.0 0.1 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 4.5 0.3 0.0 0.0 6.4 0.0 0.0 71.0 0.0 0.4 0.0 0.5 0.0 0.0 0.5 0.2 0.1 0.0 0.5 0.0 0.0 CYB561A3 CYBASC3 ENSG00000162144 "Cytochrome b561 family member A3" Q8NBI2 11 61348745-61362299 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.7;blood: 98.8" "Cell type enhanced" "Detected in many" 10 "Melanocytes: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8" "Group enriched" "Detected in all" 10 "B-cells: 50.1;dendritic cells: 98.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045674, HPA052548" Approved Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA045674: , HPA052548: AB_2681866" "unprognostic (2.61e-1)" "unprognostic (8.78e-2)" "unprognostic (4.16e-1)" "unprognostic (3.62e-2)" "unprognostic (1.37e-1)" "unprognostic (9.41e-3)" "unprognostic (7.41e-3)" "unprognostic (2.48e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.83e-1)" "unprognostic (3.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.80e-3)" 10.0 113.7 4.0 22.5 6.4 7.1 7.5 4.7 6.9 6.6 10.9 10.9 14.4 6.1 10.9 9.9 8.8 11.0 11.0 5.7 5.1 4.1 9.7 30.6 12.4 21.7 8.3 3.5 14.5 17.9 9.0 6.6 21.0 6.8 9.2 9.6 10.7 10.9 8.1 10.2 24.8 15.8 7.6 5.6 24.0 8.5 8.0 7.0 16.8 10.0 8.4 33.3 10.7 7.3 50.1 98.8 3.8 7.4 3.3 3.8 8.7 18.2 30.8 4.9 14.2 23.4 15.5 4.2 9.2 14.0 11.1 11.1 8.3 20.4 35.5 16.6 16.2 9.0 25.5 4.7 25.6 6.8 23.7 10.5 6.1 20.8 5.6 11.0 8.4 15.9 21.8 36.2 24.1 11.1 9.2 16.5 16.1 20.0 21.3 18.6 19.6 15.8 3.6 9.2 16.3 17.7 19.2 4.8 26.5 12.8 18.1 6.1 10.1 18.8 27.1 21.2 3.4 22.0 9.8 10.9 13.1 6.8 12.7 13.2 13.3 17.6 19.9 18.0 14.7 16.4 1.6 7.4 3.8 3.8 6.0 3.4 40.5 2.7 3.4 7.4 50.1 2.8 3.0 2.5 3.3 6.4 98.8 2.6 8.7 4.0 6.4 4.7 6.9 5.1 4.1 8.3 3.5 6.8 7.0 6.0 28.1 119.0 16.1 25.1 15.4 1.4 7.6 29.4 25.0 12.2 29.5 43.5 10.0 22.6 55.7 11.9 46.6 0.0 34.2 35.0 17.5 17.4 8.1 18.7 49.1 17.5 18.5 11.6 20.3 10.6 19.2 29.8 303.7 77.5 27.1 16.9 21.9 38.6 19.4 12.9 51.6 12.9 12.3 5.4 11.1 21.0 33.1 21.8 26.6 12.9 CYB5D1 FLJ32499 ENSG00000182224 "Cytochrome b5 domain containing 1" Q6P9G0 17 7857746-7862282 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 56.2;Early spermatids: 65.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA021632 Uncertain Approved "Nucleoli,Golgi apparatus" NA NA "Nucleoli, Golgi apparatus" "HPA021632: AB_1847368" "unprognostic (1.99e-1)" "unprognostic (2.91e-1)" "unprognostic (1.23e-1)" "unprognostic (5.10e-3)" "unprognostic (2.34e-1)" "unprognostic (4.44e-3)" "unprognostic (1.12e-1)" "unprognostic (2.16e-2)" "unprognostic (1.34e-1)" "unprognostic (2.69e-2)" "unprognostic (2.89e-2)" "unprognostic (2.41e-2)" "unprognostic (1.04e-4)" "unprognostic (2.38e-2)" "unprognostic (1.25e-1)" "unprognostic (5.27e-3)" "unprognostic (1.79e-2)" 14.0 13.0 13.2 5.5 22.5 7.2 13.1 14.1 16.8 10.5 7.9 14.0 12.8 6.5 10.9 17.0 7.9 28.2 9.4 13.9 14.4 12.0 19.2 13.0 8.8 4.7 9.4 13.5 14.6 13.1 9.7 18.1 7.0 16.5 11.0 7.8 11.7 10.5 13.2 9.9 10.1 6.0 9.4 6.5 5.9 8.4 14.5 11.7 6.9 22.8 8.6 5.6 7.4 7.5 3.4 3.1 2.7 2.3 1.6 5.9 1.8 16.1 12.0 5.8 15.4 10.4 9.3 3.5 8.3 8.3 9.0 8.6 7.6 3.1 7.0 5.9 6.7 5.3 14.5 12.8 10.9 13.5 4.6 14.7 4.6 15.7 10.8 4.7 8.1 3.3 7.8 13.8 15.6 14.1 5.5 9.5 17.1 3.3 4.8 4.9 7.0 12.6 3.3 7.3 10.5 12.5 8.7 2.7 7.0 14.1 3.1 7.9 5.3 13.2 7.4 7.6 6.2 8.7 3.3 6.6 7.0 6.1 12.2 10.5 2.5 6.1 3.9 14.5 4.5 4.4 0.5 2.3 0.1 2.7 1.9 3.3 3.4 2.4 1.4 3.1 1.5 5.9 3.1 2.7 1.6 1.1 1.4 2.2 1.8 13.2 22.5 14.1 16.8 14.4 12.0 9.4 13.5 16.5 11.7 11.9 24.5 1.9 4.1 4.5 4.2 0.2 10.2 56.2 15.9 5.2 19.6 3.6 11.6 3.6 65.5 6.8 5.1 0.0 2.7 2.1 5.3 8.0 10.4 7.6 3.4 1.6 5.8 6.2 1.0 34.0 4.4 4.0 5.0 0.0 7.5 6.8 5.2 3.5 3.5 9.6 18.0 6.5 3.8 2.8 2.5 5.4 2.2 1.3 7.6 1.6 CYTH1 "B2-1, cytohesin-1, D17S811E, PSCD1" ENSG00000108669 "Cytohesin 1" Q15438 17 78674048-78782297 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 139.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047498 Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA047498: " "unprognostic (3.82e-3)" "unprognostic (5.49e-2)" "unprognostic (1.34e-2)" "unprognostic (8.17e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.48e-4)" "unprognostic (6.60e-2)" "unprognostic (3.47e-2)" "unprognostic (3.26e-1)" "unprognostic (9.69e-2)" "unprognostic (4.94e-2)" "unprognostic (1.56e-2)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (4.14e-2)" "unprognostic (1.27e-1)" "unprognostic (1.10e-1)" 17.4 12.4 20.7 28.5 36.0 34.4 12.0 17.7 27.5 10.1 17.4 64.1 5.0 13.2 7.7 6.5 25.9 10.2 15.5 10.3 21.5 16.0 11.5 16.0 25.7 42.3 44.4 27.4 5.9 16.0 7.5 8.4 15.8 32.1 15.2 19.9 10.1 17.3 5.3 17.5 15.9 21.4 10.0 31.2 31.8 24.8 7.9 45.2 19.3 15.2 9.2 50.1 14.4 12.1 24.7 19.1 45.9 20.0 21.8 39.4 31.3 9.1 6.4 6.4 5.5 4.4 5.7 6.2 4.3 3.8 5.3 6.3 4.0 10.3 6.8 4.4 5.7 9.1 8.1 3.1 11.3 4.3 14.3 8.7 2.7 8.1 7.4 3.2 5.6 27.6 2.7 9.3 6.0 6.3 3.6 17.1 23.0 4.5 26.4 6.3 4.7 36.3 5.0 1.6 14.9 5.7 9.6 7.1 23.9 5.8 6.4 3.7 13.6 7.6 14.8 6.0 6.8 7.2 6.7 8.1 4.2 6.2 6.7 4.4 30.7 14.1 25.0 3.1 5.7 4.4 45.9 16.2 31.4 39.4 20.0 28.6 24.7 32.8 31.8 13.7 23.0 36.5 30.7 33.8 21.8 17.6 19.1 24.5 31.3 20.7 36.0 17.7 27.5 21.5 16.0 44.4 27.4 32.1 45.2 56.6 46.2 41.5 26.5 36.6 62.3 16.6 17.8 33.5 31.8 5.2 104.1 2.4 6.6 10.4 23.5 51.6 24.0 0.0 16.1 7.5 15.4 34.8 33.7 24.6 41.7 41.3 26.6 30.7 66.6 33.2 4.0 73.5 35.4 139.7 45.7 16.5 31.3 24.9 4.9 5.8 74.3 6.5 11.7 14.1 15.3 30.1 6.1 71.7 15.2 45.7 DCAF13 "DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1" ENSG00000164934 "DDB1 and CUL4 associated factor 13" Q9NV06 8 103414714-103443453 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Ubl conjugation pathway" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044504 Uncertain Supported "Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions, Centrosome, Cytosol" "HPA044504: AB_2678963" "prognostic unfavorable (4.06e-4)" "unprognostic (4.39e-2)" "unprognostic (1.70e-1)" "unprognostic (4.46e-3)" "unprognostic (3.57e-2)" "unprognostic (7.86e-3)" "prognostic unfavorable (8.05e-6)" "unprognostic (5.92e-3)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.54e-3)" "unprognostic (2.31e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (6.42e-2)" "unprognostic (8.63e-2)" 18.4 20.5 13.8 18.1 15.7 10.6 20.2 11.3 14.3 16.0 16.7 13.0 12.9 13.1 18.1 16.7 24.0 15.3 10.7 15.9 12.4 11.8 35.2 26.5 12.4 18.4 16.5 12.1 20.9 28.9 15.7 34.6 21.2 16.2 16.4 18.5 7.4 15.9 11.3 21.1 13.7 16.8 15.3 13.9 20.4 14.7 25.3 15.0 26.4 17.1 22.6 24.3 16.9 15.5 28.6 26.4 10.3 22.1 24.0 27.2 20.2 25.3 22.8 21.3 21.7 15.5 18.0 16.0 18.9 14.5 18.0 18.5 22.4 24.8 35.3 32.4 19.8 17.8 19.1 28.8 24.2 34.9 33.6 20.5 48.7 13.7 25.4 17.7 19.9 21.0 14.6 16.7 26.5 44.1 11.3 24.9 24.3 32.7 15.5 27.3 20.6 37.8 21.0 32.6 71.8 35.6 24.6 25.9 36.3 26.2 21.2 27.2 25.8 11.8 18.5 21.4 19.6 28.6 13.7 16.4 18.3 29.5 23.6 25.3 17.1 29.8 49.9 24.7 43.6 23.4 8.6 18.6 10.3 18.4 22.1 25.2 28.6 19.8 19.7 26.4 22.1 19.8 20.2 2.0 24.0 16.0 13.7 27.2 20.2 13.8 15.7 11.3 14.3 12.4 11.8 16.5 12.1 16.2 15.0 14.9 14.2 31.8 57.7 70.6 19.2 17.3 7.6 14.7 31.8 31.4 23.6 50.1 33.2 41.0 33.6 28.9 16.1 0.0 42.0 61.5 36.1 25.3 40.3 14.7 39.5 15.9 13.9 17.2 15.4 10.8 22.5 25.0 25.3 30.7 16.0 25.8 34.4 10.5 16.6 66.3 19.8 12.9 36.3 85.0 87.9 67.2 28.4 26.3 25.4 52.2 DCTN3 DCTN-22 ENSG00000137100 "Dynactin subunit 3" O75935 9 34613545-34620523 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044905 Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA044905: AB_10960996" "unprognostic (3.38e-1)" "unprognostic (4.13e-2)" "unprognostic (3.47e-1)" "unprognostic (6.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.92e-3)" "unprognostic (9.88e-2)" "unprognostic (4.41e-2)" "prognostic favorable (2.10e-5)" "unprognostic (1.26e-3)" "unprognostic (4.24e-3)" "prognostic favorable (5.76e-11)" "unprognostic (3.06e-1)" "unprognostic (2.25e-1)" "unprognostic (3.22e-1)" "unprognostic (4.43e-2)" 26.4 32.5 42.4 16.2 49.1 46.5 30.4 33.7 58.3 25.7 23.3 20.7 22.2 21.4 24.6 25.5 33.7 31.7 23.1 42.8 36.3 37.4 32.8 32.4 21.1 21.9 35.8 48.4 32.6 33.7 29.8 36.3 23.0 37.4 27.4 20.6 27.5 32.4 28.6 69.1 37.9 18.3 28.0 26.2 19.4 23.7 16.2 22.0 42.6 32.4 37.1 29.2 22.5 24.9 28.5 44.6 62.3 45.9 29.9 56.0 46.8 34.2 28.8 26.8 28.0 23.8 33.3 11.0 29.3 27.4 40.9 32.2 18.4 12.9 15.8 18.4 38.5 14.3 13.7 24.3 30.7 26.2 49.5 30.5 10.5 51.0 15.8 25.8 27.6 32.1 29.3 26.6 28.2 18.5 20.0 26.9 29.8 12.5 32.8 35.6 28.2 34.7 74.5 8.1 14.4 46.5 17.5 14.5 21.7 19.7 12.2 8.9 22.9 21.7 20.0 11.2 8.2 26.8 31.7 24.4 25.8 20.9 29.2 28.4 22.2 28.7 10.5 40.5 16.1 52.4 62.3 44.0 59.3 35.2 44.2 32.0 28.5 37.8 37.2 44.0 28.3 29.9 35.7 38.4 29.9 45.9 44.6 56.0 46.8 42.4 49.1 33.7 58.3 36.3 37.4 35.8 48.4 37.4 22.0 29.8 31.8 49.9 82.5 90.2 76.0 72.8 63.7 57.6 43.3 76.8 23.6 100.4 175.8 103.7 8.3 78.7 68.5 210.2 135.3 93.0 101.4 62.7 86.5 74.9 115.9 69.9 71.7 73.1 79.5 15.7 95.8 80.9 141.7 86.6 53.8 145.8 101.0 66.0 115.2 170.3 63.4 58.2 101.0 73.5 71.3 124.6 83.4 96.6 55.1 72.9 DCTN6 WS-3 ENSG00000104671 "Dynactin subunit 6" O00399 8 30156297-30183640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024049, HPA024558" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Nucleoli, Cytosol" "Plasma membrane" "HPA024049: AB_1847524, HPA024558: AB_1847525" "unprognostic (1.28e-1)" "unprognostic (8.32e-3)" "unprognostic (1.65e-2)" "unprognostic (1.88e-1)" "unprognostic (1.69e-1)" "unprognostic (7.50e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.26e-1)" "unprognostic (7.84e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-2)" "unprognostic (9.26e-2)" "prognostic favorable (5.42e-4)" "unprognostic (1.06e-1)" "unprognostic (3.10e-1)" "unprognostic (7.54e-2)" "unprognostic (1.43e-1)" 29.5 34.6 41.4 15.6 39.4 23.3 32.6 23.6 43.6 21.0 20.6 27.4 15.4 14.2 24.1 27.2 24.1 18.0 20.0 44.5 37.7 35.2 32.8 27.5 20.3 15.3 42.3 36.3 26.3 19.5 31.0 27.7 32.7 41.4 21.9 22.5 16.5 20.3 23.7 20.4 17.5 15.6 26.0 46.2 16.8 19.3 13.9 30.3 15.4 33.7 18.2 17.9 25.7 18.8 7.4 19.8 9.5 15.9 10.2 11.2 6.9 19.1 18.3 23.3 12.2 21.1 29.2 14.9 26.1 30.1 25.4 26.7 11.9 12.8 14.2 28.0 27.2 23.8 14.2 16.1 22.0 30.0 11.4 12.5 20.4 15.8 18.6 16.3 11.5 17.4 24.6 31.4 18.2 19.5 22.1 22.7 20.5 22.8 15.7 27.0 14.5 21.3 16.6 18.9 32.2 11.7 11.4 17.5 12.4 36.1 18.8 38.1 21.6 15.2 18.6 25.8 12.3 18.0 16.3 21.8 13.8 48.3 11.3 18.5 6.7 7.4 18.4 25.5 13.2 24.0 9.5 14.1 4.9 8.6 15.9 9.8 7.4 7.8 10.1 16.8 5.5 9.0 11.2 4.5 10.2 15.1 19.8 8.7 6.9 41.4 39.4 23.6 43.6 37.7 35.2 42.3 36.3 41.4 30.3 23.8 31.2 37.4 81.1 50.8 33.7 73.4 45.9 57.6 37.5 41.8 13.7 76.0 104.5 78.2 11.6 53.1 26.3 0.0 74.2 71.3 55.9 41.2 46.1 41.8 61.9 25.4 39.2 44.2 46.4 7.3 74.8 51.6 65.8 65.9 27.4 43.3 77.1 38.6 70.7 114.8 36.3 51.8 70.0 42.8 48.2 55.6 170.3 40.5 29.2 81.2 DCUN1D5 "FLJ32431, MGC2714" ENSG00000137692 "Defective in cullin neddylation 1 domain containing 5" Q9BTE7 11 103062076-103092215 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050863 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA050863: AB_2681259" "unprognostic (4.47e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (4.62e-4)" "prognostic unfavorable (2.01e-7)" "unprognostic (1.92e-3)" "unprognostic (1.21e-2)" "prognostic favorable (9.52e-5)" "unprognostic (2.08e-2)" "prognostic unfavorable (4.12e-4)" "unprognostic (2.64e-3)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-2)" "unprognostic (1.43e-3)" 20.9 18.3 18.9 17.2 24.5 13.4 19.1 22.5 28.8 12.9 13.5 15.9 11.5 11.4 15.9 13.7 26.5 12.9 10.6 24.2 20.3 16.6 14.4 19.0 13.9 21.5 15.6 21.0 12.2 17.7 14.5 17.0 17.3 23.6 15.4 13.9 9.9 15.6 13.5 38.7 14.0 11.3 18.4 17.5 15.7 16.0 24.0 21.0 19.4 13.2 24.2 21.3 14.4 14.7 14.4 17.3 11.8 13.1 20.5 17.0 13.4 22.3 12.4 13.7 21.0 11.2 14.2 15.2 22.2 12.1 18.3 18.9 47.5 26.2 10.8 39.3 15.8 19.0 21.3 28.8 28.1 18.9 19.0 19.4 28.9 10.7 18.4 19.0 41.4 15.0 12.4 25.0 24.5 25.4 9.6 22.7 26.4 47.2 0.0 17.3 20.2 27.3 32.4 26.7 19.5 31.7 11.6 21.9 27.4 13.9 23.0 18.6 19.7 20.7 21.2 18.4 14.7 24.8 17.4 18.4 14.9 18.1 26.4 19.8 9.1 14.4 36.0 10.6 40.7 15.4 11.8 11.1 10.2 13.8 13.1 16.3 14.4 16.3 14.2 13.7 14.1 14.0 16.3 4.0 20.5 10.0 17.3 17.0 13.4 18.9 24.5 22.5 28.8 20.3 16.6 15.6 21.0 23.6 21.0 14.9 8.3 25.2 44.6 70.6 11.0 26.6 15.3 14.7 14.8 8.7 7.9 51.2 41.4 60.4 3.0 19.7 6.9 23.3 48.3 76.2 37.5 35.6 15.1 21.3 40.1 6.4 13.8 20.9 29.7 5.9 13.3 22.6 28.7 25.2 16.1 14.8 51.7 14.0 18.4 31.1 12.3 25.8 31.1 118.2 114.7 73.1 36.6 24.5 23.4 57.0 DCXR "DCR, KIDCR, SDR20C1" ENSG00000169738 "Dicarbonyl and L-xylulose reductase" Q7Z4W1 17 82035136-82037732 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Xylose metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 293.8" "Group enriched" "Detected in all" 5 "Distal tubular cells: 688.1;Hepatocytes: 2593.4;Proximal tubular cells: 1817.7" "Cancer enhanced" "Detected in all" "liver cancer: 305.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 65.1;MCF7: 80.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023371, HPA023863" Enhanced Uncertain Nucleoli,Microtubules NA NA 2700000 "Nucleoli, Microtubules" "HPA023371: AB_1847530, HPA023863: AB_1847531" "unprognostic (3.33e-2)" "unprognostic (1.67e-3)" "unprognostic (3.75e-1)" "unprognostic (1.16e-2)" "unprognostic (1.19e-1)" "unprognostic (8.43e-2)" "unprognostic (4.54e-3)" "unprognostic (1.86e-2)" "unprognostic (3.05e-1)" "unprognostic (2.56e-2)" "prognostic favorable (4.70e-4)" "unprognostic (1.72e-1)" "prognostic favorable (2.13e-4)" "unprognostic (1.81e-1)" "unprognostic (1.36e-1)" "unprognostic (2.64e-1)" "unprognostic (1.10e-2)" 12.7 6.1 12.8 4.3 12.1 5.7 12.2 9.0 15.1 9.9 9.5 8.4 18.1 7.8 4.4 62.7 11.7 6.1 4.8 11.8 9.8 9.7 50.8 293.8 10.5 5.3 14.4 7.3 8.1 13.0 6.7 7.2 9.0 13.4 22.3 5.4 7.8 19.3 14.0 22.5 8.6 6.8 3.6 8.4 4.4 14.9 8.7 9.7 8.3 15.6 12.6 9.1 7.5 6.4 32.8 52.7 25.3 33.1 35.2 43.7 35.8 8.9 12.4 5.7 10.3 23.1 5.8 15.2 4.6 6.0 12.7 8.7 21.8 3.9 18.6 9.0 6.4 1.6 10.6 10.4 9.3 4.4 3.9 26.8 17.8 9.3 65.1 24.7 13.7 21.9 8.4 11.5 4.0 14.6 2.7 7.1 11.1 20.2 13.6 6.7 80.0 11.4 32.8 6.6 40.3 13.1 10.5 7.7 24.2 9.4 12.8 16.0 9.4 6.5 55.1 8.0 3.6 41.3 13.5 3.6 6.7 8.4 9.1 8.6 13.9 10.2 8.8 5.8 15.0 4.9 13.9 33.1 25.3 24.7 30.6 23.6 28.6 30.8 23.6 52.7 32.8 43.7 31.9 16.5 35.2 28.0 42.5 33.1 35.8 12.8 12.1 9.0 15.1 9.8 9.7 14.4 7.3 13.4 9.7 47.6 155.8 118.2 185.0 52.0 15.8 102.4 124.9 20.1 28.4 169.3 17.7 343.4 688.1 41.9 5.1 35.2 135.9 23.3 37.0 376.5 68.0 203.5 64.5 2593.4 145.3 20.6 52.6 88.4 114.9 15.1 65.6 57.1 170.4 47.7 117.0 81.8 32.4 105.2 44.6 1817.7 18.5 19.4 66.5 6.6 48.3 64.0 286.5 126.9 129.4 155.9 DDA1 "C19orf58, MGC2594, PCIA1" ENSG00000130311 "DET1 and DDB1 associated 1" Q9BW61 19 17309518-17323301 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 364.2;Syncytiotrophoblasts: 212.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042134, HPA055272" Approved Approved Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA042134: AB_10794169, HPA055272: AB_2682767" "unprognostic (1.30e-1)" "unprognostic (6.35e-3)" "unprognostic (3.13e-2)" "unprognostic (1.49e-3)" "unprognostic (5.38e-2)" "unprognostic (1.26e-2)" "unprognostic (3.41e-2)" "unprognostic (4.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (8.55e-2)" "unprognostic (1.48e-1)" "unprognostic (4.38e-2)" "unprognostic (6.33e-2)" "unprognostic (1.45e-1)" "unprognostic (3.15e-3)" 11.6 15.5 24.5 12.7 26.6 16.1 9.9 14.6 36.2 10.8 14.6 13.5 9.6 15.4 11.6 9.9 13.4 13.5 11.8 16.4 18.9 19.8 12.9 17.9 14.6 14.7 19.0 24.4 12.9 13.4 10.9 10.9 26.4 23.0 12.9 13.1 10.8 13.6 15.9 17.8 20.8 16.9 11.5 13.2 13.4 17.4 29.6 12.0 15.9 10.5 10.9 13.7 12.4 9.9 7.1 12.7 11.5 8.0 6.5 8.8 5.7 12.5 11.2 8.5 6.7 8.9 6.4 13.2 8.5 10.9 13.1 12.1 9.9 11.1 5.0 11.9 8.7 6.3 10.7 6.2 12.4 6.4 8.2 16.5 6.1 8.8 9.3 10.8 6.8 11.9 9.7 14.3 7.8 7.3 8.0 7.6 11.6 7.2 8.7 6.8 6.3 13.7 10.2 9.7 12.6 19.2 8.7 6.7 8.3 10.3 9.4 8.7 13.0 6.2 14.4 7.4 5.3 7.3 9.1 11.4 8.8 7.4 22.6 11.8 10.7 14.5 6.9 19.3 11.8 8.6 5.0 7.3 11.5 8.6 8.0 7.4 7.1 7.2 8.5 5.9 6.6 8.3 8.0 8.2 6.5 6.9 12.7 8.8 5.7 24.5 26.6 14.6 36.2 18.9 19.8 19.0 24.4 23.0 12.0 26.8 13.1 28.4 28.3 48.4 17.7 14.5 2.5 16.0 18.2 26.2 11.8 121.6 33.2 69.0 364.2 20.2 49.3 0.0 40.5 112.0 27.8 33.7 38.1 21.7 56.2 12.7 19.4 14.7 21.1 84.5 20.8 27.9 28.7 77.5 38.9 25.1 96.6 38.6 25.5 44.5 14.3 19.4 29.8 67.3 35.1 54.1 212.0 34.6 23.5 76.5 DDAH1 DDAH ENSG00000153904 "Dimethylarginine dimethylaminohydrolase 1" O94760 1 85318481-85578363 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.6" "Cell type enhanced" "Detected in many" 8 "Proximal tubular cells: 219.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.3;naive B-cell: 1.0" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Cell line enhanced" "Detected in many" "OE19: 36.9;SH-SY5Y: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006308, HPA071064" Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" NA NA 140000 "Plasma membrane, Cytosol" Nucleoli "HPA006308: AB_1847532, HPA071064: " "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "prognostic favorable (5.99e-4)" "unprognostic (6.82e-2)" "unprognostic (1.04e-1)" "unprognostic (1.62e-2)" "unprognostic (2.55e-1)" "unprognostic (3.85e-2)" "unprognostic (2.57e-1)" "unprognostic (1.02e-2)" "unprognostic (3.62e-2)" "unprognostic (1.56e-1)" "prognostic favorable (5.21e-6)" "unprognostic (5.37e-2)" "unprognostic (9.06e-2)" "unprognostic (5.81e-2)" "unprognostic (1.56e-2)" 4.3 14.3 43.9 5.8 44.9 0.7 6.6 14.4 37.2 7.7 22.1 20.7 4.3 21.1 6.0 33.8 4.9 18.4 12.2 6.4 29.5 24.1 61.6 39.9 11.8 1.1 24.9 37.0 3.4 13.8 13.0 7.2 3.1 13.8 13.1 21.4 4.1 8.5 6.2 13.8 2.8 19.9 7.4 8.1 4.1 15.6 9.3 11.0 0.0 14.1 1.0 1.2 6.0 3.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 18.3 2.3 6.5 1.2 10.9 9.2 0.8 21.7 13.2 7.7 8.2 26.1 4.9 0.0 9.1 24.6 7.6 5.3 23.5 4.5 9.9 0.0 9.0 0.0 6.2 9.1 3.9 16.7 1.0 7.7 0.4 6.5 4.1 9.8 12.3 0.0 0.0 1.8 19.8 1.5 0.8 0.0 7.8 36.9 6.8 0.0 15.2 0.2 33.0 13.7 18.3 35.6 2.8 16.5 2.6 9.7 8.9 1.2 24.0 6.8 5.5 1.6 15.1 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 43.9 44.9 14.4 37.2 29.5 24.1 24.9 37.0 13.8 11.0 32.8 31.3 4.2 4.0 12.2 2.7 11.4 68.8 30.8 13.6 66.3 3.9 1.7 106.1 15.6 17.1 4.5 78.7 0.0 26.7 0.8 23.5 37.8 0.0 94.3 0.9 0.0 32.8 9.2 2.2 18.4 14.7 1.5 11.8 1.0 77.8 59.7 34.2 73.6 70.4 219.6 8.0 12.9 18.9 5.0 5.6 12.5 0.7 3.3 85.4 6.5 DDRGK1 "C20orf116, dJ1187M17.3, UFBP1" ENSG00000198171 "DDRGK domain containing 1" Q96HY6 20 3190350-3204685 "Predicted intracellular proteins" "Ubl conjugation pathway" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013373, HPA013705" Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoli "HPA013373: AB_2091955, HPA013705: AB_2668872" "unprognostic (2.99e-1)" "unprognostic (1.55e-1)" "unprognostic (3.42e-2)" "unprognostic (1.60e-1)" "unprognostic (6.54e-3)" "unprognostic (2.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.63e-1)" "unprognostic (4.10e-3)" "unprognostic (8.16e-2)" "unprognostic (5.44e-3)" "unprognostic (7.29e-2)" "prognostic favorable (2.01e-5)" "unprognostic (6.80e-3)" "unprognostic (1.43e-2)" "unprognostic (2.48e-2)" "unprognostic (6.90e-2)" 29.5 47.3 28.5 18.6 45.7 17.8 20.5 33.4 38.2 22.1 23.9 29.8 23.7 35.3 21.5 17.8 21.1 21.0 24.3 17.7 27.0 21.8 28.5 54.0 27.0 17.5 47.9 22.9 23.9 43.6 37.5 17.7 31.3 30.9 27.3 16.6 20.6 48.5 29.3 29.5 22.2 31.9 17.1 36.8 20.2 31.5 14.7 39.3 12.6 34.0 14.2 16.2 20.8 29.4 15.1 32.0 24.4 20.2 12.3 21.0 12.9 29.9 37.8 9.4 17.4 21.3 8.1 13.5 19.1 9.2 11.8 13.0 29.7 21.9 18.0 15.7 10.6 22.8 33.7 9.6 28.6 4.4 12.2 18.0 15.2 12.6 51.5 29.2 17.1 16.5 12.7 28.1 22.6 16.2 13.1 10.8 13.0 21.1 21.7 7.5 16.4 11.7 32.0 11.6 20.6 17.5 15.5 8.3 27.3 19.2 28.3 20.8 12.8 19.6 55.7 17.8 5.9 23.6 10.5 16.2 19.1 8.5 13.4 29.1 16.2 18.2 7.6 5.3 14.5 11.1 11.7 20.2 24.4 19.6 13.3 19.5 15.1 20.9 21.0 20.5 15.1 18.7 18.2 5.4 12.3 12.1 32.0 18.6 12.9 28.5 45.7 33.4 38.2 27.0 21.8 47.9 22.9 30.9 39.3 41.7 48.8 26.8 54.1 23.4 43.2 27.9 104.4 44.2 40.9 66.3 60.9 110.7 16.6 129.1 42.5 50.1 133.4 0.0 154.4 53.3 42.9 64.4 27.6 109.1 106.6 49.3 51.3 39.3 55.8 12.9 51.8 50.8 37.1 61.3 57.4 61.1 136.8 122.8 64.7 61.9 91.7 64.7 41.2 35.6 20.7 33.9 122.1 30.5 77.9 57.1 DDX10 "Dbp4, HRH-J8" ENSG00000178105 "DEAD-box helicase 10" Q13206 11 108665025-108940930 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 90.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 58.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004691 Approved Approved Nucleoli NA NA Nucleoli "HPA004691: AB_1078629" "unprognostic (9.49e-2)" "unprognostic (9.32e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (7.97e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.52e-5)" "unprognostic (2.86e-2)" "unprognostic (1.23e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (1.00e-1)" "prognostic favorable (2.14e-5)" "unprognostic (5.20e-2)" "unprognostic (1.98e-1)" "unprognostic (4.64e-1)" "unprognostic (2.43e-3)" 14.0 11.9 17.3 15.0 20.3 10.4 15.5 20.5 18.3 14.3 12.2 8.1 11.7 8.8 18.4 12.8 12.6 16.8 8.8 12.1 13.5 11.5 19.6 12.5 10.6 13.1 12.2 16.3 18.6 18.0 16.7 22.2 12.9 13.1 12.4 13.3 7.9 10.6 14.7 13.6 14.8 9.1 16.8 13.3 15.0 11.3 25.1 12.6 13.8 13.4 8.8 14.2 14.3 18.8 11.6 8.4 1.4 6.7 9.4 11.3 4.3 7.4 7.3 6.9 9.7 6.9 5.6 7.2 8.0 4.3 9.7 9.6 20.8 10.9 25.3 15.1 6.1 10.5 8.3 19.8 9.7 14.0 9.6 8.9 17.1 4.3 7.7 12.3 17.4 8.2 5.0 7.6 11.0 13.8 5.8 8.8 6.6 24.0 2.8 9.5 4.8 14.6 14.7 9.0 14.0 11.1 12.5 11.3 23.6 6.0 6.4 12.9 6.8 11.2 9.9 4.2 9.7 12.0 6.1 9.2 10.2 10.4 9.7 10.8 4.3 7.5 58.4 3.5 21.1 10.3 1.4 5.0 1.0 8.6 6.7 11.3 10.4 7.5 10.1 8.4 11.6 8.1 7.8 0.7 9.4 6.4 8.2 6.3 4.3 17.3 20.3 20.5 18.3 13.5 11.5 12.2 16.3 13.1 12.6 14.9 30.3 22.6 17.3 25.2 21.1 18.2 7.6 18.7 22.7 3.5 90.3 21.4 16.6 13.2 28.6 19.8 2.9 0.0 18.3 17.8 17.6 12.7 13.9 10.2 13.1 17.5 14.5 9.2 9.2 5.9 27.3 18.2 6.8 18.0 7.8 8.9 15.1 3.5 20.1 46.2 25.2 12.9 15.6 64.4 44.6 25.3 21.6 14.4 13.6 12.2 DDX18 "Has1, MrDb" ENSG00000088205 "DEAD-box helicase 18" Q9NVP1 2 117814650-117832379 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 90.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035400, HPA041056" Approved Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA035400: AB_10672091, HPA041056: AB_2677277" "unprognostic (1.44e-1)" "unprognostic (2.22e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.64e-4)" "unprognostic (2.06e-1)" "unprognostic (1.77e-3)" "prognostic unfavorable (3.07e-4)" "unprognostic (8.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.44e-1)" "unprognostic (1.42e-2)" "unprognostic (4.94e-2)" "unprognostic (8.51e-2)" "unprognostic (1.45e-1)" "unprognostic (1.53e-1)" "unprognostic (7.28e-2)" "unprognostic (5.65e-2)" 35.3 21.3 20.5 28.7 26.0 17.4 31.2 27.1 25.6 31.2 27.9 16.7 21.6 20.9 32.0 22.9 27.8 28.5 21.3 22.9 19.6 19.1 32.0 40.3 24.1 35.0 25.5 22.9 36.3 29.5 21.0 25.9 25.0 25.0 25.0 30.3 11.5 24.2 26.6 37.0 24.9 26.3 28.3 30.8 46.5 26.2 22.9 31.1 40.7 31.3 23.9 37.6 37.6 23.7 22.2 20.5 9.4 18.5 17.2 23.6 16.3 22.0 10.0 15.0 13.5 8.9 8.0 24.8 13.1 10.4 18.1 16.0 24.6 14.6 32.5 21.5 10.8 16.8 17.1 29.0 16.9 26.8 16.5 20.3 31.0 9.4 24.7 12.4 41.4 16.2 8.3 15.7 23.0 23.3 9.2 10.8 16.9 33.8 14.1 13.8 13.7 22.6 21.6 37.6 18.7 15.2 19.7 23.4 28.4 12.0 13.1 14.4 24.5 15.2 16.8 17.0 15.9 10.6 22.9 8.3 16.2 23.9 11.4 23.5 16.3 20.2 90.0 11.9 19.6 7.2 6.2 13.8 9.4 16.2 17.3 20.6 22.2 19.3 18.5 12.5 19.1 23.6 20.7 3.6 17.2 18.5 20.5 15.0 16.3 20.5 26.0 27.1 25.6 19.6 19.1 25.5 22.9 25.0 31.1 89.3 53.4 123.6 65.7 171.3 131.1 44.8 122.3 89.7 94.4 115.1 78.5 95.4 99.5 87.4 10.8 105.7 49.3 23.3 99.4 101.8 89.3 52.4 108.5 162.0 78.1 77.9 54.6 103.7 79.2 10.1 98.7 99.7 87.7 93.8 85.3 76.8 106.8 59.6 97.6 93.5 118.7 64.7 108.2 111.4 127.7 140.4 74.3 107.1 93.0 50.8 DDX23 "prp28, PRPF28, SNRNP100, U5-100K" ENSG00000174243 "DEAD-box helicase 23" Q9BUQ8 12 48829764-48852842 "Enzymes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038680, HPA039037" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA038680: AB_10795401, HPA039037: AB_2676317" "unprognostic (1.32e-3)" "unprognostic (8.90e-2)" "unprognostic (8.92e-2)" "unprognostic (7.12e-2)" "unprognostic (5.34e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (3.03e-5)" "unprognostic (3.54e-2)" "unprognostic (5.68e-2)" "unprognostic (2.19e-2)" "unprognostic (1.69e-1)" "unprognostic (8.34e-2)" "unprognostic (5.94e-2)" "unprognostic (9.78e-2)" "unprognostic (6.88e-2)" "unprognostic (2.59e-2)" "unprognostic (1.44e-1)" 26.1 26.5 29.5 35.6 34.2 19.4 27.2 32.8 35.6 26.7 32.8 23.3 27.5 27.9 31.0 22.3 31.0 31.1 25.2 25.1 29.8 20.3 25.2 37.7 27.7 35.2 26.5 25.3 36.2 30.4 32.2 28.1 34.4 25.0 29.9 32.6 24.7 31.1 27.0 44.4 30.6 32.3 29.4 24.1 40.0 30.6 24.9 32.0 46.8 28.2 29.8 38.9 28.9 47.9 12.0 11.5 19.6 13.3 11.2 19.8 10.6 22.0 50.5 24.0 25.4 24.0 16.6 25.5 27.4 21.1 31.1 19.8 49.1 29.5 27.9 30.1 22.7 29.4 20.0 52.0 24.9 26.7 43.7 27.6 37.0 43.0 22.1 12.9 37.3 33.7 16.0 22.4 33.0 19.8 21.4 25.5 24.8 48.9 25.0 22.6 30.7 35.3 35.4 35.7 31.4 24.0 37.8 28.4 22.2 18.4 31.1 29.6 17.3 27.4 31.5 11.4 25.7 30.8 34.3 22.8 23.6 17.3 11.6 21.7 18.9 26.3 33.7 20.0 26.3 12.9 17.1 11.1 19.6 19.5 13.3 19.8 12.0 14.5 17.6 10.8 11.4 14.0 16.9 11.9 11.2 8.9 11.5 13.1 10.6 29.5 34.2 32.8 35.6 29.8 20.3 26.5 25.3 25.0 32.0 23.8 25.5 22.4 12.7 11.4 16.9 17.1 22.9 44.2 31.8 12.2 23.6 22.5 13.3 22.3 6.9 21.0 23.3 23.3 33.5 24.6 16.2 21.2 17.4 16.3 16.7 14.3 13.4 17.8 9.9 4.1 22.7 15.0 13.5 24.4 22.7 24.3 28.9 31.6 20.8 10.2 24.0 19.4 18.4 33.8 36.1 13.2 22.2 24.2 23.9 17.1 DDX24 ENSG00000089737 "DEAD-box helicase 24" Q9GZR7 14 94048291-94081245 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 103.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002554 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA002554: AB_1078631" "unprognostic (7.48e-2)" "unprognostic (3.02e-2)" "unprognostic (8.95e-2)" "unprognostic (2.12e-1)" "unprognostic (2.31e-1)" "unprognostic (4.06e-3)" "unprognostic (8.81e-2)" "unprognostic (2.66e-3)" "unprognostic (2.77e-1)" "unprognostic (2.28e-2)" "unprognostic (1.60e-3)" "unprognostic (4.13e-2)" "prognostic favorable (3.06e-9)" "prognostic unfavorable (2.89e-4)" "unprognostic (6.15e-2)" "unprognostic (1.23e-1)" "unprognostic (5.66e-2)" 18.0 45.5 19.7 13.7 41.3 53.3 18.5 31.4 40.8 17.4 20.9 21.9 14.3 13.6 23.2 103.0 20.1 18.9 21.3 28.6 25.0 31.3 36.3 30.1 16.4 27.4 22.0 29.0 21.4 12.5 8.3 32.0 11.2 38.7 16.0 14.6 17.4 15.9 17.7 28.5 23.4 12.6 17.9 21.8 18.1 15.0 38.5 17.4 14.3 25.3 11.8 25.8 21.7 14.9 4.1 3.1 10.6 3.3 6.2 5.3 5.0 3.8 1.1 7.2 4.6 4.3 5.7 1.7 10.8 9.1 14.1 12.7 1.4 2.5 17.9 4.1 2.4 4.2 2.5 7.4 0.6 15.4 7.8 0.4 9.5 2.1 5.8 3.6 13.7 4.2 0.9 4.1 2.6 2.5 4.7 2.3 3.4 4.9 5.3 6.0 10.8 4.1 11.7 4.8 1.2 0.1 5.5 16.7 2.1 10.2 1.4 5.7 5.3 10.6 2.6 5.0 1.3 4.2 4.9 6.9 4.0 2.7 5.1 3.3 2.1 13.8 19.3 5.8 7.5 3.1 10.6 3.3 2.5 5.0 2.6 1.4 2.9 2.9 3.0 2.0 4.1 5.3 5.3 2.6 6.2 2.5 3.1 3.3 5.0 19.7 41.3 31.4 40.8 25.0 31.3 22.0 29.0 38.7 17.4 157.8 151.6 175.7 121.2 162.3 169.0 198.2 58.6 192.7 154.7 139.6 123.7 76.5 230.5 124.3 63.9 107.4 65.5 116.8 86.3 59.9 133.4 81.0 147.1 96.2 75.0 219.3 93.7 105.0 83.4 46.7 214.3 119.2 94.5 181.3 57.7 131.2 82.3 69.1 230.2 135.3 189.8 161.7 156.5 383.4 396.2 127.2 131.4 217.1 54.9 94.1 DDX27 "dJ686N3.1, DRS1" ENSG00000124228 "DEAD-box helicase 27" Q96GQ7 20 49219295-49244077 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047087 Uncertain Approved Nucleoli Yes No Nucleoli "HPA047087: AB_10964059" "unprognostic (4.47e-2)" "unprognostic (2.41e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (2.82e-1)" "unprognostic (7.12e-2)" "prognostic unfavorable (6.70e-7)" "unprognostic (2.28e-1)" "unprognostic (9.53e-2)" "unprognostic (2.74e-1)" "unprognostic (7.18e-2)" "unprognostic (5.84e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.26e-1)" "unprognostic (4.32e-1)" "unprognostic (1.99e-2)" "unprognostic (1.27e-1)" 22.0 22.5 21.9 33.0 23.2 40.9 23.6 34.8 26.3 24.3 26.4 16.3 20.4 23.2 26.2 19.1 26.5 23.9 27.1 19.2 22.6 17.3 25.9 21.0 20.1 32.3 19.9 18.8 37.4 27.3 25.9 25.6 23.9 21.2 22.0 22.1 14.4 22.9 24.3 32.9 27.8 33.6 20.0 20.7 34.1 22.9 25.0 24.0 30.6 23.5 19.4 35.3 24.0 27.2 30.4 28.0 22.2 24.2 18.2 26.7 18.6 20.2 19.3 9.9 7.6 11.0 10.2 28.2 13.5 11.1 42.6 19.8 62.7 22.7 24.1 25.2 10.9 37.0 28.8 22.0 21.6 31.7 8.5 12.9 18.3 16.2 30.4 16.2 23.1 21.5 10.8 25.4 24.8 19.1 9.7 7.0 19.0 24.9 13.4 13.8 13.6 24.3 30.6 18.7 24.8 25.1 21.0 24.6 22.2 15.4 15.7 12.9 15.3 37.6 54.4 22.6 14.3 28.8 26.9 8.8 27.4 24.1 22.9 28.0 15.3 16.5 31.6 17.5 18.5 17.6 11.1 19.8 22.2 21.7 21.2 22.8 29.4 20.6 19.7 23.3 30.4 26.7 20.3 8.1 18.2 24.2 28.0 26.3 18.6 21.9 23.2 34.8 26.3 22.6 17.3 19.9 18.8 21.2 24.0 26.8 43.1 49.7 41.1 31.7 24.0 22.7 20.4 40.2 45.5 31.4 13.7 49.9 16.6 46.3 131.4 24.2 38.6 0.0 38.0 41.7 28.8 24.4 110.8 20.3 29.9 27.0 29.7 12.3 16.4 107.1 36.8 41.8 18.6 43.3 30.5 32.3 46.2 37.4 31.8 34.2 27.6 25.8 29.7 67.4 60.0 28.1 62.4 50.1 43.2 37.1 DDX28 "FLJ11282, MDDX28" ENSG00000182810 "DEAD-box helicase 28" Q9NUL7 16 68021274-68023442 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Syncytiotrophoblasts: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041911, HPA053585" Approved Supported Nucleoli,Mitochondria,Cytosol No No "Mitochondria, Cytosol" Nucleoli "HPA041911: AB_10794161, HPA053585: AB_2682200" "unprognostic (8.11e-2)" "unprognostic (1.18e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-2)" "unprognostic (8.46e-2)" "unprognostic (9.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.63e-2)" "unprognostic (8.14e-3)" "unprognostic (8.53e-2)" "prognostic favorable (2.07e-10)" "unprognostic (1.58e-2)" "unprognostic (6.21e-2)" "unprognostic (2.23e-1)" "unprognostic (2.47e-1)" 9.8 12.7 6.2 6.7 8.3 19.7 7.1 6.0 12.9 8.3 7.2 6.4 6.8 5.2 7.5 7.3 9.7 7.1 7.0 9.2 5.2 5.9 8.9 12.4 5.8 18.4 6.4 5.1 8.6 13.3 6.8 4.6 17.1 6.6 6.1 6.0 7.8 6.3 5.2 16.2 9.9 7.9 5.3 3.0 11.1 7.0 11.5 2.7 14.6 10.2 7.3 10.6 8.0 4.8 17.8 18.0 22.9 19.1 17.0 22.9 16.6 6.1 9.2 4.5 5.4 6.3 3.5 10.6 4.2 6.3 10.7 7.6 8.9 9.8 23.2 6.5 5.2 5.8 11.2 6.4 10.2 6.3 3.1 10.6 8.4 4.8 9.2 8.5 13.1 9.0 6.9 11.2 8.8 8.1 3.7 5.9 15.7 14.9 3.6 4.7 13.8 13.7 18.5 11.1 6.3 6.8 13.5 4.2 24.8 7.5 7.2 9.5 6.4 17.2 4.9 9.3 5.4 9.5 14.4 4.2 4.7 4.0 6.7 6.9 8.2 9.9 22.3 5.8 10.1 6.4 17.7 19.1 22.9 15.7 18.8 17.3 12.6 14.6 16.9 18.0 17.8 22.9 16.9 6.3 17.0 18.5 9.0 13.8 16.6 6.2 8.3 6.0 12.9 5.2 5.9 6.4 5.1 6.6 2.7 6.0 5.0 7.5 13.5 8.1 4.8 3.1 2.5 2.7 5.7 3.5 0.0 24.0 11.6 9.5 5.9 6.0 1.7 0.0 8.5 9.4 4.2 3.1 3.5 9.7 15.4 3.2 4.6 4.3 10.3 3.1 4.6 6.6 6.8 11.8 2.8 7.2 7.2 4.5 3.2 14.6 3.4 12.9 4.1 20.6 15.1 9.4 83.5 10.1 5.8 10.3 DDX31 "FLJ13633, FLJ14578, FLJ23349, PPP1R25" ENSG00000125485 "DEAD-box helicase 31" Q9H8H2 9 132592997-132670401 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020891 Supported "Nucleoli,Golgi apparatus,Vesicles" NA NA Nucleoli "Golgi apparatus, Vesicles" "HPA020891: " "unprognostic (5.71e-2)" "unprognostic (1.76e-2)" "unprognostic (2.56e-1)" "unprognostic (7.91e-2)" "unprognostic (5.79e-2)" "unprognostic (9.94e-2)" "prognostic unfavorable (1.68e-7)" "unprognostic (1.34e-1)" "unprognostic (2.02e-2)" "unprognostic (1.66e-1)" "unprognostic (3.90e-2)" "unprognostic (9.57e-3)" "unprognostic (4.57e-3)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.03e-1)" 6.8 6.9 8.2 15.3 11.2 6.0 12.3 18.4 8.5 7.5 6.6 9.4 12.6 5.0 8.9 8.8 9.8 8.8 7.5 5.4 6.3 6.3 8.4 9.2 12.0 15.1 9.1 5.7 16.9 17.3 10.0 8.8 5.8 9.8 9.2 8.0 7.4 12.7 12.6 12.9 14.0 7.2 12.7 12.9 8.7 6.8 15.2 8.3 6.8 22.7 10.8 13.8 7.2 12.6 5.0 4.5 1.9 2.7 3.1 6.9 3.0 7.0 13.2 6.4 8.8 7.9 7.1 12.6 7.6 7.5 12.0 9.2 14.6 14.6 17.7 6.9 7.1 12.5 19.8 20.2 8.9 9.7 10.8 7.5 9.6 11.7 7.6 9.5 17.0 7.8 6.3 12.2 12.3 17.3 4.6 7.8 13.2 17.6 6.9 9.9 15.2 11.8 9.3 15.9 21.0 13.5 12.5 11.4 20.3 10.9 6.8 11.6 8.3 13.9 12.4 10.5 7.8 25.9 5.0 6.6 20.4 9.2 11.5 11.7 3.4 10.7 13.8 7.3 10.8 15.3 0.0 1.9 1.9 5.7 2.7 4.7 4.2 5.5 4.4 4.5 5.0 6.9 5.1 0.3 3.1 1.9 2.8 3.6 3.0 8.2 11.2 18.4 8.5 6.3 6.3 9.1 5.7 9.8 8.3 6.0 5.9 3.4 3.1 4.9 3.4 3.1 0.0 6.7 15.9 7.0 3.9 4.6 1.7 4.1 2.1 3.9 0.7 0.0 4.6 5.8 2.6 4.1 1.1 3.2 4.6 1.6 23.6 3.1 2.4 2.4 16.7 2.8 1.7 4.6 3.7 1.5 4.7 0.0 12.4 4.3 3.1 0.0 2.1 11.2 15.7 5.5 2.5 4.1 5.7 2.6 DDX41 "ABS, MGC8828" ENSG00000183258 "DEAD-box helicase 41" Q9UJV9 5 177511577-177517469 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017911, HPA048803" Supported Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA017911: AB_1847558, HPA048803: AB_2680527" "unprognostic (2.52e-1)" "unprognostic (1.51e-1)" "unprognostic (7.57e-2)" "unprognostic (1.02e-1)" "unprognostic (2.34e-1)" "unprognostic (2.61e-2)" "unprognostic (4.21e-3)" "unprognostic (2.60e-2)" "unprognostic (1.92e-1)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" "unprognostic (4.47e-2)" "prognostic unfavorable (2.21e-6)" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (1.75e-1)" 17.9 22.7 27.0 25.1 30.7 17.2 16.5 22.8 39.2 19.1 21.2 16.9 18.5 25.5 19.5 16.5 23.0 22.1 17.1 15.3 29.3 20.1 23.7 29.3 16.8 19.9 22.1 24.8 21.2 18.0 22.2 15.1 22.1 27.4 16.3 15.4 19.0 19.0 17.5 36.6 21.7 26.8 16.7 14.8 21.9 19.7 16.8 15.4 24.9 22.9 18.2 23.5 19.6 18.4 15.9 22.5 16.4 22.8 18.6 20.6 18.0 21.2 24.3 13.3 15.7 13.7 16.3 44.9 19.1 11.6 14.1 10.4 39.6 19.8 23.9 29.1 18.0 24.7 17.4 17.4 43.7 9.6 57.0 21.8 30.3 24.7 23.5 18.2 31.3 32.2 15.9 15.4 13.3 17.9 12.0 17.9 23.9 26.2 17.0 16.5 45.8 26.1 15.4 23.5 19.9 19.7 28.4 16.2 28.1 15.7 24.8 15.8 17.3 20.3 27.0 22.8 8.1 18.9 45.8 19.1 25.7 15.2 16.4 29.7 20.5 24.0 40.7 28.2 34.6 16.9 10.6 22.8 16.4 16.1 21.5 20.6 15.9 16.0 15.3 22.5 14.1 14.8 15.5 7.7 18.6 21.4 10.2 15.6 18.0 27.0 30.7 22.8 39.2 29.3 20.1 22.1 24.8 27.4 15.4 23.8 19.1 26.4 18.3 18.7 17.4 7.1 25.5 14.7 15.9 8.7 2.0 40.7 34.9 39.1 8.4 20.3 22.6 23.3 34.4 49.6 19.5 16.0 28.9 16.3 43.7 7.9 10.9 12.3 22.2 16.2 13.8 21.8 11.8 41.5 23.7 15.8 29.9 20.1 19.8 28.9 9.4 12.9 20.6 24.2 23.2 17.8 31.4 22.3 26.3 16.3 DDX47 "DKFZp564O176, FLJ30012, HQ0256, RRP3" ENSG00000213782 "DEAD-box helicase 47" Q9H0S4 12 12813316-12829981 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 21.7;Exocrine glandular cells: 15.4;monocytes: 16.2;Pancreatic endocrine cells: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014855 Approved Supported Nucleoli NA NA Nucleoli "HPA014855: AB_1847567" "unprognostic (3.14e-2)" "unprognostic (1.21e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-2)" "unprognostic (2.38e-1)" "unprognostic (4.91e-2)" "unprognostic (5.84e-4)" "unprognostic (1.96e-1)" "unprognostic (1.11e-2)" "unprognostic (1.13e-3)" "unprognostic (2.79e-1)" "unprognostic (3.49e-3)" "unprognostic (6.55e-9)" "unprognostic (1.68e-1)" "unprognostic (1.27e-1)" "unprognostic (3.24e-1)" "unprognostic (8.20e-6)" 29.3 24.1 19.9 21.6 25.6 31.0 29.1 27.4 26.9 26.7 26.2 28.2 21.4 16.0 33.7 21.0 28.9 27.5 17.9 22.6 20.0 19.4 29.6 38.1 23.2 26.1 28.2 19.9 33.7 31.0 25.8 23.8 27.6 25.1 29.2 24.2 25.5 27.1 27.7 40.6 28.1 20.4 34.1 21.4 25.6 28.0 26.8 29.8 29.7 39.4 27.9 33.7 35.7 26.7 22.0 25.0 3.5 19.1 16.6 26.0 14.0 39.7 17.2 16.9 13.7 16.7 16.4 28.9 17.1 19.7 36.6 34.3 26.0 25.7 20.5 6.7 23.2 22.7 26.0 24.2 19.7 41.3 28.9 17.4 18.7 12.8 14.8 14.2 21.3 12.1 15.8 18.8 21.7 18.0 28.8 28.1 16.2 18.1 4.6 20.0 14.2 17.2 14.8 74.3 18.5 10.6 19.2 32.9 12.4 22.3 28.7 7.4 18.8 20.8 13.4 17.0 43.8 5.4 16.1 12.6 14.8 35.9 9.5 25.7 6.5 11.8 37.1 15.7 11.2 17.0 3.3 14.4 3.5 21.8 19.1 26.0 22.0 19.4 20.1 25.0 21.2 25.8 24.2 1.7 16.6 18.2 14.7 18.7 14.0 19.9 25.6 27.4 26.9 20.0 19.4 28.2 19.9 25.1 29.8 3.0 8.0 0.9 2.5 1.9 0.8 0.1 0.0 10.7 13.6 0.0 0.0 1.3 1.7 21.7 0.1 1.6 2.0 0.0 15.4 1.6 1.0 1.6 11.5 0.8 0.7 0.0 4.6 1.3 0.6 0.0 0.6 1.3 0.0 16.2 4.5 1.4 18.4 2.9 0.4 0.6 1.3 6.5 0.5 0.2 0.6 1.6 1.1 5.0 6.2 2.0 DDX5 "G17P1, HLR1, p68" ENSG00000108654 "DEAD-box helicase 5" P17844 17 64499616-64508199 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005868, HPA020043, HPA071154" Supported Supported Nucleoplasm,Nucleoli No No 150000 "Nucleoplasm, Nucleoli" "CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: " "unprognostic (6.64e-2)" "unprognostic (6.98e-2)" "prognostic favorable (2.12e-4)" "unprognostic (8.94e-2)" "unprognostic (5.08e-2)" "unprognostic (9.85e-2)" "unprognostic (5.80e-2)" "unprognostic (1.61e-2)" "unprognostic (3.17e-2)" "unprognostic (4.71e-2)" "unprognostic (3.03e-3)" "unprognostic (1.44e-1)" "unprognostic (4.00e-1)" "unprognostic (2.08e-1)" "unprognostic (2.37e-1)" "unprognostic (2.17e-1)" "unprognostic (9.28e-3)" 91.6 61.4 46.9 80.0 68.0 108.3 94.7 61.6 58.9 81.6 81.1 53.3 104.2 27.4 106.7 94.5 64.5 96.9 101.4 53.9 48.5 30.6 53.1 68.0 84.8 70.9 62.8 44.1 74.0 49.3 88.9 110.5 56.6 73.1 59.5 55.4 50.9 62.2 103.6 77.6 59.7 54.7 113.1 71.0 67.6 69.0 39.7 57.8 82.1 81.1 77.7 69.3 91.0 63.9 46.9 59.6 66.4 66.2 40.3 60.8 109.8 55.1 20.8 63.0 39.9 58.4 55.0 40.1 54.7 70.6 67.1 67.2 22.5 33.8 80.9 31.4 71.8 47.8 32.9 67.8 62.9 75.9 28.7 48.7 52.6 15.9 17.2 42.8 66.9 56.1 61.9 54.3 61.3 47.8 37.4 71.6 69.9 41.7 69.1 51.7 32.8 139.9 19.5 36.7 50.9 64.3 87.6 66.6 56.9 41.1 26.5 44.3 74.3 53.1 51.5 66.6 56.7 48.2 37.7 50.3 40.8 45.6 43.9 56.6 38.6 76.1 142.8 43.2 32.9 48.1 66.4 62.5 66.4 53.7 56.9 60.8 46.9 42.9 51.7 59.6 46.8 44.5 43.1 37.8 40.3 66.2 37.0 50.2 109.8 46.9 68.0 61.6 58.9 48.5 30.6 62.8 44.1 73.1 57.8 497.3 661.1 481.3 1231.3 781.2 369.6 221.7 262.4 725.4 624.4 350.7 316.1 372.7 283.5 416.6 432.3 643.3 503.6 116.8 366.6 307.8 528.8 417.0 836.7 222.3 399.0 397.3 638.0 483.1 539.2 80.3 384.6 631.0 410.0 779.1 366.4 576.1 376.0 445.4 411.5 208.8 514.0 485.0 599.5 374.0 341.8 652.0 741.9 719.3 310.9 1106.4 DDX50 "GU2, GUB, MGC3199, RH-II/GuB" ENSG00000107625 "DExD-box helicase 50" Q9BQ39 10 68901278-68946847 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037388, HPA037389, HPA058196" Approved Enhanced Nucleoli NA NA Nucleoli "HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635" "unprognostic (2.05e-1)" "unprognostic (3.36e-1)" "unprognostic (9.90e-2)" "unprognostic (9.75e-2)" "unprognostic (1.29e-1)" "unprognostic (1.23e-1)" "unprognostic (1.47e-3)" "unprognostic (2.62e-1)" "unprognostic (1.97e-1)" "unprognostic (8.78e-2)" "unprognostic (4.57e-2)" "unprognostic (1.44e-1)" "unprognostic (4.22e-3)" "unprognostic (1.22e-2)" "unprognostic (2.38e-2)" "unprognostic (4.91e-2)" "unprognostic (1.02e-1)" 25.0 17.8 16.7 25.5 19.2 14.7 24.8 20.8 17.0 26.5 25.3 13.1 24.0 12.9 30.0 22.6 24.0 23.0 17.5 20.3 15.7 15.0 18.6 16.1 16.4 24.5 17.6 15.0 35.3 24.1 24.9 35.2 23.0 16.1 30.0 18.1 12.6 19.5 25.0 26.6 18.3 17.4 31.9 18.3 22.0 19.9 25.6 17.3 33.0 26.1 21.5 25.7 35.4 27.2 14.2 10.3 10.7 12.2 13.8 20.2 10.9 19.3 12.5 22.2 27.5 18.9 24.8 14.2 20.7 22.8 18.7 17.7 28.0 16.9 25.2 12.5 18.2 11.7 17.4 21.5 15.2 23.5 22.1 16.3 13.5 12.4 12.2 19.1 28.1 16.9 19.0 15.9 17.8 49.8 33.6 15.0 22.0 24.1 15.4 23.0 15.5 26.9 27.0 12.9 18.6 28.1 23.3 25.3 4.6 14.7 11.6 15.5 21.4 15.2 17.8 22.8 21.6 20.7 18.3 13.0 14.6 17.1 16.5 28.1 20.9 18.8 21.4 15.7 29.4 8.5 5.5 7.8 10.7 15.0 12.2 18.3 13.6 18.5 15.4 10.3 14.2 20.2 17.7 2.7 13.8 9.6 10.2 16.1 10.9 16.7 19.2 20.8 17.0 15.7 15.0 17.6 15.0 16.1 17.3 17.9 17.1 30.4 30.5 10.5 42.7 23.6 20.4 29.4 34.2 19.2 37.3 35.2 48.0 24.1 57.6 24.3 8.9 0.0 21.8 33.0 25.7 18.5 40.6 13.5 20.5 35.0 15.5 22.1 18.1 12.1 33.6 21.7 11.8 39.7 18.2 20.9 20.8 18.4 36.7 25.1 51.1 19.4 28.1 54.0 56.0 12.5 34.4 41.5 21.3 16.8 DDX51 ENSG00000185163 "DEAD-box helicase 51" Q8N8A6 12 132136594-132144335 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039503 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA039503: AB_10796328" "unprognostic (2.84e-3)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (8.66e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (4.88e-1)" "unprognostic (3.05e-3)" "unprognostic (5.31e-2)" "unprognostic (3.97e-2)" "unprognostic (2.48e-1)" "unprognostic (4.69e-2)" "unprognostic (3.28e-1)" "unprognostic (1.65e-3)" 10.5 8.5 12.7 12.7 17.1 17.2 10.3 23.5 18.9 8.8 8.4 11.8 10.6 7.8 11.5 12.2 8.5 12.4 10.0 8.1 11.6 9.9 9.5 7.2 8.9 11.1 10.5 16.9 19.6 14.8 10.1 9.8 7.2 11.8 9.3 7.3 8.9 10.7 12.4 13.8 18.0 8.2 10.4 10.5 10.6 9.3 6.7 12.0 9.5 9.9 7.1 10.4 9.3 8.6 2.5 2.3 2.6 2.1 1.6 2.0 1.0 6.2 10.1 4.2 5.3 4.0 3.9 8.0 4.8 2.9 7.2 3.0 6.2 3.1 10.9 4.2 2.9 1.7 6.6 10.5 7.7 3.5 2.6 10.1 12.9 5.4 2.0 4.9 9.0 7.5 3.4 5.7 4.0 3.6 8.1 3.8 12.2 9.5 3.6 2.1 6.2 11.0 18.5 7.4 5.3 17.4 13.1 5.8 12.1 4.9 5.0 10.3 5.4 5.3 7.5 5.3 3.7 6.6 8.3 6.7 2.7 8.3 6.6 11.1 10.2 5.9 12.8 5.6 6.9 6.3 1.1 2.1 1.2 2.0 1.0 0.7 1.5 1.3 0.9 0.6 2.5 1.2 1.6 2.6 1.6 1.0 2.3 0.6 1.0 12.7 17.1 23.5 18.9 11.6 9.9 10.5 16.9 11.8 12.0 3.0 15.9 3.0 6.8 11.1 27.9 4.0 10.2 4.0 13.6 3.5 23.6 6.0 1.7 4.0 0.9 7.7 3.5 0.0 4.5 4.9 6.5 7.3 5.8 6.4 4.9 31.8 8.1 7.4 6.2 0.7 7.8 5.7 10.1 3.6 8.3 11.1 5.4 7.0 7.8 2.9 27.4 0.0 6.4 5.7 9.4 12.3 3.4 6.9 12.1 5.8 DDX52 ROK1 ENSG00000278053 "DExD-box helicase 52" Q9Y2R4 17 37609739-37643464 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 210.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056173 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA056173: AB_2683056" "unprognostic (1.05e-2)" "unprognostic (1.85e-1)" "prognostic favorable (9.41e-4)" "unprognostic (4.26e-2)" "unprognostic (9.96e-3)" "unprognostic (6.77e-2)" "prognostic unfavorable (2.44e-6)" "unprognostic (5.10e-2)" "unprognostic (2.94e-2)" "unprognostic (2.79e-1)" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (6.95e-2)" "unprognostic (5.58e-1)" "unprognostic (1.26e-2)" "unprognostic (1.28e-1)" 6.4 4.5 4.3 5.3 5.5 9.1 4.6 8.1 6.5 6.9 6.1 4.8 5.0 5.9 7.8 10.7 6.7 3.5 5.0 3.0 4.5 9.4 7.1 4.2 5.1 5.4 3.1 6.3 4.4 6.2 8.8 5.8 6.5 6.1 6.0 4.0 4.1 4.8 6.7 6.0 10.6 4.8 6.2 5.7 4.8 4.8 4.9 8.7 5.7 5.8 6.1 6.0 6.9 4.0 5.7 3.5 4.2 3.5 4.7 1.5 4.8 9.9 1.0 9.8 5.5 4.9 4.2 6.5 5.8 8.6 8.3 5.0 1.8 2.7 4.5 4.3 1.8 4.4 10.9 7.1 11.5 6.5 12.3 6.1 6.2 4.0 5.4 7.8 3.2 5.1 7.3 5.6 6.9 4.1 9.8 2.7 0.8 1.9 5.0 1.5 11.7 4.0 5.6 2.7 0.4 7.6 8.6 5.0 9.7 5.4 7.2 5.8 7.8 1.8 4.8 5.7 3.4 6.0 6.6 7.0 4.4 3.6 7.4 2.4 3.9 5.5 5.7 4.9 5.5 3.4 3.2 3.5 4.2 4.2 3.3 3.6 4.0 3.5 2.3 4.0 3.4 4.7 2.8 3.5 2.4 5.7 3.1 1.5 38.7 19.5 26.1 27.2 30.7 28.6 28.7 28.1 28.1 38.7 26.2 31.4 30.7 29.9 64.6 210.7 26.3 24.7 0.0 45.3 25.7 21.9 24.4 26.5 32.8 22.8 44.5 25.2 29.4 23.8 70.2 22.7 23.7 16.9 47.7 26.7 23.2 47.9 21.0 22.6 32.3 32.6 25.8 12.6 28.9 57.6 29.1 20.9 34.4 36.5 43.1 DDX53 "CAGE, CT26" ENSG00000184735 "DEAD-box helicase 53" Q86TM3 X 22999961-23003589 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 11.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 47.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.6;K-562: 6.3;RPMI-8226: 3.3;U-2197: 2.1;U-266/84: 14.1" "Low region specificity" "Detected in many" HPA003186 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003186: AB_1078637" "unprognostic (5.76e-1)" "unprognostic (1.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.4 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.0 8.8 0.0 0.0 0.0 0.0 0.0 DDX54 "APR-5, DP97, MGC2835" ENSG00000123064 "DEAD-box helicase 54" Q8TDD1 12 113157174-113185479 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028244, HPA070786" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA028244: AB_10603885, HPA070786: AB_2686311" "unprognostic (1.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (8.54e-2)" "unprognostic (8.57e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.39e-4)" "unprognostic (2.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.83e-2)" "unprognostic (1.15e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" 17.2 17.6 9.2 20.7 12.8 25.4 17.2 9.9 13.6 17.9 16.4 12.4 18.1 20.3 18.0 19.4 19.5 17.2 17.9 20.1 8.8 7.9 22.3 28.6 14.0 19.9 8.1 9.4 22.4 27.0 18.3 7.4 22.6 10.0 16.6 9.0 13.4 17.4 13.9 45.4 18.7 19.4 14.8 8.1 22.2 16.1 11.4 8.6 26.6 23.1 21.6 22.2 16.7 17.5 12.1 13.3 8.0 15.2 11.9 13.0 10.0 26.8 28.1 10.5 19.3 7.0 8.5 27.1 14.6 13.6 20.0 11.0 28.9 13.1 34.9 17.2 12.2 14.9 20.0 18.6 19.0 7.6 20.0 22.8 20.9 15.1 19.7 12.4 34.9 24.8 13.9 15.1 19.3 11.9 16.4 16.3 21.2 30.3 12.5 10.2 24.8 30.0 49.8 24.5 18.9 20.0 22.3 15.5 35.6 10.9 28.1 13.6 12.4 20.7 31.8 13.2 9.0 27.3 27.3 12.1 17.0 19.0 20.1 30.4 18.3 20.8 39.2 15.0 19.5 17.8 8.0 10.0 2.3 12.4 15.2 13.0 11.6 11.4 12.2 13.3 12.1 11.8 12.5 0.6 11.9 9.8 10.0 9.4 10.0 9.2 12.8 9.9 13.6 8.8 7.9 8.1 9.4 10.0 8.6 29.8 28.0 32.1 27.0 15.3 20.2 12.4 20.4 10.7 21.6 12.2 2.0 51.4 21.6 35.0 0.9 19.7 30.2 23.3 43.1 46.0 18.7 23.5 24.3 35.5 34.5 25.4 27.1 15.4 31.7 2.1 27.3 23.0 11.8 23.4 28.6 23.8 38.0 38.2 22.6 34.9 18.1 6.5 18.9 15.4 18.9 17.1 60.5 37.3 38.2 32.3 DDX55 KIAA1595 ENSG00000111364 "DEAD-box helicase 55" Q8NHQ9 12 123602077-123620941 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039962, HPA044101" Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA039962: AB_2676774, HPA044101: AB_2678810" "unprognostic (1.14e-1)" "unprognostic (2.30e-2)" "unprognostic (2.29e-1)" "unprognostic (3.71e-3)" "unprognostic (1.92e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (2.11e-9)" "unprognostic (1.60e-1)" "unprognostic (4.49e-2)" "unprognostic (7.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.67e-3)" "prognostic unfavorable (8.97e-12)" "unprognostic (9.15e-3)" "unprognostic (2.94e-1)" "unprognostic (3.47e-2)" "unprognostic (1.23e-3)" 15.0 13.5 12.3 16.4 14.0 27.7 16.3 21.4 13.9 13.0 13.2 15.7 16.2 12.0 14.7 13.2 14.2 15.0 11.8 8.8 11.4 10.9 10.2 17.8 11.2 19.9 15.6 10.3 17.5 25.9 13.8 20.3 12.3 14.4 14.4 14.5 11.9 15.2 12.6 12.6 21.4 12.9 11.9 10.5 18.8 11.6 11.2 14.8 16.9 12.2 12.5 16.5 11.9 23.1 13.4 12.8 7.3 10.0 12.2 15.7 8.5 10.1 14.5 11.1 11.2 9.6 7.6 16.8 12.6 4.6 11.3 7.8 16.4 7.5 15.1 10.1 5.5 10.2 12.6 16.9 9.4 13.2 11.3 15.3 20.4 16.0 12.1 7.3 25.0 16.1 6.4 10.0 13.4 15.5 8.8 8.1 12.3 20.8 8.0 7.9 10.5 24.5 34.1 17.2 11.8 14.4 18.5 11.9 9.8 7.9 17.7 13.2 11.0 10.3 13.4 17.2 9.7 23.8 16.2 8.3 9.8 12.9 15.9 15.6 14.8 18.3 27.4 9.3 18.0 16.6 2.8 9.2 7.3 12.0 10.0 12.7 13.4 11.6 12.5 7.5 11.3 15.7 14.7 5.6 12.2 5.9 12.8 9.1 8.5 12.3 14.0 21.4 13.9 11.4 10.9 15.6 10.3 14.4 14.8 20.8 11.5 9.0 8.3 9.7 18.5 2.2 7.6 13.4 10.3 7.0 21.6 11.2 6.6 9.6 42.5 10.5 5.1 46.7 10.4 13.9 10.1 8.4 24.3 8.5 12.6 14.3 6.9 6.2 6.6 50.7 15.8 7.9 6.8 4.6 10.5 15.6 11.6 7.0 13.8 5.4 25.4 6.5 8.5 17.9 19.6 14.8 6.4 10.2 8.3 7.8 DDX56 NOH61 ENSG00000136271 "DEAD-box helicase 56" Q9NY93 7 44565417-44575051 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019749, CAB037320" Uncertain Supported "Nucleoli,Mitotic chromosome" NA NA Nucleoli "Mitotic chromosome" "CAB037320: , HPA019749: AB_1847579" "unprognostic (3.28e-1)" "unprognostic (1.05e-1)" "unprognostic (5.00e-2)" "unprognostic (1.93e-1)" "unprognostic (6.08e-3)" "unprognostic (2.12e-3)" "prognostic unfavorable (1.38e-5)" "unprognostic (5.17e-2)" "unprognostic (2.76e-1)" "unprognostic (7.07e-2)" "unprognostic (1.00e-2)" "unprognostic (6.01e-3)" "prognostic unfavorable (8.41e-7)" "unprognostic (2.60e-1)" "unprognostic (2.88e-2)" "unprognostic (1.50e-1)" "unprognostic (4.90e-2)" 12.8 12.0 10.3 12.4 11.9 12.4 9.2 13.6 18.9 11.9 10.0 12.2 8.6 11.9 12.8 10.3 13.1 12.6 12.5 9.3 10.6 9.9 17.7 29.2 8.9 13.2 10.4 9.3 15.0 22.5 13.1 11.9 12.3 12.2 14.1 9.0 11.0 16.9 11.5 16.9 16.3 11.4 8.4 8.8 12.1 10.6 14.6 10.9 14.5 13.8 16.7 15.1 9.2 10.3 12.8 16.0 6.9 16.5 15.7 12.3 12.7 7.6 20.5 1.6 4.4 2.0 2.0 6.8 7.3 3.7 8.3 7.3 13.2 7.6 13.5 9.5 2.7 11.4 13.1 3.3 7.3 1.5 5.0 20.8 8.9 13.0 10.1 3.6 9.3 5.0 2.9 5.3 7.4 4.6 1.5 4.2 5.0 18.3 3.8 5.3 10.1 4.7 8.6 11.1 6.6 19.3 3.8 7.2 5.3 4.7 8.2 5.2 8.4 9.6 15.0 5.5 1.3 10.9 9.6 8.9 6.8 9.9 4.6 18.3 12.4 19.0 19.4 7.5 11.4 9.5 6.9 11.8 4.3 9.9 15.3 12.3 11.5 10.7 11.1 16.0 12.8 12.3 10.3 0.4 15.7 16.5 7.7 10.1 12.7 10.3 11.9 13.6 18.9 10.6 9.9 10.4 9.3 12.2 10.9 14.9 25.3 16.0 20.1 15.1 25.2 10.8 12.7 24.1 34.2 21.0 13.7 48.6 23.2 34.9 39.1 23.8 26.9 0.0 28.4 38.8 18.4 15.9 27.7 27.7 31.4 6.4 17.7 18.4 10.1 30.0 19.5 17.4 13.5 32.5 19.6 20.6 31.1 20.1 18.7 40.8 23.2 12.9 20.6 30.2 29.0 17.3 39.5 18.7 27.0 18.1 DEGS2 "C14orf66, DES2, FADS8" ENSG00000168350 "Delta 4-desaturase, sphingolipid 2" Q6QHC5 14 100143957-100160163 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.5;skin 1: 30.6" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 77.6;Collecting duct cells: 78.5;Intestinal endocrine cells: 53.2;Undifferentiated cells: 46.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 22.9" "Cell type enhanced" "Detected in many" "memory B-cell: 11.9" "Group enriched" "Detected in many" 5 "B-cells: 11.9;granulocytes: 6.4" "Group enriched" "Detected in some" 16 "OE19: 29.1;T-47d: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA046644 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA046644: AB_2797231" "unprognostic (8.18e-2)" "unprognostic (3.83e-3)" "unprognostic (2.33e-1)" "unprognostic (1.32e-2)" "unprognostic (3.55e-1)" "unprognostic (4.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "prognostic favorable (7.94e-7)" "unprognostic (1.03e-3)" "unprognostic (1.26e-1)" "unprognostic (1.14e-1)" "prognostic favorable (1.66e-4)" 0.4 0.3 2.0 2.3 4.6 0.5 5.8 22.9 6.4 5.3 20.2 1.8 0.6 20.8 3.4 4.6 20.9 1.9 13.3 0.3 2.0 1.5 8.7 17.2 2.6 0.8 2.4 1.4 0.8 13.0 0.3 1.6 0.6 2.7 2.5 4.2 0.8 4.5 2.3 0.5 30.6 44.5 0.7 1.9 0.5 17.9 0.7 0.7 0.0 2.4 7.3 11.1 7.1 5.2 11.9 0.7 6.4 0.5 0.2 1.8 0.8 0.0 0.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.7 0.1 0.1 0.0 29.1 0.0 0.1 0.0 1.5 0.0 0.7 2.2 0.0 0.0 1.3 0.0 0.0 45.3 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.7 0.5 6.4 1.8 0.0 0.0 11.9 0.1 0.8 0.7 5.9 0.0 1.2 0.2 0.2 0.0 0.1 0.0 0.8 2.0 4.6 22.9 6.4 2.0 1.5 2.4 1.4 2.7 0.7 3.0 5.3 0.0 2.8 1.5 4.4 0.4 38.2 77.6 11.4 78.5 0.0 5.9 1.7 13.4 1.0 0.9 31.3 0.0 1.3 1.5 0.3 1.1 9.2 0.2 1.6 0.0 53.2 0.6 1.9 1.5 0.3 1.0 0.0 0.0 43.3 1.2 2.8 43.8 0.0 0.1 24.4 0.0 0.2 0.9 1.9 13.4 31.2 1.3 46.7 17.4 DENND5B MGC24039 ENSG00000170456 "DENN domain containing 5B" Q6ZUT9 12 31382223-31591097 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 41.3;Cardiomyocytes: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 4.0;naive B-cell: 4.1;plasmacytoid DC: 2.2" "Group enriched" "Detected in many" 5 "B-cells: 4.1;dendritic cells: 2.2" "Cell line enhanced" "Detected in many" "SuSa: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038865 Approved Approved Nucleoli,Microtubules NA NA Microtubules Nucleoli "HPA038865: AB_2676245" "unprognostic (5.41e-2)" "unprognostic (2.23e-2)" "unprognostic (4.13e-1)" "unprognostic (1.08e-1)" "unprognostic (1.24e-1)" "unprognostic (1.99e-1)" "unprognostic (3.08e-2)" "unprognostic (7.23e-2)" "unprognostic (2.13e-1)" "unprognostic (1.16e-2)" "unprognostic (4.96e-2)" "unprognostic (3.14e-1)" "unprognostic (8.27e-2)" "unprognostic (5.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.26e-1)" "unprognostic (2.60e-2)" 6.0 9.5 9.9 9.3 16.6 3.1 5.9 24.5 17.8 6.5 8.1 7.9 2.7 12.4 9.7 3.4 3.9 6.0 6.2 14.4 9.3 12.4 10.7 17.0 4.6 9.3 8.7 10.9 30.5 7.9 6.0 12.8 6.9 16.0 4.7 6.3 7.7 3.2 5.0 10.9 2.8 14.6 10.2 6.4 8.9 6.8 20.3 8.4 0.4 4.6 3.2 11.1 6.6 7.3 4.1 2.2 0.6 0.3 0.4 0.2 0.2 1.5 15.2 11.2 4.3 4.1 5.1 1.7 3.7 4.1 9.5 6.9 10.2 6.1 5.6 6.2 8.0 10.4 0.4 2.2 1.0 9.5 0.0 4.7 0.1 12.0 6.1 3.8 5.1 0.1 3.1 3.3 6.3 10.5 8.7 8.7 3.2 2.1 11.5 5.9 1.4 3.0 5.3 11.4 3.5 2.7 2.9 15.5 0.1 8.0 2.0 3.6 5.4 9.3 1.0 8.1 33.8 1.6 2.8 9.0 3.6 9.1 6.4 7.8 6.1 6.8 5.7 6.1 0.6 6.0 0.3 0.3 0.3 0.2 0.1 0.1 4.0 0.1 0.1 0.6 4.1 0.1 0.1 0.6 0.4 0.2 2.2 0.0 0.2 9.9 16.6 24.5 17.8 9.3 12.4 8.7 10.9 16.0 8.4 3.0 0.3 20.1 2.6 2.6 41.3 39.9 20.4 2.7 3.4 7.0 29.5 0.5 3.3 1.4 15.1 5.8 9.9 0.0 8.0 2.5 8.9 2.1 0.0 29.2 3.6 27.0 8.1 23.4 4.3 6.4 7.8 2.5 21.9 3.6 2.3 12.5 6.9 3.4 9.9 11.1 23.4 6.5 8.0 29.0 14.3 1.3 0.6 0.5 2.3 0.9 DEPDC7 ENSG00000121690 "DEP domain containing 7" Q96QD5 11 33015864-33033582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 51.8;liver: 42.2" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 30.9;Early spermatids: 98.0;Extravillous trophoblasts: 40.1;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 27.2;RH-30: 20.6;SiHa: 18.8;U-2197: 17.5" "Low region specificity" "Detected in many" HPA015800 Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoli "Nucleoplasm, Cytosol" "HPA015800: AB_1847610" "unprognostic (2.34e-1)" "unprognostic (5.57e-2)" "unprognostic (1.27e-1)" "unprognostic (2.27e-1)" "unprognostic (2.66e-2)" "unprognostic (7.26e-2)" "prognostic favorable (7.26e-4)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.17e-3)" "unprognostic (8.99e-2)" "unprognostic (1.89e-2)" "unprognostic (9.30e-2)" "unprognostic (8.09e-3)" "unprognostic (2.64e-1)" "unprognostic (2.94e-2)" 0.6 0.5 2.0 1.4 4.1 0.9 2.0 0.5 2.6 1.7 15.3 4.3 1.2 14.1 1.2 1.4 3.1 0.8 3.1 0.9 2.6 1.4 10.9 42.2 0.7 0.4 4.0 1.5 1.3 2.7 3.5 0.8 1.2 2.8 1.4 3.1 1.2 1.7 1.0 3.3 3.4 51.8 1.0 3.2 0.5 2.2 15.6 3.3 1.8 0.6 2.0 0.9 0.9 2.4 0.0 4.4 9.0 0.7 3.0 3.1 0.6 4.5 2.5 3.7 1.6 2.0 1.9 2.5 8.2 2.7 5.0 6.8 6.7 0.4 0.0 1.9 8.1 2.3 4.7 5.4 1.9 6.0 0.0 7.5 1.3 7.9 9.4 1.6 4.4 5.6 2.4 2.9 2.9 2.1 2.7 0.0 0.0 3.0 0.0 27.2 0.5 0.0 7.1 2.4 3.8 0.0 0.0 20.6 0.0 1.6 0.6 0.8 2.1 18.8 3.3 16.3 2.7 0.8 2.3 0.0 3.2 5.4 17.5 5.2 0.0 0.0 0.0 1.2 0.0 15.9 4.0 0.7 9.0 0.3 0.2 0.0 0.0 0.6 0.3 4.4 0.0 2.9 3.1 0.0 3.0 0.0 1.8 0.0 0.6 2.0 4.1 0.5 2.6 2.6 1.4 4.0 1.5 2.8 3.3 0.0 0.0 0.0 8.3 30.9 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.3 3.3 0.4 98.0 0.1 8.6 0.0 0.5 40.1 1.6 0.8 2.3 19.4 2.7 0.0 3.4 2.5 0.3 6.3 1.4 2.4 1.7 1.8 1.0 0.0 1.0 0.0 1.1 11.2 0.0 0.0 1.4 27.7 7.6 6.5 1.3 0.0 2.1 0.7 DFFB "CAD, CPAN, DFF-40, DFF40" ENSG00000169598 "DNA fragmentation factor subunit beta" O76075 1 3857267-3885429 "Predicted intracellular proteins" Apoptosis "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 43.2;Extravillous trophoblasts: 23.7;Horizontal cells: 14.3;Rod photoreceptor cells: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004328, HPA052904" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "CAB004328: AB_626776, HPA052904: AB_2681985" "unprognostic (2.98e-1)" "unprognostic (5.09e-2)" "unprognostic (4.37e-2)" "unprognostic (1.52e-3)" "unprognostic (6.12e-2)" "unprognostic (1.83e-2)" "unprognostic (1.38e-2)" "unprognostic (1.28e-3)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (7.82e-3)" "unprognostic (4.07e-1)" "unprognostic (1.90e-2)" "unprognostic (9.86e-3)" "unprognostic (3.39e-1)" "unprognostic (2.27e-1)" "prognostic favorable (6.29e-5)" 4.7 4.1 6.0 5.0 7.8 3.8 4.0 13.2 7.8 3.8 4.3 4.2 2.0 12.5 5.9 1.5 3.1 4.9 4.2 4.1 4.1 1.8 2.9 2.0 3.5 2.9 5.4 4.1 6.7 9.3 1.3 8.7 4.8 2.9 3.0 1.6 4.3 3.3 3.3 1.9 2.3 5.6 2.6 3.0 5.6 4.1 1.7 6.3 2.8 3.2 1.0 5.6 4.7 3.4 3.1 6.3 6.9 8.2 2.7 6.4 3.7 3.1 2.9 1.4 4.0 0.9 1.0 0.9 2.7 0.9 3.0 2.9 1.7 1.3 1.2 1.8 0.6 0.3 0.9 0.4 1.7 0.2 7.3 7.5 11.0 1.2 1.6 2.6 6.0 8.6 0.5 0.3 2.7 0.1 0.8 3.3 4.9 6.1 1.3 0.7 0.9 6.6 3.6 2.2 1.1 6.3 5.5 2.3 2.4 0.6 0.4 2.9 5.0 2.0 3.0 8.3 0.0 0.7 3.6 5.0 1.2 1.0 5.8 2.4 2.4 3.6 3.4 1.4 9.4 1.7 5.3 5.5 6.9 4.7 5.1 2.9 3.1 3.0 3.8 6.3 1.2 2.8 4.5 1.7 2.7 8.2 0.1 6.4 3.7 6.0 7.8 13.2 7.8 4.1 1.8 5.4 4.1 2.9 6.3 3.0 5.8 0.0 1.0 0.6 4.4 0.8 2.5 1.4 2.3 1.8 43.2 3.0 1.7 1.9 0.8 2.1 2.0 0.0 1.4 23.7 2.1 0.7 0.0 1.6 2.5 14.3 2.4 3.1 5.3 1.1 1.1 1.9 0.0 0.0 4.1 3.5 1.6 0.0 4.6 2.2 19.3 0.0 0.5 1.8 3.2 0.3 1.1 3.2 3.7 0.7 DGAT1 "ARGP1, DGAT" ENSG00000185000 "Diacylglycerol O-acyltransferase 1" O75907 8 144314584-144326910 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "intestine: 161.0" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 291.1;Paneth cells: 112.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 15.8;PC-3: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB032853 Enhanced Approved "Nucleoli,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoli "CAB032853: AB_2090798" "unprognostic (9.24e-3)" "unprognostic (1.61e-1)" "unprognostic (1.75e-2)" "unprognostic (2.23e-1)" "unprognostic (3.49e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (5.10e-2)" "unprognostic (2.78e-2)" "unprognostic (6.88e-2)" "unprognostic (3.52e-1)" "unprognostic (2.65e-3)" "unprognostic (3.83e-2)" "unprognostic (1.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.67e-3)" 11.8 18.5 3.6 5.7 4.7 6.4 6.8 6.6 5.6 3.3 60.2 4.0 6.4 44.7 3.9 3.6 5.5 3.1 7.9 6.3 3.7 2.7 6.7 14.4 3.8 3.1 4.1 2.7 3.3 3.9 5.0 4.0 4.3 3.6 3.4 6.3 4.1 5.9 4.3 10.0 4.8 161.0 3.6 2.6 5.3 5.7 10.7 4.2 5.1 3.8 6.2 5.0 4.7 3.4 0.7 2.2 2.8 2.0 0.3 1.7 0.8 3.8 4.2 2.0 3.6 3.2 1.3 2.3 2.8 2.7 2.6 1.8 9.7 2.6 1.5 10.7 1.7 1.3 3.3 1.6 3.8 0.6 2.8 4.0 2.8 3.4 15.8 2.3 0.7 2.9 1.8 2.9 1.7 1.9 1.8 2.0 4.9 2.2 3.6 1.7 3.2 4.8 3.1 0.9 9.2 17.6 6.3 0.8 2.5 2.4 2.1 2.0 3.4 3.6 4.4 1.8 0.8 2.5 2.7 1.6 1.4 4.9 2.8 2.2 2.1 0.4 0.6 1.5 4.9 2.3 0.0 2.0 2.8 1.2 1.3 1.7 0.7 0.9 1.1 2.2 0.5 0.7 0.3 2.3 0.3 1.7 1.1 0.7 0.8 3.6 4.7 6.6 5.6 3.7 2.7 4.1 2.7 3.6 4.2 14.9 21.3 6.5 9.8 7.1 24.2 17.9 15.3 4.0 7.9 17.4 27.5 10.2 1.7 6.8 13.4 13.5 291.1 0.0 10.4 8.3 7.1 8.8 6.9 49.5 16.5 17.5 22.4 10.4 25.4 16.4 6.4 15.0 5.0 1.0 70.1 18.1 11.4 112.2 6.3 6.8 21.9 0.0 10.5 25.1 15.9 8.2 13.7 8.5 84.8 18.4 DHRS3 "RDH17, retSDR1, Rsdr1, SDR1, SDR16C1" ENSG00000162496 "Dehydrogenase/reductase 3" O75911 1 12567910-12617731 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8" "Group enriched" "Detected in many" 9 "dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5" "Cell line enhanced" "Detected in many" "A549: 27.6;CAPAN-2: 56.6;hTERT-RPE1: 55.9;SK-BR-3: 30.4;WM-115: 52.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010844 Supported Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA010844: AB_1847653" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-2)" "unprognostic (1.74e-3)" "unprognostic (1.87e-1)" "unprognostic (3.68e-2)" "unprognostic (2.25e-3)" "unprognostic (5.06e-2)" "unprognostic (3.40e-2)" "unprognostic (5.18e-2)" "unprognostic (1.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.80e-1)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "prognostic favorable (2.65e-4)" "unprognostic (5.48e-2)" 22.7 4.4 6.3 6.2 8.6 2.5 30.6 4.0 7.9 16.7 16.3 3.4 9.2 13.6 7.6 15.5 19.0 12.2 11.2 16.1 6.8 8.6 12.3 45.6 11.6 8.3 9.0 4.5 11.8 20.3 0.5 8.9 11.5 9.8 16.3 5.6 20.3 11.8 14.3 10.2 5.6 18.9 11.1 9.8 4.2 12.3 5.2 4.2 3.1 40.5 5.4 5.2 21.0 9.4 0.2 8.6 2.1 0.3 13.8 33.5 15.6 4.8 27.6 0.0 12.2 16.0 1.3 3.2 1.6 0.0 0.0 0.1 3.3 56.6 0.0 1.3 16.2 4.9 22.3 6.0 3.1 0.0 0.0 9.9 4.3 2.8 15.4 2.4 0.0 0.0 8.1 3.7 0.0 0.1 55.9 5.2 0.1 6.5 0.0 0.1 0.8 1.1 0.2 1.8 5.2 11.2 0.1 0.0 5.6 0.0 9.5 0.3 0.5 9.3 30.4 1.7 3.9 2.9 1.2 3.8 0.1 0.6 8.5 0.1 0.8 0.0 0.0 6.4 0.3 52.5 2.1 0.2 0.0 33.5 0.1 24.2 0.2 18.3 15.7 8.6 0.2 31.6 19.7 1.7 13.8 0.3 1.0 0.5 15.6 6.3 8.6 4.0 7.9 6.8 8.6 9.0 4.5 9.8 4.2 89.3 49.3 3.7 141.7 22.8 0.8 31.9 38.2 58.9 55.7 19.2 17.7 22.8 19.9 81.6 86.2 36.5 70.9 23.3 142.3 39.4 26.7 66.3 15.1 157.8 60.3 0.0 24.1 62.0 40.2 235.9 21.0 19.3 6.8 17.2 30.8 13.7 112.0 49.1 9.2 39.4 2.0 0.0 30.1 1.4 1.4 23.6 22.0 22.3 29.9 124.6 DHX33 "DDX33, DKFZp762F2011, FLJ21972" ENSG00000005100 "DEAH-box helicase 33" Q9H6R0 17 5440912-5469060 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073875 Supported Supported Nucleoli NA NA Nucleoli "HPA073875: AB_2686638" "unprognostic (4.96e-2)" "unprognostic (1.35e-1)" "unprognostic (3.41e-2)" "unprognostic (2.51e-2)" "unprognostic (9.24e-2)" "unprognostic (1.90e-1)" "unprognostic (1.49e-2)" "unprognostic (6.15e-2)" "unprognostic (3.11e-2)" "unprognostic (3.80e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.03e-1)" "unprognostic (4.66e-1)" "unprognostic (3.55e-1)" "unprognostic (4.69e-2)" "unprognostic (3.37e-2)" 10.0 10.4 11.6 11.0 14.6 7.0 12.9 15.8 22.0 9.0 8.7 14.1 8.6 8.6 12.4 7.9 11.2 11.2 9.2 7.7 9.7 7.0 8.2 13.4 8.0 10.1 11.0 13.2 11.1 12.1 16.5 7.3 11.5 10.3 10.0 10.7 11.3 10.4 10.8 13.9 12.5 8.7 11.1 8.0 11.1 9.6 10.1 11.7 8.4 9.5 9.4 10.3 9.6 9.5 3.7 3.4 2.6 3.5 3.0 2.5 0.7 10.3 15.4 9.8 17.6 4.1 8.4 12.3 10.3 6.4 15.9 12.8 9.6 4.5 25.5 7.2 8.4 6.3 12.3 20.0 16.1 20.4 8.2 19.2 10.1 12.6 16.3 8.2 13.5 9.1 7.1 9.8 16.9 23.2 4.7 11.7 12.4 13.4 12.6 8.7 7.3 13.6 7.4 21.8 6.9 7.8 18.3 14.5 13.8 7.2 8.1 8.6 12.4 10.7 9.3 15.9 8.7 7.2 7.1 10.9 11.0 11.6 8.7 21.7 4.7 5.1 13.1 7.8 16.0 15.7 0.6 3.5 1.8 2.2 1.4 2.1 2.5 2.5 1.4 1.4 3.7 2.5 2.4 2.6 3.0 1.3 3.4 1.8 0.7 11.6 14.6 15.8 22.0 9.7 7.0 11.0 13.2 10.3 11.7 11.9 10.4 3.0 12.0 18.7 16.4 13.4 20.4 5.3 11.4 7.0 19.6 7.3 1.7 6.5 40.0 11.1 5.7 0.0 13.2 7.9 14.1 7.4 3.5 25.4 5.4 12.7 8.7 12.3 15.3 4.8 7.2 8.2 13.5 1.0 10.6 14.7 9.5 3.5 9.2 6.3 10.1 0.0 11.3 11.2 15.2 17.3 4.2 4.5 11.0 10.8 DHX57 DDX57 ENSG00000163214 "DExH-box helicase 57" Q6P158 2 38797729-38875934 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 120.8;Late spermatids: 273.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036160 Uncertain Approved "Nucleoli,Intermediate filaments,Microtubules,Cytosol" NA NA "Intermediate filaments, Microtubules" "Nucleoli, Cytosol" "HPA036160: AB_10670711" "unprognostic (6.78e-2)" "unprognostic (3.08e-1)" "unprognostic (3.49e-2)" "unprognostic (2.03e-3)" "unprognostic (3.25e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (3.32e-6)" "unprognostic (1.75e-2)" "unprognostic (2.74e-1)" "unprognostic (1.45e-1)" "unprognostic (7.35e-2)" "unprognostic (1.82e-2)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (3.88e-2)" "unprognostic (7.03e-3)" "unprognostic (1.77e-1)" 9.6 11.2 9.7 8.5 16.7 7.0 10.4 11.9 16.4 14.1 9.4 9.9 9.8 4.2 13.9 17.1 8.4 11.2 9.5 9.3 9.6 11.0 11.2 7.2 7.9 9.2 8.9 9.5 13.2 9.5 18.9 17.9 11.2 13.1 10.5 9.2 11.6 7.8 14.2 11.5 11.1 6.9 11.8 7.7 9.9 7.9 27.7 8.3 13.9 11.8 8.1 11.1 10.5 8.3 7.1 5.2 1.7 10.1 3.3 6.0 4.2 16.9 13.6 15.3 11.5 10.1 12.4 12.5 11.8 11.7 11.2 11.1 10.9 5.2 5.0 11.9 12.0 12.7 8.8 17.2 13.1 18.5 20.5 12.7 9.7 9.2 14.9 9.1 10.2 5.6 11.8 7.9 14.5 9.1 7.9 14.9 3.7 12.4 7.1 12.1 12.4 10.2 9.4 19.0 7.3 8.1 5.1 20.2 9.8 10.3 6.5 12.6 18.6 11.8 12.2 13.8 11.2 8.6 5.6 11.5 11.2 13.0 8.5 12.7 7.4 8.3 2.1 8.7 7.1 7.4 1.7 10.1 1.7 4.5 6.9 6.0 5.7 4.0 3.5 5.2 7.1 4.8 3.0 0.5 3.3 8.0 1.7 3.3 4.2 9.7 16.7 11.9 16.4 9.6 11.0 8.9 9.5 13.1 8.3 3.0 7.5 8.2 2.2 2.4 23.0 5.9 5.1 28.1 13.6 22.7 53.0 6.0 0.0 6.9 120.8 4.3 1.6 23.3 6.4 5.8 5.6 1.6 10.4 5.7 6.1 17.5 11.3 9.2 13.6 273.7 14.7 9.5 1.7 5.4 5.5 11.2 6.9 3.5 13.1 4.9 28.3 0.0 3.9 15.2 6.4 2.3 2.4 6.9 5.1 1.3 DHX9 "DDX9, LKP, RHA" ENSG00000135829 "DExH-box helicase 9" Q08211 1 182839369-182887751 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport" "Activator, DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011819, HPA028050, HPA055684" Supported Supported Nucleoplasm,Nucleoli NA NA 97000 Nucleoplasm Nucleoli "CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885" "unprognostic (8.14e-2)" "unprognostic (9.32e-2)" "unprognostic (1.84e-2)" "unprognostic (4.80e-2)" "unprognostic (1.58e-1)" "unprognostic (7.40e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (9.98e-2)" "prognostic unfavorable (6.04e-4)" "unprognostic (2.76e-1)" "unprognostic (2.88e-2)" "unprognostic (5.53e-2)" "unprognostic (7.51e-2)" "unprognostic (1.43e-1)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-1)" 30.2 25.9 25.7 28.5 28.6 68.9 32.9 42.5 33.1 31.9 24.5 23.3 25.2 19.8 38.2 24.2 27.7 30.6 19.7 22.9 24.4 22.6 36.2 31.4 27.8 32.0 34.2 23.1 37.5 24.9 51.8 35.8 28.5 28.0 25.7 30.1 21.1 28.2 29.4 27.6 26.6 27.0 31.6 25.3 32.8 26.5 29.4 37.4 68.3 30.1 31.6 41.2 32.4 31.9 16.8 22.9 12.0 17.4 14.7 21.9 15.0 35.7 35.0 50.3 27.6 26.3 20.4 49.7 31.7 29.1 46.1 31.3 39.1 27.6 57.4 31.0 28.4 27.6 31.0 76.3 34.3 51.7 23.3 37.9 38.2 28.7 26.4 14.8 55.3 26.2 18.1 17.3 45.2 12.3 20.9 36.0 29.5 60.0 20.6 36.9 31.4 55.9 13.6 63.7 38.5 21.6 51.0 46.9 32.8 29.8 41.6 36.3 41.6 44.9 28.4 18.5 44.2 33.3 31.3 28.1 28.6 32.0 29.0 42.9 21.7 35.4 68.1 18.0 30.4 38.8 5.6 16.0 12.0 19.2 17.4 21.9 16.8 16.8 17.6 22.9 14.6 18.4 19.9 6.5 14.7 14.3 11.1 15.4 15.0 25.7 28.6 42.5 33.1 24.4 22.6 34.2 23.1 28.0 37.4 38.7 64.9 41.5 53.0 47.7 55.9 37.2 35.7 72.3 69.4 48.8 49.1 40.4 16.6 39.6 17.1 44.9 31.7 0.0 43.7 37.7 35.9 40.6 42.8 24.3 35.2 27.0 51.6 38.1 37.7 32.0 55.8 34.4 28.7 27.1 33.8 42.7 42.4 25.9 44.2 33.5 72.8 38.8 45.7 63.0 65.2 41.3 41.4 32.4 45.7 48.7 DIAPH2 "DIA, DIA2, POF, POF2" ENSG00000147202 "Diaphanous related formin 2" O60879 X 96684663-97604997 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Oogenesis" "Developmental protein" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 117.7;Syncytiotrophoblasts: 99.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005647, CAB015461, CAB068183, CAB068184" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" Nucleoli "CAB015461: AB_831223, CAB068183: AB_2665693, CAB068184: AB_2665694, HPA005647: AB_1078657" "unprognostic (5.75e-2)" "unprognostic (4.13e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (2.16e-5)" "unprognostic (1.58e-1)" "unprognostic (6.48e-2)" "unprognostic (4.06e-1)" "unprognostic (1.07e-2)" "unprognostic (2.41e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (2.12e-4)" "unprognostic (3.39e-2)" "prognostic unfavorable (3.90e-4)" "unprognostic (6.44e-2)" "unprognostic (3.11e-2)" "unprognostic (6.99e-3)" "unprognostic (6.08e-3)" 25.3 5.7 8.2 16.5 13.6 19.9 12.0 1.6 4.6 17.8 18.5 2.9 15.1 5.5 10.7 9.1 16.3 10.4 12.6 13.0 6.6 3.0 6.1 15.7 16.8 6.9 4.1 4.4 14.2 6.6 8.7 5.5 37.2 7.1 16.0 11.4 4.7 9.4 17.2 19.9 9.3 12.0 18.5 7.3 9.8 9.9 12.3 5.1 9.4 7.5 12.0 4.9 19.8 26.9 2.7 4.3 5.7 5.8 1.4 2.8 1.0 0.0 4.0 1.9 3.9 11.1 18.5 0.0 7.0 7.4 3.8 8.0 3.3 7.6 11.3 5.6 6.0 7.2 0.0 10.4 1.1 4.9 0.3 5.9 0.0 4.9 3.6 9.3 14.6 5.2 9.3 3.7 5.0 15.8 5.1 7.3 8.5 0.0 9.4 7.0 3.2 5.5 6.0 15.4 0.0 5.9 0.0 10.5 0.0 2.1 6.0 0.0 4.0 0.0 2.0 5.6 12.5 1.7 8.0 9.1 8.1 3.7 6.7 4.5 0.1 0.0 9.5 6.8 14.9 4.7 0.0 5.8 5.7 2.3 5.4 1.8 2.7 2.4 2.8 4.3 2.4 1.6 1.5 0.6 1.4 4.5 4.1 1.3 1.0 8.2 13.6 1.6 4.6 6.6 3.0 4.1 4.4 7.1 5.1 29.8 42.7 10.6 4.8 9.6 5.7 19.0 7.6 42.8 18.2 19.2 0.0 41.5 6.6 16.9 60.0 25.2 23.6 0.0 20.1 14.6 25.5 6.7 7.0 23.1 17.8 0.0 23.6 8.0 30.6 117.7 41.7 21.4 8.5 6.4 27.6 12.5 26.4 35.1 19.1 6.1 14.0 25.8 18.6 4.9 12.2 15.9 99.0 12.5 28.1 4.8 DIMT1 "DIMT1L, HSA9761" ENSG00000086189 "DIM1 dimethyladenosine transferase 1 homolog" Q9UNQ2 5 62387254-62403939 "Enzymes, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042944 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA042944: AB_2678234" "unprognostic (1.58e-1)" "unprognostic (2.27e-1)" "unprognostic (6.02e-3)" "unprognostic (7.16e-2)" "unprognostic (8.95e-3)" "unprognostic (1.73e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (8.88e-2)" "unprognostic (1.18e-2)" "unprognostic (1.62e-1)" "unprognostic (5.31e-2)" "unprognostic (3.70e-1)" "prognostic unfavorable (8.90e-12)" "unprognostic (8.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (5.15e-2)" 16.7 14.0 18.9 16.7 17.0 10.6 18.9 11.5 23.5 18.6 11.8 12.4 11.8 11.0 16.2 11.9 20.1 14.2 15.3 19.7 19.1 17.0 11.9 16.3 11.7 22.5 18.8 8.5 17.8 28.4 8.9 13.4 16.7 12.3 18.8 9.5 10.0 16.1 18.3 17.9 12.2 11.9 24.6 20.2 22.1 10.2 10.7 9.8 16.3 19.0 19.0 19.2 21.7 13.2 7.9 7.7 5.0 5.6 7.0 13.2 6.1 14.6 8.8 16.1 21.0 11.9 15.8 16.0 18.7 7.1 14.5 15.4 14.2 15.6 30.1 17.2 13.9 15.7 11.4 10.8 11.1 18.4 21.3 18.9 20.6 11.5 11.8 14.3 16.9 15.9 13.7 9.0 14.1 13.8 14.4 12.6 19.8 20.9 13.9 14.8 14.7 24.9 26.1 15.5 6.5 18.5 16.1 16.2 41.5 13.1 13.5 18.0 15.8 16.0 15.0 16.0 12.0 12.1 15.9 13.9 10.0 10.4 14.2 25.6 18.4 19.1 27.1 15.2 30.5 14.8 5.0 3.1 2.3 7.7 5.6 11.7 7.9 10.4 9.3 5.0 6.6 13.2 11.0 0.8 7.0 4.3 7.7 9.3 6.1 18.9 17.0 11.5 14.7 19.1 17.0 18.8 8.5 12.3 9.8 3.0 7.4 18.2 65.3 45.2 5.5 27.9 22.9 13.4 21.6 14.0 9.8 38.5 18.3 24.9 5.1 26.8 3.6 0.0 19.6 38.1 27.3 43.1 12.7 10.9 28.5 0.0 4.6 16.5 16.1 3.6 26.7 17.5 27.0 21.6 11.7 6.0 17.2 2.9 19.1 22.7 4.1 6.5 49.9 12.6 21.1 33.1 29.9 25.4 15.7 57.8 DLG3 "KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102" ENSG00000082458 "Discs large MAGUK scaffold protein 3" Q92796 X 70444861-70505490 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.1;MAIT T-cell: 1.8;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.8;NK-cell: 1.7;T-reg: 2.4" "Group enriched" "Detected in many" 5 "NK-cells: 1.7;T-cells: 2.4" "Cell line enhanced" "Detected in many" "OE19: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001733, HPA078130" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA001733: AB_1078675, HPA078130: AB_2686879" "prognostic unfavorable (1.69e-4)" "unprognostic (1.87e-3)" "unprognostic (1.37e-1)" "unprognostic (2.77e-1)" "unprognostic (4.65e-2)" "unprognostic (3.44e-2)" "unprognostic (3.64e-1)" "unprognostic (1.20e-2)" "unprognostic (7.79e-2)" "unprognostic (7.92e-2)" "unprognostic (1.26e-1)" "unprognostic (5.98e-2)" "prognostic favorable (1.72e-10)" "unprognostic (3.36e-2)" "unprognostic (5.45e-2)" "unprognostic (1.51e-2)" "unprognostic (1.97e-3)" 2.7 3.3 12.5 6.5 17.6 0.7 10.8 16.4 25.2 9.2 16.0 4.3 14.7 11.7 7.6 23.7 14.5 17.4 16.3 6.0 15.2 10.0 10.8 1.4 7.8 3.1 6.5 10.2 11.2 27.1 21.2 8.9 5.5 8.0 9.6 17.1 10.2 21.0 10.4 1.1 8.4 20.8 11.3 3.4 14.6 13.8 1.9 3.5 3.2 13.8 2.6 8.0 11.2 9.9 0.4 0.0 0.0 0.0 1.7 2.4 0.3 3.4 1.6 9.9 4.2 2.6 3.1 6.9 2.0 2.3 1.1 1.1 9.8 8.1 0.0 4.8 2.0 0.8 7.5 19.2 4.5 0.7 4.0 5.8 0.0 8.8 5.3 5.0 0.1 1.3 3.2 3.0 1.4 3.2 10.2 0.4 6.6 1.8 13.8 1.1 12.1 7.8 0.0 16.7 28.0 11.6 7.3 4.9 1.4 6.7 10.6 4.7 0.3 1.6 19.2 3.7 8.6 10.1 0.0 0.7 1.3 1.3 1.2 1.5 9.1 6.8 4.3 1.9 0.0 1.9 0.0 0.0 0.0 2.1 0.0 1.8 0.4 1.7 2.4 0.0 0.0 1.1 1.8 0.0 1.7 0.0 0.0 2.4 0.3 12.5 17.6 16.4 25.2 15.2 10.0 6.5 10.2 8.0 3.5 17.9 16.1 3.2 4.8 0.7 15.6 16.7 25.5 32.1 12.5 8.7 0.0 5.5 10.0 11.9 0.0 0.3 27.4 0.0 21.3 2.0 5.0 15.9 1.1 0.0 0.6 4.8 24.6 1.8 0.3 0.0 1.4 1.3 1.7 2.8 22.3 10.3 21.5 17.3 6.0 3.7 5.8 6.5 5.1 0.4 1.7 1.8 1.4 3.8 17.2 9.0 DLK2 "EGFL9, MGC2487" ENSG00000171462 "Delta like non-canonical Notch ligand 2" Q6UY11 6 43450352-43456632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 19.3" "Cell type enriched" "Detected in some" 7 "Basal glandular cells: 79.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 16.5;HBEC3-KT: 9.0;hTCEpi: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061223, HPA068672, HPA070955" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles No No Nucleoplasm "Nucleoli, Vesicles" "HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: " "unprognostic (4.65e-5)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (9.68e-4)" "unprognostic (2.87e-1)" "unprognostic (3.80e-1)" "unprognostic (4.19e-3)" "unprognostic (1.65e-1)" "unprognostic (2.65e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.88e-1)" "unprognostic (9.27e-12)" "unprognostic (7.71e-4)" "unprognostic (8.92e-2)" "unprognostic (1.55e-1)" "unprognostic (6.43e-2)" 1.0 1.1 4.5 1.4 7.9 1.7 4.3 12.2 8.2 2.2 0.7 0.9 6.4 1.1 1.4 3.8 10.5 1.1 0.9 1.8 4.1 4.6 0.7 0.7 1.1 1.7 1.5 4.8 1.7 1.5 0.4 0.5 1.3 0.9 10.4 0.5 0.3 12.4 13.0 0.7 19.3 1.0 0.6 1.5 1.5 1.1 1.1 1.2 1.3 0.8 4.7 3.9 2.2 5.3 0.8 1.8 1.0 0.5 2.5 3.2 0.3 5.2 1.9 0.5 7.9 0.0 0.4 1.8 1.9 2.1 2.2 1.0 1.8 0.2 1.0 1.2 0.4 2.7 16.5 5.6 9.0 0.5 1.0 2.1 0.4 0.9 2.8 0.6 0.3 1.1 0.9 27.2 0.6 5.1 0.7 0.0 3.1 0.4 0.8 0.8 2.0 0.4 0.4 0.7 2.0 2.0 1.1 1.0 0.5 0.3 1.8 5.9 0.6 0.6 0.2 0.3 0.4 0.5 1.6 0.5 0.8 2.5 0.6 3.8 1.2 0.3 1.7 0.1 0.7 0.5 0.9 0.4 0.4 0.7 0.3 3.2 0.6 2.2 2.2 0.1 0.8 0.9 0.4 1.0 2.5 0.5 1.8 0.3 0.3 4.5 7.9 12.2 8.2 4.1 4.6 1.5 4.8 0.9 1.2 0.0 0.3 0.0 79.5 9.0 0.6 0.5 0.0 0.0 7.9 0.0 0.0 0.8 0.0 0.1 0.2 0.3 0.0 0.0 0.0 2.1 0.2 4.3 0.0 0.0 0.1 11.1 1.2 0.0 0.0 0.2 0.3 0.0 1.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.9 0.0 0.3 1.2 5.5 2.3 0.2 0.0 0.0 3.9 DMXL1 ENSG00000172869 "Dmx like 1" Q9Y485 5 119037772-119249138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036431, HPA036432" Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA036431: AB_10669791, HPA036432: AB_2675120" "unprognostic (2.47e-1)" "unprognostic (4.84e-2)" "unprognostic (7.87e-3)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (5.80e-3)" "unprognostic (2.80e-1)" "unprognostic (6.77e-2)" "unprognostic (1.40e-1)" "unprognostic (4.88e-2)" "unprognostic (5.93e-2)" "unprognostic (2.26e-1)" "prognostic favorable (5.16e-5)" "unprognostic (4.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.12e-2)" "unprognostic (5.18e-2)" 17.8 10.4 9.3 14.0 14.1 29.3 16.1 14.2 15.4 12.0 11.6 15.4 9.6 8.3 15.7 8.5 13.0 12.0 10.3 10.2 8.9 5.6 18.8 9.6 13.9 12.5 11.5 11.4 17.4 20.1 21.3 14.1 9.5 18.9 35.9 9.8 13.3 13.6 10.9 10.9 21.4 13.1 13.0 10.9 11.5 12.4 9.2 13.1 18.1 17.9 6.8 13.8 14.3 12.4 11.2 9.5 4.6 9.0 1.5 3.8 2.6 9.5 7.4 8.5 8.6 9.1 12.1 9.0 7.9 7.9 8.0 9.4 8.9 5.9 18.6 8.2 10.1 12.4 5.8 9.3 9.4 10.4 14.3 9.3 13.1 12.9 3.1 7.6 8.5 11.4 9.6 5.3 9.2 7.7 8.2 10.4 11.7 11.0 12.6 6.4 6.0 11.4 4.9 4.6 3.3 4.5 9.0 15.6 7.2 6.2 11.1 7.9 8.0 13.6 5.0 12.2 9.4 8.2 9.9 10.0 9.5 8.0 9.5 8.3 11.9 8.4 16.2 11.8 8.4 7.6 4.6 5.5 3.9 2.9 4.9 3.6 9.7 2.3 2.4 3.8 11.2 3.8 2.1 4.5 1.5 9.0 9.5 2.8 2.6 9.3 14.1 14.2 15.4 8.9 5.6 11.5 11.4 18.9 13.1 26.8 15.3 22.9 15.7 12.0 36.2 22.4 2.5 12.0 14.8 15.7 23.6 9.9 14.9 9.5 6.0 13.4 14.6 0.0 17.5 7.5 11.6 51.6 13.9 13.4 14.8 20.6 5.8 9.2 20.5 7.4 14.1 17.3 32.1 27.1 11.4 17.3 12.1 11.9 14.5 27.0 22.4 12.9 15.0 15.6 19.2 16.4 13.6 14.9 10.1 10.7 DNAJA2 "CPR3, DNAJ, DNJ3, HIRIP4" ENSG00000069345 "DnaJ heat shock protein family (Hsp40) member A2" O60884 16 46955362-46973788 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049789, HPA060538" Approved Approved "Nucleoli,Intermediate filaments,Cytosol" NA NA 31000 "Nucleoli, Cytosol" "Intermediate filaments" "HPA049789: AB_2680883, HPA060538: AB_2684315" "unprognostic (7.68e-3)" "unprognostic (1.05e-2)" "unprognostic (4.77e-2)" "unprognostic (3.67e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (2.81e-4)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.53e-2)" "unprognostic (5.41e-2)" "unprognostic (2.12e-1)" "prognostic favorable (1.19e-9)" "unprognostic (9.22e-2)" "unprognostic (2.28e-1)" "unprognostic (9.22e-2)" "unprognostic (4.69e-2)" 25.0 29.2 32.3 18.0 36.5 23.6 22.8 29.8 44.2 21.7 21.1 17.1 20.3 22.3 25.6 33.6 23.4 20.3 18.9 37.9 30.5 27.1 31.2 39.0 17.7 21.4 25.5 27.6 26.1 18.9 29.0 18.9 22.1 31.5 25.6 21.9 18.4 19.1 24.9 43.7 22.3 23.8 26.9 21.2 24.1 20.3 33.0 18.7 20.8 25.4 31.8 23.2 24.5 23.5 13.6 10.5 14.5 14.0 14.3 18.9 10.2 11.0 13.1 13.2 11.2 18.1 17.5 20.2 14.4 17.3 21.6 10.3 11.4 11.5 17.7 11.6 15.4 9.3 17.2 21.1 14.8 25.2 4.2 17.6 13.0 6.4 24.1 21.8 19.7 18.2 18.6 17.2 12.5 11.9 19.0 14.9 7.2 14.9 6.0 18.2 12.0 14.1 27.5 20.1 10.1 19.5 16.4 24.3 21.0 26.0 11.7 18.1 11.6 17.0 25.9 15.6 13.6 10.0 15.4 15.3 12.9 8.1 9.2 12.0 14.8 10.1 23.8 13.5 17.1 10.7 13.0 11.5 14.5 11.9 14.0 15.4 13.6 16.1 13.3 10.5 10.4 16.0 15.7 12.1 14.3 12.0 7.4 18.9 10.2 32.3 36.5 29.8 44.2 30.5 27.1 25.5 27.6 31.5 18.7 47.6 31.0 65.5 60.6 112.8 37.1 86.5 28.1 80.3 42.1 38.4 17.7 68.7 76.3 62.0 53.0 41.0 64.6 0.0 54.2 58.1 44.1 43.1 53.1 50.8 51.1 35.0 49.8 31.3 41.3 44.4 46.3 47.7 69.2 64.1 46.0 56.2 58.4 56.1 55.5 78.9 37.8 51.8 68.0 155.1 97.9 105.3 144.2 46.5 47.8 68.8 DNAJC21 "DNAJA5, GS3, JJJ1" ENSG00000168724 "DnaJ heat shock protein family (Hsp40) member C21" Q5F1R6 5 34929593-34958964 "Disease related genes, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040789 Approved Supported Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA040789: AB_10794147" "unprognostic (1.37e-1)" "unprognostic (6.01e-2)" "unprognostic (1.17e-2)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (1.42e-2)" "prognostic unfavorable (2.36e-5)" "unprognostic (1.77e-3)" "unprognostic (3.04e-2)" "unprognostic (6.68e-3)" "unprognostic (5.99e-2)" "unprognostic (6.02e-2)" "unprognostic (9.27e-3)" "unprognostic (1.54e-1)" "unprognostic (3.26e-1)" "unprognostic (2.57e-1)" "unprognostic (6.02e-2)" 13.8 12.2 13.5 12.1 16.5 15.9 20.9 17.2 16.0 20.7 17.9 7.9 13.6 11.6 16.0 11.6 20.1 11.0 10.5 26.7 12.1 11.7 19.0 19.3 13.3 16.6 16.2 12.2 13.6 17.0 16.6 18.7 19.2 17.6 16.6 14.4 6.7 15.4 14.5 50.6 11.6 13.3 23.1 14.5 12.9 15.4 41.9 17.0 17.2 16.5 18.9 14.2 23.8 25.2 5.8 4.8 8.3 3.5 7.5 6.3 1.9 14.3 9.9 12.8 16.9 16.5 19.8 23.8 19.2 15.5 15.1 10.1 16.8 17.3 30.3 8.7 17.7 19.3 10.3 15.0 19.2 17.8 17.9 11.2 16.4 38.0 14.1 27.1 23.5 15.9 14.0 18.1 16.9 27.6 10.9 14.1 11.2 25.5 23.9 11.1 12.1 20.1 17.8 8.9 15.9 8.8 18.3 31.8 13.4 15.4 18.3 7.0 7.2 51.0 24.0 16.1 15.1 16.4 26.3 17.2 19.1 19.0 11.5 15.2 17.2 15.5 20.6 15.6 28.6 10.1 4.0 2.9 8.3 3.6 2.4 5.1 5.8 5.1 3.2 4.8 3.7 5.2 5.1 0.6 7.5 3.5 4.6 6.3 1.9 13.5 16.5 17.2 16.0 12.1 11.7 16.2 12.2 17.6 17.0 71.5 99.0 29.6 53.2 32.7 48.1 137.7 43.3 29.4 46.6 34.9 41.2 41.7 74.6 18.3 74.9 35.9 26.2 0.0 26.3 24.2 33.6 57.4 8.1 50.8 21.3 71.5 17.3 35.0 23.5 29.9 37.4 29.5 35.4 47.7 33.5 29.1 23.4 29.8 35.7 52.4 61.9 12.9 29.3 68.3 51.3 40.8 54.9 29.8 33.3 61.6 DNAL4 "dJ327J16, PIG27" ENSG00000100246 "Dynein axonemal light chain 4" O96015 22 38778508-38794198 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 73.8;Late spermatids: 143.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003647 Approved Approved Nucleoplasm,Nucleoli,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Nucleoli, Cytosol" "HPA003647: AB_1078712" "unprognostic (8.45e-2)" "unprognostic (8.15e-3)" "unprognostic (2.35e-1)" "unprognostic (3.14e-3)" "unprognostic (3.74e-1)" "unprognostic (1.52e-1)" "unprognostic (6.46e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-1)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (2.07e-1)" "prognostic favorable (1.20e-6)" "unprognostic (1.60e-1)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.83e-2)" 8.2 11.4 24.1 9.6 21.9 3.9 13.7 8.6 19.8 17.8 10.1 8.5 19.7 7.3 9.8 15.0 12.3 33.5 12.7 9.9 17.7 15.2 16.0 7.1 12.8 7.5 9.5 15.7 15.8 14.9 19.2 19.3 11.9 7.9 13.2 9.2 13.1 16.4 16.3 4.4 11.4 8.0 7.7 6.4 7.5 11.1 36.5 9.7 13.2 26.1 6.6 8.6 8.4 9.1 12.6 14.8 17.5 11.2 15.7 16.6 8.1 8.9 4.5 9.1 8.2 11.7 11.8 0.0 3.8 7.4 5.9 6.5 2.8 10.5 2.2 8.3 5.5 6.8 4.3 5.7 10.1 4.2 5.5 7.5 1.3 1.3 3.1 18.6 7.1 1.9 9.5 33.2 7.8 14.2 15.5 8.4 10.9 2.6 4.5 7.3 11.1 6.6 7.1 3.6 13.3 3.7 6.5 3.9 2.9 12.4 5.3 12.9 6.9 7.9 6.1 15.4 6.9 11.0 6.9 5.1 5.4 5.5 8.1 3.8 2.8 0.8 1.0 16.1 2.4 5.2 15.6 9.6 12.8 13.5 9.5 16.6 8.7 11.2 12.1 9.8 12.6 13.3 11.0 17.5 15.7 11.2 14.8 10.2 8.1 24.1 21.9 8.6 19.8 17.7 15.2 9.5 15.7 7.9 9.7 6.0 8.0 3.7 11.7 4.9 13.6 3.6 15.3 28.1 12.5 3.5 2.0 23.5 26.6 24.0 73.8 4.5 8.0 0.0 13.8 16.6 7.6 8.9 15.0 2.9 12.2 11.1 12.1 9.8 3.8 143.7 10.9 4.9 8.5 6.4 13.8 10.1 16.3 8.6 7.1 15.7 13.1 6.5 4.4 52.4 14.3 9.3 16.6 6.5 13.4 10.8 DNMBP "ARHGEF36, KIAA1010, Tuba" ENSG00000107554 "Dynamin binding protein" Q6XZF7 10 99875577-100009919 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037878, HPA058216" Uncertain Approved "Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol" Yes No "Nucleoli, Golgi apparatus, Cytosol" "Nuclear bodies" "HPA037878: AB_10675622, HPA058216: AB_2683640" "unprognostic (3.25e-1)" "unprognostic (8.19e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.95e-6)" "unprognostic (3.92e-2)" "unprognostic (4.13e-1)" "unprognostic (9.79e-2)" "unprognostic (4.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.02e-1)" "unprognostic (8.67e-3)" "unprognostic (4.03e-2)" "unprognostic (5.07e-3)" "unprognostic (6.52e-2)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "prognostic favorable (6.15e-4)" 11.0 4.8 3.7 8.3 3.6 5.8 8.4 9.2 4.4 13.0 24.9 3.2 23.0 14.5 15.6 11.1 8.2 9.2 10.2 6.0 3.1 2.6 11.1 8.6 6.6 4.5 2.3 3.0 13.8 22.3 24.6 5.0 8.5 3.5 11.6 13.8 8.5 7.2 23.3 10.2 20.0 38.3 15.9 3.1 6.2 15.3 8.6 2.3 30.4 7.1 8.8 7.7 17.4 16.8 4.3 0.8 1.6 2.7 5.3 1.7 1.2 10.4 8.6 7.8 12.3 14.3 12.1 1.9 18.9 18.3 9.2 8.9 5.8 15.9 10.9 8.1 14.4 5.0 8.3 9.1 10.8 12.9 0.5 2.8 1.5 9.7 4.0 7.4 1.0 0.7 5.6 2.4 11.3 10.0 32.4 21.9 3.5 1.4 0.0 18.5 1.3 1.8 2.0 7.5 7.3 5.2 2.2 8.0 0.5 15.6 9.1 1.3 1.8 3.1 0.8 2.3 11.3 0.6 1.0 26.3 6.9 6.6 5.5 12.3 0.9 0.6 15.3 6.5 3.4 5.1 0.0 1.8 0.4 1.7 2.7 1.6 3.0 0.4 1.2 0.8 4.3 0.4 0.8 1.6 5.3 2.7 0.6 0.0 1.2 3.7 3.6 9.2 4.4 3.1 2.6 2.3 3.0 3.5 2.3 8.9 8.3 4.9 7.1 31.1 6.5 5.2 12.7 26.8 14.8 12.2 33.4 6.4 3.3 6.0 1.0 10.8 34.6 0.0 12.4 1.0 11.3 5.5 2.3 13.1 4.1 12.7 3.5 9.2 12.7 2.5 12.7 7.5 3.3 0.0 25.4 3.3 13.5 23.0 8.5 2.9 24.9 0.0 8.2 2.1 8.5 39.9 3.1 1.5 22.8 17.8 DNTTIP1 "C20orf167, dJ447F3.4, Tdif1" ENSG00000101457 "Deoxynucleotidyltransferase terminal interacting protein 1" Q9H147 20 45791937-45811427 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 41.0" "Group enriched" "Detected in all" 7 "dendritic cells: 14.2;granulocytes: 41.0;monocytes: 16.6" "Cell line enhanced" "Detected in all" "PC-3: 74.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045496 Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA045496: " "unprognostic (7.77e-2)" "unprognostic (2.19e-1)" "unprognostic (2.07e-1)" "unprognostic (4.52e-2)" "unprognostic (2.50e-1)" "unprognostic (3.05e-2)" "prognostic unfavorable (1.79e-5)" "unprognostic (6.29e-2)" "unprognostic (7.16e-2)" "unprognostic (1.85e-1)" "unprognostic (5.81e-3)" "unprognostic (5.63e-2)" "prognostic unfavorable (1.90e-6)" "unprognostic (3.18e-1)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" 15.2 16.3 15.8 19.0 18.0 31.6 16.0 15.5 19.9 16.4 24.2 15.4 20.5 14.0 23.3 21.3 18.8 20.6 18.6 20.6 14.6 15.3 15.6 18.7 18.2 17.7 14.5 17.6 20.1 24.1 18.2 17.8 18.3 15.1 23.5 32.0 16.1 21.0 21.6 45.0 21.8 19.6 32.6 13.8 21.2 20.7 36.9 11.8 25.2 21.1 19.4 21.7 30.1 16.1 3.2 14.2 41.0 16.6 1.0 3.4 4.5 20.4 10.9 11.3 10.7 8.7 9.4 11.8 7.7 12.5 25.0 22.7 34.5 33.6 8.5 25.3 11.2 39.9 15.5 9.9 16.5 16.6 4.6 12.4 9.2 11.5 22.0 17.7 18.0 15.4 9.4 15.6 16.3 15.8 11.5 14.6 12.4 8.5 8.7 14.8 27.2 14.7 27.9 7.6 11.6 74.6 11.9 14.0 8.8 12.5 9.8 10.6 9.6 15.7 12.8 16.1 9.2 12.7 28.9 8.5 15.0 11.2 14.5 18.4 9.5 6.1 10.5 32.8 11.6 12.8 4.8 16.6 21.6 1.4 6.9 1.4 3.2 1.9 2.4 14.2 2.7 3.4 1.6 41.0 1.0 4.2 5.5 2.7 4.5 15.8 18.0 15.5 19.9 14.6 15.3 14.5 17.6 15.1 11.8 14.9 18.5 22.9 37.2 22.7 18.5 17.9 12.7 24.1 21.6 24.4 3.9 56.0 43.1 57.6 31.1 21.1 32.8 0.0 66.5 35.6 23.6 31.5 5.8 16.8 62.7 19.1 21.4 22.7 26.5 10.6 26.2 33.7 15.1 86.6 70.1 42.1 70.4 51.8 25.5 33.4 24.1 0.0 24.5 77.5 33.7 24.1 48.3 18.1 31.6 54.5 DNTTIP2 "ERBP, HSU15552, TdIF2" ENSG00000067334 "Deoxynucleotidyltransferase terminal interacting protein 2" Q5QJE6 1 93866283-93879918 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044502, HPA053707" Supported Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA044502: AB_10960277, HPA053707: AB_2682236" "unprognostic (2.95e-3)" "unprognostic (3.84e-2)" "unprognostic (6.21e-3)" "unprognostic (1.12e-2)" "unprognostic (2.41e-1)" "unprognostic (8.92e-2)" "prognostic unfavorable (1.90e-6)" "unprognostic (7.94e-2)" "unprognostic (5.57e-3)" "unprognostic (2.69e-2)" "unprognostic (2.02e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.80e-5)" "unprognostic (2.59e-1)" "unprognostic (8.41e-2)" "unprognostic (2.25e-1)" "unprognostic (1.06e-2)" 14.0 8.5 10.7 7.3 11.4 27.6 10.9 12.0 12.5 12.4 9.4 5.8 7.9 6.1 9.4 14.1 15.1 9.7 9.7 11.4 9.4 10.3 14.5 15.1 12.1 10.7 10.4 10.5 15.9 8.3 9.9 12.1 15.5 17.7 13.0 8.1 4.6 9.0 7.3 24.6 11.7 11.7 11.0 13.2 16.2 9.0 12.0 10.9 15.9 16.2 12.6 10.7 17.3 15.5 11.1 7.2 15.8 11.6 11.9 11.6 8.0 12.4 6.0 6.8 7.1 6.5 5.8 10.3 8.4 6.0 10.1 8.7 6.6 5.6 16.7 11.3 8.8 12.7 7.1 10.8 10.1 14.4 10.1 6.1 13.7 9.9 9.6 6.8 15.3 4.9 6.4 11.0 10.8 9.1 5.1 7.2 5.5 16.1 5.8 13.7 5.4 10.7 10.0 13.0 5.6 9.7 6.2 14.4 6.4 10.3 9.7 8.1 7.3 8.8 13.2 9.2 9.0 5.7 11.1 6.8 8.2 8.6 9.4 14.1 6.1 8.1 13.7 4.8 12.1 5.4 10.9 7.9 15.8 9.6 11.6 11.6 11.1 8.9 8.7 7.2 10.5 8.2 10.4 12.1 11.9 10.7 5.0 8.8 8.0 10.7 11.4 12.0 12.5 9.4 10.3 10.4 10.5 17.7 10.9 53.6 74.1 43.3 98.3 48.3 31.6 69.0 10.2 117.8 117.2 12.2 55.0 44.4 18.3 60.2 28.9 60.6 13.1 23.3 52.7 36.6 31.7 61.4 112.5 16.6 33.8 19.1 8.1 20.9 24.1 7.4 23.9 59.5 21.9 64.1 12.1 30.7 68.6 15.3 24.4 14.7 29.6 19.4 106.0 54.0 70.5 44.3 46.7 46.5 19.7 80.3 DOC2A ENSG00000149927 "Double C2 domain alpha" Q14183 16 30005509-30023270 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.0;testis: 12.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 72.3;Early spermatids: 196.5;Late spermatids: 146.0" "Cancer enhanced" "Detected in many" "renal cancer: 5.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.8;SCLC-21H: 26.6;U-937: 12.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 13.5;cerebral cortex: 30.8;hippocampal formation: 24.4" HPA065676 Uncertain "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Cell Junctions" "Nucleoplasm, Nucleoli" "HPA065676: AB_2685528" "unprognostic (1.46e-3)" "unprognostic (3.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (4.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.66e-2)" "unprognostic (9.14e-2)" "unprognostic (3.90e-2)" "unprognostic (2.89e-2)" "unprognostic (1.28e-3)" "unprognostic (5.13e-2)" "unprognostic (8.29e-3)" "unprognostic (1.71e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" "unprognostic (2.61e-1)" 1.2 2.7 18.5 1.0 17.5 3.9 2.3 24.0 49.0 1.3 3.1 0.9 0.3 1.7 1.6 2.4 1.1 3.3 1.8 1.0 15.3 8.3 1.6 1.4 3.5 1.4 2.8 27.4 5.7 1.0 1.3 3.2 1.2 13.1 2.5 2.4 0.0 1.6 1.4 1.1 2.0 2.3 1.8 4.2 3.1 1.7 12.6 1.8 0.0 1.6 0.0 1.2 1.4 0.6 0.6 1.1 1.0 0.4 0.2 0.5 0.3 0.7 1.5 1.1 0.8 0.3 0.0 9.8 0.4 0.7 0.5 0.3 4.0 2.7 0.0 0.9 0.4 1.4 0.2 5.0 2.0 0.2 0.1 0.5 0.8 0.5 0.3 0.7 0.9 2.9 1.2 0.8 0.1 1.1 5.0 0.0 3.3 0.3 0.0 0.0 7.8 2.1 3.6 1.5 3.1 4.2 8.0 0.1 0.4 0.5 0.8 26.6 2.1 0.6 2.8 0.2 2.4 2.7 1.7 0.8 0.3 1.5 0.3 0.3 0.5 0.1 0.1 0.3 12.8 0.3 0.8 0.4 0.0 0.0 0.3 0.1 0.5 0.1 0.3 1.1 0.6 0.5 0.5 1.0 0.2 0.0 0.0 0.1 0.3 18.5 17.5 24.0 36.2 15.3 8.3 2.8 27.4 13.1 1.8 0.0 5.8 0.5 3.1 0.6 1.2 0.6 2.5 72.3 12.5 1.8 21.6 0.3 1.7 0.0 196.5 0.7 0.9 0.0 0.0 0.9 0.7 1.8 0.0 0.0 0.4 0.0 1.2 1.8 1.3 146.0 0.6 1.3 1.7 0.0 2.2 3.1 0.0 0.0 1.8 0.0 1.8 0.0 0.3 1.7 4.1 0.6 0.1 0.0 4.1 0.7 DOCK11 "ACG, FLJ32122, FLJ43653, ZIZ2" ENSG00000147251 "Dedicator of cytokinesis 11" Q5JSL3 X 118495898-118686163 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 43.8;Kupffer cells: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 27.8;HMC-1: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059695 Uncertain Approved "Nuclear membrane,Nucleoli" NA NA Nucleoli "Nuclear membrane" "HPA059695: AB_2684104" "unprognostic (4.09e-1)" "unprognostic (1.47e-1)" "unprognostic (1.68e-1)" "unprognostic (2.56e-1)" "unprognostic (1.32e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.50e-1)" "unprognostic (5.56e-2)" "unprognostic (1.76e-1)" "unprognostic (6.37e-3)" "unprognostic (3.06e-1)" "unprognostic (2.66e-1)" "unprognostic (3.49e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (8.11e-2)" "unprognostic (8.16e-3)" 27.3 6.9 5.0 15.9 15.0 23.5 30.6 1.4 3.1 7.6 11.6 1.5 4.2 2.5 7.9 8.2 7.8 7.0 7.3 6.7 4.4 3.3 7.4 2.6 11.7 27.5 5.4 2.0 3.5 1.7 2.4 15.9 10.0 3.9 6.0 4.8 1.4 4.4 4.1 2.5 4.4 9.7 9.6 7.8 13.8 7.3 3.7 5.3 19.7 9.4 3.6 13.8 9.3 13.3 5.2 4.6 13.1 7.3 7.6 11.3 2.1 0.0 2.4 2.0 1.9 27.8 11.9 5.4 2.8 6.1 2.3 6.2 0.3 0.0 7.5 0.2 10.2 2.8 0.1 3.6 0.0 2.1 9.3 3.1 16.5 2.7 0.0 9.0 9.9 39.9 8.3 0.1 2.5 2.8 1.6 0.1 6.6 5.0 13.7 1.4 1.6 5.9 13.2 2.1 2.2 3.9 4.0 5.3 0.2 0.0 0.5 0.7 4.9 8.5 7.9 2.7 1.6 0.9 8.4 0.1 1.9 0.6 10.9 1.2 4.2 6.3 7.0 4.1 15.9 1.0 6.3 4.2 7.5 8.8 6.1 5.5 4.9 7.4 7.0 4.6 5.2 6.7 8.3 13.1 7.6 7.3 3.7 11.3 2.1 5.0 15.0 1.4 3.1 4.4 3.3 5.4 2.0 3.9 5.3 26.8 3.0 16.0 0.1 2.6 0.4 1.1 0.0 1.4 13.6 7.0 0.0 3.2 0.0 0.1 0.3 2.1 0.7 0.0 0.0 2.6 8.0 0.4 43.8 0.8 17.4 0.0 4.1 3.7 50.0 0.2 11.2 27.1 8.5 10.8 3.7 0.2 0.5 0.8 4.6 4.8 0.3 25.8 9.1 0.7 3.0 1.6 5.7 23.8 0.8 0.1 DOCK4 "FLJ34238, KIAA0716" ENSG00000128512 "Dedicator of cytokinesis 4" Q8N1I0 7 111726110-112206411 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 44.7;Horizontal cells: 89.0;Ito cells: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.4" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 19.2;HUVEC TERT2: 36.4;TIME: 31.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071516 Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nucleoli, Plasma membrane" "Golgi apparatus, Cytosol" "HPA071516: AB_2686407" "unprognostic (1.37e-1)" "unprognostic (4.18e-1)" "unprognostic (1.53e-1)" "unprognostic (2.48e-2)" "unprognostic (7.10e-2)" "unprognostic (2.03e-2)" "unprognostic (9.10e-2)" "unprognostic (2.18e-2)" "unprognostic (3.03e-2)" "unprognostic (5.78e-2)" "unprognostic (7.06e-2)" "unprognostic (3.66e-1)" "unprognostic (5.71e-2)" "unprognostic (1.89e-2)" "unprognostic (9.48e-2)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" 10.7 6.5 16.5 10.0 28.2 2.3 6.8 11.7 28.2 9.1 4.4 21.0 2.0 2.8 7.9 4.4 4.4 8.7 7.9 6.9 22.2 10.1 7.3 13.9 25.5 3.7 18.2 12.4 14.2 5.0 4.7 4.0 10.8 12.2 6.5 4.9 1.7 4.4 3.9 6.7 3.5 3.2 10.7 20.3 3.2 3.1 3.5 21.8 0.0 5.8 2.7 3.6 5.7 5.2 0.2 0.3 6.4 1.2 0.1 0.1 0.2 0.0 1.7 4.1 3.3 3.4 5.0 2.3 0.4 4.5 0.8 1.3 0.0 0.0 0.3 3.4 1.0 0.9 0.2 0.6 3.9 3.5 1.2 6.7 0.1 2.8 5.7 2.4 0.5 0.2 2.6 0.4 19.2 9.9 1.2 36.4 1.6 0.0 10.3 1.7 0.4 0.8 0.2 2.2 0.5 7.0 0.2 3.0 1.6 2.8 0.1 0.9 3.2 2.5 2.1 2.5 3.8 0.3 0.1 31.4 3.2 1.5 6.1 1.3 0.4 0.1 0.3 0.3 0.8 7.1 0.2 0.7 0.1 0.0 1.2 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 6.4 0.1 0.2 0.3 0.0 0.2 16.5 28.2 11.7 18.2 22.2 10.1 18.2 12.4 12.2 21.8 44.7 5.0 0.5 3.6 4.6 26.2 11.6 2.5 12.0 21.6 3.5 21.6 0.2 0.0 1.4 2.4 32.2 0.7 0.0 0.3 0.2 6.0 9.4 2.3 14.9 13.6 89.0 10.5 40.5 15.6 1.1 5.2 17.3 8.5 8.2 0.7 4.4 1.0 9.9 7.8 1.1 10.3 12.9 3.3 0.7 1.7 2.4 0.0 0.0 0.8 1.6 DOHH "HLRC1, MGC4293" ENSG00000129932 "Deoxyhypusine hydroxylase" Q9BU89 19 3490822-3500940 "Enzymes, Predicted intracellular proteins" "Hypusine biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041953, HPA076271" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA041953: AB_10795386, HPA076271: " "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (8.63e-2)" "prognostic favorable (2.24e-4)" "unprognostic (3.66e-1)" "unprognostic (2.01e-2)" "unprognostic (9.45e-2)" "unprognostic (7.26e-2)" "unprognostic (4.65e-2)" "unprognostic (1.13e-1)" "prognostic favorable (3.58e-4)" "unprognostic (9.87e-3)" "unprognostic (1.14e-3)" "unprognostic (4.35e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.76e-3)" 8.1 6.5 10.5 6.6 13.0 9.3 3.4 5.5 13.0 3.9 5.5 6.9 2.6 18.9 3.7 4.1 4.1 3.1 4.9 5.1 14.9 9.1 6.0 6.4 4.0 4.5 18.2 6.2 3.8 7.6 3.8 3.9 3.8 8.4 5.1 2.0 3.2 6.0 4.0 23.1 7.0 12.3 2.4 25.5 5.9 7.3 4.2 6.1 4.7 2.9 7.8 4.5 3.1 4.7 11.6 11.0 1.8 6.6 6.9 12.3 4.4 9.2 11.0 1.7 3.6 0.9 1.1 7.4 8.8 1.8 4.3 3.4 15.3 3.8 7.2 6.9 1.3 3.9 9.6 2.7 3.0 0.9 10.6 12.4 7.5 6.2 18.2 3.5 10.0 10.5 1.2 3.0 4.2 1.8 1.5 2.2 8.0 16.3 8.5 1.7 10.5 10.8 11.4 9.8 3.7 14.9 12.3 4.0 10.4 2.6 5.2 10.5 7.7 6.2 5.5 8.8 0.8 7.5 5.5 5.0 5.4 7.4 14.3 16.1 11.3 8.2 9.6 6.4 22.8 6.4 1.1 5.3 1.8 6.2 6.2 8.1 8.1 8.5 12.3 8.7 11.6 12.3 10.4 0.3 6.9 6.6 11.0 9.6 4.4 10.5 13.0 5.5 13.0 14.9 9.1 18.2 6.2 8.4 6.1 6.0 2.1 18.5 14.9 20.9 17.4 7.1 10.2 1.4 2.3 5.2 9.8 25.8 18.3 21.7 7.1 12.1 9.7 0.0 18.5 26.0 13.9 16.8 13.8 8.2 19.0 23.8 12.6 11.1 7.2 17.2 13.0 8.6 18.6 24.4 11.0 13.1 19.1 14.4 14.2 23.9 11.8 0.0 13.7 11.1 12.3 24.1 29.1 12.8 16.1 15.3 DOLK "DK1, KIAA1094, TMEM15" ENSG00000175283 "Dolichol kinase" Q9UPQ8 9 128945530-128947619 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066767, HPA068706" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA066767: AB_2732751, HPA068706: AB_2732118" "unprognostic (6.35e-2)" "unprognostic (2.69e-1)" "unprognostic (2.63e-1)" "unprognostic (1.30e-3)" "unprognostic (3.55e-1)" "unprognostic (2.81e-3)" "unprognostic (8.90e-3)" "unprognostic (3.26e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.83e-2)" "prognostic favorable (5.53e-4)" "unprognostic (3.20e-2)" "unprognostic (1.06e-1)" "prognostic favorable (6.88e-5)" "unprognostic (6.13e-3)" 11.0 20.2 7.9 7.8 13.8 1.4 9.5 7.0 18.6 9.8 8.6 14.9 7.1 8.8 12.4 16.8 10.9 10.8 10.8 12.0 7.6 9.9 17.5 22.0 10.6 10.6 8.1 6.7 13.2 16.9 19.2 8.0 19.5 16.3 12.3 8.0 14.2 15.5 12.8 7.9 11.4 10.9 11.1 5.9 11.6 12.4 22.4 6.0 12.5 11.0 11.9 12.1 10.4 7.3 9.4 14.2 5.6 16.4 9.8 13.7 9.0 5.1 19.3 6.8 10.1 20.2 10.7 9.3 10.8 17.5 13.3 9.9 15.1 8.2 2.8 5.7 15.6 18.8 36.7 9.3 13.5 6.9 4.7 8.1 3.5 13.3 10.9 20.5 3.8 6.3 14.8 12.5 14.3 7.9 7.8 12.9 4.1 8.6 4.6 14.3 25.4 3.1 3.2 8.8 14.8 12.0 3.2 9.0 11.2 11.9 7.8 6.3 7.0 14.3 11.8 6.3 6.7 20.6 5.1 10.7 12.0 4.3 15.1 8.8 4.4 10.8 2.9 11.3 3.5 9.1 2.3 13.5 5.6 10.2 13.3 9.1 9.4 9.2 11.2 14.2 9.2 12.1 12.3 2.1 9.8 16.4 8.1 13.7 9.0 7.9 13.8 7.0 18.6 7.6 9.9 8.1 6.7 16.3 6.0 6.0 2.6 1.5 3.2 1.5 9.0 3.0 7.6 6.7 3.4 7.0 7.9 21.7 0.0 14.1 10.7 8.3 6.2 0.0 12.3 14.0 5.6 3.1 1.1 8.3 11.4 4.8 1.2 17.2 6.9 2.8 11.2 2.7 3.3 1.8 3.8 11.2 10.4 5.8 5.6 7.2 6.5 0.0 4.1 24.0 14.9 1.1 15.2 1.9 5.5 1.7 DPH5 CGI-30 ENSG00000117543 "Diphthamide biosynthesis 5" Q9H2P9 1 100989623-101026088 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046439, HPA076234" Approved Approved "Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" Nucleoli "HPA046439: AB_2679667, HPA076234: AB_2797274" "unprognostic (1.31e-1)" "unprognostic (3.37e-2)" "unprognostic (1.98e-2)" "unprognostic (7.82e-2)" "unprognostic (1.22e-2)" "unprognostic (2.23e-1)" "unprognostic (2.81e-2)" "unprognostic (3.57e-2)" "unprognostic (8.59e-2)" "unprognostic (8.12e-2)" "unprognostic (1.37e-2)" "unprognostic (2.56e-1)" "unprognostic (1.58e-2)" "unprognostic (2.15e-1)" "unprognostic (7.09e-2)" "unprognostic (1.88e-1)" "unprognostic (9.00e-2)" 12.6 21.5 11.2 9.1 19.0 7.9 21.4 10.4 11.9 17.3 12.8 11.5 13.2 6.8 20.6 19.0 16.1 19.3 10.0 19.2 11.2 11.9 14.1 18.1 8.5 15.2 11.9 11.4 39.0 28.4 15.5 31.7 9.3 12.3 15.3 13.7 10.8 16.1 12.7 16.8 11.5 9.2 15.4 16.7 13.6 11.5 9.2 11.3 22.2 18.4 15.5 17.7 14.4 14.7 12.1 8.4 3.3 6.2 14.9 16.2 6.7 9.6 8.8 13.1 12.8 16.2 46.2 11.3 8.5 14.0 12.5 10.6 10.5 2.4 17.0 11.4 7.2 7.8 6.3 14.6 13.0 18.4 7.1 10.7 8.9 8.5 19.9 25.3 10.8 4.7 31.0 18.9 11.7 38.0 24.1 18.6 11.8 19.9 5.4 18.8 8.3 13.2 10.6 10.6 5.2 13.8 12.2 19.1 9.8 14.1 7.4 15.2 7.4 4.7 13.1 37.7 10.4 8.5 6.4 9.4 7.4 10.4 10.7 11.2 6.4 7.4 10.4 10.1 10.2 2.7 3.3 5.1 2.6 11.1 5.5 15.1 12.1 12.3 12.1 8.4 9.6 16.2 14.8 1.9 14.9 6.2 6.2 8.2 6.7 11.2 19.0 10.4 11.9 11.2 11.9 11.9 11.4 12.3 11.3 6.0 10.5 39.8 17.8 14.1 5.0 21.8 17.8 20.1 7.9 7.0 0.0 22.0 19.9 12.0 1.2 11.3 3.4 0.0 15.9 23.6 15.8 9.8 25.3 25.4 17.0 1.6 9.8 13.5 29.4 1.5 25.0 11.3 11.8 26.2 11.4 15.8 10.5 17.5 13.1 22.8 6.2 6.5 10.3 16.4 16.4 15.7 10.9 20.0 23.2 6.3 DPH6 "ATPBD4, MGC14798" ENSG00000134146 "Diphthamine biosynthesis 6" Q7L8W6 15 35217345-35546193 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042976, HPA055496" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042976: AB_10964890, HPA055496: AB_2682835" "unprognostic (9.78e-2)" "unprognostic (1.45e-1)" "unprognostic (1.92e-1)" "unprognostic (1.14e-1)" "unprognostic (1.82e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (9.94e-2)" "unprognostic (1.76e-1)" "unprognostic (1.49e-3)" "unprognostic (7.92e-3)" "unprognostic (1.13e-1)" "unprognostic (4.65e-6)" "unprognostic (9.70e-2)" "unprognostic (5.61e-2)" "unprognostic (2.18e-2)" "unprognostic (7.44e-2)" 13.3 12.7 8.0 6.8 16.1 6.4 15.3 11.6 15.8 14.7 9.2 15.5 10.8 8.5 23.9 17.1 14.7 11.5 10.5 14.4 7.8 7.2 14.7 11.2 8.7 9.3 9.7 12.0 16.7 19.5 15.8 31.7 11.1 13.4 8.5 10.2 14.6 11.5 14.7 24.9 15.2 8.7 16.8 11.1 8.3 9.6 11.3 10.6 7.1 15.3 16.5 10.0 11.0 11.3 8.4 6.3 0.3 6.5 13.2 10.8 4.4 10.5 5.7 9.6 8.1 1.7 7.9 9.4 4.0 7.0 9.7 5.1 7.6 9.9 3.3 9.8 3.7 11.8 12.2 11.1 11.5 11.6 2.6 7.0 12.3 6.5 12.0 10.3 6.5 8.0 6.6 14.6 3.9 18.9 6.0 9.3 7.1 13.5 13.4 8.9 4.1 8.0 6.1 8.5 16.1 5.3 10.0 9.0 4.5 8.4 13.5 7.0 6.9 7.5 8.4 6.4 5.9 29.0 9.1 2.8 9.5 9.2 9.4 6.3 12.0 19.0 8.3 8.2 11.3 9.0 0.0 6.5 0.3 6.2 6.0 7.7 8.4 8.3 8.6 6.3 6.5 10.8 9.5 0.3 13.2 5.6 5.4 5.4 4.4 8.0 16.1 11.6 15.8 7.8 7.2 9.7 12.0 13.4 10.6 14.9 6.9 12.6 16.6 27.5 31.5 11.0 17.8 5.3 17.0 8.7 37.3 22.9 11.6 12.0 2.1 9.5 10.1 23.3 21.1 18.8 11.6 7.6 3.5 7.3 15.0 17.5 5.2 6.7 10.0 1.6 13.0 10.9 15.1 15.4 6.0 16.6 15.1 7.0 6.3 16.4 22.2 0.0 11.3 8.3 15.1 20.3 18.9 5.0 9.2 11.1 DPPA4 FLJ10713 ENSG00000121570 "Developmental pluripotency associated 4" Q7L190 3 109326141-109337572 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.3;lymphoid tissue: 35.8" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 18.3;Extravillous trophoblasts: 16.9;Syncytiotrophoblasts: 5.1" "Cancer enriched" "Detected in single" 218 "testis cancer: 59.0" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 10.3" "Lineage enriched" "Detected in single" 11 "dendritic cells: 10.3" "Group enriched" "Detected in some" 4 "HAP1: 22.5;NTERA-2: 83.0;SuSa: 32.3" "CAB020678, HPA035249, HPA035250" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol" Yes NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome, Cytosol" "CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536" "unprognostic (2.07e-2)" "unprognostic (2.53e-2)" "unprognostic (3.80e-1)" "unprognostic (2.53e-1)" "unprognostic (8.57e-2)" "unprognostic (1.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.52e-1)" "unprognostic (9.83e-2)" "unprognostic (2.02e-2)" "unprognostic (6.60e-2)" "unprognostic (2.48e-2)" "unprognostic (3.03e-8)" "unprognostic (5.28e-2)" "unprognostic (5.04e-2)" "unprognostic (5.56e-2)" "unprognostic (3.85e-2)" 0.1 0.1 0.2 0.3 1.0 8.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.6 0.1 0.2 1.3 0.6 0.8 0.3 0.0 0.0 0.0 0.0 2.2 4.2 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.7 0.0 8.1 0.0 35.8 0.1 0.0 1.0 0.4 0.1 0.9 10.3 0.0 0.0 0.7 0.2 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.2 0.0 0.7 0.0 10.3 0.0 0.1 0.2 1.0 0.1 0.3 0.6 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.4 1.2 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.3 0.2 1.1 1.0 1.4 0.0 0.0 0.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 2.1 0.0 5.1 0.7 0.0 0.3 DRGX "DRG11, PRRXL1" ENSG00000165606 "Dorsal root ganglia homeobox" A6NNA5 10 49364181-49396016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "adrenal gland: 13.9;brain: 8.0" "Cell type enriched" "Detected in single" 4 "Melanocytes: 1.7" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 8.2;SH-SY5Y: 37.4;U-2197: 13.5" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low region specificity" "Detected in all" HPA043978 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA043978: AB_10961154" "unprognostic (1.42e-2)" "unprognostic (5.68e-2)" "unprognostic (3.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.74e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-2)" "unprognostic (3.74e-2)" "unprognostic (8.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.09e-2)" 0.2 13.9 0.0 0.4 0.2 0.3 0.1 0.4 3.3 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.5 0.1 2.0 0.6 0.0 0.0 0.0 0.9 0.0 4.8 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.3 0.0 8.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 13.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 3.3 0.2 0.3 2.0 0.6 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DRICH1 C22orf43 ENSG00000189269 "Aspartate rich 1" Q6PGQ1 22 23608452-23632321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 68.5" "Group enriched" "Detected in some" 100 "Early spermatids: 369.6;Late spermatids: 442.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 5 "CACO-2: 15.6" HPA020446 Approved Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA020446: AB_1853151" "unprognostic (7.48e-3)" "unprognostic (3.91e-2)" "unprognostic (2.02e-2)" "unprognostic (6.22e-4)" "unprognostic (6.46e-2)" "unprognostic (8.35e-4)" "unprognostic (2.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.06e-2)" "unprognostic (2.65e-2)" "unprognostic (5.73e-4)" "unprognostic (3.05e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-2)" "unprognostic (8.68e-3)" "unprognostic (7.70e-4)" "unprognostic (1.08e-3)" 0.5 0.5 0.5 0.5 0.5 1.3 0.8 1.0 0.5 0.5 0.5 0.5 0.5 0.1 1.3 9.7 0.5 0.6 0.5 0.5 0.5 0.3 1.2 0.5 0.5 0.7 0.5 0.5 1.3 0.9 8.3 0.8 0.5 0.5 0.7 0.2 0.5 0.5 0.6 0.5 1.3 0.6 0.5 0.5 0.8 0.4 68.5 0.5 0.5 1.0 0.5 0.5 0.5 0.5 0.0 0.0 0.4 0.6 0.0 1.0 0.0 0.7 0.9 2.2 0.6 2.7 0.6 2.0 0.0 0.0 0.1 0.1 15.6 0.6 1.0 0.1 0.6 0.5 1.5 3.0 0.1 0.4 0.2 1.5 0.5 1.2 0.7 1.0 0.4 2.4 1.2 1.3 0.5 0.0 0.9 0.4 0.4 1.2 0.3 0.2 0.8 0.3 0.7 0.2 0.7 0.8 1.6 0.1 0.0 0.4 1.7 1.0 0.7 0.0 1.3 1.1 0.5 0.3 0.1 0.4 0.0 2.8 2.5 0.2 1.0 1.4 0.1 2.6 0.6 0.2 0.0 0.3 0.0 1.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.5 0.5 1.0 0.5 0.5 0.3 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 369.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 442.6 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.4 0.3 0.0 0.0 0.0 4.1 1.5 0.0 0.1 0.0 0.0 0.0 DTD1 "bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68" ENSG00000125821 "D-tyrosyl-tRNA deacylase 1" Q8TEA8 20 18587893-18766644 "Enzymes, Predicted intracellular proteins" "DNA replication" "DNA-binding, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 137.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA 180000 "Nucleoli, Cytosol" "HPA040981: AB_10673268" "unprognostic (3.32e-1)" "unprognostic (1.05e-1)" "unprognostic (1.82e-1)" "unprognostic (5.94e-2)" "unprognostic (1.83e-1)" "unprognostic (2.90e-1)" "unprognostic (1.27e-3)" "unprognostic (9.67e-2)" "unprognostic (1.72e-1)" "unprognostic (1.81e-1)" "unprognostic (6.84e-2)" "unprognostic (1.32e-1)" "unprognostic (9.09e-3)" "unprognostic (2.42e-1)" "unprognostic (8.44e-2)" "unprognostic (2.59e-2)" "unprognostic (8.53e-2)" 14.9 17.7 25.2 13.6 26.5 13.6 19.7 22.4 35.4 13.5 13.7 22.2 10.5 10.6 14.4 17.2 18.8 14.5 11.1 16.7 24.7 29.5 20.1 9.4 13.7 15.5 25.2 30.4 19.1 19.7 20.3 23.7 12.7 27.3 13.6 16.0 17.1 17.6 12.4 22.5 17.6 9.8 15.0 30.9 12.7 16.3 20.6 14.4 4.8 29.5 24.9 17.4 13.4 12.6 20.9 27.5 29.9 20.6 16.4 22.5 12.6 18.7 21.1 20.8 20.4 8.9 16.6 11.6 16.6 15.4 13.2 14.5 13.8 14.7 0.0 11.4 15.4 18.5 10.6 16.6 35.2 13.9 9.1 11.9 20.9 4.8 22.9 28.2 16.2 11.3 13.1 28.3 14.9 55.0 11.3 22.4 3.6 13.0 24.4 19.2 27.5 3.4 29.5 19.3 14.2 46.5 0.0 31.0 15.8 20.1 10.1 28.5 21.5 8.9 24.7 42.8 9.5 14.0 10.1 22.1 17.5 9.5 22.3 22.4 19.6 19.4 10.4 12.0 19.0 14.5 29.9 14.5 10.4 22.2 20.6 22.2 20.9 21.7 22.5 27.5 17.8 16.0 16.7 17.1 16.4 20.5 6.4 16.1 12.6 25.2 26.5 22.4 35.4 24.7 29.5 25.2 30.4 27.3 14.4 32.8 20.0 24.2 32.6 20.9 39.1 17.3 30.6 25.4 17.0 40.1 2.0 25.2 36.5 64.2 24.1 30.8 7.3 0.0 76.4 30.7 25.8 26.4 41.5 10.4 41.2 41.3 22.3 24.5 20.4 17.6 16.7 29.6 40.5 48.7 19.7 48.4 68.4 24.6 18.4 51.2 30.2 0.0 17.5 60.6 137.5 31.1 10.4 30.5 24.3 23.6 DTL "CDT2, DCAF2, L2DTL, RAMP" ENSG00000143476 "Denticleless E3 ubiquitin protein ligase homolog" Q9NZJ0 1 212035553-212107400 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 17.8;Erythroid cells: 23.3;Extravillous trophoblasts: 13.2;Spermatocytes: 35.9;Spermatogonia: 19.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD8 T-cell: 1.5;T-reg: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028016, HPA032023, HPA032031" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119" "unprognostic (7.61e-2)" "unprognostic (1.01e-3)" "unprognostic (2.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (8.96e-3)" "unprognostic (2.45e-3)" "unprognostic (8.83e-3)" "unprognostic (2.52e-3)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.71e-9)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (1.96e-2)" "unprognostic (2.82e-1)" 1.3 0.7 0.4 5.4 0.6 10.8 1.3 0.4 0.5 1.2 2.8 0.3 0.1 1.7 1.0 0.6 4.0 0.4 1.5 0.6 0.4 0.4 0.8 1.0 1.6 4.4 0.4 0.1 0.6 0.5 0.6 0.7 5.4 0.2 0.6 4.2 0.2 1.1 0.1 0.4 1.6 3.3 1.4 0.4 4.6 1.1 37.2 0.1 41.2 0.9 5.7 7.5 0.9 1.6 0.7 0.3 0.0 0.4 0.6 5.2 0.7 12.6 10.8 18.5 9.2 1.1 2.3 9.1 15.9 9.9 15.1 22.5 6.7 11.2 9.6 6.0 6.1 9.7 9.9 24.4 13.4 21.8 11.6 11.7 15.3 14.3 8.1 0.0 20.1 9.6 1.0 0.4 24.4 13.0 2.7 6.9 17.0 18.2 19.6 17.4 5.1 26.8 9.2 21.4 9.6 12.5 21.3 32.7 18.5 4.3 8.8 11.6 18.2 15.1 14.5 6.5 19.7 12.4 9.2 3.7 15.1 11.3 15.6 17.9 7.2 11.2 22.2 7.6 13.3 14.6 0.0 0.0 0.0 0.6 0.4 0.0 0.7 0.8 1.5 0.3 0.1 0.0 0.3 0.0 0.6 0.0 0.0 5.2 0.7 0.4 0.6 0.4 0.5 0.4 0.4 0.4 0.1 0.2 0.1 0.0 0.0 7.8 0.4 2.1 0.0 6.1 2.5 0.0 1.2 0.0 0.0 7.5 0.0 0.2 17.8 1.8 0.5 23.3 0.0 13.2 1.2 0.2 0.0 0.0 3.9 0.0 0.0 1.3 0.3 7.9 1.1 1.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 35.9 19.1 1.5 1.3 1.9 2.9 0.0 DTX3 "FLJ34766, RNF154" ENSG00000178498 "Deltex E3 ubiquitin ligase 3" Q8N9I9 12 57604622-57609804 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 66.7" "Cancer enhanced" "Detected in all" "glioma: 54.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 2.0;T-cells: 5.5" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059654 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA059654: AB_2684097" "unprognostic (2.31e-2)" "unprognostic (8.80e-2)" "unprognostic (2.06e-2)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.58e-2)" "unprognostic (6.91e-2)" "prognostic favorable (9.87e-4)" "unprognostic (1.84e-1)" "unprognostic (4.26e-2)" "prognostic favorable (1.44e-4)" "unprognostic (8.62e-2)" "unprognostic (5.44e-3)" "unprognostic (7.99e-2)" "unprognostic (8.81e-2)" "unprognostic (9.51e-2)" "unprognostic (3.48e-2)" 7.2 18.8 22.7 9.0 35.2 3.5 9.4 47.8 53.6 17.6 22.8 23.7 11.0 6.7 29.7 30.6 9.7 31.8 14.1 20.5 23.8 19.8 11.4 2.4 12.2 11.0 18.3 28.4 36.3 12.0 23.9 32.7 16.0 22.5 21.1 10.1 20.4 13.2 29.5 10.9 7.9 9.4 28.7 16.9 11.2 11.2 7.8 21.6 6.8 16.8 5.1 8.8 11.8 13.5 0.3 0.6 0.0 0.0 2.0 5.5 1.8 3.1 8.2 24.4 0.0 0.0 0.0 0.1 5.0 12.9 11.0 11.2 4.2 13.2 4.4 7.6 10.8 0.1 5.1 0.0 0.6 7.8 11.0 1.5 2.5 12.6 4.4 18.8 0.0 0.0 9.3 6.1 8.4 0.1 31.5 12.3 0.0 0.0 15.0 8.4 6.8 13.4 0.1 19.2 2.5 0.7 0.0 20.3 0.2 1.0 8.2 17.7 28.1 3.9 1.1 2.4 6.1 14.1 6.7 0.0 14.4 5.8 6.6 7.1 24.6 18.4 0.0 9.2 0.0 7.5 0.0 0.0 0.0 5.5 0.0 1.3 0.3 2.1 2.5 0.2 0.3 1.9 3.5 0.0 2.0 0.0 0.6 4.2 1.8 22.7 35.2 47.8 53.6 23.8 19.8 18.3 28.4 22.5 21.6 14.9 14.1 2.2 9.6 5.6 45.2 9.4 5.1 32.1 15.9 12.2 47.1 0.3 11.6 7.6 1.0 4.5 0.0 0.0 1.7 0.2 9.3 8.6 5.7 0.8 0.6 66.7 15.0 14.1 1.6 1.6 31.7 0.5 3.3 1.0 1.1 25.9 3.3 0.0 29.7 2.9 41.2 45.3 29.3 3.5 4.1 2.5 1.0 10.1 0.3 2.5 DUSP1 "CL100, HVH1, MKP-1, PTPN10" ENSG00000120129 "Dual specificity phosphatase 1" P28562 5 172768090-172771195 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Stress response" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 326.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 326.0" "Cell line enhanced" "Detected in many" "HHSteC: 43.7;hTCEpi: 76.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069577 Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA069577: AB_2686156" "unprognostic (1.51e-1)" "unprognostic (1.24e-1)" "unprognostic (9.73e-2)" "unprognostic (8.17e-2)" "unprognostic (4.64e-1)" "unprognostic (1.58e-3)" "unprognostic (4.18e-2)" "unprognostic (6.94e-2)" "unprognostic (3.11e-1)" "unprognostic (1.43e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (3.11e-5)" "unprognostic (2.69e-1)" "unprognostic (2.35e-2)" "unprognostic (1.41e-3)" 158.4 78.0 12.4 68.5 14.0 89.7 91.8 17.4 14.9 81.4 37.1 32.4 48.5 9.4 55.4 71.6 82.7 94.8 138.8 49.2 12.5 11.4 29.8 115.4 135.0 43.5 30.6 9.7 69.4 34.4 26.6 40.8 93.7 29.3 67.1 34.2 61.0 38.1 192.8 54.8 116.1 27.6 65.0 29.5 36.1 53.6 45.9 18.7 10.8 90.4 104.1 46.9 69.0 109.7 2.4 11.5 326.0 31.8 4.5 9.8 14.0 2.1 5.5 1.7 2.4 38.1 22.3 2.9 35.4 10.3 23.8 9.6 6.0 2.6 0.7 10.3 24.8 27.4 0.9 1.7 8.7 11.2 19.4 4.7 0.4 12.0 2.5 43.7 0.2 0.8 21.3 76.4 10.8 17.6 12.4 7.4 1.5 1.8 13.9 15.3 2.5 1.1 1.0 1.5 1.6 1.6 41.1 3.2 6.4 16.9 1.1 7.5 3.1 9.6 16.3 1.2 7.6 1.4 0.4 19.5 16.9 8.4 16.4 2.7 2.9 1.6 0.6 15.1 0.3 0.6 33.3 24.6 69.8 3.9 25.0 9.8 2.4 3.5 4.0 11.5 2.1 1.7 1.9 326.0 4.5 31.8 0.6 2.8 14.0 12.4 14.0 17.4 14.9 12.5 11.4 30.6 9.7 29.3 18.7 381.2 398.8 474.0 769.9 1136.9 64.0 181.6 236.9 45.5 126.3 200.7 25.5 239.6 48.0 361.0 67.1 510.4 567.7 46.7 76.6 355.3 824.5 763.6 295.5 297.9 967.3 46.1 687.8 403.9 1172.3 21.1 356.4 1745.4 514.5 55.9 830.1 603.1 188.6 648.8 292.4 25.4 177.1 756.7 886.8 11.8 23.0 1710.3 486.7 546.6 309.1 534.2 DUX4 ENSG00000260596 "Double homeobox 4" Q9UBX2 4 190173774-190185942 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.4" "Group enriched" "Detected in some" 21 "Early spermatids: 4.1;Late spermatids: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.5;U-2 OS: 3.7;U-266/70: 8.0;U-266/84: 10.4;U-698: 2.4" HPA058451 Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Golgi apparatus, Cytosol" "HPA058451: AB_2683722" 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.5 0.3 0.0 1.1 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 2.5 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 3.7 0.7 0.0 8.0 10.4 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DYNC1I2 "DIC74, DNCI2" ENSG00000077380 "Dynein cytoplasmic 1 intermediate chain 2" Q13409 2 171687409-171748420 "Predicted intracellular proteins" "Host-virus interaction, Transport" "Motor protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033836, HPA040619, HPA053987" Supported Supported "Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol" NA NA 33000 "Endoplasmic reticulum, Cytosol" "Nucleoli, Microtubules" "CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334" "unprognostic (3.01e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-2)" "unprognostic (8.15e-2)" "unprognostic (8.90e-2)" "unprognostic (1.37e-3)" "unprognostic (2.51e-3)" "unprognostic (6.30e-3)" "unprognostic (1.23e-1)" "unprognostic (1.89e-2)" "unprognostic (1.40e-2)" "unprognostic (4.19e-1)" "prognostic favorable (8.04e-4)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (1.35e-3)" "unprognostic (6.42e-2)" 33.4 32.9 39.6 22.5 53.2 10.8 35.5 30.1 50.0 36.1 33.0 50.0 20.1 28.8 43.1 29.3 37.5 26.5 32.0 34.3 45.2 38.3 43.5 21.8 27.3 18.5 59.3 37.9 40.6 23.3 35.8 29.9 40.2 58.7 33.7 35.8 15.1 28.3 34.7 41.3 27.9 27.7 43.7 92.7 25.8 26.5 28.6 49.2 27.9 31.2 23.5 24.3 36.7 31.8 23.5 35.3 51.7 30.8 18.9 19.9 11.5 20.0 12.9 40.1 14.7 37.2 35.9 22.7 35.2 27.5 29.7 32.4 22.4 20.0 18.4 31.0 41.8 40.7 20.4 31.5 33.8 39.0 6.9 14.2 16.1 16.6 25.3 18.6 18.3 17.3 27.8 32.2 36.7 23.7 41.6 52.0 18.0 25.3 5.1 58.6 12.6 15.6 14.9 18.5 29.5 13.2 15.8 36.1 13.3 39.5 32.3 25.1 28.3 19.5 15.7 20.9 31.9 15.3 17.9 56.3 45.3 22.5 18.0 21.0 6.3 12.0 14.9 30.8 14.9 33.1 51.7 30.8 14.7 16.9 30.1 18.0 23.1 19.5 19.6 21.4 23.5 17.6 16.7 1.8 18.9 29.4 35.3 19.9 11.5 39.6 53.2 30.1 45.7 45.2 38.3 59.3 37.9 58.7 49.2 184.6 55.8 68.6 52.1 45.0 68.0 67.4 196.1 111.1 96.7 160.5 60.9 85.6 111.0 177.4 58.5 118.7 140.2 70.0 139.8 89.1 77.0 39.2 96.2 130.7 90.2 76.3 80.9 188.4 142.1 30.8 119.0 94.7 33.7 151.5 111.3 91.1 161.5 106.7 129.7 165.2 120.2 109.9 79.3 209.8 92.5 52.4 96.7 52.4 94.0 47.0 E2F5 ENSG00000133740 "E2F transcription factor 5" Q15329 8 85177225-85217158 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "B-cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 13.3;naive B-cell: 7.6" "Lineage enriched" "Detected in many" 9 "B-cells: 13.3" "Cell line enhanced" "Detected in many" "AF22: 27.5;Daudi: 54.2;U-698: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055723, HPA065441" Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA055723: AB_2682897, HPA065441: " "unprognostic (8.73e-2)" "unprognostic (3.45e-1)" "unprognostic (3.15e-2)" "unprognostic (1.02e-3)" "unprognostic (6.73e-3)" "unprognostic (1.62e-1)" "unprognostic (3.36e-5)" "unprognostic (1.23e-1)" "unprognostic (9.53e-2)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (2.88e-2)" "unprognostic (3.25e-2)" "unprognostic (3.64e-1)" "unprognostic (2.95e-3)" 3.0 9.0 6.4 22.2 8.1 1.5 5.9 2.6 5.3 5.0 5.9 4.0 3.4 4.6 5.4 7.4 4.7 7.2 6.6 3.2 5.6 5.6 9.0 4.5 5.1 22.4 4.6 2.7 8.3 14.6 12.7 10.6 4.3 3.8 5.1 7.2 3.4 5.7 5.9 1.1 1.7 7.3 3.8 4.5 9.9 5.1 10.5 3.2 13.6 10.2 3.0 26.0 6.0 7.6 13.3 1.4 0.0 0.0 1.1 0.6 0.6 4.9 5.3 27.5 10.2 0.5 0.7 8.8 1.0 2.2 0.8 2.4 3.2 5.8 54.2 3.8 1.1 9.9 1.0 16.0 1.3 1.0 5.6 7.3 5.5 3.0 7.4 4.4 1.6 0.0 1.0 2.2 1.1 3.9 5.4 0.8 5.7 11.5 0.4 1.5 3.2 5.5 3.6 8.8 9.2 4.7 4.4 1.1 5.8 8.9 3.5 3.4 10.6 0.6 1.9 8.1 11.5 11.6 1.7 0.0 1.3 1.0 1.6 3.6 10.2 6.8 25.9 1.5 1.4 2.7 0.0 0.0 0.0 0.1 0.0 0.0 13.3 0.0 0.0 0.1 7.6 0.2 0.4 0.0 1.1 0.0 1.4 0.6 0.6 6.4 8.1 2.6 4.5 5.6 5.6 4.6 2.7 3.8 3.2 0.0 6.2 16.3 2.8 2.1 0.4 1.0 2.5 9.4 3.4 5.2 9.8 2.7 0.0 2.9 5.2 1.5 1.3 0.0 2.1 0.6 3.0 2.7 1.1 2.4 0.4 0.0 7.5 0.6 1.0 2.9 1.4 0.4 3.3 0.0 3.4 4.3 2.8 0.0 1.8 4.9 1.1 0.0 1.7 11.1 3.4 2.5 0.9 1.9 3.7 1.6 E2F8 FLJ23311 ENSG00000129173 "E2F transcription factor 8" A0AVK6 11 19224063-19241620 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.3" "Group enriched" "Detected in some" 5 "Ciliated cells: 8.1;Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.9" "Lineage enriched" "Detected in single" 24 "T-cells: 2.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA064882, HPA076614" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoli "Nucleoplasm, Cytosol" "HPA064882: AB_2685381, HPA076614: " "unprognostic (5.62e-2)" "unprognostic (5.24e-2)" "unprognostic (3.17e-2)" "unprognostic (6.99e-3)" "unprognostic (2.86e-2)" "unprognostic (1.66e-2)" "unprognostic (1.29e-5)" "unprognostic (1.94e-2)" "unprognostic (3.90e-3)" "unprognostic (2.41e-1)" "unprognostic (7.29e-4)" "unprognostic (1.16e-2)" "unprognostic (9.13e-8)" "unprognostic (1.02e-3)" "unprognostic (1.37e-1)" "unprognostic (3.81e-1)" "unprognostic (4.28e-3)" 1.0 0.4 0.4 7.2 0.2 11.5 0.3 0.2 0.4 1.6 3.6 0.2 0.2 3.3 1.2 1.4 8.2 0.9 2.0 3.4 0.2 0.2 0.4 0.5 0.8 6.1 0.2 0.2 0.7 0.3 0.0 0.2 4.0 0.2 0.6 4.8 1.2 1.8 0.9 11.5 2.6 4.6 0.7 0.2 2.4 5.1 4.7 0.2 30.3 0.3 8.0 12.5 3.4 2.1 0.0 0.1 0.0 0.0 0.0 2.9 0.4 14.2 4.2 4.4 6.1 0.2 0.6 18.9 7.9 2.2 9.3 10.1 14.7 4.7 14.1 3.3 2.5 5.5 12.6 10.7 1.0 8.4 9.5 8.7 4.9 2.4 4.0 0.0 7.4 11.8 0.2 0.0 1.9 0.6 0.5 13.0 10.1 10.3 13.7 3.7 6.9 14.6 9.3 4.0 16.1 6.0 15.9 8.2 9.5 4.0 9.6 3.8 4.3 3.5 7.0 0.8 2.4 4.8 8.0 2.5 4.5 5.6 11.0 7.1 4.7 9.5 17.9 5.7 14.7 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 1.5 0.0 1.0 0.0 2.0 0.0 8.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.4 23.3 0.0 1.4 0.6 0.0 0.0 0.0 2.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.1 0.3 0.2 0.0 2.6 0.6 EBNA1BP2 "EBP2, NOBP, P40" ENSG00000117395 "EBNA1 binding protein 2" Q99848 1 43164175-43270936 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026512, HPA028277" Approved Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA026512: AB_1847954, HPA028277: AB_10603664" "unprognostic (9.30e-2)" "unprognostic (2.02e-1)" "unprognostic (1.05e-3)" "unprognostic (2.03e-2)" "unprognostic (8.59e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (7.64e-3)" "unprognostic (2.89e-2)" "unprognostic (1.24e-3)" "unprognostic (7.11e-2)" "unprognostic (1.64e-3)" "unprognostic (4.10e-3)" "unprognostic (3.04e-3)" "unprognostic (1.69e-1)" "unprognostic (3.22e-2)" "unprognostic (1.33e-2)" 18.9 24.8 30.2 22.8 41.1 19.3 27.6 17.7 35.7 18.1 23.6 19.0 15.6 15.4 22.4 40.6 27.8 30.4 15.6 24.9 26.3 25.2 34.0 66.0 18.5 21.9 25.1 29.8 21.8 30.7 24.5 30.0 26.0 29.2 20.3 26.0 16.6 22.3 22.3 28.4 22.8 16.9 24.3 21.6 18.4 19.7 24.8 27.4 18.2 28.8 31.3 25.8 21.5 19.8 26.9 29.6 10.2 22.8 24.1 25.1 17.8 61.7 36.1 13.5 39.1 10.9 12.3 28.0 43.1 21.6 68.9 43.4 40.3 38.6 41.1 34.2 31.3 32.5 44.0 29.2 39.9 75.4 19.4 28.8 28.0 32.5 35.4 19.8 48.5 21.6 9.8 40.4 50.6 41.0 13.2 37.7 28.3 42.3 13.9 33.5 34.0 36.8 29.0 58.7 41.5 33.5 27.0 30.7 46.3 25.3 27.0 26.9 28.9 24.9 46.6 43.2 22.9 19.1 26.5 29.0 26.7 50.3 42.6 70.0 20.6 40.6 50.8 22.1 50.3 53.6 7.5 20.1 10.2 24.0 22.8 25.1 26.9 24.5 24.9 29.6 26.7 22.8 22.8 1.8 24.1 21.6 28.3 24.6 17.8 30.2 41.1 17.7 35.7 26.3 25.2 25.1 29.8 29.2 27.4 32.8 33.2 26.8 68.9 109.3 25.1 28.5 56.0 87.0 48.9 29.6 5.9 95.0 76.3 100.0 109.6 36.8 23.0 70.0 107.4 112.0 52.9 58.1 49.7 127.1 57.6 14.3 23.2 32.5 23.4 70.9 30.8 30.6 52.3 54.1 37.8 44.2 101.2 11.5 36.0 100.9 22.3 38.8 54.7 79.6 103.6 86.9 70.5 23.5 59.7 77.3 ECEL1 "DINE, XCE" ENSG00000171551 "Endothelin converting enzyme like 1" O95672 2 232479827-232487828 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;ovary: 57.1" "Group enriched" "Detected in some" 19 "Muller glia cells: 76.3;Peritubular cells: 19.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.9" "Region enriched" "Detected in many" 5 "hypothalamus: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 30.1;HeLa: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA067560, HPA069756, HPA077424" Approved Supported Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA Nucleoplasm "Nuclear membrane, Nucleoli" "HPA067560: , HPA069756: , HPA077424: " "unprognostic (1.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.39e-1)" "unprognostic (4.62e-3)" "unprognostic (2.80e-1)" "unprognostic (9.96e-4)" "unprognostic (7.56e-3)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.49e-2)" "unprognostic (1.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.24e-5)" "unprognostic (3.09e-2)" "unprognostic (3.68e-1)" "unprognostic (7.84e-2)" "unprognostic (5.45e-2)" 0.9 2.6 0.5 0.9 4.0 0.2 0.4 0.7 1.2 0.3 0.4 0.5 0.1 0.3 0.6 4.9 0.3 1.7 1.0 1.1 0.1 28.6 1.0 0.7 0.2 1.2 0.3 0.1 57.1 0.6 0.3 8.9 0.4 5.5 0.3 0.2 11.5 0.3 1.2 1.8 0.3 0.3 1.1 4.5 2.0 0.3 0.8 1.6 0.1 0.5 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.7 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.0 0.7 1.2 0.1 28.6 0.3 0.1 5.5 1.6 0.0 0.0 0.0 0.0 0.0 2.6 1.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.0 0.0 0.0 76.3 0.2 0.0 19.8 0.0 1.7 0.0 2.1 0.2 1.7 0.0 0.0 0.0 0.0 0.0 EDN1 ET1 ENSG00000078401 "Endothelin 1" P05305 6 12290363-12297194 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 804.7;Ductal cells: 273.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.9" "Lineage enriched" "Detected in many" 6 "monocytes: 7.9" "Cell line enhanced" "Detected in many" "EFO-21: 109.7;HUVEC TERT2: 72.7;T-47d: 22.4;TIME: 53.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031976, CAB032500, CAB037291" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted to blood" NA Yes 9740 "Nucleoli, Golgi apparatus" Nucleoplasm "CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "unprognostic (9.72e-2)" "unprognostic (3.40e-1)" "unprognostic (1.91e-1)" "unprognostic (6.24e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (8.92e-2)" "unprognostic (4.19e-2)" "unprognostic (3.17e-1)" "unprognostic (8.02e-3)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (1.34e-1)" "unprognostic (3.47e-1)" 35.7 1.5 8.4 6.2 30.8 3.6 19.2 3.2 22.0 8.2 9.2 4.2 1.1 9.0 7.2 15.3 10.8 8.6 11.9 5.2 19.0 6.2 5.7 2.8 25.1 6.7 10.9 5.5 4.3 8.2 1.6 1.0 16.0 25.1 5.4 12.9 6.9 9.7 8.5 25.6 8.2 6.7 9.7 13.5 10.2 6.8 4.8 5.6 0.2 2.9 3.8 2.1 5.3 4.1 0.2 0.2 1.2 7.9 0.0 0.2 0.0 1.6 9.2 0.1 0.0 0.0 0.0 0.0 2.9 2.6 2.4 2.0 11.9 1.4 0.0 109.7 1.1 1.5 0.8 0.0 1.7 1.8 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 1.0 0.4 0.3 0.7 72.7 0.0 0.0 0.0 9.2 0.2 0.0 0.0 0.1 1.6 0.1 0.0 0.8 0.0 5.8 1.5 0.1 0.0 0.3 8.7 0.0 20.3 22.4 0.1 53.8 6.2 4.9 0.1 3.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 7.9 0.1 0.0 0.0 8.4 30.8 3.2 22.0 19.0 6.2 10.9 5.5 25.1 5.6 160.8 31.6 0.8 804.7 168.7 0.0 2.0 5.1 0.0 46.6 36.6 0.0 1.4 3.3 273.4 11.4 170.8 145.3 0.0 195.7 0.6 8.2 167.4 1.1 0.8 1.7 1.6 15.0 109.2 6.3 10.0 5.2 3.6 8.5 19.0 12.9 0.2 217.0 147.3 0.4 5.7 0.0 6.5 6.2 1.1 0.4 56.3 0.7 5.7 34.9 116.8 EEF1A2 "EEF1AL, HS1, STN, STNL" ENSG00000101210 "Eukaryotic translation elongation factor 1 alpha 2" Q05639 20 63488012-63499322 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 298.6" "Group enriched" "Detected in some" 5 "Bipolar cells: 100.4;Cardiomyocytes: 108.0;Horizontal cells: 254.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "T-reg: 1.8" "Lineage enriched" "Detected in single" 9 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "HAP1: 56.2;HBF TERT88: 28.3;MCF7: 46.5;SCLC-21H: 29.6;T-47d: 24.1;U-2 OS: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034019, HPA051759, HPA053862, HPA056990" Approved Approved Nucleoli,Cytosol NA NA 55000000 Cytosol Nucleoli "CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302" "unprognostic (1.40e-2)" "unprognostic (6.82e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (2.90e-5)" "unprognostic (5.17e-2)" "prognostic unfavorable (9.11e-4)" "unprognostic (4.85e-1)" "unprognostic (1.68e-1)" "unprognostic (3.02e-2)" "unprognostic (1.74e-2)" "unprognostic (2.20e-2)" "unprognostic (2.30e-1)" "unprognostic (1.86e-1)" "unprognostic (8.29e-3)" "unprognostic (1.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" 2.2 8.0 21.3 2.3 23.5 1.9 2.2 41.1 51.3 1.9 2.3 2.3 0.1 2.2 2.0 2.3 4.1 2.1 2.6 51.9 23.0 21.0 2.0 2.0 2.0 2.1 13.9 31.0 2.0 3.5 6.1 16.6 2.0 23.1 3.7 2.1 1.8 3.4 2.2 298.6 2.2 2.3 2.1 4.8 2.0 3.6 2.3 3.6 0.0 2.0 23.9 2.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.3 0.1 10.8 0.2 2.6 0.0 0.1 1.3 2.1 0.3 10.7 3.6 1.4 7.1 0.0 18.9 0.1 2.9 5.1 56.2 0.1 28.3 0.1 2.6 0.0 4.0 0.4 0.6 0.0 2.5 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.1 46.5 0.1 0.1 1.9 19.3 18.1 1.3 0.0 1.7 0.4 0.5 29.6 18.0 17.1 1.9 0.1 0.5 24.1 0.6 0.0 0.0 32.9 0.1 0.3 0.0 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 21.3 23.5 41.1 51.3 23.0 21.0 13.9 31.0 23.1 3.6 0.0 0.0 0.0 0.5 0.3 100.4 108.0 0.0 0.0 1.2 0.0 11.8 0.0 0.0 1.5 0.1 0.1 0.0 0.0 0.2 0.1 0.2 2.9 5.7 0.0 0.0 254.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 10.8 0.3 0.0 0.0 0.3 33.6 0.0 0.3 0.0 0.1 1.6 0.0 0.0 0.0 0.9 EFCAB14 KIAA0494 ENSG00000159658 "EF-hand calcium binding domain 14" O75071 1 46675159-46719064 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011224, HPA011938" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA 58000 Cytosol "Nucleoli, Golgi apparatus" "HPA011224: AB_1852314, HPA011938: AB_1852317" "unprognostic (2.44e-1)" "unprognostic (5.90e-2)" "unprognostic (7.53e-2)" "unprognostic (2.36e-1)" "unprognostic (7.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.39e-2)" "unprognostic (6.06e-2)" "unprognostic (1.73e-1)" "unprognostic (1.66e-1)" "unprognostic (1.21e-2)" "unprognostic (3.00e-1)" "unprognostic (1.13e-3)" "unprognostic (1.00e-2)" "unprognostic (5.77e-2)" "unprognostic (1.94e-1)" "unprognostic (2.46e-1)" 29.4 17.4 29.4 14.3 29.5 6.7 22.5 16.2 24.8 25.3 26.0 40.6 15.6 17.2 23.7 27.3 30.0 22.0 19.7 20.2 27.2 20.5 27.8 24.9 24.0 16.4 31.0 15.2 25.2 16.0 107.1 17.2 25.2 27.3 24.4 24.0 23.0 19.9 24.9 24.7 20.4 26.9 22.5 36.1 24.0 36.4 21.9 30.6 28.7 30.1 13.2 20.2 25.7 20.0 16.6 16.0 30.3 21.1 17.1 28.5 18.3 14.5 8.3 7.1 11.2 34.0 21.4 16.3 15.8 23.3 17.5 18.1 9.9 9.9 11.7 16.5 21.4 23.7 17.6 12.1 17.4 23.8 22.2 7.8 14.6 9.2 4.0 11.7 18.8 28.8 18.9 29.2 13.9 11.6 16.8 21.3 11.4 9.0 16.7 18.0 5.7 12.4 8.5 10.1 17.2 9.4 9.5 19.9 10.2 18.5 29.6 3.7 5.1 19.5 27.6 14.8 20.1 12.3 16.5 19.6 15.0 7.3 17.4 16.0 17.2 23.8 9.4 19.2 16.2 11.0 15.6 18.6 30.3 23.6 21.1 28.5 16.6 20.6 20.2 16.0 16.2 18.0 19.5 12.5 17.1 18.3 12.9 17.8 18.3 29.4 29.5 16.2 24.8 27.2 20.5 31.0 15.2 27.3 30.6 68.5 69.2 34.6 40.1 28.2 30.1 33.2 45.9 45.5 45.5 108.2 29.5 31.8 26.6 31.3 50.1 52.8 51.8 0.0 33.7 27.6 35.0 57.4 96.2 51.2 37.0 44.5 36.2 46.1 67.7 14.4 43.7 41.1 25.3 34.3 62.6 50.2 37.9 57.5 46.7 30.6 17.7 25.8 28.8 37.2 23.3 38.0 49.3 41.5 41.9 98.2 EFCAB7 "KIAA1799, RP4-534K7.1" ENSG00000203965 "EF-hand calcium binding domain 7" A8K855 1 63523372-63572693 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 25.4;Sertoli cells: 25.8;Spermatocytes: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029611, HPA029612, HPA029613" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "Plasma membrane, Cytosol" "HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004" "unprognostic (8.81e-2)" "unprognostic (5.24e-2)" "unprognostic (5.13e-2)" "unprognostic (1.64e-1)" "prognostic favorable (3.65e-4)" "unprognostic (1.70e-2)" "unprognostic (6.53e-4)" "unprognostic (2.99e-1)" "unprognostic (5.81e-3)" "unprognostic (1.69e-1)" "unprognostic (6.28e-2)" "unprognostic (1.66e-1)" "unprognostic (3.78e-2)" "unprognostic (2.18e-1)" "unprognostic (6.97e-2)" "unprognostic (9.90e-2)" "unprognostic (2.73e-1)" 4.3 8.4 12.7 3.5 16.7 3.1 9.3 24.5 19.5 9.4 5.1 3.7 6.4 3.2 9.6 9.8 5.7 12.6 7.2 9.7 11.4 11.8 8.8 2.8 6.2 5.2 8.1 10.8 12.8 4.9 16.3 31.6 5.1 13.7 8.7 5.0 3.5 5.3 8.2 10.8 4.9 3.4 7.5 9.4 4.2 5.0 20.0 10.2 11.5 9.1 2.4 5.2 7.3 12.9 3.3 1.7 9.8 3.3 1.8 2.9 1.1 6.0 5.1 6.7 4.3 7.1 10.6 3.4 3.9 4.3 6.8 8.4 1.6 4.8 4.3 9.4 2.2 13.9 5.6 5.7 3.7 8.2 7.9 4.0 3.4 9.5 3.5 4.5 4.7 3.1 5.7 9.2 8.0 5.4 10.8 5.7 7.9 4.3 7.0 4.4 1.3 9.0 3.2 2.9 4.2 5.1 5.8 10.1 4.2 10.4 3.2 14.4 5.5 7.5 4.2 9.6 9.4 4.3 3.4 1.5 3.8 3.4 11.4 3.7 4.7 8.1 4.9 7.0 3.4 5.6 9.8 0.7 0.2 2.1 0.4 2.9 3.3 2.4 2.5 1.3 2.8 2.5 2.4 0.1 1.8 3.3 1.7 2.7 1.1 12.7 16.7 24.5 19.5 11.4 11.8 8.1 10.8 13.7 10.2 11.9 2.6 2.9 5.2 2.7 8.3 6.2 0.0 25.4 4.5 5.2 3.9 2.9 6.6 2.9 17.3 2.1 0.5 0.0 0.6 1.6 3.0 1.5 2.3 0.8 2.1 0.0 1.7 2.5 2.4 3.2 10.0 1.1 1.7 1.8 1.4 5.8 1.1 0.0 12.7 4.6 10.5 25.8 2.3 58.1 17.7 1.9 1.0 1.3 1.7 0.7 EFHB "CFAP21, FLJ25200" ENSG00000163576 "EF-hand domain family member B" Q8N7U6 3 19879472-19947025 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 23.3;testis: 19.2" "Group enriched" "Detected in many" 4 "Ciliated cells: 129.8;Early spermatids: 43.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 33 "RPTEC TERT1: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078067 Approved Nucleoli NA NA Nucleoli "HPA078067: AB_2732370" "unprognostic (9.70e-2)" "unprognostic (2.71e-2)" "unprognostic (2.37e-1)" "unprognostic (2.33e-2)" "unprognostic (1.20e-2)" "unprognostic (9.56e-3)" "unprognostic (1.51e-5)" "unprognostic (4.43e-2)" "unprognostic (3.66e-1)" "unprognostic (1.51e-1)" "unprognostic (4.92e-2)" "unprognostic (5.47e-2)" "unprognostic (6.06e-2)" "unprognostic (2.13e-2)" "unprognostic (9.35e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" 1.1 1.5 3.9 0.7 6.0 0.7 1.8 0.7 4.3 2.0 0.7 6.5 0.0 0.6 2.0 7.8 1.0 23.3 1.3 0.8 6.3 4.7 1.8 0.7 3.9 0.7 4.4 2.2 5.5 0.5 0.5 1.6 1.0 9.5 1.0 1.0 2.3 0.6 1.3 0.7 1.1 0.6 1.6 3.1 1.2 0.6 19.2 6.0 0.0 1.2 0.0 0.8 0.7 0.6 1.3 0.6 1.1 0.8 0.4 2.2 0.4 0.0 0.5 0.2 0.2 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 21.5 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.1 2.2 0.1 0.1 0.8 0.3 0.4 0.0 1.3 0.5 0.3 1.1 0.4 0.3 0.6 0.0 0.4 3.9 6.0 0.7 3.8 6.3 4.7 4.4 2.2 9.5 6.0 0.0 0.6 0.0 0.4 0.1 0.5 0.3 7.6 129.8 20.5 3.5 2.0 0.8 5.0 0.3 43.0 0.2 0.5 0.0 0.2 0.4 1.1 0.3 3.5 0.4 0.4 1.6 1.2 0.6 1.3 16.0 2.3 0.7 0.0 0.0 0.0 3.6 0.4 0.0 2.1 4.5 0.7 0.0 0.3 18.4 3.3 0.1 0.7 0.0 0.3 0.1 EID3 "FLJ25832, NSE4B, NSMCE4B" ENSG00000255150 "EP300 interacting inhibitor of differentiation 3" Q8N140 12 104303739-104305205 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 69.1" "Cell type enriched" "Detected in many" 6 "Spermatocytes: 291.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;NK-cells: 6.6;T-cells: 9.5" "Cell line enhanced" "Detected in many" "A549: 10.2;BJ: 9.5;BJ hTERT+: 7.8;BJ hTERT+ SV40 Large T+ RasG12V: 7.8;HeLa: 8.6" "Low region specificity" "Detected in single" HPA059367 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA059367: AB_2683992" "unprognostic (1.25e-1)" "unprognostic (5.41e-3)" "unprognostic (5.82e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (8.02e-2)" "unprognostic (5.88e-5)" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-2)" "unprognostic (5.38e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.96e-5)" "unprognostic (8.70e-2)" "unprognostic (3.54e-1)" "unprognostic (2.04e-3)" "unprognostic (2.87e-2)" 1.7 1.7 2.0 2.9 2.7 3.0 1.7 4.0 2.6 1.6 1.8 1.5 0.2 0.6 2.1 1.9 1.3 1.8 1.8 1.2 1.9 1.9 1.2 0.9 1.8 3.7 1.2 2.3 3.4 1.7 0.9 5.3 1.1 2.2 2.7 0.6 1.7 1.3 4.1 1.5 1.6 1.6 1.6 1.2 1.9 1.4 69.1 1.6 2.3 1.0 0.4 2.5 1.5 1.3 2.9 0.5 0.7 1.5 6.6 9.5 2.6 0.3 10.2 0.3 1.0 2.3 2.4 2.0 9.5 7.8 4.6 7.8 0.2 0.5 0.1 0.1 2.1 2.1 0.2 0.3 0.8 6.8 0.6 0.1 1.9 8.6 1.5 3.4 0.2 0.5 3.2 0.0 2.9 0.6 0.4 0.7 0.4 0.1 0.6 2.8 0.1 3.4 1.4 0.5 0.2 2.0 0.3 0.0 0.1 2.5 0.3 0.1 0.0 6.3 0.4 0.2 0.2 0.0 0.0 1.4 0.1 0.3 2.3 0.4 0.5 0.2 0.1 0.2 0.0 1.0 0.0 0.3 0.5 5.2 1.5 5.5 2.7 6.6 6.2 0.3 2.9 9.5 5.7 0.7 6.6 0.9 0.5 7.6 2.6 2.0 2.7 4.0 2.6 1.9 1.9 1.2 2.3 2.2 1.6 0.0 5.9 2.9 50.8 11.8 3.4 1.1 0.0 4.0 1.2 1.8 25.5 2.0 0.0 2.4 44.2 5.2 1.3 0.0 1.2 1.1 8.0 25.2 1.1 1.7 1.7 11.1 0.0 6.2 4.0 12.9 8.1 6.1 1.7 5.4 0.0 7.6 5.0 0.2 4.2 1.0 17.5 6.5 8.2 291.8 33.6 6.8 2.1 10.2 0.7 39.4 EIF2S2 "EIF2, EIF2beta, PPP1R67" ENSG00000125977 "Eukaryotic translation initiation factor 2 subunit beta" P20042 20 34088298-34112332 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034415, HPA041262, HPA041332" Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoli "CAB034415: AB_2095998, HPA041262: AB_2677381, HPA041332: AB_2677417" "unprognostic (5.76e-3)" "unprognostic (7.12e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.02e-1)" "unprognostic (1.47e-3)" "prognostic unfavorable (3.23e-5)" "unprognostic (9.36e-3)" "unprognostic (2.39e-1)" "unprognostic (6.55e-3)" "unprognostic (3.04e-3)" "unprognostic (1.25e-2)" "prognostic unfavorable (9.64e-10)" "unprognostic (2.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.04e-1)" "unprognostic (1.12e-2)" 25.9 30.1 32.8 23.3 40.7 21.4 38.1 20.2 37.7 21.1 24.3 10.9 27.1 21.2 21.2 22.4 36.3 17.0 18.3 36.3 30.1 20.4 22.0 40.1 27.2 37.7 40.0 26.2 19.9 45.4 18.7 22.4 29.9 35.8 20.4 24.7 7.4 26.3 25.5 101.8 21.2 20.4 37.0 50.2 23.0 28.1 19.6 35.6 18.2 24.1 32.7 30.1 25.0 30.7 38.8 48.5 28.1 39.3 32.4 42.4 27.3 39.3 26.5 20.1 24.2 19.7 30.0 38.4 36.1 34.6 36.0 36.4 93.1 27.8 35.4 26.6 32.6 40.1 37.3 32.6 59.3 43.8 11.3 17.8 70.1 21.8 47.5 51.0 44.8 22.9 30.6 50.7 35.6 53.3 24.7 37.6 52.5 41.1 33.9 29.6 25.3 41.5 37.5 19.5 45.8 48.5 23.9 34.3 32.7 28.4 33.0 20.5 14.0 40.0 24.3 74.0 24.4 36.7 53.1 25.3 41.2 25.4 25.8 33.8 31.8 28.0 36.9 38.7 34.9 29.8 21.2 37.0 28.1 26.9 39.3 32.9 38.8 38.2 37.6 34.7 31.8 36.4 36.5 21.9 32.4 35.6 48.5 42.4 27.3 32.8 40.7 20.2 37.7 30.1 20.4 40.0 26.2 35.8 35.6 157.8 148.8 160.1 252.4 160.3 53.2 134.4 252.3 164.6 154.7 132.6 29.5 312.1 260.2 306.9 265.0 180.9 122.1 397.1 456.4 341.9 160.2 180.5 139.9 436.7 212.4 39.7 121.7 263.9 224.1 127.6 117.1 190.4 113.1 327.4 153.0 65.4 448.4 141.1 121.6 191.6 90.0 109.9 93.7 435.4 188.7 152.4 536.6 139.5 166.4 296.5 EIF3L "EIF3EIP, EIF3S11, EIF3S6IP, HSPC021, HSPC025" ENSG00000100129 "Eukaryotic translation initiation factor 3 subunit L" Q9Y262 22 37848868-37889407 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003028 Approved Approved Nucleoplasm,Nucleoli NA NA 22000000 Nucleoli Nucleoplasm "HPA003028: AB_1078726" "unprognostic (2.07e-2)" "unprognostic (3.02e-2)" "unprognostic (5.06e-3)" "unprognostic (3.20e-1)" "unprognostic (3.79e-3)" "unprognostic (9.86e-2)" "unprognostic (1.35e-1)" "unprognostic (9.65e-2)" "unprognostic (2.66e-1)" "unprognostic (5.81e-3)" "unprognostic (2.35e-1)" "unprognostic (9.74e-2)" "prognostic favorable (6.11e-4)" "unprognostic (1.48e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (2.03e-3)" 30.9 18.4 17.4 17.5 19.8 26.4 55.1 34.4 19.3 40.7 29.1 16.1 16.7 20.8 36.1 18.9 33.4 24.2 14.0 15.5 15.0 15.6 23.7 36.1 18.4 31.3 14.0 13.4 63.4 78.8 20.2 26.8 27.9 17.7 38.7 23.8 21.5 39.6 31.0 40.3 30.6 25.2 35.8 15.6 24.7 22.7 19.6 11.4 44.0 54.8 32.3 31.0 38.6 22.0 33.6 58.1 9.8 35.9 25.0 42.5 55.2 16.8 9.6 27.1 19.6 26.3 58.8 19.5 16.2 39.0 26.2 35.8 16.0 12.5 58.2 4.5 18.9 9.1 10.9 29.8 22.4 30.9 7.6 49.8 20.5 14.0 7.5 16.4 54.4 17.7 31.6 25.7 19.3 29.2 45.4 32.5 19.3 17.0 15.9 30.2 6.6 14.5 25.2 15.4 20.6 25.3 16.6 37.2 17.0 19.9 10.2 19.8 30.6 16.0 18.8 21.9 31.8 14.3 22.0 15.7 16.3 19.9 9.9 12.9 9.5 15.5 23.7 15.3 24.1 13.3 9.8 35.9 9.6 20.7 35.4 34.6 33.6 30.0 25.0 58.1 27.5 42.5 31.8 4.8 25.0 29.1 28.4 29.1 55.2 17.4 19.8 34.4 19.3 15.0 15.6 14.0 13.4 17.7 11.4 110.2 191.5 294.7 357.3 352.7 56.1 1.4 165.6 77.6 174.0 62.8 27.5 578.0 353.1 204.0 111.9 215.8 81.1 116.8 400.6 517.3 230.5 236.6 216.1 101.7 227.0 23.8 189.5 125.8 250.1 286.2 206.0 267.8 215.9 373.3 211.0 74.0 242.7 189.4 199.4 249.7 32.9 161.7 287.4 90.7 87.1 375.5 588.1 261.5 327.6 377.5 EIPR1 "EIPR-1, TSSC1" ENSG00000032389 "EARP complex and GARP complex interacting protein 1" Q53HC9 2 3188925-3377882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 43.9;Distal tubular cells: 43.1;Extravillous trophoblasts: 29.7;Hofbauer cells: 29.7;monocytes: 28.9;Proximal tubular cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031231, HPA031232, HPA031233, HPA031234" Approved Supported "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli" "Intermediate filaments" "HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803" "unprognostic (2.16e-1)" "unprognostic (2.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.66e-1)" "unprognostic (4.27e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (3.67e-7)" "unprognostic (1.94e-1)" "unprognostic (1.57e-1)" "unprognostic (7.83e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (1.78e-1)" "unprognostic (1.02e-2)" "unprognostic (3.43e-1)" "unprognostic (2.24e-2)" "unprognostic (3.83e-2)" 7.3 12.3 20.1 17.3 24.4 14.2 9.0 26.0 22.9 8.3 11.9 12.1 10.0 10.7 7.7 18.4 14.5 12.0 7.9 10.3 17.7 19.3 12.4 11.4 7.9 15.2 15.1 14.5 5.8 11.6 14.2 20.8 8.0 13.6 7.7 10.9 10.5 9.9 7.4 10.9 9.2 9.3 9.4 12.4 12.0 9.3 9.9 11.5 14.5 20.4 15.5 15.3 11.1 7.7 15.7 23.4 13.9 13.3 16.3 16.9 14.0 10.6 20.1 10.7 12.1 6.8 9.2 24.3 11.2 11.7 13.5 10.3 13.4 13.5 18.7 19.9 11.4 12.8 11.0 8.4 16.2 7.5 14.5 15.9 16.5 12.5 30.9 13.0 16.1 20.6 8.4 14.7 13.7 17.8 7.5 17.1 33.4 18.4 13.0 12.4 19.9 14.9 23.5 12.4 25.2 16.1 17.5 11.4 25.1 16.8 14.8 23.4 27.2 7.9 13.3 12.2 6.0 12.3 15.1 12.0 10.9 5.6 8.9 15.0 14.9 36.0 15.5 12.9 16.8 10.0 13.9 11.8 9.4 16.1 13.3 16.3 13.9 13.4 16.8 21.3 15.7 14.7 15.8 5.0 16.3 11.9 23.4 16.9 14.0 20.1 24.4 26.0 22.9 17.7 19.3 15.1 14.5 13.6 11.5 3.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 11.4 19.2 0.0 43.9 43.1 25.6 0.0 0.0 0.0 0.0 13.9 29.7 0.0 0.0 3.5 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 28.9 0.0 0.0 17.8 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 ELAVL1 "Hua, HuR, MelG" ENSG00000066044 "ELAV like RNA binding protein 1" Q15717 19 7958579-8005659 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005256, HPA046298" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA 210000 Nucleoplasm "Nucleoli, Cytosol" "CAB005256: AB_2096342, HPA046298: AB_2679618" "unprognostic (1.19e-1)" "unprognostic (9.66e-3)" "unprognostic (2.46e-2)" "unprognostic (3.98e-1)" "unprognostic (1.04e-1)" "unprognostic (6.37e-3)" "unprognostic (1.81e-2)" "unprognostic (8.44e-2)" "unprognostic (3.75e-2)" "prognostic favorable (4.93e-4)" "unprognostic (2.09e-1)" "unprognostic (1.59e-2)" "unprognostic (7.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 19.7 23.8 28.0 22.4 34.1 17.2 22.4 35.4 28.0 23.1 21.4 21.2 19.6 17.9 27.5 19.7 24.4 25.7 16.9 25.2 23.6 17.6 20.8 21.4 19.4 26.5 27.5 22.2 25.7 20.4 29.4 25.4 23.3 26.5 20.4 20.2 19.7 21.2 23.0 27.6 19.2 18.4 30.4 17.7 21.9 19.7 46.7 26.5 40.4 20.6 18.7 30.7 23.4 32.2 17.1 17.6 24.3 14.7 23.2 19.6 9.4 36.1 24.0 40.3 30.3 15.8 15.9 22.7 27.0 22.7 40.2 31.5 34.7 21.1 43.6 38.0 29.6 22.6 25.3 44.9 30.9 34.1 38.9 41.7 38.2 17.7 32.3 23.2 36.2 30.6 19.7 18.6 28.0 17.1 19.1 30.7 33.3 39.2 32.7 27.7 26.8 60.5 29.2 35.9 27.2 30.6 68.1 26.3 28.7 25.5 26.7 29.0 21.2 25.6 25.9 20.4 25.4 29.5 28.6 23.0 37.7 26.4 34.9 46.4 33.4 32.3 45.8 21.1 43.6 32.5 16.4 13.0 24.3 12.2 11.7 12.9 14.0 17.8 19.6 17.6 17.1 16.1 12.4 3.8 23.2 14.7 8.8 13.5 9.4 28.0 34.1 35.4 28.0 23.6 17.6 27.5 22.2 26.5 26.5 23.8 23.9 31.2 59.2 64.3 42.6 27.2 30.6 14.7 13.6 45.4 53.0 76.4 56.3 31.1 188.6 49.4 29.5 0.0 29.2 87.0 49.8 55.0 20.7 78.0 55.5 57.2 40.4 43.0 50.2 108.9 46.6 53.3 49.0 30.7 47.6 43.8 29.8 48.6 53.4 49.4 54.8 51.8 58.0 132.2 59.8 62.0 62.6 49.8 53.0 69.3 ELL3 FLJ22637 ENSG00000128886 "Elongation factor for RNA polymerase II 3" Q9HB65 15 43772600-43777543 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.3;lymphoid tissue: 24.2" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 5.3;Early spermatids: 1.5;Enterocytes: 1.7;Late spermatids: 1.8;Mucus-secreting cells: 2.0;Undifferentiated cells: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "memory B-cell: 5.3;naive B-cell: 8.5" "Lineage enriched" "Detected in many" 7 "B-cells: 8.5" "Cell line enhanced" "Detected in some" "Daudi: 7.9;U-698: 19.2" "Region enriched" "Detected in single" 11 "olfactory region: 2.4" "Not detected" "Not detected" "HPA028938, HPA073494" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" NA NA "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA028938: AB_10795352, HPA073494: " "unprognostic (2.59e-2)" "unprognostic (4.41e-1)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (3.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.17e-1)" "unprognostic (2.42e-3)" "unprognostic (1.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.19e-1)" "unprognostic (3.53e-1)" "unprognostic (1.87e-1)" "unprognostic (3.67e-2)" "unprognostic (8.95e-2)" "unprognostic (1.08e-1)" "unprognostic (1.24e-2)" 0.7 1.1 1.0 24.2 0.6 0.4 2.5 4.7 0.6 2.3 10.6 0.5 1.6 4.8 1.0 1.0 5.5 1.3 0.9 0.6 1.0 0.6 1.8 0.5 0.9 7.5 1.3 0.0 1.3 0.7 0.6 1.2 0.8 2.6 2.1 1.8 0.8 2.0 0.7 1.0 7.0 13.3 0.9 0.6 1.5 1.1 12.3 0.5 0.8 1.1 2.8 16.7 1.3 1.7 8.5 1.0 0.1 0.1 0.1 1.2 0.6 0.6 0.1 0.6 0.2 1.6 0.1 0.1 0.2 0.5 0.8 1.3 0.1 0.5 7.9 0.1 0.7 0.1 2.9 0.3 0.0 0.5 0.7 3.4 0.3 2.6 0.8 0.5 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.1 1.2 0.3 0.9 0.0 1.1 0.8 0.8 0.1 0.1 0.2 0.0 3.6 0.2 0.3 1.5 0.3 0.1 3.6 0.2 0.1 0.2 0.0 0.3 0.2 0.0 0.0 19.2 0.2 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.2 5.3 0.5 0.2 0.0 8.5 1.2 0.3 0.1 0.1 0.0 1.0 0.3 0.6 1.0 0.6 4.7 0.6 1.0 0.6 1.3 0.0 2.6 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 1.7 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.2 0.0 2.0 0.1 ELMOD2 MGC10084 ENSG00000179387 "ELMO domain containing 2" Q8IZ81 4 140524158-140553770 "Predicted intracellular proteins" "Antiviral defense" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047600 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "HPA047600: AB_2680098" "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (6.70e-3)" "unprognostic (2.10e-3)" "unprognostic (4.91e-2)" "unprognostic (3.93e-1)" "unprognostic (1.66e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-1)" "unprognostic (7.93e-2)" "unprognostic (1.05e-2)" "unprognostic (3.65e-1)" "prognostic favorable (1.17e-8)" "unprognostic (3.17e-1)" "unprognostic (4.03e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (1.82e-2)" 11.6 20.8 9.2 11.9 14.0 8.5 16.7 14.0 10.6 13.8 17.9 10.4 24.7 14.4 15.4 15.8 13.9 13.9 10.9 18.0 10.4 11.2 20.6 19.3 14.5 13.9 13.6 9.2 13.0 17.2 20.2 24.1 17.3 13.6 15.5 15.2 12.1 13.5 21.2 8.4 10.5 31.0 12.4 14.4 11.6 12.1 9.1 12.3 18.2 19.6 10.5 11.2 12.1 11.6 6.0 10.6 17.0 7.8 7.8 8.6 4.8 6.6 7.4 15.2 11.6 15.9 18.4 9.8 15.8 15.0 8.8 10.6 7.3 14.2 10.9 7.0 9.8 10.7 6.1 14.4 10.0 10.9 10.5 8.5 8.9 5.8 9.4 14.5 13.6 8.0 12.6 16.7 7.4 7.7 13.9 9.6 13.3 11.4 18.0 15.0 4.8 14.8 4.7 8.0 9.7 6.1 17.4 11.7 7.0 12.7 10.6 7.2 26.8 10.3 10.6 11.3 17.8 10.4 5.7 9.6 20.3 7.3 9.4 16.2 18.9 26.8 13.8 14.8 10.8 15.2 2.6 7.2 8.7 7.5 7.8 8.6 3.8 6.9 8.3 6.1 6.0 7.1 7.0 17.0 7.8 5.9 10.6 8.0 4.8 9.2 14.0 14.0 10.6 10.4 11.2 13.6 9.2 13.6 12.3 26.8 15.3 5.2 9.6 8.1 19.0 12.3 5.1 25.4 5.7 17.4 17.7 19.0 1.7 20.2 2.0 11.7 15.3 0.0 22.7 7.3 13.3 8.8 19.6 24.6 17.2 14.3 8.7 11.1 17.4 1.0 12.0 13.4 16.9 11.8 12.5 18.5 21.7 12.2 10.3 15.1 22.8 6.5 6.1 25.6 19.4 10.2 16.8 10.7 10.8 4.8 ELOC "SIII, TCEB1" ENSG00000154582 "Elongin C" Q15369 8 73939169-73972287 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 271.8;Hofbauer cells: 287.3;Pancreatic endocrine cells: 255.4;Proximal tubular cells: 236.7;Syncytiotrophoblasts: 278.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078113 Approved "Nucleoli,Vesicles,Cell Junctions" NA NA 250000 Vesicles "Nucleoli, Cell Junctions" "HPA078113: AB_2686877" "prognostic unfavorable (6.48e-4)" "unprognostic (1.60e-1)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" "unprognostic (2.46e-2)" "unprognostic (8.02e-3)" "unprognostic (5.84e-3)" "unprognostic (2.19e-2)" "unprognostic (1.77e-1)" "unprognostic (6.99e-3)" "unprognostic (4.02e-3)" "unprognostic (3.33e-2)" "unprognostic (2.77e-3)" "unprognostic (3.84e-2)" "unprognostic (5.33e-2)" "unprognostic (1.67e-1)" "unprognostic (8.95e-2)" 27.0 29.5 39.1 19.2 37.6 35.4 24.2 25.6 43.3 17.5 19.6 12.2 21.0 13.4 18.2 31.7 24.5 17.2 17.9 50.1 33.9 29.5 28.2 36.1 21.2 35.2 32.5 28.4 17.9 25.5 17.6 20.0 25.7 27.3 19.2 20.6 12.1 16.3 21.0 62.5 16.6 14.5 24.4 33.9 18.7 18.5 51.0 18.8 19.7 19.6 31.9 27.9 19.3 16.7 38.9 55.3 51.7 35.4 32.5 44.9 26.4 43.9 36.0 33.0 23.9 25.3 33.1 23.7 43.7 35.7 42.9 44.1 32.0 38.4 22.4 35.4 38.7 58.0 31.5 36.4 43.6 56.8 25.8 30.2 39.0 38.5 50.6 33.0 25.0 29.3 33.4 35.0 38.8 50.2 31.9 39.8 38.8 34.4 30.1 56.3 32.5 64.3 44.9 30.0 72.1 58.4 23.5 20.8 21.3 46.8 38.6 31.2 29.6 18.3 99.9 40.8 35.8 36.8 27.0 30.4 31.2 35.3 34.1 43.7 34.2 41.8 41.3 37.5 27.4 37.8 51.7 32.2 38.2 31.2 35.4 34.0 38.9 37.5 34.8 34.2 34.0 34.3 34.4 37.7 32.5 33.8 55.3 44.9 26.4 39.1 37.6 25.6 43.3 33.9 29.5 32.5 28.4 27.3 18.8 62.5 90.6 0.0 0.0 0.0 0.0 0.0 0.0 116.4 91.0 113.4 0.0 190.4 225.5 210.9 0.0 0.0 0.0 0.0 197.5 271.8 0.0 0.0 64.0 0.0 287.3 0.0 0.0 0.0 0.0 0.0 0.0 68.7 0.0 196.6 0.0 0.0 255.4 0.0 0.0 236.7 0.0 0.0 0.0 0.0 0.0 0.0 278.0 0.0 0.0 0.0 EMX1 ENSG00000135638 "Empty spiracles homeobox 1" Q04741 2 72916260-72936071 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.8;kidney: 27.4" "Group enriched" "Detected in some" 8 "Collecting duct cells: 52.4;Proximal tubular cells: 31.6" "Cancer enhanced" "Detected in some" "renal cancer: 3.7" "Region enhanced" "Detected in many" "cerebral cortex: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.7;CACO-2: 5.7;HEK 293: 12.8;HMC-1: 2.5;RPTEC TERT1: 2.2;U-2 OS: 2.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 13 "amygdala: 3.8;cerebral cortex: 11.1;hippocampal formation: 8.6" "HPA006230, HPA006421" Approved Supported "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA006230: AB_2667542, HPA006421: AB_1078739" "unprognostic (4.54e-2)" "unprognostic (5.59e-2)" "unprognostic (8.71e-2)" "unprognostic (2.22e-6)" "unprognostic (4.82e-2)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.04e-1)" "unprognostic (2.99e-1)" "unprognostic (3.07e-1)" "prognostic favorable (1.54e-6)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.08e-3)" "unprognostic (5.02e-2)" 0.2 0.3 5.2 0.2 3.1 0.1 0.1 0.1 14.8 0.1 0.5 0.0 0.8 1.4 0.1 6.0 0.2 0.1 0.1 0.2 5.0 0.4 27.4 0.2 0.1 0.2 0.4 1.5 0.2 0.4 4.8 0.2 0.1 0.0 0.2 0.2 0.0 0.6 0.2 0.2 0.2 1.1 0.1 0.1 0.1 0.3 2.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.8 0.0 0.0 1.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 3.1 0.1 14.8 5.0 0.4 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 52.4 0.0 0.0 5.0 0.0 0.8 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 ENSA "ARPP-19e, MGC4319, MGC78563, MGC8394" ENSG00000143420 "Endosulfine alpha" O43768 1 150600851-150629612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 625.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 13 "U-698: 429.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051294 Uncertain Approved Nucleoplasm,Nucleoli,Microtubules,Cytosol NA NA 22000 "Nucleoplasm, Nucleoli" "Microtubules, Cytosol" "HPA051294: AB_2681425" "unprognostic (6.27e-2)" "prognostic favorable (8.24e-4)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (2.58e-1)" "unprognostic (8.24e-2)" "unprognostic (1.94e-3)" "unprognostic (1.82e-1)" "unprognostic (2.02e-1)" "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (5.40e-2)" "unprognostic (2.21e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-1)" "unprognostic (7.64e-2)" "unprognostic (8.07e-3)" 30.3 26.4 48.9 26.9 48.9 46.8 33.0 33.8 69.3 31.7 31.8 28.0 26.8 34.4 29.7 45.4 66.3 26.3 28.5 30.0 42.4 37.9 31.7 32.3 28.6 30.0 42.0 39.0 27.7 30.5 33.0 25.2 37.5 34.6 23.9 30.4 28.5 29.4 22.8 67.7 49.8 34.0 27.3 38.3 23.8 28.7 12.8 27.3 25.8 35.2 42.9 35.5 31.7 36.3 34.4 39.5 49.5 33.6 33.0 33.2 38.4 14.7 7.7 10.8 10.4 6.9 5.7 11.7 6.6 6.7 9.9 8.4 8.7 11.1 13.2 11.0 5.3 6.2 11.9 8.7 14.7 7.3 22.8 12.1 18.9 10.9 6.6 4.6 15.2 24.4 4.5 9.1 10.3 13.2 5.5 9.3 10.5 14.4 27.8 6.6 31.8 15.0 12.4 21.6 17.4 9.6 14.6 9.0 16.4 13.0 13.0 16.2 10.2 9.4 19.8 10.3 9.5 27.1 22.4 9.8 7.4 13.7 8.8 17.1 15.6 22.7 429.6 10.2 17.7 9.7 28.7 30.7 49.5 32.2 33.6 28.9 34.4 27.0 33.2 39.5 31.8 22.3 32.9 29.0 33.0 31.9 30.2 29.8 38.4 48.9 48.9 33.8 69.3 42.4 37.9 42.0 39.0 34.6 27.3 38.7 144.0 138.7 185.4 169.1 60.1 89.1 79.0 109.7 114.9 78.5 43.2 247.9 215.5 139.6 6.0 100.3 151.4 46.7 132.7 150.0 85.0 114.8 218.3 71.0 175.6 63.5 125.5 52.8 77.7 11.1 79.7 128.3 97.8 625.8 119.8 57.9 90.7 136.8 97.9 148.1 46.3 71.1 92.7 22.2 27.4 250.8 320.0 133.9 128.5 226.6 ESF1 "bA526K24.1, C20orf6" ENSG00000089048 "ESF1 nucleolar pre-rRNA processing protein homolog" Q9H501 20 13714322-13784886 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047083, HPA050396" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA047083: AB_2679924, HPA050396: AB_2681111" "unprognostic (2.81e-1)" "unprognostic (1.54e-1)" "unprognostic (1.82e-1)" "unprognostic (1.31e-2)" "unprognostic (4.83e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (7.81e-9)" "unprognostic (2.52e-2)" "unprognostic (3.17e-2)" "unprognostic (1.78e-1)" "unprognostic (4.17e-3)" "unprognostic (3.91e-2)" "unprognostic (7.34e-2)" "unprognostic (2.16e-2)" "unprognostic (2.02e-1)" "unprognostic (1.60e-2)" "unprognostic (1.57e-1)" 12.4 10.5 13.5 9.7 19.7 7.1 11.9 17.0 17.4 10.8 8.8 6.9 9.2 7.7 11.2 11.5 11.9 9.2 9.1 9.7 17.2 11.6 10.8 14.6 7.0 10.3 16.8 17.5 14.1 8.7 12.9 20.0 11.9 17.2 12.2 10.7 4.2 8.9 8.6 29.9 11.3 7.5 12.9 28.9 10.7 8.1 14.3 17.9 9.2 11.5 12.1 10.1 11.2 9.2 13.8 14.6 2.0 10.6 11.5 12.4 3.7 13.4 12.8 11.9 6.0 9.1 11.0 6.6 14.4 8.8 10.5 9.0 13.6 12.7 17.7 7.3 6.8 19.6 20.7 17.7 14.4 18.7 4.7 8.4 23.3 5.2 31.9 12.7 28.0 6.4 8.8 10.3 17.2 14.0 7.8 7.9 9.2 32.3 8.1 11.9 11.9 21.2 16.8 11.4 12.5 7.7 13.8 29.5 12.9 7.4 11.9 11.7 7.2 11.6 18.3 17.9 11.6 9.2 12.3 10.7 16.2 11.2 11.8 26.6 8.2 19.7 21.7 6.8 12.3 14.7 1.8 6.9 2.0 8.7 8.6 10.0 13.6 10.0 9.3 6.9 13.8 12.4 11.3 0.4 11.5 10.6 14.6 7.5 3.7 13.5 19.7 17.0 17.4 17.2 11.6 16.8 17.5 17.2 17.9 20.8 32.3 50.2 39.5 55.0 83.6 53.4 40.8 40.2 51.2 31.4 43.2 41.7 28.2 45.6 67.2 39.8 42.3 0.0 36.5 34.4 44.1 25.1 25.4 49.7 38.2 90.6 46.6 38.1 29.7 20.6 60.4 41.3 25.3 49.5 47.3 45.9 48.7 42.1 69.3 31.9 67.2 32.3 50.5 168.4 174.8 46.9 34.7 29.9 52.5 31.5 ETV6 TEL ENSG00000139083 "ETS variant 6" P41212 12 11649854-11895402 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 39.7;NB-4: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA000264 Enhanced Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA000264: AB_611466" "unprognostic (4.03e-3)" "unprognostic (3.08e-2)" "unprognostic (7.54e-3)" "unprognostic (2.60e-1)" "unprognostic (2.07e-1)" "unprognostic (1.35e-3)" "unprognostic (2.74e-2)" "unprognostic (4.02e-2)" "unprognostic (3.16e-1)" "unprognostic (9.46e-2)" "prognostic unfavorable (9.38e-5)" "unprognostic (1.15e-1)" "prognostic unfavorable (4.66e-8)" "unprognostic (1.33e-2)" "unprognostic (5.99e-2)" "unprognostic (8.92e-2)" "prognostic favorable (1.54e-5)" 17.2 8.9 5.1 20.0 7.6 32.8 20.4 1.6 9.1 10.5 14.5 6.0 9.8 7.2 10.8 14.2 11.3 8.9 15.3 6.7 5.6 3.8 9.2 9.6 16.0 13.4 6.0 3.1 10.5 10.4 8.4 8.7 7.7 7.4 14.9 11.0 8.0 41.9 12.4 6.9 23.9 14.6 25.0 9.4 17.8 9.7 4.7 5.7 30.6 10.0 10.0 19.9 19.0 15.8 2.9 6.2 11.4 7.1 2.4 2.2 1.3 2.6 3.5 3.2 5.6 2.5 2.3 3.9 1.9 3.3 2.5 3.0 0.2 12.4 2.2 1.9 3.3 3.0 3.4 1.4 5.9 3.1 39.7 0.7 14.0 1.9 1.3 3.1 14.7 15.3 4.6 3.7 2.5 5.2 4.9 7.6 10.2 1.0 7.4 2.3 1.7 8.3 21.1 5.3 2.7 0.9 2.3 3.1 5.7 5.8 16.5 0.6 3.3 3.8 3.7 3.6 5.4 1.2 9.3 8.6 5.7 4.9 1.9 4.1 3.3 2.5 1.2 3.7 0.1 6.5 5.6 5.7 6.6 1.5 6.6 2.0 2.9 2.2 1.4 4.1 2.3 1.3 0.8 11.4 2.4 7.1 6.2 1.4 1.3 5.1 7.6 1.6 9.1 5.6 3.8 6.0 3.1 7.4 5.7 6.0 8.1 21.4 28.1 13.3 1.9 7.5 17.8 28.1 22.7 14.0 5.9 11.8 1.7 15.2 4.5 23.5 22.5 0.0 30.8 3.6 10.8 33.7 10.4 9.3 17.1 0.0 31.2 38.6 48.1 3.6 7.2 48.8 27.0 40.5 26.8 4.8 31.2 24.9 10.3 7.9 4.0 19.4 28.8 0.6 7.0 19.6 7.2 14.6 20.4 60.6 EXOC4 "KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p" ENSG00000131558 "Exocyst complex component 4" Q96A65 7 133253073-134066589 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Rod photoreceptor cells: 229.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031443, HPA031444" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA031443: AB_10602496, HPA031444: AB_2673886" "unprognostic (1.70e-1)" "unprognostic (1.62e-2)" "unprognostic (2.05e-1)" "unprognostic (5.09e-2)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (8.63e-2)" "unprognostic (2.33e-1)" "unprognostic (4.40e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (6.19e-4)" "unprognostic (9.78e-3)" "prognostic favorable (6.85e-5)" "unprognostic (5.91e-2)" "unprognostic (2.18e-1)" "unprognostic (3.37e-1)" "unprognostic (3.35e-2)" 21.2 23.7 18.5 17.7 22.3 10.5 19.4 25.7 24.4 20.8 17.0 19.7 22.2 11.2 25.8 20.6 21.5 24.2 16.8 16.5 14.7 15.4 15.6 15.2 16.5 12.6 14.2 19.3 27.7 26.5 28.5 31.2 16.4 22.0 16.9 18.8 19.3 20.5 18.8 50.7 24.4 13.7 20.8 18.7 17.9 16.3 17.2 17.3 34.7 22.9 18.3 22.1 26.3 20.6 8.3 16.3 8.1 12.7 18.4 12.4 10.4 17.8 14.7 20.4 20.1 23.9 25.0 7.1 13.1 21.9 11.9 15.7 8.5 25.2 13.4 9.5 24.6 17.5 11.4 10.9 17.9 19.8 20.4 13.1 10.8 15.5 8.9 26.3 14.2 11.8 24.3 22.4 17.0 31.5 26.4 20.3 17.8 15.5 13.4 22.1 11.7 25.8 15.7 15.3 21.5 13.8 11.5 18.1 24.1 19.2 16.0 15.9 25.1 19.7 18.2 21.1 24.0 12.0 13.4 22.0 13.3 7.0 14.0 14.3 21.3 13.0 13.0 39.3 16.7 20.2 8.1 12.0 6.9 11.8 12.7 10.5 8.3 12.3 12.4 16.3 8.0 10.1 10.4 4.0 18.4 10.5 7.3 12.4 10.4 18.5 22.3 25.7 24.4 14.7 15.4 14.2 19.3 22.0 17.3 20.8 21.1 11.9 14.2 16.8 35.3 24.9 7.6 18.7 15.9 14.0 88.4 13.6 3.3 12.9 23.1 21.5 15.8 0.0 15.7 13.8 11.9 17.0 8.1 14.4 15.6 47.7 16.7 24.5 30.4 20.6 16.1 18.0 13.5 12.6 21.4 20.6 13.9 17.5 17.7 13.3 229.7 12.9 10.8 18.1 12.6 14.9 9.4 20.8 18.4 16.9 EXOSC10 "p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p" ENSG00000171824 "Exosome component 10" Q01780 1 11066618-11099881 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028470, HPA028484, CAB037141" Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" No No "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250" "unprognostic (1.23e-2)" "unprognostic (3.46e-2)" "unprognostic (1.85e-2)" "unprognostic (1.62e-1)" "unprognostic (6.88e-2)" "unprognostic (6.37e-2)" "prognostic unfavorable (2.49e-6)" "unprognostic (3.36e-1)" "unprognostic (4.66e-2)" "unprognostic (2.52e-1)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (7.68e-3)" "unprognostic (3.43e-1)" "unprognostic (9.03e-2)" "prognostic favorable (5.27e-4)" "unprognostic (1.33e-1)" 28.2 21.8 30.4 22.1 31.9 30.8 27.9 58.8 34.7 24.8 22.0 31.9 22.4 18.5 27.0 22.9 27.6 22.7 18.3 18.3 27.8 16.2 22.4 18.2 20.8 26.0 31.5 26.3 31.2 24.2 23.1 32.1 23.5 24.3 22.1 25.9 20.4 24.6 20.5 27.3 33.2 22.7 25.6 23.2 26.0 25.2 20.3 32.7 28.2 20.8 12.5 29.9 23.6 24.6 21.0 21.6 24.8 26.4 27.5 25.9 22.3 23.4 15.0 31.5 12.1 16.8 18.6 18.0 23.2 17.1 40.9 37.2 22.1 34.4 23.7 15.1 22.0 18.2 23.4 34.8 25.9 37.6 26.5 34.8 34.4 29.5 22.4 16.5 27.9 27.4 14.6 22.4 40.1 23.7 15.3 25.4 21.2 36.1 21.9 22.5 13.2 27.4 25.8 20.8 18.0 18.0 28.3 26.8 20.7 24.0 12.0 20.3 19.9 25.0 21.7 27.8 23.1 18.9 25.8 23.0 21.9 22.7 19.6 27.1 13.3 20.8 46.9 22.3 41.7 26.2 24.8 18.2 14.6 22.2 23.4 25.9 21.0 23.1 22.1 21.6 19.9 19.8 22.0 3.6 27.5 26.4 11.0 21.8 22.3 30.4 31.9 58.8 34.7 27.8 16.2 31.5 26.3 24.3 32.7 26.8 16.5 14.1 12.2 11.7 15.3 5.6 10.2 32.1 35.2 5.2 45.2 23.7 8.3 21.4 12.5 17.4 11.3 0.0 27.7 27.8 14.3 7.5 18.6 8.1 21.3 20.6 8.6 12.9 13.8 5.4 27.3 19.0 11.8 23.4 14.7 5.6 24.4 11.9 21.5 6.7 34.8 12.9 11.3 20.9 22.8 11.7 19.0 16.2 16.2 8.0 EXOSC2 "hRrp4p, p7, RRP4, Rrp4p" ENSG00000130713 "Exosome component 2" Q13868 9 130693721-130704894 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Deafness, Disease mutation, Dwarfism, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021756, HPA021790" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA021756: AB_2670809, HPA021790: AB_1848320" "unprognostic (8.19e-2)" "unprognostic (1.93e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-2)" "prognostic unfavorable (1.39e-5)" "unprognostic (8.33e-3)" "unprognostic (4.82e-2)" "unprognostic (1.48e-1)" "unprognostic (8.55e-2)" "unprognostic (1.20e-3)" "unprognostic (4.73e-2)" "unprognostic (6.57e-2)" "unprognostic (3.01e-1)" "unprognostic (5.05e-2)" "unprognostic (1.41e-1)" 13.0 14.2 14.4 18.6 17.0 12.7 17.9 22.7 18.0 16.1 14.3 15.8 13.6 11.0 18.7 10.1 16.6 19.0 11.7 12.5 15.8 12.5 14.3 18.4 11.1 16.7 18.5 17.3 22.1 25.0 19.6 12.6 13.1 13.9 13.9 17.4 14.6 14.1 13.7 22.3 13.1 11.5 18.7 12.3 14.0 13.4 8.4 17.6 17.3 14.2 15.7 21.3 15.8 13.9 11.0 10.4 5.6 7.9 16.8 11.7 7.7 13.6 27.9 16.7 14.8 6.0 6.8 12.2 20.5 9.9 20.5 15.9 22.5 11.9 27.2 11.2 11.0 22.6 25.0 26.7 20.4 22.8 16.1 13.0 21.7 27.4 15.6 11.4 32.7 14.4 8.7 7.7 28.8 33.7 7.5 14.5 18.3 23.6 11.8 14.2 24.2 23.0 9.1 20.7 37.4 18.1 18.2 30.7 29.6 9.6 12.7 10.3 11.5 23.9 18.3 10.8 12.2 19.0 11.8 8.9 20.3 15.8 18.0 28.9 6.1 23.8 41.2 14.5 19.1 15.8 1.5 7.7 5.6 10.9 7.9 11.2 11.0 11.0 9.2 10.4 10.4 11.7 10.0 2.0 16.8 5.4 6.8 9.9 7.7 14.4 17.0 22.7 18.0 15.8 12.5 18.5 17.3 13.9 17.6 6.0 18.6 18.5 10.3 9.4 12.8 7.4 2.5 9.4 5.7 3.5 5.9 14.1 5.0 10.0 1.0 6.8 3.6 0.0 9.8 17.2 9.3 5.7 12.7 8.6 11.5 4.8 1.2 7.4 3.8 0.2 7.8 8.0 6.8 4.6 6.4 10.4 7.3 0.0 7.4 8.7 12.5 6.5 10.8 4.2 13.5 7.3 7.0 10.2 10.5 7.1 EXOSC5 "hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p" ENSG00000077348 "Exosome component 5" Q9NQT4 19 41386374-41397479 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Extravillous trophoblasts: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053150, HPA055677" Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA053150: AB_2682058, HPA055677: AB_2682882" "unprognostic (1.24e-1)" "unprognostic (5.68e-2)" "unprognostic (2.99e-1)" "unprognostic (2.53e-3)" "unprognostic (7.50e-3)" "unprognostic (5.74e-2)" "unprognostic (3.83e-3)" "unprognostic (9.23e-2)" "unprognostic (2.36e-1)" "unprognostic (1.54e-1)" "unprognostic (9.39e-2)" "unprognostic (2.35e-2)" "prognostic unfavorable (3.45e-7)" "unprognostic (6.84e-2)" "unprognostic (2.27e-1)" "unprognostic (7.79e-2)" "unprognostic (7.82e-2)" 9.1 14.3 12.6 12.3 16.6 13.1 11.1 7.6 21.3 8.8 12.1 10.8 9.0 10.0 8.1 6.0 14.6 13.6 6.4 11.6 12.0 10.3 7.9 25.1 5.7 17.0 13.4 9.9 13.2 46.9 3.2 4.9 6.5 10.3 9.5 6.6 6.3 14.0 8.1 30.9 18.5 9.5 6.6 14.0 12.7 9.8 7.5 11.8 16.8 15.1 15.7 12.2 11.3 8.6 22.9 36.8 3.3 23.7 17.1 21.1 13.5 17.9 33.5 4.7 13.8 3.0 3.8 11.0 7.6 3.6 12.5 10.3 19.5 13.3 28.0 19.8 3.7 6.4 6.8 9.3 8.5 3.9 17.8 32.1 12.5 12.7 14.9 9.6 22.4 12.4 4.7 19.1 10.0 9.6 3.4 5.8 16.0 16.6 20.1 4.1 23.4 19.3 15.8 16.6 25.4 16.6 18.3 12.9 25.2 5.0 12.8 18.2 13.6 11.0 18.3 18.6 3.2 8.5 27.7 4.6 13.1 11.0 8.3 23.3 31.7 40.5 30.4 10.2 32.4 11.1 3.3 21.7 0.6 13.2 23.7 15.8 21.1 14.4 13.3 34.1 22.9 21.1 18.5 1.5 17.1 14.0 36.8 11.1 13.5 12.6 16.6 7.6 21.3 12.0 10.3 13.4 9.9 10.3 11.8 3.0 3.7 19.5 26.4 27.1 5.6 8.1 17.8 18.7 11.4 17.4 3.9 24.0 31.5 14.5 7.3 9.0 5.1 23.3 18.3 115.4 11.0 15.5 4.7 17.9 26.6 6.4 8.2 4.3 13.8 5.6 15.5 19.8 13.5 14.4 16.8 4.8 20.0 5.8 11.7 19.5 2.1 6.5 18.4 11.9 27.2 29.1 17.7 11.7 30.9 22.0 EXOSC9 "p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p" ENSG00000123737 "Exosome component 9" Q06265 4 121801317-121817021 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 108.4;Spermatocytes: 107.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041838, HPA048257, CAB070171" Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331" "unprognostic (7.36e-2)" "unprognostic (1.22e-2)" "unprognostic (2.81e-2)" "unprognostic (2.23e-1)" "unprognostic (2.78e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (7.89e-2)" "unprognostic (3.73e-2)" "unprognostic (1.66e-2)" "unprognostic (9.25e-2)" "unprognostic (9.85e-3)" "prognostic unfavorable (6.49e-4)" "unprognostic (3.28e-2)" "unprognostic (6.66e-2)" "unprognostic (1.68e-1)" "unprognostic (7.21e-2)" 12.5 12.7 10.1 18.9 14.7 29.7 13.9 16.8 18.6 11.2 9.7 8.1 12.5 7.5 12.5 12.4 13.3 11.8 7.8 13.1 13.5 11.3 11.3 14.0 11.9 19.8 11.3 12.2 12.6 10.4 14.2 15.5 12.1 12.9 10.3 12.0 9.6 10.9 8.9 17.6 12.1 10.3 10.6 11.7 14.2 10.4 36.7 10.0 33.7 9.2 15.4 18.9 12.2 10.5 19.9 15.9 20.1 17.7 11.6 23.6 14.0 19.5 9.2 24.9 14.8 3.9 8.0 12.1 25.4 14.7 36.4 28.2 9.9 16.4 34.3 6.3 15.8 11.0 7.0 26.9 11.8 32.5 15.2 12.3 17.2 14.2 12.8 8.2 29.1 16.0 6.0 6.1 25.4 7.3 7.5 17.9 22.1 29.4 13.6 34.0 11.4 44.6 22.5 13.1 7.6 10.8 24.9 41.7 15.4 12.4 6.4 15.9 16.7 9.3 13.9 15.4 13.2 11.8 18.8 10.8 16.3 24.1 13.7 24.4 19.8 15.0 41.2 16.9 20.3 10.7 12.0 13.3 20.1 18.7 17.7 18.4 19.9 20.5 23.6 15.9 19.9 23.3 20.7 3.3 11.6 17.0 15.7 21.6 14.0 10.1 14.7 16.8 18.6 13.5 11.3 11.3 12.2 12.9 10.0 41.7 15.5 16.4 12.6 11.3 10.7 11.1 7.6 18.7 26.1 3.5 9.8 24.1 1.7 17.1 108.4 14.2 4.5 0.0 26.6 25.0 13.6 7.6 30.1 4.9 21.1 15.9 5.8 12.3 10.3 9.2 12.0 18.0 8.5 20.8 7.9 13.8 16.5 8.7 10.3 7.1 16.3 6.5 11.3 107.2 58.5 12.9 9.2 19.2 10.5 12.9 FAM102B "DKFZp779B126, SYM-3B" ENSG00000162636 "Family with sequence similarity 102 member B" Q5T8I3 1 108560089-108644900 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028451 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA028451: AB_10602497" "unprognostic (1.30e-1)" "unprognostic (2.19e-1)" "unprognostic (4.08e-3)" "unprognostic (3.87e-2)" "unprognostic (1.11e-1)" "unprognostic (3.68e-3)" "unprognostic (1.87e-3)" "unprognostic (3.10e-1)" "unprognostic (2.62e-2)" "unprognostic (1.32e-2)" "unprognostic (2.17e-1)" "unprognostic (4.11e-2)" "prognostic unfavorable (3.47e-6)" "unprognostic (1.06e-1)" "unprognostic (2.49e-1)" "unprognostic (1.21e-1)" "unprognostic (1.86e-1)" 11.6 5.2 11.8 10.4 11.4 19.0 11.3 23.3 20.0 8.5 13.8 3.8 6.6 11.4 7.5 8.2 6.5 6.7 15.7 9.2 15.6 14.3 4.6 5.1 8.1 8.8 12.6 19.0 10.5 5.8 12.1 7.3 6.0 11.4 8.5 15.7 5.5 13.5 9.6 2.3 4.2 11.5 11.4 10.2 8.6 7.9 8.8 5.0 9.4 6.7 4.3 8.4 16.4 18.0 0.9 2.7 5.7 2.3 0.7 1.4 0.5 3.6 2.6 5.4 2.8 9.7 5.9 3.5 2.2 2.9 3.4 5.8 0.9 3.7 4.0 2.0 5.6 3.5 7.2 18.2 0.7 4.4 2.6 2.6 5.7 20.5 0.4 2.5 7.3 11.0 3.1 0.8 5.0 0.3 6.9 2.2 6.8 13.8 22.8 7.9 15.1 4.7 5.3 4.2 8.7 13.4 10.8 13.6 0.8 0.9 4.3 17.5 5.1 8.7 15.2 4.5 4.0 3.2 12.1 0.4 5.5 10.4 4.7 8.2 4.1 1.0 3.8 8.1 5.8 2.9 5.7 1.1 1.0 1.0 2.3 0.6 0.9 1.0 1.4 2.7 0.9 0.7 0.5 1.0 0.7 0.9 0.5 0.8 0.5 11.8 11.4 23.3 20.0 15.6 14.3 12.6 19.0 11.4 5.0 0.0 2.1 0.0 2.1 5.5 4.6 1.2 10.2 2.7 2.3 1.8 0.0 2.1 1.7 1.7 9.2 5.8 7.1 0.0 5.3 2.1 7.3 2.6 7.0 0.8 8.9 0.0 6.9 6.7 22.2 4.5 13.3 16.8 5.0 10.0 10.0 1.2 4.3 10.5 19.4 0.4 0.9 0.0 3.9 1.7 6.0 3.1 2.9 5.0 13.0 4.6 FAM105A "FLJ11127, NET20" ENSG00000145569 "Family with sequence similarity 105 member A" Q9NUU6 5 14581775-14615007 "Enzymes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 35.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 89.3;Hofbauer cells: 83.6;Intestinal endocrine cells: 59.1;Kupffer cells: 69.4;Spermatogonia: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 14.0;HMC-1: 44.0;OE19: 12.3;THP-1: 12.2;U-937: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046638 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA046638: AB_2679731" "unprognostic (1.47e-1)" "unprognostic (6.64e-3)" "unprognostic (1.92e-2)" "unprognostic (1.15e-3)" "unprognostic (6.26e-2)" "unprognostic (1.13e-3)" "unprognostic (2.33e-2)" "unprognostic (2.27e-2)" "unprognostic (6.44e-2)" "unprognostic (2.42e-1)" "prognostic favorable (1.02e-4)" "unprognostic (2.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.38e-2)" "prognostic unfavorable (7.62e-4)" "unprognostic (3.14e-1)" "unprognostic (8.79e-3)" 5.1 3.5 4.0 7.9 4.9 35.4 5.2 3.1 5.1 6.3 15.4 9.0 4.5 8.3 3.0 5.6 2.9 3.1 4.1 3.0 3.9 4.3 5.2 1.9 28.8 16.7 6.1 3.8 4.0 13.3 1.9 8.7 6.7 7.9 12.6 17.3 10.3 3.1 13.5 1.3 2.6 13.7 3.3 10.8 13.2 5.4 4.4 4.1 3.5 27.2 3.0 6.2 7.1 5.8 0.1 26.7 6.9 26.2 14.1 9.6 16.2 0.0 0.6 1.2 0.0 0.2 0.0 5.3 1.5 1.4 0.4 0.7 1.9 1.4 0.0 0.8 0.7 2.2 0.1 2.6 1.2 0.6 0.8 3.6 3.4 14.0 0.3 1.3 0.0 44.0 0.1 0.3 0.2 0.0 0.0 0.0 2.2 0.0 5.5 0.1 1.1 0.0 1.2 1.9 12.3 9.4 0.4 0.5 1.6 0.0 10.5 4.6 5.1 0.7 0.5 0.0 1.3 0.5 12.2 0.0 0.6 3.4 0.2 1.1 0.0 0.0 0.0 0.8 20.8 0.2 0.0 26.2 0.1 4.5 12.4 6.0 0.1 5.7 6.1 26.7 0.1 7.8 7.5 6.9 14.1 9.4 19.7 9.6 16.2 4.0 4.9 3.1 5.1 3.9 4.3 6.1 3.8 7.9 4.1 89.3 8.2 0.9 4.4 7.4 0.7 0.0 2.5 0.0 3.4 0.0 0.0 0.7 0.0 0.0 1.1 6.3 22.2 0.0 0.0 1.5 5.9 7.8 49.6 0.2 83.6 0.0 59.1 4.3 69.4 2.0 4.0 37.7 11.8 0.0 39.6 2.5 0.0 37.1 3.2 0.0 0.9 0.0 3.8 20.5 57.7 5.9 1.1 30.5 41.5 2.7 FAM131C "C1orf117, FLJ36766" ENSG00000185519 "Family with sequence similarity 131 member C" Q96AQ9 1 16057769-16073632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.1" "Cell type enhanced" "Detected in some" 15 "Distal tubular cells: 16.6;Horizontal cells: 36.5;Muller glia cells: 32.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 41.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 10.8;HEK 293: 7.0;PC-3: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031046 Uncertain Approved "Nucleoli,Intermediate filaments,Cytosol" NA NA "Nucleoli, Intermediate filaments, Cytosol" "HPA031046: AB_2673711" "unprognostic (4.69e-3)" "unprognostic (4.98e-2)" "unprognostic (7.26e-2)" "unprognostic (2.46e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (1.63e-2)" "unprognostic (4.67e-4)" "unprognostic (2.82e-1)" "unprognostic (1.93e-2)" "unprognostic (1.75e-1)" "unprognostic (1.68e-1)" "prognostic favorable (9.33e-6)" "unprognostic (1.93e-1)" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.44e-1)" 0.7 7.8 5.6 0.6 4.0 0.5 1.1 41.1 9.1 1.1 1.0 7.7 0.0 0.7 1.0 1.4 1.2 1.1 1.4 5.2 5.0 6.5 10.4 2.2 0.6 0.5 10.7 3.8 1.2 7.1 2.0 5.6 0.7 8.7 0.8 0.6 0.8 6.3 1.6 0.6 3.2 0.8 0.9 17.7 0.6 1.6 1.3 4.9 0.0 1.7 0.0 1.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.3 10.8 0.4 0.6 0.0 0.0 0.0 1.0 0.9 1.2 2.7 0.2 2.4 0.0 0.4 0.5 2.7 1.2 1.4 0.3 0.4 0.0 7.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.9 3.8 0.7 0.3 0.0 0.0 0.1 2.2 0.0 0.0 0.5 2.2 8.0 0.0 0.0 4.6 0.8 0.0 1.5 3.1 0.4 1.3 0.3 0.0 0.3 0.0 1.7 0.2 3.8 0.0 0.0 1.7 0.1 0.0 3.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 4.0 41.1 7.1 5.0 6.5 10.7 3.8 8.7 4.9 0.0 0.0 0.0 0.3 0.2 3.5 1.6 2.5 0.0 0.0 8.7 3.9 0.0 16.6 2.6 1.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.0 36.5 3.4 0.6 0.0 1.3 0.0 0.0 0.0 4.6 0.0 32.7 0.4 0.0 0.0 0.3 2.0 0.0 0.3 0.6 1.9 1.0 0.0 0.0 0.0 0.4 FAM133A "CT115, FLJ37659, RP1-32F7.2" ENSG00000179083 "Family with sequence similarity 133 member A" Q8N9E0 X 93674013-93712274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.8;pituitary gland: 8.2;testis: 16.1" "Group enriched" "Detected in some" 9 "Bipolar cells: 12.3;Early spermatids: 14.0;Horizontal cells: 19.1;Late spermatids: 18.2;Spermatocytes: 21.3;Spermatogonia: 34.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.1;Karpas-707: 22.2;U-2197: 11.6;U-266/70: 17.4;U-266/84: 37.7" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Uncertain Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA066175: AB_2685629, HPA069513: AB_2686143" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-3)" "unprognostic (4.45e-1)" "unprognostic (4.05e-2)" "unprognostic (3.86e-3)" "unprognostic (4.22e-2)" "unprognostic (8.76e-2)" "unprognostic (1.09e-2)" "unprognostic (7.42e-2)" "unprognostic (1.39e-2)" "unprognostic (7.12e-4)" "unprognostic (1.67e-3)" "unprognostic (2.13e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-3)" 0.5 3.0 4.7 0.4 14.8 0.3 0.8 2.3 7.7 1.7 0.5 0.5 0.0 0.4 1.0 0.8 0.4 1.1 0.7 2.2 2.5 4.5 0.4 0.4 0.5 0.4 2.3 4.4 1.4 0.4 0.4 8.2 0.4 3.7 0.4 0.5 0.2 0.4 0.5 0.3 0.6 0.5 0.8 4.5 0.5 0.4 16.1 2.6 0.0 0.9 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 22.2 0.0 0.0 0.0 0.0 0.5 0.0 5.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.4 0.5 11.6 0.5 17.4 37.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 14.8 2.3 7.3 2.5 4.5 2.3 4.4 3.7 2.6 0.0 0.0 0.0 0.0 0.6 12.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 19.1 0.0 1.3 0.0 18.2 1.1 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.7 0.0 1.1 0.0 0.2 21.3 34.9 0.1 0.0 0.0 0.0 0.0 FAM133B MGC40405 ENSG00000234545 "Family with sequence similarity 133 member B" Q5BKY9 7 92560793-92590394 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA066175: AB_2685629, HPA069513: AB_2686143" "unprognostic (5.54e-2)" "unprognostic (4.42e-1)" "unprognostic (1.07e-1)" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (6.70e-2)" "unprognostic (2.42e-2)" "unprognostic (1.54e-2)" "unprognostic (2.87e-3)" "unprognostic (8.56e-3)" "unprognostic (1.11e-1)" "unprognostic (8.85e-2)" "unprognostic (2.73e-3)" "unprognostic (9.01e-3)" "unprognostic (3.16e-1)" "unprognostic (1.87e-1)" "unprognostic (2.38e-2)" 10.5 11.7 18.5 11.1 23.6 32.1 15.1 25.7 23.3 13.6 10.4 8.2 12.0 11.9 13.0 22.5 11.4 10.4 9.2 9.2 13.8 9.1 11.2 14.3 11.2 14.1 15.3 13.2 15.1 13.6 13.4 21.3 12.9 18.0 12.0 11.7 7.5 11.4 10.5 17.1 12.8 10.8 15.7 18.5 12.1 10.6 7.3 17.3 15.9 12.5 7.5 12.8 10.6 12.0 22.5 23.2 9.8 11.7 10.7 17.0 5.9 13.1 6.8 19.2 29.4 11.3 12.0 11.5 14.9 16.1 14.6 17.8 10.9 14.6 21.5 14.5 10.1 12.7 10.6 15.1 9.4 22.4 12.1 19.7 17.4 10.0 21.8 11.8 19.1 15.1 8.0 9.9 11.2 14.0 11.5 8.6 16.8 22.9 27.3 15.6 16.0 30.0 29.9 26.2 12.0 8.8 21.8 19.3 17.8 14.5 14.1 18.6 18.0 12.8 16.3 17.3 18.8 15.1 14.1 9.9 16.8 26.7 19.5 16.7 7.1 7.5 38.5 10.1 25.2 21.6 9.5 11.7 9.8 10.7 10.5 13.9 22.5 13.6 13.2 9.6 18.8 17.0 14.4 4.9 10.7 7.8 23.2 14.3 5.9 18.5 23.6 25.7 23.3 13.8 9.1 15.3 13.2 18.0 17.3 53.6 65.5 102.1 185.5 101.5 81.2 25.7 180.9 38.8 62.6 83.7 70.7 55.8 84.6 78.1 31.4 87.5 92.6 163.5 75.9 52.0 92.4 103.6 86.4 97.3 62.9 52.4 131.6 108.1 107.2 13.2 95.0 114.5 72.6 69.5 83.4 83.5 72.6 112.3 83.4 48.4 75.1 51.8 103.0 97.0 117.4 91.7 59.0 97.2 97.8 127.1 FAM13A "ARHGAP48, FAM13A1, KIAA0914" ENSG00000138640 "Family with sequence similarity 13 member A" O94988 4 88725955-89111398 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 111.2;Syncytiotrophoblasts: 233.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 5.7;monocytes: 6.5;T-cells: 5.2" "Cell line enhanced" "Detected in many" "ASC diff: 32.6" "Low region specificity" "Detected in all" "HPA038108, HPA038109" Uncertain Approved "Nucleoli,Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" Nucleoli "HPA038108: AB_2675837, HPA038109: AB_10672619" "unprognostic (1.14e-1)" "unprognostic (1.53e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.81e-1)" "unprognostic (8.20e-2)" "unprognostic (1.75e-1)" "unprognostic (1.46e-3)" "unprognostic (6.36e-2)" "unprognostic (4.71e-1)" "unprognostic (3.49e-3)" "unprognostic (1.90e-2)" "unprognostic (7.44e-2)" "prognostic favorable (4.28e-4)" 58.6 10.8 9.1 11.0 9.3 6.5 19.0 17.9 18.5 15.5 41.0 3.7 7.4 30.5 10.9 12.0 9.3 14.8 10.7 8.8 9.6 5.7 14.0 22.9 13.3 5.3 10.0 6.8 17.8 23.5 45.5 11.2 20.7 11.4 15.9 9.3 11.5 13.3 8.0 8.4 17.5 30.5 15.6 19.4 4.9 13.4 11.1 12.9 3.2 20.4 16.1 4.0 30.4 23.8 0.1 5.7 1.4 6.5 0.7 5.2 2.6 2.4 3.7 5.6 7.3 32.6 13.5 9.2 5.8 7.0 2.3 2.1 3.1 5.8 0.1 2.3 4.1 3.6 1.5 8.2 4.1 5.2 0.3 5.7 4.1 5.2 0.4 9.6 3.4 0.5 12.9 3.4 5.8 2.1 10.1 3.9 1.4 10.6 0.4 4.9 0.1 0.3 1.5 6.9 0.4 3.9 5.6 9.5 2.2 4.2 12.2 14.2 3.8 1.4 4.5 5.4 5.8 3.1 0.1 1.4 6.5 3.6 3.1 3.3 2.0 1.1 0.0 9.6 0.3 3.3 0.1 6.5 0.1 1.8 3.2 1.3 0.1 4.7 0.6 5.7 0.1 5.2 1.3 1.4 0.7 1.0 1.9 2.5 2.6 9.1 9.3 17.9 18.5 9.6 5.7 10.0 6.8 11.4 12.9 11.9 27.5 3.7 19.8 9.0 19.2 22.7 22.9 81.7 46.6 10.4 33.4 57.4 24.9 8.6 2.3 12.5 34.9 0.0 14.6 29.6 23.6 13.3 1.1 111.2 17.5 0.0 4.7 8.0 29.1 2.4 41.7 12.6 18.6 4.6 37.9 26.9 31.2 63.3 31.5 34.7 10.7 0.0 24.2 4.8 6.1 6.8 233.8 6.4 14.6 16.6 FAM193B "FLJ10404, IRIZIO, KIAA1931" ENSG00000146067 "Family with sequence similarity 193 member B" Q96PV7 5 177519788-177554541 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035847, HPA035848" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA035847: , HPA035848: AB_10601320" "unprognostic (6.58e-3)" "unprognostic (1.07e-1)" "unprognostic (8.95e-3)" "unprognostic (2.94e-1)" "unprognostic (1.81e-1)" "unprognostic (1.15e-3)" "unprognostic (4.07e-2)" "unprognostic (1.48e-2)" "unprognostic (1.91e-1)" "unprognostic (2.24e-1)" "unprognostic (1.71e-3)" "unprognostic (2.78e-2)" "prognostic unfavorable (3.71e-8)" "unprognostic (1.08e-1)" "unprognostic (1.35e-1)" "unprognostic (3.15e-1)" "prognostic favorable (1.30e-5)" 13.5 9.5 18.5 16.5 17.2 35.6 15.8 37.9 20.4 18.1 13.5 13.6 17.2 15.4 19.8 11.6 13.8 13.3 12.3 9.1 18.4 8.0 16.3 18.5 17.0 20.5 17.3 18.3 22.1 22.1 10.3 15.2 15.2 17.0 19.0 11.6 17.1 14.3 14.6 11.6 34.9 18.7 12.7 10.9 27.8 14.9 14.0 16.2 11.7 16.9 9.5 15.3 13.7 23.1 1.3 1.6 2.9 1.8 2.0 2.8 0.9 5.3 7.1 15.8 13.8 7.8 7.6 34.3 4.9 5.2 8.1 7.7 19.1 10.4 10.2 7.5 4.7 10.2 9.3 7.2 10.2 6.0 22.4 7.5 7.2 11.2 9.1 4.6 7.0 14.8 7.5 11.4 6.8 7.5 14.5 8.1 16.2 6.9 10.1 5.7 17.9 12.7 20.4 11.0 4.7 5.7 20.8 3.5 8.6 7.7 15.3 14.7 9.4 5.6 16.3 4.8 12.5 15.9 9.7 10.0 9.0 7.4 5.8 5.7 11.1 4.6 8.2 7.2 11.4 7.4 0.0 1.8 0.7 2.8 0.2 1.8 0.7 1.4 2.0 1.1 1.3 0.7 1.0 2.9 2.0 1.1 1.6 0.9 0.9 18.5 17.2 37.9 20.4 18.4 8.0 17.3 18.3 17.0 16.2 17.9 29.0 6.0 5.1 7.7 10.9 6.4 22.9 8.1 13.6 10.4 17.7 4.3 0.0 5.4 5.1 9.2 9.1 0.0 7.6 6.8 7.8 7.9 4.7 10.4 4.2 11.1 8.1 14.1 7.6 7.4 9.2 7.8 8.5 3.6 13.9 9.1 5.5 5.8 4.9 2.2 12.4 6.5 9.9 10.6 12.9 11.3 3.8 7.9 10.3 5.4 FAM204A "bA319I23.1, C10orf84, FLJ13188" ENSG00000165669 "Family with sequence similarity 204 member A" Q9H8W3 10 118297930-118342328 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038182, HPA062025" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA038182: AB_10669519, HPA062025: AB_2684663" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "unprognostic (1.35e-2)" "unprognostic (8.45e-2)" "unprognostic (8.52e-3)" "unprognostic (4.47e-2)" "unprognostic (2.42e-2)" "unprognostic (2.13e-2)" "unprognostic (9.68e-2)" "unprognostic (1.32e-1)" "unprognostic (3.33e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (8.59e-4)" "unprognostic (5.55e-2)" "unprognostic (8.33e-2)" "unprognostic (1.22e-1)" "unprognostic (6.76e-3)" 31.2 17.5 30.0 18.5 31.6 40.3 28.1 18.9 37.8 24.9 26.8 20.0 19.6 17.9 27.4 29.5 26.1 19.2 19.2 29.5 25.4 21.7 25.0 24.8 21.4 22.4 23.4 25.9 26.2 21.4 19.1 31.3 19.1 30.4 21.1 21.6 19.4 21.9 20.7 36.3 17.1 18.5 34.0 31.2 24.1 20.8 39.9 20.9 19.8 26.0 21.9 23.0 32.8 18.4 27.4 32.4 36.6 35.1 17.5 27.2 28.7 21.6 9.8 16.1 22.4 16.1 17.6 9.2 17.1 32.3 24.9 22.6 11.5 20.3 15.4 10.7 18.4 11.2 18.7 13.4 17.9 22.7 24.1 16.7 12.7 10.0 10.1 24.1 33.1 18.2 12.1 22.0 18.2 38.4 20.9 21.1 19.9 13.3 18.2 20.5 12.0 20.3 30.8 11.4 9.5 8.7 17.4 31.2 11.2 22.5 11.0 10.4 16.4 11.7 11.0 25.2 8.3 17.5 24.0 14.7 13.1 12.2 11.5 26.0 13.1 11.6 22.1 25.5 35.9 13.2 29.8 31.7 36.6 21.7 34.4 22.7 27.4 24.6 19.8 32.4 20.2 21.3 24.7 17.6 17.5 35.1 23.5 27.2 28.7 30.0 31.6 18.9 37.8 25.4 21.7 23.4 25.9 30.4 20.9 56.6 51.4 57.2 54.8 49.3 36.8 71.2 50.9 53.5 47.8 41.8 68.7 32.9 114.4 58.3 206.7 61.6 25.0 46.7 98.7 40.6 62.0 51.0 65.9 40.6 54.1 31.8 40.3 59.5 64.6 82.8 70.8 79.5 57.3 48.7 48.6 54.4 77.4 58.3 65.7 92.5 54.8 25.8 71.2 217.2 170.6 44.3 25.6 57.4 45.3 52.2 FAM212B "C1orf183, FLJ31105, INKA2" ENSG00000197852 "Family with sequence similarity 212 member B" Q9NTI7 1 111680630-111739424 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "Hofbauer cells: 3.6" "Cancer enhanced" "Detected in many" "glioma: 6.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 13 "neutrophil: 19.2" "Lineage enriched" "Detected in many" 13 "granulocytes: 19.2" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.2;U-87 MG: 37.5;WM-115: 14.2" "HPA027809, HPA027810, HPA027811" Approved Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA027809: AB_10599616, HPA027810: , HPA027811: AB_10600872" "unprognostic (1.92e-1)" "unprognostic (9.70e-3)" "unprognostic (1.84e-1)" "unprognostic (1.85e-2)" "unprognostic (2.81e-2)" "prognostic favorable (4.51e-5)" "unprognostic (9.96e-4)" "unprognostic (1.15e-1)" "unprognostic (1.36e-2)" "unprognostic (9.50e-3)" "unprognostic (9.92e-5)" "unprognostic (8.66e-2)" "unprognostic (1.31e-3)" "unprognostic (2.84e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-3)" "unprognostic (5.07e-2)" 12.1 1.4 14.9 4.6 11.5 4.0 8.6 5.5 22.4 2.6 3.7 2.9 1.5 1.8 4.9 1.8 11.1 7.9 4.7 12.9 13.1 3.5 3.9 1.4 6.9 2.4 4.8 13.4 3.2 1.7 4.5 0.9 9.4 3.9 4.6 3.3 1.8 2.7 6.3 8.3 8.8 2.9 8.1 3.9 6.3 4.9 4.3 3.7 0.5 3.8 3.5 2.9 3.1 3.9 0.4 0.8 19.2 1.4 0.0 0.0 0.4 1.2 1.1 2.1 1.6 10.7 3.8 0.9 0.9 2.0 1.7 4.0 2.1 0.0 0.9 0.4 0.8 0.8 1.1 1.1 2.4 1.5 2.3 1.1 7.4 0.7 1.9 3.6 0.3 1.2 2.6 10.7 18.2 0.8 0.4 4.5 1.1 0.0 1.7 2.0 1.1 0.4 0.3 0.3 0.9 1.0 1.1 9.9 0.3 0.5 1.7 5.6 1.6 0.5 0.0 4.9 2.3 1.4 1.2 1.7 3.8 6.0 2.0 0.7 10.8 1.9 0.9 37.5 1.8 14.2 0.0 1.3 1.0 0.0 1.1 0.0 0.2 0.0 0.0 0.8 0.4 0.0 0.0 19.2 0.0 1.4 0.3 0.0 0.4 14.9 11.5 5.5 22.4 13.1 3.5 4.8 13.4 3.9 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 FAM212B "C1orf183, FLJ31105, INKA2" ENSG00000284755 "Family with sequence similarity 212 member B" 1 111722064-111755824 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.4" "Group enriched" "Detected in many" 5 "Early spermatids: 52.0;Late spermatids: 39.5;Sertoli cells: 32.3" "Cell type enriched" "Detected in single" 5 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 5 "NK-cells: 3.4" "Cell line enhanced" "Detected in some" "AF22: 2.5;HHSteC: 3.7;HSkMC: 2.9;LHCN-M2: 3.5;SuSa: 3.5;THP-1: 2.5;U-87 MG: 2.5" "HPA027810, HPA027811" Uncertain Uncertain Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Vesicles" Nucleoli "HPA027810: , HPA027811: AB_10600872" 0.1 0.3 0.1 0.4 2.8 0.2 0.1 0.1 1.7 0.1 0.2 1.5 0.1 0.3 1.7 2.0 0.1 0.0 0.3 0.4 0.1 0.7 0.1 0.5 0.2 0.1 0.1 0.1 1.0 0.0 0.1 1.0 1.6 0.8 1.3 0.1 0.1 1.2 0.1 0.0 1.0 2.5 2.6 2.2 0.0 0.7 1.2 2.6 0.8 0.1 0.1 1.9 0.1 0.1 0.2 0.7 0.1 3.4 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 3.7 1.5 0.0 2.9 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 3.5 1.3 0.5 1.9 1.8 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.8 3.5 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 2.5 2.2 0.0 0.7 0.0 0.0 0.2 0.0 0.2 0.1 0.5 0.3 0.0 0.1 0.3 0.3 0.0 3.4 0.1 0.2 0.2 0.0 0.0 0.0 0.5 3.1 6.2 6.2 0.0 0.0 2.7 0.0 0.0 7.9 0.0 0.0 0.0 52.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 6.9 1.3 2.8 39.5 2.0 2.0 6.8 0.0 4.6 1.2 0.0 1.1 5.3 0.0 5.9 32.3 6.1 4.2 2.1 3.4 0.0 0.0 0.9 0.6 FAM229B "C6orf225, DKFZp586F0922, LOC619208" ENSG00000203778 "Family with sequence similarity 229 member B" Q4G0N7 6 112087599-112102790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 118.9" "Group enriched" "Detected in many" 10 "Early spermatids: 2880.3;Late spermatids: 5153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036068 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA036068: AB_10673495" "unprognostic (1.65e-1)" "unprognostic (9.41e-2)" "unprognostic (4.29e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (2.71e-2)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-3)" "unprognostic (4.74e-2)" "prognostic favorable (8.76e-4)" "unprognostic (3.74e-3)" "unprognostic (1.36e-1)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" 4.7 7.4 18.4 2.1 16.8 2.0 7.7 5.8 14.8 8.2 4.2 17.3 4.3 2.2 9.6 17.0 3.8 23.7 8.8 16.8 15.7 16.2 11.6 11.0 5.2 2.0 20.7 11.2 10.7 4.3 10.0 15.4 5.2 15.3 7.3 3.1 8.6 3.9 11.0 5.9 1.9 2.3 8.6 21.7 2.3 4.3 118.9 13.6 1.6 9.7 2.6 2.0 4.6 2.6 4.0 3.4 2.7 0.3 5.4 8.1 2.8 1.6 4.2 17.4 8.5 15.4 15.3 0.8 6.4 24.5 9.2 19.5 0.7 4.1 1.3 19.0 11.8 9.6 1.0 3.6 9.3 14.8 0.4 12.0 1.5 1.9 6.5 9.6 3.3 0.8 9.3 6.3 15.2 2.6 21.5 9.0 15.2 2.0 3.4 11.2 0.4 6.2 5.4 4.5 1.2 10.1 9.7 4.3 1.3 13.5 0.2 16.2 6.8 5.1 0.6 9.9 9.8 8.3 3.1 5.1 7.7 3.3 29.4 8.5 2.5 0.1 11.7 12.3 2.8 10.2 0.1 0.1 2.7 4.2 0.0 5.3 2.5 3.7 3.3 0.5 4.0 8.1 7.2 0.4 5.4 0.3 3.4 0.4 2.8 18.4 16.8 5.8 14.0 15.7 16.2 20.7 11.2 15.3 13.6 3.0 10.7 4.7 14.7 7.4 29.1 81.9 22.9 313.2 31.8 48.8 11.8 1.2 112.7 25.4 2880.3 27.2 0.0 0.0 9.2 4.2 30.9 16.9 1.1 39.9 2.7 15.9 2.9 34.4 1.9 5153.7 67.3 6.2 23.6 2.8 0.3 63.3 6.5 0.0 85.2 62.8 30.9 58.2 24.7 416.7 35.0 7.5 0.5 4.4 0.6 7.9 FAM32A "DKFZP586O0120, OTAG-12" ENSG00000105058 "Family with sequence similarity 32 member A" Q9Y421 19 16185380-16192046 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051712 Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051712: AB_2681582" "unprognostic (3.20e-2)" "unprognostic (1.44e-3)" "unprognostic (1.25e-1)" "unprognostic (1.16e-3)" "unprognostic (1.23e-2)" "unprognostic (2.75e-1)" "unprognostic (3.31e-2)" "unprognostic (1.37e-2)" "unprognostic (3.86e-3)" "unprognostic (1.18e-3)" "unprognostic (1.56e-1)" "unprognostic (9.31e-2)" "unprognostic (3.23e-2)" "unprognostic (4.27e-2)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" "unprognostic (6.49e-3)" 37.2 42.9 56.2 34.0 37.6 53.1 43.9 33.4 56.2 29.0 39.9 18.7 33.1 50.5 37.2 35.1 41.2 30.9 35.4 32.5 51.6 35.7 39.8 54.9 31.7 35.5 34.9 45.9 30.3 32.5 25.1 24.8 51.1 41.5 30.4 38.8 18.6 34.6 33.4 52.0 42.7 56.7 35.2 45.8 43.2 40.4 24.1 34.3 32.8 33.5 29.8 37.5 40.3 38.9 27.9 41.5 94.9 65.7 27.6 32.2 51.5 29.3 22.6 35.5 22.9 42.0 32.4 33.7 28.6 32.5 35.4 39.0 31.0 35.6 19.5 50.0 36.8 25.5 22.7 36.3 31.2 31.3 25.7 39.9 36.2 20.4 27.4 34.0 45.5 42.6 37.3 32.9 28.3 26.1 31.5 38.1 40.6 28.3 28.9 34.9 39.1 35.1 47.6 51.0 48.9 55.9 37.1 24.6 32.2 38.7 29.5 30.7 46.6 24.1 23.1 30.6 26.7 19.6 52.1 35.3 27.6 16.4 50.3 35.8 34.5 57.0 30.8 40.1 55.5 23.8 41.0 47.8 94.9 24.7 60.1 26.1 27.9 23.7 26.7 41.5 27.8 28.8 31.4 41.0 27.6 65.7 28.5 32.2 51.5 56.2 37.6 33.4 56.2 51.6 35.7 34.9 45.9 41.5 34.3 41.7 44.0 67.1 29.7 41.4 26.9 32.3 50.9 45.5 35.2 34.9 19.6 83.5 77.9 90.3 13.7 55.9 94.4 0.0 90.4 92.4 53.1 40.3 61.2 86.3 76.1 39.7 65.1 40.5 62.3 28.5 35.9 54.8 55.6 104.6 53.1 39.3 101.4 119.3 49.1 57.2 18.8 25.8 42.9 23.5 40.4 46.5 88.4 65.0 48.0 48.7 FAM90A1 FLJ10408 ENSG00000171847 "Family with sequence similarity 90 member A1" Q86YD7 12 8221260-8227618 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.8" "Cell type enhanced" "Detected in some" 15 "Cholangiocytes: 2.5;Early spermatids: 1.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "classical monocyte: 1.1;myeloid DC: 2.8;plasmacytoid DC: 2.0" "Group enriched" "Detected in many" 8 "dendritic cells: 2.8;monocytes: 1.1" "Cell line enhanced" "Detected in some" "BEWO: 5.3;HDLM-2: 7.9;NTERA-2: 19.1" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " "unprognostic (2.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.21e-2)" "prognostic unfavorable (3.92e-4)" "unprognostic (2.69e-3)" "unprognostic (1.94e-4)" "unprognostic (4.37e-3)" "unprognostic (4.43e-2)" "unprognostic (3.93e-2)" "unprognostic (3.97e-2)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (5.30e-5)" "unprognostic (1.50e-1)" "unprognostic (5.15e-2)" "unprognostic (2.04e-1)" "unprognostic (2.06e-2)" 0.2 2.5 2.1 1.2 4.1 0.1 0.3 4.1 9.8 0.3 0.2 0.6 1.9 1.4 1.0 1.6 2.9 2.0 2.3 2.7 0.5 0.0 1.4 0.8 2.2 5.8 2.5 0.0 3.3 0.4 1.7 0.0 2.8 0.6 0.4 2.3 0.3 0.2 1.8 0.7 0.4 2.1 3.1 0.1 0.6 0.5 0.1 2.8 0.0 1.1 0.1 0.2 0.2 0.0 0.0 0.7 1.3 0.2 0.0 5.3 0.4 0.4 0.1 0.0 0.0 2.2 0.3 0.9 0.1 0.3 0.0 3.4 0.0 0.0 7.9 0.4 0.5 0.0 0.1 0.0 0.1 0.0 0.5 1.3 0.3 0.2 2.5 0.2 0.8 2.9 0.4 0.0 1.1 0.1 2.9 19.1 0.0 0.0 0.2 0.1 0.0 1.3 0.4 0.2 0.4 0.0 0.0 0.1 0.3 0.0 0.9 0.0 0.8 0.0 0.2 0.1 0.4 2.9 0.0 2.0 2.5 0.0 0.0 1.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.1 0.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.3 0.5 0.7 0.0 0.0 0.0 0.3 0.0 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.0 FAM90A26 FAM90A26P ENSG00000229924 "Family with sequence similarity 90 member A26" 4 9170409-9176730 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTERT-RPE1: 1.1" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " "unprognostic (1.80e-2)" "unprognostic (3.76e-1)" "unprognostic (1.56e-1)" "unprognostic (1.37e-2)" "unprognostic (2.32e-3)" "unprognostic (1.08e-1)" "unprognostic (5.86e-2)" "unprognostic (4.41e-1)" 0.0 0.6 0.1 0.0 0.3 0.1 0.1 0.2 1.6 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.4 0.3 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.7 0.3 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM98C FLJ44669 ENSG00000130244 "Family with sequence similarity 98 member C" Q17RN3 19 38403135-38409088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040930, HPA041730" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA040930: AB_10795484, HPA041730: AB_10804114" "unprognostic (3.01e-2)" "unprognostic (6.44e-3)" "unprognostic (5.15e-2)" "unprognostic (1.94e-1)" "unprognostic (3.18e-1)" "unprognostic (8.10e-3)" "unprognostic (3.06e-1)" "unprognostic (2.15e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (8.51e-5)" "unprognostic (2.82e-2)" "unprognostic (8.91e-3)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (2.43e-1)" "unprognostic (2.96e-1)" "prognostic favorable (5.53e-4)" 10.8 8.9 18.3 9.3 16.9 11.0 9.8 17.0 19.9 8.7 14.2 12.8 9.0 19.6 9.9 7.2 14.3 13.8 9.1 11.6 16.0 13.1 9.1 13.4 8.7 9.5 12.3 16.9 10.2 22.4 10.6 8.1 7.6 13.0 12.5 7.0 8.2 17.7 9.5 2.5 17.0 22.2 6.8 12.7 10.1 19.2 5.4 9.7 5.3 11.8 7.7 11.2 9.4 9.5 6.0 3.2 12.6 3.4 3.3 5.6 1.6 10.9 11.9 1.4 6.9 1.5 5.2 6.1 6.4 5.4 6.3 6.7 2.0 8.0 10.0 7.2 3.7 2.2 5.3 2.7 4.6 1.0 16.1 5.6 3.2 2.0 4.6 6.8 2.8 6.0 5.0 9.6 3.2 5.8 3.5 3.7 16.4 9.0 11.0 3.7 12.1 4.0 2.1 1.0 18.2 12.8 8.3 2.9 5.9 7.7 5.8 2.4 7.1 6.4 11.4 3.8 0.7 8.6 8.7 4.8 2.8 7.8 8.8 7.6 11.9 6.0 4.2 7.4 6.5 4.5 0.0 2.3 12.6 3.1 3.3 4.2 2.6 5.6 4.6 3.2 6.0 4.3 3.4 2.0 3.3 3.4 1.2 4.4 1.6 18.3 16.9 17.0 19.9 16.0 13.1 12.3 16.9 13.0 9.7 8.9 9.9 17.1 21.7 19.2 13.2 4.3 10.2 6.7 5.7 22.7 11.8 10.3 18.3 17.4 5.0 9.3 43.8 0.0 28.7 9.4 10.0 14.8 15.0 11.9 9.9 11.1 24.6 10.4 10.5 2.1 17.3 14.7 21.9 12.6 32.7 11.1 19.7 34.5 17.3 15.9 11.6 12.9 11.4 27.3 41.1 26.1 5.1 20.3 33.5 22.0 FANCD2 "FA-D2, FACD, FAD, FANCD" ENSG00000144554 "Fanconi anemia complementation group D2" Q9BXW9 3 10026414-10101930 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 24.4;testis: 23.3" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 46.7;Spermatocytes: 55.1;Spermatogonia: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 46.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB016117, HPA063742" Approved Supported "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" No No Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB016117: AB_2278211, HPA063742: AB_2685110" "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "unprognostic (6.21e-2)" "unprognostic (1.12e-2)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (1.08e-5)" "unprognostic (2.96e-2)" "unprognostic (1.59e-3)" "prognostic unfavorable (5.00e-5)" "unprognostic (1.23e-2)" "unprognostic (9.14e-2)" "unprognostic (4.41e-10)" "unprognostic (9.11e-3)" "unprognostic (3.99e-1)" "unprognostic (7.76e-2)" "unprognostic (2.89e-2)" 2.0 1.3 0.8 10.3 2.6 12.2 2.4 1.6 2.7 1.7 2.9 1.1 1.0 2.2 2.2 1.8 4.7 2.4 2.5 1.1 0.8 0.9 2.3 1.0 2.4 9.5 1.3 1.2 3.5 3.5 0.6 1.1 5.3 1.4 2.2 4.9 1.6 3.3 0.4 3.0 3.3 6.2 1.2 2.0 7.3 2.4 23.3 1.6 24.4 1.6 5.6 14.6 2.2 2.4 6.8 3.7 5.3 2.6 2.1 2.9 1.0 8.7 9.3 17.8 5.0 0.9 1.4 46.0 8.0 3.6 11.5 9.4 6.9 8.7 17.1 3.8 2.6 9.5 7.6 18.3 6.2 11.5 8.1 12.4 23.3 14.3 6.6 0.1 17.3 14.6 0.4 1.0 13.0 7.2 1.6 6.9 14.7 14.2 19.6 8.7 10.0 14.4 6.7 21.4 6.7 6.5 15.8 14.5 12.1 4.0 9.8 4.9 9.8 9.8 7.7 3.1 13.5 11.8 11.0 4.0 9.6 11.0 5.8 11.6 8.3 16.3 28.9 5.5 17.8 16.3 5.3 1.4 3.7 1.5 1.0 1.3 4.9 2.0 1.2 0.9 6.8 2.5 1.9 3.3 2.1 2.6 3.7 2.9 1.0 0.8 2.6 1.6 2.7 0.8 0.9 1.3 1.2 1.4 1.6 0.0 0.3 9.7 2.8 4.0 2.8 1.6 0.0 1.4 1.2 1.8 9.8 6.6 0.0 1.6 4.4 1.5 0.7 46.7 2.9 12.7 1.3 2.2 1.1 1.0 5.0 0.0 1.2 3.7 3.4 5.6 2.0 5.2 3.3 7.2 2.0 0.8 1.4 2.8 1.4 0.5 5.8 19.4 0.8 55.1 32.4 2.4 5.8 3.8 5.0 2.3 FANCG "FAG, XRCC9" ENSG00000221829 "Fanconi anemia complementation group G" O15287 9 35073835-35080016 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 17.3;Spermatogonia: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008105, HPA045335" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" Nucleoli "CAB008105: AB_2231542, HPA045335: AB_2679292" "unprognostic (9.41e-2)" "unprognostic (2.62e-2)" "unprognostic (1.82e-1)" "unprognostic (1.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.83e-3)" "prognostic unfavorable (2.02e-4)" "unprognostic (8.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.27e-3)" "unprognostic (9.01e-2)" "unprognostic (5.62e-2)" "prognostic unfavorable (2.38e-7)" "unprognostic (1.14e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" 5.8 5.0 4.4 7.1 6.5 14.9 7.5 13.9 8.5 6.2 5.9 5.3 8.4 6.7 6.8 3.2 9.2 8.6 4.7 5.9 7.6 4.0 5.2 4.5 5.1 9.9 8.7 4.4 9.2 17.0 6.7 4.8 7.6 6.6 7.0 5.5 3.5 8.7 9.7 2.9 8.9 6.5 6.4 4.2 8.6 5.8 8.9 7.6 25.6 9.3 4.8 9.2 6.8 6.9 6.8 4.8 8.9 2.5 8.8 9.2 3.4 15.7 19.6 14.4 13.3 3.2 5.1 12.1 11.1 8.0 21.8 21.0 9.3 9.9 15.6 7.7 3.5 15.6 9.7 11.9 10.2 8.4 18.3 7.2 11.2 21.0 5.7 0.9 11.3 12.9 4.2 2.0 19.0 8.6 3.8 11.1 19.2 7.3 21.0 11.0 14.0 19.1 15.6 14.9 11.8 15.1 19.9 16.9 11.0 5.1 6.7 7.0 12.7 7.3 10.4 4.1 6.5 13.5 8.2 6.7 10.4 20.7 13.3 14.9 5.7 10.8 9.4 9.2 8.4 14.2 8.9 0.8 7.7 7.4 2.5 6.5 6.8 6.1 5.7 2.2 6.5 4.8 5.0 1.3 8.8 2.3 4.8 9.2 3.4 4.4 6.5 13.9 8.5 7.6 4.0 8.7 4.4 6.6 7.6 3.0 5.8 5.2 3.6 3.9 4.3 1.0 0.0 0.0 2.3 3.5 3.9 8.2 3.3 3.7 0.3 2.8 1.6 0.0 2.0 17.3 3.8 3.5 13.9 1.0 6.5 4.8 1.7 3.7 0.3 0.4 3.1 2.0 3.3 3.6 3.9 3.5 2.3 3.2 3.9 1.7 3.0 0.0 2.7 10.9 23.7 2.3 5.5 5.3 5.0 3.3 FAR2 "FLJ10462, MLSTD1, SDR10E2" ENSG00000064763 "Fatty acyl-CoA reductase 2" Q96K12 12 29149103-29340980 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Syncytiotrophoblasts: 162.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 26.3;HUVEC TERT2: 30.8;NB-4: 26.4;SK-BR-3: 32.5;TIME: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015884 Approved Approved "Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" Nucleoli "HPA015884: AB_1853998" "unprognostic (6.32e-2)" "unprognostic (2.40e-2)" "unprognostic (1.50e-3)" "unprognostic (3.33e-3)" "unprognostic (2.41e-1)" "unprognostic (4.13e-3)" "unprognostic (4.30e-2)" "unprognostic (1.18e-1)" "unprognostic (3.11e-2)" "unprognostic (6.37e-2)" "unprognostic (5.70e-3)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.93e-4)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.33e-1)" "unprognostic (5.22e-3)" 9.4 7.2 9.8 6.9 17.4 12.0 7.6 5.1 18.2 4.6 25.7 3.2 6.1 13.3 6.2 29.4 6.0 3.7 4.2 5.4 12.8 10.9 4.0 3.1 8.6 6.7 9.4 10.4 2.1 2.6 1.0 2.9 19.2 6.6 2.8 22.3 4.1 4.8 1.7 4.5 8.7 14.0 6.0 5.1 12.3 3.7 8.4 5.9 7.2 3.5 4.5 2.3 6.6 4.3 0.9 4.0 23.7 11.5 1.8 7.6 4.4 0.9 1.8 1.8 0.4 2.6 10.1 0.8 7.6 9.0 2.1 2.0 3.0 10.3 1.3 2.0 1.0 1.5 0.5 4.7 0.0 0.5 0.6 11.8 26.3 4.2 0.9 5.4 10.5 8.8 2.8 0.0 3.2 4.1 5.4 30.8 1.0 2.3 1.0 0.3 0.3 6.7 26.4 7.1 0.5 20.1 5.6 2.9 1.1 9.5 2.6 3.1 2.8 1.7 32.5 12.9 3.8 1.5 9.9 25.0 5.7 1.7 2.0 3.3 1.6 1.7 0.6 9.1 13.8 4.9 1.3 11.5 23.7 2.7 6.9 1.8 0.9 4.5 3.2 4.0 0.7 1.5 1.7 20.7 1.8 3.7 1.5 7.6 4.4 9.8 17.4 5.1 18.2 12.8 10.9 9.4 10.4 6.6 5.9 0.0 3.5 0.0 0.1 1.1 1.9 8.7 0.0 4.0 2.3 0.0 0.0 14.0 0.0 0.0 16.3 11.1 22.3 0.0 0.2 16.9 4.3 0.4 10.4 0.0 16.4 4.8 6.9 3.7 19.8 4.2 1.1 7.2 15.1 1.0 19.9 0.4 1.9 31.9 0.4 0.3 1.1 0.0 3.3 0.2 0.9 0.3 162.1 4.4 19.4 0.1 FAU "asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30" ENSG00000149806 "FAU, ubiquitin like and ribosomal protein S30 fusion" "P35544, P62861" 11 65120628-65122473 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059015 Supported Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" No No "Endoplasmic reticulum, Cytosol" Nucleoli "HPA059015: AB_2683881" "unprognostic (1.81e-3)" "unprognostic (3.47e-2)" "unprognostic (2.89e-1)" "unprognostic (2.91e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-3)" "unprognostic (1.97e-1)" "unprognostic (5.40e-2)" "unprognostic (1.26e-1)" "unprognostic (7.06e-3)" "unprognostic (7.77e-2)" "unprognostic (1.14e-1)" "unprognostic (1.61e-2)" "unprognostic (1.13e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-2)" 79.7 95.0 90.6 84.9 76.2 186.7 95.4 50.9 80.9 103.6 134.8 77.6 63.4 77.8 84.0 80.5 115.2 100.0 87.2 133.9 70.0 58.9 88.0 162.9 77.5 182.6 78.9 40.8 176.0 202.8 27.5 56.1 73.2 46.6 123.5 53.0 67.8 97.3 76.7 190.8 86.8 93.8 97.5 72.4 130.9 79.2 53.6 53.2 126.8 121.5 83.6 149.5 122.0 136.6 291.3 169.7 90.9 119.0 116.3 253.8 346.5 78.9 52.0 46.0 72.8 45.0 67.3 63.0 45.1 43.9 63.2 40.1 58.8 79.3 94.1 122.5 38.7 42.6 69.8 42.6 60.1 26.3 69.0 65.3 75.8 54.7 80.7 82.8 89.8 83.6 82.9 100.1 54.3 73.9 60.2 48.7 91.0 70.7 111.5 33.4 98.7 103.8 181.4 126.5 59.2 86.7 101.0 36.8 184.5 58.2 44.7 64.0 64.3 35.0 101.3 140.8 28.6 90.5 124.6 46.0 57.2 66.0 88.2 72.0 121.3 115.2 160.1 69.3 70.0 64.7 90.9 119.0 70.6 128.9 107.0 176.1 291.3 212.1 165.5 132.1 281.7 253.8 198.1 78.9 116.3 92.8 169.7 153.8 346.5 90.6 76.2 50.9 80.9 70.0 58.9 78.9 40.8 46.6 53.2 595.5 951.7 2941.4 2547.1 3351.7 327.7 460.8 1579.6 745.5 1039.6 909.0 184.6 1889.5 1737.5 1225.7 710.1 1573.3 1664.2 1027.9 2337.8 2188.3 1714.1 2189.0 1307.1 1658.9 1928.3 179.6 1179.1 1412.4 2371.4 1489.6 2116.5 2866.9 2014.3 2418.4 1788.3 428.5 1806.3 2457.4 1155.5 1844.9 362.4 1099.5 2206.1 745.0 649.0 3667.7 2335.8 2033.7 2040.2 2956.6 FBXL2 "FBL2, FBL3" ENSG00000153558 "F-box and leucine rich repeat protein 2" Q9UKC9 3 33277025-33403662 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 23.6;Early spermatids: 41.5;Late spermatids: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 8.9;LHCN-M2: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061783 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA061783: AB_2684605" "unprognostic (5.73e-2)" "unprognostic (4.47e-2)" "unprognostic (7.92e-2)" "unprognostic (7.21e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.10e-2)" "unprognostic (2.09e-1)" "unprognostic (3.16e-1)" "unprognostic (2.00e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "prognostic favorable (3.35e-4)" "unprognostic (3.30e-3)" "unprognostic (9.72e-2)" "unprognostic (4.28e-2)" "unprognostic (5.90e-2)" 3.2 5.2 8.0 2.2 15.0 1.9 4.1 7.2 18.1 3.7 2.9 4.1 1.8 3.2 5.2 8.2 2.3 6.0 3.0 2.7 8.7 11.3 5.5 1.4 4.6 1.8 6.6 13.4 4.5 3.5 7.7 16.1 5.5 13.1 4.3 1.5 6.4 3.1 6.5 1.5 2.9 2.0 3.5 4.5 2.3 2.5 4.3 2.8 0.0 8.6 0.6 1.5 2.6 2.5 1.3 0.9 2.8 1.0 0.9 1.1 0.1 3.9 1.1 1.6 1.8 2.3 3.8 0.6 3.1 2.5 2.8 4.1 0.8 4.7 0.2 0.9 2.0 1.3 1.0 1.4 3.4 1.9 0.4 1.9 0.7 3.2 0.8 2.8 0.3 0.7 1.5 2.5 1.8 1.3 8.9 5.0 2.8 0.9 0.3 9.4 0.4 0.8 0.7 1.2 0.5 0.9 0.1 1.0 0.1 7.1 1.1 2.0 2.0 1.3 0.8 2.3 2.7 2.2 1.2 3.9 1.4 1.3 1.1 1.7 0.4 0.2 0.2 1.3 0.3 0.9 1.5 1.0 0.7 0.9 0.5 0.7 0.5 0.7 0.9 0.3 1.3 1.1 1.1 2.8 0.9 0.7 0.9 0.4 0.1 8.0 15.0 7.2 18.1 8.7 11.3 6.6 13.4 13.1 2.8 3.0 8.2 0.0 5.1 1.0 16.5 2.0 2.5 13.4 4.5 5.2 23.6 0.4 3.3 3.5 41.5 2.2 0.0 0.0 0.3 1.0 3.6 2.9 0.0 0.0 0.4 17.5 0.0 3.1 0.3 37.9 1.4 1.2 1.7 0.0 0.1 6.7 3.4 0.0 3.9 2.1 14.2 6.5 2.9 11.7 7.9 1.0 0.6 1.3 0.0 3.3 FBXL22 "Fbl22, FLJ39626" ENSG00000197361 "F-box and leucine rich repeat protein 22" Q6P050 15 63597353-63602428 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 65.9;smooth muscle: 68.0" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 10.5;Muller glia cells: 9.8;Peritubular cells: 10.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 8.0;SCLC-21H: 9.1;U-937: 5.7" "HPA047624, HPA054627" Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA047624: AB_2680107, HPA054627: AB_2682548" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (3.03e-2)" "unprognostic (1.29e-2)" "unprognostic (1.15e-1)" "unprognostic (6.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (1.07e-3)" "unprognostic (1.90e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" 1.9 0.4 0.4 5.5 0.4 0.0 1.1 0.6 0.7 31.4 26.0 0.0 20.8 1.4 65.9 7.6 11.9 10.5 31.1 10.3 0.4 0.4 0.6 0.4 0.7 0.2 0.4 0.3 7.1 0.4 0.0 0.4 1.0 0.2 20.1 2.9 1.9 3.3 24.0 2.2 0.7 4.1 68.0 0.4 0.4 6.3 4.2 0.0 0.0 0.6 1.0 0.4 38.2 4.8 1.5 4.3 0.5 0.2 2.0 2.9 0.5 1.2 2.2 0.3 1.3 0.7 0.9 0.1 0.4 0.1 0.5 0.0 1.4 1.6 0.5 1.1 0.2 0.8 1.3 0.7 0.4 0.0 1.3 0.9 0.4 1.5 3.5 0.2 0.5 0.2 0.5 0.3 0.1 0.7 0.1 0.2 3.7 0.0 1.9 0.0 8.0 1.2 1.0 2.5 1.3 0.8 1.1 0.0 3.9 0.3 0.4 9.1 0.3 1.1 1.8 0.3 0.0 3.2 0.9 1.3 0.6 1.8 0.8 0.4 1.2 2.0 1.3 0.9 5.7 1.3 0.4 0.1 0.0 1.2 0.1 1.6 1.5 1.3 1.4 0.0 1.2 2.9 1.0 0.5 2.0 0.2 4.3 0.1 0.5 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.3 0.2 0.0 0.0 0.0 2.2 1.7 0.1 10.5 7.2 5.1 0.0 1.2 7.0 3.9 0.6 8.3 0.9 0.6 0.6 1.3 0.0 1.0 0.7 0.6 1.4 0.0 3.6 0.7 0.0 4.7 5.5 1.5 0.2 0.3 0.4 0.0 0.0 5.6 9.8 0.6 3.5 10.6 2.1 2.5 0.0 1.3 3.9 3.4 0.6 0.5 0.5 3.6 0.5 FBXO11 "FBX11, UBR6" ENSG00000138081 "F-box protein 11" Q86XK2 2 47789316-47905793 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002690 Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA002690: AB_1848448" "unprognostic (1.18e-1)" "unprognostic (8.65e-3)" "unprognostic (3.93e-2)" "unprognostic (2.05e-2)" "unprognostic (7.92e-2)" "unprognostic (1.42e-1)" "unprognostic (3.85e-2)" "unprognostic (1.02e-1)" "unprognostic (2.55e-2)" "unprognostic (9.82e-2)" "unprognostic (5.77e-2)" "unprognostic (2.33e-2)" "unprognostic (3.21e-2)" "unprognostic (1.55e-1)" "unprognostic (3.71e-1)" "unprognostic (2.19e-1)" "unprognostic (3.20e-2)" 18.0 13.8 18.6 15.7 18.8 17.5 26.1 42.2 31.7 21.3 15.3 12.7 15.1 10.4 28.9 16.8 14.5 16.3 15.0 14.1 16.9 13.6 14.3 17.0 22.3 15.0 17.4 21.7 28.9 12.4 25.2 14.4 14.5 19.7 15.3 13.3 12.0 15.6 16.5 22.9 14.5 13.5 19.9 16.4 14.5 13.3 25.1 16.0 14.6 17.3 9.8 17.2 19.3 21.9 4.7 4.3 8.2 2.7 4.8 6.6 2.0 25.5 13.3 31.9 27.2 22.4 21.1 19.0 17.9 24.6 16.7 16.5 11.2 13.0 16.5 23.4 25.1 20.8 12.7 21.8 18.9 24.7 11.0 10.8 15.4 10.9 17.8 21.5 16.0 16.4 20.6 21.3 14.9 25.2 26.6 21.4 8.3 15.0 17.1 20.5 12.3 15.3 15.6 19.4 16.9 13.1 20.0 29.6 12.3 23.9 20.9 22.5 26.6 16.9 15.9 26.1 24.7 7.4 13.7 23.1 20.8 19.2 13.9 19.6 14.8 7.7 30.1 14.1 15.1 21.1 8.2 2.3 4.3 3.8 2.7 3.8 4.7 3.4 4.1 3.1 3.6 6.6 4.1 4.1 4.8 2.4 4.3 3.6 2.0 18.6 18.8 42.2 31.7 16.9 13.6 17.4 21.7 19.7 16.0 14.9 36.6 13.7 38.4 59.5 42.4 7.8 12.7 37.5 23.9 17.4 31.4 16.6 10.0 15.5 22.2 26.9 15.8 0.0 13.2 13.7 43.3 34.1 27.8 17.0 21.7 52.4 23.0 29.4 42.9 29.9 27.9 40.9 33.7 17.2 16.7 30.9 20.6 14.4 37.4 11.3 39.1 19.4 35.3 51.9 40.4 51.6 30.1 26.6 16.9 57.8 FBXO36 "Fbx36, FLJ37592" ENSG00000153832 "F-box protein 36" Q8NEA4 2 229922302-230013109 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 54.9;Cone photoreceptor cells: 33.4;Early spermatids: 33.5;Spermatocytes: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053865 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA053865: AB_2682282" "unprognostic (4.39e-3)" "unprognostic (6.51e-2)" "unprognostic (2.38e-2)" "prognostic favorable (2.28e-4)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.15e-2)" "unprognostic (2.38e-2)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (1.28e-2)" "unprognostic (8.04e-2)" "unprognostic (7.79e-3)" "unprognostic (3.72e-2)" "unprognostic (1.86e-1)" "unprognostic (1.03e-2)" "unprognostic (2.68e-1)" 4.0 7.8 8.9 1.9 12.6 1.9 7.3 4.1 12.2 6.7 2.8 11.9 4.7 3.2 5.4 8.9 3.8 21.7 3.9 2.9 8.3 9.1 10.3 3.7 4.9 2.1 8.1 6.9 6.8 3.7 11.7 11.7 3.6 10.1 6.4 3.0 9.3 5.0 5.8 2.0 6.1 3.2 3.9 8.9 2.1 3.7 14.0 5.2 2.7 14.8 2.8 2.7 2.9 3.3 2.8 3.6 0.8 1.7 2.7 4.5 1.2 1.3 2.6 3.1 1.2 1.5 9.4 6.1 1.6 4.3 2.3 4.0 0.8 4.1 0.1 0.9 2.8 2.8 1.0 1.4 0.8 4.0 0.3 0.9 0.5 0.9 1.6 6.0 1.0 0.4 9.9 7.0 4.4 3.4 3.0 2.4 4.5 1.8 0.8 2.7 5.2 2.2 2.4 8.1 2.8 2.9 2.6 0.9 0.6 4.1 1.0 2.9 3.7 2.6 2.1 1.1 3.6 4.5 1.8 1.8 3.8 1.4 6.1 0.6 2.8 2.3 0.9 4.7 0.5 2.8 0.1 1.7 0.1 2.5 1.3 2.1 2.8 1.9 1.7 3.6 2.0 4.5 2.5 0.8 2.7 0.9 1.7 3.5 1.2 8.9 12.6 4.1 12.2 8.3 9.1 8.1 6.9 10.1 5.2 8.9 1.4 0.0 2.9 3.4 7.0 3.1 0.0 54.9 10.3 10.4 33.4 1.6 13.3 4.9 33.5 2.4 1.8 0.0 5.8 1.5 3.1 2.8 0.0 2.4 0.9 9.5 0.0 1.8 1.0 5.4 3.1 1.2 3.3 4.6 1.4 6.6 4.5 0.0 3.9 7.5 27.5 6.5 2.7 34.9 10.3 4.0 1.8 0.5 1.5 1.1 FEN1 "FEN-1, MF1, RAD2" ENSG00000168496 "Flap structure-specific endonuclease 1" P39748 11 61792637-61797244 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.3" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 61.7;Spermatogonia: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002262, HPA006748" Enhanced Enhanced Nucleoplasm,Nucleoli NA Yes 38000 Nucleoplasm Nucleoli "CAB002262: AB_563729, HPA006748: AB_1848494" "unprognostic (1.82e-1)" "unprognostic (2.71e-2)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (1.26e-1)" "unprognostic (6.45e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (1.50e-2)" "unprognostic (9.82e-2)" "prognostic favorable (7.85e-4)" "unprognostic (2.82e-3)" "unprognostic (5.86e-2)" "prognostic unfavorable (5.73e-6)" "prognostic favorable (9.46e-4)" "unprognostic (1.10e-1)" "unprognostic (4.49e-3)" "unprognostic (4.04e-2)" 4.8 9.6 7.9 14.6 8.5 23.9 7.4 16.9 14.9 4.9 11.0 8.5 5.0 8.1 5.0 6.6 13.3 4.2 7.0 4.6 8.6 8.5 4.9 9.3 5.0 22.5 8.3 9.8 3.9 6.3 5.2 7.9 11.2 12.6 4.7 12.0 7.3 9.3 4.6 11.2 6.8 8.2 6.4 7.1 12.3 7.2 16.2 5.9 36.3 3.5 10.6 25.5 6.1 4.2 11.5 18.1 14.5 9.4 13.3 18.0 7.3 31.2 28.8 31.6 17.0 3.1 3.9 20.1 27.7 15.8 33.9 38.6 25.1 23.6 45.1 21.6 11.7 32.0 33.1 44.4 24.2 34.8 23.7 24.5 23.8 39.3 25.6 2.4 37.0 24.7 2.7 3.3 31.3 8.3 5.0 13.2 25.5 36.0 32.7 28.1 39.4 51.6 33.3 34.7 24.6 28.2 35.4 36.6 46.6 13.5 29.6 36.0 29.9 18.5 24.2 15.9 15.5 35.1 26.0 8.8 30.2 38.2 38.4 27.8 25.9 40.2 46.9 21.1 24.8 26.0 14.5 5.0 10.2 12.4 9.4 13.1 11.5 10.0 11.8 5.8 11.5 11.2 11.3 2.1 13.3 8.8 18.1 18.0 7.3 7.9 8.5 16.9 14.9 8.6 8.5 8.3 9.8 12.6 5.9 0.0 2.1 12.6 4.8 9.2 21.1 4.0 5.1 6.7 3.4 0.0 11.8 28.6 6.6 11.6 16.8 2.7 3.1 23.3 10.5 61.7 7.6 4.4 0.0 6.8 21.8 14.3 4.6 1.3 5.1 9.8 5.2 7.1 5.0 19.0 5.3 29.9 9.3 6.0 6.7 4.7 20.5 0.0 4.2 33.0 63.4 5.4 25.9 14.1 13.0 3.7 FEZ2 ENSG00000171055 "Fasciculation and elongation protein zeta 2" Q9UHY8 2 36531805-36646087 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035978 Uncertain Approved "Nucleoli,Nucleoli rim,Golgi apparatus,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Golgi apparatus, Cytosol" "HPA035978: AB_10672235" "unprognostic (1.42e-1)" "unprognostic (5.02e-3)" "unprognostic (2.89e-1)" "unprognostic (1.15e-2)" "unprognostic (2.91e-2)" "unprognostic (1.94e-3)" "prognostic unfavorable (7.79e-6)" "unprognostic (1.09e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (1.09e-1)" "unprognostic (1.28e-1)" "unprognostic (6.65e-2)" "unprognostic (7.82e-3)" "unprognostic (7.07e-2)" "unprognostic (3.47e-2)" "unprognostic (1.82e-1)" 31.7 23.4 28.7 12.0 25.3 8.1 18.6 20.1 31.2 18.3 17.2 28.0 6.0 13.1 20.4 13.1 20.4 13.1 14.6 28.5 26.1 22.6 21.4 18.4 16.5 13.1 27.6 21.6 18.3 6.8 14.2 8.5 29.6 29.3 15.6 18.4 19.0 9.7 22.1 51.0 9.1 18.7 26.9 33.8 17.8 12.2 12.6 25.4 9.4 14.8 12.2 12.1 15.5 13.5 1.7 13.6 4.7 3.5 3.1 1.5 0.7 15.6 9.4 12.8 5.4 25.4 33.6 10.1 39.8 20.4 24.4 15.5 6.5 5.1 9.7 24.5 51.5 10.7 6.2 10.8 13.7 26.7 2.2 5.9 7.9 3.3 10.8 12.2 7.9 2.0 32.2 11.8 15.0 18.1 16.7 34.9 2.3 8.5 3.0 45.1 5.5 4.8 6.8 6.7 9.0 14.8 3.2 11.6 3.3 19.4 15.3 0.3 11.7 9.8 8.1 9.5 15.0 2.8 9.8 40.5 15.3 8.1 8.4 23.1 2.3 2.7 6.6 15.2 5.5 21.5 2.4 3.5 4.7 1.5 3.3 1.0 1.7 1.1 0.8 3.6 1.0 1.3 0.5 4.0 3.1 1.9 13.6 1.3 0.7 28.7 25.3 20.1 28.8 26.1 22.6 27.6 21.6 29.3 25.4 50.6 29.1 13.8 81.0 27.8 33.3 36.3 12.7 30.8 70.5 55.8 43.2 85.1 48.0 58.2 4.3 78.7 55.8 0.0 26.7 74.7 58.7 87.3 23.1 32.1 80.7 20.6 23.1 93.3 74.8 4.9 50.3 60.5 54.0 36.9 29.6 75.8 51.7 37.4 62.2 31.6 34.6 58.2 52.3 13.0 27.6 28.1 150.6 28.0 32.6 117.0 FGF7 KGF ENSG00000140285 "Fibroblast growth factor 7" P21781 15 49423096-49488775 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 101.2;Fibroblasts: 91.0;Leydig cells: 77.1;Smooth muscle cells: 82.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 24.2;ASC TERT1: 22.3;fHDF/TERT166: 10.0;HSkMC: 22.6;RH-30: 18.0;U-138 MG: 12.2" "Region enriched" "Detected in single" 9 "cerebellum: 9.7" HPA043605 Uncertain Approved Nucleoplasm,Nucleoli "Secreted in other tissues" NA NA "Nucleoplasm, Nucleoli" "HPA043605: AB_10960215" "unprognostic (4.65e-1)" "unprognostic (7.62e-2)" "unprognostic (2.50e-1)" "unprognostic (6.98e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (3.62e-2)" "unprognostic (5.74e-3)" "unprognostic (2.56e-2)" "unprognostic (7.30e-2)" "unprognostic (5.79e-2)" "unprognostic (1.91e-3)" "unprognostic (1.22e-3)" "unprognostic (7.59e-2)" "unprognostic (1.98e-3)" "unprognostic (1.63e-3)" 39.7 2.7 0.6 9.9 0.6 0.0 16.5 0.6 2.4 73.3 22.2 0.0 10.1 1.1 13.1 16.1 25.2 14.1 25.4 19.1 0.6 0.6 5.9 1.2 44.8 5.5 2.1 0.0 43.7 2.5 2.9 2.8 9.1 0.8 42.5 4.5 2.7 6.4 8.1 25.6 3.6 4.2 38.3 1.4 1.0 6.6 12.7 0.0 0.0 23.2 24.7 2.9 72.2 32.4 0.2 0.1 1.6 0.2 0.3 0.5 0.0 0.1 0.0 0.1 0.1 24.2 22.3 0.0 7.3 4.5 0.0 0.0 0.0 0.1 0.0 0.1 10.0 0.2 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 2.1 0.1 0.0 22.6 0.4 1.9 0.0 0.1 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.1 0.1 0.0 0.1 0.0 18.0 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.0 0.1 0.1 0.1 0.1 12.2 0.2 0.4 0.0 0.2 0.1 0.0 3.3 0.0 0.2 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.5 0.2 0.0 0.3 0.2 0.1 0.4 0.0 0.6 0.6 0.6 0.6 0.6 0.6 2.1 0.0 0.8 0.0 11.9 13.4 0.9 13.5 12.8 7.9 40.0 5.1 0.0 0.0 8.7 2.0 4.7 101.2 1.1 2.8 5.3 0.0 0.0 0.6 3.8 91.0 9.0 1.1 2.5 1.8 3.2 0.0 0.0 1.0 3.1 77.1 3.1 6.8 0.0 0.0 7.3 0.6 0.0 4.6 24.5 6.0 6.5 82.4 0.3 0.1 11.0 2.4 1.0 0.0 7.1 FKBP15 "FKBP133, KIAA0674, PPP1R76, WAFL" ENSG00000119321 "FK506 binding protein 15" Q5T1M5 9 113161006-113221361 "Predicted intracellular proteins" "Endocytosis, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 53.0;Kupffer cells: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007979 Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA007979: AB_1848615" "unprognostic (2.81e-1)" "unprognostic (2.51e-1)" "unprognostic (2.55e-3)" "unprognostic (1.61e-3)" "unprognostic (2.54e-1)" "unprognostic (2.67e-1)" "unprognostic (2.16e-3)" "unprognostic (1.17e-1)" "unprognostic (1.91e-1)" "unprognostic (8.68e-3)" "unprognostic (1.02e-1)" "unprognostic (6.45e-2)" "unprognostic (4.28e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (3.44e-2)" "unprognostic (5.62e-3)" 19.8 17.8 16.7 25.3 21.9 19.2 19.4 18.6 21.6 16.9 15.3 25.4 14.2 15.1 18.1 17.0 18.8 16.7 14.4 16.4 16.2 13.1 15.7 17.2 26.7 30.9 22.6 15.4 18.6 17.5 34.7 22.1 24.4 19.2 17.2 18.7 17.6 20.0 22.3 19.2 22.3 18.2 20.5 23.5 36.5 15.9 6.8 20.9 25.1 18.7 13.4 23.3 18.6 18.3 2.8 8.5 5.7 20.5 3.7 3.4 4.5 11.7 12.1 8.1 7.9 17.7 15.6 11.0 14.7 22.3 16.6 14.9 7.6 12.3 19.7 7.2 18.7 32.9 25.8 9.9 14.4 15.3 15.0 6.6 7.6 13.2 7.3 14.4 16.1 19.9 15.7 14.7 18.2 19.0 17.1 16.1 11.4 9.3 12.1 16.9 18.0 12.0 8.5 8.5 16.9 9.7 10.9 17.2 7.1 12.0 10.9 7.2 7.2 17.9 13.7 8.6 11.2 16.4 6.0 18.7 17.9 6.7 17.6 15.2 10.4 11.3 9.1 18.7 9.3 14.6 1.8 11.6 1.6 3.4 14.6 2.8 2.0 2.1 2.1 8.5 2.8 2.5 1.9 5.7 3.7 20.5 3.5 2.2 4.5 16.7 21.9 18.6 21.6 16.2 13.1 22.6 15.4 19.2 20.9 14.9 29.0 13.4 5.8 5.0 12.3 12.0 10.2 14.7 14.8 14.0 25.5 11.9 1.7 10.8 0.9 11.3 8.1 0.0 11.8 10.2 12.4 6.3 10.5 7.8 53.0 11.1 4.6 17.8 50.5 1.1 15.5 49.5 6.8 1.0 7.4 8.3 13.5 8.6 14.9 4.3 16.1 19.4 6.1 3.9 11.5 3.6 10.2 11.8 8.0 9.2 FOXI1 "FKHL10, FREAC6" ENSG00000168269 "Forkhead box I1" Q12951 5 170105897-170109725 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 37.0;salivary gland: 12.4" "Cell type enriched" "Detected in some" 13 "Distal tubular cells: 23.2" "Group enriched" "Detected in many" 7 "breast cancer: 5.8;renal cancer: 23.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 48 "eosinophil: 4.7" "Lineage enriched" "Detected in single" 48 "granulocytes: 4.7" "Group enriched" "Detected in some" 5 "MCF7: 4.0;SuSa: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA071469 Enhanced Uncertain Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "HPA071469: AB_2686403" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (2.09e-1)" "unprognostic (2.48e-2)" "unprognostic (8.06e-2)" "unprognostic (7.47e-2)" "unprognostic (2.73e-1)" "unprognostic (1.52e-2)" "unprognostic (9.71e-3)" "unprognostic (4.88e-3)" "unprognostic (6.20e-2)" "unprognostic (1.34e-2)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 37.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 3.3 0.0 0.0 12.4 3.7 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.9 1.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.8 0.0 0.0 0.0 FOXM1 "FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident" ENSG00000111206 "Forkhead box M1" Q08050 12 2857681-2877155 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.5;testis: 40.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 16.5;Erythroid cells: 23.3;Extravillous trophoblasts: 15.0;Late spermatids: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB017832 Uncertain Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Cytosol "CAB017832: " "unprognostic (3.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.95e-6)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (6.09e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (1.94e-1)" 1.7 1.7 1.0 9.3 0.9 13.8 2.4 0.4 1.2 2.0 6.5 0.4 1.1 6.0 1.2 2.1 13.5 0.4 4.1 1.2 0.8 0.6 1.3 1.6 2.8 6.6 0.8 0.3 0.8 0.6 0.0 0.5 3.9 0.9 0.9 8.2 0.6 2.6 1.1 0.7 3.7 7.1 4.4 1.2 5.0 3.2 40.1 0.4 47.5 0.6 11.4 11.6 2.0 3.7 0.7 0.6 1.0 0.6 0.4 1.9 0.1 28.5 29.0 22.5 20.7 3.4 4.5 28.7 18.7 18.4 37.9 34.4 36.6 25.6 18.5 4.0 26.7 43.1 22.2 33.7 17.1 37.2 34.5 18.0 20.8 27.8 15.6 0.5 16.7 17.1 2.3 1.9 35.2 24.8 9.0 26.7 21.2 11.6 41.5 29.8 26.8 22.7 7.9 49.7 29.7 21.7 16.5 34.2 9.6 8.9 18.3 12.7 20.1 23.9 20.1 10.9 44.4 19.6 18.7 10.7 30.8 46.8 35.9 64.8 5.5 9.1 26.8 14.3 16.1 32.6 0.4 0.6 0.1 0.4 0.2 0.4 0.7 0.5 0.4 0.2 0.7 0.9 0.3 1.0 0.4 0.1 0.6 1.9 0.1 1.0 0.9 0.4 1.2 0.8 0.6 0.8 0.3 0.9 0.4 0.0 2.2 0.8 0.7 2.6 1.6 0.5 2.5 0.0 1.2 1.8 3.9 1.4 1.7 0.2 16.5 0.3 1.7 23.3 0.0 15.0 1.3 0.8 0.0 0.9 7.3 4.8 0.0 3.1 1.9 20.0 0.9 1.7 0.0 1.8 3.7 0.6 0.2 0.0 0.7 0.0 4.4 0.0 0.0 7.6 5.9 1.3 1.6 2.5 3.7 1.3 FP565260.1 ENSG00000275464 21 5130871-5154734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 17.2" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 10.8;Ductal cells: 8.0;Exocrine glandular cells: 6.9;Hofbauer cells: 5.1;monocytes: 5.4;Pancreatic endocrine cells: 7.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 38.1" HPA024573 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (4.43e-1)" "unprognostic (9.66e-3)" "unprognostic (2.58e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-3)" "unprognostic (8.40e-3)" "unprognostic (5.16e-2)" "unprognostic (1.07e-2)" "unprognostic (9.34e-3)" "unprognostic (1.74e-2)" "unprognostic (5.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" 3.0 3.0 1.1 3.0 2.2 3.3 1.4 1.1 6.8 1.7 1.9 7.2 1.1 2.8 1.6 2.6 1.9 2.4 4.8 2.9 3.2 1.8 1.1 1.8 4.2 2.4 1.1 1.9 2.0 2.5 1.1 2.3 2.9 1.8 2.7 1.1 1.7 1.1 6.8 1.8 2.2 3.4 1.1 2.8 1.4 1.4 1.1 1.1 1.7 1.1 2.3 2.4 1.1 8.9 6.6 5.0 12.9 7.4 17.2 7.5 11.8 8.9 6.0 9.3 2.6 2.0 3.5 0.0 0.0 0.0 0.0 0.0 7.6 0.0 5.5 4.0 8.0 7.9 16.7 7.3 0.0 2.5 5.4 38.1 4.6 4.5 4.2 17.4 11.3 7.2 8.9 10.2 8.0 1.9 7.8 5.9 21.2 4.2 2.5 10.4 12.8 12.0 23.7 13.7 11.1 20.1 5.6 10.5 5.3 9.5 5.7 10.4 9.8 14.8 5.6 1.6 12.3 9.4 3.8 4.5 11.6 0.1 12.3 4.9 5.3 23.9 8.1 23.1 6.3 2.6 5.5 5.0 15.0 9.7 17.2 8.7 9.1 11.0 6.6 8.9 9.2 12.6 3.3 7.4 12.9 4.4 6.0 7.5 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.0 2.3 0.0 8.0 0.0 0.0 0.0 0.0 6.9 1.6 0.0 0.0 4.7 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.4 0.0 0.0 7.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 FPR1 "FMLP, FPR" ENSG00000171051 "Formyl peptide receptor 1" P21462 19 51745172-51804110 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 213.3;lymphoid tissue: 64.4" "Cell type enhanced" "Detected in many" 21 "Hofbauer cells: 97.2;Kupffer cells: 262.0;Macrophages: 111.7" "Cancer enhanced" "Detected in all" "glioma: 23.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 213.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 213.3" "Cell line enriched" "Detected in some" 5 "U-87 MG: 35.0" "Not detected" "Not detected" "HPA046550, HPA061744" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA046550: AB_2679694, HPA061744: AB_2684600" "unprognostic (5.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-1)" "unprognostic (5.48e-3)" "unprognostic (4.59e-2)" "unprognostic (8.34e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.03e-2)" "unprognostic (4.52e-3)" "unprognostic (1.54e-2)" "unprognostic (1.70e-3)" 22.6 3.7 5.2 52.2 12.4 54.5 2.9 1.1 6.3 2.6 2.4 5.9 0.0 1.1 2.3 2.3 3.3 8.4 9.6 11.2 15.7 4.3 6.0 7.5 28.8 58.4 15.5 0.8 1.9 3.5 0.8 2.3 13.0 9.7 1.8 1.2 2.4 2.4 0.9 3.2 1.1 2.2 12.8 14.3 64.4 3.2 2.9 10.1 0.9 2.7 0.7 3.2 7.9 4.6 0.0 8.9 213.3 36.3 0.0 0.0 16.9 0.3 0.5 0.2 0.3 0.4 1.1 0.3 0.2 0.0 0.3 1.0 0.2 0.3 0.6 0.3 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 2.8 0.2 0.4 2.4 0.1 0.9 0.8 4.2 0.0 0.2 0.1 0.4 7.1 0.5 0.1 0.2 0.2 0.2 0.4 0.2 0.4 0.0 0.6 0.3 0.1 0.2 0.4 0.1 0.3 0.1 0.6 0.6 0.5 1.2 0.3 0.0 1.7 0.1 0.0 0.3 35.0 0.9 0.1 13.0 36.3 10.0 0.0 15.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 213.3 0.0 9.5 0.3 0.0 16.9 5.2 12.4 1.1 6.3 15.7 4.3 15.5 0.8 9.7 10.1 14.9 40.8 6.2 0.2 0.6 0.4 0.2 0.0 16.0 28.4 0.0 0.0 0.9 0.0 0.0 1.2 0.4 0.0 0.0 0.0 1.2 0.9 0.2 24.4 1.7 97.2 0.0 0.0 4.3 262.0 1.3 0.3 111.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 6.5 1.0 0.5 0.6 0.0 2.5 0.0 0.0 0.0 FTSJ3 SPB1 ENSG00000108592 "FtsJ RNA methyltransferase homolog 3" Q8IY81 17 63819433-63830012 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055544, HPA062628" Supported Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA055544: AB_2682843, HPA062628: AB_2684813" "unprognostic (1.33e-1)" "unprognostic (1.41e-1)" "unprognostic (6.60e-2)" "unprognostic (7.82e-2)" "unprognostic (6.45e-2)" "unprognostic (2.92e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.27e-1)" "unprognostic (2.57e-1)" "unprognostic (2.41e-2)" "unprognostic (2.85e-1)" "unprognostic (1.12e-1)" "unprognostic (4.99e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (5.10e-1)" "unprognostic (3.43e-1)" 20.1 19.9 14.2 15.8 18.2 12.5 16.4 13.6 15.2 17.5 17.4 22.4 25.0 12.9 22.7 19.4 17.6 17.3 16.8 19.2 14.8 9.2 24.4 24.9 13.9 17.5 18.9 9.5 22.3 14.6 30.6 13.3 15.4 16.2 19.3 17.1 17.4 16.5 18.1 25.1 21.2 16.2 21.5 17.7 19.8 16.5 13.0 17.8 31.1 22.4 19.7 26.0 18.0 16.8 9.8 13.3 6.5 12.8 12.3 15.1 9.0 20.6 32.6 12.6 17.9 20.4 17.6 19.6 20.7 15.2 23.7 18.9 27.1 13.9 27.6 8.5 12.1 12.5 14.3 23.5 19.7 30.6 4.7 23.5 24.8 23.2 25.2 14.9 31.3 18.1 12.4 15.6 36.8 17.8 12.1 19.7 17.0 24.6 11.3 15.8 34.8 27.5 10.2 34.0 23.3 33.3 24.6 34.7 19.4 15.5 18.9 11.7 45.9 24.4 20.8 14.1 26.3 19.8 10.5 17.7 17.7 24.9 19.7 38.2 27.4 38.5 27.5 15.8 20.9 17.1 4.5 10.8 6.5 11.4 12.8 15.1 9.8 12.2 14.9 13.3 9.8 9.8 12.0 2.4 12.3 9.2 10.1 14.2 9.0 14.2 18.2 13.6 15.2 14.8 9.2 18.9 9.5 16.2 17.8 29.8 23.8 10.4 12.4 12.2 6.9 26.9 20.4 29.4 30.7 14.0 9.8 13.8 11.6 21.2 6.1 18.5 13.1 0.0 29.2 13.7 11.6 9.0 24.2 17.1 12.5 3.2 12.2 9.2 15.2 11.9 22.5 14.0 8.5 20.8 11.2 13.8 23.1 13.6 18.0 21.6 8.6 45.3 17.9 10.4 12.8 11.2 13.6 10.0 16.4 9.1 FXYD1 PLM ENSG00000266964 "FXYD domain containing ion transport regulator 1" O00168 19 35138808-35143109 "Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8" "Group enriched" "Detected in many" 4 "Fibroblasts: 170.5;Hepatocytes: 393.6;Leydig cells: 398.4;Muller glia cells: 148.5;Peritubular cells: 120.6;Sertoli cells: 116.4;Smooth muscle cells: 231.4" "Cancer enhanced" "Detected in many" "liver cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 11.7" "Group enriched" "Detected in many" 5 "B-cells: 11.7;T-cells: 7.1" "Cell line enhanced" "Detected in some" "ASC diff: 31.0;ASC TERT1: 9.0;HSkMC: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026873 Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Cytosol" Nucleoli "HPA026873: AB_1855471" "unprognostic (5.58e-3)" "unprognostic (6.60e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (6.91e-4)" "unprognostic (1.54e-2)" "unprognostic (1.72e-2)" "unprognostic (3.54e-3)" "unprognostic (8.13e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (7.59e-8)" "unprognostic (9.97e-3)" "unprognostic (2.25e-1)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" 28.2 8.1 35.7 5.2 40.7 2.0 21.8 16.8 34.7 46.5 16.9 25.5 7.1 5.0 26.3 17.9 18.8 31.1 14.8 134.1 23.8 19.9 4.5 137.1 14.1 3.0 36.1 23.7 34.0 6.2 2.1 4.3 8.6 21.5 21.6 7.9 14.1 6.4 20.7 299.8 5.8 7.5 27.7 19.0 6.2 8.4 7.5 14.8 0.0 3.9 29.0 3.5 12.7 23.7 11.7 0.7 1.2 0.7 2.0 7.1 0.7 0.7 0.0 0.0 0.1 31.0 9.0 0.8 3.7 0.1 0.0 0.0 0.0 0.2 2.4 1.0 0.0 0.1 0.6 0.7 0.4 0.0 2.2 0.9 0.4 0.0 1.2 3.5 0.2 0.2 12.8 0.0 0.1 0.3 0.3 0.1 0.1 0.6 2.5 0.1 0.0 0.0 0.5 0.1 1.8 0.4 0.0 0.1 0.6 0.0 0.0 0.2 0.1 0.4 0.1 1.0 0.2 0.1 4.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.6 0.4 5.1 1.2 0.3 0.0 1.4 0.7 0.9 11.7 4.1 1.7 0.3 6.6 0.8 1.0 0.6 2.0 0.7 0.7 7.1 0.7 35.7 40.7 16.8 34.7 23.8 19.9 36.1 23.7 21.5 14.8 0.0 0.0 3.7 5.1 26.2 1.4 0.3 2.5 5.3 0.0 24.4 3.9 1.3 0.0 0.1 1.2 6.0 1.3 0.0 4.2 1.5 170.5 2.1 0.0 393.6 4.2 0.0 0.0 49.1 11.0 5.1 398.4 4.1 50.6 0.0 0.4 148.5 1.6 2.5 120.6 0.0 7.0 116.4 231.4 3.8 11.7 23.8 2.4 4.9 0.6 2.3 GALNT17 "GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17" ENSG00000185274 "Polypeptide N-acetylgalactosaminyltransferase 17" Q6IS24 7 71132169-71713600 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.9" "Cell type enhanced" "Detected in single" 28 "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.6;NTERA-2: 7.2;RPMI-8226: 8.0;SK-BR-3: 30.5;SuSa: 10.0" "Low region specificity" "Detected in all" "HPA013624, HPA047986" Approved Uncertain "Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "Nucleoli, Nuclear bodies" "HPA013624: AB_1858787, HPA047986: " "unprognostic (2.79e-2)" "unprognostic (6.83e-2)" "unprognostic (5.54e-2)" "unprognostic (3.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.62e-1)" "unprognostic (6.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.00e-1)" "prognostic favorable (4.60e-4)" "unprognostic (2.00e-1)" "unprognostic (4.73e-1)" "unprognostic (1.96e-2)" "unprognostic (9.63e-3)" "prognostic favorable (3.91e-4)" "unprognostic (1.92e-1)" "unprognostic (7.94e-3)" 1.8 7.8 8.2 2.1 13.9 0.5 1.2 25.7 42.9 2.3 4.9 1.7 1.9 0.8 7.9 4.6 8.9 4.4 2.7 19.4 13.2 4.6 2.3 0.6 3.5 0.5 2.1 12.0 22.3 9.4 0.6 4.1 0.7 4.5 9.1 1.4 1.2 1.7 8.3 1.9 0.8 1.5 12.3 1.2 3.3 1.1 3.8 0.8 0.3 9.4 0.0 1.8 10.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.5 0.0 0.0 30.5 0.0 10.0 0.0 0.0 0.0 0.0 2.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 13.9 25.7 22.5 13.2 4.6 2.1 12.0 4.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GALNT5 GalNAc-T5 ENSG00000136542 "Polypeptide N-acetylgalactosaminyltransferase 5" Q7Z7M9 2 157257598-157314211 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.2" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 145.9;Mucus-secreting cells: 66.8;Urothelial cells: 121.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "cerebellum: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 23.6;BJ: 15.5;BJ hTERT+: 27.8;CAPAN-2: 13.6;fHDF/TERT166: 32.4;HaCaT: 27.7;K-562: 16.0;LHCN-M2: 27.7;U-138 MG: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008963, HPA009035" Approved Approved "Nucleoli,Golgi apparatus,Vesicles,Cytosol" NA NA 630000 "Golgi apparatus, Cytosol" "Nucleoli, Vesicles" "HPA008963: AB_1078942, HPA009035: AB_1078943" "unprognostic (6.34e-3)" "unprognostic (9.31e-2)" "unprognostic (2.11e-2)" "unprognostic (9.89e-2)" "unprognostic (3.19e-2)" "unprognostic (2.46e-2)" "unprognostic (4.63e-3)" "unprognostic (1.88e-1)" "unprognostic (1.09e-1)" "unprognostic (6.93e-2)" "unprognostic (4.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-2)" "unprognostic (6.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-3)" 0.4 0.2 0.2 1.5 0.2 0.5 1.1 28.2 0.2 7.5 12.0 0.7 0.0 2.3 0.5 0.5 9.0 0.2 17.1 0.9 0.4 0.2 0.3 0.2 15.5 0.0 0.2 0.0 0.3 1.5 0.0 6.8 0.1 4.4 1.6 16.1 0.3 18.9 0.2 0.2 0.5 8.4 0.8 0.3 0.3 15.2 0.5 0.0 0.1 0.3 12.2 11.7 2.3 6.6 0.2 0.1 0.2 0.1 0.1 0.5 0.0 23.6 2.6 0.0 0.0 1.0 8.3 0.0 15.5 27.8 0.2 0.6 1.1 13.6 0.0 0.0 32.4 0.0 27.7 0.5 5.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.5 0.0 0.0 0.0 16.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.1 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.5 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.2 0.2 28.2 0.2 0.4 0.2 0.2 0.0 4.4 0.0 145.9 29.7 0.0 10.3 0.7 0.0 0.4 2.5 5.3 36.4 0.0 0.0 0.0 0.0 0.8 5.1 0.0 18.6 23.3 2.9 0.0 2.1 7.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.6 3.3 2.8 66.8 0.0 31.4 31.7 0.0 0.0 0.0 0.0 0.1 2.6 0.2 0.1 0.0 0.0 20.7 121.3 GAS2 ENSG00000148935 "Growth arrest specific 2" O43903 11 22625642-22813055 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell shape, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 10.9;Cholangiocytes: 10.2;Ciliated cells: 6.7;Hepatocytes: 20.2" "Cancer enhanced" "Detected in many" "liver cancer: 4.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Hep G2: 19.9;JURKAT: 11.3;Karpas-707: 40.7;SCLC-21H: 11.9;U-266/84: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058904 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" Yes NA "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "HPA058904: AB_2683850" "unprognostic (5.48e-3)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (1.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-2)" "unprognostic (1.08e-1)" "unprognostic (1.49e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.30e-5)" "prognostic favorable (6.13e-4)" "unprognostic (5.85e-2)" "unprognostic (4.22e-2)" "unprognostic (7.94e-2)" "unprognostic (3.58e-2)" 0.7 1.1 2.1 1.1 3.6 0.4 0.9 0.9 2.2 1.2 0.7 1.4 1.2 2.0 1.1 1.3 1.0 1.5 2.7 3.6 2.1 2.5 5.3 37.2 1.3 1.1 4.3 1.2 2.3 22.7 0.5 4.8 0.7 4.5 1.3 0.7 0.5 2.2 0.9 4.8 1.0 1.8 0.6 8.6 1.5 2.6 1.1 3.2 19.6 1.1 3.0 1.0 1.8 0.7 1.0 0.6 0.3 0.0 0.1 1.7 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.2 0.1 0.0 19.9 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 11.3 0.7 40.7 0.0 0.1 0.1 0.0 0.1 1.1 0.0 0.4 0.2 2.0 0.0 0.5 11.9 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.2 0.5 0.0 0.5 13.5 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.0 1.7 1.0 0.4 0.0 0.0 0.9 1.6 0.4 0.0 0.1 0.0 0.6 0.3 0.1 2.1 3.6 0.9 2.2 2.1 2.5 4.3 1.2 4.5 3.2 0.0 0.0 0.0 0.2 0.1 2.7 10.9 10.2 6.7 0.0 0.0 0.0 0.0 0.0 0.8 1.7 0.0 0.0 0.0 2.9 0.0 0.3 0.1 0.0 20.2 0.0 0.0 0.0 0.6 0.0 3.7 0.6 0.0 0.0 0.0 0.0 0.3 2.6 0.3 0.0 2.1 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.9 0.3 GCLC "GCS, GLCL, GLCLC" ENSG00000001084 "Glutamate-cysteine ligase catalytic subunit" P48506 6 53497341-53616970 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.2" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 102.4;Intestinal endocrine cells: 212.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 49.2;Hep G2: 42.0;OE19: 68.1;RT4: 45.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009569, HPA036359, HPA036360" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 3600000 Nucleoplasm "Nucleoli, Cytosol" "CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789" "unprognostic (8.41e-2)" "unprognostic (1.27e-2)" "unprognostic (5.65e-2)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (2.76e-1)" "unprognostic (2.60e-1)" "unprognostic (7.50e-2)" "unprognostic (9.94e-3)" "unprognostic (4.67e-3)" "unprognostic (1.30e-1)" "unprognostic (5.23e-2)" "prognostic favorable (3.83e-6)" "unprognostic (3.78e-2)" "unprognostic (8.91e-2)" "prognostic unfavorable (8.24e-4)" "unprognostic (2.30e-2)" 15.8 11.1 12.9 9.0 16.0 14.4 13.0 5.4 15.1 6.8 16.2 21.6 8.2 18.9 9.2 5.3 20.0 29.1 14.9 7.4 13.1 10.6 15.4 69.2 12.9 10.1 21.6 12.2 6.2 12.4 6.6 5.4 6.2 13.0 13.0 12.2 5.2 11.2 10.1 7.0 8.6 14.8 11.9 13.6 16.8 14.8 5.2 17.5 3.1 14.1 32.4 10.6 34.4 12.3 1.6 4.2 2.2 1.9 8.0 2.3 0.6 7.3 49.2 4.0 9.5 4.8 2.2 5.4 3.7 6.0 2.8 3.3 7.2 17.1 14.0 7.1 3.3 21.5 10.5 12.3 27.1 3.8 11.0 7.6 9.3 9.5 42.0 5.5 12.3 5.8 3.4 11.5 3.1 14.1 3.7 4.2 12.3 5.1 4.4 1.3 7.7 10.5 4.9 7.5 68.1 4.6 3.5 2.5 12.3 9.1 45.4 11.7 5.7 6.2 10.0 6.5 6.1 6.8 5.8 5.9 2.5 8.8 6.4 5.5 5.9 9.1 8.1 6.3 8.8 4.2 2.2 1.1 0.6 1.2 1.9 0.8 1.6 1.0 2.3 4.2 1.0 0.6 1.3 0.5 8.0 1.8 3.0 1.6 0.6 12.9 16.0 5.4 11.9 13.1 10.6 21.6 12.2 13.0 17.5 0.0 3.7 7.8 42.9 30.9 12.8 17.8 25.5 48.2 47.8 0.0 23.6 5.2 10.0 12.8 1.4 13.5 19.9 46.7 11.0 6.5 8.7 44.8 2.3 102.4 19.8 7.9 212.1 9.2 60.1 1.0 6.1 16.4 8.5 6.4 16.3 13.8 17.1 8.5 8.9 19.8 4.0 12.9 10.3 3.3 8.1 21.8 6.5 10.7 13.8 89.1 GEMIN2 SIP1 ENSG00000092208 "Gem nuclear organelle associated protein 2" O14893 14 39114223-39136973 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015426, HPA046570, HPA057114" Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "CAB015426: AB_629517, HPA046570: AB_2679703, HPA057114: AB_2683340" "unprognostic (4.53e-1)" "unprognostic (1.56e-1)" "unprognostic (1.52e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.88e-6)" "unprognostic (8.62e-3)" "unprognostic (3.05e-2)" "unprognostic (1.99e-3)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (4.53e-3)" "unprognostic (1.52e-1)" "unprognostic (1.58e-1)" "unprognostic (3.95e-1)" "unprognostic (6.78e-2)" 10.0 8.2 13.2 8.1 16.9 15.2 13.3 15.7 15.2 10.1 9.5 10.9 5.2 11.4 9.3 12.5 10.2 9.9 7.2 12.4 13.8 10.1 8.2 9.2 9.1 14.1 11.0 13.8 11.3 8.5 4.3 16.1 9.0 13.4 8.4 10.9 8.9 7.7 7.7 18.9 10.4 8.0 12.6 12.4 9.5 8.4 13.2 12.8 11.9 9.8 9.9 13.3 11.3 9.6 17.1 15.8 8.9 12.6 11.6 15.5 8.7 11.6 16.7 16.5 12.0 5.8 6.7 8.5 5.5 4.4 14.9 14.8 14.6 13.7 17.2 11.6 4.7 5.3 8.9 22.1 9.4 15.7 8.8 12.9 10.0 10.2 36.2 11.8 15.2 6.6 3.6 9.0 9.4 13.5 4.4 13.0 15.2 11.9 12.6 8.3 23.1 16.6 14.6 11.5 14.1 18.8 15.5 18.0 10.8 8.3 7.6 16.1 3.2 11.7 9.0 6.0 9.4 20.5 6.7 5.3 6.9 10.2 6.7 9.0 13.2 20.5 25.2 3.3 16.2 9.6 8.1 12.3 8.9 14.3 12.6 10.1 15.4 13.2 14.0 15.6 17.1 14.9 15.5 3.4 11.6 10.4 15.8 11.4 8.7 13.2 16.9 15.7 15.2 13.8 10.1 11.0 13.8 13.4 12.8 6.0 3.0 7.5 7.2 7.6 6.3 5.2 2.5 13.4 6.8 5.2 9.8 12.3 10.0 9.9 33.1 8.0 1.8 0.0 5.6 15.4 11.2 5.3 5.7 5.8 10.0 4.8 3.5 9.8 10.0 32.0 8.3 6.6 6.8 7.2 6.7 7.1 6.1 0.0 9.2 11.5 6.4 6.5 5.2 19.3 14.7 6.9 3.2 10.2 8.8 4.2 GET4 "C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35" ENSG00000239857 "Golgi to ER traffic protein 4" Q7L5D6 7 876552-896436 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Cone photoreceptor cells: 3.9;Horizontal cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019765 Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol" Yes No "Nucleoplasm, Cytosol" "Nucleoli, Mitotic chromosome" "HPA019765: AB_1845750" "unprognostic (2.80e-2)" "unprognostic (2.40e-2)" "unprognostic (2.10e-2)" "unprognostic (9.66e-4)" "unprognostic (9.86e-2)" "unprognostic (8.64e-2)" "unprognostic (4.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.59e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-1)" "unprognostic (1.21e-1)" "unprognostic (7.65e-2)" "unprognostic (8.18e-2)" "unprognostic (1.26e-1)" "unprognostic (5.93e-2)" "unprognostic (9.47e-2)" 13.7 39.8 22.4 14.8 21.4 28.5 15.3 22.1 23.5 10.3 15.5 20.9 19.0 21.8 12.3 23.8 18.8 14.6 12.8 18.7 16.4 15.4 27.8 37.5 12.2 15.1 22.9 21.5 16.5 32.6 11.3 32.9 21.7 18.9 16.8 9.9 15.2 25.0 21.9 53.7 29.7 20.9 12.6 18.9 16.9 22.2 32.0 22.7 12.5 16.0 21.8 12.5 14.3 17.3 23.3 31.5 28.9 30.7 24.9 27.3 21.9 26.3 13.0 9.1 13.4 4.7 3.3 28.9 7.3 5.2 9.4 9.4 35.3 33.0 9.7 7.7 4.2 26.2 16.8 10.2 8.0 4.1 3.9 17.5 5.3 10.2 19.9 10.4 9.1 9.9 4.9 9.7 8.2 5.4 7.1 7.4 11.3 34.5 9.0 5.2 20.0 6.9 21.9 32.7 15.6 19.5 14.5 1.6 10.4 8.3 15.6 16.5 17.8 6.7 24.9 10.6 11.6 18.9 16.2 7.4 6.9 15.6 16.0 10.0 13.6 8.5 12.5 7.1 15.7 17.5 16.8 27.4 28.9 24.2 24.7 23.7 23.3 26.5 24.0 27.7 23.2 26.0 27.3 21.1 24.9 30.7 31.5 24.5 21.9 22.4 21.4 22.1 23.5 16.4 15.4 22.9 21.5 18.9 22.7 0.0 1.9 0.0 0.2 0.9 0.8 0.4 0.0 2.7 3.4 0.0 3.9 0.9 0.0 0.6 3.6 0.1 1.6 0.0 0.6 0.6 0.3 0.4 1.1 0.0 0.6 7.9 0.0 0.0 0.3 1.5 0.0 2.5 0.0 0.0 1.9 0.2 0.8 0.0 0.0 0.6 1.1 0.0 0.2 0.5 1.0 0.9 1.4 0.9 1.7 0.8 GFPT1 "GFA, GFAT, GFAT1, GFPT" ENSG00000198380 "Glutamine--fructose-6-phosphate transaminase 1" Q06210 2 69319769-69387254 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms" "Aminotransferase, Transferase" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Mucus-secreting cells: 215.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047240 Approved "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli" "Nucleoli fibrillar center" "HPA047240: " "unprognostic (4.38e-3)" "unprognostic (8.20e-2)" "prognostic favorable (7.13e-5)" "unprognostic (2.97e-1)" "unprognostic (1.32e-1)" "unprognostic (2.40e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (2.99e-1)" "unprognostic (3.14e-1)" "unprognostic (4.84e-2)" "unprognostic (5.00e-2)" "unprognostic (3.83e-2)" "unprognostic (9.49e-2)" "unprognostic (1.78e-1)" "unprognostic (1.63e-1)" "unprognostic (2.58e-1)" 16.7 11.4 6.4 12.7 7.8 5.6 18.3 7.8 10.1 16.8 27.0 6.4 41.2 14.5 10.1 18.7 11.6 9.5 19.4 11.3 6.0 9.8 17.8 49.1 14.1 4.7 6.5 5.7 11.1 34.9 13.9 39.6 36.5 7.0 17.2 27.5 7.7 39.7 34.0 9.2 6.1 28.2 8.7 6.2 8.2 24.6 13.9 4.8 8.5 35.2 7.7 18.1 10.6 16.2 5.6 4.1 5.9 3.4 4.1 6.8 3.0 9.6 6.7 8.7 5.4 24.2 16.7 18.7 18.5 17.2 8.7 11.1 21.4 8.8 8.7 6.7 17.1 10.9 4.7 10.8 5.6 14.4 7.9 4.1 10.1 5.0 22.1 28.7 6.9 4.0 10.5 27.6 16.9 32.4 12.1 8.1 7.5 8.4 14.2 17.0 5.7 7.2 7.2 11.2 19.9 5.6 7.3 18.0 4.4 14.2 7.7 5.3 3.0 6.9 12.8 24.7 18.7 5.1 4.3 12.4 7.8 10.4 13.3 8.8 10.2 6.8 6.6 12.7 4.7 8.9 5.9 2.8 3.4 6.8 3.2 6.5 5.6 6.1 6.6 3.6 3.4 6.1 5.6 1.3 4.1 3.4 4.1 4.3 3.0 6.4 7.8 7.8 10.1 6.0 9.8 6.5 5.7 7.0 4.8 47.6 43.8 21.6 18.1 25.2 14.6 39.1 43.3 62.9 45.5 41.8 11.8 23.5 14.9 29.0 71.7 15.1 126.6 0.0 78.9 58.2 37.0 83.5 24.2 49.7 15.2 6.4 72.2 19.6 8.8 12.1 21.6 14.3 50.6 39.7 215.3 10.9 58.8 74.8 26.5 24.3 13.7 19.4 31.7 89.0 45.3 18.3 28.7 16.6 120.1 30.1 GIN1 "FLJ20125, GIN-1, TGIN1, ZH2C2" ENSG00000145723 "Gypsy retrotransposon integrase 1" Q9NXP7 5 103086000-103120151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 24.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037402, HPA061362" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037402: AB_10672790, HPA061362: AB_2684491" "unprognostic (3.89e-2)" "unprognostic (5.52e-2)" "unprognostic (1.57e-2)" "unprognostic (1.53e-1)" "unprognostic (7.98e-2)" "unprognostic (1.81e-1)" "unprognostic (4.64e-2)" "unprognostic (3.02e-2)" "unprognostic (4.66e-2)" "unprognostic (3.01e-2)" "unprognostic (9.60e-3)" "unprognostic (1.20e-1)" "prognostic favorable (1.63e-4)" "unprognostic (1.89e-1)" "unprognostic (4.39e-1)" "unprognostic (3.14e-2)" "unprognostic (3.08e-2)" 6.0 9.3 5.0 5.7 9.5 1.4 8.0 15.0 9.6 9.0 7.0 6.5 6.1 4.9 7.0 5.6 7.2 6.4 3.7 12.7 5.8 5.1 7.9 8.3 5.6 6.6 14.0 4.2 11.0 6.0 8.4 17.4 5.1 9.4 8.3 6.7 3.6 6.1 7.6 14.6 4.5 5.9 5.8 11.4 6.9 6.3 9.3 10.8 8.6 9.1 6.1 6.7 9.4 9.5 4.6 3.3 4.8 7.1 3.7 8.3 2.8 5.5 6.0 7.6 5.5 3.6 9.3 6.2 7.4 5.1 5.6 5.0 3.6 7.2 3.3 7.0 2.9 4.8 6.6 7.0 10.5 7.6 4.2 5.6 4.8 5.8 4.0 7.5 4.3 3.1 3.6 11.7 5.1 10.5 6.0 4.4 5.5 4.2 4.9 8.8 4.0 5.9 2.8 6.5 4.0 9.4 5.3 8.7 8.6 7.4 4.6 6.2 4.5 4.9 4.1 7.1 5.7 12.0 6.5 3.6 5.7 3.5 6.1 5.6 6.0 4.8 4.8 7.3 6.8 4.6 0.4 2.7 4.8 3.4 3.4 3.9 4.6 4.6 5.0 3.3 3.8 5.6 5.6 3.8 3.7 7.1 3.2 8.3 2.8 5.0 9.5 15.0 9.6 5.8 5.1 14.0 4.2 9.4 10.8 8.9 4.0 1.4 4.8 0.8 9.5 16.5 0.0 8.1 3.4 5.2 0.0 6.6 19.9 6.7 1.0 3.0 3.2 0.0 3.7 4.0 2.4 3.6 16.1 3.9 4.8 0.0 4.1 3.1 3.2 0.2 4.6 5.3 0.0 3.6 3.3 8.5 3.6 3.1 6.3 6.7 12.1 6.5 3.9 24.0 12.8 1.8 6.9 4.3 3.2 3.1 GJC1 "CX45, GJA7" ENSG00000182963 "Gap junction protein gamma 1" P36383 17 44798448-44830816 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 23 "Sertoli cells: 155.2;Smooth muscle cells: 65.3;Spermatogonia: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA071788 Uncertain "Nucleoli,Cell Junctions,Cytosol" NA NA Nucleoli "Cell Junctions, Cytosol" "HPA071788: " "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (2.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (7.02e-2)" "unprognostic (4.01e-1)" "unprognostic (1.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.02e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.55e-8)" "unprognostic (5.18e-2)" "unprognostic (2.20e-1)" "unprognostic (8.52e-2)" "prognostic unfavorable (7.83e-4)" 7.3 0.8 2.2 4.1 3.4 1.0 4.7 8.2 4.2 14.8 23.0 2.8 7.0 1.6 24.2 3.1 3.2 5.0 5.4 10.0 3.3 1.8 1.5 0.9 6.5 2.3 2.5 4.0 2.2 1.3 2.6 0.7 28.5 3.4 8.2 2.8 3.7 1.7 17.0 5.4 1.9 4.8 27.5 2.2 0.9 7.8 8.0 2.9 1.4 5.3 2.9 1.7 12.6 10.4 1.2 1.0 4.7 1.0 1.9 1.0 0.4 17.4 9.0 22.7 7.8 3.0 4.7 8.9 19.4 15.3 20.9 22.5 5.2 9.7 0.1 1.0 18.1 28.6 4.5 11.8 6.0 29.4 0.1 8.8 0.1 4.8 0.5 1.8 0.1 0.7 3.2 0.6 15.9 5.3 7.8 7.1 3.9 0.8 0.2 12.1 0.1 2.8 1.7 10.2 0.0 7.7 16.5 28.8 0.1 5.0 7.3 4.3 9.9 2.2 0.1 6.5 15.3 4.7 2.7 5.9 18.5 17.9 8.4 16.5 0.1 4.5 12.9 6.4 0.1 17.3 4.7 1.0 1.1 0.9 0.6 0.8 0.9 0.7 0.6 0.3 1.2 0.9 1.0 3.9 1.9 0.7 1.0 0.6 0.4 2.2 3.4 8.2 4.2 3.3 1.8 2.5 4.0 3.4 2.9 0.0 0.0 0.0 1.6 1.8 1.0 18.1 0.0 0.0 0.0 1.8 2.0 0.3 0.0 1.3 1.3 11.7 0.0 0.0 0.0 2.1 5.7 1.2 0.0 0.0 1.2 12.7 0.0 6.2 0.8 0.0 1.4 0.0 3.3 1.0 0.0 0.4 0.6 0.0 2.1 0.3 1.0 155.2 65.3 10.2 32.0 2.6 0.5 0.0 0.0 1.4 GLCCI1 "FAM117C, GIG18, TSSN1" ENSG00000106415 "Glucocorticoid induced 1" Q86VQ1 7 7968794-8094272 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 55.7" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 77.4;Bipolar cells: 61.8;Early spermatids: 62.5;Spermatocytes: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 17.7;U-266/70: 41.2;U-698: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001674, HPA005987" Approved Approved Nucleoli NA NA Nucleoli "HPA001674: AB_1078971, HPA005987: AB_1078970" "unprognostic (6.12e-2)" "unprognostic (7.81e-2)" "unprognostic (1.90e-1)" "unprognostic (1.45e-1)" "unprognostic (6.17e-3)" "unprognostic (1.02e-2)" "unprognostic (4.40e-1)" "unprognostic (1.68e-3)" "unprognostic (3.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.17e-3)" "unprognostic (3.35e-1)" "unprognostic (9.30e-2)" "unprognostic (2.14e-1)" "unprognostic (1.56e-1)" "unprognostic (3.09e-1)" "unprognostic (9.20e-3)" 4.6 4.3 5.6 19.1 12.5 7.6 4.1 26.6 8.0 5.4 4.9 3.4 0.9 5.7 3.4 1.8 3.0 2.8 3.9 2.2 3.7 4.1 3.9 3.8 18.4 13.8 3.1 5.6 5.1 2.3 8.0 6.5 9.3 4.4 3.2 4.7 3.1 6.3 2.0 3.0 7.5 5.6 2.5 3.2 9.2 6.4 14.2 3.7 55.7 20.7 1.9 15.9 7.7 3.3 3.1 2.4 3.7 0.4 4.7 4.5 0.7 2.3 0.3 3.9 0.9 1.2 1.7 0.8 2.0 2.8 1.2 1.1 1.2 0.8 6.5 0.5 1.6 2.0 0.4 3.6 1.1 1.6 3.2 2.8 1.9 5.0 0.8 2.0 3.0 2.8 0.8 1.3 0.8 2.7 2.0 1.0 2.4 7.0 17.7 2.1 1.3 1.4 3.0 9.8 1.0 2.4 6.9 3.0 3.4 1.1 2.7 6.5 12.8 3.1 3.9 0.2 11.1 4.6 7.9 0.9 2.2 1.0 1.9 1.0 41.2 13.1 18.6 2.3 3.2 1.6 3.7 0.1 1.5 2.7 0.4 2.5 1.8 2.8 2.0 0.1 3.1 1.6 1.8 1.2 4.7 0.1 2.4 4.5 0.7 5.6 12.5 26.6 8.0 3.7 4.1 3.1 5.6 4.4 3.7 77.4 34.3 13.7 7.2 9.2 61.8 5.7 0.0 5.3 31.8 7.0 41.2 10.4 1.7 0.7 62.5 3.8 2.4 0.0 1.4 7.5 6.9 15.8 5.7 5.9 10.7 7.9 18.6 6.7 3.5 12.3 7.5 5.2 8.5 0.0 6.2 14.3 2.4 3.5 10.6 1.5 20.5 6.5 6.4 66.0 37.4 11.4 24.0 18.7 3.9 8.0 GLE1 "GLE1L, hGLE1, LCCS1" ENSG00000119392 "GLE1, RNA export mediator" Q53GS7 9 128504700-128542288 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 55.3;Late spermatids: 44.8;Spermatocytes: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041689, HPA043538, HPA061560" Supported Supported "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane" Nucleoli "HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560" "unprognostic (8.74e-3)" "unprognostic (2.18e-2)" "unprognostic (1.17e-1)" "prognostic favorable (7.49e-4)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (7.91e-2)" "unprognostic (1.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.95e-2)" "unprognostic (4.00e-2)" "prognostic favorable (7.04e-4)" "unprognostic (2.62e-1)" "unprognostic (1.99e-3)" "unprognostic (5.64e-2)" 12.5 17.0 11.1 13.5 13.2 12.2 14.7 22.1 13.8 13.1 15.7 16.5 17.6 14.6 13.8 11.4 18.5 13.5 12.6 13.2 10.5 8.9 13.1 20.4 11.3 23.0 11.2 9.9 15.7 21.1 20.8 16.3 16.4 10.6 13.4 17.2 13.1 13.6 16.7 23.3 18.3 14.9 12.0 9.8 17.5 12.1 42.8 11.8 27.2 12.4 14.6 20.0 14.3 13.5 16.0 19.2 26.2 22.5 22.6 20.5 15.8 10.8 20.4 10.0 17.1 9.9 10.1 13.3 11.0 9.4 15.5 11.0 13.7 7.6 22.0 8.9 12.3 14.9 38.3 17.3 15.7 13.4 20.9 11.3 11.3 22.5 12.7 11.2 18.2 14.9 7.1 15.3 17.5 18.8 8.6 8.7 20.7 16.1 19.5 17.7 25.2 17.9 12.9 8.5 29.2 17.7 18.3 24.6 29.1 10.4 9.7 11.9 8.9 26.8 16.3 9.6 8.5 30.0 12.9 6.3 16.5 11.0 19.2 15.2 19.6 47.1 17.2 15.4 13.9 17.7 26.2 18.1 20.3 20.5 22.5 16.7 12.0 16.0 18.1 19.2 16.0 14.4 16.6 15.4 22.6 22.0 11.4 18.3 15.8 11.1 13.2 22.1 13.8 10.5 8.9 11.2 9.9 10.6 11.8 8.9 7.0 10.2 6.2 5.8 6.6 10.9 0.0 9.4 4.5 7.0 7.9 14.2 5.0 9.6 55.3 3.1 11.4 0.0 5.4 9.5 5.1 4.8 9.2 10.5 13.4 9.5 5.2 3.7 12.6 44.8 9.5 9.9 3.3 20.8 13.4 8.4 7.6 5.8 6.0 11.1 8.2 12.9 5.1 45.3 28.1 5.9 11.1 11.5 13.9 4.3 GLI2 "HPE9, THP1, THP2" ENSG00000074047 "GLI family zinc finger 2" P10070 2 120735623-120992653 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 23.3" "Group enriched" "Detected in some" 4 "Leydig cells: 23.3;Peritubular cells: 29.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 19.6;NTERA-2: 11.9;U-2 OS: 20.3;WM-115: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "CAB008558, HPA074275" Approved Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "CAB008558: AB_2111910, HPA074275: AB_2686677" "unprognostic (6.76e-2)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (9.83e-3)" "unprognostic (4.63e-2)" "unprognostic (2.04e-1)" "unprognostic (9.43e-2)" "unprognostic (1.65e-2)" "unprognostic (2.19e-3)" "unprognostic (2.58e-1)" "unprognostic (9.23e-3)" "unprognostic (1.81e-2)" "unprognostic (4.49e-10)" "unprognostic (1.13e-1)" "unprognostic (8.88e-2)" "unprognostic (2.32e-2)" "unprognostic (1.42e-3)" 2.1 1.6 3.6 2.9 5.3 0.2 2.3 3.1 3.4 8.0 4.4 1.9 1.5 0.9 8.6 2.6 3.9 5.8 8.8 3.3 3.7 1.0 1.7 0.8 2.9 0.7 1.3 1.5 23.3 0.8 0.7 2.6 1.7 3.6 6.2 1.4 5.9 1.8 2.4 1.6 3.7 3.2 4.5 1.6 2.0 3.9 5.4 2.1 1.7 1.6 4.7 2.6 4.3 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 19.6 3.9 2.1 4.2 0.0 7.5 1.7 3.3 2.1 0.0 0.6 0.0 0.8 3.7 0.5 0.3 5.5 0.0 1.6 0.0 3.5 0.5 4.8 0.0 4.7 0.0 1.5 2.1 0.0 10.6 0.0 2.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 11.9 1.2 6.0 0.0 2.2 1.2 0.0 0.0 0.8 3.4 3.4 0.0 0.5 4.1 0.0 0.2 5.9 0.0 20.3 2.1 0.0 0.0 0.0 0.0 7.4 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 5.3 3.1 3.4 3.7 1.0 1.3 1.5 3.6 2.1 0.0 0.0 0.0 0.0 1.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.1 6.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 23.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 29.0 0.0 0.0 0.0 2.3 0.0 3.8 1.5 0.0 0.0 0.0 0.0 GLI3 "ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV" ENSG00000106571 "GLI family zinc finger 3" P10071 7 41960950-42237870 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 31.6" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 20.8;Syncytiotrophoblasts: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.6;WM-115: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005534 Approved Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA005534: AB_1078973" "unprognostic (2.53e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (8.22e-3)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.35e-3)" "unprognostic (2.24e-1)" "unprognostic (7.38e-2)" "unprognostic (4.03e-1)" "unprognostic (3.54e-2)" "unprognostic (1.48e-5)" "unprognostic (9.13e-3)" "unprognostic (5.41e-2)" "unprognostic (3.21e-3)" "unprognostic (7.00e-2)" 7.3 2.6 4.6 6.8 5.4 0.3 9.4 0.8 6.4 21.1 13.1 2.9 10.9 1.4 31.6 10.0 7.3 10.8 7.0 2.0 4.2 1.7 2.3 0.7 5.8 2.4 1.8 2.1 17.6 1.5 0.8 1.9 13.4 1.8 10.6 3.8 5.1 3.7 14.3 2.2 9.7 4.2 13.8 0.9 1.8 3.8 2.3 3.0 1.7 6.1 8.7 4.0 6.4 9.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 26.6 0.2 6.9 12.6 1.7 1.6 5.6 4.8 5.6 0.1 0.0 0.0 1.0 11.1 6.2 5.5 3.6 4.3 4.1 0.0 3.3 0.0 3.3 0.0 4.4 0.0 0.1 10.4 6.3 5.0 4.0 2.8 4.4 2.9 0.0 0.1 2.2 2.4 0.3 0.0 12.0 0.0 10.1 6.3 0.1 0.7 0.0 4.4 0.7 0.0 2.6 3.3 2.0 11.4 4.4 0.0 4.6 5.9 8.5 8.2 2.8 0.0 0.0 0.0 4.4 0.1 19.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.6 5.4 0.8 6.4 4.2 1.7 1.8 2.1 1.8 3.0 0.0 4.8 0.0 6.8 20.8 1.8 1.4 0.0 1.4 1.2 1.8 0.0 17.7 0.0 0.0 11.6 2.8 0.0 0.0 0.0 12.0 18.1 3.2 1.1 0.0 2.8 0.0 0.0 2.5 0.3 4.3 17.8 0.0 8.5 0.0 0.0 11.8 0.1 0.0 3.2 3.4 0.8 12.9 14.6 0.4 0.9 13.6 28.6 0.0 0.0 3.7 GMPR2 ENSG00000100938 "Guanosine monophosphate reductase 2" Q9P2T1 14 24232422-24239242 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000904, HPA067884, HPA068782" Uncertain Approved Nucleoplasm,Nucleoli No No 160000 Nucleoplasm Nucleoli "HPA000904: AB_1078998, HPA067884: AB_2685916, HPA068782: AB_2686032" "unprognostic (1.95e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (9.86e-2)" "unprognostic (5.98e-2)" "unprognostic (3.24e-1)" "unprognostic (5.21e-3)" "unprognostic (9.24e-2)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.21e-5)" "unprognostic (2.30e-1)" "unprognostic (1.96e-1)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" 18.9 44.2 19.6 14.6 24.2 11.5 26.2 13.6 31.7 22.5 21.1 25.1 20.3 21.3 18.8 26.3 17.8 28.7 23.4 15.0 20.1 21.9 39.1 26.3 19.0 18.1 23.0 21.2 26.1 26.9 49.1 22.4 22.7 26.0 20.3 21.6 21.9 22.6 23.7 16.1 14.4 21.7 18.2 20.3 25.5 21.2 10.6 19.1 21.6 43.0 11.2 21.0 21.8 17.6 7.5 14.4 32.3 14.0 7.6 14.9 11.0 9.2 10.6 14.3 9.3 16.6 23.5 13.1 10.9 19.4 15.3 19.6 12.4 7.3 12.3 9.9 15.9 9.8 12.8 15.8 23.6 21.9 11.6 11.6 9.7 6.6 45.2 15.6 15.8 15.2 22.0 16.9 8.1 16.8 21.4 24.8 17.7 5.6 11.6 15.4 17.2 15.7 14.2 11.1 13.6 13.8 11.9 9.7 10.1 21.1 15.2 10.1 14.4 7.8 17.2 14.6 15.2 14.9 12.7 12.7 7.3 5.8 9.5 7.9 25.9 24.8 8.1 6.0 12.1 7.0 9.0 14.0 7.2 10.1 11.2 10.7 7.5 10.2 11.2 14.4 7.1 9.1 10.2 32.3 7.6 11.3 6.5 14.9 11.0 19.6 24.2 13.6 31.7 20.1 21.9 23.0 21.2 26.0 19.1 23.8 16.0 23.8 32.5 9.7 16.4 10.5 40.8 33.5 25.0 50.6 3.9 53.9 86.2 34.2 9.9 19.0 34.2 0.0 29.0 39.0 17.4 19.6 31.1 22.4 45.3 17.5 9.9 11.6 32.6 7.7 26.7 30.1 20.3 23.4 20.4 34.1 30.5 30.6 23.7 96.9 13.6 25.8 25.8 15.2 9.6 9.4 41.2 23.0 27.6 21.0 GNAI1 ENSG00000127955 "G protein subunit alpha i1" P63096 7 80133955-80219402 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 195.4;Suprabasal keratinocytes: 187.2;Syncytiotrophoblasts: 153.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "NK-cell: 20.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 20.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022449, HPA042141" Approved Supported Nucleoplasm,Nucleoli,Centrosome NA NA 9000000 Centrosome "Nucleoplasm, Nucleoli" "CAB022449: , HPA042141: AB_2677870" "unprognostic (2.29e-1)" "unprognostic (2.83e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-1)" "unprognostic (7.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (5.09e-4)" "unprognostic (9.78e-2)" "unprognostic (1.26e-1)" "unprognostic (4.48e-1)" "unprognostic (9.41e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.12e-1)" "unprognostic (1.94e-2)" "unprognostic (1.53e-1)" 33.2 23.4 17.2 5.4 26.2 1.5 14.4 14.4 33.7 9.4 10.5 36.9 3.0 6.9 10.0 3.0 16.6 9.0 8.6 5.7 23.8 18.3 25.9 13.1 10.3 3.4 40.3 21.9 14.3 5.4 2.5 7.3 30.4 26.2 10.1 9.0 2.8 4.9 9.5 4.2 32.4 5.3 12.2 49.7 5.7 8.3 11.1 32.0 0.9 11.1 3.2 4.6 15.5 9.0 0.1 3.7 2.1 1.5 20.0 2.3 0.7 2.9 20.8 19.0 0.1 23.7 15.2 8.7 12.6 15.2 11.2 13.9 0.0 3.2 0.1 4.1 13.5 9.6 3.0 10.6 12.9 14.9 0.1 9.7 17.8 18.3 1.3 24.0 2.3 3.8 16.3 32.8 6.0 17.3 9.1 7.5 0.0 1.4 0.0 21.0 0.5 0.1 0.1 5.5 0.1 7.5 8.3 7.3 8.9 33.5 10.0 13.9 9.6 13.5 0.2 10.8 16.3 2.6 0.4 13.3 25.1 17.7 5.8 4.7 0.1 0.0 0.1 6.6 1.3 11.1 2.1 0.7 0.7 0.1 0.7 0.0 0.0 0.3 0.2 3.7 0.1 2.3 0.9 0.3 20.0 1.5 0.3 0.2 0.7 17.2 26.2 14.4 25.5 23.8 18.3 40.3 21.9 26.2 32.0 17.9 14.4 0.8 17.7 195.4 3.7 6.1 15.3 36.1 13.6 27.9 0.0 72.1 74.6 6.5 0.9 24.0 2.9 0.0 3.3 66.5 57.4 6.1 27.9 16.8 8.7 25.4 19.1 18.4 1.0 3.5 31.1 5.8 97.8 4.6 7.3 46.1 6.8 7.0 70.0 9.8 5.0 109.9 38.2 6.2 40.1 187.2 153.4 0.0 8.5 14.5 GNAI3 87U6 ENSG00000065135 "G protein subunit alpha i3" P08754 1 109548611-109618321 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 329.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022099, HPA042141" Approved Approved Nucleoplasm,Nucleoli,Centrosome NA NA 8400000 Centrosome "Nucleoplasm, Nucleoli" "CAB022099: , HPA042141: AB_2677870" "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "prognostic favorable (1.62e-4)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (9.45e-3)" "prognostic unfavorable (5.30e-6)" "unprognostic (2.56e-3)" "unprognostic (2.18e-2)" "prognostic favorable (4.59e-4)" "unprognostic (1.83e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (4.34e-4)" "unprognostic (7.27e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.66e-2)" 25.2 13.0 12.3 15.5 11.3 26.4 15.8 12.8 10.7 19.0 14.7 10.3 14.3 12.1 19.7 15.7 34.8 12.5 13.2 9.3 12.3 9.4 18.1 25.8 13.2 23.8 13.1 8.3 18.4 13.7 10.7 11.0 22.4 11.5 17.2 13.8 8.0 16.2 14.4 8.6 27.9 17.0 15.9 12.9 21.6 12.1 14.0 12.0 22.2 12.9 25.2 20.6 20.0 20.4 6.1 9.6 16.8 13.1 5.8 7.2 9.3 14.1 5.0 9.6 5.6 9.2 11.1 7.9 10.7 8.6 10.9 10.9 7.6 4.9 7.6 7.1 11.4 6.7 7.5 9.0 10.9 15.3 8.5 5.5 6.6 8.6 6.5 7.9 10.3 6.1 8.2 9.3 12.6 8.7 7.6 13.1 5.8 8.6 7.5 10.8 9.6 7.9 8.4 9.6 6.8 5.8 5.7 22.6 4.9 12.1 10.8 6.2 10.8 7.5 8.5 11.7 7.8 6.5 9.1 11.8 9.2 12.7 13.8 12.1 8.0 9.0 8.8 15.3 10.2 14.3 8.5 9.1 16.6 6.8 13.1 7.2 6.1 6.7 6.5 9.6 5.0 5.6 6.4 16.8 5.8 12.3 4.3 6.9 9.3 12.3 11.3 12.8 10.7 12.3 9.4 13.1 8.3 11.5 12.0 41.7 29.8 72.9 89.8 134.3 27.1 11.7 28.1 46.8 34.2 55.8 329.9 74.3 54.7 94.8 7.0 65.3 47.7 23.3 88.0 115.2 72.4 62.2 45.1 49.5 96.4 23.8 80.9 47.9 103.4 6.0 45.1 89.9 70.9 77.5 58.1 44.4 82.3 52.6 44.6 40.9 23.4 51.8 82.4 64.2 49.4 164.6 89.4 82.8 47.9 147.8 GNL2 "HUMAUANTIG, Ngp-1, Nog2, Nug2" ENSG00000134697 "G protein nucleolar 2" Q13823 1 37566816-37595935 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027163, HPA060026" Approved Enhanced "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA027163: AB_10601655, HPA060026: AB_2684191" "unprognostic (1.38e-2)" "unprognostic (5.23e-2)" "unprognostic (2.61e-1)" "unprognostic (9.49e-2)" "unprognostic (2.00e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.86e-9)" "unprognostic (2.28e-1)" "unprognostic (7.80e-2)" "prognostic favorable (7.89e-4)" "unprognostic (1.01e-2)" "unprognostic (8.19e-2)" "prognostic unfavorable (2.90e-11)" "unprognostic (3.36e-2)" "unprognostic (7.33e-3)" "unprognostic (3.37e-1)" "unprognostic (1.87e-1)" 24.1 17.4 13.8 24.1 15.0 30.7 21.9 11.2 14.2 15.9 15.7 11.7 16.8 12.4 20.2 18.3 21.8 16.4 14.8 17.9 12.5 11.3 18.0 26.9 18.7 19.6 21.2 11.5 19.6 17.4 15.2 21.6 24.5 15.8 16.4 18.7 10.1 19.4 18.9 40.3 22.2 16.3 17.4 15.0 21.8 17.8 21.4 15.2 24.3 17.1 27.5 22.2 20.5 19.8 18.4 25.2 14.4 22.7 20.7 17.4 12.2 19.3 10.0 19.4 20.3 15.6 18.0 31.6 29.5 20.5 27.3 27.9 27.3 22.9 31.8 19.3 21.7 15.4 18.3 31.7 24.0 37.7 18.0 24.8 31.9 20.1 21.9 20.9 41.8 22.9 11.3 22.1 37.2 44.6 13.0 19.6 13.9 42.3 22.9 26.4 17.1 22.5 25.3 50.9 14.0 19.6 24.1 35.3 36.1 22.8 21.2 23.8 21.9 22.3 22.5 21.9 30.2 16.1 24.4 15.7 18.5 26.1 39.1 40.9 21.5 19.3 55.3 21.3 33.7 23.5 10.3 17.1 14.4 15.3 22.7 17.4 18.4 14.3 16.5 25.2 13.5 15.1 14.5 1.8 20.7 20.7 18.5 16.9 12.2 13.8 15.0 11.2 14.2 12.5 11.3 21.2 11.5 15.8 15.2 14.9 47.4 26.7 52.5 56.2 7.6 18.2 5.1 73.6 79.6 7.0 9.8 32.5 23.2 37.6 45.3 20.2 13.4 0.0 54.2 43.6 26.3 29.5 46.2 16.2 28.9 6.4 16.6 11.6 17.1 7.8 22.2 29.8 8.5 36.1 16.0 19.1 39.6 17.8 18.0 12.9 8.6 0.0 33.0 50.5 54.9 46.2 38.6 26.7 19.7 42.6 GNL3L "FLJ10613, GNL3B" ENSG00000130119 "G protein nucleolar 3 like" Q9NVN8 X 54530211-54561071 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036314, HPA036315" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA036314: AB_10669986, HPA036315: AB_2675055" "unprognostic (9.71e-3)" "unprognostic (6.58e-2)" "unprognostic (6.24e-2)" "unprognostic (1.99e-2)" "unprognostic (1.13e-2)" "unprognostic (1.38e-1)" "unprognostic (2.92e-2)" "unprognostic (5.46e-2)" "unprognostic (8.44e-2)" "unprognostic (9.97e-2)" "unprognostic (4.91e-3)" "unprognostic (7.87e-2)" "unprognostic (8.05e-3)" "unprognostic (2.99e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.10e-1)" 12.7 12.9 10.3 16.1 12.3 19.2 12.5 8.6 13.1 10.8 10.2 14.8 10.5 8.5 15.2 10.2 16.3 11.0 10.1 15.3 8.1 8.0 12.0 12.5 13.0 15.5 13.0 10.8 13.2 17.5 15.9 16.9 12.0 10.2 10.6 13.3 12.3 13.3 12.4 24.0 13.2 13.5 15.0 11.5 17.6 11.7 5.9 13.9 20.5 18.0 12.0 18.6 13.7 13.1 17.2 11.4 20.2 15.2 21.8 17.7 11.5 11.2 28.0 5.8 11.9 6.0 4.1 10.7 6.7 4.9 7.6 6.0 23.6 9.3 15.8 13.0 9.7 9.9 11.0 19.3 8.4 10.5 10.9 10.0 15.9 22.4 11.1 4.6 24.6 15.7 5.8 4.1 17.7 10.7 3.1 8.1 9.0 10.3 16.0 7.6 21.8 13.9 5.1 16.7 6.7 15.7 15.0 13.2 15.3 5.7 17.8 9.4 5.7 22.0 13.6 6.3 12.2 17.9 6.3 11.6 13.8 13.8 13.3 11.4 12.0 15.3 20.3 7.1 20.4 15.3 18.9 14.2 15.1 17.7 12.6 16.1 15.0 16.2 15.4 11.4 17.2 12.4 13.0 20.2 21.8 15.2 9.6 8.6 11.5 10.3 12.3 8.6 13.1 8.1 8.0 13.0 10.8 10.2 13.9 11.9 21.0 11.9 2.9 1.1 9.4 7.0 5.1 12.0 18.2 3.5 11.8 6.4 3.3 6.0 0.2 6.0 4.6 0.0 7.6 5.4 3.3 2.8 10.4 3.9 4.4 7.9 3.4 7.4 11.9 0.0 5.2 6.1 0.0 6.4 4.3 3.7 7.8 3.5 2.8 3.3 8.0 6.5 4.1 1.2 7.4 1.8 4.6 8.2 3.9 3.1 GORAB "FLJ11752, GO, NTKL-BP1, SCYL1BP1" ENSG00000120370 "Golgin, RAB6 interacting" Q5T7V8 1 170532129-170553446 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027208, HPA027250, HPA027746" Approved Enhanced "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Nucleoli" "HPA027208: AB_10599622, HPA027250: AB_10611253, HPA027746: " "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (4.75e-3)" "prognostic favorable (1.39e-4)" "prognostic unfavorable (5.26e-4)" "unprognostic (8.48e-3)" "unprognostic (2.94e-2)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.77e-2)" "prognostic unfavorable (7.83e-12)" "unprognostic (2.52e-2)" "unprognostic (2.83e-1)" "unprognostic (7.71e-2)" "unprognostic (1.70e-1)" 7.7 14.7 8.4 9.4 9.2 0.5 10.6 8.7 9.5 10.7 9.4 4.8 7.0 4.8 8.8 10.5 6.3 6.8 6.7 8.2 7.4 7.8 7.2 11.1 6.8 9.6 6.3 8.1 12.6 9.7 6.5 20.6 9.4 8.7 11.1 10.4 6.3 8.8 13.1 3.3 6.5 7.0 6.4 11.1 10.4 5.6 8.6 7.3 8.7 10.5 4.2 9.7 10.4 10.0 6.2 7.3 1.2 7.4 7.9 9.4 5.5 5.1 5.0 9.6 3.6 12.9 9.6 6.3 7.8 12.1 6.9 7.2 3.2 8.8 7.5 9.0 7.9 4.5 6.5 9.5 4.6 9.2 8.0 2.9 5.0 6.5 4.0 8.7 6.6 5.1 8.3 4.5 7.4 6.9 8.6 5.4 4.3 6.8 3.7 7.3 1.2 9.5 6.0 8.5 11.6 6.3 5.7 6.4 10.0 6.2 3.8 2.5 5.3 6.5 7.9 18.2 6.4 5.0 11.7 6.9 11.0 5.8 4.3 10.8 6.7 7.3 6.6 9.2 6.0 9.8 1.0 7.4 0.0 4.7 7.4 7.4 6.1 8.3 7.2 7.3 6.2 7.3 6.2 1.2 7.9 5.7 4.6 9.4 5.5 8.4 9.2 8.7 9.5 7.4 7.8 6.3 8.1 8.7 7.3 0.0 10.7 6.0 2.9 2.5 3.9 6.7 7.6 1.4 6.8 5.2 2.0 5.2 3.3 9.4 1.6 7.4 5.1 0.0 5.3 5.6 10.4 4.1 12.8 5.8 6.3 4.8 0.0 3.7 6.3 2.6 13.0 3.9 3.3 10.0 6.4 3.4 5.8 7.0 6.0 4.4 7.2 6.5 8.5 13.1 7.7 1.4 4.7 5.7 6.0 2.7 GPATCH4 "DKFZP434F1735, FLJ20249, GPATC4" ENSG00000160818 "G-patch domain containing 4" 1 156594487-156601496 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028323, HPA054319" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA028323: AB_10601017, HPA054319: AB_2682447" "unprognostic (2.80e-2)" "unprognostic (4.61e-2)" "unprognostic (3.45e-1)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (3.17e-5)" "unprognostic (2.40e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-3)" "unprognostic (9.60e-2)" "unprognostic (6.39e-3)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.07e-1)" "unprognostic (1.71e-1)" "unprognostic (6.03e-2)" "unprognostic (6.80e-2)" 18.2 13.3 14.7 16.9 27.7 9.4 15.1 6.9 22.5 10.0 12.1 8.3 3.9 9.7 13.8 10.0 14.0 11.6 7.2 11.9 12.6 12.1 18.0 23.1 10.0 15.7 15.3 12.4 15.3 12.9 19.6 16.2 10.0 24.2 12.6 14.6 5.7 11.5 11.9 47.1 10.9 10.0 15.1 10.2 16.6 12.5 8.8 13.2 8.0 10.3 19.0 19.1 12.5 10.1 16.6 10.1 0.3 11.2 10.7 15.9 7.6 17.1 23.7 10.0 14.4 9.2 7.1 13.0 21.3 8.5 16.7 9.8 24.2 13.0 41.4 17.7 14.9 10.8 12.0 22.7 18.8 18.5 12.3 22.5 24.7 23.2 18.5 8.3 55.1 16.0 8.0 15.9 31.6 28.0 4.7 11.7 13.5 40.4 10.4 13.5 32.0 22.6 13.3 43.8 29.9 25.0 22.6 17.1 28.7 11.5 20.4 15.8 23.8 20.4 44.9 13.1 11.4 14.7 26.8 17.8 15.9 21.7 16.5 38.1 19.1 21.0 53.4 14.4 28.6 24.0 0.0 5.4 0.1 13.3 10.5 13.4 16.6 13.5 14.7 10.1 16.6 15.4 15.9 0.3 10.7 11.2 6.4 8.5 7.6 14.7 27.7 6.9 22.5 12.6 12.1 15.3 12.4 24.2 13.2 29.8 34.7 41.0 38.8 65.5 7.1 24.8 28.1 16.0 40.9 15.7 7.9 31.9 21.6 38.5 7.6 30.2 8.5 23.3 48.9 40.5 22.6 43.6 56.6 37.8 33.7 7.9 35.5 14.7 10.7 7.4 24.7 22.6 21.9 19.8 19.7 4.3 44.1 14.0 25.1 25.9 5.9 32.3 59.0 37.1 39.9 54.7 12.9 29.7 28.3 36.6 GPER1 "CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR" ENSG00000164850 "G protein-coupled estrogen receptor 1" Q99527 7 1082208-1093815 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 22.2;Kupffer cells: 13.5;Paneth cells: 8.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 4.3;intermediate monocyte: 4.2;myeloid DC: 8.4" "Group enriched" "Detected in many" 18 "dendritic cells: 8.4;monocytes: 4.3" "Cell line enhanced" "Detected in many" "AN3-CA: 10.1;Daudi: 10.6;Hep G2: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA016718, HPA027052" Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol NA NA Nucleoli "Nucleoplasm, Vesicles, Cytosol" "HPA016718: , HPA027052: AB_10612112" "unprognostic (4.74e-2)" "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "prognostic favorable (1.17e-4)" "unprognostic (2.17e-1)" "unprognostic (6.17e-2)" "unprognostic (3.45e-1)" "unprognostic (6.38e-2)" "unprognostic (2.40e-1)" "unprognostic (1.23e-1)" "unprognostic (1.42e-2)" "unprognostic (2.49e-1)" "unprognostic (2.37e-2)" "unprognostic (1.79e-2)" "unprognostic (1.58e-1)" "unprognostic (7.26e-2)" "unprognostic (7.78e-2)" 14.2 10.9 12.1 3.6 13.2 1.2 11.5 5.1 11.1 6.4 7.1 5.6 3.5 2.0 5.4 1.8 5.5 4.8 3.2 6.0 8.3 6.2 7.4 19.5 25.6 6.4 8.6 8.7 3.3 4.0 1.8 4.7 13.3 6.1 6.8 3.7 5.2 4.2 11.8 8.6 2.8 2.6 5.5 4.1 6.5 23.9 2.2 8.6 1.3 16.5 2.3 2.8 6.4 7.2 0.3 8.4 0.0 4.3 0.0 0.0 1.6 0.9 0.4 0.2 10.1 2.5 2.4 1.0 5.8 3.9 1.8 3.3 0.2 0.2 10.6 1.0 7.3 0.1 0.5 0.1 0.0 0.2 2.2 1.8 0.0 1.3 19.4 0.3 0.1 0.7 1.3 0.0 1.1 0.0 1.4 0.5 0.2 0.1 0.1 0.4 0.7 0.0 0.3 1.9 2.0 6.9 0.9 0.0 0.0 0.2 0.0 0.1 4.0 0.0 0.4 2.1 0.8 0.2 0.1 1.4 0.4 2.6 6.1 1.8 0.0 0.0 3.6 3.4 0.2 0.2 0.0 4.3 0.0 0.0 4.2 0.0 0.3 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 1.6 12.1 13.2 5.1 11.1 8.3 6.2 8.6 8.7 6.1 8.6 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 2.2 1.3 0.0 2.8 0.5 1.4 0.7 0.0 22.2 0.5 0.0 1.2 0.6 13.5 0.6 2.6 1.7 0.0 0.0 2.5 4.3 0.8 8.2 1.1 3.0 0.4 0.0 4.1 0.3 3.1 0.3 0.0 0.0 1.5 0.0 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 157.3;Late spermatids: 445.6;Spermatocytes: 157.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" NA NA "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: AB_2684889" "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavorable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favorable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 10.3 12.2 18.6 12.8 21.8 10.4 12.0 20.0 23.1 8.9 10.5 13.2 13.8 11.2 9.0 10.4 10.5 13.3 10.3 9.7 18.5 14.3 14.0 14.1 9.3 10.8 15.4 9.1 7.3 9.4 16.4 10.1 28.9 16.5 10.5 5.8 12.4 13.9 12.8 9.9 15.9 11.4 7.1 12.7 11.3 13.6 64.8 14.4 9.9 14.3 5.5 9.3 9.5 16.2 3.9 3.4 15.7 3.0 1.9 3.4 1.4 9.0 20.3 7.0 20.2 13.7 7.3 29.7 10.8 9.1 10.8 7.0 14.9 12.8 9.3 18.8 6.8 19.4 18.2 9.8 6.0 3.1 29.5 12.3 8.9 20.8 9.5 7.8 5.8 17.3 9.1 9.5 9.4 7.2 7.4 5.8 11.2 7.9 22.8 6.4 23.0 6.5 15.8 9.5 7.4 20.2 13.2 7.5 15.1 7.5 12.4 11.2 13.6 13.1 18.0 11.7 7.4 19.7 2.5 9.3 30.0 20.8 22.6 7.8 18.3 33.5 7.8 21.4 5.0 18.2 1.7 3.0 5.3 2.7 2.8 3.4 2.8 2.3 2.0 3.1 3.9 2.6 2.2 15.7 1.9 2.3 3.4 1.6 1.4 18.6 21.8 20.0 23.1 18.5 14.3 15.4 9.1 16.5 14.4 3.0 9.1 11.8 16.0 12.8 13.4 4.4 10.2 9.4 4.5 12.2 11.8 40.6 13.3 33.8 157.3 14.0 21.2 0.0 23.3 58.9 21.7 17.8 2.3 8.9 21.4 19.1 15.5 9.8 9.1 445.6 17.8 11.8 13.5 20.8 13.8 33.6 24.9 14.0 15.2 15.2 6.0 25.8 12.5 157.6 37.2 13.2 100.0 12.8 13.4 18.0 GPR157 FLJ12132 ENSG00000180758 "G protein-coupled receptor 157" Q5UAW9 1 9100305-9129170 "G-protein coupled receptors, Predicted membrane proteins" Differentiation "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.2" "Cell type enriched" "Detected in many" 5 "monocytes: 184.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 17.3;SK-BR-3: 34.0;U-266/70: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028697 Uncertain Uncertain "Nucleoli,Nucleoli rim,Plasma membrane,Cell Junctions" NA NA "Nucleoli, Nucleoli rim" "Plasma membrane, Cell Junctions" "HPA028697: AB_10601810" "unprognostic (2.83e-3)" "unprognostic (1.13e-2)" "unprognostic (5.91e-2)" "unprognostic (5.42e-2)" "unprognostic (2.13e-4)" "unprognostic (7.11e-2)" "unprognostic (7.52e-3)" "unprognostic (3.60e-2)" "unprognostic (9.20e-2)" "unprognostic (1.26e-1)" "unprognostic (9.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.02e-2)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-3)" 3.5 3.1 0.3 3.7 0.6 0.5 3.5 0.5 0.4 6.2 2.8 0.9 3.9 2.2 2.1 2.1 23.4 2.1 6.9 10.7 0.8 0.4 2.9 6.9 5.5 3.1 0.3 0.1 4.5 4.3 9.8 1.2 19.0 1.4 2.9 1.2 5.2 14.7 7.1 32.2 14.2 3.3 4.0 0.4 2.4 2.2 2.1 0.8 3.6 4.8 25.2 16.2 4.4 8.3 2.4 1.1 4.6 1.5 1.2 2.6 0.7 4.7 2.7 0.8 2.2 0.7 0.7 4.4 1.5 1.0 1.2 1.7 2.1 1.8 0.6 1.9 1.5 1.6 10.1 2.4 1.0 1.8 13.1 4.0 0.0 7.8 3.2 2.7 0.0 1.1 0.7 2.1 2.1 1.3 1.2 1.0 2.0 0.7 17.3 0.5 3.4 1.9 1.0 0.9 2.3 3.4 0.3 0.7 2.3 0.8 3.2 1.2 3.3 5.8 34.0 2.8 1.7 4.8 0.6 7.1 4.3 1.1 11.1 0.7 16.7 2.7 0.0 3.2 6.7 1.8 1.9 1.5 0.4 2.6 1.2 2.0 1.5 1.9 2.3 0.8 2.4 1.9 2.2 4.6 1.2 0.6 1.1 0.8 0.7 0.3 0.6 0.5 0.4 0.8 0.4 0.3 0.1 1.4 0.8 6.0 9.9 0.5 6.4 12.0 0.2 12.1 5.1 2.7 6.8 5.2 2.0 25.6 0.0 3.0 0.0 2.9 5.6 0.0 3.3 9.1 3.8 4.4 0.0 12.9 3.8 1.6 0.0 0.0 1.2 0.0 1.7 4.5 6.8 184.0 4.3 1.4 9.2 4.8 4.9 1.4 1.5 0.0 3.9 0.5 2.5 21.2 40.3 2.1 4.3 13.7 GPR161 RE2 ENSG00000143147 "G protein-coupled receptor 161" Q8N6U8 1 168079543-168137667 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 27.1;smooth muscle: 21.0" "Cell type enriched" "Detected in many" 8 "Horizontal cells: 149.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015576, HPA072047" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA015576: AB_1849283, HPA072047: AB_2686484" "unprognostic (1.45e-1)" "unprognostic (3.78e-2)" "unprognostic (2.68e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (3.24e-3)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (5.04e-2)" "unprognostic (5.45e-2)" "unprognostic (1.31e-2)" "unprognostic (5.57e-6)" "unprognostic (3.93e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" 2.4 0.9 2.1 3.6 1.7 0.0 1.9 1.2 4.0 7.3 4.9 3.1 8.5 0.8 27.1 8.2 7.4 7.7 5.6 2.4 2.8 1.5 1.1 0.4 2.8 0.4 3.0 1.2 7.6 11.0 4.9 1.3 1.3 3.0 8.2 2.3 3.4 2.3 9.4 0.8 1.5 2.1 21.0 3.0 1.2 2.2 3.0 0.8 1.4 1.2 1.7 0.7 2.8 6.8 0.3 1.2 1.5 0.5 0.2 0.3 0.2 6.1 3.8 15.5 9.9 3.7 6.6 0.0 5.9 6.5 5.1 5.4 24.0 1.0 0.0 3.3 8.9 9.6 18.4 3.7 5.8 3.0 2.3 4.8 2.2 3.0 0.1 1.6 0.6 1.5 2.3 3.8 4.4 7.1 11.9 10.2 1.9 2.0 0.1 7.7 0.5 0.7 0.1 6.3 10.3 6.0 1.8 6.7 0.0 2.7 1.7 3.1 13.7 6.5 0.2 17.8 6.1 3.4 0.7 13.7 10.5 5.5 14.1 6.7 0.0 0.0 0.0 2.8 0.0 2.7 1.5 0.3 0.2 0.1 0.3 0.1 0.1 0.1 0.0 1.2 0.3 0.1 0.3 1.3 0.2 0.5 0.3 0.0 0.2 2.1 1.7 1.2 4.0 2.8 1.5 3.0 1.2 3.0 0.8 3.0 0.6 0.0 5.0 1.9 1.7 2.0 0.0 1.4 1.2 0.0 0.0 0.4 0.0 3.6 0.4 6.3 0.0 0.0 7.2 0.2 6.3 4.6 0.0 0.0 0.7 149.4 0.0 4.3 1.8 0.6 6.9 1.3 1.7 1.8 1.7 2.7 2.9 0.0 15.9 0.0 1.5 19.4 12.2 0.0 0.7 1.3 0.3 0.0 2.3 2.3 GPR65 "hTDAG8, TDAG8" ENSG00000140030 "G protein-coupled receptor 65" Q8IYL9 14 88005124-88014811 "G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.4;lymphoid tissue: 40.8" "Cell type enhanced" "Detected in many" 19 "granulocytes: 306.4;Kupffer cells: 79.3;monocytes: 79.4;T-cells: 135.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 6.3;HEL: 6.8;HL-60: 8.1;HMC-1: 10.4;RH-30: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA072624, HPA077397" Enhanced Approved Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA072624: , HPA077397: " "unprognostic (8.56e-2)" "unprognostic (8.65e-3)" "unprognostic (1.98e-3)" "unprognostic (3.59e-3)" "unprognostic (3.10e-1)" "unprognostic (3.55e-3)" "unprognostic (1.15e-1)" "unprognostic (3.01e-2)" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (3.79e-1)" "unprognostic (4.46e-3)" "unprognostic (9.03e-2)" "unprognostic (3.80e-1)" 9.8 3.1 1.8 12.1 6.4 15.2 2.3 0.7 3.0 1.9 2.4 0.9 0.9 2.3 2.2 2.2 2.3 2.2 4.1 2.3 6.0 2.1 4.0 6.9 10.6 13.1 8.2 0.0 1.7 1.8 0.8 6.2 3.6 6.3 2.9 2.3 1.2 2.6 0.9 0.9 1.2 7.7 3.3 15.7 40.8 2.5 1.5 6.2 12.5 1.8 2.3 8.9 4.8 2.3 4.3 5.9 19.1 13.7 21.3 30.4 9.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.8 0.0 0.0 0.3 8.1 10.4 0.4 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.2 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 14.6 9.1 19.1 16.5 12.8 30.4 4.3 8.4 12.6 5.9 4.0 4.4 9.7 6.9 21.3 13.7 2.7 4.0 9.4 1.8 6.4 0.7 3.0 6.0 2.1 8.2 0.0 6.3 6.2 3.0 35.3 38.9 0.4 3.8 0.0 0.3 5.1 1.4 2.3 0.0 0.0 0.2 0.0 0.0 5.5 0.1 0.0 0.0 0.0 0.1 1.5 0.2 306.4 1.0 60.2 0.0 0.0 4.3 79.3 1.0 0.6 64.5 3.3 79.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.3 0.0 0.1 4.5 0.3 135.4 0.0 0.1 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 108.0" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 172.9;Late spermatids: 145.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Cell line enhanced" "Detected in many" "EFO-21: 39.2;HHSteC: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 12.6 4.4 45.2 3.2 55.9 1.0 7.3 22.8 108.0 5.4 2.9 95.1 4.9 4.0 7.1 9.3 5.5 12.7 9.2 22.3 47.8 28.7 12.1 2.7 3.9 4.6 63.1 34.9 13.7 12.7 9.5 3.8 9.3 38.6 6.3 2.3 3.8 20.8 11.5 35.1 2.5 3.3 5.1 61.6 2.2 22.7 19.6 63.1 0.0 7.2 2.6 2.7 6.2 3.0 0.0 0.0 0.0 1.5 0.0 6.5 1.3 0.4 12.6 12.5 2.2 12.9 0.9 2.3 0.1 3.1 1.2 0.8 11.5 0.4 0.0 39.2 0.4 8.2 0.6 9.2 0.0 0.7 0.0 3.3 0.0 0.0 0.0 26.8 0.0 0.0 1.1 0.0 2.1 0.0 3.3 6.1 0.3 2.6 0.2 2.8 0.6 0.0 0.0 13.7 0.0 6.0 3.6 0.0 0.0 0.4 5.8 9.7 0.8 1.4 0.8 11.3 4.1 0.0 0.2 1.2 0.0 1.5 6.1 0.3 0.1 0.0 0.0 0.6 0.1 0.7 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 1.3 45.2 55.9 22.8 40.5 47.8 28.7 63.1 34.9 38.6 63.1 0.0 4.0 0.9 4.6 1.1 30.1 13.4 35.7 5.3 7.9 29.6 0.0 3.9 1.7 47.7 172.9 30.1 0.0 0.0 56.2 1.2 9.7 4.3 0.0 0.0 3.3 0.0 0.0 6.2 1.0 145.0 22.2 1.1 15.1 1.8 0.0 20.5 53.7 0.0 25.1 0.1 5.7 12.9 9.2 2.8 1.5 1.5 2.1 0.0 0.0 1.7 GPRIN3 "FLJ42625, GRIN3" ENSG00000185477 "GPRIN family member 3" Q6ZVF9 4 89236386-89308010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.0" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 75.7;Sertoli cells: 77.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 41.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 47.1;RPMI-8226: 12.1;SCLC-21H: 12.6;U-266/70: 7.3;U-266/84: 5.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "basal ganglia: 53.1" "HPA043148, HPA057666, HPA059092" Enhanced Approved Nucleoplasm,Nucleoli No NA Nucleoli Nucleoplasm "HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902" "unprognostic (9.05e-2)" "unprognostic (4.92e-2)" "prognostic favorable (7.22e-5)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.07e-3)" "unprognostic (3.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.34e-3)" "unprognostic (3.13e-1)" "prognostic favorable (8.33e-4)" "unprognostic (1.91e-1)" "unprognostic (5.35e-2)" "unprognostic (3.93e-1)" "unprognostic (7.82e-4)" 7.0 1.8 4.0 11.5 9.1 8.9 3.2 41.0 5.0 3.5 7.2 2.8 0.0 8.4 2.3 1.7 1.8 2.1 5.6 5.4 3.6 4.1 5.5 2.8 11.2 12.7 4.1 3.1 4.8 7.0 1.1 12.4 1.4 6.5 2.1 9.8 6.4 2.9 1.0 2.1 1.6 7.0 2.0 6.0 12.9 4.7 1.1 6.2 5.3 2.9 1.4 10.5 4.5 2.4 0.3 1.5 0.1 2.2 2.9 6.6 1.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 12.1 0.1 0.0 12.6 0.2 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.3 5.7 0.0 0.2 0.0 0.0 0.1 0.5 0.0 4.8 1.7 6.6 0.3 4.7 3.7 1.5 0.1 1.9 1.9 0.1 2.9 2.2 0.0 5.3 1.4 4.0 9.1 41.0 5.0 3.6 4.1 4.1 3.1 6.5 6.2 0.0 19.9 3.7 0.7 1.0 9.4 14.6 5.1 1.4 9.1 3.5 0.0 0.1 1.7 1.1 0.1 3.6 9.6 0.0 8.2 0.0 2.3 0.2 7.0 0.0 18.9 25.4 75.7 2.5 26.9 0.0 0.3 31.5 1.7 5.4 25.1 0.8 1.7 5.8 1.1 1.8 10.3 77.6 8.2 0.1 0.1 0.9 0.2 34.6 21.8 0.3 GRAMD2A GRAMD2 ENSG00000175318 "GRAM domain containing 2A" Q8IUY3 15 72159807-72197785 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 24.6;placenta: 49.2" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 65.5;Cytotrophoblasts: 93.9;Syncytiotrophoblasts: 123.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "myeloid DC: 2.3" "Lineage enriched" "Detected in single" 7 "dendritic cells: 2.3" "Group enriched" "Detected in some" 12 "BEWO: 59.5;SK-BR-3: 27.1" "Low region specificity" "Detected in many" HPA029435 Uncertain Approved "Nucleoli,Nuclear speckles,Cytosol" NA NA "Nucleoli, Nuclear speckles" Cytosol "HPA029435: AB_10601811" "unprognostic (5.70e-2)" "unprognostic (7.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.24e-1)" "unprognostic (9.51e-3)" "unprognostic (2.95e-1)" "unprognostic (9.96e-2)" "unprognostic (3.90e-3)" "unprognostic (2.80e-1)" "unprognostic (1.96e-1)" "unprognostic (2.62e-1)" "unprognostic (5.77e-2)" "unprognostic (4.45e-1)" "unprognostic (2.35e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (7.01e-4)" "unprognostic (7.29e-2)" 0.1 0.0 2.0 0.2 4.5 0.0 6.8 1.1 1.0 3.1 0.7 1.2 9.8 0.6 0.4 24.6 1.0 8.2 0.8 0.1 2.9 6.5 1.9 0.1 9.7 0.2 1.1 0.1 1.1 1.0 0.2 0.9 49.2 3.9 1.2 0.5 1.0 1.8 4.0 0.3 1.5 3.6 0.1 1.0 0.1 0.4 0.7 0.9 0.2 7.7 1.3 1.1 0.3 0.6 0.0 2.3 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 27.1 0.0 2.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.5 1.1 1.0 2.9 6.5 1.1 0.1 3.9 0.9 65.5 13.3 0.0 0.0 0.0 0.0 0.0 0.0 18.7 13.6 3.5 0.0 93.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 1.1 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 123.0 0.0 0.0 0.0 GRB2 NCKAP2 ENSG00000177885 "Growth factor receptor bound protein 2" P62993 17 75318076-75405709 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Extravillous trophoblasts: 288.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002589, HPA030749, HPA030750" Approved Supported Nucleoplasm,Nucleoli NA NA 1900000 Nucleoplasm Nucleoli "CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591" "unprognostic (4.83e-3)" "unprognostic (1.85e-1)" "unprognostic (1.14e-1)" "unprognostic (3.42e-3)" "unprognostic (1.70e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (6.04e-7)" "unprognostic (1.01e-2)" "unprognostic (2.73e-1)" "unprognostic (1.80e-2)" "unprognostic (1.06e-2)" "unprognostic (1.89e-2)" "unprognostic (1.08e-2)" "unprognostic (8.13e-2)" "unprognostic (3.40e-2)" "unprognostic (1.56e-1)" "unprognostic (1.58e-1)" 29.0 29.2 36.1 48.2 40.3 56.3 23.6 42.2 41.6 18.5 27.8 28.2 19.1 29.2 28.3 19.4 27.0 22.1 22.5 32.2 34.7 33.9 24.9 32.2 33.7 54.8 30.9 29.2 21.8 16.7 21.8 21.8 33.1 26.9 21.4 27.9 21.8 21.2 25.6 27.8 18.6 30.5 30.6 42.6 56.7 22.8 10.8 27.1 45.8 20.4 15.6 53.1 29.8 19.2 24.7 25.0 64.9 42.8 12.0 13.4 20.7 25.3 22.1 15.2 18.3 16.9 15.8 34.7 26.8 21.8 28.3 27.2 19.0 17.1 33.1 15.9 24.4 23.4 15.2 21.9 19.3 29.3 16.3 20.1 35.5 14.6 27.6 15.2 40.8 69.4 14.6 20.2 29.5 14.7 16.3 33.9 31.9 23.9 23.0 20.5 31.6 47.8 39.5 10.5 24.6 22.6 28.6 32.6 24.0 21.5 18.9 18.4 26.6 22.7 22.1 28.3 28.3 24.4 66.0 21.5 27.1 20.6 21.5 27.3 42.3 32.5 53.3 20.9 32.0 19.4 25.1 32.1 38.5 13.4 38.4 11.7 23.7 12.1 13.2 25.0 24.7 12.7 12.0 64.9 12.0 42.8 16.7 13.2 20.7 36.1 40.3 42.2 41.6 34.7 33.9 30.9 29.2 26.9 27.1 56.6 54.7 133.3 29.5 41.8 36.1 52.5 45.9 71.0 58.0 15.7 29.5 59.8 44.7 59.4 2.0 57.8 58.2 23.3 55.2 288.5 37.3 45.6 117.1 36.3 231.5 33.4 40.2 41.7 166.3 4.0 23.3 221.8 43.9 209.2 41.2 45.1 62.3 69.1 39.3 55.3 47.2 6.5 46.7 17.7 47.0 39.1 72.9 66.3 37.4 100.3 GRWD1 "GRWD, RRB1, WDR28" ENSG00000105447 "Glutamate rich WD repeat containing 1" Q9BQ67 19 48445773-48457022 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042643, HPA055680" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042643: AB_10795510, HPA055680: AB_2682884" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (4.99e-2)" "unprognostic (1.00e-1)" "unprognostic (3.46e-1)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.71e-2)" "unprognostic (5.68e-2)" "unprognostic (2.69e-2)" "unprognostic (7.70e-2)" "unprognostic (2.83e-2)" "unprognostic (8.10e-2)" "unprognostic (1.78e-1)" "unprognostic (3.09e-1)" "unprognostic (2.02e-1)" "unprognostic (5.07e-2)" 16.9 15.5 9.2 15.7 11.1 14.8 15.5 12.9 14.1 13.6 14.1 10.4 11.9 15.6 18.7 12.8 20.0 15.0 16.2 16.9 7.8 8.6 13.0 26.3 12.5 17.5 11.0 10.3 19.3 35.5 16.5 10.3 14.7 9.5 13.8 8.0 12.0 18.6 14.4 29.1 18.3 11.5 13.3 8.2 19.4 14.7 13.1 10.9 18.6 17.3 19.0 17.3 14.1 18.0 21.1 18.4 1.4 17.8 17.4 22.6 16.5 17.0 45.1 7.7 14.4 6.3 6.2 6.6 13.3 6.4 19.2 16.1 25.3 12.7 24.4 11.6 8.3 10.8 14.6 19.1 20.6 7.6 18.2 25.8 22.2 15.3 18.0 7.3 20.9 14.3 7.4 11.4 18.1 9.2 4.3 9.5 13.4 31.0 15.4 8.0 17.7 22.0 52.6 20.9 18.2 13.2 27.4 8.6 17.5 8.0 21.1 17.3 9.6 15.0 21.3 6.6 4.8 10.5 10.6 10.1 17.9 15.1 7.8 31.6 15.7 35.9 22.8 6.0 18.9 20.8 0.1 11.0 1.4 19.6 17.8 22.6 21.1 18.1 19.5 18.4 20.4 21.3 19.7 0.8 17.4 13.5 13.6 15.6 16.5 9.2 11.1 12.9 14.1 7.8 8.6 11.0 10.3 9.5 10.9 3.0 17.4 22.9 20.9 41.1 12.6 6.5 15.3 18.7 14.8 12.2 0.0 35.6 19.9 28.0 1.7 18.0 7.3 0.0 15.7 30.6 18.6 13.5 19.6 14.7 21.5 20.6 18.4 11.6 10.7 14.6 15.8 12.4 27.0 35.1 9.0 5.3 18.5 7.0 11.7 15.3 13.0 19.4 20.2 6.1 34.7 35.5 29.3 20.0 13.4 17.6 GSKIP C14orf129 ENSG00000100744 "GSK3B interacting protein" Q9P0R6 14 96363452-96387288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 63.0" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 337.2;Late spermatids: 220.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043054, HPA046782" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" No No "Golgi apparatus, Vesicles" Nucleoli "HPA043054: AB_2678293, HPA046782: AB_2679803" "unprognostic (3.48e-1)" "unprognostic (1.16e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (6.23e-3)" "unprognostic (1.11e-1)" "unprognostic (9.35e-2)" "unprognostic (1.16e-3)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" "unprognostic (8.74e-3)" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" 6.6 7.1 11.2 8.0 21.9 7.1 6.7 5.1 14.6 6.6 29.5 5.4 6.7 23.5 5.5 6.4 20.8 5.5 7.0 5.2 12.0 9.6 12.8 36.4 5.3 8.7 9.2 9.7 3.6 6.1 4.0 10.8 11.1 10.7 7.1 28.3 8.7 7.8 5.2 5.5 8.5 63.0 8.0 10.4 6.6 11.3 26.4 7.2 9.0 5.8 10.7 10.7 8.2 9.0 20.1 11.2 27.5 16.6 17.8 34.1 14.8 9.6 13.8 15.5 10.5 11.7 13.6 26.3 18.0 13.8 11.9 13.2 10.2 16.4 9.3 11.0 13.6 7.4 10.7 10.1 10.7 17.4 21.9 9.6 3.8 7.9 7.8 10.9 9.9 6.7 11.0 17.2 15.2 15.3 9.4 15.5 10.6 8.4 8.4 15.1 23.9 7.2 8.0 17.2 15.1 17.5 7.3 14.4 8.4 28.0 36.1 5.5 17.7 20.3 19.2 15.6 16.3 14.4 6.4 17.0 5.5 7.1 11.7 5.6 10.0 28.4 7.8 14.1 7.2 8.8 27.5 10.8 24.3 15.5 12.6 24.0 20.1 21.7 18.3 11.2 16.6 21.4 19.8 21.7 17.8 16.6 9.6 34.1 14.8 11.2 21.9 5.1 14.6 12.0 9.6 9.2 9.7 10.7 7.2 11.9 9.0 19.3 19.8 40.2 24.1 14.2 20.4 14.7 5.7 19.2 39.3 37.6 61.3 30.4 337.2 14.6 80.6 0.0 34.7 35.8 17.9 30.7 19.6 15.5 20.9 22.3 26.9 17.8 22.8 220.8 7.5 17.5 18.6 32.5 63.8 16.2 32.2 98.2 7.4 38.6 79.0 19.4 18.4 37.4 36.7 57.6 100.0 26.1 53.7 34.5 GTF3C1 TFIIIC220 ENSG00000077235 "General transcription factor IIIC subunit 1" Q12789 16 27459555-27549913 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "gdT-cell: 20.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051617, HPA075900" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051617: AB_2681553, HPA075900: " "unprognostic (6.46e-2)" "unprognostic (6.86e-3)" "unprognostic (2.16e-1)" "unprognostic (5.59e-2)" "unprognostic (6.65e-2)" "unprognostic (2.90e-2)" "prognostic unfavorable (8.73e-4)" "unprognostic (8.23e-2)" "unprognostic (9.25e-3)" "unprognostic (5.32e-2)" "prognostic favorable (9.56e-4)" "unprognostic (2.10e-1)" "prognostic favorable (1.25e-4)" "unprognostic (2.06e-1)" "unprognostic (5.67e-2)" "unprognostic (5.56e-3)" "unprognostic (8.23e-3)" 13.6 18.4 19.4 12.1 25.9 17.3 10.6 25.3 31.2 17.3 12.8 21.0 18.8 11.0 19.0 12.0 39.3 19.9 16.5 23.7 15.8 16.2 16.9 13.2 14.1 13.5 14.3 19.1 20.7 24.0 33.8 33.2 13.5 15.8 35.4 12.4 22.3 15.3 16.9 29.5 41.5 11.7 19.3 12.8 14.2 15.7 24.4 17.1 25.2 35.8 18.8 21.0 12.3 20.7 1.9 4.2 2.1 2.1 7.8 20.6 3.6 12.9 28.5 21.0 24.5 18.9 15.3 11.9 14.1 15.9 19.6 16.8 21.3 12.2 14.2 20.8 17.2 15.0 14.5 26.6 17.9 16.2 6.4 25.5 11.8 24.1 30.4 10.6 13.4 15.7 18.7 13.7 24.0 10.7 13.2 19.4 16.5 14.5 11.7 15.4 31.8 14.9 16.2 28.2 7.0 13.6 27.9 26.0 14.6 12.3 13.6 26.6 17.8 14.2 12.1 8.7 17.6 21.7 10.2 20.5 19.8 12.0 12.4 14.4 12.5 11.3 14.5 8.2 15.0 14.5 1.0 2.1 2.1 20.6 1.9 15.2 1.9 2.4 10.3 2.7 1.6 2.5 6.7 1.6 7.8 2.0 4.2 2.5 3.6 19.4 25.9 25.3 31.2 15.8 16.2 14.3 19.1 15.8 17.1 17.9 22.9 5.6 6.3 16.4 42.3 23.4 10.2 25.4 15.9 12.2 88.4 6.4 5.0 10.2 2.0 12.8 10.9 0.0 9.9 3.8 13.3 16.1 18.5 12.5 9.2 25.4 28.8 15.4 12.3 4.0 17.8 6.4 3.3 8.2 15.9 13.3 13.1 8.6 14.9 7.9 30.3 12.9 7.2 19.1 14.9 18.1 3.5 27.7 11.1 6.2 GTPBP4 "CRFG, FLJ10686, FLJ10690, NGB, NOG1" ENSG00000107937 "GTP binding protein 4" Q9BZE4 10 988019-1019936 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039618, HPA056468" Uncertain Supported "Nuclear membrane,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" "Nuclear membrane" "HPA039618: AB_10795292, HPA056468: AB_2683141" "unprognostic (2.11e-3)" "unprognostic (3.10e-3)" "unprognostic (7.77e-3)" "prognostic unfavorable (4.57e-4)" "unprognostic (3.72e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (8.85e-12)" "unprognostic (9.06e-2)" "unprognostic (1.72e-1)" "unprognostic (8.45e-2)" "unprognostic (1.11e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (2.38e-5)" "unprognostic (7.90e-2)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (3.67e-2)" 19.0 24.6 11.3 13.9 14.9 24.8 14.2 11.6 15.0 11.0 10.5 12.2 10.3 9.6 14.8 10.1 12.2 15.8 8.9 11.9 14.1 11.8 11.8 14.0 9.5 13.8 14.0 10.1 16.3 22.8 12.7 18.3 13.8 15.3 11.1 12.2 8.9 10.3 9.9 24.8 11.4 11.0 14.4 18.1 13.5 12.7 22.9 12.2 14.2 11.9 16.3 16.3 11.6 10.4 10.5 11.3 10.7 14.2 15.8 14.2 7.7 21.0 17.2 14.5 12.7 10.3 12.3 10.4 19.8 6.9 24.3 20.7 25.4 16.4 30.6 6.0 15.7 8.4 16.7 28.6 18.1 28.4 15.1 17.9 33.5 12.4 15.5 16.3 14.5 18.1 15.9 15.4 26.7 18.6 9.9 13.2 23.8 34.3 12.7 22.2 19.4 22.2 13.7 21.1 28.0 11.9 22.1 12.7 21.1 14.4 13.4 7.3 22.0 13.0 16.7 22.9 14.9 23.9 14.5 11.4 11.6 6.4 27.8 24.0 16.5 31.5 38.5 13.0 15.4 9.5 10.7 8.4 3.0 11.6 14.2 13.6 10.5 11.0 11.7 11.3 9.9 12.2 11.8 1.4 15.8 10.8 7.4 14.2 7.7 11.3 14.9 11.6 15.0 14.1 11.8 14.0 10.1 15.3 12.2 53.6 69.5 32.8 58.3 55.6 25.5 29.7 22.9 66.9 108.1 27.9 17.7 41.8 28.2 54.3 49.0 30.8 10.0 23.3 37.9 45.9 31.1 41.3 62.7 24.3 30.8 22.3 21.2 20.9 25.9 13.8 23.0 29.0 21.9 38.7 24.5 27.3 52.1 17.5 27.6 24.0 31.8 19.4 25.8 86.5 85.2 58.7 79.8 24.5 28.6 76.5 GTSF1L "C20orf65, dJ1028D15.4, FAM112A" ENSG00000124196 "Gametocyte specific factor 1 like" Q9H1H1 20 43726164-43726998 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 104.1" "Group enriched" "Detected in some" 119 "Early spermatids: 2558.4;Late spermatids: 2369.0" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 7.5" "Lineage enriched" "Detected in many" 5 "T-cells: 7.5" "Cell line enhanced" "Detected in some" "Daudi: 1.3;EFO-21: 1.3;REH: 4.0;U-698: 4.4" "Low region specificity" "Detected in some" HPA054694 Enhanced Uncertain Nucleoli NA NA Nucleoli "HPA054694: AB_2682576" "unprognostic (2.61e-2)" "unprognostic (4.24e-6)" "unprognostic (9.96e-3)" "unprognostic (1.30e-4)" "unprognostic (3.50e-2)" "unprognostic (6.70e-2)" "unprognostic (2.15e-2)" "unprognostic (3.06e-2)" "unprognostic (2.45e-7)" "unprognostic (1.19e-1)" "unprognostic (9.54e-2)" "unprognostic (6.07e-3)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 104.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.9 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 1.0 0.0 1.4 0.6 0.8 0.0 0.0 0.0 0.0 7.5 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2558.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2369.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 6.5 0.0 20.6 8.0 0.0 0.0 0.0 0.0 0.0 GYG2 GN-2 ENSG00000056998 "Glycogenin 2" O15488 X 2828788-2882820 "Enzymes, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 76.7;brain: 21.2;breast: 30.4" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 15.8;Intestinal endocrine cells: 19.5" "Cancer enhanced" "Detected in all" "melanoma: 42.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 17.1;Hep G2: 13.7;NTERA-2: 16.9;SK-MEL-30: 36.5;SuSa: 27.1" "Low region specificity" "Detected in all" "HPA005495, HPA064686" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoli, Cytosol" Nucleoplasm "HPA005495: AB_1079035, HPA064686: AB_2685323" "unprognostic (4.45e-2)" "unprognostic (4.21e-2)" "unprognostic (6.41e-3)" "unprognostic (8.50e-2)" "unprognostic (2.07e-3)" "unprognostic (5.16e-1)" "unprognostic (1.74e-2)" "unprognostic (1.18e-1)" "unprognostic (7.43e-3)" "unprognostic (6.74e-2)" "prognostic favorable (3.01e-5)" "unprognostic (9.76e-2)" "unprognostic (6.10e-5)" "unprognostic (1.78e-1)" "unprognostic (5.05e-3)" "unprognostic (5.41e-2)" "unprognostic (6.60e-2)" 76.7 1.4 4.6 1.3 4.6 0.5 30.4 2.1 3.7 2.1 3.5 8.2 0.7 1.2 4.2 0.9 1.0 3.6 1.7 1.7 3.9 2.9 1.4 9.9 0.7 0.7 5.5 2.9 1.9 3.2 0.4 0.5 1.6 12.9 2.7 2.0 4.2 2.8 4.4 0.5 1.2 1.3 2.8 21.2 0.5 2.2 0.8 5.1 0.0 1.3 0.5 0.6 2.9 1.4 1.0 0.6 0.6 0.4 1.2 0.7 0.0 0.0 5.2 17.1 0.0 10.2 0.0 12.4 0.5 3.0 3.0 3.8 12.7 0.3 0.0 1.4 2.1 3.1 0.0 9.6 0.2 2.9 0.1 2.7 0.0 0.2 13.7 3.0 0.0 4.2 3.7 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.8 0.0 0.4 16.9 0.1 0.0 2.8 5.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 36.5 27.1 1.6 10.4 0.0 0.0 3.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.2 0.7 0.5 0.4 0.3 0.1 1.0 0.3 0.2 0.6 1.2 0.4 0.6 0.4 0.0 4.6 4.6 2.1 3.7 3.9 2.9 5.5 2.9 12.9 5.1 0.0 0.0 0.0 0.9 0.3 0.9 0.6 2.5 0.0 0.0 0.0 3.9 5.3 5.0 0.8 0.3 0.0 0.2 0.0 3.4 7.0 1.9 1.7 0.0 15.8 0.9 0.0 19.5 0.0 1.3 0.0 0.6 0.0 3.3 0.0 1.3 1.8 2.8 0.0 2.8 2.1 0.0 0.0 0.9 0.3 0.4 0.3 1.9 0.0 2.0 0.5 GZF1 "dJ322G13.2, ZBTB23, ZNF336" ENSG00000125812 "GDNF inducible zinc finger protein 1" Q9H116 20 23362182-23373063 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024520 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA024520: AB_10963938" "unprognostic (3.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (9.81e-7)" "unprognostic (8.98e-2)" "unprognostic (2.66e-1)" "unprognostic (8.70e-2)" "unprognostic (3.88e-2)" "unprognostic (1.92e-1)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-1)" 7.6 25.8 12.3 7.1 12.5 35.7 6.6 14.1 17.2 8.8 7.1 14.9 8.0 5.4 9.0 7.6 6.1 8.2 7.5 15.6 11.5 10.6 9.2 8.7 7.1 6.5 13.0 10.4 11.4 7.8 12.0 9.8 8.4 12.9 8.3 5.9 7.1 7.7 11.2 10.0 5.8 5.6 10.7 12.4 6.7 6.6 16.5 13.0 7.4 9.6 5.3 6.3 9.3 9.8 3.2 4.4 3.4 4.5 1.3 3.2 2.4 5.6 9.9 6.4 6.4 7.5 7.4 5.1 6.9 6.4 7.1 6.7 7.5 4.5 11.5 6.1 5.9 13.9 10.1 7.3 9.3 8.1 1.9 4.8 10.6 4.0 10.1 9.8 6.3 6.5 7.4 6.9 7.7 11.8 10.0 4.7 8.0 7.2 18.0 10.1 7.4 9.8 7.9 4.7 7.9 13.7 6.5 15.3 7.9 5.3 5.7 9.9 5.7 6.1 11.0 14.4 5.5 7.2 9.2 6.1 11.6 6.7 8.7 7.3 14.7 6.0 10.1 3.4 29.0 6.2 0.0 4.5 2.0 2.0 2.7 1.5 3.2 3.0 3.1 4.4 1.6 3.0 3.2 3.4 1.3 3.2 3.7 0.9 2.4 12.3 12.5 14.1 17.2 11.5 10.6 13.0 10.4 12.9 13.0 6.0 8.1 15.7 2.5 9.6 11.4 16.2 0.0 8.1 4.5 3.5 17.7 4.0 6.6 3.2 14.0 6.7 2.7 0.0 2.9 2.8 5.9 2.4 12.8 4.5 7.4 6.4 5.2 2.5 13.7 21.5 8.6 10.9 1.7 0.0 2.6 10.8 3.5 2.9 7.8 3.8 11.4 0.0 11.2 16.3 8.0 7.3 4.7 2.5 3.3 1.6 H1FX "H1X, MGC15959, MGC8350" ENSG00000184897 "H1 histone family member X" Q92522 3 129314771-129316277 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "bone marrow: 381.6;lymphoid tissue: 238.6" "Cell type enhanced" "Detected in all" 6 "Basal glandular cells: 485.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 139.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012235, HPA040099, HPA068431" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB012235: , HPA040099: AB_2676846, HPA068431: " "unprognostic (1.01e-2)" "unprognostic (1.12e-2)" "unprognostic (4.13e-2)" "unprognostic (8.48e-2)" "unprognostic (6.94e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.46e-2)" "unprognostic (1.16e-1)" "unprognostic (5.51e-2)" "unprognostic (5.28e-3)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (3.24e-1)" "unprognostic (2.50e-2)" 23.1 13.1 11.9 19.0 14.5 381.6 33.7 29.0 22.9 30.9 21.0 9.6 13.4 21.1 26.0 19.6 34.5 25.1 24.0 27.5 11.3 11.2 12.9 24.9 30.9 44.2 6.7 16.3 39.0 22.4 18.4 20.5 15.0 6.9 26.2 7.8 18.4 32.3 16.3 30.8 40.5 26.0 19.1 9.6 29.9 29.0 14.2 6.3 238.6 21.9 18.1 20.5 35.6 25.0 5.7 10.8 15.9 5.3 4.8 8.3 2.2 19.9 10.6 20.1 8.7 2.0 2.4 19.1 8.8 6.4 10.5 11.1 6.3 11.0 2.5 9.7 3.1 7.0 20.1 8.4 5.6 1.6 18.3 16.3 7.6 8.2 8.6 8.7 8.8 2.0 4.9 7.7 4.2 9.7 4.7 6.0 35.4 11.7 45.5 1.4 20.9 40.7 17.5 18.8 3.6 12.0 29.4 8.6 23.7 3.2 4.2 32.1 37.2 9.3 4.6 26.6 4.0 18.2 17.8 5.9 8.1 42.6 7.9 7.3 139.5 53.3 21.5 6.6 8.4 8.9 0.4 5.3 15.9 4.3 3.7 4.0 4.4 6.7 5.1 7.4 5.7 8.3 4.3 1.2 4.8 3.3 10.8 5.1 2.2 11.9 14.5 29.0 22.9 11.3 11.2 6.7 16.3 6.9 6.3 14.9 12.8 95.3 485.3 89.5 119.1 25.5 63.7 2.7 3.4 89.0 29.5 60.0 94.5 42.6 7.4 89.9 34.4 70.0 71.0 93.0 97.3 173.5 5.7 38.5 77.7 138.2 153.1 85.3 93.5 8.0 92.0 75.7 118.1 25.2 86.3 209.9 59.2 48.9 48.8 25.1 84.3 122.9 82.1 13.2 36.5 96.0 57.2 72.6 52.5 312.3 HAP1 "HAP2, hHLP1, HIP5, HLP" ENSG00000173805 "Huntingtin associated protein 1" P54257 17 41717742-41734644 "Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;stomach 1: 23.3" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 5.8;Syncytiotrophoblasts: 13.2" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "REH: 45.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023394, HPA076992" Enhanced Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA023394: AB_1850492, HPA076992: AB_2686822" "unprognostic (2.84e-3)" "unprognostic (3.74e-3)" "unprognostic (2.42e-2)" "unprognostic (2.30e-1)" "unprognostic (7.53e-2)" "unprognostic (4.90e-2)" "unprognostic (1.64e-1)" "unprognostic (1.32e-1)" "unprognostic (6.11e-2)" "unprognostic (8.76e-2)" "prognostic favorable (4.26e-4)" "unprognostic (1.38e-1)" "unprognostic (2.46e-2)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-2)" "unprognostic (9.29e-2)" 0.7 3.2 11.7 1.1 16.2 0.8 2.0 5.6 13.1 4.8 1.3 3.8 2.2 5.2 4.6 3.5 0.9 2.8 3.1 0.6 10.1 30.5 1.1 1.2 1.4 0.9 6.6 6.6 1.0 2.2 0.5 6.8 3.1 15.5 1.6 1.4 0.4 3.4 3.0 1.0 1.6 2.5 1.7 8.3 3.3 23.3 3.4 2.2 0.0 7.2 0.0 1.0 0.9 1.2 1.2 0.8 2.6 0.6 1.5 1.0 0.1 0.1 1.5 0.7 1.5 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.9 0.1 0.1 0.5 0.1 0.2 6.3 3.3 0.2 0.0 0.0 1.6 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.8 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.8 9.0 0.4 45.8 0.0 1.7 0.3 0.5 0.2 0.0 0.3 0.2 0.0 0.8 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.6 0.6 0.5 0.6 0.3 0.4 0.5 0.5 0.6 0.2 1.2 0.8 1.0 2.6 1.5 0.6 0.8 0.8 0.1 11.7 16.2 5.6 9.3 10.1 30.5 6.6 6.6 15.5 2.2 0.0 1.7 0.0 5.8 2.7 1.4 2.0 0.0 2.7 2.3 0.0 2.0 1.2 0.0 0.3 0.2 2.5 0.2 0.0 0.8 0.6 2.3 3.9 0.0 0.8 0.4 0.0 0.0 0.6 0.8 0.0 0.3 1.9 0.0 0.0 0.2 0.8 0.8 0.0 0.7 0.0 1.2 0.0 1.0 0.0 4.5 2.8 13.2 0.7 1.0 3.1 HAUS7 "UCHL5IP, UIP1" ENSG00000213397 "HAUS augmin like complex subunit 7" Q99871 X 153447666-153495516 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003614 Approved "Nucleoli,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" Nucleoli "HPA003614: AB_1080368" "unprognostic (2.06e-1)" "prognostic favorable (6.12e-4)" "unprognostic (3.81e-2)" "unprognostic (3.21e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-2)" "unprognostic (1.75e-2)" "unprognostic (7.50e-2)" "unprognostic (1.56e-1)" "unprognostic (3.39e-1)" "unprognostic (4.65e-3)" "unprognostic (6.28e-2)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.98e-1)" "unprognostic (1.15e-1)" "unprognostic (4.25e-2)" "unprognostic (1.09e-2)" 13.1 9.4 16.1 10.3 16.4 9.4 7.9 9.1 19.3 12.7 9.3 8.9 20.3 7.9 10.8 17.1 7.0 9.9 15.1 11.9 20.3 9.1 13.3 11.9 9.4 12.1 12.0 16.5 9.3 4.3 3.1 6.4 12.6 11.1 11.8 6.2 7.8 8.5 17.4 7.2 46.9 7.4 12.1 8.9 16.4 8.8 6.1 18.4 14.2 10.8 8.8 9.8 7.5 11.8 20.2 22.3 10.1 31.1 16.7 18.5 15.8 13.9 22.4 10.0 19.3 3.5 4.8 13.8 9.7 5.5 11.2 19.9 16.3 7.8 13.3 31.1 6.5 15.5 11.9 14.2 9.7 8.7 16.0 23.5 9.7 20.9 12.2 3.2 16.0 14.0 7.4 2.5 9.9 6.3 4.9 7.9 12.2 12.2 6.8 6.6 26.9 15.0 19.3 6.2 22.3 22.4 14.1 16.4 20.1 3.5 8.8 11.1 8.4 5.2 11.5 3.9 5.0 4.5 7.7 5.1 9.7 19.2 22.5 17.7 10.1 26.5 52.2 5.1 28.8 13.2 4.7 26.2 10.1 17.0 31.1 17.8 20.2 18.5 17.1 22.3 16.6 18.4 16.7 3.4 16.7 27.1 12.6 15.5 15.8 16.1 16.4 9.1 19.3 20.3 9.1 12.0 16.5 11.1 18.4 6.0 7.2 4.5 1.3 6.4 1.9 2.0 2.5 5.3 2.3 0.0 3.9 10.4 5.0 7.9 0.0 5.0 5.8 0.0 7.1 20.6 6.2 1.0 19.6 3.9 10.6 3.2 2.4 11.1 11.1 0.0 5.5 8.1 3.3 14.4 11.6 1.9 6.1 10.5 7.1 11.8 1.3 6.5 6.6 1.6 6.3 4.1 7.8 7.4 13.3 1.1 HDDC2 "C6orf74, CGI-130, dJ167O5.2" ENSG00000111906 "HD domain containing 2" Q7Z4H3 6 125219962-125302078 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 286.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035677 Approved Approved Nucleoplasm,Nucleoli NA NA 19000 Nucleoli Nucleoplasm "HPA035677: AB_10603768" "unprognostic (8.34e-2)" "unprognostic (5.41e-2)" "unprognostic (6.52e-2)" "unprognostic (6.25e-2)" "unprognostic (2.78e-2)" "unprognostic (6.39e-3)" "unprognostic (1.04e-3)" "unprognostic (1.76e-1)" "unprognostic (2.18e-1)" "unprognostic (2.38e-2)" "unprognostic (8.59e-3)" "unprognostic (5.13e-2)" "unprognostic (4.56e-2)" "unprognostic (2.54e-1)" "unprognostic (3.68e-2)" "unprognostic (1.80e-2)" "unprognostic (9.54e-2)" 17.5 29.8 50.5 12.0 36.1 11.3 21.1 26.4 31.7 14.8 15.2 11.1 31.6 12.4 12.9 25.2 19.6 17.2 12.4 34.7 41.1 37.0 31.3 8.9 13.4 18.8 45.0 18.9 18.3 22.9 16.3 15.6 11.5 23.4 15.7 16.9 19.3 54.8 42.0 42.8 13.5 16.1 19.0 25.8 12.2 14.4 25.7 16.8 12.9 24.3 35.4 18.2 17.7 11.2 27.3 15.4 4.4 14.2 23.6 33.9 17.7 8.6 24.1 15.0 61.5 12.2 16.8 20.9 11.6 17.7 12.6 13.1 37.9 10.4 40.0 25.2 22.1 29.1 8.6 21.0 17.0 16.1 15.7 49.3 18.5 13.4 37.2 27.8 23.9 13.7 23.5 26.2 17.9 41.3 19.8 9.0 22.2 69.9 17.3 27.2 48.0 18.5 25.2 17.6 25.8 19.6 27.9 11.9 8.4 29.4 11.0 29.4 14.3 14.2 27.7 25.4 14.7 16.2 40.6 5.5 12.7 14.0 19.5 23.4 20.6 14.2 33.1 18.3 43.3 25.9 4.4 14.2 2.5 22.9 12.2 18.7 27.3 25.3 31.0 14.7 22.0 31.4 33.9 3.2 23.6 11.1 15.4 21.5 17.7 50.5 36.1 26.4 31.7 41.1 37.0 45.0 18.9 23.4 16.8 23.8 38.7 42.4 51.6 39.6 51.4 109.7 33.1 34.8 30.7 59.3 13.7 75.6 286.8 71.8 43.7 26.4 42.4 23.3 86.1 127.4 62.7 54.8 36.9 18.1 98.5 65.2 61.9 11.6 46.6 33.2 84.3 41.0 75.9 12.6 64.1 45.8 55.3 45.6 107.8 202.1 18.2 38.8 76.2 115.5 66.8 37.6 38.2 62.3 78.2 45.1 HDHD3 "C9orf158, MGC12904" ENSG00000119431 "Haloacid dehalogenase like hydrolase domain containing 3" Q9BSH5 9 113373419-113376999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 54.7" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 204.4;Paneth cells: 171.9;Proximal tubular cells: 218.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020427, HPA024158, HPA024585" Enhanced Enhanced Nucleoli,Vesicles NA NA Nucleoli Vesicles "HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565" "unprognostic (1.30e-1)" "prognostic favorable (2.72e-4)" "unprognostic (3.01e-2)" "unprognostic (1.31e-2)" "unprognostic (8.24e-3)" "unprognostic (1.57e-2)" "unprognostic (6.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.76e-2)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (5.87e-2)" "prognostic favorable (3.54e-7)" "unprognostic (2.16e-2)" "unprognostic (1.84e-1)" "unprognostic (4.68e-1)" "unprognostic (1.19e-3)" 4.9 54.7 5.1 10.1 8.4 3.3 12.7 6.2 8.5 6.0 29.8 5.6 10.6 38.2 6.4 15.5 13.8 5.8 18.1 9.1 4.6 5.3 17.7 36.6 4.4 6.3 4.5 9.4 7.2 23.7 20.5 9.1 6.5 7.3 10.6 16.8 8.3 24.4 12.5 2.8 11.4 47.1 8.0 4.8 6.0 17.7 4.5 4.0 8.0 18.2 6.1 6.8 7.0 6.9 12.1 10.6 5.9 2.9 5.6 12.3 5.8 3.4 9.7 2.1 5.8 5.2 2.3 17.7 2.5 4.8 4.1 4.5 17.8 17.0 7.5 3.2 1.4 8.2 13.3 3.3 3.9 1.4 10.4 7.6 10.3 5.3 11.0 6.1 0.6 8.0 3.6 8.3 3.3 9.5 4.8 2.1 7.0 8.1 1.9 1.9 22.1 4.7 3.0 4.7 34.0 7.6 3.9 0.0 6.0 5.2 7.1 5.3 3.4 4.3 18.8 6.3 4.8 11.8 2.1 2.1 0.8 0.0 0.7 0.8 4.6 9.0 3.1 1.0 0.0 0.6 0.1 2.9 5.9 9.9 1.6 11.2 11.3 11.5 9.0 4.5 12.1 12.0 8.9 1.9 5.6 0.2 10.6 12.3 5.8 5.1 8.4 6.2 8.5 4.6 5.3 4.5 9.4 7.3 4.0 8.9 8.5 18.1 18.5 8.9 9.4 12.0 73.9 22.7 11.4 22.7 9.8 23.7 72.9 66.3 0.1 8.9 204.4 23.3 138.2 16.2 7.5 24.3 7.0 74.9 17.6 1.6 38.8 8.6 5.1 0.9 13.3 6.7 10.1 19.8 61.9 10.8 96.2 171.9 8.5 218.3 12.1 6.5 7.5 0.2 6.1 12.8 26.4 17.3 72.5 40.4 HECTD1 KIAA1131 ENSG00000092148 "HECT domain E3 ubiquitin protein ligase 1" Q9ULT8 14 31100112-31207804 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Urothelial cells: 267.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002929, HPA054461" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA002929: AB_1850574, HPA054461: AB_2682496" "unprognostic (6.71e-2)" "unprognostic (4.86e-2)" "unprognostic (5.31e-2)" "unprognostic (1.25e-1)" "unprognostic (1.64e-1)" "unprognostic (6.99e-2)" "unprognostic (1.32e-1)" "unprognostic (7.03e-2)" "unprognostic (2.29e-2)" "unprognostic (3.13e-2)" "unprognostic (3.60e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.20e-6)" "unprognostic (6.53e-2)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (9.91e-3)" 22.0 22.3 14.2 21.0 16.8 22.0 18.5 22.3 18.9 19.4 17.9 15.2 20.2 11.5 17.6 15.7 30.4 16.1 15.2 26.2 13.5 14.3 18.0 35.2 15.0 14.1 14.5 14.5 18.2 15.1 34.8 20.5 27.0 18.8 16.8 15.5 16.8 18.9 16.4 88.5 24.3 16.3 15.6 13.7 16.4 18.8 18.9 14.4 16.7 24.8 23.0 18.6 18.6 22.3 10.6 9.3 12.6 8.6 8.9 8.1 3.3 28.8 18.1 15.9 9.9 50.4 26.4 15.2 17.7 17.9 15.8 13.7 13.5 15.7 22.7 18.8 32.3 11.3 19.6 21.2 16.0 24.1 13.9 8.7 23.2 14.9 54.0 23.5 24.1 17.0 23.2 22.1 17.8 28.0 22.0 29.1 13.5 16.6 10.5 24.6 23.7 9.3 10.3 12.1 25.3 16.5 17.3 18.4 9.9 24.7 30.0 11.8 13.9 25.9 18.0 15.7 20.2 18.9 15.6 29.1 18.4 14.4 13.2 15.0 11.5 16.4 25.6 8.7 12.2 15.5 12.6 8.6 11.3 7.1 7.1 8.1 7.2 8.0 6.3 9.3 10.6 6.7 6.6 4.4 8.9 5.3 7.8 8.0 3.3 14.2 16.8 22.3 18.9 13.5 14.3 14.5 14.5 18.8 14.4 44.7 63.3 37.1 68.0 76.9 78.2 103.0 22.9 155.2 84.2 68.0 92.3 53.4 10.0 37.6 2.9 56.2 38.8 23.3 31.4 36.2 49.1 82.9 31.3 79.7 25.8 62.0 46.8 39.9 39.7 6.7 63.9 34.4 32.1 29.7 30.4 36.8 41.9 28.1 70.0 20.0 175.8 45.3 41.2 53.4 107.2 100.5 117.1 37.4 37.3 267.3 HELZ "DHRC, HUMORF5, KIAA0054" ENSG00000198265 "Helicase with zinc finger" P42694 17 67070438-67245989 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028276 Approved Approved "Nucleoli,Nucleoli rim,Plasma membrane,Actin filaments" NA NA "Nucleoli, Nucleoli rim" "Plasma membrane, Actin filaments" "HPA028276: AB_10601814" "unprognostic (3.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.56e-3)" "unprognostic (1.29e-1)" "unprognostic (4.83e-2)" "unprognostic (4.71e-2)" "unprognostic (5.85e-2)" "unprognostic (5.31e-2)" "unprognostic (3.60e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-3)" "unprognostic (1.42e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" 17.9 12.9 11.2 14.3 14.3 17.7 12.6 24.3 17.7 14.4 14.0 11.6 12.9 7.9 17.0 13.0 9.1 11.1 11.5 11.1 12.0 9.7 11.8 17.3 14.8 14.6 10.7 6.2 20.5 13.9 34.1 33.5 19.2 16.5 11.9 10.9 12.2 12.4 10.9 18.9 9.0 15.6 12.2 13.5 17.3 11.7 16.4 12.7 34.1 15.3 8.8 13.9 15.3 11.9 4.8 4.4 4.3 4.9 4.0 11.0 3.2 7.6 7.6 9.3 9.6 11.8 6.6 14.3 6.8 6.7 8.9 9.7 11.1 6.0 15.7 5.6 9.0 5.7 8.0 17.8 8.6 14.3 6.0 5.5 20.1 8.4 9.1 5.7 16.6 12.3 7.8 8.2 8.8 11.1 6.9 13.7 11.7 13.9 10.0 7.4 9.7 21.3 5.7 5.7 6.9 7.3 14.4 16.9 6.9 7.2 10.8 9.4 8.6 10.7 8.9 11.7 13.5 10.6 10.3 12.3 11.5 13.2 6.2 6.0 8.3 9.6 11.9 5.7 10.3 11.9 3.6 4.9 4.3 8.8 4.5 11.0 2.9 5.4 5.3 4.4 4.8 3.3 4.5 3.7 4.0 2.9 3.6 4.8 3.2 11.2 14.3 24.3 17.7 12.0 9.7 10.7 6.2 16.5 12.7 17.9 29.6 17.6 21.6 28.5 49.3 24.4 22.9 21.4 29.6 26.2 88.4 26.8 6.6 15.0 3.7 24.5 22.3 0.0 12.2 34.0 24.9 25.4 33.4 40.0 27.1 63.5 36.8 63.8 75.2 7.2 35.9 25.6 13.5 10.8 29.0 24.5 16.1 21.0 40.3 12.1 51.1 12.9 22.6 36.7 24.8 17.7 15.3 76.1 22.6 32.3 HERPUD2 FLJ22313 ENSG00000122557 "HERPUD family member 2" Q9BSE4 7 35632659-35695571 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 290.9;Late spermatids: 471.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015630, HPA076087" Approved Approved "Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" "HPA015630: AB_1850609, HPA076087: AB_2686774" "unprognostic (1.85e-2)" "unprognostic (5.31e-3)" "unprognostic (2.76e-1)" "unprognostic (3.79e-1)" "unprognostic (3.46e-1)" "unprognostic (2.73e-2)" "unprognostic (2.48e-1)" "unprognostic (1.26e-1)" "unprognostic (2.35e-1)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (2.30e-2)" "unprognostic (7.95e-2)" "unprognostic (5.13e-2)" "unprognostic (1.95e-1)" "unprognostic (5.42e-2)" "unprognostic (6.54e-2)" 22.7 13.7 19.2 25.6 21.7 34.3 21.9 25.0 21.7 24.2 20.3 18.6 18.8 16.1 24.3 17.1 21.2 19.9 26.4 16.6 17.5 14.0 17.6 25.3 22.7 33.7 16.7 18.3 37.0 31.4 18.0 22.5 21.6 15.4 21.6 19.3 19.5 19.6 23.8 17.9 20.9 20.5 23.9 18.5 24.1 18.0 39.5 18.3 34.3 22.5 15.4 23.2 25.0 22.0 5.7 5.9 19.2 9.2 12.1 12.2 4.8 18.0 6.9 13.0 12.7 19.5 14.9 10.5 12.9 18.1 8.4 9.5 8.2 21.6 13.0 20.5 16.3 28.8 22.8 7.2 9.3 13.1 8.6 9.3 9.0 8.4 5.5 16.8 9.1 11.5 18.6 16.8 10.6 17.2 17.3 13.9 16.1 14.1 17.4 14.5 7.6 10.3 14.9 10.9 11.2 9.5 12.5 15.7 10.4 10.9 8.1 10.8 17.9 16.3 15.5 11.1 20.7 15.6 11.0 16.2 13.2 15.2 12.8 10.2 24.3 27.6 13.7 12.7 14.1 24.1 5.8 6.8 19.2 10.6 7.6 12.2 4.4 9.5 11.3 5.9 5.7 5.9 8.0 11.7 12.1 9.2 3.6 8.6 4.8 19.2 21.7 25.0 21.7 17.5 14.0 16.7 18.3 15.4 18.3 23.8 17.9 41.2 14.4 14.9 13.6 11.8 15.3 10.7 11.4 5.2 7.9 14.5 14.9 21.2 290.9 17.4 20.8 0.0 25.4 21.7 16.6 16.1 35.8 17.9 15.8 11.1 13.7 20.9 26.3 471.7 25.3 19.2 21.9 22.6 12.2 22.4 26.9 14.0 23.7 11.2 13.0 12.9 15.0 27.7 18.3 13.8 26.0 62.3 13.4 18.2 HES7 bHLHb37 ENSG00000179111 "Hes family bHLH transcription factor 7" Q9BYE0 17 8120590-8124092 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.3;salivary gland: 10.5" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 2.4;Melanocytes: 3.3;Smooth muscle cells: 4.2" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.7;Daudi: 7.2;HAP1: 9.2;HDLM-2: 7.3;HeLa: 13.7" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "cerebellum: 0.8" HPA072105 Uncertain Approved Nucleoplasm,Nucleoli No NA Nucleoplasm Nucleoli "HPA072105: AB_2686488" "unprognostic (1.98e-1)" "unprognostic (7.91e-3)" "unprognostic (1.16e-3)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (4.99e-2)" "unprognostic (2.84e-1)" "unprognostic (5.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.04e-1)" "unprognostic (2.74e-1)" "unprognostic (1.22e-5)" "unprognostic (2.99e-2)" "unprognostic (4.79e-2)" "unprognostic (2.69e-2)" "unprognostic (1.55e-1)" 0.4 0.4 1.0 0.3 1.0 0.2 0.5 9.3 2.4 1.4 0.3 0.6 0.2 0.0 2.0 0.2 0.7 0.6 0.6 1.3 1.5 0.5 1.1 0.2 0.9 0.6 1.0 0.2 1.5 0.5 0.0 0.4 3.6 2.1 0.6 0.2 0.9 10.5 2.5 1.1 0.6 0.3 0.4 1.5 0.3 0.2 2.3 0.2 0.2 0.8 0.2 0.5 1.3 0.9 0.2 0.1 0.0 0.1 0.3 0.2 0.1 6.7 0.5 0.5 2.3 0.2 0.3 0.3 0.4 0.6 0.8 2.4 0.1 0.4 7.2 0.1 0.0 1.1 0.7 9.2 0.6 0.0 7.3 4.4 0.3 13.7 0.1 0.8 0.8 0.9 0.2 1.2 2.0 5.2 1.3 0.1 1.2 0.2 3.2 0.1 0.1 0.1 0.4 0.2 0.5 1.7 0.7 0.4 1.2 0.2 0.0 0.3 3.3 0.4 0.0 0.4 0.1 0.1 0.0 0.7 0.0 1.5 1.6 2.3 4.5 0.9 0.4 0.7 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 1.0 1.0 9.3 2.4 1.5 0.5 1.0 0.2 2.1 0.2 0.0 0.0 0.0 0.9 1.9 2.4 0.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 1.2 1.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 3.3 1.0 0.0 0.5 0.0 0.0 0.4 0.0 0.8 0.0 4.2 0.0 0.6 1.4 0.2 0.0 0.0 0.1 HINT3 FLJ33126 ENSG00000111911 "Histidine triad nucleotide binding protein 3" Q9NQE9 6 125956781-125980244 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 65.8" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 260.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027914 Approved Approved Nucleoli,Mitochondria,Cytosol NA NA "Nucleoli, Mitochondria" Cytosol "HPA027914: AB_10602424" "prognostic unfavorable (4.99e-4)" "unprognostic (4.75e-3)" "unprognostic (3.75e-2)" "unprognostic (1.29e-1)" "unprognostic (1.59e-1)" "unprognostic (1.71e-1)" "unprognostic (1.74e-1)" "unprognostic (4.88e-3)" "unprognostic (3.82e-1)" "unprognostic (1.27e-1)" "unprognostic (2.18e-2)" "unprognostic (1.05e-1)" "prognostic favorable (1.05e-6)" "unprognostic (4.09e-2)" "unprognostic (4.76e-2)" "unprognostic (9.56e-2)" "unprognostic (1.64e-1)" 11.4 16.3 27.4 8.0 23.3 7.2 15.6 19.4 24.3 13.1 13.1 24.8 10.6 10.4 11.5 12.6 15.2 11.4 10.9 19.0 28.1 23.0 15.1 18.5 13.9 7.0 28.7 17.0 10.4 12.8 16.3 13.4 12.1 20.7 20.5 12.1 10.3 16.0 16.2 65.8 11.6 10.5 15.2 40.8 6.8 16.0 21.9 17.0 7.7 15.9 16.8 7.4 16.1 8.8 11.0 11.1 15.0 13.2 7.9 9.9 7.0 7.0 5.6 7.8 16.1 3.1 8.4 9.7 7.6 11.0 5.9 6.1 13.6 3.9 15.3 14.2 5.1 13.1 10.6 9.9 6.4 6.9 14.4 12.8 6.4 8.4 11.4 14.4 10.1 10.9 6.6 14.3 5.9 15.0 15.2 8.8 11.4 19.9 10.3 5.8 10.6 8.0 7.3 2.6 14.4 5.4 6.7 5.3 5.1 12.1 12.9 15.7 9.7 6.9 9.9 35.6 5.9 10.0 15.5 6.2 4.0 5.6 19.2 10.8 15.0 17.2 9.7 11.4 9.6 5.1 14.4 13.2 11.4 7.2 8.4 7.8 11.0 9.2 7.5 11.1 10.4 9.9 8.7 15.0 7.9 10.8 6.9 9.1 7.0 27.4 23.3 19.4 24.3 28.1 23.0 28.7 17.0 20.7 17.0 74.5 57.0 16.0 9.5 16.1 22.3 37.6 10.2 24.1 31.8 15.7 7.9 16.0 28.2 27.0 260.9 11.3 12.3 0.0 17.5 5.7 10.8 19.4 9.2 16.3 23.3 6.4 15.6 6.2 14.5 54.5 9.2 17.0 20.3 9.0 22.7 30.7 20.3 28.1 16.3 21.4 23.9 6.5 13.7 89.1 27.7 15.2 22.1 7.0 19.9 17.1 HJURP "DKFZp762E1312, FAKTS, hFLEG1, URLC9" ENSG00000123485 "Holliday junction recognition protein" Q8NCD3 2 233833416-233854566 "Predicted intracellular proteins" "Cell cycle" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 12.4;Erythroid cells: 46.7;Extravillous trophoblasts: 13.7;Spermatocytes: 18.4;Spermatogonia: 12.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.2" "Group enriched" "Detected in many" 4 "granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA008436, HPA027261" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria" Yes Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Mitochondria "HPA008436: AB_1850757, HPA027261: AB_2672184" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.87e-1)" "unprognostic (1.44e-3)" "unprognostic (3.62e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.37e-5)" "prognostic unfavorable (2.46e-4)" "prognostic unfavorable (6.49e-4)" "unprognostic (9.48e-2)" "prognostic unfavorable (7.72e-5)" "unprognostic (7.60e-2)" "unprognostic (0.00e+0)" "unprognostic (7.42e-2)" "unprognostic (5.58e-2)" "unprognostic (1.89e-2)" "unprognostic (5.74e-2)" 1.4 0.9 0.1 12.2 0.4 27.4 2.2 0.1 0.7 1.1 3.7 0.3 0.1 2.6 0.6 1.8 8.0 0.3 0.7 1.1 0.1 0.2 1.0 1.2 2.0 8.1 0.2 0.1 0.6 0.4 0.0 0.2 3.1 0.2 0.7 3.6 0.3 1.5 1.0 0.2 2.6 4.8 1.1 0.4 5.8 2.4 20.9 0.1 51.1 0.4 3.0 11.6 1.0 2.8 0.5 0.3 1.2 1.3 0.5 4.2 1.7 17.0 23.1 22.6 10.6 0.8 1.8 14.1 25.6 12.3 18.3 20.0 16.2 18.7 5.3 2.9 10.1 32.6 20.0 18.0 13.3 24.4 12.5 6.8 20.6 18.6 15.7 0.1 16.9 14.2 0.6 0.5 14.9 10.3 5.2 11.4 16.5 17.4 13.3 33.6 17.2 23.7 18.7 19.3 13.4 16.0 18.4 33.9 9.5 9.4 10.3 13.0 8.1 14.8 11.2 10.5 10.8 8.4 13.1 8.3 19.8 21.6 14.5 27.7 12.7 10.0 21.4 11.9 12.5 49.3 0.6 0.2 0.2 0.3 0.2 0.2 0.4 0.7 0.6 0.3 0.5 0.3 0.5 1.2 0.5 1.3 0.2 4.2 1.7 0.1 0.4 0.1 0.7 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.3 0.8 0.4 1.1 0.0 0.8 0.0 0.0 3.4 0.0 0.0 1.1 0.0 0.0 12.4 0.1 0.9 46.7 0.0 13.7 0.3 0.4 0.0 0.0 5.7 0.0 0.0 2.5 2.4 7.4 0.6 2.1 0.0 0.0 0.7 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.3 18.4 12.9 0.6 1.3 1.3 1.2 0.6 HMGA1 HMGIY ENSG00000137309 "High mobility group AT-hook 1" P17096 6 34236873-34246231 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 107.3" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 784.6;Pancreatic endocrine cells: 1097.2;Urothelial cells: 1250.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB032200, HPA065612, HPA068442" Enhanced Approved Nucleoplasm,Nucleoli NA NA 18000 Nucleoplasm Nucleoli "CAB032200: AB_2117771, HPA065612: , HPA068442: " "unprognostic (1.81e-1)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (7.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.29e-6)" "prognostic unfavorable (3.36e-4)" "unprognostic (8.54e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (8.71e-4)" "unprognostic (1.55e-1)" "unprognostic (8.22e-2)" "unprognostic (4.52e-3)" "unprognostic (1.19e-1)" "unprognostic (4.37e-1)" "unprognostic (2.65e-2)" 15.8 3.5 14.8 35.7 13.5 55.4 13.0 13.8 19.0 26.1 22.0 5.9 7.7 42.3 8.6 7.2 79.4 15.1 17.8 13.0 11.7 12.6 14.6 6.9 16.0 46.1 10.7 8.7 3.9 13.0 4.1 5.1 31.8 12.5 8.7 21.2 9.9 22.0 6.9 33.7 38.3 36.0 3.8 8.4 31.6 24.2 32.6 7.2 107.3 12.5 39.6 72.7 13.0 29.6 26.6 33.4 12.8 10.1 7.3 22.4 11.0 121.6 48.2 24.7 17.2 11.5 85.4 108.0 49.2 56.3 38.2 21.3 31.5 85.4 57.4 24.8 20.1 24.0 26.1 29.1 87.7 30.4 12.5 19.5 17.6 16.2 42.1 24.4 62.8 20.3 36.6 9.8 69.1 36.1 98.7 115.2 32.8 70.8 2.9 53.1 12.3 54.4 77.4 120.4 60.7 81.6 80.9 0.5 63.3 25.8 11.2 43.2 18.3 5.2 25.0 45.4 40.8 10.0 67.4 99.8 19.9 62.8 28.9 46.0 23.6 36.5 74.1 42.1 26.2 99.3 6.2 10.1 12.8 10.2 10.1 13.3 26.6 18.7 16.0 30.7 16.4 22.4 17.7 2.6 7.3 9.4 33.4 21.0 11.0 14.8 13.5 13.8 19.0 11.7 12.6 10.7 8.7 12.5 7.2 26.8 23.7 124.5 686.8 384.1 27.4 24.5 38.2 10.7 36.4 38.4 3.9 784.6 39.7 243.5 6.1 27.0 148.7 46.7 242.2 663.0 71.9 750.7 66.8 10.6 337.7 11.1 112.2 16.0 59.4 17.5 5.2 107.5 86.0 66.7 165.5 27.9 1097.2 162.4 2.5 9.0 27.8 0.0 34.9 38.5 398.0 315.9 688.1 51.7 282.8 1250.0 HMGA2 "BABL, HMGIC, LIPO" ENSG00000149948 "High mobility group AT-hook 2" P52926 12 65824131-65966295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.3" "Cell type enhanced" "Detected in some" 10 "Early spermatids: 15.7;Hofbauer cells: 6.8;Late spermatids: 6.8;Pancreatic endocrine cells: 11.8;Undifferentiated cells: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 63.0;hTERT-RPE1: 46.0;SuSa: 44.3" "Not detected" "Not detected" "CAB017809, HPA039076" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB017809: , HPA039076: AB_2676335" "unprognostic (2.39e-1)" "unprognostic (6.00e-2)" "unprognostic (2.08e-1)" "unprognostic (3.68e-3)" "unprognostic (5.21e-3)" "prognostic unfavorable (4.79e-4)" "unprognostic (4.05e-3)" "unprognostic (6.17e-3)" "unprognostic (6.71e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-6)" "unprognostic (3.33e-2)" "unprognostic (4.55e-5)" "unprognostic (4.22e-2)" "unprognostic (2.53e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (2.86e-4)" 6.5 0.3 0.5 3.8 0.8 8.1 2.1 0.2 0.6 2.5 7.6 0.4 0.0 2.4 2.7 0.1 1.1 2.4 3.3 0.5 0.3 0.4 1.0 0.4 0.5 0.1 0.3 1.3 2.1 1.7 0.0 1.7 0.3 0.6 0.5 4.6 0.4 0.5 1.8 2.0 0.7 5.1 0.7 1.7 0.8 2.1 25.3 0.0 0.8 1.1 3.0 0.1 0.8 2.8 0.7 0.3 3.8 2.1 1.3 0.7 0.1 9.1 4.0 63.0 9.0 3.0 16.5 0.0 29.1 13.3 5.1 5.1 5.2 3.9 0.0 18.9 1.3 24.0 4.0 10.4 25.1 24.5 0.0 10.9 0.0 0.1 31.5 1.7 0.8 0.1 12.5 1.5 11.0 19.8 46.0 20.1 0.0 0.0 0.1 29.1 0.0 0.0 5.1 36.9 0.8 18.1 2.4 3.1 0.0 13.6 0.0 0.0 0.0 0.0 0.0 16.0 44.3 0.1 0.1 23.5 18.5 5.5 14.1 8.7 0.0 0.0 0.0 22.4 0.0 4.2 3.8 1.0 0.7 0.5 0.6 0.3 0.3 0.4 0.5 0.2 0.7 0.4 0.7 2.5 1.3 2.1 0.3 0.3 0.1 0.5 0.8 0.2 0.6 0.3 0.4 0.3 1.3 0.6 0.0 0.0 1.4 0.0 2.2 0.0 0.0 1.2 0.0 4.0 0.0 0.0 0.0 0.8 0.0 3.0 15.7 0.1 3.3 0.0 0.7 0.3 0.9 0.4 0.0 0.0 6.8 0.0 0.0 0.6 0.0 6.8 0.3 0.0 0.0 0.0 4.7 0.0 11.8 3.5 0.0 0.0 0.0 0.0 0.8 0.5 0.2 0.1 0.7 0.0 8.5 0.9 HMGB2 HMG2 ENSG00000164104 "High mobility group box 2" P26583 4 173331695-173335125 "Plasma proteins, Predicted intracellular proteins" "Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1" "Cell type enhanced" "Detected in all" 15 "Erythroid cells: 2616.4;Extravillous trophoblasts: 751.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 166.6;MOLT-4: 171.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003506, CAB037206, HPA053314" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" NA Yes 380000 Nucleoplasm Nucleoli "CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109" "unprognostic (2.82e-1)" "unprognostic (8.52e-3)" "unprognostic (2.56e-1)" "unprognostic (8.37e-2)" "unprognostic (8.05e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (3.76e-5)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (4.41e-2)" "prognostic unfavorable (7.04e-4)" "unprognostic (9.65e-2)" "prognostic unfavorable (7.60e-12)" "unprognostic (1.60e-2)" "unprognostic (2.83e-2)" "unprognostic (2.68e-2)" "unprognostic (1.21e-2)" 18.8 5.9 10.3 48.9 13.2 325.8 19.9 6.6 9.5 17.1 24.0 8.6 7.9 15.7 18.6 16.2 28.6 15.4 13.8 23.4 9.5 10.2 13.2 6.9 25.4 59.8 12.5 8.2 29.0 5.8 2.9 8.0 18.5 9.3 19.0 21.2 12.2 13.8 8.6 46.2 15.5 21.5 25.3 13.3 36.7 13.0 26.7 10.6 187.1 18.7 23.0 61.6 27.1 18.5 11.6 16.8 95.9 20.5 11.9 39.9 14.3 34.9 8.4 72.2 32.2 9.0 9.0 27.7 26.1 19.9 28.8 25.8 23.7 48.8 118.3 5.9 14.5 15.4 13.7 47.3 14.2 45.0 72.4 22.1 130.0 21.2 34.7 8.8 115.0 50.2 8.7 4.3 14.4 32.8 15.7 29.5 62.9 49.0 166.6 26.3 29.2 171.4 106.6 26.3 20.9 14.6 86.7 37.1 43.9 16.5 15.0 62.5 56.4 26.3 15.3 11.7 26.4 21.2 83.9 16.9 12.9 38.3 15.9 39.1 53.9 30.1 135.4 11.0 84.1 33.6 95.9 20.5 57.6 15.6 8.5 14.1 11.6 22.7 21.2 16.8 8.8 15.0 14.3 47.8 11.9 6.8 6.8 39.9 14.3 10.3 13.2 6.6 9.5 9.5 10.2 12.5 8.2 9.3 10.6 26.8 58.1 117.6 176.4 141.0 43.0 211.0 35.7 147.2 66.0 52.4 33.4 154.7 121.0 20.6 24.5 124.1 53.3 2616.4 14.4 751.8 109.8 81.7 104.4 22.2 176.6 42.9 71.7 149.1 275.5 29.5 97.5 149.6 64.1 109.2 104.0 79.8 10.0 83.9 54.1 36.3 129.5 77.6 96.6 461.9 435.2 117.1 107.7 264.5 185.0 64.8 HMGB3 "HMG2A, HMG4, MGC90319" ENSG00000029993 "High mobility group box 3" O15347 X 150980509-150990775 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" DNA-binding Microphthalmia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 54.3" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 337.0;Extravillous trophoblasts: 539.5;Syncytiotrophoblasts: 1171.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HBEC3-KT: 108.8;U-698: 98.0" HPA062583 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA062583: AB_2684800" "unprognostic (2.85e-3)" "unprognostic (2.82e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.60e-2)" "unprognostic (2.66e-3)" "unprognostic (4.54e-3)" "unprognostic (2.70e-2)" "prognostic favorable (9.85e-5)" "unprognostic (6.03e-2)" "unprognostic (1.96e-2)" "prognostic favorable (6.15e-4)" "unprognostic (2.58e-2)" "unprognostic (9.29e-2)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" 4.4 5.4 7.9 4.8 7.1 20.3 4.1 2.8 10.3 10.8 12.0 4.7 3.9 7.3 6.3 13.4 10.2 4.4 3.2 4.5 9.8 7.6 9.0 41.6 5.9 6.3 6.1 7.3 3.1 7.1 18.7 1.6 54.3 9.7 3.7 9.2 5.3 9.7 4.3 20.5 6.8 7.6 3.6 5.0 8.4 4.0 26.0 3.2 18.2 6.2 5.1 9.5 4.9 3.7 3.1 6.5 11.8 5.3 0.9 6.2 2.3 37.7 16.7 52.8 27.5 2.2 6.6 65.8 16.6 10.9 19.3 10.0 13.2 15.7 26.5 53.5 12.7 10.9 18.2 48.1 108.8 21.8 18.0 14.0 23.0 16.2 20.8 3.3 34.6 11.7 5.2 25.8 7.9 20.0 4.9 24.9 16.3 11.9 15.7 22.9 29.0 38.1 26.6 31.3 24.8 20.5 46.8 43.0 15.0 14.2 18.1 38.1 24.9 24.7 26.6 8.2 31.5 23.5 22.9 18.7 8.0 19.0 25.5 36.5 14.3 17.8 98.0 9.6 17.7 16.3 0.0 4.8 11.8 0.5 3.2 0.1 3.1 2.4 3.3 6.5 0.6 0.0 0.2 0.6 0.9 5.3 3.3 6.2 2.3 7.9 7.1 2.8 10.3 9.8 7.6 6.1 7.3 9.7 3.2 35.7 27.4 16.2 16.0 21.1 0.5 13.2 10.2 145.9 134.2 29.6 2.0 337.0 31.5 72.8 184.3 11.3 24.9 186.9 75.5 539.5 20.8 18.7 8.1 72.9 88.3 0.0 63.0 10.4 18.3 46.6 3.4 26.0 20.3 35.1 29.3 3.1 76.6 25.9 3.2 39.4 1.4 0.0 8.3 19.9 49.6 17.8 1171.0 14.0 52.8 17.0 HMGN2 HMG17 ENSG00000198830 "High mobility group nucleosomal binding domain 2" P05204 1 26472450-26475972 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB018371, HPA077364" Supported Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "CAB018371: , HPA077364: AB_2686835" "unprognostic (3.10e-2)" "unprognostic (6.88e-2)" "unprognostic (3.10e-3)" "unprognostic (4.13e-2)" "unprognostic (4.06e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (2.36e-1)" "unprognostic (2.44e-3)" "unprognostic (2.86e-2)" "unprognostic (1.05e-3)" "unprognostic (5.23e-3)" "prognostic unfavorable (3.92e-4)" "unprognostic (3.00e-2)" "unprognostic (2.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.15e-1)" 30.6 34.9 36.0 52.4 32.3 169.1 37.6 30.8 39.1 51.3 43.4 30.3 53.6 30.0 46.1 60.6 44.1 50.1 51.6 37.6 30.5 32.0 35.9 37.1 62.9 100.2 32.7 30.5 64.7 59.4 16.7 52.7 49.6 26.0 48.0 49.9 42.5 58.9 51.9 41.1 33.9 41.3 68.1 40.4 50.0 33.2 29.9 31.1 104.6 48.6 52.5 83.2 43.7 38.7 60.4 81.4 157.4 73.6 38.6 83.4 103.5 83.3 28.9 83.9 35.2 7.8 18.1 32.8 41.3 23.8 80.9 62.5 29.8 78.2 93.9 39.5 33.6 23.6 48.2 105.8 41.0 68.9 57.8 74.9 100.8 34.3 29.1 14.7 213.4 58.9 19.0 21.6 44.2 26.2 16.9 37.6 62.7 79.7 45.1 42.4 61.6 152.1 97.0 70.3 96.0 53.8 105.9 131.8 57.5 25.4 22.9 83.7 51.9 124.1 34.9 45.7 21.8 57.2 101.2 27.9 40.4 75.5 77.3 68.8 55.2 74.8 104.6 25.9 224.6 80.0 30.3 59.9 157.4 34.2 69.0 32.0 60.4 46.8 41.4 60.9 59.1 51.5 41.7 53.1 38.6 73.6 81.4 83.4 103.5 36.0 32.3 30.8 39.1 30.5 32.0 32.7 30.5 26.0 31.1 318.6 348.4 323.5 270.1 256.3 146.9 79.2 191.1 714.7 343.5 247.7 133.5 686.4 315.0 197.4 143.3 140.8 163.3 537.3 235.1 491.1 459.0 285.8 361.7 123.4 660.0 89.0 554.4 172.5 336.2 26.8 172.0 473.8 215.9 762.9 372.7 230.4 94.5 305.1 142.8 214.8 300.1 122.9 297.7 273.8 419.4 186.6 772.2 318.1 517.4 227.4 HMGXB3 "HMGX3, KIAA0194, SMF" ENSG00000113716 "HMG-box containing 3" Q12766 5 150000046-150053142 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "parathyroid gland: 151.8" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005967 Approved Nucleoli NA NA Nucleoli "HPA005967: AB_1080044" "unprognostic (3.66e-2)" "unprognostic (3.74e-1)" "unprognostic (1.47e-1)" "unprognostic (1.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (3.37e-5)" "unprognostic (9.72e-2)" "unprognostic (3.36e-1)" "unprognostic (3.89e-3)" "unprognostic (3.74e-2)" "unprognostic (2.11e-1)" "unprognostic (3.24e-3)" "unprognostic (1.30e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-2)" 12.0 14.2 8.2 14.5 14.4 15.3 16.1 14.5 17.4 11.3 10.3 15.0 15.4 8.3 13.9 20.0 9.3 13.5 12.1 9.4 8.6 8.3 11.6 11.7 14.7 10.3 10.1 11.0 15.0 13.8 151.8 15.3 11.8 12.9 17.6 10.8 16.8 12.4 18.4 12.5 13.1 9.9 12.8 8.9 14.4 12.0 17.7 7.3 15.3 14.7 10.1 12.0 11.2 10.1 5.8 6.2 5.1 5.9 2.2 8.1 3.7 11.5 13.5 9.6 15.0 13.8 11.7 16.7 11.1 20.6 16.8 21.2 18.9 14.1 11.0 13.1 15.2 35.9 8.5 18.1 19.1 14.6 10.2 13.0 9.6 14.2 9.2 19.2 18.4 21.9 15.2 14.4 24.5 19.4 21.4 11.9 8.9 12.6 11.6 17.6 9.1 11.4 9.6 7.2 7.7 20.3 10.0 13.3 10.6 10.0 14.4 12.4 12.4 9.7 23.9 24.7 8.7 11.1 12.0 10.2 25.1 10.7 12.1 20.5 13.6 12.9 15.7 29.3 14.1 12.9 5.1 4.7 4.0 7.0 5.9 5.5 5.8 5.7 4.9 6.2 5.0 4.4 4.6 0.5 2.2 3.9 4.6 8.1 3.7 8.2 14.4 14.5 17.4 8.6 8.3 10.1 11.0 12.9 7.3 8.9 13.8 19.3 22.2 10.1 30.5 6.7 17.8 30.8 21.6 8.7 33.4 13.0 18.3 19.2 5.0 17.9 6.9 0.0 19.0 10.2 11.0 28.3 17.4 11.3 23.8 68.3 14.9 16.0 9.4 1.6 12.4 12.5 3.3 27.1 10.4 22.7 26.2 8.6 11.7 8.5 42.8 12.9 8.5 22.9 20.4 10.7 12.9 12.5 14.0 24.4 HOMEZ KIAA1443 ENSG00000215271 "Homeobox and leucine zipper encoding" Q8IX15 14 23272422-23299447 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 220.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036316, HPA036317" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA036316: AB_2675056, HPA036317: AB_10669787" "unprognostic (3.70e-2)" "unprognostic (7.58e-2)" "unprognostic (6.36e-2)" "unprognostic (3.93e-2)" "unprognostic (9.11e-2)" "unprognostic (5.23e-2)" "unprognostic (1.20e-2)" "unprognostic (1.59e-2)" "unprognostic (1.37e-1)" "prognostic favorable (2.41e-5)" "unprognostic (2.23e-1)" "unprognostic (1.77e-1)" "prognostic favorable (1.17e-11)" "unprognostic (2.62e-1)" "unprognostic (2.00e-1)" "prognostic favorable (1.75e-4)" "unprognostic (3.23e-1)" 7.6 8.3 6.6 7.2 6.8 1.7 9.2 4.6 6.6 9.3 8.5 12.1 18.5 8.1 8.4 11.2 14.4 9.1 12.7 8.9 6.4 5.1 11.6 8.8 7.2 6.4 6.5 5.4 12.5 11.0 8.0 7.0 6.6 7.2 11.1 7.6 12.2 13.6 22.0 12.0 9.1 8.4 8.6 7.6 8.1 9.9 39.9 7.4 16.0 14.7 6.3 11.3 12.9 8.3 4.3 7.4 10.8 7.2 3.6 6.3 3.9 4.3 4.4 8.5 8.2 13.4 5.9 9.5 4.8 6.2 4.5 5.6 1.8 9.5 9.5 3.9 4.4 10.7 14.6 11.4 11.6 5.6 5.1 3.9 3.3 3.6 8.8 16.8 4.8 2.8 9.2 11.9 3.4 7.7 10.2 8.6 11.0 9.2 4.0 7.9 9.8 3.7 3.4 3.4 13.8 2.6 5.8 6.4 4.1 8.6 18.3 2.7 3.5 4.5 12.9 5.1 13.9 7.8 5.9 9.1 3.2 1.4 3.9 2.1 16.0 6.8 3.3 1.7 3.5 4.6 4.1 7.2 10.8 5.7 7.1 4.6 4.3 4.9 4.8 7.4 3.9 5.4 6.3 1.4 3.6 4.9 4.7 6.2 3.9 6.6 6.8 4.6 6.6 6.4 5.1 6.5 5.4 7.2 7.4 6.0 6.5 6.9 14.8 2.5 4.7 6.5 10.2 6.7 9.1 22.7 5.9 6.0 11.6 9.6 220.5 3.5 6.3 0.0 9.5 5.4 4.6 9.3 3.5 4.4 7.6 9.5 3.5 5.5 2.9 54.5 6.4 5.5 3.3 20.8 9.8 6.8 8.8 3.5 7.1 15.1 3.4 6.5 3.8 5.7 4.5 4.4 7.8 2.9 9.3 27.4 HORMAD1 "CT46, DKFZP434A1315" ENSG00000143452 "HORMA domain containing 1" Q86X24 1 150698060-150720888 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 78.1" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 709.1" "Cancer enhanced" "Detected in many" "testis cancer: 6.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 1.2;neutrophil: 4.4" "Group enriched" "Detected in many" 4 "granulocytes: 4.4;monocytes: 1.2" "Cell line enhanced" "Detected in some" "A549: 5.7;HeLa: 4.5;hTCEpi: 19.4;SiHa: 5.9;SuSa: 6.8;THP-1: 11.2;U-2 OS: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028346, HPA037850" Enhanced Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA028346: AB_2672564, HPA037850: AB_10696358" "unprognostic (7.21e-2)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (9.06e-2)" "unprognostic (3.91e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-2)" "unprognostic (5.17e-3)" "unprognostic (3.79e-9)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 1.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 3.2 0.1 0.1 0.1 0.4 0.0 78.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.6 4.4 1.2 0.0 0.2 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.1 0.0 0.1 4.5 0.0 0.0 0.0 0.1 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.1 6.8 0.0 11.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.2 0.3 0.2 0.4 0.0 0.2 0.1 0.0 0.6 0.1 0.0 0.0 4.4 0.0 0.5 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 54.2 0.1 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.6 22.1 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 32.3 0.1 709.1 118.4 8.2 1.8 0.0 0.0 0.0 HOXD9 "HOX4, HOX4C" ENSG00000128709 "Homeobox D9" P28356 2 176122720-176124937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 26.2" "Cell type enhanced" "Detected in some" 10 "Collecting duct cells: 22.7;Distal tubular cells: 31.5;Leydig cells: 31.7;Peritubular cells: 25.1;Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.7;HEK 293: 12.2;RPTEC TERT1: 14.4;SH-SY5Y: 16.8;SK-MEL-30: 9.2;TIME: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA068683 Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA068683: AB_2686018" "unprognostic (1.89e-1)" "unprognostic (9.41e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (1.37e-1)" "unprognostic (1.03e-2)" "prognostic favorable (9.58e-4)" "prognostic unfavorable (1.08e-5)" "unprognostic (6.62e-2)" "unprognostic (4.58e-2)" "unprognostic (1.54e-2)" "unprognostic (2.56e-3)" "unprognostic (6.71e-2)" "unprognostic (4.77e-3)" "unprognostic (8.38e-2)" "unprognostic (5.94e-2)" "unprognostic (1.89e-1)" "unprognostic (9.44e-2)" 4.1 2.7 0.2 1.7 0.4 0.0 11.4 0.2 0.2 13.1 10.8 0.2 10.4 0.0 26.2 12.0 1.6 5.1 2.6 0.5 0.2 0.0 19.7 0.2 0.7 2.4 0.2 0.2 8.9 0.2 0.0 0.2 1.6 0.4 13.0 2.2 0.2 0.4 16.0 3.8 3.9 1.1 12.6 0.6 3.7 0.1 9.8 0.2 0.3 2.2 2.2 1.3 2.4 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 1.2 0.8 1.0 0.8 0.0 0.0 0.0 8.7 1.1 0.6 5.7 0.0 0.0 0.7 0.0 12.2 0.0 0.7 0.0 0.1 0.0 0.0 2.8 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 14.4 5.3 3.3 16.8 4.1 0.0 9.2 0.8 0.0 0.0 12.7 0.0 2.8 4.1 4.4 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 1.5 2.2 0.0 0.6 0.0 0.0 0.0 22.7 0.0 0.0 31.5 0.0 0.2 11.7 0.0 0.0 0.0 0.2 1.0 0.9 0.0 0.0 0.2 0.0 7.5 0.0 0.0 0.5 31.7 0.0 1.7 0.0 2.1 0.0 0.0 0.0 25.1 2.2 0.0 38.8 0.8 0.7 1.2 1.6 0.0 0.0 4.1 0.5 HS1BP3 "FLJ14249, HS1-BP3" ENSG00000118960 "HCLS1 binding protein 3" Q53T59 2 20560448-20651089 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035050 Approved Approved Nucleoli,Cytosol No No 32000 Nucleoli Cytosol "HPA035050: AB_10601816" "unprognostic (4.52e-2)" "unprognostic (5.93e-2)" "unprognostic (2.67e-1)" "unprognostic (4.39e-1)" "unprognostic (4.61e-2)" "unprognostic (1.45e-3)" "prognostic unfavorable (2.97e-5)" "unprognostic (2.06e-3)" "unprognostic (1.88e-2)" "unprognostic (2.16e-1)" "unprognostic (9.53e-2)" "unprognostic (8.00e-2)" "prognostic favorable (2.30e-4)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (1.02e-1)" "unprognostic (3.20e-1)" 17.9 23.1 10.4 8.8 15.7 10.7 11.8 6.7 17.6 17.6 22.6 21.3 14.3 11.7 17.6 18.6 22.6 13.9 28.4 17.5 11.0 9.1 18.5 47.8 14.2 11.7 16.7 9.4 14.8 13.9 10.6 14.3 22.3 13.5 20.3 11.7 17.0 12.9 17.3 9.6 17.0 16.0 27.3 13.8 14.5 16.4 9.7 14.1 6.6 18.5 8.0 9.9 20.8 17.1 6.0 8.0 14.6 13.3 2.9 5.3 6.1 8.4 9.9 5.0 6.1 26.6 17.9 9.9 3.2 15.0 7.7 10.1 7.7 10.3 5.7 2.6 4.7 35.0 5.3 9.9 10.2 3.7 7.3 8.2 3.0 5.0 25.6 25.0 2.3 13.3 18.9 23.9 8.7 16.2 9.2 14.6 5.1 1.9 12.3 8.7 7.3 1.0 3.9 4.1 12.5 7.2 5.5 10.1 5.5 17.1 10.3 4.7 7.3 2.3 10.1 19.2 10.6 6.3 4.7 9.4 7.7 8.3 11.7 4.9 8.8 9.8 5.2 16.5 10.8 8.1 11.4 11.3 11.0 5.3 11.2 3.7 6.0 3.2 4.0 8.0 4.0 2.7 2.8 14.6 2.9 13.3 3.0 2.9 6.1 10.4 15.7 6.7 17.6 11.0 9.1 16.7 9.4 13.5 14.1 6.0 17.0 9.3 7.5 3.9 3.8 6.1 7.6 10.7 14.8 7.0 0.0 7.7 14.9 17.0 16.8 4.9 13.5 23.3 12.9 14.6 8.0 7.2 2.3 8.2 26.5 14.3 6.4 10.4 16.7 28.4 7.8 10.9 13.5 10.8 6.1 8.6 10.8 7.8 9.9 21.3 4.9 0.0 15.6 11.6 9.6 4.5 14.6 7.5 6.6 4.6 HSD3B1 "HSD3B, HSDB3, SDR11E1" ENSG00000203857 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1" P14060 1 119507198-119515054 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Isomerase, Multifunctional enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 231.4" "Group enriched" "Detected in some" 23 "Extravillous trophoblasts: 115.9;Syncytiotrophoblasts: 419.8" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 36.4;SuSa: 16.3" "HPA043261, HPA043264, HPA044028" Supported Approved "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" NA NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "prognostic favorable (4.59e-5)" 0.1 0.6 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 231.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.5 11.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 4.0 0.4 0.5 16.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 115.9 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 419.8 0.0 0.0 0.0 HSD3B2 SDR11E2 ENSG00000203859 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2" P26439 1 119414931-119423035 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis "Isomerase, Multifunctional enzyme, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "adrenal gland: 223.2" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 1.6;Exocrine glandular cells: 1.1;Peritubular cells: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Region enriched" "Detected in single" 198 "basal ganglia: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;SuSa: 1.9;TIME: 1.2;WM-115: 3.2" "HPA043261, HPA043264, HPA044028" Supported Uncertain "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" NA NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (3.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.80e-1)" "unprognostic (2.72e-2)" "unprognostic (8.87e-2)" "unprognostic (3.91e-2)" "unprognostic (3.43e-2)" "unprognostic (1.94e-1)" "unprognostic (6.51e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" 0.0 223.2 0.0 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.5 43.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 1.4 0.0 0.0 5.1 1.9 0.0 0.0 1.2 0.2 0.1 0.1 0.7 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 HSPB6 "FLJ32389, Hsp20, PPP1R91" ENSG00000004776 "Heat shock protein family B (small) member 6" O14558 19 35754569-35758079 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 356.8" "Group enriched" "Detected in many" 5 "Leydig cells: 251.7;Peritubular cells: 207.2;Smooth muscle cells: 65.1" "Cancer enhanced" "Detected in all" "stomach cancer: 93.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 189.0;ASC TERT1: 79.8;HHSteC: 64.1;HSkMC: 74.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB001974, HPA044153, HPA054811" Enhanced Supported "Nucleoli,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 86000 Cytosol "Nucleoli, Golgi apparatus" "CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610" "unprognostic (3.19e-2)" "unprognostic (8.07e-2)" "unprognostic (1.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.21e-3)" "unprognostic (7.02e-2)" "unprognostic (9.67e-2)" "unprognostic (7.57e-2)" "unprognostic (1.18e-1)" "unprognostic (7.23e-2)" "unprognostic (1.20e-1)" "unprognostic (7.02e-2)" "prognostic unfavorable (1.93e-5)" "unprognostic (3.32e-2)" "unprognostic (6.65e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (1.43e-6)" 95.3 39.5 3.9 18.3 8.1 1.1 40.5 1.1 6.1 49.7 48.4 3.8 18.6 5.7 42.6 57.4 24.6 33.3 80.6 132.0 4.4 2.4 6.2 3.5 8.7 7.2 5.4 2.8 53.4 5.8 1.7 1.2 12.7 8.1 42.1 8.7 18.2 8.6 35.8 356.8 2.5 14.3 128.2 10.2 1.9 32.4 22.6 4.9 0.0 11.0 153.5 16.4 121.6 23.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.2 189.0 79.8 0.1 8.4 0.1 0.5 0.9 0.1 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 64.1 0.0 0.1 74.6 0.0 1.9 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 1.8 0.0 0.1 0.2 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 8.1 1.1 6.1 4.4 2.4 5.4 2.8 8.1 4.9 3.0 1.1 0.0 0.2 1.5 7.4 26.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 19.2 2.2 0.0 0.0 0.0 2.8 35.4 0.4 0.0 0.0 4.5 0.0 0.0 28.3 0.3 14.1 251.7 2.0 1.7 1.0 0.0 30.6 0.2 0.0 207.2 0.0 2.1 25.8 65.1 2.2 1.2 1.8 4.0 0.0 0.0 0.5 HTD2 ENSG00000255154 "Hydroxyacyl-thioester dehydratase type 2" P86397 3 58306262-58318574 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Club cells: 2.3;granulocytes: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066812, HPA077228" Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA066812: AB_2685727, HPA077228: " "unprognostic (1.95e-1)" "unprognostic (3.20e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "unprognostic (2.28e-2)" "unprognostic (2.01e-1)" "unprognostic (2.56e-1)" "unprognostic (2.05e-1)" "unprognostic (9.19e-3)" "unprognostic (1.11e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "unprognostic (7.50e-2)" "unprognostic (3.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-2)" 7.9 8.9 9.0 6.6 13.9 6.9 9.4 17.0 11.5 7.4 9.2 6.4 7.1 11.3 8.6 8.5 9.4 7.8 7.1 15.9 7.9 9.3 12.1 16.2 6.9 8.2 8.5 10.7 11.0 12.9 8.8 14.2 6.7 7.8 9.6 10.1 9.7 9.2 9.4 35.2 7.2 9.7 12.6 6.0 9.7 8.6 9.8 6.4 6.8 10.7 19.8 9.2 7.8 8.1 23.9 21.6 23.7 20.4 21.3 26.5 13.5 8.2 6.3 9.6 6.8 8.2 9.2 12.3 11.7 8.9 14.6 12.9 13.7 6.2 16.3 3.5 8.4 11.7 7.2 16.0 10.6 15.0 9.1 11.2 9.8 13.9 11.5 8.9 12.8 9.3 11.3 10.9 15.5 9.4 7.8 12.7 12.1 9.6 15.5 9.1 4.8 8.3 6.5 12.4 8.4 14.2 5.8 6.1 11.7 9.8 12.1 6.0 9.0 7.2 6.8 13.3 10.6 9.1 11.4 7.4 12.4 8.8 11.2 14.3 11.9 21.3 12.7 10.0 9.5 7.5 13.5 17.3 23.7 18.7 20.4 20.1 23.9 18.7 23.5 17.5 23.8 26.5 20.2 18.4 21.3 16.7 21.6 13.4 13.5 9.0 13.9 17.0 11.5 7.9 9.3 8.5 10.7 7.8 6.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IDH3G ENSG00000067829 "Isocitrate dehydrogenase 3 (NAD(+)) gamma" P51553 X 153785766-153794523 "Citric acid cycle related proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000425, HPA002017" Supported Approved Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" "HPA000425: AB_1079097, HPA002017: AB_1079096" "unprognostic (4.24e-2)" "unprognostic (1.43e-3)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (6.57e-2)" "unprognostic (2.25e-1)" "unprognostic (4.35e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-2)" "unprognostic (1.59e-2)" "unprognostic (2.81e-2)" "unprognostic (1.96e-1)" "prognostic favorable (5.73e-6)" "unprognostic (1.50e-1)" "unprognostic (3.35e-1)" "unprognostic (2.91e-2)" "unprognostic (2.46e-1)" 24.5 34.0 27.7 26.8 47.2 37.1 24.1 37.2 61.5 25.0 28.8 25.7 24.6 34.7 26.6 21.3 31.8 29.4 25.6 50.8 35.0 25.2 40.6 29.5 20.9 25.6 27.3 35.6 31.8 40.5 29.1 24.9 22.5 40.5 21.4 25.2 26.0 34.5 29.8 54.9 36.3 34.9 24.8 20.1 26.9 24.8 16.0 23.3 31.2 24.3 37.1 28.2 24.4 21.1 20.6 45.5 43.7 44.4 23.7 28.8 33.6 29.1 26.9 15.9 22.3 24.9 20.7 19.5 15.2 21.4 27.0 28.7 22.2 22.2 37.1 26.3 24.4 22.1 21.8 24.0 20.7 9.9 12.2 30.7 13.9 36.5 17.8 28.3 19.4 29.4 23.2 15.0 20.8 22.7 17.4 20.6 15.5 7.7 20.4 21.7 40.8 22.0 22.8 7.1 27.1 35.6 19.4 13.6 32.3 30.1 18.2 20.3 13.9 9.5 32.2 15.1 6.8 13.3 16.7 18.2 17.1 10.7 25.1 35.9 28.1 7.0 47.3 28.0 24.0 18.9 42.5 43.9 43.7 21.5 44.4 19.9 19.1 22.0 20.9 45.5 20.6 17.6 19.2 16.3 23.7 43.1 27.9 28.8 33.6 27.7 47.2 37.2 61.5 35.0 25.2 27.3 35.6 40.5 23.3 32.8 32.7 56.5 52.5 71.9 33.9 48.4 43.3 30.8 7.9 48.8 27.5 80.9 175.8 81.7 113.6 44.1 164.4 46.7 79.1 82.6 56.8 36.9 91.2 33.0 116.8 17.5 59.8 43.6 88.9 226.7 49.5 66.0 64.1 101.0 81.8 37.0 65.2 122.8 55.2 192.8 37.1 51.8 69.3 14.0 17.0 67.8 92.7 54.5 93.0 43.8 IER5 ENSG00000162783 "Immediate early response 5" Q5VY09 1 181088712-181092899 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029894 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA029894: AB_10601433" "unprognostic (1.18e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "prognostic favorable (2.42e-7)" "unprognostic (1.00e-2)" "unprognostic (1.47e-1)" "unprognostic (2.63e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (2.81e-3)" "unprognostic (8.37e-2)" "unprognostic (1.46e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (2.36e-4)" "unprognostic (1.26e-2)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (1.09e-1)" 9.4 7.2 4.7 16.2 5.4 45.7 13.8 6.2 12.6 7.8 7.8 5.1 5.9 6.6 12.8 5.3 20.9 14.3 10.3 22.9 6.0 4.9 3.7 6.7 22.6 9.6 10.1 5.7 4.4 4.3 1.8 4.6 34.5 6.9 6.7 6.9 3.7 5.7 4.9 42.3 16.6 10.8 9.6 7.2 27.3 6.8 5.1 5.0 11.2 4.3 22.9 19.8 8.4 16.3 5.4 1.6 5.4 7.8 1.5 2.1 0.9 12.1 10.7 5.9 5.1 8.2 11.4 15.8 21.6 23.0 12.3 10.9 2.9 6.9 4.0 9.6 8.3 8.6 22.5 1.9 14.7 8.0 23.0 9.3 3.6 5.5 2.0 12.9 4.1 11.7 8.1 15.0 14.2 9.5 9.3 8.3 3.4 14.8 18.3 21.6 5.5 4.1 6.6 6.1 4.6 5.4 4.7 10.3 15.1 4.4 6.7 8.6 9.3 10.9 10.7 23.9 7.5 8.5 3.6 12.5 8.8 15.5 10.0 13.0 12.1 4.2 3.1 6.9 4.4 2.4 5.4 2.1 3.8 1.6 7.8 1.9 5.4 1.4 2.1 1.6 3.6 0.3 0.9 1.8 1.5 7.3 0.2 1.8 0.9 4.7 5.4 6.2 12.6 6.0 4.9 10.1 5.7 6.9 5.0 20.8 75.0 63.8 120.3 62.0 22.9 92.8 17.8 14.7 19.4 8.7 35.3 8.9 0.0 9.0 3.6 66.0 73.5 0.0 6.0 36.7 51.2 79.2 34.7 4.9 43.9 7.9 54.2 36.2 111.7 8.2 11.2 133.8 43.9 41.5 70.2 18.9 15.6 54.7 8.9 1.1 19.9 0.0 68.4 3.6 5.0 52.1 28.6 25.4 34.5 130.7 IFI16 "IFNGIP1, PYHIN2" ENSG00000163565 "Interferon gamma inducible protein 16" Q16666 1 158999968-159055155 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA002134, CAB016293" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "CAB016293: AB_627775, HPA002134: AB_1079099" "unprognostic (7.23e-3)" "unprognostic (2.20e-2)" "unprognostic (5.15e-2)" "unprognostic (7.70e-3)" "unprognostic (1.87e-1)" "unprognostic (6.08e-2)" "unprognostic (1.80e-1)" "unprognostic (5.83e-2)" "unprognostic (5.04e-2)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (7.62e-2)" "prognostic unfavorable (1.11e-16)" "unprognostic (5.07e-2)" "unprognostic (4.08e-1)" "unprognostic (7.97e-2)" "unprognostic (1.14e-1)" 64.2 21.0 10.9 42.5 18.0 10.2 34.8 6.7 11.4 28.5 18.6 9.6 7.8 7.5 32.5 21.8 32.8 25.0 33.4 24.8 16.5 7.5 13.3 10.2 32.1 51.0 19.5 6.3 32.6 5.5 3.2 7.0 21.4 18.0 23.0 15.2 10.9 33.6 11.2 14.6 23.7 21.6 29.1 32.2 63.2 11.8 14.2 16.0 81.8 19.1 24.2 41.8 30.9 27.6 28.9 20.8 51.2 21.0 27.9 24.6 16.9 7.0 0.5 2.4 0.1 17.0 56.4 0.0 15.0 40.3 42.3 56.3 0.0 9.1 41.5 12.9 9.2 13.6 20.5 0.3 15.2 16.9 12.8 0.1 10.6 3.1 0.0 31.9 3.6 0.7 53.1 27.3 21.6 30.8 20.3 44.4 36.7 0.2 30.4 23.4 0.0 48.7 3.4 6.5 0.0 5.5 23.0 15.6 47.9 5.9 2.7 1.1 0.0 19.6 0.1 42.6 10.2 0.0 4.3 25.0 10.9 5.1 30.6 6.3 28.4 13.2 39.0 31.3 12.0 26.2 2.5 21.0 0.1 18.9 20.5 16.9 27.6 18.1 19.3 20.8 28.9 11.5 14.6 51.2 27.9 18.5 15.6 24.6 16.9 10.9 18.0 6.7 11.4 16.5 7.5 19.5 6.3 18.0 16.0 35.7 66.1 149.1 95.2 84.3 0.2 6.9 22.9 58.9 119.4 40.1 0.0 3.0 1.7 32.6 4.0 196.0 5.6 0.0 40.2 1.9 91.8 23.0 129.9 2.9 175.9 0.0 11.6 126.4 165.6 4.9 108.7 168.3 79.2 49.5 16.2 31.8 42.0 24.6 49.8 4.4 0.9 84.1 124.0 2.6 1.9 59.6 2.7 201.5 21.7 108.0 IFI27L2 "FAM14A, TLH29" ENSG00000119632 "Interferon alpha inducible protein 27 like 2" Q9H2X8 14 94127779-94130253 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 57.7" "Low region specificity" "Detected in all" HPA049588 Approved Nucleoli,Cytosol "Intracellular and membrane" No No Cytosol Nucleoli "HPA049588: " "unprognostic (9.70e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-1)" "unprognostic (1.76e-1)" "unprognostic (2.45e-1)" "unprognostic (2.80e-2)" "unprognostic (7.46e-3)" "unprognostic (4.76e-2)" "unprognostic (4.69e-2)" "unprognostic (1.58e-2)" "unprognostic (4.79e-3)" "unprognostic (3.96e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (3.88e-1)" "unprognostic (5.09e-2)" "unprognostic (3.52e-2)" 11.4 39.9 38.6 18.3 23.8 17.0 18.8 15.2 24.7 19.9 16.0 23.5 8.7 11.6 15.8 9.6 24.5 21.9 20.8 38.9 29.7 32.4 13.2 3.7 16.5 21.5 37.1 22.8 25.9 13.2 11.7 20.6 5.4 27.4 10.6 9.7 20.4 7.2 12.5 4.0 16.0 13.5 15.5 35.7 17.0 15.7 9.1 22.9 13.8 8.5 16.0 22.5 12.0 17.2 31.5 29.6 19.8 38.7 6.0 30.5 31.9 8.4 5.9 1.7 12.1 8.7 22.4 1.1 15.9 16.4 12.0 14.1 1.6 3.9 3.7 17.4 17.1 10.6 10.5 1.3 21.1 4.9 25.3 0.9 5.8 5.9 0.5 14.8 6.8 16.0 20.3 7.8 7.1 4.4 20.5 7.9 14.6 0.5 57.7 12.4 15.9 3.9 4.1 2.1 5.6 6.8 0.1 5.6 4.9 18.2 3.3 3.1 4.7 0.4 0.1 10.2 3.3 19.6 11.4 7.7 8.0 4.9 10.7 4.4 23.6 19.5 1.3 25.6 15.2 5.2 19.8 38.7 7.1 25.6 25.9 16.4 31.5 24.4 28.1 29.6 27.4 17.6 23.0 5.7 6.0 18.8 24.6 30.5 31.9 38.6 23.8 15.2 22.8 29.7 32.4 37.1 22.8 27.4 22.9 35.7 60.1 82.7 48.1 82.4 19.9 126.7 48.4 18.7 11.4 169.3 19.6 1.8 150.9 127.6 5.8 62.7 86.6 0.0 26.4 2.5 85.0 7.4 88.9 2.6 167.2 22.3 95.7 122.2 166.9 22.7 169.5 141.7 224.4 80.2 146.1 108.3 55.0 123.8 108.5 51.2 76.6 122.9 100.0 4.5 24.8 58.5 2.4 89.6 75.5 44.4 ILF3 "DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1" ENSG00000129351 "Interleukin enhancer binding factor 3" Q12906 19 10654261-10692417 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001897 Supported Enhanced Nucleoplasm,Nucleoli,Mitochondria No No 1100000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA001897: AB_1078703" "unprognostic (2.39e-1)" "unprognostic (9.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (5.55e-3)" "unprognostic (1.11e-3)" "unprognostic (2.96e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (3.45e-2)" "unprognostic (1.04e-1)" "unprognostic (4.38e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (7.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.03e-1)" "unprognostic (6.20e-2)" 31.0 39.0 29.6 45.5 26.8 88.2 34.5 48.3 35.2 34.2 30.2 30.8 35.2 30.3 45.4 31.7 40.5 41.9 32.5 34.0 25.5 20.0 28.1 25.6 34.1 44.9 24.7 27.8 52.8 36.8 34.9 34.9 31.8 32.3 34.9 27.3 35.5 35.1 46.2 50.1 37.7 37.2 33.2 33.3 44.5 32.6 54.3 28.0 58.6 43.4 32.4 41.1 38.5 32.1 18.7 18.7 11.5 14.3 15.4 19.4 8.0 45.7 37.3 60.4 55.2 13.1 18.0 35.2 29.3 24.9 49.2 38.6 42.7 26.6 57.2 29.1 26.3 30.1 41.0 65.2 39.6 44.4 36.5 58.0 74.2 32.9 39.8 18.8 53.4 37.1 17.0 17.7 39.0 43.8 18.8 42.0 33.4 63.3 45.0 28.6 37.7 88.5 85.8 72.5 24.2 41.0 65.2 57.5 39.5 19.6 48.6 66.7 48.5 37.7 30.0 21.8 28.6 25.4 34.3 33.7 40.4 38.4 41.8 57.7 38.6 52.8 69.4 22.6 57.1 43.5 11.5 13.4 7.1 19.4 10.4 16.1 14.7 15.9 17.3 16.8 18.7 15.7 16.0 2.1 15.4 14.3 18.7 15.0 8.0 29.6 26.8 48.3 35.2 25.5 20.0 24.7 27.8 32.3 28.0 92.3 128.4 63.8 84.3 76.5 92.4 59.0 50.9 96.4 131.9 40.1 80.5 65.6 23.2 66.6 12.8 60.9 40.0 46.7 69.0 90.4 57.8 80.9 92.6 46.1 63.0 89.0 109.3 33.7 53.5 14.4 70.8 66.0 37.1 46.9 68.0 70.5 72.3 56.1 58.7 38.2 92.6 32.3 67.0 108.6 117.8 67.2 59.3 68.2 82.6 87.0 IMP3 "BRMS2, C15orf12, FLJ10968, MRPS4" ENSG00000177971 "IMP3, U3 small nucleolar ribonucleoprotein" Q9NV31 15 75639085-75648706 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060955, HPA061177" Enhanced Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA060955: AB_2684397, HPA061177: AB_2684445" "unprognostic (6.01e-2)" "unprognostic (5.40e-3)" "unprognostic (7.04e-2)" "unprognostic (7.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.22e-1)" "unprognostic (8.44e-2)" "unprognostic (4.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.14e-1)" "unprognostic (1.25e-1)" "unprognostic (8.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.23e-1)" "unprognostic (3.22e-2)" 21.2 28.4 21.9 23.0 24.0 18.9 34.3 20.1 28.8 19.4 31.0 15.4 17.5 27.5 14.7 24.5 35.6 20.1 25.2 21.7 21.1 19.7 28.2 49.7 21.1 28.5 17.6 19.6 23.0 29.1 12.6 17.3 16.9 16.7 23.3 19.2 17.5 28.3 25.4 37.6 29.3 31.5 11.0 15.5 28.5 25.9 12.4 13.3 33.7 30.0 37.5 27.9 19.6 21.8 40.7 34.0 23.0 31.1 33.3 47.2 48.1 20.4 23.2 11.3 19.5 20.1 11.5 16.7 17.3 13.8 14.2 16.4 17.8 18.1 24.5 18.9 9.0 15.7 34.0 37.1 28.0 12.6 18.4 44.5 25.7 19.1 30.8 14.8 26.0 17.9 10.5 23.2 11.4 14.1 10.6 9.3 20.1 33.1 20.0 12.8 24.6 20.6 63.7 30.3 20.9 24.5 22.5 13.8 26.9 19.2 27.9 19.3 19.9 14.6 25.6 31.4 17.1 22.3 24.3 10.5 18.5 14.9 13.2 23.3 27.4 50.4 27.5 20.4 42.3 12.1 18.5 31.1 23.0 42.0 23.9 45.1 40.7 40.5 40.4 33.4 38.7 47.2 44.5 4.0 33.3 23.0 34.0 38.7 48.1 21.9 24.0 20.1 28.8 21.1 19.7 17.6 19.6 16.7 13.3 35.7 34.5 89.1 67.5 203.1 22.0 11.4 66.2 52.2 52.4 38.4 13.7 88.6 122.7 81.1 1.3 74.4 52.6 23.3 93.2 83.2 66.4 58.7 46.3 101.8 81.8 20.6 42.2 68.2 45.6 4.1 56.4 60.5 92.8 116.4 61.3 53.7 92.0 59.6 41.4 158.4 20.3 25.8 71.8 14.0 43.8 207.5 45.9 74.0 84.6 70.1 IMP4 "BXDC4, MGC19606" ENSG00000136718 "IMP4, U3 small nucleolar ribonucleoprotein" Q96G21 2 130342225-130347810 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066222, HPA066673" Enhanced Nucleoli NA NA Nucleoli "HPA066222: AB_2685638, HPA066673: AB_2685701" "unprognostic (8.26e-2)" "unprognostic (5.10e-2)" "unprognostic (3.00e-1)" "unprognostic (2.55e-1)" "unprognostic (3.70e-3)" "unprognostic (2.18e-3)" "prognostic unfavorable (4.72e-4)" "unprognostic (1.33e-1)" "unprognostic (1.67e-1)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "unprognostic (1.11e-1)" "unprognostic (1.28e-2)" "unprognostic (5.08e-2)" "unprognostic (4.47e-2)" "unprognostic (1.09e-1)" "unprognostic (6.10e-2)" 19.0 15.7 13.1 19.5 15.7 17.9 14.2 6.6 25.1 9.4 12.2 11.7 9.2 15.6 11.1 7.4 20.1 9.2 12.7 30.5 11.8 10.1 13.5 29.1 10.6 22.2 14.9 12.7 9.0 36.3 2.6 7.4 10.5 15.4 9.5 3.4 7.1 26.0 12.5 52.3 10.8 15.5 12.5 8.5 11.2 16.4 9.1 13.7 8.5 12.0 10.9 11.5 17.1 9.7 34.8 31.6 7.0 26.8 26.6 25.4 26.7 19.4 17.8 0.8 15.0 2.9 3.5 13.9 11.9 5.7 8.5 8.8 38.4 12.4 52.2 18.7 5.7 8.4 11.8 1.6 12.5 0.3 11.9 13.4 16.0 5.0 32.3 15.8 15.0 11.5 5.8 7.7 15.2 6.8 1.2 8.5 12.4 17.9 16.1 2.2 36.2 11.2 6.3 13.5 9.1 23.6 15.7 6.3 26.7 3.7 13.8 9.2 10.3 9.1 27.7 9.9 0.2 10.6 10.8 9.4 16.0 15.3 16.9 24.6 16.3 20.1 43.3 12.3 9.6 22.5 2.4 25.5 7.0 25.4 26.8 22.6 34.8 22.4 21.9 29.3 30.7 22.4 22.2 2.9 26.6 25.1 31.6 21.5 26.7 13.1 15.7 6.6 25.1 11.8 10.1 14.9 12.7 15.4 13.7 14.9 22.7 67.7 56.9 94.6 23.3 49.6 61.1 13.4 33.0 41.8 3.9 56.3 86.2 67.2 18.1 38.3 44.6 23.3 95.4 82.6 49.8 54.8 46.1 77.4 68.9 15.9 52.4 25.8 29.9 46.7 28.4 45.9 74.2 73.1 42.6 14.0 74.6 45.6 24.1 115.0 21.1 25.8 72.6 26.3 45.4 96.5 41.2 37.4 60.5 76.3 INO80B "hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4" ENSG00000115274 "INO80 complex subunit B" Q9C086 2 74455023-74457960 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA070644 Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA070644: AB_2732159" "prognostic favorable (2.89e-4)" "unprognostic (2.24e-2)" "unprognostic (5.62e-2)" "unprognostic (6.59e-3)" "unprognostic (9.45e-2)" "unprognostic (3.82e-2)" "unprognostic (2.20e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-2)" "unprognostic (7.52e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (1.56e-5)" "prognostic favorable (8.44e-4)" "unprognostic (1.51e-1)" "unprognostic (3.21e-1)" "unprognostic (1.18e-3)" 18.7 22.4 31.0 20.5 33.4 21.4 22.6 31.3 48.6 23.3 16.2 15.6 24.8 24.0 28.5 23.4 22.6 26.8 21.5 19.7 39.3 20.0 20.3 22.5 18.7 22.5 19.6 32.6 39.8 31.8 36.6 32.3 14.0 38.2 25.6 16.7 15.5 32.1 37.6 28.1 39.7 18.0 20.0 49.6 19.3 22.1 28.3 25.0 21.3 30.0 15.9 24.7 20.6 23.8 4.9 6.5 6.8 5.4 4.4 3.8 1.3 12.8 14.3 3.9 5.7 8.2 13.3 11.9 12.2 9.8 8.4 7.4 9.2 14.2 22.1 15.0 8.0 8.0 13.6 3.7 8.3 8.0 20.8 14.2 16.6 6.7 8.9 8.4 16.1 7.4 12.0 14.7 12.0 14.7 22.8 10.9 11.5 9.3 7.2 7.2 15.4 18.3 21.3 2.8 8.0 19.7 10.7 15.8 20.1 10.2 9.0 7.3 15.3 6.3 16.2 5.4 5.3 5.4 5.1 9.7 6.9 12.5 14.0 8.7 28.5 22.1 8.0 15.3 9.6 7.0 3.9 5.4 2.0 2.7 3.7 3.2 4.8 2.9 1.5 3.1 4.9 2.7 2.3 6.8 4.4 2.8 6.5 3.8 1.3 31.0 33.4 31.3 48.6 39.3 20.0 19.6 32.6 38.2 25.0 0.0 2.1 4.8 2.3 24.8 13.2 0.8 2.5 9.4 4.5 3.5 11.8 3.7 0.0 13.2 1.7 3.1 6.9 0.0 23.3 3.6 3.3 1.2 5.7 8.9 4.9 12.7 4.6 4.3 7.8 5.1 2.8 5.6 5.0 16.2 7.5 4.9 15.7 3.5 2.8 6.8 15.3 0.0 8.0 4.9 2.3 27.7 4.5 6.4 5.5 1.4 INPP5J "INPP5, PIB5PA, PIPP" ENSG00000185133 "Inositol polyphosphate-5-phosphatase J" Q15735 22 31122731-31134696 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 65.2;thyroid gland: 71.2" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 33.2;Enterocytes: 31.9;Muller glia cells: 20.3" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 63.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 2.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.4" "Cell line enhanced" "Detected in many" "HL-60: 12.3;SK-BR-3: 26.8;T-47d: 16.9;U-698: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034539 Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA034539: AB_10670974" "unprognostic (1.76e-1)" "unprognostic (2.09e-1)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" "unprognostic (1.68e-1)" "unprognostic (1.19e-2)" "unprognostic (2.21e-3)" "prognostic favorable (1.47e-5)" "unprognostic (6.81e-2)" "unprognostic (1.86e-2)" "unprognostic (4.29e-4)" "unprognostic (1.47e-1)" "prognostic favorable (1.12e-7)" "unprognostic (2.79e-3)" "unprognostic (3.65e-2)" "unprognostic (2.14e-1)" "unprognostic (1.39e-2)" 0.8 0.9 4.6 0.8 6.3 0.5 3.7 27.4 13.4 1.5 6.4 0.8 16.7 7.9 1.3 0.8 1.0 1.0 1.0 9.5 7.4 2.0 9.5 0.5 1.5 0.7 2.3 4.6 0.8 5.3 65.2 3.7 0.5 5.5 3.5 2.2 5.6 15.5 19.2 1.6 1.7 21.7 1.2 0.9 0.6 3.8 1.6 1.1 0.0 71.2 0.0 0.7 1.1 0.9 0.3 2.4 0.0 0.4 0.0 0.0 0.2 1.3 1.3 0.8 1.5 0.2 0.2 0.7 0.5 0.5 2.7 2.6 0.8 0.8 0.0 0.6 0.2 0.3 1.6 1.6 0.7 1.1 0.0 4.3 0.0 5.6 0.2 0.5 12.3 0.1 0.1 0.8 2.2 0.2 1.8 0.1 0.0 1.1 1.9 0.0 4.1 0.1 0.0 1.5 1.7 0.2 0.0 0.3 2.9 1.1 1.6 6.5 4.9 1.0 26.8 0.3 0.7 16.9 1.0 0.0 0.1 4.9 0.5 0.3 0.0 2.1 11.6 0.4 0.0 2.0 0.0 0.4 0.0 0.0 0.3 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.2 4.6 6.3 27.4 13.4 7.4 2.0 2.3 4.6 5.5 1.1 0.0 2.6 0.0 2.3 0.8 7.9 4.8 0.0 0.0 1.2 33.2 0.0 0.0 10.0 1.2 0.3 0.0 31.9 0.0 1.9 0.1 0.2 3.7 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 5.0 20.3 1.0 10.5 0.0 0.6 2.3 0.0 0.3 1.7 0.9 1.1 0.1 0.0 6.8 0.9 INTS3 "C1orf60, FLJ21919, INT3, SOSS-A" ENSG00000143624 "Integrator complex subunit 3" Q68E01 1 153728067-153774808 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074391 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA Nucleoli Nucleoplasm "HPA074391: AB_2686685" "unprognostic (2.36e-1)" "unprognostic (1.94e-2)" "unprognostic (8.75e-3)" "unprognostic (6.97e-3)" "unprognostic (3.26e-1)" "unprognostic (4.48e-2)" "unprognostic (1.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "prognostic favorable (5.42e-4)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.21e-1)" "unprognostic (1.85e-1)" "unprognostic (1.18e-3)" "unprognostic (8.29e-2)" 16.2 21.9 18.8 14.4 20.0 12.0 16.3 20.7 23.1 20.4 19.9 19.5 25.1 10.0 24.4 23.7 14.3 26.7 20.5 15.3 16.0 10.6 17.9 11.1 16.6 12.6 15.9 16.4 30.8 17.5 23.6 23.6 16.5 15.6 15.9 11.4 16.1 14.0 31.0 16.2 16.9 14.7 21.2 13.4 15.4 17.6 16.5 16.0 16.2 18.6 9.2 14.1 19.9 18.8 1.8 3.8 2.7 6.2 2.7 2.5 1.5 13.2 13.9 10.1 14.5 11.5 13.0 10.3 10.1 7.3 12.1 9.8 9.7 12.6 11.5 20.3 13.3 7.2 13.5 19.3 13.0 9.9 12.1 11.3 7.2 21.2 4.6 7.8 10.7 13.0 11.7 6.5 10.4 9.5 11.0 11.6 8.6 10.1 9.4 9.3 10.8 10.0 5.7 12.4 15.3 12.9 13.6 5.7 7.4 6.2 17.4 8.0 11.7 9.6 23.2 6.4 14.7 13.4 14.5 8.5 12.0 5.2 11.8 9.1 8.4 7.7 12.7 13.1 6.6 8.3 1.3 1.8 2.0 2.1 1.4 2.5 1.3 1.3 2.0 3.8 1.8 1.4 1.5 2.7 2.7 6.2 0.8 1.3 1.5 18.8 20.0 20.7 23.1 16.0 10.6 15.9 16.4 15.6 16.0 20.8 21.4 8.8 8.7 9.3 22.5 4.0 10.2 13.4 10.3 29.6 19.6 11.5 0.0 10.1 12.1 12.6 8.1 0.0 7.1 11.7 11.9 9.9 5.7 13.6 10.7 20.6 11.6 27.0 11.8 5.9 8.9 14.3 6.8 13.6 16.1 19.3 9.6 10.8 11.3 12.4 23.9 25.8 9.0 9.3 13.0 8.9 8.6 7.7 12.2 11.2 IPCEF1 "KIAA0403, PIP3-E" ENSG00000074706 "Interaction protein for cytohesin exchange factors 1" Q8WWN9 6 154154496-154356792 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9" "Cell type enhanced" "Detected in many" 17 "Kupffer cells: 14.6;Macrophages: 9.5;T-cells: 30.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HMC-1: 19.7;THP-1: 10.0;U-937: 10.5" "HPA028708, HPA028710" Enhanced Approved "Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies" NA NA "Nuclear speckles, Plasma membrane" "Nucleoli, Cytoplasmic bodies" "HPA028708: AB_10601916, HPA028710: AB_2732442" "unprognostic (1.23e-2)" "unprognostic (8.93e-3)" "unprognostic (4.18e-2)" "unprognostic (5.63e-3)" "unprognostic (2.05e-1)" "unprognostic (6.55e-3)" "unprognostic (1.30e-3)" "unprognostic (2.57e-2)" "unprognostic (3.87e-1)" "unprognostic (5.84e-2)" "unprognostic (3.27e-2)" "unprognostic (4.87e-2)" "unprognostic (5.01e-2)" "unprognostic (8.64e-2)" "unprognostic (5.45e-2)" "unprognostic (1.42e-2)" "unprognostic (1.51e-4)" 1.3 0.7 5.3 6.9 12.9 15.2 1.9 20.0 26.4 3.4 1.6 5.5 0.0 1.1 1.7 1.8 1.9 2.5 3.2 1.0 3.8 4.6 3.4 2.4 2.0 12.4 3.9 14.1 1.3 1.4 0.4 1.3 2.0 5.5 1.3 1.6 0.0 1.4 0.8 0.7 1.2 2.9 1.3 4.2 6.4 2.6 1.5 4.9 10.0 36.9 0.0 11.7 2.4 1.1 0.0 7.1 30.1 6.3 6.0 13.5 5.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 19.7 0.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 2.8 1.1 1.0 0.0 0.5 0.2 0.2 0.5 1.0 2.1 0.3 0.4 0.0 0.1 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.5 0.0 1.4 6.3 30.1 6.1 2.8 13.1 0.0 7.7 5.8 7.1 0.0 13.5 7.9 19.3 6.0 3.4 0.2 9.9 5.3 5.3 12.9 20.0 26.4 3.8 4.6 3.9 14.1 5.5 4.9 0.0 1.7 0.5 0.4 0.6 0.0 0.9 0.0 1.4 2.3 1.8 0.0 1.4 6.6 0.9 0.7 1.4 0.0 0.0 0.0 0.1 0.8 0.4 0.0 0.8 2.2 3.2 0.0 2.5 14.6 0.0 0.3 9.5 0.0 0.0 0.3 0.3 0.0 0.0 0.4 1.2 0.1 0.0 0.4 0.2 0.1 0.5 2.3 30.5 0.2 1.2 IQSEC1 "ARF-GEP100, BRAG2, GEP100, KIAA0763" ENSG00000144711 "IQ motif and Sec7 domain 1" Q6DN90 3 12897220-13073117 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 163.4;Cone photoreceptor cells: 182.6;Horizontal cells: 222.5;Rod photoreceptor cells: 119.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 34.9;U-266/84: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038143, HPA038144" Uncertain Supported "Nucleoli,Nucleoli rim,Vesicles" NA NA "Nucleoli, Nucleoli rim, Vesicles" "HPA038143: AB_10697241, HPA038144: AB_2675860" "prognostic unfavorable (3.03e-5)" "unprognostic (1.80e-1)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (8.19e-3)" "unprognostic (2.64e-3)" "unprognostic (5.60e-2)" "unprognostic (1.67e-1)" "unprognostic (3.00e-1)" "unprognostic (1.14e-2)" "prognostic favorable (9.07e-4)" "unprognostic (4.42e-1)" "prognostic favorable (3.58e-6)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (1.00e-3)" "unprognostic (4.65e-2)" 17.8 14.1 27.8 12.3 27.0 32.5 7.1 31.9 41.5 9.5 6.7 18.5 3.5 4.8 8.0 4.7 6.1 8.5 7.4 16.0 25.0 17.8 7.0 11.5 12.4 14.8 16.4 24.8 12.3 13.0 25.7 7.8 13.4 36.7 11.6 4.8 17.0 9.3 10.0 21.0 6.2 7.7 8.4 10.6 20.6 6.9 5.6 15.5 2.6 6.3 4.3 14.0 7.8 5.9 6.2 6.8 12.9 4.0 1.8 3.6 2.3 5.0 6.9 6.2 7.0 5.2 7.2 34.9 5.7 4.7 3.8 2.9 4.7 4.5 10.7 6.6 10.7 4.2 2.8 4.7 3.0 2.8 7.2 9.9 6.3 4.1 20.0 5.7 0.1 2.7 7.1 5.5 7.8 4.4 5.2 3.5 4.4 17.9 11.4 2.6 16.2 4.0 6.8 6.5 4.0 14.1 5.4 2.0 15.4 2.2 6.6 5.4 9.9 4.1 14.4 3.3 5.6 6.1 4.4 9.4 4.2 10.6 3.5 0.7 22.8 31.2 4.2 7.9 3.2 3.3 5.0 3.8 4.8 3.6 4.0 2.7 6.2 2.4 2.7 1.9 6.1 2.4 3.0 12.9 1.8 3.9 6.8 1.7 2.3 27.8 27.0 31.9 41.5 25.0 17.8 16.4 24.8 36.7 15.5 3.0 22.7 41.9 6.8 10.2 106.3 163.4 28.1 12.0 7.9 3.5 182.6 7.8 6.6 5.7 2.1 20.1 2.0 23.3 11.1 36.0 17.8 15.7 14.0 38.5 19.4 222.5 9.8 28.3 52.6 3.4 15.5 24.7 6.8 3.6 13.6 16.7 7.9 0.0 21.2 4.7 119.9 25.8 33.0 1.8 1.5 6.8 18.2 16.2 7.6 10.7 IRAK4 NY-REN-64 ENSG00000198001 "Interleukin 1 receptor associated kinase 4" Q9NWZ3 12 43758944-43789543 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016685, CAB022077" Uncertain Approved Nucleoli,Microtubules,Cytosol NA NA Microtubules "Nucleoli, Cytosol" "CAB016685: AB_1618505, CAB022077: " "unprognostic (2.76e-2)" "unprognostic (5.63e-2)" "unprognostic (1.47e-2)" "prognostic favorable (3.46e-5)" "unprognostic (6.15e-2)" "unprognostic (3.50e-3)" "unprognostic (1.44e-2)" "unprognostic (8.49e-2)" "unprognostic (6.44e-3)" "unprognostic (7.50e-2)" "unprognostic (4.00e-3)" "unprognostic (6.29e-2)" "unprognostic (4.52e-2)" "unprognostic (2.95e-1)" "unprognostic (2.31e-1)" "unprognostic (1.84e-1)" "prognostic favorable (4.42e-5)" 18.0 9.4 5.1 15.0 10.4 10.3 11.3 3.7 6.0 10.3 12.2 9.1 12.5 10.2 13.0 14.1 15.0 9.4 10.8 7.6 6.7 5.2 13.3 11.8 12.0 24.0 13.2 3.9 9.3 20.1 9.1 16.1 14.0 9.8 10.5 10.0 11.9 11.9 15.1 4.1 15.2 15.0 11.8 13.0 25.0 12.3 7.1 11.7 30.3 17.0 7.7 18.9 11.1 10.7 5.1 5.8 16.9 6.0 8.8 7.7 4.7 5.3 4.0 2.8 3.7 10.2 17.2 4.0 7.6 5.4 6.0 5.5 3.4 5.2 9.2 7.5 6.3 4.0 4.4 3.1 4.9 8.7 13.2 2.9 8.8 3.1 2.1 5.8 12.1 10.8 9.1 7.8 7.6 4.5 10.6 8.9 9.0 8.1 6.9 16.6 2.9 10.5 6.8 1.0 0.0 4.7 7.0 3.4 4.8 4.7 5.1 2.0 2.0 3.7 4.7 3.6 4.0 5.9 10.8 7.9 7.4 1.4 9.1 5.2 8.4 10.9 8.0 7.7 32.7 4.1 16.9 4.6 9.4 7.4 5.4 7.7 4.0 6.1 6.3 4.5 5.1 5.5 5.9 9.3 8.8 6.0 5.8 7.5 4.7 5.1 10.4 3.7 6.0 6.7 5.2 13.2 3.9 9.8 11.7 17.9 17.0 15.7 9.4 9.6 5.7 4.1 22.9 6.7 10.3 31.4 19.6 12.5 18.3 10.9 12.6 12.4 13.8 0.0 15.4 7.3 9.3 8.1 20.9 7.3 15.2 7.9 3.5 12.9 29.8 16.3 11.5 22.9 10.1 18.0 9.3 9.1 12.5 5.8 10.6 11.3 25.0 6.5 8.6 27.0 12.6 10.3 23.3 41.5 7.8 11.2 IRX2 ENSG00000170561 "Iroquois homeobox 2" Q9BZI1 5 2745845-2751662 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 101.3;Alveolar cells type 2: 59.1;Basal keratinocytes: 179.6;Suprabasal keratinocytes: 114.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "pons and medulla: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 40.5;BEWO: 24.3;HaCaT: 13.8;hTCEpi: 26.6;SK-BR-3: 16.3" "Group enriched" "Detected in many" 5 "midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3" "Low region specificity" "Detected in all" "HPA050895, HPA054669" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA050895: AB_2616458, HPA054669: AB_2682566" "unprognostic (9.79e-2)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (5.50e-3)" "unprognostic (8.12e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-1)" "unprognostic (7.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.07e-1)" "prognostic favorable (8.84e-4)" "unprognostic (2.62e-2)" "unprognostic (3.98e-7)" "unprognostic (4.40e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (8.97e-2)" 2.4 0.1 0.8 0.1 2.8 0.1 27.9 8.4 1.7 0.4 0.7 0.7 4.4 0.1 0.1 2.5 3.1 0.2 0.1 2.1 1.9 1.7 14.3 0.1 32.8 0.3 3.9 0.2 0.1 1.9 2.7 1.4 9.0 36.9 3.9 0.3 1.8 26.6 1.4 0.3 17.7 0.1 0.1 4.8 0.1 8.7 3.1 2.2 0.0 1.4 3.1 3.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 40.5 0.0 2.2 1.6 24.3 2.4 1.3 2.0 1.6 4.8 0.0 0.0 0.0 4.5 0.0 13.8 0.0 9.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 26.6 0.9 8.2 0.0 0.0 0.0 0.0 0.0 1.4 7.8 0.0 0.0 4.5 10.5 0.0 0.0 2.5 0.0 9.0 0.0 1.5 0.0 7.9 16.3 0.0 6.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.8 8.4 0.5 1.9 1.7 3.9 0.2 36.9 2.2 101.3 59.1 0.0 14.0 179.6 0.5 2.4 0.0 10.7 30.7 7.0 0.0 23.0 23.2 0.1 3.9 0.5 0.5 0.0 0.0 17.1 12.8 15.9 1.1 0.0 2.8 0.0 0.0 0.0 0.0 8.9 0.0 1.3 18.6 0.0 1.5 0.2 0.5 1.9 0.0 0.5 2.4 0.0 16.9 0.7 3.8 114.7 12.7 0.0 1.9 9.2 JADE3 "JADE-3, KIAA0215, PHF16" ENSG00000102221 "Jade family PHD finger 3" Q92613 X 46912276-47061242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatogonia: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 4.8;naive B-cell: 3.7;plasmacytoid DC: 1.7" "Group enriched" "Detected in many" 9 "B-cells: 4.8;dendritic cells: 1.7" "Cell line enhanced" "Detected in many" "BEWO: 36.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA006007, HPA064697" Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA006007: AB_1079605, HPA064697: AB_2685326" "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" "unprognostic (2.24e-1)" "unprognostic (1.52e-3)" "unprognostic (1.18e-2)" "unprognostic (3.01e-2)" "unprognostic (1.05e-3)" "unprognostic (1.59e-1)" "unprognostic (6.83e-3)" "unprognostic (4.55e-2)" "unprognostic (8.97e-3)" "unprognostic (2.82e-1)" "unprognostic (4.25e-2)" "unprognostic (4.42e-2)" "unprognostic (2.69e-1)" "unprognostic (8.18e-2)" "unprognostic (9.70e-2)" 4.9 12.6 3.5 2.7 5.1 1.5 6.2 3.3 4.9 5.7 4.5 7.1 14.0 1.9 9.5 16.3 4.7 4.3 3.2 5.2 3.9 3.3 3.7 7.7 4.3 4.1 9.2 1.4 7.2 8.7 3.0 2.1 15.9 4.7 5.4 3.2 2.1 4.3 12.2 3.3 3.8 3.5 6.0 8.5 9.8 4.7 14.5 8.4 8.4 4.2 1.4 7.5 7.6 13.1 4.8 1.7 0.0 0.3 0.2 0.2 0.4 6.4 5.8 9.5 6.5 3.5 2.6 36.4 3.8 3.2 4.3 4.9 6.6 5.6 0.0 2.7 2.8 6.4 2.5 11.5 3.1 6.3 17.1 7.5 5.1 6.5 6.4 5.7 3.8 2.7 2.0 4.3 3.0 9.9 2.6 8.1 9.8 3.5 3.0 3.3 6.6 13.8 4.6 7.4 4.1 4.9 14.2 10.7 8.9 3.6 5.9 8.2 7.3 11.0 10.2 6.0 16.4 6.8 4.0 5.0 4.6 8.0 6.4 2.5 2.3 2.0 12.2 1.2 3.3 4.4 0.0 0.1 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.1 3.7 0.0 0.0 0.0 0.2 0.3 1.7 0.0 0.4 3.5 5.1 3.3 4.9 3.9 3.3 9.2 1.4 4.7 8.4 0.0 8.5 0.5 2.3 3.8 1.5 3.3 2.5 0.0 1.2 5.2 0.0 7.9 0.0 2.1 0.3 4.5 0.9 0.0 3.2 8.1 2.2 3.8 0.0 11.1 1.5 0.0 8.1 3.7 1.2 2.0 4.4 0.8 3.3 4.6 1.9 1.2 2.9 0.0 3.5 2.1 1.6 6.5 1.9 9.2 26.6 7.0 11.9 0.5 2.3 3.3 JPT1 "ARM2, HN1, HN1A" ENSG00000189159 "Jupiter microtubule associated homolog 1" Q9UK76 17 75135248-75168281 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 109.4;testis: 101.3" "Cell type enhanced" "Detected in many" 13 "Ductal cells: 365.7;Exocrine glandular cells: 382.5;Extravillous trophoblasts: 1210.3;monocytes: 655.6;Pancreatic endocrine cells: 967.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 109.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059729 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA Nucleoplasm "Nuclear membrane, Nucleoli" "HPA059729: AB_2684114" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-3)" "unprognostic (3.57e-3)" "unprognostic (6.71e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (1.58e-7)" "unprognostic (3.58e-2)" "unprognostic (1.37e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.25e-3)" "unprognostic (8.24e-2)" "prognostic unfavorable (1.77e-7)" "unprognostic (1.83e-1)" "unprognostic (8.99e-2)" "unprognostic (4.84e-2)" "unprognostic (1.51e-1)" 8.0 18.5 15.6 25.9 22.2 23.0 8.1 30.7 25.4 9.4 43.3 4.6 7.7 37.5 6.1 5.4 52.8 4.3 23.7 6.1 17.9 19.6 15.5 12.8 13.9 26.3 11.1 15.0 5.6 6.5 1.2 6.6 29.2 13.7 7.0 23.7 3.3 15.9 17.6 23.7 9.3 51.3 7.3 8.3 26.2 42.5 101.3 4.9 32.6 5.8 28.9 28.7 17.9 17.0 15.4 14.5 109.4 28.4 10.2 28.7 14.6 92.5 92.3 48.6 48.2 10.3 10.6 38.8 48.7 14.5 47.9 36.9 75.5 55.6 26.1 31.3 39.0 50.4 55.4 45.3 60.7 36.2 26.0 57.0 41.9 36.7 74.7 24.2 31.4 40.5 16.2 29.1 39.0 40.1 14.1 87.1 49.7 23.6 53.7 43.8 67.0 100.7 30.7 28.3 76.6 121.7 64.4 58.0 40.4 51.2 58.2 60.4 49.1 69.8 37.0 25.9 53.6 99.1 19.3 50.1 27.5 77.6 38.5 56.6 21.0 33.9 39.0 23.9 29.5 31.3 27.5 18.5 51.6 12.4 26.6 8.9 15.4 17.2 14.9 14.5 8.0 8.2 12.0 109.4 10.2 28.4 9.6 28.7 14.6 15.6 22.2 30.7 25.4 17.9 19.6 11.1 15.0 13.7 4.9 23.8 17.8 0.0 0.0 0.0 0.0 0.0 0.0 30.8 33.0 233.8 0.0 95.9 84.6 365.7 0.0 0.0 0.0 0.0 382.5 1210.3 0.0 0.0 7.0 0.0 299.4 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 655.6 0.0 0.0 967.6 0.0 0.0 121.9 0.0 0.0 0.0 0.0 0.0 0.0 81.0 0.0 0.0 0.0 JRK "jerky, JH8" ENSG00000234616 "Jrk helix-turn-helix protein" 8 142657460-142681968 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3;Spermatogonia: 21.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052675 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" No No "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA052675: AB_2681910" "unprognostic (3.65e-2)" "unprognostic (5.30e-2)" "unprognostic (9.67e-2)" "unprognostic (3.90e-3)" "unprognostic (1.27e-1)" "unprognostic (1.84e-2)" "unprognostic (6.58e-6)" "unprognostic (1.05e-1)" "unprognostic (3.87e-1)" "unprognostic (6.90e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (7.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.53e-1)" "unprognostic (1.22e-2)" "unprognostic (1.69e-2)" 2.6 3.3 6.4 4.0 6.5 1.6 3.7 11.1 7.1 2.8 2.8 6.1 6.8 2.9 5.4 3.6 3.1 4.7 2.6 3.7 4.4 2.9 0.7 2.6 5.3 5.2 5.2 9.6 4.6 5.6 4.4 3.0 4.3 4.5 2.8 5.4 4.1 4.5 6.2 6.5 3.2 4.9 3.5 4.8 4.3 6.1 5.3 4.3 4.2 2.6 6.1 2.6 7.9 4.5 2.3 3.3 2.3 2.0 4.4 1.2 5.5 6.0 7.0 5.7 6.8 10.0 4.4 8.6 3.6 10.6 6.1 5.3 11.5 9.5 3.7 7.1 7.3 7.5 6.2 5.3 5.4 7.2 10.5 9.5 19.0 6.2 2.8 7.3 6.7 6.4 4.7 6.7 3.9 5.3 5.9 11.2 10.1 4.2 8.9 9.5 8.4 4.1 6.0 3.9 8.5 11.1 4.4 5.3 3.7 9.5 12.9 8.6 15.8 6.5 3.7 4.6 6.4 4.6 7.0 8.3 17.7 8.1 4.7 5.6 6.2 5.6 6.2 9.2 7.9 3.3 2.3 2.9 3.1 1.6 1.8 1.4 3.5 3.1 2.3 4.5 4.4 3.5 2.5 2.0 0.8 2.2 2.0 1.2 6.0 0.6 5.1 1.9 0.0 12.9 9.6 7.6 1.4 1.2 7.0 19.6 3.6 3.3 2.7 1.3 6.2 2.3 23.3 2.2 2.1 1.1 3.6 1.1 2.4 2.6 9.5 8.7 10.4 5.6 1.1 10.6 1.9 0.0 1.8 3.1 5.4 4.1 0.0 11.0 2.4 10.2 0.0 1.4 9.8 21.3 0.0 1.8 0.0 4.5 4.1 KAT6A "MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220" ENSG00000083168 "Lysine acetyltransferase 6A" Q92794 8 41929479-42051990 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017023, HPA063266, HPA065052" Supported Approved "Nucleoli,Nuclear speckles,Cytosol" NA NA "Nuclear speckles" "Nucleoli, Cytosol" "CAB017023: , HPA063266: AB_2684973, HPA065052: AB_2685414" "unprognostic (3.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (3.23e-2)" "unprognostic (2.28e-1)" "unprognostic (9.27e-3)" "unprognostic (3.61e-1)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.50e-1)" "unprognostic (4.45e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (8.58e-2)" "unprognostic (2.95e-2)" 20.8 10.9 15.3 19.8 20.3 36.8 22.6 29.9 18.7 19.7 14.6 19.4 14.4 10.7 20.6 12.1 16.9 16.5 14.3 13.0 15.5 11.5 12.3 13.6 26.9 28.2 23.2 10.3 27.2 13.1 26.8 22.3 20.9 15.7 14.1 12.0 12.8 15.1 17.0 21.0 25.5 18.0 25.0 22.9 20.4 14.0 14.1 21.7 30.4 17.9 14.3 20.1 16.9 24.2 4.7 1.8 10.9 1.6 3.1 3.9 1.4 13.1 10.8 17.8 11.3 10.0 11.4 6.0 8.8 11.5 10.9 8.5 6.8 6.3 19.5 8.9 8.7 10.6 8.5 13.8 8.4 13.0 10.0 8.1 28.1 6.7 5.1 7.5 14.8 12.9 9.5 9.6 10.1 12.6 8.0 10.5 17.3 23.5 12.4 10.0 5.8 30.0 4.7 6.8 9.9 4.3 24.0 19.9 6.2 5.4 15.1 11.1 9.5 10.3 6.9 7.1 8.4 15.9 6.5 12.2 13.5 9.6 12.0 9.4 10.1 16.4 21.2 7.3 6.7 11.6 3.5 1.6 2.8 3.5 1.2 3.9 2.4 2.6 3.3 1.0 4.7 3.6 2.9 10.9 3.1 1.2 1.8 3.5 1.4 15.3 20.3 29.9 18.7 15.5 11.5 23.2 10.3 15.7 21.7 32.8 30.4 27.2 23.8 44.8 44.6 22.6 25.5 21.4 30.7 12.2 51.1 12.1 3.3 11.8 1.8 50.4 18.7 46.7 10.4 13.1 28.5 21.6 33.6 22.2 14.6 55.6 23.7 43.0 37.4 3.5 26.2 31.3 21.9 8.2 25.7 32.4 13.2 17.5 21.5 9.3 45.4 19.4 33.9 41.9 36.2 53.4 17.6 45.8 18.9 26.1 KCNB2 Kv2.2 ENSG00000182674 "Potassium voltage-gated channel subfamily B member 2" Q92953 8 72537391-72938349 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2" "Cell type enriched" "Detected in some" 15 "Cone photoreceptor cells: 249.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 3.2;HDLM-2: 3.1;HEK 293: 7.6;SCLC-21H: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065970 Approved "Nucleoli,Plasma membrane,Midbody" Yes NA "Plasma membrane" "Nucleoli, Midbody" "HPA065970: AB_2685591" "unprognostic (9.87e-3)" "unprognostic (1.71e-1)" "unprognostic (7.57e-2)" "unprognostic (1.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (2.72e-1)" "unprognostic (6.93e-5)" "unprognostic (5.53e-3)" "unprognostic (3.30e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-2)" "unprognostic (3.26e-1)" 0.8 1.9 3.8 0.6 5.3 0.4 0.7 0.3 9.7 0.5 0.7 0.0 0.0 1.2 0.4 0.4 1.1 2.1 0.5 0.4 7.1 3.1 0.5 0.4 0.6 0.5 0.9 7.8 0.4 2.4 0.4 9.2 0.5 3.2 0.7 0.7 4.2 0.5 0.5 0.4 0.4 1.6 0.5 1.6 8.6 2.4 1.7 0.4 0.9 0.4 0.0 0.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 5.3 0.3 9.7 7.1 3.1 0.9 7.8 3.2 0.4 0.0 0.0 0.0 0.0 0.0 12.9 0.2 0.0 0.0 0.0 1.8 249.4 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 17.1 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.4 0.0 2.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 KCNC4 "C1orf30, HKSHIIIC, Kv3.4" ENSG00000116396 "Potassium voltage-gated channel subfamily C member 4" Q03721 1 110211343-110283100 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 39.3;Ito cells: 63.3;Rod photoreceptor cells: 44.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 16.5;U-87 MG: 14.7;WM-115: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014740 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA014740: AB_1855580" "unprognostic (9.16e-2)" "unprognostic (1.92e-3)" "unprognostic (2.06e-2)" "unprognostic (3.72e-1)" "unprognostic (4.12e-2)" "unprognostic (6.13e-2)" "unprognostic (2.33e-2)" "unprognostic (2.68e-1)" "unprognostic (7.48e-2)" "unprognostic (2.03e-1)" "unprognostic (4.26e-2)" "unprognostic (1.26e-1)" "unprognostic (3.04e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-1)" "unprognostic (1.83e-1)" "unprognostic (1.25e-2)" 2.3 4.7 12.1 1.6 3.2 0.7 3.3 9.2 12.7 1.9 1.4 1.9 1.1 0.8 4.5 3.1 2.1 3.7 4.8 4.5 9.1 14.2 5.1 1.1 3.0 1.9 6.8 2.0 3.4 4.3 11.2 3.8 2.8 14.3 2.4 1.3 4.7 7.1 3.7 4.5 4.0 2.0 2.6 3.6 3.3 2.8 2.2 1.1 7.2 2.3 7.8 2.3 1.2 1.5 0.8 0.7 0.9 0.4 0.3 1.5 0.1 1.9 1.5 0.4 2.9 1.1 0.3 3.5 8.5 1.5 0.6 0.8 4.8 0.9 3.3 3.4 3.1 2.6 3.2 1.4 0.7 0.4 16.5 1.6 0.1 3.3 0.7 0.5 2.7 0.8 0.3 0.3 1.9 0.2 0.5 4.4 1.8 0.6 1.4 0.0 0.4 1.8 0.6 1.7 0.7 3.9 2.7 0.1 0.5 4.1 0.1 0.6 0.8 0.4 8.3 0.8 2.7 1.1 1.4 1.6 1.1 4.0 0.7 0.3 2.1 1.9 0.6 14.7 2.3 9.5 0.8 0.4 0.2 0.5 0.2 1.5 0.6 0.9 0.4 0.0 0.8 1.3 0.5 0.9 0.3 0.3 0.7 0.4 0.1 12.1 3.2 9.2 12.7 9.1 14.2 6.8 2.0 14.3 1.1 0.0 1.4 0.0 12.5 2.9 1.4 6.7 7.6 4.0 2.3 3.5 39.3 0.3 0.0 5.0 0.3 9.8 2.2 0.0 14.8 0.3 2.4 7.4 1.1 0.5 1.2 3.2 12.7 63.3 3.1 0.4 1.4 0.5 1.7 1.8 5.7 3.7 8.7 6.6 3.9 0.5 44.8 25.8 5.1 0.0 5.7 2.6 0.9 1.3 8.3 10.3 KCNJ14 "IRK4, Kir2.4" ENSG00000182324 "Potassium voltage-gated channel subfamily J member 14" Q9UNX9 19 48455509-48466980 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 22.9" "Cell type enriched" "Detected in many" 8 "Rod photoreceptor cells: 311.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071765 Approved Nucleoli NA NA Nucleoli "HPA071765: AB_2686444" "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (1.33e-5)" "unprognostic (5.77e-2)" "unprognostic (9.41e-2)" "unprognostic (5.26e-2)" "unprognostic (7.05e-4)" "unprognostic (7.83e-4)" "unprognostic (1.26e-1)" "unprognostic (6.48e-2)" "unprognostic (4.43e-3)" "unprognostic (4.92e-2)" "unprognostic (5.02e-6)" "unprognostic (1.47e-1)" "unprognostic (4.98e-2)" "unprognostic (6.82e-3)" "unprognostic (4.41e-2)" 1.0 0.4 1.1 0.9 6.1 4.9 1.8 2.3 2.2 0.9 0.9 0.9 0.9 0.6 0.9 1.8 1.5 1.1 1.0 0.9 1.4 1.3 0.9 0.9 0.9 1.2 1.2 0.9 1.3 1.4 1.0 1.0 1.4 1.4 1.5 0.7 22.9 0.9 0.9 3.3 4.9 0.9 0.9 0.9 0.9 0.6 2.8 0.9 0.9 1.6 0.9 0.9 0.9 1.1 1.5 0.8 3.5 0.8 0.6 1.0 0.2 1.6 3.8 0.8 2.5 1.7 1.7 2.6 0.6 0.3 0.8 1.3 3.9 2.2 1.8 0.8 0.6 2.0 5.5 1.2 0.6 2.1 1.3 2.0 1.1 2.2 1.0 1.0 1.6 3.2 1.6 2.8 2.0 2.3 1.1 0.5 1.7 1.8 2.0 0.5 2.4 0.6 12.4 1.4 2.0 2.2 2.6 1.5 0.4 0.6 4.6 1.4 1.7 1.8 2.6 1.4 1.5 1.8 1.3 1.1 2.7 3.6 2.7 3.0 2.1 3.1 1.3 0.7 4.0 2.8 3.5 0.8 0.6 0.6 0.6 0.5 1.2 0.7 1.0 0.4 1.5 0.8 1.0 2.9 0.6 0.3 0.8 0.6 0.2 1.1 6.1 2.3 2.0 1.4 1.3 1.2 0.9 1.4 0.9 0.0 4.3 0.0 3.7 3.9 15.0 0.4 2.5 1.4 0.0 1.8 39.3 1.3 0.0 0.8 4.1 1.0 0.4 0.0 0.9 2.1 0.8 2.5 0.0 0.5 0.5 14.3 0.0 0.6 0.0 0.0 1.1 0.2 0.0 0.0 1.2 17.5 2.1 0.0 0.4 0.0 311.1 0.0 0.9 3.4 2.7 4.6 0.8 0.0 1.7 2.1 KCTD1 C18orf5 ENSG00000134504 "Potassium channel tetramerization domain containing 1" Q719H9 18 26454910-26657401 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 35.9;HaCaT: 37.3;hTCEpi: 33.7;RPTEC TERT1: 32.8" "HPA057808, HPA062486" Approved "Nucleoplasm,Nucleoli,Cytokinetic bridge,Centriolar satellite" NA NA Nucleoplasm "Nucleoli, Cytokinetic bridge, Centriolar satellite" "HPA057808: , HPA062486: " "unprognostic (1.15e-3)" "unprognostic (5.66e-2)" "unprognostic (2.35e-4)" "prognostic unfavorable (2.22e-4)" "unprognostic (3.65e-3)" "unprognostic (7.43e-2)" "unprognostic (2.03e-3)" "unprognostic (6.77e-2)" "unprognostic (2.74e-1)" "unprognostic (1.88e-3)" "unprognostic (5.68e-3)" "unprognostic (1.77e-2)" "prognostic favorable (4.60e-8)" "unprognostic (3.87e-3)" "unprognostic (7.39e-2)" "unprognostic (1.50e-1)" "unprognostic (8.02e-2)" 3.9 11.8 15.9 2.1 37.3 0.7 22.2 13.7 29.0 12.6 5.0 6.9 6.2 3.2 10.0 15.8 32.8 33.8 5.8 12.9 16.7 6.7 20.1 2.6 4.0 2.0 6.6 18.4 11.1 5.2 7.4 6.1 17.2 6.8 15.3 7.3 8.4 12.5 16.4 2.8 39.3 2.2 8.7 6.0 2.9 7.0 4.1 10.7 5.7 13.6 20.1 11.7 8.5 18.3 0.3 0.7 0.7 0.3 0.0 1.8 0.2 5.5 19.1 35.9 3.8 21.1 3.4 4.6 4.6 7.0 7.4 7.4 1.8 6.4 1.1 17.9 9.8 6.1 37.3 6.8 10.1 7.0 1.0 3.3 1.2 4.2 3.0 4.0 0.6 1.8 5.7 33.7 2.1 14.0 9.5 7.0 8.2 0.4 0.5 5.2 7.9 5.5 1.7 3.6 18.4 8.8 2.9 2.1 0.8 32.8 8.2 3.7 14.2 6.8 9.2 3.1 21.6 8.4 1.5 3.8 8.3 2.6 1.6 5.1 1.7 1.4 0.1 3.1 3.7 12.3 0.0 0.1 0.7 0.8 0.1 1.6 0.0 1.8 0.6 0.7 0.3 0.7 0.5 0.0 0.0 0.3 0.3 0.0 0.2 15.9 37.3 13.7 29.0 16.7 6.7 6.6 18.4 6.8 10.7 3.0 2.6 0.0 39.9 28.2 3.9 10.1 5.1 29.4 14.8 24.4 7.9 41.6 99.5 7.7 26.4 2.4 1.3 0.0 3.2 5.2 2.6 13.8 0.0 1.8 3.9 20.6 1.2 2.5 1.0 6.7 4.9 1.0 21.9 0.0 4.3 19.5 8.6 0.0 2.8 6.8 6.3 0.0 3.1 1.9 3.7 38.9 27.8 0.0 4.7 35.3 KCTD6 "KCASH3, MGC27385" ENSG00000168301 "Potassium channel tetramerization domain containing 6" Q8NC69 3 58492114-58502360 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036100, HPA036101" Uncertain Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA036100: AB_10673230, HPA036101: AB_2674941" "unprognostic (8.63e-3)" "unprognostic (1.28e-2)" "unprognostic (3.37e-2)" "unprognostic (5.71e-2)" "unprognostic (9.00e-3)" "unprognostic (2.45e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (3.19e-2)" "unprognostic (1.81e-1)" "unprognostic (4.67e-3)" "unprognostic (9.36e-3)" "unprognostic (7.48e-2)" "prognostic favorable (8.63e-4)" "unprognostic (1.56e-2)" "unprognostic (1.71e-1)" "unprognostic (3.48e-1)" "unprognostic (2.44e-2)" 7.8 8.4 15.3 4.4 13.2 13.5 11.4 35.9 21.8 11.1 7.9 10.0 6.4 5.6 12.3 28.8 10.9 12.4 8.8 7.7 16.9 11.7 15.4 12.2 6.6 9.1 15.3 10.5 13.1 7.1 10.4 14.4 10.9 11.9 9.2 8.1 14.7 7.3 9.4 6.8 7.5 5.3 11.2 12.5 8.8 5.7 5.7 12.4 6.3 14.1 6.3 7.3 6.4 11.9 13.0 20.2 17.1 14.6 8.2 15.6 6.6 5.5 5.3 15.9 6.8 14.0 10.0 5.9 6.7 6.0 9.9 11.7 5.1 3.1 11.0 2.2 4.8 11.7 3.0 12.8 3.9 8.9 11.3 5.8 5.1 12.1 6.3 6.6 4.0 4.1 6.0 6.2 7.9 5.0 23.6 6.5 3.9 2.8 5.3 8.6 5.2 5.9 6.1 11.7 5.0 10.1 5.9 4.4 7.7 9.4 2.6 9.0 7.8 3.8 8.8 4.8 12.7 35.4 2.9 3.5 9.1 8.2 11.6 10.0 5.8 8.9 13.0 7.8 8.2 6.9 17.1 14.6 9.8 13.7 14.6 15.6 13.0 10.1 12.8 20.2 10.3 11.5 9.8 5.0 8.2 10.5 7.8 9.5 6.6 15.3 13.2 35.9 16.2 16.9 11.7 15.3 10.5 11.9 12.4 3.0 2.4 0.9 10.6 7.9 14.6 7.5 7.6 5.3 10.3 8.7 23.6 8.7 16.6 7.1 3.7 9.0 2.1 0.0 3.7 6.3 12.4 5.1 0.0 4.7 6.2 23.8 8.7 4.9 10.3 1.7 10.0 7.2 11.8 4.6 4.2 19.3 3.3 5.5 11.3 24.5 17.9 0.0 12.0 5.6 20.7 8.8 7.3 0.0 7.0 3.0 KDM6A UTX ENSG00000147050 "Lysine demethylase 6A" O15550 X 44873177-45112602 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000568, HPA001165, HPA002111" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim" "Intracellular and membrane" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704" "unprognostic (1.73e-3)" "unprognostic (6.86e-3)" "unprognostic (1.45e-2)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.65e-2)" "unprognostic (2.58e-3)" "unprognostic (8.22e-3)" "unprognostic (3.23e-1)" "unprognostic (2.44e-1)" "unprognostic (2.56e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-1)" "unprognostic (2.24e-2)" "unprognostic (5.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.16e-2)" 12.3 12.1 16.5 17.6 24.5 47.9 21.4 26.1 22.0 16.9 11.8 16.7 12.0 13.1 22.6 11.3 15.4 16.9 15.2 9.1 18.2 6.5 11.6 13.5 19.7 15.1 28.8 11.3 23.8 14.9 21.3 20.2 13.3 18.3 10.3 11.3 10.3 16.1 12.6 15.1 21.3 17.6 13.5 14.9 18.1 15.0 17.7 26.1 19.1 14.5 6.9 13.6 14.9 22.8 5.5 7.1 15.7 7.5 6.2 7.9 3.5 8.7 7.6 11.3 11.4 8.1 8.4 24.2 6.8 4.8 8.2 8.6 17.9 7.5 5.7 3.7 6.3 17.0 18.8 14.5 12.0 7.6 8.3 15.5 7.1 9.6 6.7 5.7 3.8 20.2 4.5 9.9 13.5 14.1 8.8 6.3 7.0 9.8 14.2 5.1 5.7 7.8 11.2 9.4 6.7 8.8 8.7 10.9 1.0 4.7 16.3 9.7 5.2 21.7 10.9 9.2 24.8 10.6 0.1 5.3 7.8 6.0 7.8 3.5 9.0 10.8 8.6 5.4 4.0 4.5 15.7 3.8 3.5 5.3 7.5 6.0 5.5 7.2 7.9 7.1 3.8 7.0 6.3 7.3 6.2 7.2 3.8 5.6 3.5 16.5 24.5 26.1 22.0 18.2 6.5 28.8 11.3 18.3 26.1 6.0 8.8 5.2 11.3 23.2 6.5 11.4 10.2 5.3 7.9 7.0 13.7 3.8 0.0 6.5 1.0 9.4 18.8 0.0 6.6 4.9 8.9 11.4 2.3 13.9 6.1 23.8 12.6 6.2 8.9 1.1 6.1 9.7 10.1 7.2 14.2 7.4 7.7 14.4 6.7 3.3 8.4 6.5 10.3 5.6 11.7 23.1 9.2 10.1 11.0 16.3 KDM7A "JHDM1D, KIAA1718" ENSG00000006459 "Lysine demethylase 7A" Q6ZMT4 7 140084746-140177035 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012114 Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA012114: AB_1852429" "unprognostic (1.55e-1)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "unprognostic (4.08e-3)" "unprognostic (3.52e-1)" "unprognostic (1.69e-2)" "unprognostic (4.00e-1)" "unprognostic (3.44e-2)" "unprognostic (2.56e-1)" "unprognostic (3.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.29e-1)" "unprognostic (9.55e-2)" "unprognostic (3.42e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-1)" "unprognostic (1.18e-1)" 20.1 3.2 6.6 15.2 4.7 18.7 10.4 8.7 6.1 13.2 12.0 4.7 4.6 10.3 8.9 5.8 13.0 5.8 6.0 8.0 5.7 3.5 4.9 8.5 9.7 10.1 4.8 2.8 5.0 6.4 7.0 6.7 15.5 6.7 6.9 12.2 3.7 11.4 4.5 24.6 15.0 16.3 9.3 6.0 6.7 11.9 9.4 5.9 10.8 6.4 10.3 15.2 13.1 9.1 2.8 3.0 6.1 2.3 1.8 1.6 0.8 0.9 0.4 2.9 3.1 2.7 2.3 5.9 1.3 1.9 0.5 0.6 0.3 0.4 2.0 2.0 1.3 1.6 1.1 4.1 2.5 0.9 11.3 2.5 0.1 0.4 5.3 2.7 1.9 2.1 2.7 5.6 1.6 8.8 1.4 2.8 5.4 6.4 8.9 0.5 0.8 3.5 3.1 4.7 6.5 1.6 4.0 0.2 4.0 1.0 1.2 5.2 6.3 3.0 7.0 3.0 4.9 9.6 0.7 4.9 0.6 1.1 1.9 0.8 3.1 0.4 6.6 1.6 5.2 1.1 1.6 2.3 0.9 1.1 1.3 0.9 1.5 1.6 1.5 3.0 2.8 1.5 1.0 6.1 1.8 0.5 1.2 1.3 0.8 6.6 4.7 8.7 6.1 5.7 3.5 4.8 2.8 6.7 5.9 14.9 27.5 13.2 37.9 44.3 12.4 12.1 10.2 26.8 25.0 15.7 25.5 7.1 1.7 6.4 4.1 20.3 28.2 23.3 8.2 2.5 15.4 28.1 8.1 16.9 9.7 6.4 50.6 24.5 36.3 3.4 7.2 33.7 3.3 3.6 38.6 3.7 10.2 26.8 3.9 2.6 9.5 6.5 17.6 24.7 10.0 40.7 31.7 13.1 21.9 43.9 KIAA0319L "AAVR, KIAA1837" ENSG00000142687 "KIAA0319 like" Q8IZA0 1 35433490-35557950 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 27.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072692 Supported Supported "Nucleoli,Golgi apparatus" NA NA 870000 "Golgi apparatus" Nucleoli "HPA072692: AB_2686549" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (4.23e-3)" "unprognostic (1.75e-1)" "unprognostic (1.30e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.92e-5)" "unprognostic (3.41e-3)" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (2.05e-2)" "unprognostic (3.79e-1)" "prognostic favorable (1.27e-4)" "unprognostic (1.47e-1)" "unprognostic (1.26e-1)" "unprognostic (5.44e-2)" "unprognostic (1.84e-1)" 10.6 23.5 20.3 10.6 29.0 9.9 20.1 21.9 37.2 19.2 17.7 24.1 17.0 18.1 19.7 19.2 14.4 25.1 15.7 30.7 19.4 20.0 27.5 32.1 21.3 11.0 19.4 20.1 13.0 32.8 38.5 28.1 21.1 23.0 25.3 21.3 24.5 33.9 20.5 27.4 13.8 19.8 12.7 16.6 17.1 23.3 14.0 17.5 11.9 29.3 11.9 17.4 12.9 12.0 2.3 3.2 27.1 11.0 5.5 3.5 4.5 5.4 8.1 16.9 13.3 23.0 16.2 16.1 7.4 15.9 10.9 16.2 8.7 22.2 6.1 20.6 8.1 16.3 10.9 12.5 12.0 12.5 9.7 9.1 8.3 9.9 9.6 18.0 6.8 11.4 22.8 15.5 12.5 16.4 36.2 17.7 7.6 10.8 8.9 14.7 5.5 4.0 5.8 19.2 15.3 4.9 4.6 14.4 7.6 18.0 13.4 3.7 10.5 10.8 13.0 22.2 38.9 13.6 9.7 18.1 7.5 8.1 6.3 11.5 13.3 10.6 4.0 19.1 9.0 7.4 4.5 11.0 5.0 3.0 3.6 2.9 2.0 2.5 2.8 3.2 2.3 3.5 2.5 27.1 5.5 2.2 2.1 2.3 4.5 20.3 29.0 21.9 37.2 19.4 20.0 19.4 20.1 23.0 17.5 68.5 67.8 11.2 13.5 7.0 71.9 47.3 48.4 52.2 52.4 33.2 102.1 26.5 3.3 15.2 7.8 22.2 31.6 0.0 28.2 18.9 16.7 25.7 20.8 40.4 16.3 60.4 20.7 21.5 29.5 4.9 16.1 17.1 13.5 11.8 53.3 28.9 26.4 24.6 16.3 17.3 62.2 6.5 8.2 21.2 17.7 8.2 26.1 17.3 28.1 10.8 KIAA1551 "C12orf35, FLJ10652, FLJ20696, GET, UTA2-1" ENSG00000174718 KIAA1551 Q9HCM1 12 31959370-31993107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.8;lymphoid tissue: 56.3" "Cell type enhanced" "Detected in many" 7 "Urothelial cells: 190.4" "Cancer enhanced" "Detected in all" "testis cancer: 65.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 58.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 58.8" "Cell line enhanced" "Detected in all" "SuSa: 44.6" "Low region specificity" "Detected in all" "HPA013816, HPA015622" Approved Supported "Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Intermediate filaments, Cytosol" "HPA013816: AB_1848661, HPA015622: AB_1848663" "unprognostic (7.97e-3)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (8.49e-2)" "unprognostic (3.21e-1)" "unprognostic (3.09e-3)" "unprognostic (2.24e-1)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (5.04e-9)" "unprognostic (3.83e-1)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (7.26e-3)" 12.4 5.8 4.7 28.8 6.1 9.0 10.3 8.7 7.0 15.7 17.5 2.7 7.1 10.7 11.2 10.3 12.3 19.0 8.9 6.2 4.8 3.5 8.1 14.2 17.0 56.3 7.5 4.1 38.3 7.0 3.6 8.0 17.5 5.4 11.6 6.5 3.5 8.6 5.5 5.4 6.7 30.0 8.5 8.1 39.1 8.8 8.7 5.9 48.5 10.0 7.6 27.6 17.3 13.9 9.6 3.3 58.8 4.5 8.0 13.2 5.0 2.7 4.8 8.4 3.2 3.8 4.6 12.6 3.3 3.3 2.4 2.6 18.3 18.0 13.1 8.3 2.7 8.1 3.6 11.5 2.2 3.4 9.6 1.6 18.3 2.4 2.4 7.5 13.2 29.7 2.5 3.4 2.6 4.4 9.6 18.5 9.0 10.4 20.9 2.5 1.3 18.5 5.5 18.0 10.4 2.0 8.6 8.0 5.7 2.3 5.1 3.4 3.0 4.3 2.2 2.3 44.6 7.7 14.6 11.7 2.5 4.0 4.3 3.5 12.7 13.4 16.1 1.3 7.4 2.7 12.5 3.9 3.9 12.5 4.4 11.8 9.6 11.2 11.6 3.3 7.5 13.2 12.6 58.8 8.0 4.5 2.0 10.2 5.0 4.7 6.1 8.7 7.0 4.8 3.5 7.5 4.1 5.4 5.9 32.8 30.1 76.8 35.9 16.7 12.1 16.6 12.7 10.7 22.7 7.0 9.8 10.5 0.0 11.8 4.8 41.3 43.3 0.0 10.4 2.2 15.8 43.7 43.9 40.9 27.9 17.5 8.6 25.8 50.9 5.2 23.9 40.7 10.1 26.2 12.5 8.5 24.6 14.0 22.3 6.7 15.8 77.6 22.7 5.2 36.4 30.5 4.2 83.0 13.0 190.4 KIAA1755 RP5-1054A22.3 ENSG00000149633 KIAA1755 Q5JYT7 20 38210488-38260772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2" "Cell type enhanced" "Detected in some" 16 "Leydig cells: 3.4;Peritubular cells: 7.1;Proximal tubular cells: 2.9" "Cancer enhanced" "Detected in many" "melanoma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 40.9;ASC diff: 6.2;ASC TERT1: 9.4;WM-115: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051064 Approved Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA Nucleoli "Golgi apparatus, Vesicles" "HPA051064: AB_2681331" "unprognostic (3.98e-3)" "unprognostic (2.20e-2)" "unprognostic (3.79e-1)" "unprognostic (3.01e-3)" "unprognostic (1.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (4.50e-2)" "unprognostic (2.70e-1)" "unprognostic (3.88e-2)" "unprognostic (1.69e-1)" "unprognostic (2.42e-8)" "unprognostic (1.41e-2)" "unprognostic (2.78e-2)" "unprognostic (1.25e-2)" "unprognostic (5.53e-3)" 6.1 2.5 13.6 5.8 27.3 0.7 3.8 4.8 22.1 13.2 8.1 47.2 3.1 2.7 15.5 7.2 5.6 10.0 16.9 11.5 13.9 8.4 4.6 1.7 2.7 4.9 22.7 13.7 14.7 1.5 0.3 3.1 0.4 24.5 7.3 4.7 8.8 6.1 8.2 1.3 1.6 4.5 15.8 20.4 2.8 4.1 2.9 29.2 0.0 2.6 1.6 4.9 6.8 5.4 0.3 0.5 0.9 0.4 0.4 0.7 0.0 1.5 0.2 40.9 0.0 6.2 9.4 0.0 4.0 2.3 0.0 0.0 0.2 1.2 0.0 0.2 1.2 1.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.0 1.2 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.0 0.1 0.0 0.0 0.2 0.0 0.6 0.2 0.7 0.0 0.0 0.0 0.1 0.0 10.3 0.9 0.4 0.1 0.7 0.2 0.5 0.1 0.5 0.6 0.1 0.3 0.4 0.4 0.7 0.4 0.1 0.5 0.0 0.0 13.6 27.3 4.8 15.7 13.9 8.4 22.7 13.7 24.5 29.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.6 0.0 1.3 3.4 0.0 1.7 0.0 0.0 0.0 0.3 0.0 7.1 2.9 0.0 0.0 0.9 0.4 0.2 0.3 0.0 0.0 0.0 0.0 KIAA1841 ENSG00000162929 KIAA1841 Q6NSI8 2 61065871-61138034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 69.6;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051240 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051240: AB_2681401" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.18e-2)" "unprognostic (5.71e-8)" "unprognostic (1.13e-1)" "unprognostic (5.06e-3)" "unprognostic (7.53e-2)" "unprognostic (6.09e-2)" "unprognostic (8.92e-2)" "unprognostic (7.85e-6)" "unprognostic (8.54e-2)" "unprognostic (1.04e-2)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" 5.1 3.6 9.8 3.9 8.9 2.3 4.3 13.3 12.4 10.0 7.1 7.0 1.0 5.5 4.4 6.8 3.8 7.5 3.6 5.2 9.6 11.6 2.6 2.3 8.0 3.2 8.8 12.1 2.4 3.6 3.9 8.2 3.5 20.6 9.6 8.3 3.6 3.6 3.1 3.7 8.5 5.9 5.4 10.1 3.3 5.6 7.5 6.2 3.3 4.0 2.7 3.5 4.3 3.7 1.5 1.2 4.8 2.5 1.4 3.7 0.6 4.6 9.0 11.8 5.1 6.8 7.7 3.7 8.9 2.2 4.6 4.3 2.7 3.0 1.9 2.4 6.8 9.5 5.9 7.5 3.0 6.5 8.1 1.8 1.7 6.2 7.5 3.7 2.1 1.7 3.6 4.9 8.3 2.9 5.3 6.4 2.7 1.7 1.5 12.8 0.4 1.8 1.4 3.7 5.4 1.8 6.0 9.7 0.4 5.8 9.5 7.0 4.4 10.7 2.4 3.2 9.2 1.8 2.5 8.4 7.5 2.8 6.0 6.0 0.8 2.4 2.8 5.4 1.5 5.1 0.8 1.4 4.8 1.3 1.5 1.2 1.5 1.2 0.6 1.2 0.6 0.2 1.0 3.0 1.4 2.5 0.8 3.7 0.6 9.8 8.9 13.3 12.4 9.6 11.6 8.8 12.1 20.6 6.2 6.0 4.3 0.0 2.9 2.3 12.4 6.5 2.5 69.6 15.9 3.5 53.0 0.9 0.0 3.1 2.4 3.8 5.1 0.0 5.4 2.2 6.6 4.4 1.1 1.0 5.0 7.9 7.5 5.5 4.0 1.7 3.4 4.2 3.3 9.0 4.3 4.8 7.6 7.0 1.8 0.5 45.8 0.0 3.6 10.4 19.2 2.9 0.3 2.2 4.5 2.6 KIF2A "HK2, KIF2" ENSG00000068796 "Kinesin family member 2A" O00139 5 62306162-62537249 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Motor protein" "Cancer-related genes, Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004715, HPA004716" Approved Enhanced Nucleoplasm,Nucleoli,Centrosome Yes No 2100000 "Nucleoplasm, Nucleoli, Centrosome" "HPA004715: AB_2667215, HPA004716: AB_1079211" "unprognostic (2.40e-2)" "unprognostic (3.43e-1)" "prognostic favorable (1.70e-4)" "unprognostic (2.74e-2)" "unprognostic (1.43e-1)" "prognostic favorable (5.45e-4)" "prognostic unfavorable (3.17e-6)" "unprognostic (8.77e-3)" "unprognostic (4.69e-2)" "unprognostic (9.10e-2)" "unprognostic (1.85e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (3.81e-5)" "unprognostic (3.53e-2)" "unprognostic (2.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.58e-1)" 11.3 9.3 25.4 21.9 26.4 12.4 15.5 15.4 40.1 19.7 13.5 19.4 8.0 10.3 12.9 7.6 14.3 17.5 13.7 7.2 26.2 24.1 8.2 5.8 10.6 29.4 24.9 24.6 13.0 12.3 15.2 14.3 27.8 37.0 10.2 14.5 6.8 10.7 11.9 7.4 7.9 15.8 13.5 34.3 17.4 9.6 39.2 26.4 28.7 13.0 5.6 26.7 17.4 14.8 9.0 8.4 7.1 3.0 15.8 25.4 9.7 17.3 17.4 29.1 25.8 11.0 15.5 23.8 18.6 15.4 20.3 25.8 18.7 19.1 43.1 20.6 16.4 24.0 11.0 22.0 14.9 27.1 43.2 15.4 43.2 16.3 10.2 13.0 23.5 16.5 12.8 9.9 19.7 17.9 11.9 18.5 24.9 30.6 26.3 16.9 13.1 39.4 11.7 16.9 4.2 11.0 29.0 23.0 23.8 9.1 21.1 26.1 21.7 25.3 10.6 13.1 22.5 13.9 13.3 16.0 12.1 20.0 14.0 18.5 24.9 35.9 45.5 14.0 28.4 14.8 7.1 3.0 3.4 20.2 2.6 22.8 9.0 20.3 20.6 4.0 7.8 17.9 18.4 5.3 15.8 1.8 8.4 25.4 9.7 25.4 26.4 15.4 31.2 26.2 24.1 24.9 24.6 37.0 26.4 14.9 13.1 22.3 22.3 14.9 41.8 7.0 7.6 71.0 25.0 19.2 98.2 16.2 11.6 30.0 88.3 17.5 11.4 0.0 27.0 18.7 10.4 29.9 16.3 3.4 13.1 49.3 20.2 14.7 10.2 90.3 12.0 18.7 11.8 152.3 5.1 22.4 23.3 7.4 12.4 13.5 88.2 25.8 13.3 80.2 42.1 8.3 36.7 39.6 9.5 40.0 KIF2B ENSG00000141200 "Kinesin family member 2B" Q8N4N8 17 53822901-53825213 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 261 "testis: 103.6" "Group enriched" "Detected in some" 82 "Early spermatids: 638.1;Late spermatids: 419.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023081, HPA023103, HPA024795" Uncertain Supported "Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Microtubules, Cytokinetic bridge, Mitotic spindle" Nucleoli "HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 638.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 419.7 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 6.5 0.0 4.2 2.0 0.0 0.0 0.0 0.0 0.0 KIF3B "FLA8, KIAA0359, KLP-11" ENSG00000101350 "Kinesin family member 3B" O15066 20 32277664-32335011 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007119 Approved Uncertain "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA007119: AB_1852498" "unprognostic (1.74e-2)" "unprognostic (2.25e-1)" "unprognostic (5.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.73e-1)" "unprognostic (2.89e-1)" "unprognostic (1.49e-2)" "unprognostic (2.14e-1)" "unprognostic (9.01e-3)" "unprognostic (9.30e-2)" "unprognostic (1.41e-1)" "unprognostic (1.18e-1)" "prognostic favorable (1.44e-12)" "unprognostic (2.41e-2)" "unprognostic (2.68e-1)" "unprognostic (5.11e-2)" "unprognostic (4.42e-2)" 8.4 11.0 22.9 7.7 30.2 5.5 9.1 17.6 24.6 11.6 13.4 13.3 7.7 14.3 8.8 13.5 5.8 15.4 11.0 6.2 19.9 15.1 26.4 17.8 9.3 7.7 15.1 18.7 10.5 16.9 38.5 18.1 6.4 13.2 9.0 14.2 11.8 8.4 8.6 5.3 5.8 17.1 9.0 16.0 6.8 12.7 15.3 13.7 4.3 14.3 4.1 8.4 8.5 6.5 6.5 3.1 3.7 5.9 2.6 6.6 1.8 22.9 15.6 10.9 13.9 14.5 23.1 11.1 11.4 16.0 13.9 10.9 26.5 12.7 12.4 13.8 21.5 19.8 14.9 13.9 16.9 17.7 5.8 6.3 10.7 12.5 13.0 9.2 9.0 8.2 14.1 12.2 23.9 9.5 11.4 11.2 5.0 6.6 4.9 11.1 10.5 4.1 4.1 5.8 12.3 13.7 3.8 17.9 4.5 14.2 17.0 17.9 15.1 29.8 8.0 11.4 9.5 17.6 7.0 13.6 26.1 17.8 15.1 14.1 8.3 11.9 6.4 25.9 15.8 10.5 1.3 3.1 3.7 6.6 4.2 5.5 6.1 5.0 6.1 1.7 6.5 3.1 4.6 3.2 2.6 5.9 3.1 3.9 1.8 22.9 30.2 17.6 24.6 19.9 15.1 15.1 18.7 13.2 13.7 20.8 25.5 9.3 7.3 6.0 31.6 7.0 35.7 53.5 14.8 12.2 100.1 6.5 3.3 29.6 52.5 12.5 61.3 0.0 33.7 5.2 11.0 13.5 8.1 20.4 7.0 30.2 37.8 13.5 7.3 61.7 12.4 5.9 0.0 4.6 25.9 20.6 28.0 33.1 19.1 19.9 58.5 0.0 6.2 30.1 6.9 4.4 5.5 8.6 21.8 7.8 KLF6 "BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9" ENSG00000067082 "Kruppel like factor 6" Q99612 10 3775996-3785281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Basal glandular cells: 1442.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013529, HPA069585" Supported Supported Nucleoplasm,Nucleoli,Vesicles,Cytosol No No Nucleoplasm "Nucleoli, Vesicles, Cytosol" "CAB013529: AB_2533431, HPA069585: AB_2686157" "unprognostic (1.23e-1)" "unprognostic (1.53e-2)" "unprognostic (1.47e-3)" "unprognostic (4.53e-2)" "unprognostic (1.47e-1)" "unprognostic (7.55e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-3)" "unprognostic (1.61e-1)" "unprognostic (2.83e-2)" "unprognostic (1.36e-2)" "unprognostic (2.35e-2)" "prognostic favorable (2.28e-4)" "unprognostic (8.07e-3)" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (1.37e-2)" 69.8 10.0 8.4 26.3 10.6 80.6 101.1 7.4 10.1 28.6 31.7 10.3 9.7 11.0 24.9 28.8 38.6 28.0 38.6 18.6 7.8 5.1 32.2 32.5 46.0 35.8 13.8 4.2 20.2 23.8 7.5 4.7 26.1 11.2 20.1 21.0 13.2 26.9 16.5 57.8 60.2 44.8 42.8 17.0 20.3 26.7 14.3 10.0 12.5 41.0 28.8 21.5 44.7 30.7 15.6 29.8 77.8 18.7 13.0 30.8 23.2 13.2 3.6 6.9 2.2 40.3 40.4 4.3 22.8 11.7 24.4 16.6 9.3 17.9 3.8 5.3 24.7 19.0 8.1 4.2 21.1 20.5 18.6 2.5 0.5 4.1 8.7 17.3 2.5 13.1 13.3 40.3 17.4 33.2 8.7 24.9 2.5 4.1 29.7 31.0 0.9 4.6 3.8 2.6 7.1 6.5 3.0 7.1 13.4 24.0 13.2 3.0 2.9 5.6 16.3 34.2 19.6 8.0 2.1 32.4 33.1 4.6 19.5 10.4 5.7 18.5 7.0 8.9 3.3 10.2 50.9 17.0 43.7 27.1 14.2 23.9 15.6 30.8 26.8 13.1 12.5 9.6 14.8 77.8 13.0 18.7 29.8 22.2 23.2 8.4 10.6 7.4 10.1 7.8 5.1 13.8 4.2 11.2 10.0 1158.3 540.6 237.0 1442.7 520.2 42.2 53.1 293.0 254.3 251.4 130.9 31.4 113.5 18.3 616.6 54.4 455.0 961.8 70.0 474.3 369.8 410.0 832.0 597.5 234.2 510.8 35.0 381.0 212.4 420.1 42.4 120.8 593.9 458.9 839.6 556.8 32.1 706.5 466.4 125.9 61.9 78.0 135.8 372.0 6.2 13.6 549.2 163.8 409.2 300.8 382.6 KLHDC4 DKFZp434G0522 ENSG00000104731 "Kelch domain containing 4" Q8TBB5 16 87696485-87765992 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 59.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 46.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041665 Approved Approved Nucleoli Yes No Nucleoli "HPA041665: AB_10796352" "unprognostic (2.96e-2)" "unprognostic (2.31e-2)" "unprognostic (1.28e-3)" "unprognostic (3.54e-1)" "unprognostic (2.94e-1)" "unprognostic (2.26e-2)" "unprognostic (7.61e-3)" "unprognostic (6.40e-2)" "unprognostic (1.20e-1)" "unprognostic (2.87e-1)" "prognostic favorable (1.14e-4)" "unprognostic (3.84e-2)" "unprognostic (2.73e-2)" "unprognostic (1.54e-1)" "unprognostic (4.56e-2)" "unprognostic (3.88e-1)" "prognostic favorable (1.69e-4)" 12.7 12.1 13.5 23.1 15.5 17.0 12.7 15.5 15.8 9.9 13.8 14.6 16.1 13.1 17.5 14.4 12.8 13.1 17.7 10.2 14.7 12.9 11.4 16.1 12.5 21.0 14.7 13.6 12.1 20.6 15.6 14.2 8.7 12.9 11.0 15.8 10.7 16.6 16.3 30.7 15.9 12.0 12.7 15.5 14.9 14.5 26.6 12.9 22.7 14.0 14.5 19.5 12.7 11.8 6.1 6.1 4.4 11.1 17.6 14.4 6.4 6.7 12.4 6.3 9.5 2.5 3.4 9.8 6.4 6.0 10.6 5.0 18.3 9.7 10.7 8.6 5.0 3.7 11.1 9.6 8.5 7.6 1.6 10.7 6.1 7.8 12.0 6.5 5.6 6.4 1.5 4.5 9.5 10.7 5.2 8.8 18.1 19.5 5.6 7.0 29.0 13.1 16.6 10.6 7.6 9.3 12.7 7.3 6.1 6.3 7.9 9.7 9.3 13.4 6.9 3.1 5.4 10.9 9.0 5.5 5.9 10.1 3.0 12.1 27.3 9.3 46.5 5.7 14.5 4.0 0.0 6.0 4.4 14.4 7.8 12.6 6.1 6.0 11.6 4.4 5.5 6.1 9.2 0.4 17.6 11.1 6.1 5.0 6.4 13.5 15.5 15.5 15.8 14.7 12.9 14.7 13.6 12.9 12.9 0.0 15.6 9.0 8.9 4.0 14.4 8.5 12.7 9.4 15.9 8.7 25.5 12.5 10.0 9.5 50.2 6.7 11.1 23.3 14.4 7.3 5.9 11.1 3.5 11.3 11.7 11.1 23.1 9.8 16.5 59.9 6.1 6.8 8.5 9.0 12.0 6.2 11.7 11.5 7.1 19.2 17.7 0.0 6.2 19.4 11.7 5.8 10.0 30.2 18.5 15.3 KLHDC9 KARCA1 ENSG00000162755 "Kelch domain containing 9" Q8NEP7 1 161098361-161100346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.3" "Group enriched" "Detected in many" 6 "Early spermatids: 336.6;Late spermatids: 352.6;Spermatocytes: 259.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 5.0;HDLM-2: 3.5;HEK 293: 3.7;MCF7: 3.4;T-47d: 3.3;U-266/70: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032058, HPA043197" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes NA "Nucleoplasm, Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA032058: AB_10601439, HPA043197: AB_2678359" "unprognostic (1.79e-1)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "unprognostic (1.04e-3)" "unprognostic (2.53e-2)" "unprognostic (1.52e-1)" "unprognostic (1.62e-1)" "unprognostic (4.87e-3)" "unprognostic (6.31e-2)" "prognostic favorable (4.20e-6)" "unprognostic (1.81e-3)" "unprognostic (1.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.53e-1)" "unprognostic (5.51e-2)" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" 1.0 3.7 4.0 1.0 8.4 0.9 1.4 3.1 9.5 1.8 2.4 2.3 5.6 1.6 2.4 3.9 1.1 5.7 2.4 1.7 3.3 4.9 5.9 2.6 1.7 1.0 3.6 7.4 2.5 3.6 4.1 4.8 1.0 5.6 3.2 1.6 3.5 2.9 2.4 2.5 0.8 1.6 1.1 1.6 1.1 2.4 24.3 2.2 0.0 5.0 0.0 1.1 1.5 0.6 0.9 0.1 0.0 0.2 0.0 1.1 0.1 0.4 2.7 1.0 2.9 0.0 0.3 0.3 0.0 0.7 0.1 0.0 0.0 0.2 0.0 5.0 0.0 0.0 1.6 0.0 0.0 0.0 3.5 3.7 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.5 0.0 1.5 0.5 2.4 2.6 0.0 1.9 0.6 0.0 2.5 1.1 0.0 1.0 0.0 0.8 3.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 4.0 8.4 3.1 9.5 3.3 4.9 3.6 7.4 5.6 2.2 0.0 4.1 0.0 11.1 0.8 13.0 8.5 7.6 53.5 9.1 27.9 2.0 2.3 48.0 6.8 336.6 3.3 3.2 0.0 4.9 2.8 3.5 10.5 1.1 7.3 0.5 3.2 5.2 1.8 0.3 352.6 7.5 0.3 6.8 1.0 12.5 27.9 4.2 7.0 7.8 29.8 16.9 12.9 1.9 259.8 11.1 0.6 0.7 0.0 7.6 5.6 KLLN killin ENSG00000227268 "Killin, p53 regulated DNA replication inhibitor" B2CW77 10 87859161-87863437 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 6.3;skeletal muscle: 7.4" "Cell type enhanced" "Detected in many" 7 "granulocytes: 5.7;Sertoli cells: 6.5" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 8.1;Karpas-707: 8.4" "Low region specificity" "Detected in many" HPA074502 Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA074502: AB_2686695" "unprognostic (4.53e-2)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (3.71e-1)" "unprognostic (6.53e-2)" "unprognostic (1.37e-1)" "unprognostic (3.59e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (3.12e-3)" "unprognostic (1.57e-2)" "unprognostic (4.79e-4)" "unprognostic (1.38e-2)" "unprognostic (1.00e-1)" "unprognostic (9.02e-4)" "unprognostic (1.60e-1)" 1.7 1.5 1.2 0.8 1.9 0.6 1.4 2.0 1.4 1.3 1.6 0.7 1.2 2.0 0.6 2.9 0.6 0.7 1.0 1.8 1.7 1.7 0.5 1.3 1.1 0.7 0.6 1.3 1.9 0.9 0.6 1.6 0.4 0.8 7.4 0.4 0.7 0.8 0.9 1.7 0.9 2.4 1.3 1.4 0.9 0.9 1.7 1.4 6.3 1.6 1.7 1.2 0.5 1.4 1.6 1.9 1.4 1.0 0.6 1.5 1.2 1.5 0.9 1.2 0.9 4.3 3.3 0.6 0.5 0.9 1.6 1.2 1.3 0.6 0.8 0.5 1.1 2.5 1.0 1.1 2.4 0.9 1.1 1.4 1.1 1.5 1.6 0.5 8.1 0.7 8.4 0.9 2.8 6.4 2.6 0.8 1.0 0.8 4.2 0.3 4.1 0.8 1.4 0.8 1.6 1.4 1.1 0.2 1.4 2.7 1.9 0.5 1.0 0.5 1.6 0.6 4.9 5.0 4.7 1.7 4.7 1.0 3.1 1.0 1.5 0.7 1.4 1.1 1.2 0.9 0.9 0.8 1.7 1.2 1.1 6.3 1.7 1.6 1.4 0.7 0.5 0.0 0.0 0.0 0.1 0.1 1.5 2.0 0.0 2.7 2.3 0.0 0.0 0.6 0.0 0.2 2.7 0.5 1.6 0.0 0.2 0.3 0.5 0.2 5.7 0.4 0.3 3.2 0.0 0.6 0.3 1.1 0.0 0.0 0.0 0.0 1.6 2.4 0.2 0.9 0.0 1.3 1.1 6.5 0.5 0.2 1.4 0.4 0.5 0.0 1.0 0.1 KNOP1 "101F10.1, C16orf88, FAM191A, TSG118" ENSG00000103550 "Lysine rich nucleolar protein 1" Q1ED39 16 19701934-19718235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041079, HPA066169" Uncertain Enhanced "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA041079: AB_10962350, HPA066169: AB_2685628" "unprognostic (6.55e-3)" "unprognostic (3.96e-1)" "unprognostic (2.16e-2)" "unprognostic (2.42e-2)" "unprognostic (8.57e-3)" "unprognostic (2.35e-1)" "prognostic unfavorable (3.75e-6)" "unprognostic (2.50e-2)" "unprognostic (2.03e-2)" "unprognostic (1.18e-3)" "unprognostic (5.84e-2)" "unprognostic (2.14e-2)" "unprognostic (7.91e-2)" "unprognostic (3.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.34e-3)" "unprognostic (1.08e-1)" 6.9 7.1 13.9 7.6 34.7 3.9 13.8 11.1 23.7 7.1 9.5 20.9 8.5 8.2 8.5 10.9 10.1 8.1 7.3 6.9 17.0 10.5 6.2 7.6 5.5 9.4 33.1 9.1 12.8 19.6 17.2 6.4 10.3 18.1 8.1 11.1 4.9 13.9 9.8 15.2 15.0 8.2 5.8 21.2 6.4 9.3 10.0 33.2 4.9 7.3 5.8 7.5 8.4 7.7 7.0 5.2 1.6 8.0 4.5 12.8 4.4 12.4 19.2 21.4 16.2 5.3 5.0 11.0 7.7 4.2 7.4 7.5 13.5 10.9 14.9 31.7 4.7 6.5 11.6 16.6 10.6 7.2 10.0 11.6 8.8 10.9 17.7 9.7 13.7 6.9 3.2 15.2 9.7 8.0 6.5 7.8 10.6 26.9 6.7 6.9 16.3 12.1 11.4 41.7 12.4 7.7 26.1 11.5 17.3 7.8 11.9 19.3 16.3 9.6 12.4 12.6 12.8 14.5 9.3 9.0 11.7 12.0 7.1 10.2 9.9 20.5 18.7 6.3 10.5 11.3 0.4 3.5 1.6 4.8 8.0 7.2 6.6 6.9 4.8 4.2 7.0 12.8 7.2 1.0 4.5 7.0 5.2 4.4 4.4 13.9 34.7 11.1 23.7 17.0 10.5 33.1 9.1 18.1 33.2 6.0 16.2 27.4 24.0 10.9 38.4 6.5 40.8 17.4 12.5 36.6 82.5 46.7 39.7 78.4 1.8 39.8 26.2 0.0 57.5 34.0 26.3 21.6 5.8 47.9 31.3 33.4 14.5 23.4 23.1 5.2 56.1 24.0 11.8 27.1 35.8 17.1 64.2 10.5 50.5 25.8 56.7 45.3 37.1 37.0 132.6 14.1 20.6 20.0 51.0 21.1 KRCC1 FLJ22333 ENSG00000172086 "Lysine rich coiled-coil 1" Q9NPI7 2 88027205-88055729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045618, HPA052666" Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA045618: AB_10960406, HPA052666: AB_2681907" "unprognostic (7.37e-3)" "unprognostic (1.30e-1)" "unprognostic (2.09e-1)" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (2.59e-2)" "unprognostic (1.25e-1)" "unprognostic (1.73e-2)" "unprognostic (1.46e-1)" "unprognostic (4.83e-2)" "unprognostic (2.22e-1)" "unprognostic (6.04e-2)" "unprognostic (1.99e-2)" "unprognostic (2.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-3)" 22.5 15.0 23.1 30.6 27.3 5.7 25.9 23.5 20.4 23.3 29.9 15.8 19.9 20.7 17.8 29.1 26.4 18.4 16.5 21.4 27.0 15.7 21.5 28.1 23.4 22.3 30.3 15.2 20.3 19.4 24.8 23.8 17.3 23.8 24.0 29.7 12.1 20.8 37.9 23.0 16.7 28.9 24.7 28.2 22.0 17.5 10.0 29.9 20.2 26.9 14.5 20.5 22.1 20.2 18.3 12.7 37.2 11.6 14.8 16.5 8.0 11.5 7.1 11.2 8.2 27.1 32.1 8.3 18.3 20.5 9.8 9.7 0.6 15.6 16.4 6.6 11.6 15.0 6.0 2.5 3.8 11.1 17.2 3.5 3.1 1.9 1.1 19.8 4.7 2.2 16.0 19.1 6.5 14.1 25.7 11.0 13.3 4.4 8.2 21.1 9.8 5.4 6.6 8.5 16.8 4.8 11.1 2.0 1.7 14.8 6.3 8.7 8.8 7.0 9.7 21.3 8.7 6.8 19.6 15.3 11.7 0.8 19.1 5.7 18.7 13.0 13.1 12.5 12.7 27.4 24.7 11.0 37.2 10.1 11.6 11.7 18.3 12.4 12.3 12.7 16.9 14.2 11.2 17.9 14.8 10.0 11.2 16.5 8.0 23.1 27.3 23.5 20.4 27.0 15.7 30.3 15.2 23.8 29.9 32.8 32.4 29.1 30.1 29.3 9.3 36.0 35.7 69.6 47.8 33.2 2.0 40.4 51.4 41.9 2.6 25.4 58.0 0.0 62.9 15.7 37.7 49.3 41.6 47.4 42.5 9.5 40.0 35.6 34.9 3.1 44.3 35.7 27.0 47.7 57.8 33.8 42.5 69.1 40.7 60.7 5.4 19.4 29.2 38.7 19.0 37.3 35.0 34.6 65.3 23.8 KREMEN2 "KRM2, MGC10791" ENSG00000131650 "Kringle containing transmembrane protein 2" Q8NCW0 16 2963944-2968383 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1;skin 1: 12.5" "Cell type enhanced" "Detected in some" 9 "Basal keratinocytes: 12.6;Cone photoreceptor cells: 5.9;Mucus-secreting cells: 9.5;Rod photoreceptor cells: 10.0;Spermatogonia: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "memory B-cell: 3.2;naive B-cell: 3.0;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 6 "B-cells: 3.2;monocytes: 1.4" "Cell line enhanced" "Detected in many" "HMC-1: 20.3;MCF7: 10.2;RPMI-8226: 19.1;T-47d: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA003223 Uncertain Approved Nucleoli "Intracellular and membrane" NA NA Nucleoli "HPA003223: AB_1079217" "unprognostic (8.36e-2)" "unprognostic (4.65e-1)" "unprognostic (6.24e-3)" "unprognostic (4.61e-2)" "unprognostic (1.69e-1)" "unprognostic (1.73e-1)" "unprognostic (4.02e-3)" "prognostic unfavorable (8.98e-4)" "unprognostic (3.34e-2)" "unprognostic (1.57e-2)" "unprognostic (8.03e-2)" "unprognostic (8.57e-2)" "unprognostic (7.79e-12)" "unprognostic (6.69e-2)" "unprognostic (1.14e-1)" "unprognostic (1.46e-2)" "unprognostic (6.58e-3)" 0.2 0.1 1.6 2.0 0.7 1.7 0.2 0.2 3.0 1.8 0.4 0.2 4.5 0.3 0.3 0.8 3.8 0.6 0.3 0.2 1.9 0.3 0.2 0.2 0.2 0.8 0.7 0.2 0.2 0.4 0.0 0.2 0.2 0.3 1.6 0.0 1.9 1.6 0.2 0.6 12.5 0.6 0.2 1.7 0.9 0.5 2.1 0.2 13.1 0.2 1.8 6.8 0.2 0.6 3.2 0.3 0.0 1.4 0.0 0.0 0.0 1.2 0.8 0.3 7.3 0.0 0.0 1.1 0.4 0.0 0.0 0.0 2.9 1.1 5.3 1.5 0.0 0.8 6.0 0.9 0.5 0.0 0.8 0.8 0.3 1.7 1.7 0.0 0.4 20.3 0.2 0.0 0.0 0.1 0.6 0.0 0.6 2.1 2.1 0.0 10.2 1.2 2.4 2.0 2.1 1.5 3.2 8.3 19.1 0.0 0.2 2.1 1.2 1.4 3.3 3.3 0.2 10.3 1.9 0.1 0.6 8.9 0.7 0.5 3.8 0.8 3.2 0.3 0.9 0.5 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.6 0.7 0.2 2.3 1.9 0.3 0.7 0.2 0.3 0.2 0.0 0.0 0.0 0.6 12.6 0.4 0.8 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.0 0.4 0.0 0.5 0.0 2.4 1.6 0.0 2.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 3.3 0.0 9.5 0.2 0.2 0.2 0.0 0.0 10.0 0.0 0.0 0.5 5.9 4.8 0.1 0.0 0.2 0.3 KRI1 FLJ12949 ENSG00000129347 "KRI1 homolog" Q8N9T8 19 10553078-10566037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 57.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043110, HPA043574" Approved Enhanced Nucleoli Yes No Nucleoli "HPA043110: AB_2678321, HPA043574: AB_2678561" "unprognostic (6.38e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (9.37e-4)" "unprognostic (6.70e-2)" "unprognostic (2.35e-2)" "unprognostic (5.10e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (3.46e-2)" "unprognostic (1.68e-2)" "unprognostic (2.51e-2)" "unprognostic (2.30e-2)" "unprognostic (4.43e-2)" "prognostic unfavorable (4.89e-10)" "unprognostic (2.99e-2)" "unprognostic (3.06e-2)" "unprognostic (2.70e-1)" "unprognostic (1.02e-1)" 14.7 12.5 10.4 23.6 20.6 19.1 14.3 27.8 19.6 14.5 13.4 16.6 12.4 12.7 15.9 17.6 17.2 14.3 15.0 12.1 13.1 10.3 11.9 13.3 12.4 25.2 16.7 9.8 17.2 19.5 21.0 18.3 10.9 14.9 15.6 9.8 20.3 14.7 18.2 23.0 25.3 16.8 15.0 17.2 23.0 12.7 14.6 18.6 46.8 15.6 10.9 21.3 15.8 15.9 8.5 14.1 2.5 4.9 8.5 11.2 3.9 12.3 6.3 8.1 11.7 4.4 4.9 5.6 11.4 5.4 7.2 6.7 9.1 4.5 18.2 13.5 4.6 6.3 9.7 9.9 8.9 8.2 19.8 22.5 57.8 12.2 5.9 8.1 22.6 21.0 6.0 7.3 10.4 10.7 6.3 4.6 11.1 16.1 18.6 6.2 11.0 23.2 33.7 13.0 10.0 15.1 9.8 10.6 9.0 6.1 11.0 13.4 6.3 13.4 7.9 8.4 7.5 9.9 16.6 5.5 9.4 7.9 25.2 23.8 13.2 15.3 13.1 7.9 18.4 14.0 1.3 4.5 2.5 11.2 4.9 10.3 7.1 7.5 9.0 5.8 8.5 8.4 9.0 0.8 8.5 2.5 14.1 5.4 3.9 10.4 20.6 27.8 19.6 13.1 10.3 16.7 9.8 14.9 18.6 14.9 23.8 9.3 12.1 11.9 14.0 6.1 7.6 22.7 22.7 14.0 37.3 9.8 1.7 6.5 3.2 7.3 6.7 0.0 6.4 7.3 8.2 6.6 18.5 7.4 6.8 11.1 9.2 9.8 10.2 5.0 7.8 8.2 8.5 1.8 7.8 8.9 5.0 7.0 8.5 3.9 51.4 0.0 7.3 28.7 15.0 12.0 3.8 15.3 9.5 5.9 KRR1 "HRB2, RIP-1" ENSG00000111615 "KRR1, small subunit processome component homolog" Q13601 12 75490861-75511636 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043433, HPA051690" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA043433: AB_10960988, HPA051690: AB_2681574" "unprognostic (2.77e-1)" "unprognostic (1.02e-1)" "unprognostic (8.21e-2)" "unprognostic (1.71e-1)" "unprognostic (2.02e-1)" "unprognostic (4.71e-2)" "unprognostic (6.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.38e-1)" "unprognostic (5.85e-2)" "unprognostic (1.88e-1)" "unprognostic (2.32e-2)" "unprognostic (1.69e-1)" "unprognostic (1.61e-1)" "unprognostic (3.26e-1)" "unprognostic (1.12e-2)" 22.5 18.4 14.2 15.1 22.0 38.0 17.8 29.1 23.3 21.2 14.3 6.7 14.6 12.6 18.3 15.2 24.2 14.7 10.5 12.5 12.6 10.8 23.7 25.0 13.5 18.2 12.8 16.4 21.7 15.0 17.8 33.5 21.4 19.8 20.9 11.8 6.3 20.7 14.2 28.8 16.6 15.2 15.7 16.1 19.8 15.1 12.3 17.3 24.3 20.5 22.4 18.1 19.6 16.4 15.8 10.8 8.9 4.6 8.6 14.7 5.6 25.4 21.1 13.3 11.8 10.5 9.6 24.3 22.3 14.2 17.6 11.3 15.4 13.4 27.1 18.2 11.0 17.6 13.4 17.8 19.6 19.9 22.3 18.1 26.2 11.7 17.9 12.7 46.1 16.6 9.9 16.8 20.2 19.3 17.8 12.0 25.9 28.9 8.7 17.2 16.8 26.8 13.1 19.6 14.1 19.3 21.3 25.6 16.3 19.6 32.2 16.0 13.3 21.1 15.0 26.3 13.3 24.9 18.8 14.9 16.3 10.8 16.8 23.1 17.4 21.8 17.0 8.8 16.3 29.3 7.7 2.4 8.9 10.1 4.6 12.4 15.8 14.1 11.4 3.9 14.4 14.7 13.8 1.1 8.6 3.7 10.8 12.5 5.6 14.2 22.0 29.1 23.3 12.6 10.8 12.8 16.4 19.8 17.3 65.5 42.2 31.8 91.0 43.6 53.3 22.4 15.3 48.2 54.6 38.4 31.4 56.6 49.7 37.5 4.0 32.2 15.1 0.0 42.7 45.8 41.4 40.8 36.9 36.7 26.1 69.9 17.2 22.1 18.8 5.3 48.6 29.3 11.8 32.5 23.2 65.0 33.7 27.9 50.2 37.3 53.6 12.9 36.3 55.6 54.8 38.8 58.9 48.4 29.3 62.9 KYAT3 "CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3" ENSG00000137944 "Kynurenine aminotransferase 3" Q6YP21 1 88935773-88992953 "Enzymes, Predicted intracellular proteins" "Aminotransferase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 59.0;monocytes: 55.9;Syncytiotrophoblasts: 69.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026538, HPA027168" Enhanced Approved "Nucleoli,Cytokinetic bridge,Cytosol" NA NA Cytosol "Nucleoli, Cytokinetic bridge" "HPA026538: AB_1852076, HPA027168: AB_1852078" "prognostic favorable (3.19e-5)" "unprognostic (3.36e-3)" "unprognostic (1.88e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-2)" "prognostic favorable (1.86e-4)" "unprognostic (2.61e-1)" "unprognostic (3.61e-3)" "unprognostic (2.11e-1)" "prognostic favorable (2.80e-4)" "unprognostic (1.04e-1)" "unprognostic (3.17e-1)" "prognostic favorable (5.02e-6)" "unprognostic (1.17e-1)" "unprognostic (1.06e-1)" "unprognostic (2.51e-1)" "unprognostic (2.78e-1)" 22.2 26.8 16.6 13.2 19.3 10.6 27.5 14.9 23.5 23.7 17.5 20.0 13.0 19.4 24.1 21.2 27.2 18.9 17.8 13.2 18.6 14.2 27.3 23.8 17.1 17.6 16.9 22.2 27.4 28.6 27.0 19.5 21.9 23.4 19.0 19.6 19.5 21.0 20.7 10.4 22.0 17.2 22.1 14.8 20.7 23.5 15.6 17.2 15.5 24.5 13.4 20.2 25.2 17.7 9.6 17.0 9.2 12.7 11.5 16.7 8.2 20.8 4.4 21.4 7.1 7.7 21.5 18.6 12.8 24.2 16.5 21.5 6.4 7.3 13.8 9.8 9.5 11.0 5.9 6.0 9.9 25.2 8.1 8.6 12.3 4.2 10.5 25.1 17.2 3.4 18.1 10.0 11.3 20.4 10.5 15.9 16.2 15.9 7.3 15.5 6.9 18.4 8.4 12.7 16.1 3.8 18.8 15.0 7.3 34.6 21.3 15.6 19.1 17.0 22.8 11.1 14.3 12.6 4.2 10.6 6.9 4.6 22.1 9.3 9.9 4.9 9.2 3.4 7.7 5.9 5.6 12.7 7.1 9.1 7.9 12.6 9.6 11.8 10.5 17.0 9.3 12.4 10.4 9.2 11.5 10.2 6.3 16.7 8.2 16.6 19.3 14.9 23.5 18.6 14.2 16.9 22.2 23.4 17.2 11.9 8.3 0.0 0.0 0.0 0.0 0.0 0.0 6.7 14.8 12.2 0.0 59.0 21.6 29.8 0.0 0.0 0.0 0.0 33.6 33.1 0.0 0.0 4.7 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 55.9 0.0 0.0 21.3 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 69.8 0.0 0.0 0.0 L3MBTL3 KIAA1798 ENSG00000198945 "L3MBTL3, histone methyl-lysine binding protein" Q96JM7 6 130013699-130141451 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 31.5;HUVEC TERT2: 30.6;TIME: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044382, HPA053035" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" Yes No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044382: AB_2678920, HPA053035: AB_2682021" "unprognostic (2.33e-1)" "unprognostic (9.92e-2)" "unprognostic (1.40e-1)" "unprognostic (7.82e-2)" "unprognostic (4.22e-3)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.48e-2)" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (7.56e-3)" "unprognostic (1.07e-1)" "unprognostic (8.44e-2)" "unprognostic (3.94e-3)" "unprognostic (2.88e-1)" "unprognostic (2.45e-2)" "unprognostic (1.60e-2)" 8.8 16.7 5.2 16.4 8.2 7.5 7.5 2.4 7.7 17.1 5.6 3.6 9.3 3.1 17.5 14.1 5.7 7.4 6.0 4.1 5.4 5.8 6.1 6.4 7.4 11.4 5.2 5.9 12.1 3.8 8.1 17.0 6.5 5.7 10.3 5.7 4.8 5.8 7.5 5.3 4.3 7.6 9.9 5.4 18.5 4.6 7.5 3.9 25.5 10.2 4.3 12.8 10.4 11.6 10.7 10.8 3.9 14.1 1.7 4.2 0.6 0.8 3.2 7.4 1.1 5.1 6.9 1.5 3.7 7.7 1.5 2.7 3.8 4.0 1.3 5.4 4.8 4.6 3.2 4.2 6.6 2.3 2.9 4.3 8.6 1.6 1.0 2.6 5.1 31.5 4.3 4.8 1.7 5.1 7.6 30.6 4.1 6.2 3.5 3.8 0.3 10.8 0.9 3.5 0.7 1.6 4.0 2.1 0.0 4.9 1.2 0.2 1.0 1.4 0.3 3.0 9.5 7.8 4.5 20.9 2.5 3.5 0.4 2.4 0.6 0.0 2.3 1.2 2.1 2.5 3.9 3.5 3.5 2.7 4.0 2.7 7.6 2.7 3.8 1.3 10.7 2.4 3.0 3.7 1.7 14.1 10.8 4.2 0.6 5.2 8.2 2.4 7.7 5.4 5.8 5.2 5.9 5.7 3.9 3.0 9.2 7.5 4.8 4.5 2.9 2.9 2.5 5.3 3.4 8.7 2.0 10.2 1.7 4.3 18.5 5.6 0.7 0.0 4.9 6.0 6.7 4.2 38.3 4.9 3.3 0.0 3.5 7.4 8.2 1.6 8.9 3.6 1.7 4.6 7.2 5.6 7.5 3.5 5.6 4.3 0.7 6.5 5.1 5.4 6.1 3.9 5.1 10.0 4.1 5.2 LBX1 "HPX6, LBX1H" ENSG00000138136 "Ladybird homeobox 1" P52954 10 101226195-101229794 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 76 "brain: 11.8;skeletal muscle: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "cerebellum: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 5.0;RH-30: 6.4;SCLC-21H: 13.6" "Group enriched" "Detected in some" 24 "cerebellum: 1.8;pons and medulla: 3.2" "Group enriched" "Detected in some" 21 "cerebellum: 2.9;pons and medulla: 2.8" "HPA002016, HPA002086, CAB079927" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242" "unprognostic (4.13e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" "unprognostic (2.29e-1)" "unprognostic (7.28e-3)" "unprognostic (3.31e-1)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.4 0.0 0.0 0.0 13.6 0.0 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.8 0.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LDB2 "CLIM1, LDB1" ENSG00000169744 "LIM domain binding 2" O43679 4 16501541-16898809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 21 "Endothelial cells: 120.7;Ito cells: 249.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "amygdala: 14.5;basal ganglia: 30.3;cerebral cortex: 45.3;hippocampal formation: 16.6;olfactory region: 21.7" "Cell type enriched" "Detected in single" 13 "NK-cell: 5.1" "Lineage enriched" "Detected in single" 13 "NK-cells: 5.1" "Cell line enhanced" "Detected in some" "AF22: 9.7;ASC TERT1: 9.3;fHDF/TERT166: 9.8;HAP1: 18.0;HUVEC TERT2: 34.0;U-138 MG: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017544, HPA068634" Supported Supported "Nucleoplasm,Nucleoli,Plasma membrane" No NA "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB017544: AB_2137013, HPA068634: AB_2686012" "unprognostic (3.43e-1)" "unprognostic (2.77e-1)" "unprognostic (9.10e-2)" "unprognostic (4.37e-1)" "unprognostic (7.25e-2)" "unprognostic (4.62e-3)" "unprognostic (2.10e-3)" "unprognostic (1.57e-1)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.96e-2)" "unprognostic (2.05e-3)" "unprognostic (1.26e-3)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "unprognostic (7.10e-3)" 27.9 9.5 14.5 4.6 30.3 0.4 26.8 1.1 45.3 27.1 6.8 2.7 8.0 4.0 54.9 14.4 9.5 15.6 18.3 18.5 16.6 4.8 14.9 15.0 31.3 6.9 5.5 21.7 11.9 4.6 15.2 5.6 33.7 3.4 10.4 5.4 15.4 6.1 8.6 7.5 5.4 6.8 32.8 4.2 32.9 6.7 6.4 3.4 0.7 17.8 7.5 3.0 14.7 13.3 0.2 0.0 0.3 0.0 5.1 0.0 0.6 0.0 0.0 9.7 0.0 5.6 9.3 0.0 5.3 4.1 0.6 1.5 0.0 0.0 0.0 0.0 9.8 0.0 0.0 18.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 5.2 0.0 6.7 0.0 1.4 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 2.8 0.0 0.0 8.9 13.7 0.0 0.7 0.0 4.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.6 14.5 30.3 1.1 45.3 16.6 4.8 5.5 21.7 3.4 3.4 0.0 8.5 1.9 0.2 7.7 21.5 9.2 5.1 1.4 0.0 0.0 0.0 0.2 0.0 1.7 1.1 120.7 0.0 0.0 0.2 0.2 22.0 0.3 5.7 1.3 0.3 0.0 0.0 249.8 20.4 1.5 35.4 2.3 8.5 0.0 0.0 9.8 0.3 0.0 47.4 0.0 1.7 6.5 13.4 0.0 0.6 5.9 0.1 5.4 0.0 0.1 LDOC1 "BCUR1, Mar7, Mart7, RTL7, SIRH7" ENSG00000182195 "LDOC1, regulator of NFKB signaling" O95751 X 141175745-141177125 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 36.5;Peritubular cells: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 19.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 29.8;MCF7: 40.1;PC-3: 50.3;U-251 MG: 29.9" "Region enriched" "Detected in many" 5 "cerebellum: 21.5" "Low region specificity" "Detected in all" "HPA051768, HPA061842" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051768: AB_2681599, HPA061842: AB_2684624" "unprognostic (4.09e-1)" "unprognostic (4.72e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-3)" "unprognostic (2.47e-1)" "unprognostic (2.42e-1)" "unprognostic (4.51e-2)" "unprognostic (2.08e-2)" "unprognostic (8.92e-2)" "unprognostic (1.21e-1)" "unprognostic (6.40e-3)" "unprognostic (1.21e-1)" "unprognostic (1.27e-2)" "unprognostic (1.98e-2)" "unprognostic (3.06e-2)" "unprognostic (4.38e-3)" "unprognostic (2.76e-2)" 21.1 24.2 24.4 5.9 31.8 2.0 9.9 18.3 51.2 24.2 5.5 21.0 11.0 5.1 17.3 12.1 10.0 30.3 10.4 6.7 27.3 25.6 15.6 3.1 9.7 5.5 23.2 23.3 31.8 18.3 13.0 54.9 1.8 30.2 23.1 3.5 13.5 47.9 36.4 3.8 17.9 5.2 12.5 19.5 9.3 7.8 6.6 16.6 1.8 22.6 3.7 5.7 11.2 9.9 8.2 4.8 8.2 0.0 19.2 8.9 3.0 0.0 29.8 4.6 12.8 8.0 9.8 0.0 7.1 8.8 9.7 13.6 0.0 11.7 0.0 5.6 11.6 9.6 14.0 5.0 10.4 6.9 0.0 9.2 0.0 16.1 0.0 3.1 0.0 2.8 17.3 5.4 8.4 4.5 7.8 8.2 0.0 0.2 0.0 8.7 40.1 0.0 0.0 4.8 0.0 50.3 0.0 4.1 0.0 11.9 7.0 0.0 4.0 0.0 6.2 0.0 2.6 7.9 0.0 14.8 0.0 9.6 0.0 29.9 0.0 0.0 0.0 5.0 0.0 0.0 8.2 0.0 0.1 4.3 0.0 3.1 3.3 8.9 3.3 0.8 8.2 7.9 5.1 0.2 19.2 0.0 4.8 8.1 3.0 24.4 31.8 18.3 47.4 27.3 25.6 23.2 23.3 30.2 16.6 0.0 4.0 0.0 15.7 5.4 25.2 1.6 22.9 5.3 10.3 22.7 7.9 1.9 36.5 12.0 0.5 11.3 0.0 0.0 12.3 1.6 11.7 14.6 2.3 0.0 0.8 19.1 5.2 11.1 0.8 0.9 20.4 1.6 3.3 0.0 0.2 20.6 11.6 0.0 36.4 26.8 9.6 12.9 19.4 0.9 7.7 5.9 1.3 5.7 0.0 14.0 LEKR1 FLJ16641 ENSG00000197980 "Leucine, glutamate and lysine rich 1" Q6ZMV7 3 156825481-157046129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 29.8" "Group enriched" "Detected in many" 10 "Ciliated cells: 34.8;Early spermatids: 63.2;Late spermatids: 32.2;Spermatocytes: 49.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 6.6;U-266/70: 6.2" "Low region specificity" "Detected in all" "HPA044039, HPA047774" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA044039: AB_10794288, HPA047774: " "unprognostic (5.42e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (8.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.94e-1)" "unprognostic (2.29e-3)" "unprognostic (1.98e-2)" "unprognostic (7.55e-2)" "unprognostic (2.20e-1)" "unprognostic (5.66e-3)" "unprognostic (3.50e-2)" "unprognostic (5.99e-2)" "unprognostic (6.59e-2)" "unprognostic (3.28e-1)" "unprognostic (2.17e-3)" "unprognostic (1.80e-2)" 1.4 1.7 1.4 2.5 4.6 0.6 2.7 1.4 2.2 1.5 1.0 1.6 3.5 1.7 1.3 8.2 0.9 6.3 1.7 1.4 1.5 2.0 2.8 1.3 3.0 1.6 1.1 1.4 2.9 2.7 4.8 4.5 0.5 2.2 1.7 1.1 2.5 1.6 4.9 0.7 0.9 1.6 0.8 1.9 1.8 1.5 29.8 0.7 4.4 4.0 0.7 1.4 1.2 1.8 3.2 1.9 2.5 0.3 2.5 2.0 0.4 6.6 2.7 0.1 1.6 1.2 0.6 0.4 0.4 1.0 1.4 1.1 0.3 3.8 0.1 2.0 1.1 2.6 2.5 0.0 0.5 2.7 1.2 0.6 2.5 0.5 0.0 0.0 2.1 0.6 3.1 1.6 0.5 1.9 0.8 0.6 0.1 1.5 1.6 2.4 2.4 0.0 1.9 2.2 1.9 1.5 0.0 1.8 1.5 2.1 0.6 4.2 1.7 2.2 1.5 0.1 0.5 4.6 3.6 0.0 0.4 0.7 0.5 1.0 6.2 1.0 0.0 1.2 1.5 2.3 2.5 0.3 0.3 0.7 0.1 1.4 3.1 1.6 0.6 1.2 3.2 1.8 0.9 0.3 2.5 0.2 1.9 2.0 0.4 1.4 4.6 1.4 2.2 1.5 2.0 1.1 1.4 2.2 0.7 0.0 1.4 0.0 1.1 1.1 1.3 0.8 2.5 34.8 3.4 3.5 2.0 0.2 3.3 0.6 63.2 0.4 1.3 0.0 1.4 0.1 0.5 0.7 1.1 1.6 0.2 3.2 0.0 0.0 1.8 32.2 1.4 1.1 1.7 1.8 0.6 1.4 0.7 0.0 1.8 3.3 4.5 0.0 0.3 49.4 3.2 0.6 0.1 1.3 0.8 0.8 LEMD1 "CT50, LEMP-1" ENSG00000186007 "LEM domain containing 1" Q68G75 1 205381378-205457091 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 13.1;testis: 34.8" "Group enriched" "Detected in some" 129 "Early spermatids: 869.0;Late spermatids: 3077.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.6" "Group enriched" "Detected in some" 13 "cerebellum: 2.6;pons and medulla: 5.3" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 29.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045425 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA045425: AB_10960538" "unprognostic (1.78e-1)" "unprognostic (2.00e-1)" "unprognostic (1.88e-2)" "unprognostic (4.20e-3)" "unprognostic (7.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.72e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.26e-4)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.31e-1)" "unprognostic (5.66e-6)" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-2)" 0.2 0.2 0.2 0.0 0.3 0.0 0.3 2.6 0.2 0.4 1.4 0.0 3.8 0.6 1.0 13.1 1.0 1.5 0.7 0.2 0.2 0.3 0.9 0.2 0.4 0.0 0.3 0.0 0.6 0.6 0.0 0.6 4.7 5.3 0.3 0.0 0.3 3.2 0.4 0.2 0.3 1.4 0.1 0.2 0.2 0.3 34.8 0.0 0.0 4.8 2.2 2.6 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.7 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 29.9 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.9 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.2 0.3 2.6 0.2 0.2 0.3 0.3 0.0 5.3 0.0 0.0 1.6 0.0 1.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.4 869.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3077.5 11.8 0.0 0.0 0.0 0.0 0.9 4.0 0.0 13.1 1.5 0.7 6.5 0.0 15.3 7.2 0.0 0.3 0.0 0.0 2.2 LETMD1 "HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3" ENSG00000050426 "LETM1 domain containing 1" Q6P1Q0 12 51047962-51060424 "Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074361 Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Mitochondria "Nucleoplasm, Nucleoli" "HPA074361: AB_2686682" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.11e-1)" "unprognostic (2.20e-2)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "unprognostic (5.05e-2)" "unprognostic (7.86e-2)" "unprognostic (6.57e-2)" "prognostic favorable (3.26e-4)" "unprognostic (4.07e-1)" "unprognostic (7.79e-2)" "unprognostic (2.58e-1)" "prognostic favorable (3.16e-4)" 25.7 27.5 23.0 18.1 31.2 17.1 27.1 23.1 37.5 18.6 26.8 18.8 21.5 31.9 22.9 22.4 16.2 30.0 23.5 16.4 21.2 19.0 29.3 35.1 16.6 18.5 20.6 21.3 34.3 38.6 28.5 20.2 12.3 21.6 19.1 26.1 22.6 28.2 24.0 23.8 18.5 28.5 18.7 21.4 17.5 22.6 15.5 14.3 19.9 34.1 10.7 20.1 20.3 14.8 11.3 7.2 2.9 11.6 8.6 17.1 9.3 7.4 6.7 5.0 13.5 22.8 37.4 5.1 7.7 12.8 8.1 9.2 16.2 15.4 19.7 9.6 8.3 5.9 13.9 10.3 10.4 9.4 7.1 12.9 14.1 9.3 12.7 15.1 12.7 10.3 31.5 33.7 9.6 22.8 24.8 8.2 19.1 14.6 14.3 11.1 11.6 8.9 12.3 3.4 9.3 18.3 7.6 6.1 10.7 10.2 11.4 15.0 6.9 5.8 13.1 17.6 5.3 20.7 11.6 6.2 5.1 5.5 8.4 4.4 13.0 20.2 8.4 9.5 8.3 3.6 2.5 7.3 2.9 8.6 7.8 12.5 11.3 14.2 10.6 7.2 8.1 17.1 15.5 2.4 8.6 11.6 6.4 12.6 9.3 23.0 31.2 23.1 37.5 21.2 19.0 20.6 21.3 21.6 14.3 20.8 22.7 30.4 41.1 44.1 20.2 12.5 22.9 25.4 11.4 22.7 9.8 40.0 77.9 12.6 6.3 19.6 22.0 23.3 28.4 18.9 32.4 29.0 25.3 16.3 26.2 17.5 26.7 20.3 41.0 11.9 30.2 21.2 37.1 17.2 34.4 24.4 16.0 28.1 28.7 31.5 16.5 25.8 38.1 20.6 19.4 38.8 23.3 42.4 49.8 24.8 LEUTX ENSG00000213921 "Leucine twenty homeobox" A8MZ59 19 39776595-39786167 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "CACO-2: 1.0;HDLM-2: 2.3" HPA041498 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041498: AB_10796346" "unprognostic (6.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LHFPL6 "LHFP, MGC22429" ENSG00000183722 "LHFPL tetraspan subfamily member 6" Q9Y693 13 39342892-39603528 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "Extravillous trophoblasts: 146.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "myeloid DC: 9.4;plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 14 "dendritic cells: 9.4" "Cell line enhanced" "Detected in many" "ASC diff: 66.1;HSkMC: 48.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058975 Approved Approved Nucleoli NA NA Nucleoli "HPA058975: AB_2683866" "unprognostic (6.98e-2)" "unprognostic (2.71e-1)" "unprognostic (2.00e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (4.10e-2)" "unprognostic (5.84e-2)" "unprognostic (1.08e-1)" "unprognostic (2.76e-1)" "unprognostic (5.45e-2)" "unprognostic (8.68e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (1.20e-7)" "unprognostic (4.41e-3)" "unprognostic (5.25e-2)" "unprognostic (7.75e-2)" "prognostic unfavorable (2.30e-4)" 57.2 26.8 12.5 14.8 17.7 0.9 45.7 40.8 19.0 20.3 16.4 12.3 8.5 5.3 28.6 23.7 17.9 27.0 34.9 49.4 12.7 12.9 12.8 6.9 27.0 27.4 19.3 12.6 25.7 8.3 7.1 14.3 62.0 16.8 21.4 8.4 19.8 11.4 18.8 13.6 13.1 9.6 33.1 18.5 18.5 10.2 16.2 11.9 1.3 22.7 22.1 8.3 20.1 25.8 0.2 9.4 0.1 0.6 0.0 0.0 0.4 2.7 1.0 30.0 1.3 66.1 30.0 13.1 15.3 22.1 7.8 5.9 0.1 2.9 4.2 0.3 21.3 10.2 4.3 3.7 8.9 6.5 4.1 4.4 11.5 0.9 0.0 6.9 0.2 0.3 48.3 1.2 7.0 11.7 7.0 7.2 0.2 0.0 0.0 15.0 2.4 0.0 3.5 2.2 0.0 4.0 1.8 13.0 0.0 5.2 3.7 0.1 0.9 1.4 1.8 4.1 17.9 1.7 0.0 13.5 19.9 2.9 6.1 8.3 0.2 0.0 12.0 8.3 0.0 14.3 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.4 0.2 0.0 0.0 0.1 0.0 0.1 3.2 0.0 0.4 12.5 17.7 40.8 19.0 12.7 12.9 19.3 12.6 16.8 11.9 3.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 4.0 18.2 0.0 0.0 3.1 1.7 0.6 0.0 0.0 0.0 0.0 0.6 146.6 0.0 0.0 2.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 LHX8 Lhx7 ENSG00000162624 "LIM homeobox 8" Q68G74 1 75128434-75161533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9" "Cell type enhanced" "Detected in single" 26 "Spermatogonia: 2.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 9.5;thalamus: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 23.8;U-266/70: 8.0" "Region enhanced" "Detected in some" "basal ganglia: 9.9" "Group enriched" "Detected in some" 32 "basal ganglia: 15.3;hypothalamus: 4.4" HPA071806 Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA071806: AB_2686449" "unprognostic (2.28e-2)" "unprognostic (6.23e-2)" "unprognostic (3.85e-3)" "unprognostic (1.52e-9)" "unprognostic (1.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.1 0.0 9.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 2.1 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.3 0.0 3.9 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.3 0.0 0.5 4.9 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.2 0.0 0.0 8.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.5 0.0 1.1 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 LIN28A "CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1" ENSG00000131914 "Lin-28 homolog A" Q9H9Z2 1 26410778-26429722 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 9.8" "Group enriched" "Detected in some" 42 "Early spermatids: 24.2;Late spermatids: 49.8" "Cancer enriched" "Detected in single" 261 "testis cancer: 101.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "NTERA-2: 136.8;SuSa: 50.5" "Not detected" "Not detected" "CAB020785, HPA063074, HPA068814" Enhanced Supported "Nucleoli,Cytosol,Rods & Rings" NA NA Cytosol "Nucleoli, Rods & Rings" "CAB020785: , HPA063074: , HPA068814: " "unprognostic (9.64e-3)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.85e-1)" "unprognostic (2.21e-1)" "unprognostic (2.49e-2)" "unprognostic (1.83e-1)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.5 0.5 0.1 0.1 0.1 0.2 0.3 9.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.6 2.3 0.5 1.0 0.8 0.1 0.0 0.0 13.5 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.5 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.5 0.7 0.7 0.3 0.4 1.0 0.5 0.6 0.2 1.3 0.8 0.7 2.2 1.0 0.3 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.4 0.1 0.0 0.0 0.0 0.1 LIN28B "CSDD2, FLJ16517" ENSG00000187772 "Lin-28 homolog B" Q6ZN17 6 104936616-105083332 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "placenta: 51.9" "Cell type enhanced" "Detected in some" 13 "Cytotrophoblasts: 66.0;Extravillous trophoblasts: 67.8;Syncytiotrophoblasts: 46.7" "Cancer enriched" "Detected in single" 25 "testis cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 14.1;BEWO: 73.1;Hep G2: 12.2;K-562: 23.6;NTERA-2: 12.9;SuSa: 13.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036630, HPA061745" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA036630: AB_10669911, HPA061745: AB_2684601" "unprognostic (2.00e-4)" "unprognostic (6.75e-2)" "unprognostic (2.02e-1)" "unprognostic (2.57e-2)" "unprognostic (1.59e-2)" "unprognostic (4.10e-2)" 0.1 0.1 1.2 0.0 0.8 0.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.1 0.1 0.1 0.5 0.8 0.0 0.0 0.0 1.0 51.9 1.2 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 5.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.7 2.1 0.4 0.2 0.5 0.3 0.0 0.9 14.1 2.8 0.0 0.0 73.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.8 0.0 8.8 0.0 0.0 0.0 6.8 10.1 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.3 0.0 0.0 1.5 1.7 12.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 1.1 13.5 0.0 2.9 0.3 0.0 1.5 0.0 0.0 4.3 6.0 0.0 0.0 0.0 0.0 1.6 0.4 0.2 0.5 0.4 0.3 0.5 0.3 0.1 0.2 0.7 0.1 0.2 2.1 0.2 0.4 0.7 0.2 0.3 1.2 0.8 0.1 1.3 0.9 1.3 0.5 0.8 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 5.9 66.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 67.8 0.0 0.0 0.0 0.0 8.0 1.6 0.0 0.0 0.0 17.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 6.5 0.0 5.8 9.2 0.0 46.7 0.0 0.0 0.0 LLPH "C12orf31, hLLP, MGC14817" ENSG00000139233 "LLP homolog, long-term synaptic facilitation" Q9BRT6 12 66116555-66130768 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048920, HPA058786" Enhanced "Nucleoli,Mitotic chromosome" Yes No Nucleoli "Mitotic chromosome" "HPA048920: AB_2680556, HPA058786: AB_2683820" "unprognostic (3.60e-3)" "unprognostic (4.94e-2)" "unprognostic (4.07e-2)" "unprognostic (3.03e-2)" "unprognostic (2.13e-1)" "unprognostic (4.31e-2)" "prognostic unfavorable (6.44e-7)" "unprognostic (7.15e-2)" "unprognostic (1.30e-2)" "unprognostic (8.49e-3)" "unprognostic (2.15e-2)" "unprognostic (1.07e-2)" "unprognostic (3.87e-2)" "unprognostic (9.65e-3)" "unprognostic (2.49e-2)" "unprognostic (3.37e-1)" "unprognostic (2.94e-2)" 20.4 38.1 16.4 20.4 16.9 40.9 17.9 10.9 20.0 16.4 20.2 11.2 19.7 16.4 17.2 17.1 21.3 14.4 13.4 19.9 15.7 13.9 27.8 31.3 14.5 21.4 20.6 16.7 18.2 16.2 11.1 18.0 24.3 17.3 18.1 18.6 9.9 15.9 14.5 47.3 13.9 27.9 21.0 26.7 29.7 18.6 20.0 17.6 23.8 22.9 23.5 21.6 23.6 22.4 23.6 24.6 34.9 34.7 20.0 29.4 21.1 27.2 22.1 13.6 16.8 15.9 15.7 16.8 32.0 20.7 23.8 20.2 19.1 11.6 31.7 26.4 21.2 18.8 23.4 21.2 19.4 32.3 27.7 18.2 33.5 16.0 17.0 19.2 58.2 23.6 15.8 20.1 20.2 21.8 18.7 20.5 16.1 28.9 22.8 27.8 29.3 26.0 39.2 29.2 22.3 23.5 22.1 25.1 22.8 23.3 33.0 13.7 16.9 20.7 22.1 33.7 15.0 28.4 31.8 22.1 18.7 26.8 22.7 29.0 17.7 27.4 46.9 24.4 27.4 28.3 22.2 25.6 26.4 23.7 29.0 27.0 23.6 27.6 25.5 24.6 21.7 23.9 25.2 34.9 20.0 34.7 21.2 29.4 21.1 16.4 16.9 10.9 20.0 15.7 13.9 20.6 16.7 17.3 17.6 11.9 36.4 61.0 44.6 24.2 16.2 20.7 50.9 30.8 53.4 29.6 3.9 54.4 56.3 64.5 29.5 27.6 32.9 0.0 61.6 55.9 32.7 30.8 87.7 53.9 56.6 20.6 13.3 33.2 50.4 10.0 40.6 51.5 33.7 79.4 24.4 25.7 76.7 34.5 28.3 61.5 14.5 25.8 23.6 77.7 46.2 26.7 60.8 41.5 28.5 46.2 LRCH1 "CHDC1, KIAA1016" ENSG00000136141 "Leucine rich repeats and calponin homology domain containing 1" Q9Y2L9 13 46553168-46753040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 46.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021536 Approved Approved "Nucleoli,Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" Nucleoli "HPA021536: AB_1853258" "unprognostic (7.13e-3)" "prognostic unfavorable (6.24e-4)" "unprognostic (3.59e-2)" "unprognostic (8.93e-2)" "unprognostic (7.50e-2)" "unprognostic (1.37e-1)" "unprognostic (5.16e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (2.16e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.04e-4)" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-1)" "unprognostic (1.98e-2)" 17.9 5.0 6.5 20.3 5.9 7.2 15.2 46.4 7.2 17.5 14.6 4.6 11.5 7.0 24.6 9.8 10.6 11.9 14.1 8.0 6.3 5.9 13.8 10.9 14.3 13.5 6.6 4.9 9.5 5.1 5.2 13.1 24.1 8.0 12.8 9.3 8.4 11.3 14.5 5.3 18.1 12.0 20.9 8.5 13.7 14.6 5.0 6.0 31.7 7.8 6.4 13.7 16.6 18.3 6.2 2.3 1.8 2.0 5.1 3.6 1.8 4.3 6.3 5.7 5.9 4.2 8.0 14.7 7.5 9.9 9.4 8.9 14.2 7.5 14.0 2.1 7.1 6.1 6.3 4.3 7.6 13.6 14.4 4.1 12.6 2.5 6.6 5.2 8.1 21.6 5.1 6.0 8.6 10.5 7.7 8.0 9.5 2.4 4.3 6.9 8.5 8.7 10.2 3.2 27.7 3.3 4.8 6.2 3.7 17.5 4.6 9.1 9.1 4.2 4.2 11.2 10.6 3.2 11.0 7.6 5.5 3.7 6.8 7.1 0.8 2.1 6.3 6.4 7.2 6.6 1.5 2.0 1.8 3.6 1.6 2.1 5.3 2.7 2.6 1.9 6.2 2.1 2.1 0.7 5.1 1.2 2.3 1.9 1.8 6.5 5.9 46.4 7.2 6.3 5.9 6.6 4.9 8.0 6.0 6.0 6.7 15.1 9.1 33.3 8.2 6.7 25.5 1.4 6.8 21.0 21.6 11.1 8.3 7.2 1.2 25.9 6.9 0.0 3.5 10.0 10.5 7.9 27.6 7.9 11.4 3.2 1.7 16.5 16.7 1.1 12.0 9.9 28.7 5.4 9.7 6.4 9.5 5.8 15.9 7.3 8.9 12.9 21.7 0.7 3.2 29.1 8.1 10.2 6.5 7.8 LRCH2 KIAA1495 ENSG00000130224 "Leucine rich repeats and calponin homology domain containing 2" Q5VUJ6 X 115110616-115234072 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 10.5;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 17.8;hTERT-RPE1: 9.1;U-266/70: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003233 Approved Approved "Nucleoli,Plasma membrane" NA NA Nucleoli "Plasma membrane" "HPA003233: AB_2265929" "unprognostic (9.74e-2)" "unprognostic (9.48e-2)" "unprognostic (1.14e-2)" "unprognostic (4.22e-5)" "unprognostic (2.88e-2)" "unprognostic (1.17e-1)" "unprognostic (1.42e-1)" "unprognostic (9.39e-2)" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "unprognostic (1.01e-2)" "unprognostic (1.84e-1)" "unprognostic (4.29e-5)" "unprognostic (1.09e-3)" "unprognostic (1.34e-1)" "unprognostic (7.75e-2)" "unprognostic (1.16e-2)" 5.1 8.7 11.6 3.4 10.2 0.7 3.3 11.2 10.6 11.2 11.6 5.5 4.0 1.6 9.9 4.5 3.6 4.6 5.3 4.7 7.9 8.9 2.6 1.0 5.7 1.8 5.7 4.6 13.8 1.6 1.3 20.9 13.7 7.6 16.4 4.2 2.5 1.3 14.5 1.2 1.1 3.2 13.7 6.4 3.7 3.6 4.3 7.9 0.0 4.8 0.4 1.1 11.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 3.9 5.5 4.6 0.0 3.5 7.6 3.4 7.9 0.0 0.0 0.1 0.0 4.6 2.7 0.3 17.8 0.0 5.2 0.0 4.8 0.0 0.0 0.0 4.4 0.0 0.1 2.7 0.0 1.4 0.2 9.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 5.2 0.0 3.8 0.0 4.3 0.5 0.0 6.8 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 2.1 0.0 4.9 11.8 2.0 0.0 1.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 10.2 11.2 8.4 7.9 8.9 5.7 4.6 7.6 7.9 3.0 10.5 0.0 0.0 0.6 6.7 5.5 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.0 5.7 4.5 0.0 0.0 0.0 0.1 5.4 1.2 0.0 0.0 0.5 1.6 0.0 1.8 0.0 1.5 8.1 0.0 1.7 0.0 0.0 6.6 0.0 0.0 6.0 0.0 2.4 25.8 7.1 3.6 3.0 0.1 0.2 0.0 0.0 0.0 LRP10 "DKFZP564C1940, LRP9, MGC8675, MST087, MSTP087" ENSG00000197324 "LDL receptor related protein 10" Q7Z4F1 14 22871613-22881580 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 29.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 29.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000932 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA000932: AB_2281523" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (3.72e-2)" "unprognostic (4.59e-2)" "unprognostic (1.72e-1)" "unprognostic (5.01e-2)" "prognostic unfavorable (3.54e-7)" "prognostic unfavorable (9.17e-4)" "unprognostic (8.32e-2)" "unprognostic (1.48e-2)" "unprognostic (1.97e-2)" "unprognostic (4.55e-2)" "prognostic favorable (6.31e-5)" "unprognostic (3.06e-2)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (4.14e-2)" 33.1 20.1 12.7 26.0 13.1 23.7 37.2 5.8 10.3 32.0 52.4 16.2 41.0 31.7 39.0 46.8 66.1 27.1 65.1 27.7 13.6 6.0 46.5 63.3 34.1 30.0 14.2 8.1 30.7 36.6 31.4 11.7 32.0 14.4 36.9 19.0 22.6 36.1 41.1 21.2 32.9 65.9 32.0 11.2 26.1 37.9 19.1 12.9 20.7 46.9 34.1 36.2 43.3 42.8 3.8 2.3 29.7 2.6 2.4 6.3 3.4 15.4 18.9 4.1 10.8 56.7 32.9 14.1 24.5 46.6 15.5 21.5 5.8 55.1 8.1 12.3 55.1 17.7 22.2 2.7 28.0 6.1 13.2 2.9 2.8 10.4 4.0 25.3 6.4 25.9 35.9 32.8 23.1 12.0 43.0 28.2 3.7 3.4 31.4 20.8 17.8 1.8 1.9 0.9 15.0 25.5 4.1 4.2 8.1 16.6 27.6 0.3 4.5 13.5 26.0 10.6 3.2 13.6 4.6 29.3 23.9 6.8 12.3 10.0 14.7 8.7 3.7 12.3 2.6 10.2 5.9 2.2 15.8 5.1 2.3 5.0 3.8 6.3 6.0 2.3 2.7 5.5 3.1 29.7 2.4 2.6 1.9 6.0 3.4 12.7 13.1 5.8 10.3 13.6 6.0 14.2 8.1 14.4 12.9 98.3 51.7 60.9 74.0 34.2 2.2 27.2 107.0 37.5 59.1 78.5 0.0 55.7 8.3 146.7 9.9 50.6 243.0 46.7 208.6 82.1 65.3 100.3 34.6 35.4 52.6 0.0 63.9 69.3 49.2 11.4 52.6 36.1 52.3 101.0 99.6 89.2 227.5 199.9 68.6 40.8 8.3 64.7 65.9 2.6 6.7 41.5 110.6 62.3 73.3 132.4 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856868-46918642 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;skin 1: 33.0" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 17.0;SuSa: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 1.2 1.9 16.0 1.3 20.3 0.5 2.1 7.3 23.7 3.0 5.4 11.6 0.6 3.9 2.1 1.3 2.4 2.0 2.5 7.2 20.4 5.8 1.2 0.7 3.4 0.5 9.6 12.6 5.4 2.7 9.3 3.3 3.1 14.5 2.7 4.1 1.3 2.1 3.0 4.4 33.0 5.3 2.0 9.7 4.2 9.6 1.6 19.0 0.0 2.9 1.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 17.0 5.2 10.6 2.9 3.9 0.7 1.5 2.3 2.5 2.2 0.0 0.0 1.1 8.7 2.4 3.0 9.5 5.8 1.8 0.0 7.9 0.8 3.0 5.2 2.2 0.1 1.5 3.6 3.4 3.5 0.9 2.0 1.9 2.1 0.7 0.0 1.3 0.6 0.1 0.2 9.2 0.0 0.7 1.2 5.8 0.0 0.2 2.2 0.0 11.2 0.9 0.0 2.8 13.6 0.2 0.4 0.1 4.6 2.9 5.2 1.6 0.0 0.0 0.3 3.4 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 20.3 7.3 17.3 20.4 5.8 9.6 12.6 14.5 19.0 0.0 3.4 0.0 2.5 7.2 0.4 4.8 0.0 0.0 2.3 1.8 39.3 1.8 1.7 0.0 0.4 0.7 6.3 0.0 0.3 0.4 4.3 0.3 4.7 0.0 0.2 0.0 0.0 1.3 0.0 0.0 1.7 0.0 1.7 1.0 2.2 8.7 0.5 2.3 1.1 0.2 2.6 0.0 1.2 0.1 0.7 9.5 1.1 0.0 1.8 0.7 LRRC10B ENSG00000204950 "Leucine rich repeat containing 10B" A6NIK2 11 61508800-61511018 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 20.1;Muller glia cells: 7.8;Sertoli cells: 19.4;Smooth muscle cells: 11.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 12.2;RH-30: 13.2;SCLC-21H: 6.8" "Region enriched" "Detected in many" 7 "basal ganglia: 202.0" "Group enriched" "Detected in many" 5 "basal ganglia: 39.3;hippocampal formation: 35.0" HPA047619 Uncertain Approved Nucleoplasm,Nucleoli No NA Nucleoplasm Nucleoli "HPA047619: AB_2680106" "unprognostic (9.95e-2)" "unprognostic (2.67e-2)" "unprognostic (4.92e-2)" "unprognostic (1.26e-2)" "unprognostic (2.11e-1)" "unprognostic (1.32e-1)" "unprognostic (6.10e-2)" "unprognostic (9.22e-2)" "unprognostic (4.88e-3)" "unprognostic (1.62e-1)" "unprognostic (9.21e-3)" "unprognostic (2.52e-2)" "unprognostic (5.27e-4)" "unprognostic (5.07e-2)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (6.63e-2)" 2.4 1.6 4.8 0.9 27.8 0.5 1.9 0.2 5.8 3.4 1.6 1.2 1.0 0.9 2.2 3.7 1.1 36.2 0.8 1.2 5.2 1.9 0.9 0.6 3.7 0.5 1.1 4.3 3.0 1.5 2.1 14.8 1.2 1.2 0.9 1.0 0.0 1.1 1.2 0.7 0.5 0.9 2.5 0.2 0.6 1.0 2.4 8.3 0.9 0.8 0.2 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.0 0.0 13.2 0.0 0.0 0.0 6.8 0.6 0.3 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 27.8 0.2 5.8 5.2 1.9 1.1 4.3 1.2 8.3 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 20.1 4.5 1.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 7.8 0.1 0.0 0.0 0.0 0.0 19.4 11.8 0.5 0.9 0.3 0.1 0.0 0.0 0.0 LRRC23 "B7, LRPB7" ENSG00000010626 "Leucine rich repeat containing 23" Q53EV4 12 6873569-6914243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "fallopian tube: 94.2" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 279.7;Rod photoreceptor cells: 113.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037766, HPA057533" Enhanced Supported "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA037766: AB_10672609, HPA057533: AB_2683459" "prognostic favorable (6.02e-4)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (4.37e-3)" "unprognostic (1.23e-1)" "unprognostic (5.90e-2)" "unprognostic (7.94e-3)" "unprognostic (1.42e-1)" "unprognostic (3.54e-2)" "unprognostic (4.64e-1)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (2.29e-1)" "unprognostic (6.57e-2)" "unprognostic (1.60e-1)" "unprognostic (2.68e-1)" "unprognostic (6.25e-2)" 3.6 4.2 11.4 2.4 12.8 3.4 4.8 10.5 10.9 5.8 3.1 10.8 6.9 2.2 6.0 13.1 2.9 94.2 4.2 4.7 12.2 12.9 6.9 3.7 9.4 2.9 7.3 9.6 5.9 2.5 9.3 9.0 3.4 9.9 4.8 3.3 9.4 4.0 5.0 5.5 3.5 2.1 4.8 7.0 3.5 4.5 21.1 8.4 2.2 7.1 2.4 3.7 3.1 3.1 7.8 5.9 9.0 4.4 5.3 4.7 2.2 5.2 10.1 1.7 3.8 7.6 5.9 6.0 2.1 7.2 3.5 6.7 2.1 10.7 4.6 2.3 5.5 10.1 1.3 3.1 4.4 7.5 3.6 1.5 3.2 4.0 4.1 6.2 1.7 3.1 4.1 8.2 6.7 6.1 9.1 4.7 11.3 1.9 2.6 4.0 5.8 4.0 1.2 1.1 7.7 3.0 3.7 8.4 5.3 7.1 1.5 2.8 6.6 3.3 4.5 6.3 11.2 2.3 4.1 2.0 3.5 9.2 3.9 2.3 2.5 1.7 3.8 8.5 2.3 5.0 1.3 4.4 9.0 3.7 4.2 4.7 7.8 3.6 3.1 4.0 4.8 4.1 4.0 0.7 5.3 3.8 5.9 0.2 2.2 11.4 12.8 10.5 10.9 12.2 12.9 7.3 9.6 9.9 8.4 0.0 28.5 7.0 9.6 5.8 17.2 7.5 22.9 279.7 46.6 12.2 47.1 7.2 31.5 10.7 32.5 6.2 4.2 23.3 15.1 9.4 10.8 6.9 5.7 6.4 11.8 12.7 17.2 9.2 8.6 32.8 7.8 8.7 8.5 8.2 7.9 28.7 13.0 3.5 11.7 28.1 113.4 12.9 10.0 62.1 12.6 5.1 3.8 9.6 6.5 6.3 LRRC40 FLJ20331 ENSG00000066557 "Leucine rich repeat containing 40" Q9H9A6 1 70144805-70205620 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026564 Approved Approved Nucleoli NA NA Nucleoli "HPA026564: AB_2250054" "unprognostic (9.39e-2)" "unprognostic (1.01e-1)" "prognostic favorable (4.54e-4)" "unprognostic (6.42e-2)" "unprognostic (6.65e-3)" "unprognostic (3.94e-2)" "unprognostic (7.69e-3)" "unprognostic (9.90e-2)" "unprognostic (3.40e-2)" "unprognostic (3.77e-1)" "unprognostic (1.45e-2)" "unprognostic (2.50e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-3)" "unprognostic (1.95e-1)" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" 14.3 10.4 15.7 10.0 18.5 16.4 13.2 22.0 27.4 13.4 10.7 10.4 8.0 17.0 12.6 10.2 11.5 9.0 10.1 13.5 16.5 16.6 20.4 27.2 9.6 14.2 13.7 15.7 11.3 8.8 7.9 13.8 13.9 19.8 10.6 11.8 7.5 9.0 8.8 13.6 9.0 18.0 13.3 15.6 13.2 9.0 13.4 11.0 23.0 9.9 10.0 14.2 11.1 9.6 10.4 8.4 7.4 8.2 9.8 10.9 6.5 11.3 4.7 18.9 14.8 6.9 7.7 11.4 11.0 8.0 16.7 20.6 6.9 6.4 15.3 9.7 8.5 16.5 8.4 44.3 9.8 22.8 12.2 8.9 11.5 8.7 11.1 8.7 15.0 2.8 6.4 5.7 11.1 11.2 7.7 9.6 9.8 14.2 7.4 14.0 2.9 18.1 11.8 24.8 7.5 10.0 14.5 19.5 9.9 15.2 7.0 9.7 9.8 13.2 13.3 12.2 14.0 6.3 8.6 11.9 11.8 9.5 17.8 12.4 6.3 6.0 24.8 9.5 15.9 12.1 6.8 6.6 7.4 8.5 8.2 10.9 10.4 9.0 7.9 8.4 9.2 10.6 8.8 0.9 9.8 7.6 6.5 10.8 6.5 15.7 18.5 22.0 27.4 16.5 16.6 13.7 15.7 19.8 11.0 11.9 9.3 7.5 7.2 11.4 14.9 9.2 5.1 6.7 6.8 14.0 5.9 14.2 10.0 11.9 0.9 8.9 6.7 23.3 7.6 11.1 13.9 5.2 15.0 17.4 10.1 14.3 22.3 12.3 11.7 1.9 9.5 8.0 5.0 10.8 5.8 6.6 7.9 3.5 9.6 20.3 11.9 19.4 12.3 19.1 25.5 9.7 6.1 12.9 7.7 5.0 LRRC75A "C17orf76, FAM211A, FLJ35696" ENSG00000181350 "Leucine rich repeat containing 75A" Q8NAA5 17 16441577-16492153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 42.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 12.0;HUVEC TERT2: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028528, HPA065840" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA028528: AB_10600755, HPA065840: " "unprognostic (1.09e-1)" "unprognostic (5.60e-2)" "unprognostic (5.79e-2)" "unprognostic (3.85e-5)" "unprognostic (3.93e-2)" "unprognostic (3.23e-2)" "unprognostic (3.44e-1)" "unprognostic (7.66e-3)" "unprognostic (7.74e-2)" "unprognostic (2.84e-1)" "prognostic favorable (7.46e-5)" "unprognostic (8.36e-2)" "unprognostic (4.28e-3)" "unprognostic (8.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-3)" "unprognostic (2.06e-1)" 1.0 8.9 5.2 2.8 3.7 1.7 0.6 0.7 6.3 2.2 26.3 1.5 1.4 15.0 1.9 0.5 0.4 0.9 0.5 0.4 4.1 2.4 0.8 0.2 1.6 1.9 1.6 3.2 1.8 1.6 3.7 4.1 1.5 2.1 1.1 10.4 1.9 0.3 1.7 0.4 0.4 42.3 3.0 0.8 6.4 1.3 8.5 0.4 0.5 1.2 0.0 1.9 1.3 0.7 0.8 0.0 0.3 0.6 0.3 0.6 0.2 1.2 1.0 1.2 0.8 0.3 0.5 0.1 0.3 0.8 2.8 2.3 1.1 0.3 0.0 0.8 0.1 0.5 0.4 0.3 0.2 0.1 0.4 0.9 12.0 0.6 0.0 0.4 0.2 0.9 0.0 0.0 0.6 0.0 0.4 3.9 1.3 0.5 0.2 0.0 2.0 1.9 0.8 0.2 2.8 0.1 0.7 0.7 0.1 0.6 0.2 2.3 0.6 0.0 0.2 2.8 0.5 0.2 0.1 0.0 0.3 1.4 0.9 1.5 1.5 0.3 0.2 0.1 0.7 1.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.6 0.3 0.3 0.6 0.0 0.0 0.2 5.2 3.7 0.7 6.3 4.1 2.4 1.6 3.2 2.1 0.4 38.7 51.3 11.9 7.2 0.0 8.7 0.3 7.6 16.0 36.4 1.8 5.9 13.7 16.6 3.8 5.3 6.0 49.1 23.3 6.1 16.9 3.9 6.4 27.8 8.1 10.5 3.2 23.7 9.2 10.7 5.9 15.3 6.7 0.0 1.8 44.8 16.7 5.7 23.0 10.6 15.2 16.4 12.9 2.3 3.8 6.7 0.0 14.0 8.9 47.2 6.2 LRRN4 "C20orf75, dJ1056H1.1, NLRR4" ENSG00000125872 "Leucine rich repeat neuronal 4" Q8WUT4 20 6040778-6054049 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 9.5;kidney: 13.0;lung: 36.4" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 3.8;Ductal cells: 3.6;Proximal tubular cells: 2.2" "Group enriched" "Detected in many" 7 "lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7" "Region enriched" "Detected in single" 5 "basal ganglia: 1.1" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 11 "RPTEC TERT1: 40.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA075974 Uncertain "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 32000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA075974: AB_2686770" "unprognostic (6.16e-2)" "unprognostic (1.69e-3)" "unprognostic (2.40e-3)" "unprognostic (9.04e-3)" "unprognostic (5.95e-2)" "unprognostic (1.32e-2)" "unprognostic (2.59e-1)" "unprognostic (8.94e-2)" "unprognostic (2.73e-1)" "unprognostic (2.44e-2)" "unprognostic (2.79e-2)" "unprognostic (4.83e-3)" "unprognostic (1.15e-3)" "unprognostic (2.33e-2)" "unprognostic (6.88e-2)" "unprognostic (2.31e-1)" "unprognostic (9.84e-3)" 9.5 0.1 0.0 2.4 1.1 0.1 0.1 0.0 0.2 0.7 2.2 0.0 0.0 0.1 0.1 2.8 0.1 1.5 0.1 1.1 0.0 0.2 13.0 0.4 36.4 0.1 0.0 0.0 1.6 2.6 0.1 0.0 3.4 0.0 0.1 0.1 0.0 0.1 0.5 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 40.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.8 0.4 0.2 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.9 3.8 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 1.8 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LRWD1 "CENP-33, DKFZp434K1815, ORCA" ENSG00000161036 "Leucine rich repeats and WD repeat domain containing 1" Q9UFC0 7 102464929-102473168 "Predicted intracellular proteins" "DNA replication" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "testis: 129.9" "Group enriched" "Detected in many" 8 "Early spermatids: 733.2;Spermatocytes: 397.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021320 Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Vesicles" "HPA021320: AB_1853372" "unprognostic (1.50e-1)" "unprognostic (1.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.66e-3)" "unprognostic (1.60e-2)" "unprognostic (2.08e-3)" "unprognostic (1.72e-3)" "unprognostic (4.97e-2)" "unprognostic (3.34e-1)" "unprognostic (3.04e-2)" "prognostic favorable (8.71e-5)" "unprognostic (1.00e-1)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.46e-2)" "unprognostic (4.14e-2)" "unprognostic (7.82e-2)" "unprognostic (9.20e-2)" 2.7 4.6 3.6 3.8 5.0 7.6 1.9 7.9 5.8 2.5 2.5 3.4 3.4 2.9 2.8 2.8 2.1 7.1 2.5 2.6 4.3 4.0 4.0 5.1 2.6 4.4 3.4 3.7 3.1 3.4 3.4 4.9 2.0 4.2 2.2 1.6 1.7 3.3 4.0 3.6 2.2 4.3 2.7 2.4 6.6 3.3 129.9 3.8 3.9 2.7 1.6 4.2 2.3 1.8 12.6 9.8 9.2 4.0 9.9 10.4 5.8 7.4 10.3 5.6 15.7 4.3 3.2 8.7 7.9 5.2 13.6 9.4 9.9 4.3 18.4 11.4 6.0 16.0 7.9 8.2 7.1 4.0 6.4 15.9 3.8 4.7 6.1 5.7 7.1 7.4 3.0 4.3 15.7 3.3 4.6 7.1 14.4 17.8 5.7 7.3 22.4 21.3 16.9 11.9 9.4 15.0 11.3 5.2 19.8 4.0 4.7 7.4 21.1 8.7 8.4 7.7 6.8 4.8 5.9 4.1 7.5 16.1 23.2 12.6 20.9 36.0 17.6 8.3 6.6 13.0 9.1 2.5 9.2 10.4 4.0 9.9 11.1 9.1 9.1 2.8 12.6 5.8 7.4 5.9 9.9 3.5 9.8 9.0 5.8 3.6 5.0 7.9 5.8 4.3 4.0 3.4 3.7 4.2 3.8 0.0 0.6 5.2 5.8 9.3 11.7 0.7 2.5 16.0 6.8 12.2 2.0 7.7 6.6 12.2 733.2 5.8 7.9 0.0 9.2 9.8 5.7 3.5 0.0 6.8 7.8 4.8 7.5 5.5 5.7 71.5 17.5 3.9 5.0 10.0 6.3 8.6 9.9 6.0 14.9 11.5 8.1 0.0 5.1 397.6 39.9 8.5 5.1 7.0 6.3 3.3 LSM3 "SMX4, USS2, YLR438C" ENSG00000170860 "LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated" P62310 3 14178358-14201119 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044966 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA044966: AB_2679159" "unprognostic (3.84e-3)" "unprognostic (7.00e-3)" "unprognostic (3.61e-2)" "unprognostic (2.87e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-1)" "unprognostic (2.94e-3)" "unprognostic (5.01e-2)" "unprognostic (2.70e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-2)" "unprognostic (8.07e-3)" "unprognostic (4.93e-3)" "unprognostic (5.57e-2)" "unprognostic (2.88e-1)" "unprognostic (1.46e-1)" "unprognostic (1.89e-3)" 14.1 13.6 18.2 12.5 17.1 18.9 15.5 13.2 17.3 11.5 15.6 11.8 7.6 15.0 11.6 13.4 19.1 10.3 11.3 20.1 15.1 12.5 27.6 26.7 10.1 14.2 14.2 13.5 12.4 15.6 7.3 12.4 16.5 14.4 14.2 13.9 12.3 13.3 11.0 31.9 12.1 17.6 15.8 15.0 16.3 12.5 21.5 13.9 24.4 19.7 21.4 13.9 12.9 11.1 21.3 23.1 27.2 18.3 17.1 17.7 18.7 14.6 11.9 12.8 13.2 6.0 7.0 32.7 12.2 8.1 15.6 15.0 13.4 11.6 16.2 10.1 8.4 11.0 6.9 14.4 11.8 15.4 15.3 17.9 17.1 17.2 12.8 3.1 19.1 12.5 5.2 8.6 15.6 6.7 7.0 8.0 14.2 18.4 13.0 11.5 16.8 20.2 26.1 22.2 16.5 16.2 11.2 15.9 17.8 14.5 15.2 7.2 11.7 13.9 19.5 11.3 15.4 22.5 24.4 7.2 10.0 16.0 12.1 20.7 9.2 26.9 30.5 12.7 18.8 14.2 27.2 15.9 23.3 12.8 18.3 15.0 21.3 15.0 14.9 14.6 17.1 16.5 17.3 15.2 17.1 15.3 23.1 17.7 18.7 18.2 17.1 13.2 17.3 15.1 12.5 14.2 13.5 14.4 13.9 62.5 87.7 130.3 102.5 86.8 44.5 230.9 170.7 87.0 91.0 120.4 17.7 322.3 411.1 178.6 266.0 108.5 137.9 70.0 230.7 336.7 102.8 94.5 135.1 199.8 207.0 52.4 100.7 114.8 112.2 107.8 129.8 142.9 92.8 201.0 161.2 94.1 180.4 182.4 131.5 513.1 53.0 103.5 91.2 226.0 285.5 88.3 266.3 100.1 174.8 132.7 LURAP1L "bA3L8.2, C9orf150, FLJ38505, MGC46502" ENSG00000153714 "Leucine rich adaptor protein 1 like" Q8IV03 9 12775021-12822131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 48.7" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 80.1;Glandular cells: 116.6;Paneth cells: 77.2;Urothelial cells: 93.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.2" "Cell line enhanced" "Detected in many" "HHSteC: 45.3;hTERT-HME1: 36.3;T-47d: 52.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024407 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA024407: AB_10603780" "unprognostic (1.20e-1)" "unprognostic (2.15e-1)" "unprognostic (7.45e-2)" "unprognostic (1.73e-2)" "unprognostic (2.08e-2)" "unprognostic (5.61e-3)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" "unprognostic (2.92e-1)" "unprognostic (1.06e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-2)" "unprognostic (5.68e-3)" "unprognostic (4.38e-1)" "unprognostic (5.67e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-2)" 10.6 7.2 2.9 7.9 9.2 0.1 13.0 23.4 5.5 11.5 13.7 7.1 2.9 4.0 5.0 7.9 8.5 4.1 14.7 3.5 3.5 3.3 4.1 48.7 17.8 5.3 7.7 4.0 4.5 19.9 0.2 7.3 21.0 5.9 8.0 9.6 4.7 21.6 7.3 2.4 8.8 6.6 13.2 8.1 11.0 9.9 3.7 7.9 0.9 8.6 2.8 5.3 10.3 9.4 0.0 0.1 1.2 0.0 0.0 0.0 1.6 0.9 3.2 0.0 1.0 4.9 6.8 0.0 1.7 9.1 2.2 2.5 0.0 1.1 0.0 0.6 8.7 10.8 1.3 0.0 0.1 1.7 0.0 0.4 0.4 3.0 1.7 45.3 0.0 0.0 2.6 4.3 8.1 36.3 3.8 1.5 0.0 0.0 11.9 1.2 0.7 0.0 0.0 0.0 4.1 3.5 0.0 0.6 0.0 8.9 0.5 6.9 0.6 1.9 1.2 1.5 0.8 52.1 0.1 0.5 2.0 0.3 5.0 1.2 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.9 9.2 23.4 5.5 3.5 3.3 7.7 4.0 5.9 7.9 8.9 17.3 0.0 29.2 80.1 4.1 5.3 15.3 5.3 17.0 1.8 2.0 0.4 6.6 56.6 2.6 6.3 32.8 0.0 10.3 1.2 27.7 116.6 10.4 28.7 0.5 17.5 25.6 1.8 0.0 0.8 8.6 0.6 25.3 0.0 8.9 3.6 22.9 77.2 2.8 4.1 9.3 38.8 40.0 0.1 0.3 56.2 0.9 0.0 13.4 93.3 LYAR "ZC2HC2, ZLYAR" ENSG00000145220 "Ly1 antibody reactive" Q9NX58 4 4267701-4290169 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.2" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 435.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035880, HPA035881" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA035880: , HPA035881: AB_10669980" "unprognostic (2.81e-1)" "unprognostic (3.79e-1)" "unprognostic (2.64e-2)" "unprognostic (6.22e-3)" "unprognostic (1.44e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (3.20e-5)" "unprognostic (1.08e-3)" "unprognostic (2.92e-2)" "prognostic favorable (8.82e-4)" "unprognostic (5.05e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (4.36e-10)" "unprognostic (4.94e-2)" "unprognostic (1.61e-1)" "unprognostic (5.90e-2)" "unprognostic (2.72e-1)" 11.1 5.7 6.8 11.9 10.1 10.9 8.2 7.3 8.0 6.6 6.9 4.3 4.1 5.7 6.9 5.5 11.2 7.1 5.4 10.1 7.0 4.6 5.0 9.9 7.7 13.8 10.9 4.5 11.1 6.3 4.4 15.6 7.1 8.4 7.8 6.8 3.7 5.4 6.4 15.1 5.9 6.2 9.1 7.9 18.2 5.8 60.2 12.0 10.0 6.3 11.9 10.9 10.1 10.4 7.3 7.1 8.9 12.9 10.7 32.8 10.3 13.3 7.0 6.3 9.2 5.5 6.3 10.8 12.2 4.2 12.7 8.8 22.0 17.6 35.9 8.8 5.2 20.5 8.5 23.5 12.7 16.7 6.4 17.3 36.0 6.7 24.6 9.4 41.5 9.8 4.9 8.1 14.6 24.9 3.3 10.9 20.5 48.1 12.0 8.8 13.5 14.1 53.5 31.3 14.2 23.0 21.7 11.5 17.3 5.7 9.3 15.0 6.4 6.6 7.3 12.4 8.4 7.5 12.4 10.2 12.7 10.1 16.5 38.4 8.5 12.8 57.4 8.6 35.1 10.2 8.9 9.7 8.5 28.6 9.6 32.8 7.3 18.9 30.8 7.1 5.7 8.9 19.0 2.8 10.7 12.9 5.3 8.8 10.3 6.8 10.1 7.3 8.0 7.0 4.6 10.9 4.5 8.4 12.0 14.9 30.0 19.7 34.4 106.7 9.4 21.6 12.7 26.8 36.4 1.8 7.9 43.0 8.3 15.1 74.2 29.5 2.8 0.0 17.0 43.6 29.4 25.4 20.8 10.6 32.5 14.3 10.3 8.6 30.8 61.9 31.7 32.1 20.3 19.0 16.0 9.6 22.6 13.9 25.1 5.1 28.7 38.8 35.0 435.9 39.2 101.3 16.9 130.7 24.0 62.3 LZTS1 FEZ1 ENSG00000061337 "Leucine zipper tumor suppressor 1" Q9Y250 8 20246165-20303963 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 19.0;parathyroid gland: 64.9" "Cell type enhanced" "Detected in some" 21 "Horizontal cells: 19.1;Melanocytes: 18.6;Rod photoreceptor cells: 17.9;Sertoli cells: 64.7" "Cancer enhanced" "Detected in all" "melanoma: 59.2" "Group enriched" "Detected in many" 5 "amygdala: 13.3;basal ganglia: 19.0;cerebral cortex: 19.0;hippocampal formation: 8.9;olfactory region: 8.8" "Cell type enhanced" "Detected in single" "gdT-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-MEL-30: 36.7;U-698: 11.2;WM-115: 24.8" "Group enriched" "Detected in many" 5 "amygdala: 47.8;basal ganglia: 76.8;cerebral cortex: 46.2;hippocampal formation: 41.3;olfactory region: 26.1" "Group enriched" "Detected in many" 9 "amygdala: 28.4;basal ganglia: 66.4;cerebral cortex: 45.3;hippocampal formation: 38.6;olfactory region: 47.4" "HPA006294, HPA022046" Approved Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA006294: AB_1079288, HPA022046: AB_1853455" "unprognostic (7.76e-2)" "unprognostic (1.02e-1)" "unprognostic (3.49e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (6.27e-2)" "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (5.76e-2)" "unprognostic (1.41e-2)" "unprognostic (9.06e-3)" "unprognostic (6.81e-2)" "unprognostic (3.63e-2)" "prognostic unfavorable (9.28e-6)" "unprognostic (3.35e-2)" "unprognostic (2.71e-1)" "unprognostic (1.11e-1)" "unprognostic (6.82e-3)" 2.4 2.1 13.3 1.8 19.0 0.8 1.9 0.6 19.0 1.6 1.1 2.2 0.4 1.1 2.2 1.5 3.5 1.4 3.5 2.3 8.9 2.6 1.9 1.1 4.0 1.5 2.5 8.8 1.7 1.6 64.9 1.4 5.8 1.9 1.7 1.1 10.3 1.3 1.7 1.6 4.2 1.2 2.7 0.8 1.1 1.3 6.6 1.5 0.3 2.0 0.9 1.1 1.9 1.0 0.2 0.1 0.7 0.1 0.1 2.2 0.5 0.0 0.0 4.8 4.0 0.0 0.0 0.6 2.4 0.0 2.1 1.8 0.1 0.0 5.3 1.7 1.5 0.8 0.1 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.0 0.8 0.0 0.3 0.0 5.7 0.0 0.0 7.0 0.0 9.2 0.0 6.0 0.0 0.0 0.0 7.7 0.0 1.3 0.2 7.4 6.4 0.0 0.0 36.7 4.2 0.0 0.2 0.0 2.5 1.7 0.0 0.7 0.0 0.0 11.2 0.0 0.5 24.8 0.2 0.1 0.0 2.2 0.0 0.8 0.0 0.7 0.4 0.0 0.2 0.2 0.3 0.7 0.1 0.0 0.1 0.0 0.5 13.3 19.0 0.6 19.0 8.9 2.6 2.5 8.8 1.9 1.5 0.0 0.0 0.0 0.6 1.1 1.5 1.0 0.0 0.0 0.0 0.0 3.9 6.1 1.7 0.0 0.4 0.7 0.0 0.0 0.0 1.6 1.0 0.1 0.0 0.0 0.8 19.1 0.0 0.0 0.0 0.4 1.1 0.0 18.6 0.0 0.0 0.9 0.0 0.0 0.4 0.2 17.9 64.7 10.5 0.2 1.1 0.1 0.7 0.0 0.0 0.0 M1AP "C2orf65, D6Mm5e, SPATA37" ENSG00000159374 "Meiosis 1 associated protein" Q8TC57 2 74557883-74648338 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 8.8;testis: 13.2" "Group enriched" "Detected in some" 4 "Spermatocytes: 8.7;Spermatogonia: 22.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "NTERA-2: 6.1;RT4: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045420, HPA059302" Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA045420: AB_10961177, HPA059302: AB_2683972" "unprognostic (1.76e-1)" "unprognostic (6.58e-3)" "unprognostic (1.26e-2)" "unprognostic (2.87e-1)" "unprognostic (9.15e-2)" "unprognostic (1.35e-3)" "unprognostic (1.86e-1)" "unprognostic (2.17e-3)" "unprognostic (3.42e-1)" "unprognostic (2.37e-1)" "unprognostic (2.00e-1)" "unprognostic (2.15e-2)" "unprognostic (6.11e-2)" "unprognostic (7.74e-2)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (1.46e-1)" 0.7 0.6 5.2 0.2 1.5 3.7 3.7 1.2 3.4 4.6 0.2 0.3 1.0 0.2 2.1 0.5 0.3 4.6 0.5 0.1 0.9 1.8 1.5 0.1 0.6 0.1 0.5 1.6 0.3 0.4 1.7 8.8 1.2 0.9 0.2 0.0 2.0 1.5 1.0 0.1 0.2 0.2 0.2 0.7 0.4 0.7 13.2 0.2 1.0 3.6 0.0 0.5 0.9 0.5 0.0 0.9 0.2 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.5 0.2 0.5 0.6 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 6.1 0.8 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 5.2 1.5 1.2 3.4 0.9 1.8 0.5 1.6 0.9 0.2 0.0 1.4 0.0 0.0 0.1 0.3 0.3 0.0 2.7 0.0 3.5 0.0 0.3 0.0 0.2 2.5 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 3.5 0.0 0.0 0.0 1.0 3.1 0.0 2.3 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 1.3 0.0 0.0 8.7 22.0 0.0 0.2 0.0 0.0 0.1 MACROD2 "C20orf133, dJ631M13.5" ENSG00000172264 "MACRO domain containing 2" A1Z1Q3 20 13995369-16053197 "Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.5" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 151.9;Bipolar cells: 89.0;Club cells: 67.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 7.4;naive B-cell: 14.1;neutrophil: 3.8" "Group enriched" "Detected in many" 5 "B-cells: 14.1;granulocytes: 3.8" "Cell line enhanced" "Detected in many" "EFO-21: 14.7;Karpas-707: 18.2;RT4: 8.0;SCLC-21H: 10.0" "Low region specificity" "Detected in all" HPA049076 Enhanced Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA049076: " "unprognostic (1.70e-1)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (5.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.63e-3)" "unprognostic (1.24e-1)" "unprognostic (2.32e-2)" "unprognostic (3.02e-1)" "unprognostic (2.96e-2)" "unprognostic (4.02e-1)" "unprognostic (7.83e-2)" "unprognostic (4.15e-5)" "unprognostic (9.80e-2)" "unprognostic (9.91e-3)" "unprognostic (3.23e-1)" "unprognostic (2.02e-2)" 2.8 5.1 15.2 3.0 47.5 2.0 4.2 20.8 13.6 6.4 2.7 3.7 2.0 1.4 12.1 3.9 2.3 10.3 4.1 1.9 10.5 8.2 5.6 2.7 15.7 5.5 7.6 8.9 4.5 4.2 5.4 12.0 1.8 10.5 7.1 2.1 4.0 2.4 14.9 3.1 3.9 1.8 5.8 6.9 6.9 3.4 7.9 9.9 0.0 4.1 0.1 7.2 10.6 3.1 14.1 0.5 3.8 1.8 0.3 0.6 0.5 1.0 0.6 2.8 0.9 0.9 0.8 0.5 0.5 2.0 1.1 0.6 1.0 0.7 1.9 14.7 1.4 2.6 1.4 0.4 0.7 1.9 1.0 0.9 1.1 1.1 1.9 3.6 0.3 0.3 1.6 1.1 0.0 0.8 1.0 1.1 0.3 1.3 18.2 3.1 0.4 0.5 0.7 1.0 6.3 0.4 1.1 0.5 3.5 2.1 8.0 10.0 4.3 1.5 0.1 0.7 1.3 1.0 1.6 0.8 1.5 3.1 0.2 0.1 1.5 0.5 1.8 0.9 1.0 1.8 0.3 0.6 0.6 0.4 1.3 0.4 7.4 0.3 0.4 0.5 14.1 0.4 0.6 3.8 0.3 1.8 0.2 0.2 0.5 15.2 47.5 20.8 12.8 10.5 8.2 7.6 8.9 10.5 9.9 47.6 151.9 14.5 37.6 3.9 89.0 4.0 12.7 12.0 67.1 12.2 37.3 4.4 8.3 9.1 28.4 2.1 1.1 0.0 1.4 0.2 2.6 4.4 1.1 3.9 0.8 7.9 1.2 2.5 0.3 46.6 3.1 1.0 3.3 0.0 3.7 9.3 4.6 1.1 16.6 5.1 18.6 6.5 4.1 17.9 16.4 5.8 1.7 0.0 2.4 3.8 MAD2L1BP "CMT2, dJ261G23.1, KIAA0110" ENSG00000124688 "MAD2L1 binding protein" Q15013 6 43629540-43640952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 66.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028729 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No Nucleoplasm "Nuclear membrane, Nucleoli" "HPA028729: AB_2672752" "unprognostic (2.60e-1)" "unprognostic (2.06e-1)" "unprognostic (3.92e-2)" "unprognostic (6.97e-2)" "unprognostic (6.91e-2)" "unprognostic (6.92e-2)" "unprognostic (5.74e-3)" "unprognostic (2.67e-3)" "unprognostic (3.60e-1)" "unprognostic (7.18e-2)" "unprognostic (1.71e-1)" "unprognostic (6.64e-2)" "unprognostic (4.61e-2)" "unprognostic (1.18e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-1)" "unprognostic (3.25e-3)" 12.1 16.6 11.0 13.3 14.4 35.7 13.8 16.5 24.4 12.2 21.3 10.1 6.3 18.1 12.9 14.1 17.0 13.4 13.2 19.2 11.9 12.1 18.3 18.9 11.4 18.2 11.0 12.6 11.3 18.5 11.5 12.8 12.6 14.0 12.6 22.0 13.6 24.2 11.3 25.1 11.9 22.0 12.4 9.8 17.5 16.8 17.6 7.9 29.0 18.9 13.9 19.9 14.3 13.2 27.9 27.6 39.7 22.2 26.8 39.8 21.4 15.9 7.4 11.7 13.0 10.2 11.1 7.1 9.6 15.6 21.4 20.1 15.1 6.5 12.5 5.5 11.3 19.5 10.5 18.2 13.4 16.5 11.4 14.1 15.4 8.2 13.0 11.0 9.0 9.3 11.2 16.5 15.9 9.7 10.8 16.0 10.1 19.7 6.7 14.8 15.0 8.0 16.8 7.2 66.4 9.6 9.3 9.1 11.8 15.2 12.8 14.0 14.2 6.9 10.7 45.4 9.3 12.5 24.2 8.7 11.5 9.6 7.5 15.3 8.7 7.4 29.3 10.4 15.3 12.6 39.7 22.2 25.0 25.7 22.1 25.8 27.9 30.8 28.4 27.6 25.6 32.3 29.0 18.6 26.8 19.9 18.3 39.8 21.4 11.0 14.4 16.5 24.4 11.9 12.1 11.0 12.6 14.0 7.9 23.8 10.1 16.1 16.9 12.8 12.1 10.4 10.2 21.4 21.6 3.5 11.8 18.1 23.2 24.8 36.4 11.3 26.9 23.3 18.5 17.9 15.3 9.1 30.1 11.3 15.5 9.5 16.7 14.7 10.8 27.8 11.2 13.0 27.0 20.8 15.1 12.4 20.4 25.9 11.3 16.5 12.0 25.8 12.2 18.4 18.8 8.4 5.1 15.4 19.2 21.6 MAD2L2 "FANCV, MAD2B, POLZ2, REV7" ENSG00000116670 "Mitotic arrest deficient 2 like 2" Q9UI95 1 11674480-11691650 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Late spermatids: 383.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008110, HPA024176, HPA024612" Approved Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB008110: AB_217976, HPA024176: AB_2671467, HPA024612: " "unprognostic (1.26e-2)" "unprognostic (2.55e-1)" "unprognostic (2.43e-1)" "unprognostic (3.27e-1)" "unprognostic (2.41e-1)" "unprognostic (6.84e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (4.60e-2)" "unprognostic (1.24e-1)" "unprognostic (9.09e-3)" "unprognostic (1.54e-1)" "unprognostic (9.27e-2)" "unprognostic (8.43e-2)" "unprognostic (2.36e-1)" 12.4 10.1 15.4 15.7 15.6 37.9 13.7 15.5 13.5 10.0 10.5 14.5 11.9 8.6 10.4 11.8 9.8 9.9 10.3 17.3 13.2 11.2 13.2 34.4 12.9 18.3 19.6 9.7 14.6 23.0 5.8 11.1 8.2 12.4 11.8 6.1 8.4 21.0 9.2 23.0 12.0 7.4 11.5 15.0 11.9 12.4 37.0 15.8 42.1 12.0 10.4 19.0 11.9 13.4 19.5 46.9 13.8 31.7 13.2 29.8 27.7 11.7 10.8 18.2 20.5 5.6 11.0 7.3 10.9 12.3 21.5 19.2 14.0 11.4 16.6 13.4 11.4 12.6 5.2 22.5 11.3 12.5 25.0 25.0 7.4 16.7 17.1 9.9 15.0 12.3 7.1 11.6 15.7 13.6 8.4 9.7 22.4 30.5 26.6 10.6 17.4 69.0 70.9 46.8 4.8 17.6 46.9 20.0 20.4 7.8 2.5 33.8 23.7 18.2 7.0 31.6 13.1 10.2 32.6 5.1 17.9 22.7 16.6 15.4 21.4 14.9 43.0 13.2 52.7 13.7 11.9 29.4 13.8 29.8 31.7 23.9 19.5 20.1 23.1 34.0 15.9 13.7 20.3 12.5 13.2 27.2 46.9 22.9 27.7 15.4 15.6 15.5 13.4 13.2 11.2 19.6 9.7 12.4 15.8 0.0 5.3 24.6 22.8 34.3 5.5 13.9 12.7 4.0 5.7 14.0 3.9 14.0 43.1 34.8 122.4 28.4 2.1 70.0 66.1 41.4 31.5 29.1 13.9 52.9 36.0 11.1 32.6 23.9 40.3 383.8 28.7 45.0 45.5 100.0 10.5 7.5 37.7 3.5 15.9 23.1 3.9 38.8 30.9 46.4 40.3 30.4 7.0 38.7 7.5 12.9 MAF1 DKFZp586G1123 ENSG00000179632 "MAF1 homolog, negative regulator of RNA polymerase III" Q9H063 8 144104499-144107611 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024821, HPA058548" Uncertain Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA024821: AB_2671696, HPA058548: AB_2683751" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.71e-2)" "unprognostic (2.21e-1)" "unprognostic (8.51e-2)" "unprognostic (9.67e-2)" "prognostic unfavorable (7.09e-4)" "unprognostic (6.12e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-3)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (9.40e-3)" "unprognostic (9.02e-2)" "unprognostic (2.59e-1)" "unprognostic (2.38e-1)" "unprognostic (3.99e-2)" 26.8 23.2 17.5 18.4 17.5 43.6 35.7 20.5 26.3 27.3 47.2 23.7 22.8 19.5 33.0 22.5 34.4 26.1 33.6 72.5 17.3 15.5 24.1 21.4 21.2 28.2 19.7 18.6 36.3 39.8 25.2 20.8 23.8 14.9 36.8 18.9 23.8 28.7 32.3 114.3 18.7 29.8 50.9 17.2 27.7 28.9 30.2 16.2 35.5 40.4 38.7 22.8 35.2 46.7 48.0 39.9 45.1 34.5 33.2 46.2 32.6 24.2 39.1 18.1 18.1 49.6 24.8 14.7 19.1 31.6 29.9 30.6 14.3 27.1 27.0 32.6 31.9 16.6 15.0 24.6 27.0 22.1 23.8 29.8 29.5 26.9 22.3 33.5 12.5 20.3 21.8 31.7 23.9 45.3 33.5 32.2 19.8 22.7 18.4 17.8 57.9 46.6 23.0 13.6 44.2 105.0 18.7 25.4 28.7 18.7 18.3 26.5 22.1 25.4 33.1 30.9 17.7 22.5 19.2 19.3 14.0 31.9 24.6 24.0 22.3 16.9 12.6 23.2 23.4 9.2 15.8 34.5 45.1 28.5 26.8 32.3 40.1 41.0 46.2 39.9 48.0 44.2 41.4 19.9 33.2 27.0 29.8 29.2 32.6 17.5 17.5 20.5 26.3 17.3 15.5 19.7 18.6 14.9 16.2 14.9 17.0 89.7 75.9 82.5 41.2 46.4 7.6 4.0 3.4 41.8 13.7 87.2 89.5 88.1 49.3 67.4 88.9 70.0 94.2 87.3 63.4 114.9 33.3 25.2 87.3 35.0 89.6 44.8 58.6 27.8 81.7 78.7 74.2 166.9 77.1 55.4 88.3 79.3 87.7 90.2 29.0 97.0 72.8 85.0 43.7 78.4 120.7 94.5 78.4 80.6 MAFB KRML ENSG00000204103 "MAF bZIP transcription factor B" Q9Y5Q3 20 40685848-40689240 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 87.6;parathyroid gland: 154.1" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 322.7;Kupffer cells: 488.8;Macrophages: 252.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 27.4;non-classical monocyte: 36.7" "Lineage enriched" "Detected in many" 14 "monocytes: 36.7" "Cell line enhanced" "Detected in some" "HSkMC: 16.2;hTCEpi: 34.0;SCLC-21H: 9.3;SiHa: 8.4;U-138 MG: 9.2;U-2197: 13.4;U-87 MG: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA005653 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Nucleoli, Golgi apparatus, Cytosol" "HPA005653: AB_1079293" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.16e-3)" "prognostic unfavorable (5.64e-4)" "unprognostic (9.16e-2)" "unprognostic (3.92e-2)" "unprognostic (1.10e-1)" "unprognostic (2.10e-1)" "unprognostic (2.57e-2)" "unprognostic (6.09e-2)" "unprognostic (5.45e-3)" "unprognostic (9.92e-2)" "unprognostic (3.95e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-3)" "unprognostic (3.49e-2)" "unprognostic (2.30e-2)" 38.3 7.9 3.2 13.0 4.0 17.0 19.5 1.0 9.7 10.6 6.9 3.0 1.2 3.3 5.6 8.9 16.8 7.0 9.2 12.4 3.6 2.3 10.9 14.0 21.9 28.9 4.7 3.4 7.0 6.1 154.1 2.3 9.4 5.0 7.6 3.3 5.6 10.4 2.7 11.0 41.6 7.6 5.5 7.7 87.6 4.7 7.5 3.8 6.9 18.2 20.5 11.4 8.2 10.9 0.0 2.5 0.7 36.7 0.0 0.0 2.5 0.0 0.0 0.0 1.4 0.8 0.1 0.2 0.2 0.0 0.1 0.0 0.2 0.1 0.0 1.1 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.1 0.5 0.0 0.1 16.2 34.0 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 3.9 1.4 3.3 0.0 0.0 0.0 0.0 0.3 0.2 9.3 0.7 8.4 0.8 2.0 3.1 0.8 0.1 0.2 9.2 0.1 13.4 0.0 0.0 0.0 0.0 8.9 0.3 0.0 0.1 7.3 0.0 0.0 27.4 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.7 0.0 36.7 0.0 0.0 2.5 3.2 4.0 1.0 9.7 3.6 2.3 4.7 3.4 5.0 3.8 20.8 32.3 6.7 25.3 60.9 14.6 153.6 7.6 0.0 13.6 48.8 23.6 7.5 1.7 2.0 0.6 19.9 50.9 0.0 3.0 2.1 61.9 37.1 10.4 32.6 322.7 3.2 55.5 34.4 488.8 0.7 27.3 252.1 20.3 0.0 13.7 25.8 5.4 24.6 23.0 0.8 8.2 12.9 44.3 0.5 0.9 77.0 10.4 4.4 8.1 17.7 MAGED2 "11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386" ENSG00000102316 "MAGE family member D2" Q9UNF1 X 54807599-54816012 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Bartter syndrome, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 301.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031572, HPA031573" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli, Cytosol" "HPA031572: AB_10599819, HPA031573: AB_10602181" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.32e-1)" "unprognostic (1.69e-3)" "unprognostic (4.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.41e-3)" "unprognostic (1.39e-1)" "unprognostic (2.97e-1)" "prognostic favorable (2.88e-4)" "prognostic favorable (2.82e-4)" "unprognostic (6.34e-2)" "unprognostic (3.55e-3)" "prognostic unfavorable (9.43e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" "unprognostic (3.58e-1)" 22.1 38.4 26.9 14.8 26.5 8.2 50.2 24.4 43.0 55.7 27.3 27.8 21.4 16.2 41.1 31.8 21.9 45.9 28.5 40.7 23.8 38.2 42.7 17.3 24.0 13.5 30.3 36.0 79.7 23.5 34.5 57.6 58.6 57.1 63.9 16.4 43.1 32.0 53.7 25.6 16.5 17.6 41.6 24.7 17.5 22.5 21.8 18.3 23.4 45.1 17.3 22.0 31.9 29.2 17.1 11.7 43.1 37.0 28.5 35.5 32.5 5.4 10.0 60.2 18.3 28.7 39.1 11.1 22.5 40.2 17.9 31.8 10.0 13.9 7.6 59.1 45.3 14.7 7.4 17.1 17.0 12.9 13.5 14.2 15.7 11.9 19.5 24.6 4.0 12.1 51.1 7.1 18.1 9.2 36.9 33.9 8.9 3.8 9.3 34.1 15.0 8.9 6.7 22.2 9.5 12.0 5.9 21.6 10.8 24.5 4.1 9.5 24.5 8.9 10.4 52.0 73.5 42.9 6.8 29.2 15.3 23.8 22.7 6.3 6.0 5.0 5.4 22.3 10.6 77.7 43.1 9.1 35.5 35.5 22.4 27.3 16.3 29.4 33.1 11.7 17.1 29.7 34.1 3.4 28.5 37.0 7.2 29.2 32.5 26.9 26.5 24.4 43.0 23.8 38.2 30.3 36.0 57.1 18.3 41.7 33.9 29.8 80.0 37.7 72.3 51.6 53.5 66.9 30.7 73.3 27.5 185.2 208.9 88.2 2.4 76.6 14.7 0.0 47.8 117.1 94.0 95.1 100.4 13.2 60.7 130.3 56.0 66.9 12.9 8.5 216.0 36.3 150.1 64.9 42.6 178.6 48.5 32.3 301.2 111.7 49.9 155.2 150.8 13.5 12.4 30.6 141.5 45.4 24.9 55.9 MAGEH1 APR1 ENSG00000187601 "MAGE family member H1" Q9H213 X 55452105-55453566 "Predicted membrane proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "epididymis: 207.1" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011324, HPA011971" Uncertain Supported "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA011324: AB_1853499, HPA011971: " "unprognostic (2.50e-1)" "unprognostic (3.01e-1)" "unprognostic (4.07e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (3.95e-2)" "unprognostic (8.50e-2)" "unprognostic (1.13e-2)" "unprognostic (9.93e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "prognostic favorable (2.60e-4)" "unprognostic (6.37e-2)" "unprognostic (1.81e-2)" "unprognostic (1.29e-3)" "unprognostic (1.90e-1)" "unprognostic (3.95e-2)" "unprognostic (2.52e-1)" 8.3 13.2 21.5 7.6 21.6 3.0 8.1 19.9 29.7 13.5 7.5 14.4 13.8 5.2 13.3 207.1 5.2 19.2 8.3 10.2 22.8 32.1 11.4 8.7 10.2 9.0 19.8 20.6 16.1 11.9 9.0 22.5 9.2 17.9 20.8 5.9 11.4 8.9 19.6 5.7 5.6 6.3 11.8 17.2 8.1 9.3 18.2 15.3 10.8 12.4 5.2 7.5 8.5 10.0 9.4 14.0 9.5 8.5 8.3 26.0 9.4 0.0 2.6 15.0 0.0 24.3 14.7 0.2 16.2 15.0 4.5 12.1 0.0 3.4 0.0 22.3 16.3 8.5 2.2 5.6 6.1 7.1 18.7 0.9 5.0 0.0 2.0 8.0 0.2 6.5 12.2 0.5 2.6 1.9 4.2 6.8 5.4 2.8 20.1 4.9 9.6 13.3 4.3 4.2 0.0 3.1 8.4 1.9 10.5 8.2 0.0 0.1 11.4 0.0 4.4 6.7 11.8 2.1 3.8 7.9 6.2 7.2 3.7 0.8 12.0 15.1 2.1 11.5 7.0 7.8 5.0 4.4 9.5 11.3 6.8 10.1 9.4 18.7 12.9 6.7 8.8 26.0 16.1 0.6 8.3 8.5 14.0 24.7 9.4 21.5 21.6 19.9 28.4 22.8 32.1 19.8 20.6 17.9 15.3 6.0 11.8 20.4 7.1 7.1 37.4 7.9 22.9 9.4 18.2 12.2 9.8 2.2 11.6 27.6 0.8 20.5 1.0 0.0 9.3 1.3 39.5 9.9 12.7 13.6 12.7 35.0 15.2 30.7 2.5 2.1 43.7 7.1 20.3 10.8 6.4 51.7 5.9 7.0 60.1 14.4 15.4 25.8 37.6 1.2 1.7 5.5 1.4 10.7 4.5 3.0 MAK16 "MAK16L, RBM13" ENSG00000198042 "MAK16 homolog" Q9BXY0 8 33484750-33501260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044417, HPA050574" Uncertain Approved Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "HPA044417: AB_2678935, HPA050574: AB_2681181" "unprognostic (2.10e-1)" "unprognostic (1.74e-1)" "unprognostic (8.48e-3)" "unprognostic (2.28e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.00e-4)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.66e-4)" "unprognostic (8.04e-2)" "unprognostic (1.20e-1)" "unprognostic (6.74e-2)" "unprognostic (1.47e-1)" 22.3 11.0 10.6 14.9 15.3 13.5 15.2 11.5 17.6 13.2 11.5 12.5 8.3 9.1 20.8 9.1 15.2 13.6 11.3 13.1 10.5 13.4 17.9 20.0 10.5 17.3 11.4 10.3 24.8 15.7 10.4 19.2 13.1 19.2 14.2 11.3 8.9 10.6 10.3 25.2 12.4 10.8 19.7 13.1 17.3 11.9 9.5 7.1 20.3 14.8 14.3 17.4 16.8 11.3 3.8 4.0 0.9 9.4 5.7 6.2 3.3 6.0 8.5 6.0 13.7 7.1 8.5 9.0 10.9 7.2 11.9 11.3 12.6 5.4 21.3 10.9 9.6 10.3 8.0 20.0 12.1 16.1 4.6 5.5 20.2 6.1 11.1 10.6 8.1 12.3 8.8 11.3 15.5 18.3 4.3 8.7 14.8 25.1 12.4 9.9 7.1 28.9 9.8 31.6 15.1 6.0 10.4 9.0 9.6 10.1 10.3 15.3 12.1 6.7 9.6 13.1 7.7 6.5 8.6 7.7 11.3 8.8 14.5 12.5 6.1 6.8 22.0 7.0 17.4 11.9 0.0 3.2 0.9 4.8 6.8 5.4 3.2 4.7 4.1 3.9 3.8 6.0 6.2 0.7 5.7 9.4 4.0 3.6 3.3 10.6 15.3 11.5 17.6 10.5 13.4 11.4 10.3 19.2 7.1 14.9 8.9 13.8 10.9 13.9 4.7 11.0 10.2 14.7 15.9 8.7 2.0 9.5 6.6 9.5 1.1 7.3 3.5 0.0 6.6 12.6 9.2 6.6 9.2 6.0 8.0 9.5 1.7 4.3 4.3 0.8 8.3 7.9 1.7 5.4 4.2 3.8 9.0 3.7 7.1 7.2 4.2 6.5 9.2 11.9 18.8 13.0 6.3 8.7 6.5 8.4 MAP1S "BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1" ENSG00000130479 "Microtubule associated protein 1S" Q66K74 19 17719242-17734516 "Predicted intracellular proteins" Apoptosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 78.9;Late spermatids: 220.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050934, HPA054637" Approved Supported "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" NA NA Cytosol "Nucleoplasm, Nucleoli, Cell Junctions" "HPA050934: AB_2681281, HPA054637: AB_2682552" "unprognostic (8.47e-2)" "unprognostic (2.39e-2)" "unprognostic (1.60e-1)" "unprognostic (2.72e-1)" "unprognostic (3.70e-1)" "unprognostic (8.23e-2)" "prognostic unfavorable (5.29e-4)" "unprognostic (2.53e-1)" "unprognostic (6.17e-2)" "unprognostic (4.39e-2)" "prognostic favorable (2.65e-4)" "unprognostic (6.33e-2)" "unprognostic (1.19e-1)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (8.65e-2)" 14.7 7.1 18.9 14.0 27.0 14.9 13.4 15.4 42.1 12.3 11.5 15.5 4.9 12.5 13.4 9.8 11.6 11.1 13.1 9.3 17.2 12.9 8.3 6.9 17.6 13.2 11.4 18.1 16.8 13.8 8.9 11.9 16.1 14.3 10.0 4.7 8.4 12.6 12.1 21.2 6.0 10.5 8.8 10.3 14.2 16.0 34.1 13.1 13.2 8.5 4.3 8.6 12.6 7.6 13.1 20.7 24.9 17.7 9.4 13.3 12.5 13.0 20.5 6.2 8.1 5.2 7.8 15.7 8.6 4.4 5.5 6.2 27.9 7.5 7.7 15.9 5.5 6.4 7.2 5.0 7.0 2.3 9.6 28.7 6.9 18.2 18.2 11.1 7.6 10.0 8.5 4.0 8.3 5.2 3.9 10.9 5.9 10.7 4.4 2.9 18.3 9.3 19.3 13.6 8.2 24.0 15.1 4.8 7.8 7.1 20.0 11.0 12.1 4.8 7.4 8.6 4.7 4.7 8.4 16.8 10.1 8.7 19.5 12.9 8.3 10.0 7.8 11.6 12.2 11.8 13.3 17.0 19.2 13.3 17.7 12.8 13.1 10.4 13.1 20.7 13.1 8.8 11.7 24.9 9.4 13.1 16.7 9.5 12.5 18.9 27.0 15.4 42.1 17.2 12.9 11.4 18.1 14.3 13.1 3.0 6.9 9.5 12.3 9.2 10.0 4.8 10.2 0.0 4.5 3.5 7.9 17.5 3.3 18.4 78.9 12.8 21.7 0.0 14.9 13.7 10.1 12.1 10.3 3.9 23.4 38.1 19.5 25.8 19.1 220.0 20.8 18.7 1.7 16.2 12.9 7.8 17.9 14.0 29.7 5.2 5.9 12.9 11.4 16.3 26.4 2.9 28.3 10.9 13.1 12.3 MAP2K5 "HsT17454, MAPKK5, MEK5, PRKMK5" ENSG00000137764 "Mitogen-activated protein kinase kinase 5" Q13163 15 67542709-67807123 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 115.1;Late spermatids: 149.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022094, HPA027347, HPA027755" Supported Approved Nucleoli,Microtubules NA NA "Nucleoli, Microtubules" "CAB022094: , HPA027347: AB_10599290, HPA027755: AB_10600883" "unprognostic (4.54e-2)" "unprognostic (1.87e-2)" "unprognostic (4.16e-2)" "unprognostic (9.06e-2)" "unprognostic (1.77e-3)" "unprognostic (1.06e-1)" "unprognostic (1.96e-1)" "unprognostic (3.73e-1)" "unprognostic (2.41e-2)" "unprognostic (2.83e-1)" "unprognostic (1.47e-2)" "unprognostic (5.41e-2)" "prognostic favorable (8.03e-5)" "unprognostic (1.68e-1)" "unprognostic (2.74e-1)" "unprognostic (3.99e-2)" "unprognostic (2.73e-2)" 18.6 22.2 20.3 13.8 30.9 14.6 23.7 25.0 25.4 17.0 19.3 17.2 19.9 14.7 17.4 11.3 13.5 16.2 14.4 18.8 17.1 16.4 14.2 15.5 13.5 27.9 12.6 11.5 29.0 21.0 34.1 14.4 17.7 22.2 15.9 14.8 15.6 15.7 18.5 28.5 18.7 15.0 19.4 17.2 13.0 15.4 20.3 16.2 40.2 16.9 9.2 11.9 17.0 17.9 6.6 10.2 10.3 7.3 11.7 11.2 5.5 5.3 14.2 8.5 10.0 12.6 22.2 6.7 5.4 10.9 10.1 11.1 5.7 9.6 8.8 11.4 8.9 11.0 8.1 14.5 8.6 8.4 12.8 14.5 12.0 10.6 6.1 15.9 7.2 7.5 15.2 11.3 7.3 16.6 22.3 13.3 20.5 10.5 14.8 8.3 6.9 11.8 8.6 12.0 6.2 6.9 11.7 9.9 14.7 6.1 9.8 5.4 8.4 6.0 8.9 21.4 15.4 11.2 14.2 11.0 10.5 6.9 7.2 7.2 21.0 24.6 10.3 14.0 16.6 7.5 10.3 7.3 6.6 7.7 5.6 11.2 6.6 7.3 9.0 10.2 6.2 10.4 9.5 1.7 11.7 6.2 3.9 7.4 5.5 20.3 30.9 25.0 25.4 17.1 16.4 12.6 11.5 22.2 16.2 6.0 4.3 4.2 7.5 6.2 10.0 8.0 2.5 1.4 1.2 5.2 9.8 10.3 6.6 7.7 115.1 7.0 8.8 0.0 7.4 9.1 7.1 4.5 2.3 6.8 8.8 4.8 9.1 9.8 9.2 149.4 11.5 5.3 10.1 2.8 8.4 16.0 6.9 10.5 11.0 6.8 7.2 0.0 5.1 10.4 8.2 7.2 8.2 8.7 9.4 2.7 MAP3K9 "MEKK9, MLK1, PRKE1" ENSG00000006432 "Mitogen-activated protein kinase kinase kinase 9" P80192 14 70722526-70809534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.1" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 28.6;Urothelial cells: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000942 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "HPA000942: AB_1079360" "unprognostic (1.20e-1)" "unprognostic (3.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.16e-3)" "unprognostic (2.45e-2)" "unprognostic (3.75e-5)" "unprognostic (2.58e-1)" "unprognostic (4.20e-2)" "unprognostic (4.38e-2)" "unprognostic (1.53e-2)" "unprognostic (2.48e-2)" "unprognostic (4.23e-6)" "unprognostic (5.71e-3)" "unprognostic (6.86e-3)" "unprognostic (1.79e-1)" "unprognostic (2.35e-1)" 0.5 2.2 5.8 2.0 9.2 1.4 2.8 20.1 16.5 2.4 3.1 1.8 0.4 3.0 1.1 3.4 10.1 2.2 1.5 1.2 5.7 7.1 3.1 2.4 3.9 2.6 5.9 5.9 1.4 4.3 6.8 4.7 2.8 12.8 2.0 3.1 3.1 3.2 1.3 1.9 7.8 2.9 0.7 1.6 1.9 3.4 10.1 1.8 0.6 5.3 3.2 6.8 2.0 3.9 2.3 0.5 1.3 0.2 1.1 1.4 0.3 18.1 8.4 1.6 2.0 0.0 0.0 5.6 0.4 0.2 1.7 1.6 6.0 7.0 3.7 2.5 0.1 3.7 8.6 5.3 10.2 1.9 2.4 1.5 0.2 2.9 4.0 0.3 0.4 0.8 0.1 5.6 1.2 10.6 3.1 0.0 3.3 1.3 0.8 0.4 7.3 2.8 0.4 3.5 7.2 3.9 1.0 3.2 0.7 3.9 8.3 11.6 2.5 5.2 6.2 1.0 3.2 5.6 0.6 0.0 0.0 7.4 0.0 2.8 1.9 4.4 1.9 2.8 0.3 1.1 0.5 0.2 0.8 0.6 0.1 0.1 1.0 0.6 1.0 0.0 2.3 1.0 0.7 1.3 1.1 0.2 0.5 1.4 0.3 5.8 9.2 20.1 16.5 5.7 7.1 5.9 5.9 12.8 1.8 6.0 14.9 0.9 10.9 7.7 15.8 1.8 15.3 0.0 10.3 7.0 11.8 2.5 1.7 5.5 13.2 0.7 3.1 0.0 4.0 1.3 0.8 9.0 1.1 4.9 1.0 28.6 8.1 0.6 0.8 15.9 0.6 1.4 3.3 0.0 3.4 3.4 7.4 3.5 0.0 1.9 12.3 0.0 1.0 5.4 8.5 8.0 3.3 2.9 5.0 25.4 MAPK13 "p38delta, PRKM13, SAPK4" ENSG00000156711 "Mitogen-activated protein kinase 13" O15264 6 36127809-36144524 "Enzymes, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 143.1;Late spermatids: 214.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 16.5;T-cells: 27.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 46.2;RPMI-8226: 27.9;RT4: 28.9" "Region enhanced" "Detected in some" "cerebellum: 6.5" "Region enriched" "Detected in some" 15 "cerebellum: 59.9" "HPA007667, CAB025854" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol" "CAB025854: , HPA007667: AB_1079867" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" "unprognostic (2.93e-1)" "unprognostic (6.64e-3)" "unprognostic (1.13e-2)" "unprognostic (4.80e-2)" "unprognostic (4.30e-3)" "unprognostic (5.28e-2)" "unprognostic (1.77e-1)" "unprognostic (2.14e-2)" "unprognostic (1.57e-1)" "unprognostic (7.21e-2)" "prognostic favorable (9.00e-4)" "unprognostic (3.12e-2)" "unprognostic (1.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.41e-1)" 6.5 22.0 2.2 5.4 4.0 2.9 6.8 2.8 7.3 6.8 18.9 0.5 36.8 18.8 1.9 10.3 41.1 2.4 12.0 1.2 1.7 1.8 6.5 2.8 9.6 11.2 0.8 3.8 3.9 24.6 18.8 12.4 10.5 2.5 6.8 16.0 2.4 20.7 26.3 0.9 28.6 37.7 2.1 0.8 5.9 12.2 23.7 1.1 5.0 13.8 16.0 18.5 7.3 13.9 16.5 0.1 5.2 0.3 2.8 27.8 6.7 19.6 0.1 0.3 0.2 1.2 5.7 2.7 1.6 0.2 0.2 0.5 16.3 19.4 4.7 1.2 1.5 2.8 15.2 0.0 46.2 0.4 12.0 5.2 0.1 0.5 16.2 2.0 0.1 1.2 4.9 16.4 3.0 0.6 2.3 3.0 0.5 0.3 5.3 0.5 10.3 0.1 1.2 0.1 19.4 0.3 11.6 0.2 27.9 9.0 28.9 19.6 0.3 1.7 0.3 0.1 0.6 22.0 2.5 4.1 1.4 0.2 0.5 0.3 0.3 7.0 1.4 0.0 0.5 0.1 5.2 0.3 4.5 16.2 0.0 10.5 10.8 11.6 13.0 0.1 16.5 10.6 11.9 3.9 2.8 0.0 0.0 27.8 6.7 2.2 4.0 2.8 7.3 1.7 1.8 0.8 3.8 2.5 1.1 26.8 24.1 11.5 34.8 24.3 0.8 1.6 22.9 1.4 22.7 27.9 5.9 41.4 13.3 48.4 89.5 2.3 143.1 0.0 102.6 8.3 3.2 28.0 2.3 1.6 35.8 0.0 63.0 0.6 6.1 214.3 6.6 6.4 16.9 22.6 80.8 1.5 76.0 89.2 9.2 7.9 2.2 0.0 1.0 6.1 1.5 46.5 27.0 20.2 93.7 47.8 MAPKBP1 KIAA0596 ENSG00000137802 "Mitogen-activated protein kinase binding protein 1" O60336 15 41774434-41827855 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.1" "Cell type enhanced" "Detected in many" 18 "Basal keratinocytes: 48.5;Cone photoreceptor cells: 192.4;Suprabasal keratinocytes: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030832, HPA030833" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA030832: AB_10601869, HPA030833: AB_2673628" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (6.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (9.84e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (6.80e-4)" "unprognostic (1.08e-3)" "unprognostic (6.03e-3)" "unprognostic (7.94e-2)" "unprognostic (1.68e-1)" "unprognostic (8.98e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" 4.7 6.0 10.6 5.0 13.8 4.4 5.7 48.1 13.9 6.1 5.7 8.8 4.4 10.6 9.3 5.4 12.5 8.0 5.3 4.2 8.6 6.7 3.9 2.3 4.7 4.0 8.6 9.2 15.4 4.3 5.8 9.5 6.1 9.3 5.9 4.3 7.0 5.1 7.1 4.9 26.3 10.5 10.2 6.8 5.7 5.4 19.5 10.7 4.4 8.7 5.2 7.4 8.4 6.6 1.9 1.9 4.3 2.1 2.2 3.3 1.6 4.9 2.6 7.1 6.7 7.9 7.8 4.8 7.1 17.7 6.4 4.7 5.2 1.8 1.2 5.8 5.7 8.9 12.0 6.8 19.7 4.6 4.5 2.0 5.0 8.1 1.7 3.4 3.2 10.3 4.0 15.8 10.2 18.5 10.6 9.4 8.3 3.1 2.3 9.0 1.0 2.6 2.8 0.8 2.9 5.4 2.9 5.1 0.5 3.7 5.6 8.0 4.6 4.1 4.1 3.1 7.6 4.9 2.5 7.4 9.2 4.5 8.9 6.9 5.2 8.5 2.9 6.2 4.3 7.7 4.3 1.3 1.1 3.3 0.7 2.4 1.9 1.9 1.4 1.9 1.8 2.4 2.0 0.7 2.2 2.1 0.7 0.8 1.6 10.6 13.8 48.1 13.9 8.6 6.7 8.6 9.2 9.3 10.7 6.0 13.0 2.2 7.6 48.5 11.4 2.8 2.5 10.7 9.1 3.5 192.4 5.0 0.0 2.7 11.7 7.0 4.0 0.0 3.0 3.5 5.5 3.6 1.1 1.8 3.3 14.3 4.6 4.9 2.1 19.1 6.6 4.6 8.5 4.6 1.4 6.1 3.3 1.5 7.4 0.3 8.2 12.9 3.9 8.1 4.1 46.9 4.5 4.4 2.0 12.1 MBIP ENSG00000151332 "MAP3K12 binding inhibitory protein 1" Q9NS73 14 36298558-36320676 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.2" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 202.5;Alveolar cells type 2: 218.5;Club cells: 169.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003388 Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA003388: AB_1079322" "unprognostic (8.79e-2)" "unprognostic (9.92e-2)" "unprognostic (5.07e-2)" "unprognostic (8.66e-2)" "unprognostic (9.85e-2)" "unprognostic (4.71e-2)" "unprognostic (2.71e-1)" "prognostic favorable (1.52e-4)" "unprognostic (5.24e-2)" "prognostic favorable (1.14e-4)" "unprognostic (4.65e-1)" "unprognostic (9.27e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-3)" "unprognostic (1.09e-1)" 10.4 11.7 11.4 5.7 17.0 15.4 12.9 16.4 14.9 15.4 12.2 11.5 3.6 8.6 14.0 11.3 14.0 9.1 8.6 7.2 10.7 13.0 19.5 15.0 46.2 8.1 9.9 8.9 20.0 9.0 10.4 25.1 9.8 13.3 13.8 11.7 10.1 7.7 8.9 6.0 14.3 13.2 11.0 13.6 9.8 19.0 8.8 11.8 14.4 61.2 4.0 7.9 12.4 9.3 12.0 10.4 5.1 9.3 8.3 17.9 9.6 16.6 8.7 18.7 18.8 18.8 18.2 14.1 14.3 17.8 19.0 20.0 17.8 16.8 15.8 21.9 18.4 10.0 12.8 19.6 13.2 23.4 22.8 14.7 9.2 8.7 30.3 20.5 18.8 10.3 18.6 20.4 12.4 16.1 19.7 11.8 22.2 15.8 19.8 14.0 16.0 18.0 15.3 15.8 14.3 26.0 8.7 16.3 11.0 21.4 12.9 28.0 11.1 11.8 11.4 18.9 16.7 18.6 12.3 9.2 21.2 13.8 15.5 14.7 16.4 18.9 24.8 8.1 9.7 14.6 1.4 9.3 2.0 11.2 6.8 14.1 12.0 13.7 13.8 9.2 8.7 17.9 14.5 5.1 8.3 5.3 10.4 16.1 9.6 11.4 17.0 16.4 14.9 10.7 13.0 9.9 8.9 13.3 11.8 202.5 218.5 10.4 31.7 80.1 24.3 9.4 2.5 50.9 169.5 24.4 2.0 20.7 49.7 17.7 2.7 17.7 14.6 0.0 16.6 17.7 24.9 20.7 12.7 21.2 15.9 87.4 30.2 15.4 9.9 2.5 29.7 14.5 20.3 9.0 12.1 23.6 16.8 17.5 25.5 38.3 22.5 12.9 21.2 42.9 36.4 57.2 16.6 14.9 17.7 12.9 MCEE GLOD2 ENSG00000124370 "Methylmalonyl-CoA epimerase" Q96PE7 2 71109684-71130239 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 76.7;Distal tubular cells: 77.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035196 Approved Nucleoli "Intracellular and membrane" No No 16000 Nucleoli "HPA035196: AB_10601871" "unprognostic (7.65e-2)" "unprognostic (8.20e-2)" "unprognostic (3.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.35e-1)" "prognostic favorable (4.76e-4)" "prognostic favorable (5.78e-4)" "unprognostic (4.86e-3)" "unprognostic (6.48e-2)" "unprognostic (1.08e-1)" "unprognostic (7.43e-3)" "unprognostic (8.59e-2)" "unprognostic (9.40e-3)" "unprognostic (4.90e-2)" "unprognostic (3.55e-1)" "unprognostic (6.51e-2)" "unprognostic (5.38e-2)" 10.5 20.4 8.5 10.1 9.2 4.3 18.9 10.5 9.8 14.1 13.8 9.4 24.6 11.1 8.8 19.7 16.9 8.6 12.6 19.8 6.6 6.2 18.8 39.7 9.1 9.5 13.1 6.6 12.4 29.0 9.8 24.5 9.9 9.1 13.7 13.5 11.1 28.9 20.5 18.2 15.2 14.9 10.9 11.5 10.1 13.1 5.7 11.4 9.3 11.0 18.7 10.9 13.0 13.3 15.9 17.6 20.0 18.4 11.2 24.9 11.1 6.4 3.1 5.7 4.1 19.4 26.4 16.5 9.9 12.6 5.0 7.6 7.7 8.0 9.9 3.0 9.7 3.8 6.7 6.9 5.1 5.3 9.2 6.0 6.8 8.7 22.1 10.9 7.6 5.6 17.5 7.5 3.4 6.7 11.2 5.7 7.9 8.9 17.4 4.8 8.2 5.6 8.9 5.2 17.7 7.7 6.7 6.5 18.4 7.7 5.2 6.5 4.7 3.7 21.9 9.7 6.9 17.3 7.3 7.4 5.9 4.6 6.0 3.9 16.7 6.8 10.5 9.6 12.4 5.3 13.0 18.3 20.0 12.8 18.4 17.3 15.9 15.7 12.3 14.9 13.2 14.6 12.3 4.5 11.2 17.6 17.6 24.9 11.1 8.5 9.2 10.5 9.8 6.6 6.2 13.1 6.6 9.1 11.4 23.8 8.3 13.7 11.3 7.6 2.6 76.7 22.9 17.4 9.1 5.2 2.0 30.6 77.9 10.4 0.8 9.0 14.7 0.0 16.1 27.7 21.1 8.8 0.0 60.2 13.5 4.8 8.6 9.8 11.6 0.9 27.0 11.2 13.5 3.6 28.7 6.7 10.6 10.5 16.6 64.3 8.7 25.8 10.8 2.4 4.1 18.2 9.5 12.9 25.1 9.2 MCM10 "CNA43, DNA43, PRO2249" ENSG00000065328 "Minichromosome maintenance 10 replication initiation factor" Q7L590 10 13161554-13211104 "Predicted intracellular proteins" "DNA damage, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.8;lymphoid tissue: 31.4" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 23.3;Extravillous trophoblasts: 17.2;Spermatogonia: 14.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045899, HPA071952" Approved Supported Nucleoplasm,Nucleoli Yes Yes "Nucleoplasm, Nucleoli" "HPA045899: AB_10960529, HPA071952: AB_2686477" "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-3)" "unprognostic (1.41e-1)" "unprognostic (6.58e-3)" "unprognostic (1.78e-8)" "unprognostic (2.42e-3)" "unprognostic (3.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.78e-4)" "unprognostic (7.81e-2)" "unprognostic (0.00e+0)" "unprognostic (8.87e-2)" "unprognostic (1.29e-1)" "unprognostic (9.73e-2)" "unprognostic (1.05e-1)" 3.0 0.5 0.3 5.6 0.3 10.8 2.1 0.3 0.5 1.4 2.6 0.4 0.3 1.8 1.1 0.6 5.9 0.2 0.7 0.7 0.3 0.3 0.6 0.9 1.4 6.0 0.3 0.6 0.7 0.3 0.3 0.4 3.6 0.5 0.6 2.9 0.4 1.1 0.3 1.5 1.3 1.8 0.9 0.7 2.9 1.1 4.3 0.3 31.4 0.9 3.3 6.9 0.9 1.8 0.5 1.0 1.5 0.4 0.8 3.4 1.5 13.7 15.5 18.4 13.9 0.6 1.1 8.0 14.4 2.2 16.2 16.9 15.1 9.8 20.7 6.5 3.6 6.0 16.1 25.8 8.5 15.0 10.8 12.3 25.8 6.9 10.0 0.0 13.2 11.7 0.2 0.3 16.4 1.5 1.3 5.2 16.8 30.4 14.2 8.8 12.3 31.3 5.7 10.9 13.2 3.8 24.8 16.3 12.8 3.7 5.0 3.7 14.0 11.6 8.3 2.2 10.0 10.4 9.1 3.2 10.3 19.4 15.5 15.5 4.4 17.1 27.2 6.6 14.6 8.0 0.2 0.3 0.2 1.1 0.1 0.2 0.5 1.6 3.4 1.0 0.4 0.4 2.8 1.5 0.8 0.4 0.2 1.6 1.5 0.3 0.3 0.3 0.5 0.3 0.3 0.3 0.6 0.5 0.3 0.0 0.0 1.5 0.2 1.4 0.0 1.2 0.0 0.0 1.2 0.0 0.0 4.1 0.0 0.4 1.1 0.1 0.0 23.3 0.2 17.2 1.0 0.2 0.0 0.0 4.3 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 1.9 5.9 14.0 0.4 2.9 1.0 1.8 0.0 MCOLN3 "FLJ11006, TRP-ML3, TRPML3" ENSG00000055732 "Mucolipin 3" Q8TDD5 1 85018082-85048499 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.2;pituitary gland: 38.3" "Group enriched" "Detected in many" 8 "Intestinal endocrine cells: 109.0;Melanocytes: 143.4" "Cancer enriched" "Detected in many" 6 "melanoma: 8.0" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 10.1;HAP1: 10.0;RH-30: 12.2;SK-MEL-30: 21.6" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory region: 1.7" "HPA018106, HPA062137" Enhanced Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA018106: AB_1853647, HPA062137: AB_2684695" "unprognostic (5.91e-2)" "unprognostic (1.24e-1)" "unprognostic (1.49e-2)" "unprognostic (3.21e-5)" "unprognostic (2.25e-1)" "unprognostic (8.80e-3)" "unprognostic (3.97e-3)" "unprognostic (1.13e-1)" "unprognostic (2.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.45e-3)" "unprognostic (3.09e-2)" "unprognostic (7.32e-5)" "unprognostic (6.36e-3)" "unprognostic (2.61e-1)" "unprognostic (6.11e-2)" "unprognostic (6.43e-2)" 4.7 29.2 1.5 0.8 0.8 0.0 3.0 0.2 0.4 6.1 2.8 0.9 2.1 3.2 5.4 15.6 0.8 1.1 0.6 5.1 3.4 0.3 4.5 0.2 4.1 0.0 0.5 0.0 2.2 6.5 17.9 38.3 1.8 2.7 0.5 0.5 4.5 8.1 0.4 1.9 2.5 1.9 1.1 0.3 0.9 1.6 0.4 0.3 2.6 1.5 0.9 0.4 0.7 2.8 0.0 0.0 0.0 0.0 0.0 2.9 0.7 6.5 1.5 0.0 0.0 5.3 4.8 1.7 0.1 10.1 2.5 7.0 0.5 1.2 0.0 0.7 0.1 2.3 0.0 10.0 3.2 1.6 2.6 5.9 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.2 2.1 1.2 2.6 0.0 0.0 0.0 0.0 4.9 0.6 0.0 0.0 0.7 0.0 0.6 0.0 12.2 0.0 0.3 0.0 0.4 0.0 0.3 0.0 21.6 0.8 4.1 5.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.8 0.2 0.4 3.4 0.3 0.5 0.0 2.7 0.3 14.9 1.7 0.0 3.6 7.7 0.0 6.9 10.2 0.0 1.2 3.5 0.0 6.4 0.0 1.9 0.3 0.5 1.3 0.0 8.4 0.1 5.1 1.1 0.0 0.0 3.4 0.0 109.0 0.0 0.0 0.0 1.7 0.8 143.4 2.8 0.6 0.0 4.9 7.8 0.0 2.2 0.0 6.5 1.2 0.9 1.6 3.0 2.2 0.0 0.6 0.3 MDN1 "KIAA0301, Rea1" ENSG00000112159 "Midasin AAA ATPase 1" Q9NU22 6 89642499-89819723 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 27.1;NTERA-2: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029666, HPA029667, HPA029668, HPA029669" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA "Nucleoli, Cytosol" "Nucleoplasm, Intermediate filaments" "HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429" "unprognostic (2.00e-1)" "unprognostic (4.46e-2)" "unprognostic (7.62e-2)" "unprognostic (2.26e-2)" "unprognostic (6.14e-3)" "unprognostic (3.46e-1)" "unprognostic (6.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-1)" "unprognostic (1.75e-1)" "unprognostic (1.77e-2)" "unprognostic (9.07e-2)" "unprognostic (2.54e-3)" "unprognostic (6.28e-3)" "unprognostic (9.22e-2)" "unprognostic (2.02e-1)" "unprognostic (6.09e-2)" 10.0 8.8 8.6 10.1 18.2 16.1 14.9 19.2 18.7 9.1 7.5 14.8 8.6 5.9 14.1 10.0 9.2 10.2 6.4 8.6 9.4 9.6 9.4 15.1 7.3 10.9 13.1 12.4 22.3 10.7 19.0 10.9 5.9 15.9 8.1 8.6 9.4 9.3 8.3 16.2 19.6 8.8 9.2 12.7 9.0 8.2 14.0 13.7 8.4 12.8 8.2 12.7 7.5 7.8 3.8 8.9 6.7 1.0 3.3 4.2 0.3 4.6 4.6 4.8 4.5 7.9 7.5 4.8 3.2 2.4 3.6 4.5 10.6 1.7 14.0 3.7 3.3 3.9 4.1 12.4 4.3 6.5 5.5 8.2 15.2 5.9 6.9 3.0 19.6 3.8 4.6 3.7 9.7 9.0 2.2 6.4 6.4 27.1 3.4 3.5 5.6 3.0 7.4 26.4 3.9 4.0 6.1 9.1 3.5 3.2 6.6 8.7 3.9 4.5 2.7 2.9 6.6 1.9 8.7 8.2 2.4 4.5 3.2 7.4 3.9 4.3 6.9 3.3 11.2 4.2 6.7 1.0 1.9 2.4 0.8 2.1 3.0 3.3 2.6 0.6 3.8 4.2 3.3 0.2 3.3 1.0 8.9 1.3 0.3 8.6 18.2 19.2 18.7 9.4 9.6 13.1 12.4 15.9 13.7 26.8 15.5 8.5 5.2 26.1 24.4 30.7 7.6 13.4 25.0 14.0 23.6 4.9 0.0 5.9 6.0 13.3 4.6 23.3 6.9 5.7 10.0 7.3 5.8 41.4 5.9 17.5 7.5 9.2 3.3 2.5 6.6 6.6 11.8 2.8 6.9 7.8 5.6 3.5 8.1 1.8 19.5 0.0 9.5 21.7 50.0 26.3 2.9 9.6 9.3 8.7 MED12L "KIAA1635, TNRC11L, TRALP, TRALPUSH" ENSG00000144893 "Mediator complex subunit 12 like" Q86YW9 3 151085697-151437072 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 14.2;Horizontal cells: 31.8;Muller glia cells: 35.7;Syncytiotrophoblasts: 22.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 15.8;HEL: 17.1;JURKAT: 10.9;MOLT-4: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036807 Enhanced Approved Nucleoli NA NA Nucleoli "HPA036807: AB_10670242" "unprognostic (1.01e-2)" "unprognostic (5.82e-2)" "unprognostic (5.12e-2)" "unprognostic (8.14e-4)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (1.23e-2)" "unprognostic (5.90e-3)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" "unprognostic (1.38e-3)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (4.36e-3)" "unprognostic (3.84e-1)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" 2.8 5.2 6.4 1.2 11.1 5.5 0.5 4.9 23.1 1.6 0.6 4.4 0.0 2.2 0.9 3.0 0.9 0.6 1.8 1.7 5.5 5.1 0.4 0.4 0.7 4.4 5.8 2.6 1.0 1.7 0.5 5.4 2.0 3.9 1.2 0.3 1.9 1.7 0.7 0.5 0.4 1.6 0.6 6.1 2.1 0.8 6.1 5.7 0.6 1.0 0.0 1.5 1.3 0.8 1.0 5.1 3.1 2.8 0.1 0.4 0.8 0.7 0.3 2.5 0.2 0.1 0.0 15.8 0.0 0.2 0.6 0.7 0.8 0.3 0.0 0.2 0.1 1.8 0.1 3.2 0.2 0.7 0.0 1.5 17.1 0.1 0.1 0.0 0.5 6.1 0.0 0.1 0.1 0.1 0.1 0.0 10.9 0.0 2.6 0.0 2.5 7.9 0.0 2.9 0.1 0.5 0.1 0.9 0.4 0.2 2.5 4.2 0.6 0.4 0.2 0.0 4.6 0.8 0.1 0.0 0.0 1.9 0.0 1.3 5.0 0.0 6.1 0.2 1.5 0.9 3.1 0.3 0.0 0.1 2.8 0.4 0.1 0.1 0.2 1.6 1.0 0.0 0.0 0.3 0.1 0.8 5.1 0.0 0.8 6.4 11.1 4.9 6.9 5.5 5.1 5.8 2.6 3.9 5.7 0.0 0.0 0.0 1.2 1.0 9.0 1.2 0.0 1.4 2.3 1.8 3.9 14.2 0.0 0.1 9.9 0.1 0.0 0.0 0.5 0.6 0.6 1.0 0.0 0.0 1.6 31.8 0.0 0.6 1.0 4.5 0.9 0.9 0.0 1.8 0.0 35.7 0.2 0.0 0.4 0.1 1.8 0.0 0.1 7.5 1.5 0.1 22.5 0.0 0.0 0.1 MED16 "DRIP92, THRAP5, TRAP95" ENSG00000175221 "Mediator complex subunit 16" Q9Y2X0 19 867630-893218 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030685, HPA046495" Uncertain Approved Nucleoli NA NA Nucleoli "HPA030685: AB_10601872, HPA046495: AB_2679674" "unprognostic (1.63e-1)" "unprognostic (1.33e-1)" "unprognostic (2.91e-1)" "prognostic favorable (5.46e-4)" "unprognostic (1.90e-1)" "unprognostic (5.25e-3)" "unprognostic (1.68e-1)" "unprognostic (1.61e-1)" "unprognostic (2.80e-1)" "unprognostic (3.15e-2)" "unprognostic (4.93e-3)" "unprognostic (3.28e-1)" "prognostic favorable (1.11e-5)" "unprognostic (4.83e-2)" "unprognostic (5.52e-1)" "unprognostic (1.57e-1)" "unprognostic (5.17e-2)" 17.8 19.8 17.0 24.2 21.1 16.1 15.9 16.8 34.5 21.8 20.4 21.4 12.5 20.5 20.7 14.9 21.0 20.3 21.9 14.0 16.0 15.4 19.4 29.5 16.2 19.4 13.4 16.3 28.6 46.1 18.9 18.8 21.9 14.7 20.6 8.5 19.4 24.4 15.6 31.1 24.6 24.4 14.9 11.2 22.3 27.0 20.1 14.0 27.0 21.6 16.1 21.6 20.5 18.9 30.3 20.8 24.7 17.0 19.2 40.3 25.4 14.1 12.3 12.4 8.3 5.3 5.6 13.6 9.6 9.5 14.8 11.4 16.0 13.6 14.7 11.9 8.9 5.1 11.2 4.7 11.9 2.5 18.2 14.9 14.7 9.2 14.7 10.3 13.8 13.3 9.7 6.0 9.1 6.0 8.9 10.9 15.7 17.1 34.0 8.6 21.3 22.2 16.3 19.2 5.5 16.0 23.3 8.9 18.7 9.9 22.8 15.4 15.0 13.4 9.2 10.8 4.9 10.5 11.1 10.9 15.3 15.4 23.1 11.1 25.7 9.2 13.4 19.6 13.1 11.0 24.7 15.7 19.0 27.6 17.0 25.0 30.3 30.3 31.5 20.8 23.1 25.8 23.8 22.2 19.2 16.9 13.6 40.3 25.4 17.0 21.1 16.8 34.5 16.0 15.4 13.4 16.3 14.7 14.0 32.8 21.9 14.5 10.0 10.3 14.2 6.4 15.3 12.0 12.5 21.0 5.9 50.4 14.9 19.5 2.9 10.9 35.5 0.0 20.9 26.3 11.3 12.1 13.9 22.5 22.0 14.3 24.6 18.4 16.8 4.7 12.7 9.4 10.1 29.7 24.7 16.5 20.5 27.5 13.8 14.6 19.2 6.5 11.3 13.7 30.5 14.1 53.3 16.6 22.2 12.9 MED21 "SRB7, SURB7" ENSG00000152944 "Mediator complex subunit 21" Q13503 12 27022546-27066343 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017177 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA017177: AB_1857665" "unprognostic (3.02e-1)" "unprognostic (7.33e-2)" "unprognostic (2.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (2.10e-1)" "unprognostic (7.18e-3)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" "unprognostic (7.32e-2)" "unprognostic (1.03e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.74e-8)" "unprognostic (3.18e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-2)" "unprognostic (1.42e-2)" 20.7 31.5 20.7 13.3 32.4 31.9 23.9 25.9 31.9 24.8 21.9 18.0 18.8 14.9 25.9 21.7 30.4 20.8 19.6 31.3 19.5 21.9 34.1 18.8 20.8 15.7 21.1 26.2 30.8 17.1 30.3 26.0 19.8 23.6 27.6 20.6 18.3 25.3 24.5 30.7 19.3 17.4 27.3 20.2 16.0 19.6 28.9 22.1 22.1 28.2 28.7 19.9 31.6 27.2 20.1 15.8 35.5 18.6 12.8 28.0 19.1 16.6 17.6 9.3 14.8 20.8 21.0 15.4 19.0 14.3 16.1 21.0 18.4 19.0 11.0 12.1 14.5 23.4 13.8 19.8 17.6 27.8 9.6 17.7 15.8 18.2 11.3 11.6 19.3 11.4 14.8 25.8 19.9 23.9 26.1 23.3 14.9 12.8 14.7 18.1 12.5 16.9 35.6 28.5 21.2 23.3 14.6 59.7 12.4 16.7 19.1 7.1 10.4 23.2 10.0 15.0 37.3 17.7 12.9 16.8 18.0 14.0 22.3 19.2 4.5 9.3 18.1 17.1 21.6 12.1 35.5 17.5 23.9 20.4 18.6 20.8 20.1 24.6 23.9 15.8 16.6 28.0 25.3 14.0 12.8 16.5 12.9 23.8 19.1 20.7 32.4 25.9 31.9 19.5 21.9 21.1 26.2 23.6 22.1 14.9 16.5 22.6 105.7 87.8 9.2 30.8 7.6 12.0 29.6 50.6 0.0 52.6 79.6 36.3 190.1 33.7 16.5 23.3 33.3 49.3 57.0 71.3 18.4 20.0 27.5 12.7 17.1 22.1 17.5 59.3 44.8 27.0 67.4 36.9 17.6 15.1 29.2 17.3 44.6 72.5 13.1 19.4 58.7 92.2 54.3 88.5 51.0 27.7 17.2 125.9 MED27 "CRSP34, CRSP8, MED3, TRAP37" ENSG00000160563 "Mediator complex subunit 27" Q6P2C8 9 131860107-132079908 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007002 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA007002: AB_1078574" "unprognostic (8.81e-2)" "prognostic favorable (1.59e-4)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" "unprognostic (9.57e-2)" "unprognostic (1.32e-2)" "unprognostic (1.55e-2)" "unprognostic (6.07e-2)" "unprognostic (6.63e-3)" "unprognostic (1.63e-1)" "unprognostic (8.59e-3)" "unprognostic (5.93e-2)" "unprognostic (7.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.19e-1)" "unprognostic (1.32e-1)" "unprognostic (4.60e-2)" 11.1 12.1 18.0 9.5 18.1 15.5 11.5 14.0 21.4 10.9 11.7 19.5 10.1 7.8 18.6 23.5 15.5 13.9 9.5 17.5 17.5 11.2 10.4 7.5 10.9 13.5 18.6 19.1 12.7 7.9 10.6 17.8 12.7 17.4 12.7 10.7 16.0 17.7 14.4 15.2 15.7 8.6 16.3 16.1 11.7 10.2 14.7 14.0 17.9 13.2 9.6 15.8 12.3 10.5 12.9 19.8 13.4 18.6 18.0 19.7 11.8 16.1 15.9 18.4 14.6 13.2 12.2 15.5 16.8 22.4 33.8 26.5 23.8 13.1 16.0 11.4 17.5 22.6 29.4 25.4 23.9 22.2 17.2 15.0 12.0 16.7 14.1 19.8 21.5 15.2 13.4 16.5 26.6 27.3 10.7 17.6 23.5 17.5 13.4 24.6 25.7 23.1 12.5 18.7 15.9 27.1 20.4 26.0 19.6 13.6 9.0 34.4 13.9 21.7 11.2 11.2 12.3 17.8 10.1 14.7 34.4 15.1 25.4 25.3 5.4 16.6 28.4 19.1 15.0 23.4 3.5 12.2 13.4 18.9 18.6 15.3 11.6 14.8 18.5 19.2 12.9 12.7 15.5 4.8 18.0 16.0 19.8 19.7 11.8 18.0 18.1 14.0 21.4 17.5 11.2 18.6 19.1 17.4 14.0 14.9 8.5 3.0 11.2 5.4 24.5 5.9 5.1 6.7 10.3 12.2 17.7 28.2 11.6 13.9 12.9 10.6 2.1 0.0 14.5 17.3 8.9 5.1 10.4 4.9 15.2 20.6 5.1 5.5 3.7 5.4 13.3 8.8 6.8 11.8 4.2 23.3 12.9 0.0 15.9 6.0 17.8 6.5 8.3 20.7 22.2 4.4 45.8 10.2 4.7 10.7 MESP1 "bHLHc5, MGC10676" ENSG00000166823 "Mesoderm posterior bHLH transcription factor 1" Q9BRJ9 15 89748661-89751310 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 14.1;prostate: 10.9" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 37.0;Glandular cells: 36.0;Spermatocytes: 42.6" "Group enriched" "Detected in many" 5 "endometrial cancer: 6.3;prostate cancer: 26.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.7;HDLM-2: 5.0;HEK 293: 5.0;PC-3: 9.5;SCLC-21H: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069981 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA069981: AB_2686225" "unprognostic (4.17e-2)" "unprognostic (1.52e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (4.83e-2)" "unprognostic (7.21e-2)" "unprognostic (2.68e-2)" "unprognostic (4.95e-3)" "unprognostic (2.26e-2)" "unprognostic (2.47e-1)" "unprognostic (8.38e-2)" "unprognostic (2.06e-1)" "unprognostic (2.24e-3)" "unprognostic (2.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (7.03e-2)" 14.1 1.6 6.8 1.4 4.3 1.1 3.8 7.3 8.8 2.5 1.9 1.1 0.1 1.3 1.0 1.0 0.9 1.0 2.9 3.9 4.9 5.0 1.3 1.2 1.1 1.1 3.3 4.3 1.0 1.2 1.1 1.1 0.8 2.4 10.9 1.0 1.3 3.0 1.2 7.0 0.9 1.1 0.9 1.4 0.9 1.0 1.4 1.9 0.0 1.0 2.2 0.9 0.9 0.4 0.0 0.1 0.0 0.1 0.0 0.8 0.1 5.7 2.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.3 0.0 2.3 0.0 0.7 0.0 0.4 0.0 0.0 5.0 5.0 0.2 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 1.5 0.0 0.2 0.0 0.1 0.8 1.4 0.0 0.0 9.5 0.2 0.0 1.3 0.1 0.0 4.4 0.1 1.1 1.9 1.2 0.0 0.1 0.7 0.0 0.0 0.3 3.4 1.1 2.3 0.8 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.1 6.8 4.3 7.3 8.8 4.9 5.0 3.3 4.3 2.4 1.9 0.0 0.6 0.8 2.6 0.2 10.5 5.2 12.7 0.0 0.0 1.8 9.8 1.8 10.0 16.5 3.7 0.7 17.0 0.0 37.0 0.1 1.0 36.0 4.6 11.5 2.0 7.9 5.8 3.1 2.2 1.0 1.1 2.1 6.8 2.8 4.6 12.7 7.1 10.5 0.0 11.1 15.3 0.0 1.0 42.6 14.3 0.3 0.2 4.4 11.0 5.0 METTL5 HSPC133 ENSG00000138382 "Methyltransferase like 5" Q9NRN9 2 169810081-169824931 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038223 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA038223: AB_10672509" "unprognostic (2.55e-2)" "unprognostic (8.41e-2)" "unprognostic (4.73e-1)" "unprognostic (3.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.25e-3)" "prognostic unfavorable (6.64e-5)" "unprognostic (2.78e-2)" "unprognostic (7.53e-2)" "unprognostic (1.24e-2)" "unprognostic (2.15e-3)" "unprognostic (3.15e-2)" "prognostic unfavorable (3.06e-8)" "unprognostic (8.53e-2)" "unprognostic (1.70e-1)" "unprognostic (1.95e-2)" "unprognostic (6.87e-3)" 28.9 25.2 30.1 15.8 29.3 17.6 31.2 18.1 30.2 19.8 28.6 14.2 14.9 17.7 18.8 40.4 29.0 17.9 17.3 38.2 25.6 28.5 27.8 29.2 15.8 19.4 25.6 20.8 16.6 32.5 18.0 24.2 22.3 30.2 25.3 26.5 11.9 27.9 20.9 50.1 19.6 24.9 38.4 26.5 17.8 25.1 14.1 23.9 18.1 26.1 33.9 22.3 31.6 26.5 28.6 21.9 15.0 14.1 18.8 29.1 15.1 24.3 13.5 19.6 21.7 18.0 27.1 32.3 20.7 19.4 25.2 20.3 42.0 28.9 31.2 25.2 16.9 33.6 25.5 26.7 43.3 35.5 24.0 19.2 47.0 11.0 45.7 24.6 58.9 23.2 19.8 58.1 31.9 39.3 26.4 23.3 42.9 43.6 26.2 32.0 23.6 28.2 47.9 26.5 31.9 25.6 28.6 18.4 48.2 43.2 22.4 23.9 17.9 13.3 21.0 35.9 23.3 19.8 26.6 16.0 27.6 22.4 17.2 26.4 25.6 38.6 51.7 23.0 28.9 24.7 15.0 11.7 9.0 19.0 14.1 29.1 28.6 26.3 25.2 14.2 24.1 27.5 24.9 3.5 18.8 12.9 21.9 24.9 15.1 30.1 29.3 18.1 30.2 25.6 28.5 25.6 20.8 30.2 23.9 11.9 24.5 38.7 74.0 34.3 24.2 70.2 53.5 52.2 44.3 41.8 15.7 76.3 94.5 98.0 3.3 34.7 33.8 0.0 128.2 98.7 39.5 65.1 45.1 44.3 68.6 22.3 58.3 36.8 31.3 6.8 46.6 34.4 52.3 48.7 58.4 27.4 118.7 49.1 56.6 81.1 18.3 51.8 54.3 46.4 73.5 35.8 32.7 42.8 68.9 70.1 MFSD9 MGC11332 ENSG00000135953 "Major facilitator superfamily domain containing 9" Q8NBP5 2 102715840-102736888 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055293, HPA061859" Approved Approved "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA055293: AB_2682775, HPA061859: AB_2684627" "unprognostic (1.27e-2)" "unprognostic (5.07e-2)" "unprognostic (5.00e-2)" "unprognostic (1.93e-2)" "prognostic unfavorable (8.38e-4)" "unprognostic (2.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.32e-1)" "unprognostic (2.60e-2)" "unprognostic (2.98e-1)" "unprognostic (1.06e-1)" "unprognostic (8.42e-2)" "unprognostic (6.88e-3)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (3.33e-1)" "unprognostic (2.28e-2)" 4.3 4.1 3.0 3.5 3.1 6.2 6.2 12.9 5.2 4.6 8.4 2.4 11.0 11.6 2.8 3.8 7.2 2.7 4.1 3.8 2.3 2.8 7.2 16.2 3.0 4.5 2.3 1.5 3.3 16.8 6.3 10.7 3.4 4.8 3.4 7.9 5.1 9.0 6.8 2.2 4.4 16.0 4.0 2.7 4.8 6.7 2.7 1.7 10.0 5.0 3.9 6.3 5.5 3.5 3.0 4.4 6.4 3.2 4.1 4.3 3.0 3.9 3.3 3.6 6.3 4.2 1.8 8.7 2.6 2.4 3.9 3.9 10.0 6.0 3.2 4.2 1.8 6.4 6.2 4.9 2.6 2.7 13.0 5.0 5.8 3.6 13.1 3.6 4.5 7.7 2.1 6.5 2.7 1.4 3.4 2.6 9.2 3.5 2.0 1.8 3.8 4.3 7.0 3.4 7.8 3.7 3.5 5.6 3.3 6.7 13.5 6.9 5.1 2.6 7.8 7.7 3.9 3.3 6.5 1.9 3.1 5.7 4.2 3.4 4.7 3.7 2.4 2.8 9.7 3.6 3.7 1.2 6.4 4.3 3.2 3.3 3.0 3.4 3.1 2.6 2.7 3.7 3.8 5.0 4.1 1.9 4.4 2.2 3.0 3.0 3.1 12.9 5.2 2.3 2.8 2.3 1.5 4.8 1.7 0.0 1.0 4.4 2.9 3.0 1.5 2.2 2.5 2.7 4.5 7.0 3.9 7.3 0.0 5.3 13.0 1.2 8.4 0.0 7.4 7.2 2.1 3.9 3.5 7.8 4.1 0.0 2.9 0.6 1.2 3.0 0.9 2.1 0.0 4.6 7.9 1.7 8.5 8.6 1.1 2.9 2.6 6.5 1.2 0.9 4.9 3.9 9.6 5.2 6.3 8.0 MIF4GD "AD023, MGC45027, MIFD, SLIP1" ENSG00000125457 "MIF4G domain containing" A9UHW6 17 75266228-75271227 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 67.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051222 Approved Supported "Nucleoli,Golgi apparatus,Cytosol" NA NA Nucleoli "Golgi apparatus, Cytosol" "HPA051222: AB_2681393" "unprognostic (1.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.94e-2)" "unprognostic (3.82e-3)" "unprognostic (2.92e-1)" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-1)" "unprognostic (8.15e-2)" "prognostic favorable (2.70e-4)" "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (9.88e-2)" "unprognostic (2.29e-1)" "unprognostic (7.12e-2)" "unprognostic (7.31e-2)" 19.0 13.9 10.4 14.5 11.1 30.5 13.3 7.4 14.6 11.9 12.9 20.8 14.2 10.3 16.8 12.8 18.3 13.9 20.4 20.4 10.2 8.2 16.0 15.1 15.1 30.4 12.0 9.9 12.2 16.2 18.2 7.4 15.9 12.0 12.0 11.7 15.5 15.4 11.5 34.4 18.6 14.1 20.4 15.4 22.0 11.7 12.6 10.9 21.8 15.0 20.7 20.9 16.6 12.2 14.1 67.0 11.3 21.5 14.5 17.5 14.4 12.0 21.3 4.7 11.0 7.7 2.3 6.8 3.1 8.8 6.2 4.2 7.5 13.6 18.8 5.6 4.9 7.3 9.6 5.7 10.8 4.7 9.3 14.6 9.3 9.3 6.6 8.5 8.1 10.8 2.2 16.9 4.3 17.7 8.5 12.8 21.2 12.2 23.0 1.6 23.5 25.8 19.4 2.1 13.9 10.4 16.9 6.0 25.6 12.5 6.5 7.1 10.4 6.3 16.6 15.4 11.4 30.8 19.0 4.9 3.2 7.7 4.0 6.1 33.5 8.7 15.8 5.9 14.4 4.2 5.7 21.5 11.3 15.4 11.0 16.2 14.1 12.5 13.7 25.4 13.0 11.4 12.0 3.8 14.5 13.1 67.0 17.5 14.4 10.4 11.1 7.4 14.6 10.2 8.2 12.0 9.9 12.0 10.9 0.0 11.2 26.7 11.3 10.2 3.8 4.0 25.5 13.4 10.3 12.2 0.0 12.2 18.3 40.4 24.1 17.9 11.2 0.0 38.2 7.9 11.3 11.9 32.2 7.2 42.0 1.6 15.0 11.1 45.6 9.9 8.6 38.5 15.1 48.7 15.0 22.4 20.7 21.6 14.9 22.6 5.3 19.4 24.2 20.0 17.4 16.6 7.8 34.5 16.9 11.4 MIS18BP1 "C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1" ENSG00000129534 "MIS18 binding protein 1" Q6P0N0 14 45203190-45253540 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006504 Approved Approved Nucleoli,Cytosol NA Yes Nucleoli Cytosol "HPA006504: AB_1078317" "unprognostic (2.12e-1)" "unprognostic (1.06e-1)" "unprognostic (2.58e-2)" "unprognostic (1.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (3.83e-4)" "unprognostic (4.18e-1)" "unprognostic (1.36e-2)" "unprognostic (3.33e-1)" "unprognostic (3.32e-2)" "unprognostic (2.32e-3)" "unprognostic (3.31e-2)" "unprognostic (5.49e-2)" "unprognostic (2.30e-1)" "unprognostic (2.97e-1)" "unprognostic (2.21e-1)" 10.3 5.2 5.1 22.5 5.7 26.3 14.1 1.8 5.7 9.0 11.8 2.3 7.6 6.0 9.8 9.5 10.2 8.6 5.7 5.3 5.1 2.8 5.0 4.3 14.3 23.9 4.5 4.1 12.5 7.1 1.8 5.2 9.5 6.7 7.9 7.6 1.9 12.5 10.2 3.0 8.4 10.7 7.3 10.2 22.5 6.9 9.5 3.1 38.4 7.1 8.2 15.5 8.2 7.7 13.1 14.7 23.6 22.6 4.5 4.8 4.0 21.0 7.9 16.5 7.2 5.1 7.3 12.2 14.6 7.7 12.2 15.2 4.2 20.4 29.1 6.4 7.2 5.2 14.8 9.7 7.4 23.0 15.3 6.1 17.4 9.8 5.4 3.4 40.1 16.3 5.2 3.0 7.2 6.8 7.9 14.8 5.6 7.6 6.9 11.8 7.7 16.7 17.7 12.5 10.4 9.9 20.0 6.7 11.2 6.2 8.8 11.6 5.1 5.9 10.0 5.3 10.3 11.9 23.0 8.1 6.5 19.8 7.9 6.4 6.2 8.2 13.6 3.6 16.8 9.1 23.6 14.2 16.2 3.9 13.2 4.1 13.1 3.6 3.2 9.6 12.9 2.4 2.5 8.5 4.5 22.6 14.7 4.8 4.0 5.1 5.7 1.8 5.7 5.1 2.8 4.5 4.1 6.7 3.1 23.8 23.8 43.1 9.7 17.9 7.9 11.8 10.2 20.1 35.2 8.7 15.7 30.2 5.0 11.5 2.9 28.7 11.1 23.3 9.7 38.0 14.2 17.4 41.7 6.7 32.5 0.0 26.5 30.1 69.4 3.6 51.2 58.2 5.0 70.3 23.5 4.8 11.1 34.8 57.0 3.6 8.2 0.0 14.2 67.2 107.7 23.1 16.2 47.3 24.4 11.0 MMP24 MT5-MMP ENSG00000125966 "Matrix metallopeptidase 24" Q9Y5R2 20 35226654-35277000 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.5" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 38.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 91.3" "HPA049280, HPA078816" Approved Approved "Nucleoli,Plasma membrane" "Secreted to extracellular matrix" Yes No "Nucleoli, Plasma membrane" "HPA049280: , HPA078816: " "unprognostic (1.52e-3)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "unprognostic (4.51e-4)" "unprognostic (2.47e-2)" "unprognostic (7.61e-3)" "unprognostic (1.22e-1)" "unprognostic (4.59e-2)" "unprognostic (2.32e-2)" "unprognostic (8.82e-2)" "unprognostic (9.20e-3)" "unprognostic (7.12e-2)" "prognostic favorable (8.17e-11)" "unprognostic (3.32e-2)" "unprognostic (5.63e-2)" "unprognostic (1.69e-2)" "unprognostic (9.90e-4)" 1.6 1.3 4.0 0.4 7.8 0.6 0.4 38.5 8.9 0.7 0.3 1.3 0.2 2.8 1.6 0.9 0.2 2.8 0.6 1.0 2.7 3.2 8.6 0.9 6.1 0.3 1.8 1.5 0.9 8.0 0.0 3.8 0.6 1.7 2.2 0.1 0.5 0.4 6.0 0.2 1.5 1.7 2.5 0.9 0.6 0.7 0.4 1.4 0.2 0.8 0.2 0.2 0.5 0.2 0.8 0.4 2.2 0.8 0.6 1.2 0.3 0.3 20.1 0.0 0.1 0.1 0.0 0.6 1.1 1.3 2.1 1.1 30.6 5.4 0.0 9.0 1.4 0.7 0.3 4.7 0.0 0.9 0.1 0.2 1.1 0.6 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.2 0.2 0.1 0.1 7.7 0.0 1.4 0.0 0.1 0.0 13.8 0.1 8.0 5.5 1.4 0.5 0.2 1.8 0.3 0.1 0.3 4.3 10.4 1.0 0.4 0.1 0.1 0.0 0.9 0.1 0.6 1.0 0.6 0.1 1.0 0.7 1.2 0.6 0.7 0.8 0.4 0.8 0.6 0.6 2.2 0.6 0.8 0.2 0.0 0.3 4.0 7.8 38.5 5.3 2.7 3.2 1.8 1.5 1.7 1.4 14.9 1.0 0.0 0.1 0.1 3.6 0.6 12.7 0.0 2.3 1.8 0.0 0.0 5.0 7.5 0.6 0.7 0.3 0.0 0.8 0.1 0.2 0.4 0.0 0.2 0.0 14.3 0.0 0.0 0.3 0.0 0.3 0.0 1.7 0.0 0.0 0.2 2.1 0.0 0.0 7.3 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MNDA PYHIN3 ENSG00000163563 "Myeloid cell nuclear differentiation antigen" P41218 1 158831317-158849506 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 289.8;bone marrow: 83.3" "Group enriched" "Detected in many" 4 "Hofbauer cells: 203.8;Kupffer cells: 493.3;Macrophages: 520.9;Muller glia cells: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 289.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 289.8" "Group enriched" "Detected in some" 15 "NB-4: 36.7;THP-1: 69.4;U-937: 45.4" "Low region specificity" "Detected in all" "HPA034532, HPA073215" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol" NA NA 110000 Nucleoplasm "Nucleoli, Nucleoli rim, Vesicles, Cytosol" "HPA034532: AB_10669677, HPA073215: AB_2686582" "unprognostic (1.53e-2)" "unprognostic (7.84e-3)" "unprognostic (2.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.42e-1)" "unprognostic (1.41e-2)" "unprognostic (2.02e-2)" "unprognostic (7.99e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (9.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (4.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" 17.6 6.3 5.4 24.4 7.9 83.3 3.0 1.4 5.8 2.1 2.1 3.2 0.2 1.1 1.7 3.4 2.3 4.7 8.4 6.3 4.9 3.2 3.9 4.2 31.3 32.2 10.7 2.6 3.4 2.4 1.1 2.2 9.9 6.8 2.6 2.5 5.0 3.6 1.2 2.0 1.9 3.6 6.2 18.6 57.3 2.6 4.0 6.3 5.5 2.1 1.4 4.2 9.1 4.9 1.6 29.7 289.8 60.9 0.1 0.1 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.4 0.0 7.1 60.9 11.1 0.1 25.4 0.1 1.6 0.0 0.1 29.7 0.6 0.0 0.0 289.8 0.1 12.0 0.4 0.0 40.2 5.4 7.9 1.4 5.8 4.9 3.2 10.7 2.6 6.8 6.3 32.8 82.3 20.5 0.0 2.2 0.6 0.7 10.2 14.7 17.0 0.0 0.0 0.8 0.0 0.0 0.2 2.1 0.0 0.0 0.3 0.9 2.3 0.0 40.7 1.3 203.8 0.0 0.0 6.2 493.3 0.9 1.1 520.9 1.7 25.2 0.0 130.5 0.0 0.0 0.0 1.1 4.7 12.9 9.2 0.3 0.2 1.9 0.8 1.0 0.0 0.0 MNX1 "HB9, HLXB9, HOXHB9, SCRA1" ENSG00000130675 "Motor neuron and pancreas homeobox 1" P50219 7 156994051-157010651 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 43.3" "Cell type enhanced" "Detected in some" 15 "Intestinal endocrine cells: 24.1;Mucus-secreting cells: 18.0;Paneth cells: 9.0;Undifferentiated cells: 12.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 11.8;BEWO: 8.8;EFO-21: 11.3;HEK 293: 9.0;RPMI-8226: 24.7;SCLC-21H: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA071717 Approved Nucleoplasm,Nucleoli,Cytosol No NA Nucleoplasm "Nucleoli, Cytosol" "HPA071717: AB_2686437" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.87e-2)" "unprognostic (3.72e-3)" "unprognostic (8.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.07e-1)" "unprognostic (4.07e-2)" "unprognostic (5.06e-2)" "unprognostic (8.62e-4)" "unprognostic (1.00e-2)" "unprognostic (3.35e-2)" "unprognostic (2.23e-5)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" 0.1 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.1 6.0 0.2 0.1 9.0 0.1 0.1 0.3 0.0 7.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 43.3 0.0 3.2 0.1 0.2 0.8 3.7 0.1 1.9 0.1 0.1 0.1 7.3 0.1 0.2 0.1 2.7 1.0 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 3.9 0.0 11.8 0.0 0.0 8.8 0.0 0.0 0.1 0.0 5.1 1.7 0.9 11.3 0.0 0.3 0.2 2.0 1.6 0.9 1.4 9.0 0.0 0.8 2.3 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 4.1 3.7 1.9 0.0 6.6 0.6 0.1 0.0 1.1 0.7 0.0 1.7 24.7 4.4 0.4 13.3 0.0 1.7 1.5 0.2 0.1 3.7 2.9 0.0 0.0 0.0 0.0 0.0 3.7 1.9 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.7 0.0 4.3 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 24.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 18.0 0.0 2.5 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 12.4 0.0 MOB1A "C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B" ENSG00000114978 "MOB kinase activator 1A" Q9H8S9 2 74152528-74178898 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 381.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA047088: AB_2679927, HPA071690: AB_2686432" "unprognostic (5.32e-2)" "unprognostic (2.45e-1)" "unprognostic (5.38e-2)" "unprognostic (2.62e-1)" "unprognostic (2.19e-1)" "unprognostic (8.19e-2)" "prognostic unfavorable (3.34e-4)" "unprognostic (9.36e-2)" "unprognostic (3.91e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-3)" "unprognostic (1.04e-1)" "unprognostic (2.20e-3)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" "unprognostic (5.11e-3)" 32.2 18.0 12.2 41.5 16.3 36.6 36.2 10.8 11.3 24.5 21.5 12.6 16.1 19.7 27.1 19.8 28.9 22.0 19.9 20.9 11.0 10.4 34.7 21.4 28.4 65.1 14.7 6.9 28.4 12.6 13.8 11.5 20.9 15.9 21.0 20.7 14.3 18.1 18.8 12.8 22.9 30.2 31.6 21.8 51.1 18.7 17.9 12.8 57.0 25.4 16.9 42.4 29.2 24.6 22.3 22.2 32.3 42.8 20.6 15.9 25.2 21.0 12.1 15.2 16.4 25.1 27.5 18.0 17.0 22.9 22.2 21.9 16.5 15.4 43.3 14.6 21.3 16.5 17.7 19.4 19.4 33.7 30.4 11.6 39.1 8.4 17.4 20.1 33.8 63.2 23.2 19.0 17.7 15.0 16.7 23.2 16.8 16.7 16.1 21.5 11.4 42.4 28.8 14.1 18.1 9.9 29.3 52.4 23.0 19.1 26.4 7.7 10.1 24.1 17.9 15.5 12.0 14.3 16.1 22.0 28.9 15.2 20.2 26.9 12.0 10.6 33.3 19.4 28.9 15.4 30.8 24.0 32.3 14.8 39.0 15.9 22.3 13.3 15.7 22.2 17.2 12.3 14.6 24.0 20.6 42.8 15.5 13.4 25.2 12.2 16.3 10.8 11.3 11.0 10.4 14.7 6.9 15.9 12.8 47.6 54.3 138.1 70.9 121.6 12.3 37.0 43.3 80.3 58.0 78.5 5.9 57.5 77.9 53.0 5.0 60.8 83.6 46.7 46.0 83.4 58.3 90.4 109.5 38.0 153.8 25.4 36.1 63.3 177.0 8.5 57.8 185.9 64.1 381.5 63.9 22.4 63.0 74.8 64.3 137.3 13.0 71.1 74.1 87.4 46.2 115.4 55.5 96.5 62.4 139.8 MOB1B "MOB4A, MOBKL1A" ENSG00000173542 "MOB kinase activator 1B" Q7L9L4 4 70902326-71022449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 70.0;monocytes: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 34.3" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA047088: AB_2679927, HPA071690: AB_2686432" "unprognostic (1.05e-1)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (2.94e-1)" "unprognostic (1.36e-1)" "unprognostic (3.45e-1)" "unprognostic (1.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.09e-3)" "unprognostic (2.70e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-3)" 9.8 10.1 15.7 17.8 13.0 30.9 11.1 10.4 20.0 10.5 9.7 17.3 4.8 6.1 13.9 8.6 9.9 11.8 9.1 11.1 19.8 10.6 29.3 8.3 20.6 13.4 15.5 18.6 13.8 11.0 18.0 10.9 11.2 12.8 12.7 8.5 8.0 11.1 8.6 10.8 11.2 8.4 14.1 17.4 10.6 10.1 7.6 15.4 52.3 14.4 8.2 12.8 10.8 9.8 0.6 5.3 2.5 3.1 0.7 1.4 1.2 3.9 3.2 12.2 9.9 6.6 8.4 10.0 11.9 6.5 6.7 5.9 4.2 7.6 22.0 5.7 10.5 4.5 2.8 7.5 10.0 16.2 11.6 2.6 34.3 3.6 3.3 6.6 7.5 6.9 6.9 5.5 7.5 6.1 7.5 7.9 11.4 21.0 7.2 10.5 4.2 23.2 4.6 4.0 2.6 4.2 7.5 11.8 3.0 11.1 6.9 4.2 8.1 5.1 2.3 15.9 6.8 5.4 4.8 9.4 18.6 9.5 8.4 4.8 4.6 1.5 9.4 6.5 5.5 8.5 0.8 3.1 2.5 1.3 1.6 1.1 0.5 0.6 0.6 4.0 0.6 0.8 0.7 0.4 0.7 0.9 5.3 1.4 1.2 15.7 13.0 10.4 20.0 19.8 10.6 15.5 18.6 12.8 15.4 23.8 15.5 2.2 5.2 15.9 2.0 14.7 7.6 21.4 12.5 41.8 17.7 4.6 8.3 4.9 0.4 9.5 0.9 70.0 4.0 4.9 11.2 9.8 10.4 6.4 9.9 6.4 36.4 9.8 34.3 1.4 4.0 21.6 10.1 52.3 8.4 6.0 8.0 0.0 8.1 15.9 4.3 25.8 21.7 7.2 9.8 14.9 4.8 5.4 5.6 8.4 MOB2 HCCA2 ENSG00000182208 "MOB kinase activator 2" Q70IA6 11 1469457-1501247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 57.3;urinary bladder: 51.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046313 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA046313: AB_10959882" "unprognostic (5.02e-1)" "unprognostic (5.71e-2)" "unprognostic (6.24e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.30e-2)" "unprognostic (1.06e-3)" "unprognostic (3.06e-2)" "unprognostic (1.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.30e-2)" "unprognostic (2.87e-1)" "prognostic favorable (2.02e-4)" "unprognostic (2.67e-1)" "unprognostic (8.56e-2)" "unprognostic (9.78e-2)" "unprognostic (1.15e-1)" 9.2 4.2 2.4 17.0 2.5 3.0 12.1 2.5 3.2 14.9 30.9 1.8 6.7 2.5 12.5 8.7 17.3 13.8 26.8 8.1 2.8 1.9 3.2 3.0 4.1 8.2 2.1 2.1 8.6 5.8 6.8 1.8 4.2 2.9 21.2 6.7 4.3 12.9 20.1 7.1 9.4 10.6 57.3 2.5 3.7 9.9 4.2 2.0 2.0 4.3 3.2 4.4 51.8 21.2 10.6 10.8 11.2 12.5 11.6 17.3 9.0 13.9 15.2 9.4 7.6 23.5 16.6 8.7 11.0 16.1 21.2 16.8 9.7 19.2 10.3 8.5 25.9 13.2 17.1 14.5 24.7 13.0 13.8 21.7 7.8 5.5 12.3 15.9 10.2 12.3 13.4 29.8 11.3 13.3 17.1 22.5 13.4 12.6 10.7 10.7 9.9 13.2 17.4 11.6 26.7 14.2 9.6 9.6 10.7 17.7 13.3 17.6 18.7 13.7 17.1 13.2 12.5 7.9 10.2 18.5 13.0 6.6 4.2 6.9 10.6 10.3 10.7 9.0 9.9 9.9 8.2 8.6 11.2 17.3 8.7 14.6 8.2 14.9 13.8 10.8 10.6 12.5 10.5 7.1 11.6 12.5 6.9 12.8 9.0 2.4 2.5 2.5 2.5 2.8 1.9 2.1 2.1 2.9 2.0 6.0 7.7 13.7 25.1 73.0 17.7 11.3 12.7 6.7 5.7 7.0 11.8 26.7 23.2 29.5 22.2 55.0 43.9 70.0 33.6 25.8 27.0 36.5 25.3 7.4 23.5 41.3 20.1 25.8 15.2 9.0 22.2 20.7 54.0 32.5 29.1 18.0 31.2 63.1 48.1 18.3 17.2 84.1 54.6 22.2 39.4 71.6 49.7 45.0 24.3 28.6 MPHOSPH10 "CT90, MPP10, MPP10P, PPP1R106" ENSG00000124383 "M-phase phosphoprotein 10" O00566 2 71130314-71150101 "Predicted intracellular proteins, Predicted membrane proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035059, HPA035060, HPA049907" Enhanced Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: AB_2680947" "unprognostic (3.20e-3)" "unprognostic (1.59e-1)" "unprognostic (8.51e-2)" "unprognostic (5.77e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (3.58e-2)" "unprognostic (1.01e-1)" "unprognostic (6.41e-3)" "unprognostic (6.13e-2)" "unprognostic (3.50e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (3.89e-7)" "unprognostic (1.24e-1)" "unprognostic (2.91e-1)" "unprognostic (2.47e-1)" "unprognostic (2.23e-2)" 20.5 17.6 21.8 20.2 28.0 21.2 23.7 26.7 25.7 23.5 17.6 12.6 22.0 16.5 22.3 26.7 30.6 19.4 17.1 20.4 21.6 20.3 22.2 27.5 15.5 21.9 30.4 22.7 25.4 20.7 20.0 36.7 18.5 26.3 24.0 18.4 8.1 21.8 28.8 48.4 24.4 16.8 25.0 25.0 22.0 17.6 13.7 29.8 22.3 20.4 26.3 24.4 22.2 22.2 13.5 12.8 8.7 17.3 12.4 17.4 8.4 15.0 11.4 14.7 17.5 13.7 13.0 20.1 16.8 13.4 13.9 10.3 20.4 11.1 21.2 10.6 11.7 10.8 14.1 18.4 11.9 18.6 14.6 14.7 25.4 9.0 46.4 12.0 32.8 20.4 11.1 15.3 11.4 15.3 9.5 11.7 13.3 36.7 16.9 13.8 16.1 26.4 33.3 24.4 21.0 13.0 22.0 23.0 25.0 11.2 16.4 17.9 13.8 11.2 26.1 16.1 13.0 13.2 14.6 12.2 16.5 17.7 15.7 21.2 14.4 16.2 34.7 14.2 27.5 16.5 8.7 9.9 7.2 12.4 13.6 16.0 13.5 15.7 14.8 11.7 12.3 17.4 15.3 1.4 12.4 17.3 12.8 13.2 8.4 21.8 28.0 26.7 25.7 21.6 20.3 30.4 22.7 26.3 29.8 32.8 49.8 36.5 30.0 29.8 35.6 38.2 17.8 38.8 66.0 17.4 3.9 41.6 21.6 35.8 4.3 33.7 11.5 23.3 36.1 40.3 37.1 24.7 46.2 28.1 23.8 17.5 17.2 20.3 16.4 5.3 45.1 24.7 11.8 28.9 19.6 22.1 29.5 10.5 41.1 21.9 47.2 38.8 34.8 57.9 88.6 29.4 27.1 34.8 22.9 28.6 MPHOSPH6 MPP6 ENSG00000135698 "M-phase phosphoprotein 6" Q99547 16 82147798-82170226 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003674, HPA026948" Approved Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "CAB003674: , HPA026948: AB_1854077" "unprognostic (2.58e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-1)" "unprognostic (2.97e-3)" "prognostic unfavorable (4.36e-5)" "unprognostic (2.00e-2)" "unprognostic (2.29e-3)" "prognostic favorable (3.41e-5)" "unprognostic (7.52e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (3.05e-1)" "unprognostic (2.95e-1)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" "unprognostic (9.43e-2)" 13.7 15.5 32.0 17.5 25.1 12.3 54.1 37.1 32.6 18.5 16.0 9.3 7.0 9.9 18.9 17.1 26.5 11.9 12.3 9.4 25.4 22.2 12.0 11.5 13.6 16.1 17.5 21.9 10.4 7.2 13.6 43.5 17.4 24.0 11.3 18.7 10.8 18.1 10.3 15.4 28.4 11.0 16.8 31.7 12.7 11.2 9.9 17.9 10.8 8.7 12.9 18.2 19.6 18.5 18.6 24.6 19.4 25.2 17.1 28.3 15.6 19.6 10.7 24.1 11.7 11.7 16.6 13.3 21.2 25.5 18.5 9.0 17.3 11.5 16.2 12.9 11.6 13.7 20.7 22.9 22.0 24.9 12.0 15.0 13.0 9.0 31.1 11.7 32.3 20.2 10.4 19.8 11.0 31.7 9.4 21.2 22.7 30.5 4.6 28.1 15.9 24.8 38.2 22.0 24.5 14.9 30.8 11.1 10.7 16.7 20.7 16.5 7.1 35.7 15.9 15.2 10.3 27.9 20.1 16.6 17.4 17.3 15.3 15.0 6.8 16.4 64.4 15.7 26.6 22.0 13.0 22.0 19.4 22.3 25.2 28.3 18.6 23.1 23.2 24.6 14.6 24.8 23.6 2.7 17.1 17.4 14.7 23.0 15.6 32.0 25.1 37.1 32.6 25.4 22.2 17.5 21.9 24.0 17.9 17.9 37.6 25.3 34.6 34.5 13.8 29.0 12.7 34.8 35.2 19.2 9.8 52.1 43.1 41.7 4.8 14.3 15.1 46.7 24.5 35.8 39.3 21.5 17.4 13.0 43.1 19.1 8.6 19.0 33.6 7.6 10.3 56.9 30.4 71.3 17.4 31.2 42.3 28.1 9.6 33.9 22.5 19.4 25.8 30.3 54.8 47.2 27.5 22.9 28.6 40.1 MPPED2 "239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638" ENSG00000066382 "Metallophosphoesterase domain containing 2" Q15777 11 30384493-30586872 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 31.0;thyroid gland: 30.0" "Cell type enhanced" "Detected in many" 21 "Cone photoreceptor cells: 269.0;Horizontal cells: 77.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 19.2;HAP1: 11.4;JURKAT: 10.0;RT4: 8.0;SH-SY5Y: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062575 Approved Nucleoli,Vesicles,Mitochondria NA NA Nucleoli "Vesicles, Mitochondria" "HPA062575: AB_2684797" "unprognostic (9.60e-3)" "unprognostic (6.12e-3)" "unprognostic (3.70e-3)" "unprognostic (4.56e-2)" "unprognostic (5.46e-2)" "unprognostic (5.04e-2)" "unprognostic (1.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.57e-2)" "unprognostic (1.13e-1)" "unprognostic (7.98e-4)" "unprognostic (6.82e-2)" "unprognostic (2.47e-7)" "unprognostic (3.64e-3)" "unprognostic (2.50e-1)" "unprognostic (2.22e-2)" "unprognostic (2.57e-2)" 2.9 7.0 6.3 1.7 19.3 1.1 5.5 4.6 8.9 31.0 4.2 1.8 4.4 1.5 8.3 7.9 1.6 11.1 1.9 4.6 8.5 9.7 12.2 1.2 1.1 0.9 7.0 6.7 1.2 2.5 5.0 10.7 2.5 11.2 15.6 1.4 7.1 12.1 10.1 5.7 1.0 1.4 5.1 4.6 3.1 1.9 3.8 3.4 9.1 30.0 1.2 1.0 4.7 4.9 1.3 0.7 0.3 0.2 2.0 4.8 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 11.4 0.0 0.0 0.0 2.1 0.0 0.2 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.8 0.0 0.2 3.2 0.1 0.0 0.0 3.1 0.2 0.0 8.0 0.1 6.1 0.0 0.0 3.1 1.3 1.7 0.0 0.1 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.9 0.0 4.8 0.0 0.0 0.6 0.4 1.3 1.3 0.2 0.2 2.0 0.0 0.7 0.1 0.2 6.3 19.3 4.6 8.8 8.5 9.7 7.0 6.7 11.2 3.4 0.0 2.1 0.0 47.3 0.9 23.4 3.1 0.0 5.3 0.0 43.6 269.0 0.2 21.6 2.9 1.6 5.0 0.0 0.0 0.0 0.1 4.1 21.0 4.7 0.2 3.2 77.9 0.0 0.6 15.9 0.5 0.3 2.3 5.0 0.0 0.0 40.1 0.1 0.0 3.2 2.2 17.1 0.0 1.4 0.1 0.7 1.0 0.5 0.0 0.0 18.4 MRPL40 "MRP-L22, NLVCF" ENSG00000185608 "Mitochondrial ribosomal protein L40" Q9NQ50 22 19431902-19436075 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 28.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006181 Uncertain Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA006181: AB_1079411" "unprognostic (4.12e-2)" "prognostic favorable (7.57e-4)" "unprognostic (2.64e-2)" "unprognostic (1.29e-1)" "unprognostic (5.76e-2)" "unprognostic (4.52e-2)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" "unprognostic (4.08e-2)" "unprognostic (1.19e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (2.67e-2)" "unprognostic (1.75e-1)" "unprognostic (8.07e-2)" "unprognostic (2.29e-1)" "unprognostic (3.14e-2)" 4.0 6.6 5.5 2.5 6.6 1.3 3.9 5.1 5.4 4.3 2.6 2.9 3.0 5.0 3.7 5.0 2.9 11.8 4.6 4.7 6.1 10.3 2.2 3.0 5.1 4.7 7.0 6.4 4.9 2.5 4.6 2.2 8.7 4.2 14.8 3.6 2.3 2.4 5.0 2.7 3.1 2.8 8.2 2.8 3.7 2.5 28.1 21.6 10.3 15.1 10.9 16.4 16.6 13.2 9.2 2.2 8.4 13.7 12.7 7.0 10.0 11.6 14.1 17.6 10.8 7.7 11.6 10.4 11.0 8.1 13.1 13.9 15.9 11.9 11.8 21.3 10.5 6.6 13.3 20.2 15.0 7.0 13.1 15.5 10.4 18.6 9.5 9.4 4.4 42.5 11.1 13.6 10.1 7.8 8.9 3.6 18.7 12.5 7.4 14.5 5.3 16.8 5.6 7.6 7.0 15.3 12.9 19.2 5.2 11.4 8.8 11.8 18.8 17.4 7.4 9.7 10.6 14.2 16.9 12.3 10.2 13.6 5.9 13.8 10.3 13.0 15.1 14.0 28.1 13.2 13.5 15.0 25.5 16.4 14.3 1.6 10.9 12.0 21.6 15.0 16.6 41.7 33.6 52.8 60.0 35.8 28.7 83.9 76.5 109.7 53.4 45.4 11.8 118.0 220.5 67.0 81.1 33.6 39.3 0.0 84.9 110.0 43.1 49.9 33.4 122.0 116.9 20.6 33.6 40.5 35.4 118.1 67.0 37.7 81.0 100.0 42.0 80.3 63.8 42.4 67.8 201.9 38.4 45.3 58.7 83.7 70.0 33.6 52.6 34.6 45.0 39.2 MRPS27 KIAA0264 ENSG00000113048 "Mitochondrial ribosomal protein S27" Q92552 5 72219409-72320646 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 88.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071751 Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA071751: AB_2686442" "unprognostic (3.05e-1)" "unprognostic (3.09e-1)" "unprognostic (1.14e-3)" "unprognostic (3.60e-2)" "unprognostic (2.23e-2)" "unprognostic (1.63e-1)" "unprognostic (1.79e-2)" "unprognostic (7.20e-3)" "unprognostic (2.12e-1)" "unprognostic (3.22e-3)" "unprognostic (5.07e-2)" "unprognostic (3.26e-2)" "unprognostic (6.58e-3)" "unprognostic (1.33e-1)" "unprognostic (5.27e-2)" "unprognostic (7.73e-2)" "unprognostic (3.95e-2)" 26.9 32.3 19.0 20.9 26.8 13.6 26.1 24.6 31.8 25.1 21.0 20.1 21.8 16.5 28.6 23.7 33.6 26.3 18.0 43.6 18.9 17.5 25.1 30.9 14.9 27.4 18.1 21.7 33.9 25.1 24.5 23.7 17.5 23.5 26.2 26.4 25.5 31.0 26.5 43.7 23.9 17.5 25.0 17.5 22.2 20.9 12.1 12.6 34.2 32.1 26.7 32.4 25.9 21.0 19.6 23.3 6.1 14.1 21.5 21.5 16.1 16.4 22.1 19.7 32.5 25.9 33.5 25.4 15.9 22.8 30.3 24.5 27.5 23.4 42.7 22.3 18.5 33.1 18.4 38.2 56.4 32.9 16.0 23.6 21.9 26.6 30.2 25.9 19.2 17.1 31.3 23.9 31.7 35.6 27.7 32.2 31.5 21.9 12.9 25.0 19.8 28.7 23.3 22.7 12.0 13.9 30.6 32.7 43.8 27.9 17.7 30.5 16.3 26.6 22.0 19.7 19.0 33.7 23.4 18.2 12.4 18.3 17.4 28.5 13.1 19.7 30.1 21.3 31.7 19.5 6.1 12.1 4.1 14.0 14.1 20.6 19.6 17.4 17.0 23.3 16.5 20.3 21.5 1.8 21.5 11.3 8.9 17.8 16.1 19.0 26.8 24.6 31.8 18.9 17.5 18.1 21.7 23.5 12.6 8.9 9.4 25.3 22.2 18.1 10.8 88.0 7.6 10.7 13.6 10.4 15.7 35.7 21.6 16.5 1.7 15.7 8.5 0.0 14.9 37.9 17.7 10.8 7.0 28.9 21.9 9.5 15.5 16.5 33.5 3.0 17.5 13.4 10.1 34.3 21.2 15.6 15.4 17.5 23.7 18.8 12.2 12.9 17.5 8.0 17.4 15.4 24.1 22.3 29.1 12.1 MRPS31 IMOGN38 ENSG00000102738 "Mitochondrial ribosomal protein S31" Q92665 13 40729135-40771173 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Ciliated cells: 350.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039083, HPA046344" Uncertain Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA039083: AB_2676340, HPA046344: AB_2679629" "unprognostic (9.62e-3)" "unprognostic (2.62e-1)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (1.04e-1)" "unprognostic (2.15e-2)" "unprognostic (5.96e-3)" "unprognostic (1.84e-3)" "unprognostic (2.87e-2)" "unprognostic (1.23e-1)" "unprognostic (1.72e-3)" "unprognostic (3.92e-2)" "unprognostic (3.13e-3)" "unprognostic (2.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.86e-2)" "unprognostic (2.54e-2)" 14.2 20.1 19.3 17.9 21.2 13.2 18.2 27.7 22.9 14.4 16.4 16.9 10.7 15.4 18.0 15.4 18.9 16.6 10.9 24.3 18.4 16.9 26.7 29.9 12.1 22.5 17.9 17.1 21.5 15.0 10.7 35.3 13.1 22.1 12.6 17.0 12.4 14.7 12.5 32.5 14.2 16.3 16.3 16.0 16.0 15.3 17.9 23.3 22.9 21.1 17.2 25.1 18.0 15.9 22.2 11.8 17.2 10.4 15.9 25.7 10.9 8.0 7.7 13.1 8.6 9.0 10.6 13.1 10.3 7.2 13.7 9.2 19.8 12.0 47.3 10.1 5.9 18.4 21.3 16.4 12.9 16.3 12.4 12.4 19.6 5.8 12.6 7.5 20.0 9.5 8.5 9.5 11.2 9.5 9.1 10.4 13.6 13.1 5.0 8.7 9.1 15.5 19.6 12.7 27.5 9.2 14.9 10.8 8.8 17.9 9.3 5.7 8.4 7.1 11.9 16.2 16.4 10.4 17.7 6.3 4.3 7.2 9.9 10.7 3.9 7.2 23.8 8.7 14.3 8.1 17.2 9.6 14.4 19.1 9.7 18.6 22.2 21.4 19.2 11.8 18.9 25.7 22.6 7.0 15.9 10.4 11.6 21.4 10.9 19.3 21.2 27.7 22.9 18.4 16.9 17.9 17.1 22.1 23.3 44.7 16.3 16.4 28.7 8.7 32.3 61.3 30.6 350.7 67.1 21.0 17.7 53.8 92.9 37.0 42.6 34.6 21.2 23.3 29.4 40.9 23.6 14.3 22.0 64.5 22.6 39.7 22.4 35.6 18.6 4.9 32.8 19.5 18.6 45.9 31.0 30.1 28.6 21.0 28.7 51.9 47.6 45.3 25.8 51.0 45.1 11.7 56.9 27.4 31.5 26.5 MRTO4 "C1orf33, dJ657E11.4, MRT4" ENSG00000053372 "MRT4 homolog, ribosome maturation factor" Q9UKD2 1 19251539-19260128 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026446 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No "Nucleoplasm, Nuclear membrane" Nucleoli "HPA026446: AB_10601441" "unprognostic (3.99e-1)" "unprognostic (1.75e-1)" "unprognostic (2.18e-2)" "unprognostic (2.94e-1)" "unprognostic (4.12e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (1.56e-8)" "unprognostic (7.46e-2)" "unprognostic (5.58e-2)" "unprognostic (2.61e-2)" "unprognostic (2.69e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.11e-8)" "unprognostic (5.87e-2)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (3.23e-2)" 17.2 16.5 20.4 16.9 18.5 12.0 21.6 10.7 21.7 12.1 13.8 12.4 10.2 17.5 15.6 15.2 21.6 18.8 11.8 11.7 19.1 15.9 13.6 23.7 10.5 23.0 16.1 19.1 18.7 41.2 10.2 8.8 12.5 15.1 12.2 17.6 10.6 13.2 11.9 22.8 15.3 19.3 17.3 10.0 14.5 13.7 21.6 11.6 14.5 12.9 29.3 22.7 11.4 12.4 14.7 12.8 1.0 8.2 10.6 15.7 7.2 24.3 17.3 14.4 18.8 7.0 11.2 12.7 19.1 10.8 32.7 21.6 24.9 25.3 36.0 16.0 15.8 14.3 19.4 39.7 28.8 33.0 12.8 30.3 26.6 15.5 21.4 8.8 35.1 11.2 9.8 19.1 36.9 19.2 8.7 18.3 16.4 40.2 11.6 19.3 17.8 28.5 25.4 18.4 25.6 26.4 26.8 17.5 27.8 17.8 8.3 23.1 17.0 14.6 20.1 20.1 10.7 14.3 20.7 12.0 17.9 22.2 27.4 32.4 9.5 16.5 47.4 17.4 45.1 28.5 0.7 7.5 0.7 7.9 8.2 15.7 14.7 9.6 10.8 11.4 13.1 13.0 11.6 1.0 10.6 6.2 12.8 6.7 7.2 20.4 18.5 10.7 21.7 19.1 15.9 16.1 19.1 15.1 11.6 6.0 12.6 26.1 38.7 33.2 19.2 9.0 35.7 17.4 23.9 7.0 9.8 42.2 34.9 44.9 14.5 23.3 5.4 0.0 47.2 51.2 28.2 15.4 25.4 14.4 42.9 14.3 20.7 11.6 12.1 27.6 21.3 21.7 18.6 39.7 19.8 19.2 44.4 14.0 19.1 30.1 13.8 19.4 28.8 37.0 43.7 29.4 21.7 14.6 31.2 31.2 MS4A12 "FLJ20217, Ms4a10" ENSG00000071203 "Membrane spanning 4-domains A12" Q9NXJ0 11 60492778-60507430 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "intestine: 64.7;lymphoid tissue: 28.6" "Group enriched" "Detected in some" 6 "Enterocytes: 108.9;Paneth cells: 59.6" "Cancer enriched" "Detected in some" 8 "colorectal cancer: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.6;LHCN-M2: 2.2;NTERA-2: 3.1;RH-30: 4.3;U-2 OS: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048616, HPA057657" Enhanced Approved "Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli, Endoplasmic reticulum, Golgi apparatus" "HPA048616: , HPA057657: AB_2683491" "unprognostic (2.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.49e-1)" "unprognostic (3.26e-1)" "unprognostic (2.83e-1)" "unprognostic (9.20e-3)" 0.1 0.0 0.1 28.6 0.1 0.0 0.1 0.1 0.1 0.1 57.7 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 64.7 0.1 0.1 0.1 0.1 0.0 0.2 1.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.1 0.0 0.0 0.2 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 1.8 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 108.9 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 59.6 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 13.2 0.0 MTUS1 "ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1" ENSG00000129422 "Microtubule associated scaffold protein 1" Q9ULD2 8 17643795-17800917 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 229.1;Endothelial cells: 164.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 2.2;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6" "Lineage enriched" "Detected in single" 21 "T-cells: 4.8" "Cell line enhanced" "Detected in many" "A549: 29.7;AN3-CA: 26.1;HUVEC TERT2: 77.2;SK-MEL-30: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067903, HPA069795" Enhanced Nucleoli,Microtubules No No "Nucleoli, Microtubules" "HPA067903: AB_2685921, HPA069795: AB_2686198" "unprognostic (3.20e-1)" "unprognostic (3.29e-1)" "prognostic favorable (1.05e-4)" "unprognostic (2.50e-2)" "unprognostic (2.27e-1)" "unprognostic (7.72e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-3)" "unprognostic (2.44e-1)" "unprognostic (9.73e-2)" "unprognostic (7.93e-3)" "unprognostic (3.33e-1)" "prognostic favorable (2.76e-4)" "unprognostic (2.04e-1)" "unprognostic (2.38e-2)" "unprognostic (2.53e-3)" "unprognostic (2.43e-1)" 45.0 20.8 20.9 6.8 38.2 0.4 21.8 51.0 27.7 19.8 19.0 56.5 9.9 16.9 16.9 12.6 20.3 12.8 20.0 44.3 27.4 17.3 14.4 29.3 20.9 4.4 34.7 18.0 28.2 47.1 43.8 15.0 36.1 33.7 17.5 21.1 10.3 24.3 14.0 49.7 12.2 17.4 20.5 48.3 8.2 21.4 6.5 49.3 0.7 15.7 10.9 7.5 21.4 26.7 0.2 0.0 0.0 0.0 0.0 4.8 1.0 5.5 29.7 4.8 26.1 0.0 0.1 8.8 0.2 2.0 0.1 0.6 2.2 2.0 0.7 2.2 0.0 1.2 5.7 8.0 2.8 0.2 3.9 3.4 0.0 5.1 14.1 1.7 0.0 0.1 2.4 4.3 0.6 8.8 0.0 77.2 2.0 0.0 11.3 0.0 1.4 1.0 1.4 6.9 11.2 0.7 0.0 4.4 2.9 1.5 11.4 2.4 0.6 3.8 6.9 21.9 3.0 5.0 0.0 15.7 0.0 6.5 0.0 0.0 1.5 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 2.2 0.6 0.0 0.2 4.8 3.6 0.0 0.0 0.0 0.0 0.0 1.0 20.9 38.2 51.0 27.7 27.4 17.3 34.7 18.0 33.7 49.3 65.5 229.1 0.8 50.7 18.7 0.0 122.8 56.0 50.9 106.9 19.2 0.0 16.2 10.0 33.7 16.9 164.1 52.5 0.0 150.0 30.8 30.4 68.9 9.2 60.6 44.7 0.0 14.5 20.9 3.7 19.2 70.8 10.5 27.0 4.6 40.5 0.0 66.3 14.0 53.7 8.9 0.0 19.4 41.9 1.7 5.1 17.8 45.2 4.4 32.2 49.8 MTX2 ENSG00000128654 "Metaxin 2" O75431 2 176269395-176338025 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 170.8;Spermatocytes: 167.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031550, HPA031551, HPA031552" Approved Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoli "HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616" "unprognostic (2.61e-1)" "unprognostic (9.86e-2)" "unprognostic (6.54e-2)" "prognostic unfavorable (5.06e-4)" "unprognostic (1.92e-2)" "unprognostic (1.62e-2)" "unprognostic (1.05e-2)" "unprognostic (1.29e-1)" "unprognostic (2.87e-2)" "unprognostic (3.97e-2)" "unprognostic (1.80e-2)" "unprognostic (8.30e-2)" "unprognostic (1.22e-1)" "unprognostic (2.03e-1)" "unprognostic (9.92e-2)" "unprognostic (3.15e-2)" "unprognostic (1.33e-2)" 13.2 26.4 21.3 12.0 22.3 5.5 18.8 15.0 44.9 13.0 20.7 18.5 16.6 15.4 15.5 27.9 22.2 20.0 12.0 33.6 23.6 26.3 31.5 20.2 10.6 8.9 21.5 16.5 13.2 16.4 23.7 25.7 17.3 21.8 18.9 24.6 16.3 24.7 16.5 45.0 12.5 14.8 17.6 25.7 9.4 14.6 40.6 14.0 10.2 14.7 19.8 13.6 14.4 13.6 16.2 12.1 4.7 12.6 15.1 13.4 7.9 17.5 10.4 21.2 13.0 14.3 16.5 20.4 18.9 17.7 17.4 20.3 17.9 19.2 22.5 32.1 16.7 28.1 11.8 23.1 23.3 24.0 22.3 16.6 21.4 13.1 31.5 22.6 33.1 7.2 18.4 29.1 18.2 31.4 21.3 24.7 22.0 28.4 17.5 20.4 16.0 11.6 33.7 20.2 34.4 16.5 0.0 15.4 20.0 49.2 31.9 30.3 26.0 15.8 21.1 39.0 42.7 11.7 21.6 21.7 17.4 15.4 18.2 19.7 19.6 20.4 26.9 21.6 16.7 21.0 4.7 7.7 3.2 8.5 12.6 11.5 16.2 10.9 9.6 12.1 11.4 13.2 13.4 0.0 15.1 10.9 9.8 13.4 7.9 21.3 22.3 15.0 44.9 23.6 26.3 21.5 16.5 21.8 14.0 17.9 16.9 20.4 33.1 27.6 0.0 60.5 28.1 33.5 20.5 54.1 0.0 65.7 170.8 45.6 18.6 25.5 29.0 0.0 34.6 53.9 27.4 37.9 42.7 32.0 41.3 0.0 39.9 12.3 17.8 12.3 32.8 24.8 33.7 34.3 41.6 0.0 41.1 17.5 30.8 83.3 0.0 38.8 36.0 167.0 118.7 36.6 54.3 16.2 51.9 46.0 MXD3 "bHLHc13, MAD3" ENSG00000213347 "MAX dimerization protein 3" Q9BW11 5 177301461-177312757 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.1;lymphoid tissue: 59.4" "Cell type enriched" "Detected in many" 7 "Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 14.1" "Group enriched" "Detected in many" 6 "granulocytes: 14.1;monocytes: 8.7" "Cell line enhanced" "Detected in many" "HDLM-2: 59.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA070111 Approved Nucleoplasm,Nucleoli NA Yes "Nucleoplasm, Nucleoli" "HPA070111: AB_2686228" "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (2.11e-1)" "unprognostic (3.63e-1)" "unprognostic (8.26e-2)" "unprognostic (6.18e-3)" "prognostic unfavorable (3.60e-4)" "unprognostic (3.32e-1)" "unprognostic (6.84e-2)" "unprognostic (3.12e-2)" "unprognostic (4.97e-2)" "unprognostic (2.84e-2)" "unprognostic (3.33e-16)" "unprognostic (8.55e-3)" "unprognostic (2.22e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-3)" 2.5 1.8 1.3 28.2 1.9 32.1 5.4 1.2 3.4 2.4 6.8 1.2 2.8 6.9 2.7 6.2 6.6 3.6 2.8 2.4 1.6 0.8 2.7 6.6 5.4 7.3 2.2 1.2 2.6 5.8 0.7 4.3 4.5 2.1 5.0 0.9 1.1 4.7 2.1 3.6 10.3 5.6 1.4 1.3 10.3 3.8 3.1 2.9 59.4 3.5 3.7 13.5 2.7 3.6 2.0 1.6 14.1 8.7 0.7 0.8 1.1 8.1 5.6 3.5 9.5 0.2 0.5 5.8 10.6 3.5 4.8 4.6 3.7 8.5 4.3 4.4 1.4 2.6 4.0 0.4 1.2 0.2 59.2 7.2 2.4 8.1 5.4 0.5 2.3 7.5 0.3 0.6 0.3 0.2 0.4 4.4 19.2 1.5 13.6 0.9 10.4 21.6 6.5 1.2 2.5 9.8 10.6 10.8 6.2 1.0 1.1 8.6 7.1 6.8 6.9 3.7 0.5 10.9 6.2 3.2 5.8 15.0 4.6 5.6 18.0 5.9 4.7 4.5 8.1 3.3 3.5 2.6 7.7 0.7 7.2 0.0 1.6 0.1 0.1 1.6 2.0 0.0 0.3 14.1 0.7 8.7 1.0 0.8 1.1 1.3 1.9 1.2 3.4 1.6 0.8 2.2 1.2 2.1 2.9 3.0 2.2 0.0 1.5 4.9 2.8 1.2 5.1 5.3 4.5 5.2 0.0 4.5 0.0 1.3 16.3 2.3 4.0 116.8 3.5 7.2 3.4 2.4 9.2 3.9 8.8 3.2 1.7 4.3 4.9 1.9 1.7 5.1 3.3 1.0 5.0 1.0 1.9 3.1 1.4 0.3 2.2 0.0 3.1 0.7 5.9 5.0 11.0 5.1 6.9 1.8 MXI1 "bHLHc11, MAD2, MXD2, MXI" ENSG00000119950 "MAX interactor 1, dimerization protein" P50539 10 110207605-110287365 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 32.0;SK-MEL-30: 52.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035319, HPA035320, HPA056762" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" Yes No Nucleoplasm "Nucleoli, Nucleoli rim, Cytosol" "HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229" "unprognostic (1.77e-2)" "unprognostic (2.02e-1)" "unprognostic (3.34e-1)" "unprognostic (3.03e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (1.59e-1)" "unprognostic (9.26e-3)" "prognostic unfavorable (9.17e-4)" "prognostic unfavorable (1.02e-5)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (2.29e-1)" "unprognostic (2.96e-1)" 16.9 19.4 37.2 7.5 34.9 32.7 26.5 56.4 36.9 20.3 26.4 33.9 20.1 12.0 26.0 23.8 39.5 19.1 17.4 36.0 35.1 26.6 23.9 30.5 16.5 7.1 37.0 25.9 46.4 23.1 25.6 12.1 14.4 26.2 24.5 22.1 15.8 41.2 32.7 22.8 25.4 22.5 18.2 44.7 7.8 14.7 13.5 38.1 7.0 29.2 13.4 9.8 32.8 33.9 4.5 2.2 11.0 4.7 1.4 8.6 2.3 5.4 2.2 5.6 11.2 8.8 6.7 2.4 3.2 10.8 2.1 6.6 0.9 9.8 7.2 5.2 5.5 3.5 7.1 6.7 7.6 5.6 3.6 9.0 1.9 4.4 4.1 5.8 3.8 4.3 7.1 29.0 3.7 14.8 32.0 2.0 5.7 7.1 15.6 3.5 3.5 2.5 7.8 2.4 8.9 6.7 1.6 7.3 11.4 7.3 0.5 9.5 15.7 3.1 2.3 52.2 7.3 2.6 12.5 2.0 3.7 6.4 4.0 1.6 12.9 6.8 2.6 10.0 14.2 3.9 2.2 3.1 11.0 3.1 2.5 5.8 3.9 6.7 3.6 1.7 4.5 8.6 2.2 7.8 1.4 4.7 2.2 5.0 2.3 37.2 34.9 56.4 36.9 35.1 26.6 37.0 25.9 26.2 38.1 14.9 15.6 8.3 48.3 51.5 37.3 78.1 28.1 21.4 31.8 31.4 45.2 3.4 39.7 15.1 4.1 38.3 50.6 116.8 12.7 13.2 31.9 46.8 3.5 46.4 10.1 49.3 16.3 19.6 18.4 7.0 41.7 19.0 99.5 18.0 20.8 127.5 14.4 35.1 52.3 53.0 43.0 45.3 88.6 8.6 26.0 58.8 8.1 21.3 15.6 33.1 MXRA8 DKFZp586E2023 ENSG00000162576 "Matrix remodeling associated 8" Q9BRK3 1 1352689-1361777 "Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Extravillous trophoblasts: 236.0;Fibroblasts: 92.6;Leydig cells: 163.1;Peritubular cells: 172.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "naive CD8 T-cell: 9.8" "Lineage enriched" "Detected in single" 98 "T-cells: 9.8" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.7;BJ: 50.0;BJ hTERT+: 23.5;fHDF/TERT166: 24.8;HHSteC: 15.7;HSkMC: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053958, HPA055780" Uncertain Approved Nucleoli NA NA 450000 Nucleoli "HPA053958: AB_2682322, HPA055780: AB_2682918" "unprognostic (1.39e-1)" "unprognostic (2.85e-1)" "unprognostic (7.31e-3)" "unprognostic (1.26e-2)" "unprognostic (1.94e-3)" "unprognostic (2.61e-1)" "unprognostic (6.75e-2)" "unprognostic (2.03e-1)" "unprognostic (4.22e-2)" "unprognostic (5.38e-2)" "unprognostic (2.97e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.43e-6)" "prognostic unfavorable (9.93e-4)" "unprognostic (1.55e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (9.87e-4)" 45.6 5.3 2.3 11.4 4.6 1.1 25.2 3.9 3.8 34.8 14.3 4.8 6.2 6.5 34.0 16.3 13.7 14.4 20.5 12.7 3.6 1.1 7.6 3.5 13.4 5.6 2.6 2.6 30.4 3.7 1.6 6.0 25.0 5.4 23.4 2.3 36.6 8.4 12.3 15.5 10.9 8.6 22.0 4.5 9.5 8.7 16.4 2.9 0.3 13.9 11.8 4.5 22.3 17.8 0.0 0.0 0.0 0.0 0.0 9.8 0.3 1.3 0.3 0.4 0.3 6.0 16.7 15.1 50.0 23.5 5.9 7.0 2.7 1.1 0.5 0.2 24.8 0.0 1.0 0.3 0.0 1.1 1.0 0.4 0.4 0.9 4.2 15.7 0.0 0.5 19.9 0.0 2.2 0.0 11.1 0.0 0.3 5.8 0.5 7.4 0.1 0.1 0.1 4.9 0.1 1.6 0.2 0.1 0.1 0.0 0.2 1.1 3.1 0.1 0.5 0.0 3.6 3.9 0.2 0.4 0.2 8.3 7.7 0.2 1.1 0.1 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.3 9.8 0.0 0.0 0.0 0.0 0.0 0.3 2.3 4.6 3.9 2.7 3.6 1.1 2.6 2.6 5.4 2.9 3.0 0.0 0.0 0.8 9.5 0.7 3.2 0.0 0.0 0.0 8.7 0.0 5.9 0.0 4.6 1.4 1.6 0.0 0.0 0.0 236.0 92.6 0.5 0.0 0.0 8.3 0.0 0.0 9.8 0.0 6.1 163.1 1.6 10.1 1.0 0.0 44.6 0.8 0.0 172.5 1.5 1.0 12.9 36.9 0.7 5.2 9.3 24.6 0.0 0.0 0.3 MYBBP1A "FLJ37886, P160, PAP2, Pol5" ENSG00000132382 "MYB binding protein 1a" Q9BQG0 17 4538897-4555631 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005466 Supported Supported Nucleoli,Vesicles No No Nucleoli Vesicles "HPA005466: AB_2667327" "unprognostic (8.06e-2)" "unprognostic (2.33e-1)" "unprognostic (1.71e-1)" "unprognostic (9.01e-2)" "unprognostic (7.81e-2)" "unprognostic (1.29e-1)" "unprognostic (1.57e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.84e-1)" "prognostic favorable (1.61e-4)" "unprognostic (3.88e-3)" "prognostic unfavorable (5.95e-4)" "unprognostic (1.78e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (8.12e-4)" "unprognostic (9.70e-2)" 14.1 11.6 13.8 16.5 14.6 13.2 16.2 15.0 21.5 11.3 10.2 14.9 11.1 12.9 15.4 11.7 17.1 15.8 12.4 11.5 11.7 9.2 8.7 21.5 11.6 16.0 15.2 11.1 15.3 23.7 10.5 13.1 7.2 13.0 17.0 7.2 12.7 24.5 15.3 30.8 25.0 12.8 10.9 7.3 15.0 12.9 9.3 12.6 14.6 11.7 18.2 17.6 15.4 13.2 5.3 4.9 0.4 4.9 4.3 5.9 3.8 19.5 31.3 4.1 18.8 5.3 6.2 14.0 13.6 6.0 13.7 10.6 23.0 8.0 26.7 15.8 8.0 6.8 24.7 17.0 20.4 6.4 13.3 45.9 12.8 19.3 20.4 8.6 15.0 11.7 9.0 11.7 20.1 10.0 3.7 9.1 15.4 20.9 12.3 5.8 16.9 17.5 5.9 18.8 6.1 16.4 22.7 6.9 17.7 3.2 15.7 8.7 16.7 13.9 9.7 9.2 2.7 9.3 6.1 11.7 11.9 10.7 11.1 38.8 11.1 7.5 10.9 11.3 17.6 15.3 0.0 2.8 0.4 5.1 2.7 5.9 5.3 4.2 5.5 4.9 3.3 4.5 4.6 0.1 4.3 4.9 3.5 1.8 3.8 13.8 14.6 15.0 21.5 11.7 9.2 15.2 11.1 13.0 12.6 8.9 16.4 12.7 5.2 11.4 7.6 3.6 15.3 10.7 19.4 3.5 11.8 2.6 0.0 8.1 0.4 10.8 5.9 0.0 10.7 4.1 5.9 5.4 4.7 6.6 5.7 9.5 10.9 8.6 3.4 0.4 5.2 5.0 3.3 3.6 8.1 3.5 7.2 3.5 11.3 2.2 5.7 6.5 10.3 2.6 12.0 10.5 0.9 6.9 10.3 5.1 MYBPH ENSG00000133055 "Myosin binding protein H" Q13203 1 203167811-203175813 "Predicted intracellular proteins" "Cell adhesion" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 53.8" "Cell type enhanced" "Detected in single" 33 "Alveolar cells type 2: 2.2" "Group enriched" "Detected in many" 7 "glioma: 4.9;head and neck cancer: 20.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 6.1" "Group enriched" "Detected in some" 5 "CACO-2: 17.6;HSkMC: 34.5;THP-1: 8.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA061383 Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Mitochondria" Nucleoli "HPA061383: AB_2684497" "unprognostic (2.26e-4)" "unprognostic (2.04e-1)" "unprognostic (3.50e-1)" "unprognostic (1.06e-1)" "unprognostic (3.82e-2)" "unprognostic (1.32e-3)" "unprognostic (3.42e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-1)" "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (1.75e-1)" "unprognostic (7.62e-4)" "unprognostic (1.51e-1)" "unprognostic (3.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.74e-1)" 0.8 0.1 1.1 0.8 0.8 0.3 0.4 0.4 0.6 0.1 0.1 0.0 0.0 0.1 0.4 4.4 3.9 0.2 0.1 0.2 0.4 0.3 1.1 1.5 0.2 0.3 1.3 0.0 0.1 0.2 0.1 0.6 0.3 1.0 4.2 0.1 0.0 8.8 0.1 53.8 0.2 0.1 0.1 0.4 0.4 0.1 0.2 2.1 0.9 3.9 12.7 2.0 0.3 0.8 0.0 6.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 34.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 6.1 0.0 0.1 1.1 0.8 0.4 0.6 0.4 0.3 1.3 0.0 1.0 2.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYCN "bHLHe37, MYCNOT, N-myc, NMYC" ENSG00000134323 "MYCN proto-oncogene, bHLH transcription factor" P04198 2 15940564-15947007 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 16.8" "Cell type enriched" "Detected in some" 8 "Extravillous trophoblasts: 75.4" "Cancer enhanced" "Detected in many" "testis cancer: 45.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.9;BEWO: 70.2;HMC-1: 16.9;NTERA-2: 26.6;RH-30: 18.6;SuSa: 12.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057420 Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA057420: AB_2683434" "unprognostic (8.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.07e-2)" "unprognostic (4.11e-1)" "unprognostic (2.46e-2)" "unprognostic (1.23e-2)" "unprognostic (3.03e-2)" "unprognostic (1.81e-1)" "unprognostic (3.35e-3)" "unprognostic (3.09e-2)" "unprognostic (2.09e-1)" "unprognostic (1.12e-3)" "unprognostic (8.89e-2)" "unprognostic (2.47e-1)" "unprognostic (4.90e-2)" "unprognostic (1.23e-1)" 0.9 1.9 5.1 1.8 5.5 1.6 1.2 1.4 8.4 3.1 1.2 12.1 0.0 3.0 1.9 0.8 1.3 1.4 2.6 2.3 7.0 4.7 6.0 1.5 1.6 2.9 6.0 2.2 10.3 0.7 0.4 0.7 16.8 6.8 0.6 1.3 1.1 6.6 0.7 1.0 2.4 1.7 0.9 8.9 0.9 8.5 6.5 4.0 5.7 5.1 2.3 3.5 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 70.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 26.6 0.6 0.0 0.0 18.6 3.5 0.0 0.9 0.2 4.7 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.5 1.4 7.0 7.0 4.7 6.0 2.2 6.8 4.0 0.0 0.0 0.0 0.1 0.5 2.6 0.7 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.2 0.2 0.0 0.0 0.0 75.4 0.6 0.0 0.0 0.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.2 0.0 0.4 2.1 0.1 0.0 0.0 0.5 3.6 0.0 9.6 0.0 0.2 0.0 MYL3 "CMH8, MLC1SB, MLC1V, VLC1" ENSG00000160808 "Myosin light chain 3" P08590 3 46857872-46882169 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "heart muscle: 398.1;skeletal muscle: 319.8" "Cell type enriched" "Detected in some" 65 "Cardiomyocytes: 3031.1" "Cancer enhanced" "Detected in many" "renal cancer: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 28.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016564, CAB018662, HPA046859, HPA063034" Enhanced Approved Nucleoli,Mitochondria NA NA 15000000 "Nucleoli, Mitochondria" "CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927" "unprognostic (3.11e-1)" "unprognostic (2.64e-2)" "unprognostic (5.55e-2)" "unprognostic (1.51e-1)" "unprognostic (1.77e-1)" "unprognostic (4.44e-2)" "unprognostic (9.67e-3)" "unprognostic (3.37e-2)" "unprognostic (4.72e-3)" "unprognostic (3.63e-2)" "unprognostic (1.08e-1)" "unprognostic (7.88e-2)" "prognostic favorable (1.22e-8)" "unprognostic (1.16e-3)" "unprognostic (9.45e-3)" "unprognostic (7.18e-5)" "unprognostic (2.53e-3)" 0.9 0.2 0.5 0.2 0.4 0.0 0.6 0.2 0.4 0.5 0.1 0.3 0.0 0.0 0.2 10.1 10.5 0.1 0.2 398.1 0.7 0.4 2.3 0.1 0.2 0.1 0.7 0.3 0.3 0.1 0.0 0.0 0.3 0.3 1.6 0.0 0.3 5.5 0.0 319.8 0.1 0.0 0.1 0.8 0.4 0.0 0.1 0.4 0.0 1.1 30.1 3.1 0.2 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.9 1.6 0.3 0.1 0.0 0.1 5.9 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.4 0.7 0.4 0.7 0.3 0.3 0.4 0.0 0.0 0.0 0.1 0.7 0.1 3031.1 0.0 0.0 0.0 1.8 0.0 0.4 46.4 0.0 2.0 0.3 0.0 0.0 0.0 5.0 7.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.5 1.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.7 46.2 0.4 6.5 1.3 0.0 0.4 0.4 0.7 0.0 0.0 0.0 MYL5 ENSG00000215375 "Myosin light chain 5" Q02045 4 673580-682033 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 61.5" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 71.2;Rod photoreceptor cells: 78.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 34.0;ASC TERT1: 23.4" "Low region specificity" "Detected in many" "HPA037381, HPA039262" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037381: AB_10672484, HPA039262: AB_2676418" "unprognostic (6.30e-3)" "unprognostic (1.42e-2)" "unprognostic (5.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.53e-2)" "unprognostic (1.33e-1)" "unprognostic (4.77e-3)" "unprognostic (2.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.61e-3)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (2.95e-2)" "unprognostic (3.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.91e-2)" 9.9 11.4 14.5 10.1 12.7 8.5 12.6 13.4 14.6 6.1 10.9 14.7 14.6 18.0 7.1 19.5 10.6 7.1 8.0 4.9 13.9 11.4 9.7 11.3 7.8 19.5 10.8 10.0 7.5 15.4 13.2 7.7 5.3 10.5 9.8 11.8 10.0 61.5 10.7 18.6 16.2 15.4 10.1 9.3 8.8 7.3 15.5 3.9 7.5 7.5 24.2 9.9 6.5 6.9 11.0 12.6 8.2 9.5 15.4 6.5 4.5 2.2 3.7 13.6 7.2 34.0 23.4 6.5 5.5 7.4 5.6 5.2 4.5 9.6 2.6 2.6 8.9 4.0 3.3 2.1 3.7 1.6 4.8 2.7 3.9 5.1 4.1 11.9 5.9 3.6 17.6 3.6 4.4 4.7 8.2 3.4 5.6 4.0 3.5 6.9 4.2 3.1 4.1 2.8 4.7 5.7 2.8 2.9 1.5 9.2 10.6 6.2 3.5 1.8 4.6 3.7 4.6 7.4 5.4 5.6 4.8 0.9 4.1 3.1 13.6 2.6 1.6 5.3 5.3 2.4 8.2 7.4 1.1 3.1 4.7 3.9 7.9 5.1 1.8 6.6 11.0 6.5 6.3 5.0 15.4 9.5 12.6 2.3 4.5 14.5 12.7 13.4 14.6 13.9 11.4 10.8 10.0 10.5 3.9 0.0 11.0 9.5 6.0 10.6 5.7 1.2 7.6 6.7 2.3 7.0 19.6 5.7 10.0 8.8 16.6 4.5 31.5 0.0 4.0 4.3 6.6 7.4 12.8 14.9 18.5 11.1 5.2 9.2 16.2 71.2 6.6 7.5 6.8 20.8 8.8 16.6 6.2 10.5 3.5 30.0 78.4 6.5 5.0 14.4 3.1 11.7 4.6 6.1 13.3 8.9 MYLK4 SgK085 ENSG00000145949 "Myosin light chain kinase family member 4" Q86YV6 6 2663629-2750966 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 23.6;tongue: 63.6" "Cell type enhanced" "Detected in some" 6 "Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Proximal tubular cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "HEL: 12.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA015860 Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoli, Vesicles" "HPA015860: AB_2147922" "unprognostic (1.75e-1)" "unprognostic (2.04e-1)" "unprognostic (1.87e-1)" "unprognostic (5.22e-3)" "unprognostic (1.85e-1)" "unprognostic (2.99e-2)" "unprognostic (7.48e-2)" "unprognostic (2.80e-1)" "unprognostic (5.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.91e-1)" "unprognostic (2.74e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-1)" "unprognostic (1.19e-2)" "unprognostic (4.63e-2)" 0.5 0.3 0.3 0.3 0.4 0.4 0.8 1.4 0.7 0.3 0.3 0.3 0.3 0.1 0.3 0.5 1.0 0.2 0.3 1.0 0.5 0.5 2.6 0.3 0.5 0.3 0.4 0.3 0.3 1.1 0.7 0.7 0.4 0.4 0.4 0.1 0.4 2.4 0.4 23.6 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.0 63.6 1.5 0.5 0.3 0.1 0.8 0.3 0.3 0.9 1.4 0.1 0.3 0.2 0.6 1.2 1.0 1.2 0.6 0.7 1.6 0.5 0.4 0.5 1.1 1.1 1.6 0.8 0.2 1.9 0.2 0.5 0.7 0.2 0.6 12.7 0.6 0.1 0.3 0.3 0.6 1.5 0.5 0.1 1.2 0.6 0.5 0.2 0.1 0.1 0.3 0.5 0.1 1.4 0.2 0.4 0.0 0.9 0.0 0.0 0.9 0.3 1.0 0.6 0.3 0.2 0.5 1.1 0.4 0.8 0.7 0.5 0.1 0.2 0.4 0.4 0.2 0.1 0.2 0.3 1.3 0.1 0.1 0.1 0.5 0.0 0.3 0.1 0.2 1.4 0.2 0.1 0.6 0.1 0.3 0.9 0.3 0.8 0.1 0.1 0.3 0.4 1.4 0.7 0.5 0.5 0.4 0.3 0.4 0.3 3.0 0.6 0.0 0.1 0.1 0.8 1.2 2.5 0.0 1.2 0.0 0.0 0.3 0.0 0.1 0.4 0.5 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.2 1.6 1.2 0.0 0.3 0.0 0.3 1.0 0.0 1.8 0.0 0.2 0.0 0.0 1.4 2.9 0.2 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.1 MYRFL "bcm1377, C12orf15, C12orf28, FLJ25056" ENSG00000166268 "Myelin regulatory factor-like" Q96LU7 12 69825304-69959097 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "intestine: 56.1" "Cell type enhanced" "Detected in some" 21 "Collecting duct cells: 5.2;Early spermatids: 12.4;Late spermatids: 22.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 7.0;SK-BR-3: 3.5;T-47d: 15.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049340 Approved Approved Nucleoli "Intracellular and membrane" NA NA Nucleoli "HPA049340: AB_2680719" "unprognostic (2.95e-2)" "unprognostic (6.25e-2)" "unprognostic (2.49e-2)" "unprognostic (1.42e-1)" "unprognostic (5.18e-2)" "unprognostic (2.34e-1)" "unprognostic (5.45e-2)" "unprognostic (6.50e-2)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (3.08e-1)" "unprognostic (8.99e-2)" "unprognostic (1.91e-2)" "unprognostic (3.89e-2)" "unprognostic (2.07e-2)" "unprognostic (1.17e-1)" "unprognostic (9.96e-2)" 0.3 0.3 0.5 0.0 0.6 0.0 0.5 3.6 0.6 0.1 20.7 0.0 0.4 21.4 0.1 0.9 0.1 0.1 0.7 0.2 0.4 0.2 2.0 0.3 0.2 0.2 0.5 0.2 0.0 0.8 0.0 1.0 0.3 0.7 0.6 0.1 0.3 1.3 0.4 0.0 1.6 56.1 0.1 1.0 0.1 0.1 2.4 0.5 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.1 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 7.0 0.1 0.0 0.1 0.0 1.1 1.0 0.0 0.3 0.1 0.0 3.5 0.0 1.2 15.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.5 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 3.6 0.6 0.4 0.2 0.5 0.2 0.7 0.5 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.0 0.0 0.0 5.2 0.0 0.2 3.3 0.8 12.4 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 22.2 0.9 0.0 0.0 0.0 0.0 0.2 0.3 2.9 0.4 0.5 0.0 0.0 0.0 0.7 0.4 1.0 0.0 0.0 0.0 0.0 MYSM1 KIAA1915 ENSG00000162601 "Myb like, SWIRM and MPN domains 1" Q5VVJ2 1 58654739-58700092 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054291, HPA057306" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA054291: AB_2682438, HPA057306: " "unprognostic (2.95e-3)" "unprognostic (3.64e-2)" "unprognostic (3.20e-2)" "unprognostic (8.68e-2)" "unprognostic (2.08e-2)" "prognostic favorable (5.09e-5)" "unprognostic (8.12e-3)" "unprognostic (9.63e-3)" "unprognostic (5.72e-3)" "unprognostic (3.74e-1)" "unprognostic (2.25e-1)" "unprognostic (4.56e-2)" "unprognostic (2.38e-3)" "unprognostic (4.22e-2)" "unprognostic (1.83e-1)" "unprognostic (8.45e-2)" "unprognostic (1.44e-2)" 13.2 12.3 14.1 14.4 15.7 24.4 17.3 16.9 24.3 14.3 13.7 11.4 11.9 12.5 17.5 14.3 13.5 13.0 9.9 14.1 11.7 8.1 11.0 11.0 12.9 14.3 14.0 13.3 18.1 14.0 16.5 19.2 11.3 18.0 14.4 11.6 9.3 15.5 15.2 23.2 20.4 14.6 13.7 15.2 14.2 11.5 8.3 14.7 11.9 15.5 10.6 12.9 13.3 14.7 1.1 0.7 2.2 2.1 0.2 2.3 0.5 8.3 2.4 6.2 6.6 5.7 7.3 8.9 5.0 5.6 5.0 4.3 4.2 3.7 8.7 1.5 3.8 5.9 6.4 6.8 2.9 9.6 5.8 4.6 10.5 1.1 4.6 6.9 15.8 8.0 5.2 5.0 6.4 3.3 6.6 1.2 5.6 11.1 5.6 5.7 2.8 7.7 13.2 9.8 3.4 4.5 6.6 14.9 5.3 4.1 3.2 5.1 5.0 4.2 8.3 11.7 11.7 2.5 9.0 4.0 8.9 4.0 6.8 9.5 10.2 4.8 11.6 5.2 11.5 9.7 0.8 0.7 0.5 2.0 1.0 1.4 0.9 1.4 1.6 0.6 1.1 2.3 1.1 2.2 0.2 2.1 0.7 1.4 0.5 14.1 15.7 16.9 24.3 11.7 8.1 14.0 13.3 18.0 14.7 20.8 28.9 12.6 19.3 16.9 20.3 24.6 10.2 22.7 48.9 10.4 23.6 7.0 13.3 7.0 3.2 17.3 18.0 0.0 8.1 4.8 11.6 20.1 54.4 12.4 9.7 17.5 15.5 31.3 13.2 4.0 11.8 14.6 8.5 15.4 16.2 12.0 10.3 14.4 16.3 6.3 26.3 25.8 14.1 13.0 20.4 16.2 9.5 25.5 13.6 22.6 NAA10 "ARD1, ARD1A, DXS707, TE2" ENSG00000102030 "N(alpha)-acetyltransferase 10, NatA catalytic subunit" P41227 X 153929242-153935223 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006269, HPA030711" Supported Supported Nucleoli,Cytosol No No Cytosol Nucleoli "CAB006269: AB_425759, HPA030711: AB_2673579" "unprognostic (7.57e-2)" "unprognostic (1.40e-2)" "unprognostic (1.81e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (1.94e-2)" "unprognostic (4.52e-3)" "unprognostic (1.22e-1)" "unprognostic (1.68e-1)" "unprognostic (1.04e-1)" "unprognostic (9.01e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (3.29e-8)" "unprognostic (1.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.29e-2)" "unprognostic (7.48e-3)" 18.9 21.2 17.7 20.3 14.0 12.5 31.8 15.5 20.8 12.4 15.3 8.1 19.2 16.7 17.2 17.6 19.7 16.5 17.6 26.4 15.0 14.2 16.3 18.6 20.7 30.0 15.0 18.0 14.1 33.3 12.3 12.0 13.7 17.5 13.6 11.7 9.3 19.0 17.9 57.8 14.1 14.7 21.7 14.7 14.9 17.7 7.1 11.8 11.4 12.2 25.3 16.3 17.1 22.1 33.7 34.8 35.0 31.9 27.6 44.8 29.0 32.1 33.9 6.4 20.8 9.1 9.6 18.1 11.3 6.6 15.5 13.6 22.0 10.2 24.5 37.7 9.3 20.1 15.4 13.4 13.6 6.0 10.2 62.5 8.8 23.7 22.1 12.5 17.1 19.5 7.3 15.3 14.4 15.0 7.8 17.5 9.6 17.6 10.4 10.2 42.2 27.3 25.5 10.7 30.4 47.1 21.7 16.5 26.8 11.3 14.8 13.7 16.5 4.4 17.9 26.7 6.3 9.6 14.2 10.1 6.5 22.3 22.5 34.3 22.0 24.5 46.0 8.8 22.1 18.9 12.0 24.2 35.0 29.0 28.0 38.0 33.7 31.2 31.7 31.6 32.6 18.7 28.0 22.6 27.6 31.9 34.8 44.8 29.0 17.7 14.0 15.5 20.8 15.0 14.2 15.0 18.0 17.5 11.8 8.9 27.5 83.3 53.7 62.3 28.9 38.0 53.5 29.4 26.1 36.6 11.8 113.1 81.2 114.3 2.1 90.5 71.7 46.7 129.7 161.7 59.9 66.0 66.9 63.8 109.5 35.0 55.8 64.4 62.9 8.3 43.1 71.4 113.1 75.7 61.8 26.2 121.2 58.3 43.9 155.0 22.4 64.7 78.5 5.8 39.4 79.2 91.0 68.3 80.9 64.7 NACC2 "BEND9, BTBD14A, BTBD31, MGC23427" ENSG00000148411 "NACC family member 2" Q96BF6 9 136006537-136095285 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 71.6;Late spermatids: 228.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047924, HPA052962" Approved Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA047924: AB_2680212, HPA052962: AB_2681998" "unprognostic (1.13e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-2)" "unprognostic (8.73e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (9.25e-3)" "unprognostic (2.25e-2)" "unprognostic (1.23e-1)" "unprognostic (4.92e-2)" "unprognostic (1.15e-2)" "unprognostic (2.23e-1)" "prognostic favorable (8.28e-5)" "prognostic favorable (8.63e-4)" "unprognostic (1.71e-1)" "unprognostic (4.98e-2)" "unprognostic (4.12e-2)" 15.3 9.0 27.4 10.9 26.3 2.7 12.8 16.3 37.3 10.0 15.5 14.5 11.7 8.3 11.4 6.9 11.6 10.1 16.6 16.8 20.7 16.7 8.0 15.2 8.3 7.6 30.3 6.4 10.3 10.0 6.2 3.8 3.9 15.2 12.7 5.5 10.2 9.9 23.8 12.6 5.8 9.5 31.7 33.4 7.8 8.2 7.8 11.0 0.0 5.8 4.7 3.1 21.8 4.6 0.0 2.4 5.7 4.5 0.5 1.7 1.4 3.1 17.3 1.9 26.3 8.5 4.8 2.4 7.7 5.2 2.5 0.8 7.3 5.7 0.0 9.3 12.2 4.0 12.4 4.2 4.2 0.8 9.6 3.8 2.1 16.6 9.1 8.7 0.0 4.0 8.0 3.9 2.3 2.3 10.3 6.9 0.0 6.5 0.0 4.8 10.6 0.0 6.0 5.9 5.0 10.8 0.0 2.0 5.2 10.3 3.6 0.7 0.8 10.9 9.2 9.5 9.2 9.3 19.8 11.4 6.7 7.6 5.6 5.3 0.0 0.0 0.1 8.9 0.7 13.4 2.8 4.5 1.5 1.7 3.6 0.7 0.0 0.6 1.5 2.4 0.0 0.5 0.6 5.7 0.5 3.4 0.3 0.4 1.4 27.4 26.3 16.3 17.7 20.7 16.7 30.3 6.4 15.2 11.0 11.9 5.3 1.5 4.0 4.0 2.1 25.0 10.2 1.4 4.5 5.2 0.0 0.6 0.0 10.1 71.6 13.0 6.8 0.0 11.7 1.6 6.4 8.7 2.3 31.1 6.9 3.2 2.4 17.8 38.6 228.0 16.7 10.8 5.0 5.4 4.1 16.7 15.4 8.6 18.0 12.6 1.8 25.8 18.9 1.8 4.5 4.4 0.3 2.9 4.5 7.0 NARF "DKFZp434G0420, FLJ10067, IOP2" ENSG00000141562 "Nuclear prelamin A recognition factor" Q9UHQ1 17 82458180-82490537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 375.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053006 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA053006: AB_2682013" "unprognostic (1.84e-1)" "prognostic favorable (1.15e-4)" "unprognostic (2.00e-1)" "unprognostic (1.10e-2)" "unprognostic (4.14e-1)" "unprognostic (6.52e-2)" "unprognostic (6.62e-3)" "unprognostic (2.37e-2)" "unprognostic (1.51e-1)" "unprognostic (1.54e-1)" "unprognostic (3.42e-3)" "unprognostic (3.80e-3)" "prognostic unfavorable (1.48e-10)" "unprognostic (3.57e-1)" "unprognostic (7.72e-2)" "unprognostic (2.47e-2)" "unprognostic (1.83e-2)" 13.7 10.6 21.2 15.7 20.2 35.0 17.4 24.2 23.5 8.2 13.1 10.1 11.1 13.8 9.5 11.0 13.1 11.2 10.6 28.5 15.7 12.3 10.1 21.3 11.8 15.1 16.4 15.0 11.2 13.8 9.0 11.9 10.2 16.3 10.9 9.0 14.7 13.6 12.0 44.4 15.4 11.0 9.8 10.6 17.7 13.6 35.4 18.1 12.4 11.7 11.2 11.5 11.7 12.4 11.6 10.1 50.6 10.6 15.9 13.6 11.5 8.7 8.2 14.0 22.1 6.6 6.5 7.9 5.2 5.5 9.0 9.3 9.5 3.1 5.6 5.9 4.2 10.3 7.8 10.2 6.6 6.2 5.9 22.7 11.8 11.8 11.7 5.9 12.0 21.0 9.7 11.0 7.1 2.4 9.1 17.0 18.5 26.8 4.2 4.0 7.5 21.0 19.4 5.9 6.8 17.9 17.5 14.2 8.9 4.2 9.1 17.1 24.3 13.7 9.3 16.0 9.5 8.0 9.8 8.5 11.7 10.0 9.6 8.9 38.7 14.6 12.4 10.7 8.5 6.9 24.4 10.6 29.5 11.6 9.4 12.7 11.6 11.4 11.2 10.1 11.0 13.1 10.9 50.6 15.9 7.0 8.3 13.6 11.5 21.2 20.2 24.2 23.5 15.7 12.3 16.4 15.0 16.3 18.1 11.9 21.0 45.4 29.2 33.2 32.8 37.2 17.8 30.8 12.5 5.2 51.1 27.5 33.2 47.7 143.2 38.3 36.0 93.5 57.8 48.2 29.1 28.2 52.9 17.3 29.6 47.7 54.6 43.0 21.3 375.7 23.3 29.7 59.1 68.5 24.8 23.0 67.6 26.0 17.0 18.3 34.2 12.9 37.1 136.6 75.4 30.9 25.6 45.7 31.0 25.5 NAT10 "FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43" ENSG00000135372 "N-acetyltransferase 10" Q9H0A0 11 34105602-34147670 "Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035546, HPA057576, HPA071628" Approved Enhanced Nucleoli,Midbody Yes No Nucleoli Midbody "CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426" "unprognostic (3.04e-1)" "unprognostic (9.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (1.07e-4)" "prognostic unfavorable (9.61e-8)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.83e-5)" "unprognostic (1.24e-1)" "unprognostic (7.18e-2)" "unprognostic (9.55e-2)" "unprognostic (8.69e-2)" 18.5 22.8 20.5 21.9 27.5 23.6 20.8 21.9 29.9 18.1 17.6 24.3 16.4 13.7 30.6 19.8 25.2 21.7 14.7 16.4 17.2 18.6 15.9 21.8 15.1 28.7 16.9 19.8 26.4 24.9 31.5 23.1 20.1 23.4 19.5 21.7 23.0 22.5 17.8 23.4 31.0 16.6 21.5 15.1 23.6 18.0 30.9 16.9 31.2 18.3 19.4 35.3 17.8 19.7 10.4 12.8 2.2 11.1 11.8 13.7 6.9 12.4 17.6 9.4 20.0 11.4 10.1 10.9 12.4 9.1 15.8 12.6 19.7 7.2 40.0 9.2 10.4 13.6 18.9 35.4 18.9 20.2 11.1 22.7 18.1 14.4 18.4 10.3 45.3 13.2 10.3 13.0 10.3 29.0 7.4 12.0 19.3 39.5 14.0 13.1 23.6 36.9 20.6 13.5 21.6 21.2 27.8 31.9 16.7 9.1 21.8 14.0 10.6 16.7 17.7 7.4 9.5 17.7 12.5 9.6 14.1 11.2 20.6 22.9 15.3 18.3 38.1 14.2 18.8 13.9 0.5 6.6 2.2 10.3 11.1 13.7 10.4 11.1 11.7 12.8 9.6 11.5 11.2 0.8 11.8 9.7 9.7 9.6 6.9 20.5 27.5 21.9 29.9 17.2 18.6 16.9 19.8 23.4 16.9 6.0 16.5 12.0 9.6 10.9 11.2 9.8 10.2 14.7 22.7 14.0 11.8 15.4 5.0 6.8 3.8 7.8 3.5 23.3 8.3 9.9 7.4 6.4 4.7 7.2 10.5 11.1 6.9 6.7 4.0 2.1 8.6 6.0 1.7 11.8 8.5 7.7 6.9 2.9 12.4 5.0 10.1 12.9 8.1 17.9 25.4 12.0 12.0 10.2 12.4 6.3 NBAS NAG ENSG00000151779 "Neuroblastoma amplified sequence" A2RRP1 2 15166909-15561330 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036817 Approved Approved "Nuclear membrane,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nuclear membrane, Nucleoli" "HPA036817: AB_10670925" "unprognostic (1.72e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.33e-1)" "unprognostic (1.55e-1)" "unprognostic (1.53e-2)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-1)" "prognostic unfavorable (5.84e-5)" 16.8 18.1 23.2 16.3 30.9 21.9 22.5 21.5 28.3 21.9 17.1 20.6 17.4 13.3 27.1 23.4 14.1 18.7 13.5 21.6 20.9 21.5 19.1 16.9 15.4 16.3 19.3 20.8 24.1 28.6 34.1 35.5 16.2 24.9 16.9 17.7 16.8 22.9 19.0 26.5 23.4 20.5 21.0 18.1 18.1 19.0 31.4 16.7 23.8 20.1 14.6 20.0 14.4 15.2 5.3 6.0 3.2 8.7 9.4 9.9 3.6 5.5 7.3 8.1 5.6 21.3 23.4 8.4 10.3 11.3 8.0 8.1 7.3 8.0 7.1 2.3 15.6 8.3 6.7 8.8 12.9 9.6 7.0 5.6 27.1 6.5 20.4 21.9 7.0 13.8 15.4 10.3 10.6 17.8 16.6 16.5 10.1 21.0 8.2 12.2 6.8 5.8 15.8 7.0 9.0 7.0 6.2 14.3 8.4 16.6 7.5 4.8 7.8 8.7 7.2 12.9 10.6 5.1 6.4 14.3 10.2 6.3 7.2 7.4 12.2 10.3 10.1 18.1 8.2 9.1 1.4 5.7 3.2 7.6 3.9 9.5 5.3 5.9 9.9 5.2 5.1 5.9 6.1 1.0 9.4 8.7 6.0 6.9 3.6 23.2 30.9 21.5 28.3 20.9 21.5 19.3 20.8 24.9 16.7 17.9 14.4 12.9 8.3 6.5 15.6 26.3 22.9 25.4 13.6 17.4 27.5 9.8 0.0 9.6 29.5 10.5 11.9 0.0 12.1 11.2 8.0 7.9 37.0 7.8 7.7 12.7 7.0 7.4 9.5 46.9 10.6 8.2 5.0 19.0 13.5 15.2 8.1 9.3 15.6 7.7 22.9 0.0 11.7 30.4 16.6 9.8 8.7 11.8 11.0 5.8 NBEA "BCL8B, FLJ10197, KIAA1544, LYST2" ENSG00000172915 Neurobeachin Q8NFP9 13 34942287-35673022 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 130.3;Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 84.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 16.5;SH-SY5Y: 41.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039730, HPA040385" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli, Cytosol" "HPA039730: AB_10794202, HPA040385: AB_10795523" "unprognostic (1.80e-2)" "unprognostic (2.90e-1)" "unprognostic (4.99e-2)" "unprognostic (3.89e-4)" "unprognostic (3.59e-1)" "unprognostic (2.04e-1)" "unprognostic (8.75e-2)" "unprognostic (6.95e-3)" "unprognostic (5.01e-1)" "unprognostic (7.43e-2)" "unprognostic (1.03e-3)" "unprognostic (2.45e-1)" "prognostic favorable (7.86e-8)" "unprognostic (2.28e-2)" "unprognostic (9.35e-2)" "unprognostic (1.17e-1)" "unprognostic (6.46e-2)" 3.9 11.9 12.2 2.7 20.6 1.0 8.2 32.6 28.5 7.4 9.8 3.9 10.9 2.7 10.3 6.2 6.2 9.4 5.4 11.7 13.5 10.6 6.6 1.7 3.6 2.6 6.9 22.2 10.4 5.7 9.3 25.0 1.5 14.2 11.9 4.8 13.3 7.0 14.2 8.5 2.0 3.8 11.4 4.7 5.1 4.8 7.7 6.0 6.1 9.6 0.7 2.4 7.1 6.4 1.1 1.3 0.0 0.5 0.4 1.4 0.1 0.0 2.3 5.3 3.0 0.4 0.0 0.1 3.4 5.2 4.0 3.3 0.0 0.5 1.4 0.0 5.8 2.2 0.1 1.8 0.7 8.4 0.6 1.8 0.0 1.6 0.5 0.3 0.9 2.2 0.9 0.6 0.0 0.4 16.5 0.7 0.6 0.0 9.7 0.5 1.0 0.5 0.0 2.3 2.9 0.9 0.6 2.3 0.4 4.6 1.0 3.1 41.0 2.5 0.0 1.7 4.3 0.9 0.2 0.0 1.0 0.6 0.0 0.7 0.9 0.2 0.7 2.5 0.3 2.1 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.1 0.2 0.0 1.1 1.4 1.3 0.0 0.4 0.0 1.3 0.0 0.1 12.2 20.6 32.6 18.4 13.5 10.6 6.9 22.2 14.2 6.0 26.8 8.6 0.5 5.0 0.9 130.3 43.7 12.7 61.6 14.8 8.7 137.4 0.1 1.7 7.3 14.9 6.3 0.0 0.0 1.5 0.1 8.3 8.7 23.3 0.0 0.7 44.5 22.0 9.2 2.4 11.0 16.4 2.9 6.8 1.0 1.4 66.5 2.3 0.0 18.0 7.1 84.5 6.5 12.2 4.9 5.9 0.6 0.0 0.0 0.8 13.1 NCAPD2 "CAP-D2, CNAP1, hCAP-D2, KIAA0159" ENSG00000010292 "Non-SMC condensin I complex subunit D2" Q15021 12 6493356-6531955 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 84.1" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012423, HPA036947, HPA037363" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-2)" "unprognostic (1.03e-2)" "unprognostic (7.84e-2)" "prognostic unfavorable (1.79e-8)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (5.00e-2)" "unprognostic (5.41e-3)" "unprognostic (4.53e-1)" "prognostic unfavorable (1.13e-7)" "unprognostic (4.80e-3)" "unprognostic (1.18e-1)" "unprognostic (4.53e-1)" "unprognostic (8.75e-2)" 6.8 8.8 6.5 24.6 12.7 16.7 7.7 7.7 9.0 8.0 11.3 16.2 7.0 10.6 11.5 8.8 17.7 8.1 6.5 6.2 7.5 5.4 7.0 5.1 7.7 20.4 16.5 6.2 7.7 7.2 9.6 6.3 13.9 8.7 8.2 12.4 8.1 10.5 8.3 7.0 14.8 13.0 8.2 12.7 16.4 9.9 17.2 11.4 84.1 11.4 12.4 24.3 10.9 9.5 5.0 4.8 7.2 2.8 7.8 7.4 3.2 22.1 20.5 22.1 16.0 5.8 6.0 25.8 15.3 12.3 24.8 20.1 18.5 23.6 23.3 4.6 10.0 21.0 19.6 36.4 17.9 47.4 42.2 20.4 21.3 23.5 10.5 2.4 26.4 15.4 3.8 6.7 19.3 19.8 11.4 16.3 15.0 13.5 9.5 21.9 11.0 29.9 17.4 34.5 20.9 16.0 25.6 50.3 12.4 8.3 12.4 9.1 9.6 22.8 10.8 8.1 36.0 4.7 16.6 10.2 16.3 26.8 11.0 29.7 7.4 10.0 33.2 9.6 15.3 20.2 7.2 2.0 3.6 6.3 2.8 5.6 5.0 6.2 7.3 3.0 3.8 7.4 7.2 1.9 7.8 1.9 4.8 7.2 3.2 6.5 12.7 7.7 9.0 7.5 5.4 16.5 6.2 8.7 11.4 6.0 6.1 13.0 3.2 3.2 3.6 2.9 7.6 5.3 3.4 1.8 7.9 6.8 0.0 4.1 14.9 2.6 5.2 46.7 3.3 16.2 3.1 2.8 3.5 2.6 8.6 4.8 1.2 9.2 10.8 20.4 5.5 5.4 0.0 5.4 6.3 10.0 4.5 5.7 5.6 2.0 7.6 0.0 3.6 17.7 10.0 3.0 5.3 6.9 8.0 3.0 NCKAP5 "ERIH1, ERIH2, NAP5" ENSG00000176771 "NCK associated protein 5" O14513 2 132671799-133568463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.3;lung: 19.2" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 244.2;Bipolar cells: 119.6;Muller glia cells: 83.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "basophil: 3.1" "Lineage enriched" "Detected in single" 8 "granulocytes: 3.1" "Cell line enriched" "Detected in some" 6 "AF22: 32.3" "Low region specificity" "Detected in all" "HPA034639, HPA044859" Uncertain Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" NA NA Nucleoli "Golgi apparatus, Plasma membrane, Cytosol" "HPA034639: AB_10669678, HPA044859: AB_2679114" "unprognostic (2.54e-1)" "unprognostic (1.95e-2)" "unprognostic (2.30e-2)" "unprognostic (2.58e-2)" "unprognostic (2.49e-2)" "unprognostic (3.13e-1)" "unprognostic (7.07e-2)" "unprognostic (1.90e-1)" "unprognostic (1.96e-2)" "unprognostic (1.82e-2)" "unprognostic (1.46e-1)" "unprognostic (2.93e-1)" "unprognostic (1.06e-11)" "unprognostic (4.56e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.03e-1)" 3.6 2.0 6.6 1.5 6.3 0.2 5.4 5.2 5.6 3.1 5.8 6.2 0.9 3.8 3.6 6.2 6.9 1.0 1.5 4.6 6.0 3.9 16.3 6.7 19.2 2.2 6.6 4.7 4.5 1.8 2.2 1.3 4.6 4.2 1.6 1.9 7.5 7.8 1.0 1.1 3.7 18.3 1.0 6.3 2.9 3.0 2.1 6.6 0.3 2.1 5.4 2.3 1.3 3.1 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.0 1.5 32.3 0.0 0.0 0.3 0.1 0.5 5.7 0.5 0.6 0.0 0.0 2.4 0.0 0.3 0.3 0.1 0.2 0.4 1.8 0.0 0.2 0.0 4.8 0.0 0.0 0.0 0.0 0.3 2.7 3.1 0.4 5.3 0.5 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.7 0.2 1.0 0.3 0.0 1.3 0.7 0.7 0.1 1.0 0.0 1.2 1.6 0.3 0.5 0.0 1.6 0.2 0.2 4.7 0.0 0.1 0.0 0.9 0.3 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 6.3 5.2 5.6 6.0 3.9 6.6 4.7 4.2 6.6 244.2 14.1 0.0 0.4 7.9 119.6 16.1 0.0 1.4 51.2 1.8 39.3 0.0 3.3 0.4 5.4 0.8 11.0 0.0 0.2 0.1 5.2 0.9 1.1 5.3 0.5 31.8 3.5 0.6 5.1 2.7 24.5 6.8 1.7 6.4 3.3 83.1 0.9 4.9 7.1 9.0 5.6 6.5 8.1 0.1 0.7 2.5 0.0 0.0 0.9 1.6 NCL "C23, Nsr1" ENSG00000115053 Nucleolin P19338 2 231453531-231483641 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004210, HPA023981, HPA071110" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes Yes 600000 "Nucleoplasm, Nucleoli, Nucleoli rim" "Mitotic chromosome" "CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: " "unprognostic (1.91e-1)" "unprognostic (2.53e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.63e-2)" "unprognostic (2.72e-3)" "prognostic unfavorable (1.41e-6)" "unprognostic (3.74e-2)" "unprognostic (4.31e-3)" "unprognostic (9.78e-2)" "unprognostic (6.70e-3)" "unprognostic (6.07e-2)" "unprognostic (1.66e-2)" "unprognostic (2.57e-2)" "unprognostic (9.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.42e-2)" 71.2 68.2 59.6 67.7 77.0 96.6 71.0 72.8 69.2 72.1 63.0 79.2 46.0 48.1 80.3 63.7 85.2 65.7 45.9 55.9 57.7 53.3 66.7 94.7 55.6 78.4 67.4 51.8 93.9 77.5 94.8 83.4 69.5 79.8 64.6 75.4 47.1 58.1 51.8 120.6 70.3 56.9 70.9 88.4 80.2 59.4 41.7 76.4 118.9 67.8 82.6 105.5 79.9 60.6 40.8 41.3 20.4 36.4 52.6 53.9 40.8 63.3 59.3 71.9 52.7 42.5 46.2 74.0 71.7 48.7 67.7 60.0 97.9 45.6 84.2 61.8 55.3 90.9 62.2 143.9 96.3 116.1 49.2 60.3 140.5 56.3 131.9 46.6 160.1 53.3 43.8 55.9 84.5 89.0 38.9 71.0 76.8 125.1 28.9 59.5 86.2 140.1 99.4 107.1 66.9 42.6 104.6 129.7 73.9 49.7 84.2 62.3 44.4 48.0 55.1 63.3 61.3 41.4 81.1 60.3 54.3 56.2 63.4 94.2 54.8 53.8 181.3 39.5 104.5 56.2 9.5 27.9 20.4 47.4 33.2 53.9 40.8 41.7 42.6 41.3 38.9 46.6 42.1 6.0 52.6 36.4 35.5 34.4 40.8 59.6 77.0 72.8 69.2 57.7 53.3 67.4 51.8 79.8 76.4 271.0 357.6 280.1 370.4 408.5 137.1 290.7 137.6 385.4 589.2 184.9 45.2 333.3 195.6 173.5 15.4 228.8 106.1 210.2 218.7 336.0 249.6 218.4 431.8 217.9 213.5 76.3 191.8 122.8 135.8 18.9 201.0 194.7 156.9 238.1 192.5 194.0 213.8 138.2 150.3 209.2 125.5 148.8 282.2 390.1 563.8 385.9 316.9 226.1 268.8 321.5 NCOA4 "ARA70, DKFZp762E1112, ELE1, PTC3, RFG" ENSG00000266412 "Nuclear receptor coactivator 4" Q13772 10 46005088-46030714 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 100.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 30.2;granulocytes: 100.1;monocytes: 40.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051260, HPA065208" Uncertain Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA Nucleoli "Golgi apparatus, Cytosol" "HPA051260: AB_2681412, HPA065208: AB_2685432" "unprognostic (4.23e-2)" "unprognostic (1.50e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.34e-1)" "unprognostic (1.80e-1)" "unprognostic (9.34e-2)" "unprognostic (4.67e-2)" "unprognostic (5.22e-2)" "unprognostic (9.16e-2)" "unprognostic (2.04e-2)" "prognostic favorable (8.04e-6)" "unprognostic (1.35e-1)" "unprognostic (4.71e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" 18.5 6.9 5.5 9.5 10.0 17.4 10.0 5.5 11.3 10.8 22.5 13.6 5.9 27.0 9.9 9.4 17.0 6.3 9.0 16.6 5.7 20.8 40.9 11.6 11.6 8.7 7.1 11.0 9.1 9.3 9.6 28.4 13.5 14.7 12.4 9.9 12.6 8.5 15.5 6.8 36.4 11.2 9.7 23.8 8.9 6.4 8.1 26.8 13.2 13.9 16.3 13.0 6.4 7.3 30.2 100.1 40.4 13.4 10.9 53.9 31.8 13.5 15.9 16.3 42.1 38.2 39.8 29.3 47.4 28.9 28.4 20.8 23.6 36.0 35.3 47.8 16.2 32.6 16.6 32.3 32.3 25.4 17.1 24.3 18.6 59.4 29.5 61.8 54.3 37.1 32.4 24.6 41.4 30.9 42.5 18.2 26.4 21.7 39.4 14.2 30.0 23.2 9.6 24.6 8.0 17.8 23.1 21.5 34.6 27.1 16.0 10.8 29.6 33.8 29.3 32.9 24.4 30.4 39.1 17.9 21.5 18.9 19.7 16.2 17.3 35.8 22.4 52.1 9.5 69.1 40.4 70.7 10.0 26.8 10.9 7.3 9.4 9.5 30.2 6.6 10.2 8.6 100.1 13.4 30.4 9.3 10.8 53.9 47.6 78.0 32.8 33.2 44.0 13.3 136.0 38.2 50.9 59.1 41.8 27.5 85.3 68.0 41.7 72.4 47.2 113.4 186.9 45.2 92.9 44.2 51.5 191.6 148.1 148.2 19.1 25.8 53.4 209.6 51.8 34.5 96.2 49.0 73.1 41.3 37.9 41.1 57.5 44.6 100.4 11.3 12.9 47.2 22.7 15.1 49.4 132.3 41.5 50.4 45.0 NDP "EVR2, norrin" ENSG00000124479 "NDP, norrin cystine knot growth factor" Q00604 X 43948776-43973504 "Disease related genes, Predicted secreted proteins" "Sensory transduction, Vision, Wnt signaling pathway" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 40.4" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 100.6" "Cancer enhanced" "Detected in many" "glioma: 25.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 14 "T-cells: 1.7" "Cell line enriched" "Detected in some" 17 "U-87 MG: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003095 Supported Nucleoplasm,Nucleoli,Vesicles "Secreted to extracellular matrix" NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA003095: AB_1079457" "unprognostic (1.12e-1)" "unprognostic (7.12e-2)" "unprognostic (2.27e-2)" "unprognostic (2.55e-3)" "unprognostic (6.84e-3)" "unprognostic (1.51e-1)" "unprognostic (9.09e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" 0.9 0.6 17.3 0.6 18.6 0.5 3.6 14.6 15.0 19.1 0.7 12.6 0.2 0.6 13.6 19.9 0.6 18.0 0.9 1.4 14.0 7.8 0.7 0.5 0.6 0.7 11.0 10.9 40.4 0.6 0.8 0.2 5.3 13.1 6.8 0.7 1.4 0.6 12.4 1.5 1.1 0.6 10.7 7.5 0.6 0.7 1.4 12.2 0.0 1.2 0.0 0.7 1.0 1.7 0.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.1 1.1 0.7 0.0 0.0 1.1 0.0 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 41.2 0.4 2.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.3 18.6 14.6 15.0 14.0 7.8 11.0 10.9 13.1 12.2 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 12.4 0.0 0.0 0.0 0.0 100.6 0.7 0.0 9.2 0.0 3.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 NEPRO "C3orf17, DKFZP434F2021, NET17" ENSG00000163608 "Nucleolus and neural progenitor protein" Q6NW34 3 113002440-113019861 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Club cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069654 Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA069654: AB_2686164" "unprognostic (8.45e-3)" "unprognostic (3.84e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.29e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (4.98e-2)" "unprognostic (1.72e-2)" "unprognostic (9.29e-3)" "unprognostic (5.40e-2)" "unprognostic (1.69e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (3.28e-2)" 15.1 12.3 12.6 12.9 19.8 15.9 15.5 22.8 21.3 14.4 12.8 15.3 11.6 12.3 15.4 19.0 12.7 12.8 13.0 14.0 13.2 12.5 12.4 10.3 11.3 19.3 14.2 13.7 14.8 16.5 13.4 18.2 12.4 15.6 12.4 9.8 11.5 13.5 15.1 28.1 18.2 13.6 16.0 17.5 17.5 14.2 19.1 12.8 21.9 20.0 16.4 15.5 17.5 10.9 3.8 3.4 2.9 3.0 7.9 6.4 2.7 10.0 8.4 13.4 10.0 4.4 8.0 7.2 9.7 6.1 5.4 3.6 7.6 6.6 13.3 5.3 3.1 7.6 10.6 9.8 4.3 7.5 2.6 6.2 20.4 7.4 5.6 8.0 12.9 7.5 12.6 7.8 4.4 11.2 14.7 4.7 13.2 6.9 10.7 3.9 6.4 11.1 7.6 13.9 8.9 10.8 9.1 10.6 6.9 6.1 8.9 9.3 13.6 5.5 7.0 15.9 10.4 8.0 11.1 9.4 7.5 7.5 2.7 6.8 10.6 8.2 15.7 12.0 10.3 5.3 2.9 2.3 2.7 4.4 3.0 4.5 3.8 5.1 3.7 3.4 3.1 6.4 6.3 1.5 7.9 1.2 2.4 2.2 2.7 12.6 19.8 22.8 21.3 13.2 12.5 14.2 13.7 15.6 12.8 8.9 10.9 0.0 0.0 0.0 0.0 0.0 0.0 16.0 19.4 17.4 0.0 15.4 14.9 12.5 0.0 0.0 0.0 0.0 11.1 12.4 0.0 0.0 16.3 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 16.2 0.0 0.0 12.4 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 NGDN "C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD" ENSG00000129460 Neuroguidin Q8NEJ9 14 23469688-23509862 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000944 Approved Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" Nucleoplasm "HPA000944: AB_1079483" "unprognostic (2.63e-3)" "unprognostic (7.65e-2)" "unprognostic (2.84e-1)" "unprognostic (4.16e-3)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (8.87e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (3.87e-3)" "unprognostic (7.10e-2)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (9.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.58e-1)" "unprognostic (1.70e-1)" 20.1 17.6 17.2 19.3 23.6 35.7 26.9 28.9 25.8 17.8 17.8 21.2 18.7 15.0 29.1 22.3 17.4 21.7 12.1 14.8 17.6 15.7 20.6 21.0 15.5 20.4 23.5 17.4 27.2 16.6 20.9 20.7 19.7 19.1 19.7 19.4 17.4 24.0 19.9 32.8 22.7 17.9 21.0 21.6 19.7 17.5 19.0 25.2 19.6 23.7 17.2 22.8 17.3 19.7 42.0 26.7 18.9 23.4 35.2 44.6 28.2 11.0 21.9 16.8 15.7 16.3 11.8 22.2 14.6 15.3 31.3 25.4 21.6 20.2 27.4 10.8 13.3 22.2 19.2 33.2 18.1 36.9 18.2 17.5 24.5 13.3 66.7 22.2 32.4 17.5 14.7 23.1 24.6 29.4 12.4 15.8 21.2 27.1 19.6 15.2 26.2 24.1 24.5 21.2 25.4 29.5 19.7 20.1 14.0 20.0 21.0 17.2 19.4 17.3 20.8 23.9 17.8 12.9 20.8 11.9 14.8 17.6 13.9 21.2 24.5 42.5 39.8 6.4 16.6 15.8 17.5 21.5 18.9 31.6 23.4 33.5 42.0 34.3 32.1 25.3 36.6 44.6 35.1 6.6 35.2 22.4 26.7 37.4 28.2 17.2 23.6 28.9 25.8 17.6 15.7 23.5 17.4 19.1 25.2 32.8 26.9 41.2 49.3 62.7 21.0 17.7 17.8 28.1 29.6 26.2 15.7 50.7 28.2 31.1 4.1 34.3 17.4 23.3 31.3 36.0 37.0 25.4 43.9 18.1 26.5 23.8 23.6 16.0 16.4 4.5 32.5 29.5 30.4 36.1 18.8 20.7 28.1 19.9 26.5 27.0 24.7 19.4 38.7 57.2 69.0 59.1 47.8 41.5 22.0 44.2 NIFK "hNIFK, MKI67IP, Nopp34" ENSG00000155438 "Nucleolar protein interacting with the FHA domain of MKI67" Q9BYG3 2 121726945-121736923 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015382, HPA035735, HPA035736, CAB075728, CAB075729" Supported Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "CAB015382: AB_2142390, CAB075728: AB_2665734, CAB075729: AB_2665735, HPA035735: AB_2674758, HPA035736: AB_2674759" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (3.49e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (1.21e-1)" "unprognostic (4.15e-3)" "prognostic unfavorable (2.92e-6)" "unprognostic (7.74e-3)" "unprognostic (4.63e-2)" "unprognostic (3.21e-2)" "unprognostic (6.02e-3)" "unprognostic (9.50e-2)" "prognostic unfavorable (5.01e-11)" "unprognostic (1.72e-1)" "unprognostic (1.29e-1)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" 25.1 18.7 18.4 22.1 19.0 19.9 28.1 14.3 20.8 24.0 17.3 14.8 9.8 16.5 21.4 17.4 28.2 20.3 16.6 15.4 16.1 15.1 24.2 40.1 14.7 30.8 15.8 15.2 32.8 33.7 12.9 28.9 19.8 18.5 21.2 19.7 10.2 16.5 14.2 35.5 22.8 17.9 20.9 18.3 28.1 19.2 18.7 18.0 31.3 23.6 21.3 29.5 26.1 21.0 28.1 25.9 12.5 23.5 27.1 32.9 24.6 28.8 8.7 18.9 18.5 16.6 23.0 22.7 22.7 20.4 28.6 31.3 25.5 14.7 39.7 28.4 17.7 24.8 18.7 40.6 30.7 42.9 24.1 21.5 39.0 12.3 23.8 23.3 35.9 21.6 23.1 35.4 37.8 50.7 13.3 20.5 15.8 43.8 19.8 24.7 14.2 27.5 35.7 46.3 34.5 31.5 26.4 21.2 48.6 25.4 18.1 23.6 24.4 14.3 28.6 49.6 17.9 13.7 30.9 11.8 19.7 32.2 22.2 32.3 23.2 34.9 44.1 15.3 35.5 27.4 12.5 19.8 9.3 22.9 23.5 32.1 27.0 28.2 26.2 25.9 28.1 32.9 30.8 1.3 27.1 20.9 22.6 23.5 24.6 18.4 19.0 14.3 20.8 16.1 15.1 15.8 15.2 18.5 18.0 41.7 23.4 49.1 90.7 87.3 25.6 18.3 15.3 44.2 64.8 14.0 11.8 63.5 39.7 65.3 10.4 41.8 15.2 23.3 39.1 70.0 52.4 39.8 53.1 31.1 49.2 12.7 27.0 22.7 32.3 3.8 53.2 41.0 21.9 45.1 37.8 44.7 45.9 21.0 42.5 40.0 38.4 38.8 44.3 54.8 72.2 88.7 40.8 39.4 44.3 93.5 NIN ENSG00000100503 Ninein Q8N4C6 14 50719763-50831121 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005939, HPA070691" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Centrosome" NA NA Centrosome "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA005939: AB_2667474, HPA070691: AB_2686296" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (3.54e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (1.43e-2)" "unprognostic (3.41e-2)" "unprognostic (3.31e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (2.07e-1)" "unprognostic (4.06e-1)" "unprognostic (2.46e-2)" "unprognostic (2.67e-1)" "unprognostic (1.28e-1)" "unprognostic (2.58e-2)" "unprognostic (7.66e-3)" 13.0 6.1 15.1 24.9 10.3 34.8 9.7 12.6 14.0 8.0 9.2 7.6 4.5 5.0 11.8 6.1 11.8 8.2 7.6 16.4 11.7 4.9 6.7 5.2 10.7 30.2 7.6 10.0 11.0 5.4 9.1 12.3 20.2 7.1 6.5 7.7 6.2 8.2 5.1 16.9 10.9 8.3 12.0 7.1 18.2 9.3 4.6 9.0 16.4 7.8 5.1 25.8 11.7 10.3 6.8 6.3 18.4 2.3 1.5 6.0 1.3 12.3 8.7 18.3 15.5 7.0 11.4 7.6 10.6 9.1 8.9 7.5 5.6 6.6 29.1 7.3 14.3 8.5 13.0 14.7 6.7 18.9 14.0 4.5 10.7 5.4 5.3 4.1 18.6 30.9 7.8 5.4 15.7 6.4 5.3 14.2 15.1 2.6 11.9 13.5 13.5 14.1 7.5 2.5 3.9 9.7 16.0 33.8 2.1 8.0 14.0 8.5 9.6 13.3 4.0 11.4 4.2 7.6 16.6 20.7 22.8 31.7 8.7 11.7 9.6 4.8 20.1 5.9 15.2 12.3 12.6 2.3 18.4 3.3 1.7 3.5 6.8 2.2 6.0 1.5 5.5 4.4 3.8 8.3 1.5 1.5 6.3 1.9 1.3 15.1 10.3 12.6 14.0 11.7 4.9 7.6 10.0 7.1 9.0 6.0 7.7 41.0 7.0 16.4 7.5 37.9 12.7 26.8 36.4 10.4 58.9 9.2 3.3 6.9 22.3 24.1 4.1 0.0 3.5 8.9 27.9 13.0 30.1 3.9 20.1 6.4 12.1 27.0 40.6 7.8 7.8 47.2 21.9 12.6 3.9 87.7 4.7 5.8 8.9 5.1 18.0 32.3 20.8 0.0 0.4 18.3 8.1 37.4 4.6 14.5 NIP7 "CGI-37, FLJ10296, HSPC031, KD93" ENSG00000132603 "NIP7, nucleolar pre-rRNA processing protein" Q9Y221 16 69339430-69343111 "Predicted intracellular proteins" "Ribosome biogenesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040856, HPA059850" Supported Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA040856: AB_2677171, HPA059850: AB_2684142" "unprognostic (2.14e-1)" "unprognostic (1.03e-1)" "unprognostic (2.76e-1)" "unprognostic (8.02e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.04e-3)" "unprognostic (1.37e-3)" "unprognostic (5.72e-2)" "unprognostic (3.86e-2)" "prognostic unfavorable (6.69e-5)" "unprognostic (6.99e-2)" "unprognostic (1.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.28e-1)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" 17.8 15.5 8.1 16.4 8.7 20.4 14.0 7.0 12.4 10.2 13.7 9.5 11.1 11.8 15.6 13.1 24.0 13.0 11.3 9.1 9.0 7.8 18.0 18.0 10.7 17.6 12.6 9.6 11.6 18.4 9.6 10.2 14.3 10.9 10.1 14.2 8.8 13.1 13.2 12.1 14.7 14.2 11.7 8.3 15.4 12.3 14.8 9.5 27.1 19.2 23.8 21.0 10.6 11.8 16.6 14.2 8.4 11.7 15.3 19.0 9.5 15.1 10.8 9.2 12.2 12.1 11.0 13.7 13.7 11.1 24.1 17.7 17.4 16.4 27.7 15.4 12.7 10.1 15.2 17.3 21.8 30.7 7.3 13.9 14.4 7.7 22.8 11.9 31.6 9.5 11.8 17.4 22.1 24.5 7.5 13.2 15.0 28.5 5.0 16.6 18.6 19.0 23.2 26.8 14.0 12.6 27.6 9.5 25.3 14.8 11.3 11.7 16.7 27.5 8.8 16.9 10.9 12.0 19.4 11.5 17.6 15.5 13.1 25.3 15.3 11.6 67.8 10.2 18.9 17.5 8.4 8.1 5.7 16.8 9.2 18.1 16.6 15.6 19.0 14.2 12.1 15.1 18.3 4.0 15.3 11.7 12.5 14.8 9.5 8.1 8.7 7.0 12.4 9.0 7.8 12.6 9.6 10.9 9.5 3.0 10.1 24.6 46.2 47.7 8.2 4.8 17.8 29.4 18.2 19.2 15.7 27.5 18.3 30.3 29.3 22.4 13.8 0.0 22.6 28.1 22.2 16.9 17.3 9.6 21.6 11.1 2.9 18.4 10.8 29.4 15.8 15.5 18.6 16.2 11.7 8.8 30.2 17.5 16.3 21.4 6.9 12.9 19.8 31.2 39.4 45.9 21.4 27.7 16.6 36.0 NKIRAS2 "DKFZP434N1526, kappaB-Ras2, KBRAS2" ENSG00000168256 "NFKB inhibitor interacting Ras like 2" Q9NYR9 17 42011382-42025644 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062861 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA062861: AB_2684884" "unprognostic (2.53e-1)" "unprognostic (1.09e-3)" "unprognostic (2.31e-2)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (5.56e-4)" "unprognostic (9.37e-3)" "unprognostic (2.89e-2)" "unprognostic (2.56e-1)" "unprognostic (6.96e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (3.25e-2)" "unprognostic (5.42e-3)" 15.3 10.9 6.7 11.5 8.4 12.5 12.9 9.2 10.3 12.0 14.6 11.0 10.3 8.7 15.4 12.5 22.0 10.5 14.1 27.5 6.1 5.6 14.0 16.1 11.7 10.4 8.5 3.6 14.9 10.7 8.4 9.0 30.8 7.2 12.5 9.9 14.6 12.3 11.1 31.5 16.1 15.6 15.7 8.3 12.4 11.3 17.1 6.0 17.7 9.5 15.4 19.1 14.5 12.7 8.2 23.0 21.0 25.5 12.0 7.4 10.4 9.2 15.9 24.5 12.7 17.2 11.6 14.6 15.7 11.9 24.7 18.5 17.3 13.0 15.3 24.8 15.9 16.4 19.5 19.8 11.8 12.6 12.7 21.6 13.7 14.8 12.7 27.0 18.2 11.3 17.2 21.0 16.3 12.6 16.4 29.9 19.5 19.3 15.5 14.0 9.1 35.1 11.3 14.4 11.9 12.2 27.7 28.2 14.3 15.9 9.5 29.4 38.5 11.5 34.8 15.5 25.0 22.1 22.1 21.6 15.6 16.7 16.7 17.5 20.4 33.0 12.6 10.4 10.9 21.8 21.0 25.5 20.5 7.0 20.5 6.9 7.8 7.1 7.0 20.5 8.2 7.4 7.1 14.4 12.0 21.5 23.0 6.0 10.4 6.7 8.4 9.2 10.3 6.1 5.6 8.5 3.6 7.2 6.0 14.9 9.3 12.9 16.9 15.0 20.3 22.4 2.5 8.1 17.0 15.7 19.6 45.4 18.3 25.5 5.4 22.4 18.3 0.0 24.7 32.7 21.6 17.9 13.9 13.4 33.2 22.3 18.4 12.3 22.5 4.0 18.1 26.6 10.1 33.3 17.6 22.0 22.8 14.0 17.3 15.0 25.1 6.5 19.6 28.1 33.2 22.5 52.1 10.0 14.0 18.0 NKRF "ITBA4, NRF" ENSG00000186416 "NFKB repressing factor" O15226 X 119588337-119605895 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001476 Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA001476: AB_1079488" "unprognostic (6.12e-3)" "unprognostic (7.58e-2)" "unprognostic (8.10e-2)" "unprognostic (2.39e-1)" "unprognostic (9.92e-2)" "unprognostic (4.74e-3)" "prognostic unfavorable (4.92e-5)" "unprognostic (2.47e-1)" "unprognostic (1.20e-1)" "unprognostic (2.65e-1)" "unprognostic (1.33e-2)" "unprognostic (9.56e-3)" "unprognostic (2.62e-2)" "unprognostic (5.06e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-3)" "unprognostic (3.08e-3)" 3.8 7.9 14.5 6.2 24.3 7.6 6.5 11.4 34.9 4.9 4.0 4.4 1.1 4.7 4.8 5.6 5.6 5.2 4.1 3.8 15.4 14.0 6.9 6.9 4.1 9.7 8.1 24.6 7.4 3.9 8.3 6.5 7.5 25.7 4.9 4.5 2.9 4.6 4.3 4.8 6.4 4.4 4.7 6.0 6.4 4.0 1.9 3.5 7.4 5.4 1.4 9.7 5.2 4.8 3.8 2.7 2.8 2.2 1.3 5.5 1.7 11.0 11.2 6.6 7.7 5.8 5.9 10.1 6.7 5.5 9.1 9.9 11.9 9.5 19.6 11.8 5.8 7.8 13.0 27.7 10.3 11.2 9.8 18.9 10.3 13.4 7.9 5.4 20.0 8.0 6.2 8.5 10.5 12.3 6.2 9.2 9.7 11.1 8.3 8.1 17.0 12.7 16.0 14.8 16.1 12.6 10.0 9.5 20.1 12.0 8.2 10.9 9.1 9.4 14.7 9.9 7.2 6.2 12.2 7.5 5.8 6.2 12.4 16.8 6.8 8.2 20.7 6.0 22.4 6.5 2.8 1.3 1.5 3.3 2.2 3.1 3.7 3.6 3.7 1.3 3.8 5.5 4.8 0.2 1.3 1.1 2.7 4.3 1.7 14.5 24.3 11.4 34.9 15.4 14.0 8.1 24.6 25.7 3.5 6.0 6.2 9.0 9.2 17.2 13.3 4.0 10.2 2.7 2.3 5.2 25.5 11.6 1.7 3.8 0.1 4.5 2.6 0.0 3.1 13.2 6.2 8.4 14.9 3.4 5.6 7.9 10.3 4.3 6.0 0.0 7.2 7.8 5.0 6.4 3.8 4.0 3.1 0.0 6.3 3.7 8.3 0.0 8.2 0.5 1.1 22.5 12.5 7.0 5.7 8.7 NKX2-3 "CSX3, NKX2.3, NKX2C, NKX4-3" ENSG00000119919 "NK2 homeobox 3" Q8TAU0 10 99532933-99536524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 12.5;intestine: 21.6;lymphoid tissue: 36.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HAP1: 2.1;NB-4: 4.8;REH: 6.2;THP-1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA047561 Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA047561: AB_2680088" "unprognostic (5.70e-2)" "unprognostic (2.95e-1)" "unprognostic (2.70e-4)" "unprognostic (6.34e-3)" "unprognostic (3.92e-2)" "unprognostic (7.40e-2)" "unprognostic (1.20e-1)" "unprognostic (4.91e-2)" "unprognostic (1.12e-1)" "unprognostic (1.19e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" 0.8 0.0 0.1 17.2 0.1 0.0 0.1 0.1 0.1 0.3 21.6 0.1 0.1 10.4 0.2 0.1 0.5 0.0 12.5 0.1 0.1 0.0 0.1 0.2 0.1 1.1 0.1 0.1 0.1 6.4 0.0 0.1 0.1 0.1 0.1 4.6 0.1 9.0 0.5 0.1 0.0 19.1 3.1 0.1 36.8 1.8 0.1 0.1 0.2 1.0 0.7 3.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 6.2 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.4 0.0 1.6 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NLE1 "FLJ10458, NLE" ENSG00000073536 "Notchless homolog 1" Q9NVX2 17 35128753-35142315 "Predicted intracellular proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 40.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018807 Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA018807: AB_1848658" "unprognostic (9.19e-2)" "unprognostic (8.40e-2)" "unprognostic (4.69e-2)" "unprognostic (4.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (8.64e-8)" "unprognostic (8.67e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-2)" "unprognostic (6.49e-2)" "unprognostic (3.90e-2)" "unprognostic (2.00e-1)" "unprognostic (4.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (6.39e-4)" 6.3 6.9 7.0 8.2 7.6 6.4 11.4 7.6 9.1 5.6 5.8 5.4 3.3 5.1 10.0 5.5 7.9 10.0 8.3 4.8 6.0 6.4 4.8 6.9 4.5 9.1 5.6 7.7 16.3 40.3 5.1 4.2 6.1 5.4 9.2 5.3 6.2 9.1 7.5 8.8 7.6 5.1 10.2 5.1 8.3 6.8 7.2 6.4 10.0 10.0 6.6 8.3 6.3 5.4 6.4 4.5 0.4 3.2 2.4 9.1 3.0 8.2 20.0 6.7 12.0 4.2 6.3 10.8 7.4 7.0 13.3 11.0 13.8 8.0 18.2 10.2 6.2 9.7 11.0 15.3 19.0 9.1 2.9 23.8 8.2 9.6 17.2 5.7 15.7 6.6 7.1 10.2 13.7 21.0 5.9 8.5 17.9 22.0 6.7 7.8 11.3 24.1 12.8 12.7 6.9 8.9 19.5 11.8 20.1 7.8 8.0 13.9 8.4 7.0 7.2 8.8 6.5 17.6 11.4 7.6 7.2 10.1 6.9 24.8 5.2 4.0 15.3 5.0 13.0 13.7 0.1 3.0 0.0 5.7 3.2 9.1 4.8 5.4 6.0 4.5 6.4 7.4 5.1 0.4 2.4 1.6 1.0 3.0 3.0 7.0 7.6 7.6 9.1 6.0 6.4 5.6 7.7 5.4 6.4 3.0 0.6 12.4 6.2 7.7 4.1 2.0 12.7 4.0 3.4 3.5 2.0 9.0 0.0 8.7 0.6 4.2 1.6 0.0 12.9 16.0 8.2 4.0 3.5 5.5 6.7 1.6 4.7 4.3 2.8 4.7 3.7 2.2 1.7 3.6 7.8 1.4 9.4 2.9 4.6 5.6 2.9 0.0 4.1 3.6 5.3 8.8 4.1 4.4 12.0 5.1 NLK ENSG00000087095 "Nemo like kinase" Q9UBE8 17 28041737-28196381 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 93.3;Cone photoreceptor cells: 145.3;Early spermatids: 243.8;Late spermatids: 250.1;Rod photoreceptor cells: 92.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 32 "basophil: 17.6" "Lineage enriched" "Detected in single" 32 "granulocytes: 17.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018192, HPA056511" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA Nucleoplasm "Nucleoli, Cell Junctions" "HPA018192: AB_1854525, HPA056511: AB_2683160" "unprognostic (7.19e-2)" "unprognostic (1.98e-1)" "unprognostic (5.54e-2)" "unprognostic (5.64e-3)" "unprognostic (2.11e-1)" "unprognostic (1.29e-1)" "unprognostic (1.67e-2)" "unprognostic (2.59e-3)" "unprognostic (2.72e-2)" "unprognostic (4.23e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (5.29e-2)" "unprognostic (1.66e-1)" "unprognostic (3.92e-1)" "unprognostic (5.27e-2)" "unprognostic (6.57e-2)" 6.4 30.5 19.4 10.9 14.1 7.4 7.5 7.5 38.2 6.2 6.7 8.3 14.4 8.3 5.7 8.8 4.5 5.1 8.2 8.5 18.2 12.0 13.0 8.2 7.1 11.7 15.2 23.6 4.6 11.5 20.8 9.4 9.1 7.0 6.7 7.1 12.7 5.8 17.4 4.9 4.5 8.3 4.6 15.3 10.1 7.0 17.4 7.5 10.9 13.2 3.7 11.0 7.2 4.4 0.5 0.3 17.6 0.3 0.1 0.5 0.2 4.6 5.4 13.0 4.5 2.8 3.6 5.8 4.7 4.8 7.8 6.0 27.1 4.2 6.3 7.1 3.8 9.9 4.4 9.2 8.5 9.0 14.6 5.8 24.8 5.0 4.6 4.7 5.2 25.6 4.7 5.3 5.1 6.2 7.6 9.1 18.0 9.5 7.7 7.1 5.5 13.4 6.0 5.0 9.1 2.7 11.2 8.4 4.6 14.2 5.7 9.5 3.6 7.1 6.8 29.1 16.4 10.6 8.3 9.3 5.6 7.6 4.6 9.4 9.0 8.6 6.1 5.5 5.7 6.1 17.6 0.2 0.2 0.3 0.3 0.1 0.5 0.4 0.4 0.2 0.3 0.2 0.5 0.1 0.1 0.3 0.3 0.4 0.2 19.4 14.1 7.5 38.2 18.2 12.0 15.2 23.6 7.0 7.5 20.8 5.9 4.7 3.5 4.7 93.3 23.0 10.2 6.7 4.5 31.4 145.3 2.5 1.7 3.3 243.8 10.6 5.9 0.0 5.5 3.0 3.7 5.4 24.2 8.9 7.2 35.0 27.1 10.4 14.2 250.1 5.2 5.0 15.1 4.6 9.4 9.4 5.7 7.0 2.5 6.3 92.4 12.9 3.9 25.8 9.5 4.3 5.4 5.1 8.3 5.8 NMD3 CGI-07 ENSG00000169251 "NMD3 ribosome export adaptor" Q96D46 3 161104696-161253532 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035019 Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA035019: AB_10600922" "unprognostic (1.37e-2)" "unprognostic (2.71e-1)" "unprognostic (9.50e-2)" "unprognostic (9.39e-3)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.03e-1)" "unprognostic (4.41e-2)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.03e-5)" "unprognostic (7.97e-2)" "unprognostic (5.57e-2)" "unprognostic (6.17e-2)" "unprognostic (8.71e-2)" "unprognostic (2.26e-2)" "unprognostic (5.86e-3)" 26.8 15.7 16.2 10.7 16.5 34.7 20.3 26.6 21.8 23.1 14.4 13.2 10.9 10.8 23.4 17.7 22.9 14.3 14.2 24.1 15.5 13.6 25.7 46.7 19.4 12.5 16.7 18.2 27.9 29.0 13.4 27.5 20.1 21.6 21.7 13.5 14.1 19.7 13.3 31.8 15.5 16.3 22.1 16.3 17.1 25.3 12.1 13.1 19.6 21.7 21.3 15.0 32.1 16.0 12.1 13.2 15.9 11.8 22.8 18.7 13.6 21.9 12.8 12.7 12.9 15.9 21.9 17.5 25.2 19.1 18.8 22.0 21.7 18.2 28.0 32.2 17.6 13.2 14.5 20.2 18.5 29.5 29.0 12.4 28.8 11.3 13.5 17.5 34.6 17.5 18.3 13.8 13.3 44.0 20.2 20.4 9.8 21.1 15.5 22.2 50.2 15.6 13.2 15.9 26.6 20.5 19.3 18.3 28.3 17.9 49.9 20.2 12.6 14.3 35.2 20.8 14.4 26.2 15.9 17.8 15.1 10.8 17.2 30.3 25.6 17.2 28.7 18.8 22.6 20.5 15.9 10.8 5.7 11.8 11.8 18.3 12.1 13.9 14.5 13.2 10.4 18.7 14.5 2.5 22.8 7.3 7.4 17.1 13.6 16.2 16.5 26.6 21.8 15.5 13.6 16.7 18.2 21.6 13.1 17.9 13.4 25.1 43.8 57.7 23.4 39.6 20.4 16.0 17.0 10.4 13.7 29.3 29.9 22.3 12.2 23.2 13.4 0.0 33.9 37.0 34.9 39.0 25.3 38.5 21.3 28.6 13.2 20.9 32.4 4.7 23.6 22.5 23.6 25.2 17.7 12.3 30.1 10.5 25.8 26.9 18.0 25.8 91.0 30.3 26.0 65.0 47.4 25.9 18.8 62.7 NOC2L "DKFZP564C186, NET15, NET7, NIR, PPP1R112" ENSG00000188976 "NOC2 like nucleolar associated transcriptional repressor" Q9Y3T9 1 944204-959309 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044258, HPA062195" Approved Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 420000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA044258: AB_10961284, HPA062195: AB_2684707" "unprognostic (3.18e-2)" "unprognostic (5.84e-2)" "unprognostic (1.59e-1)" "unprognostic (9.54e-3)" "unprognostic (6.75e-2)" "unprognostic (2.31e-3)" "unprognostic (1.94e-3)" "unprognostic (1.36e-2)" "unprognostic (1.51e-1)" "unprognostic (2.17e-1)" "unprognostic (1.51e-1)" "unprognostic (2.78e-1)" "unprognostic (1.20e-3)" "unprognostic (8.62e-2)" "unprognostic (6.25e-2)" "unprognostic (3.44e-2)" "unprognostic (1.52e-1)" 17.7 15.6 13.4 20.5 17.8 23.8 18.2 23.7 27.4 15.0 15.3 15.6 13.5 16.8 19.0 13.5 27.7 18.3 21.8 23.0 15.3 15.3 15.2 36.6 14.0 19.3 18.7 19.0 16.9 26.8 20.8 15.3 15.9 16.7 16.6 11.1 14.0 22.0 16.5 40.0 32.4 14.6 14.7 13.6 17.5 16.4 21.1 18.0 22.7 19.8 29.5 21.8 17.5 18.0 14.3 20.2 11.3 29.0 18.8 18.4 16.0 27.6 27.6 4.9 32.1 9.0 8.0 18.1 20.7 9.7 29.0 15.9 36.6 27.2 31.2 29.4 13.7 24.1 25.4 36.7 30.9 12.3 19.6 41.8 16.5 35.7 31.7 20.3 36.3 16.3 13.1 8.8 31.8 21.3 9.0 14.0 11.1 46.6 14.4 12.8 43.8 23.3 22.0 28.3 20.0 32.8 29.3 20.6 37.8 13.3 11.7 34.7 34.1 27.4 41.5 25.3 7.8 18.5 19.9 16.0 17.3 24.7 18.9 35.3 24.8 26.7 56.4 21.5 51.6 14.4 7.2 17.0 11.3 14.2 25.7 18.4 14.3 13.8 13.6 20.2 11.9 14.3 11.1 1.6 18.8 29.0 13.0 10.9 16.0 13.4 17.8 23.7 27.4 15.3 15.3 18.7 19.0 16.7 18.0 14.9 23.9 46.0 71.4 61.6 53.0 2.8 20.4 20.1 13.6 34.9 58.9 54.4 14.9 44.4 5.6 27.4 17.0 0.0 39.8 56.2 34.7 37.8 12.8 19.8 34.6 42.9 28.8 17.8 23.1 8.1 27.3 24.1 23.6 30.7 23.4 21.7 31.2 17.5 20.1 15.2 68.2 32.3 49.2 36.7 73.9 71.6 49.2 39.9 41.2 60.5 NOC3L "AD24, C10orf117, FAD24, FLJ12820" ENSG00000173145 "NOC3 like DNA replication regulator" Q8WTT2 10 94333226-94362959 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 70.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063958, HPA067638, HPA070981" Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA063958: AB_2685160, HPA067638: AB_2685876, HPA070981: AB_2686331" "unprognostic (1.29e-1)" "unprognostic (2.25e-1)" "unprognostic (5.25e-2)" "unprognostic (2.49e-1)" "unprognostic (1.27e-3)" "unprognostic (4.58e-2)" "unprognostic (6.49e-3)" "unprognostic (3.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.34e-1)" "unprognostic (9.93e-2)" "unprognostic (5.50e-2)" "unprognostic (1.47e-2)" "unprognostic (3.24e-2)" "unprognostic (2.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.30e-1)" 16.7 13.2 9.2 11.2 14.5 3.7 14.4 10.8 12.7 13.5 8.9 6.0 8.4 6.7 14.1 8.5 14.3 12.1 7.3 8.8 9.3 6.6 11.0 15.0 9.7 14.9 16.4 7.7 15.4 7.8 12.5 18.2 11.0 14.5 12.5 8.2 6.3 9.7 8.9 18.8 11.6 8.4 9.8 16.6 19.8 8.1 14.1 13.1 12.8 15.7 13.6 16.0 16.1 10.6 13.7 4.3 0.5 4.1 7.5 5.8 3.1 17.9 9.8 6.7 21.5 7.0 11.4 7.9 14.4 11.4 19.8 23.0 16.7 12.7 19.5 10.6 7.2 10.2 13.0 19.0 8.6 32.1 13.3 14.2 13.2 8.2 10.7 14.0 20.9 6.0 6.5 8.5 20.8 21.0 12.9 8.8 7.3 20.5 9.9 19.4 6.0 13.1 15.6 14.1 10.5 10.9 5.9 15.3 10.7 11.7 5.6 4.8 11.9 10.3 5.2 15.9 7.8 13.4 8.1 8.5 12.7 12.8 11.5 24.1 9.4 18.8 27.1 11.6 20.3 9.4 0.0 2.4 0.5 4.3 3.9 5.4 13.7 4.4 5.4 4.3 12.6 5.8 5.1 0.1 7.5 4.1 3.8 4.0 3.1 9.2 14.5 10.8 12.7 9.3 6.6 16.4 7.7 14.5 13.1 17.9 10.7 18.7 20.6 21.1 20.3 20.0 10.2 28.1 47.8 21.0 7.9 18.3 21.6 16.6 2.2 24.1 2.0 0.0 11.8 11.5 13.4 12.0 28.8 9.2 11.3 12.7 5.2 13.5 14.5 3.6 17.0 13.1 11.8 25.2 6.0 21.0 12.3 2.9 23.3 18.0 20.6 12.9 21.8 59.0 70.2 19.1 12.7 13.8 8.6 13.5 NOC4L "MGC3162, NET49, Noc4, UTP19" ENSG00000184967 "Nucleolar complex associated 4 homolog" Q9BVI4 12 132144448-132152473 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053424 Supported Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "HPA053424: AB_2682147" "unprognostic (9.44e-2)" "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (8.48e-2)" "unprognostic (1.13e-1)" "unprognostic (4.63e-2)" "unprognostic (4.79e-3)" "unprognostic (8.08e-2)" "unprognostic (1.06e-1)" "unprognostic (1.64e-1)" "unprognostic (8.36e-3)" "unprognostic (1.76e-1)" "unprognostic (3.85e-3)" "unprognostic (1.05e-1)" "unprognostic (2.51e-2)" "unprognostic (2.17e-1)" "unprognostic (1.61e-1)" 11.9 10.3 9.0 14.2 11.6 18.8 11.1 11.5 17.2 9.9 9.2 14.1 7.8 14.8 11.5 6.4 12.0 10.7 10.4 8.6 8.0 7.5 11.2 15.6 9.2 13.7 14.7 8.5 13.6 16.8 7.1 10.4 9.7 12.1 9.8 6.9 10.3 16.2 8.8 22.5 15.7 11.9 8.2 9.2 15.5 12.5 28.4 10.6 15.7 10.5 13.2 12.3 9.5 9.5 13.9 18.8 5.9 16.1 7.4 11.4 8.1 12.4 23.1 5.1 8.0 2.6 2.7 26.2 8.6 4.4 10.6 5.8 18.8 5.9 19.1 9.5 4.4 6.3 11.2 9.1 9.4 2.3 7.5 25.0 12.8 7.6 12.3 6.8 14.9 15.0 4.0 6.5 8.3 6.7 4.0 7.4 14.7 21.7 4.4 4.3 14.6 14.2 35.1 15.0 7.3 18.4 18.5 5.7 16.7 5.5 9.2 12.6 10.0 7.3 10.0 6.3 3.1 14.0 9.3 9.8 6.3 16.1 10.1 14.3 11.2 6.9 16.7 9.7 12.9 13.3 2.5 11.8 5.9 11.4 16.1 11.0 13.8 10.6 11.3 15.8 13.9 9.3 8.9 1.7 7.4 12.1 18.8 8.7 8.1 9.0 11.6 11.5 17.2 8.0 7.5 14.7 8.5 12.1 10.6 8.9 7.8 13.0 13.7 19.8 7.9 6.0 25.5 0.0 3.4 3.5 0.0 28.1 6.6 25.9 57.6 11.1 15.2 0.0 28.5 27.4 15.4 9.4 16.1 9.5 22.0 7.9 7.0 11.6 11.0 60.3 13.6 14.1 13.5 13.6 11.1 6.7 23.0 8.6 7.4 16.5 5.0 19.4 14.4 37.9 50.3 18.9 25.5 14.9 16.2 11.9 NOL10 "FLJ14075, PQBP5" ENSG00000115761 "Nucleolar protein 10" Q9BSC4 2 10570766-10689987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 120.4;Late spermatids: 122.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035286, HPA043075" Approved Supported Nucleoli NA NA Nucleoli "HPA035286: AB_2674552, HPA043075: AB_10794652" "unprognostic (6.53e-3)" "unprognostic (1.61e-1)" "unprognostic (6.84e-2)" "prognostic unfavorable (2.92e-5)" "unprognostic (1.31e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (1.43e-7)" "unprognostic (1.25e-1)" "unprognostic (3.29e-2)" "unprognostic (1.86e-2)" "unprognostic (1.61e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (7.51e-5)" "unprognostic (2.43e-2)" "unprognostic (2.92e-1)" "unprognostic (3.82e-1)" "unprognostic (3.87e-2)" 18.6 22.4 13.5 18.7 16.1 20.5 17.7 20.4 16.9 14.7 15.5 16.2 19.6 13.1 21.5 19.1 20.9 11.8 15.7 15.7 11.6 11.8 18.2 21.9 13.8 17.5 17.4 12.5 15.2 25.8 17.0 21.4 19.8 16.2 15.2 17.6 14.4 19.8 15.5 27.5 19.4 13.5 15.2 17.0 15.3 17.2 18.4 15.4 16.4 16.8 21.3 18.9 14.6 18.2 8.1 7.4 3.6 8.5 7.0 9.7 4.4 11.3 18.4 10.8 19.3 12.9 14.2 21.4 19.3 15.1 20.5 16.1 21.7 14.6 26.6 12.0 17.1 17.0 14.8 25.5 23.3 25.9 18.6 20.0 25.7 11.6 25.6 17.2 29.6 14.3 12.7 17.2 22.9 22.8 9.8 14.7 14.0 33.8 16.9 20.2 20.5 19.6 21.3 30.0 30.1 17.4 18.3 29.7 24.7 14.5 15.6 18.8 20.4 14.5 23.9 16.8 12.3 12.5 11.6 14.5 20.1 24.8 20.6 31.5 22.7 35.5 30.7 16.9 29.3 24.7 2.5 6.1 3.6 6.8 8.5 9.6 8.1 7.1 7.7 7.4 6.3 5.5 7.6 0.8 7.0 8.3 5.3 9.7 4.4 13.5 16.1 20.4 16.9 11.6 11.8 17.4 12.5 16.2 15.4 14.9 18.4 13.7 24.7 29.3 13.5 16.9 12.7 8.1 14.8 12.2 11.8 28.1 13.3 17.7 120.4 20.4 8.9 0.0 20.8 26.8 16.9 16.3 13.9 9.6 13.7 15.9 10.9 12.3 10.0 122.0 15.8 13.9 8.5 21.6 11.6 12.0 15.2 3.5 15.6 13.9 15.2 12.9 23.9 25.6 42.0 29.9 24.7 15.2 15.8 19.5 NOL11 DKFZP586L0724 ENSG00000130935 "Nucleolar protein 11" Q9H8H0 17 67717833-67744531 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022010 Supported Supported Nucleoli NA NA Nucleoli "HPA022010: AB_2267158" "unprognostic (6.81e-2)" "unprognostic (2.85e-2)" "prognostic favorable (1.00e-6)" "unprognostic (3.07e-3)" "unprognostic (5.04e-2)" "unprognostic (2.55e-2)" "prognostic unfavorable (2.59e-6)" "unprognostic (1.37e-2)" "unprognostic (1.25e-3)" "unprognostic (4.77e-3)" "unprognostic (8.74e-2)" "unprognostic (4.41e-3)" "unprognostic (6.55e-2)" "unprognostic (2.16e-2)" "unprognostic (2.19e-1)" "unprognostic (8.44e-2)" "unprognostic (3.11e-1)" 17.3 15.1 12.2 14.3 13.4 17.0 14.5 19.8 11.6 15.2 12.9 10.2 11.9 10.3 17.2 11.7 18.1 13.9 10.4 12.8 9.5 7.6 18.9 22.1 10.4 17.5 14.4 5.4 19.5 16.9 18.4 17.0 19.8 10.8 14.6 13.9 10.4 14.1 10.7 26.8 13.8 13.8 13.6 11.1 16.6 14.4 10.6 14.3 32.1 13.6 16.4 20.1 14.5 13.4 9.7 7.0 7.4 5.8 10.0 14.7 7.8 14.7 17.3 14.5 9.4 6.9 8.2 15.8 10.3 8.9 22.9 18.8 16.3 11.4 25.1 8.0 11.1 14.1 11.5 35.3 17.0 33.7 7.1 28.0 16.5 10.5 14.5 8.0 22.0 10.8 6.4 10.8 17.2 11.8 6.4 21.3 12.1 27.5 7.8 18.2 14.5 27.0 9.2 15.9 18.4 24.1 18.6 30.4 17.6 10.3 17.5 12.0 11.1 9.5 26.9 12.4 21.2 18.3 12.4 7.3 20.0 13.5 6.8 21.3 4.9 12.5 27.1 8.6 15.4 11.9 7.4 5.2 3.6 8.5 5.8 8.8 8.8 8.9 10.2 7.0 9.7 14.7 10.8 0.8 10.0 5.3 5.3 9.6 7.8 12.2 13.4 19.8 11.6 9.5 7.6 14.4 5.4 10.8 14.3 26.8 15.2 15.2 29.1 29.8 21.5 15.7 25.5 28.1 23.9 8.7 13.7 39.2 10.0 17.7 0.9 22.8 10.5 0.0 15.3 29.4 23.4 12.5 23.1 21.2 17.9 23.8 26.4 14.7 13.7 3.4 19.2 15.4 16.9 15.4 15.5 15.8 14.4 7.0 18.0 23.8 31.9 6.5 16.5 20.6 34.1 29.1 27.6 24.9 18.9 23.5 NOL12 "MGC3731, Nop25, RRP17" ENSG00000273899 "Nucleolar protein 12" Q9UGY1 22 37681673-37693478 "Predicted intracellular proteins" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.1" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 77.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003547 Uncertain Approved "Nucleoplasm,Nucleoli,Mitotic chromosome,Vesicles" Yes No "Nucleoli, Mitotic chromosome" "Nucleoplasm, Vesicles" "HPA003547: AB_10602012" "unprognostic (3.37e-2)" "prognostic favorable (6.80e-5)" "unprognostic (2.65e-1)" "unprognostic (9.62e-2)" "unprognostic (2.13e-1)" "unprognostic (7.89e-2)" "unprognostic (3.23e-3)" "prognostic favorable (9.41e-4)" "unprognostic (9.96e-2)" "unprognostic (4.62e-2)" "unprognostic (2.18e-3)" "unprognostic (4.60e-2)" "prognostic unfavorable (2.56e-6)" "unprognostic (1.34e-2)" "unprognostic (8.40e-2)" "unprognostic (4.65e-2)" "prognostic favorable (3.24e-4)" 3.8 11.8 9.3 9.5 10.1 14.6 5.0 13.1 10.6 3.6 6.5 7.9 5.4 8.4 4.1 4.6 7.8 6.2 5.6 7.2 7.7 5.2 4.1 4.8 11.0 8.7 6.4 5.4 5.4 5.4 3.9 6.8 7.2 4.5 6.2 4.4 8.9 4.8 7.9 11.4 7.1 4.5 3.7 8.6 5.8 4.8 9.5 7.2 7.4 7.1 8.0 5.8 5.6 8.1 9.6 31.1 17.1 8.5 11.6 6.4 16.9 15.7 11.7 13.4 3.8 4.0 14.8 8.5 3.9 3.8 4.1 8.8 7.1 14.5 5.1 3.8 4.0 18.5 6.7 22.4 1.3 15.2 24.5 12.3 12.6 20.1 10.3 29.1 18.1 5.9 7.3 15.2 5.9 5.3 7.3 8.6 9.1 13.1 3.3 14.8 15.9 21.7 13.4 7.6 21.2 21.8 7.6 10.9 8.5 6.0 9.5 18.7 9.9 9.1 13.5 1.8 13.0 13.8 10.2 16.2 16.4 11.8 15.6 11.0 13.4 18.7 15.4 21.6 18.9 21.3 14.0 14.2 9.1 14.1 6.5 8.0 8.9 7.9 9.6 8.1 9.1 7.9 31.1 8.5 17.1 7.5 11.6 6.4 3.0 11.7 16.1 10.3 34.7 11.5 3.1 7.6 9.4 7.9 14.0 5.9 16.5 3.3 23.3 77.4 12.6 26.9 0.0 25.4 13.3 12.5 7.3 15.0 4.9 12.1 27.0 12.1 9.8 8.7 31.6 9.2 16.0 20.3 19.0 18.9 9.1 18.7 31.6 10.6 6.4 8.1 12.9 8.2 14.4 24.4 34.8 16.6 16.7 18.4 13.2 NOL6 "bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22" ENSG00000165271 "Nucleolar protein 6" Q9H6R4 9 33461441-33473930 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055891, HPA061002" Supported Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA055891: AB_2682959, HPA061002: AB_2684410" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (2.37e-1)" "unprognostic (5.23e-2)" "unprognostic (2.32e-1)" "unprognostic (2.67e-1)" "prognostic unfavorable (4.83e-5)" "unprognostic (7.37e-3)" "unprognostic (8.26e-2)" "unprognostic (3.03e-2)" "unprognostic (2.09e-1)" "unprognostic (4.24e-2)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (9.49e-4)" "unprognostic (4.09e-1)" 15.3 14.9 13.3 17.7 19.7 21.0 14.9 16.8 30.8 16.0 11.4 14.6 9.0 10.3 15.3 11.9 21.1 12.8 18.2 13.1 12.4 10.6 13.8 41.6 13.5 15.8 10.1 11.4 20.5 20.5 22.7 18.2 15.4 19.2 17.5 14.8 12.5 15.5 15.5 23.4 23.5 11.3 17.0 7.3 17.6 13.0 19.0 7.8 13.8 13.2 19.7 20.9 12.4 14.5 4.2 7.1 0.3 8.4 3.9 6.0 3.4 15.6 22.6 8.6 19.5 13.5 9.3 14.8 17.5 13.1 20.5 17.2 24.9 5.8 27.3 8.0 19.6 9.0 11.0 25.0 25.1 21.7 17.3 10.4 14.0 26.3 13.8 13.3 31.9 20.6 10.3 20.8 27.1 26.2 8.5 13.4 10.1 22.8 10.5 16.2 13.8 17.8 32.1 31.2 17.5 20.6 15.4 8.5 14.2 15.8 18.8 10.2 14.1 14.6 18.9 6.2 9.6 7.6 18.6 14.9 12.6 17.0 15.8 30.4 10.0 14.0 23.1 11.2 16.9 14.4 0.0 4.0 0.3 5.4 8.4 6.0 4.2 4.1 5.2 7.1 3.6 5.1 4.8 0.2 3.9 7.9 3.8 4.0 3.4 13.3 19.7 16.8 30.8 12.4 10.6 10.1 11.4 19.2 7.8 3.0 14.6 4.5 5.1 17.7 4.5 5.5 7.6 4.0 11.4 3.5 5.9 3.4 3.3 6.7 17.3 6.0 2.3 0.0 3.4 4.8 4.1 6.5 3.5 6.7 4.4 3.2 9.8 3.7 1.2 17.9 5.5 2.7 5.0 1.8 4.1 4.2 4.9 0.0 5.6 2.1 3.5 0.0 5.1 2.3 6.1 22.6 2.5 5.0 6.8 7.4 NOL7 "C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1" ENSG00000225921 "Nucleolar protein 7" Q9UMY1 6 13615327-13632739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029185 Supported Supported "Nucleoli,Mitotic chromosome,Mitochondria" Yes Yes "Nucleoli, Mitotic chromosome" Mitochondria "HPA029185: AB_10601274" "unprognostic (8.76e-2)" "unprognostic (8.94e-2)" "unprognostic (8.38e-2)" "unprognostic (1.15e-2)" "unprognostic (3.75e-1)" "unprognostic (5.77e-2)" "unprognostic (2.50e-3)" "unprognostic (1.57e-1)" "unprognostic (4.64e-2)" "prognostic favorable (3.64e-5)" "unprognostic (1.26e-1)" "unprognostic (2.03e-2)" "unprognostic (8.04e-3)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "unprognostic (4.79e-2)" 35.8 40.5 45.2 41.4 42.3 44.9 36.6 26.7 38.7 30.5 36.7 25.9 29.2 37.2 35.2 36.7 38.6 33.0 36.6 53.4 39.9 38.4 56.9 58.6 28.8 36.6 41.6 30.2 42.4 42.6 54.0 40.5 45.6 36.8 39.5 32.4 23.1 42.3 35.6 59.3 30.6 46.4 36.7 47.7 45.2 34.8 32.5 40.4 34.3 49.5 36.9 36.0 43.3 56.0 50.7 45.5 38.3 38.0 28.8 49.6 30.9 29.8 15.5 14.6 21.0 11.4 13.2 29.7 27.4 14.9 25.7 24.4 29.4 12.6 38.5 54.3 16.6 31.4 18.5 22.0 20.7 25.2 21.6 36.0 33.1 15.4 49.4 24.5 49.1 26.1 12.4 21.8 23.5 14.5 13.4 16.7 21.7 51.3 10.5 22.2 19.2 27.9 54.5 19.1 17.5 26.6 30.2 20.8 59.2 25.6 9.9 37.2 23.9 16.0 38.8 35.8 19.0 24.1 17.9 25.3 23.7 22.3 24.3 48.1 24.6 47.7 47.0 13.6 29.1 35.8 16.0 30.2 38.3 31.0 35.3 36.6 50.7 45.5 38.3 35.9 41.4 49.6 37.8 14.0 28.8 38.0 45.5 46.9 30.9 45.2 42.3 26.7 38.7 39.9 38.4 41.6 30.2 36.8 40.4 86.4 58.0 93.0 81.6 80.6 62.4 203.3 63.7 148.5 80.8 54.1 21.6 114.5 104.5 133.3 133.2 97.2 61.4 70.0 226.4 127.6 86.4 80.3 87.8 56.9 100.9 46.1 35.6 46.6 45.5 19.9 76.5 83.5 96.2 155.9 59.8 89.8 148.3 72.9 74.6 135.1 46.0 64.7 96.7 142.1 122.5 79.2 129.9 82.8 73.6 94.7 NOL8 "C9orf34, FLJ20736, Nop132" ENSG00000198000 "Nucleolar protein 8" Q76FK4 9 92297358-92325636 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044440, HPA062922" Uncertain Supported "Nucleoli,Mitotic chromosome" Yes No Nucleoli "Mitotic chromosome" "HPA044440: AB_10963212, HPA062922: " "unprognostic (3.44e-2)" "unprognostic (1.67e-1)" "unprognostic (9.72e-2)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (9.73e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.85e-1)" "unprognostic (6.16e-3)" "unprognostic (5.17e-1)" "unprognostic (1.98e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (4.69e-2)" "unprognostic (5.38e-2)" "unprognostic (4.58e-1)" "unprognostic (5.53e-2)" 15.8 11.5 11.6 14.6 20.0 8.5 13.6 15.9 15.9 15.1 13.2 7.3 12.1 6.4 16.4 11.1 14.1 13.0 9.4 9.4 13.7 8.2 10.6 8.9 9.5 13.6 17.9 8.4 17.5 11.1 25.3 23.6 11.8 13.4 14.0 11.0 5.2 11.0 13.2 15.0 12.9 10.7 14.6 19.5 15.7 10.6 7.7 17.8 18.7 15.2 11.2 15.1 16.3 16.2 13.6 12.2 13.6 14.7 12.6 17.5 6.6 8.1 13.2 6.1 12.3 13.9 11.8 8.4 9.3 7.3 10.0 9.6 4.7 8.5 25.6 8.2 9.8 16.6 16.9 21.8 13.0 11.1 16.0 9.9 18.2 13.2 10.5 9.4 30.3 13.9 12.4 9.6 11.2 15.7 8.2 12.3 7.6 27.6 7.9 11.5 13.1 21.1 10.6 10.3 11.6 12.6 12.8 18.0 10.4 5.2 5.5 11.4 5.6 12.8 11.2 7.8 8.3 4.5 9.6 11.9 9.3 6.0 13.1 9.7 8.0 17.9 13.9 8.6 17.5 11.9 13.6 8.3 11.3 12.5 11.1 17.5 13.6 11.9 12.0 12.2 12.6 14.6 12.5 3.2 12.6 14.7 10.3 13.2 6.6 11.6 20.0 15.9 15.9 13.7 8.2 17.9 8.4 13.4 17.8 17.9 33.1 27.4 15.8 11.6 18.5 25.6 12.7 32.1 23.9 10.4 9.8 16.1 13.3 20.5 9.0 20.2 8.8 23.3 11.2 17.4 13.2 11.2 48.8 9.6 23.0 27.0 8.6 20.3 16.1 6.8 29.7 19.8 10.1 27.1 14.3 13.7 15.3 7.0 22.3 12.4 16.8 6.5 13.4 46.1 37.9 13.9 12.2 15.2 17.9 9.6 NOL9 "FLJ23323, Grc3, NET6" ENSG00000162408 "Nucleolar protein 9" Q5SY16 1 6521347-6554535 "Predicted intracellular proteins" "rRNA processing" "Kinase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036347 Supported "Nucleoli,Intermediate filaments" NA NA Nucleoli "Intermediate filaments" "HPA036347: AB_2675076" "unprognostic (3.03e-1)" "unprognostic (4.93e-2)" "unprognostic (4.99e-2)" "unprognostic (3.14e-3)" "unprognostic (2.12e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (2.48e-1)" "unprognostic (1.31e-1)" "unprognostic (8.90e-2)" "unprognostic (1.44e-3)" "unprognostic (2.32e-1)" "unprognostic (3.80e-2)" "unprognostic (3.32e-2)" "unprognostic (3.40e-1)" "unprognostic (3.54e-2)" "unprognostic (4.65e-2)" 12.7 11.3 10.4 10.3 15.1 19.3 11.0 16.4 19.3 14.7 11.2 14.1 6.8 7.7 13.3 11.6 12.1 11.4 8.8 8.3 10.8 9.7 9.6 15.2 9.4 14.4 8.6 9.6 16.8 14.7 15.5 10.5 9.8 12.0 13.0 10.0 9.4 9.1 10.3 17.9 18.0 11.4 12.4 7.2 22.0 11.0 9.4 9.2 20.9 9.4 8.9 14.9 11.0 9.3 6.9 5.8 5.0 4.8 2.8 8.4 1.9 5.1 7.4 4.2 12.6 5.6 3.4 4.5 5.1 3.3 5.3 5.6 10.1 7.0 14.3 6.1 5.7 4.6 6.8 8.4 6.9 9.2 5.8 4.5 9.7 11.4 7.9 5.6 8.2 5.4 4.9 2.1 11.3 9.9 3.1 6.2 6.4 11.4 6.0 5.4 8.9 8.0 7.4 5.7 4.0 7.2 10.2 9.8 6.7 4.2 4.8 8.1 3.7 7.9 10.0 6.2 4.5 6.5 3.8 8.1 8.5 6.9 6.0 8.5 5.1 4.8 26.1 7.9 9.2 4.0 5.0 3.5 2.6 5.7 3.2 5.7 5.1 8.1 5.2 2.3 6.9 8.4 7.0 2.2 2.8 4.8 5.8 5.1 1.9 10.4 15.1 16.4 19.3 10.8 9.7 8.6 9.6 12.0 9.2 17.9 17.9 11.5 5.7 13.7 15.8 12.1 10.2 9.4 7.9 7.0 13.7 13.0 13.3 8.4 4.6 11.3 5.8 0.0 7.4 11.0 11.7 4.8 4.7 11.6 7.8 9.5 6.4 17.2 11.4 13.3 8.9 6.5 1.7 10.0 11.7 7.2 7.8 7.0 12.0 7.8 17.0 0.0 11.1 10.8 19.7 12.9 10.6 15.7 11.8 5.3 NOM1 "C7orf3, PPP1R113, SGD1" ENSG00000146909 "Nucleolar protein with MIF4G domain 1" Q5C9Z4 7 156949723-156973182 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019866, HPA051624" Approved Enhanced Nucleoli NA NA Nucleoli "HPA019866: AB_2670300, HPA051624: AB_2681556" "unprognostic (1.24e-1)" "unprognostic (7.47e-2)" "unprognostic (5.29e-2)" "unprognostic (1.54e-1)" "unprognostic (2.05e-1)" "unprognostic (1.43e-1)" "unprognostic (3.30e-2)" "unprognostic (5.23e-2)" "unprognostic (1.15e-2)" "unprognostic (2.09e-1)" "unprognostic (4.46e-2)" "unprognostic (2.91e-2)" "unprognostic (2.08e-1)" "unprognostic (2.01e-2)" "unprognostic (3.35e-1)" "unprognostic (6.30e-3)" "unprognostic (1.49e-1)" 12.3 10.9 10.8 16.9 14.2 15.3 11.1 13.0 15.9 9.7 11.4 9.9 11.1 8.9 12.8 9.0 12.9 11.4 8.1 8.3 11.2 6.4 8.4 12.2 9.9 13.4 11.9 11.7 13.9 14.5 11.1 8.4 10.3 11.4 9.6 10.0 9.3 10.5 12.5 21.0 15.5 10.5 12.0 10.0 12.1 10.6 13.9 11.9 9.9 9.9 9.8 12.4 11.4 17.0 5.0 2.8 2.5 2.8 2.6 3.4 0.9 9.1 7.9 5.8 8.7 5.9 6.2 8.0 9.2 4.5 7.5 6.1 8.5 7.8 16.1 9.3 7.4 7.6 7.5 10.5 11.1 9.2 7.3 9.2 13.5 6.6 7.9 4.8 23.5 8.3 4.4 5.5 6.7 8.7 4.3 6.3 9.1 20.3 8.7 6.7 12.0 14.8 19.7 14.1 8.2 8.6 10.6 8.9 12.4 4.8 11.0 7.2 8.8 8.4 6.7 6.3 6.9 3.2 12.7 10.1 8.1 2.6 15.0 11.8 11.2 8.0 14.9 10.4 17.0 7.6 2.5 2.8 1.5 2.1 1.9 1.2 3.8 2.7 2.9 2.8 5.0 3.4 1.8 1.3 2.6 2.1 2.8 1.0 0.9 10.8 14.2 13.0 15.9 11.2 6.4 11.9 11.7 11.4 11.9 8.9 16.5 13.4 26.4 34.9 15.8 9.2 12.7 17.4 18.2 5.2 19.6 12.5 3.3 16.5 7.2 14.4 6.4 0.0 11.8 17.3 12.0 18.5 19.8 13.1 12.8 11.1 7.5 6.7 10.5 1.8 16.1 18.2 23.6 14.4 10.4 9.8 12.4 10.5 12.4 4.9 30.5 0.0 14.6 28.2 35.7 37.1 6.1 12.8 14.6 26.9 NOP14 "C4orf9, NOL14, RES4-25, UTP2" ENSG00000087269 "NOP14 nucleolar protein" P78316 4 2937933-2963385 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039596, HPA055652" Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA039596: AB_2676590, HPA055652: AB_2682876" "unprognostic (4.70e-2)" "unprognostic (6.47e-2)" "prognostic favorable (3.93e-5)" "unprognostic (7.32e-2)" "unprognostic (3.28e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (9.10e-4)" "unprognostic (2.41e-2)" "unprognostic (8.62e-2)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (2.55e-3)" "unprognostic (1.16e-1)" "unprognostic (1.27e-3)" "unprognostic (1.44e-1)" "unprognostic (7.15e-2)" "unprognostic (4.77e-2)" 17.3 16.8 9.8 22.4 13.2 19.0 16.2 21.1 15.2 12.0 12.6 9.0 12.6 12.0 14.3 11.7 19.0 12.1 14.7 14.8 8.9 7.1 13.6 34.0 12.9 20.8 10.0 8.7 20.7 26.8 13.9 15.5 12.8 10.6 12.3 12.8 11.1 14.7 14.6 38.6 21.4 13.1 12.4 9.8 18.0 15.1 9.8 11.4 17.9 15.4 16.3 20.9 18.1 18.9 5.2 4.9 1.3 3.8 4.4 8.4 3.0 16.3 13.9 8.3 17.1 11.2 12.7 14.5 15.1 10.8 15.8 13.0 18.1 17.3 46.3 10.7 12.2 11.5 11.3 22.8 19.6 17.0 8.8 21.8 36.8 13.2 16.4 14.8 39.9 16.1 12.8 17.7 17.8 16.3 7.8 13.2 14.3 33.3 16.5 11.8 11.7 42.1 30.1 21.6 15.1 22.8 27.3 12.6 15.4 7.9 26.4 17.2 10.1 12.5 9.3 11.8 7.9 17.8 15.8 16.4 13.2 7.7 16.1 27.7 12.4 19.9 40.0 13.8 29.6 13.7 1.3 3.2 0.6 4.8 3.8 8.4 3.4 5.8 7.0 4.0 5.2 7.0 5.2 0.5 4.4 2.5 4.9 3.8 3.0 9.8 13.2 21.1 15.2 8.9 7.1 10.0 8.7 10.6 11.4 17.9 22.5 10.4 13.9 23.0 9.0 18.2 15.3 17.4 35.2 1.8 13.7 12.7 10.0 12.9 1.7 14.3 3.6 0.0 20.6 13.2 7.6 9.5 19.7 23.1 9.9 19.1 8.6 9.2 3.2 2.1 11.5 11.3 0.0 15.4 9.7 6.0 16.8 8.6 9.2 10.1 7.1 12.9 13.3 9.2 20.6 28.4 9.6 12.5 13.4 14.8 NOP16 "HSPC111, HSPC185, LOC51491" ENSG00000048162 "NOP16 nucleolar protein" Q9Y3C1 5 176383938-176388975 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 179.6;Suprabasal keratinocytes: 179.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036506, HPA058147" Approved Enhanced Nucleoli NA NA Nucleoli "HPA036506: AB_10672223, HPA058147: AB_2683620" "unprognostic (4.55e-2)" "unprognostic (1.72e-1)" "unprognostic (2.21e-2)" "unprognostic (1.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.89e-1)" "prognostic unfavorable (5.14e-4)" "unprognostic (1.19e-2)" "unprognostic (2.27e-2)" "unprognostic (1.87e-2)" "unprognostic (1.67e-1)" "unprognostic (1.01e-2)" "prognostic unfavorable (5.75e-6)" "unprognostic (1.05e-1)" "unprognostic (1.89e-1)" "unprognostic (1.06e-1)" "unprognostic (2.76e-1)" 17.1 12.8 11.0 15.3 12.7 13.2 13.5 6.1 10.4 8.5 13.3 4.9 8.4 12.0 9.5 8.1 23.2 9.6 9.9 18.2 8.0 8.2 18.2 34.3 8.7 15.0 11.0 8.8 10.9 16.2 5.8 7.2 9.5 14.8 9.1 11.8 3.2 8.8 7.7 50.2 15.6 9.5 8.7 6.8 14.7 11.2 12.2 9.5 9.4 11.3 29.3 17.1 11.1 12.2 26.8 30.3 2.7 26.6 24.1 22.6 13.7 17.6 27.0 6.7 28.6 9.9 10.4 26.1 14.7 8.7 21.3 18.5 37.0 17.8 29.5 20.1 10.9 21.6 16.7 31.5 48.6 14.9 37.5 25.7 15.2 19.9 31.3 20.0 31.1 18.0 10.8 21.9 19.5 24.2 7.0 15.5 14.5 29.7 15.1 15.3 51.4 23.7 42.9 23.7 27.0 34.3 19.9 9.5 31.3 19.8 15.1 20.2 17.0 8.6 35.0 19.5 6.8 15.6 22.8 14.0 16.3 16.7 15.2 36.6 19.4 23.0 32.7 12.7 42.6 14.0 2.1 16.8 2.7 17.4 26.6 22.6 25.1 19.6 18.7 24.9 26.8 21.5 22.5 1.7 24.1 13.0 30.3 13.6 13.7 11.0 12.7 6.1 10.4 8.0 8.2 11.0 8.8 14.8 9.5 6.0 18.7 26.1 87.2 179.6 3.6 28.3 30.6 17.4 51.2 1.8 3.9 42.2 31.5 52.0 5.5 36.6 15.8 0.0 45.6 43.9 34.5 39.0 25.5 35.6 34.5 0.0 20.1 9.2 8.5 3.1 18.1 22.4 54.0 27.1 25.0 3.4 46.9 8.6 13.8 56.7 2.9 6.5 76.9 28.6 31.6 179.5 32.0 17.3 40.3 81.4 NOP2 "NOL1, NOP120, NSUN1, p120" ENSG00000111641 "NOP2 nucleolar protein" P46087 12 6556863-6568691 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040119 Supported Enhanced Nucleoli No No Nucleoli "HPA040119: AB_10965321" "unprognostic (2.88e-1)" "unprognostic (2.78e-2)" "unprognostic (1.04e-1)" "unprognostic (7.15e-2)" "unprognostic (8.74e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (6.38e-2)" "unprognostic (2.19e-2)" "unprognostic (8.82e-2)" "unprognostic (2.41e-1)" "unprognostic (2.53e-1)" "prognostic unfavorable (2.35e-10)" "unprognostic (1.43e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.96e-3)" 16.5 12.7 14.8 21.7 17.1 30.9 15.3 14.8 14.9 10.8 12.8 6.9 7.3 14.0 15.2 11.4 19.5 15.0 11.2 12.8 11.9 8.7 12.8 31.2 14.0 25.9 14.7 8.9 14.5 21.5 12.1 15.1 12.3 13.8 17.4 14.7 9.0 21.3 9.4 32.6 19.1 15.7 14.7 8.9 23.1 13.4 19.4 13.2 24.7 16.8 18.5 27.2 11.5 17.1 12.6 16.5 3.3 11.5 11.9 20.3 10.9 16.3 26.4 7.2 24.7 9.2 7.9 39.2 14.9 9.6 17.7 15.3 32.2 16.7 35.1 4.1 7.3 18.6 20.3 27.6 16.5 17.2 41.4 25.9 34.4 25.2 18.6 12.4 33.8 19.8 8.0 16.3 21.4 33.3 7.8 11.9 18.8 24.1 5.6 14.0 20.3 18.1 29.4 60.3 21.9 14.8 25.9 21.1 17.2 12.9 22.7 5.5 11.0 23.4 25.5 12.3 29.8 4.2 16.2 11.2 12.2 16.3 15.8 34.3 7.8 11.4 52.4 11.2 19.4 21.1 1.4 8.2 0.9 14.8 11.5 20.3 12.6 14.1 16.6 16.5 10.1 17.3 17.6 3.3 11.9 10.0 14.5 9.7 10.9 14.8 17.1 14.8 14.9 11.9 8.7 14.7 8.9 13.8 13.2 11.9 5.0 12.3 13.4 21.2 5.5 5.6 5.1 2.7 1.2 3.5 2.0 10.0 1.7 10.0 16.0 8.0 2.9 0.0 10.3 10.4 8.5 9.5 7.0 6.6 10.6 6.4 6.9 9.8 9.2 6.6 8.6 8.1 8.5 9.0 7.6 2.5 10.6 5.8 4.6 1.0 2.8 12.9 12.0 10.7 19.5 18.6 6.1 7.2 11.2 11.5 NOP53 "GLTSCR2, PICT-1, PICT1" ENSG00000105373 "NOP53 ribosome biogenesis factor" Q9NZM5 19 47745522-47757058 "Predicted intracellular proteins" "Host-virus interaction, Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 374.2;Exocrine glandular cells: 855.6;Extravillous trophoblasts: 474.7;monocytes: 470.7;Pancreatic endocrine cells: 426.7;Syncytiotrophoblasts: 423.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 51.0;NK-cells: 20.5;T-cells: 52.7" "Cell line enhanced" "Detected in all" "NB-4: 161.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018999, HPA049600" Approved Supported Nucleoli NA NA Nucleoli "HPA018999: AB_1849733, HPA049600: AB_2680831" "unprognostic (2.08e-3)" "unprognostic (1.84e-1)" "unprognostic (4.02e-3)" "prognostic favorable (2.35e-4)" "unprognostic (1.76e-2)" "unprognostic (1.16e-1)" "unprognostic (5.83e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-1)" "unprognostic (1.56e-2)" "unprognostic (3.62e-3)" "unprognostic (1.89e-1)" "unprognostic (9.27e-2)" "unprognostic (2.99e-1)" "unprognostic (3.11e-1)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" 35.2 34.8 13.4 35.1 19.7 39.3 40.6 21.0 21.6 44.4 36.9 15.4 30.7 35.9 41.4 30.8 37.2 32.2 36.1 24.5 12.7 10.2 24.8 24.7 22.6 48.7 18.2 19.7 90.1 92.0 18.6 19.8 20.3 16.1 42.3 12.7 22.8 67.3 28.2 51.6 54.7 32.8 50.2 16.4 49.8 39.0 31.9 17.4 49.7 54.9 33.8 40.9 39.6 68.7 51.0 8.8 4.8 7.2 20.5 52.7 2.9 12.3 13.0 11.7 27.6 14.6 24.5 22.2 7.7 14.2 7.5 11.1 12.0 24.9 54.1 11.1 8.9 5.7 17.6 6.7 11.3 3.9 15.8 22.4 17.7 11.0 14.0 21.6 25.5 34.8 21.5 26.0 6.6 17.8 24.6 11.8 23.4 21.5 26.7 6.7 10.7 69.3 161.6 26.7 21.6 7.5 46.5 20.9 25.1 14.3 19.1 12.4 43.5 6.5 42.7 38.5 9.0 20.1 62.1 14.5 7.4 19.7 6.3 15.7 39.0 34.8 14.7 9.3 18.2 11.8 3.6 4.8 4.8 12.0 7.2 16.7 51.0 23.9 21.2 6.9 36.0 52.7 24.0 0.7 20.5 5.0 8.8 22.7 2.9 13.4 19.7 21.0 21.6 12.7 10.2 18.2 19.7 16.1 17.4 38.7 121.7 0.0 0.0 0.0 0.0 0.0 0.0 33.5 127.4 99.5 0.0 374.2 225.5 211.0 0.0 0.0 0.0 0.0 855.6 474.7 0.0 0.0 62.8 0.0 225.5 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 470.7 0.0 0.0 426.7 0.0 0.0 291.0 0.0 0.0 0.0 0.0 0.0 0.0 423.8 0.0 0.0 0.0 NOP9 C14orf21 ENSG00000196943 "NOP9 nucleolar protein" Q86U38 14 24299862-24309124 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000850 Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA000850: AB_1078287" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (4.57e-3)" "unprognostic (1.85e-1)" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.69e-2)" "unprognostic (9.37e-2)" "unprognostic (7.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "prognostic favorable (9.39e-6)" "unprognostic (7.03e-3)" "unprognostic (3.80e-1)" "unprognostic (1.95e-1)" "unprognostic (1.59e-2)" 12.0 12.9 11.3 11.4 11.4 14.4 10.0 13.3 17.5 11.3 14.4 16.8 9.6 16.5 11.1 10.1 16.6 10.3 13.8 19.4 10.9 10.6 9.7 14.2 9.5 15.1 13.7 10.0 13.3 13.3 20.1 8.9 11.6 10.9 10.8 12.3 13.0 12.5 11.5 29.7 13.5 12.4 12.3 12.3 18.8 10.9 13.0 10.7 11.8 11.2 18.3 14.9 12.1 9.4 1.6 2.1 1.8 5.2 0.4 1.6 1.4 5.0 10.1 8.2 10.3 7.2 6.1 8.2 9.1 6.8 10.7 8.4 7.6 9.0 13.0 5.1 8.2 8.7 13.2 16.3 11.3 11.2 8.2 6.2 9.5 14.0 17.3 5.8 21.8 11.0 6.1 8.8 7.9 7.4 5.8 9.9 7.6 8.1 6.5 7.4 8.7 10.1 8.3 3.7 17.8 13.0 12.7 5.0 8.3 6.6 11.6 8.3 6.4 12.7 14.9 2.8 6.2 6.3 5.8 10.1 7.3 6.0 5.9 8.5 9.1 8.0 9.8 3.9 10.0 5.7 1.4 2.3 1.8 1.5 2.4 1.6 1.2 1.4 0.7 2.1 1.6 1.0 1.0 0.5 0.4 5.2 1.1 1.2 1.4 11.3 11.4 13.3 17.5 10.9 10.6 13.7 10.0 10.9 10.7 3.0 3.5 3.7 3.0 11.1 8.2 0.8 5.1 5.3 9.1 8.7 7.9 5.4 0.0 6.6 2.4 4.1 11.3 23.3 8.7 4.6 4.7 4.7 1.1 16.3 6.5 6.4 10.3 3.7 9.7 0.5 6.1 4.7 0.0 2.8 8.1 3.9 9.7 9.9 4.2 6.5 7.4 6.5 3.1 3.5 6.0 11.8 5.4 3.2 12.1 3.9 NOVA1 ENSG00000139910 "NOVA alternative splicing regulator 1" P51513 14 26443093-26597754 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 198.3;Horizontal cells: 128.7;Leydig cells: 139.2;Spermatocytes: 170.1" "Cancer enriched" "Detected in many" 5 "glioma: 14.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 25.9;ASC diff: 14.1;HAP1: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004155 Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA004155: AB_1079497" "unprognostic (1.46e-1)" "unprognostic (4.43e-3)" "unprognostic (6.55e-3)" "unprognostic (4.00e-2)" "unprognostic (6.69e-3)" "unprognostic (4.29e-2)" "unprognostic (3.74e-3)" "unprognostic (2.41e-1)" "unprognostic (5.21e-1)" "unprognostic (4.32e-2)" "unprognostic (5.04e-4)" "unprognostic (2.40e-1)" "unprognostic (1.93e-3)" "unprognostic (9.27e-4)" "unprognostic (9.20e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-4)" 17.8 6.7 17.5 3.4 17.4 1.3 32.9 54.7 49.2 12.2 6.3 13.3 5.0 2.5 9.4 6.9 4.0 6.2 6.2 3.0 17.1 25.1 7.0 2.2 2.7 4.4 19.2 17.8 6.3 2.7 4.4 14.1 1.3 26.4 5.4 6.5 4.0 2.8 17.5 6.9 3.1 3.4 9.9 22.5 2.1 3.3 10.3 14.9 0.0 4.1 2.7 5.2 5.6 9.4 0.3 0.3 0.6 0.4 2.2 0.5 0.0 0.0 6.1 25.9 0.0 14.1 7.6 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.4 0.4 4.2 0.1 12.7 0.1 0.0 0.0 1.0 0.0 0.0 0.2 5.3 0.0 1.2 9.4 0.0 1.9 1.9 9.4 5.4 5.4 0.0 0.0 4.1 0.0 5.3 0.1 7.6 0.0 6.1 0.7 8.6 0.1 3.6 4.9 8.3 4.8 0.0 0.0 0.0 2.6 0.7 0.0 0.0 3.6 4.2 3.1 0.7 0.0 0.0 0.0 5.1 0.0 3.8 0.6 0.0 0.2 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.3 0.2 0.5 0.6 2.2 0.4 0.3 0.4 0.0 17.5 17.4 54.7 26.9 17.1 25.1 19.2 17.8 26.4 14.9 0.0 1.0 0.0 6.8 4.6 198.3 0.8 2.5 8.1 0.0 14.0 3.9 0.0 8.3 0.0 14.7 6.2 0.5 0.0 0.3 0.0 12.1 2.1 0.0 0.2 0.2 128.7 63.4 35.0 1.2 11.2 139.2 1.9 3.3 0.0 2.3 26.6 3.1 10.5 61.9 20.4 13.0 6.5 19.8 170.1 57.9 2.8 0.0 0.0 3.7 0.6 NPM2 ENSG00000158806 "Nucleophosmin/nucleoplasmin 2" Q86SE8 8 22024125-22036897 "Predicted intracellular proteins" Fertilization "Chaperone, Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.6;parathyroid gland: 40.2;thyroid gland: 23.2" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 28.1;Cone photoreceptor cells: 19.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 10.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.1" "Group enriched" "Detected in many" 6 "granulocytes: 4.1;T-cells: 2.2" "Cell line enhanced" "Detected in many" "HaCaT: 13.3;HEL: 10.7;Hep G2: 23.7;JURKAT: 7.2;THP-1: 8.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA041070 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041070: AB_2677285" "unprognostic (1.40e-2)" "unprognostic (3.30e-2)" "unprognostic (3.11e-2)" "unprognostic (2.49e-2)" "unprognostic (1.55e-1)" "unprognostic (2.06e-1)" "unprognostic (1.61e-1)" "unprognostic (3.03e-2)" "unprognostic (5.30e-3)" "unprognostic (1.01e-1)" "prognostic favorable (9.02e-4)" "unprognostic (2.23e-1)" "prognostic favorable (3.18e-6)" "unprognostic (8.05e-3)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" "unprognostic (1.30e-1)" 0.8 15.6 14.4 0.5 11.4 1.3 2.3 20.4 27.6 1.9 1.4 0.8 0.3 2.4 4.9 1.3 1.4 2.8 2.2 1.5 13.0 13.8 2.9 1.3 2.0 1.0 14.9 15.7 0.8 7.4 40.2 7.8 0.9 7.2 4.7 1.4 3.7 3.1 1.8 0.8 2.0 1.4 4.0 3.0 7.5 2.0 3.1 2.4 0.1 23.2 0.0 0.8 1.4 0.8 0.4 0.0 4.1 0.0 0.0 2.2 0.1 2.9 0.4 0.1 0.2 0.7 0.0 1.2 0.3 0.4 1.9 3.8 1.2 2.8 0.0 0.9 0.0 0.2 13.3 0.3 0.0 1.1 0.1 0.3 10.7 0.7 23.7 2.4 1.4 1.0 0.4 1.8 0.0 0.2 2.9 0.0 7.2 0.3 0.0 0.1 0.0 0.1 2.8 0.6 4.7 0.3 0.2 1.0 0.6 4.4 0.0 2.9 0.2 0.0 0.0 3.5 0.0 0.5 8.4 0.0 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.9 0.0 2.2 0.0 0.9 2.1 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.0 1.4 0.1 14.4 11.4 20.4 27.6 13.0 13.8 14.9 15.7 7.2 2.4 0.0 1.4 0.5 8.2 0.1 28.1 2.0 2.5 9.4 11.4 0.0 19.6 0.1 3.3 6.3 15.2 0.3 0.4 0.0 7.0 0.2 0.4 3.3 0.0 0.4 3.5 6.4 10.9 2.5 0.0 10.4 0.6 1.2 10.1 1.8 1.5 0.9 5.4 0.0 0.4 9.8 3.9 0.0 1.4 0.5 0.3 1.0 0.2 4.3 0.6 5.8 NPM3 ENSG00000107833 "Nucleophosmin/nucleoplasmin 3" O75607 10 101781325-101783413 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036295, HPA036296" Approved Approved "Nucleoli,Actin filaments,Cytosol" NA NA "Nucleoli, Actin filaments, Cytosol" "HPA036295: AB_10671244, HPA036296: AB_10672083" "unprognostic (3.41e-2)" "unprognostic (3.70e-2)" "unprognostic (4.33e-2)" "unprognostic (1.75e-1)" "unprognostic (8.06e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (1.00e-2)" "unprognostic (1.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.75e-1)" "unprognostic (2.45e-2)" "unprognostic (1.35e-2)" "unprognostic (2.86e-2)" "unprognostic (3.55e-2)" "unprognostic (1.81e-1)" "unprognostic (5.69e-2)" "unprognostic (9.58e-2)" 9.8 17.0 14.3 20.9 8.5 17.2 14.3 1.5 16.8 13.3 12.3 2.4 6.2 6.0 15.7 15.0 22.7 11.7 12.4 8.9 9.9 7.3 13.6 13.7 8.8 26.3 7.3 11.4 17.7 39.0 11.3 11.1 12.0 9.1 11.5 15.1 3.7 13.2 7.1 11.7 14.0 8.7 15.0 4.8 14.7 11.0 16.4 7.7 18.5 9.8 23.7 18.8 13.0 13.9 4.5 8.3 0.1 3.7 7.0 10.4 5.7 17.3 22.1 6.6 43.2 15.1 15.9 6.9 9.4 14.4 14.7 12.5 23.6 22.2 28.8 17.6 10.5 8.0 18.7 36.6 40.0 11.6 12.2 38.0 23.1 10.3 37.9 17.0 52.5 16.9 13.7 19.4 20.3 81.4 7.6 19.2 35.5 28.5 16.0 12.0 32.1 21.9 68.4 11.6 24.3 17.0 17.2 34.6 29.2 14.3 8.6 13.5 8.7 5.9 13.8 26.3 8.4 18.0 10.9 7.5 5.8 18.6 8.6 17.4 6.9 7.1 33.1 8.1 48.9 6.0 0.0 2.7 0.0 3.8 3.7 7.0 4.3 6.3 7.2 6.3 4.5 10.4 10.4 0.1 7.0 0.8 8.3 2.6 5.7 14.3 8.5 1.5 16.8 9.9 7.3 7.3 11.4 9.1 7.7 3.0 5.3 14.5 57.6 55.6 1.3 2.9 20.4 4.0 9.1 34.9 0.0 79.7 66.3 48.2 5.3 26.4 2.6 0.0 35.4 70.4 52.3 31.9 16.1 16.1 61.3 0.0 23.3 13.5 17.1 8.8 25.9 36.7 28.7 12.6 30.0 2.2 35.2 3.5 22.3 41.9 1.9 6.5 31.6 40.9 83.0 43.5 50.8 26.6 45.2 53.9 NPR1 "ANPa, ANPRA, GUCY2A, NPRA" ENSG00000169418 "Natriuretic peptide receptor 1" P16066 1 153678637-153693992 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "cGMP biosynthesis" "Lyase, Receptor, Vasoactive" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 98.4" "Cell type enriched" "Detected in many" 10 "Ito cells: 136.2" "Cancer enhanced" "Detected in all" "ovarian cancer: 39.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "ASC diff: 60.5" "Region enriched" "Detected in many" 5 "olfactory region: 23.0" "Region enhanced" "Detected in single" "olfactory region: 11.1" HPA031087 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA Nucleoli "Nucleoplasm, Plasma membrane" "HPA031087: AB_10601975" "unprognostic (2.54e-1)" "unprognostic (3.03e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (1.55e-1)" "unprognostic (6.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.03e-1)" "unprognostic (2.46e-1)" "unprognostic (3.27e-2)" "prognostic favorable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (6.69e-2)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" "unprognostic (4.06e-1)" "unprognostic (1.74e-2)" 41.1 4.3 0.5 5.9 0.9 0.1 98.4 0.5 0.8 8.1 8.2 0.3 7.3 1.2 16.8 11.1 8.7 25.0 9.3 19.6 0.9 0.5 28.7 3.7 34.8 8.6 0.7 0.0 19.5 4.2 7.8 4.5 11.8 2.5 4.9 1.5 2.0 2.0 9.0 6.9 3.4 4.6 15.6 2.2 1.2 5.0 6.4 0.2 0.8 7.6 5.1 1.1 11.6 26.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 60.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.0 0.0 7.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.7 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.5 0.8 0.9 0.5 0.7 0.0 2.5 0.2 0.0 5.8 0.0 0.4 1.3 0.0 4.8 5.1 0.0 0.0 14.0 0.0 0.1 0.0 0.6 8.0 14.2 0.0 0.0 0.0 0.9 3.9 0.4 0.0 1.5 0.2 0.0 0.0 136.2 6.0 7.9 9.5 0.0 0.0 9.0 0.0 0.0 0.7 0.0 3.9 2.8 0.0 0.0 0.9 0.2 0.1 0.9 0.6 0.0 0.0 0.0 NRG2 "Don-1, HRG2, NTAK" ENSG00000158458 "Neuregulin 2" O14511 5 139846779-140043299 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.3" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 9.0;Bipolar cells: 15.1;Leydig cells: 8.9;Muller glia cells: 9.7;Peritubular cells: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Lineage enriched" "Detected in single" 4 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "AN3-CA: 8.4;Karpas-707: 5.6;PC-3: 14.8;RPTEC TERT1: 7.5;SCLC-21H: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038935, HPA047973" Approved Supported Nucleoplasm,Nucleoli "Secreted to blood" No NA Nucleoplasm Nucleoli "HPA038935: AB_10672833, HPA047973: AB_2680226" "unprognostic (8.66e-4)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (6.04e-2)" "unprognostic (3.22e-1)" "unprognostic (2.96e-2)" "unprognostic (8.66e-3)" "unprognostic (1.11e-1)" "unprognostic (3.99e-1)" "unprognostic (1.88e-1)" "unprognostic (4.26e-3)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (3.64e-3)" "unprognostic (9.54e-2)" "unprognostic (2.23e-2)" "unprognostic (2.07e-2)" 4.5 4.5 4.0 1.4 7.0 0.6 4.4 27.3 5.1 13.1 2.3 3.8 2.6 1.0 3.0 2.9 3.7 7.6 7.6 1.5 4.2 3.5 1.3 0.6 1.2 2.1 5.2 3.4 15.9 3.2 15.8 7.7 1.1 4.1 4.5 0.9 2.9 13.6 4.7 6.0 5.0 1.0 5.1 3.6 3.3 1.1 2.7 4.9 0.0 0.8 1.0 1.5 4.8 3.7 0.4 0.1 0.0 0.1 0.0 2.1 0.1 0.0 2.0 0.2 8.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.0 0.4 0.0 4.0 2.4 0.4 0.2 0.1 4.8 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.5 0.9 0.2 0.2 0.0 5.6 0.0 0.4 0.0 0.0 0.1 0.0 14.8 0.1 0.0 0.0 7.5 1.8 5.6 3.4 0.0 3.2 3.3 0.0 0.0 0.0 0.2 2.6 0.4 0.0 1.6 1.1 0.0 0.0 3.7 0.0 0.7 0.0 0.0 0.0 2.1 0.1 0.5 0.1 0.2 0.4 0.0 0.4 0.4 1.2 0.0 0.0 0.0 0.1 0.0 0.1 4.0 7.0 27.3 5.1 4.2 3.5 5.2 3.4 4.1 4.9 0.0 0.0 0.0 9.0 2.5 15.1 1.4 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.3 0.5 0.9 0.0 0.0 1.9 0.0 1.8 1.3 0.0 0.0 0.1 6.4 0.0 0.0 0.0 0.6 8.9 0.0 3.3 0.0 0.0 9.7 0.8 0.0 9.6 1.5 0.7 6.5 1.1 3.0 4.3 0.3 0.0 0.8 0.0 5.9 NRIP1 RIP140 ENSG00000180530 "Nuclear receptor interacting protein 1" P48552 21 14961235-15065936 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029785, HPA046571, HPA060036" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193" "unprognostic (5.60e-2)" "unprognostic (1.87e-1)" "unprognostic (5.20e-3)" "unprognostic (4.64e-3)" "unprognostic (7.98e-2)" "unprognostic (2.59e-2)" "unprognostic (2.74e-1)" "unprognostic (2.75e-3)" "unprognostic (8.94e-3)" "unprognostic (1.55e-1)" "unprognostic (2.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-2)" "unprognostic (6.53e-2)" "unprognostic (1.07e-1)" "unprognostic (2.72e-1)" "unprognostic (2.80e-1)" 29.0 15.0 10.8 12.6 7.5 19.6 18.4 20.8 10.5 23.1 21.2 6.7 8.5 14.5 16.6 13.4 13.1 18.8 9.0 11.8 9.3 5.8 16.0 22.7 9.3 8.9 5.9 7.3 14.4 15.8 8.3 11.2 16.8 7.2 13.9 15.8 12.7 10.3 7.7 36.5 7.6 30.3 17.3 12.9 17.0 8.4 6.8 7.7 22.1 7.3 12.4 5.9 13.0 14.9 2.6 1.7 0.5 1.4 1.2 5.6 0.7 9.7 20.7 16.3 0.0 8.2 5.3 5.8 11.6 5.2 7.8 5.9 3.8 7.7 0.0 6.6 11.0 3.6 5.1 1.0 6.9 15.7 0.0 4.5 14.7 7.2 11.9 4.9 7.4 3.2 6.5 9.7 8.0 9.4 8.1 5.7 2.2 10.4 8.1 5.1 5.5 3.4 0.0 6.6 3.9 6.2 41.5 12.8 0.3 4.5 16.9 1.4 0.0 9.6 5.1 3.9 13.3 12.4 5.6 9.8 6.3 4.2 9.8 4.7 3.9 0.0 0.0 13.8 0.0 3.2 0.0 1.4 0.5 1.0 0.8 5.6 0.9 1.0 1.1 1.7 2.6 1.7 0.6 0.3 1.2 1.4 1.7 0.5 0.7 10.8 7.5 20.8 10.5 9.3 5.8 5.9 7.3 7.2 7.7 44.7 32.8 11.5 54.8 16.6 33.5 15.3 17.8 18.7 61.4 27.9 47.1 13.0 8.3 20.2 11.9 25.5 34.2 0.0 23.8 109.4 21.7 35.8 29.1 42.3 36.7 20.6 36.1 28.3 37.6 14.4 34.8 26.2 8.5 33.3 38.8 58.9 25.8 40.3 25.5 33.6 60.2 32.3 17.0 9.3 2.3 16.4 11.8 7.7 42.0 78.2 NSA2 "FLJ94393, HCLG1, HUSSY-29, TINP1" ENSG00000164346 "NSA2, ribosome biogenesis homolog" O95478 5 74766991-74780113 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA043487 Approved Enhanced Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA043487: AB_2678507" "unprognostic (4.79e-3)" "unprognostic (1.92e-1)" "unprognostic (5.49e-2)" "unprognostic (7.80e-2)" "unprognostic (1.54e-1)" "unprognostic (4.07e-2)" "unprognostic (6.14e-3)" "unprognostic (4.24e-1)" "unprognostic (2.15e-2)" "unprognostic (9.14e-2)" "unprognostic (8.66e-2)" "unprognostic (1.03e-1)" "unprognostic (4.92e-2)" "unprognostic (3.98e-1)" "unprognostic (1.64e-1)" "unprognostic (2.31e-2)" "unprognostic (1.44e-1)" 25.4 32.6 17.4 26.8 29.3 28.3 24.0 14.0 29.4 31.8 25.8 8.0 18.0 26.2 26.5 22.6 27.9 22.9 13.5 27.7 20.8 13.6 27.4 35.4 27.0 42.5 16.7 19.1 54.2 31.2 13.5 35.4 25.4 20.3 27.8 20.6 10.4 33.8 17.9 51.1 17.3 22.2 23.1 28.5 28.5 24.3 44.5 15.7 26.4 27.2 21.7 26.1 36.7 26.1 17.0 11.1 4.4 11.9 13.1 19.3 6.1 20.6 11.3 14.0 18.8 8.7 16.1 21.4 14.8 7.7 9.5 7.5 18.7 20.3 16.7 31.6 8.2 23.3 12.8 11.0 16.3 13.4 11.4 17.0 8.7 22.0 21.4 8.1 15.2 20.5 10.6 15.4 12.7 9.4 15.5 7.9 15.2 8.6 14.1 10.1 15.7 25.5 38.2 9.3 8.8 9.9 18.3 16.4 31.5 11.9 22.8 15.0 19.6 8.9 17.3 39.9 11.0 16.3 43.3 9.1 7.3 22.1 13.7 42.5 14.1 18.8 27.3 18.3 27.0 10.8 4.4 7.2 4.2 10.5 11.9 15.1 17.0 16.0 15.8 11.1 12.4 19.3 19.1 1.3 13.1 8.8 10.4 15.8 6.1 17.4 29.3 14.0 29.4 20.8 13.6 16.7 19.1 20.3 15.7 74.5 77.0 155.5 140.9 83.6 31.6 79.5 137.6 66.9 104.6 59.3 13.7 119.1 127.6 113.6 331.3 86.4 114.1 116.8 204.5 170.1 84.0 110.5 116.6 184.7 121.5 47.7 134.0 113.5 170.4 102.0 257.7 109.4 79.2 149.7 219.3 47.0 172.0 119.3 161.2 158.4 31.4 135.8 91.0 120.5 95.0 75.2 113.3 107.1 207.0 165.4 NSMAF "FAN, GRAMD5" ENSG00000035681 "Neutral sphingomyelinase activation associated factor" Q92636 8 58583504-58659844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023067, HPA023148, HPA023151" Uncertain Approved Nucleoli NA NA Nucleoli "HPA023067: AB_1854653, HPA023148: AB_10670028, HPA023151: AB_1854654" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "unprognostic (1.75e-1)" "unprognostic (8.86e-3)" "unprognostic (2.69e-1)" "unprognostic (8.73e-2)" "unprognostic (2.96e-3)" "unprognostic (9.03e-2)" "unprognostic (2.29e-1)" "unprognostic (8.11e-2)" "unprognostic (1.52e-1)" "unprognostic (4.44e-1)" "prognostic unfavorable (4.61e-9)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (2.38e-1)" "unprognostic (1.69e-1)" 19.3 18.9 13.3 19.2 23.5 8.9 22.7 19.5 14.8 15.2 16.8 11.3 6.0 11.0 17.9 11.5 16.1 12.7 13.1 17.3 12.8 10.9 9.9 6.7 17.7 27.2 13.4 11.7 15.5 20.9 25.6 16.3 15.6 12.9 14.9 17.9 12.7 14.1 15.9 20.3 22.4 16.9 22.3 12.1 20.9 16.8 8.4 11.1 43.8 16.3 11.2 25.0 19.2 17.9 4.8 14.5 15.4 7.2 6.4 8.7 4.5 13.3 13.0 5.9 8.3 22.6 18.4 10.2 10.7 23.9 15.0 14.1 7.2 8.4 16.2 9.0 16.9 15.6 10.7 10.0 8.6 17.1 18.0 5.5 30.3 8.1 8.1 28.7 13.2 21.1 12.4 13.8 10.8 41.6 12.4 14.9 15.0 13.0 11.9 16.9 10.0 27.7 10.7 10.5 10.7 5.1 10.5 8.7 4.6 8.4 10.7 5.5 7.0 9.0 3.4 9.8 8.2 8.3 16.6 13.7 14.9 9.0 19.9 10.9 2.2 1.1 12.8 21.9 10.4 9.4 8.3 7.2 4.8 6.8 5.3 7.0 4.8 7.2 7.1 14.5 4.6 5.1 4.8 15.4 6.4 3.6 5.0 8.7 4.5 13.3 23.5 19.5 14.8 12.8 10.9 13.4 11.7 12.9 11.1 8.9 5.1 13.2 8.6 16.4 8.7 13.7 2.5 2.7 11.4 8.7 3.9 10.5 3.3 6.7 0.2 11.3 6.9 0.0 7.5 7.1 11.3 7.8 27.7 3.4 16.5 30.2 13.8 5.5 29.2 1.5 15.3 27.7 10.1 10.0 8.7 6.0 6.9 7.0 12.0 3.7 5.7 6.5 9.8 1.6 3.2 15.6 7.8 17.3 9.9 8.9 NSUN5 "FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL" ENSG00000130305 "NOP2/Sun RNA methyltransferase family member 5" Q96P11 7 73302517-73308867 "Disease related genes, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020536, HPA045590, HPA046867" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847" "unprognostic (3.94e-1)" "unprognostic (1.12e-1)" "unprognostic (3.79e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.92e-1)" "prognostic unfavorable (3.96e-4)" "unprognostic (3.54e-1)" "unprognostic (2.46e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (3.21e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-2)" 9.0 7.7 11.2 13.1 12.8 40.9 8.7 12.9 14.4 8.5 10.3 15.0 4.8 12.6 12.3 6.9 10.8 12.0 8.1 9.4 10.8 9.3 9.4 9.8 8.0 16.1 19.4 11.9 10.6 19.6 9.5 8.3 8.3 13.6 9.7 6.2 7.7 13.6 9.7 27.1 11.8 12.1 10.9 11.6 15.8 9.6 14.6 13.6 23.5 10.6 11.2 12.1 10.6 8.9 33.5 21.2 18.7 14.4 16.8 22.3 15.3 12.2 17.0 4.8 10.5 2.0 2.5 18.2 5.9 3.4 9.1 9.8 22.9 9.1 20.2 4.0 2.9 13.4 10.6 9.0 5.9 3.0 13.3 20.9 7.6 12.4 13.1 7.8 16.8 10.4 3.4 9.9 7.8 6.6 2.1 1.2 15.2 24.9 4.8 4.3 29.5 14.2 34.6 19.3 9.0 13.1 17.4 3.6 28.9 3.9 6.1 12.4 20.7 10.3 27.6 13.3 5.4 17.7 13.4 1.9 0.1 13.3 13.2 3.9 19.3 24.9 28.8 0.2 23.6 0.9 14.2 14.4 15.0 14.0 12.5 11.0 21.5 15.9 14.3 16.5 33.5 22.3 18.8 18.7 16.8 9.3 21.2 17.3 15.3 11.2 12.8 12.9 14.4 10.8 9.3 19.4 11.9 13.6 13.6 6.0 6.1 51.6 17.1 15.0 25.1 17.1 25.5 10.7 12.5 34.9 11.8 33.4 31.5 36.0 12.8 7.3 18.6 0.0 28.6 37.8 16.9 12.9 26.5 20.3 30.9 30.2 3.5 6.7 17.4 16.3 27.0 19.4 20.3 46.9 16.4 13.8 24.0 17.5 19.4 19.5 21.4 6.5 14.1 60.6 58.5 18.6 18.2 25.4 19.9 15.5 NTRK3 TRKC ENSG00000140538 "Neurotrophic receptor tyrosine kinase 3" Q16288 15 87859751-88256768 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 58.9;Early spermatids: 85.5;Late spermatids: 103.3;Sertoli cells: 51.8;Smooth muscle cells: 37.7" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "U-138 MG: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009233, HPA027484, HPA048065" Approved Supported "Nuclear membrane,Nucleoli,Nucleoli rim" NA NA 11000000 "Nucleoli, Nucleoli rim" "Nuclear membrane" "CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245" "unprognostic (1.27e-3)" "unprognostic (1.24e-2)" "unprognostic (1.98e-2)" "unprognostic (2.04e-2)" "unprognostic (1.65e-1)" "unprognostic (3.34e-1)" "unprognostic (3.18e-2)" "unprognostic (2.23e-2)" "unprognostic (2.34e-1)" "unprognostic (3.91e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-3)" "unprognostic (6.45e-3)" "unprognostic (1.06e-2)" "unprognostic (1.26e-2)" "unprognostic (2.49e-3)" 20.8 7.4 22.0 2.5 28.1 1.5 6.2 30.4 41.8 7.0 4.0 8.4 1.3 2.0 12.4 6.7 3.4 9.5 3.9 5.5 22.0 11.1 5.1 2.0 5.7 3.1 11.2 18.7 5.1 2.9 1.6 7.9 2.8 14.7 6.8 4.7 8.0 11.5 8.7 1.9 2.9 2.5 7.7 13.7 4.1 3.0 13.8 13.7 0.0 2.5 0.7 4.3 7.1 4.8 0.7 0.4 1.3 0.5 0.5 0.8 0.0 0.0 6.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 48.6 0.9 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.1 1.2 0.5 0.4 0.3 0.1 0.2 0.4 0.3 0.3 0.1 0.7 0.4 0.4 1.3 0.5 0.1 0.4 0.8 0.0 22.0 28.1 30.4 28.9 22.0 11.1 11.2 18.7 14.7 13.7 0.0 0.0 0.0 5.9 0.5 58.9 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 85.5 0.7 0.0 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.9 1.6 0.0 1.8 0.0 103.3 3.1 0.2 0.0 0.0 0.0 8.9 0.0 0.0 25.8 0.0 2.7 51.8 37.7 8.8 1.9 0.1 0.1 0.0 0.0 0.1 NUB1 "BS4, NUB1L, NYREN18" ENSG00000013374 "Negative regulator of ubiquitin like proteins 1" Q9Y5A7 7 151341699-151378449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "monocytes: 930.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021220, HPA050722, HPA053648" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA021220: AB_2670630, HPA050722: AB_2681220, HPA053648: AB_2682217" "unprognostic (7.04e-3)" "unprognostic (2.47e-2)" "unprognostic (1.84e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" "unprognostic (3.22e-2)" "prognostic unfavorable (8.70e-4)" "unprognostic (1.42e-1)" "unprognostic (2.75e-1)" "unprognostic (2.67e-2)" "unprognostic (2.10e-1)" "unprognostic (8.76e-2)" "unprognostic (2.69e-2)" "unprognostic (9.44e-2)" "unprognostic (1.45e-1)" "unprognostic (2.64e-2)" "unprognostic (5.83e-3)" 20.1 17.3 17.1 22.1 15.5 13.2 20.5 20.5 20.0 22.2 25.0 17.6 17.3 30.9 24.4 17.6 18.1 19.8 17.0 16.5 14.8 12.9 17.1 18.9 21.2 28.7 14.3 15.4 25.4 21.7 28.0 26.4 23.7 18.5 21.6 15.3 16.2 19.8 15.7 30.3 16.9 38.3 20.8 19.8 26.5 17.7 56.0 16.0 32.3 26.5 15.9 19.8 25.3 22.3 21.1 18.9 28.9 24.0 24.5 24.7 17.1 27.0 12.3 16.6 9.8 17.3 21.2 13.8 21.8 20.1 16.6 19.2 12.0 24.0 29.2 28.9 13.6 21.3 13.7 9.9 14.2 10.7 25.8 16.7 10.6 11.7 7.6 24.3 24.6 13.8 13.5 16.7 11.9 11.3 20.6 10.9 14.9 27.7 0.8 13.3 14.5 43.5 18.7 26.0 27.7 16.2 24.2 17.2 4.4 12.3 13.4 15.6 26.0 40.9 17.6 20.8 12.1 12.0 14.2 22.0 14.1 5.0 18.7 20.6 28.5 21.7 25.7 28.5 21.2 23.0 10.4 15.7 20.7 20.9 20.3 24.7 21.1 18.3 21.1 13.6 19.9 20.4 19.0 28.9 24.5 24.0 18.9 14.3 17.1 17.1 15.5 20.5 20.0 14.8 12.9 14.3 15.4 18.5 16.0 68.5 57.3 44.2 28.5 22.0 35.4 51.7 30.6 72.3 71.7 24.4 11.8 39.1 51.4 43.6 181.4 36.0 42.1 0.0 60.6 37.7 28.4 41.4 69.4 33.4 27.3 46.1 28.2 30.7 34.8 15.4 40.9 42.6 15.1 930.6 41.4 52.7 51.5 17.5 38.5 30.5 40.1 25.8 38.7 96.0 12.7 25.3 41.9 48.0 21.9 30.6 NUCKS1 NUCKS ENSG00000069275 "Nuclear casein kinase and cyclin dependent kinase substrate 1" Q9H1E3 1 205712819-205750276 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062351, HPA063843" Supported Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA062351: AB_2684745, HPA063843: AB_2685134" "unprognostic (1.68e-1)" "unprognostic (3.92e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.87e-1)" "unprognostic (2.93e-1)" "unprognostic (9.20e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-2)" "unprognostic (5.16e-3)" "unprognostic (1.18e-3)" "unprognostic (1.37e-1)" "unprognostic (5.82e-3)" "unprognostic (7.45e-3)" "unprognostic (1.44e-1)" "unprognostic (2.25e-2)" "unprognostic (7.57e-2)" 25.6 25.3 46.9 17.3 55.5 12.1 31.3 45.0 49.2 33.0 24.2 38.3 18.8 12.5 36.5 27.8 25.3 32.1 22.5 40.6 43.8 35.6 30.9 43.9 20.6 29.4 43.6 47.6 49.1 17.4 50.3 21.0 20.8 32.8 31.9 21.1 21.9 19.0 32.7 43.1 21.7 14.6 42.9 49.1 22.6 17.9 14.2 38.9 35.3 42.5 20.6 24.8 32.0 22.6 7.8 7.4 4.5 4.9 10.7 11.8 4.0 40.6 25.0 67.5 26.6 18.7 25.9 31.8 29.4 30.3 41.3 33.3 13.7 47.0 45.2 17.1 28.6 13.1 30.1 51.2 24.6 47.4 21.6 25.6 29.4 22.1 14.9 13.8 46.1 10.5 20.5 22.3 24.5 42.8 22.2 32.2 29.3 47.1 14.5 32.2 47.0 41.8 23.3 68.9 16.3 18.7 43.7 83.2 25.9 23.1 25.1 28.1 52.0 43.3 34.7 23.5 54.6 53.1 34.8 32.1 31.7 28.2 36.1 51.9 13.4 15.7 36.5 21.8 26.0 42.6 4.5 3.4 3.7 9.9 4.9 9.6 5.8 9.2 8.6 4.7 7.8 11.5 11.8 0.6 10.7 4.0 7.4 5.5 4.0 46.9 55.5 45.0 36.6 43.8 35.6 43.6 47.6 32.8 38.9 199.5 245.2 149.9 252.8 229.2 349.8 365.7 310.8 239.6 291.2 287.9 68.7 230.3 326.6 177.1 41.7 224.6 54.9 233.6 148.6 321.5 312.0 255.4 201.9 550.1 225.1 298.8 172.0 219.1 173.7 32.2 474.1 194.8 165.4 192.0 193.2 516.1 113.3 94.7 456.1 297.2 177.2 310.4 243.6 46.5 115.0 213.3 148.2 154.5 216.0 173.7 NUDT14 UGPP ENSG00000183828 "Nudix hydrolase 14" O95848 14 105172938-105181323 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046755, HPA058759" Approved Approved Nucleoli,Microtubules NA NA Microtubules Nucleoli "HPA046755: AB_10963433, HPA058759: AB_2683809" "unprognostic (1.05e-2)" "unprognostic (6.01e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.55e-1)" "unprognostic (1.05e-3)" "unprognostic (9.17e-3)" "unprognostic (2.02e-1)" "prognostic favorable (1.66e-4)" "unprognostic (3.16e-3)" "unprognostic (3.13e-1)" "prognostic favorable (1.18e-5)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (7.21e-3)" "unprognostic (2.38e-1)" 18.2 12.6 22.4 5.0 16.0 3.1 14.3 2.5 23.4 6.5 11.0 7.9 5.9 16.7 4.7 11.7 7.1 12.6 9.8 20.9 15.4 13.5 16.7 11.2 12.6 9.4 16.1 14.8 4.0 26.0 4.7 27.6 4.8 11.2 10.5 4.6 14.7 16.7 9.9 28.7 6.2 13.8 3.1 13.2 6.3 12.7 8.9 7.8 3.1 17.9 9.2 5.7 4.9 4.7 5.8 15.1 1.7 27.3 6.1 5.8 8.9 8.2 11.3 1.0 4.4 1.3 1.6 18.1 2.3 3.1 3.8 5.5 8.0 8.8 0.6 11.6 1.2 8.5 10.4 0.5 6.3 0.3 4.3 8.3 1.8 4.9 5.5 9.7 2.2 22.3 2.3 8.0 0.9 0.7 1.6 7.5 4.1 2.8 1.4 1.3 24.0 0.2 0.0 5.9 19.5 15.8 4.3 10.4 4.8 4.1 23.8 15.7 2.3 4.1 0.1 9.6 1.9 8.9 10.7 17.6 6.3 2.8 4.5 2.3 0.7 0.4 1.0 9.3 2.5 2.3 1.7 18.5 0.5 5.8 17.4 3.6 5.8 4.6 3.8 15.1 4.0 4.5 5.2 0.6 6.1 27.3 7.3 2.5 8.9 22.4 16.0 2.5 23.4 15.4 13.5 16.1 14.8 11.2 7.8 11.9 22.0 13.7 80.0 34.6 11.8 47.7 35.7 34.8 5.7 33.2 17.7 39.7 149.2 84.7 2.5 43.4 95.9 0.0 26.5 19.7 19.5 39.7 39.1 21.8 112.1 33.4 35.8 22.7 24.1 8.2 10.6 28.5 43.9 36.9 61.8 28.1 58.1 126.7 3.5 138.7 12.3 0.0 9.5 10.0 28.9 16.7 31.9 15.2 80.1 65.1 NUDT16 FLJ31265 ENSG00000198585 "Nudix hydrolase 16" Q96DE0 3 131381671-131388830 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Kupffer cells: 138.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 18.2;eosinophil: 18.8;intermediate monocyte: 21.9;myeloid DC: 13.6;neutrophil: 14.6;non-classical monocyte: 24.5" "Group enriched" "Detected in all" 4 "dendritic cells: 13.6;granulocytes: 18.8;monocytes: 24.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060452, HPA062492" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA060452: AB_2684279, HPA062492: AB_2684781" "unprognostic (4.85e-3)" "prognostic favorable (9.39e-5)" "unprognostic (3.19e-3)" "unprognostic (9.21e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (9.96e-2)" "unprognostic (1.15e-1)" "unprognostic (5.16e-2)" "unprognostic (1.94e-1)" "unprognostic (1.77e-1)" "unprognostic (5.88e-2)" "prognostic favorable (1.05e-7)" "unprognostic (3.29e-1)" "unprognostic (1.62e-1)" "unprognostic (2.00e-2)" "unprognostic (9.44e-2)" 25.9 13.4 22.1 13.1 22.0 8.7 13.1 13.5 20.5 11.1 32.8 23.9 13.9 20.2 11.7 11.6 8.7 14.0 13.6 22.2 21.1 19.6 25.9 23.1 16.2 31.1 27.7 16.9 23.0 18.3 32.9 9.7 7.6 20.1 13.4 18.4 13.6 11.7 13.6 20.3 6.8 37.5 18.5 30.4 22.2 13.8 9.5 21.6 2.2 17.1 11.5 9.1 12.4 8.4 4.3 13.6 18.8 24.5 3.7 4.3 6.7 12.6 6.8 11.2 5.8 22.5 20.5 5.2 10.4 9.6 7.0 7.3 10.4 5.7 2.1 9.1 9.6 13.9 9.3 9.9 6.5 11.2 6.3 7.2 5.4 8.7 10.0 14.4 9.0 9.9 18.2 5.8 4.6 12.7 6.3 10.9 0.0 6.1 11.0 6.8 13.2 0.0 2.4 8.7 12.7 10.1 7.1 8.1 16.0 7.0 10.3 5.5 9.6 6.2 6.3 9.5 9.9 13.8 7.2 10.7 11.5 5.0 21.0 8.0 11.0 10.8 0.3 7.4 7.0 6.3 2.2 18.2 18.8 2.6 21.9 2.7 4.3 2.7 2.4 13.6 4.2 2.4 2.4 14.6 3.7 24.5 1.8 4.3 6.7 22.1 22.0 13.5 20.5 21.1 19.6 27.7 16.9 20.1 21.6 14.9 31.3 19.1 10.7 7.4 22.7 83.1 40.8 16.0 18.2 19.2 7.9 18.7 58.0 20.4 59.4 30.8 62.9 23.3 32.8 21.8 21.4 14.7 18.5 95.7 54.0 41.3 24.3 84.1 138.2 27.2 24.5 46.3 16.9 14.4 61.2 10.0 23.8 50.3 37.1 92.4 18.3 25.8 23.7 17.6 5.1 4.6 6.1 20.8 42.4 14.7 NUDT19 RP2 ENSG00000213965 "Nudix hydrolase 19" A8MXV4 19 32691961-32713796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042761 Uncertain Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli, Cytosol" "HPA042761: " "unprognostic (1.20e-1)" "unprognostic (2.90e-1)" "unprognostic (2.35e-3)" "unprognostic (6.61e-3)" "unprognostic (2.62e-2)" "unprognostic (2.44e-1)" "unprognostic (6.18e-3)" "unprognostic (1.97e-1)" "unprognostic (3.14e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (2.64e-2)" "unprognostic (2.81e-1)" "unprognostic (1.23e-1)" "prognostic favorable (1.35e-4)" 9.9 18.7 7.2 11.1 7.0 10.8 10.7 7.4 7.6 5.6 12.8 6.1 8.4 10.2 6.6 8.8 16.9 6.3 7.6 19.3 6.1 6.5 10.5 16.4 15.9 9.2 6.2 5.5 8.5 18.9 9.5 9.3 6.6 6.1 11.2 10.7 9.4 14.7 11.8 29.5 13.2 12.9 6.9 5.6 8.9 11.3 6.8 6.6 6.8 5.9 13.1 13.0 9.9 8.4 8.4 11.9 9.0 23.6 18.7 14.8 6.5 13.7 16.0 1.8 15.9 5.5 7.2 0.3 7.8 2.9 5.8 5.5 9.0 7.6 0.2 9.4 9.0 4.5 9.0 11.0 9.1 7.7 15.8 6.6 17.8 6.4 3.3 7.6 13.3 5.5 5.8 12.1 4.9 12.0 6.8 8.5 2.8 13.7 10.2 10.4 9.1 0.1 12.3 1.9 3.8 7.6 0.1 3.5 7.7 9.6 10.3 7.2 10.3 13.9 11.9 9.8 3.3 6.5 16.3 6.8 8.1 5.2 8.0 13.9 12.0 10.1 4.5 9.7 12.8 7.4 6.6 17.3 9.0 11.9 21.7 12.8 8.4 12.5 14.8 11.9 5.9 10.0 13.8 3.3 18.7 23.6 9.5 13.8 6.5 7.2 7.0 7.4 7.6 6.1 6.5 6.2 5.5 6.1 6.6 11.9 12.6 8.2 6.5 19.5 12.8 18.7 5.1 4.0 4.5 7.0 11.8 9.8 23.2 2.6 7.7 4.5 9.7 0.0 9.9 9.4 9.4 8.5 1.1 9.3 12.6 3.2 11.6 12.3 12.1 3.1 3.7 10.8 11.8 7.2 13.0 5.5 9.5 14.0 8.9 14.8 26.4 0.0 6.6 1.4 1.9 27.6 6.5 13.3 15.8 7.9 NUDT8 FLJ41567 ENSG00000167799 "Nudix hydrolase 8" Q8WV74 11 67627938-67629930 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 96.8;Hepatocytes: 168.1;Proximal tubular cells: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 68.5" "Low region specificity" "Detected in all" "HPA041252, HPA041466" Enhanced Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA041252: AB_10794551, HPA041466: AB_10793967" "unprognostic (8.31e-2)" "unprognostic (7.26e-3)" "unprognostic (7.31e-2)" "unprognostic (7.32e-2)" "unprognostic (2.87e-1)" "unprognostic (2.36e-3)" "unprognostic (2.69e-1)" "unprognostic (4.12e-2)" "unprognostic (8.28e-2)" "unprognostic (2.69e-2)" "unprognostic (3.11e-2)" "unprognostic (2.74e-1)" "prognostic favorable (3.70e-4)" "unprognostic (4.70e-2)" "unprognostic (2.29e-1)" "unprognostic (3.50e-1)" "unprognostic (2.19e-1)" 5.5 2.0 3.0 4.1 4.1 2.1 10.8 4.1 2.7 3.9 8.1 3.5 10.1 10.6 1.7 4.8 22.0 2.4 5.9 32.5 2.6 3.0 16.0 21.4 3.8 4.3 4.9 2.3 2.2 7.7 4.3 1.3 2.5 5.9 4.2 4.2 2.0 28.3 8.2 38.2 12.4 12.2 2.4 4.1 1.9 6.9 1.4 2.3 2.0 13.6 25.0 15.3 1.6 4.7 7.1 11.8 1.0 11.2 8.1 3.4 2.1 10.4 4.2 1.6 2.7 1.5 2.0 2.6 2.2 1.0 0.9 0.9 3.5 2.7 10.9 3.4 1.7 1.3 5.1 1.9 1.3 0.1 10.6 4.6 0.6 1.8 10.6 0.4 3.4 5.3 1.2 2.6 1.1 0.3 0.2 1.9 13.9 3.0 9.8 0.7 17.5 5.7 5.0 0.9 18.4 8.6 3.5 0.8 68.5 2.7 1.8 0.8 1.1 0.5 6.1 2.1 0.6 3.3 1.4 0.5 2.3 3.3 14.9 0.4 7.0 4.6 2.1 1.6 4.7 1.3 0.0 1.0 1.0 3.1 3.9 2.6 3.3 1.8 3.4 4.3 7.1 1.6 1.9 0.0 8.1 11.2 11.8 1.1 2.1 3.0 4.1 4.1 2.7 2.6 3.0 4.9 2.3 5.9 2.3 0.0 6.2 15.0 11.1 10.8 4.3 66.8 17.8 2.7 0.0 27.9 0.0 21.3 71.3 11.4 2.7 7.5 96.8 23.3 20.8 17.7 10.7 20.1 9.2 168.1 7.9 4.8 2.4 9.8 4.7 5.6 4.6 3.0 27.0 2.8 66.6 7.0 11.3 22.4 4.9 147.8 6.0 6.5 11.3 9.1 6.3 22.3 14.5 9.6 56.6 16.3 NUFIP1 NUFIP ENSG00000083635 "NUFIP1, FMR1 interacting protein 1" Q9UHK0 13 44939249-44989483 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029958, HPA029959" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA029958: AB_10598911, HPA029959: AB_10602308" "unprognostic (2.01e-1)" "unprognostic (5.32e-3)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (1.70e-2)" "unprognostic (2.98e-3)" "unprognostic (2.32e-1)" "unprognostic (1.45e-2)" "unprognostic (2.91e-2)" "unprognostic (9.74e-3)" "unprognostic (4.52e-1)" "unprognostic (3.95e-2)" "unprognostic (3.73e-2)" "unprognostic (4.04e-2)" "unprognostic (4.89e-2)" "unprognostic (3.31e-1)" "unprognostic (5.24e-2)" 8.9 9.8 10.4 10.7 16.4 17.4 11.6 11.0 17.2 9.8 7.8 10.8 4.8 7.1 11.7 14.4 9.2 9.2 6.3 6.4 12.7 9.6 10.2 13.7 11.2 8.5 8.9 12.6 13.7 11.5 9.3 9.6 7.7 7.9 9.1 7.9 6.3 8.6 8.8 17.0 10.1 6.4 10.3 10.0 8.4 8.6 14.1 8.8 11.4 10.1 6.8 9.3 8.9 8.3 6.6 6.3 1.1 3.7 8.3 6.9 2.5 5.4 4.3 7.3 6.1 5.0 5.3 8.8 6.5 5.6 12.1 7.8 11.6 8.8 16.0 5.5 6.0 7.3 8.6 13.6 9.2 15.8 4.9 10.7 12.2 2.9 10.4 8.4 15.7 5.0 5.5 8.6 8.1 12.4 4.7 6.0 8.3 9.7 2.7 8.5 6.2 12.9 9.9 17.3 14.6 7.1 12.8 7.0 9.8 7.3 4.7 4.0 9.0 5.6 7.6 7.0 7.2 5.8 8.8 4.5 6.2 5.3 7.9 8.9 3.7 5.7 20.2 7.0 11.1 8.7 0.0 3.7 1.1 3.9 3.7 6.9 5.9 4.3 4.1 4.7 6.6 6.8 5.1 0.2 8.3 2.3 6.3 2.4 2.5 10.4 16.4 11.0 17.2 12.7 9.6 8.9 12.6 7.9 8.8 6.0 9.8 6.7 10.1 13.7 7.2 4.0 5.1 5.3 18.2 5.2 11.8 13.3 14.9 11.0 34.3 7.7 2.4 23.3 14.4 12.0 9.3 4.8 17.3 8.1 9.3 7.9 5.2 8.0 4.3 47.9 10.0 7.9 8.5 6.4 4.7 8.2 8.9 0.0 10.6 12.2 6.6 6.5 8.5 26.7 28.3 14.4 7.3 6.2 8.1 7.1 NUP188 KIAA0169 ENSG00000095319 "Nucleoporin 188" Q5SRE5 9 128947699-129007096 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.3" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2;Spermatocytes: 41.6;Spermatogonia: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061750, HPA063942" Approved Uncertain Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA061750: AB_2684602, HPA063942: AB_2685156" "unprognostic (4.64e-1)" "unprognostic (6.91e-3)" "unprognostic (2.36e-1)" "prognostic favorable (5.20e-5)" "unprognostic (9.50e-2)" "unprognostic (4.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.91e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (7.78e-2)" "unprognostic (4.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.68e-2)" "unprognostic (2.87e-1)" "unprognostic (2.81e-3)" "unprognostic (3.53e-3)" 10.2 11.1 7.6 12.6 9.2 14.3 14.0 13.3 8.7 9.2 9.3 10.1 9.6 5.8 9.8 6.7 16.6 8.3 7.6 9.2 5.6 6.3 8.1 9.6 13.1 16.6 6.5 6.7 10.8 13.3 12.6 13.6 9.1 7.3 9.5 9.3 11.2 9.9 8.3 10.9 16.4 9.0 11.0 7.7 12.2 9.5 60.3 7.3 26.5 9.2 11.3 17.3 8.5 10.5 6.1 7.9 6.3 10.7 6.0 12.0 7.0 10.9 21.0 17.4 23.7 13.2 13.1 15.6 15.4 12.2 28.3 18.9 25.3 8.8 19.2 5.8 16.9 18.3 32.6 39.0 19.1 21.2 15.4 18.8 17.1 39.2 19.9 8.4 29.2 17.3 9.1 9.0 29.7 15.2 8.3 16.2 25.0 37.5 13.7 19.9 27.8 24.9 11.9 23.3 21.1 20.2 22.9 37.7 19.6 8.7 12.4 24.5 11.8 39.9 15.2 5.9 13.4 16.7 10.8 13.1 23.5 16.7 23.6 27.5 11.7 21.6 26.0 13.7 18.7 17.3 6.3 5.3 1.9 9.3 10.7 12.0 6.1 7.9 9.0 7.9 5.9 8.1 8.6 0.8 6.0 5.9 3.3 9.5 7.0 7.6 9.2 13.3 8.7 5.6 6.3 6.5 6.7 7.3 7.3 0.0 13.0 7.5 5.2 5.8 14.9 2.7 7.6 4.0 2.3 5.2 43.2 6.4 1.7 5.5 10.1 6.8 3.2 0.0 5.6 5.9 6.9 7.5 5.8 3.8 7.4 19.1 8.7 12.9 4.9 3.1 8.9 7.2 1.7 4.6 6.7 7.5 7.5 0.0 11.0 1.9 25.0 25.8 4.2 41.6 37.7 9.8 7.2 7.0 6.0 7.2 NVL NVL2 ENSG00000143748 "Nuclear VCP-like" O15381 1 224227334-224330387 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028207, HPA028219, HPA028224, HPA028654" Supported Enhanced Nucleoli NA NA Nucleoli "HPA028207: AB_10601382, HPA028219: AB_2672526, HPA028224: AB_2672529, HPA028654: AB_2672714" "unprognostic (1.50e-1)" "unprognostic (1.61e-1)" "unprognostic (2.35e-2)" "unprognostic (2.03e-1)" "unprognostic (3.76e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (5.77e-5)" "prognostic favorable (2.95e-4)" "unprognostic (4.43e-2)" "unprognostic (7.14e-2)" "unprognostic (3.15e-1)" "unprognostic (2.42e-1)" "prognostic unfavorable (4.10e-11)" "unprognostic (1.67e-1)" "unprognostic (2.01e-1)" "unprognostic (1.75e-1)" "unprognostic (1.37e-1)" 11.3 12.6 13.3 14.3 12.6 12.5 16.2 24.4 15.7 14.2 13.8 16.9 11.4 9.0 17.1 12.2 11.6 13.5 8.5 9.8 10.4 9.9 13.6 9.4 11.8 16.9 10.5 10.8 16.9 19.3 16.8 20.7 25.8 13.4 14.2 16.0 16.5 11.6 12.6 9.8 22.7 12.5 17.5 13.3 16.4 11.1 9.4 12.0 23.8 15.5 8.5 19.1 14.4 13.7 14.0 9.9 12.5 15.2 12.3 13.5 7.9 14.6 8.3 17.4 13.9 6.5 9.4 17.5 12.5 8.7 16.5 15.2 12.7 12.6 20.4 13.5 7.9 6.6 13.9 18.9 11.7 18.0 15.9 26.1 9.8 14.2 6.5 11.2 19.3 15.6 7.6 9.3 14.7 16.6 7.9 10.8 12.4 25.6 12.6 10.8 11.4 14.9 9.6 26.8 11.0 14.9 18.8 21.7 13.1 10.0 10.3 15.4 13.5 18.9 28.9 17.1 15.5 13.8 17.6 10.4 13.2 8.6 15.3 23.1 8.3 18.1 21.7 8.4 15.7 13.7 12.5 8.2 8.2 13.1 13.0 13.0 14.0 13.5 9.6 9.9 10.1 11.3 11.5 0.8 12.3 15.2 9.6 9.5 7.9 13.3 12.6 24.4 15.7 10.4 9.9 10.5 10.8 13.4 12.0 20.8 23.9 8.8 3.8 4.6 13.9 8.8 5.1 21.4 13.6 1.8 9.8 16.6 11.6 8.1 5.6 6.0 8.6 0.0 7.2 11.3 8.7 4.4 15.1 2.9 9.1 9.5 4.1 5.5 5.7 2.2 8.9 6.6 5.0 5.4 11.5 9.4 6.7 17.5 10.3 5.6 21.0 0.0 8.3 14.6 12.6 4.0 15.3 7.5 14.5 3.8 NWD1 ENSG00000188039 "NACHT and WD repeat domain containing 1" Q149M9 19 16719976-16817963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;fallopian tube: 14.1" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 101.7" "Cancer enriched" "Detected in many" 6 "prostate cancer: 9.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 12 "MCF7: 3.4;U-937: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075476 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA075476: " "unprognostic (5.29e-3)" "unprognostic (3.08e-2)" "unprognostic (3.05e-2)" "prognostic favorable (2.55e-4)" "unprognostic (2.49e-1)" "unprognostic (4.20e-4)" "unprognostic (6.54e-2)" "unprognostic (5.15e-2)" "unprognostic (2.95e-1)" "unprognostic (1.60e-1)" "unprognostic (7.94e-2)" "unprognostic (1.76e-1)" "unprognostic (9.20e-2)" "unprognostic (1.31e-1)" "unprognostic (5.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.25e-1)" 0.6 0.7 6.9 0.6 8.1 0.8 1.0 0.9 5.9 1.7 0.9 11.3 0.5 0.7 1.1 6.5 0.6 14.1 0.8 0.7 10.9 4.2 1.0 0.7 1.8 0.7 3.9 7.8 0.7 4.3 0.6 1.3 0.7 27.8 10.6 0.9 10.3 2.7 3.9 0.8 0.6 0.7 0.8 2.2 0.6 1.0 1.4 4.6 0.0 1.6 0.0 0.6 0.8 0.5 0.5 0.1 1.3 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.5 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 1.3 0.5 0.0 0.1 0.0 0.1 6.9 8.1 0.9 5.9 10.9 4.2 3.9 7.8 27.8 4.6 0.0 1.0 0.0 1.6 0.2 0.1 0.6 0.0 101.7 5.7 0.0 0.0 0.1 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.1 0.0 6.7 0.0 0.0 0.1 0.0 1.2 0.0 0.0 2.7 0.6 0.2 0.0 0.0 0.6 9.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.0 0.4 1.4 OARD1 "C6orf130, dJ34B21.3, MGC19570, TARG1" ENSG00000124596 "O-acyl-ADP-ribose deacylase 1" Q9Y530 6 41033627-41097787 "Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 72.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029036 Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA029036: AB_10602336" "unprognostic (2.33e-2)" "unprognostic (5.23e-2)" "unprognostic (1.05e-1)" "unprognostic (1.92e-1)" "unprognostic (6.50e-2)" "unprognostic (1.45e-1)" "unprognostic (3.62e-2)" "unprognostic (7.06e-2)" "unprognostic (5.54e-2)" "unprognostic (3.99e-3)" "unprognostic (3.46e-2)" "unprognostic (2.15e-1)" "prognostic favorable (1.13e-4)" "unprognostic (4.78e-1)" "unprognostic (7.85e-2)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" 14.6 19.1 19.1 15.8 19.3 15.3 19.3 13.2 20.2 13.6 17.4 18.8 30.3 19.1 12.6 26.6 15.8 20.1 15.9 13.5 19.1 18.6 27.8 35.4 16.2 24.8 21.4 19.6 22.5 25.3 21.6 22.4 13.8 20.9 16.8 20.4 17.6 15.9 24.2 16.7 14.9 17.9 15.8 21.4 16.2 22.7 44.7 20.9 21.4 24.6 14.2 20.7 16.0 14.1 27.6 16.5 23.4 16.2 27.4 24.4 13.2 11.4 7.4 16.0 10.8 9.2 10.6 9.5 7.0 10.1 8.4 9.4 11.1 8.4 15.8 7.8 4.3 9.2 8.5 9.9 9.5 12.5 13.9 5.4 19.2 7.8 20.8 8.7 13.2 12.6 8.3 14.0 8.1 27.9 7.6 5.8 20.5 24.4 13.6 9.0 17.1 21.4 15.5 15.1 72.4 4.9 10.0 14.0 15.4 16.6 6.3 16.8 11.3 6.6 6.7 23.0 12.8 11.8 12.2 6.0 8.7 10.3 5.6 12.1 18.0 17.9 35.3 7.2 13.4 7.4 20.4 13.8 23.4 17.2 14.2 21.6 27.6 19.7 17.0 16.5 25.8 24.4 23.2 13.4 27.4 16.2 16.0 21.8 13.2 19.1 19.3 13.2 20.2 19.1 18.6 21.4 19.6 20.9 20.9 14.9 40.0 42.2 37.8 25.3 59.8 37.9 43.3 57.6 34.2 57.6 43.2 77.5 72.9 37.0 142.4 30.6 31.5 0.0 42.0 52.6 25.1 27.9 47.3 57.2 39.6 39.7 21.2 19.6 46.1 120.0 26.2 34.7 33.7 36.9 47.2 59.6 29.7 43.8 24.4 76.7 60.3 25.8 35.0 186.5 159.6 25.6 38.1 48.9 57.7 23.1 ODF3L2 "C19orf19, FLJ40059" ENSG00000181781 "Outer dense fiber of sperm tails 3 like 2" Q3SX64 19 463346-474983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "skeletal muscle: 12.5;testis: 16.7" "Cell type enriched" "Detected in some" 5 "Late spermatids: 894.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.5;BEWO: 2.2;EFO-21: 3.1;HMC-1: 2.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA067065, HPA067973" Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoli "Nucleoplasm, Golgi apparatus" "HPA067065: , HPA067973: AB_2685937" "unprognostic (3.75e-4)" "unprognostic (1.79e-2)" "unprognostic (1.83e-3)" "unprognostic (9.69e-3)" "unprognostic (5.88e-2)" "unprognostic (5.65e-2)" "unprognostic (9.32e-2)" "unprognostic (1.35e-1)" "unprognostic (2.34e-2)" "unprognostic (1.77e-2)" "unprognostic (2.13e-2)" "unprognostic (4.06e-2)" "unprognostic (2.02e-5)" "unprognostic (3.13e-3)" "unprognostic (8.99e-2)" "unprognostic (3.05e-1)" "unprognostic (1.99e-1)" 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.3 0.5 0.0 16.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 2.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 3.1 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.3 0.0 0.2 1.1 0.0 0.0 0.6 0.1 0.6 1.0 0.1 0.0 0.8 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.5 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 187.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 894.9 7.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 0.7 0.0 0.1 6.4 5.2 0.0 0.0 0.0 0.0 0.0 OLFM1 "AMY, NOE1, NOELIN, OlfA" ENSG00000130558 "Olfactomedin 1" Q99784 9 135075422-135121179 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 159.5" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 41.2;Horizontal cells: 36.5;Ito cells: 74.3;Leydig cells: 41.1" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 38 "classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 51 "dendritic cells: 5.1;monocytes: 5.0" "Cell line enhanced" "Detected in some" "HeLa: 25.5;MCF7: 21.5;NTERA-2: 28.6;OE19: 20.3;SCLC-21H: 41.3;SiHa: 34.2;T-47d: 53.0;U-2197: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057444 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in brain" NA NA 130000000 Nucleoli "Nucleoplasm, Cytosol" "HPA057444: AB_2683443" "unprognostic (6.77e-2)" "prognostic favorable (7.14e-4)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.69e-3)" "unprognostic (2.67e-1)" "unprognostic (6.04e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (9.46e-3)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (6.20e-2)" "unprognostic (7.53e-4)" 7.7 10.0 80.5 5.0 41.5 0.9 4.7 30.9 159.5 7.4 5.4 4.6 0.7 2.5 6.9 26.4 5.0 4.4 3.8 3.9 77.2 19.1 3.4 2.4 4.7 5.2 18.8 36.5 6.2 5.1 3.6 9.9 1.1 13.5 4.8 5.7 0.9 2.6 7.5 6.1 4.5 3.5 6.9 6.1 5.8 3.9 2.8 2.8 0.3 2.7 0.8 7.1 4.1 6.2 0.0 5.1 0.0 5.0 0.0 0.0 0.6 0.0 1.6 3.2 0.0 0.4 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.3 13.1 0.6 0.6 0.0 0.0 3.6 0.2 0.0 25.5 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 21.5 0.1 0.0 28.6 20.3 0.0 0.0 0.0 12.0 0.0 0.0 41.3 5.5 34.2 0.1 2.1 2.2 53.0 0.0 0.0 2.0 4.6 23.1 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 3.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 80.5 41.5 30.9 119.7 77.2 19.1 18.8 36.5 13.5 2.8 0.0 9.3 0.0 2.8 8.7 20.7 5.8 7.6 0.0 3.4 0.0 41.2 0.0 0.0 7.4 5.8 26.1 0.0 0.0 2.3 0.0 8.2 6.1 2.3 0.5 0.3 36.5 2.4 74.3 4.5 8.9 41.1 2.8 20.3 0.0 1.7 32.6 3.6 2.9 27.6 0.0 12.0 0.0 11.7 0.6 3.4 5.5 0.0 0.0 5.5 0.9 OR1N2 ENSG00000171501 "Olfactory receptor family 1 subfamily N member 2" Q8NGR9 9 122553112-122554214 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" 33 "Cardiomyocytes: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "RT4: 1.1" "Not detected" "Not detected" HPA060968 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoli, Plasma membrane" Nucleoplasm "HPA060968: " 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 ORC4 "HsORC4, ORC4L, Orc4p" ENSG00000115947 "Origin recognition complex subunit 4" O43929 2 147930397-148021604 "Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015124, HPA064562" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "CAB015124: AB_2157883, HPA064562: AB_2685287" "unprognostic (5.04e-2)" "unprognostic (6.56e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (7.27e-4)" "unprognostic (8.28e-2)" "unprognostic (6.45e-2)" "prognostic unfavorable (4.98e-8)" "unprognostic (5.55e-2)" "unprognostic (8.00e-2)" "unprognostic (1.81e-2)" "unprognostic (4.92e-2)" "unprognostic (1.19e-1)" "prognostic favorable (4.10e-6)" "unprognostic (2.49e-1)" "unprognostic (1.34e-1)" "unprognostic (1.62e-1)" "unprognostic (1.95e-3)" 11.5 14.3 19.0 11.4 20.5 19.6 17.3 29.8 27.2 13.6 14.6 11.0 12.0 13.9 14.8 13.5 13.1 17.3 11.9 13.8 18.1 22.3 24.5 15.5 10.9 11.9 18.1 18.1 21.2 12.1 18.9 29.5 14.3 30.9 14.9 16.8 12.7 15.2 14.6 16.0 11.6 15.6 13.8 18.1 11.0 10.9 17.3 11.8 20.4 19.0 12.7 13.6 13.3 12.6 16.1 18.1 21.5 19.1 20.2 16.6 13.1 12.4 10.9 21.4 11.7 8.3 8.2 23.2 14.3 12.0 18.0 18.0 26.8 12.7 16.1 15.6 8.4 16.0 12.7 24.2 14.0 18.8 11.3 20.6 22.3 11.8 18.1 11.1 14.0 8.4 6.9 17.0 19.6 7.9 13.4 12.1 15.4 21.1 8.5 11.7 13.2 10.9 11.4 24.2 10.3 15.9 12.0 14.4 14.6 19.9 25.9 20.3 15.9 12.8 14.1 17.1 20.3 10.8 6.8 8.8 13.7 13.5 9.9 13.0 8.5 20.0 15.3 11.2 11.0 8.3 21.5 15.0 19.8 16.2 19.1 16.6 16.1 15.8 16.6 18.1 15.4 16.6 16.3 21.1 20.2 14.8 9.2 16.0 13.1 19.0 20.5 29.8 27.2 18.1 22.3 18.1 18.1 30.9 11.8 77.4 53.4 11.0 19.9 23.1 44.5 24.2 10.2 96.4 80.8 12.2 37.3 33.7 38.1 27.8 19.2 16.5 17.2 0.0 15.1 40.8 23.7 20.2 42.9 15.3 20.8 50.9 22.1 17.2 20.0 13.4 20.8 22.1 20.3 18.0 18.1 32.9 16.3 14.0 20.1 41.6 35.2 32.3 19.5 55.5 25.3 21.8 27.3 22.4 22.5 17.3 OSBPL3 "KIAA0704, ORP-3, ORP3, OSBP3" ENSG00000070882 "Oxysterol binding protein like 3" Q9H4L5 7 24796539-24981634 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 75.0;Club cells: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000691, HPA048401" Enhanced Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA000691: AB_1854814, HPA048401: AB_2680386" "unprognostic (3.57e-1)" "unprognostic (1.14e-1)" "unprognostic (6.11e-3)" "unprognostic (3.89e-2)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (1.57e-3)" "unprognostic (4.51e-2)" "unprognostic (2.26e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (2.34e-1)" "unprognostic (7.95e-3)" "unprognostic (3.38e-2)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (2.06e-2)" 3.7 2.2 3.9 18.2 9.5 3.8 6.6 1.2 16.0 12.1 6.1 6.2 0.7 9.8 3.8 3.7 10.2 6.2 10.4 5.3 4.3 4.3 14.4 1.9 9.0 10.9 4.2 7.4 8.4 3.9 23.1 4.2 6.3 3.1 4.3 6.7 3.7 6.9 2.9 6.7 12.8 10.4 4.0 6.7 10.2 8.7 3.5 4.1 13.9 16.8 7.2 14.7 12.4 9.6 3.7 3.5 6.3 2.1 8.1 9.8 2.4 14.7 4.0 3.0 5.5 6.8 13.7 6.7 16.7 18.7 7.9 12.5 10.0 19.7 8.2 2.4 17.9 10.4 13.0 9.0 12.6 12.2 4.9 3.7 1.9 5.9 7.5 9.7 5.6 44.0 6.7 10.5 10.2 12.4 10.1 11.7 7.2 10.3 11.5 13.3 0.0 3.4 6.8 5.8 14.1 5.2 2.7 8.3 3.3 7.9 10.5 0.6 6.2 11.4 8.2 2.5 9.3 4.2 0.5 13.9 3.5 7.0 18.9 12.5 8.0 11.5 20.7 7.6 9.2 38.7 6.3 2.1 1.5 9.8 1.8 8.4 3.7 6.2 6.3 3.5 1.7 2.1 4.2 0.4 8.1 1.2 2.5 9.8 2.4 3.9 9.5 1.2 16.0 4.3 4.3 4.2 7.4 3.1 4.1 0.0 25.0 4.5 6.6 10.8 0.0 4.7 0.0 75.0 30.7 24.4 0.0 7.1 3.3 3.3 0.3 2.9 2.9 0.0 3.4 1.3 2.6 2.1 0.0 0.2 9.4 0.0 1.7 4.3 12.0 0.0 0.6 9.2 15.1 7.2 0.5 5.8 14.9 3.5 0.0 0.5 0.1 0.0 2.2 0.5 4.1 6.9 3.3 13.1 3.4 12.9 OSCP1 "C1orf102, NOR1" ENSG00000116885 "Organic solute carrier partner 1" Q8WVF1 1 36415827-36450451 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 35.8;testis: 49.9" "Group enriched" "Detected in many" 5 "Ciliated cells: 144.6;Early spermatids: 336.5;Spermatocytes: 91.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028436, HPA052655" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA028436: AB_10600885, HPA052655: " "unprognostic (3.46e-3)" "unprognostic (7.57e-2)" "unprognostic (4.67e-2)" "prognostic favorable (6.88e-4)" "unprognostic (1.28e-2)" "unprognostic (4.81e-2)" "unprognostic (3.38e-2)" "unprognostic (4.52e-2)" "unprognostic (5.52e-2)" "unprognostic (8.80e-2)" "unprognostic (2.21e-2)" "unprognostic (3.87e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (1.02e-2)" "unprognostic (4.20e-2)" 3.9 5.3 6.2 1.5 14.0 1.2 6.0 3.6 12.7 6.2 3.6 6.5 7.5 1.8 6.3 14.1 3.2 35.8 5.5 4.7 6.5 8.9 11.9 1.8 6.7 1.3 4.9 5.3 5.9 6.2 15.7 15.7 8.9 7.8 6.4 2.5 6.7 5.3 6.8 2.4 3.4 1.3 5.0 3.2 0.9 3.5 49.9 3.2 1.3 11.1 3.5 2.4 3.2 2.6 0.8 3.8 0.3 1.7 0.3 3.1 0.8 5.2 5.0 6.2 7.1 7.4 7.2 1.1 3.2 7.8 7.9 5.4 0.1 4.6 1.1 6.0 5.7 5.8 4.1 0.2 6.0 5.1 0.9 4.7 0.0 3.3 0.5 9.1 0.6 0.9 8.1 9.8 11.1 4.9 11.5 5.4 5.0 0.1 1.3 6.2 3.7 2.7 1.9 6.3 2.0 2.1 2.9 2.5 0.9 12.9 1.8 16.6 7.3 5.9 2.8 4.1 6.1 6.1 0.9 4.6 5.7 2.1 10.3 5.3 2.3 2.3 0.5 11.0 0.1 3.8 0.0 0.7 0.0 0.9 1.7 0.0 0.4 0.9 0.7 1.8 0.8 2.2 3.1 0.3 0.3 0.2 3.8 2.2 0.8 6.2 14.0 3.6 12.7 6.5 8.9 4.9 5.3 7.8 3.2 8.9 7.5 0.5 6.7 1.3 5.3 4.7 5.1 144.6 19.4 12.2 15.7 9.8 19.9 11.2 336.5 2.4 0.7 0.0 8.1 2.6 4.1 4.3 0.0 1.9 3.8 4.8 4.7 2.5 0.6 35.1 11.5 1.2 3.3 0.0 2.6 12.3 7.9 4.0 8.5 18.1 18.9 0.0 3.3 91.2 18.9 2.8 16.8 0.7 2.6 3.3 OSER1 "C20orf111, dJ1183I21.1, HSPC207, Osr1, Perit1" ENSG00000132823 "Oxidative stress responsive serine rich 1" Q9NX31 20 44196496-44210791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 722.5;Late spermatids: 1504.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045125 Approved Approved "Nucleoli,Nucleoli rim,Nuclear speckles" NA Yes "Nucleoli, Nucleoli rim, Nuclear speckles" "HPA045125: AB_10961629" "unprognostic (2.77e-2)" "unprognostic (3.01e-2)" "unprognostic (3.22e-1)" "prognostic unfavorable (2.58e-5)" "unprognostic (1.18e-1)" "unprognostic (6.07e-2)" "unprognostic (8.44e-3)" "unprognostic (3.31e-1)" "unprognostic (1.14e-1)" "unprognostic (8.78e-2)" "unprognostic (8.01e-3)" "unprognostic (9.87e-2)" "unprognostic (3.96e-1)" "unprognostic (2.14e-1)" "unprognostic (2.45e-1)" "unprognostic (8.39e-2)" "unprognostic (1.06e-1)" 18.7 11.8 11.9 18.4 13.3 62.5 20.0 17.8 13.3 19.1 17.2 13.0 13.0 15.1 17.5 17.6 23.5 14.2 13.7 16.9 12.4 10.0 15.0 16.3 17.7 16.9 16.3 10.9 21.4 10.9 19.3 12.5 31.7 13.1 22.6 14.1 12.4 17.0 13.2 46.3 22.3 18.9 23.5 16.9 18.2 14.7 47.4 13.3 15.1 19.0 15.4 17.4 29.6 16.7 28.4 14.6 74.3 21.9 15.1 17.6 19.8 20.4 16.0 11.6 9.1 31.1 22.2 13.5 18.9 28.5 29.8 27.4 38.3 21.2 20.5 18.7 17.2 38.8 27.9 13.2 17.4 25.1 6.9 8.6 6.6 34.5 25.9 18.0 11.3 11.0 26.3 29.3 19.5 35.8 15.5 13.5 12.5 9.7 25.3 16.3 30.6 9.1 13.8 10.6 18.7 16.4 12.7 19.7 14.1 14.8 14.0 11.7 11.8 26.9 35.8 23.9 14.3 18.2 10.2 11.8 24.6 18.9 14.6 16.2 17.2 18.4 19.9 17.4 8.5 12.7 50.2 16.8 27.7 12.7 15.7 13.7 28.4 14.8 12.5 14.6 26.9 17.6 15.9 74.3 15.1 21.9 9.5 17.1 19.8 11.9 13.3 17.8 13.3 12.4 10.0 16.3 10.9 13.1 13.3 17.9 28.4 24.4 119.5 230.4 9.6 33.9 17.8 24.1 22.7 12.2 3.9 33.6 31.5 38.1 722.5 31.5 56.3 0.0 32.0 30.4 33.9 80.1 33.4 26.0 38.1 11.1 47.4 17.2 27.0 1504.1 37.7 43.4 72.6 117.2 30.0 23.4 42.0 45.6 33.2 26.2 14.1 19.4 49.5 76.2 55.8 173.4 145.2 35.9 35.3 99.2 OSGIN2 "C8orf1, hT41" ENSG00000164823 "Oxidative stress induced growth inhibitor family member 2" Q9Y236 8 89901859-89927888 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 59.6;Early spermatids: 185.9;Late spermatids: 163.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Lineage enriched" "Detected in all" 6 "granulocytes: 17.0" "Cell line enhanced" "Detected in all" "SK-BR-3: 57.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028515, HPA050595" Approved Approved Nucleoli NA NA Nucleoli "HPA028515: AB_10602014, HPA050595: AB_2681186" "unprognostic (3.29e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (4.32e-3)" "unprognostic (1.42e-3)" "unprognostic (3.26e-2)" "prognostic unfavorable (3.91e-6)" "prognostic unfavorable (2.93e-4)" "unprognostic (2.32e-1)" "unprognostic (2.22e-3)" "unprognostic (4.38e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.66e-1)" "unprognostic (1.09e-1)" "unprognostic (7.25e-2)" 15.2 7.5 12.5 7.8 13.9 40.4 16.8 9.6 17.5 7.6 13.3 26.4 6.0 6.8 26.1 6.1 11.7 8.1 14.2 11.2 14.2 13.4 14.7 16.2 15.7 9.1 13.7 13.0 15.9 7.8 53.5 25.2 6.5 18.2 9.1 8.6 8.3 8.6 7.3 13.2 7.6 8.7 17.1 25.3 9.0 7.5 20.5 14.7 7.1 12.9 8.0 8.9 11.1 8.5 3.0 1.5 17.0 1.4 2.0 2.5 1.3 12.2 12.0 3.0 6.1 6.7 4.9 4.0 8.8 16.9 8.1 7.9 5.6 11.7 8.4 18.0 4.5 10.1 4.5 5.7 6.9 12.7 12.1 4.6 12.8 4.7 3.0 11.4 6.4 8.0 5.7 9.1 9.4 7.8 7.0 9.9 11.1 7.4 15.0 5.8 9.5 11.1 4.3 1.5 12.3 6.4 4.9 4.5 7.2 12.2 9.5 2.8 7.1 6.5 57.5 10.6 5.4 11.7 9.6 6.7 8.9 8.2 7.3 8.0 13.9 11.9 9.2 14.8 7.9 6.2 17.0 1.4 5.8 1.7 0.9 2.4 3.0 2.5 1.5 1.5 1.8 2.1 2.3 10.3 2.0 1.1 1.1 2.5 1.3 12.5 13.9 9.6 17.5 14.2 13.4 13.7 13.0 18.2 14.7 59.6 15.0 11.9 5.9 5.4 7.8 11.6 20.4 10.7 13.6 7.0 2.0 6.5 8.3 12.6 185.9 5.6 2.6 0.0 13.9 6.9 9.4 6.7 16.2 15.8 14.2 3.2 9.2 15.4 18.3 163.7 11.5 10.8 6.8 7.2 4.6 23.0 11.2 3.5 11.7 11.9 5.2 12.9 6.2 12.2 5.9 3.8 1.4 5.3 5.2 5.2 OSMR OSMRB ENSG00000145623 "Oncostatin M receptor" Q99650 5 38845858-38945596 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 38.4;GAMG: 39.5;HSkMC: 47.5;U-2197: 38.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017278 Approved Approved Nucleoli "Intracellular and membrane" NA NA 21000000 Nucleoli "HPA017278: AB_1854818" "unprognostic (6.34e-3)" "prognostic unfavorable (4.87e-4)" "unprognostic (2.58e-1)" "unprognostic (2.11e-1)" "unprognostic (2.18e-3)" "unprognostic (1.13e-1)" "unprognostic (8.00e-3)" "unprognostic (5.70e-2)" "unprognostic (1.79e-3)" "unprognostic (1.72e-3)" "unprognostic (1.60e-3)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.96e-6)" "unprognostic (1.88e-2)" "unprognostic (1.49e-2)" "unprognostic (4.43e-1)" "unprognostic (1.75e-2)" 41.1 18.0 7.3 18.7 9.4 0.3 31.0 3.1 9.4 14.1 13.7 2.8 4.6 4.4 14.4 12.9 14.7 14.5 22.4 22.4 5.4 3.5 19.7 23.6 25.7 31.7 9.0 1.3 33.6 10.1 6.6 10.5 40.1 13.3 20.8 8.6 9.2 17.2 11.1 13.0 12.5 8.0 32.5 15.6 23.5 11.5 10.8 6.9 3.6 17.5 10.4 11.3 40.4 43.6 0.6 0.6 1.6 0.4 0.7 0.6 0.1 7.4 9.7 1.6 4.2 17.9 38.4 5.6 12.2 19.4 12.0 16.2 0.0 20.3 0.0 5.8 12.9 39.5 10.4 2.1 15.0 19.5 0.0 1.2 0.5 7.6 7.3 20.3 0.0 0.1 47.5 9.0 27.0 23.1 22.4 1.8 0.0 0.0 0.0 7.5 2.0 0.0 0.0 0.2 1.5 3.2 0.0 0.5 0.0 24.2 2.2 0.0 0.0 27.6 0.0 0.0 2.4 8.4 0.0 2.8 29.4 11.1 38.0 6.5 0.0 0.0 0.0 23.6 0.0 6.3 1.6 0.4 0.4 0.5 0.3 0.2 0.3 0.3 0.1 0.1 0.6 0.4 0.6 1.0 0.7 0.1 0.6 0.2 0.1 7.3 9.4 3.1 9.4 5.4 3.5 9.0 1.3 13.3 6.9 41.7 42.5 0.0 57.8 27.0 0.0 2.8 22.9 9.4 46.6 12.2 0.0 5.3 0.0 43.3 0.5 37.0 0.0 0.0 41.7 6.0 25.9 39.4 1.1 11.3 1.3 0.0 0.0 60.2 9.7 0.4 38.6 1.3 6.8 2.8 0.0 0.8 60.1 0.0 7.1 3.3 0.6 19.4 24.0 0.3 0.6 21.0 14.3 0.5 0.0 57.6 OTUD7A "C15orf16, CEZANNE2, OTUD7" ENSG00000169918 "OTU deubiquitinase 7A" Q8TE49 15 31475398-31870789 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.4" "Group enriched" "Detected in many" 4 "Bipolar cells: 20.5;Horizontal cells: 23.8;Spermatogonia: 6.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044554 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA044554: AB_10794895" "unprognostic (3.61e-2)" "unprognostic (1.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.25e-3)" "unprognostic (1.29e-1)" "unprognostic (1.03e-4)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (3.24e-3)" "unprognostic (1.34e-1)" "unprognostic (1.79e-11)" "unprognostic (6.78e-2)" "unprognostic (2.76e-1)" "unprognostic (8.27e-2)" "unprognostic (1.79e-1)" 2.6 2.0 12.4 1.7 13.9 5.9 1.5 13.2 17.0 1.8 3.4 16.0 0.0 1.5 1.9 1.9 1.9 2.0 2.3 2.1 10.0 4.6 2.3 1.0 1.5 3.5 20.4 7.1 2.0 2.5 4.6 1.7 0.9 10.5 1.2 3.1 0.7 1.6 2.0 1.8 3.2 2.1 2.9 9.1 2.2 2.3 8.2 17.4 0.0 2.3 0.0 2.4 1.9 1.3 0.1 3.2 0.3 1.4 0.1 0.7 0.4 3.7 4.1 4.5 6.1 0.4 1.3 3.2 2.5 1.3 3.9 2.0 2.5 3.2 2.9 2.2 0.9 2.2 4.6 4.9 2.1 3.2 5.9 6.6 3.7 8.3 2.0 0.3 4.1 5.8 0.0 0.2 3.9 4.3 1.1 3.5 6.4 6.0 5.5 1.8 2.9 3.1 3.9 2.1 4.8 2.0 5.7 3.1 1.4 1.6 3.9 11.0 6.0 3.4 3.0 1.0 2.3 2.5 4.3 2.3 5.4 5.3 3.0 6.3 3.4 2.4 3.0 2.9 5.8 4.5 0.0 0.4 0.3 0.6 0.5 0.3 0.0 0.3 0.7 0.2 0.1 0.2 0.2 0.0 0.1 1.4 3.2 0.0 0.4 12.4 13.9 13.2 13.8 10.0 4.6 20.4 7.1 10.5 17.4 3.0 0.0 0.0 0.6 0.3 20.5 2.2 0.0 0.0 1.2 1.8 2.0 0.0 0.0 0.4 1.0 1.0 0.9 0.0 0.8 0.0 0.7 1.3 0.0 0.8 0.2 23.8 3.5 1.3 0.0 1.1 0.9 0.0 1.7 0.0 1.0 3.7 0.4 0.0 2.5 1.2 2.9 0.0 1.0 4.1 6.1 0.4 0.1 0.0 1.0 0.8 P2RX6 "MGC129625, P2RXL1, P2X6, P2XM" ENSG00000099957 "Purinergic receptor P2X 6" O15547 22 21009808-21028830 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 12.4" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 7.4;Ciliated cells: 4.0;Intestinal endocrine cells: 3.4" "Cancer enhanced" "Detected in some" "melanoma: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 11.4;LHCN-M2: 7.7;RH-30: 4.8;U-87 MG: 13.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028776, HPA028777" Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA028776: AB_2672771, HPA028777: AB_2672772" "unprognostic (1.81e-2)" "unprognostic (5.15e-3)" "unprognostic (2.11e-2)" "unprognostic (1.12e-1)" "unprognostic (4.28e-2)" "unprognostic (1.79e-5)" "unprognostic (1.70e-2)" "unprognostic (6.20e-2)" "unprognostic (1.49e-1)" "unprognostic (2.59e-2)" "unprognostic (1.89e-2)" "unprognostic (2.45e-2)" "unprognostic (2.88e-10)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (7.33e-2)" "unprognostic (2.39e-3)" 0.2 1.6 0.0 0.2 0.2 0.0 0.0 0.9 3.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 1.1 1.9 0.2 0.8 0.1 0.0 0.2 0.0 0.6 0.3 0.0 0.0 1.6 1.1 0.2 0.0 0.1 1.1 12.4 0.0 0.0 0.0 0.8 2.3 0.1 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.8 0.3 0.1 0.0 1.0 0.1 1.9 0.8 1.4 0.0 0.0 0.0 1.3 0.5 3.4 1.6 0.0 0.1 0.1 0.3 0.0 2.1 0.8 0.0 3.3 0.0 2.8 0.4 0.0 1.4 0.1 11.4 0.0 0.0 2.3 0.7 7.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.8 0.2 0.0 0.0 0.2 3.6 1.4 0.1 0.6 0.2 0.0 0.0 0.0 2.5 0.4 0.0 0.0 0.2 0.0 0.0 13.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.8 0.1 7.4 2.4 0.0 4.0 0.0 1.8 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 2.3 0.0 0.1 1.6 3.4 2.5 0.0 1.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.4 0.0 0.6 0.0 0.0 1.4 0.4 0.1 0.3 0.0 0.0 0.0 P3H1 "GROS1, LEPRE1, LEPRECAN, MGC117314" ENSG00000117385 "Prolyl 3-hydroxylase 1" Q32P28 1 42746335-42767084 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 37.3;Extravillous trophoblasts: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 50.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA012113, HPA016980" Approved Approved Nucleoli,Vesicles "Intracellular and membrane" NA NA 13000 Vesicles Nucleoli "HPA012113: AB_2668626, HPA016980: AB_2669498" "unprognostic (3.24e-1)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (4.57e-1)" "unprognostic (2.03e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.95e-7)" "unprognostic (5.41e-2)" "unprognostic (2.70e-3)" "unprognostic (9.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" "unprognostic (2.67e-2)" "unprognostic (1.60e-3)" 11.9 11.2 7.1 8.6 6.3 5.2 9.7 6.4 5.3 14.0 7.1 6.0 7.7 2.6 13.8 11.1 6.4 8.8 12.1 8.8 3.8 2.9 7.9 19.9 10.8 10.1 6.1 3.3 13.1 6.8 5.8 15.2 36.1 4.6 7.8 5.7 10.5 6.4 6.5 4.3 7.2 6.6 19.7 3.4 13.3 6.6 13.1 4.7 10.2 7.4 5.3 7.8 11.4 8.5 3.1 16.2 11.0 16.2 11.7 7.9 6.1 2.2 5.8 13.1 30.6 30.9 23.7 5.4 26.9 35.1 19.5 33.3 2.9 4.9 3.3 21.6 50.7 7.8 2.0 5.5 6.8 13.4 5.0 7.0 7.9 9.2 8.4 17.9 7.8 9.1 20.1 4.6 19.6 8.4 27.7 27.4 4.8 4.4 4.3 13.0 1.2 5.1 4.5 14.3 1.2 4.2 5.0 19.3 4.5 10.2 1.2 2.7 4.6 16.4 0.4 11.6 23.9 0.9 33.0 22.3 14.6 12.9 11.6 10.6 3.8 4.3 3.0 16.7 10.6 20.2 3.5 13.2 11.0 6.0 14.0 6.4 3.1 4.6 5.1 16.2 2.6 3.9 3.9 1.2 11.7 16.2 7.6 7.9 6.1 7.1 6.3 6.4 5.3 3.8 2.9 6.1 3.3 4.6 4.7 3.0 2.9 4.8 5.7 0.0 10.0 4.2 5.1 1.4 1.2 10.4 23.6 37.3 0.0 10.4 16.8 15.7 0.4 0.0 6.6 47.0 22.9 3.0 1.1 10.6 15.4 14.3 5.8 17.8 6.7 7.5 17.8 8.7 0.0 10.0 2.8 2.6 6.7 2.0 15.2 1.7 20.0 0.0 7.6 21.8 11.1 0.0 14.6 12.5 1.7 3.5 P3H3 "GRCB, HSU47926, LEPREL2" ENSG00000110811 "Prolyl 3-hydroxylase 3" Q8IVL6 12 6828410-6839851 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Bipolar cells: 28.3;Cone photoreceptor cells: 94.2;Horizontal cells: 41.3;Leydig cells: 46.1;Peritubular cells: 36.0;Rod photoreceptor cells: 26.9" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1;naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 21 "T-cells: 2.1" "Cell line enhanced" "Detected in many" "BJ: 22.1;hTERT-RPE1: 15.7;NTERA-2: 15.7;U-251 MG: 15.3" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 17.6" HPA043695 Approved Approved "Nucleoli,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA043695: AB_10797146" "unprognostic (2.54e-1)" "unprognostic (6.66e-2)" "unprognostic (1.14e-1)" "unprognostic (3.34e-2)" "unprognostic (5.76e-2)" "unprognostic (6.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.92e-1)" "unprognostic (6.90e-2)" "unprognostic (1.44e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.64e-4)" "unprognostic (2.58e-2)" "unprognostic (9.67e-2)" "unprognostic (2.27e-1)" "unprognostic (7.77e-3)" 3.7 3.1 1.2 2.2 2.6 0.3 3.0 10.7 2.5 12.1 2.7 0.0 7.6 1.1 11.0 8.5 2.5 2.1 5.6 4.4 1.2 1.1 0.4 1.6 1.9 0.0 2.2 9.3 3.6 12.1 7.4 2.5 0.8 5.6 0.5 8.1 5.9 6.5 0.5 1.8 1.7 8.8 0.5 1.0 2.8 2.1 0.1 0.0 3.5 1.2 1.4 5.9 4.7 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.8 4.2 7.9 4.9 6.0 0.1 22.1 12.7 7.0 7.7 0.3 0.0 0.0 0.3 8.3 0.2 0.0 2.5 0.2 1.6 0.0 10.6 0.5 2.3 1.0 3.4 0.5 0.0 6.5 0.2 3.4 1.9 15.7 7.4 0.7 2.0 0.0 3.3 0.0 0.0 0.2 15.7 0.0 0.6 0.0 3.9 0.1 0.3 0.0 1.6 6.0 0.0 0.0 2.4 2.1 0.1 0.1 12.9 6.9 10.3 10.6 15.3 0.0 0.1 0.2 5.9 0.0 2.7 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.9 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 28.3 9.0 2.5 2.7 3.4 5.2 94.2 0.3 1.7 1.6 0.7 2.3 0.0 0.0 2.3 0.4 7.4 4.6 0.0 0.0 1.2 41.3 1.2 3.7 0.0 1.3 46.1 0.0 0.0 1.8 2.5 4.8 1.9 0.0 36.0 0.3 26.9 6.5 9.2 0.7 0.9 0.0 0.8 0.0 0.4 1.4 PAFAH1B2 ENSG00000168092 "Platelet activating factor acetylhydrolase 1b catalytic subunit 2" P68402 11 117144267-117176894 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051836 Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA 1600000 Cytosol "Nucleoli, Plasma membrane" "HPA051836: AB_2681630" "unprognostic (1.08e-2)" "unprognostic (3.14e-2)" "unprognostic (2.07e-2)" "unprognostic (3.88e-2)" "unprognostic (9.94e-2)" "unprognostic (1.21e-3)" "prognostic unfavorable (9.44e-4)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.01e-1)" "prognostic favorable (4.25e-4)" "prognostic unfavorable (7.79e-5)" "unprognostic (8.18e-2)" "unprognostic (1.11e-2)" "unprognostic (9.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" 21.5 34.1 30.6 19.2 29.7 33.5 32.3 43.5 41.3 21.6 20.2 33.3 12.7 21.1 23.4 22.8 23.3 20.8 19.3 26.2 31.9 36.8 24.6 22.5 20.5 17.7 39.3 31.6 23.6 23.0 23.1 24.2 26.9 39.6 22.2 19.6 17.3 19.3 17.4 14.1 20.8 18.0 19.9 51.6 18.3 21.4 29.9 26.3 15.1 30.9 10.8 20.4 25.9 20.3 26.8 21.6 36.8 35.7 18.9 31.4 26.9 15.0 17.2 19.9 28.7 22.2 15.6 15.5 25.3 22.1 14.1 12.9 31.4 33.2 16.2 36.3 30.3 14.1 24.1 28.9 32.7 18.6 14.5 11.1 41.8 15.7 20.1 19.9 14.4 16.0 17.2 25.9 28.1 35.5 15.4 23.0 9.1 22.1 12.4 21.5 9.6 13.9 21.2 18.2 20.9 13.6 15.6 22.5 17.8 21.5 23.5 22.2 29.4 29.2 22.1 9.6 17.6 24.6 12.4 36.8 25.8 17.1 12.6 17.9 3.9 6.0 21.8 10.4 27.7 21.6 32.1 30.8 26.7 24.2 33.3 28.2 26.8 28.0 25.3 21.6 25.4 29.3 31.4 36.8 18.9 35.7 15.8 19.5 26.9 30.6 29.7 43.5 37.8 31.9 36.8 39.3 31.6 39.6 26.3 26.8 33.3 41.0 38.7 108.6 36.9 31.1 68.8 17.4 26.1 62.8 45.2 36.3 39.7 52.6 7.3 54.4 31.6 0.0 34.5 77.2 42.9 53.9 18.5 39.2 38.5 44.5 79.3 57.7 59.6 8.9 42.0 55.7 47.2 49.5 37.2 33.5 72.8 46.7 32.2 44.8 33.5 12.9 46.4 45.1 75.6 101.4 45.7 38.5 39.1 38.8 PAK1IP1 "bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84" ENSG00000111845 "PAK1 interacting protein 1" Q9NWT1 6 10694695-10709782 "Predicted intracellular proteins" "Ribosome biogenesis" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 48.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030111, HPA030112" Supported Supported Nucleoli NA NA Nucleoli "HPA030111: AB_2732454, HPA030112: AB_10603125" "unprognostic (9.41e-2)" "unprognostic (3.79e-1)" "unprognostic (1.67e-2)" "unprognostic (1.17e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.35e-6)" "unprognostic (7.23e-2)" "unprognostic (9.29e-3)" "unprognostic (1.06e-3)" "unprognostic (2.14e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (7.02e-8)" "unprognostic (8.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.11e-1)" "unprognostic (2.10e-1)" 12.8 9.9 12.0 12.2 9.7 11.5 15.9 9.1 15.7 12.7 8.7 5.8 7.7 5.9 10.5 9.9 15.7 8.7 7.2 8.6 9.2 9.8 12.3 17.5 7.2 16.3 10.9 9.2 13.8 10.6 6.8 9.1 9.1 11.3 48.8 9.8 4.2 10.3 10.4 20.6 7.8 6.8 10.5 10.1 10.9 7.4 6.3 9.9 8.4 9.3 18.5 11.7 8.2 9.1 8.4 11.5 2.4 10.3 8.1 12.3 5.8 14.3 5.6 7.3 12.7 9.2 8.4 10.6 9.4 7.8 14.3 14.1 12.4 6.4 14.5 23.6 8.0 17.9 7.7 15.0 12.1 20.6 8.5 10.1 8.0 5.3 14.2 13.5 22.1 10.5 7.7 10.6 13.9 23.6 4.8 9.5 8.0 24.1 4.2 11.8 8.5 11.0 20.3 16.0 13.4 10.1 11.5 9.6 22.5 10.3 8.6 11.1 9.6 7.0 18.1 20.1 13.0 8.0 8.0 8.2 11.6 8.3 12.4 23.2 10.0 27.3 15.9 4.7 14.9 21.7 1.1 7.1 2.4 8.4 10.3 8.6 8.4 7.6 8.4 10.0 6.4 10.2 12.3 0.3 8.1 8.0 11.5 4.8 5.8 12.0 9.7 9.1 15.7 9.2 9.8 10.9 9.2 11.3 9.9 17.9 10.5 28.3 38.3 59.0 12.9 16.6 17.8 22.7 36.4 10.4 3.9 22.4 16.6 36.8 10.2 17.7 5.4 0.0 23.3 24.5 23.5 36.7 34.6 18.1 32.0 12.7 5.2 16.0 9.9 8.3 19.8 14.9 11.8 19.0 10.5 11.8 25.6 3.5 19.4 17.9 10.1 6.5 25.9 23.4 49.7 43.5 14.6 12.5 19.9 26.0 PARP1 "ADPRT, PARP, PPOL" ENSG00000143799 "Poly(ADP-ribose) polymerase 1" P09874 1 226360691-226408079 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "DNA-binding, Glycosyltransferase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cytotrophoblasts: 400.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727" Supported Supported Enhanced Nucleoplasm,Nucleoli NA NA 39000 Nucleoplasm Nucleoli "CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240" "unprognostic (2.02e-1)" "unprognostic (9.40e-2)" "unprognostic (7.44e-3)" "unprognostic (1.32e-1)" "unprognostic (4.29e-1)" "unprognostic (9.22e-2)" "prognostic unfavorable (3.40e-4)" "unprognostic (2.20e-1)" "unprognostic (3.62e-2)" "unprognostic (1.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.35e-5)" "unprognostic (2.38e-2)" "unprognostic (1.82e-1)" "unprognostic (3.14e-2)" "unprognostic (2.64e-1)" 17.3 16.6 31.2 35.7 31.2 14.3 15.3 21.1 29.2 14.3 21.8 37.4 10.3 15.0 18.2 13.0 18.1 15.0 10.8 24.2 27.8 21.9 13.4 24.8 14.1 56.3 40.7 21.8 14.6 28.1 62.6 22.9 28.7 30.4 22.0 19.2 16.3 17.0 24.7 47.3 11.7 19.6 25.5 49.1 32.7 15.9 22.5 34.8 29.5 14.5 16.5 70.2 19.9 13.7 53.0 16.5 9.0 17.5 11.1 21.8 11.5 28.9 15.5 43.2 30.6 11.3 9.4 24.6 19.2 17.1 26.1 21.5 24.7 14.2 84.4 28.7 11.6 11.5 21.8 59.4 18.8 23.1 35.4 82.9 32.6 20.7 16.1 6.8 54.2 15.8 9.2 7.5 21.0 14.9 7.3 20.3 19.6 51.9 43.1 13.5 13.8 17.3 19.6 79.5 40.9 30.8 52.5 74.0 78.0 12.2 20.7 43.5 38.1 25.0 28.0 15.7 31.8 23.5 34.0 15.4 13.9 23.0 18.7 35.9 17.6 29.4 72.5 11.6 18.3 31.1 9.0 6.7 6.9 18.3 11.3 21.6 46.8 19.4 18.0 14.3 53.0 15.2 16.4 1.0 11.1 17.5 16.5 21.8 11.5 31.2 31.2 21.1 28.4 27.8 21.9 40.7 21.8 30.4 34.8 50.6 68.3 130.2 75.6 64.2 94.4 106.4 43.3 75.0 97.8 54.1 133.5 400.4 61.3 77.0 28.3 54.0 16.8 23.3 91.9 75.6 55.5 70.8 116.9 65.7 117.1 85.8 72.1 31.9 42.2 16.3 37.2 45.7 59.1 93.8 46.5 78.6 54.3 24.6 32.9 36.1 102.8 45.3 47.4 92.8 211.4 42.0 115.1 74.0 57.9 42.9 PARP2 ADPRTL2 ENSG00000129484 "Poly(ADP-ribose) polymerase 2" Q9UGN5 14 20343582-20357905 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052003 Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA052003: AB_2681689" "unprognostic (3.93e-1)" "unprognostic (7.92e-2)" "unprognostic (4.12e-1)" "unprognostic (1.24e-1)" "unprognostic (3.40e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (6.48e-4)" "unprognostic (1.97e-2)" "unprognostic (4.43e-2)" "unprognostic (9.35e-3)" "unprognostic (1.44e-2)" "unprognostic (1.42e-2)" "unprognostic (3.37e-3)" "unprognostic (2.83e-1)" "unprognostic (9.19e-2)" "unprognostic (1.91e-1)" "unprognostic (2.89e-2)" 11.5 16.6 23.6 8.9 28.5 20.9 15.2 36.7 31.3 12.0 11.7 16.8 9.3 11.2 18.8 16.8 10.7 14.7 8.9 14.0 19.2 17.8 14.0 15.0 12.0 11.8 16.6 30.8 20.2 11.8 11.6 14.6 11.3 22.1 11.3 12.9 10.8 10.5 12.9 25.9 15.1 10.8 14.6 13.9 11.4 11.6 20.4 17.4 6.0 11.7 13.9 15.2 9.3 10.4 6.7 5.6 1.8 5.0 6.9 12.3 4.9 20.3 14.9 23.0 17.2 7.6 7.3 16.7 22.7 12.4 28.9 35.8 14.1 19.5 15.1 10.3 7.1 25.8 19.2 30.6 10.4 34.2 12.1 14.9 13.8 18.1 23.5 6.8 28.6 7.9 5.0 8.9 18.0 19.9 8.0 14.8 18.5 14.6 20.7 19.8 12.6 14.6 12.3 12.6 23.2 23.3 18.3 31.3 9.8 11.5 10.6 16.0 11.0 25.3 14.1 6.6 15.3 13.0 9.7 10.1 17.6 26.7 12.1 18.4 19.4 24.7 20.1 7.3 12.7 19.5 1.8 5.0 0.5 9.5 4.5 12.3 6.7 8.9 8.3 5.4 4.6 9.6 9.3 0.1 6.9 2.5 5.6 5.2 4.9 23.6 28.5 36.7 31.3 19.2 17.8 16.6 30.8 22.1 17.4 23.8 6.2 10.4 9.3 5.8 26.8 12.3 5.1 36.1 21.6 7.0 11.8 19.1 6.6 10.5 7.3 10.0 3.4 23.3 7.7 17.9 8.4 3.7 8.1 9.6 10.2 28.6 4.6 6.2 4.9 7.3 10.6 6.4 8.5 4.6 4.2 21.9 8.0 5.5 15.9 5.6 21.7 6.5 9.5 17.7 33.3 4.3 12.5 4.4 5.2 4.6 PBDC1 "CXorf26, MGC874" ENSG00000102390 "Polysaccharide biosynthesis domain containing 1" Q9BVG4 X 76172936-76178204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003155 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA 88000 Nucleoplasm "Nucleoli, Cytosol" "HPA003155: AB_1078592" "unprognostic (6.95e-2)" "unprognostic (9.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.78e-2)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (2.47e-3)" "unprognostic (7.23e-2)" "unprognostic (1.78e-1)" "unprognostic (1.56e-3)" "unprognostic (8.82e-3)" "unprognostic (3.64e-1)" "unprognostic (1.39e-2)" "unprognostic (1.05e-1)" "unprognostic (4.98e-2)" "prognostic favorable (8.57e-4)" "unprognostic (1.62e-1)" 24.9 25.4 12.7 15.1 14.3 28.9 17.1 15.3 14.9 21.3 31.5 10.0 14.8 28.5 21.3 18.4 26.9 15.1 14.2 14.7 12.5 12.5 36.3 39.1 16.6 17.0 17.6 8.8 23.1 16.1 15.2 22.8 21.9 15.0 22.3 20.9 10.3 18.0 14.3 19.2 19.5 48.9 22.3 22.7 23.8 17.8 8.4 14.6 21.1 22.5 21.2 18.2 20.8 17.6 28.1 24.0 17.0 27.8 27.1 30.6 17.1 12.1 17.7 15.2 10.4 19.5 19.5 13.1 21.6 18.5 19.9 17.2 16.9 16.8 16.6 14.6 21.8 24.8 17.5 25.3 24.2 26.0 12.3 16.0 12.3 9.9 25.3 30.7 36.1 18.1 15.5 19.9 27.2 23.3 12.1 25.3 6.0 17.4 8.3 24.3 14.2 17.0 26.5 42.2 30.2 27.8 14.6 16.0 2.1 29.1 22.5 8.9 11.5 9.5 15.9 0.1 20.5 9.7 13.6 21.7 14.9 14.9 17.7 19.7 14.6 25.8 9.9 16.5 12.7 11.7 6.7 17.6 17.0 30.6 25.6 22.2 28.1 27.5 29.7 22.5 23.7 28.2 26.9 3.3 27.1 27.8 24.0 22.5 17.1 12.7 14.3 15.3 14.9 12.5 12.5 17.6 8.8 15.0 14.6 32.8 23.2 24.8 69.4 47.1 21.4 36.9 33.1 33.5 30.7 38.4 13.7 48.2 41.4 60.7 1.0 28.6 58.6 0.0 54.4 49.7 36.0 52.4 50.7 46.4 62.6 7.9 26.5 19.6 30.5 1.1 44.3 40.9 43.9 80.2 37.2 21.5 53.5 34.8 36.4 66.3 19.3 51.8 41.1 2.3 16.4 61.6 46.0 44.5 46.0 68.1 PCDH1 pc42 ENSG00000156453 "Protocadherin 1" Q08174 5 141853111-141879246 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 37.9;Exocrine glandular cells: 40.1;Pancreatic endocrine cells: 44.8;Urothelial cells: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.5;HaCaT: 36.8;HUVEC TERT2: 19.3;OE19: 26.1;RT4: 25.2;TIME: 25.1;WM-115: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047720, HPA050538" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA 270000 "Nucleoplasm, Cell Junctions" Nucleoli "HPA047720: AB_2680130, HPA050538: AB_2681162" "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (5.30e-2)" "unprognostic (4.61e-3)" "unprognostic (5.03e-2)" "unprognostic (4.16e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (1.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.43e-1)" "prognostic favorable (7.55e-5)" "unprognostic (2.05e-1)" "unprognostic (4.16e-2)" "unprognostic (3.13e-2)" "unprognostic (1.91e-1)" 22.4 4.5 14.8 7.4 17.6 1.4 19.0 16.1 25.6 8.3 22.2 7.3 11.4 20.6 7.0 7.0 26.9 9.7 6.8 8.9 11.6 7.4 14.9 13.0 18.9 3.4 8.8 16.9 2.5 11.0 1.3 5.2 32.5 9.2 11.1 14.4 6.0 23.7 12.3 7.4 17.3 15.8 7.5 7.5 1.6 22.8 1.5 9.8 0.0 9.1 3.9 8.8 8.6 11.7 0.0 0.0 0.3 0.0 0.0 2.2 0.5 6.2 0.3 2.6 2.9 0.1 0.0 1.9 0.0 0.0 0.0 0.0 1.5 29.5 0.0 15.2 0.2 0.3 36.8 3.4 2.7 0.0 0.0 0.1 0.0 0.1 0.0 2.4 0.0 0.1 0.0 6.2 0.0 0.4 6.3 19.3 0.0 0.0 3.1 0.0 5.0 0.1 0.0 11.2 26.1 5.0 0.1 0.0 4.2 2.1 25.2 0.3 0.6 0.1 8.1 6.5 7.9 6.5 0.1 25.1 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.2 0.0 17.8 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.5 14.8 17.6 16.1 25.6 11.6 7.4 8.8 16.9 9.2 9.8 0.0 4.0 0.0 10.2 0.9 9.1 2.2 22.9 4.0 2.3 12.2 0.0 0.6 3.3 13.6 0.3 21.8 37.9 0.0 40.1 0.2 1.6 22.4 0.0 26.0 0.2 25.4 7.5 6.2 1.9 0.8 0.6 0.5 0.0 0.0 17.6 4.0 44.8 19.3 0.4 5.1 0.4 12.9 15.1 0.2 0.2 2.3 16.8 0.0 14.7 43.0 PCDHAC1 ENSG00000248383 "Protocadherin alpha subfamily C, 1" Q9H158 5 140926369-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "parathyroid gland: 33.3" "Cell type enhanced" "Detected in some" 27 "Alveolar cells type 1: 6.0;Bipolar cells: 1.7;Ciliated cells: 1.4;Rod photoreceptor cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.7;EFO-21: 3.7;hTCEpi: 11.3;PC-3: 6.4;SCLC-21H: 5.0" "Low region specificity" "Detected in all" HPA052775 Approved Nucleoplasm,Nucleoli,Vesicles No No "Nucleoplasm, Nucleoli" Vesicles "HPA052775: AB_2681942" "unprognostic (2.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.32e-3)" "unprognostic (9.52e-3)" "unprognostic (1.36e-1)" "unprognostic (9.63e-2)" "unprognostic (4.27e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" "unprognostic (3.64e-3)" "unprognostic (1.04e-3)" "unprognostic (3.25e-3)" "unprognostic (1.35e-1)" "unprognostic (2.96e-1)" "unprognostic (3.29e-2)" 0.3 0.4 0.9 0.3 1.0 0.0 0.0 2.0 2.8 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.9 0.0 1.0 1.6 0.2 0.1 0.8 1.0 1.1 0.0 1.5 33.3 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.8 0.4 0.0 0.0 0.2 0.1 0.5 0.2 0.2 0.1 0.0 0.0 8.7 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 1.1 0.0 0.3 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 11.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 6.4 0.0 0.0 0.0 0.5 0.4 5.0 2.4 0.0 0.7 0.0 1.2 0.5 0.0 0.0 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.2 0.1 0.0 0.0 6.0 0.3 0.0 0.0 0.0 1.7 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PCDHGA2 PCDH-GAMMA-A2 ENSG00000081853 "Protocadherin gamma subfamily A, 2" Q9Y5H1 5 141338760-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 2.7;Cardiomyocytes: 1.6;Leydig cells: 1.1;Peritubular cells: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.8;BJ: 5.4;fHDF/TERT166: 6.3;HSkMC: 5.0;hTERT-RPE1: 5.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA038625" Approved Approved "Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480" "unprognostic (2.43e-3)" "unprognostic (2.10e-2)" "unprognostic (1.32e-2)" "unprognostic (4.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.14e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.45e-3)" "unprognostic (9.68e-3)" "unprognostic (1.04e-2)" "unprognostic (1.18e-2)" "unprognostic (2.23e-4)" 5.1 4.3 6.7 2.1 8.0 0.6 4.2 5.2 12.6 6.6 2.6 4.6 1.0 0.9 6.5 5.7 2.4 5.5 5.5 11.1 6.5 4.6 3.3 2.4 4.6 1.1 6.0 2.3 15.3 8.4 9.2 10.6 2.2 7.8 5.3 1.4 13.8 3.3 5.8 2.6 2.9 1.4 5.2 5.6 1.9 2.1 10.4 3.5 0.0 4.3 1.2 1.1 3.2 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 3.9 9.8 0.1 5.4 2.1 0.5 0.9 0.1 0.1 0.1 0.7 6.3 0.8 0.2 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.0 0.2 0.1 0.3 5.8 2.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.3 0.2 0.8 0.0 0.3 0.7 0.0 3.6 0.1 0.5 0.7 0.0 3.3 0.9 0.5 0.3 0.1 0.0 0.4 0.0 2.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 8.0 5.2 7.2 6.5 4.6 6.0 2.3 7.8 3.5 0.0 0.0 0.0 0.1 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.5 0.3 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PCID2 FLJ11305 ENSG00000126226 "PCI domain containing 2" Q5JVF3 13 113177539-113208715 "Predicted intracellular proteins" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069107, HPA073074" Uncertain Approved Nucleoplasm,Nucleoli NA Yes Nucleoli Nucleoplasm "HPA069107: AB_2686088, HPA073074: AB_2686568" "unprognostic (2.53e-2)" "unprognostic (2.94e-2)" "unprognostic (4.02e-1)" "unprognostic (1.26e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (7.80e-5)" "unprognostic (1.73e-3)" "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (1.47e-1)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (4.24e-6)" "unprognostic (1.41e-2)" "unprognostic (5.41e-3)" "unprognostic (1.45e-1)" "unprognostic (6.28e-2)" 17.6 22.6 13.7 14.6 16.0 11.3 21.0 33.5 15.9 20.9 18.2 14.6 20.4 10.3 24.0 20.7 15.6 22.5 14.7 31.3 12.8 10.8 15.4 18.1 14.8 19.6 16.9 13.0 30.6 28.6 12.1 37.6 13.4 14.9 20.0 16.3 14.4 21.4 19.3 21.6 15.0 15.2 19.7 13.4 20.1 19.2 43.4 16.5 19.4 25.4 11.6 20.6 18.0 21.2 15.1 9.7 8.1 12.5 7.6 32.4 19.0 21.9 9.3 14.3 12.6 26.3 19.8 10.0 16.9 25.5 23.6 21.9 18.3 20.8 17.6 11.3 22.9 30.0 14.0 22.6 15.3 26.3 15.3 22.3 22.7 24.3 16.1 26.2 38.4 9.3 16.2 17.1 14.8 26.3 19.0 18.6 24.6 17.3 7.2 26.7 10.6 20.4 27.2 14.1 40.6 11.9 18.7 15.9 16.8 21.4 11.1 19.1 11.8 10.5 26.3 19.3 15.1 14.5 47.0 12.0 7.0 25.2 10.1 12.7 11.1 10.3 24.6 24.2 26.2 15.9 8.1 9.6 7.1 27.6 12.5 32.4 15.1 23.6 28.7 9.7 14.2 21.5 22.3 1.5 7.6 11.5 9.2 23.5 19.0 13.7 16.0 33.5 15.9 12.8 10.8 16.9 13.0 14.9 16.5 17.9 11.8 26.0 26.1 19.2 21.0 26.8 15.3 30.8 14.8 14.0 15.7 25.3 23.2 19.0 26.4 26.3 7.9 23.3 12.0 20.4 25.7 26.0 10.4 17.8 18.1 35.0 7.5 15.4 20.8 8.0 38.3 13.8 15.1 26.2 14.1 19.5 17.0 19.5 38.2 18.4 24.9 19.4 28.9 129.6 82.8 21.7 26.0 34.8 19.9 21.4 PCTP STARD2 ENSG00000141179 "Phosphatidylcholine transfer protein" Q9UKL6 17 55750979-55842830 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 56.4;liver: 53.2" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 61.2;Hepatocytes: 64.8;Syncytiotrophoblasts: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 56.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 38.8" "Low region specificity" "Detected in all" HPA022979 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA022979: AB_2671018" "unprognostic (1.14e-1)" "unprognostic (5.20e-2)" "unprognostic (4.27e-2)" "unprognostic (7.35e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (3.43e-6)" "unprognostic (9.35e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" "unprognostic (8.65e-2)" "unprognostic (6.63e-3)" "unprognostic (1.16e-1)" "unprognostic (5.36e-3)" "unprognostic (1.26e-1)" "unprognostic (4.93e-1)" "unprognostic (6.89e-3)" "unprognostic (3.04e-1)" 8.2 5.6 4.9 8.2 8.2 5.1 8.4 3.1 5.3 6.2 11.9 3.0 29.8 9.3 5.2 15.8 6.6 4.9 10.1 12.1 5.1 4.7 17.0 53.2 11.6 7.8 6.2 4.9 5.2 7.5 4.2 5.3 19.4 5.5 7.5 12.7 5.3 7.1 32.1 10.8 4.1 9.8 8.3 5.0 10.0 12.5 8.0 3.9 3.0 5.7 5.8 5.2 8.1 9.9 2.0 12.1 56.4 15.3 6.2 2.7 6.5 8.7 8.1 6.1 2.2 8.2 8.0 15.7 3.4 4.6 5.5 5.4 9.1 11.4 2.4 26.8 5.4 5.1 4.9 3.5 5.8 5.0 38.8 8.2 21.7 2.4 16.9 7.3 8.2 17.2 6.6 7.7 3.2 6.0 6.8 10.6 7.4 15.6 8.8 6.0 7.6 6.5 6.7 6.6 0.0 7.2 3.3 8.8 2.0 5.8 6.5 3.0 6.9 1.7 3.8 14.5 14.0 10.1 14.3 7.7 6.3 4.5 7.0 4.5 24.9 7.8 1.5 5.8 13.6 10.8 15.1 15.3 56.4 2.5 12.6 1.5 2.0 1.6 2.5 12.1 1.4 0.9 2.2 15.9 6.2 13.2 0.9 2.7 6.5 4.9 8.2 3.1 5.3 5.1 4.7 6.2 4.9 5.5 3.9 3.0 7.2 5.1 2.5 0.9 3.8 15.3 17.8 2.7 0.0 8.7 2.0 42.8 10.0 11.2 13.2 7.3 11.8 0.0 12.0 61.2 6.7 1.4 15.0 64.8 19.2 1.6 12.6 9.2 22.6 15.4 15.3 12.6 11.8 10.8 16.2 3.5 8.3 7.0 24.4 30.7 2.2 12.9 10.3 9.8 8.1 1.3 56.2 8.5 14.3 1.7 PDCD7 "ES18, HES18" ENSG00000090470 "Programmed cell death 7" Q8N8D1 15 65117379-65133836 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 165.8;Cone photoreceptor cells: 208.1;Rod photoreceptor cells: 177.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049388 Approved Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA049388: AB_2680741" "unprognostic (7.71e-3)" "unprognostic (3.25e-1)" "unprognostic (4.09e-1)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (6.68e-3)" "unprognostic (2.36e-2)" "unprognostic (3.18e-3)" "unprognostic (8.18e-2)" "unprognostic (3.28e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (1.00e-4)" "unprognostic (5.29e-2)" "unprognostic (3.42e-2)" "unprognostic (1.44e-1)" "unprognostic (1.62e-2)" 16.0 16.8 22.4 17.6 26.9 13.1 23.8 43.7 28.5 19.0 19.4 21.3 12.6 14.6 23.8 19.8 23.2 18.6 12.7 14.4 21.0 16.3 13.7 15.6 21.5 19.5 22.9 24.7 26.5 16.6 16.5 15.7 17.4 20.6 17.4 14.3 15.0 14.2 19.0 17.5 16.4 15.4 20.4 17.5 18.7 15.1 27.4 32.1 19.7 18.0 12.7 21.5 18.4 18.6 5.9 4.0 4.0 3.2 7.1 4.5 1.4 8.8 7.4 12.6 13.0 12.7 17.9 7.6 10.2 11.3 12.6 9.7 8.9 9.9 17.1 11.1 8.1 9.4 16.9 32.0 7.3 9.1 10.3 8.6 16.6 6.3 7.8 11.7 22.5 11.2 10.4 11.2 6.9 13.1 12.1 9.9 12.8 21.1 14.0 10.9 6.7 23.6 16.1 15.3 10.3 6.7 20.9 16.2 19.0 7.6 14.2 10.4 12.4 11.4 9.7 14.9 14.4 7.8 18.6 10.1 13.1 12.8 7.5 15.7 25.1 28.6 12.3 11.8 25.0 6.6 4.0 3.2 1.8 4.5 2.6 3.8 4.8 4.3 4.1 2.8 5.9 4.5 4.5 0.8 7.1 2.5 4.0 3.1 1.4 22.4 26.9 43.7 28.5 21.0 16.3 22.9 24.7 20.6 32.1 0.0 11.0 24.3 63.5 33.8 165.8 15.9 15.3 9.4 14.8 27.9 208.1 49.6 24.9 7.2 4.9 27.4 10.0 0.0 7.0 25.2 28.2 37.6 19.6 16.1 20.7 71.5 13.8 16.5 21.8 6.6 53.8 17.5 11.8 5.4 17.4 63.4 6.5 10.5 45.3 17.1 177.0 45.3 24.4 137.9 102.2 34.9 59.7 40.6 21.3 41.6 PDGFRL PRLTS ENSG00000104213 "Platelet derived growth factor receptor like" Q15198 8 17576433-17644071 "Disease related genes, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 14.3" "Cell type enhanced" "Detected in many" 11 "Fibroblasts: 36.0;Leydig cells: 69.0;Peritubular cells: 66.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "AN3-CA: 49.5;BJ hTERT+: 40.1;HSkMC: 21.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052801 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted - unknown location" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA052801: AB_2681956" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (5.10e-2)" "unprognostic (1.59e-2)" "unprognostic (7.39e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (6.54e-2)" "unprognostic (3.86e-1)" "unprognostic (7.46e-2)" "unprognostic (1.63e-1)" "unprognostic (6.72e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.58e-3)" "unprognostic (1.26e-1)" "unprognostic (4.47e-3)" "unprognostic (6.00e-3)" 7.7 0.4 0.5 0.1 0.9 0.0 14.3 0.6 0.5 8.0 1.3 0.0 3.6 2.0 0.3 5.8 2.6 1.2 0.3 0.4 0.4 0.3 0.7 0.0 0.4 11.6 1.6 2.3 2.0 1.5 0.9 0.0 1.4 1.1 3.3 1.8 0.6 6.3 0.5 0.2 1.0 0.9 8.3 0.0 0.9 2.0 0.0 0.9 1.4 1.4 0.0 0.0 0.1 0.0 4.5 0.2 49.5 1.5 0.6 3.2 0.9 40.1 1.8 8.0 0.2 0.0 0.0 0.2 0.6 6.0 0.0 2.7 0.2 1.0 0.0 3.0 0.0 1.4 1.0 3.8 0.0 0.0 21.9 0.0 2.2 0.0 0.0 3.3 0.4 0.0 0.6 0.2 3.2 0.0 0.1 2.4 0.2 0.7 0.0 0.0 0.1 0.2 2.9 0.1 0.3 0.3 0.3 0.8 3.0 0.1 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.4 11.7 0.4 2.2 0.0 0.0 3.4 0.0 0.0 14.1 0.0 2.5 19.2 2.7 0.1 0.0 6.4 17.2 36.0 1.7 0.0 0.0 2.7 0.0 1.2 2.5 0.0 3.1 69.0 0.3 10.1 2.8 1.0 1.3 4.9 0.0 66.4 0.0 0.4 0.0 6.1 0.5 1.0 8.7 8.1 0.0 0.2 0.3 PDK3 ENSG00000067992 "Pyruvate dehydrogenase kinase 3" Q15120 X 24465221-24539837 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046583, HPA072492" Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA046583: AB_2679707, HPA072492: AB_2686526" "unprognostic (5.41e-3)" "unprognostic (5.43e-3)" "unprognostic (5.35e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-3)" "unprognostic (5.38e-2)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.51e-1)" "unprognostic (5.57e-2)" "unprognostic (1.35e-1)" "unprognostic (1.39e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "unprognostic (1.02e-1)" "unprognostic (2.92e-1)" "unprognostic (2.28e-2)" "unprognostic (9.43e-3)" 9.6 5.6 5.7 9.8 17.3 16.3 12.8 3.3 23.6 8.0 14.7 5.5 5.6 13.6 7.3 15.7 9.5 13.2 7.0 16.9 12.5 6.8 13.7 11.1 11.2 13.4 6.2 13.7 11.0 7.3 12.8 14.1 7.7 14.9 8.3 10.1 9.9 19.3 5.2 3.9 14.2 15.6 8.6 6.1 17.9 12.7 23.1 4.8 12.5 6.2 4.1 14.9 10.3 9.2 4.5 7.2 36.4 10.9 7.1 11.0 6.7 9.0 4.6 3.9 6.6 0.1 0.0 4.1 2.7 2.4 3.7 6.5 0.4 11.1 9.2 1.9 0.7 10.5 2.1 11.3 6.9 10.0 7.8 5.4 4.9 5.3 2.6 1.3 4.2 4.8 0.7 3.1 0.9 0.9 0.4 5.5 9.6 0.9 14.0 0.5 17.0 7.8 5.4 7.0 9.7 5.4 4.0 7.0 13.5 3.2 17.7 2.5 3.2 14.7 6.0 4.6 6.2 8.3 1.6 0.2 2.6 3.8 4.8 3.2 9.0 6.9 11.0 7.1 6.4 5.4 9.4 8.9 21.3 7.6 10.9 11.0 4.5 6.2 6.2 7.2 4.1 4.9 5.7 36.4 7.1 10.4 2.3 5.1 6.7 5.7 17.3 3.3 23.6 12.5 6.8 6.2 13.7 14.9 4.8 3.0 1.3 2.9 8.6 4.0 3.4 6.3 0.0 1.4 2.3 1.8 0.0 4.0 3.3 3.6 53.4 2.8 4.5 0.0 4.5 26.4 3.2 5.2 5.7 4.2 13.2 7.9 4.1 4.3 18.9 22.4 3.4 9.6 15.1 8.2 2.4 3.2 2.8 0.0 5.3 11.3 3.9 0.0 9.2 6.4 6.3 3.9 14.9 14.9 3.3 7.1 PELI1 ENSG00000197329 "Pellino E3 ubiquitin protein ligase 1" Q96FA3 2 64092652-64144454 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 105.7" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 199.1;Suprabasal keratinocytes: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 33.9" "Group enriched" "Detected in all" 4 "granulocytes: 33.9;monocytes: 9.2" "Cell line enhanced" "Detected in many" "CACO-2: 21.8;U-698: 54.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.33e-2)" "unprognostic (3.43e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (3.12e-3)" "unprognostic (6.73e-3)" "unprognostic (8.01e-3)" "unprognostic (4.16e-2)" "unprognostic (3.52e-3)" "unprognostic (5.99e-3)" "unprognostic (3.33e-1)" "prognostic unfavorable (5.67e-6)" "unprognostic (6.72e-2)" "unprognostic (6.22e-2)" "unprognostic (8.88e-2)" "unprognostic (1.03e-1)" 15.7 5.1 10.0 15.1 20.5 105.7 22.3 15.1 8.9 9.9 14.5 11.0 3.3 9.9 14.5 7.1 26.4 8.0 14.9 11.6 11.3 6.8 6.7 8.6 20.1 16.8 15.6 5.2 4.8 6.2 11.0 14.8 13.7 10.8 7.6 11.8 6.0 12.3 8.5 4.5 17.5 17.3 8.4 15.0 17.8 10.2 7.8 12.8 19.9 6.3 10.2 19.3 14.1 14.8 3.9 2.3 33.9 9.2 1.3 5.0 2.5 1.3 1.0 14.0 9.3 1.6 1.2 3.2 1.8 2.0 1.6 2.6 21.8 1.5 17.9 4.4 0.6 0.6 2.1 4.2 3.9 3.3 4.4 3.3 1.6 0.7 3.5 4.9 1.7 3.2 1.6 3.1 2.4 8.4 1.7 9.2 6.9 1.0 4.5 1.4 0.1 3.8 2.5 9.1 4.1 0.6 4.8 4.8 10.2 6.7 4.0 6.4 9.0 1.3 2.1 4.8 4.5 1.1 1.2 6.5 1.5 2.2 1.5 2.6 10.4 1.0 54.2 0.8 1.6 4.1 5.1 6.5 6.3 0.4 6.1 0.7 3.9 2.2 0.9 2.3 2.4 2.7 1.1 33.9 1.3 9.2 0.2 5.0 2.5 10.0 20.5 15.1 8.8 11.3 6.8 15.6 5.2 10.8 12.8 26.8 45.1 22.4 65.1 199.1 0.9 5.1 10.2 30.8 55.7 5.2 0.0 1.4 1.7 4.5 8.5 42.7 37.0 0.0 23.1 6.5 25.9 43.3 14.0 6.8 19.1 3.2 24.6 36.2 52.6 7.8 1.4 57.1 106.3 13.6 22.2 4.5 18.2 28.1 1.8 7.7 1.8 0.0 48.4 6.1 7.8 190.1 3.3 11.5 27.3 104.0 PELI2 ENSG00000139946 "Pellino E3 ubiquitin protein ligase family member 2" Q9HAT8 14 56117814-56301526 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 21.4" "Cell type enhanced" "Detected in many" "neutrophil: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 19.3;JURKAT: 24.9;MOLT-4: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.26e-1)" "unprognostic (2.25e-1)" "unprognostic (9.21e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (2.53e-2)" "unprognostic (3.36e-3)" "unprognostic (1.81e-1)" "unprognostic (2.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.14e-1)" "prognostic favorable (1.53e-6)" "unprognostic (3.64e-1)" "unprognostic (2.15e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" 12.3 3.3 5.2 5.6 4.6 16.5 8.7 21.4 6.5 7.5 9.4 5.4 9.7 11.1 9.3 7.1 4.7 5.9 11.5 3.4 4.6 4.5 9.7 3.1 7.3 4.8 5.2 3.9 16.0 38.9 1.7 5.5 3.3 4.4 8.2 4.2 9.2 7.6 12.4 3.8 6.5 12.6 17.7 5.8 6.6 14.1 10.0 4.2 38.2 4.9 3.4 2.6 13.3 14.9 0.9 2.0 9.0 3.0 0.5 0.8 1.1 0.0 1.8 5.1 0.0 2.8 4.2 0.1 0.7 2.4 0.5 0.0 0.1 0.4 0.1 2.4 1.4 0.0 0.5 3.9 0.0 0.2 1.2 1.4 4.4 7.9 0.0 2.4 0.6 19.3 2.7 0.2 0.0 0.0 2.8 0.9 24.9 3.2 0.0 0.5 0.0 21.6 0.2 8.3 0.0 0.7 10.6 0.3 0.9 2.1 8.7 10.2 0.0 0.4 0.0 5.7 3.3 0.0 3.5 0.3 1.5 2.6 0.4 2.5 0.4 0.0 0.5 2.7 3.0 1.5 1.4 3.0 3.5 0.5 1.6 0.8 0.2 0.6 0.3 2.0 0.9 0.4 0.3 9.0 0.5 1.2 0.5 0.0 1.1 5.2 4.6 21.4 4.4 4.6 4.5 5.2 3.9 4.4 4.2 0.0 7.7 2.7 11.0 12.7 30.0 1.9 7.6 14.7 10.3 12.2 27.5 0.0 3.3 4.4 2.3 10.9 8.4 0.0 12.2 0.1 5.6 7.0 5.7 0.8 1.1 20.6 6.9 11.1 16.5 4.1 15.8 11.1 16.9 2.8 7.4 10.0 8.6 3.7 17.0 8.8 18.5 12.9 22.1 1.4 27.2 15.9 0.1 3.5 3.0 9.7 PELI3 MGC35521 ENSG00000174516 "Pellino E3 ubiquitin protein ligase family member 3" Q8N2H9 11 66466327-66477337 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 20.6;Intestinal endocrine cells: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033750, HPA038875, HPA062281" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Vesicles" Nucleoli "CAB033750: AB_2161361, HPA038875: AB_2676249, HPA062281: AB_2684735" "unprognostic (1.15e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (1.94e-1)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.19e-3)" "unprognostic (7.91e-3)" "prognostic favorable (8.19e-4)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.01e-2)" 6.7 9.5 14.5 3.8 17.0 1.8 7.4 19.6 33.1 7.4 8.3 6.7 6.4 4.8 10.3 9.1 10.6 8.2 10.1 7.7 17.4 13.5 4.6 3.2 7.1 4.3 13.0 12.5 15.3 9.9 21.5 8.3 3.8 15.8 11.5 2.9 6.4 10.4 22.3 10.8 11.2 4.7 11.3 6.2 5.0 5.8 6.2 7.8 0.3 8.5 2.7 3.4 9.0 11.8 3.3 3.3 1.3 6.8 1.2 3.1 1.4 15.5 6.6 5.4 4.2 8.6 3.4 4.3 5.0 6.5 4.8 4.1 9.6 3.5 3.9 5.0 5.4 8.6 8.4 3.5 6.3 2.0 7.6 3.1 1.0 5.4 2.8 5.4 0.8 7.6 3.2 7.1 4.9 1.7 7.0 1.0 5.2 1.8 6.1 2.0 9.5 3.2 2.4 3.4 8.2 6.8 10.8 3.9 4.1 2.6 5.0 6.5 3.6 2.5 7.2 17.0 2.4 8.4 4.2 2.7 4.2 6.5 18.3 4.1 5.6 3.2 2.1 8.9 2.5 3.5 1.3 2.5 0.4 2.5 1.8 2.0 2.8 2.1 3.1 3.3 3.3 2.2 1.8 0.1 1.2 6.8 1.0 2.4 1.4 14.5 17.0 19.6 33.1 17.4 13.5 13.0 12.5 15.8 7.8 6.0 1.3 0.0 3.4 1.4 12.1 6.2 2.5 0.0 0.0 0.0 9.8 1.9 1.7 2.7 3.7 2.5 0.0 0.0 2.1 1.7 3.1 2.0 0.0 2.4 2.9 20.6 25.4 1.8 0.6 5.6 6.9 3.2 0.0 2.8 0.5 5.5 1.9 0.8 9.2 2.2 8.5 6.5 4.8 1.9 3.2 0.3 0.2 0.0 0.6 1.6 PELP1 MNAR ENSG00000141456 "Proline, glutamate and leucine rich protein 1" Q8IZL8 17 4669774-4704337 "Predicted intracellular proteins" Transcription "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053966, HPA056028, HPA060760" Supported Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355" "unprognostic (8.81e-2)" "unprognostic (1.22e-2)" "unprognostic (2.81e-3)" "unprognostic (2.24e-1)" "unprognostic (1.39e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (6.44e-4)" "unprognostic (2.72e-1)" "unprognostic (2.76e-1)" "unprognostic (4.31e-2)" "prognostic favorable (4.07e-5)" "unprognostic (2.20e-2)" "unprognostic (4.05e-2)" "unprognostic (1.31e-2)" "unprognostic (3.31e-1)" "unprognostic (8.32e-2)" "unprognostic (5.15e-2)" 14.0 12.3 19.8 13.8 22.0 10.5 10.9 22.9 28.0 12.6 11.8 25.5 8.4 12.9 14.3 9.8 17.4 17.3 11.4 18.2 19.9 18.8 9.6 10.6 11.2 17.2 20.2 18.6 21.0 18.9 18.2 17.0 12.4 18.3 13.8 8.6 13.8 16.5 14.7 38.2 17.2 11.6 12.2 18.7 13.6 12.4 21.3 18.1 17.0 14.5 12.3 13.3 11.2 10.6 3.8 3.5 5.8 3.4 3.8 4.5 1.9 15.9 35.0 13.9 21.9 10.8 8.0 31.2 11.6 8.1 16.1 17.3 34.1 11.8 38.5 17.9 9.1 11.4 24.6 25.8 18.1 9.2 19.9 36.8 17.1 17.6 27.5 14.0 13.8 23.1 9.8 11.3 19.8 16.7 8.3 11.9 20.8 20.6 16.9 8.8 21.9 26.0 16.3 22.8 15.5 11.8 27.5 12.3 18.9 11.2 12.1 14.0 18.7 19.9 14.7 14.9 13.9 17.7 9.4 12.0 12.5 17.7 18.9 22.3 9.1 15.6 16.0 14.1 14.3 16.0 0.9 2.4 5.8 3.1 3.1 3.1 2.6 3.0 2.4 2.4 3.8 3.3 4.5 1.4 3.8 3.4 3.5 2.0 1.9 19.8 22.0 22.9 28.0 19.9 18.8 20.2 18.6 18.3 18.1 20.8 29.6 16.3 12.9 13.2 23.9 19.8 5.1 20.1 19.4 8.7 15.7 24.8 1.7 13.2 47.9 13.2 6.2 0.0 12.6 23.5 14.1 12.3 29.0 9.0 14.7 33.4 12.1 4.9 4.5 17.5 8.6 13.8 10.1 107.4 16.1 12.5 11.1 12.4 18.0 4.1 16.6 6.5 9.9 21.4 71.6 14.3 17.7 13.1 18.8 10.6 PES1 "NOP7, PES" ENSG00000100029 "Pescadillo ribosomal biogenesis factor 1" O00541 22 30576625-30607083 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040210, HPA062439, HPA066670" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes Yes "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700" "unprognostic (1.82e-1)" "unprognostic (5.88e-2)" "unprognostic (5.59e-3)" "unprognostic (4.83e-2)" "unprognostic (1.48e-1)" "unprognostic (3.23e-3)" "prognostic unfavorable (1.84e-9)" "unprognostic (3.29e-2)" "unprognostic (3.40e-1)" "unprognostic (1.73e-1)" "unprognostic (4.79e-2)" "unprognostic (2.46e-2)" "unprognostic (5.65e-2)" "unprognostic (1.27e-3)" "unprognostic (1.65e-1)" "unprognostic (4.56e-2)" "unprognostic (1.42e-1)" 24.4 28.1 26.0 26.1 30.1 28.2 29.6 19.0 31.8 19.7 21.9 27.2 18.1 20.4 28.0 21.3 31.2 28.0 22.7 18.1 26.3 18.5 24.2 34.9 19.8 30.0 27.2 26.6 30.5 49.0 31.3 17.0 20.2 23.6 24.2 19.2 18.6 22.2 22.1 34.1 32.3 19.8 22.9 24.3 26.4 25.2 34.5 27.2 21.2 25.3 23.1 24.9 21.8 22.6 14.4 17.8 3.9 19.4 12.4 16.2 16.3 34.3 39.2 14.5 30.8 16.7 16.4 22.3 22.9 18.8 39.1 30.5 45.4 14.8 46.6 20.5 26.0 30.2 24.0 44.5 40.8 28.8 19.9 42.8 22.6 22.5 39.1 41.7 54.5 23.8 23.1 25.7 40.6 40.9 18.7 25.1 16.7 37.2 19.0 23.6 43.3 26.4 55.3 28.1 33.8 28.8 33.8 25.3 45.6 21.4 23.8 25.1 26.0 22.6 25.8 30.3 12.1 18.1 28.0 19.8 45.9 34.8 23.3 38.2 24.2 20.7 47.6 32.2 25.1 29.3 3.9 15.8 3.9 13.3 19.4 16.2 14.4 12.4 12.7 17.8 13.8 14.2 12.7 0.6 12.4 13.9 15.4 9.5 16.3 26.0 30.1 19.0 31.8 26.3 18.5 27.2 26.6 23.6 27.2 3.0 17.6 13.7 18.1 20.0 6.4 3.4 25.5 26.8 19.4 24.4 7.9 30.6 21.6 36.3 38.4 21.1 24.6 0.0 38.0 33.3 14.9 13.1 17.4 20.7 33.9 3.2 22.5 28.8 29.7 10.4 18.4 20.8 20.3 31.5 19.9 13.1 33.1 14.0 19.1 39.6 8.1 19.4 18.4 23.5 19.3 19.9 23.8 15.0 24.7 12.2 PFDN1 PFD1 ENSG00000113068 "Prefoldin subunit 1" O60925 5 140245039-140303121 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006499 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA 10000 "Plasma membrane, Cytosol" Nucleoli "HPA006499: AB_1079596" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.11e-2)" "unprognostic (5.66e-3)" "prognostic unfavorable (8.81e-5)" "unprognostic (2.12e-2)" "unprognostic (2.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.50e-1)" "unprognostic (2.33e-1)" "unprognostic (4.10e-1)" "unprognostic (8.60e-3)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.00e-1)" 36.1 24.8 39.5 18.8 38.8 26.4 25.8 28.5 48.7 23.1 27.0 29.3 15.8 20.9 28.2 29.6 26.8 22.5 18.6 46.7 38.2 34.7 32.7 20.2 24.2 21.6 38.8 35.3 20.6 18.1 26.5 19.9 26.9 45.6 24.3 23.0 19.8 23.1 24.4 69.5 20.9 22.0 32.1 37.1 23.1 19.2 19.6 24.1 23.7 24.4 28.7 25.5 23.0 19.2 38.9 36.3 45.6 46.4 39.5 45.1 37.2 39.1 18.4 32.8 18.9 21.5 22.1 31.7 53.6 26.7 41.2 45.9 39.1 25.1 26.4 54.2 28.5 43.1 14.6 23.8 52.6 48.6 27.9 24.0 23.4 18.8 25.2 25.3 48.1 18.4 23.5 28.0 35.0 36.9 26.7 45.2 31.1 20.9 17.3 34.6 17.5 32.7 33.0 21.7 16.0 27.6 23.2 46.7 19.4 46.0 18.0 18.6 19.6 40.1 35.3 30.6 32.1 24.1 28.5 58.1 29.1 28.9 17.1 47.9 16.9 43.3 68.4 29.4 31.8 33.7 43.2 31.1 45.6 33.4 46.4 35.3 38.9 38.4 38.4 36.3 35.9 38.5 34.6 5.1 39.5 44.1 33.9 45.1 37.2 39.5 38.8 28.5 48.7 38.2 34.7 38.8 35.3 45.6 24.1 62.5 27.0 57.4 56.0 33.8 39.1 71.1 56.0 54.9 56.9 62.8 43.2 99.5 104.5 108.2 2.6 70.9 60.6 70.0 88.5 69.1 54.6 45.1 52.1 56.2 74.9 23.8 44.7 68.2 54.4 9.4 48.3 63.8 70.9 117.2 33.8 53.2 101.0 51.8 49.1 83.4 38.8 64.7 38.1 20.0 47.7 30.6 71.6 50.7 39.3 59.1 PFKFB4 ENSG00000114268 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4" Q16877 3 48517684-48562015 "Enzymes, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.0" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 36.2;Mucus-secreting cells: 11.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.5;eosinophil: 11.4;intermediate monocyte: 7.3;neutrophil: 21.6;non-classical monocyte: 12.2" "Group enriched" "Detected in many" 6 "granulocytes: 21.6;monocytes: 12.2" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 22.9;U-87 MG: 36.5;WM-115: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047719, HPA066058" Uncertain Approved Nucleoli NA NA Nucleoli "HPA047719: AB_2680129, HPA066058: AB_2685606" "unprognostic (7.60e-2)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (3.90e-3)" "unprognostic (7.96e-2)" "unprognostic (1.72e-6)" "unprognostic (1.65e-1)" "unprognostic (3.75e-2)" "unprognostic (6.78e-2)" "unprognostic (3.78e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.91e-8)" "unprognostic (2.04e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-3)" "unprognostic (3.35e-2)" 2.0 2.2 4.0 3.9 4.9 12.7 2.1 6.3 6.3 2.6 17.1 8.6 3.0 17.8 2.1 18.5 6.4 1.5 1.8 1.4 4.2 5.2 3.6 1.7 3.8 6.3 7.4 2.7 3.5 18.9 4.1 5.1 9.5 6.9 3.3 3.5 3.3 2.5 2.0 4.8 3.3 24.0 2.5 5.3 10.0 1.2 26.0 5.2 0.4 1.6 3.6 2.6 4.9 4.2 0.2 2.7 21.6 12.2 0.2 0.5 2.1 5.0 1.5 3.6 3.3 1.2 1.8 7.1 2.5 4.3 5.2 12.6 2.5 1.8 2.2 2.4 1.9 12.4 1.4 1.5 4.4 4.6 1.5 1.2 5.1 3.3 2.7 1.0 0.9 2.3 1.8 6.6 8.3 0.8 22.9 1.2 2.9 1.7 1.9 4.1 1.1 0.3 7.1 2.2 1.0 3.4 0.4 1.7 2.3 2.0 4.7 1.0 2.2 2.7 1.2 9.9 3.7 2.8 2.2 0.3 5.3 2.1 0.6 15.3 8.8 1.9 1.3 36.5 1.8 31.7 0.0 6.5 11.4 0.2 7.3 0.1 0.2 0.3 0.0 2.7 0.1 0.5 0.1 21.6 0.2 12.2 0.3 0.0 2.1 4.0 4.9 6.3 6.3 4.2 5.2 7.4 2.7 6.9 5.2 0.0 2.2 0.0 0.3 2.9 5.0 0.6 0.0 1.4 1.2 0.0 2.0 11.1 0.0 2.0 2.6 0.4 1.7 0.0 1.3 36.2 1.5 0.4 1.1 0.0 5.3 6.4 4.1 1.8 11.0 2.0 0.9 4.4 1.7 0.0 11.8 3.6 2.9 0.3 0.7 0.0 4.3 0.0 0.8 0.5 0.5 1.5 4.6 0.0 1.5 0.0 PFKL ENSG00000141959 "Phosphofructokinase, liver type" P17858 21 44300051-44327376 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 285.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030047 Approved Uncertain Nucleoli,Mitochondria NA NA 1800000 "Nucleoli, Mitochondria" "HPA030047: AB_10602815" "unprognostic (6.21e-3)" "unprognostic (2.93e-1)" "unprognostic (4.46e-2)" "unprognostic (1.23e-2)" "unprognostic (1.87e-2)" "unprognostic (1.23e-1)" "unprognostic (1.10e-1)" "unprognostic (6.98e-2)" "unprognostic (9.75e-2)" "prognostic unfavorable (4.41e-4)" "unprognostic (5.69e-2)" "unprognostic (5.40e-2)" "unprognostic (1.55e-1)" "unprognostic (4.99e-1)" "unprognostic (2.49e-1)" "unprognostic (8.06e-2)" "unprognostic (3.01e-2)" 32.0 16.7 28.0 26.0 29.5 26.4 23.1 21.3 46.0 28.3 38.7 40.9 30.1 65.5 21.3 33.5 33.5 22.8 37.5 18.4 28.8 23.4 40.3 31.3 21.0 25.2 32.4 33.0 19.5 27.1 12.3 17.1 31.9 29.1 20.2 17.2 36.3 28.8 28.5 8.3 31.1 59.3 20.5 36.1 28.1 42.7 24.0 29.1 16.4 20.4 15.4 26.0 27.2 23.9 20.3 26.9 5.2 38.0 7.7 25.2 22.8 32.6 14.3 10.2 29.4 16.1 12.0 45.0 24.6 16.0 14.3 14.1 19.2 7.2 19.4 29.3 16.4 13.7 17.8 8.1 22.3 3.3 16.3 18.4 39.2 12.5 31.3 12.4 29.5 25.0 15.7 13.6 14.6 7.2 21.7 21.0 14.2 24.1 22.2 9.7 41.5 12.7 23.0 16.0 29.3 16.1 31.5 9.7 52.6 6.5 36.2 18.0 13.5 35.8 30.4 15.7 4.3 24.1 26.1 30.4 21.7 14.0 14.2 9.4 43.2 11.7 7.9 36.1 23.5 17.3 5.1 22.2 5.2 12.9 37.9 10.8 14.4 17.0 11.8 26.9 20.3 10.2 7.9 4.5 7.7 38.0 17.0 25.2 22.8 28.0 29.5 21.3 46.0 28.8 23.4 32.4 33.0 29.1 29.1 20.8 27.5 37.6 33.4 31.7 71.1 12.6 17.8 21.4 28.4 87.2 62.8 106.3 84.6 68.0 1.8 43.0 285.1 0.0 45.0 147.2 44.6 37.8 41.5 60.1 95.6 28.6 44.5 41.1 58.5 5.2 36.2 60.1 65.8 177.7 107.9 59.6 51.1 112.2 52.3 108.3 44.6 25.8 42.9 1.4 8.7 31.6 134.4 31.9 139.6 44.5 PGAM2 PGAM-M ENSG00000164708 "Phosphoglycerate mutase 2" P15259 7 44062727-44065587 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0" "Group enriched" "Detected in many" 13 "Early spermatids: 421.0;Late spermatids: 1332.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 39.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA043801, HPA050314, HPA060173" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA 60000000 Nucleoplasm "Nucleoli, Cytosol" "HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215" 1.4 0.8 2.0 0.4 2.2 0.4 0.5 6.9 2.1 0.5 0.5 3.6 0.0 0.6 0.5 9.1 6.1 0.6 0.7 111.6 2.1 3.2 0.8 0.4 0.4 0.4 4.2 1.6 0.5 0.6 0.6 1.3 0.4 2.0 1.9 0.4 2.3 7.6 0.5 379.1 0.4 0.4 0.4 3.2 0.5 0.5 16.7 1.1 4.8 1.5 119.0 4.8 0.4 0.0 0.3 1.3 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 4.3 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 1.3 1.7 0.2 2.0 2.2 6.9 2.1 2.1 3.2 4.2 1.6 2.0 1.1 0.0 0.0 0.5 0.2 1.0 4.3 0.0 0.0 0.0 0.0 0.0 9.8 0.0 68.0 0.0 421.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 22.0 0.0 0.3 1332.7 7.2 0.4 1.7 0.0 0.0 3.8 0.2 0.2 5.6 1.9 4.2 25.8 3.1 30.5 5.6 0.5 0.0 0.0 0.2 0.4 PGRMC1 HPR6.6 ENSG00000101856 "Progesterone receptor membrane component 1" O00264 X 119236245-119244466 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 163.9" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 412.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002877, HPA064724" Enhanced Supported "Nucleoli,Endoplasmic reticulum" NA NA 6000000 "Endoplasmic reticulum" Nucleoli "HPA002877: AB_1079602, HPA064724: " "unprognostic (6.97e-2)" "unprognostic (1.99e-1)" "unprognostic (1.72e-1)" "unprognostic (4.35e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (1.58e-3)" "unprognostic (9.28e-2)" "unprognostic (4.66e-2)" "unprognostic (6.20e-2)" "unprognostic (3.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-3)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 25.0 46.0 37.7 11.9 36.9 5.6 60.2 21.8 37.8 36.2 30.5 30.9 42.9 27.0 39.9 71.4 15.0 38.9 20.1 10.0 38.6 50.4 58.7 163.9 15.6 8.8 38.1 29.6 24.7 10.9 23.8 15.5 12.3 35.3 33.5 22.5 22.1 17.5 53.7 5.7 12.5 42.9 22.0 46.9 10.0 18.9 14.2 27.1 6.9 24.7 12.2 7.7 21.3 17.3 3.6 9.9 11.4 11.8 4.8 8.0 28.7 27.3 17.3 34.0 39.1 73.6 35.3 22.1 41.3 48.2 22.0 27.4 20.9 33.6 7.9 45.3 42.8 25.7 21.9 37.1 17.3 29.7 8.4 42.6 8.9 16.6 23.4 12.3 14.5 4.8 36.3 9.8 26.7 13.9 16.3 14.1 9.5 9.3 4.9 25.7 29.2 10.9 10.7 89.1 30.0 29.2 13.0 21.3 11.4 29.0 20.9 31.8 14.2 30.2 50.3 16.2 34.3 11.6 9.3 10.9 15.3 22.6 54.1 38.9 5.2 9.5 8.5 41.9 23.2 29.2 9.2 11.8 11.4 5.5 11.3 7.3 3.6 7.5 8.0 9.9 3.1 7.7 6.3 5.7 4.8 10.0 7.1 7.6 28.7 37.7 36.9 21.8 37.2 38.6 50.4 38.1 29.6 35.3 27.1 116.1 75.0 12.3 114.6 83.6 185.1 15.3 109.5 124.5 78.5 69.8 64.8 71.9 58.0 77.8 2.7 78.8 222.6 23.3 64.6 112.3 104.2 108.1 39.3 412.3 46.0 62.0 55.4 54.6 35.5 4.9 159.3 45.1 97.8 14.4 77.2 101.7 56.7 112.1 170.8 277.5 72.5 103.5 130.8 27.1 70.9 76.7 51.9 21.5 125.9 110.4 PHF6 "BFLS, BORJ, CENP-31, KIAA1823, MGC14797" ENSG00000156531 "PHD finger protein 6" Q8IWS0 X 134373253-134428791 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Epilepsy, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001023 Enhanced Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA001023: AB_1079606" "unprognostic (2.38e-3)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (3.04e-3)" "unprognostic (6.03e-3)" "unprognostic (5.20e-3)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.81e-1)" "unprognostic (4.85e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (9.96e-4)" "unprognostic (1.09e-1)" "unprognostic (5.96e-2)" "unprognostic (4.84e-2)" "unprognostic (7.45e-2)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" 7.4 19.3 10.2 14.1 12.2 6.5 9.7 18.2 13.5 8.7 8.0 11.6 20.3 7.8 9.0 30.1 11.5 7.3 6.1 7.2 11.0 11.1 9.9 7.5 8.4 20.4 12.5 9.3 30.7 10.4 24.1 18.1 8.2 13.3 8.6 9.5 5.4 11.3 16.8 6.2 7.4 10.2 8.1 17.1 17.8 8.1 8.3 14.4 30.2 11.8 6.0 25.0 8.9 9.8 18.4 11.0 5.3 7.4 9.6 9.9 5.0 11.5 9.6 42.3 17.3 7.9 10.1 8.0 11.6 9.3 12.5 15.5 5.7 12.0 18.6 26.7 7.0 12.2 10.4 29.5 13.1 21.1 15.1 13.7 18.0 16.5 6.6 8.4 17.9 10.0 6.7 10.0 13.6 17.0 12.6 17.4 18.2 13.2 9.2 15.3 7.6 28.9 8.9 12.9 15.8 13.0 28.5 15.4 14.1 13.3 14.0 14.7 17.2 8.9 8.2 12.2 13.1 7.7 9.9 13.2 11.7 8.4 14.6 17.8 4.7 10.9 25.1 7.6 21.4 14.5 5.3 6.1 3.7 7.9 6.0 8.5 18.4 8.2 7.1 8.8 12.8 9.9 8.2 2.5 9.6 7.4 11.0 8.3 5.0 10.2 12.2 18.2 13.5 11.0 11.1 12.5 9.3 13.3 14.4 20.8 17.3 24.1 12.5 11.6 21.9 13.7 7.6 16.0 13.6 15.7 17.7 9.9 19.9 12.5 2.6 14.3 7.9 0.0 11.8 6.8 11.3 10.2 23.2 12.7 13.2 17.5 10.9 19.6 12.6 2.1 19.2 15.3 6.8 19.0 13.4 25.6 12.4 15.0 14.5 16.5 18.2 25.8 9.2 4.6 17.9 10.0 3.9 22.0 16.6 11.0 PHLDA1 "DT1P1B11, PHRIP, TDAG51" ENSG00000139289 "Pleckstrin homology like domain family A member 1" Q8WV24 12 76025447-76033932 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 142.4" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 1037.1;Smooth muscle cells: 353.3;Urothelial cells: 680.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.4;MAIT T-cell: 3.9;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.5;non-classical monocyte: 2.5;T-reg: 4.1" "Group enriched" "Detected in many" 7 "monocytes: 2.5;T-cells: 4.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 65.6;RPTEC TERT1: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016160, HPA019000, HPA063520" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: AB_2685028" "unprognostic (9.09e-2)" "unprognostic (2.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.51e-3)" "unprognostic (2.33e-1)" "unprognostic (2.60e-3)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (2.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.21e-3)" "unprognostic (5.03e-2)" "unprognostic (1.21e-1)" "unprognostic (3.34e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-1)" "unprognostic (4.55e-3)" 13.2 15.9 9.4 8.4 12.1 9.0 13.5 6.4 15.7 11.5 4.5 11.1 4.8 3.4 7.1 3.1 33.3 5.1 20.0 9.6 8.2 7.9 13.8 33.2 14.2 3.0 8.4 5.6 10.8 8.8 2.6 6.0 7.1 10.0 4.8 5.5 24.9 142.4 6.5 3.3 6.3 7.0 7.6 9.7 14.6 10.8 2.3 10.1 2.5 18.0 13.2 19.9 17.0 17.8 0.3 0.1 0.4 2.5 0.3 4.1 0.6 12.7 15.3 12.0 6.6 5.6 11.7 0.8 10.8 29.2 4.9 6.8 8.4 15.6 0.0 3.2 4.5 16.3 6.5 0.3 18.1 10.6 1.9 0.2 0.3 0.7 14.3 8.2 0.3 3.3 3.6 13.3 20.4 40.6 65.6 11.8 0.0 1.0 0.3 25.1 1.6 0.0 1.6 4.4 7.7 23.6 0.0 3.1 0.3 51.5 28.9 0.8 2.3 1.8 0.1 35.1 15.6 7.7 0.1 10.9 16.8 1.6 19.5 10.6 0.1 0.0 0.0 28.4 0.1 20.9 0.3 0.1 0.2 2.4 0.2 3.9 0.3 2.5 2.5 0.0 0.2 0.5 0.6 0.4 0.3 2.5 0.1 4.1 0.6 9.4 12.1 6.4 7.7 8.2 7.9 8.4 5.6 10.0 10.1 11.9 17.2 2.7 1037.1 173.4 1.5 29.5 10.2 6.7 22.7 29.6 2.0 4.8 71.3 68.6 1.0 95.1 0.7 0.0 35.8 6.3 85.4 57.9 80.5 117.3 97.6 1.6 112.7 23.9 10.8 1.3 8.6 53.3 271.7 41.5 10.3 90.9 162.8 3.5 14.5 32.7 4.0 265.1 353.3 0.5 0.4 66.0 6.2 23.0 8.0 680.5 PHLDA2 "BWR1C, HLDA2, IPL, TSSC3" ENSG00000181649 "Pleckstrin homology like domain family A member 2" Q53GA4 11 2928273-2929455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 163.9" "Cell type enhanced" "Detected in many" 18 "Cytotrophoblasts: 3794.0;Syncytiotrophoblasts: 8329.2;Urothelial cells: 2915.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 8.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 83.8;PC-3: 68.1;SK-MEL-30: 53.5;WM-115: 73.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003994 Uncertain Nucleoli NA NA Nucleoli "HPA003994: AB_1855311" "unprognostic (1.90e-1)" "unprognostic (3.13e-2)" "unprognostic (9.93e-3)" "unprognostic (6.16e-2)" "unprognostic (4.28e-2)" "unprognostic (8.01e-3)" "prognostic unfavorable (4.22e-5)" "unprognostic (1.24e-3)" "unprognostic (3.84e-2)" "unprognostic (8.35e-2)" "unprognostic (1.67e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (2.83e-1)" "unprognostic (6.13e-2)" "unprognostic (2.16e-2)" "unprognostic (1.59e-1)" 3.8 1.1 0.5 3.6 0.7 1.4 7.7 0.3 1.4 5.6 7.9 0.5 1.7 5.9 2.3 5.5 20.3 2.4 15.6 1.5 0.5 1.9 4.8 3.7 3.9 0.8 1.3 0.5 1.8 4.6 1.2 1.2 163.9 1.9 8.0 1.4 0.8 5.3 2.0 0.8 9.6 7.4 1.9 1.0 1.8 11.1 1.0 0.5 0.2 3.5 24.7 15.1 6.1 8.7 1.5 8.2 0.0 4.9 0.0 3.9 1.5 9.4 8.4 0.3 0.1 0.1 1.7 9.1 21.0 5.3 3.0 2.2 3.4 18.7 0.0 10.3 2.3 6.9 11.7 0.0 8.3 0.3 83.8 2.8 0.0 4.5 2.1 6.9 0.0 5.0 2.8 3.8 2.5 2.0 1.7 2.5 0.0 1.8 0.1 1.2 29.8 0.0 1.4 3.4 4.7 68.1 0.0 0.0 5.7 6.1 2.9 0.9 0.0 6.7 4.6 53.5 0.4 1.4 0.8 13.9 6.7 3.6 9.4 7.1 0.1 0.1 0.0 5.5 1.4 73.4 0.0 4.9 0.0 0.7 3.0 0.8 1.5 3.9 0.9 8.2 0.0 1.0 0.2 0.0 0.0 0.6 0.0 1.4 1.5 0.5 0.7 0.3 1.4 0.5 1.9 1.3 0.5 1.9 0.5 17.9 37.7 0.5 1363.4 350.5 0.0 4.8 48.4 16.0 48.9 41.8 0.0 3794.0 8.3 172.2 2.1 8.7 316.4 0.0 128.2 1743.3 110.0 1372.9 82.9 3.4 356.1 0.0 189.0 11.6 9.2 0.4 3.4 47.2 97.8 17.2 122.2 0.0 313.5 273.8 2.8 0.3 0.1 51.8 311.1 0.5 4.5 599.1 8329.2 3.8 109.0 2915.8 PHTF1 PHTF ENSG00000116793 "Putative homeodomain transcription factor 1" Q9UMS5 1 113696831-113759489 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 138.9;Late spermatids: 106.5;Spermatocytes: 106.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059486 Approved "Nucleoli,Nuclear bodies" No No "Nuclear bodies" Nucleoli "HPA059486: " "unprognostic (1.52e-1)" "unprognostic (3.33e-1)" "unprognostic (2.58e-2)" "unprognostic (4.54e-2)" "unprognostic (5.92e-2)" "unprognostic (1.62e-2)" "unprognostic (6.55e-2)" "unprognostic (1.30e-1)" "unprognostic (3.30e-3)" "unprognostic (1.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" 6.5 10.4 11.5 7.9 8.6 19.5 11.8 31.6 15.1 7.1 5.4 4.0 7.6 4.5 6.6 9.6 3.4 13.1 8.8 8.2 10.1 12.4 8.9 10.1 10.8 11.9 8.2 12.9 4.0 8.2 15.3 20.9 8.5 10.4 5.8 6.5 8.2 5.2 6.9 5.5 2.4 4.9 8.4 6.4 10.5 8.0 33.8 6.6 3.4 6.1 2.4 7.7 8.1 6.3 3.0 4.5 6.0 2.6 4.3 5.7 1.7 12.8 6.7 19.1 10.1 9.5 8.6 5.0 11.8 15.7 10.6 17.4 7.3 10.4 3.7 16.8 8.2 7.8 7.1 7.2 4.7 12.2 15.2 7.2 8.9 14.1 8.4 7.9 10.9 12.6 7.2 1.3 14.2 3.1 15.4 19.5 0.0 5.3 17.1 12.8 19.0 0.1 11.0 15.1 4.8 10.9 11.5 28.7 7.4 17.0 5.6 13.5 12.4 13.2 6.5 7.0 10.4 2.6 8.9 20.6 8.4 11.6 15.4 11.4 23.9 24.2 6.9 20.6 9.5 22.7 3.0 2.6 4.9 3.0 1.3 2.3 3.0 3.7 3.7 4.5 1.6 0.1 2.6 6.0 4.3 1.7 3.0 5.7 1.7 11.5 8.6 31.6 15.1 10.1 12.4 8.2 12.9 10.4 6.6 6.0 10.9 21.0 6.3 2.2 28.1 7.4 15.3 49.5 10.3 5.2 51.1 17.2 8.3 9.9 138.9 17.6 2.7 23.3 18.2 7.7 11.1 7.1 20.8 7.6 10.9 27.0 18.4 9.2 13.2 106.5 7.5 9.8 5.0 10.8 2.7 5.3 15.5 0.0 8.5 5.4 45.4 0.0 11.4 106.3 31.1 1.5 22.1 18.7 2.9 6.5 PIGO "DKFZp434M222, FLJ00135" ENSG00000165282 "Phosphatidylinositol glycan anchor biosynthesis class O" Q8TEQ8 9 35088688-35096601 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014905 Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA014905: AB_1855369" "unprognostic (1.41e-2)" "unprognostic (1.06e-1)" "unprognostic (4.03e-1)" "unprognostic (3.54e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-1)" "unprognostic (6.98e-3)" "unprognostic (4.14e-2)" "unprognostic (5.08e-2)" "unprognostic (2.25e-1)" "unprognostic (3.63e-1)" "unprognostic (1.54e-1)" "prognostic favorable (3.05e-10)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (5.23e-3)" "unprognostic (3.81e-2)" 9.4 16.6 7.2 8.7 11.7 5.4 11.6 12.6 15.6 10.8 11.5 17.8 15.6 14.1 14.0 13.6 12.6 15.8 13.4 9.5 7.4 6.4 16.1 15.2 10.6 13.8 9.0 10.1 15.9 17.5 47.3 13.4 27.6 11.5 13.1 13.2 18.0 17.5 17.4 7.6 10.0 12.9 10.7 11.0 14.2 13.9 16.5 9.7 11.3 20.0 8.3 13.4 13.6 9.9 7.4 13.7 8.0 8.8 7.1 10.0 4.1 15.9 27.4 7.8 11.2 7.0 7.9 14.0 6.8 11.9 16.5 13.5 10.1 16.3 9.0 12.4 8.1 23.0 11.7 13.1 21.3 10.0 9.9 8.4 5.4 17.9 7.6 13.7 7.3 9.4 9.6 23.6 14.6 24.1 13.1 8.5 13.5 5.9 12.9 13.5 8.8 8.5 8.3 5.0 10.0 11.3 8.9 6.3 9.8 18.1 11.1 6.6 8.9 9.4 23.4 5.3 9.0 17.5 4.8 5.1 12.1 10.7 6.5 12.4 7.9 11.6 3.8 13.1 5.4 15.0 7.0 6.7 8.0 9.2 8.8 9.3 5.0 5.1 10.0 13.7 7.4 6.5 7.6 2.4 7.1 5.9 9.5 7.6 4.1 7.2 11.7 12.6 15.6 7.4 6.4 9.0 10.1 11.5 9.7 3.0 11.5 5.2 4.4 2.3 9.1 2.4 20.4 13.4 7.9 15.7 2.0 17.4 0.0 11.1 0.7 3.1 10.6 0.0 12.1 13.5 3.1 3.6 6.9 11.1 10.0 11.1 2.9 4.9 6.3 1.0 4.0 3.9 3.3 8.2 7.8 14.9 8.2 7.0 2.8 5.6 10.9 6.5 2.5 17.4 7.0 1.8 18.9 7.2 8.5 3.1 PIK3CB PIK3C1 ENSG00000051382 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta" P42338 3 138652699-138834938 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Autophagy, Cell adhesion, Endocytosis" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 42.0;HMC-1: 66.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031938, HPA042288, HPA064207" Approved Supported Nucleoplasm,Nucleoli,Vesicles,Midbody Yes No Nucleoplasm "Nucleoli, Vesicles, Midbody" "CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212" "unprognostic (4.89e-2)" "unprognostic (1.42e-2)" "unprognostic (5.97e-2)" "unprognostic (7.85e-2)" "unprognostic (4.89e-2)" "unprognostic (6.01e-2)" "prognostic unfavorable (6.42e-4)" "unprognostic (3.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.99e-5)" "unprognostic (2.15e-1)" "unprognostic (6.18e-3)" "unprognostic (9.33e-2)" "unprognostic (7.82e-2)" "unprognostic (2.79e-1)" "unprognostic (4.59e-2)" 12.5 9.9 10.6 9.7 20.6 17.4 11.5 29.9 25.0 12.4 14.6 11.9 11.7 13.7 9.6 6.9 15.2 10.9 8.7 12.7 12.2 14.2 22.6 9.3 9.5 9.1 11.9 15.2 8.8 20.3 20.2 10.9 18.1 24.1 13.4 15.7 12.2 14.9 15.9 33.4 19.6 16.4 8.3 12.5 9.9 11.0 6.4 10.7 14.4 37.4 7.1 11.9 13.4 11.0 4.6 9.1 11.3 7.8 1.3 6.5 2.6 23.0 10.0 4.3 3.6 3.9 5.3 29.3 5.4 5.2 5.5 5.9 10.7 8.8 9.3 14.8 5.3 10.6 9.9 5.6 8.6 9.9 11.8 6.3 42.0 6.8 6.4 4.0 10.2 66.6 4.5 6.6 3.8 7.8 9.8 8.3 4.5 16.0 6.9 6.9 10.6 5.9 7.2 6.2 17.0 9.4 4.3 4.5 6.6 8.5 12.8 3.7 2.7 15.0 6.5 19.3 13.2 16.3 24.4 8.7 3.5 4.5 7.7 7.6 11.7 7.6 8.5 8.6 9.9 4.9 7.0 7.8 11.3 4.0 4.5 2.7 4.6 5.2 3.0 9.1 4.1 6.5 4.4 10.0 1.3 4.3 1.4 2.2 2.6 10.6 20.6 29.9 25.0 12.2 14.2 11.9 15.2 24.1 10.7 8.9 14.7 4.7 12.9 16.9 15.4 30.2 12.7 14.7 21.6 17.4 23.6 29.1 5.0 9.4 0.9 8.5 21.3 0.0 16.5 46.3 6.5 23.0 13.9 15.8 13.4 20.6 15.6 11.6 28.8 1.1 3.4 19.7 6.8 14.4 14.9 8.2 15.2 21.8 6.3 18.9 17.9 6.5 6.1 10.7 14.9 20.5 40.0 6.1 12.7 15.3 PIM1 PIM ENSG00000137193 "Pim-1 proto-oncogene, serine/threonine kinase" P11309 6 37170203-37175426 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Suprabasal keratinocytes: 199.7;Urothelial cells: 399.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 64.6" "Group enriched" "Detected in all" 5 "granulocytes: 64.6;T-cells: 19.0" "Cell line enhanced" "Detected in many" "HEL: 35.7;HMC-1: 66.4;K-562: 30.6;U-698: 119.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003941, CAB017040" Uncertain Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB017040: , HPA003941: AB_1079618" "unprognostic (1.25e-2)" "unprognostic (4.77e-1)" "unprognostic (3.61e-2)" "prognostic unfavorable (9.73e-4)" "unprognostic (1.91e-2)" "unprognostic (1.06e-1)" "unprognostic (3.75e-1)" "unprognostic (4.64e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.65e-2)" "unprognostic (7.32e-2)" "unprognostic (2.14e-3)" "unprognostic (8.16e-3)" "unprognostic (1.04e-1)" "unprognostic (5.26e-3)" "unprognostic (2.90e-1)" 39.3 5.4 7.4 18.5 8.9 80.9 20.1 8.1 9.9 23.0 17.9 4.7 4.2 17.9 15.4 9.8 56.3 21.6 24.7 20.8 8.2 3.7 7.5 24.5 14.5 35.7 7.4 2.2 20.0 9.6 2.0 5.6 28.7 12.7 15.6 8.8 6.9 12.8 4.5 26.5 31.3 26.1 31.6 10.7 21.4 12.1 6.8 7.6 15.0 7.2 20.1 28.8 32.6 31.2 1.7 1.4 64.6 1.7 8.4 19.0 8.5 3.0 1.3 2.0 1.1 4.7 2.5 24.0 1.1 3.4 2.3 3.6 4.6 4.3 6.2 1.7 1.3 5.1 3.6 2.1 3.3 2.1 28.1 1.4 35.7 1.3 5.9 4.8 0.6 66.4 8.5 4.1 2.1 1.4 2.5 0.6 1.5 30.6 10.0 0.3 0.8 1.9 3.2 3.8 5.7 2.0 4.8 3.7 7.3 0.6 18.8 10.0 2.0 2.4 0.3 0.6 4.9 0.5 1.0 1.2 1.3 4.0 6.0 1.3 4.7 2.5 119.4 0.5 9.0 1.3 64.6 1.7 24.4 14.7 1.6 19.0 1.7 13.1 12.9 1.4 1.3 11.9 9.0 14.1 8.4 0.9 0.4 9.4 8.5 7.4 8.9 8.1 9.9 8.2 3.7 7.4 2.2 12.7 7.6 20.8 23.1 27.2 134.9 113.6 4.2 17.3 12.7 4.0 22.7 8.7 0.0 27.3 5.0 30.7 3.8 14.3 33.2 46.7 15.5 92.9 73.9 69.5 46.4 27.1 44.8 14.3 35.6 9.2 40.0 10.4 7.5 45.8 42.2 101.0 11.9 4.3 37.7 17.5 2.8 13.0 0.9 0.0 57.5 3.3 34.5 199.7 67.5 126.4 6.6 399.5 PIN4 "EPVH, PAR14, PAR17" ENSG00000102309 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 4" Q9Y237 X 72181353-72302926 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 68.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054483, HPA064504" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA054483: AB_2682503, HPA064504: AB_2685274" "unprognostic (2.47e-1)" "unprognostic (6.97e-3)" "unprognostic (1.65e-1)" "unprognostic (3.77e-2)" "unprognostic (8.42e-2)" "unprognostic (1.30e-2)" "unprognostic (1.14e-2)" "prognostic favorable (6.37e-4)" "unprognostic (1.56e-1)" "unprognostic (2.13e-2)" "unprognostic (2.49e-1)" "unprognostic (9.54e-2)" "unprognostic (2.09e-3)" "unprognostic (1.92e-1)" "prognostic favorable (2.58e-4)" "unprognostic (3.34e-3)" "prognostic favorable (2.66e-4)" 14.4 11.3 15.0 8.0 14.7 6.1 18.8 10.7 16.2 9.7 9.7 8.4 6.7 9.5 11.6 19.3 8.9 8.7 30.7 11.2 15.2 12.2 15.6 23.2 7.9 7.9 12.9 11.0 12.7 8.1 8.0 9.2 9.8 10.0 10.4 11.1 6.6 30.7 37.1 68.7 7.3 9.6 9.2 12.4 16.7 9.3 4.7 6.9 9.7 12.9 40.1 9.1 7.8 9.2 28.9 26.8 23.4 23.6 22.4 33.4 22.7 15.4 18.1 19.0 12.9 13.0 10.9 10.1 10.6 12.2 13.0 13.4 9.1 11.5 4.6 31.0 10.9 17.6 11.0 16.8 18.6 16.1 11.7 37.8 7.9 21.6 23.9 7.2 12.5 6.7 7.3 10.3 14.2 4.9 14.7 13.2 14.2 13.3 20.6 9.7 18.7 10.9 21.1 13.5 17.6 16.4 10.9 15.1 13.7 16.5 10.8 12.2 21.7 12.4 5.8 10.9 14.6 9.0 11.5 13.2 5.9 9.1 16.2 7.7 7.1 7.6 7.7 17.0 12.6 6.4 21.9 23.3 23.4 26.8 23.6 26.4 28.9 28.3 25.5 22.8 26.4 29.3 29.4 9.7 22.4 21.8 26.8 33.4 22.7 15.0 14.7 10.7 16.2 15.2 12.2 12.9 11.0 10.0 6.9 62.5 35.0 52.8 54.1 38.4 26.9 74.7 81.5 84.3 51.2 113.4 7.9 137.4 154.2 102.6 10.6 70.5 117.6 23.3 102.2 92.0 70.9 50.1 55.5 238.7 95.4 27.0 88.9 80.4 73.2 6.2 69.0 61.7 57.3 68.5 76.9 55.6 124.5 101.7 76.4 218.0 33.7 84.1 78.3 14.4 39.1 40.9 100.9 62.3 82.1 54.0 PINX1 "FLJ20565, Gno1, LPTL, LPTS, MGC8850, PinX1, Pxr1" ENSG00000254093 "PIN2/TERF1 interacting telomerase inhibitor 1" Q96BK5 8 10764963-10839884 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023139, HPA023146" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Nucleoli "Nucleoplasm, Mitochondria" "HPA023139: AB_1855384, HPA023146: " "unprognostic (4.01e-1)" "prognostic favorable (2.45e-5)" "unprognostic (7.80e-3)" "unprognostic (3.35e-2)" "unprognostic (4.10e-1)" "unprognostic (4.61e-2)" "unprognostic (1.83e-2)" "unprognostic (3.40e-2)" "unprognostic (9.73e-3)" "unprognostic (2.49e-1)" "unprognostic (1.40e-1)" "unprognostic (4.37e-1)" "unprognostic (2.59e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" 14.3 14.4 9.9 16.0 13.9 14.8 13.8 14.5 16.5 12.6 14.2 12.6 7.1 11.5 15.7 8.9 19.3 10.7 9.3 11.7 10.6 10.1 13.1 19.4 11.2 19.2 13.2 10.9 16.1 17.2 7.6 10.7 13.3 17.6 11.4 12.0 15.6 14.9 8.5 21.2 19.0 11.3 15.9 11.1 14.8 11.7 24.0 9.7 18.7 12.4 17.8 19.6 11.5 14.3 9.8 8.8 4.4 8.4 8.9 16.0 8.4 6.4 8.7 9.4 8.9 8.0 6.5 10.8 9.9 4.5 10.9 7.4 9.1 5.7 17.4 3.5 5.3 13.4 13.1 23.8 18.3 14.1 7.0 7.1 7.3 6.1 9.8 9.0 7.8 4.6 5.4 11.7 8.6 16.1 3.9 15.1 11.9 23.1 10.8 10.7 7.7 25.5 9.8 21.6 28.3 9.7 20.9 11.5 15.9 8.1 8.0 7.8 8.1 6.6 7.9 21.7 12.0 8.4 9.7 9.1 6.6 14.3 8.4 12.7 4.9 12.7 31.7 6.8 14.8 14.9 1.5 6.8 4.4 12.5 8.4 16.0 9.7 10.9 13.1 8.8 9.8 15.0 11.6 0.4 8.9 7.3 6.8 12.3 8.4 9.9 13.9 14.5 16.5 10.6 10.1 13.2 10.9 17.6 9.7 3.0 4.1 9.9 14.8 23.7 5.2 3.3 7.6 10.7 9.1 3.5 11.8 14.9 10.0 0.0 29.6 11.4 4.0 0.0 0.0 9.6 8.0 5.2 13.9 6.6 14.3 3.2 8.1 11.6 4.0 22.3 8.6 9.6 6.8 0.0 3.9 6.2 0.0 4.8 6.0 8.2 21.5 0.0 6.2 24.9 25.1 25.0 40.3 11.7 7.7 8.0 PITX1 "BFT, POTX, PTX1" ENSG00000069011 "Paired like homeodomain 1" P78337 5 135027735-135034813 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 119.4;lymphoid tissue: 60.8;tongue: 58.8" "Cell type enhanced" "Detected in some" 27 "Basal glandular cells: 84.7;Glandular cells: 52.7;Urothelial cells: 214.7" "Cancer enhanced" "Detected in many" "cervical cancer: 73.6" "Region enriched" "Detected in single" 11 "pons and medulla: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 40.4;HeLa: 33.0;K-562: 32.2;T-47d: 48.1" "Not detected" "Not detected" HPA008743 Approved Approved Nucleoli Yes No Nucleoli "HPA008743: AB_1855413" "unprognostic (1.84e-1)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (4.62e-2)" "unprognostic (5.08e-2)" "unprognostic (5.26e-3)" "unprognostic (1.03e-2)" "unprognostic (1.66e-2)" "unprognostic (5.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.60e-2)" "unprognostic (2.27e-1)" "unprognostic (5.80e-14)" "unprognostic (6.22e-2)" "unprognostic (1.33e-1)" "unprognostic (5.98e-3)" "unprognostic (4.97e-3)" 0.3 0.3 0.0 4.7 0.0 0.3 0.2 0.0 0.2 14.8 2.8 0.0 0.0 5.6 0.5 1.2 119.4 0.3 1.9 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.2 32.9 1.3 1.0 8.8 1.1 10.8 33.0 0.2 8.6 0.5 3.2 18.6 0.0 0.2 7.4 0.4 0.0 0.0 0.4 58.8 60.8 18.2 28.9 0.3 0.3 1.4 0.4 0.4 1.1 0.2 17.2 10.6 0.0 14.2 0.6 0.2 4.4 3.4 5.0 1.7 0.6 40.4 10.2 19.4 5.5 0.2 4.2 5.9 2.3 8.3 0.1 0.2 15.0 4.8 33.0 11.1 5.2 1.7 0.0 0.4 6.0 0.0 1.9 0.1 0.0 3.0 32.2 0.0 0.5 5.3 0.1 3.8 0.0 1.5 9.5 5.7 0.3 0.3 0.2 5.4 6.6 0.0 15.1 8.2 0.0 0.1 48.1 1.1 0.6 1.9 4.8 1.0 5.3 0.0 0.0 12.7 2.5 0.1 0.0 1.4 0.3 0.1 0.9 0.3 0.5 0.3 0.6 1.1 0.2 0.3 0.3 1.0 0.7 0.4 0.4 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 84.7 1.1 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 3.4 0.0 0.3 0.0 0.4 2.0 0.9 52.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.4 0.3 0.0 0.0 0.0 0.3 0.0 9.9 0.3 0.0 0.0 2.0 0.0 1.4 1.4 4.1 5.9 6.4 0.0 0.6 214.7 PJA1 "FLJ11830, RNF70" ENSG00000181191 "Praja ring finger ubiquitin ligase 1" Q8NG27 X 69160851-69165793 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 98.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000595 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA000595: AB_1079826" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (4.03e-2)" "unprognostic (2.58e-3)" "unprognostic (5.44e-2)" "unprognostic (1.30e-2)" "unprognostic (1.26e-3)" "unprognostic (4.61e-2)" "unprognostic (3.82e-3)" "unprognostic (1.84e-2)" "unprognostic (6.10e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.44e-5)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (2.01e-1)" "unprognostic (2.10e-1)" 12.6 9.9 21.6 5.5 35.7 2.6 7.9 13.4 23.7 12.2 5.8 8.9 19.3 4.7 9.2 98.7 5.7 10.2 7.1 7.5 18.4 23.4 7.5 4.4 7.4 5.9 14.9 16.7 16.2 6.0 27.1 12.5 10.7 11.7 9.9 5.3 7.2 6.4 20.3 4.7 7.1 4.4 9.8 12.0 5.9 6.5 13.7 9.5 3.0 13.8 2.9 7.4 7.8 7.9 11.2 4.3 2.7 4.5 14.8 17.8 9.0 10.4 8.0 25.1 17.6 8.8 9.3 7.6 7.0 8.4 6.6 8.9 6.5 9.9 1.6 10.9 11.1 15.6 9.1 38.6 13.7 8.3 7.8 13.7 3.1 6.6 4.3 11.0 1.8 6.0 9.7 9.1 11.3 6.7 6.4 7.4 5.3 2.9 1.1 6.7 5.6 0.8 3.6 17.1 8.9 13.2 7.5 11.2 2.5 10.6 8.8 18.7 12.1 11.2 1.9 8.5 20.9 3.1 2.6 6.7 5.7 9.2 16.9 3.2 0.0 0.1 3.8 6.2 5.1 7.6 2.7 3.3 1.0 15.5 4.5 17.8 8.7 13.7 14.2 3.6 11.2 14.4 16.6 1.1 14.8 2.9 4.3 8.3 9.0 21.6 35.7 13.4 23.7 18.4 23.4 14.9 16.7 11.7 9.5 14.9 4.5 5.1 14.7 36.5 16.4 6.3 5.1 2.7 11.4 3.5 7.9 30.0 13.3 20.5 77.4 5.1 0.7 0.0 10.2 12.8 18.9 7.8 4.6 1.7 6.7 4.8 5.2 5.5 3.8 22.6 25.0 4.1 5.0 1.8 2.8 28.6 13.9 1.4 18.4 4.4 5.9 6.5 17.0 0.9 1.0 25.7 17.4 7.9 2.3 17.6 PKMYT1 "MYT1, PPP1R126" ENSG00000127564 "Protein kinase, membrane associated tyrosine/threonine 1" Q99640 16 2968024-2980539 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4" "Group enriched" "Detected in many" 6 "Extravillous trophoblasts: 39.8;Spermatocytes: 108.0;Spermatogonia: 40.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 4.4" "Lineage enriched" "Detected in single" 5 "T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068860 Supported "Nucleoplasm,Nucleoli,Golgi apparatus" NA Yes "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA068860: AB_2686050" "unprognostic (7.82e-2)" "unprognostic (8.70e-2)" "unprognostic (5.93e-2)" "unprognostic (2.04e-2)" "unprognostic (4.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (8.33e-4)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.52e-2)" "unprognostic (2.15e-1)" "unprognostic (1.61e-2)" "unprognostic (7.95e-3)" "unprognostic (0.00e+0)" "unprognostic (1.09e-3)" "unprognostic (9.13e-2)" "unprognostic (1.96e-1)" "unprognostic (5.91e-2)" 0.9 0.7 0.7 9.4 0.6 19.5 1.3 2.6 0.8 1.3 2.9 0.3 0.5 1.9 0.8 1.5 7.2 0.2 1.5 1.4 0.7 0.7 0.8 1.0 1.3 6.2 0.8 0.2 0.3 1.3 0.0 0.7 4.3 0.4 0.6 0.8 0.3 1.3 0.2 1.6 3.4 3.2 0.6 1.0 4.4 2.7 61.4 0.2 42.8 0.3 9.2 12.7 0.7 2.0 0.8 0.4 0.3 0.5 0.4 4.4 1.0 24.9 17.5 6.8 9.8 0.1 0.3 18.6 19.4 4.6 12.3 11.8 13.6 14.8 15.6 8.7 2.1 7.3 32.1 4.8 6.2 2.2 20.0 15.7 7.9 15.8 11.9 0.0 8.8 22.5 0.2 0.5 7.3 2.0 1.5 2.5 17.3 22.7 27.7 4.0 37.4 24.6 24.5 11.2 11.7 9.3 26.9 15.3 30.2 2.3 5.5 13.0 13.8 9.4 24.5 7.3 3.9 14.0 17.6 2.3 16.6 21.0 24.2 20.3 21.0 15.6 26.8 6.3 11.8 19.2 0.0 0.4 0.3 0.3 0.3 0.0 0.8 0.5 0.5 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.1 4.4 1.0 0.7 0.6 2.6 0.8 0.7 0.7 0.8 0.2 0.4 0.2 0.0 1.4 0.0 0.8 2.3 0.1 0.4 2.5 0.0 2.3 1.8 5.9 3.0 0.0 1.1 11.2 0.3 0.2 0.0 0.5 39.8 0.4 0.5 0.0 0.2 10.2 0.0 1.7 0.0 1.3 7.5 0.3 1.3 0.0 1.0 1.2 0.3 0.3 0.0 0.4 0.0 6.7 0.0 0.0 108.0 40.5 0.5 6.2 0.7 3.5 0.4 PLEK P47 ENSG00000115956 Pleckstrin P08567 2 68365173-68397453 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 80.4;bone marrow: 120.1;lymphoid tissue: 51.0" "Group enriched" "Detected in many" 5 "B-cells: 62.6;granulocytes: 59.1;Hofbauer cells: 195.0;Kupffer cells: 185.4;Macrophages: 211.6;monocytes: 179.5;T-cells: 116.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 93.6;HL-60: 21.1;HMC-1: 35.8;NB-4: 31.4;THP-1: 36.6;U-266/84: 24.3;U-698: 24.9;U-937: 58.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA031838, HPA057341" Enhanced Approved Nucleoli NA NA 970000000 Nucleoli "HPA031838: AB_10602146, HPA057341: AB_2732609" "unprognostic (2.57e-2)" "unprognostic (5.18e-2)" "unprognostic (1.87e-3)" "unprognostic (4.52e-3)" "unprognostic (3.52e-1)" "unprognostic (3.08e-2)" "unprognostic (4.67e-2)" "unprognostic (3.40e-2)" "unprognostic (4.00e-2)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (3.57e-1)" "unprognostic (4.42e-2)" "unprognostic (2.03e-1)" "unprognostic (1.56e-1)" 27.8 3.6 3.0 21.7 7.7 120.1 4.6 1.0 3.0 1.8 4.2 7.0 0.4 2.4 2.4 7.5 3.5 5.5 4.9 4.9 2.6 2.4 3.8 6.5 17.0 36.6 6.4 0.8 4.3 2.8 0.7 2.0 8.5 5.0 4.0 4.5 2.7 3.5 0.8 2.3 1.7 8.0 5.0 8.6 51.0 3.2 5.7 3.7 8.2 3.8 2.7 25.7 7.3 2.0 22.9 66.9 80.4 50.8 33.2 44.7 65.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.6 0.0 0.0 0.0 21.1 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 10.3 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.0 0.0 1.4 24.3 24.9 0.0 58.0 0.0 24.8 39.7 57.2 44.7 49.2 23.5 22.9 8.2 32.2 32.1 13.5 2.3 25.3 80.4 33.2 50.8 66.9 0.8 65.9 3.0 7.7 1.0 3.0 2.6 2.4 6.4 0.8 5.0 3.7 17.9 30.6 62.6 0.1 5.8 0.0 1.7 0.0 24.1 28.4 1.8 0.0 1.0 0.0 0.1 1.4 3.1 0.0 0.0 0.5 1.3 6.1 0.1 59.1 0.9 195.0 0.0 0.0 4.9 185.4 4.5 0.6 211.6 16.9 179.5 0.0 0.0 0.1 0.0 0.4 0.6 0.0 12.9 2.6 0.9 0.7 5.8 2.2 116.7 0.0 0.1 PLEKHM1 KIAA0356 ENSG00000225190 "Pleckstrin homology and RUN domain containing M1" Q9Y4G2 17 45435900-45490749 "Disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 9.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025018, HPA039473" Approved Supported Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA025018: AB_1855465, HPA039473: AB_2676526" "unprognostic (1.52e-1)" "unprognostic (3.13e-2)" "unprognostic (4.29e-2)" "prognostic favorable (1.28e-6)" "unprognostic (8.71e-2)" "unprognostic (3.06e-2)" "prognostic unfavorable (3.25e-4)" "unprognostic (2.20e-2)" "unprognostic (1.88e-1)" "unprognostic (2.93e-2)" "unprognostic (4.02e-1)" "unprognostic (3.93e-2)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.60e-1)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" 8.0 3.6 2.5 3.6 4.5 10.9 5.3 7.6 5.6 6.1 4.1 2.6 0.9 2.2 2.9 2.0 17.2 3.7 3.8 3.9 4.2 1.7 1.7 3.1 4.5 7.3 10.5 2.9 2.5 4.2 3.5 3.6 2.8 4.7 2.6 3.0 3.4 7.6 2.7 6.3 5.8 3.4 2.5 5.3 4.5 3.0 2.4 3.4 6.7 3.8 6.5 10.4 5.2 6.7 2.4 1.3 9.8 1.4 1.3 1.4 0.9 5.2 7.6 1.3 2.5 5.4 2.6 4.7 1.5 3.5 2.7 2.8 2.4 2.8 2.7 4.6 5.0 13.2 1.4 3.1 1.9 0.8 10.6 3.7 0.0 2.8 3.1 5.7 0.0 4.0 10.2 6.0 4.3 7.1 2.3 8.0 2.1 2.6 3.1 4.3 3.3 5.2 1.0 0.8 15.5 5.4 2.3 2.8 2.4 3.9 8.1 2.3 2.1 2.6 2.0 2.9 2.5 4.7 2.3 9.2 6.5 2.5 4.9 2.7 3.2 3.4 1.1 3.7 1.3 2.7 3.8 1.4 1.3 1.4 1.0 0.8 2.4 1.0 1.1 1.3 1.0 0.7 0.6 9.8 1.3 1.3 1.0 1.2 0.9 2.5 4.5 7.6 5.6 4.2 1.7 10.5 2.9 4.7 3.4 11.9 21.5 8.3 16.6 16.0 9.3 7.2 12.7 8.1 12.5 12.2 15.7 3.8 5.0 7.1 4.0 8.7 14.8 23.3 7.0 4.0 7.3 22.8 1.1 6.8 7.8 15.9 13.2 9.2 24.5 1.4 6.6 12.6 6.8 4.6 11.8 6.3 12.8 14.4 7.4 6.3 8.0 0.0 7.1 5.9 3.4 14.3 7.2 13.8 10.1 35.7 PLOD2 LH2 ENSG00000152952 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2" O00469 3 146069440-146163653 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 73.1" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 109.4;Pancreatic endocrine cells: 83.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Cell line enhanced" "Detected in many" "HBF TERT88: 82.6;hTERT-RPE1: 93.9;U-87 MG: 73.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB025898, HPA069126" Approved Uncertain Nucleoli,Cytosol "Intracellular and membrane" NA NA "Nucleoli, Cytosol" "CAB025898: , HPA069126: " "unprognostic (8.68e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (2.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.34e-2)" "unprognostic (1.29e-3)" "prognostic unfavorable (7.64e-10)" "prognostic unfavorable (1.42e-4)" "unprognostic (2.97e-2)" "unprognostic (3.36e-2)" "unprognostic (6.27e-3)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.99e-11)" "prognostic unfavorable (2.83e-4)" "unprognostic (6.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.41e-3)" 36.7 14.1 11.2 18.0 12.1 0.7 28.5 7.9 13.5 8.8 25.2 5.1 8.3 21.6 14.8 7.5 12.0 8.0 22.3 16.6 12.5 8.2 16.4 73.1 9.3 3.0 10.7 4.8 17.7 14.4 13.9 7.8 41.0 13.0 11.1 16.1 7.2 7.7 11.3 4.8 3.2 24.7 24.2 19.4 3.2 13.6 6.3 10.9 6.1 47.6 3.5 3.0 21.8 28.7 0.0 0.0 1.5 0.3 0.0 0.0 1.9 16.4 11.8 3.7 1.2 13.5 14.5 9.4 58.5 17.9 31.9 60.2 0.9 1.7 0.0 11.4 9.9 14.6 3.5 4.3 50.3 82.6 0.0 6.8 4.1 11.5 8.2 34.7 0.0 0.0 25.4 7.2 27.6 13.5 93.9 44.0 0.0 5.4 0.2 56.3 6.0 0.0 0.0 2.3 0.0 5.1 0.0 2.4 0.0 13.4 0.8 1.8 0.0 46.6 5.0 4.9 18.1 13.6 0.5 55.2 39.5 12.0 12.5 34.9 17.9 2.5 0.0 73.6 0.0 7.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 11.2 12.1 7.9 13.5 12.5 8.2 10.7 4.8 13.0 10.9 14.9 10.7 0.5 5.9 6.3 14.5 10.6 61.1 12.0 13.6 26.2 33.4 6.8 8.3 62.8 0.4 21.2 46.1 0.0 45.9 109.4 34.5 8.1 0.0 50.8 4.7 0.0 19.0 18.4 1.5 1.3 12.0 2.7 13.5 1.0 18.3 65.1 83.0 31.5 4.6 6.9 22.4 19.4 38.1 8.0 16.3 4.8 15.7 0.7 21.3 5.4 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120456954-120589855 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5;kidney: 12.6" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 12.7;Distal tubular cells: 6.6;Early spermatids: 7.1;Late spermatids: 7.9;Leydig cells: 17.8;Peritubular cells: 7.4;Proximal tubular cells: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 62.8;U-251 MG: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA045188: AB_2679246" "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.6 1.7 11.4 1.2 13.6 4.9 3.1 11.6 18.2 3.4 1.2 12.1 1.0 0.7 1.7 2.7 0.9 1.2 11.3 0.7 15.9 17.4 12.6 2.8 0.5 0.6 15.5 6.0 0.6 0.6 0.4 0.5 0.6 26.5 3.0 0.8 0.0 2.0 6.1 0.4 1.7 0.8 1.5 19.1 0.5 1.2 11.1 12.5 0.0 1.5 0.0 0.5 0.8 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.8 1.7 1.0 0.0 1.0 0.0 0.0 8.0 6.3 0.1 0.7 0.1 0.9 1.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.0 62.8 6.5 0.0 0.7 1.6 0.7 0.0 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.0 3.3 0.0 0.6 0.1 0.5 0.0 0.5 3.5 1.4 0.0 9.0 7.2 4.0 0.3 34.8 0.0 0.0 0.0 6.6 0.0 1.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.6 11.6 10.0 15.9 17.4 15.5 6.0 26.5 12.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 12.7 0.0 0.0 3.5 0.0 0.0 6.6 0.0 7.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 2.5 0.0 7.9 17.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 7.4 7.6 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.3 PNKP PNK ENSG00000039650 "Polynucleotide kinase 3'-phosphatase" Q96T60 19 49859882-49878351 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006782 Supported Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA006782: AB_1855496" "prognostic favorable (9.18e-4)" "unprognostic (1.87e-1)" "unprognostic (4.31e-2)" "unprognostic (4.23e-1)" "unprognostic (1.00e-1)" "unprognostic (4.40e-2)" "unprognostic (1.08e-2)" "unprognostic (1.24e-1)" "unprognostic (3.36e-1)" "unprognostic (1.58e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-1)" "unprognostic (4.55e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.24e-2)" "unprognostic (3.68e-3)" 13.1 32.4 11.2 22.0 11.8 24.3 15.0 18.0 13.8 14.0 17.4 17.0 26.4 15.6 16.7 25.3 13.6 18.1 18.2 16.8 12.3 9.5 20.1 16.8 15.9 21.0 13.9 14.2 17.1 22.5 19.7 26.8 17.1 12.9 18.7 15.0 19.6 20.3 22.4 12.8 15.3 15.7 13.2 10.1 30.7 17.9 17.2 13.9 22.3 23.0 17.0 20.6 14.6 12.4 7.9 7.5 19.3 12.7 2.7 7.7 3.8 13.0 8.8 8.9 14.0 8.5 6.6 14.5 21.1 10.8 9.8 8.6 7.0 17.2 8.5 6.7 6.4 5.7 10.7 3.2 11.9 5.8 10.9 13.5 14.4 16.6 6.1 6.4 13.6 19.3 6.2 6.3 8.9 5.8 8.7 12.8 10.7 7.0 17.1 12.7 8.3 13.7 10.8 8.3 13.5 18.0 11.7 8.2 17.1 10.0 27.9 10.6 17.1 9.2 27.8 4.7 8.1 4.8 8.4 18.1 19.1 11.7 4.6 17.4 18.9 7.6 6.9 17.3 6.1 15.2 1.4 8.8 12.2 7.7 8.5 6.4 6.5 6.6 5.8 7.5 7.9 4.9 4.4 19.3 2.7 12.7 4.3 6.8 3.8 11.2 11.8 18.0 13.8 12.3 9.5 13.9 14.2 12.9 13.9 14.9 23.4 40.2 28.5 11.8 40.7 8.9 15.3 24.1 9.1 19.2 76.6 37.9 19.9 36.3 12.0 20.2 24.9 0.0 34.6 29.2 14.8 28.4 27.8 18.7 34.1 31.8 29.3 31.9 22.4 20.0 55.0 24.9 13.5 42.3 23.1 20.6 38.1 20.1 42.1 26.9 76.0 19.4 14.4 18.2 29.6 11.4 41.2 42.4 27.4 25.2 PNMA6A "MGC15827, PNMA6C" ENSG00000235961 "PNMA family member 6A" P0CW24 X 153072482-153075018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3" "Group enriched" "Detected in some" 5 "Bipolar cells: 21.6;Distal tubular cells: 10.0;Horizontal cells: 22.3;Muller glia cells: 18.8;Proximal tubular cells: 20.3;Rod photoreceptor cells: 7.1" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 28 "granulocytes: 5.3" "Cell line enhanced" "Detected in some" "HHSteC: 8.0;HMC-1: 6.9;SK-MEL-30: 6.6;U-2 OS: 15.2;U-698: 8.3" "HPA045007, HPA052115" Uncertain Uncertain Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA045007: AB_2679181, HPA052115: AB_2681734" "unprognostic (2.14e-2)" "unprognostic (2.35e-1)" "unprognostic (2.33e-2)" "unprognostic (4.12e-3)" "unprognostic (4.39e-2)" "unprognostic (3.44e-2)" "unprognostic (9.27e-3)" "unprognostic (2.15e-1)" "unprognostic (1.85e-1)" "unprognostic (2.46e-1)" "unprognostic (7.76e-4)" "unprognostic (5.75e-3)" "prognostic favorable (1.93e-5)" "unprognostic (4.61e-2)" "unprognostic (3.04e-1)" "unprognostic (4.04e-3)" "unprognostic (3.22e-2)" 1.3 2.0 7.2 0.1 6.2 0.2 0.3 7.0 16.3 3.7 0.2 0.5 1.8 7.0 0.1 1.5 0.9 2.1 6.5 11.0 6.2 7.9 0.1 0.2 5.5 3.1 0.7 0.4 3.9 0.1 0.1 0.1 0.9 0.7 0.0 0.3 0.3 0.6 1.6 0.5 0.5 0.8 1.8 0.2 0.1 0.0 0.0 0.0 5.3 0.0 0.0 0.1 0.0 0.0 5.3 0.1 1.6 0.0 0.0 0.0 0.9 0.2 0.3 0.0 0.0 0.5 0.0 1.9 0.4 0.9 0.0 2.9 0.0 0.0 0.0 0.6 0.0 0.3 0.2 8.0 3.2 6.9 1.2 0.0 0.1 0.0 0.2 0.2 5.7 1.3 0.0 0.1 0.4 1.1 0.0 3.4 5.8 0.0 0.0 0.0 0.0 0.3 0.0 3.3 1.9 0.4 0.0 6.6 0.3 0.0 4.1 0.0 0.0 15.2 0.0 0.0 5.8 4.3 8.3 0.0 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 21.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 2.5 3.2 22.3 0.0 0.6 0.0 0.4 2.6 0.0 0.0 0.0 0.0 18.8 0.4 0.0 2.8 20.3 7.1 0.0 0.2 1.0 2.2 0.0 0.0 0.0 0.0 0.1 PNO1 "KHRBP1, RRP20" ENSG00000115946 "Partner of NOB1 homolog" Q9NRX1 2 68157844-68176238 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056928 Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA056928: " "unprognostic (1.81e-3)" "unprognostic (4.83e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (5.88e-2)" "unprognostic (1.66e-3)" "prognostic unfavorable (3.04e-8)" "unprognostic (5.82e-2)" "unprognostic (2.59e-2)" "unprognostic (1.16e-1)" "unprognostic (9.13e-3)" "unprognostic (3.33e-2)" "unprognostic (1.46e-2)" "unprognostic (1.42e-1)" "unprognostic (2.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.66e-2)" 18.5 19.2 13.0 17.2 19.0 21.8 15.4 10.0 12.8 10.8 13.1 9.1 10.2 9.9 15.3 15.4 14.9 13.8 13.2 24.5 19.1 9.6 16.6 27.4 12.9 15.0 15.0 11.9 20.0 27.0 13.2 15.7 16.3 13.1 14.4 12.2 8.9 12.7 15.0 48.8 12.4 9.5 15.1 11.7 13.6 13.2 11.4 13.9 9.7 16.6 15.1 15.2 15.8 21.4 14.7 12.6 2.0 13.2 10.6 15.5 14.4 15.1 16.6 7.7 12.6 9.5 7.9 19.3 14.4 9.4 16.3 11.6 31.7 9.0 20.7 12.1 9.5 22.6 13.0 24.7 17.0 25.6 14.4 17.3 20.1 7.9 23.2 14.8 16.0 9.3 10.2 12.6 16.4 18.8 4.7 11.9 13.4 27.7 11.3 14.5 11.1 15.6 15.2 21.6 27.5 18.1 13.3 18.9 22.0 12.4 12.8 13.8 10.2 10.7 13.4 23.1 12.9 9.4 9.0 8.9 18.7 20.2 16.6 39.9 9.1 13.0 32.0 15.4 24.1 25.5 0.4 9.4 1.9 10.1 13.2 15.5 14.7 11.4 11.5 12.6 11.1 13.3 12.2 2.0 10.6 9.4 9.0 11.7 14.4 13.0 19.0 10.0 12.8 19.1 9.6 15.0 11.9 13.1 13.9 14.9 10.4 31.0 31.3 73.8 22.7 10.4 12.7 33.5 46.6 7.0 11.8 34.1 16.6 26.1 20.1 20.3 4.2 0.0 25.8 33.6 22.6 19.3 30.1 14.3 23.5 17.5 16.6 13.5 10.6 4.2 11.5 23.3 11.8 20.8 9.7 13.7 24.7 7.0 15.6 27.9 40.1 6.5 48.7 23.9 42.8 49.1 39.8 20.4 13.6 22.3 PNPLA3 "adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon" ENSG00000100344 "Patatin like phospholipase domain containing 3" Q9NST1 22 43923739-43964488 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "liver: 31.1;retina: 39.3" "Group enriched" "Detected in some" 6 "Bipolar cells: 37.1;Cholangiocytes: 15.3;Cone photoreceptor cells: 17.7;Hepatocytes: 42.7;Rod photoreceptor cells: 34.3" "Cancer enhanced" "Detected in many" "liver cancer: 4.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 13.5;LHCN-M2: 15.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA058058 Approved Approved Nucleoli,Mitochondria,Cytosol NA NA Nucleoli "Mitochondria, Cytosol" "HPA058058: AB_2683590" "unprognostic (4.74e-3)" "unprognostic (4.52e-2)" "unprognostic (1.76e-1)" "unprognostic (2.31e-1)" "unprognostic (1.36e-2)" "unprognostic (1.89e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.63e-1)" "unprognostic (2.93e-1)" "unprognostic (2.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.39e-3)" "unprognostic (2.52e-3)" "unprognostic (5.91e-2)" "unprognostic (2.02e-2)" "unprognostic (1.01e-1)" 2.8 0.4 0.5 0.7 1.0 0.3 4.0 0.3 2.4 0.8 1.3 0.4 0.0 1.0 0.5 1.9 0.4 1.1 0.5 0.9 0.8 0.6 4.6 31.1 1.4 0.4 0.3 1.8 0.5 0.2 0.6 0.2 0.4 2.2 0.2 0.2 39.3 0.9 0.2 2.2 5.3 0.6 0.2 0.5 0.6 0.3 0.5 0.3 0.0 0.2 0.0 0.3 0.2 0.4 1.2 0.7 1.8 0.6 0.9 0.8 0.0 3.9 1.3 13.5 5.5 3.8 4.3 0.4 2.4 1.4 3.3 7.2 3.9 7.1 0.0 2.1 4.0 1.9 3.4 8.4 3.9 2.8 0.0 0.7 0.2 3.2 7.2 6.2 0.0 0.2 4.9 3.1 10.6 0.5 5.7 0.4 0.1 0.0 0.0 15.3 0.6 0.2 0.0 9.2 0.4 0.0 0.0 7.3 0.1 1.5 0.2 1.2 0.1 2.7 1.1 3.8 2.4 4.2 4.6 0.4 1.3 4.1 0.1 0.1 0.0 0.0 0.0 11.6 0.0 4.8 1.5 0.6 0.4 0.5 0.4 0.3 0.7 0.4 0.3 0.2 1.2 0.6 0.8 1.8 0.9 0.3 0.7 0.2 0.0 0.5 1.0 0.3 2.4 0.8 0.6 0.3 1.8 2.2 0.3 0.0 0.0 0.0 0.5 0.3 37.1 1.1 15.3 0.0 0.0 0.0 17.7 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.4 0.0 42.7 0.6 0.0 1.7 0.6 2.6 0.0 0.3 0.0 1.7 0.0 0.5 1.3 1.5 0.0 0.7 5.0 34.3 0.0 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.4 PNRC1 "B4-2, PROL2, PRR2" ENSG00000146278 "Proline rich nuclear receptor coactivator 1" Q12796 6 89080751-89085160 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 1093.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 54.1;hTCEpi: 57.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029839, HPA066513" Approved Approved Nucleoplasm,Nucleoli NA Yes "Nucleoplasm, Nucleoli" "HPA029839: AB_10601247, HPA066513: AB_2685684" "unprognostic (9.02e-3)" "unprognostic (7.65e-2)" "unprognostic (3.01e-2)" "unprognostic (2.31e-2)" "unprognostic (6.10e-2)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (1.78e-1)" "unprognostic (5.20e-2)" "unprognostic (5.28e-3)" "unprognostic (1.96e-2)" "unprognostic (6.29e-2)" "prognostic unfavorable (6.88e-6)" "unprognostic (8.63e-3)" "unprognostic (2.05e-1)" "unprognostic (1.03e-1)" "unprognostic (5.09e-2)" 70.5 58.1 21.3 46.1 28.3 105.4 48.1 30.8 31.8 55.9 51.5 30.3 27.0 23.6 60.3 30.9 45.4 73.6 45.0 48.5 20.8 17.9 32.9 97.9 59.5 87.1 23.1 22.3 83.4 41.3 31.3 29.5 38.8 20.4 56.6 26.0 46.5 35.5 40.8 154.1 49.0 32.4 63.6 31.1 46.9 38.2 35.5 20.8 91.2 38.4 30.8 45.4 113.2 41.0 9.6 7.3 37.5 7.1 6.9 10.4 3.8 2.9 2.8 6.1 10.3 24.8 41.8 4.2 3.8 26.8 7.2 16.9 2.4 8.2 6.4 18.7 4.6 29.6 10.1 3.2 5.8 11.0 8.0 10.0 1.1 16.5 7.7 54.1 5.9 14.8 30.0 57.5 4.8 22.2 27.2 11.8 7.6 0.9 19.7 7.9 2.9 1.5 31.3 1.7 3.3 6.1 7.0 7.4 5.1 16.9 5.2 3.9 11.0 9.9 13.6 10.0 19.0 6.7 29.9 11.2 5.7 3.4 4.0 1.4 31.0 15.1 2.1 11.5 5.1 3.5 10.3 6.6 36.7 7.5 7.1 7.8 8.3 8.9 7.8 4.2 9.6 10.4 10.4 37.5 6.9 6.3 7.3 7.1 3.8 21.3 28.3 30.8 31.8 20.8 17.9 23.1 22.3 20.4 20.8 131.0 125.0 333.4 716.3 860.7 129.0 174.7 124.9 45.5 52.4 85.5 47.1 189.8 198.9 158.1 59.9 195.6 165.4 23.3 206.9 57.7 278.7 681.2 165.7 181.5 204.0 68.3 237.9 148.0 328.8 20.9 446.1 557.5 416.7 926.1 131.7 222.1 145.2 115.8 354.7 216.2 99.3 413.9 840.5 47.0 44.3 1093.4 229.5 380.5 99.7 411.4 POLE3 "CHARAC17, CHRAC17, p17, Ybl1" ENSG00000148229 "DNA polymerase epsilon 3, accessory subunit" Q9NRF9 9 113407235-113410672 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047945 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA047945: AB_2680218" "unprognostic (9.55e-2)" "unprognostic (3.39e-3)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (6.52e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (8.35e-4)" "unprognostic (1.04e-2)" "unprognostic (1.60e-2)" "unprognostic (1.10e-1)" "unprognostic (4.59e-3)" "unprognostic (2.31e-3)" "unprognostic (1.75e-2)" "unprognostic (1.56e-2)" "unprognostic (1.04e-1)" "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" 16.9 23.9 18.2 22.0 18.5 56.3 19.3 36.0 25.0 17.0 17.6 15.8 12.5 15.1 18.2 16.5 27.8 17.6 17.0 17.9 16.1 14.8 14.3 29.5 15.8 29.0 15.1 18.5 15.4 20.8 13.1 8.4 21.2 20.0 15.9 20.3 12.4 17.9 16.3 48.3 24.7 17.3 16.9 16.9 26.8 17.2 29.9 15.9 35.0 16.3 27.3 32.4 18.8 16.7 34.9 33.5 34.3 34.4 28.0 44.0 47.7 15.9 19.9 14.0 21.0 8.0 7.2 12.3 21.3 10.9 24.2 19.1 18.4 14.5 58.1 13.3 12.4 14.7 27.4 27.3 23.4 22.4 11.0 16.5 30.1 20.7 18.8 8.6 62.4 18.2 8.1 16.2 21.0 27.0 8.8 16.7 29.6 41.9 32.5 16.7 40.6 42.8 33.6 18.1 34.3 36.1 43.9 58.5 32.6 10.5 15.3 30.5 17.6 31.0 19.6 16.7 8.9 29.3 28.1 13.7 17.9 24.3 22.7 36.4 17.0 55.5 78.3 16.4 36.9 21.4 25.4 34.0 34.3 35.5 34.4 44.0 34.9 34.0 33.7 33.2 33.5 36.9 34.3 7.2 28.0 26.6 33.5 39.0 47.7 18.2 18.5 36.0 25.0 16.1 14.8 15.1 18.5 20.0 15.9 35.7 27.5 46.8 23.7 83.3 13.9 39.7 22.9 46.8 44.3 29.6 5.9 49.3 36.5 26.8 4.0 34.3 14.2 0.0 39.2 47.2 34.7 19.7 54.5 37.2 44.5 12.7 23.6 23.4 27.8 11.5 33.1 54.6 38.8 53.3 31.4 30.3 28.9 10.5 40.0 22.0 17.1 12.9 47.2 27.9 98.5 82.9 29.2 63.4 39.3 18.2 POLR1B "FLJ10816, FLJ21921, RPA2, Rpo1-2" ENSG00000125630 "RNA polymerase I subunit B" Q9H9Y6 2 112541915-112577150 "Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 133.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037528 Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA037528: AB_10671627" "unprognostic (1.66e-1)" "unprognostic (3.17e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (2.71e-5)" "unprognostic (2.07e-1)" "unprognostic (1.16e-2)" "unprognostic (1.98e-3)" "unprognostic (1.98e-1)" "unprognostic (2.05e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (6.12e-2)" "unprognostic (1.29e-2)" "unprognostic (1.18e-1)" "unprognostic (2.19e-1)" "unprognostic (1.08e-1)" "unprognostic (3.56e-2)" 8.8 11.0 6.4 10.6 6.8 4.9 15.7 8.0 8.2 7.6 7.0 7.7 8.6 5.8 9.3 7.4 12.8 9.2 9.2 6.1 5.7 6.1 11.3 20.5 8.0 11.3 6.8 3.7 11.3 25.2 20.7 11.5 7.2 5.2 7.7 8.5 7.3 10.0 8.3 14.7 9.2 8.0 7.9 4.8 11.4 8.1 15.7 5.0 9.6 15.7 11.5 14.6 8.9 11.8 9.4 11.0 2.5 6.3 10.2 17.1 7.3 9.5 10.0 6.3 13.1 6.9 6.6 11.9 7.2 5.5 12.2 10.6 22.4 5.7 22.9 10.7 4.7 9.5 13.5 26.7 14.6 14.1 10.3 13.5 13.2 9.9 16.9 7.3 21.1 9.2 6.3 10.6 12.6 19.5 5.1 9.4 4.8 23.9 8.3 6.3 8.4 9.5 13.7 30.9 14.1 19.8 14.3 10.5 24.3 8.4 9.1 16.1 14.9 6.6 16.6 9.0 7.1 7.7 7.5 8.5 7.5 11.0 6.8 10.5 11.2 18.4 19.8 5.7 13.6 6.2 0.2 6.0 2.5 8.3 6.3 17.1 9.4 8.4 8.9 11.0 9.3 10.3 10.4 0.4 10.2 4.8 2.6 11.3 7.3 6.4 6.8 8.0 8.2 5.7 6.1 6.8 3.7 5.2 5.0 14.9 5.1 8.2 2.2 13.4 3.4 5.7 10.2 2.7 7.9 8.7 2.0 2.9 5.0 4.0 133.9 5.6 1.2 0.0 3.9 2.3 2.8 2.2 4.7 8.5 3.3 1.6 3.5 1.8 2.5 29.4 2.8 2.9 1.7 1.8 4.4 3.8 2.9 6.0 2.8 4.1 2.9 0.0 2.8 9.5 7.5 15.1 0.5 6.4 4.5 3.4 POMT2 LGMD2N ENSG00000009830 "Protein O-mannosyltransferase 2" Q9UKY4 14 77274956-77320884 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003663 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003663: AB_1079655" "unprognostic (2.15e-1)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.40e-4)" "unprognostic (7.10e-3)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-3)" "unprognostic (1.94e-3)" "unprognostic (8.50e-3)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.75e-3)" "unprognostic (3.46e-2)" 6.7 10.8 10.4 6.8 11.4 3.8 7.7 12.5 13.3 6.8 6.3 18.0 9.8 4.6 6.9 17.1 5.7 8.7 6.9 7.7 9.3 7.7 8.1 8.3 6.2 3.0 11.7 6.2 7.6 10.6 14.7 16.1 11.4 9.7 7.3 5.8 8.2 10.1 12.3 17.0 4.3 4.6 7.8 8.4 5.2 5.6 30.9 14.4 2.5 11.5 4.9 3.8 5.7 5.0 1.4 1.9 0.8 1.9 0.0 1.7 0.4 10.4 13.4 13.0 14.7 9.3 7.5 10.4 9.2 7.6 13.8 11.8 6.6 9.4 3.1 7.5 8.6 19.1 11.7 6.1 9.2 9.6 4.6 8.3 1.9 6.6 5.4 11.4 2.1 6.3 7.6 9.8 12.9 12.6 9.6 8.0 3.1 4.9 7.3 9.0 20.6 3.6 10.1 3.7 14.5 11.3 3.5 12.7 2.8 14.3 7.7 11.0 10.8 6.0 10.2 7.7 8.9 10.5 4.4 6.6 10.4 16.4 12.0 8.0 4.8 9.4 1.4 5.3 3.2 9.1 0.0 0.4 0.0 1.7 1.9 0.4 1.4 0.0 0.3 0.9 0.2 0.1 0.0 0.8 0.0 0.8 1.9 0.0 0.4 10.4 11.4 12.5 13.3 9.3 7.7 11.7 6.2 9.7 14.4 6.0 3.2 2.2 2.3 2.7 6.5 4.0 5.1 0.0 0.0 1.8 15.7 5.0 0.0 6.6 8.0 2.8 3.9 0.0 6.4 8.6 6.0 3.5 2.3 4.4 4.8 7.9 17.2 3.1 2.4 12.1 1.7 2.2 1.7 3.6 3.0 8.2 5.8 1.9 3.9 3.0 15.0 0.0 3.9 9.8 8.5 1.6 4.8 0.0 2.6 1.4 POP1 ENSG00000104356 "POP1 homolog, ribonuclease P/MRP subunit" Q99575 8 98117297-98159834 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066194 Supported Nucleoli NA NA Nucleoli "HPA066194: AB_2732742" "prognostic unfavorable (2.54e-4)" "unprognostic (9.42e-2)" "unprognostic (5.96e-3)" "unprognostic (3.31e-2)" "unprognostic (1.46e-1)" "unprognostic (7.46e-2)" "prognostic unfavorable (1.26e-6)" "prognostic unfavorable (9.88e-4)" "unprognostic (4.85e-1)" "unprognostic (1.47e-1)" "unprognostic (3.79e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.97e-4)" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (1.34e-1)" "unprognostic (2.96e-1)" 6.1 5.5 7.8 9.0 9.7 3.7 5.8 14.3 10.2 4.3 5.4 5.2 2.7 4.3 6.0 4.2 9.1 6.6 3.9 5.0 5.7 4.7 10.5 6.4 5.2 9.1 4.1 7.6 8.4 5.8 7.6 11.1 3.5 7.4 5.0 13.8 6.2 5.1 4.2 5.7 8.2 5.1 5.2 4.0 8.8 5.7 11.8 6.2 8.8 5.0 5.6 11.3 4.3 5.0 10.5 7.7 10.9 7.4 4.1 9.8 2.5 12.7 7.7 8.4 7.7 2.9 2.1 5.6 10.9 9.2 11.4 8.5 7.9 8.3 9.0 15.8 7.9 5.5 8.5 24.2 10.8 12.3 6.5 10.2 17.8 6.1 5.3 1.3 9.4 11.3 1.8 2.0 12.6 5.0 3.5 8.9 4.3 9.7 8.1 10.7 10.1 13.6 4.8 6.3 14.9 10.6 11.3 4.9 6.5 8.3 6.8 20.0 4.7 5.0 8.6 3.8 5.0 11.6 3.5 12.0 10.0 7.2 12.6 21.6 8.1 7.6 19.3 7.9 10.2 8.8 10.9 6.7 4.6 9.8 7.4 7.8 6.2 7.1 6.5 6.2 10.5 9.3 8.6 0.9 4.1 3.4 7.7 5.9 2.5 7.8 9.7 14.3 10.2 5.7 4.7 4.1 7.6 7.4 6.2 3.0 3.8 5.1 4.8 3.3 7.8 2.8 0.0 2.7 4.5 5.2 0.0 3.2 5.0 9.5 9.8 2.9 1.3 0.0 5.0 2.8 2.7 3.5 1.1 5.5 3.0 1.6 0.0 3.1 1.6 1.8 4.9 3.2 0.0 9.0 1.6 3.1 6.4 0.0 4.2 7.8 9.6 6.5 2.7 3.9 15.7 2.0 2.5 1.9 2.7 3.9 POP5 ENSG00000167272 "POP5 homolog, ribonuclease P/MRP subunit" Q969H6 12 120578764-120581398 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047598, HPA069204" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA047598: AB_2680096, HPA069204: " "unprognostic (1.50e-2)" "prognostic favorable (2.68e-5)" "unprognostic (1.55e-1)" "unprognostic (3.61e-3)" "unprognostic (3.81e-1)" "unprognostic (1.50e-1)" "unprognostic (4.80e-3)" "unprognostic (1.28e-1)" "unprognostic (7.34e-2)" "unprognostic (5.75e-2)" "unprognostic (4.13e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (4.85e-4)" "unprognostic (3.07e-1)" "unprognostic (6.21e-2)" "unprognostic (2.68e-1)" "unprognostic (5.68e-2)" 16.3 33.8 16.2 25.6 14.4 14.1 23.9 8.7 16.7 18.6 17.5 13.6 24.2 11.8 14.5 27.1 15.9 14.6 19.5 25.8 18.1 13.9 24.1 24.1 18.3 19.7 16.9 15.9 11.7 18.9 25.0 17.5 8.2 14.2 15.6 18.0 15.1 20.9 22.6 13.3 12.7 15.1 19.5 14.4 20.3 15.2 9.0 12.1 24.2 19.8 18.9 19.6 13.7 19.2 32.0 33.5 3.6 19.7 18.2 28.2 22.8 20.1 34.6 12.3 15.0 23.4 12.6 19.6 17.0 11.0 20.8 16.0 29.8 9.3 11.9 25.9 13.6 10.9 21.4 20.6 32.4 18.7 28.1 31.2 14.5 22.6 33.7 16.5 20.4 15.2 15.9 18.7 24.0 11.0 11.7 17.3 28.4 17.7 7.7 20.6 44.4 16.6 18.4 14.7 29.3 29.9 19.5 15.1 32.5 29.1 20.8 9.6 10.6 28.8 8.5 21.9 14.6 39.4 19.7 12.5 10.9 16.3 17.3 18.5 19.9 33.5 21.0 21.2 24.9 17.3 3.6 16.2 3.5 24.7 19.7 22.6 32.0 22.6 23.0 19.0 22.4 28.2 26.8 1.1 18.2 16.7 33.5 21.4 22.8 16.2 14.4 8.7 16.7 18.1 13.9 16.9 15.9 14.2 12.1 11.9 25.1 40.9 40.5 17.4 19.6 53.8 40.8 25.4 37.5 73.3 13.7 49.9 131.0 34.2 1.3 26.7 23.2 23.3 38.8 36.9 22.4 23.7 54.2 46.1 46.0 17.5 21.2 23.9 18.3 2.7 33.4 31.2 47.2 27.1 27.7 54.1 31.5 24.6 35.3 99.7 28.3 19.4 28.8 19.1 33.4 21.7 14.8 37.4 37.5 25.7 POP7 "RPP2, RPP20" ENSG00000172336 "POP7 homolog, ribonuclease P/MRP subunit" O75817 7 100706053-100707495 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021007 Uncertain Supported Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "HPA021007: AB_10963575" "unprognostic (3.19e-1)" "unprognostic (2.45e-2)" "unprognostic (2.72e-2)" "unprognostic (1.80e-3)" "unprognostic (6.47e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.99e-5)" "unprognostic (2.98e-2)" "unprognostic (2.28e-1)" "unprognostic (3.12e-2)" "unprognostic (9.50e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (6.21e-2)" "unprognostic (6.73e-2)" 12.3 16.6 20.5 15.1 21.0 25.3 16.1 25.1 33.2 11.3 14.7 8.7 14.0 17.5 13.9 12.5 20.4 13.4 13.9 19.6 18.3 18.1 13.1 31.4 11.7 18.2 16.8 22.0 13.2 21.2 6.6 11.5 18.1 13.3 16.0 8.1 10.0 24.2 15.8 46.4 22.6 17.6 12.3 12.9 12.3 15.5 7.0 9.4 11.0 11.6 20.5 11.8 11.5 12.5 32.1 30.4 46.4 35.6 42.1 37.0 32.0 24.6 24.6 9.9 17.5 5.3 5.1 19.5 14.0 6.6 15.6 15.5 35.9 16.0 20.0 23.6 6.1 17.2 15.7 14.5 16.5 7.7 18.2 43.9 9.0 16.0 34.4 9.0 13.8 11.1 5.9 6.2 15.9 15.7 4.4 8.6 14.3 31.9 17.9 8.1 70.0 34.6 47.3 30.5 15.7 34.0 26.2 10.5 34.0 9.3 13.6 20.0 20.3 11.3 34.9 16.6 9.3 11.5 14.0 8.4 21.6 26.0 42.4 27.5 7.6 20.6 35.9 13.6 23.9 23.4 46.4 35.6 38.2 32.4 34.1 29.4 32.1 32.5 31.6 30.4 26.4 29.9 31.1 21.9 42.1 35.3 27.9 37.0 32.0 20.5 21.0 25.1 33.2 18.3 18.1 16.8 22.0 13.3 9.4 17.9 14.2 18.6 25.5 93.3 23.7 23.0 33.1 25.4 10.3 33.2 5.9 127.6 79.6 64.3 1.9 39.5 51.5 70.0 76.1 144.7 43.7 49.5 17.3 88.3 57.5 30.2 38.6 28.8 23.7 5.6 38.9 27.4 54.0 41.5 44.2 33.8 71.6 45.0 35.0 66.2 18.4 45.3 39.1 7.5 43.1 104.3 116.5 27.4 49.7 41.7 POPDC3 "bA355M14.1, MGC22671, POP3" ENSG00000132429 "Popeye domain containing 3" Q9HBV1 6 105158280-105179995 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "heart muscle: 23.9;skeletal muscle: 68.9" "Cell type enhanced" "Detected in some" 27 "Cardiomyocytes: 40.0;Early spermatids: 75.0;Late spermatids: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 25.2;LHCN-M2: 11.9;RH-30: 13.4;U-87 MG: 12.0;WM-115: 11.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA012514 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA012514: " "unprognostic (2.17e-1)" "unprognostic (2.15e-2)" "unprognostic (3.65e-1)" "unprognostic (1.14e-3)" "unprognostic (7.74e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.79e-4)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (5.12e-3)" "unprognostic (2.37e-1)" "unprognostic (2.83e-9)" "unprognostic (6.25e-2)" "unprognostic (1.24e-1)" "unprognostic (3.75e-3)" "unprognostic (1.33e-2)" 0.9 0.8 2.2 1.4 4.5 0.6 2.5 0.4 6.8 0.8 1.4 2.1 0.8 0.7 1.3 2.2 2.1 0.7 1.1 23.9 3.7 2.3 0.6 0.6 0.7 0.7 6.1 3.5 0.7 0.6 0.6 3.2 1.2 4.0 1.2 0.6 1.9 1.0 0.8 68.9 0.6 0.6 0.6 3.6 0.6 1.6 3.6 4.0 0.0 0.8 8.8 0.6 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.4 0.1 2.4 6.3 0.5 2.4 2.6 4.3 5.2 0.0 1.4 0.0 1.0 4.9 25.2 0.0 1.2 1.1 3.6 0.0 2.6 0.0 0.9 0.0 0.1 0.0 0.0 2.5 0.2 6.9 0.9 1.2 0.3 0.0 2.6 7.3 11.9 0.0 0.0 0.9 2.8 0.0 4.1 0.4 13.4 0.0 0.0 0.0 6.1 11.0 0.0 0.0 8.6 1.5 0.0 4.7 5.4 2.6 0.0 1.7 9.0 0.0 0.0 0.0 12.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.5 0.4 6.8 3.7 2.3 6.1 3.5 4.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 75.0 0.0 0.0 0.0 0.0 1.1 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.6 0.6 0.0 0.0 3.6 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 1.6 1.4 0.0 0.1 0.0 0.0 0.0 POU2F3 "Epoc-1, OCT11, PLA-1, Skn-1a" ENSG00000137709 "POU class 2 homeobox 3" Q9UKI9 11 120236640-120319944 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 18.5;Pancreatic endocrine cells: 12.7;Suprabasal keratinocytes: 33.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;EFO-21: 2.7;SK-BR-3: 5.3;T-47d: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019652, HPA073468" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear bodies, Plasma membrane, Cytosol" "HPA019652: AB_1855585, HPA073468: " "unprognostic (1.75e-1)" "unprognostic (2.12e-2)" "unprognostic (6.37e-2)" "unprognostic (2.41e-4)" "unprognostic (2.60e-1)" "unprognostic (4.46e-3)" "unprognostic (8.56e-3)" "unprognostic (9.34e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.69e-3)" "unprognostic (1.70e-1)" "prognostic favorable (8.14e-4)" "unprognostic (1.45e-1)" 0.2 0.2 0.1 0.2 0.1 0.0 1.6 0.1 0.1 1.2 0.9 0.0 36.5 0.7 0.4 1.2 2.5 0.3 0.4 0.2 0.1 0.1 0.3 0.2 1.6 0.4 0.1 0.0 0.2 0.3 6.4 1.3 4.4 0.1 1.1 0.1 0.0 1.1 13.2 0.1 38.2 1.0 0.2 0.1 0.2 0.4 0.6 0.0 0.4 4.5 4.8 2.2 0.7 2.6 1.0 0.7 2.1 0.5 0.9 0.6 0.2 2.5 0.0 0.0 0.2 0.0 0.0 0.8 0.3 0.6 0.0 0.0 0.1 7.2 0.3 2.7 0.0 0.1 1.3 0.0 0.4 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.7 0.4 0.2 0.0 0.1 0.0 1.4 0.0 0.1 0.1 0.2 0.3 0.1 0.6 0.0 0.0 0.1 0.0 1.9 0.5 0.1 0.1 5.3 0.0 0.9 9.7 0.4 0.8 0.0 0.2 0.4 0.1 0.1 0.1 0.0 1.1 0.2 0.1 1.4 0.4 0.5 0.5 0.3 0.5 0.5 0.6 0.4 0.1 1.0 0.6 0.6 2.1 0.9 0.5 0.7 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 5.1 0.0 9.0 18.5 0.0 0.8 0.0 1.4 2.3 10.4 0.0 1.2 0.0 3.6 1.7 0.0 0.3 0.0 1.2 0.2 0.2 5.0 0.0 0.4 0.1 0.0 2.9 0.0 0.0 3.8 0.0 0.0 5.0 0.0 0.0 0.2 12.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 33.0 6.6 0.0 0.5 10.1 PPDPF "C20orf149, dJ697K14.9, exdpf" ENSG00000125534 "Pancreatic progenitor cell differentiation and proliferation factor" Q9H3Y8 20 63520724-63522206 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 2540.0;Paneth cells: 2816.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 18.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040929 Approved Nucleoplasm,Nucleoli,Microtubules Yes No "Nucleoplasm, Microtubules" Nucleoli "HPA040929: AB_10794155" "unprognostic (3.75e-2)" "unprognostic (5.39e-2)" "unprognostic (4.37e-2)" "unprognostic (9.03e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.03e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-2)" "unprognostic (1.91e-1)" "unprognostic (2.00e-1)" "unprognostic (4.20e-1)" "prognostic favorable (3.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-1)" "unprognostic (4.20e-1)" "unprognostic (2.09e-2)" 63.9 19.9 42.2 46.0 43.0 36.5 38.8 22.3 55.1 54.3 78.6 61.5 43.5 41.3 39.9 46.0 112.6 44.7 67.3 53.2 32.9 31.0 72.1 28.4 56.5 42.8 44.5 34.9 45.6 69.5 15.4 35.0 22.2 48.7 75.3 32.2 58.8 143.7 54.1 116.1 86.2 48.5 61.8 72.0 40.0 120.2 49.0 21.6 28.7 48.0 73.3 87.9 68.6 65.2 5.8 3.4 18.9 4.5 2.4 5.2 3.4 44.6 13.9 9.5 19.2 10.8 18.2 30.7 27.5 8.9 36.0 14.2 25.4 26.9 9.6 37.1 18.3 13.7 47.3 4.8 31.4 5.8 17.1 9.5 3.9 13.0 4.8 29.7 0.0 20.6 17.9 63.4 9.1 12.7 11.9 14.1 12.2 16.1 22.7 13.1 60.8 45.7 0.4 10.3 35.8 80.8 20.9 21.5 19.4 25.7 18.4 32.6 24.9 27.3 44.1 18.9 6.6 63.0 26.2 23.2 30.4 34.6 40.2 22.7 18.1 14.2 6.5 21.5 11.3 19.8 1.9 2.4 18.9 5.2 3.1 4.3 4.6 4.6 4.8 2.9 5.8 4.1 4.5 1.1 2.4 4.5 3.4 5.0 3.4 42.2 43.0 22.3 55.1 32.9 31.0 44.5 34.9 48.7 21.6 291.8 201.0 276.1 613.6 510.4 42.1 61.0 749.1 294.5 174.0 910.7 11.8 432.7 2540.0 793.9 185.5 235.8 2093.0 327.1 669.9 547.6 555.3 988.2 330.2 190.7 548.2 47.7 765.2 266.4 322.1 856.1 344.3 360.7 1130.3 1110.9 1414.5 95.8 744.2 2816.1 271.2 1340.7 49.4 194.1 670.9 133.9 288.9 814.8 346.3 385.8 996.5 1073.4 PPID CYP-40 ENSG00000171497 "Peptidylprolyl isomerase D" Q08752 4 158709134-158723396 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Protein transport, Transport" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019520, HPA019692" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA Cytosol "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA019520: AB_1847400, HPA019692: AB_1847401" "unprognostic (4.26e-2)" "unprognostic (2.03e-2)" "unprognostic (8.91e-3)" "unprognostic (8.17e-3)" "unprognostic (1.50e-1)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.62e-2)" "unprognostic (4.72e-2)" "unprognostic (5.92e-2)" "unprognostic (4.54e-2)" "unprognostic (1.46e-2)" "unprognostic (2.66e-3)" "unprognostic (8.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.64e-1)" "unprognostic (1.09e-1)" 16.8 25.8 20.1 15.5 21.4 14.9 22.3 26.7 26.8 12.6 16.8 14.4 18.2 33.4 14.6 13.6 16.5 15.4 13.0 28.8 19.4 22.1 21.5 45.3 11.0 17.4 22.6 18.9 14.6 17.5 11.3 30.3 14.5 26.0 16.1 14.2 9.1 15.4 13.7 53.3 24.0 29.2 13.1 22.7 16.5 15.5 16.9 23.4 22.7 21.7 16.0 16.8 15.4 55.0 15.6 17.2 33.4 22.2 23.9 24.4 17.1 15.5 14.5 14.6 20.0 21.7 16.3 22.1 15.4 8.4 14.2 10.8 18.8 10.7 16.5 6.9 14.3 22.3 12.0 44.2 17.7 17.3 54.5 15.4 29.5 13.1 25.8 16.8 18.4 22.2 10.3 14.4 12.1 18.2 18.4 15.4 28.2 36.7 29.4 15.8 14.9 26.4 16.7 20.1 25.5 19.4 12.0 7.2 14.1 15.6 7.8 24.7 16.6 11.5 24.0 21.9 22.1 11.0 17.7 14.9 14.2 16.0 15.6 20.3 16.9 35.0 21.0 18.1 20.0 14.2 33.4 15.3 33.2 21.2 22.2 24.4 14.6 20.7 19.6 16.7 15.6 21.5 22.0 20.9 23.9 22.0 17.2 22.4 17.1 20.1 21.4 26.7 26.8 19.4 22.1 22.6 18.9 26.0 23.4 6.0 12.0 18.8 25.3 9.0 24.6 50.0 28.1 76.3 33.0 26.2 21.6 33.4 31.5 34.8 23.6 25.6 19.0 0.0 20.1 39.2 21.3 25.8 31.2 16.1 36.7 71.5 18.8 18.4 11.0 15.7 19.0 21.8 13.5 63.1 22.9 21.7 26.7 21.6 21.2 24.9 25.3 6.5 30.2 78.8 76.3 10.3 39.8 27.4 24.2 17.2 PPIL1 CYPL1 ENSG00000137168 "Peptidylprolyl isomerase like 1" Q9Y3C6 6 36854827-36875024 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062916 Supported Nucleoli NA NA Nucleoli "HPA062916: AB_2684904" "unprognostic (3.51e-2)" "unprognostic (2.33e-1)" "unprognostic (2.64e-3)" "unprognostic (1.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.81e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (2.01e-1)" "unprognostic (3.37e-2)" "prognostic favorable (4.90e-4)" "unprognostic (6.58e-2)" "unprognostic (5.49e-2)" "unprognostic (8.99e-2)" "unprognostic (1.30e-1)" "unprognostic (2.30e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-2)" 9.0 17.2 15.9 11.1 23.1 7.3 12.3 16.6 18.7 11.1 10.2 13.0 5.7 8.7 13.7 11.7 13.1 17.5 7.5 29.7 13.2 19.8 17.6 34.3 7.5 13.4 15.0 15.5 13.2 36.7 10.6 19.4 16.0 15.3 11.2 13.2 11.0 12.0 12.5 11.7 5.6 8.2 17.4 15.8 10.3 8.5 14.0 11.0 10.2 23.5 13.4 17.4 12.2 8.1 7.7 6.6 1.1 4.4 5.0 15.0 6.9 14.3 11.3 29.9 19.9 4.0 8.5 16.2 14.5 9.7 22.0 18.3 19.8 9.5 22.0 18.4 10.2 29.0 11.6 35.3 24.2 25.2 18.3 29.5 26.0 7.4 26.1 13.4 22.2 10.9 6.3 11.5 16.9 31.6 8.1 19.6 21.3 48.8 10.7 15.8 13.6 26.4 10.2 19.8 27.5 15.3 21.3 26.2 19.7 13.0 10.1 31.8 16.8 9.7 10.4 19.1 23.0 15.2 18.9 11.9 17.0 15.7 12.9 24.2 11.8 30.6 40.1 5.4 41.2 32.3 1.1 3.2 0.8 11.2 4.4 15.0 7.7 9.3 10.7 6.6 6.2 10.5 12.3 0.9 5.0 2.1 5.6 6.8 6.9 15.9 23.1 16.6 18.7 13.2 19.8 15.0 15.5 15.3 11.0 6.0 6.9 6.7 16.2 2.7 14.1 40.3 7.6 20.1 7.9 5.2 3.9 50.9 19.9 22.9 21.9 9.2 2.6 0.0 17.8 54.4 8.4 9.5 10.4 6.8 25.9 15.9 3.5 3.7 2.8 8.5 6.4 9.5 6.8 11.8 8.5 25.1 18.1 7.0 11.7 10.2 10.5 6.5 8.9 14.4 49.0 4.0 21.2 7.5 10.3 8.6 PPIL3 CyPJ ENSG00000240344 "Peptidylprolyl isomerase like 3" Q9H2H8 2 200870907-200889303 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040765, HPA062187" Approved Approved Nucleoplasm,Nucleoli NA NA 35000 Nucleoplasm Nucleoli "HPA040765: AB_2677125, HPA062187: AB_2684706" "unprognostic (8.96e-3)" "unprognostic (6.07e-2)" "unprognostic (5.34e-2)" "unprognostic (8.16e-2)" "unprognostic (2.69e-2)" "unprognostic (9.61e-2)" "unprognostic (8.31e-2)" "unprognostic (8.05e-2)" "unprognostic (1.40e-2)" "prognostic favorable (1.19e-4)" "unprognostic (5.23e-2)" "unprognostic (6.60e-2)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.14e-1)" "unprognostic (5.96e-2)" "unprognostic (2.21e-2)" "unprognostic (4.87e-2)" 12.4 17.9 18.1 15.5 19.2 24.2 21.1 20.1 20.2 19.4 16.4 18.4 21.1 12.7 17.2 24.3 25.4 19.1 15.9 17.6 17.5 21.8 15.9 19.4 15.9 23.7 20.0 11.8 31.4 16.7 11.9 17.4 15.5 23.0 19.5 16.6 16.3 13.8 15.8 13.4 14.7 15.7 16.8 23.2 20.2 15.7 18.2 13.0 26.3 23.7 19.4 25.5 28.6 13.6 23.4 21.7 18.7 14.1 20.6 20.6 10.7 8.0 7.1 22.1 9.6 17.3 37.2 7.2 12.8 13.9 14.8 15.0 5.2 15.2 7.7 13.6 13.8 17.4 10.6 7.7 15.6 13.3 16.3 18.5 32.5 19.9 35.1 8.9 31.1 16.5 13.5 15.3 12.1 19.1 25.0 9.8 15.3 25.7 18.9 18.8 12.8 23.9 24.8 13.5 8.1 11.5 9.1 12.4 12.1 19.4 12.4 9.2 8.5 12.9 12.3 20.6 27.1 10.2 14.2 13.4 21.3 12.1 12.6 10.5 20.7 19.6 36.3 16.3 13.9 13.5 18.7 12.7 12.7 12.7 10.8 18.5 23.4 15.6 13.7 21.7 18.9 19.1 20.6 3.0 20.6 14.1 17.9 20.1 10.7 18.1 19.2 20.1 20.2 17.5 21.8 20.0 11.8 23.0 13.0 0.0 11.5 24.3 38.6 28.2 12.5 17.8 17.8 21.4 11.4 15.7 9.8 45.1 48.0 20.2 14.8 15.7 12.9 0.0 14.0 44.2 34.2 17.7 25.4 15.7 41.6 3.2 9.1 16.0 41.1 2.7 33.9 45.8 27.0 23.4 25.0 17.1 18.9 24.6 26.5 45.3 10.5 19.4 29.4 36.5 22.3 40.5 25.7 32.6 29.2 23.7 PPM1B "PP2CB, PP2CBETA, PPC2BETAX" ENSG00000138032 "Protein phosphatase, Mg2+/Mn2+ dependent 1B" O75688 2 44167969-44244384 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016745 Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA016745: AB_1855622" "unprognostic (5.49e-2)" "unprognostic (2.67e-2)" "unprognostic (1.11e-2)" "unprognostic (2.96e-3)" "unprognostic (1.92e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-1)" "unprognostic (1.50e-2)" "unprognostic (1.58e-1)" "unprognostic (1.94e-1)" "unprognostic (2.25e-1)" "unprognostic (6.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (1.75e-2)" 23.7 13.8 31.2 12.2 33.8 24.7 15.2 32.6 25.2 16.3 18.2 26.0 13.6 13.2 15.7 20.4 14.9 12.7 14.3 21.1 29.6 24.6 19.4 27.7 13.4 16.6 34.6 22.4 15.8 20.9 34.6 17.9 12.1 22.9 20.7 19.0 24.3 16.4 16.4 72.0 12.5 14.3 21.1 27.3 16.1 14.8 13.3 34.1 19.1 15.0 13.1 16.8 18.2 15.9 6.5 5.5 11.1 5.0 4.7 9.5 1.6 17.0 15.3 20.4 14.8 25.4 11.9 23.1 13.2 15.3 13.8 12.2 20.5 11.1 18.8 20.8 15.3 11.2 9.3 22.7 8.7 20.4 18.9 8.8 19.8 9.1 14.1 20.6 17.7 16.6 11.4 15.2 10.9 18.6 10.8 11.2 8.8 14.4 20.0 12.3 14.2 17.5 28.5 25.1 15.8 5.2 18.6 22.7 12.6 32.1 17.3 16.4 20.7 11.9 17.9 15.3 31.7 9.7 12.4 10.2 12.1 17.4 10.0 12.7 17.5 11.4 17.6 6.4 29.5 8.7 8.3 3.3 11.1 7.2 4.5 6.2 5.8 6.9 6.1 5.5 6.5 9.5 6.4 9.2 4.7 5.0 5.3 6.2 1.6 31.2 33.8 32.6 24.9 29.6 24.6 34.6 22.4 22.9 34.1 17.9 17.3 29.6 37.1 53.8 47.2 45.6 28.1 5.3 20.5 38.4 60.9 27.6 39.7 35.0 59.2 17.3 39.4 0.0 41.1 24.4 27.3 58.6 26.5 49.9 23.3 101.7 38.6 16.5 48.5 32.9 33.1 41.2 54.0 37.9 27.4 54.4 35.2 40.3 31.8 30.8 128.5 25.8 38.7 33.8 26.0 54.5 54.0 54.2 32.8 45.7 PPM1D "PP2C-DELTA, Wip1" ENSG00000170836 "Protein phosphatase, Mg2+/Mn2+ dependent 1D" O15297 17 60600183-60666280 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Hydrolase, Protein phosphatase" "Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022277, HPA061848" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA022277: AB_1858839, HPA061848: " "unprognostic (1.48e-1)" "unprognostic (1.36e-2)" "prognostic favorable (3.52e-4)" "unprognostic (1.76e-1)" "unprognostic (1.02e-1)" "unprognostic (5.12e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (5.50e-2)" "unprognostic (1.70e-2)" "unprognostic (6.07e-2)" "unprognostic (2.52e-3)" "unprognostic (3.46e-2)" "unprognostic (1.95e-3)" "unprognostic (7.33e-2)" "unprognostic (1.58e-1)" "unprognostic (1.71e-2)" "unprognostic (1.98e-1)" 12.2 7.0 6.1 5.7 9.2 13.6 11.9 30.8 6.6 11.1 10.0 10.6 7.8 7.6 12.0 8.3 8.6 11.1 8.3 5.8 7.7 4.4 7.4 7.4 9.2 7.9 10.3 4.6 17.3 12.3 8.1 8.9 18.5 8.8 9.3 9.4 8.2 8.1 6.8 9.7 8.1 8.1 8.2 7.3 9.2 7.3 16.2 12.5 15.5 8.7 6.9 7.0 7.8 11.3 7.3 13.1 20.5 13.2 6.8 8.3 6.8 2.7 5.5 6.2 5.3 4.2 2.6 8.0 4.3 2.9 2.8 4.0 5.6 1.6 7.9 3.6 3.0 1.1 3.0 4.0 1.8 3.8 1.4 8.8 5.7 5.4 6.5 3.5 2.3 4.4 2.3 2.9 4.2 2.5 2.3 6.4 3.4 4.1 3.3 3.0 26.9 6.2 3.4 2.7 2.6 4.3 7.6 7.9 4.7 2.5 3.4 8.5 6.2 5.7 1.9 1.3 6.9 2.3 3.1 4.7 3.7 10.1 2.8 2.3 5.4 5.7 6.0 1.5 2.3 2.8 8.2 13.2 14.1 6.7 10.2 5.9 7.3 5.6 6.1 13.1 5.9 6.1 6.2 20.5 6.8 6.1 5.8 8.3 6.8 6.1 9.2 30.8 6.6 7.7 4.4 10.3 4.6 8.8 12.5 29.8 7.7 13.7 4.0 18.7 12.0 5.6 5.1 2.7 4.5 5.2 3.9 13.6 3.3 6.0 51.4 15.8 10.1 0.0 6.0 5.1 11.2 6.9 1.1 2.8 7.5 3.2 13.8 20.3 23.0 8.1 12.7 9.8 3.3 6.4 9.0 6.4 5.1 8.6 7.1 4.2 10.1 0.0 12.0 24.5 13.9 15.7 32.3 7.5 10.5 5.5 PPM1E "CaMKP-N, KIAA1072, POPX1, PP2CH" ENSG00000175175 "Protein phosphatase, Mg2+/Mn2+ dependent 1E" Q8WY54 17 58755869-58985176 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 10.7;brain: 36.5;testis: 13.1" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 16.0;Cone photoreceptor cells: 29.5;Early spermatids: 22.1;Horizontal cells: 73.1" "Cancer enhanced" "Detected in some" "prostate cancer: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 2.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.5" "Cell line enhanced" "Detected in many" "AF22: 10.2;HAP1: 16.5;MOLT-4: 7.8;SCLC-21H: 7.6;SH-SY5Y: 15.8;THP-1: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018462, HPA019263" Approved Approved Nucleoplasm,Nucleoli Yes No Nucleoli Nucleoplasm "HPA018462: AB_1855623, HPA019263: AB_1855624" "unprognostic (2.50e-2)" "unprognostic (5.75e-2)" "unprognostic (8.12e-2)" "unprognostic (2.99e-2)" "unprognostic (5.30e-1)" "unprognostic (8.19e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (3.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.80e-5)" "unprognostic (4.97e-2)" "unprognostic (1.23e-7)" "unprognostic (1.05e-4)" "unprognostic (1.64e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" 0.7 10.7 15.0 0.8 7.5 0.7 0.7 11.9 23.3 1.0 0.7 3.6 0.0 0.8 1.1 2.2 0.7 3.3 0.8 2.3 36.5 5.4 1.9 2.4 1.0 0.9 3.2 9.2 1.0 1.7 0.8 3.4 0.6 10.5 3.2 0.7 3.5 0.8 0.7 0.6 0.7 1.0 1.3 2.7 0.8 1.4 13.1 2.0 0.0 0.8 0.0 1.0 0.6 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.5 0.0 0.0 0.8 0.0 0.0 0.8 1.2 0.0 0.0 6.5 0.1 0.1 2.3 0.0 16.5 0.0 0.4 0.1 4.9 0.0 0.1 0.0 1.2 0.5 2.1 0.3 1.3 0.1 0.0 0.5 0.0 4.1 1.6 0.0 0.0 2.9 7.8 0.0 2.9 0.0 0.8 0.0 1.3 0.0 0.0 0.0 7.6 15.8 0.2 0.0 1.0 0.1 0.0 7.0 0.0 0.0 1.9 0.0 2.4 0.0 0.1 4.4 0.3 0.0 2.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 7.5 11.9 14.0 36.5 5.4 3.2 9.2 10.5 2.0 0.0 0.0 0.0 0.0 0.0 16.0 1.6 0.0 0.0 3.4 0.0 29.5 0.0 0.0 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.1 73.1 2.9 0.0 0.3 14.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.4 0.0 11.7 0.0 0.0 9.3 2.5 0.0 0.0 0.0 0.0 0.0 PPP1R1C Inhibitor-1-like ENSG00000150722 "Protein phosphatase 1 regulatory inhibitor subunit 1C" Q8WVI7 2 181954241-182131398 "Predicted intracellular proteins" "Cell cycle, Cell division" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 7.5;heart muscle: 27.8" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 106.6;Late spermatids: 139.1;Spermatocytes: 41.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;HAP1: 1.2;JURKAT: 1.1;MOLT-4: 2.1;SiHa: 1.3;SuSa: 1.2;U-266/70: 1.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA055043 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA055043: AB_2797251" "unprognostic (1.70e-1)" "unprognostic (3.15e-1)" "unprognostic (4.54e-3)" "unprognostic (1.08e-2)" "unprognostic (1.36e-1)" "unprognostic (1.01e-1)" "unprognostic (2.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.57e-2)" "unprognostic (6.59e-3)" "unprognostic (1.13e-1)" "unprognostic (7.98e-2)" "unprognostic (3.70e-2)" "unprognostic (1.00e-3)" "unprognostic (7.68e-2)" "unprognostic (3.07e-2)" "unprognostic (9.75e-3)" 0.2 0.1 0.7 0.1 3.5 0.1 0.2 3.5 1.8 0.1 0.2 3.0 0.0 0.2 0.2 0.1 0.3 0.2 0.5 27.8 1.5 1.1 0.2 1.2 0.3 0.2 0.8 0.6 0.1 0.6 0.1 0.4 0.2 7.5 1.4 0.2 0.5 0.5 0.2 4.3 0.2 0.7 0.1 2.5 0.2 0.4 0.6 1.3 0.0 0.2 3.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.4 2.1 0.0 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.3 0.2 0.3 1.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.9 0.0 0.2 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.5 3.5 1.8 1.5 1.1 0.8 0.6 7.5 1.3 11.9 5.4 0.0 0.5 0.2 0.8 34.2 10.2 1.4 11.4 3.5 0.0 2.7 1.7 2.3 106.6 0.0 0.0 0.0 9.8 5.6 0.7 0.1 0.0 17.9 0.5 0.0 5.8 0.0 0.3 139.1 5.5 0.0 3.3 6.4 0.3 6.0 14.6 0.0 0.7 0.5 1.9 0.0 0.5 41.8 2.0 0.3 2.1 0.0 0.7 0.9 PPP1R3D PPP1R6 ENSG00000132825 "Protein phosphatase 1 regulatory subunit 3D" O95685 20 59936668-59940297 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041146 Approved Approved Nucleoli,Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" Nucleoli "HPA041146: AB_10793870" "unprognostic (2.50e-3)" "unprognostic (3.55e-3)" "unprognostic (6.90e-2)" "unprognostic (1.23e-1)" "unprognostic (7.23e-2)" "unprognostic (5.87e-2)" "unprognostic (5.73e-2)" "unprognostic (2.39e-3)" "unprognostic (5.54e-2)" "unprognostic (3.27e-1)" "unprognostic (3.52e-2)" "unprognostic (1.20e-1)" "unprognostic (1.48e-2)" "prognostic favorable (9.14e-4)" "unprognostic (4.71e-2)" "unprognostic (1.47e-2)" "unprognostic (5.71e-2)" 8.2 6.1 9.3 8.2 9.5 9.9 17.2 8.6 9.5 9.1 8.2 6.4 7.1 9.5 9.0 6.5 13.3 7.4 6.5 11.3 8.4 7.8 7.8 2.0 10.0 16.8 9.5 5.4 8.8 17.5 13.3 12.1 9.8 9.3 12.0 5.6 7.6 9.1 11.2 12.9 9.1 10.1 7.1 8.9 11.2 9.6 4.7 6.6 4.0 8.0 8.8 8.9 9.1 8.8 0.7 1.2 6.0 3.5 0.8 1.0 0.4 4.0 2.5 1.7 3.5 3.9 4.1 14.4 5.4 5.8 6.6 3.2 3.9 5.6 1.7 6.7 4.5 4.1 12.0 3.5 3.8 4.3 3.9 2.8 4.5 3.3 2.1 3.6 1.8 12.7 2.9 10.6 2.3 2.0 3.5 3.6 1.1 0.8 0.4 4.2 6.3 1.5 5.9 1.2 7.7 6.0 1.9 0.8 2.6 4.4 6.6 3.3 2.0 6.7 20.3 5.8 3.4 7.4 6.6 3.8 3.9 1.6 4.1 0.8 1.4 3.5 0.4 2.9 6.5 2.4 0.6 1.6 6.0 1.0 0.7 0.9 0.7 0.7 0.8 1.2 0.6 0.9 0.6 4.2 0.8 3.5 0.5 1.0 0.4 9.3 9.5 8.6 9.5 8.4 7.8 9.5 5.4 9.3 6.6 8.9 0.3 2.4 4.4 1.1 6.1 4.7 7.6 4.0 4.5 5.2 2.0 12.2 5.0 1.9 0.3 5.8 4.2 0.0 2.7 3.7 2.6 5.9 5.7 0.2 4.6 12.7 1.7 9.2 8.9 0.0 2.8 3.4 5.0 1.0 3.1 10.3 3.0 6.5 4.2 5.0 10.8 6.5 4.0 0.2 4.3 2.8 4.1 7.5 2.8 7.8 PPP1R7 sds22 ENSG00000115685 "Protein phosphatase 1 regulatory subunit 7" Q15435 2 241149576-241183652 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 735.0;Late spermatids: 1235.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034500, HPA034501" Supported Approved Nucleoli NA NA 650000 Nucleoli "HPA034500: AB_2674192, HPA034501: AB_10670965" "unprognostic (1.63e-1)" "unprognostic (4.51e-2)" "unprognostic (1.18e-1)" "unprognostic (1.16e-2)" "unprognostic (3.62e-2)" "unprognostic (4.38e-1)" "unprognostic (8.07e-3)" "unprognostic (5.01e-2)" "unprognostic (2.49e-1)" "unprognostic (9.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (1.15e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (4.51e-3)" "unprognostic (1.23e-1)" 21.5 21.9 39.2 19.4 82.1 22.2 19.7 25.0 40.5 19.0 24.8 16.4 18.8 22.2 18.9 24.8 31.5 32.2 20.5 36.9 31.3 23.3 24.9 28.8 20.4 27.2 23.7 35.2 16.4 22.8 21.9 18.4 17.3 23.5 37.9 25.3 17.6 22.9 22.2 46.4 24.2 22.7 21.3 20.8 17.6 21.8 57.3 29.4 21.2 25.5 26.1 29.6 24.4 25.0 31.4 37.5 48.5 41.0 32.8 53.3 37.4 31.3 19.0 21.6 27.3 42.9 43.1 29.9 34.7 31.8 24.0 34.0 10.3 40.2 16.2 10.4 29.7 36.1 30.9 35.4 32.8 36.9 42.0 34.9 28.3 31.0 40.8 27.7 39.0 29.8 33.2 26.0 28.3 21.0 32.7 35.5 33.4 28.5 24.0 56.0 41.7 34.8 30.1 29.6 50.2 18.2 24.2 56.3 32.7 44.6 31.8 29.4 23.4 18.6 43.8 31.7 25.4 26.1 42.5 34.9 21.8 20.7 40.9 27.9 25.6 15.4 43.8 61.1 41.7 28.6 40.4 39.8 48.5 32.1 40.0 33.7 31.4 38.4 37.7 37.5 28.8 29.8 34.5 31.4 32.8 41.0 22.4 53.3 37.4 39.2 82.1 25.0 40.5 31.3 23.3 23.7 35.2 23.5 29.4 53.6 46.2 73.1 40.9 24.6 40.6 88.8 48.4 119.1 70.5 41.8 15.7 79.0 102.8 76.7 735.0 40.9 60.8 0.0 127.1 78.3 37.5 46.6 56.7 41.4 87.4 30.2 24.6 27.6 40.5 1235.7 47.2 67.7 82.7 65.9 50.2 55.2 81.2 63.3 63.3 96.6 36.4 71.1 54.5 161.9 125.6 33.2 59.8 59.5 47.6 47.3 PRAG1 "DKFZp761P0423, NACK, PEAK2, PRAGMIN, SgK223" ENSG00000275342 "PEAK1 related, kinase-activating pseudokinase 1" Q86YV5 8 8317736-8386498 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.4" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 6.2;Cytotrophoblasts: 6.4;Ductal cells: 6.6;Extravillous trophoblasts: 5.5;Hofbauer cells: 14.8;Pancreatic endocrine cells: 5.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 27.5;NTERA-2: 17.8;SuSa: 19.0" "Low region specificity" "Detected in all" "HPA011776, HPA012066" Uncertain Uncertain "Nucleoli,Focal adhesion sites" NA NA Nucleoli "Focal adhesion sites" "HPA011776: , HPA012066: AB_1847706" "unprognostic (7.04e-3)" "unprognostic (7.90e-2)" "unprognostic (2.32e-1)" "unprognostic (2.95e-2)" "unprognostic (1.60e-1)" "unprognostic (2.92e-1)" "unprognostic (1.05e-1)" "unprognostic (4.78e-3)" "unprognostic (2.64e-3)" "unprognostic (5.19e-2)" "unprognostic (4.95e-2)" "unprognostic (1.78e-1)" "prognostic favorable (4.81e-4)" "unprognostic (5.27e-2)" "unprognostic (1.23e-1)" "unprognostic (5.04e-2)" "unprognostic (5.22e-3)" 7.6 0.2 6.4 8.8 4.9 0.1 5.4 30.4 7.0 2.4 5.7 1.8 3.2 9.8 0.8 1.7 2.6 5.0 4.0 1.8 2.1 1.3 0.9 4.3 9.1 0.0 1.4 1.7 1.0 2.2 0.0 5.4 1.2 1.5 3.4 0.0 1.7 5.7 5.6 2.8 9.4 0.9 1.4 5.7 3.9 0.7 1.2 1.8 15.4 4.7 6.2 1.5 0.2 3.1 4.6 2.2 1.6 1.3 3.9 0.4 3.3 27.5 3.1 0.4 0.0 0.2 7.8 7.0 1.5 2.8 1.1 13.6 8.0 5.5 4.8 3.3 7.6 12.0 0.5 8.4 0.6 0.2 0.8 0.0 3.3 7.6 3.0 0.8 8.7 0.7 5.5 0.4 1.2 1.6 5.7 0.8 0.0 0.0 2.1 4.6 0.7 2.6 17.8 10.5 7.1 3.5 3.3 1.3 4.1 9.5 1.5 1.0 2.7 7.7 2.7 19.0 6.0 3.4 7.5 0.2 7.4 0.0 1.7 0.4 0.6 7.5 1.7 1.8 4.1 0.0 0.5 2.2 1.2 0.1 0.9 3.1 1.5 0.4 0.7 2.6 3.9 3.2 0.0 1.3 1.6 4.6 0.2 0.4 8.9 6.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 6.4 0.0 6.6 0.0 0.0 0.0 0.0 2.7 5.5 0.0 0.0 2.3 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.8 0.0 0.0 5.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 PRDM1 "BLIMP1, PRDI-BF1" ENSG00000057657 "PR/SET domain 1" O75626 6 106086320-106109939 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 49.9" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 49.1;T-cells: 100.2;Urothelial cells: 77.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "eosinophil: 5.6;gdT-cell: 12.6;MAIT T-cell: 19.3;memory CD4 T-cell: 12.0;memory CD8 T-cell: 11.6;naive CD8 T-cell: 6.8;neutrophil: 6.8;T-reg: 15.4" "Group enriched" "Detected in many" 5 "granulocytes: 6.8;T-cells: 19.3" "Cell line enhanced" "Detected in some" "Karpas-707: 68.5;RPMI-8226: 12.8;U-266/70: 25.7;U-266/84: 16.6" "Region enriched" "Detected in single" 6 "olfactory region: 4.4" "Low region specificity" "Detected in all" "HPA030033, HPA075427" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA030033: AB_10601050, HPA075427: " "unprognostic (9.60e-2)" "unprognostic (3.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.98e-2)" "unprognostic (4.03e-1)" "unprognostic (3.77e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (2.42e-1)" "unprognostic (1.81e-1)" "unprognostic (3.50e-2)" "unprognostic (7.56e-2)" "prognostic unfavorable (9.81e-5)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (2.45e-3)" "unprognostic (7.90e-2)" 11.6 1.5 1.6 26.3 3.2 10.4 7.0 5.3 1.6 14.0 16.5 1.9 1.4 5.4 11.6 2.2 33.4 3.8 8.1 2.3 1.9 2.0 3.1 2.4 18.8 33.3 2.1 0.5 4.2 1.8 1.2 2.1 9.0 4.9 3.6 11.0 4.3 10.6 3.0 2.0 8.9 18.2 3.4 7.4 24.2 8.6 3.0 1.5 3.1 7.7 35.7 49.9 12.8 18.0 1.5 0.2 6.8 0.6 2.5 19.3 1.3 0.4 0.1 0.3 0.0 0.5 0.7 0.0 2.3 7.2 0.7 1.3 0.4 2.8 0.6 0.1 4.6 0.1 0.1 0.0 1.1 0.8 6.4 0.0 0.1 1.4 0.0 1.1 0.2 0.5 0.7 3.6 1.0 3.0 0.2 0.9 0.3 0.4 68.5 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.1 0.0 12.8 0.6 0.1 0.0 0.0 0.3 0.3 0.0 0.5 0.3 0.7 0.4 1.1 0.6 0.6 2.1 25.7 16.6 1.5 1.6 0.4 0.6 1.2 0.4 5.6 12.6 0.6 19.3 1.5 12.0 11.6 0.2 0.5 1.1 6.8 6.8 2.5 0.1 0.2 15.4 1.3 1.6 3.2 5.3 1.6 1.9 2.0 2.1 0.5 4.9 1.5 0.0 9.0 19.7 8.0 17.3 0.8 1.4 0.0 2.7 7.9 3.5 49.1 0.4 0.0 0.3 0.8 20.4 7.3 23.3 0.2 0.5 5.1 3.1 3.5 1.5 19.3 0.0 1.7 8.0 24.7 0.0 0.0 38.5 35.4 47.7 3.1 0.5 4.8 4.3 1.1 0.1 0.4 0.0 16.4 0.3 1.3 36.3 0.6 100.2 2.5 77.0 PRDM5 PFM2 ENSG00000138738 "PR/SET domain 5" Q9NQX1 4 120684919-120922870 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 57.4;Late spermatids: 22.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "eosinophil: 9.1;neutrophil: 6.7" "Lineage enriched" "Detected in single" 29 "granulocytes: 9.1" "Cell line enhanced" "Detected in many" "U-266/84: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051406 Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "HPA051406: AB_2681472" "unprognostic (7.74e-2)" "unprognostic (8.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.09e-1)" "unprognostic (7.20e-2)" "unprognostic (9.30e-2)" "unprognostic (3.28e-2)" "unprognostic (4.52e-2)" "unprognostic (5.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.13e-1)" "unprognostic (3.00e-2)" "unprognostic (4.91e-4)" "unprognostic (2.34e-1)" "unprognostic (1.29e-1)" "unprognostic (5.56e-3)" 5.0 5.9 3.5 3.6 3.9 4.6 5.4 1.9 5.4 9.3 5.2 2.7 6.3 1.9 8.6 7.0 3.3 7.7 6.1 5.0 3.2 3.1 3.1 0.8 7.4 2.7 3.4 4.2 15.2 10.3 19.3 12.5 5.0 6.1 7.7 4.4 9.4 3.3 6.8 2.2 2.7 3.2 9.5 6.2 3.3 4.1 5.0 3.3 0.5 8.4 5.1 2.3 5.8 14.1 0.0 0.0 9.1 0.0 0.0 0.3 0.0 1.8 2.9 6.6 0.1 4.0 8.3 7.8 3.9 8.6 4.0 3.5 3.7 1.1 0.4 1.1 5.2 3.8 0.0 0.0 0.8 5.3 0.0 1.1 2.4 2.6 0.2 4.3 8.1 0.1 5.8 2.6 2.8 3.6 3.7 2.9 1.0 0.0 12.1 4.9 0.3 1.2 0.0 4.9 0.6 2.2 0.0 7.7 5.0 1.4 0.0 1.2 5.3 0.0 0.1 0.8 3.6 5.5 3.4 1.1 0.2 2.4 4.1 3.8 11.2 15.6 0.0 3.0 0.0 3.0 0.1 0.0 9.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 6.7 0.0 0.0 0.0 0.0 0.0 3.5 3.9 1.9 5.4 3.2 3.1 3.4 4.2 6.1 3.3 11.9 3.5 0.5 2.5 1.4 9.5 7.3 0.0 2.7 5.7 1.8 7.9 0.8 1.7 1.8 57.4 4.9 0.0 0.0 2.1 2.1 4.4 2.0 2.3 0.0 0.7 0.0 3.5 3.7 0.3 22.0 8.1 0.8 1.7 0.0 2.7 8.2 1.9 0.0 8.9 0.0 8.0 6.5 3.6 5.0 3.3 1.5 0.5 0.0 2.4 0.6 PRIMA1 PRIMA ENSG00000175785 "Proline rich membrane anchor 1" Q86XR5 14 93718298-93788481 "Predicted membrane proteins" "Neurotransmitter degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 26.2" "Cell type enriched" "Detected in some" 11 "Muller glia cells: 33.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 7.5;Hep G2: 4.8;NTERA-2: 3.0;SCLC-21H: 13.2;SH-SY5Y: 7.5" "Region enhanced" "Detected in many" "basal ganglia: 16.2" "Low region specificity" "Detected in all" "HPA046671, HPA060047" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoli, Cytosol" "HPA046671: AB_2679744, HPA060047: AB_2684194" "unprognostic (3.60e-2)" "unprognostic (1.97e-1)" "unprognostic (7.54e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.03e-2)" "unprognostic (3.73e-2)" "unprognostic (1.07e-1)" "unprognostic (5.81e-2)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (8.94e-2)" "unprognostic (6.61e-3)" "prognostic unfavorable (2.62e-7)" "unprognostic (2.33e-2)" "unprognostic (2.67e-1)" "unprognostic (7.94e-4)" "unprognostic (4.57e-3)" 4.6 6.0 4.2 5.9 16.7 0.4 2.4 4.5 8.2 7.7 26.2 21.7 4.2 4.6 7.9 7.9 13.7 10.7 3.3 4.8 5.8 3.3 1.2 0.7 1.0 0.7 20.2 4.0 6.9 1.2 0.6 0.3 2.2 15.5 8.6 7.6 9.9 4.6 10.2 0.7 2.1 11.6 14.9 24.3 0.7 12.1 1.8 14.7 0.0 1.3 0.9 4.4 4.7 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 7.5 0.0 0.0 0.2 0.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 13.2 7.5 0.4 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 16.7 4.5 8.2 5.8 3.3 20.2 4.0 15.5 14.7 0.0 0.0 0.0 1.0 0.5 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.4 2.6 0.0 0.0 0.0 0.0 33.7 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.1 PRMT6 "FLJ10559, HRMT1L6" ENSG00000198890 "Protein arginine methyltransferase 6" Q96LA8 1 107056679-107059294 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "MCF7: 83.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059424 Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA059424: AB_2684012" "unprognostic (5.17e-3)" "unprognostic (1.48e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (2.68e-1)" "unprognostic (2.55e-1)" "unprognostic (1.36e-3)" "unprognostic (2.13e-2)" "unprognostic (9.72e-2)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.63e-1)" "unprognostic (3.15e-2)" "unprognostic (1.03e-1)" "unprognostic (8.34e-2)" "unprognostic (1.01e-1)" "unprognostic (1.73e-3)" 6.6 16.1 14.4 10.5 13.4 4.6 10.8 12.6 13.9 8.9 10.3 11.5 10.4 8.1 9.7 11.3 10.9 12.2 9.8 5.0 11.8 16.2 16.7 16.3 5.9 11.5 12.2 14.1 12.3 16.8 15.0 13.8 9.6 13.2 11.8 9.7 12.6 8.3 11.4 2.1 7.6 9.3 8.0 13.6 11.5 9.5 9.4 10.6 18.2 9.5 3.4 11.1 10.1 7.3 9.7 14.7 1.8 10.1 14.6 10.9 7.6 3.6 0.0 7.3 3.2 4.8 5.4 2.0 4.9 3.7 4.8 4.9 4.7 2.5 9.0 6.8 4.5 2.6 5.2 6.6 7.2 3.8 0.0 7.1 5.4 10.2 6.7 4.8 11.2 3.4 5.0 4.0 4.3 4.4 3.2 4.1 5.2 7.2 1.4 4.3 83.6 6.5 3.9 3.1 2.9 6.9 8.3 15.9 3.4 11.5 7.4 13.6 16.6 6.7 9.7 3.2 4.6 6.7 8.4 4.7 3.5 7.3 7.4 7.3 1.5 1.0 1.5 5.3 5.3 2.8 1.8 8.9 1.6 7.5 10.1 8.4 6.9 7.6 6.8 11.9 9.7 10.9 10.9 0.5 14.6 9.2 14.7 7.8 7.6 14.4 13.4 12.6 13.9 11.8 16.2 12.2 14.1 13.2 10.6 0.0 4.1 8.2 6.2 3.9 12.5 2.2 0.0 8.1 2.3 14.0 0.0 16.1 23.2 9.0 0.9 4.2 3.5 0.0 6.5 11.9 3.9 3.6 1.1 0.0 8.5 14.3 16.8 4.9 7.0 2.3 8.1 3.6 1.7 1.8 8.7 6.9 4.9 7.0 8.5 15.2 4.3 12.9 8.4 8.4 8.8 5.4 5.9 5.4 9.5 5.8 PRR19 MGC70924 ENSG00000188368 "Proline rich 19" A6NJB7 19 42302098-42310821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 25.8" "Group enriched" "Detected in some" 8 "Early spermatids: 22.2;Late spermatids: 45.8;Spermatocytes: 32.9;Spermatogonia: 25.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA070350 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Mitochondria" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA070350: AB_2686259" "unprognostic (2.05e-1)" "unprognostic (8.03e-3)" "unprognostic (4.02e-2)" "unprognostic (7.55e-3)" "unprognostic (7.33e-2)" "unprognostic (1.08e-2)" "unprognostic (2.44e-5)" "unprognostic (3.57e-1)" "unprognostic (1.92e-2)" "unprognostic (8.10e-3)" "unprognostic (3.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.87e-3)" "unprognostic (4.21e-1)" "unprognostic (7.26e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-2)" 0.5 1.0 2.2 1.3 5.8 3.5 0.8 2.6 2.9 1.0 0.5 0.7 0.6 0.7 0.8 0.8 1.0 0.9 1.1 0.3 1.8 1.6 0.7 0.9 0.6 0.9 0.9 0.8 0.9 0.5 1.0 0.8 1.2 1.7 0.9 0.5 0.6 1.0 0.8 0.6 1.3 0.8 0.7 1.6 0.7 0.6 25.8 1.0 1.3 0.8 0.3 0.9 0.8 0.5 3.1 2.3 2.8 2.2 2.6 2.9 1.3 3.9 6.1 3.3 4.5 0.2 0.3 3.5 2.3 1.8 5.4 5.1 2.5 3.8 0.7 7.0 1.9 4.0 1.3 1.6 1.7 1.2 2.6 1.5 4.2 3.6 1.5 1.2 1.1 2.6 1.8 2.4 3.5 0.7 1.1 0.9 4.4 2.2 2.0 2.4 9.3 3.9 2.0 3.5 3.7 0.0 1.6 0.6 0.4 1.8 3.4 7.6 3.0 3.2 2.3 0.9 1.1 3.0 1.5 1.2 3.6 5.3 0.9 3.1 0.4 1.4 1.2 3.8 2.9 3.6 2.8 2.2 0.6 2.4 1.8 0.8 3.1 1.7 2.3 2.3 2.2 2.3 1.3 2.4 2.6 0.7 1.5 2.9 1.3 2.2 5.8 2.6 2.9 1.8 1.6 0.9 0.8 1.7 1.0 0.0 0.3 0.0 0.7 0.6 0.4 0.4 0.0 4.0 0.0 0.0 0.0 0.7 1.7 0.9 22.2 0.5 0.4 0.0 1.0 0.6 0.4 0.4 0.0 0.2 0.7 1.6 0.0 0.0 0.0 45.8 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.1 0.5 0.1 0.0 0.6 32.9 25.6 0.6 0.5 0.0 0.5 0.4 PRR29 "C17orf72, DKFZp761M2312, FLJ11724" ENSG00000224383 "Proline rich 29" P0C7W0 17 63998351-64004304 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 17.9;fallopian tube: 48.7;testis: 23.5" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 164.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.8;REH: 7.0;TIME: 5.6" HPA051264 Uncertain Nucleoli NA NA Nucleoli "HPA051264: " "unprognostic (2.05e-2)" "unprognostic (6.46e-2)" "unprognostic (2.87e-2)" "unprognostic (2.92e-3)" "unprognostic (4.71e-3)" "unprognostic (3.22e-2)" "unprognostic (3.84e-1)" "unprognostic (3.95e-2)" "unprognostic (1.04e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (5.76e-2)" "unprognostic (1.30e-3)" "unprognostic (6.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (9.98e-3)" 0.9 0.5 3.3 0.8 7.6 0.6 0.9 0.1 2.1 4.0 0.5 8.3 0.4 0.6 1.0 17.9 0.6 48.7 1.0 0.7 5.6 5.5 0.6 0.6 7.3 0.7 1.6 0.8 8.1 0.5 0.9 5.8 0.7 15.2 0.6 0.4 0.2 0.9 0.9 0.6 0.5 0.5 0.6 1.1 2.5 0.5 23.5 1.0 0.0 2.5 0.0 0.7 1.0 0.0 1.0 0.7 3.1 1.8 1.0 3.0 1.6 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.2 0.0 0.0 0.4 0.0 6.8 0.0 0.7 0.0 1.5 0.0 0.1 0.5 0.2 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.8 0.2 1.9 1.0 0.0 0.0 0.0 2.4 0.0 0.2 1.4 0.2 7.0 0.1 2.9 0.5 0.0 0.4 2.1 0.0 0.3 0.4 1.1 1.1 0.0 5.6 0.2 2.4 0.7 0.2 0.7 0.2 0.5 0.9 0.3 0.0 3.1 0.9 0.0 2.0 1.8 0.4 0.7 1.7 1.0 0.7 1.0 3.0 1.7 0.8 1.0 1.7 0.1 1.1 1.6 3.3 7.6 0.1 2.1 5.6 5.5 1.6 0.8 15.2 1.0 0.0 3.2 0.5 0.0 0.0 0.0 0.1 0.0 164.6 18.2 3.5 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 2.5 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 21.8 1.4 0.0 0.2 0.0 0.0 0.0 PRRG2 PRGP2 ENSG00000126460 "Proline rich and Gla domain 2" O14669 19 49580646-49591015 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 38.8;Paneth cells: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.7;OE19: 13.8;RT4: 9.0;SK-BR-3: 10.5;T-47d: 11.4;U-266/84: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010702 Approved Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Nucleoli" Cytosol "HPA010702: AB_1079693" "unprognostic (2.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (1.04e-2)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (5.60e-1)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.67e-1)" "prognostic favorable (3.82e-9)" "unprognostic (4.89e-2)" "unprognostic (1.46e-1)" "unprognostic (6.58e-3)" "unprognostic (3.68e-2)" 0.9 0.4 0.5 1.1 0.6 0.0 4.8 1.1 1.3 4.0 14.3 0.4 17.5 8.3 1.9 9.6 13.7 3.3 9.8 0.7 0.5 0.4 15.0 12.1 5.2 0.4 0.7 0.4 1.9 13.4 13.8 16.1 8.6 0.7 5.4 5.3 0.7 24.9 14.6 1.2 10.1 23.2 1.4 0.5 1.0 7.1 1.7 0.4 2.1 21.9 9.8 7.8 4.2 4.2 1.2 4.2 2.1 0.9 0.0 1.4 0.4 8.4 0.3 0.2 0.7 1.0 0.0 3.6 0.2 0.0 0.3 0.3 1.7 11.7 0.5 1.3 0.1 0.2 6.8 0.2 6.6 0.3 0.8 0.9 0.4 0.5 0.6 0.7 0.3 0.9 0.7 5.8 0.2 0.2 0.6 2.6 0.7 0.2 0.6 0.0 1.8 0.1 0.7 0.5 13.8 1.1 0.2 0.3 6.6 5.2 9.0 1.9 0.2 1.0 10.5 0.1 0.9 11.4 0.1 0.4 0.7 0.5 0.3 0.1 4.1 13.7 0.4 0.1 0.2 0.3 0.0 0.9 0.4 1.4 0.1 0.7 1.2 0.6 0.6 0.1 0.7 0.8 0.7 2.1 0.0 0.7 4.2 0.6 0.4 0.5 0.6 1.1 1.3 0.5 0.4 0.7 0.4 0.7 0.4 6.0 12.0 1.3 12.1 3.7 1.9 0.8 10.2 4.0 9.1 12.2 2.0 11.6 3.3 27.3 0.7 6.2 38.8 0.0 29.0 5.4 0.8 11.8 2.3 4.9 2.1 4.8 15.5 0.6 3.2 0.0 0.3 2.3 1.7 12.6 13.9 0.8 24.3 31.6 0.0 12.1 3.7 0.0 1.8 0.5 1.5 4.1 10.6 0.8 14.2 12.8 PRY "PRY1, PTPN13LY" ENSG00000169789 "PTPN13-like, Y-linked" O14603 Y 22490397-22514637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 1.9;epididymis: 2.3;testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "memory CD4 T-cell: 1.9" "Lineage enriched" "Detected in single" 20 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "A549: 3.1;HDLM-2: 2.3;SK-MEL-30: 1.5" "HPA046366, HPA059887" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA046366: AB_2679639, HPA059887: " 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRY2 PTPN13LY2 ENSG00000169807 "PTPN13-like, Y-linked 2" O14603 Y 22071756-22096007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.4;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.4;naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in single" "SK-MEL-30: 3.6" "HPA046366, HPA059887" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA046366: AB_2679639, HPA059887: " 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSTK "C10orf89, MGC35392" ENSG00000179988 "Phosphoseryl-tRNA kinase" Q8IV42 10 122954381-122997513 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037780, HPA037781" Approved Approved "Nucleoli,Nuclear bodies,Actin filaments" No No "Actin filaments" "Nucleoli, Nuclear bodies" "HPA037780: AB_2675662, HPA037781: AB_10670530" "unprognostic (8.95e-3)" "unprognostic (5.51e-3)" "unprognostic (1.37e-1)" "unprognostic (7.39e-4)" "unprognostic (5.21e-2)" "unprognostic (4.08e-3)" "unprognostic (1.60e-2)" "unprognostic (5.92e-4)" "unprognostic (3.55e-2)" "unprognostic (1.16e-1)" "unprognostic (6.22e-3)" "unprognostic (7.10e-3)" "unprognostic (2.39e-1)" "unprognostic (4.50e-2)" "unprognostic (4.92e-2)" "unprognostic (3.02e-2)" "unprognostic (5.55e-4)" 2.8 5.6 7.0 2.5 8.8 12.5 8.8 4.3 10.4 5.8 4.3 10.5 4.7 4.6 5.4 11.4 3.7 5.6 3.5 4.7 7.5 7.3 5.5 10.6 2.8 4.0 8.8 8.7 3.8 5.4 4.2 7.2 3.7 9.3 5.6 4.3 3.8 4.3 3.6 6.8 3.8 3.8 5.4 8.7 2.9 3.0 11.1 8.6 2.9 6.8 1.4 3.6 4.8 3.2 6.5 7.4 6.3 5.5 6.6 10.0 6.0 5.4 3.9 2.1 1.0 2.5 4.7 2.6 2.1 5.2 4.6 5.6 5.6 4.9 5.5 5.1 3.8 2.9 3.0 1.0 4.7 5.4 3.0 10.4 3.8 0.9 4.4 6.0 7.7 4.6 5.3 8.1 4.2 8.1 4.3 3.2 5.0 5.2 8.6 6.8 8.2 2.7 4.8 4.7 2.3 5.6 5.5 3.6 5.1 6.9 3.4 2.2 2.4 4.6 5.3 7.7 2.4 2.5 0.6 3.8 3.6 3.4 1.4 5.2 3.2 1.7 7.6 3.3 5.3 1.4 0.0 5.5 6.3 8.9 3.3 10.0 6.5 6.9 8.4 7.4 5.8 9.2 9.4 0.6 6.6 3.9 7.0 4.2 6.0 7.0 8.8 4.3 10.4 7.5 7.3 8.8 8.7 9.3 8.6 8.9 8.2 3.4 4.6 3.9 8.1 4.4 12.7 8.1 4.5 5.2 7.9 6.8 8.3 3.9 20.0 3.1 1.7 0.0 5.6 2.2 4.1 3.4 2.3 5.1 4.2 4.8 4.1 4.3 1.3 2.6 4.9 3.0 5.0 5.4 2.3 8.5 3.4 3.4 5.3 6.4 9.6 0.0 4.7 16.8 13.8 4.1 8.0 5.7 3.8 2.6 PTMS ParaT ENSG00000159335 Parathymosin P20962 12 6765516-6770952 "Predicted intracellular proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 12.9;eosinophil: 3.3;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 6 "dendritic cells: 4.2;granulocytes: 12.9" "Cell line enhanced" "Detected in many" "HDLM-2: 84.1" HPA038186 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" No No 31000 "Nucleoli, Nucleoli rim" Nucleoplasm "HPA038186: AB_10673042" "unprognostic (3.11e-2)" "unprognostic (1.31e-3)" "unprognostic (1.76e-1)" "unprognostic (3.57e-2)" "unprognostic (1.09e-1)" "unprognostic (2.83e-1)" "unprognostic (1.13e-1)" "unprognostic (2.47e-1)" "unprognostic (4.16e-1)" "unprognostic (1.01e-1)" "unprognostic (8.69e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (6.18e-5)" "unprognostic (1.02e-1)" "unprognostic (3.21e-1)" "unprognostic (2.35e-3)" "unprognostic (1.55e-2)" 47.0 24.7 45.4 23.5 54.9 7.5 79.3 54.0 40.3 46.0 58.1 7.9 32.4 17.8 71.3 24.9 43.7 36.5 30.8 21.8 31.7 20.0 43.4 155.3 50.7 19.4 11.1 28.6 72.9 18.3 45.8 21.0 26.3 17.9 58.7 19.1 26.6 22.7 58.1 22.6 29.9 24.4 62.5 17.7 20.8 28.3 16.1 15.3 9.5 28.3 29.8 13.0 44.4 81.6 0.1 4.2 12.9 0.3 0.2 1.3 0.3 6.1 27.1 46.7 43.7 25.2 21.2 16.9 26.7 30.0 24.4 21.0 17.2 25.2 2.3 20.1 48.6 20.5 12.9 27.1 24.9 9.7 84.1 36.8 3.0 16.0 5.9 28.6 0.7 7.2 20.1 10.1 17.5 36.2 37.4 27.3 1.2 21.3 6.2 22.2 15.4 1.1 4.9 44.5 13.1 29.4 0.5 12.2 5.1 19.2 1.2 14.3 46.5 29.3 11.0 22.9 34.4 10.0 3.1 37.0 33.6 46.8 4.6 24.4 5.4 2.6 3.2 26.1 2.0 24.5 12.9 0.3 3.3 1.3 0.1 0.6 0.1 0.1 1.2 0.3 0.0 0.0 0.2 1.0 0.2 0.0 4.2 0.5 0.3 45.4 54.9 54.0 40.3 31.7 20.0 11.1 28.6 17.9 15.3 0.0 19.7 44.0 264.1 257.1 332.2 6.9 79.0 10.7 12.5 146.5 188.5 124.4 198.9 34.5 5.5 262.5 134.0 116.8 29.5 354.7 255.9 393.3 54.0 544.5 395.5 109.7 492.9 234.5 56.9 9.0 453.3 138.5 215.9 116.4 209.5 249.7 32.6 106.6 650.6 469.2 250.9 588.6 361.9 5.8 34.1 217.8 136.5 54.3 187.5 139.3 PTPN6 "HCP, HCPH, PTP-1C, SHP-1, SHP1" ENSG00000111679 "Protein tyrosine phosphatase, non-receptor type 6" P29350 12 6946468-6961316 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 107.1;lymphoid tissue: 69.0" "Group enriched" "Detected in many" 5 "B-cells: 106.2;Early spermatids: 45.6;granulocytes: 130.8;Hofbauer cells: 168.2;Kupffer cells: 145.1;Macrophages: 118.2;T-cells: 105.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 28.7;HL-60: 25.5;HMC-1: 112.6;THP-1: 43.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001466, CAB004572, CAB072845" Enhanced Supported Nucleoplasm,Nucleoli NA NA 7400000 Nucleoplasm Nucleoli "CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930" "unprognostic (4.28e-3)" "prognostic favorable (1.87e-4)" "prognostic unfavorable (5.42e-4)" "prognostic favorable (6.65e-4)" "unprognostic (6.54e-2)" "unprognostic (7.92e-2)" "unprognostic (2.36e-1)" "unprognostic (1.44e-2)" "unprognostic (6.93e-3)" "unprognostic (3.57e-1)" "unprognostic (1.41e-2)" "unprognostic (2.61e-1)" "unprognostic (1.60e-3)" "unprognostic (1.98e-3)" "unprognostic (2.60e-2)" "unprognostic (5.91e-2)" "prognostic favorable (2.64e-8)" 6.6 8.8 2.4 42.9 4.4 27.7 4.6 1.2 2.7 2.8 7.0 5.1 4.7 7.5 3.7 8.8 7.0 5.0 9.8 2.9 3.1 2.3 7.0 6.8 25.4 58.1 5.2 1.8 2.3 6.7 2.7 5.6 7.7 3.9 5.6 5.2 3.6 10.6 7.0 1.3 6.1 21.0 2.6 4.9 69.0 6.6 1.5 3.3 31.4 6.3 4.1 50.7 8.5 4.2 63.9 38.0 107.1 103.2 22.2 28.2 63.2 2.9 5.6 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 3.0 6.6 2.0 1.5 0.0 0.0 3.4 0.0 3.9 0.0 1.2 1.2 28.7 0.6 2.4 0.0 25.5 112.6 0.0 2.8 0.0 1.2 0.0 0.0 10.3 0.0 0.2 0.0 6.1 9.2 14.9 1.5 6.8 0.9 8.4 0.0 14.5 3.1 5.5 0.5 0.0 0.9 4.6 0.0 4.1 1.4 43.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 11.2 0.1 54.4 35.9 107.1 28.2 71.3 18.2 62.3 13.7 21.0 38.0 63.9 15.8 19.9 66.7 22.2 103.2 10.0 14.4 63.2 2.4 4.4 1.2 2.7 3.1 2.3 5.2 1.8 3.9 3.3 6.0 18.1 106.2 8.1 8.0 0.0 1.6 12.7 12.0 11.4 5.2 0.0 21.7 13.3 12.3 45.6 4.1 15.8 23.3 13.5 15.5 3.5 4.1 130.8 10.2 168.2 0.0 23.7 9.8 145.1 8.7 0.9 118.2 13.5 6.4 12.0 0.4 11.8 17.3 0.0 10.5 0.6 6.5 2.3 0.3 1.1 7.5 15.4 105.5 15.6 5.6 PTTG1 "EAP1, HPTTG, PTTG, securin, TUTR1" ENSG00000164611 "Pituitary tumor-transforming 1" O95997 5 160421822-160428744 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.5;testis: 100.1" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 470.4;Erythroid cells: 654.1;Spermatocytes: 278.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 54.5" "Lineage enriched" "Detected in all" 7 "T-cells: 54.5" "Low cell line specificity" "Detected in all" "CAB008373, HPA008890, HPA045034" Enhanced Supported Nucleoli,Cytosol NA Yes Cytosol Nucleoli "CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: AB_2679192" "unprognostic (6.48e-2)" "unprognostic (1.03e-2)" "unprognostic (1.40e-3)" "unprognostic (4.46e-3)" "unprognostic (5.81e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.62e-6)" "unprognostic (7.50e-3)" "unprognostic (5.24e-2)" "unprognostic (3.47e-2)" "unprognostic (2.13e-3)" "unprognostic (6.70e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.17e-2)" "unprognostic (1.72e-1)" "unprognostic (4.23e-2)" "unprognostic (3.35e-2)" 1.5 1.7 2.1 16.2 5.5 34.1 2.9 1.4 4.6 3.8 8.2 1.0 0.7 5.8 1.3 2.6 24.1 1.0 1.9 2.3 5.1 2.7 1.7 1.4 3.8 19.2 1.5 2.2 1.1 1.2 0.2 2.0 5.0 2.2 1.6 11.3 1.5 4.5 1.1 1.2 8.7 5.8 4.5 1.4 7.5 3.4 100.1 1.0 29.8 23.9 23.2 35.1 3.3 7.2 8.1 6.1 2.4 2.1 3.3 54.5 4.7 45.7 23.8 53.8 38.5 9.1 9.0 16.8 24.3 55.7 64.6 70.8 46.0 40.3 50.0 21.7 27.6 74.3 24.0 33.4 67.6 92.7 57.1 30.3 26.4 32.2 27.7 1.8 23.9 23.2 4.2 11.3 43.8 26.6 19.8 45.5 33.5 21.1 39.0 66.3 21.5 28.6 58.8 27.1 37.7 34.6 26.7 63.3 42.9 32.9 9.3 33.5 21.3 35.1 21.4 72.2 45.5 43.7 26.2 19.4 29.2 39.1 22.8 70.9 33.6 29.9 57.2 31.5 41.4 51.7 1.9 0.7 2.4 7.0 2.1 2.5 8.1 14.4 16.2 6.1 5.5 3.6 8.9 0.8 3.3 1.4 5.8 54.5 4.7 2.1 5.5 1.4 4.6 5.1 2.7 1.5 2.2 2.2 1.0 6.0 15.5 20.5 54.1 220.3 1.3 4.9 7.6 1.4 11.4 5.2 0.0 50.4 3.3 4.0 470.4 10.3 6.3 654.1 4.5 163.8 37.7 15.3 38.0 2.9 72.7 0.0 5.8 17.8 20.0 39.3 10.3 35.9 82.7 39.7 15.4 2.7 3.5 9.1 7.4 1.2 0.7 6.5 35.3 278.1 72.8 136.5 26.7 44.5 34.5 30.7 PTTG2 ENSG00000250254 "Pituitary tumor-transforming 2" Q9NZH5 4 37960435-37961125 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.8" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 4.1;Early spermatids: 3.1;Spermatocytes: 1.9;Suprabasal keratinocytes: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.4;T-reg: 1.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 1.5;MOLT-4: 3.1;U-698: 2.1" "HPA008890, HPA045034" Uncertain Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA008890: AB_1079717, HPA045034: AB_2679192" "unprognostic (3.29e-1)" "unprognostic (4.41e-4)" "unprognostic (1.11e-1)" "unprognostic (2.07e-2)" "unprognostic (1.74e-2)" "unprognostic (9.58e-2)" "unprognostic (2.27e-1)" "unprognostic (2.74e-1)" "unprognostic (7.07e-2)" "unprognostic (2.74e-2)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (1.64e-1)" "unprognostic (1.34e-1)" "unprognostic (3.32e-1)" "unprognostic (8.60e-5)" 1.0 0.4 0.9 5.2 1.2 5.0 0.5 2.2 2.4 1.1 3.9 0.2 0.0 0.0 1.6 2.2 3.3 1.8 1.5 2.5 1.0 0.4 0.7 0.5 0.9 1.0 0.7 0.4 1.2 1.0 1.4 0.4 1.8 0.3 0.8 0.7 0.0 0.2 1.4 1.9 0.6 3.1 2.0 0.9 2.3 1.0 5.3 0.0 15.8 1.3 7.5 7.3 1.8 0.7 0.4 0.0 1.4 0.4 0.0 1.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 3.1 0.5 0.0 0.0 0.0 0.7 0.5 0.9 0.0 0.5 0.3 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 2.1 0.0 1.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.4 0.0 1.4 0.0 0.0 0.0 1.0 0.1 0.9 1.2 2.2 2.4 1.0 0.4 0.7 0.4 0.3 0.0 0.0 0.0 1.4 0.5 4.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.7 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.2 2.5 0.0 0.0 0.0 0.3 PUM3 "HA-8, hPUF-A, KIAA0020, PEN, PUF6, XTP5" ENSG00000080608 "Pumilio RNA binding family member 3" Q15397 9 2720469-2844241 "Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 73.4;HEL: 71.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002353 Approved Supported Nucleoli NA NA Nucleoli "HPA002353: AB_1852266" "unprognostic (1.39e-2)" "unprognostic (1.32e-2)" "unprognostic (7.54e-2)" "unprognostic (2.50e-1)" "unprognostic (2.06e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (4.89e-5)" "unprognostic (2.02e-1)" "unprognostic (6.92e-2)" "unprognostic (1.56e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (2.44e-3)" "unprognostic (8.44e-2)" "unprognostic (1.46e-1)" "unprognostic (7.11e-2)" "unprognostic (8.43e-2)" 19.4 17.0 11.5 19.0 15.2 14.8 22.1 15.6 17.7 18.9 16.9 8.3 9.8 11.2 17.1 10.6 29.3 15.7 10.5 15.1 16.7 5.9 23.2 18.4 18.6 18.9 14.0 14.3 24.4 17.8 11.5 23.1 15.9 15.8 18.0 17.3 6.1 20.7 10.3 21.0 16.4 13.2 19.5 18.2 17.8 14.2 13.8 14.9 15.4 15.1 14.5 18.9 20.1 21.6 15.3 13.7 3.8 12.8 15.9 18.4 7.8 17.0 12.6 10.6 10.8 8.9 9.5 12.1 15.9 8.4 16.4 15.4 9.5 8.0 18.9 3.7 10.9 9.8 8.6 19.2 13.7 21.5 73.4 6.8 71.5 12.7 11.4 11.9 31.5 13.4 7.7 6.1 13.3 19.1 7.5 12.1 12.4 7.4 8.6 14.3 7.7 15.9 25.7 27.2 13.1 5.6 18.8 8.3 8.1 11.1 11.5 11.0 10.6 9.6 8.9 8.6 12.4 5.6 17.1 11.5 11.1 9.1 10.6 21.2 4.0 6.5 26.6 8.4 11.5 8.0 3.8 9.2 2.7 13.2 12.8 18.4 15.3 13.7 13.2 12.1 13.5 15.3 14.8 1.3 15.9 10.4 13.7 10.0 7.8 11.5 15.2 15.6 17.7 16.7 5.9 14.0 14.3 15.8 14.9 44.7 39.5 24.8 31.5 0.0 23.8 0.0 20.4 58.9 76.2 22.7 9.8 29.4 39.7 30.6 3.5 15.7 3.1 0.0 22.9 37.0 25.8 19.6 16.3 15.7 19.1 25.4 8.2 20.3 14.3 2.2 43.7 23.0 0.0 35.1 10.7 18.3 24.5 7.0 21.5 99.1 25.6 0.0 0.0 32.5 43.2 0.0 29.3 8.7 16.7 27.1 PURG "PURG-A, PURG-B" ENSG00000172733 "Purine rich element binding protein G" Q9UJV8 8 30995802-31033715 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7" "Group enriched" "Detected in some" 7 "Bipolar cells: 11.8;Early spermatids: 11.1;Horizontal cells: 19.1;Late spermatids: 16.8;Muller glia cells: 11.3" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.7;JURKAT: 6.1;NTERA-2: 6.8;SH-SY5Y: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047746 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" Nucleoli "HPA047746: AB_2680145" "unprognostic (3.37e-1)" "unprognostic (2.15e-1)" "unprognostic (6.69e-2)" "unprognostic (7.33e-3)" "unprognostic (3.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.51e-3)" "unprognostic (1.10e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (4.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.27e-1)" "unprognostic (1.83e-2)" "unprognostic (5.30e-2)" 1.3 1.9 11.0 1.2 10.3 0.6 0.9 14.7 13.5 2.4 1.0 2.4 0.5 1.0 5.6 2.6 1.5 1.6 3.0 1.6 9.4 6.2 1.7 0.7 1.4 1.3 4.9 7.3 1.6 0.7 0.6 3.9 1.5 6.2 1.9 1.1 1.7 1.6 2.6 1.0 0.9 1.0 5.0 4.5 2.5 1.3 8.1 6.4 0.0 0.8 0.0 1.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.2 0.1 0.0 0.0 0.2 0.4 0.7 1.8 0.0 0.0 0.2 0.0 0.0 3.0 0.0 2.9 0.0 1.0 0.0 4.4 1.6 0.0 0.2 0.0 0.0 0.2 1.3 0.0 1.3 0.0 1.0 4.3 6.1 0.4 0.5 0.2 0.0 0.9 0.0 6.8 0.0 0.3 2.2 1.2 0.0 0.0 0.0 1.2 8.2 0.0 0.0 0.0 3.3 0.0 0.0 2.6 2.9 3.7 0.0 0.4 0.3 0.0 0.2 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.3 14.7 8.9 9.4 6.2 4.9 7.3 6.2 6.4 0.0 0.0 0.0 0.0 0.0 11.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 11.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 16.8 0.6 0.0 0.0 0.0 0.0 11.3 0.0 0.0 1.4 0.0 1.8 0.0 0.3 1.7 1.1 0.0 0.0 0.0 0.0 0.0 PUS7L DKFZP434G1415 ENSG00000129317 "Pseudouridylate synthase 7 like" Q9H0K6 12 43718993-43758817 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056203, HPA058750" Uncertain Approved "Nucleoli,Nuclear speckles" NA NA "Nuclear speckles" Nucleoli "HPA056203: AB_2683064, HPA058750: AB_2683807" "unprognostic (3.41e-3)" "unprognostic (1.03e-1)" "unprognostic (2.51e-3)" "unprognostic (1.83e-1)" "unprognostic (3.05e-2)" "unprognostic (1.79e-1)" "unprognostic (5.87e-4)" "unprognostic (1.11e-1)" "unprognostic (8.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.49e-1)" "unprognostic (2.54e-2)" "unprognostic (1.80e-3)" "unprognostic (1.32e-1)" "unprognostic (2.56e-1)" "unprognostic (2.50e-2)" "unprognostic (9.27e-2)" 8.0 7.0 14.9 9.1 18.5 6.1 10.6 20.3 16.6 9.2 7.3 3.7 8.3 7.3 7.3 7.9 9.7 6.1 7.7 6.9 14.2 9.0 9.3 7.9 5.4 10.4 8.3 12.6 10.2 9.5 12.7 21.7 7.7 11.5 8.3 9.1 2.7 8.4 9.4 6.1 7.2 7.6 6.3 12.1 9.2 7.6 5.6 11.3 13.0 11.6 6.1 11.3 8.6 8.3 6.6 5.2 8.6 4.3 5.1 6.9 3.4 6.4 4.9 4.3 2.5 3.0 10.8 7.7 5.6 4.8 7.6 5.9 17.4 4.7 14.9 7.2 6.9 4.4 5.9 6.2 5.7 13.1 4.6 3.9 10.9 5.5 6.5 3.7 17.4 7.1 4.5 4.3 7.9 8.3 7.1 5.5 8.8 18.9 6.6 17.7 2.6 8.9 4.5 7.9 0.0 5.2 8.5 10.2 8.9 3.3 5.0 7.3 2.4 7.0 7.6 3.0 5.4 9.0 4.9 4.0 7.8 5.1 9.0 8.9 5.8 9.9 15.1 7.2 28.8 2.6 8.6 4.3 4.8 5.0 3.8 6.2 4.4 5.4 5.3 4.4 6.6 4.8 6.9 3.1 5.1 3.1 5.2 2.1 3.4 14.9 18.5 20.3 16.6 14.2 9.0 8.3 12.6 11.5 11.3 8.9 12.1 29.0 16.6 10.3 66.3 11.7 12.7 5.3 14.8 24.4 64.8 29.4 34.9 17.4 1.7 17.6 11.0 0.0 20.2 20.3 20.3 16.9 16.2 18.3 17.8 41.3 18.6 17.2 23.4 2.1 18.7 16.6 11.8 12.6 22.4 37.1 15.1 14.0 25.1 17.7 103.5 19.4 16.6 23.6 34.3 9.7 20.3 25.4 28.5 8.7 PVALB D22S749 ENSG00000100362 Parvalbumin P20472 22 36800684-36819479 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 125.0;parathyroid gland: 137.5" "Group enriched" "Detected in some" 10 "Distal tubular cells: 543.8;Horizontal cells: 1442.9" "Group enriched" "Detected in many" 10 "breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3" "Region enhanced" "Detected in all" "cerebellum: 125.0" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.4" "Cell line enriched" "Detected in single" 198 "RPMI-8226: 134.1" "Region enriched" "Detected in many" 5 "cerebellum: 2377.5" "Low region specificity" "Detected in all" "CAB002515, HPA048536" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" No NA Nucleoplasm "Nucleoli, Cell Junctions" "CAB002515: AB_563948, HPA048536: AB_2680433" "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "unprognostic (9.75e-2)" "unprognostic (1.79e-3)" "unprognostic (7.80e-2)" "unprognostic (2.49e-2)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (2.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-1)" "unprognostic (5.21e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-1)" "unprognostic (1.65e-2)" "unprognostic (8.99e-3)" 0.9 0.8 1.2 0.9 3.9 0.8 4.3 125.0 47.2 0.8 0.8 6.6 0.0 0.8 1.1 0.9 0.8 0.8 0.9 0.8 4.5 9.4 16.7 1.8 1.2 1.2 28.6 2.5 0.8 0.8 137.5 0.2 1.2 22.9 0.9 0.9 27.3 1.2 1.0 5.0 0.8 0.8 0.9 12.6 1.2 0.9 1.1 1.2 0.0 0.9 0.0 1.4 1.2 1.0 0.0 0.5 3.4 0.4 0.0 0.3 12.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 134.1 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.4 0.0 0.0 0.5 0.3 12.2 1.2 3.9 125.0 47.2 4.5 9.4 28.6 2.5 22.9 1.2 0.0 0.0 0.0 0.0 0.0 39.1 0.2 0.0 0.0 0.0 36.6 9.8 0.2 543.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.5 0.0 40.7 1442.9 0.0 40.5 3.7 0.0 0.6 0.9 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.8 104.1 0.0 0.0 0.0 0.6 0.0 0.3 1.0 0.0 0.0 PVRIG "C7orf15, CD112R, MGC2463" ENSG00000213413 "PVR related immunoglobulin domain containing" Q6DKI7 7 100218241-100221490 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 51.7;lymphoid tissue: 21.0" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 1.1;granulocytes: 2.3;Horizontal cells: 3.2;T-cells: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 32 "gdT-cell: 43.5;MAIT T-cell: 51.7;memory B-cell: 24.8;memory CD4 T-cell: 28.9;memory CD8 T-cell: 42.9;naive B-cell: 19.3;naive CD4 T-cell: 32.6;naive CD8 T-cell: 32.2;NK-cell: 42.9;T-reg: 22.8" "Group enriched" "Detected in many" 37 "B-cells: 24.8;NK-cells: 42.9;T-cells: 51.7" "Group enriched" "Detected in some" 26 "Daudi: 36.9;JURKAT: 21.8;MOLT-4: 40.2;U-698: 11.9" "Low region specificity" "Detected in all" HPA047497 Uncertain Approved "Nucleoli,Endoplasmic reticulum" NA NA "Nucleoli, Endoplasmic reticulum" "HPA047497: AB_2680069" "unprognostic (1.63e-2)" "unprognostic (1.28e-2)" "unprognostic (2.21e-3)" "unprognostic (5.13e-2)" "unprognostic (9.89e-2)" "unprognostic (1.53e-3)" "unprognostic (1.35e-3)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.81e-1)" "unprognostic (5.58e-2)" "unprognostic (5.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.17e-1)" "unprognostic (2.43e-2)" "unprognostic (4.12e-1)" "unprognostic (2.71e-3)" 0.5 0.1 0.4 5.6 0.7 1.2 0.4 0.4 1.1 0.4 0.5 0.7 0.4 0.5 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.0 0.5 0.9 0.9 15.9 0.4 0.4 0.6 0.5 0.0 0.4 0.4 0.8 0.4 0.0 0.4 0.7 0.4 2.0 0.0 8.9 0.4 0.4 21.0 1.4 0.6 0.4 18.0 0.5 0.4 4.2 1.0 0.4 24.8 0.2 1.0 0.1 42.9 51.7 17.5 0.1 0.8 0.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 21.8 0.0 0.1 0.0 0.1 40.2 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.1 0.1 0.0 43.5 0.1 51.7 24.8 28.9 42.9 0.1 19.3 32.6 32.2 1.0 42.9 0.1 0.2 22.8 17.5 0.4 0.7 0.4 0.4 0.4 0.0 0.4 0.4 0.8 0.4 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 PWP2 "EHOC-17, PWP2H, UTP1" ENSG00000241945 "PWP2, small subunit processome component" Q15269 21 44107290-44131181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 9.5;Smooth muscle cells: 13.4;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 31.0;Daudi: 26.8" HPA024573 Uncertain Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (1.85e-1)" "unprognostic (4.73e-2)" "unprognostic (2.67e-1)" "unprognostic (6.81e-2)" "unprognostic (2.06e-1)" "unprognostic (8.39e-2)" "unprognostic (3.02e-1)" "unprognostic (1.87e-1)" "unprognostic (1.76e-1)" "unprognostic (3.31e-3)" "unprognostic (9.48e-2)" "unprognostic (1.50e-1)" "unprognostic (6.36e-4)" "unprognostic (6.37e-5)" "unprognostic (6.12e-2)" "unprognostic (5.62e-2)" "unprognostic (1.55e-1)" 6.1 6.1 11.3 7.7 14.6 3.6 6.3 9.7 12.8 4.0 9.0 9.6 2.4 4.4 7.8 9.2 8.2 5.9 4.8 4.6 6.8 4.8 6.9 8.7 5.0 7.9 15.4 5.7 5.0 12.8 1.4 4.0 7.6 8.9 8.1 1.8 4.9 8.2 5.2 8.0 14.7 5.6 2.2 6.4 8.8 10.6 5.3 17.2 3.6 4.8 8.6 16.8 5.0 5.7 6.8 2.6 2.9 4.3 3.4 6.9 5.0 1.2 0.4 0.3 1.2 3.6 3.6 9.3 12.0 6.3 16.0 10.8 31.0 0.5 26.8 0.4 0.0 0.9 1.4 0.5 9.1 9.2 6.6 19.4 3.2 5.6 7.2 2.3 2.4 0.9 0.3 0.0 11.1 0.0 2.8 0.5 11.4 10.2 10.8 5.3 0.4 0.1 0.7 0.3 0.7 1.2 1.5 0.1 13.9 0.0 0.4 9.4 1.6 0.6 1.0 7.5 4.6 0.0 1.0 6.1 6.5 1.1 14.4 1.4 14.5 17.3 1.2 0.4 2.9 9.2 0.2 2.2 2.9 6.0 3.1 6.6 6.8 4.9 6.9 1.6 4.1 4.9 6.1 1.2 3.4 4.3 2.6 3.5 5.0 11.3 14.6 9.7 12.8 6.8 4.8 15.4 5.7 8.9 17.2 0.0 1.3 0.5 0.1 9.5 0.1 3.4 0.0 1.4 2.3 0.0 0.0 0.1 1.7 0.0 0.1 1.4 2.6 0.0 0.0 1.2 1.0 0.7 0.0 0.0 1.7 0.0 2.4 3.1 5.4 0.0 1.1 0.0 1.7 0.0 4.7 0.2 0.0 3.2 0.0 0.0 0.2 0.0 13.4 0.6 1.7 7.4 0.6 2.9 4.7 0.0 PYCARD "ASC, CARD5, TMS-1" ENSG00000103490 "PYD and CARD domain containing" Q9ULZ3 16 31201485-31203450 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 130.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 312.0;Hofbauer cells: 375.8;Kupffer cells: 516.6;Macrophages: 364.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 37.8;classical monocyte: 90.4;eosinophil: 71.4;intermediate monocyte: 87.5;myeloid DC: 66.8;neutrophil: 130.8;non-classical monocyte: 85.0;plasmacytoid DC: 61.0" "Group enriched" "Detected in all" 6 "dendritic cells: 66.8;granulocytes: 130.8;monocytes: 90.4" "Cell line enhanced" "Detected in many" "MCF7: 34.5;NB-4: 54.4;THP-1: 40.1;U-937: 24.9" "CAB006853, CAB015948, HPA049074, HPA054496" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA 1100000 Nucleoplasm "Nucleoli, Cytosol" "CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506" "unprognostic (1.00e-3)" "unprognostic (2.62e-2)" "unprognostic (2.40e-1)" "unprognostic (4.67e-3)" "unprognostic (3.34e-1)" "unprognostic (1.87e-1)" "unprognostic (5.29e-2)" "unprognostic (2.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.33e-1)" "unprognostic (6.52e-3)" "unprognostic (3.88e-2)" "prognostic unfavorable (6.09e-7)" "unprognostic (4.45e-3)" "unprognostic (2.51e-1)" "unprognostic (3.61e-2)" "unprognostic (6.97e-2)" 11.6 4.4 3.6 16.7 4.6 22.4 8.6 3.6 3.3 8.2 26.8 6.8 4.1 38.7 5.4 7.9 20.7 6.8 8.5 6.6 2.4 2.6 5.6 6.8 15.0 32.8 6.4 1.8 6.6 6.1 1.3 3.2 6.6 4.0 9.7 4.4 4.7 9.6 5.6 3.5 31.2 29.9 3.5 6.4 34.1 13.3 3.7 3.3 20.6 5.5 22.3 26.3 7.9 11.8 17.1 66.8 130.8 90.4 16.0 16.0 53.1 5.7 13.5 0.1 0.0 1.3 3.0 0.1 2.8 4.0 1.8 1.2 0.0 7.2 2.4 0.0 2.7 0.0 16.0 0.7 10.7 0.0 17.3 0.0 2.2 1.6 4.4 4.6 20.1 16.0 4.0 5.6 0.8 0.1 0.0 3.9 0.0 9.9 3.7 0.5 34.5 0.0 54.4 3.7 2.3 0.0 17.5 0.0 7.6 0.1 5.6 0.1 0.0 2.4 0.0 2.7 0.0 3.3 40.1 2.6 0.1 0.2 2.4 0.0 0.1 0.0 0.0 1.4 24.9 0.0 37.8 90.4 71.4 15.1 87.5 9.5 17.1 12.7 15.5 66.8 15.2 8.9 12.3 130.8 16.0 85.0 61.0 16.0 53.1 3.6 4.6 3.6 3.3 2.4 2.6 6.4 1.8 4.0 3.3 20.8 28.2 73.7 67.5 65.8 0.1 2.8 28.1 36.1 29.6 24.4 0.0 46.3 5.0 83.5 0.3 38.6 312.0 23.3 50.3 8.9 26.7 26.8 108.5 3.0 375.8 0.0 56.6 41.7 516.6 1.5 43.7 364.0 92.8 16.2 110.6 0.0 56.2 271.9 21.2 1.4 0.6 25.8 23.3 0.3 1.1 143.2 14.9 75.0 247.3 42.2 PYHIN1 "IFIX, MGC23885" ENSG00000163564 "Pyrin and HIN domain family member 1" Q6K0P9 1 158930796-158977054 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.4;lymphoid tissue: 23.3" "Cell type enriched" "Detected in some" 11 "T-cells: 126.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 33.4;MAIT T-cell: 19.1;memory CD4 T-cell: 14.2;memory CD8 T-cell: 25.2;naive CD8 T-cell: 16.0;NK-cell: 11.4;T-reg: 21.0" "Group enriched" "Detected in many" 5 "NK-cells: 11.4;T-cells: 33.4" "Cell line enriched" "Detected in some" 6 "U-698: 33.1" "HPA051224, HPA055373" Enhanced Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA051224: AB_2681394, HPA055373: " "unprognostic (1.64e-3)" "unprognostic (1.75e-3)" "unprognostic (2.93e-3)" "unprognostic (2.64e-3)" "unprognostic (3.99e-2)" "unprognostic (3.57e-3)" "unprognostic (2.44e-3)" "unprognostic (2.10e-2)" "unprognostic (1.52e-1)" "unprognostic (1.47e-3)" "unprognostic (3.94e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-6)" "unprognostic (1.83e-1)" "unprognostic (2.31e-1)" "unprognostic (2.76e-2)" "unprognostic (4.45e-3)" 4.0 0.6 0.5 20.1 0.5 3.9 2.1 0.4 0.4 2.0 2.7 0.2 0.3 1.2 2.2 1.4 1.7 1.6 3.2 1.2 0.6 0.5 1.8 2.6 11.7 18.8 0.7 0.0 1.6 0.8 0.0 0.8 1.7 0.4 2.6 1.8 1.2 3.4 1.2 0.7 0.9 7.8 0.4 1.3 20.7 2.0 1.0 0.0 6.6 2.5 1.9 23.3 5.7 1.6 4.9 0.1 1.2 0.1 11.4 33.4 6.0 0.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.6 0.0 33.1 0.0 5.1 0.0 0.4 0.1 0.1 33.4 0.1 19.1 4.9 14.2 25.2 0.1 2.4 4.8 16.0 1.2 11.4 0.1 0.1 21.0 6.0 0.5 0.5 0.4 0.4 0.6 0.5 0.7 0.0 0.4 0.0 11.9 3.2 9.5 0.7 0.3 0.2 0.3 0.0 9.4 3.4 3.5 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.1 0.4 2.3 1.3 2.1 0.0 0.0 3.1 4.3 0.0 0.0 1.4 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.6 0.0 0.2 0.0 0.1 0.5 0.1 126.8 0.0 0.3 PYM1 "PYM, WIBG" ENSG00000170473 "PYM homolog 1, exon junction complex associated factor" Q9BRP8 12 55901413-55932618 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 146.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012803, HPA039717, HPA046200" Supported Supported "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" No No "Nucleoplasm, Nucleoli, Cytosol" "Cell Junctions" "CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556" "unprognostic (3.03e-2)" "unprognostic (1.00e-1)" "unprognostic (5.65e-2)" "unprognostic (8.82e-2)" "unprognostic (1.97e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (3.29e-1)" "unprognostic (2.17e-3)" "unprognostic (2.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.29e-1)" "unprognostic (1.32e-2)" "unprognostic (1.59e-2)" "unprognostic (2.22e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.34e-4)" 17.5 21.4 16.2 21.2 14.8 13.2 20.3 16.3 17.1 15.2 21.2 14.2 27.1 21.8 16.1 30.8 46.7 16.3 21.5 13.6 14.0 14.7 19.4 31.3 14.4 28.6 14.7 14.0 13.3 24.8 15.3 19.8 21.5 12.8 20.7 21.5 18.3 22.9 24.5 18.2 27.2 29.9 16.3 13.2 25.5 15.8 21.1 14.1 26.3 22.5 31.2 39.1 16.5 19.9 29.5 35.9 21.6 27.2 14.4 53.6 24.1 17.5 14.1 20.6 11.4 12.5 16.3 33.8 13.0 15.7 12.3 10.4 20.5 21.0 22.1 19.8 12.5 5.7 13.9 15.8 27.8 9.9 17.0 11.8 18.0 12.0 25.2 15.3 20.8 16.5 14.7 17.9 13.8 20.8 15.6 13.0 9.9 15.3 24.6 14.4 26.5 13.3 37.2 35.9 20.1 7.3 12.0 8.2 25.3 25.2 25.0 13.9 16.0 16.6 22.3 11.6 20.0 27.1 44.1 10.1 7.4 10.5 11.5 9.4 13.0 19.7 34.1 12.7 14.5 11.6 3.9 24.5 21.6 18.7 27.2 22.9 29.5 34.0 26.1 35.9 25.2 22.6 22.6 5.8 14.4 18.5 19.6 53.6 24.1 16.2 14.8 16.3 17.1 14.0 14.7 14.7 14.0 12.8 14.1 17.9 15.9 15.9 26.4 0.0 13.6 0.0 28.1 30.8 26.1 22.7 7.9 72.4 66.3 34.7 9.6 12.4 38.3 23.3 44.0 61.6 11.5 34.5 17.4 32.7 48.8 6.4 7.0 19.0 44.8 7.4 21.6 40.2 0.0 146.1 41.7 34.7 43.4 37.0 22.3 44.1 10.6 12.9 0.0 18.1 24.3 0.0 51.8 37.4 37.7 28.0 RABGEF1 "rabex-5, RABEX5" ENSG00000154710 "RAB guanine nucleotide exchange factor 1" Q9UJ41 7 66682164-66811464 "Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA001407 Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA001407: AB_1856024" "unprognostic (6.65e-2)" "unprognostic (6.44e-4)" "unprognostic (7.32e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (4.06e-5)" "unprognostic (3.77e-1)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (8.51e-2)" "unprognostic (3.32e-1)" "unprognostic (4.64e-4)" "unprognostic (6.45e-2)" "prognostic favorable (1.27e-4)" "unprognostic (1.43e-1)" "unprognostic (5.55e-1)" "unprognostic (2.83e-1)" "unprognostic (1.39e-1)" 18.4 15.2 13.0 14.7 14.4 59.2 12.0 22.4 16.8 16.9 14.1 12.6 9.4 9.1 16.4 9.5 20.6 12.0 13.5 10.8 13.5 15.6 14.9 17.2 10.5 10.6 12.8 12.1 14.7 13.2 13.3 10.2 18.8 13.5 13.1 11.0 13.8 10.6 16.1 12.1 21.9 15.5 15.3 11.9 15.3 11.9 21.5 9.8 13.1 22.3 20.7 18.2 19.1 16.3 15.7 10.4 18.1 13.5 15.4 10.9 7.6 20.6 6.2 5.4 9.1 14.7 20.6 5.4 18.2 23.3 19.2 18.3 5.8 13.4 10.1 7.1 26.3 14.1 8.7 7.4 9.8 26.8 6.9 5.9 5.4 7.3 5.7 11.7 9.2 7.7 10.2 12.7 24.7 27.4 15.9 5.0 6.9 9.9 7.4 19.0 10.4 6.2 12.9 7.1 9.6 9.0 5.5 9.4 7.6 16.8 9.5 6.2 9.7 8.4 18.6 9.8 9.4 10.7 5.8 6.5 31.2 6.5 19.1 14.2 9.6 12.5 12.0 14.4 10.3 9.9 18.1 7.8 9.4 8.6 6.9 9.3 11.2 8.1 10.9 7.3 15.7 8.8 8.2 15.1 15.4 13.5 10.4 6.7 7.6 13.0 14.4 22.4 16.8 13.5 15.6 12.8 12.1 13.5 9.8 11.9 13.8 5.2 6.5 3.7 9.7 4.2 0.0 20.1 18.2 5.2 15.7 3.2 10.0 4.5 4.1 5.8 5.9 0.0 4.8 3.0 5.1 10.1 13.9 5.9 4.2 7.9 17.2 4.9 12.3 1.8 5.5 9.3 1.7 5.4 5.1 4.8 12.5 14.0 8.9 4.0 16.7 0.0 7.3 6.6 6.4 5.8 11.3 2.5 4.7 11.1 RAC1 "p21-Rac1, Rac-1, TC-25" ENSG00000136238 "Rac family small GTPase 1" P63000 7 6374523-6403977 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035994, HPA047820" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 44000000 "Nucleoplasm, Cytosol" Nucleoli "CAB035994: , HPA047820: AB_2680167" "unprognostic (8.66e-3)" "unprognostic (2.47e-1)" "unprognostic (4.00e-1)" "unprognostic (2.40e-2)" "unprognostic (1.88e-3)" "unprognostic (4.06e-2)" "prognostic unfavorable (1.74e-5)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.63e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.95e-1)" "unprognostic (2.11e-2)" "unprognostic (4.13e-2)" "unprognostic (8.72e-3)" 45.2 35.0 71.0 28.4 64.0 24.4 46.5 42.1 93.0 48.7 58.9 75.5 22.5 51.6 48.7 49.5 93.4 47.2 40.0 48.4 73.8 59.8 47.8 42.9 45.6 38.3 76.7 60.9 45.1 29.2 51.0 25.2 55.8 54.9 40.5 64.0 37.2 43.3 48.9 57.4 58.6 49.8 57.3 88.2 35.0 49.7 28.1 47.1 41.3 40.9 42.8 50.7 52.2 54.0 11.0 32.0 49.1 31.9 7.3 11.8 10.7 75.1 34.1 35.3 38.3 41.9 53.5 21.1 42.4 52.1 56.6 57.7 33.5 71.1 21.2 27.5 59.1 58.6 53.6 37.6 51.4 72.5 9.9 31.2 21.3 27.6 24.1 50.4 19.2 17.4 35.6 46.0 40.7 45.7 43.1 49.8 21.0 38.0 16.8 60.9 54.8 10.5 45.2 63.2 38.3 40.9 18.7 35.9 31.1 72.7 47.7 26.8 45.1 29.9 109.6 34.0 42.1 61.8 57.8 52.2 37.2 56.0 45.5 48.9 12.8 14.0 20.0 34.3 36.7 70.4 7.6 31.9 16.4 7.2 22.2 4.5 11.0 8.1 9.2 32.0 11.0 9.8 6.5 49.1 7.3 22.1 18.2 11.8 10.7 71.0 64.0 42.1 93.0 73.8 59.8 76.7 60.9 54.9 47.1 137.0 112.5 192.8 745.4 829.8 84.3 183.1 481.6 92.3 104.6 338.5 23.6 691.3 454.3 121.1 58.5 522.9 706.2 303.7 149.3 914.8 466.9 1152.5 132.3 288.4 738.1 138.2 323.2 535.2 736.9 43.7 441.0 745.3 435.3 408.4 531.5 280.9 231.2 471.0 444.5 611.5 54.4 472.1 495.6 210.1 328.6 1004.1 707.0 194.1 436.1 1582.5 RARA "NR1B1, RAR" ENSG00000131759 "Retinoic acid receptor alpha" P10276 17 40309192-40357643 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 26.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 63.9;SK-BR-3: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058282, HPA071548" Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" NA NA Nucleoplasm "Nucleoli, Actin filaments, Cytosol" "HPA058282: AB_2683666, HPA071548: " "unprognostic (8.05e-3)" "unprognostic (1.89e-1)" "unprognostic (9.48e-3)" "prognostic favorable (2.60e-4)" "unprognostic (8.67e-3)" "unprognostic (4.87e-3)" "unprognostic (2.77e-1)" "unprognostic (5.73e-2)" "unprognostic (1.45e-1)" "unprognostic (3.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (2.29e-3)" "unprognostic (1.59e-2)" "unprognostic (5.60e-2)" "unprognostic (1.60e-1)" "unprognostic (1.09e-2)" 27.6 13.5 5.0 18.6 7.6 32.3 23.7 11.5 15.2 30.2 29.6 5.0 16.8 18.0 23.8 23.9 17.3 23.3 30.2 24.3 5.9 6.1 14.6 24.0 32.0 23.4 4.6 7.8 50.0 9.3 7.4 18.1 16.6 6.5 22.9 8.5 26.8 12.1 32.7 43.1 14.3 31.6 18.6 3.7 31.1 14.3 21.8 2.9 9.7 16.3 15.4 20.2 31.5 20.3 1.0 6.1 26.6 9.3 2.5 2.6 1.9 5.1 12.1 3.6 6.1 7.1 10.9 3.6 4.2 6.4 6.2 4.0 8.3 4.4 2.7 6.6 9.5 5.7 15.0 4.1 10.0 3.6 20.5 6.1 7.8 6.1 8.1 11.4 2.8 24.7 15.3 2.9 6.6 8.4 23.7 9.2 2.4 4.9 6.0 7.0 63.9 1.8 9.5 3.1 4.7 3.8 3.6 21.3 10.3 3.6 4.1 1.5 12.4 9.0 40.6 12.4 3.6 38.2 11.2 10.7 7.8 13.3 13.6 4.6 14.4 4.8 2.3 13.1 5.5 23.0 8.7 4.2 15.7 1.6 6.9 2.6 1.0 1.7 1.7 6.1 0.9 0.8 1.3 26.6 2.5 9.3 1.8 1.4 1.9 5.0 7.6 11.5 15.2 5.9 6.1 4.6 7.8 6.5 2.9 3.0 9.5 5.6 22.6 17.3 24.2 3.2 10.2 4.0 2.3 7.0 5.9 1.9 11.6 14.3 58.0 20.4 52.7 0.0 16.9 5.1 23.8 11.2 34.6 22.8 11.3 3.2 9.2 22.7 35.4 50.8 38.6 37.4 27.0 0.0 14.2 9.3 16.8 24.6 21.5 11.8 8.2 32.3 33.0 2.9 6.9 16.6 4.3 11.5 13.2 19.2 RASSF4 "AD037, MGC44914" ENSG00000107551 "Ras association domain family member 4" Q9H2L5 10 44959407-44995891 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Hofbauer cells: 128.5;monocytes: 389.5;Muller glia cells: 247.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 28.3;intermediate monocyte: 21.7;myeloid DC: 28.5;non-classical monocyte: 11.5" "Group enriched" "Detected in many" 9 "dendritic cells: 28.5;monocytes: 28.3" "Cell line enhanced" "Detected in many" "Karpas-707: 21.5;RH-30: 54.6;RPMI-8226: 17.8;U-937: 27.9;WM-115: 18.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038834, HPA077069" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA038834: AB_10795576, HPA077069: " "unprognostic (1.83e-1)" "unprognostic (8.21e-3)" "unprognostic (1.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (5.14e-2)" "unprognostic (3.15e-2)" "unprognostic (2.18e-2)" "unprognostic (8.81e-2)" "unprognostic (4.83e-2)" "unprognostic (8.75e-3)" "unprognostic (4.20e-1)" "unprognostic (4.11e-3)" "unprognostic (4.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.42e-1)" "unprognostic (6.20e-2)" 23.4 5.9 16.7 17.0 25.5 6.0 8.4 12.5 36.5 3.6 8.2 26.7 12.1 11.2 2.6 14.9 4.3 3.3 9.0 29.1 16.6 15.1 37.2 10.5 9.7 14.1 34.5 9.7 3.0 11.5 2.2 8.4 10.4 19.4 4.5 5.3 8.4 14.0 9.9 7.6 2.9 10.8 7.0 21.8 12.6 4.3 5.7 31.5 1.2 23.0 2.9 7.4 8.3 3.9 0.0 28.5 0.9 28.3 2.2 3.0 13.8 0.4 0.1 2.0 3.9 6.1 0.3 1.4 0.2 0.3 0.6 1.2 1.6 0.2 0.0 0.7 0.2 1.3 0.0 0.8 0.9 0.9 12.2 0.0 0.0 0.0 12.7 6.5 0.8 0.0 4.5 0.0 0.6 0.0 3.7 0.9 0.5 0.0 21.5 0.9 0.0 0.9 13.9 0.4 0.0 0.4 2.6 54.6 17.8 0.1 0.3 0.3 0.3 0.0 0.1 0.6 3.7 0.3 10.6 0.2 0.1 1.2 1.0 2.1 0.2 0.2 0.0 6.4 27.9 18.1 0.0 28.3 0.0 3.0 21.7 0.0 0.0 0.2 1.3 28.5 0.0 0.2 1.0 0.9 2.2 11.5 0.7 0.1 13.8 16.7 25.5 12.5 18.2 16.6 15.1 34.5 9.7 19.4 31.5 17.9 15.0 4.7 1.2 3.3 17.2 38.7 38.2 6.7 10.3 15.7 3.9 0.9 14.9 40.8 1.2 4.7 11.8 0.0 3.4 1.1 7.0 1.3 1.1 15.5 128.5 35.0 11.1 8.0 63.6 3.2 9.8 81.9 8.5 389.5 8.7 247.8 4.1 14.0 2.1 98.2 13.3 25.8 17.6 0.3 0.9 1.5 2.2 6.4 16.6 0.5 RBBP5 "RBQ3, SWD1" ENSG00000117222 "RB binding protein 5, histone lysine methyltransferase complex subunit" Q15291 1 205086142-205122015 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049042, HPA058085" Uncertain Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA049042: AB_2680610, HPA058085: AB_2683600" "unprognostic (8.72e-2)" "unprognostic (6.35e-2)" "unprognostic (2.14e-2)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-1)" "unprognostic (4.61e-3)" "unprognostic (1.24e-1)" "unprognostic (3.07e-2)" "unprognostic (2.88e-1)" "unprognostic (2.75e-1)" "unprognostic (4.98e-2)" "unprognostic (6.90e-2)" "unprognostic (3.78e-3)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "unprognostic (4.88e-2)" 12.9 17.0 13.7 10.9 23.1 13.5 13.0 20.9 23.3 13.7 11.2 16.4 6.7 11.3 16.4 12.8 11.9 12.6 9.9 10.4 13.2 12.9 20.6 17.3 10.5 16.5 13.5 12.5 16.2 16.8 15.9 21.5 10.3 15.0 11.8 13.2 12.7 14.6 12.0 18.8 14.9 12.7 11.6 10.5 14.0 10.7 9.5 13.7 22.5 17.4 8.9 19.8 11.7 16.7 8.6 6.1 19.1 7.7 7.7 9.6 3.3 10.7 11.4 11.0 13.0 15.4 8.9 12.0 10.2 8.8 13.1 13.1 12.0 13.0 16.8 7.9 7.5 10.7 12.4 18.3 6.8 15.6 14.2 9.8 14.0 11.6 9.7 10.0 17.5 11.5 7.1 8.9 12.2 10.4 8.8 10.5 12.1 27.0 17.2 10.9 9.9 16.8 7.5 17.9 9.4 19.0 15.1 23.5 20.9 9.1 7.9 17.3 14.0 14.4 15.3 13.0 13.8 16.5 9.9 7.9 10.9 11.7 15.9 13.4 8.5 11.7 20.6 9.7 11.0 16.7 19.1 5.2 7.5 8.6 6.3 9.2 8.6 8.1 8.8 5.4 7.1 8.0 9.6 11.9 7.7 7.7 6.1 8.1 3.3 13.7 23.1 20.9 23.3 13.2 12.9 13.5 12.5 15.0 13.7 17.9 13.5 16.3 9.4 23.9 13.8 6.5 7.6 14.7 17.0 21.0 27.5 8.0 8.3 10.8 6.4 13.8 14.0 0.0 10.0 8.2 9.8 10.8 12.8 20.2 9.7 15.9 11.6 17.8 14.1 1.7 11.8 15.2 18.6 10.0 12.4 15.8 11.6 10.5 15.2 23.1 18.8 19.4 9.8 8.8 18.1 29.5 9.0 21.7 13.3 12.2 RBM19 "DKFZp586F1023, KIAA0682, Mrd1" ENSG00000122965 "RNA binding motif protein 19" Q9Y4C8 12 113816738-113966371 "Plasma proteins, Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038860, HPA058732" Supported Supported Nucleoli NA NA Nucleoli "HPA038860: AB_10697400, HPA058732: AB_2683801" "unprognostic (2.10e-1)" "unprognostic (1.54e-1)" "unprognostic (3.61e-2)" "unprognostic (4.83e-3)" "unprognostic (1.50e-1)" "unprognostic (9.14e-2)" "prognostic unfavorable (5.87e-7)" "unprognostic (9.32e-3)" "unprognostic (2.61e-1)" "unprognostic (5.14e-2)" "unprognostic (4.43e-2)" "unprognostic (3.53e-3)" "unprognostic (8.37e-2)" "unprognostic (3.18e-2)" "unprognostic (2.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.06e-2)" 15.4 18.4 19.9 23.5 26.1 23.8 17.1 25.0 26.7 13.7 15.4 27.5 16.0 14.7 17.7 15.1 15.7 15.1 13.0 14.3 19.4 12.6 16.5 15.7 15.2 22.1 22.4 16.2 25.5 21.3 22.0 16.6 16.9 19.4 19.0 15.8 16.0 16.1 16.2 20.0 16.3 16.5 19.6 14.5 19.1 16.7 17.3 26.3 16.8 26.7 14.4 21.5 17.1 21.7 8.1 6.7 1.4 11.9 7.9 9.1 4.8 7.1 14.4 8.6 16.8 8.7 7.0 13.1 13.0 10.2 14.7 10.8 19.2 10.1 12.8 8.1 11.0 10.8 10.2 20.3 12.5 11.6 23.2 11.8 27.6 14.2 18.4 6.6 20.8 13.2 8.6 8.3 17.9 6.5 9.4 10.7 10.1 29.6 5.3 9.1 10.7 11.7 15.7 18.9 7.2 12.4 15.6 8.3 11.1 10.0 14.0 10.4 8.3 11.6 16.9 7.9 7.5 18.5 6.0 12.0 9.7 11.9 8.3 7.9 9.7 7.2 12.9 13.0 14.9 12.2 0.0 4.9 1.4 9.1 8.8 6.9 8.1 6.4 7.4 6.7 7.0 5.2 7.1 0.3 7.9 11.9 4.6 5.5 4.8 19.9 26.1 25.0 26.7 19.4 12.6 22.4 16.2 19.4 26.3 14.9 8.1 9.3 11.1 12.2 9.7 17.6 7.6 20.1 12.5 10.4 7.9 8.8 1.7 9.6 4.9 10.8 4.8 0.0 11.2 7.5 8.9 11.8 14.0 6.4 11.0 6.4 8.6 3.1 6.3 6.5 10.0 9.5 3.3 21.6 7.3 4.9 11.4 6.2 6.7 7.5 13.5 0.0 12.2 15.6 13.2 10.0 9.5 11.4 7.3 11.2 RBM20 ENSG00000203867 "RNA binding motif protein 20" Q5T481 10 110644397-110839469 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 45.9;skeletal muscle: 20.9" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 137.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 5.7;HEL: 4.8;K-562: 4.6;RH-30: 15.7;SH-SY5Y: 14.6;SuSa: 5.0;T-47d: 8.8" "Region enhanced" "Detected in some" "olfactory region: 4.6" "Not detected" "Not detected" "HPA035806, HPA070358" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Yes No "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA035806: AB_10672097, HPA070358: " "unprognostic (2.43e-1)" "unprognostic (8.24e-3)" "unprognostic (5.81e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (2.03e-2)" "unprognostic (2.75e-2)" "unprognostic (5.47e-3)" "unprognostic (1.33e-1)" "unprognostic (2.78e-2)" "unprognostic (4.14e-3)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "unprognostic (3.34e-1)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (6.46e-2)" 1.7 0.1 0.4 0.6 1.9 0.1 2.2 0.5 1.5 0.9 2.6 1.3 0.0 0.2 2.5 7.5 3.6 1.9 2.3 45.9 0.6 0.2 1.1 0.1 0.5 0.1 0.3 1.3 2.4 13.7 0.9 1.2 1.4 1.4 1.0 0.5 4.3 6.3 0.7 20.9 0.7 1.0 2.1 0.6 0.1 0.6 0.9 1.4 0.0 0.7 3.4 0.5 1.8 3.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.5 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.0 0.0 2.3 5.7 4.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 15.7 0.0 0.0 0.0 0.1 14.6 0.1 0.0 0.6 5.0 8.8 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.9 0.5 1.5 0.6 0.2 0.3 1.3 1.4 1.4 0.0 0.0 0.0 0.2 0.1 1.3 137.1 0.0 17.4 0.0 0.0 2.0 1.0 1.7 0.0 0.7 0.6 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.4 4.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 12.7 1.4 2.3 6.5 1.9 0.0 0.5 0.0 2.6 0.0 0.0 0.1 RBM28 FLJ10377 ENSG00000106344 "RNA binding motif protein 28" Q9NW13 7 128297685-128343908 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019058, HPA026672, HPA031519" Enhanced Supported Nucleoli Yes No Nucleoli "HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: AB_2673920" "unprognostic (2.34e-1)" "unprognostic (1.87e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.72e-11)" "unprognostic (6.83e-2)" "prognostic unfavorable (6.44e-4)" "unprognostic (7.20e-2)" "unprognostic (4.01e-2)" "unprognostic (3.97e-3)" "unprognostic (1.45e-3)" "unprognostic (7.15e-3)" "unprognostic (3.05e-1)" "unprognostic (2.18e-2)" "unprognostic (1.04e-1)" 22.1 17.7 16.3 18.4 25.1 14.2 17.5 26.5 25.3 12.8 13.7 19.7 9.6 13.2 17.1 9.9 15.1 12.5 10.9 24.4 18.1 8.6 12.0 18.8 13.2 17.9 26.5 16.2 19.7 15.7 16.5 18.4 14.5 17.3 13.1 12.7 12.3 13.0 13.0 33.5 17.3 11.2 14.2 25.4 13.8 14.1 18.4 24.4 11.7 16.1 12.2 15.6 13.8 18.9 14.5 14.3 9.8 11.5 12.3 13.7 5.5 18.6 20.6 12.5 35.7 8.9 5.7 17.1 17.2 7.1 15.6 17.0 17.1 16.4 24.8 9.4 7.8 22.8 12.7 18.3 14.6 20.3 12.4 17.6 24.9 14.4 15.7 7.9 31.3 22.4 6.4 9.6 20.7 12.5 5.9 14.4 13.8 46.5 14.5 12.1 15.1 22.4 17.9 23.8 12.9 16.2 17.8 15.0 23.8 7.6 12.7 14.0 17.0 22.2 37.2 11.8 15.6 9.5 9.6 13.8 22.7 11.8 20.1 20.8 15.0 12.8 43.0 14.9 26.5 24.4 3.5 11.5 4.4 13.7 8.9 9.4 12.8 11.6 12.2 11.5 14.5 10.5 12.0 9.8 12.3 7.8 14.3 7.1 5.5 16.3 25.1 26.5 25.3 18.1 8.6 26.5 16.2 17.3 24.4 14.9 32.7 12.7 12.1 14.3 55.3 21.5 5.1 21.4 38.7 12.2 88.4 17.7 21.6 15.9 2.1 18.8 6.2 0.0 19.6 22.7 16.4 9.7 34.8 12.8 16.8 38.1 10.9 7.4 14.3 1.3 25.6 14.5 5.0 13.6 13.8 23.3 15.5 7.0 19.4 12.9 52.9 6.5 21.7 41.1 51.3 12.7 15.6 16.0 14.8 10.9 RBM34 KIAA0117 ENSG00000188739 "RNA binding motif protein 34" P42696 1 235131183-235161457 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028606 Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No Nucleoli "Nucleoplasm, Mitotic chromosome" "HPA028606: AB_10601494" "unprognostic (4.53e-2)" "unprognostic (3.64e-2)" "unprognostic (7.30e-2)" "unprognostic (3.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.32e-2)" "unprognostic (6.57e-4)" "unprognostic (2.98e-2)" "unprognostic (5.65e-3)" "unprognostic (2.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.69e-8)" "unprognostic (8.50e-2)" "unprognostic (1.85e-1)" "unprognostic (8.73e-2)" "unprognostic (7.09e-4)" 15.8 10.5 17.2 16.4 18.1 30.6 14.8 15.5 22.3 11.0 13.5 10.6 7.0 16.7 10.9 15.2 15.4 9.9 11.3 15.2 13.4 11.6 19.4 14.2 11.5 20.0 16.9 9.9 13.9 13.5 6.6 24.9 14.7 20.9 13.5 12.6 7.6 18.3 11.2 22.2 17.9 17.6 10.9 17.9 14.6 13.1 28.8 17.3 17.5 14.7 10.9 17.1 14.1 16.0 34.2 27.2 38.0 19.2 25.3 35.5 22.7 12.0 9.1 9.5 12.1 7.2 13.0 23.6 12.8 8.9 11.5 11.1 12.3 13.8 20.8 13.9 7.7 9.2 18.1 11.3 11.7 11.1 18.8 18.4 15.6 6.5 8.5 14.4 24.6 15.3 11.4 13.5 10.7 7.4 10.6 9.2 20.8 22.1 10.7 14.5 6.9 21.4 21.2 27.6 16.6 6.5 20.1 10.5 24.0 11.9 9.2 11.8 21.5 17.7 11.3 28.9 6.9 24.6 26.8 9.6 11.7 10.2 16.1 25.6 13.0 21.0 22.0 13.7 16.5 18.2 38.0 16.9 20.4 23.7 19.2 28.2 34.2 27.3 30.4 17.2 26.3 26.0 29.9 8.2 25.3 19.1 27.2 35.5 22.7 17.2 18.1 15.5 22.3 13.4 11.6 16.9 9.9 20.9 17.3 17.9 10.9 5.1 5.4 2.9 3.3 2.6 5.1 16.0 11.4 3.5 9.8 5.2 5.0 5.6 5.6 3.5 3.6 0.0 5.4 3.7 3.5 4.5 22.0 3.0 2.9 0.0 7.5 5.5 6.8 4.4 3.7 4.3 3.3 9.0 2.6 4.1 7.1 2.9 5.3 7.9 4.9 0.0 5.2 6.1 5.3 3.3 5.1 11.4 3.7 5.7 RBM43 "C2orf38, FLJ45645" ENSG00000184898 "RNA binding motif protein 43" Q6ZSC3 2 151247940-151261879 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.2;HSkMC: 16.4" "Low region specificity" "Detected in all" HPA038204 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA038204: AB_10669520" "unprognostic (3.50e-2)" "unprognostic (5.45e-2)" "unprognostic (2.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-1)" "unprognostic (1.12e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (9.72e-3)" "unprognostic (2.57e-2)" "unprognostic (3.43e-3)" "unprognostic (1.22e-2)" "unprognostic (3.07e-2)" "unprognostic (1.12e-2)" "unprognostic (9.94e-2)" 10.7 14.8 5.2 7.6 6.4 6.0 7.9 1.6 4.9 14.4 8.1 5.4 7.4 3.1 14.6 14.6 8.4 13.6 7.2 4.4 6.0 4.8 7.8 7.0 14.3 13.6 4.5 5.3 17.6 6.8 8.7 7.8 6.0 4.3 14.4 4.7 14.3 6.2 8.9 4.5 6.2 6.3 11.5 5.6 8.4 5.9 6.5 4.1 11.0 13.4 3.6 6.9 20.5 6.6 3.2 1.1 5.9 4.6 5.3 4.9 1.2 2.9 1.9 3.1 4.1 8.3 18.2 2.0 3.4 7.8 4.3 6.3 0.1 4.9 2.3 1.3 6.1 2.3 1.5 0.9 3.9 2.2 3.4 2.1 5.5 0.7 0.2 8.1 6.7 1.9 16.4 4.4 3.4 2.6 6.5 9.1 2.5 2.2 2.6 5.8 2.9 3.8 3.2 1.1 0.0 3.6 2.6 3.5 1.3 7.3 2.5 1.1 3.6 3.3 2.4 6.4 0.5 3.5 4.4 5.1 3.2 2.9 2.8 1.4 0.9 0.6 0.0 8.5 2.7 1.9 1.9 1.7 5.9 2.8 2.1 4.6 2.8 3.9 3.5 1.1 3.2 4.9 3.4 2.0 5.3 4.6 0.5 1.9 1.2 5.2 6.4 1.6 4.9 6.0 4.8 4.5 5.3 4.3 4.1 3.0 6.2 4.7 2.3 3.0 7.5 2.1 15.3 32.1 6.8 17.4 0.0 5.6 23.2 4.9 2.3 9.0 2.9 0.0 5.1 3.3 8.7 3.3 3.5 8.6 4.7 6.4 5.8 15.4 11.3 1.1 25.9 4.8 3.3 8.2 6.9 21.7 3.8 5.3 27.3 8.8 0.9 0.0 5.7 0.7 3.2 2.8 1.1 5.9 4.3 2.0 RBMX2 "CGI-79, Snu17" ENSG00000134597 "RNA binding motif protein, X-linked 2" Q9Y388 X 130401969-130413343 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026609 Approved Approved "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane" Nucleoli "HPA026609: AB_1846601" "unprognostic (2.54e-1)" "unprognostic (1.17e-2)" "unprognostic (1.80e-3)" "unprognostic (3.32e-2)" "unprognostic (1.16e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (7.04e-4)" "prognostic favorable (9.15e-4)" "unprognostic (1.34e-3)" "unprognostic (1.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (8.44e-9)" "unprognostic (1.06e-1)" "unprognostic (4.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.63e-3)" 19.4 16.7 22.3 16.7 20.0 17.1 25.0 22.7 22.9 25.1 19.9 18.9 19.1 17.0 29.4 29.5 18.7 19.8 18.8 17.8 21.0 18.7 17.7 21.1 16.9 21.2 18.6 22.1 28.2 21.9 17.9 24.4 17.3 21.0 23.0 20.0 16.3 20.5 23.7 21.0 21.4 15.9 23.0 18.9 21.1 18.4 10.8 19.0 26.4 23.0 17.9 26.7 27.2 20.2 12.6 10.5 11.0 9.5 9.4 19.3 5.4 14.0 14.7 14.7 15.2 14.7 27.6 15.0 13.2 13.5 15.0 16.4 10.9 17.2 13.5 31.7 10.0 19.8 15.2 23.5 12.2 21.9 12.3 20.9 12.1 13.5 11.4 13.3 18.7 14.4 20.0 17.4 16.8 23.4 21.8 16.8 16.8 10.5 11.8 16.7 24.4 21.4 23.3 11.1 24.6 23.9 16.6 14.6 18.2 15.2 11.2 17.2 20.6 8.3 17.7 23.2 12.5 11.5 13.8 10.9 12.1 9.9 28.2 27.4 15.7 17.0 19.2 14.8 30.5 15.3 11.0 9.4 10.8 11.1 9.5 11.1 12.4 13.8 14.0 7.8 12.6 15.1 14.2 8.0 9.4 9.4 10.5 19.3 5.4 22.3 20.0 22.7 22.9 21.0 18.7 18.6 22.1 21.0 19.0 17.9 14.7 30.6 27.8 28.5 21.4 20.3 25.5 29.4 45.5 10.4 9.8 28.5 13.3 28.8 2.9 30.2 14.2 0.0 30.8 34.2 26.7 22.1 34.6 23.6 30.5 15.9 39.0 35.0 46.7 3.5 30.0 32.5 27.0 31.5 21.9 19.8 26.5 17.5 41.4 32.3 10.4 32.3 30.7 16.5 47.3 26.0 21.6 32.0 27.7 20.3 RDM1 "MGC33977, RAD52B" ENSG00000278023 "RAD52 motif containing 1" Q8NG50 17 35918066-35930773 "Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.7;lymphoid tissue: 6.2;testis: 24.0" "Group enriched" "Detected in some" 16 "Early spermatids: 50.7;Late spermatids: 58.2;Spermatocytes: 19.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 5.7" "Group enriched" "Detected in many" 14 "NK-cells: 1.5;T-cells: 5.7" "Cell line enhanced" "Detected in many" "CACO-2: 10.2;JURKAT: 14.1;T-47d: 16.7" "Low region specificity" "Detected in all" "HPA024794, HPA067546" Enhanced Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA024794: AB_1856039, HPA067546: AB_2732769" "unprognostic (9.36e-2)" "unprognostic (2.40e-2)" "unprognostic (8.00e-2)" "unprognostic (4.57e-3)" "unprognostic (1.91e-2)" "unprognostic (1.26e-1)" "unprognostic (2.06e-4)" "unprognostic (5.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.71e-2)" "unprognostic (2.58e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-8)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (7.00e-3)" "unprognostic (1.53e-1)" 0.0 0.0 0.9 0.9 1.2 0.6 0.0 0.0 1.8 0.0 0.9 0.1 0.0 1.3 0.2 0.7 0.3 0.1 0.3 0.0 1.0 0.1 0.0 0.1 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.2 0.2 1.7 0.0 0.0 0.0 0.0 1.1 1.5 0.1 0.2 0.1 1.1 24.0 0.0 6.2 0.3 0.0 2.8 0.0 0.0 0.1 0.2 0.0 0.0 1.5 5.7 0.3 5.7 6.8 1.3 2.4 0.1 0.0 2.1 1.4 0.1 0.8 1.3 10.2 5.7 6.3 2.8 0.4 3.8 0.9 3.9 1.7 3.9 1.5 8.0 4.1 1.8 0.0 0.0 0.2 2.9 0.0 0.7 0.5 0.4 1.0 0.1 14.1 1.8 0.0 0.5 2.3 2.2 2.2 0.9 5.0 2.5 0.7 0.0 0.0 1.5 3.3 4.6 0.8 1.8 1.7 2.5 3.7 16.7 0.3 0.0 0.1 2.0 0.0 0.4 5.3 1.9 2.2 3.3 2.3 1.0 0.0 0.0 0.0 1.4 0.0 2.3 0.1 1.6 5.7 0.2 0.0 0.0 0.7 0.0 1.5 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 50.7 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.0 0.4 1.4 0.0 1.2 0.6 0.0 58.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 19.7 2.6 0.0 0.6 0.0 0.6 0.3 RETSAT FLJ20296 ENSG00000042445 "Retinol saturase" Q6NUM9 2 85342088-85354620 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 86.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 209.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 65.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007961, HPA046513" Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA007961: AB_1079802, HPA046513: AB_2679680" "unprognostic (6.17e-2)" "unprognostic (1.02e-1)" "unprognostic (1.29e-1)" "unprognostic (5.84e-3)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "prognostic favorable (4.23e-4)" "unprognostic (1.89e-1)" "unprognostic (2.16e-1)" "unprognostic (3.59e-2)" "unprognostic (1.77e-2)" "unprognostic (1.59e-1)" "prognostic favorable (1.95e-10)" "unprognostic (2.73e-2)" "unprognostic (5.34e-1)" "unprognostic (8.24e-3)" "unprognostic (9.90e-2)" 65.7 24.8 7.7 9.8 9.1 0.9 35.6 5.6 9.3 7.4 46.5 12.4 12.7 49.0 6.8 12.3 16.7 5.0 17.7 7.3 7.4 5.7 20.6 51.9 7.2 5.1 10.2 7.7 5.5 11.5 13.1 3.5 5.7 8.9 10.1 22.6 10.0 12.5 7.6 24.3 14.3 86.1 7.0 12.7 4.0 18.2 9.2 10.1 3.5 27.2 13.9 9.3 9.9 9.0 3.8 5.6 5.3 10.0 6.5 9.2 4.1 16.2 9.4 5.5 12.7 65.6 12.3 7.1 11.9 14.7 7.2 10.2 6.5 11.4 5.7 9.8 9.4 5.8 13.6 7.3 20.7 7.1 7.0 5.0 2.8 7.8 15.9 15.8 5.4 6.3 16.1 28.4 9.3 12.4 16.8 12.0 5.0 2.9 13.7 13.5 3.4 3.9 2.8 1.7 16.4 11.6 2.5 10.8 7.4 12.8 9.5 2.6 4.4 10.0 19.1 32.3 3.8 9.0 0.9 9.4 8.2 4.5 7.6 6.2 7.4 6.9 2.3 10.0 6.5 5.6 0.0 5.1 2.4 7.0 5.5 9.2 3.8 5.6 8.8 5.6 2.5 3.8 4.0 5.3 6.5 10.0 4.0 5.8 4.1 7.7 9.1 5.6 9.3 7.4 5.7 10.2 7.7 8.9 10.1 26.8 23.5 2.2 8.5 10.1 3.5 18.5 20.4 9.4 10.3 12.2 17.7 9.6 0.0 19.1 27.2 9.2 209.6 0.0 31.4 5.6 6.6 11.3 10.4 39.3 8.7 11.1 10.4 8.0 9.9 41.4 13.6 7.5 28.7 9.0 43.9 8.2 29.0 59.4 11.7 15.6 4.3 0.0 7.8 2.6 3.0 13.0 7.1 8.9 33.1 8.4 REXO2 "CGI-114, DKFZP566E144, SFN" ENSG00000076043 "RNA exonuclease 2" Q9Y3B8 11 114439386-114450279 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038450, HPA038451" Enhanced Supported "Nucleoli,Focal adhesion sites,Mitochondria" NA NA 390000 Mitochondria "Nucleoli, Focal adhesion sites" "HPA038450: AB_10672516, HPA038451: AB_10697391" "unprognostic (3.26e-3)" "unprognostic (2.36e-2)" "prognostic favorable (6.51e-4)" "unprognostic (6.84e-3)" "unprognostic (5.80e-3)" "unprognostic (1.06e-1)" "unprognostic (1.40e-3)" "unprognostic (1.78e-1)" "unprognostic (8.18e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-3)" "unprognostic (1.02e-1)" "unprognostic (1.73e-2)" "unprognostic (6.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.69e-2)" "prognostic unfavorable (6.70e-4)" 21.8 31.1 13.5 15.8 14.2 16.2 30.0 14.9 12.6 31.4 36.0 11.2 24.0 8.4 38.4 24.8 33.5 17.7 23.9 64.3 13.3 10.5 35.7 28.6 20.1 13.9 17.0 13.1 28.5 27.7 61.2 24.9 45.0 15.3 32.0 17.7 11.6 61.6 22.8 27.8 22.7 15.8 44.6 15.7 18.6 31.5 29.6 14.5 9.9 20.0 25.2 15.2 34.9 40.6 15.5 28.6 19.0 7.9 18.1 30.5 12.2 27.8 16.2 6.3 16.9 50.7 53.8 15.0 47.3 37.0 23.9 30.5 42.6 47.7 15.3 47.7 41.7 36.3 17.8 14.1 41.8 39.5 14.9 10.9 16.9 22.4 26.5 66.7 12.3 5.4 37.2 40.1 30.2 32.1 42.0 42.7 15.9 31.2 9.4 53.5 6.6 8.9 15.5 19.4 22.3 28.7 7.9 20.6 55.8 34.2 22.7 11.2 7.0 21.7 16.8 19.9 27.5 34.1 6.5 40.4 30.8 36.8 23.7 28.9 7.4 8.8 25.9 21.2 29.1 16.4 19.0 6.0 8.8 14.3 7.9 16.5 15.5 21.6 17.9 7.8 11.7 19.9 16.1 1.5 18.1 7.9 28.6 30.5 12.2 13.5 14.2 14.9 12.6 13.3 10.5 17.0 13.1 15.3 14.5 98.3 49.6 36.3 126.2 123.4 12.0 342.7 43.3 89.7 68.2 90.7 2.0 149.0 235.4 121.0 59.3 101.2 22.2 93.5 62.0 153.2 153.3 156.6 32.2 67.6 83.4 4.8 77.7 89.6 17.6 35.4 195.1 39.5 229.5 53.3 64.2 27.2 110.2 31.6 166.2 264.0 6.7 51.8 115.4 227.9 71.1 142.2 225.1 37.4 70.7 116.6 REXO4 "hPMC2, XPMC2H" ENSG00000148300 "REX4 homolog, 3'-5' exonuclease" Q9GZR2 9 133406059-133418096 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047006 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA047006: AB_2679900" "unprognostic (2.69e-2)" "unprognostic (3.76e-1)" "unprognostic (8.13e-2)" "unprognostic (1.30e-1)" "unprognostic (6.77e-2)" "unprognostic (6.52e-2)" "prognostic unfavorable (4.76e-6)" "unprognostic (2.15e-3)" "unprognostic (2.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.14e-3)" "unprognostic (1.55e-2)" "prognostic favorable (2.65e-4)" "unprognostic (2.25e-2)" "unprognostic (2.86e-2)" "unprognostic (9.20e-2)" "unprognostic (1.20e-1)" 9.9 13.7 16.9 15.1 18.4 10.9 14.5 21.6 18.3 12.7 11.9 11.9 13.2 13.8 14.5 10.7 15.5 13.5 11.2 14.6 13.8 11.8 12.0 19.3 9.7 18.3 18.0 13.2 22.2 21.4 13.3 14.6 14.1 15.4 13.7 10.1 8.8 14.9 13.1 36.4 15.1 13.5 11.9 16.1 16.9 13.0 18.7 18.4 15.0 15.2 9.1 16.3 12.5 21.3 5.5 3.6 3.3 2.5 7.2 5.2 1.8 5.7 13.5 6.3 9.3 6.6 6.9 11.3 10.0 5.7 10.6 7.0 16.0 7.5 18.9 6.8 5.4 8.6 15.8 13.2 10.5 6.1 12.2 12.3 10.2 14.3 12.5 8.3 23.3 10.0 6.4 8.9 11.1 15.3 8.1 7.7 10.2 22.4 8.3 6.7 16.6 16.3 14.0 12.8 20.9 19.4 11.6 10.4 18.7 6.7 5.5 18.2 9.9 10.6 12.4 11.4 6.6 15.2 9.4 6.7 19.4 10.1 9.2 12.1 5.5 6.7 12.9 7.2 13.5 11.5 0.7 2.5 3.3 3.9 2.5 4.3 4.7 4.0 4.0 2.0 5.5 5.1 5.2 0.1 7.2 2.0 3.6 3.4 1.8 16.9 18.4 21.6 18.3 13.8 11.8 18.0 13.2 15.4 18.4 20.8 16.7 29.8 15.4 22.1 25.1 8.3 20.4 10.7 5.7 24.4 21.6 30.4 16.6 26.8 36.5 13.7 23.1 0.0 24.7 31.4 12.1 12.4 17.3 25.5 18.7 15.9 12.7 14.1 16.4 56.5 26.7 12.6 6.8 50.5 19.2 14.2 26.4 17.5 22.6 14.7 29.5 19.4 11.7 39.0 65.9 24.1 26.3 27.7 26.9 11.2 REXO5 NEF-sp ENSG00000005189 "RNA exonuclease 5" Q96IC2 16 20806429-20849668 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "blood: 33.9;testis: 119.4" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 2.7;Club cells: 2.3;Cytotrophoblasts: 1.7;Extravillous trophoblasts: 2.0;Hofbauer cells: 1.9;monocytes: 2.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 15 "basophil: 33.9" "Lineage enriched" "Detected in single" 39 "granulocytes: 33.9" "Cell line enhanced" "Detected in many" "K-562: 24.4;U-266/70: 25.2" "Low region specificity" "Detected in all" "HPA040755, HPA040868, HPA066145" Approved Approved "Nuclear membrane,Nucleoli,Endoplasmic reticulum" NA NA "Nuclear membrane" "Nucleoli, Endoplasmic reticulum" "HPA040755: AB_10965790, HPA040868: AB_10963549, HPA066145: " "unprognostic (2.39e-1)" "unprognostic (2.09e-3)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" "unprognostic (1.68e-1)" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (6.24e-2)" "unprognostic (2.26e-1)" "unprognostic (1.80e-2)" "unprognostic (8.24e-2)" "unprognostic (4.72e-2)" "unprognostic (2.42e-4)" "unprognostic (1.01e-2)" "unprognostic (8.23e-2)" "unprognostic (2.00e-1)" "unprognostic (6.93e-2)" 0.8 0.7 0.7 1.4 1.9 2.6 1.0 1.0 1.0 0.4 0.6 0.6 0.2 0.7 0.9 0.8 0.6 1.1 0.7 1.1 0.6 0.5 0.5 0.5 0.6 0.7 0.4 1.2 0.8 0.6 3.3 0.4 0.4 0.6 1.4 0.8 0.7 0.8 0.7 0.4 0.6 0.6 0.7 0.3 0.3 1.6 119.4 0.4 4.1 0.3 0.5 0.9 0.8 0.6 0.0 0.3 33.9 0.2 0.8 0.7 0.1 6.4 3.6 5.7 2.5 2.3 4.8 1.9 4.3 4.8 4.8 5.3 2.7 5.6 3.9 6.9 3.6 3.3 3.2 4.3 1.9 5.0 4.1 3.1 6.5 5.4 3.7 0.5 9.6 9.5 2.2 0.8 5.6 7.3 2.1 1.6 0.0 24.4 17.5 11.7 8.3 1.5 7.2 3.1 2.5 3.7 7.8 10.8 7.0 1.4 2.2 5.1 5.7 4.0 5.5 1.4 1.7 9.3 8.2 0.8 3.5 3.2 4.7 5.1 25.2 17.0 1.5 7.4 12.4 3.4 33.9 0.2 2.2 0.1 0.0 0.2 0.0 0.2 0.2 0.3 0.0 0.0 0.1 0.1 0.8 0.1 0.1 0.7 0.1 0.7 1.9 1.0 1.0 0.6 0.5 0.4 1.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.0 1.3 2.0 0.0 0.0 1.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 RGCC "bA157L14.2, C13orf15, RGC-32, RGC32" ENSG00000102760 "Regulator of cell cycle" Q9H4X1 13 41457559-41470882 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 109.9;lung: 120.1" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 621.5;Erythroid cells: 303.7;Glandular cells: 288.4;Hofbauer cells: 320.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 46.2" "Lineage enriched" "Detected in many" 26 "T-cells: 46.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 15.4;BJ hTERT+: 80.7;Daudi: 26.2;U-698: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035638, HPA063701" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" No No 390000 Nucleoplasm Nucleoli "HPA035638: AB_10670152, HPA063701: AB_2685096" "unprognostic (1.39e-3)" "unprognostic (4.61e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.28e-1)" "unprognostic (4.27e-2)" "unprognostic (2.85e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-2)" "unprognostic (3.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-3)" 58.6 6.7 26.7 8.8 33.1 109.9 27.7 21.6 22.7 12.8 5.6 36.1 4.2 5.7 8.7 3.1 5.4 7.6 14.3 15.1 32.1 16.8 11.0 8.3 120.1 10.8 41.7 15.2 1.8 13.4 8.7 7.1 70.6 21.1 10.7 3.6 16.1 33.2 6.8 12.7 10.8 4.9 11.3 22.2 7.3 8.0 7.1 34.8 15.2 26.9 5.8 6.9 9.5 8.7 1.7 1.7 0.2 0.2 0.1 46.2 2.8 0.2 0.1 9.0 0.0 1.7 15.4 0.3 0.2 80.7 0.0 0.3 11.2 0.1 26.2 0.2 1.0 0.0 0.2 0.3 0.5 0.1 2.7 1.3 0.0 1.9 0.8 0.9 0.9 0.3 1.2 1.7 0.3 11.2 0.1 9.2 6.1 2.0 0.0 0.2 0.0 5.8 0.5 0.1 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.8 0.2 5.0 6.2 0.0 1.0 0.5 0.1 0.0 0.0 27.6 0.0 0.6 0.2 0.0 0.2 0.0 1.6 0.1 1.6 1.2 13.8 4.4 1.7 1.7 46.2 10.5 0.2 0.1 0.0 0.5 23.1 2.8 26.7 33.1 21.6 21.7 32.1 16.8 41.7 15.2 21.1 34.8 229.3 54.7 23.2 621.5 76.8 0.8 12.0 0.0 38.8 47.8 3.5 2.0 3.9 29.9 0.6 7.3 237.2 0.3 303.7 0.0 5.3 88.9 288.4 49.5 0.8 320.9 0.0 81.3 31.9 23.8 7.0 7.5 180.3 183.9 0.0 7.4 1.4 0.3 3.4 2.1 0.5 1.4 122.9 80.2 14.1 4.1 57.0 9.3 44.5 6.6 105.6 RGS12 ENSG00000159788 "Regulator of G protein signaling 12" O14924 4 3293028-3439913 "Plasma proteins, Predicted intracellular proteins" Transcription "GTPase activation, Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.2" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 118.6;Suprabasal keratinocytes: 96.1;Urothelial cells: 169.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054646, HPA067421" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA054646: AB_2682555, HPA067421: AB_2685836" "unprognostic (2.08e-1)" "unprognostic (1.71e-3)" "unprognostic (7.50e-2)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.03e-4)" "unprognostic (3.43e-2)" "unprognostic (1.93e-1)" "unprognostic (1.76e-1)" "unprognostic (9.02e-2)" "unprognostic (1.70e-2)" "unprognostic (2.13e-1)" "prognostic favorable (8.43e-4)" "unprognostic (2.54e-1)" "unprognostic (2.60e-1)" "unprognostic (5.92e-2)" "unprognostic (1.11e-2)" 4.7 4.4 20.7 4.1 22.0 2.3 4.4 10.2 37.2 5.4 2.9 10.2 1.5 5.3 6.4 5.6 13.5 7.5 4.4 4.7 13.4 5.6 4.4 6.7 6.5 3.4 12.3 16.3 8.9 3.1 3.1 6.1 4.1 9.4 6.8 2.2 3.1 6.5 5.7 6.8 20.6 4.6 3.0 18.9 4.1 3.2 5.5 9.9 4.3 3.8 3.4 3.6 5.5 7.9 1.0 1.5 1.6 3.9 0.4 1.3 0.7 4.0 5.1 10.3 7.4 3.5 2.7 4.3 4.3 3.5 4.5 3.3 4.1 2.4 1.0 2.7 3.8 6.6 3.9 2.0 13.9 1.5 0.1 1.6 0.4 2.9 10.0 3.1 0.3 5.7 2.3 9.5 2.3 3.2 4.1 9.9 3.6 4.7 0.2 4.1 3.4 0.7 10.8 4.9 2.3 4.9 10.2 4.0 3.3 2.3 12.0 11.7 12.0 2.7 1.9 9.1 2.6 4.7 6.9 7.4 8.8 5.8 1.8 4.6 5.1 4.0 2.3 5.1 6.0 6.2 1.0 1.2 0.3 0.9 3.9 0.3 0.2 0.8 0.5 1.5 1.0 1.3 0.5 1.6 0.4 3.7 0.8 0.6 0.7 20.7 22.0 10.2 37.2 13.4 5.6 12.3 16.3 9.4 9.9 6.0 8.3 0.5 118.6 75.0 19.0 7.5 15.3 29.4 20.5 5.2 27.5 5.3 3.3 9.0 3.8 21.1 5.1 0.0 9.2 1.0 10.0 34.2 13.9 22.7 19.8 9.5 14.3 25.8 6.1 4.2 13.8 19.0 16.9 5.4 9.9 38.9 11.1 0.0 7.4 18.1 18.7 0.0 8.8 20.2 14.9 96.1 5.6 4.5 8.0 169.4 RGS6 ENSG00000182732 "Regulator of G protein signaling 6" P49758 14 71932439-72566529 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8" "Group enriched" "Detected in some" 9 "Early spermatids: 155.9;Late spermatids: 221.8" "Group enriched" "Detected in some" 7 "glioma: 3.1;thyroid cancer: 1.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.6;T-reg: 1.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HEL: 8.3;Karpas-707: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003067 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA003067: AB_1079807" "unprognostic (7.18e-2)" "unprognostic (7.78e-2)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (5.61e-2)" "unprognostic (3.80e-2)" "unprognostic (1.24e-4)" "unprognostic (7.83e-2)" "unprognostic (2.03e-1)" "unprognostic (8.17e-2)" "unprognostic (1.30e-1)" "unprognostic (2.06e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-2)" "unprognostic (8.06e-3)" "unprognostic (2.10e-1)" "unprognostic (3.68e-2)" 6.9 0.8 8.6 1.1 11.1 2.0 4.9 4.0 18.0 7.9 1.8 2.8 0.3 0.8 2.7 4.2 1.0 3.6 1.9 15.7 3.7 7.5 3.3 0.6 1.7 0.5 15.4 9.3 2.3 0.6 10.9 2.6 4.6 20.8 0.7 1.8 1.3 1.3 2.5 1.7 1.4 1.4 2.2 5.2 1.5 0.8 13.9 2.4 0.0 8.5 0.3 1.0 1.1 1.3 0.5 0.4 1.6 0.2 0.6 1.2 4.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 30.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.6 0.0 0.4 1.2 4.1 8.6 11.1 4.0 18.0 3.7 7.5 15.4 9.3 20.8 2.4 0.0 0.0 0.0 0.0 0.2 1.4 19.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 155.9 0.7 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 221.8 1.7 0.0 0.0 8.2 0.0 0.0 0.0 0.0 7.1 0.1 0.4 12.9 20.2 1.2 1.0 0.1 0.7 0.0 0.0 0.4 RHOJ "ARHJ, FLJ14445, RASL7B, TCL" ENSG00000126785 "Ras homolog family member J" Q9H4E5 14 63204114-63293219 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 18 "Endothelial cells: 65.7;Ito cells: 34.4;Peritubular cells: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.6;HUVEC TERT2: 90.5;TIME: 24.0;WM-115: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003050 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA003050: AB_1079812" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (4.37e-2)" "unprognostic (2.42e-1)" "unprognostic (6.71e-2)" "unprognostic (1.77e-2)" "unprognostic (2.89e-1)" "unprognostic (2.33e-2)" "unprognostic (2.19e-1)" "unprognostic (3.04e-3)" "unprognostic (1.42e-2)" "unprognostic (7.07e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (3.50e-3)" "unprognostic (4.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.06e-3)" 17.0 2.9 11.4 6.4 12.0 0.2 14.3 7.3 15.8 15.1 12.0 3.4 7.9 5.8 22.8 14.7 12.4 15.6 20.0 13.0 11.3 4.6 7.3 4.0 18.6 7.0 8.0 9.8 11.9 3.6 3.3 6.5 7.3 6.8 15.9 8.8 14.8 7.2 11.8 5.8 6.0 8.4 25.3 5.4 9.4 9.4 4.7 8.5 0.0 13.1 13.9 3.9 16.9 9.2 1.2 0.9 2.6 0.8 1.4 0.6 0.1 0.0 0.0 15.6 0.0 0.0 0.0 0.0 2.5 10.5 0.9 1.5 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 8.9 90.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.2 0.0 0.0 24.0 0.0 0.2 0.2 1.4 0.0 0.0 0.0 0.0 0.0 26.0 1.0 0.8 0.6 0.5 0.4 0.3 0.7 0.4 0.4 0.2 1.2 0.6 0.6 2.6 1.4 0.2 0.9 0.2 0.1 11.4 12.0 7.3 15.8 11.3 4.6 8.0 9.8 6.8 8.5 0.0 2.2 0.0 0.2 5.3 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.4 0.4 65.7 0.0 0.0 0.7 0.0 11.6 0.5 0.0 0.0 0.1 0.0 0.0 34.4 1.0 0.5 10.9 1.7 3.3 0.0 0.0 9.1 0.1 0.0 15.2 0.0 0.2 6.5 8.0 0.1 0.4 4.3 0.1 0.0 0.0 0.5 RIMS3 "NIM3, RIM3" ENSG00000117016 "Regulating synaptic membrane exocytosis 3" Q9UJD0 1 40620679-40665657 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.7" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 10.7;Late spermatids: 23.5;Muller glia cells: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 1.8;plasmacytoid DC: 4.6" "Group enriched" "Detected in many" 9 "dendritic cells: 4.6;T-cells: 1.8" "Cell line enhanced" "Detected in many" "Daudi: 37.3;JURKAT: 13.2;SH-SY5Y: 17.7;U-87 MG: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055285 Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA055285: AB_2682771" "unprognostic (3.51e-3)" "unprognostic (7.18e-3)" "unprognostic (4.44e-3)" "unprognostic (1.44e-4)" "unprognostic (3.70e-1)" "unprognostic (2.88e-2)" "unprognostic (1.44e-5)" "unprognostic (2.41e-1)" "unprognostic (1.53e-1)" "unprognostic (2.87e-1)" "unprognostic (2.54e-1)" "unprognostic (7.93e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.25e-2)" "unprognostic (3.11e-2)" "unprognostic (2.19e-2)" 1.3 7.2 13.6 2.2 19.2 3.7 3.1 21.5 47.7 1.4 3.4 3.4 0.0 1.1 3.0 2.2 2.9 2.1 1.3 1.5 7.8 17.4 1.4 0.7 3.1 2.0 7.4 22.3 2.5 1.1 4.0 0.5 3.8 4.9 3.2 3.8 2.0 2.0 4.1 0.6 2.7 1.7 4.8 3.4 1.7 2.5 3.1 4.4 0.7 2.8 0.0 2.8 1.7 1.0 0.1 4.6 0.1 0.3 0.1 1.8 0.1 1.9 0.7 2.9 3.1 0.1 0.0 0.4 0.0 0.0 0.5 0.6 0.3 0.6 37.3 0.0 0.0 1.4 0.3 1.9 0.3 0.3 6.4 0.9 2.1 0.2 1.0 0.1 0.3 1.7 0.0 1.5 0.1 0.1 0.1 0.1 13.2 1.8 1.4 0.0 3.4 5.5 0.2 1.8 0.3 0.2 2.5 2.6 6.9 0.5 0.5 10.0 17.7 0.4 1.8 1.2 4.0 0.4 10.4 0.0 0.3 3.0 0.0 0.5 0.3 2.7 8.2 16.3 0.6 0.3 0.1 0.0 0.0 0.1 0.0 1.8 0.0 0.5 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.3 4.6 0.4 0.1 13.6 19.2 21.5 47.7 7.8 17.4 7.4 22.3 4.9 4.4 6.0 0.0 0.0 0.2 0.5 6.3 1.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 10.7 0.1 1.7 0.0 1.3 0.1 0.3 0.4 1.1 0.0 2.4 4.8 0.0 0.0 2.1 23.5 0.0 1.1 0.0 1.0 1.9 12.8 2.3 0.8 0.7 0.3 0.6 0.0 2.2 3.3 1.1 0.1 0.2 0.0 0.6 0.1 RIN2 RASSF4 ENSG00000132669 "Ras and Rab interactor 2" Q8WYP3 20 19886521-20002457 "Disease related genes, Predicted intracellular proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 81.6;Ito cells: 94.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 6 "dendritic cells: 1.2;granulocytes: 2.2;monocytes: 3.3" "Cell line enhanced" "Detected in many" "PC-3: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034641 Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA Cytosol "Nucleoli, Golgi apparatus" "HPA034641: AB_10671230" "unprognostic (8.23e-3)" "unprognostic (8.09e-3)" "unprognostic (3.71e-2)" "unprognostic (1.97e-1)" "unprognostic (3.12e-2)" "unprognostic (3.86e-2)" "unprognostic (1.61e-2)" "unprognostic (3.69e-2)" "unprognostic (2.69e-2)" "unprognostic (1.78e-3)" "unprognostic (2.49e-1)" "unprognostic (6.27e-2)" "prognostic favorable (8.34e-6)" "unprognostic (3.10e-1)" "unprognostic (2.08e-2)" "unprognostic (8.02e-3)" "unprognostic (3.63e-2)" 19.2 6.7 9.9 6.1 8.7 4.0 24.4 4.3 10.2 11.7 21.6 9.5 7.6 10.5 12.7 6.6 11.1 9.7 14.7 13.7 10.0 6.2 12.2 4.6 26.8 4.3 8.3 4.4 12.7 5.1 4.2 4.9 16.7 9.3 8.0 10.4 16.5 12.0 11.3 10.9 6.6 23.4 13.2 7.7 17.5 6.5 3.5 9.9 0.3 13.1 5.5 3.7 9.9 15.6 0.3 1.2 2.2 3.3 0.1 0.3 0.4 3.4 11.4 2.1 6.8 12.5 7.7 7.1 2.8 11.8 3.0 1.7 5.4 3.1 0.0 12.4 7.1 5.7 12.7 0.1 18.1 3.3 1.4 0.0 0.0 2.0 0.4 2.8 0.0 0.0 11.2 3.1 5.7 6.3 6.8 16.2 0.0 0.0 0.2 9.0 2.5 0.0 0.2 0.3 1.6 25.3 0.1 7.6 1.8 3.9 4.9 1.8 0.4 2.7 11.2 0.0 2.2 1.0 0.9 17.5 6.3 1.4 3.7 4.7 0.0 0.0 0.0 4.0 0.0 1.0 0.6 3.3 0.2 0.2 2.7 0.2 0.2 0.2 0.2 1.2 0.3 0.3 0.3 2.2 0.1 2.8 0.6 0.1 0.4 9.9 8.7 4.3 10.2 10.0 6.2 8.3 4.4 9.3 9.9 59.6 13.7 4.7 21.9 37.3 5.7 26.6 10.2 13.4 15.9 29.6 7.9 3.8 36.5 15.5 0.6 37.6 17.0 0.0 30.1 5.9 38.6 19.7 0.0 3.8 81.6 6.4 13.8 94.5 62.1 0.8 17.8 36.0 20.3 4.6 16.1 26.2 24.4 7.0 14.5 34.2 0.7 0.0 17.4 0.0 0.1 47.2 5.9 2.5 18.9 24.1 RIOX2 "FLJ14393, JMJD10, mdig, MINA, MINA53, NO52" ENSG00000170854 "Ribosomal oxygenase 2" Q8IUF8 3 97941818-97972457 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 25.4;Cytotrophoblasts: 30.5;Distal tubular cells: 41.4;Extravillous trophoblasts: 36.7;Syncytiotrophoblasts: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007603, HPA008080, CAB013458" Supported Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960" "prognostic unfavorable (4.41e-4)" "unprognostic (8.64e-2)" "unprognostic (1.59e-3)" "unprognostic (2.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.53e-3)" "unprognostic (1.64e-3)" "unprognostic (8.68e-2)" "unprognostic (9.68e-2)" "unprognostic (5.34e-2)" "unprognostic (1.56e-3)" "unprognostic (6.95e-2)" "unprognostic (1.35e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (3.44e-3)" "unprognostic (1.76e-1)" 13.9 9.6 12.7 13.6 16.7 2.2 14.1 8.1 11.1 9.8 11.0 12.2 14.5 8.1 10.7 11.3 20.4 11.3 12.1 8.2 10.9 12.6 13.1 14.2 9.1 13.1 13.9 11.9 14.2 22.5 13.8 15.0 27.1 14.1 11.2 13.9 10.2 20.3 11.3 27.1 14.9 8.3 11.2 14.7 12.1 10.5 6.6 11.2 6.3 48.4 12.8 15.6 14.7 12.5 13.1 21.8 1.6 11.1 8.2 13.6 9.1 20.3 12.3 4.4 9.5 10.3 15.9 11.6 10.0 7.6 11.8 9.7 8.3 10.8 27.3 11.5 11.3 16.0 11.9 13.9 14.2 18.5 51.7 6.4 8.6 5.4 9.9 16.8 17.6 4.1 12.1 19.2 9.0 22.1 5.8 11.9 12.3 11.9 12.2 11.9 6.0 13.9 5.7 9.5 22.4 16.4 0.0 14.8 27.3 11.9 12.0 23.5 8.5 10.7 14.8 16.6 5.1 13.1 7.3 9.6 11.8 13.0 6.4 20.6 18.0 9.3 27.5 13.9 17.6 12.7 1.6 10.9 0.6 8.7 9.4 13.3 13.1 13.6 10.6 13.4 10.3 13.2 10.8 0.7 8.2 11.1 21.8 12.0 9.1 12.7 16.7 8.1 11.1 10.9 12.6 13.9 11.9 14.1 11.2 8.9 10.2 0.0 0.0 0.0 0.0 0.0 0.0 25.4 19.4 7.0 0.0 30.5 41.4 14.2 0.0 0.0 0.0 0.0 11.5 36.7 0.0 0.0 2.3 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 12.6 0.0 0.0 10.2 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 RLF "Zn-15L, ZNF292L" ENSG00000117000 "Rearranged L-myc fusion" Q13129 1 40161373-40240921 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054653, HPA057300" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA054653: AB_2682557, HPA057300: AB_2683404" "unprognostic (1.71e-1)" "unprognostic (2.24e-2)" "unprognostic (6.46e-2)" "unprognostic (1.88e-2)" "unprognostic (6.78e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.75e-4)" "unprognostic (5.84e-2)" "unprognostic (3.43e-2)" "unprognostic (2.18e-2)" "unprognostic (2.60e-2)" "unprognostic (9.38e-2)" "prognostic unfavorable (7.68e-6)" "unprognostic (1.86e-1)" "unprognostic (2.59e-1)" "unprognostic (1.12e-1)" "unprognostic (4.69e-2)" 14.8 8.1 12.6 11.3 12.6 44.5 13.9 20.8 17.1 12.4 11.1 11.6 7.1 8.6 14.1 8.6 12.4 9.9 11.2 12.3 11.0 8.3 8.7 12.7 12.8 11.8 12.8 11.8 14.6 9.4 12.5 15.1 11.9 15.4 13.2 9.2 10.2 9.4 9.9 13.4 17.7 9.9 14.3 14.1 10.1 9.3 15.9 11.8 14.9 10.0 8.4 13.5 18.1 14.8 4.1 3.5 10.1 4.1 4.1 4.9 2.4 12.4 4.8 9.5 9.9 8.5 6.9 11.3 4.7 7.0 8.1 10.8 9.7 6.6 12.4 6.2 6.0 6.1 11.8 11.9 8.2 14.8 5.8 8.1 10.2 5.9 5.9 6.7 8.4 6.2 6.8 8.7 8.6 9.8 9.7 5.5 6.9 15.5 7.7 7.4 3.9 7.1 5.1 12.6 4.6 5.6 5.6 15.6 7.2 5.2 12.6 6.8 9.5 8.7 11.7 8.3 15.4 5.5 30.8 4.7 9.6 10.2 7.8 8.7 7.0 6.6 11.7 8.3 7.9 5.9 10.1 2.8 5.5 3.7 3.9 4.9 4.1 3.7 3.8 3.5 4.1 4.8 4.0 6.3 4.1 4.1 1.6 3.3 2.4 12.6 12.6 20.8 17.1 11.0 8.3 12.8 11.8 15.4 11.8 29.8 10.8 22.4 42.2 58.3 17.2 13.4 5.1 30.8 30.7 3.5 15.7 6.9 5.0 10.9 32.9 23.3 8.4 0.0 5.9 8.0 34.2 25.7 26.5 8.3 8.5 25.4 19.4 16.0 13.9 4.9 8.3 16.8 16.9 10.0 7.8 17.0 9.3 14.0 7.4 5.7 15.8 12.9 27.8 26.5 20.0 53.3 14.4 14.1 6.7 27.2 RNF115 "CL469780, ZNF364" ENSG00000265491 "Ring finger protein 115" Q9Y4L5 1 145738868-145824077 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019130 Approved Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA019130: AB_1859220" "unprognostic (3.44e-2)" "unprognostic (2.47e-3)" "unprognostic (2.24e-1)" "unprognostic (1.09e-1)" "unprognostic (5.48e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (2.29e-2)" "unprognostic (1.46e-2)" "unprognostic (1.35e-1)" "unprognostic (2.64e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-2)" "unprognostic (3.23e-1)" "unprognostic (4.77e-2)" "unprognostic (2.46e-2)" "unprognostic (1.08e-1)" 7.2 5.2 6.8 4.8 6.8 6.4 7.7 16.2 7.0 6.3 3.4 4.6 5.7 3.5 8.9 5.0 5.8 4.3 4.8 23.5 5.8 5.6 5.1 3.9 5.6 4.7 6.2 4.7 4.5 5.8 5.9 3.5 5.2 6.5 3.8 7.3 3.6 5.6 27.6 3.8 3.1 10.9 4.5 4.2 3.8 3.4 4.5 6.0 5.0 5.4 4.5 4.1 6.3 2.7 2.4 9.0 2.2 3.2 3.2 1.4 11.3 4.7 5.8 4.3 10.7 14.0 4.7 8.6 16.0 6.4 7.8 5.1 4.1 8.0 9.8 12.2 6.3 8.0 6.4 5.9 6.9 8.0 4.2 6.4 6.1 4.7 6.7 9.9 14.8 8.1 5.2 6.4 7.8 7.3 8.1 6.3 6.3 13.1 11.5 8.6 7.2 6.3 7.3 7.2 10.0 7.0 5.8 6.6 12.4 3.8 5.9 8.1 7.0 8.6 6.4 7.5 9.5 9.5 10.0 9.3 7.3 5.6 9.1 11.0 10.4 8.4 4.7 6.7 5.9 9.0 2.2 3.2 3.2 1.5 2.7 2.7 2.2 3.2 1.8 2.4 2.3 3.1 1.7 3.2 1.6 2.4 2.0 1.4 14.9 29.8 29.4 28.9 18.3 96.0 134.9 25.5 24.1 26.1 17.4 108.0 23.1 28.2 34.8 52.4 66.1 14.0 23.3 69.3 24.5 48.2 51.0 31.1 28.7 32.3 77.9 26.0 66.3 32.6 18.4 36.5 29.9 37.1 88.4 19.7 66.7 49.7 20.9 76.0 37.2 104.3 58.2 49.2 78.7 54.1 15.7 16.6 66.0 23.8 32.8 RNF125 FLJ20456 ENSG00000101695 "Ring finger protein 125" Q96EQ8 18 32018372-32073213 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 67.5;T-cells: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "HMC-1: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041514 Uncertain Supported "Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" Nucleoli "HPA041514: AB_10795596" "unprognostic (2.13e-2)" "unprognostic (2.05e-2)" "unprognostic (2.88e-1)" "unprognostic (3.93e-1)" "unprognostic (5.03e-1)" "unprognostic (4.50e-2)" "unprognostic (2.30e-3)" "unprognostic (6.15e-2)" "unprognostic (4.21e-2)" "unprognostic (3.24e-1)" "unprognostic (1.68e-1)" "unprognostic (4.35e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (2.99e-1)" "unprognostic (4.12e-1)" "unprognostic (1.82e-1)" "unprognostic (7.07e-3)" 21.9 2.3 4.1 9.1 5.7 18.2 20.4 1.2 6.6 5.0 8.9 12.2 3.3 12.3 7.2 5.5 3.9 4.3 6.0 5.4 6.1 4.1 2.1 14.1 10.3 13.5 7.7 3.1 2.4 4.2 2.5 1.3 4.4 7.0 3.1 7.8 1.6 5.0 1.9 4.4 6.0 26.0 4.1 12.0 7.4 4.2 3.3 8.3 14.8 3.2 2.9 7.2 4.5 6.2 2.1 3.4 9.0 3.8 11.7 12.5 5.1 0.7 0.1 0.1 0.2 0.3 0.5 0.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.0 0.2 0.5 0.9 0.8 0.1 4.0 1.6 0.2 0.2 0.2 0.1 5.2 32.5 1.0 1.5 0.0 1.8 0.2 0.3 1.6 0.1 1.2 0.0 1.2 1.3 4.9 2.6 5.3 0.9 5.5 0.4 0.1 0.3 0.3 0.5 0.2 0.1 0.1 8.0 1.1 0.8 2.5 0.1 0.1 0.5 0.1 0.0 3.8 0.1 0.1 0.4 7.0 4.2 9.0 3.8 3.3 12.5 2.0 8.2 2.0 10.1 10.5 3.4 2.1 8.2 10.6 1.5 11.7 1.9 3.4 10.0 5.1 4.1 5.7 1.2 6.6 6.1 4.1 7.7 3.1 7.0 8.3 3.0 8.0 9.9 2.9 8.8 0.4 1.4 2.5 2.7 5.7 12.2 0.0 0.3 1.7 0.8 67.5 23.2 25.5 0.0 1.6 0.1 1.9 2.4 17.4 15.5 8.9 0.0 1.2 6.7 14.8 11.5 2.6 13.9 1.7 1.0 8.2 1.2 1.3 0.0 0.0 1.1 0.6 0.0 1.9 0.5 0.7 5.9 0.7 66.0 13.6 2.1 RNF144B "bA528A10.3, IBRDC2, P53RFP" ENSG00000137393 "Ring finger protein 144B" Q7Z419 6 18387350-18468874 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Basal keratinocytes: 563.5;Suprabasal keratinocytes: 1312.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 28.8" "Group enriched" "Detected in many" 9 "dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8" "Cell line enhanced" "Detected in many" "Daudi: 55.9;EFO-21: 15.4;hTCEpi: 17.8;HUVEC TERT2: 16.5;TIME: 16.5;U-698: 47.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046013, HPA054127, HPA072469" Uncertain Approved Nucleoli,Mitochondria NA NA Nucleoli Mitochondria "CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: " "unprognostic (2.24e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.48e-3)" "unprognostic (5.89e-2)" "unprognostic (1.18e-2)" "unprognostic (6.55e-2)" "unprognostic (2.87e-3)" "unprognostic (2.44e-2)" "unprognostic (2.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "unprognostic (3.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" 16.3 2.0 4.6 11.1 6.8 15.7 21.1 5.1 7.5 8.0 4.2 2.8 4.6 1.5 6.8 7.5 9.4 9.0 6.8 8.7 5.3 4.3 13.8 11.4 39.0 11.1 8.3 2.3 4.2 3.7 3.0 2.3 11.1 8.8 12.8 2.3 8.3 16.9 6.2 36.8 19.2 3.7 4.9 9.2 37.1 4.3 3.3 6.9 5.8 32.9 11.4 12.2 7.3 6.6 2.0 7.9 15.6 28.8 0.2 0.7 2.6 1.3 0.2 0.1 0.0 0.0 0.6 2.9 1.5 1.7 3.3 3.6 0.0 0.1 55.9 15.4 0.6 0.2 4.8 0.0 4.7 4.7 0.2 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.8 17.8 1.3 4.0 1.5 16.5 1.2 0.0 0.0 0.8 0.5 0.4 0.0 0.5 0.1 0.3 0.2 0.5 3.3 10.0 3.1 0.5 0.0 0.3 7.1 5.3 0.4 8.4 0.1 16.5 2.6 0.5 0.2 0.3 0.0 0.0 47.0 0.3 0.1 0.2 0.1 9.1 5.1 0.2 16.4 0.7 2.0 0.3 0.3 5.6 1.6 0.7 0.4 15.6 0.2 28.8 7.9 0.2 2.6 4.6 6.8 5.1 7.5 5.3 4.3 8.3 2.3 8.8 6.9 41.7 12.9 4.2 36.0 563.5 0.9 10.4 10.2 21.4 36.4 36.6 2.0 9.7 16.6 8.2 1.6 32.1 1.0 0.0 7.7 2.9 12.4 85.1 3.5 17.4 13.8 0.0 1.2 28.8 98.2 1.6 1.1 68.0 57.3 44.1 1.3 16.0 6.0 2.9 2.8 16.3 1.0 0.0 10.1 1.7 2.6 1312.2 1.3 3.2 2.4 20.3 RNF169 KIAA1991 ENSG00000166439 "Ring finger protein 169" Q8NCN4 11 74748868-74842413 "Enzymes, Predicted intracellular proteins" "DNA damage, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038505, HPA046138, HPA047952" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Nucleoli, Nucleoli rim, Cytosol" "HPA038505: , HPA046138: AB_2679553, HPA047952: " "unprognostic (1.71e-1)" "unprognostic (4.18e-2)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (3.86e-2)" "unprognostic (3.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-1)" "unprognostic (6.47e-2)" "prognostic unfavorable (8.04e-4)" "unprognostic (2.76e-1)" "unprognostic (1.46e-1)" "unprognostic (3.23e-1)" "unprognostic (2.34e-1)" "unprognostic (9.55e-3)" "unprognostic (1.21e-1)" 12.3 7.0 12.0 11.6 14.0 23.1 12.0 22.6 15.6 13.1 11.2 12.2 6.3 7.4 14.2 8.2 20.6 10.7 10.8 9.2 12.6 5.9 8.9 9.3 16.9 11.3 15.4 9.1 14.6 10.7 17.5 10.4 8.6 13.9 10.5 10.0 8.4 12.4 8.8 15.0 14.1 10.3 14.2 10.1 12.6 10.3 7.2 14.9 12.6 11.5 7.4 12.5 13.1 15.8 0.6 0.8 5.0 1.9 1.2 1.6 0.6 8.3 6.4 7.8 7.6 5.0 6.8 3.1 6.5 6.2 7.3 6.4 10.7 6.3 14.9 6.7 7.8 5.0 8.1 10.4 7.8 9.6 7.4 6.7 10.3 11.8 4.2 5.8 5.4 8.6 6.2 6.2 8.3 19.0 8.2 11.8 10.2 9.1 12.0 7.3 7.0 9.3 9.8 3.0 10.6 4.2 8.7 18.5 8.1 4.7 8.7 3.5 6.3 8.8 6.7 14.2 6.5 8.4 7.0 7.8 12.2 10.3 7.6 5.8 8.7 4.5 17.7 2.4 6.0 7.0 2.8 1.9 1.5 1.6 1.1 1.2 0.3 1.5 0.9 0.8 0.6 1.1 0.9 5.0 1.2 1.0 0.8 1.2 0.6 12.0 14.0 22.6 15.6 12.6 5.9 15.4 9.1 13.9 14.9 8.9 10.7 13.0 26.3 17.6 51.9 2.8 2.5 5.3 7.9 3.5 49.1 5.0 5.0 8.8 2.2 11.7 6.7 0.0 9.5 5.0 9.3 37.6 6.9 11.0 7.6 35.0 11.5 8.6 10.7 2.2 6.9 9.2 10.1 1.8 7.8 33.2 9.1 5.8 9.9 9.1 32.5 25.8 15.1 10.4 10.9 16.3 6.8 16.6 9.7 39.6 RNF215 ENSG00000099999 "Ring finger protein 215" Q9Y6U7 22 30368811-30421771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 12.9;Cone photoreceptor cells: 11.8;Muller glia cells: 10.3;Rod photoreceptor cells: 12.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029427, HPA056498" Approved Approved Nucleoli,Microtubules NA NA Microtubules Nucleoli "HPA029427: AB_2732447, HPA056498: AB_2683154" "unprognostic (1.24e-2)" "unprognostic (3.20e-1)" "unprognostic (3.67e-4)" "unprognostic (8.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (2.47e-2)" "unprognostic (1.97e-1)" "unprognostic (5.32e-2)" "unprognostic (1.03e-1)" "unprognostic (2.45e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (6.37e-10)" "unprognostic (2.48e-1)" "unprognostic (1.99e-1)" "unprognostic (3.17e-1)" "unprognostic (1.78e-2)" 9.8 7.1 17.5 7.3 12.6 8.0 8.0 20.7 24.5 10.1 7.8 7.3 11.9 10.4 14.0 13.0 6.4 10.6 13.3 7.7 11.3 14.4 8.5 8.0 6.9 6.5 10.4 15.2 10.8 15.4 12.6 7.9 9.0 10.7 12.3 5.2 11.2 8.8 11.8 7.4 7.9 5.5 10.9 8.1 8.8 6.9 10.0 5.5 2.2 10.3 1.6 5.0 7.9 8.0 4.8 3.5 3.5 2.1 6.1 4.8 0.9 4.3 9.0 9.5 15.4 9.3 9.8 9.4 7.4 6.7 7.4 4.6 2.5 4.8 1.7 13.4 6.0 14.1 5.4 5.8 8.5 6.0 10.0 7.0 3.0 9.8 3.2 12.9 2.2 12.2 13.3 10.5 12.8 6.9 24.5 8.7 4.6 2.5 8.3 8.8 6.9 1.6 5.4 3.0 6.2 10.1 7.8 5.5 6.8 9.7 6.6 4.2 10.7 7.4 5.5 5.5 9.1 5.0 2.5 12.0 20.2 9.0 5.8 4.3 8.8 2.2 2.3 11.8 1.7 7.8 1.9 2.1 3.5 2.5 1.9 2.5 2.7 2.6 2.0 1.1 4.8 4.8 4.3 1.6 6.1 1.7 3.5 1.3 0.9 17.5 12.6 20.7 24.5 11.3 14.4 10.4 15.2 10.7 5.5 3.0 3.8 0.0 1.2 0.2 12.9 1.7 0.0 0.0 3.4 0.0 11.8 1.4 0.0 1.3 0.6 1.4 0.5 0.0 1.2 1.2 1.6 1.1 0.0 1.7 1.5 7.9 0.0 4.3 1.9 0.2 0.9 0.6 1.7 2.8 0.6 10.3 1.5 0.0 1.1 0.8 12.8 6.5 1.0 1.9 0.9 0.1 1.4 0.0 0.6 1.0 RNFT1 PTD016 ENSG00000189050 "Ring finger protein, transmembrane 1" Q5M7Z0 17 59952240-59964761 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.5" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 175.4;Spermatocytes: 283.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013739 Approved Nucleoli NA NA Nucleoli "HPA013739: AB_1856382" "unprognostic (1.61e-1)" "unprognostic (2.83e-1)" "prognostic favorable (6.57e-4)" "unprognostic (3.04e-2)" "unprognostic (6.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "prognostic favorable (7.48e-4)" "unprognostic (5.42e-2)" "unprognostic (3.45e-1)" "unprognostic (8.26e-3)" "unprognostic (9.44e-3)" "unprognostic (1.19e-3)" "unprognostic (1.44e-2)" "unprognostic (2.05e-1)" "prognostic favorable (2.57e-4)" "unprognostic (2.60e-1)" 7.9 6.2 2.8 5.3 4.3 3.8 4.2 5.1 3.7 3.1 4.0 2.4 3.7 5.3 2.7 8.1 4.6 3.2 3.1 4.1 3.1 2.2 4.7 12.0 5.0 4.4 2.9 3.1 3.5 7.5 4.7 6.1 4.4 3.4 4.5 4.8 4.2 5.1 3.0 6.7 2.7 7.6 3.0 3.4 4.1 3.9 45.5 3.0 5.9 6.1 4.3 6.0 5.1 3.7 9.5 10.1 20.2 17.1 8.9 7.7 7.9 4.8 2.2 2.3 3.1 7.6 5.7 4.5 6.2 3.3 4.9 6.0 6.9 1.9 7.2 10.4 5.2 11.1 5.6 7.3 4.7 8.5 6.8 7.9 6.1 5.8 6.2 5.7 9.4 9.4 6.3 2.5 4.6 2.0 2.5 4.9 1.7 17.4 4.5 4.1 6.3 3.8 4.5 0.9 6.6 5.1 5.2 17.5 4.2 3.9 3.5 1.4 2.7 8.9 2.2 12.4 3.2 10.3 17.9 3.5 9.5 8.4 5.5 5.3 6.5 18.1 4.3 6.6 5.3 4.7 17.3 11.8 20.2 5.6 13.9 7.7 9.5 5.2 6.3 10.1 6.1 6.8 6.1 5.7 8.9 17.1 6.7 6.5 7.9 2.8 4.3 5.1 3.7 3.1 2.2 2.9 3.1 3.4 3.0 0.0 6.1 15.9 13.3 10.1 7.7 5.6 2.5 16.0 6.8 8.7 19.6 29.6 5.0 12.0 175.4 7.8 14.4 0.0 12.5 30.4 15.3 14.5 18.5 27.2 40.4 17.5 4.1 11.6 25.1 60.1 8.3 27.8 16.9 36.9 7.6 4.5 12.5 19.3 11.0 8.6 6.8 19.4 8.6 283.8 42.4 8.4 24.1 16.0 10.1 7.2 RPAP2 "C1orf82, FLJ13150, Rtr1" ENSG00000122484 "RNA polymerase II associated protein 2" Q8IXW5 1 92298965-92402056 "Enzymes, Predicted membrane proteins" "Transcription, Transcription regulation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cone photoreceptor cells: 104.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046443 Approved Supported Nucleoli,Cytosol No No "Nucleoli, Cytosol" "HPA046443: AB_2679669" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.71e-2)" "unprognostic (4.12e-2)" "unprognostic (4.96e-3)" "unprognostic (5.73e-2)" "unprognostic (1.23e-3)" "unprognostic (3.29e-2)" "unprognostic (8.01e-3)" "unprognostic (4.09e-2)" "unprognostic (2.59e-1)" "unprognostic (6.09e-2)" "unprognostic (7.02e-4)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (3.62e-3)" "unprognostic (4.10e-2)" 6.8 7.0 7.8 7.3 10.5 12.0 7.6 27.2 11.6 8.4 6.3 7.1 7.2 6.6 11.1 11.5 5.6 6.3 5.5 5.9 8.1 8.6 8.1 10.6 5.2 8.2 7.7 6.7 8.2 8.6 9.4 16.1 6.7 11.7 7.6 5.8 6.4 7.2 7.1 10.5 10.7 6.3 7.4 9.9 7.6 6.4 6.7 8.7 12.8 9.4 6.5 6.3 6.6 7.6 4.4 3.5 4.9 2.4 4.0 4.8 1.2 6.3 3.9 6.8 6.3 5.6 7.2 5.8 5.0 3.5 3.3 2.7 2.8 2.9 9.5 8.7 3.7 4.5 4.4 5.6 3.2 5.1 6.5 4.0 5.8 7.0 3.7 3.3 10.0 5.8 3.7 4.0 4.2 4.1 4.9 3.5 5.9 5.9 6.4 5.0 3.3 8.4 6.3 5.3 3.6 4.4 6.3 9.0 4.1 4.3 5.7 6.4 4.7 8.1 7.5 4.0 5.3 3.9 7.7 6.1 5.0 6.4 5.7 7.1 6.2 7.1 5.0 3.5 6.3 3.4 4.8 2.4 1.9 4.1 1.7 4.8 3.4 3.2 3.5 1.8 4.4 3.5 3.8 4.9 4.0 1.9 3.5 2.8 1.2 7.8 10.5 27.2 11.6 8.1 8.6 7.7 6.7 11.7 8.7 59.6 66.2 8.2 15.1 8.1 55.5 21.2 5.1 75.0 68.2 7.0 104.1 17.6 10.0 16.4 39.3 17.1 7.7 23.3 11.9 12.3 13.6 12.8 59.1 7.4 8.5 33.4 12.1 8.0 10.8 4.7 17.5 8.8 1.7 15.4 11.9 39.3 12.8 10.7 20.1 13.0 87.8 25.8 12.0 18.9 18.8 8.5 19.8 24.2 11.1 9.8 RPF1 BXDC5 ENSG00000117133 "Ribosome production factor 1 homolog" Q9H9Y2 1 84479259-84497790 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024642 Supported Supported Nucleoli No No Nucleoli "HPA024642: AB_1856428" "unprognostic (1.56e-3)" "unprognostic (2.65e-1)" "unprognostic (3.63e-2)" "unprognostic (7.95e-3)" "unprognostic (2.16e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (4.81e-2)" "unprognostic (1.73e-2)" "unprognostic (2.45e-1)" "unprognostic (1.45e-1)" "unprognostic (3.90e-2)" "unprognostic (1.53e-2)" "unprognostic (1.42e-2)" "unprognostic (2.71e-1)" 20.9 20.4 21.3 25.1 36.2 42.7 26.3 14.8 24.7 21.3 24.8 12.8 18.8 18.8 25.5 27.4 26.0 20.8 18.2 39.8 17.9 16.5 33.1 33.8 21.3 27.2 16.7 15.1 23.9 21.3 16.8 25.7 19.8 16.0 23.7 24.0 14.1 20.8 26.2 56.8 22.1 22.7 20.8 16.6 33.9 22.8 31.0 20.3 31.8 29.3 27.9 30.2 30.0 23.1 36.9 23.1 29.2 26.0 31.8 33.9 26.1 18.9 13.4 17.0 14.1 13.3 17.7 19.2 19.6 17.3 25.6 22.8 10.1 8.2 14.6 22.1 15.4 42.0 14.4 25.4 20.1 28.3 21.0 26.7 36.8 15.1 17.4 18.4 35.3 12.1 14.0 30.0 26.7 19.0 14.6 20.4 27.7 35.5 18.8 22.3 9.9 33.2 23.8 42.3 19.5 29.9 21.4 27.2 11.8 24.3 22.3 21.4 19.9 11.4 24.4 46.7 16.3 13.8 24.2 14.0 19.3 19.2 30.4 40.4 13.0 15.3 32.3 9.0 31.9 17.2 29.2 21.3 19.6 26.6 24.6 29.3 36.9 30.4 26.9 22.5 31.0 33.8 33.9 8.9 31.8 26.0 23.1 31.3 26.1 21.3 36.2 14.8 24.7 17.9 16.5 16.7 15.1 16.0 20.3 35.7 39.9 29.5 37.1 30.8 16.6 33.9 28.1 56.2 31.8 15.7 15.7 30.8 63.0 50.8 38.7 32.2 14.2 0.0 55.7 26.7 25.8 24.7 62.5 32.6 39.0 7.9 32.1 25.2 28.4 6.4 30.2 41.3 27.0 25.2 25.0 24.4 43.8 28.1 32.9 47.6 20.8 45.3 26.9 66.1 60.2 28.5 23.0 49.8 33.6 38.2 RPF2 "bA397G5.4, BXDC1, FLJ21087" ENSG00000197498 "Ribosome production factor 2 homolog" Q9H7B2 6 110982015-111028263 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-2197: 83.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035475 Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA035475: AB_10669861" "unprognostic (2.85e-3)" "unprognostic (2.19e-2)" "unprognostic (6.00e-2)" "unprognostic (2.90e-3)" "unprognostic (4.45e-1)" "prognostic unfavorable (2.04e-4)" "prognostic unfavorable (2.25e-4)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (1.99e-1)" "unprognostic (8.43e-2)" "unprognostic (9.16e-2)" "prognostic unfavorable (2.07e-6)" "unprognostic (2.39e-2)" "unprognostic (2.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.86e-1)" 21.1 17.1 13.9 14.1 19.2 15.4 20.7 16.7 17.3 14.5 13.8 9.0 10.3 10.3 15.4 12.1 19.2 15.8 14.4 19.6 16.5 11.0 18.8 30.7 12.2 15.3 16.8 11.3 20.9 25.9 13.7 21.6 15.5 19.3 15.5 14.1 9.5 14.0 11.5 46.3 16.7 10.6 19.8 17.4 16.3 14.2 18.1 18.7 10.0 20.4 29.3 15.8 22.1 15.1 10.3 9.3 0.8 7.7 11.1 12.4 6.1 8.0 3.9 4.4 17.4 7.7 12.1 11.6 11.6 6.9 10.3 10.3 15.7 5.9 19.0 11.1 5.8 15.3 9.2 14.6 11.0 23.4 8.0 13.4 12.4 4.9 9.1 9.3 18.8 6.0 7.3 8.8 14.3 29.3 6.9 8.2 8.8 33.0 10.5 12.9 7.8 13.9 19.8 12.8 13.1 7.1 13.3 8.4 13.5 9.9 8.1 7.5 9.7 5.1 6.8 19.1 6.6 6.2 16.1 5.3 8.5 7.5 83.2 31.0 4.5 7.0 23.7 11.3 23.8 17.1 0.3 6.9 0.8 5.9 7.7 12.4 10.3 8.4 7.7 8.1 7.8 11.1 10.5 0.2 11.1 4.9 9.3 7.3 6.1 13.9 19.2 16.7 17.3 16.5 11.0 16.8 11.3 19.3 18.7 17.9 26.9 21.2 94.7 69.6 12.6 61.4 45.9 61.6 63.7 17.4 0.0 40.8 58.0 40.9 72.5 33.0 12.0 0.0 41.1 44.2 40.8 42.1 44.0 66.6 48.0 17.5 10.9 22.7 27.3 20.4 31.9 26.8 35.4 18.0 26.8 18.6 37.2 21.0 25.5 70.4 8.2 12.9 35.4 37.2 27.3 58.0 28.9 17.9 32.7 65.4 RPL10A "Csa-19, L10A, NEDD6" ENSG00000198755 "Ribosomal protein L10a" P62906 6 35468408-35470785 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053803 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 360000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA053803: AB_2682268" "unprognostic (5.47e-2)" "unprognostic (8.02e-2)" "unprognostic (1.45e-1)" "unprognostic (3.37e-1)" "unprognostic (3.40e-2)" "unprognostic (1.36e-1)" "unprognostic (3.34e-2)" "unprognostic (4.74e-2)" "unprognostic (1.52e-2)" "unprognostic (1.18e-1)" "unprognostic (1.37e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.21e-2)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" "unprognostic (9.72e-2)" 55.0 41.7 35.5 80.8 28.0 79.0 96.9 25.3 37.6 71.5 76.4 22.8 62.3 35.0 91.2 62.5 88.7 91.0 72.6 45.2 28.1 23.1 45.4 71.1 44.8 94.0 28.5 38.0 155.3 141.2 18.6 35.6 56.6 25.6 86.5 55.2 34.7 104.5 66.1 98.5 92.9 47.2 56.8 27.3 51.4 55.5 33.2 20.1 70.6 62.0 121.6 76.5 77.4 86.4 165.3 104.4 8.5 62.8 101.1 186.5 235.1 66.6 68.9 78.3 73.6 117.4 214.2 88.8 69.1 142.3 97.5 77.8 99.6 64.6 200.2 63.8 93.6 47.9 59.2 105.5 157.7 81.0 69.4 92.9 76.8 63.8 139.1 174.0 112.0 64.1 249.0 185.0 71.4 239.9 158.1 142.7 100.7 90.5 99.0 110.5 117.8 118.1 136.2 82.2 105.4 60.8 93.6 75.5 154.9 123.2 110.4 55.3 81.0 42.5 97.8 195.2 66.0 105.8 204.3 82.3 31.9 57.7 42.3 86.9 62.6 101.9 132.2 40.0 130.7 57.0 8.5 62.8 5.9 82.7 61.2 146.9 165.3 137.8 106.1 104.4 146.8 186.5 145.8 6.1 101.1 52.4 98.5 104.4 235.1 35.5 28.0 25.3 37.6 28.1 23.1 28.5 38.0 25.6 20.1 497.3 826.2 3505.8 4941.4 4796.5 207.9 239.4 1668.8 799.0 1510.5 567.0 68.7 3327.1 2528.3 1289.0 177.8 1494.7 980.5 513.9 2845.5 4591.2 2345.1 3300.9 883.5 1243.6 1940.9 103.3 1454.5 1261.4 1687.0 354.9 2330.6 2284.0 2282.6 2326.4 2431.8 212.5 2052.4 1855.2 1390.9 2230.9 177.0 756.7 2794.2 210.8 382.0 5789.4 3433.4 2382.6 3597.4 4457.4 RPL13 "BBC1, D16S444E, L13" ENSG00000167526 "Ribosomal protein L13" P26373 16 89560657-89566828 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051702 Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 53000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA051702: AB_2681579" "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (1.14e-2)" "prognostic favorable (6.26e-4)" "unprognostic (1.57e-2)" "unprognostic (3.68e-2)" "unprognostic (7.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.70e-1)" "unprognostic (1.44e-2)" "unprognostic (2.14e-1)" "unprognostic (7.57e-2)" "prognostic unfavorable (6.64e-4)" "unprognostic (4.34e-2)" "unprognostic (7.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" 82.5 56.0 46.7 105.0 38.4 112.7 150.9 37.7 44.0 114.5 114.9 31.3 76.9 65.5 118.4 85.4 144.0 98.4 101.6 85.2 38.6 32.1 60.8 118.3 90.4 385.1 38.8 37.4 231.3 255.8 36.5 57.5 66.0 27.0 136.2 44.4 43.0 267.3 87.6 197.4 137.7 66.7 90.2 44.8 104.7 71.1 106.5 24.6 135.0 102.4 129.6 98.6 109.3 156.8 277.8 163.1 26.9 96.9 120.7 299.0 355.4 67.5 75.1 53.4 86.5 96.1 160.2 111.9 42.7 92.6 89.3 36.3 113.4 104.8 95.0 88.2 72.4 35.5 94.0 63.4 112.3 44.6 26.6 176.0 32.3 41.9 150.3 205.8 39.2 39.5 194.0 239.4 57.2 144.3 145.7 93.0 120.4 98.7 54.2 68.5 211.6 107.4 308.2 109.2 133.6 79.9 160.2 56.6 133.5 108.4 56.8 75.3 110.2 59.1 77.3 128.1 35.2 152.0 233.4 54.2 57.7 62.3 50.8 58.5 82.2 77.2 96.9 75.3 138.7 60.5 26.9 96.9 15.3 129.1 74.9 239.2 252.5 234.3 176.5 116.8 277.8 299.0 230.2 10.7 120.7 56.7 163.1 163.7 355.4 46.7 38.4 37.7 44.0 38.6 32.1 38.8 37.4 27.0 24.6 1676.5 3076.1 8572.3 13242.6 11129.2 658.9 392.1 3263.7 1810.8 3433.9 1533.6 178.7 5497.3 3942.5 3304.0 3376.6 4985.3 2353.5 1588.5 9512.5 8594.0 5542.1 9230.0 2503.8 3991.9 4585.6 235.2 2827.6 3949.3 6200.5 9204.7 7634.3 6835.9 5176.0 5670.1 5289.2 713.9 6690.8 4380.2 3433.2 5399.2 577.3 2050.2 5882.2 1406.9 1082.9 14135.8 5156.1 7058.2 8155.8 12161.4 RPL13A "L13A, TSTA1" ENSG00000142541 "Ribosomal protein L13a" P40429 19 49487554-49492308 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038751 Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA038751: AB_10962004" "unprognostic (2.35e-3)" "unprognostic (2.15e-1)" "unprognostic (4.08e-2)" "unprognostic (2.02e-1)" "unprognostic (2.95e-3)" "unprognostic (2.55e-1)" "prognostic unfavorable (9.97e-4)" "unprognostic (1.21e-1)" "unprognostic (3.86e-2)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (7.81e-2)" "unprognostic (7.85e-2)" "unprognostic (3.22e-1)" "unprognostic (1.87e-1)" 85.4 87.0 45.7 114.3 46.9 132.5 106.4 38.9 41.2 103.8 145.5 38.8 89.2 84.1 129.4 80.7 117.7 83.5 119.9 112.5 37.2 31.2 65.4 113.9 71.8 265.3 41.5 37.0 203.8 334.9 21.8 54.2 76.7 44.1 114.3 46.8 65.4 169.0 95.4 216.0 122.9 77.0 121.1 44.2 121.4 87.8 54.5 27.8 124.0 119.8 147.0 115.0 112.7 196.5 284.6 144.9 40.5 81.3 148.0 268.3 354.3 120.1 147.8 70.3 205.2 134.2 212.6 83.8 105.2 130.3 75.9 82.4 125.3 92.4 304.9 84.7 78.6 31.8 79.7 87.6 152.2 45.0 85.4 206.5 153.9 96.2 178.5 163.5 231.1 122.4 245.8 254.2 53.8 182.8 168.6 122.3 107.9 132.5 115.1 87.3 104.5 161.5 234.8 135.9 114.9 133.0 157.1 160.5 132.9 103.1 204.3 120.6 158.6 54.9 244.9 232.4 58.8 108.0 266.7 150.6 95.8 103.4 59.4 138.5 116.5 157.9 137.6 59.9 158.5 87.8 40.5 81.3 20.7 132.2 70.3 194.3 284.6 226.2 180.3 126.7 264.8 268.3 212.3 13.6 148.0 60.4 144.9 165.3 354.3 45.7 46.9 38.9 41.2 37.2 31.2 41.5 37.0 44.1 27.8 1503.7 1729.8 9229.7 10612.9 10289.3 512.1 472.1 3870.0 2000.9 3534.0 1509.2 202.2 6720.7 4604.1 3662.2 243.1 4976.1 2426.8 1868.9 11119.9 8860.9 5735.6 8516.9 2404.2 3758.5 5124.9 208.2 3836.4 4121.8 6096.6 467.8 8451.2 6154.9 5402.0 6444.6 6340.8 679.2 7721.8 5811.0 4166.9 5142.4 507.0 2612.9 6508.5 432.4 584.7 12485.0 7026.2 7155.4 9081.3 10590.2 RPL18 L18 ENSG00000063177 "Ribosomal protein L18" Q07020 19 48615328-48619536 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "NB-4: 559.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046572 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 100000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA046572: AB_2679705" "unprognostic (2.12e-2)" "unprognostic (1.86e-2)" "unprognostic (7.30e-2)" "unprognostic (2.57e-2)" "unprognostic (3.48e-3)" "unprognostic (4.76e-2)" "unprognostic (3.21e-3)" "unprognostic (2.80e-1)" "unprognostic (2.39e-1)" "unprognostic (9.15e-2)" "unprognostic (6.15e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.40e-1)" "unprognostic (3.04e-2)" "unprognostic (6.36e-2)" "unprognostic (1.27e-2)" 56.2 57.3 50.3 79.1 40.8 122.4 84.9 35.2 51.1 89.8 76.6 44.8 60.8 66.1 100.6 56.1 129.6 78.2 99.2 43.4 38.3 33.1 56.4 101.9 62.1 194.1 40.3 27.0 206.5 260.5 19.8 57.1 74.8 26.8 100.5 39.6 54.6 136.7 62.3 78.8 108.6 60.5 69.1 39.7 88.7 64.0 45.8 28.6 114.9 115.8 116.5 122.2 91.2 90.5 137.1 84.5 19.0 57.5 71.1 144.1 148.6 58.3 91.0 33.5 58.2 34.2 67.5 49.0 26.8 44.7 55.7 46.9 82.1 54.3 85.4 28.2 25.6 21.1 48.4 30.4 61.0 21.2 36.4 105.9 30.9 42.6 78.4 69.2 43.0 48.3 79.5 89.5 29.8 40.2 40.8 54.7 62.6 43.6 75.3 34.9 74.1 67.6 559.5 53.4 76.1 45.4 70.8 27.0 77.4 45.0 72.2 47.7 62.1 24.2 85.4 81.0 16.2 48.0 83.8 31.2 41.3 45.9 25.6 61.5 62.6 72.9 50.9 26.0 66.4 48.6 19.0 57.5 12.2 65.7 47.6 115.3 130.3 116.4 88.1 79.2 137.1 144.1 113.9 8.6 71.1 37.3 84.5 89.6 148.6 50.3 40.8 35.2 51.1 38.3 33.1 40.3 27.0 26.8 28.6 550.9 838.5 3591.6 3815.8 3969.4 373.7 225.2 1370.7 546.0 953.2 671.7 135.5 3294.6 1175.5 1414.5 62.6 1818.4 1578.0 724.2 3930.9 4507.0 2016.4 3365.3 983.1 1161.9 1943.0 127.1 1609.4 1403.2 2086.4 135.2 3008.2 2285.6 2161.1 2417.6 2644.1 668.4 2833.8 2163.8 1372.2 1352.6 310.0 1015.4 2447.3 225.6 356.8 4859.7 3460.6 2407.5 3173.8 4275.2 RPL18A L18A ENSG00000105640 "Ribosomal protein L18a" Q02543 19 17859876-17864153 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 430.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055259 Approved Approved Nucleoli,Cytosol No No "Nucleoli, Cytosol" "HPA055259: AB_2682764" "unprognostic (3.40e-2)" "unprognostic (1.18e-1)" "unprognostic (1.66e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-2)" "unprognostic (1.09e-1)" "unprognostic (3.79e-3)" "unprognostic (6.46e-2)" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (6.71e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (5.44e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-2)" "unprognostic (1.36e-1)" 48.8 33.8 24.9 42.2 43.0 85.7 53.6 27.8 61.1 49.9 46.0 26.5 28.1 40.4 47.8 36.4 65.5 56.5 38.9 31.5 22.6 16.2 50.0 85.9 34.8 83.7 22.3 26.1 109.2 106.6 9.3 30.5 46.9 30.9 41.8 26.8 30.4 99.8 31.6 157.7 90.1 43.3 36.6 21.9 57.6 50.1 67.3 17.6 59.5 65.3 107.9 54.0 45.0 57.1 395.8 193.6 24.8 110.7 126.0 278.4 430.5 126.2 98.3 65.7 92.6 98.7 162.7 166.5 77.5 98.5 102.6 97.9 135.7 127.1 191.0 179.7 66.7 41.0 95.2 77.4 165.0 35.9 97.6 208.7 89.2 94.6 154.5 171.0 128.3 97.8 203.0 217.6 56.7 122.3 106.8 112.2 157.6 113.3 123.9 64.7 196.8 173.5 169.5 154.6 142.0 151.7 156.2 69.7 226.4 93.6 120.2 95.2 142.9 27.5 192.0 239.8 33.9 91.2 249.4 85.9 63.6 74.1 126.9 129.9 166.2 151.1 123.3 83.5 205.4 78.8 24.8 110.4 16.5 134.8 110.7 234.6 368.3 232.2 167.1 166.6 395.8 278.4 212.5 11.3 126.0 85.6 193.6 195.9 430.5 24.9 43.0 27.8 61.1 22.6 16.2 22.3 26.1 30.9 17.6 482.4 926.8 6413.8 4901.3 7713.4 240.4 390.4 1829.3 614.3 1162.5 875.9 119.8 4308.9 2022.7 2828.9 39.6 2919.7 1766.7 1097.9 7783.8 7254.8 3471.5 4168.2 1383.3 2046.3 2960.9 123.9 1772.7 2331.9 4202.4 100.2 3856.5 5199.5 4502.8 5216.5 3612.2 346.7 5814.1 2767.0 1530.2 2592.2 347.7 1235.3 4175.6 138.6 661.5 9733.7 3896.6 4323.4 4712.9 6201.7 RPL19 "DKFZp779D216, FLJ27452, L19, MGC71997" ENSG00000108298 "Ribosomal protein L19" P84098 17 39200283-39204727 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "SK-BR-3: 959.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043014, HPA051987" Approved Enhanced Nucleoli,Cytosol NA NA 100000 "Nucleoli, Cytosol" "HPA043014: AB_10965840, HPA051987: AB_2681682" "unprognostic (4.07e-3)" "unprognostic (1.33e-1)" "unprognostic (3.18e-1)" "unprognostic (4.46e-2)" "unprognostic (4.25e-2)" "unprognostic (6.40e-2)" "unprognostic (9.70e-3)" "unprognostic (1.50e-1)" "unprognostic (5.46e-1)" "unprognostic (1.16e-2)" "unprognostic (3.32e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.33e-1)" "unprognostic (2.20e-2)" "unprognostic (2.48e-2)" "unprognostic (8.60e-2)" 72.3 57.7 51.3 56.7 56.9 122.5 94.7 41.8 88.6 72.2 64.5 42.2 62.7 48.7 67.0 56.7 77.7 78.1 65.9 87.3 49.2 37.0 62.3 124.4 70.7 229.5 50.5 53.0 156.4 124.4 33.1 51.7 57.3 58.7 60.0 52.5 48.1 113.8 67.6 91.4 95.8 58.8 57.5 57.1 74.4 66.1 45.2 34.1 53.0 63.3 94.9 103.4 63.1 75.9 208.2 143.4 40.4 108.7 116.2 236.3 325.8 48.1 65.5 47.5 57.6 87.0 110.0 49.2 45.3 92.6 93.9 75.5 71.4 45.6 117.8 79.8 64.7 54.9 81.9 71.4 93.7 48.4 47.8 125.4 42.0 48.9 92.8 135.7 102.9 58.2 122.5 103.0 72.3 130.9 88.2 80.9 101.1 73.1 69.0 64.8 47.4 136.4 143.9 48.6 56.3 48.8 80.9 67.6 117.8 84.6 60.3 57.8 64.3 27.2 959.6 141.5 53.6 92.9 131.0 47.6 36.7 49.7 55.9 83.3 91.1 90.1 86.7 49.8 78.6 47.2 36.7 108.7 40.4 116.1 90.3 180.1 208.2 187.2 146.8 143.4 193.1 236.3 190.8 17.1 116.2 72.6 132.4 146.2 325.8 51.3 56.9 41.8 88.6 49.2 37.0 50.5 53.0 58.7 34.1 821.9 1155.8 5178.5 5153.7 4931.6 221.1 502.6 2265.0 995.7 1437.7 1080.0 88.4 3138.3 3070.4 2271.3 1107.8 2991.3 1604.9 1214.8 5434.8 4726.5 2858.0 4250.3 1510.1 1935.0 3620.1 125.5 1883.0 2240.5 3562.4 3346.4 3629.9 4014.1 3104.2 3202.1 2957.8 586.7 3801.6 2980.9 1917.8 3691.6 289.1 1506.9 3219.7 1098.4 764.8 5786.0 3261.3 3671.2 4220.8 5947.6 RPL22 "EAP, L22" ENSG00000116251 "Ribosomal protein L22" P35268 1 6181269-6209389 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068294 Approved Nucleoplasm,Nucleoli NA NA 320000 Nucleoli Nucleoplasm "HPA068294: AB_2732781" "unprognostic (3.16e-3)" "unprognostic (1.28e-1)" "unprognostic (3.13e-1)" "unprognostic (3.62e-2)" "unprognostic (2.27e-2)" "unprognostic (1.09e-1)" "unprognostic (1.29e-3)" "unprognostic (4.40e-2)" "unprognostic (7.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.48e-1)" "unprognostic (4.24e-2)" "unprognostic (1.46e-3)" "unprognostic (3.83e-1)" "unprognostic (3.88e-2)" "unprognostic (2.46e-1)" "unprognostic (1.98e-1)" 75.5 71.5 54.3 79.7 42.8 124.7 75.0 46.7 39.5 95.8 73.9 39.2 53.9 66.5 133.6 63.9 103.9 59.1 61.8 50.8 47.4 38.6 58.8 90.2 55.3 142.6 50.6 39.7 163.1 154.8 30.4 57.0 49.8 37.4 90.8 46.4 57.0 140.3 66.8 114.0 79.7 62.6 106.6 58.3 79.1 62.0 38.2 35.0 95.3 91.0 112.8 81.1 101.5 91.9 75.6 62.3 11.0 38.9 42.2 98.8 73.9 89.4 25.5 54.4 55.5 38.3 60.3 43.0 78.2 31.5 28.8 24.6 50.6 77.8 138.9 64.4 28.9 19.9 51.8 40.8 40.6 38.0 68.0 66.5 135.0 58.1 62.8 38.0 178.6 54.2 53.1 33.7 25.6 53.1 59.6 35.9 39.0 111.2 84.2 33.0 39.5 78.0 145.7 33.8 59.9 56.7 75.3 112.8 107.6 42.1 31.1 75.2 69.0 63.6 184.4 143.1 49.3 59.3 141.6 87.7 41.1 45.3 54.2 73.4 67.7 92.9 210.2 27.2 184.7 25.4 11.0 38.9 8.8 38.0 34.3 66.9 75.6 71.1 52.3 59.8 72.4 98.8 78.1 2.9 42.2 27.8 62.3 54.0 73.9 54.3 42.8 46.7 39.5 47.4 38.6 50.6 39.7 37.4 35.0 413.9 647.4 2117.2 1742.6 1617.7 195.0 241.8 1080.3 472.4 833.7 554.8 123.7 1561.4 1614.8 1042.5 368.7 1236.7 707.2 537.3 1569.0 2352.9 1052.3 1320.4 878.8 1234.2 1317.3 133.5 877.3 1218.4 1697.8 247.8 1877.2 1676.9 1020.7 1556.4 1647.3 322.2 1580.5 1090.7 1160.1 1724.2 283.7 763.2 1114.2 317.0 420.5 1692.2 1548.7 1448.0 2302.5 1714.3 RPL22L1 ENSG00000163584 "Ribosomal protein L22 like 1" Q6P5R6 3 170864875-170870483 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 101.9" "Low region specificity" "Detected in all" "HPA048060, HPA056207, HPA068294" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA048060: AB_2732544, HPA056207: AB_2683065, HPA068294: AB_2732781" "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.59e-1)" "unprognostic (1.45e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-3)" "unprognostic (1.01e-2)" "unprognostic (9.50e-2)" "unprognostic (1.97e-1)" "prognostic favorable (8.60e-5)" "unprognostic (1.17e-3)" "unprognostic (4.52e-2)" "prognostic unfavorable (5.13e-12)" "unprognostic (5.12e-2)" "unprognostic (3.55e-1)" "unprognostic (1.23e-1)" "unprognostic (6.96e-2)" 17.2 14.6 8.9 28.1 9.5 36.0 21.5 6.0 9.3 14.3 15.7 5.3 6.6 8.4 12.2 12.3 33.6 15.3 11.8 11.3 7.4 8.5 11.4 64.3 18.8 31.4 10.1 5.7 18.6 71.6 1.9 12.1 10.5 10.7 14.7 15.7 6.4 15.7 14.0 17.7 19.4 13.7 12.2 11.5 37.5 17.4 9.7 8.9 17.9 15.2 32.5 27.8 18.9 15.9 24.1 24.2 1.9 7.6 13.1 13.8 3.5 15.8 17.9 5.8 67.6 17.3 101.9 17.8 16.1 37.2 13.1 8.5 7.6 3.7 49.0 3.7 15.0 41.1 4.1 14.4 41.1 7.3 2.9 2.6 4.4 2.2 17.1 70.0 9.0 6.5 74.0 84.0 4.1 44.6 20.5 44.5 27.2 3.1 3.1 71.8 20.1 65.7 5.1 90.9 6.1 3.2 88.2 2.1 7.5 32.5 35.3 0.9 4.9 1.6 8.1 7.0 3.3 11.3 8.0 20.6 2.5 19.3 5.0 22.4 5.0 3.5 7.8 45.9 5.5 52.1 1.0 4.8 1.9 6.8 5.7 13.8 24.1 10.0 9.0 5.1 17.9 6.7 7.4 1.0 13.1 7.6 24.2 6.3 3.5 8.9 9.5 6.0 8.1 7.4 8.5 10.1 5.7 10.7 8.9 8.9 36.6 274.9 201.6 175.5 13.0 14.5 53.5 57.6 92.1 19.2 3.9 84.0 56.3 132.5 30.8 89.5 76.2 23.3 199.7 252.2 105.2 161.6 105.0 90.9 170.2 7.9 138.8 87.8 140.5 29.1 129.2 89.6 74.2 57.7 130.6 34.1 350.4 115.2 83.8 69.0 18.4 45.3 94.8 47.6 26.2 216.6 82.3 126.9 150.6 274.6 RPL26 L26 ENSG00000161970 "Ribosomal protein L26" P61254 17 8377516-8383250 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 586.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030449, CAB037301" Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "CAB037301: AB_796168, HPA030449: AB_10602125" "unprognostic (2.02e-2)" "unprognostic (3.73e-1)" "unprognostic (2.12e-1)" "unprognostic (2.76e-1)" "unprognostic (6.82e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-1)" "unprognostic (3.95e-1)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (1.12e-1)" "unprognostic (7.15e-2)" "unprognostic (1.96e-3)" "unprognostic (2.73e-1)" "unprognostic (1.08e-1)" "unprognostic (5.44e-2)" "unprognostic (2.38e-1)" 122.5 64.5 70.2 102.5 49.8 132.2 170.4 44.4 52.4 127.6 131.6 34.8 68.1 53.1 76.4 97.0 161.2 87.6 98.6 68.1 54.8 42.5 100.6 138.3 97.5 117.5 61.6 32.6 183.0 586.0 32.2 41.1 82.2 47.7 129.0 84.0 41.5 95.3 87.4 170.8 106.3 98.6 103.6 62.9 129.0 75.9 53.0 45.1 104.9 131.6 145.8 107.9 154.7 127.6 154.9 120.8 25.1 92.1 93.0 158.2 165.0 103.5 95.3 93.8 111.0 177.2 291.8 91.7 90.0 133.9 122.3 92.4 100.7 53.4 181.0 103.5 106.6 50.0 115.1 119.2 184.4 144.0 67.6 214.8 70.6 105.2 116.1 207.2 104.9 91.7 248.7 369.2 101.2 304.3 172.0 150.5 104.1 79.9 54.6 128.4 71.3 115.6 143.5 88.1 108.9 63.3 115.5 95.3 112.6 164.3 77.9 39.0 83.3 48.5 90.6 208.1 86.7 92.7 140.5 94.3 49.5 61.8 68.2 157.5 43.9 51.2 79.1 81.0 149.3 73.3 25.1 92.1 18.2 89.9 78.3 130.5 154.9 134.3 116.8 120.8 140.1 158.2 136.0 10.9 93.0 69.5 104.5 111.3 165.0 70.2 49.8 44.4 52.4 54.8 42.5 61.6 32.6 47.7 45.1 833.7 960.0 5357.4 2721.4 4954.5 234.8 252.2 2797.5 959.6 1909.7 952.6 125.7 3974.4 3344.0 2212.2 695.5 2535.1 1389.0 1425.0 4263.0 6092.8 2980.6 2437.9 1777.7 2307.8 2989.4 128.7 2198.5 2802.7 4762.9 1400.7 4423.2 3635.2 3033.3 3719.6 3654.9 300.8 3633.9 3236.9 2028.4 4497.4 340.9 1487.5 2382.4 569.4 578.1 6200.9 3820.5 3284.3 5356.2 2887.4 RPL26L1 RPL26P1 ENSG00000037241 "Ribosomal protein L26 like 1" Q9UNX3 5 172958729-172969771 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.6" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 286.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030449 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA030449: AB_10602125" "unprognostic (3.02e-1)" "unprognostic (1.41e-1)" "unprognostic (3.39e-2)" "unprognostic (4.12e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (2.04e-3)" "unprognostic (2.45e-1)" "unprognostic (7.51e-2)" "unprognostic (5.86e-3)" "unprognostic (3.18e-1)" "unprognostic (1.06e-1)" "unprognostic (7.17e-2)" "unprognostic (2.55e-1)" "unprognostic (1.90e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-3)" 11.2 23.0 17.9 14.7 17.9 18.0 15.2 10.5 21.1 13.1 12.8 8.2 14.4 13.5 14.5 21.6 18.1 14.7 11.9 19.5 20.7 16.8 20.0 25.9 10.5 16.7 16.2 18.0 14.1 25.5 9.1 15.4 14.2 16.3 12.1 14.6 11.5 18.4 16.7 19.0 9.7 10.8 14.0 12.8 13.3 12.2 73.6 11.8 20.0 16.2 18.2 14.9 13.1 11.9 19.7 40.0 17.5 36.2 14.6 21.7 20.9 29.6 26.9 24.4 33.5 16.9 17.9 31.6 28.4 16.7 41.1 36.7 32.8 32.0 22.3 73.0 38.9 43.8 19.3 40.2 56.3 38.0 28.5 52.3 16.5 31.5 40.1 33.2 24.0 14.7 22.3 23.8 42.3 29.7 16.7 23.5 22.0 22.6 18.8 29.2 65.8 29.3 38.0 15.5 13.8 42.8 21.4 37.8 29.6 23.9 18.7 24.6 15.1 26.0 23.9 37.7 16.3 29.3 25.9 24.7 47.0 26.1 27.4 21.2 16.9 26.3 41.8 37.0 30.2 27.8 7.8 36.2 15.5 14.3 31.4 18.3 19.7 17.4 19.6 40.0 15.1 14.5 18.4 17.5 14.6 26.8 27.5 21.7 20.9 17.9 17.9 10.5 21.1 20.7 16.8 16.2 18.0 16.3 11.8 38.7 26.2 23.1 45.5 43.4 14.3 38.4 50.9 62.9 35.2 55.8 17.7 94.5 154.2 102.8 286.5 45.0 32.9 93.5 97.7 103.7 39.0 47.6 25.5 104.6 100.3 14.3 38.7 41.7 51.6 40.1 35.1 50.7 49.0 97.4 42.9 42.9 113.2 38.6 38.5 146.6 13.9 19.4 39.1 214.9 161.4 46.2 66.0 27.7 55.4 43.0 RPL27 L27 ENSG00000131469 "Ribosomal protein L27" P61353 17 42998273-43002959 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes, Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002649 Approved Enhanced Nucleoplasm,Nucleoli NA NA 30000 Nucleoli Nucleoplasm "HPA002649: AB_1079840" "unprognostic (8.53e-3)" "unprognostic (7.15e-2)" "unprognostic (3.97e-2)" "unprognostic (2.81e-2)" "unprognostic (4.99e-2)" "unprognostic (4.31e-2)" "unprognostic (1.91e-3)" "unprognostic (7.32e-2)" "unprognostic (9.17e-2)" "unprognostic (1.19e-1)" "unprognostic (5.12e-2)" "unprognostic (3.86e-1)" "prognostic unfavorable (7.80e-8)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "unprognostic (2.70e-1)" "unprognostic (1.14e-1)" 78.4 66.9 61.7 82.2 45.7 150.0 148.7 63.1 82.7 75.1 76.8 27.2 65.4 48.8 74.8 80.1 91.9 64.9 80.8 120.6 46.2 38.5 76.2 121.7 109.5 222.2 49.2 49.0 123.7 185.0 17.2 44.1 81.0 48.3 65.3 55.0 43.8 119.1 78.5 127.5 113.8 61.9 82.4 43.6 84.4 69.7 40.3 28.8 72.6 70.5 153.8 78.5 86.1 80.9 178.5 152.7 44.2 99.0 111.4 184.7 216.0 114.1 144.8 88.7 128.4 157.1 233.0 143.3 133.0 109.3 143.0 102.6 205.0 89.9 216.5 113.2 104.6 77.6 100.2 101.6 169.8 137.6 100.2 241.7 85.0 121.4 216.7 193.9 244.1 89.5 219.6 145.5 96.5 123.8 146.7 118.5 114.9 158.0 134.0 132.0 111.6 203.2 206.9 134.3 132.4 92.7 142.6 249.8 244.5 120.8 154.3 99.8 110.2 52.2 103.0 211.8 125.8 173.2 258.0 133.7 106.6 105.6 130.2 195.6 117.1 188.5 211.9 95.8 151.7 108.6 44.2 99.0 29.5 106.6 87.9 150.2 178.5 159.0 124.5 118.6 168.3 184.7 159.1 20.4 111.4 67.3 152.7 112.5 216.0 61.7 45.7 63.1 82.7 46.2 38.5 49.2 49.0 48.3 28.8 681.9 960.2 2744.7 1731.4 2247.5 123.8 670.7 1245.8 627.7 1104.4 492.0 84.4 1811.7 1268.3 1382.3 339.9 1526.1 906.3 700.8 2626.7 2977.9 1476.5 1638.9 947.9 1517.2 1848.2 62.0 876.6 1298.9 2145.4 659.2 2254.1 2398.0 1353.0 2460.8 1687.2 280.7 2397.9 1157.3 1202.8 1660.9 156.7 853.7 1593.4 457.6 394.4 2946.9 1827.2 1797.0 2037.9 2132.8 RPL29 "HIP, HUMRPL29, L29, RPL29P10" ENSG00000162244 "Ribosomal protein L29" P47914 3 51993600-51995942 "Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 434.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA069064 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA069064: AB_2686077" "unprognostic (3.77e-3)" "unprognostic (2.72e-1)" "unprognostic (2.18e-1)" "unprognostic (2.32e-3)" "unprognostic (2.89e-3)" "unprognostic (5.46e-2)" "unprognostic (6.79e-3)" "unprognostic (1.79e-1)" "unprognostic (2.16e-1)" "unprognostic (5.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (9.99e-2)" "unprognostic (6.25e-2)" "unprognostic (7.56e-2)" 91.6 61.7 42.5 64.6 33.0 110.2 111.0 30.1 39.7 102.4 98.1 30.3 57.1 53.6 59.6 72.8 124.7 76.0 68.7 72.1 33.8 26.0 55.7 122.9 64.8 219.4 36.0 26.0 150.1 434.1 16.3 34.3 50.7 26.3 91.1 41.2 38.9 103.7 54.8 160.8 102.5 73.8 80.2 38.1 83.9 59.7 58.7 25.2 85.9 83.3 123.3 92.4 88.5 87.1 137.9 98.1 32.8 80.0 74.8 132.2 202.9 69.9 91.0 70.2 107.0 125.2 196.8 99.0 78.3 96.8 107.6 89.5 108.3 107.5 195.7 34.1 79.5 65.9 63.7 101.2 166.6 51.5 79.6 137.7 101.3 117.7 180.6 148.5 146.9 97.8 240.5 236.9 79.3 141.3 123.3 120.4 87.9 79.0 150.3 79.2 159.8 127.5 191.1 116.5 106.6 154.5 59.3 77.3 189.8 137.5 146.3 56.8 110.8 58.5 135.2 133.7 46.8 101.2 251.4 104.3 60.4 81.1 93.1 116.7 98.1 139.0 139.2 79.9 176.2 79.8 32.8 80.0 22.6 68.8 61.7 115.0 137.9 112.2 87.6 98.1 128.2 132.2 109.9 10.8 74.8 48.4 82.8 100.8 202.9 42.5 33.0 30.1 39.7 33.8 26.0 36.0 26.0 26.3 25.2 175.7 330.0 3392.7 4367.8 3531.6 218.0 72.2 1398.7 310.5 437.9 675.2 96.2 2332.5 1848.6 1477.5 867.6 2040.8 1839.8 957.8 3975.0 4390.8 2112.5 3132.4 683.0 1270.4 2074.0 101.7 1376.0 1509.4 2270.2 3389.8 3344.0 2646.2 2103.8 1980.2 2585.2 359.2 2990.7 2489.9 1488.6 2639.2 288.1 1125.4 2454.4 526.4 450.8 4436.8 2053.3 2519.7 3632.3 5133.1 RPL3 L3 ENSG00000100316 "Ribosomal protein L3" P39023 22 39312882-39320389 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003365, HPA055361" Uncertain Supported Nucleoli,Cytosol NA NA 120000 "Nucleoli, Cytosol" "HPA003365: AB_1079841, HPA055361: AB_2732594" "unprognostic (9.79e-3)" "unprognostic (2.06e-1)" "unprognostic (2.31e-1)" "unprognostic (1.68e-3)" "unprognostic (5.44e-3)" "unprognostic (1.72e-1)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (3.63e-1)" "unprognostic (5.81e-2)" "unprognostic (5.87e-2)" "unprognostic (7.09e-2)" "unprognostic (2.54e-2)" "unprognostic (1.85e-1)" "unprognostic (6.09e-2)" "unprognostic (2.72e-1)" "unprognostic (4.32e-2)" 71.7 71.8 51.3 72.3 50.3 107.0 134.5 50.8 49.3 102.2 94.4 42.7 78.1 63.1 207.5 79.6 126.9 101.6 96.2 54.5 41.4 38.8 66.6 102.5 74.5 205.9 47.4 57.7 217.8 453.1 50.9 75.0 74.5 58.0 138.7 57.0 74.8 216.3 68.5 48.9 118.1 62.6 115.6 50.7 84.3 74.4 76.4 23.3 105.5 158.5 82.3 109.8 119.9 105.7 198.9 114.8 18.9 56.4 150.3 249.0 326.4 87.2 80.8 92.5 102.2 118.4 256.8 124.7 67.7 128.8 67.7 60.9 101.6 66.7 361.2 93.8 81.4 40.8 58.2 98.7 144.7 45.1 61.4 97.2 90.9 96.7 151.9 174.9 129.1 76.7 248.1 196.1 58.5 208.7 177.2 131.6 96.4 102.3 125.6 97.9 112.4 131.1 188.1 96.8 92.9 56.4 105.3 89.8 181.3 125.1 129.4 84.7 100.1 42.5 139.0 221.5 61.4 104.7 210.6 130.4 45.5 72.0 47.7 77.0 96.5 72.9 159.9 102.6 114.2 51.4 18.9 56.4 11.9 132.5 51.7 205.6 198.9 192.1 153.7 101.2 175.8 249.0 195.2 8.1 150.3 44.5 114.8 126.1 326.4 51.3 50.3 50.8 49.3 41.4 38.8 47.4 57.7 58.0 23.3 914.2 2163.5 5410.7 7867.8 9248.8 998.0 126.1 2876.4 1092.1 2307.8 1367.8 400.5 4667.0 4993.6 2515.3 1583.9 3488.3 1382.2 934.5 5706.5 6677.9 4026.4 5687.6 1692.6 1824.7 2890.1 338.5 2624.6 2557.1 2528.9 3527.0 5167.6 3086.7 4841.9 3599.8 3269.3 905.4 3905.0 2588.2 3289.3 3749.1 924.0 1552.2 5807.1 1006.7 702.5 10743.1 4590.8 4458.7 5068.7 8140.4 RPL34 L34 ENSG00000109475 "Ribosomal protein L34" P49207 4 108620566-108630412 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 400.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035139 Uncertain Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA035139: AB_10602925" "unprognostic (1.49e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-2)" "prognostic favorable (2.76e-5)" "unprognostic (2.45e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (8.22e-2)" "unprognostic (7.14e-2)" "unprognostic (2.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (3.72e-3)" "unprognostic (6.17e-2)" "unprognostic (8.96e-3)" "unprognostic (2.71e-1)" "unprognostic (1.19e-2)" 68.5 52.6 65.9 77.6 63.7 118.0 165.2 43.7 52.9 82.0 70.1 25.5 57.5 47.3 106.0 111.1 76.4 75.2 61.9 59.2 53.7 41.4 60.2 98.4 56.1 110.1 54.6 49.7 157.4 305.1 17.8 68.3 63.8 59.0 74.3 61.0 35.2 129.9 60.2 87.1 77.6 57.6 87.5 57.5 70.8 60.3 43.2 32.2 63.3 82.2 109.5 95.4 67.6 102.3 300.5 153.8 56.2 116.4 134.2 331.0 400.6 59.2 43.3 78.7 111.9 170.9 270.5 77.5 91.6 116.4 75.6 63.3 109.7 105.5 180.4 55.2 89.0 37.8 42.3 84.6 142.9 99.3 66.5 135.5 75.3 91.0 167.9 143.9 188.8 84.4 240.5 204.2 61.7 140.4 146.0 135.9 100.8 131.9 103.6 124.5 115.1 115.6 230.6 90.3 132.9 87.7 106.2 84.6 109.2 157.8 100.0 84.5 108.2 37.4 218.5 128.3 65.5 72.6 172.7 100.3 51.9 70.4 54.2 80.9 77.4 100.9 145.4 70.7 118.0 63.4 56.2 116.4 35.6 122.0 86.8 207.8 300.5 247.8 165.5 121.2 257.1 331.0 244.9 24.9 134.2 74.9 153.8 176.2 400.6 65.9 63.7 43.7 52.9 53.7 41.4 54.6 49.7 59.0 32.2 1313.2 2435.5 8127.2 9688.6 11162.7 321.1 1043.1 4914.6 1694.4 3137.0 2053.6 70.7 5336.7 5859.0 3087.8 1166.8 4211.1 1851.3 2850.1 7573.3 5633.2 3960.7 4740.0 3107.4 4896.8 3604.2 146.2 2618.2 5127.8 6804.9 1575.7 6923.4 6371.5 5538.7 4548.4 5463.9 625.8 5524.0 4699.4 3790.7 6994.4 382.0 1882.0 3701.7 706.0 481.2 13381.8 5336.0 5116.7 7038.7 7765.2 RPL4 L4 ENSG00000174444 "Ribosomal protein L4" P36578 15 66498015-66524532 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034600 Uncertain Supported "Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol" Yes No 830000 "Endoplasmic reticulum, Cytosol" "Nucleoli, Nuclear bodies" "HPA034600: AB_10601483" "unprognostic (1.51e-2)" "unprognostic (3.77e-1)" "unprognostic (6.02e-2)" "unprognostic (3.68e-2)" "unprognostic (6.23e-3)" "unprognostic (1.03e-1)" "unprognostic (1.90e-2)" "unprognostic (3.20e-2)" "unprognostic (3.73e-1)" "unprognostic (2.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.20e-5)" "unprognostic (1.27e-1)" "unprognostic (5.60e-2)" "unprognostic (4.63e-2)" "unprognostic (2.27e-1)" 63.6 33.4 37.0 59.0 40.4 70.6 88.2 34.5 42.2 73.6 60.5 33.5 42.3 18.8 67.3 49.8 81.3 65.7 39.4 38.8 31.7 26.4 53.2 84.5 46.1 103.9 35.1 26.3 139.1 159.9 33.1 42.0 52.0 34.1 67.6 50.9 35.9 66.2 51.0 87.2 77.1 36.4 67.3 47.9 60.3 46.3 42.8 20.0 81.3 66.1 91.7 102.8 74.2 55.9 72.5 58.7 5.9 40.9 45.0 97.0 135.7 45.1 91.1 38.6 64.9 173.7 316.0 68.1 55.1 113.9 85.4 66.3 100.7 79.3 178.9 62.9 131.3 40.4 82.2 275.6 213.2 94.6 49.4 165.2 109.6 81.7 83.7 244.9 114.8 54.9 310.0 278.0 92.8 371.0 105.2 136.6 84.9 100.3 70.4 127.7 74.5 76.4 51.1 84.4 100.9 65.3 85.8 88.0 173.6 117.4 89.7 68.6 71.7 34.0 96.8 136.2 84.5 71.5 166.0 80.0 44.7 67.5 41.5 87.6 69.2 107.3 119.6 55.0 154.6 50.2 3.5 40.9 5.9 38.2 36.2 71.1 72.5 74.6 53.7 58.7 60.5 97.0 75.7 2.7 45.0 33.5 37.4 57.0 135.7 37.0 40.4 34.5 42.2 31.7 26.4 35.1 26.3 34.1 20.0 419.9 882.0 1803.2 2287.0 2152.7 118.6 357.6 588.5 738.8 1063.5 324.5 76.6 1844.2 1399.3 929.4 510.9 791.2 291.1 327.1 1855.6 3103.9 1180.5 1227.4 901.9 616.8 1082.4 38.1 731.3 578.2 1045.6 1022.7 1235.2 1320.8 1032.5 1779.1 995.5 130.7 1271.8 480.5 936.2 1212.4 111.6 452.7 1291.3 308.9 412.0 2258.1 2005.7 1400.6 1218.5 2270.0 RPL5 "L5, PPP1R135" ENSG00000122406 "Ribosomal protein L5" P46777 1 92831983-92841924 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Cancer-related genes, Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043717, HPA054444" Approved Supported "Nucleoli,Nucleoli rim,Endoplasmic reticulum,Cytosol" NA NA 130000 "Endoplasmic reticulum, Cytosol" "Nucleoli, Nucleoli rim" "HPA043717: AB_10964719, HPA054444: AB_2732584" "unprognostic (5.81e-3)" "unprognostic (3.96e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (9.44e-3)" "unprognostic (1.96e-1)" "unprognostic (1.03e-3)" "unprognostic (9.95e-2)" "unprognostic (8.68e-2)" "unprognostic (1.23e-1)" "unprognostic (3.98e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (6.81e-5)" "unprognostic (2.26e-2)" "unprognostic (3.12e-2)" "unprognostic (1.09e-1)" "unprognostic (3.97e-1)" 119.4 80.3 50.0 70.0 50.1 113.8 140.5 46.9 46.8 158.6 111.4 45.0 75.1 61.7 135.2 114.6 159.4 100.5 73.1 73.0 43.5 43.1 99.7 114.9 89.9 148.2 54.5 36.2 296.8 306.5 40.8 90.3 90.2 44.3 175.4 78.8 64.3 121.5 73.2 109.1 97.8 95.3 153.4 61.9 130.1 90.0 68.8 45.7 156.6 210.0 97.7 118.9 191.2 146.6 104.5 85.2 12.8 45.9 72.4 143.0 142.1 118.8 51.1 91.0 76.7 118.4 239.2 146.0 71.1 95.2 88.5 63.5 135.2 52.0 224.2 114.2 79.8 84.0 76.0 104.3 133.2 113.2 71.0 142.8 116.3 85.0 124.4 142.0 178.1 49.1 195.6 210.2 78.6 173.1 160.6 122.3 118.5 144.0 118.2 101.4 67.4 141.8 201.9 140.6 90.4 96.5 130.3 176.3 144.8 107.4 99.0 77.6 92.9 46.3 129.2 206.7 78.2 71.2 245.0 74.2 44.7 81.8 84.6 128.1 73.2 69.5 151.7 30.3 153.6 30.3 12.8 45.9 7.2 60.9 44.8 122.1 104.5 111.5 91.6 85.2 88.4 143.0 123.9 4.4 72.4 38.3 71.1 83.2 142.1 50.0 50.1 46.9 46.8 43.5 43.1 54.5 36.2 44.3 45.7 607.4 848.7 2690.4 3540.6 2525.4 316.8 352.2 1200.0 674.6 1189.7 390.8 84.4 2237.8 1689.4 1278.7 1159.8 1643.6 564.1 537.3 2338.5 3530.6 1572.9 2535.7 1002.7 856.3 1297.7 138.2 1189.1 1198.2 1468.3 888.7 2620.2 1565.9 1334.5 1646.5 1585.6 343.0 1936.2 1164.3 2027.0 1766.3 226.7 1034.8 1885.9 531.9 457.4 2528.9 2185.2 1965.9 2487.8 3230.9 RPL7 "humL7-1, L7" ENSG00000147604 "Ribosomal protein L7" P18124 8 73290267-73295789 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 536.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 638.4" HPA058373 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 170000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA058373: AB_2683694" "unprognostic (3.75e-1)" "unprognostic (3.60e-2)" "unprognostic (6.99e-2)" "unprognostic (1.80e-1)" "unprognostic (2.37e-2)" "unprognostic (7.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.41e-2)" "unprognostic (8.31e-2)" "unprognostic (4.78e-2)" "unprognostic (1.76e-1)" "unprognostic (3.09e-1)" "unprognostic (1.63e-2)" "unprognostic (9.89e-2)" "unprognostic (5.52e-2)" "unprognostic (3.14e-1)" "unprognostic (2.31e-1)" 54.7 36.5 54.6 37.9 49.3 67.6 86.9 55.9 54.1 57.5 46.2 36.4 41.0 33.6 54.9 50.6 59.5 50.6 26.5 36.7 32.1 22.0 46.4 67.6 40.3 53.3 55.9 20.5 125.8 87.5 22.9 67.7 33.4 55.0 43.6 44.9 44.1 51.8 36.6 61.9 72.7 37.0 49.5 46.9 46.5 51.2 135.1 54.9 33.7 42.6 69.0 66.6 50.8 58.5 338.1 231.5 66.1 171.7 205.0 464.0 536.3 99.7 72.5 78.0 93.8 159.2 204.1 76.7 109.7 88.2 75.0 59.2 87.2 104.6 296.9 89.8 88.4 51.2 95.8 102.9 140.1 117.1 79.8 85.4 162.5 94.9 89.7 95.7 114.5 83.4 191.0 165.6 69.4 217.2 138.4 121.5 100.9 144.9 112.7 106.4 84.7 181.7 175.2 90.9 182.4 78.0 122.9 89.3 115.7 116.9 100.1 108.0 78.7 51.5 638.4 153.6 67.0 161.3 150.6 114.0 57.7 88.3 73.3 101.3 65.2 92.3 191.6 60.3 142.3 94.7 66.1 171.7 41.1 179.1 138.9 322.3 338.1 314.4 232.5 231.5 282.6 464.0 327.0 22.3 205.0 118.6 192.4 237.0 536.3 54.6 49.3 55.9 54.1 32.1 22.0 55.9 20.5 55.0 54.9 759.3 1377.6 4083.1 8227.6 7155.0 251.0 580.3 2023.0 1007.8 1723.2 1244.0 117.8 3979.6 4725.1 2246.6 1393.0 2953.4 897.4 1004.5 4388.5 6073.2 3431.1 4195.6 1418.7 1830.9 2853.5 89.0 1556.2 2090.7 3232.1 609.0 3931.9 3610.7 3514.2 2982.9 2652.3 679.5 3206.0 2051.6 2172.0 4500.4 280.8 1435.8 4545.3 828.4 372.8 8292.9 4080.0 3000.7 4416.0 6170.5 RPL7A "L7A, SURF3, TRUP" ENSG00000148303 "Ribosomal protein L7a" P62424 9 133348214-133351426 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046794 Approved Nucleoli,Vesicles NA NA 160000 Nucleoli Vesicles "HPA046794: AB_2732534" "unprognostic (5.01e-2)" "unprognostic (1.49e-1)" "unprognostic (8.83e-3)" "unprognostic (1.07e-3)" "unprognostic (4.17e-3)" "unprognostic (7.95e-2)" "prognostic unfavorable (8.99e-4)" "unprognostic (1.98e-1)" "unprognostic (8.88e-2)" "prognostic unfavorable (3.60e-5)" "unprognostic (4.91e-2)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (4.09e-2)" "unprognostic (4.06e-2)" "unprognostic (1.92e-2)" "unprognostic (9.89e-2)" 58.8 72.8 34.9 64.0 39.6 78.6 96.3 33.1 43.2 70.1 66.6 27.6 66.9 38.9 137.4 81.5 96.0 94.8 74.4 48.2 29.5 25.7 51.0 59.3 48.1 159.6 32.7 45.2 164.9 193.1 29.1 50.6 42.4 34.1 90.1 67.6 47.3 204.8 70.0 85.2 91.9 48.6 91.0 35.5 68.1 61.4 78.2 24.0 80.5 77.9 70.1 93.2 75.1 109.7 79.7 56.4 12.1 35.8 50.2 80.4 94.0 44.6 68.0 77.7 77.3 136.7 227.0 74.2 56.3 115.3 101.6 56.7 103.3 58.9 140.1 34.8 98.1 54.9 109.5 114.8 135.3 82.0 59.4 65.0 49.3 101.1 100.4 90.7 116.6 58.4 228.3 202.5 73.4 127.5 165.7 128.9 98.9 94.2 73.9 116.6 151.6 90.4 122.1 84.4 200.3 67.1 79.6 97.5 178.2 130.8 57.2 73.0 64.5 46.1 118.7 71.9 67.4 129.4 123.6 70.3 67.1 48.3 60.3 66.7 28.9 57.5 86.1 52.4 81.5 52.1 12.1 35.8 7.7 52.2 33.6 77.3 79.7 71.2 64.3 56.4 71.8 80.4 73.5 5.5 50.2 29.3 56.1 54.6 94.0 34.9 39.6 33.1 43.2 29.5 25.7 32.7 45.2 34.1 24.0 482.4 687.0 2813.3 3757.7 2882.1 278.7 355.9 1538.8 477.8 915.6 567.0 135.5 3181.9 1798.9 1584.8 1644.9 1944.8 1276.3 864.3 3823.0 4356.2 1751.6 3047.6 827.3 1030.7 2186.7 123.9 1445.6 1391.5 1793.3 3226.4 3459.6 1682.6 1434.0 2247.1 2534.7 429.4 2742.5 1749.9 1813.9 2011.8 362.0 950.7 1790.0 984.2 735.4 3479.5 2766.0 1939.0 3532.0 4275.0 RPL7L1 dJ475N16.4 ENSG00000146223 "Ribosomal protein L7 like 1" Q6DKI1 6 42879618-42889925 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046049, HPA050478" Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA046049: AB_10964167, HPA050478: AB_2681138" "unprognostic (1.03e-3)" "unprognostic (4.37e-2)" "unprognostic (3.37e-1)" "unprognostic (7.97e-2)" "unprognostic (7.73e-3)" "unprognostic (4.26e-2)" "prognostic unfavorable (8.53e-5)" "unprognostic (2.56e-1)" "unprognostic (2.98e-2)" "unprognostic (3.78e-2)" "unprognostic (2.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.94e-2)" "unprognostic (7.53e-2)" "unprognostic (1.06e-1)" "unprognostic (7.31e-3)" "unprognostic (4.58e-2)" 17.5 22.1 19.9 14.4 27.5 9.0 19.9 20.5 35.9 14.8 14.2 16.9 16.4 11.9 15.7 17.4 18.9 17.2 10.2 14.4 17.6 16.5 18.8 23.5 11.9 16.5 14.9 20.4 17.4 16.9 22.9 22.4 15.1 17.9 17.0 17.0 13.2 17.4 14.4 19.9 16.3 12.8 16.5 13.9 15.4 13.7 33.0 14.5 25.1 17.8 15.6 20.3 13.7 13.3 15.4 12.5 10.2 13.6 16.4 18.6 10.6 31.3 10.0 17.8 28.5 16.8 21.7 12.1 25.1 18.3 24.4 20.2 24.8 12.0 47.2 22.8 21.1 19.9 15.1 40.4 30.6 40.6 24.7 30.4 25.1 14.1 22.4 18.5 38.7 19.5 22.2 23.5 32.0 31.0 16.6 23.9 20.9 48.5 16.3 22.2 23.1 22.0 25.2 17.9 96.5 14.8 25.3 20.0 29.9 19.0 19.9 34.1 20.8 21.5 16.5 26.4 14.7 22.1 37.5 22.8 23.7 19.8 18.7 43.3 20.6 32.1 71.8 13.2 36.8 24.6 5.6 11.4 10.2 14.9 13.6 18.6 13.3 14.6 15.5 10.8 15.4 15.5 14.9 2.6 16.4 11.9 12.5 12.0 10.6 19.9 27.5 20.5 35.9 17.6 16.5 14.9 20.4 17.9 14.5 71.5 90.2 79.6 70.6 50.7 62.2 36.8 43.3 96.4 85.3 40.1 31.4 75.2 72.9 77.0 9.5 60.8 22.6 93.5 57.9 63.9 52.5 52.0 48.7 57.8 46.3 68.3 90.5 48.5 37.5 8.6 73.4 44.1 28.7 74.9 39.6 69.6 70.8 31.6 67.1 57.2 58.0 51.8 56.9 40.4 84.8 52.7 66.9 64.5 43.4 52.0 RPL8 L8 ENSG00000161016 "Ribosomal protein L8" P62917 8 144789765-144792587 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 323.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045095, HPA050165" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 240000000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA045095: AB_2679213, HPA050165: AB_2681038" "unprognostic (2.52e-2)" "unprognostic (2.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (9.84e-2)" "prognostic unfavorable (7.22e-4)" "unprognostic (4.48e-2)" "unprognostic (1.41e-1)" "unprognostic (1.54e-1)" "unprognostic (9.28e-2)" "unprognostic (1.92e-1)" "unprognostic (1.19e-3)" "unprognostic (1.79e-2)" "unprognostic (1.77e-1)" "unprognostic (2.31e-1)" "unprognostic (4.13e-2)" 65.9 45.5 32.1 53.7 34.7 120.1 115.2 31.0 61.9 63.9 78.4 26.4 51.1 95.2 106.4 57.1 76.0 51.2 68.9 78.7 27.2 23.6 48.2 62.6 54.5 169.4 29.0 28.8 125.7 349.6 11.8 45.2 38.4 28.8 61.3 15.7 45.6 174.7 57.3 202.1 89.0 82.8 84.9 29.2 79.7 96.4 48.9 17.0 61.2 73.2 103.2 72.8 64.7 100.0 174.8 117.5 31.1 82.7 77.9 136.8 251.3 120.9 142.8 10.2 44.4 11.5 26.1 98.2 87.7 16.5 26.9 19.1 124.7 65.5 162.8 126.9 10.3 8.9 73.3 13.4 30.5 4.9 70.7 162.5 96.5 110.0 87.9 28.7 63.2 52.7 28.1 34.8 12.1 20.7 12.7 19.7 35.6 130.0 37.8 11.4 323.4 90.3 85.7 95.4 33.2 162.0 88.5 59.1 153.0 14.3 91.8 62.5 104.4 84.2 45.9 120.4 4.3 106.3 61.3 78.7 35.7 135.8 74.4 105.3 69.1 58.9 140.8 71.0 105.2 48.8 24.1 80.3 31.1 70.5 82.7 117.9 166.8 119.3 86.9 117.5 174.8 136.8 105.0 9.8 77.9 78.5 64.5 113.8 251.3 32.1 34.7 31.0 61.9 27.2 23.6 29.0 28.8 28.8 17.0 792.1 1172.5 3639.8 5704.0 5720.2 400.0 926.5 1594.9 667.9 1239.8 975.3 253.3 3837.7 3756.8 1939.3 708.6 1998.1 1895.6 1261.4 5072.3 5914.7 2684.9 4292.9 1005.1 1181.4 2697.5 157.3 1633.5 1478.1 2282.6 2004.1 2891.5 2666.3 3338.7 2696.1 3081.8 500.6 3359.4 2949.4 1346.4 3180.5 483.0 1060.7 3222.8 573.1 569.6 7189.2 3651.1 2078.6 4568.6 6042.4 RPL9 L9 ENSG00000163682 "Ribosomal protein L9" P32969 4 39452521-39458949 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003372 Approved Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 24000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA003372: AB_1079843" "unprognostic (1.08e-3)" "unprognostic (2.14e-1)" "unprognostic (1.24e-1)" "unprognostic (8.06e-3)" "unprognostic (5.59e-2)" "unprognostic (1.27e-2)" "unprognostic (3.16e-2)" "unprognostic (2.14e-1)" "unprognostic (8.58e-2)" "unprognostic (6.68e-2)" "unprognostic (2.50e-2)" "unprognostic (7.85e-2)" "prognostic unfavorable (7.34e-4)" "unprognostic (1.34e-1)" "unprognostic (2.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-2)" 52.6 35.2 42.2 73.9 44.4 179.1 202.3 35.7 51.6 63.0 59.8 34.5 42.2 69.8 50.4 226.8 49.9 48.1 69.7 58.2 42.3 27.6 47.4 73.2 35.8 48.7 34.7 51.7 158.5 126.2 37.4 44.7 38.7 42.5 47.8 59.1 31.7 93.7 71.4 66.3 62.9 38.8 49.5 34.0 45.2 46.5 56.9 25.9 36.0 63.2 70.1 59.0 46.0 56.6 118.3 72.5 26.2 41.4 63.0 145.0 148.9 3.2 2.8 122.9 2.8 6.6 9.0 4.8 57.9 87.4 72.3 54.8 8.1 65.7 143.5 6.6 58.2 57.3 65.4 5.5 6.3 79.1 52.3 115.6 4.5 24.2 7.8 8.6 9.3 38.0 11.9 181.8 4.4 83.1 107.6 5.5 5.8 109.7 67.0 5.0 4.3 77.9 9.9 109.8 79.6 3.9 71.9 123.2 4.9 89.9 3.8 4.6 49.0 2.0 47.5 7.4 118.9 104.9 6.8 4.1 3.1 4.6 84.1 8.0 103.0 144.6 124.7 83.4 87.3 3.3 26.2 41.4 12.3 52.1 40.1 101.2 118.3 102.2 71.4 57.2 103.8 145.0 111.7 6.9 63.0 31.2 72.5 77.0 148.9 42.2 44.4 35.7 51.6 42.3 27.6 34.7 51.7 42.5 25.9 616.4 695.5 3946.9 4635.1 3670.9 362.7 367.2 1765.6 426.9 687.0 673.4 151.2 2652.9 2316.1 1697.3 1288.9 2348.7 1394.0 817.7 3813.6 4743.2 2040.6 3407.8 885.2 1749.4 2435.4 187.5 1780.1 1927.4 2668.8 1161.7 4462.6 2606.9 1756.2 2952.2 2900.0 510.1 3233.5 2563.6 2250.5 2828.8 405.3 1487.5 2143.4 695.4 462.3 4086.9 2843.5 2427.5 4009.2 4396.5 RPP30 TSG15 ENSG00000148688 "Ribonuclease P/MRP subunit p30" P78346 10 90871716-90908553 "Enzymes, Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037578 Approved Approved "Nucleoplasm,Nucleoli,Microtubule ends,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Microtubule ends, Cytosol" "HPA037578: AB_10696939" "unprognostic (1.55e-1)" "unprognostic (1.77e-3)" "unprognostic (2.35e-1)" "unprognostic (4.08e-1)" "unprognostic (5.64e-2)" "unprognostic (3.05e-2)" "unprognostic (3.80e-3)" "unprognostic (1.27e-1)" "unprognostic (2.73e-1)" "unprognostic (1.03e-1)" "unprognostic (2.27e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.01e-6)" "unprognostic (1.98e-1)" "unprognostic (9.84e-3)" "unprognostic (3.43e-2)" "unprognostic (2.10e-2)" 24.2 19.0 20.9 16.8 20.3 27.2 22.3 26.0 24.0 18.9 19.0 16.2 16.3 11.5 25.2 18.6 23.8 19.2 16.0 26.6 19.8 16.8 20.6 18.4 17.1 23.2 18.5 20.4 23.9 17.7 37.7 23.6 23.6 19.3 18.8 19.3 18.7 19.2 16.5 35.9 23.5 16.4 20.6 19.2 21.3 19.2 32.0 21.6 31.2 18.1 24.0 26.3 21.7 18.9 19.4 22.2 16.2 19.5 14.2 20.3 16.2 28.6 19.1 20.0 24.1 13.0 14.1 7.1 20.5 18.5 34.4 36.1 32.2 23.1 16.9 15.7 13.0 22.4 20.1 26.6 18.2 35.5 27.1 18.3 11.4 12.2 25.4 12.4 23.0 14.4 11.5 11.9 25.9 29.4 14.5 19.4 15.6 22.6 15.5 22.7 17.7 26.6 31.3 12.4 16.3 21.7 14.9 17.1 17.8 12.9 13.6 10.9 10.9 12.0 8.7 24.1 19.2 23.5 14.6 11.0 17.2 17.2 9.7 42.3 10.5 26.8 36.3 21.5 12.5 13.1 4.3 19.5 16.2 17.1 18.7 18.6 19.4 19.6 18.7 22.2 16.7 17.0 18.5 2.2 14.2 15.3 20.7 20.3 16.2 20.9 20.3 26.0 24.0 19.8 16.8 18.5 20.4 19.3 21.6 29.8 20.0 24.7 27.9 30.6 18.6 39.9 22.9 17.4 20.5 14.0 17.7 50.9 26.6 34.6 73.2 18.4 8.7 0.0 30.3 55.9 20.4 16.0 23.1 12.4 49.9 15.9 19.0 20.3 22.6 37.3 26.7 27.6 21.9 32.5 17.8 20.3 27.7 14.0 27.6 27.1 20.1 38.8 28.1 53.2 47.3 29.6 28.3 27.3 17.5 21.8 RPP38 ENSG00000152464 "Ribonuclease P/MRP subunit p38" P78345 10 15097180-15139818 "Enzymes, Predicted intracellular proteins, Ribosomal proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 439.8;Late spermatids: 144.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045128, HPA050398" Approved Supported Nucleoli NA NA Nucleoli "HPA045128: AB_2797230, HPA050398: AB_2732560" "unprognostic (1.75e-1)" "unprognostic (3.91e-2)" "unprognostic (3.76e-2)" "unprognostic (1.51e-1)" "unprognostic (9.93e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.41e-2)" "unprognostic (4.86e-1)" "unprognostic (1.57e-3)" "unprognostic (3.42e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (6.13e-2)" "unprognostic (1.95e-1)" "unprognostic (5.11e-2)" "prognostic favorable (2.89e-6)" 13.1 12.2 12.4 10.7 13.6 9.7 18.3 22.4 12.4 13.6 16.7 12.0 15.8 14.4 15.7 16.1 15.2 18.2 10.3 10.0 11.6 10.2 17.4 21.6 12.5 16.3 15.0 10.0 14.4 16.8 11.3 16.0 17.4 12.7 18.4 15.7 11.7 17.1 14.9 20.9 14.8 17.9 14.3 11.5 16.7 13.5 38.6 12.7 18.8 19.8 13.9 18.5 13.4 13.6 31.0 25.7 23.4 24.5 18.6 31.4 20.2 21.0 15.9 8.8 11.2 11.9 12.2 15.4 10.2 7.7 16.0 16.5 16.0 22.2 17.7 11.0 9.6 13.3 19.7 17.5 17.7 14.8 13.4 15.9 18.2 9.7 14.1 25.5 10.2 15.3 14.5 24.5 13.1 11.6 12.5 12.8 18.0 20.9 12.6 12.2 17.3 18.3 11.2 10.1 26.3 7.8 15.0 8.8 21.9 20.5 8.3 8.3 10.5 14.1 24.5 28.2 14.9 21.9 16.5 11.0 7.5 12.9 15.7 13.4 17.6 18.7 24.0 14.6 12.5 7.0 8.5 24.5 23.4 25.6 23.7 25.1 28.8 26.2 31.4 25.3 31.0 30.6 27.8 8.3 18.6 18.6 25.7 22.0 20.2 12.4 13.6 22.4 12.4 11.6 10.2 15.0 10.0 12.7 12.7 14.9 15.8 18.2 26.3 27.9 13.0 6.5 7.6 107.1 38.7 8.7 5.9 26.5 23.2 28.9 439.8 16.8 18.2 0.0 29.4 37.0 16.2 26.9 12.7 24.6 21.7 7.9 12.7 14.7 16.5 144.4 21.9 21.4 8.5 14.4 19.9 14.9 25.8 21.0 18.7 25.9 29.8 12.9 11.3 28.6 38.0 31.6 26.9 20.8 20.5 39.4 RPS11 S11 ENSG00000142534 "Ribosomal protein S11" P62280 19 49496365-49499689 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049719 Uncertain Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA049719: AB_2680860" "unprognostic (1.49e-3)" "unprognostic (3.71e-2)" "unprognostic (1.22e-1)" "unprognostic (1.50e-2)" "unprognostic (5.89e-3)" "unprognostic (3.57e-1)" "unprognostic (1.04e-2)" "unprognostic (4.10e-1)" "unprognostic (1.58e-1)" "unprognostic (1.47e-1)" "unprognostic (5.68e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.50e-7)" "unprognostic (5.19e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "unprognostic (1.71e-3)" 103.0 76.8 80.6 187.8 68.7 161.8 165.7 50.4 75.3 138.6 134.1 43.2 105.8 67.0 149.4 132.4 142.8 132.3 133.0 135.9 63.2 53.5 84.3 105.7 101.9 354.2 71.5 64.2 242.4 490.0 41.7 89.7 72.2 63.4 116.6 103.4 72.7 193.2 104.0 223.4 140.8 88.1 198.4 69.9 132.6 96.3 67.2 48.3 137.3 119.0 190.7 169.5 145.6 230.6 232.4 173.3 45.1 96.7 91.3 161.6 231.8 109.9 171.4 130.3 201.2 188.4 285.3 87.3 93.6 185.0 133.4 127.9 118.7 91.9 269.9 58.4 127.4 58.2 74.2 153.6 185.5 131.5 115.1 266.6 163.2 112.8 170.5 176.0 288.2 121.3 283.0 302.6 89.1 229.4 226.9 192.4 166.1 161.1 143.9 143.9 122.9 134.5 217.1 120.3 276.2 176.8 129.7 165.0 143.5 191.4 259.9 139.2 185.8 63.7 214.8 139.2 132.5 69.8 299.8 110.2 106.0 95.2 51.4 123.1 144.1 219.0 191.9 44.1 198.6 90.3 45.1 96.7 29.9 95.6 82.8 127.6 232.4 137.5 110.9 144.1 221.1 161.6 135.7 25.9 91.3 70.6 173.3 109.8 231.8 80.6 68.7 50.4 75.3 63.2 53.5 71.5 64.2 63.4 48.3 777.2 1364.0 2990.9 2041.9 2385.3 290.8 613.7 1123.6 1019.8 1465.0 450.1 135.5 1657.4 1031.2 1067.3 717.3 1435.9 1074.1 934.5 2445.2 2866.6 1515.8 1592.1 1273.2 1366.5 1658.3 89.0 1443.9 1317.9 2294.0 1350.9 2974.6 2278.1 1459.3 1700.6 2280.4 469.1 1978.0 1439.5 1446.5 1386.6 340.6 860.2 1282.2 599.4 586.0 2983.4 1970.5 1736.0 2339.2 2255.1 RPS17 "MGC72007, RPS17L, RPS17L1, RPS17L2, S17" ENSG00000182774 "Ribosomal protein S17" P08708 15 82536750-82540564 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 149.0" "Low region specificity" "Detected in all" HPA055060 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 39000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA055060: AB_2682686" "unprognostic (3.37e-3)" "unprognostic (1.49e-1)" "unprognostic (2.06e-2)" "unprognostic (6.90e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-2)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (4.49e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.83e-1)" "unprognostic (5.40e-2)" "unprognostic (2.09e-1)" "unprognostic (2.31e-1)" 40.1 37.3 23.9 41.5 28.0 78.5 93.7 20.5 39.7 41.3 35.4 18.0 32.7 12.0 34.4 69.6 58.2 48.5 36.3 36.2 24.9 16.0 33.0 56.8 30.4 75.5 22.2 22.4 100.0 160.7 8.0 28.1 28.7 29.1 32.2 54.1 21.2 64.2 38.1 47.5 60.8 33.0 54.2 26.6 40.9 38.1 29.3 19.2 36.1 38.5 85.2 82.2 34.1 55.8 42.1 34.6 12.5 19.7 26.5 48.5 63.4 10.4 75.5 24.4 15.8 41.3 57.4 18.9 5.7 10.6 18.1 16.6 107.6 34.5 14.9 10.7 23.1 32.1 33.1 58.8 58.3 32.6 9.1 149.0 2.6 78.0 72.2 56.4 13.2 14.4 73.9 107.7 22.3 76.5 48.5 38.3 39.2 10.2 39.9 27.8 84.1 16.9 46.6 36.7 67.8 60.3 11.4 6.2 26.8 53.9 95.3 17.8 11.5 2.3 32.0 31.5 42.3 38.9 40.7 9.9 28.2 20.6 17.4 12.6 12.0 18.6 13.0 23.1 34.1 15.4 12.5 19.7 4.5 16.6 17.2 43.6 39.9 41.3 26.8 27.2 42.1 48.5 42.4 2.5 26.5 14.8 34.6 23.7 63.4 23.9 28.0 20.5 39.7 24.9 16.0 22.2 22.4 29.1 19.2 756.3 1289.8 2965.8 4861.9 38.4 77.5 373.2 1826.7 922.1 1902.9 167.5 47.1 3046.0 462.6 1389.5 55.8 1090.9 569.4 1962.4 2604.1 5603.8 1698.1 3804.0 863.8 2556.7 2408.0 39.7 929.1 1950.1 2775.5 119.3 4074.2 1038.9 28.7 2043.3 2571.6 141.3 2469.3 1560.6 1761.1 737.0 85.0 1164.2 222.0 396.6 646.1 55.8 2855.8 2041.0 4254.9 4758.2 RPS19BP1 "FLJ21770, MGC52010" ENSG00000187051 "Ribosomal protein S19 binding protein 1" Q86WX3 22 39529093-39532855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042874 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoli, Cytosol" Nucleoplasm "HPA042874: AB_10793988" "unprognostic (2.44e-1)" "unprognostic (1.67e-1)" "unprognostic (7.79e-2)" "unprognostic (5.07e-3)" "unprognostic (1.65e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.65e-1)" "unprognostic (5.68e-2)" "unprognostic (8.31e-2)" "unprognostic (7.00e-2)" "unprognostic (6.73e-2)" "unprognostic (1.04e-1)" "unprognostic (6.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.34e-1)" "unprognostic (4.32e-2)" 32.8 38.8 38.9 29.5 30.6 36.9 47.5 24.2 34.7 26.4 28.0 19.2 40.6 31.4 18.8 25.2 24.1 18.0 25.0 30.5 38.9 28.4 30.8 40.7 22.5 29.4 40.3 27.0 23.4 45.0 15.4 18.8 21.9 31.9 31.6 14.4 19.2 65.2 35.4 55.0 19.8 30.9 28.5 31.1 27.1 32.6 28.8 24.6 16.3 40.8 28.0 23.7 24.3 54.5 64.2 73.5 67.3 57.7 42.8 60.3 50.5 20.9 25.9 12.5 17.6 14.1 9.2 26.3 24.1 19.6 21.1 16.8 28.7 13.9 26.2 25.2 14.2 17.2 17.0 19.6 24.7 7.3 37.7 62.7 25.2 22.0 25.3 20.6 36.8 32.9 13.8 18.7 18.1 22.2 11.4 14.3 19.9 28.1 19.0 13.3 23.2 17.6 36.7 21.7 46.7 49.7 28.1 16.3 39.4 22.1 20.8 27.9 15.6 19.5 31.1 43.3 8.0 22.4 29.8 16.9 17.6 40.2 19.6 31.4 33.1 30.4 40.7 23.9 25.6 41.1 42.1 57.7 67.3 53.4 52.1 49.2 62.0 54.4 55.2 46.3 64.2 53.2 54.1 63.4 42.8 42.0 73.5 60.3 50.5 38.9 30.6 24.2 34.7 38.9 28.4 40.3 27.0 31.9 24.6 41.7 44.3 107.2 91.0 121.8 95.6 68.3 109.5 34.8 36.4 92.5 49.1 134.1 184.1 166.7 17.8 129.5 196.8 46.7 167.0 202.1 94.9 166.3 69.2 175.1 185.7 33.4 136.9 111.1 105.7 22.2 126.8 125.3 102.9 172.3 137.0 80.8 187.2 164.9 118.5 232.2 81.9 77.6 104.0 59.0 146.0 129.4 110.1 136.4 130.8 112.7 RPS25 S25 ENSG00000118181 "Ribosomal protein S25" P62851 11 119015712-119018691 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031801, HPA078683" Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 54000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA031801: AB_10610419, HPA078683: " "unprognostic (1.60e-2)" "unprognostic (1.79e-1)" "unprognostic (2.12e-1)" "unprognostic (1.40e-1)" "unprognostic (8.32e-2)" "unprognostic (1.78e-2)" "unprognostic (1.55e-2)" "unprognostic (8.47e-2)" "unprognostic (5.23e-2)" "unprognostic (1.54e-2)" "unprognostic (2.36e-2)" "unprognostic (7.75e-3)" "prognostic unfavorable (3.00e-7)" "unprognostic (1.16e-1)" "unprognostic (1.07e-1)" "unprognostic (8.58e-2)" "unprognostic (2.20e-1)" 72.3 68.1 54.9 99.5 60.7 117.7 140.7 38.1 62.2 84.9 69.4 26.8 87.7 53.5 79.6 93.4 92.9 68.0 78.6 87.3 44.4 41.7 58.6 76.5 88.4 256.5 57.1 48.1 190.0 274.5 34.3 67.5 52.5 54.3 77.1 52.2 41.6 113.5 131.7 173.6 82.0 57.7 125.4 68.3 80.7 68.3 35.3 47.3 78.5 83.9 128.8 86.4 112.2 110.6 136.6 83.3 30.0 43.2 64.7 166.9 150.1 39.1 22.5 48.5 48.5 65.3 101.1 39.8 53.0 47.7 31.3 27.3 59.5 68.7 99.1 92.7 36.9 37.1 54.4 42.9 57.0 35.7 48.7 46.8 141.1 19.9 49.9 50.7 100.2 44.1 91.0 101.7 29.9 74.7 98.9 56.9 80.2 73.3 59.8 43.5 80.7 78.3 137.7 50.0 99.7 54.5 68.7 50.9 107.6 57.8 34.5 35.6 67.8 28.2 87.8 54.8 57.4 70.6 109.3 54.0 30.7 35.7 31.1 50.8 50.7 41.3 81.9 21.3 99.7 36.2 30.0 43.2 27.1 75.8 42.5 120.7 136.6 133.4 102.4 69.1 112.6 166.9 128.2 11.7 64.7 37.2 83.3 88.7 150.1 54.9 60.7 38.1 62.2 44.4 41.7 57.1 48.1 54.3 47.3 753.4 1471.8 4134.9 3644.0 3526.8 272.7 156.5 1931.2 1062.7 1885.9 884.5 108.0 3031.7 2773.7 1545.4 1495.6 2111.7 1048.3 1191.4 2746.5 3534.5 2149.5 2685.4 1909.4 2155.6 2228.4 127.1 1279.9 2210.4 2932.5 2021.0 3541.3 3243.7 2073.4 4078.5 2284.3 466.6 2362.4 1995.5 1610.5 3361.8 311.5 1312.9 2458.2 606.9 848.3 4074.2 3057.4 2507.2 2899.2 3437.7 RPS26 S26 ENSG00000197728 "Ribosomal protein S26" P62854 12 56041351-56044676 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043961, HPA055803" Uncertain Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA043961: AB_10963579, HPA055803: AB_2682927" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (3.36e-1)" "unprognostic (9.58e-2)" "unprognostic (3.74e-1)" "unprognostic (7.84e-3)" "unprognostic (1.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.25e-1)" "unprognostic (3.76e-2)" "unprognostic (2.49e-1)" "unprognostic (3.03e-1)" "unprognostic (2.06e-2)" "unprognostic (1.41e-1)" "unprognostic (4.40e-2)" "unprognostic (2.18e-1)" "unprognostic (7.99e-2)" 36.5 66.6 33.3 29.0 48.8 39.2 49.7 23.8 73.7 44.5 45.6 34.9 20.5 20.0 35.9 50.4 49.9 43.5 28.4 39.8 25.8 24.8 61.8 154.3 29.5 56.0 31.4 26.2 75.8 80.4 25.6 29.7 28.7 45.1 35.4 49.1 28.5 38.0 41.1 62.2 50.9 57.5 36.9 30.0 51.6 40.3 47.0 32.5 47.3 58.4 60.0 78.4 46.7 41.2 93.0 69.8 29.8 42.8 63.6 107.4 108.8 53.4 65.8 75.0 27.8 103.9 154.2 75.2 54.5 81.0 90.9 53.2 101.0 24.2 119.3 34.5 57.5 30.0 25.2 84.2 46.9 62.3 47.2 135.1 63.0 43.9 60.2 96.0 40.9 34.6 93.3 150.3 47.9 54.6 35.9 69.0 85.6 42.9 39.8 73.5 82.9 30.6 74.3 73.6 65.4 149.1 41.7 22.5 73.4 75.9 54.2 28.2 48.8 21.3 47.2 30.9 23.3 41.7 45.8 22.3 22.6 46.3 28.8 43.7 34.3 65.6 64.4 25.1 81.7 28.9 29.8 41.4 27.1 74.6 42.8 83.8 93.0 97.8 81.8 55.3 79.8 107.4 99.3 17.0 63.6 38.2 69.8 101.7 108.8 33.3 48.8 23.8 73.7 25.8 24.8 31.4 26.2 45.1 32.5 208.4 201.5 1424.8 560.8 1563.9 119.2 23.8 1184.7 333.3 536.9 408.2 58.9 1212.8 824.0 801.2 63.2 800.7 1808.5 1004.5 2275.1 2554.3 1158.0 914.2 500.2 1753.2 1234.1 71.5 826.4 935.4 838.0 37.7 273.5 701.1 1386.7 874.7 1010.7 278.9 1348.0 1392.2 208.2 969.4 134.7 304.0 900.2 204.7 313.7 1585.9 1428.5 824.9 1127.8 1109.2 RPS27 "MPS-1, MPS1, S27" ENSG00000177954 "Ribosomal protein S27" P42677 1 153990755-153992155 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 778.4;lymphoid tissue: 769.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066851 Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: AB_2685737" "prognostic favorable (9.69e-4)" "unprognostic (1.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.35e-1)" "unprognostic (1.01e-2)" "unprognostic (1.28e-1)" "unprognostic (8.62e-2)" "unprognostic (5.88e-3)" "unprognostic (2.05e-2)" "unprognostic (5.04e-2)" "unprognostic (2.55e-2)" "unprognostic (6.81e-2)" "prognostic unfavorable (4.86e-7)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (2.44e-1)" "unprognostic (8.81e-2)" 120.7 72.5 74.9 188.7 118.6 186.7 268.2 51.3 91.4 172.5 114.2 35.9 136.4 58.1 169.0 135.6 107.5 129.0 144.1 176.5 59.6 50.1 98.6 102.5 167.8 769.0 92.1 76.0 317.8 227.2 44.6 91.5 67.5 71.2 117.6 113.6 63.5 248.2 116.1 243.8 160.1 115.9 254.3 65.6 159.3 111.5 119.0 81.9 118.2 113.0 224.0 270.9 162.9 286.0 720.2 296.5 132.9 139.9 324.1 750.5 778.4 103.7 121.7 160.9 87.6 378.8 373.5 99.8 125.8 301.7 169.5 153.2 243.8 114.7 236.3 105.7 181.5 56.5 104.6 141.7 208.3 143.3 114.7 182.7 93.1 161.4 158.1 251.1 206.9 122.8 362.6 409.8 134.8 248.4 252.8 138.9 197.5 113.6 128.5 160.9 260.8 222.5 131.0 194.8 347.8 177.5 142.6 117.8 183.8 156.6 210.3 85.5 190.7 72.1 254.0 218.7 229.1 141.6 415.8 82.0 58.6 97.1 93.4 125.7 258.2 263.2 286.4 101.7 116.2 80.3 132.9 139.9 68.1 393.0 138.9 473.7 720.2 594.4 502.0 179.5 637.3 750.5 579.6 32.4 324.1 127.0 296.5 397.8 778.4 74.9 118.6 51.3 91.4 59.6 50.1 92.1 76.0 71.2 81.9 2045.7 3610.2 12664.6 4456.3 11098.6 390.9 812.1 5699.4 2137.4 3923.0 2044.8 182.6 5213.2 3755.2 3414.7 2254.7 2990.8 2165.3 4461.9 9085.2 5382.4 5444.6 3827.3 4020.8 6408.4 3759.0 181.1 2910.0 5208.2 8634.5 6446.8 6571.4 6944.5 5609.6 8769.4 6097.0 734.9 5926.8 6112.7 3330.7 4371.1 465.9 2690.5 3231.1 1566.2 1451.5 12519.6 5337.4 8309.1 7958.0 4025.9 RPS27A "S27A, Uba80, UBCEP80" ENSG00000143947 "Ribosomal protein S27a" P62979 2 55231903-55235853 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033319, HPA041344, HPA049132, HPA054087" Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "CAB033319: AB_793618, HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373" "unprognostic (7.32e-2)" "unprognostic (1.41e-2)" "unprognostic (1.11e-1)" "unprognostic (3.20e-3)" "unprognostic (2.16e-1)" "unprognostic (9.75e-2)" "prognostic unfavorable (2.26e-4)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (2.46e-1)" "unprognostic (6.89e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (1.09e-1)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (3.60e-1)" 54.1 45.0 46.8 66.0 85.5 111.5 120.1 33.3 77.9 74.5 60.0 21.4 43.0 37.3 66.0 57.8 68.3 61.4 51.2 47.1 57.0 32.7 71.1 172.7 43.9 84.3 42.4 68.3 167.1 88.9 20.7 53.7 57.1 52.1 57.7 52.5 25.3 70.5 46.9 101.9 69.1 52.5 46.3 40.4 77.1 58.9 48.6 36.4 62.8 64.0 144.0 82.1 52.1 71.1 194.8 130.9 42.2 62.9 122.8 253.3 267.6 106.0 61.7 67.7 112.4 94.5 180.5 129.4 83.7 96.3 91.9 58.2 115.1 120.4 148.5 141.5 79.8 54.7 100.8 97.7 114.4 107.5 125.9 113.1 136.8 66.4 153.9 137.5 204.0 93.8 162.3 227.7 61.6 168.3 153.5 124.6 92.0 122.0 136.4 105.0 83.0 119.2 245.7 162.6 130.4 79.0 113.8 172.4 175.6 103.9 101.6 89.5 71.0 57.4 250.0 186.5 110.1 111.1 174.3 118.6 84.3 128.3 75.2 141.6 122.8 85.1 96.5 120.6 173.6 83.9 42.2 62.9 24.1 129.3 59.1 183.5 194.8 197.3 154.8 91.1 179.3 253.3 206.8 14.4 122.8 52.5 130.9 120.7 267.6 46.8 85.5 33.3 77.9 57.0 32.7 42.4 68.3 52.1 36.4 1182.1 2168.7 6366.0 7790.9 7391.5 428.3 362.3 2830.5 1535.1 2713.9 1326.0 202.2 4414.5 3436.8 2947.8 844.4 3491.0 1693.7 1752.0 6390.1 5764.5 3524.5 5396.1 2833.4 2701.0 3058.4 206.6 1979.6 3107.2 4338.7 1140.7 4705.1 4812.5 3451.8 4888.3 3292.1 886.8 4792.0 3026.5 2708.4 4047.2 553.4 1616.9 4201.8 922.6 805.1 7807.0 4507.9 4717.9 5337.4 6552.6 RPS27L ENSG00000185088 "Ribosomal protein S27 like" Q71UM5 15 63125872-63158021 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Proximal tubular cells: 1955.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066851 Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: AB_2685737" "unprognostic (4.62e-2)" "unprognostic (5.81e-2)" "unprognostic (1.38e-1)" "prognostic favorable (9.08e-6)" "unprognostic (1.75e-1)" "unprognostic (7.24e-2)" "unprognostic (1.42e-3)" "unprognostic (2.98e-1)" "unprognostic (6.38e-2)" "unprognostic (1.80e-1)" "unprognostic (2.19e-3)" "unprognostic (2.51e-1)" "unprognostic (1.97e-2)" "unprognostic (5.31e-2)" "unprognostic (1.36e-1)" "unprognostic (1.97e-3)" "unprognostic (5.10e-3)" 46.8 64.2 21.3 19.8 29.7 18.2 53.6 16.3 23.4 29.4 58.5 15.5 30.4 46.0 30.2 49.3 40.4 27.0 38.3 47.1 22.8 22.2 61.0 75.2 31.7 23.4 32.6 19.2 26.5 65.9 19.2 38.8 35.6 43.9 56.2 55.3 18.3 99.8 46.0 47.1 18.1 80.4 54.8 39.9 28.2 41.9 15.7 27.3 19.4 53.9 25.7 19.8 55.0 36.3 34.5 30.9 51.5 47.6 27.2 75.4 38.3 16.5 46.4 42.1 11.3 61.6 73.0 42.2 52.4 37.4 11.5 28.2 8.5 23.1 15.6 18.8 50.1 20.6 6.4 14.2 25.8 19.5 11.5 19.2 12.8 39.2 60.7 70.9 10.2 35.7 57.1 34.7 26.1 19.8 87.6 65.3 9.8 11.8 15.7 96.0 23.0 13.1 15.9 12.4 21.2 13.6 10.2 20.2 17.6 32.4 33.6 6.1 9.3 19.0 8.0 37.1 88.4 17.8 23.7 69.0 61.2 57.6 13.2 23.2 17.7 15.0 13.8 64.9 28.2 55.1 51.5 34.3 40.0 27.5 35.9 33.9 34.5 41.6 32.0 30.9 26.9 32.9 33.1 11.4 27.2 47.6 30.8 75.4 38.3 21.3 29.7 16.3 23.4 22.8 22.2 32.6 19.2 43.9 27.3 89.3 200.0 257.3 226.5 226.9 32.3 318.9 598.7 234.2 153.6 389.0 45.2 244.0 766.0 754.9 35.9 230.2 819.3 233.6 678.9 1142.2 251.0 333.1 292.5 900.4 483.1 12.7 274.1 300.8 377.4 21.8 291.4 318.2 442.1 1587.0 624.8 110.3 1030.5 691.6 279.7 1955.0 68.4 258.7 357.4 142.8 82.2 216.4 196.7 234.3 638.5 176.3 RPS3A "MFTL, S3A" ENSG00000145425 "Ribosomal protein S3A" P61247 4 151099573-151104652 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Differentiation "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 440.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047100, HPA053454" Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" No No 63000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA047100: AB_2679931, HPA053454: AB_2682156" "unprognostic (6.24e-3)" "unprognostic (3.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.16e-1)" "unprognostic (1.79e-2)" "unprognostic (5.46e-2)" "prognostic unfavorable (6.56e-4)" "unprognostic (1.17e-1)" "unprognostic (1.16e-2)" "unprognostic (1.01e-1)" "unprognostic (6.41e-2)" "unprognostic (1.27e-1)" "unprognostic (6.81e-3)" "unprognostic (2.36e-1)" "unprognostic (1.96e-1)" "unprognostic (2.00e-1)" "unprognostic (3.39e-1)" 71.7 46.9 48.4 69.2 47.7 124.7 160.3 40.4 43.5 114.1 98.4 30.4 61.9 45.0 75.3 84.4 142.8 73.3 53.9 51.1 36.8 33.3 72.8 94.2 79.4 102.5 42.6 43.5 179.5 143.8 18.1 49.3 70.5 38.0 113.3 62.4 39.0 113.8 48.5 116.8 97.1 73.5 62.0 43.1 94.2 64.2 61.9 30.7 120.4 126.8 111.6 90.6 111.4 86.3 211.6 187.7 44.3 92.8 142.9 282.7 440.7 80.5 59.3 113.1 111.1 145.6 285.0 115.5 85.9 132.7 121.8 75.4 114.6 117.8 365.6 43.0 93.6 43.0 53.5 114.6 143.5 115.8 80.5 110.9 78.9 73.3 132.3 168.6 187.3 81.9 211.3 296.1 74.9 199.3 172.0 144.4 137.0 126.9 191.5 144.6 120.4 202.3 222.6 106.1 129.0 45.9 148.2 110.4 122.3 141.0 97.9 108.8 107.7 38.6 141.4 189.2 83.4 94.6 227.8 87.6 59.6 78.9 65.7 94.5 148.9 239.5 223.9 76.5 136.8 70.6 44.3 92.8 27.2 120.6 74.5 203.9 211.6 203.1 157.9 156.5 185.7 282.7 226.9 15.1 142.9 62.1 187.7 145.5 440.7 48.4 47.7 40.4 43.5 36.8 33.3 42.6 43.5 38.0 30.7 902.2 1351.4 4981.2 6887.5 5470.3 389.5 334.4 1689.1 1088.1 1918.8 783.4 113.9 3954.4 3630.9 1946.8 1331.3 2405.0 1231.3 1425.0 3246.4 6519.9 2822.1 4092.8 1400.9 1318.9 2985.4 154.1 2072.9 2006.5 3842.5 3230.8 4100.5 4536.3 3092.4 3236.3 3439.0 634.6 3016.2 2304.0 2436.9 3691.6 432.9 1739.7 3595.7 655.4 688.2 5905.5 3840.1 4239.4 5672.4 6561.2 RPS6KA3 "CLS, HU-3, MRX19, RSK, RSK2" ENSG00000177189 "Ribosomal protein S6 kinase A3" P51812 X 20149911-20267519 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 69.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003221, CAB003853, CAB013520" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (1.80e-2)" "unprognostic (4.26e-2)" "unprognostic (3.53e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-2)" "unprognostic (1.61e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (5.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (4.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-1)" 19.7 12.5 9.9 23.0 12.5 8.2 16.5 15.2 12.1 11.4 23.2 4.4 22.1 13.7 12.4 10.1 13.6 12.7 15.7 21.3 9.7 8.8 14.1 25.8 21.6 34.0 9.9 10.0 12.7 14.0 36.6 9.8 11.0 10.2 14.5 18.8 7.7 14.3 11.3 45.2 11.7 23.7 16.1 11.7 25.8 11.8 4.8 9.7 29.4 13.5 15.0 18.2 20.3 19.0 4.2 8.6 12.5 6.9 8.3 11.3 2.7 12.9 22.7 8.6 4.4 8.4 14.8 2.6 11.2 17.1 8.4 11.6 25.7 16.7 8.5 3.9 11.8 12.3 9.2 9.8 9.5 15.7 7.1 7.8 10.0 14.3 69.0 8.6 19.5 10.4 9.4 7.6 13.2 16.7 7.4 30.4 9.0 6.6 24.4 8.8 6.1 12.6 6.0 6.2 16.9 13.7 6.7 18.2 9.8 7.3 10.9 4.0 3.9 15.1 4.6 16.4 11.2 0.0 5.8 16.9 9.2 6.4 29.1 6.3 19.5 11.9 9.5 17.4 9.7 21.7 12.5 4.7 9.5 6.3 6.9 11.3 2.9 7.3 6.9 7.0 4.2 5.0 6.0 7.5 8.3 6.9 8.6 3.5 2.7 9.9 12.5 15.2 12.1 9.7 8.8 9.9 10.0 10.2 9.7 41.7 68.2 18.2 31.8 48.3 33.6 19.4 38.2 21.4 51.2 15.7 21.6 3.3 3.3 23.3 0.1 48.1 43.4 0.0 26.0 5.7 28.8 47.0 42.8 61.1 20.6 12.7 24.0 29.4 46.1 1.1 12.0 60.4 35.4 20.8 53.4 26.6 30.0 46.0 19.8 23.7 8.7 19.4 35.0 3.3 7.7 48.6 3.0 56.7 46.1 54.2 RPS6KA6 RSK4 ENSG00000072133 "Ribosomal protein S6 kinase A6" Q9UK32 X 84058346-84187907 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 20.7" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 19.9;Collecting duct cells: 17.4;Cone photoreceptor cells: 23.6;Intestinal endocrine cells: 24.0;Rod photoreceptor cells: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 11.0;PC-3: 11.9;RH-30: 14.6;SH-SY5Y: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002852, HPA003904" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Mitochondria" Nucleoli "HPA002852: AB_1079854, HPA003904: AB_1079853" "unprognostic (1.17e-1)" "unprognostic (1.02e-2)" "unprognostic (3.44e-1)" "unprognostic (4.93e-4)" "unprognostic (1.71e-1)" "unprognostic (3.04e-3)" "unprognostic (2.09e-2)" "unprognostic (2.50e-1)" "unprognostic (2.86e-1)" "unprognostic (4.88e-2)" "unprognostic (3.38e-3)" "unprognostic (2.88e-1)" "unprognostic (2.12e-9)" "unprognostic (4.44e-3)" "unprognostic (1.30e-2)" "unprognostic (2.34e-2)" "unprognostic (8.49e-3)" 0.7 2.9 5.9 1.0 12.2 0.0 2.3 4.7 5.1 3.1 4.5 1.1 20.7 1.7 2.7 4.0 1.5 4.0 1.9 1.2 5.1 2.9 9.2 0.9 0.8 0.2 1.5 3.3 4.9 3.4 13.5 9.1 0.5 4.4 4.3 3.7 1.5 3.0 15.0 1.4 2.3 2.0 1.7 1.0 0.6 2.4 2.6 2.7 0.8 14.5 0.9 0.6 3.3 2.3 1.2 0.8 2.4 0.5 0.7 2.8 0.1 0.0 3.7 3.6 0.0 3.4 3.4 0.0 7.7 4.1 3.4 2.9 2.8 3.0 0.0 0.0 4.1 0.0 0.1 9.1 6.1 8.1 0.0 4.6 0.0 0.1 0.0 3.1 0.0 0.0 1.9 0.0 0.0 3.8 3.8 0.8 0.0 0.0 0.2 2.7 0.0 1.3 0.1 11.0 0.0 11.9 0.0 14.6 0.0 0.6 8.5 0.0 11.7 0.0 4.2 0.0 5.2 2.0 0.0 0.0 0.1 4.4 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 2.4 0.4 0.5 0.5 0.3 0.4 1.2 0.4 0.7 0.8 0.6 0.4 0.4 1.1 0.7 0.5 0.4 2.8 0.1 5.9 12.2 4.7 5.1 5.1 2.9 1.5 3.3 4.4 2.7 8.9 2.4 2.0 4.4 0.2 19.9 2.0 12.7 6.7 3.4 17.4 23.6 2.1 1.7 0.4 0.4 0.6 3.4 0.0 1.1 0.6 0.3 7.4 0.0 1.5 0.2 1.6 24.0 1.3 0.0 0.0 4.0 0.0 0.0 0.0 5.0 2.8 1.3 2.9 5.6 3.3 18.2 0.0 0.6 3.7 6.3 0.4 1.9 0.0 5.3 4.2 RRNAD1 "C1orf66, CGI-41, METTL25B" ENSG00000143303 "Ribosomal RNA adenine dimethylase domain containing 1" Q96FB5 1 156728442-156736960 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047426 Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA047426: AB_2680041" "unprognostic (2.12e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (2.00e-1)" "unprognostic (1.86e-2)" "unprognostic (2.75e-1)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.07e-1)" "unprognostic (1.98e-1)" "unprognostic (2.89e-3)" "unprognostic (2.24e-1)" "unprognostic (2.76e-1)" "unprognostic (2.14e-1)" "unprognostic (3.35e-2)" "unprognostic (1.49e-1)" "unprognostic (5.03e-3)" 14.1 19.4 12.4 22.6 19.0 8.7 19.1 15.3 18.8 17.6 25.7 20.8 31.2 22.5 20.3 22.9 18.4 24.4 20.2 12.5 13.3 10.9 15.9 25.8 14.5 14.4 19.9 14.5 24.5 29.2 24.3 18.8 20.5 16.1 21.8 14.8 20.2 22.5 24.5 21.9 23.9 26.6 12.9 14.7 18.5 19.3 25.9 17.7 11.9 30.3 13.5 15.9 21.7 27.9 4.9 5.9 7.0 4.0 6.5 8.6 2.9 5.9 11.8 8.8 8.6 23.7 10.9 13.4 4.5 13.9 7.8 5.9 6.4 27.6 10.2 13.6 7.1 11.0 25.6 12.2 10.6 3.2 20.2 10.3 6.1 11.2 4.7 14.9 9.1 16.8 16.8 20.4 7.8 14.9 9.3 6.5 9.2 14.6 23.1 4.1 14.4 4.6 10.7 10.1 26.0 3.7 7.6 5.8 23.6 9.3 6.5 11.4 16.5 8.0 16.5 9.8 14.0 21.8 19.6 6.3 4.9 6.0 7.5 6.0 26.9 26.3 12.6 5.4 10.3 5.8 6.7 3.3 4.7 6.8 2.5 6.9 3.4 6.6 4.8 5.9 4.9 5.3 6.0 7.0 6.5 4.0 2.2 8.6 2.9 12.4 19.0 15.3 18.8 13.3 10.9 19.9 14.5 16.1 17.7 6.0 10.8 9.7 21.1 9.0 9.9 6.1 20.4 6.7 10.3 3.5 11.8 21.2 8.3 10.3 44.1 11.3 18.0 0.0 11.6 14.3 9.4 17.5 4.7 18.5 9.6 7.9 9.2 9.2 10.2 10.3 10.3 6.6 8.5 9.0 16.6 20.3 9.4 17.5 8.9 11.6 11.6 12.9 6.2 15.8 22.8 10.0 27.1 8.3 16.5 15.9 RRP1 "D21S2056E, NNP-1, Nop52, RRP1A" ENSG00000160214 "Ribosomal RNA processing 1" P56182 21 43789513-43805293 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016818, HPA018166" Approved Enhanced "Nucleoli,Mitotic chromosome" Yes No "Nucleoli, Mitotic chromosome" "HPA016818: AB_1854561, HPA018166: AB_1854562" "unprognostic (5.38e-2)" "unprognostic (3.48e-1)" "unprognostic (3.43e-1)" "unprognostic (2.53e-2)" "unprognostic (9.44e-2)" "unprognostic (1.13e-2)" "unprognostic (7.69e-3)" "unprognostic (1.26e-1)" "unprognostic (7.63e-3)" "unprognostic (9.42e-2)" "unprognostic (6.94e-2)" "unprognostic (5.25e-2)" "prognostic unfavorable (6.29e-5)" "unprognostic (1.13e-1)" "unprognostic (9.21e-3)" "unprognostic (2.64e-1)" "unprognostic (1.88e-1)" 12.0 10.6 12.1 12.8 15.6 9.7 9.4 11.4 20.0 8.6 8.9 18.0 6.0 10.6 10.0 9.1 19.8 10.9 9.3 8.5 14.3 11.3 8.3 16.6 7.3 15.1 16.3 14.4 14.8 16.6 9.4 7.6 10.3 14.9 9.4 6.7 9.9 14.7 9.8 15.6 20.1 9.7 7.4 11.5 11.1 11.9 13.8 15.6 10.5 9.6 11.4 14.7 8.9 9.8 10.9 8.8 1.5 4.3 10.4 12.3 6.0 16.3 8.8 6.0 10.1 3.3 3.8 11.7 8.4 4.9 11.7 8.3 23.1 9.7 15.8 7.0 4.5 10.8 8.4 11.2 8.1 5.3 7.8 22.0 22.5 8.1 14.0 6.9 14.2 8.1 5.0 7.7 11.7 9.2 3.0 6.2 14.9 29.4 11.9 5.4 19.3 12.3 19.5 20.3 11.3 13.2 22.8 4.9 29.1 6.0 9.1 14.4 8.6 8.7 9.4 11.0 1.7 9.8 9.8 7.0 7.8 8.9 8.2 14.4 14.9 12.8 16.4 11.9 23.8 10.1 0.1 4.3 1.5 9.7 4.0 12.3 9.6 10.1 9.9 8.8 10.9 11.2 7.4 0.9 10.4 1.9 7.5 5.8 6.0 12.1 15.6 11.4 20.0 14.3 11.3 16.3 14.4 14.9 15.6 14.9 20.8 16.0 24.4 64.2 17.6 4.5 7.6 20.1 39.8 7.0 19.6 27.0 6.6 26.5 3.5 19.1 9.1 23.3 28.6 31.6 22.6 15.8 20.7 13.5 29.5 7.9 20.1 12.9 6.7 2.4 17.8 19.7 40.5 19.8 15.3 9.9 31.9 5.8 19.4 17.0 17.4 32.3 24.7 22.6 29.6 61.4 25.4 13.1 25.2 35.2 RRP12 KIAA0690 ENSG00000052749 "Ribosomal RNA processing 12 homolog" Q5JTH9 10 97356358-97426076 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 62.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049945, HPA074403" Supported "Nucleoli,Vesicles,Plasma membrane,Cytosol" No No Nucleoli "Vesicles, Plasma membrane, Cytosol" "HPA049945: AB_2680965, HPA074403: " "unprognostic (2.79e-1)" "unprognostic (7.65e-2)" "unprognostic (5.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.42e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.12e-8)" "unprognostic (2.64e-1)" "unprognostic (1.30e-2)" "unprognostic (1.54e-1)" "unprognostic (3.94e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (2.54e-5)" "unprognostic (2.58e-2)" "unprognostic (3.32e-1)" "unprognostic (4.81e-2)" "unprognostic (6.99e-3)" 7.1 8.4 5.9 7.4 11.9 62.6 4.6 3.8 15.7 4.1 4.0 5.4 2.9 5.2 6.4 3.9 7.1 6.4 6.4 8.4 4.4 7.2 4.4 9.3 5.6 6.0 5.9 6.1 6.0 16.4 9.6 10.6 3.9 9.6 5.5 3.6 4.1 6.6 3.9 31.7 8.2 3.8 5.3 3.2 7.1 5.3 13.9 6.1 4.6 4.9 7.2 5.4 4.2 4.3 3.4 4.3 19.3 11.1 1.2 2.4 3.7 15.9 21.4 5.7 12.3 4.4 5.2 12.5 10.1 6.1 10.5 8.2 23.2 14.8 17.6 13.2 6.4 9.4 20.6 15.6 11.7 7.1 9.6 18.7 13.6 8.0 18.0 7.3 21.1 17.9 5.4 16.6 25.8 23.9 11.9 5.9 9.9 19.4 11.8 5.9 20.8 14.3 13.6 24.5 8.5 14.5 15.7 7.8 17.4 7.3 8.9 7.7 16.4 8.1 7.8 10.1 4.6 18.8 11.0 7.7 7.1 12.2 15.8 31.9 24.2 21.0 20.7 10.1 27.2 7.5 0.2 7.3 4.6 2.0 9.3 2.4 2.9 1.2 1.6 4.3 3.4 1.9 2.1 19.3 1.2 11.1 3.6 0.8 3.7 5.9 11.9 3.8 15.7 4.4 7.2 5.9 6.1 9.6 6.1 32.8 39.8 13.7 10.9 20.8 6.2 9.5 7.6 25.4 34.2 14.0 39.3 4.4 0.0 9.1 5.6 6.7 3.9 0.0 7.4 5.9 7.6 10.1 39.4 6.8 10.4 4.8 20.6 4.9 10.8 3.6 3.4 8.4 6.8 1.0 7.2 2.2 7.8 5.1 2.5 6.8 12.3 0.0 6.1 9.9 18.4 17.1 7.7 4.4 7.8 12.4 RRP1B "KIAA0179, Nnp1, PPP1R136, RRP1" ENSG00000160208 "Ribosomal RNA processing 1B" Q14684 21 43659548-43696079 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 123.7;Early spermatids: 195.5;Late spermatids: 173.7;Rod photoreceptor cells: 138.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA017893, HPA020324" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA017893: AB_1852274, HPA020324: AB_1852276" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (4.03e-1)" "unprognostic (1.32e-3)" "unprognostic (1.24e-1)" "unprognostic (1.92e-2)" "unprognostic (2.03e-2)" "unprognostic (7.19e-2)" "unprognostic (1.98e-2)" "unprognostic (5.55e-3)" "unprognostic (1.08e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.95e-9)" "unprognostic (1.45e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (4.24e-2)" 12.7 10.3 10.7 20.0 13.7 7.6 14.5 13.9 12.5 13.1 11.1 11.5 9.4 9.5 16.1 9.2 15.7 14.0 12.2 8.4 9.5 8.6 7.5 17.7 10.4 22.8 13.1 7.5 20.0 20.6 11.8 11.4 8.4 10.3 11.3 10.9 15.0 13.9 12.8 21.6 14.1 11.1 12.9 9.9 16.9 11.8 32.5 12.6 25.6 9.6 12.6 20.5 13.5 14.1 6.0 3.2 2.1 2.7 5.8 9.8 5.3 16.9 10.0 10.7 16.1 7.0 7.5 8.8 8.9 6.4 9.9 8.2 22.7 7.4 33.2 5.9 7.0 11.5 7.6 26.4 15.4 11.8 11.1 21.0 19.6 11.6 14.2 9.7 30.5 7.8 7.7 9.9 11.9 13.8 6.1 11.0 14.4 30.6 9.8 8.7 8.8 24.2 9.3 36.5 11.0 11.2 32.0 10.8 23.2 7.2 8.1 21.3 11.4 16.8 12.4 12.4 4.1 8.1 9.6 9.8 3.1 9.7 8.1 16.2 13.3 16.9 39.7 9.7 33.0 10.0 2.1 2.6 0.7 7.2 2.7 8.5 6.0 9.1 8.6 3.2 5.3 8.6 9.8 0.1 5.8 2.3 2.6 7.0 5.3 10.7 13.7 13.9 12.5 9.5 8.6 13.1 7.5 10.3 12.6 29.8 16.0 22.1 12.1 20.3 28.9 10.4 12.7 21.4 28.4 5.2 123.7 6.5 1.7 12.9 195.5 15.9 4.7 0.0 13.7 13.6 13.6 12.0 33.7 16.6 16.5 23.8 5.2 11.1 11.9 173.7 20.8 11.6 8.5 11.8 8.5 14.7 16.6 0.0 25.1 9.5 138.2 0.0 16.0 24.0 34.2 27.7 3.7 27.3 13.8 12.2 RRP36 "C6orf153, dJ20C7.4" ENSG00000124541 "Ribosomal RNA processing 36" Q96EU6 6 43021645-43034156 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029904, HPA029905" Uncertain Enhanced Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA029904: AB_10611817, HPA029905: AB_2673244" "unprognostic (1.76e-1)" "unprognostic (4.47e-1)" "unprognostic (3.78e-2)" "unprognostic (1.46e-2)" "unprognostic (3.25e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (2.61e-1)" "unprognostic (6.83e-2)" "unprognostic (1.32e-3)" "unprognostic (1.39e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (3.53e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-2)" 25.0 29.7 21.0 24.9 27.2 23.3 57.7 18.0 42.1 21.3 22.4 16.0 24.9 19.4 23.8 24.7 31.9 20.6 20.1 31.3 22.7 21.4 25.2 32.7 24.1 46.5 21.1 28.0 17.3 37.4 37.0 28.8 23.4 27.3 24.6 23.8 19.5 23.5 36.4 61.9 28.4 21.4 28.3 28.5 29.4 25.7 23.9 15.8 25.0 22.6 30.9 31.8 23.7 28.2 6.5 9.7 4.0 4.6 3.1 7.7 1.2 39.4 22.3 22.2 32.4 24.0 22.5 18.7 31.3 28.4 40.2 39.5 40.5 17.3 18.3 25.6 32.6 29.5 21.2 37.1 38.0 44.5 23.1 37.8 29.4 24.8 43.2 27.9 24.4 22.9 22.7 23.3 48.0 20.6 14.4 32.6 16.6 35.5 20.0 37.2 41.6 29.3 26.7 24.6 70.7 23.2 27.7 21.9 21.1 24.6 37.4 28.5 25.0 23.1 21.2 35.8 21.8 29.2 30.1 26.2 37.2 28.3 24.4 49.1 18.8 28.2 48.9 16.2 30.9 34.5 3.9 3.6 3.1 5.9 4.6 4.7 6.5 4.2 7.0 3.7 2.6 3.9 7.7 4.0 3.1 3.6 9.7 2.1 1.2 21.0 27.2 18.0 42.1 22.7 21.4 21.1 28.0 27.3 15.8 0.0 14.1 20.6 9.5 11.8 15.3 13.7 28.1 8.1 12.5 19.2 15.7 25.9 11.6 31.6 8.6 11.3 10.5 0.0 38.9 36.9 13.2 13.1 5.8 34.3 25.3 17.5 13.4 22.1 14.3 18.5 10.9 13.4 13.5 28.9 11.3 25.1 32.5 7.0 17.7 16.1 17.2 6.5 12.0 7.6 10.2 16.3 28.1 10.0 12.8 12.1 RRP7A "CGI-96, Rrp7" ENSG00000189306 "Ribosomal RNA processing 7 homolog A" Q9Y3A4 22 42509968-42519802 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001586, HPA046768" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA001586: AB_1078506, HPA046768: AB_2679796" "unprognostic (8.46e-2)" "unprognostic (3.30e-3)" "unprognostic (5.96e-2)" "unprognostic (3.21e-3)" "unprognostic (9.71e-3)" "unprognostic (2.92e-1)" "prognostic unfavorable (1.21e-5)" "unprognostic (6.73e-2)" "unprognostic (3.00e-1)" "unprognostic (2.28e-1)" "unprognostic (2.41e-1)" "unprognostic (3.22e-2)" "unprognostic (9.53e-3)" "unprognostic (8.02e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" 10.4 12.9 19.9 15.4 26.6 16.5 13.5 18.5 20.9 12.8 12.2 15.1 9.4 10.2 12.0 47.3 15.1 18.9 12.0 11.1 17.5 14.8 14.0 18.1 11.3 21.5 14.8 9.3 21.2 12.0 16.6 10.3 17.7 17.4 17.8 10.8 12.6 15.2 14.6 13.5 14.9 13.3 11.9 11.7 15.6 12.0 11.2 18.6 17.4 11.6 8.7 16.4 10.7 11.0 26.2 30.5 17.4 27.5 15.2 18.4 20.3 13.0 18.4 10.1 11.9 6.5 4.3 20.5 11.1 6.7 14.4 12.2 23.4 7.5 21.8 5.7 7.9 8.0 14.5 11.6 15.5 6.2 5.5 23.7 11.8 12.8 12.6 6.2 28.3 10.2 5.5 7.8 19.5 9.9 5.2 8.7 11.7 16.6 6.3 8.5 26.5 27.2 11.6 8.4 10.4 13.4 47.4 10.4 9.6 7.5 16.0 5.5 3.9 8.2 23.6 10.8 5.4 9.6 12.8 6.5 11.0 14.2 8.4 11.3 9.7 7.2 25.6 9.2 10.9 15.8 10.0 23.5 17.4 18.4 26.4 17.7 20.5 16.1 16.8 18.1 26.2 17.7 16.5 4.7 15.2 27.5 30.5 13.5 20.3 19.9 26.6 18.5 20.9 17.5 14.8 14.8 9.3 17.4 18.6 20.8 35.8 52.9 72.3 38.9 26.5 14.2 25.5 34.8 33.0 21.0 15.7 80.7 14.9 65.2 48.5 37.9 36.0 23.3 23.4 117.3 32.9 62.0 46.2 29.2 83.7 25.4 25.3 31.3 37.8 94.1 20.4 49.8 32.1 146.1 29.9 22.2 58.6 42.1 17.3 34.2 28.7 6.5 26.9 30.9 22.8 33.1 100.7 41.5 40.0 87.7 RRP8 "KIAA0409, NML" ENSG00000132275 "Ribosomal RNA processing 8" O43159 11 6595075-6603620 "Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038487, HPA057562" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA038487: AB_10672518, HPA057562: AB_2683468" "unprognostic (9.01e-2)" "unprognostic (5.84e-2)" "unprognostic (2.53e-1)" "unprognostic (1.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.10e-7)" "unprognostic (4.64e-2)" "unprognostic (2.48e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.23e-2)" "unprognostic (3.81e-3)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.87e-2)" 13.8 11.9 13.9 15.8 14.8 32.1 17.9 18.1 15.3 15.9 24.9 16.1 10.5 14.0 15.5 21.3 13.8 11.9 15.4 16.2 16.0 10.3 13.3 24.7 14.3 16.0 18.4 13.6 12.4 12.7 12.0 12.3 12.8 14.2 19.8 14.4 11.8 10.9 19.7 18.6 15.5 12.8 19.5 11.0 17.7 15.1 12.3 18.6 11.8 14.2 9.7 16.6 20.2 13.9 13.3 14.4 20.3 12.0 14.4 13.8 10.2 10.1 10.2 4.1 5.2 8.5 7.4 5.8 5.2 6.6 12.2 11.5 10.4 12.0 14.3 5.2 5.0 9.0 10.3 11.6 9.3 13.0 6.8 16.6 6.7 12.2 11.8 9.8 12.2 9.4 6.3 12.1 5.8 10.6 8.1 12.5 6.7 13.3 8.4 9.6 12.6 11.8 18.2 10.0 17.9 9.2 10.6 3.3 3.2 11.4 8.2 6.3 7.4 7.5 15.4 8.6 7.0 8.4 10.7 6.4 11.6 5.3 11.2 10.1 9.4 8.4 13.6 9.8 12.3 7.4 20.3 11.0 10.7 13.7 11.8 13.2 10.9 13.5 12.6 14.4 13.3 13.3 13.8 4.4 14.4 12.0 11.0 12.6 10.2 13.9 14.8 18.1 15.3 16.0 10.3 18.4 13.6 14.2 18.6 20.8 12.9 13.7 14.7 20.6 17.1 18.3 7.6 10.7 15.9 8.7 13.7 19.6 10.0 15.6 5.3 16.6 10.9 23.3 13.9 17.0 14.6 9.7 17.3 19.1 16.3 3.2 6.9 9.8 8.4 10.4 12.0 12.0 8.5 19.8 12.8 13.3 18.6 13.3 9.2 16.5 27.4 0.0 20.9 21.2 17.2 23.7 16.7 14.9 15.9 12.2 RRS1 KIAA0112 ENSG00000179041 "Ribosome biogenesis regulator homolog" Q15050 8 66429028-66430733 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055549, HPA060937" Approved Supported Nucleoli Yes No Nucleoli "HPA055549: AB_2682846, HPA060937: AB_2684390" "unprognostic (7.68e-2)" "unprognostic (1.02e-1)" "unprognostic (3.72e-2)" "unprognostic (5.25e-2)" "unprognostic (2.64e-1)" "unprognostic (3.84e-3)" "unprognostic (4.93e-3)" "unprognostic (2.82e-3)" "unprognostic (3.55e-1)" "unprognostic (1.96e-2)" "unprognostic (2.13e-2)" "unprognostic (1.01e-2)" "unprognostic (3.46e-2)" "unprognostic (8.61e-2)" "unprognostic (2.30e-1)" "unprognostic (5.29e-2)" "unprognostic (8.35e-3)" 12.0 11.2 8.7 14.1 12.4 7.0 9.9 8.5 9.8 8.5 9.6 7.1 7.2 10.3 13.4 6.6 12.2 11.2 9.8 9.6 8.5 7.5 9.5 18.0 6.7 14.6 11.5 7.9 19.0 41.4 8.3 5.8 7.6 11.1 9.0 7.1 6.4 9.8 9.7 31.7 10.2 7.7 14.0 7.8 9.5 12.0 4.9 9.9 8.6 7.5 19.2 11.5 13.7 13.1 6.8 15.2 0.6 11.8 11.2 17.8 6.8 22.8 28.9 5.9 12.5 6.4 5.2 9.6 14.4 6.4 11.2 8.3 12.9 15.2 31.1 5.0 7.6 15.8 21.5 14.5 16.4 12.4 17.0 24.5 24.7 8.7 22.8 9.5 14.6 13.1 6.8 13.3 12.3 16.5 4.6 7.2 9.5 21.5 13.2 8.1 26.5 29.1 26.7 38.6 25.8 34.0 6.2 7.6 12.9 15.6 18.9 8.1 18.0 7.0 11.7 16.0 6.4 20.2 13.1 12.4 20.9 18.7 17.5 33.2 23.8 21.2 24.0 9.7 23.2 14.1 0.0 8.9 0.6 10.0 11.8 17.8 6.8 12.7 11.7 15.2 6.7 11.9 13.6 0.3 11.2 7.2 7.1 9.1 6.8 8.7 12.4 8.5 9.8 8.5 7.5 11.5 7.9 11.1 9.9 29.8 15.2 9.7 26.7 62.2 9.6 27.1 2.5 12.0 25.0 12.2 11.8 18.5 10.0 21.9 0.1 14.2 1.9 0.0 24.3 16.0 12.9 12.3 7.0 13.9 18.3 6.4 6.4 11.6 9.1 0.8 17.5 10.2 21.9 2.8 12.4 7.2 19.3 7.0 16.3 20.6 11.3 19.4 31.4 5.7 14.0 52.2 32.3 20.0 17.7 24.5 RSAD1 FLJ11164 ENSG00000136444 "Radical S-adenosyl methionine domain containing 1" Q9HA92 17 50478800-50485975 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA022436, HPA022967, HPA024459" Approved Approved "Nucleoli,Mitotic chromosome,Mitochondria" NA NA Mitochondria "Nucleoli, Mitotic chromosome" "HPA022436: AB_2180789, HPA022967: AB_1856484, HPA024459: " "unprognostic (8.21e-2)" "unprognostic (4.11e-3)" "unprognostic (3.72e-2)" "unprognostic (1.83e-2)" "unprognostic (3.49e-2)" "unprognostic (2.93e-2)" "unprognostic (6.01e-2)" "unprognostic (1.07e-2)" "unprognostic (2.52e-1)" "unprognostic (1.13e-2)" "prognostic favorable (5.04e-4)" "unprognostic (1.06e-1)" "unprognostic (1.65e-2)" "unprognostic (4.89e-2)" "unprognostic (2.95e-1)" "unprognostic (7.85e-2)" "unprognostic (3.22e-2)" 13.5 22.2 16.1 16.8 23.9 8.9 14.1 32.2 20.3 16.8 13.1 12.7 13.5 13.9 13.8 15.1 8.8 12.9 13.6 25.7 13.7 11.6 18.5 28.2 14.0 16.6 19.0 13.7 20.9 46.0 20.3 12.9 10.1 16.3 12.8 14.9 12.6 21.4 14.0 37.0 13.5 12.0 13.7 23.6 16.7 16.0 8.8 19.1 11.6 15.8 20.9 14.0 11.7 12.4 7.4 5.8 3.8 4.6 6.7 10.9 5.1 5.7 19.7 9.5 15.6 16.3 13.3 3.4 10.2 9.9 13.1 11.1 19.5 7.4 15.7 22.6 7.1 13.0 5.5 10.7 14.2 11.3 17.3 19.5 21.1 8.8 18.9 11.4 12.7 14.9 9.7 15.7 8.7 16.9 10.9 12.7 38.8 16.3 15.0 10.9 13.5 21.2 9.3 3.8 24.6 21.3 8.7 10.9 14.2 15.8 8.8 5.2 17.8 2.6 12.2 13.1 12.6 18.4 13.0 8.9 13.7 14.6 10.4 11.9 23.5 16.4 6.1 10.3 18.2 9.5 1.1 4.1 3.8 9.5 4.6 9.9 5.1 8.2 9.4 5.1 7.4 10.9 10.5 0.0 6.7 4.3 5.8 6.2 5.1 16.1 23.9 32.2 20.3 13.7 11.6 19.0 13.7 16.3 19.1 3.0 12.5 11.2 4.6 9.0 12.3 23.6 12.7 1.4 6.8 15.7 2.0 15.8 19.9 10.9 7.3 13.7 8.7 0.0 25.4 9.6 10.3 5.5 3.5 15.8 14.2 7.9 24.2 6.7 7.8 5.4 14.4 9.6 16.9 10.8 12.6 30.7 11.1 3.5 10.3 8.7 7.4 12.9 12.4 8.4 21.2 8.7 8.5 13.1 13.0 2.8 RSL24D1 "C15orf15, HRP-L30-iso, L30, RPL24, RPL24L" ENSG00000137876 "Ribosomal L24 domain containing 1" Q9UHA3 15 55180806-55197067 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062724, HPA063392" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA062724: AB_2684850, HPA063392: AB_2685002" "unprognostic (3.40e-2)" "unprognostic (3.00e-1)" "unprognostic (3.83e-1)" "unprognostic (7.28e-2)" "unprognostic (3.80e-2)" "unprognostic (1.07e-3)" "unprognostic (6.71e-3)" "unprognostic (1.15e-1)" "unprognostic (6.56e-3)" "unprognostic (1.34e-1)" "unprognostic (6.19e-3)" "unprognostic (7.22e-2)" "unprognostic (1.13e-1)" "unprognostic (4.44e-1)" "unprognostic (4.54e-2)" "unprognostic (4.95e-1)" "unprognostic (2.41e-1)" 27.7 24.3 26.7 23.4 28.8 76.1 47.8 35.7 29.9 40.6 32.2 10.0 25.6 18.1 34.5 26.6 34.2 26.4 21.4 25.3 25.1 25.3 24.3 26.7 27.0 35.8 25.4 25.8 54.7 37.8 15.0 23.2 22.4 24.1 44.3 20.5 11.2 25.8 21.3 47.2 19.3 21.1 50.4 27.5 28.6 28.8 24.2 20.6 39.5 43.1 36.9 27.4 61.9 49.6 29.1 27.0 11.4 24.1 22.7 45.1 47.7 16.1 16.4 18.1 23.7 14.2 26.8 14.7 17.1 19.2 14.4 18.4 15.7 9.9 50.4 15.5 12.3 14.1 19.8 23.8 19.8 19.4 24.5 14.8 25.8 13.2 19.5 32.8 48.5 16.9 22.7 42.0 14.4 41.9 23.3 17.8 37.9 48.6 36.6 16.7 16.5 26.5 42.8 22.3 33.1 14.8 21.2 22.7 75.9 21.6 15.0 25.7 30.8 7.9 22.3 55.4 15.0 21.4 71.8 12.4 11.9 13.9 13.8 24.4 35.3 53.9 50.1 18.5 48.1 19.9 11.4 23.8 11.4 19.6 23.4 31.1 29.1 29.5 24.3 27.0 22.5 45.1 34.0 6.0 22.7 24.1 21.1 32.4 47.7 26.7 28.8 35.7 29.9 25.1 25.3 25.4 25.8 24.1 20.6 92.3 65.6 256.3 349.8 515.7 83.5 63.5 89.2 77.6 80.8 80.3 21.6 138.6 242.1 170.0 67.8 119.6 46.1 70.0 234.1 222.4 198.3 186.8 150.0 57.1 128.0 14.3 134.4 79.8 196.0 28.6 188.4 183.5 269.9 194.8 102.0 68.6 201.1 134.0 140.4 191.4 51.1 155.2 258.6 71.0 148.8 456.4 145.9 187.5 118.2 292.9 RSPH14 RTDR1 ENSG00000100218 "Radial spoke head 14 homolog" Q9UHP6 22 23059415-23145021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.3;testis: 24.8" "Group enriched" "Detected in some" 6 "Ciliated cells: 53.5;Early spermatids: 109.2;Late spermatids: 198.9" "Cancer enhanced" "Detected in some" "renal cancer: 2.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 10.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.8" "Cell line enhanced" "Detected in many" "GAMG: 6.5;RPTEC TERT1: 6.9;U-266/70: 7.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA018420, HPA050425" Approved Uncertain Nucleoli NA NA Nucleoli "HPA018420: AB_1856496, HPA050425: " "unprognostic (8.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.15e-3)" "unprognostic (3.80e-3)" "unprognostic (1.97e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.41e-1)" "unprognostic (1.22e-2)" "unprognostic (8.31e-2)" "unprognostic (7.28e-2)" "prognostic favorable (4.04e-4)" "unprognostic (5.18e-2)" "unprognostic (4.40e-2)" "unprognostic (3.16e-1)" "unprognostic (7.73e-2)" 0.8 3.0 4.8 0.5 6.8 0.4 0.5 1.2 8.8 1.4 0.7 2.6 0.9 0.4 1.3 4.9 0.6 15.3 1.8 0.3 4.7 4.7 9.3 0.3 1.8 0.5 2.9 3.3 5.5 0.6 0.9 3.1 0.4 6.4 1.1 0.5 1.0 1.0 2.4 0.9 1.6 0.4 0.6 1.6 0.4 0.8 24.8 1.6 0.0 2.7 0.0 0.5 0.6 0.3 0.1 0.0 10.8 2.0 0.2 0.3 0.6 0.4 3.9 3.5 3.3 0.0 1.6 0.2 0.0 0.8 0.7 0.6 0.7 1.2 0.8 1.2 0.0 6.5 0.1 0.2 0.0 0.0 0.0 0.2 0.4 0.2 1.5 0.2 0.2 1.7 0.0 0.4 0.6 0.0 2.0 0.0 1.4 0.1 1.7 0.0 0.5 0.8 0.6 0.0 1.0 0.1 0.2 0.1 3.7 6.9 0.0 4.5 2.1 0.1 0.1 0.2 0.2 0.7 0.8 0.0 3.1 0.8 0.2 0.0 7.9 3.0 2.2 2.5 0.4 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.2 10.8 0.2 2.0 0.0 0.1 0.6 4.8 6.8 1.2 8.8 4.7 4.7 2.9 3.3 6.4 1.6 0.0 0.0 0.0 0.6 0.0 0.8 0.0 2.5 53.5 6.8 0.0 3.9 0.0 6.6 0.7 109.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 11.1 0.0 0.6 0.0 198.9 2.0 0.0 0.0 0.0 0.0 3.1 0.3 0.0 1.8 13.9 4.5 0.0 0.0 21.7 7.5 0.0 0.0 0.0 0.0 0.3 RTF2 "C20orf43, CDAO5, HSPC164, RTFDC1" ENSG00000022277 "Replication termination factor 2" Q9BY42 20 56468585-56519449 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 133.3;Distal tubular cells: 132.6;monocytes: 160.5;Syncytiotrophoblasts: 153.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053986 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA053986: AB_2682333" "unprognostic (1.65e-1)" "unprognostic (1.94e-3)" "unprognostic (2.01e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.54e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (8.90e-2)" "unprognostic (4.02e-3)" "unprognostic (1.16e-1)" "unprognostic (8.98e-2)" "unprognostic (3.66e-2)" "unprognostic (1.55e-2)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "unprognostic (4.58e-1)" "unprognostic (8.48e-3)" 33.4 34.2 43.5 29.1 43.9 52.6 28.9 27.4 48.7 28.8 29.4 53.0 20.1 28.0 31.4 24.1 30.5 31.6 23.2 38.7 40.6 35.6 31.8 30.3 24.2 29.7 49.6 35.7 35.2 27.5 26.0 29.3 30.5 46.6 28.5 26.0 26.0 25.8 31.7 74.6 27.9 29.8 34.1 59.7 30.2 25.3 29.1 45.2 31.4 29.1 28.9 34.4 29.0 23.9 20.0 35.1 91.6 31.8 29.4 23.0 33.2 28.9 20.8 21.1 20.6 26.4 23.6 19.6 45.2 34.2 65.3 37.5 42.4 28.1 24.8 53.7 36.6 32.1 32.5 21.1 34.8 45.2 11.6 16.4 31.0 22.8 32.8 30.3 44.1 42.9 20.9 36.2 29.1 25.3 27.8 28.0 26.6 24.0 26.0 32.0 55.3 36.9 37.6 15.6 41.1 39.7 25.4 57.5 32.7 27.2 19.1 21.8 23.7 47.5 80.6 42.5 16.3 37.3 42.1 30.0 55.9 36.2 30.4 36.5 21.7 24.9 35.3 44.0 30.1 30.4 39.2 31.8 84.1 20.9 29.6 17.6 18.6 18.0 20.3 35.1 20.0 20.5 18.8 91.6 29.4 28.8 29.9 23.0 33.2 43.5 43.9 27.4 48.7 40.6 35.6 49.6 35.7 46.6 45.2 47.6 50.4 0.0 0.0 0.0 0.0 0.0 0.0 62.9 62.6 62.8 0.0 133.3 132.6 81.8 0.0 0.0 0.0 0.0 83.7 92.1 0.0 0.0 83.7 0.0 98.1 0.0 0.0 0.0 0.0 0.0 0.0 45.0 0.0 160.5 0.0 0.0 80.1 0.0 0.0 106.9 0.0 0.0 0.0 0.0 0.0 0.0 153.0 0.0 0.0 0.0 S100A13 ENSG00000189171 "S100 calcium binding protein A13" Q99584 1 153618787-153631360 "Predicted intracellular proteins, Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 714.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 19.4" "Group enriched" "Detected in many" 5 "dendritic cells: 8.4;NK-cells: 19.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 94.7;SuSa: 111.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019592, CAB025494" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Secreted in other tissues" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "CAB025494: , HPA019592: AB_10601499" "unprognostic (1.50e-2)" "unprognostic (9.09e-2)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (7.77e-2)" "unprognostic (9.72e-3)" "unprognostic (1.75e-3)" "unprognostic (9.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.67e-1)" "unprognostic (1.21e-2)" "unprognostic (4.83e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.43e-2)" "unprognostic (8.10e-2)" "unprognostic (1.82e-3)" "unprognostic (1.72e-2)" 38.2 20.9 49.6 13.8 48.3 1.2 61.8 11.5 28.2 39.1 32.3 25.0 13.9 9.4 23.5 25.0 19.9 34.5 32.0 56.3 30.3 32.0 28.0 20.2 23.3 12.7 54.2 32.7 29.9 13.9 45.9 9.7 21.6 37.7 23.0 19.3 21.1 19.8 21.7 73.8 14.1 13.7 27.2 38.9 13.7 11.9 10.3 28.5 2.4 79.0 28.2 14.6 21.1 16.0 2.6 8.4 3.0 1.5 19.4 0.9 0.8 21.1 17.7 20.5 13.0 18.1 53.1 7.4 29.4 46.6 17.8 20.5 17.2 23.6 0.5 55.9 49.8 2.6 20.2 8.5 18.2 15.8 0.0 7.9 1.3 22.2 14.6 12.0 0.6 4.6 42.7 6.9 15.9 17.2 52.5 40.2 0.1 6.8 0.0 55.3 74.9 0.0 0.3 16.5 18.2 53.5 3.3 21.2 0.1 94.7 16.2 6.3 0.2 62.8 32.4 63.5 111.1 26.4 0.7 56.9 12.3 6.9 16.4 35.3 0.2 0.5 0.9 22.0 0.3 7.2 3.0 1.5 0.1 0.3 0.7 0.6 2.6 0.3 0.2 5.0 1.6 0.5 0.3 0.2 19.4 0.9 8.4 0.9 0.8 49.6 48.3 11.5 28.2 30.3 32.0 54.2 32.7 37.7 28.5 26.8 88.4 17.1 154.8 98.1 2.0 108.1 175.8 60.2 93.3 441.4 0.0 118.0 210.5 277.9 6.5 300.3 126.3 46.7 281.2 170.7 294.9 188.4 23.1 34.1 128.8 0.0 119.8 371.4 32.4 21.5 714.6 43.9 226.0 20.8 107.7 97.5 336.0 115.8 295.2 330.9 5.7 0.0 84.3 7.5 18.3 66.1 62.5 8.6 64.8 157.7 S100A2 "CAN19, S100L" ENSG00000196754 "S100 calcium binding protein A2" P29034 1 153561108-153567890 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 224.8;tongue: 246.5" "Cell type enhanced" "Detected in many" 20 "Basal glandular cells: 2667.8;Basal keratinocytes: 10183.7;Suprabasal keratinocytes: 3170.0;Urothelial cells: 4604.3" "Cancer enhanced" "Detected in all" "head and neck cancer: 1229.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 11.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 11.9" "Group enriched" "Detected in some" 5 "HBEC3-KT: 671.5;RT4: 262.5" "Not detected" "Not detected" "CAB002600, CAB047340, HPA062451" Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" NA NA 130000 "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "CAB002600: , CAB047340: , HPA062451: AB_2684767" "unprognostic (8.47e-3)" "unprognostic (5.54e-2)" "unprognostic (1.57e-2)" "unprognostic (1.42e-3)" "unprognostic (1.98e-1)" "unprognostic (3.20e-1)" "unprognostic (4.21e-4)" "unprognostic (9.00e-2)" "unprognostic (1.64e-1)" "unprognostic (1.23e-2)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.52e-2)" "unprognostic (8.91e-2)" "unprognostic (1.35e-1)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" 0.4 0.0 0.4 0.5 0.4 0.0 2.1 0.4 0.5 16.9 0.4 0.4 0.9 0.0 1.8 1.9 224.8 0.5 0.4 0.4 0.4 0.0 16.6 0.4 1.6 0.4 0.4 0.4 0.4 0.4 0.0 0.5 0.6 0.6 3.3 0.0 0.4 23.3 2.1 0.7 27.5 0.4 1.5 0.5 0.4 0.0 0.5 0.4 0.7 1.0 246.5 48.4 36.2 43.8 0.5 2.6 11.9 0.6 0.0 2.9 0.7 25.4 0.2 0.0 0.0 0.3 0.1 0.0 0.3 0.3 0.2 0.2 0.0 0.8 0.0 13.5 0.5 0.5 63.2 0.0 671.5 0.3 0.1 0.1 0.1 1.7 0.1 0.1 0.0 0.0 0.2 89.4 0.7 102.0 0.7 0.4 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.6 4.9 0.0 16.0 0.0 15.9 262.5 0.5 0.0 1.1 0.1 0.2 0.2 0.1 0.1 0.1 0.4 22.2 2.9 8.6 0.0 0.0 0.1 0.8 0.0 0.7 11.9 0.5 0.0 2.9 0.0 1.8 0.5 2.0 1.6 0.4 0.0 0.6 0.5 5.0 0.0 0.6 2.6 1.8 0.7 0.4 0.4 0.4 0.5 0.4 0.0 0.4 0.4 0.6 0.4 8.9 15.9 2.2 2667.8 10183.7 0.0 2.0 2.5 307.9 1714.1 207.6 0.0 0.1 1039.5 26.2 3.0 3.6 1.3 0.0 24.2 0.9 117.2 609.3 16.2 0.0 1.8 0.0 1.7 0.6 1.5 3.8 0.6 38.5 720.4 9.0 1.7 1.0 390.7 2.9 0.7 9.8 0.0 0.0 213.2 0.2 2.3 3170.0 0.2 1.3 1.5 4604.3 SALL1 "Hsal1, TBS, ZNF794" ENSG00000103449 "Spalt like transcription factor 1" Q9NSC2 16 51135975-51151367 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.9;kidney: 26.8;liver: 32.0" "Group enriched" "Detected in some" 14 "Cholangiocytes: 7.6;Collecting duct cells: 8.7;Cone photoreceptor cells: 23.6;Distal tubular cells: 10.0;Hepatocytes: 27.2;Proximal tubular cells: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.2;BJ hTERT+: 12.9;NTERA-2: 24.6;RPTEC TERT1: 20.9;U-87 MG: 24.1" "Region enriched" "Detected in many" 5 "olfactory region: 64.6" "Low region specificity" "Detected in many" "HPA049829, HPA074673" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear speckles, Cytosol" "HPA049829: AB_2680902, HPA074673: " "unprognostic (9.91e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-6)" "prognostic favorable (1.28e-4)" "unprognostic (2.55e-1)" "unprognostic (1.17e-1)" "unprognostic (1.96e-2)" "unprognostic (4.41e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (1.48e-1)" "unprognostic (3.96e-1)" "prognostic favorable (1.91e-7)" "unprognostic (1.86e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-2)" "unprognostic (1.76e-1)" 0.8 0.7 12.2 1.2 14.5 0.7 0.9 1.7 18.9 16.1 3.1 31.9 0.0 1.6 17.8 1.5 0.8 10.4 1.1 1.2 13.6 5.5 26.8 32.0 0.6 0.6 21.8 9.1 5.2 1.6 0.9 4.3 4.3 17.6 1.3 3.2 0.0 0.9 2.3 0.6 0.7 1.4 9.4 19.7 0.7 3.0 2.2 19.4 0.0 23.7 0.0 0.6 2.2 4.8 1.0 1.9 2.3 3.1 0.1 1.1 1.1 0.0 0.8 15.2 0.1 0.4 0.3 0.0 5.0 12.9 0.3 0.7 0.0 0.0 0.0 5.8 7.1 4.5 0.0 9.4 0.0 0.4 0.0 5.7 0.0 0.0 9.1 0.3 0.0 4.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 1.8 0.9 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 24.1 0.0 5.0 0.6 3.1 2.3 0.7 2.0 0.7 1.0 1.0 0.9 1.9 0.8 0.6 0.6 1.8 0.1 1.5 1.9 1.1 1.1 12.2 14.5 1.7 10.3 13.6 5.5 21.8 9.1 17.6 19.4 0.0 0.0 0.0 0.0 0.2 0.0 1.1 7.6 0.0 0.0 8.7 23.6 0.0 10.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 27.2 0.1 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 16.7 0.2 0.0 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.1 SAMD15 "C14orf174, FAM15A, FLJ35963" ENSG00000100583 "Sterile alpha motif domain containing 15" Q9P1V8 14 77376689-77391497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 29.1;testis: 22.1" "Group enriched" "Detected in many" 7 "Ciliated cells: 65.6;Cone photoreceptor cells: 58.9;Early spermatids: 61.5;Late spermatids: 75.0;Rod photoreceptor cells: 75.7;Spermatocytes: 45.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 10.8" "Low region specificity" "Detected in many" "HPA030673, HPA030677" Enhanced Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nuclear membrane, Nucleoli" "HPA030673: AB_10600655, HPA030677: AB_10599938" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (1.38e-2)" "unprognostic (3.70e-3)" "unprognostic (5.20e-2)" "unprognostic (5.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.83e-3)" "unprognostic (6.19e-2)" "unprognostic (2.53e-3)" "unprognostic (6.87e-3)" "unprognostic (9.90e-2)" "unprognostic (3.73e-3)" "unprognostic (1.76e-2)" 0.8 1.3 5.3 0.5 6.7 0.9 1.5 0.8 3.3 1.2 0.7 2.2 3.1 0.6 1.5 7.5 0.7 6.2 1.5 0.6 3.7 2.9 6.0 0.6 1.8 1.9 1.4 3.1 3.2 2.7 5.2 29.1 0.5 7.9 1.3 0.5 4.4 0.8 1.1 0.5 0.8 0.6 0.6 1.5 0.7 0.7 22.1 2.3 0.1 6.9 0.0 1.8 1.9 0.7 0.6 0.2 2.3 0.5 0.6 0.4 0.1 3.6 4.9 1.9 4.1 0.5 2.1 1.8 1.5 1.3 4.0 3.6 3.5 3.3 4.0 1.6 1.5 3.5 3.5 1.4 2.0 5.5 0.3 0.7 0.6 1.4 0.9 0.2 0.7 4.3 2.0 1.3 3.4 0.4 1.7 2.7 2.0 0.4 1.2 1.6 10.8 0.9 0.4 0.8 0.9 1.6 1.7 1.9 0.2 6.9 2.0 4.3 2.7 5.1 0.8 0.7 0.8 6.4 1.2 1.0 3.7 2.2 3.9 1.9 0.7 3.3 2.6 4.7 0.2 1.9 0.7 0.5 1.2 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.6 0.3 0.4 2.3 0.6 0.5 0.1 0.4 0.1 5.3 6.7 0.8 3.3 3.7 2.9 1.4 3.1 7.9 2.3 0.0 0.0 0.0 0.4 0.2 9.7 0.8 2.5 65.6 2.3 0.0 58.9 0.2 1.7 2.4 61.5 0.3 0.0 0.0 0.6 0.2 0.6 0.5 0.0 0.0 0.1 3.2 3.5 0.0 0.0 75.0 1.4 0.0 0.0 0.0 0.0 4.8 1.0 0.0 0.0 3.4 75.7 0.0 0.3 45.6 6.0 0.0 0.2 0.0 0.0 0.1 SAPCD2 "C9orf140, p42.3" ENSG00000186193 "Suppressor APC domain containing 2" Q86UD0 9 137062124-137070588 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 3.8;Mucus-secreting cells: 6.4;Paneth cells: 4.9;Undifferentiated cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044154 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "HPA044154: AB_10959464" "unprognostic (3.68e-2)" "unprognostic (9.85e-2)" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.80e-2)" "unprognostic (1.27e-1)" "unprognostic (5.42e-8)" "prognostic unfavorable (5.88e-4)" "unprognostic (8.33e-2)" "unprognostic (7.47e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (9.83e-7)" "unprognostic (4.37e-3)" "unprognostic (4.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.35e-2)" 1.0 0.4 11.5 10.5 7.0 3.3 2.6 1.4 14.4 2.5 6.2 10.1 0.0 7.6 1.0 0.4 7.8 0.8 5.4 0.4 9.6 7.5 1.2 0.4 2.7 4.7 8.0 3.8 0.3 0.8 0.3 0.4 1.8 5.4 5.4 3.5 0.0 7.3 0.4 0.4 5.4 7.7 1.0 7.0 2.7 4.6 1.5 2.7 9.2 0.6 3.5 10.0 1.0 1.9 0.5 0.8 0.5 1.7 0.0 0.4 0.4 16.0 8.7 3.4 10.2 0.1 0.2 18.5 2.6 1.8 2.8 1.3 16.4 7.4 16.8 8.6 1.3 2.6 22.8 10.8 3.0 0.6 11.5 12.4 7.3 9.6 18.3 0.0 8.3 12.7 0.0 0.5 1.0 1.8 0.7 4.6 8.6 10.1 7.6 0.8 37.7 2.4 22.4 6.4 37.2 19.8 25.6 13.1 18.6 3.5 4.6 17.9 10.6 10.2 28.6 3.9 0.8 23.1 15.8 2.9 2.6 8.8 7.7 13.0 2.6 7.6 8.1 6.0 9.9 8.1 0.2 1.7 0.0 0.0 0.5 0.4 0.5 0.3 0.0 0.8 0.2 0.1 0.0 0.5 0.0 0.8 0.2 0.3 0.4 11.5 7.0 1.4 6.1 9.6 7.5 8.0 3.8 5.4 2.7 0.0 0.0 0.0 0.6 3.8 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.7 1.7 0.3 0.0 0.0 0.4 0.0 0.0 2.7 0.6 2.1 0.0 0.0 2.5 0.0 0.0 0.6 3.0 0.0 0.0 1.8 0.0 0.0 6.4 0.6 0.3 4.9 0.0 0.0 0.5 0.0 0.3 0.0 1.2 2.4 0.5 1.0 4.5 0.5 SCML2 ENSG00000102098 "Scm polycomb group protein like 2" Q9UQR0 X 18239314-18354727 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Spermatocytes: 22.8;Spermatogonia: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 7.0" "Lineage enriched" "Detected in single" 7 "dendritic cells: 7.0" "Cell line enhanced" "Detected in many" "NTERA-2: 20.0;REH: 17.8" "Low region specificity" "Detected in all" "HPA001662, HPA064713" Enhanced Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA001662: AB_1079879, HPA064713: AB_2685333" "unprognostic (5.15e-2)" "unprognostic (2.57e-2)" "unprognostic (7.93e-2)" "unprognostic (7.26e-5)" "unprognostic (1.24e-1)" "unprognostic (2.24e-2)" "unprognostic (4.95e-5)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (1.18e-1)" "unprognostic (6.15e-4)" "unprognostic (1.83e-1)" "unprognostic (2.35e-4)" "unprognostic (3.30e-1)" "unprognostic (2.54e-1)" "unprognostic (1.97e-2)" "unprognostic (3.31e-3)" 2.4 7.7 3.1 2.1 4.1 8.6 3.1 3.4 3.8 3.7 3.7 3.7 2.0 2.1 4.9 2.5 2.3 2.9 2.8 2.0 2.3 2.0 1.5 2.6 1.3 2.0 3.6 0.5 9.5 3.9 3.2 8.0 7.1 2.3 2.9 2.3 3.6 10.0 2.2 2.0 3.4 2.0 6.5 2.2 2.3 1.7 19.0 4.2 12.5 4.3 2.3 2.1 2.7 4.2 0.8 7.0 0.2 0.2 0.9 0.7 0.2 0.9 3.3 11.8 3.0 0.9 1.5 3.5 2.0 1.4 4.0 4.5 4.8 0.7 0.0 0.4 0.9 2.9 0.0 16.5 0.2 4.9 0.0 13.5 0.0 3.0 2.1 0.5 10.3 2.7 0.6 0.6 2.9 3.4 1.0 0.2 10.5 7.7 0.0 2.8 1.5 16.5 5.5 20.0 0.3 4.2 17.8 5.9 2.4 0.0 0.2 7.2 8.4 3.5 3.3 0.0 13.6 4.2 4.6 0.3 3.6 2.6 8.0 1.8 0.0 9.4 16.6 1.2 7.1 2.7 0.0 0.2 0.2 0.7 0.2 0.7 0.2 0.3 0.2 0.9 0.8 0.2 0.1 0.2 0.9 0.1 7.0 0.0 0.2 3.1 4.1 3.4 3.8 2.3 2.0 3.6 0.5 2.3 4.2 0.0 0.3 0.8 1.0 3.2 2.2 1.0 0.0 0.0 1.2 0.0 0.0 1.2 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.3 1.3 0.7 0.0 0.9 1.5 6.4 1.2 0.0 0.0 1.1 1.7 0.0 0.0 0.0 0.5 2.1 0.3 0.0 1.1 0.6 3.6 0.0 0.4 22.8 28.0 3.6 0.3 0.0 1.2 0.3 SCN5A "CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1" ENSG00000183873 "Sodium voltage-gated channel alpha subunit 5" Q14524 3 38548057-38649673 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 67.3" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 66.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "LHCN-M2: 22.0;RH-30: 18.3" "Group enriched" "Detected in some" 5 "amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0" "Low region specificity" "Detected in many" HPA063346 Supported "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA063346: " "unprognostic (9.29e-4)" "unprognostic (4.05e-2)" "unprognostic (9.95e-2)" "unprognostic (1.74e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (8.48e-2)" "unprognostic (7.12e-3)" "unprognostic (5.28e-2)" "unprognostic (1.16e-4)" "unprognostic (4.85e-3)" "unprognostic (1.09e-1)" "unprognostic (5.35e-2)" "unprognostic (4.95e-3)" 0.3 0.2 1.3 0.2 0.3 0.4 0.6 0.1 2.3 2.0 0.4 0.0 0.4 0.3 0.9 0.8 0.2 0.4 0.3 67.3 0.5 0.7 0.1 0.1 0.2 0.1 0.1 0.3 0.6 0.2 0.1 0.8 0.3 0.0 1.3 0.2 1.2 0.3 1.6 5.5 0.2 0.3 0.4 0.1 0.2 0.2 0.5 0.0 0.0 0.3 0.1 0.1 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.8 0.4 0.0 0.1 0.3 2.7 0.0 0.0 0.0 0.9 0.9 2.7 0.0 0.4 0.0 1.2 0.7 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.5 0.0 1.7 3.6 0.4 0.0 0.0 22.0 1.1 0.0 0.0 2.0 0.0 0.0 0.0 18.3 0.0 0.0 2.4 0.3 2.4 0.0 0.0 0.0 0.7 0.0 0.0 4.4 0.0 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.1 2.3 0.5 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 3.1 66.1 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.3 0.9 0.0 0.0 0.0 0.0 1.0 SDAD1 FLJ10498 ENSG00000198301 "SDA1 domain containing 1" Q9NVU7 4 75940950-75990962 "Predicted intracellular proteins" "Protein transport, Ribosome biogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035949 Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA035949: AB_10673225" "unprognostic (8.82e-3)" "unprognostic (3.39e-3)" "unprognostic (7.62e-3)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (5.15e-2)" "unprognostic (1.44e-1)" "unprognostic (1.59e-1)" "unprognostic (2.08e-2)" "unprognostic (3.98e-2)" "prognostic favorable (2.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.41e-1)" "unprognostic (2.24e-2)" "unprognostic (4.62e-1)" 17.0 17.9 19.6 16.5 30.2 7.3 21.5 17.6 26.7 19.9 17.9 9.6 14.0 14.0 26.2 23.2 19.5 18.9 10.6 16.4 18.2 15.4 21.9 23.9 14.6 22.8 16.4 19.1 22.7 26.9 20.4 30.6 17.5 22.6 18.5 18.6 9.4 18.3 20.8 32.3 19.6 16.1 24.9 16.2 23.5 18.1 24.1 19.9 21.5 25.8 17.1 22.9 21.3 17.5 13.2 10.3 5.6 16.8 15.4 17.8 10.5 14.6 5.9 14.6 19.5 17.4 15.7 15.3 20.8 18.1 17.4 15.2 18.2 21.0 23.0 15.7 19.0 16.7 15.1 22.2 20.1 21.9 20.2 11.7 19.6 13.1 15.0 16.4 33.3 22.4 13.7 22.8 18.4 20.3 10.8 15.2 15.7 35.1 19.0 17.8 16.2 33.7 11.8 23.7 23.7 9.0 20.5 27.5 19.3 16.6 16.4 22.1 18.4 14.2 29.0 23.5 16.6 13.3 19.6 14.3 18.8 19.0 22.4 17.3 17.5 18.2 31.4 21.1 15.1 23.2 5.6 9.9 2.7 14.2 12.7 17.7 12.1 17.4 16.1 10.3 13.2 17.8 14.9 1.6 15.4 16.8 9.0 14.7 10.5 19.6 30.2 17.6 26.7 18.2 15.4 16.4 19.1 22.6 19.9 17.9 26.7 35.6 21.5 24.5 19.7 10.6 15.3 33.5 50.0 21.0 5.9 26.9 29.9 34.3 86.0 21.1 13.9 0.0 21.5 26.1 23.2 22.2 48.5 20.5 32.6 12.7 21.9 16.0 23.5 81.4 23.6 29.5 23.6 39.7 22.8 22.4 28.9 22.9 31.1 37.2 19.7 19.4 24.5 58.5 94.3 29.0 20.9 32.0 26.0 19.7 SDHA "FP, SDH2, SDHF" ENSG00000073578 "Succinate dehydrogenase complex flavoprotein subunit A" P31040 5 218241-256700 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 100.1;skeletal muscle: 114.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034929, HPA041981, HPA064582" Enhanced Supported Nucleoli,Mitochondria No No 780000 Mitochondria Nucleoli "CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293" "prognostic unfavorable (6.00e-4)" "unprognostic (1.93e-1)" "unprognostic (5.97e-2)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (1.62e-1)" "unprognostic (2.80e-1)" "unprognostic (3.14e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "prognostic favorable (9.53e-8)" "unprognostic (1.11e-2)" "unprognostic (2.62e-1)" "unprognostic (3.57e-1)" "unprognostic (1.79e-1)" 17.6 31.4 15.3 11.5 20.3 10.6 12.8 18.8 29.0 10.2 29.4 17.3 10.0 44.3 11.3 12.1 15.3 12.6 14.8 100.1 15.8 14.5 36.5 55.4 10.7 11.7 19.6 19.3 14.5 14.7 23.2 9.5 9.2 29.7 10.7 24.6 14.5 17.3 12.0 114.0 11.5 39.9 16.5 13.2 13.9 21.2 14.6 14.8 15.7 12.5 39.6 12.5 13.2 11.1 28.3 31.9 29.1 29.2 27.1 48.9 32.4 18.7 30.4 12.5 20.4 21.6 16.2 34.0 14.5 18.4 25.0 25.5 32.9 25.6 23.2 45.8 16.5 18.9 24.3 22.1 29.6 14.8 49.4 20.2 11.8 84.1 42.8 13.4 14.7 15.4 16.1 19.0 18.6 9.9 19.9 27.0 16.6 19.0 19.3 11.7 28.7 19.4 39.7 4.3 20.5 38.6 25.1 18.2 45.0 53.1 24.9 13.8 7.9 68.2 44.1 17.9 8.1 26.7 18.6 19.5 18.5 18.2 11.0 11.9 20.6 8.8 17.1 17.9 21.2 11.7 17.8 24.4 29.1 36.4 29.2 32.1 28.3 34.8 35.1 31.9 24.5 34.5 31.7 5.9 27.1 24.1 20.5 48.9 32.4 15.3 20.3 18.8 29.0 15.8 14.5 19.6 19.3 29.7 14.8 32.8 63.8 52.9 58.0 54.4 45.7 238.2 76.5 58.9 40.9 71.5 96.2 94.1 121.0 78.8 32.8 37.6 207.8 0.0 39.4 87.2 53.2 29.4 42.7 135.6 60.4 95.3 45.6 43.0 39.1 20.2 63.3 43.9 86.0 78.5 75.8 40.3 44.9 92.8 52.3 129.8 77.8 77.6 45.0 66.5 55.1 31.5 129.4 59.9 128.8 78.3 SDHAF2 "C11orf79, FLJ20487, PGL2, SDH5" ENSG00000167985 "Succinate dehydrogenase complex assembly factor 2" Q9NX18 11 61430042-61447529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039464, HPA039732" Supported Approved Nucleoli,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoli "HPA039464: AB_10962146, HPA039732: AB_10962868" "unprognostic (5.31e-2)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (1.30e-2)" "unprognostic (1.40e-1)" "unprognostic (6.71e-2)" "unprognostic (1.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.17e-1)" "unprognostic (2.09e-3)" "unprognostic (4.21e-3)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (1.45e-1)" "unprognostic (4.48e-2)" 23.7 33.0 22.2 22.4 27.2 34.1 24.8 19.9 33.8 20.5 22.1 23.4 21.0 22.3 23.3 33.5 25.3 25.8 21.1 32.5 20.8 26.9 26.8 39.1 19.9 36.7 24.3 25.0 25.7 22.7 23.3 38.4 26.7 25.2 26.1 24.9 32.0 28.1 21.5 31.4 22.9 27.9 26.6 20.8 32.2 24.3 19.2 21.1 36.1 27.0 20.2 30.9 24.0 19.2 31.3 23.2 44.6 25.4 32.7 43.7 26.7 15.4 22.3 13.2 9.2 19.2 15.7 10.3 12.0 17.4 16.3 12.5 20.8 16.7 15.6 22.1 17.4 22.2 16.8 17.2 17.1 17.5 23.1 16.3 13.4 18.3 30.0 20.0 15.8 18.8 19.4 20.9 17.7 17.3 11.6 26.2 16.8 15.4 20.1 19.6 34.2 16.1 35.9 20.4 15.9 32.8 17.4 17.1 28.8 23.2 23.0 14.2 17.7 16.5 19.3 33.4 14.1 30.1 18.9 16.3 16.6 13.5 19.7 14.2 12.4 19.3 19.9 16.1 14.1 17.4 41.9 25.4 44.6 32.4 22.8 38.4 31.3 35.9 34.7 20.3 29.9 39.5 38.4 37.0 32.7 17.9 23.2 43.7 26.7 22.2 27.2 19.9 33.8 20.8 26.9 24.3 25.0 25.2 21.1 32.8 38.1 35.3 31.0 18.3 14.0 20.5 12.7 32.1 21.6 27.9 5.9 61.5 46.4 50.2 11.4 29.8 27.1 23.3 52.7 47.1 28.8 26.8 31.2 37.0 45.9 14.3 32.8 36.8 33.7 13.8 29.1 32.1 42.2 81.2 28.5 36.7 49.4 31.7 29.0 38.3 14.1 32.3 24.7 15.8 23.5 19.6 83.3 44.5 23.9 29.9 SELENBP1 "hSBP, hSP56, LPSB" ENSG00000143416 "Selenium binding protein 1" Q13228 1 151364302-151372733 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein transport, Transport" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 112.3" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 401.2;Enterocytes: 467.1;Hepatocytes: 434.3;Paneth cells: 327.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "myeloid DC: 4.8" "Lineage enriched" "Detected in many" 4 "dendritic cells: 4.8" "Cell line enhanced" "Detected in many" "ASC diff: 38.5;HEL: 28.5;HSkMC: 19.8;OE19: 23.2;SK-BR-3: 68.7" "Low region specificity" "Detected in all" "HPA005741, CAB008366, HPA011731" Enhanced Supported Nucleoli NA NA 57000000 Nucleoli "CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663" "unprognostic (1.51e-1)" "unprognostic (7.01e-2)" "unprognostic (8.52e-3)" "unprognostic (6.25e-3)" "unprognostic (6.28e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.08e-2)" "unprognostic (1.21e-2)" "unprognostic (3.78e-3)" "unprognostic (2.86e-1)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-2)" "unprognostic (6.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.86e-2)" "unprognostic (6.86e-3)" 27.9 5.1 17.2 28.9 16.4 17.6 18.4 6.5 11.9 15.1 105.1 10.4 15.8 17.2 13.5 23.1 11.0 32.4 28.8 11.7 18.5 5.1 20.8 56.3 64.9 5.6 10.9 14.9 13.2 7.2 1.4 4.1 5.6 11.3 19.1 112.3 27.9 14.5 15.4 15.9 6.4 29.1 22.9 6.5 13.0 29.1 4.1 13.0 0.0 52.9 18.3 6.0 15.8 8.1 0.0 4.8 0.0 1.1 0.0 0.0 5.5 0.0 4.3 8.0 0.4 38.5 15.4 2.0 1.6 0.8 0.8 1.6 4.3 1.3 0.0 7.4 2.6 0.0 0.0 0.0 0.1 0.6 0.0 3.7 28.5 14.4 6.9 8.1 0.0 0.0 19.8 0.2 1.3 0.0 0.1 4.8 0.0 2.8 0.0 2.0 3.2 0.0 0.0 6.4 23.2 8.1 0.0 0.4 0.1 1.8 0.0 0.1 0.1 0.0 68.7 0.0 6.8 11.8 0.4 0.4 0.0 0.2 4.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 17.2 16.4 6.5 11.9 18.5 5.1 10.9 14.9 11.3 13.0 273.9 401.2 14.3 27.8 9.6 0.2 107.6 81.5 93.7 100.1 5.2 0.0 2.2 97.8 10.9 0.6 13.2 467.1 280.4 7.9 1.9 45.2 28.8 26.5 434.3 11.9 0.0 149.0 21.5 23.4 2.0 61.5 8.5 32.1 0.0 88.1 35.2 8.1 327.6 76.0 115.0 1.0 51.8 66.0 0.0 0.2 8.7 3.3 6.9 282.5 68.5 SELENOF SEP15 ENSG00000183291 "Selenoprotein F" 1 86862445-86914424 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 217.7;Extravillous trophoblasts: 290.7;Hofbauer cells: 216.8;Syncytiotrophoblasts: 263.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054937 Approved Nucleoli,Cytosol "Intracellular and membrane" No No Nucleoli Cytosol "HPA054937: AB_2682642" "unprognostic (6.15e-2)" "unprognostic (6.98e-3)" "prognostic favorable (6.53e-4)" "unprognostic (6.20e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (8.17e-4)" "prognostic unfavorable (1.98e-5)" "unprognostic (1.65e-1)" "unprognostic (6.51e-3)" "unprognostic (3.38e-2)" "unprognostic (3.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.79e-3)" "unprognostic (2.39e-2)" "unprognostic (1.09e-1)" "unprognostic (8.24e-3)" "unprognostic (1.34e-2)" 41.5 48.9 34.7 32.4 33.2 27.1 41.4 20.4 33.9 44.3 37.0 28.9 42.7 32.9 34.9 62.0 36.9 36.8 36.1 31.4 33.4 35.8 68.4 85.3 47.8 45.4 36.0 25.1 47.6 38.5 20.6 46.9 65.6 34.3 41.5 37.4 30.8 35.8 33.7 22.0 21.7 51.1 30.2 45.0 58.7 32.3 36.4 29.0 57.0 100.7 22.8 33.7 40.0 29.7 68.9 57.5 44.3 41.8 26.8 41.3 51.1 39.1 26.9 22.5 24.8 73.7 87.7 36.8 49.4 56.6 46.5 47.4 38.0 47.7 48.4 63.4 43.8 40.3 24.7 25.4 27.5 54.9 45.1 35.9 49.2 25.7 35.9 46.6 64.3 33.6 56.3 43.6 30.9 46.7 37.9 39.1 40.2 45.5 50.6 45.1 17.6 46.7 43.3 33.0 40.7 37.2 39.1 41.6 47.2 64.5 40.5 29.2 24.2 49.2 44.9 65.1 21.5 19.6 56.1 40.8 34.1 25.4 65.6 53.9 30.5 30.9 49.5 19.9 53.2 39.9 44.3 40.0 36.8 32.8 38.4 41.3 56.7 35.8 34.7 39.0 68.9 37.1 37.5 36.7 26.8 41.8 57.5 38.3 51.1 34.7 33.2 20.4 33.9 33.4 35.8 36.0 25.1 34.3 29.0 110.2 143.1 0.0 0.0 0.0 0.0 0.0 0.0 128.5 137.6 102.9 0.0 217.7 63.0 187.2 0.0 0.0 0.0 0.0 170.1 290.7 0.0 0.0 59.3 0.0 216.8 0.0 0.0 0.0 0.0 0.0 0.0 83.2 0.0 111.8 0.0 0.0 167.0 0.0 0.0 129.7 0.0 0.0 0.0 0.0 0.0 0.0 263.6 0.0 0.0 0.0 SELENOH "C11orf31, SELH" ENSG00000211450 "Selenoprotein H" Q8IZQ5 11 57741250-57743554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 376.4;Hofbauer cells: 352.0;Proximal tubular cells: 359.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048362 Uncertain Approved Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA048362: AB_2680370" "unprognostic (1.12e-2)" "unprognostic (3.05e-2)" "unprognostic (6.14e-2)" "unprognostic (1.18e-1)" "unprognostic (2.39e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (4.30e-4)" "unprognostic (3.61e-2)" "unprognostic (1.23e-2)" "prognostic favorable (1.80e-4)" "unprognostic (1.58e-1)" "unprognostic (7.56e-2)" "unprognostic (4.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (2.60e-1)" 27.5 49.3 34.8 35.6 49.9 36.2 30.4 17.0 52.5 23.6 30.6 14.8 23.3 38.5 22.1 38.1 36.3 26.9 28.7 32.7 29.7 31.9 33.8 49.5 26.4 40.1 29.3 40.0 28.4 41.5 9.7 30.7 28.9 22.2 32.8 16.2 22.8 48.2 26.0 52.7 21.1 37.8 15.5 19.5 49.3 36.8 30.8 18.7 44.4 43.2 25.4 35.5 21.6 23.3 61.7 83.7 39.6 71.7 29.9 53.1 71.6 32.3 23.7 25.6 14.7 3.9 12.5 4.7 13.1 11.1 11.2 6.6 6.4 16.4 15.6 36.6 7.2 10.4 14.4 11.9 15.9 7.5 22.7 25.7 20.7 15.1 15.6 23.0 30.5 40.6 13.2 13.5 13.2 12.4 16.8 19.5 22.5 19.7 14.8 13.3 31.1 26.3 46.9 45.4 10.5 31.1 33.6 24.7 29.7 10.7 15.1 13.8 28.1 11.5 10.8 33.6 15.8 29.7 22.9 19.4 12.7 28.0 25.0 18.9 74.4 53.4 10.3 27.4 24.3 30.1 39.6 71.7 34.5 29.9 71.0 28.2 59.7 39.7 31.3 71.2 61.7 53.1 37.6 5.4 29.9 65.4 83.7 29.4 71.6 34.8 49.9 17.0 52.5 29.7 31.9 29.3 40.0 22.2 18.7 154.9 129.2 0.0 0.0 0.0 0.0 0.0 0.0 262.3 136.5 143.1 0.0 264.9 376.4 215.3 0.0 0.0 0.0 0.0 273.6 236.1 0.0 0.0 123.2 0.0 352.0 0.0 0.0 0.0 0.0 0.0 0.0 84.9 0.0 178.5 0.0 0.0 265.5 0.0 0.0 359.8 0.0 0.0 0.0 0.0 0.0 0.0 123.1 0.0 0.0 0.0 SENP3 "DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1" ENSG00000161956 "SUMO1/sentrin/SMT3 specific peptidase 3" Q9H4L4 17 7561875-7571969 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA060290 Supported Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA060290: AB_2684244" "unprognostic (5.68e-2)" "unprognostic (2.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.01e-1)" "unprognostic (3.34e-1)" "unprognostic (3.48e-1)" "unprognostic (1.30e-3)" "unprognostic (2.82e-1)" "unprognostic (7.37e-2)" "unprognostic (3.72e-2)" "prognostic favorable (6.22e-5)" "unprognostic (2.71e-2)" "unprognostic (1.96e-1)" "unprognostic (1.42e-1)" "unprognostic (1.37e-1)" "unprognostic (8.21e-2)" "unprognostic (2.56e-2)" 16.3 16.0 22.3 20.9 23.4 16.6 18.0 29.2 38.4 15.9 22.5 18.4 16.8 16.2 18.6 22.7 18.6 19.9 17.0 26.1 21.0 19.2 17.5 15.1 18.7 18.8 20.0 23.3 19.6 17.8 29.5 17.3 23.6 17.2 16.0 20.5 17.3 18.6 21.9 22.0 20.8 17.6 23.1 15.3 18.9 17.2 28.8 16.4 18.9 19.0 14.2 23.4 16.8 32.8 0.8 0.7 1.1 0.7 1.1 1.7 0.3 26.5 32.2 19.1 29.6 21.7 15.9 20.0 19.5 20.0 34.0 32.0 19.2 11.6 31.8 19.4 25.6 23.5 25.6 41.1 30.5 28.6 22.4 37.5 16.5 27.3 19.7 29.3 15.1 21.0 20.3 31.2 38.8 38.1 19.6 27.3 36.3 21.1 9.0 26.2 17.8 36.8 11.5 23.7 24.8 19.6 33.7 17.9 18.3 22.7 15.6 19.1 24.7 19.5 18.9 20.7 25.5 15.9 9.9 14.3 19.6 17.0 18.6 41.8 13.2 13.7 20.2 19.7 16.1 28.9 0.1 0.7 0.2 0.4 0.4 0.1 0.4 0.2 1.3 0.1 0.8 1.7 0.5 1.1 1.1 0.1 0.7 0.3 0.3 22.3 23.4 29.2 38.4 21.0 19.2 20.0 23.3 17.2 16.4 3.0 4.8 2.7 5.7 7.6 5.8 5.9 7.6 1.4 4.5 1.8 21.6 2.6 0.0 1.9 1.1 4.5 2.3 0.0 2.1 1.9 3.9 4.1 1.1 2.6 1.3 6.4 6.3 9.8 6.9 0.4 3.7 4.1 3.3 1.8 2.5 5.0 1.9 0.0 2.1 0.7 8.0 0.0 3.6 2.8 3.5 10.2 3.4 4.9 3.4 5.6 SENP5 MGC27076 ENSG00000119231 "SUMO1/sentrin specific peptidase 5" Q96HI0 3 196867856-196934714 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006575 Approved Nucleoplasm,Nucleoli,Centrosome,Cytosol NA NA "Nucleoplasm, Nucleoli" "Centrosome, Cytosol" "HPA006575: " "unprognostic (4.07e-2)" "unprognostic (4.91e-3)" "unprognostic (7.63e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (4.13e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (2.95e-1)" "unprognostic (2.20e-1)" "unprognostic (2.88e-1)" "unprognostic (2.89e-1)" "unprognostic (9.57e-3)" "prognostic unfavorable (2.14e-5)" "unprognostic (2.02e-1)" "unprognostic (1.62e-1)" "unprognostic (1.62e-2)" "unprognostic (6.71e-2)" 13.8 13.5 20.0 15.3 20.0 25.7 16.1 28.3 23.8 15.0 15.1 16.1 14.5 11.3 14.6 16.2 16.3 12.9 14.4 15.9 18.9 21.7 13.6 19.5 15.2 15.9 19.4 18.4 17.5 15.7 19.8 21.5 17.8 23.5 15.1 14.0 12.0 13.2 15.9 17.8 16.4 13.0 16.8 18.2 17.1 14.0 36.6 16.4 19.3 14.1 9.2 21.1 14.9 20.1 8.9 7.8 15.8 8.7 7.6 8.9 4.2 13.3 6.1 9.8 8.8 8.3 9.9 7.8 8.5 9.1 9.3 15.0 10.6 5.3 12.5 23.8 9.3 15.9 9.2 10.1 4.5 15.1 6.7 6.6 16.9 9.1 7.4 9.6 14.0 8.0 8.5 12.3 9.5 10.1 6.7 9.0 11.2 11.2 19.4 10.8 11.5 13.1 8.2 7.6 7.3 12.0 8.5 7.9 8.5 4.5 7.6 6.1 8.1 9.5 10.8 10.5 10.3 18.1 10.7 10.1 9.1 9.3 12.4 17.4 20.8 36.3 27.0 12.2 11.3 10.3 15.8 7.6 7.1 8.9 8.1 8.1 8.9 8.6 8.8 5.0 8.5 8.0 8.6 14.9 7.6 8.7 7.8 6.9 4.2 20.0 20.0 28.3 23.8 18.9 21.7 19.4 18.4 23.5 16.4 20.8 13.0 17.1 20.7 54.0 26.0 12.5 10.2 9.4 14.8 8.7 15.7 15.8 10.0 14.8 27.7 20.4 12.4 0.0 12.2 12.8 21.0 19.3 25.5 16.6 12.0 27.0 20.7 13.5 16.1 36.8 15.0 18.8 13.5 14.4 13.2 15.4 20.6 17.5 15.6 14.7 27.7 25.8 24.0 36.7 40.5 54.3 19.1 26.7 10.1 28.1 SEPT7 "CDC10, CDC3, SEPT7A" ENSG00000122545 "Septin 7" Q16181 7 35800932-35907105 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 1164.8;Sertoli cells: 802.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023309, HPA029524" Enhanced Enhanced "Nucleoli,Actin filaments,Midbody,Cytosol" Yes No 16000000 "Actin filaments" "Nucleoli, Midbody, Cytosol" "HPA023309: AB_10600093, HPA029524: AB_10601573" "unprognostic (7.91e-3)" "unprognostic (6.89e-3)" "unprognostic (9.49e-2)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (2.22e-2)" "prognostic unfavorable (2.37e-4)" "unprognostic (2.00e-2)" "unprognostic (4.43e-2)" "unprognostic (7.13e-2)" "unprognostic (3.56e-2)" "unprognostic (7.66e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (2.86e-2)" "unprognostic (1.74e-1)" "unprognostic (1.71e-1)" "unprognostic (2.43e-3)" 35.5 28.5 89.0 26.8 77.8 31.9 29.5 41.9 81.5 35.1 28.7 54.3 11.5 15.7 37.8 36.2 31.7 25.4 34.2 47.5 86.4 58.1 24.3 21.5 28.3 38.8 79.6 66.2 42.8 11.2 22.9 31.9 41.0 72.0 28.4 28.2 9.6 14.9 29.9 21.7 29.1 20.1 42.6 76.8 29.5 18.1 19.3 98.2 33.0 22.6 17.3 41.4 36.9 24.0 40.4 24.0 47.3 24.8 69.1 56.8 48.6 36.1 17.4 44.5 29.2 50.2 51.9 22.8 46.7 43.1 39.9 34.4 27.0 28.1 34.3 31.7 47.5 53.6 27.5 31.4 31.1 57.0 23.4 16.5 27.6 24.4 14.6 29.3 33.2 30.5 33.6 24.4 31.3 30.9 41.8 41.5 27.1 21.6 27.1 64.7 16.9 33.5 55.8 47.7 33.9 24.7 34.6 42.4 19.7 38.6 27.0 23.9 42.0 32.6 42.0 27.9 76.2 31.0 36.8 35.0 40.3 47.8 24.7 51.4 32.0 29.1 86.5 25.7 55.6 85.0 47.3 20.7 34.9 55.4 24.0 56.8 40.4 39.6 50.5 24.0 37.4 35.6 44.9 39.3 69.1 24.8 17.2 34.2 48.6 89.0 77.8 41.9 81.5 86.4 58.1 79.6 66.2 72.0 98.2 142.9 97.9 186.4 0.0 141.0 199.4 207.8 40.8 222.1 184.2 129.1 43.2 148.6 127.6 0.0 342.3 214.2 64.6 23.3 0.0 161.3 239.6 0.0 368.3 69.5 168.4 1164.8 58.6 187.2 128.6 256.8 324.7 171.1 178.8 0.0 61.0 328.2 0.0 106.6 426.0 108.1 113.7 802.0 509.2 101.6 233.2 140.9 103.9 294.1 77.5 0.0 SERF2 "4F5REL, FAM2C, H4F5rel, HsT17089" ENSG00000140264 "Small EDRK-rich factor 2" P84101 15 43777087-43802589 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056613 Uncertain Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA056613: " "unprognostic (3.29e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-3)" "prognostic favorable (5.33e-4)" "unprognostic (1.40e-1)" "unprognostic (3.91e-2)" "unprognostic (6.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (2.50e-1)" "unprognostic (3.04e-1)" "unprognostic (1.36e-1)" "unprognostic (3.37e-2)" "unprognostic (2.84e-1)" "unprognostic (3.35e-2)" "unprognostic (2.76e-2)" "unprognostic (9.42e-2)" 78.4 109.1 61.4 103.2 58.1 110.6 115.0 33.0 45.9 71.2 107.6 45.1 99.7 59.2 65.1 121.7 109.6 60.0 128.9 166.4 56.1 48.2 97.5 153.1 79.7 81.4 72.9 42.6 51.8 125.4 23.5 62.5 102.9 89.4 84.7 87.6 63.0 134.3 106.7 98.7 59.9 86.4 68.5 66.7 79.5 79.5 65.5 45.8 77.0 122.5 116.7 82.9 84.8 116.3 146.1 259.3 225.7 218.7 91.4 142.8 413.5 34.8 58.0 43.3 59.0 150.7 111.1 33.4 62.2 78.0 40.5 51.9 74.4 35.1 18.1 51.6 106.7 53.7 46.4 33.8 46.7 20.3 49.5 40.1 43.7 84.4 142.7 73.9 40.7 94.4 104.9 60.6 32.8 35.2 63.3 59.0 51.4 45.0 119.6 79.4 106.8 52.0 96.5 36.9 136.5 67.6 53.4 28.7 83.0 110.5 127.6 32.5 35.0 33.3 140.1 31.8 39.2 117.3 174.4 49.9 69.4 35.4 104.1 45.4 44.2 59.2 125.6 74.8 74.1 71.8 127.3 218.7 225.7 113.6 194.5 103.1 142.2 125.7 116.0 185.9 146.1 116.7 118.3 129.1 91.4 166.0 259.3 142.8 413.5 61.4 58.1 33.0 45.9 56.1 48.2 72.9 42.6 89.4 45.8 470.5 717.5 1171.8 1145.4 1022.8 54.4 1942.2 1490.4 1019.8 757.5 1647.0 51.1 2342.3 3302.5 1581.0 331.8 1228.3 2242.3 817.7 1967.3 2747.0 1831.7 2360.8 754.3 2534.0 3171.2 44.5 1122.7 1502.0 1926.7 193.3 1134.5 1999.7 1724.2 2939.6 2776.8 318.1 1792.5 2080.9 932.7 3520.7 108.9 595.0 1152.9 641.0 342.8 1360.5 2739.6 1068.3 1696.1 2044.0 SERTAD3 RBT1 ENSG00000167565 "SERTA domain containing 3" Q9UJW9 19 40440844-40444705 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 156.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068262 Approved Nucleoli NA NA Nucleoli "HPA068262: AB_2685965" "unprognostic (1.56e-2)" "unprognostic (3.57e-2)" "unprognostic (1.10e-1)" "unprognostic (6.55e-3)" "unprognostic (6.50e-2)" "unprognostic (6.74e-2)" "unprognostic (2.24e-2)" "unprognostic (3.51e-3)" "unprognostic (7.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.28e-3)" "unprognostic (2.80e-2)" "unprognostic (8.74e-3)" "unprognostic (2.34e-1)" "unprognostic (2.88e-1)" "unprognostic (1.18e-1)" "unprognostic (4.66e-3)" 28.3 13.0 5.7 16.8 7.1 10.8 18.6 3.7 6.9 29.3 31.5 13.0 22.0 12.3 24.6 22.2 29.6 18.8 24.9 21.1 5.8 5.7 21.4 19.6 23.6 12.3 8.8 4.5 33.1 8.0 8.8 14.1 49.1 6.6 24.8 14.2 13.6 15.7 25.1 32.1 13.5 25.2 18.9 7.9 21.4 18.6 16.6 6.8 7.8 25.6 24.2 17.3 31.8 18.3 14.4 24.8 28.7 20.6 7.8 7.7 12.2 15.5 30.2 10.6 13.8 11.9 18.3 14.7 12.7 17.2 18.2 15.8 10.9 12.2 7.6 5.7 16.4 11.1 5.7 10.7 12.4 10.3 8.5 4.7 5.0 9.9 9.3 14.1 1.2 16.1 16.1 17.1 11.3 8.2 14.8 14.8 3.5 15.0 5.1 14.4 23.3 3.1 6.1 5.6 13.5 7.4 4.6 6.5 6.2 14.4 12.3 1.5 6.6 10.8 18.9 9.5 17.0 16.5 12.6 12.3 15.6 12.5 12.0 10.0 8.7 4.6 6.5 12.4 5.5 6.9 12.2 20.6 22.0 7.1 20.4 7.1 14.4 7.7 7.6 23.0 12.7 5.7 6.8 28.7 7.8 17.1 24.8 6.0 12.2 5.7 7.1 3.7 6.9 5.8 5.7 8.8 4.5 6.6 6.8 8.9 11.8 24.9 34.2 41.0 3.3 9.2 10.2 9.4 5.7 22.7 3.9 75.5 26.6 27.3 5.4 27.8 37.4 0.0 26.8 74.2 58.2 42.4 20.7 6.0 31.4 3.2 47.1 31.9 20.3 5.1 26.4 36.8 32.1 30.7 43.9 19.3 27.7 44.4 28.7 18.2 0.5 58.2 28.6 11.4 13.0 37.6 156.8 15.0 27.5 37.6 SETD7 "KIAA1717, KMT7, SET7, SET7/9, Set9" ENSG00000145391 "SET domain containing lysine methyltransferase 7" Q8WTS6 4 139495941-139606699 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058111 Enhanced Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA058111: AB_2683607" "prognostic unfavorable (8.28e-4)" "unprognostic (7.07e-2)" "unprognostic (4.04e-1)" "unprognostic (2.07e-1)" "unprognostic (2.92e-1)" "unprognostic (4.82e-2)" "unprognostic (1.48e-2)" "unprognostic (2.04e-1)" "unprognostic (1.71e-2)" "unprognostic (9.10e-2)" "unprognostic (6.44e-2)" "unprognostic (7.75e-2)" "unprognostic (1.37e-1)" "unprognostic (6.16e-3)" "unprognostic (1.17e-1)" "unprognostic (6.92e-2)" "unprognostic (6.56e-3)" 26.1 13.2 12.0 9.6 12.3 5.7 26.3 10.2 16.2 27.9 17.7 17.9 11.0 4.8 23.8 12.0 18.3 13.8 16.9 25.2 13.0 10.0 7.2 30.7 12.1 6.9 18.0 10.1 13.3 13.8 26.8 9.3 12.0 15.4 22.8 10.2 12.4 13.7 13.9 56.4 14.2 9.9 33.3 19.0 11.8 17.7 10.6 16.5 2.9 10.3 15.2 9.9 24.2 30.1 2.3 6.8 1.8 5.6 0.5 5.6 1.6 9.0 11.7 4.5 2.6 26.5 22.9 9.9 21.5 22.4 11.0 9.3 6.9 12.4 21.1 8.5 36.2 7.6 4.6 14.9 17.0 17.9 10.4 10.5 2.9 15.3 0.2 13.1 10.1 4.5 19.8 19.9 17.5 18.7 14.0 13.9 9.0 1.7 32.9 14.0 15.1 6.6 1.5 2.2 13.3 7.7 6.2 15.5 12.1 10.7 8.3 17.4 5.8 14.3 21.3 5.1 4.5 8.4 9.2 22.5 19.5 13.9 23.2 17.8 28.4 27.2 13.4 22.5 10.2 9.3 1.0 5.6 0.5 0.6 3.2 4.1 1.8 1.8 1.8 6.8 2.3 0.8 0.5 1.8 0.5 4.8 3.5 5.6 1.6 12.0 12.3 10.2 16.2 13.0 10.0 18.0 10.1 15.4 16.5 6.0 13.1 3.4 10.9 15.2 6.6 35.4 17.8 4.0 6.8 8.7 11.8 21.9 0.0 20.5 0.9 24.7 1.8 23.3 18.1 14.4 19.2 35.1 2.3 64.4 18.3 7.9 1.2 36.8 29.7 3.5 21.3 18.3 10.1 7.2 11.2 13.3 21.5 0.0 26.5 3.9 12.6 19.4 21.0 3.2 1.9 19.3 38.6 5.0 9.9 14.2 SETMAR metnase ENSG00000170364 "SET domain and mariner transposase fusion gene" Q53H47 3 4303304-4317567 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA057999 Supported Nucleoli NA NA Nucleoli "HPA057999: AB_2683574" "unprognostic (1.59e-1)" "unprognostic (1.22e-2)" "unprognostic (5.24e-3)" "unprognostic (4.89e-2)" "unprognostic (7.73e-2)" "unprognostic (4.73e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.58e-2)" "unprognostic (1.54e-2)" "unprognostic (3.29e-1)" "unprognostic (1.19e-3)" "unprognostic (1.19e-1)" "prognostic favorable (6.61e-6)" "unprognostic (5.42e-1)" "unprognostic (3.06e-2)" "unprognostic (1.08e-1)" "unprognostic (1.26e-3)" 14.1 6.2 7.3 7.2 9.2 3.7 14.2 6.9 8.5 12.5 6.5 6.2 5.2 4.3 19.4 7.6 7.2 12.5 8.2 6.3 6.6 4.3 10.1 5.3 5.1 6.5 9.1 8.7 19.4 9.8 5.7 7.4 5.6 6.5 13.9 6.9 5.7 11.9 10.0 7.7 7.3 5.7 16.8 7.2 5.0 6.0 7.3 10.8 13.1 11.5 8.3 4.4 11.3 13.3 3.8 1.6 1.9 3.3 0.5 5.3 1.5 3.0 2.7 8.2 1.7 19.7 6.5 8.3 3.3 1.0 3.3 3.1 2.8 2.3 8.0 3.5 1.8 6.0 2.6 7.2 5.0 3.6 5.4 6.2 10.0 4.9 4.5 2.3 4.7 4.2 7.7 3.9 2.4 0.8 3.0 4.8 9.1 6.6 3.0 5.1 4.1 7.0 3.0 8.0 1.9 4.7 8.3 8.1 3.3 3.1 4.2 6.5 9.6 4.0 5.0 4.3 5.4 4.8 2.7 3.1 4.9 6.9 4.1 4.3 4.0 9.5 19.8 1.8 5.4 4.1 1.9 1.1 1.3 2.3 3.3 2.0 2.9 2.7 2.9 1.0 3.8 4.5 5.3 0.2 0.5 1.9 1.6 1.7 1.5 7.3 9.2 6.9 8.5 6.6 4.3 9.1 8.7 6.5 10.8 0.0 5.3 2.7 7.6 2.2 5.2 5.9 5.1 9.4 13.6 0.0 0.0 20.4 11.6 10.1 0.6 6.8 2.3 0.0 11.6 12.2 7.4 3.2 1.1 2.5 5.2 0.0 3.5 3.7 1.0 0.9 8.9 1.8 0.0 4.6 2.6 4.1 6.6 5.1 12.4 4.3 2.8 6.5 5.7 4.6 5.1 0.5 13.6 1.3 5.6 3.1 SF3B3 "KIAA0017, RSE1, SAP130, SF3b130" ENSG00000189091 "Splicing factor 3b subunit 3" Q15393 16 70523788-70577670 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041134, HPA042986" Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA041134: AB_2677317, HPA042986: AB_10960386" "unprognostic (3.39e-2)" "unprognostic (1.53e-1)" "unprognostic (7.47e-2)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (1.06e-2)" "unprognostic (7.67e-2)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (6.97e-2)" "unprognostic (2.29e-1)" "unprognostic (3.28e-2)" "unprognostic (1.60e-1)" "unprognostic (8.76e-2)" "unprognostic (7.91e-2)" "unprognostic (1.73e-1)" 23.8 21.1 11.8 22.1 23.2 24.7 22.4 24.9 26.9 23.4 20.6 20.9 15.6 17.1 27.5 13.9 31.8 22.1 15.6 20.1 14.0 12.8 17.0 19.0 18.4 28.5 16.9 15.0 33.3 22.5 34.0 26.8 19.9 16.5 18.4 16.4 20.2 22.6 17.3 30.9 28.9 18.8 20.1 15.4 21.0 17.9 15.5 15.9 47.7 25.1 17.2 31.9 23.7 25.0 23.2 21.4 16.4 18.8 21.0 25.9 19.7 18.7 19.7 25.6 17.9 12.7 11.8 19.3 17.8 15.3 23.3 18.9 20.1 15.1 25.2 14.4 13.9 13.9 22.1 27.0 15.2 37.7 8.1 18.9 19.6 16.2 21.3 8.6 27.6 23.2 11.2 11.1 26.0 19.2 14.9 13.9 14.8 26.7 9.0 18.5 23.2 24.2 13.6 23.5 11.9 11.3 42.8 19.9 28.3 7.5 25.9 22.3 16.5 58.0 9.2 9.0 11.2 19.9 13.7 14.2 17.3 19.0 13.3 18.7 10.2 22.3 67.6 11.5 17.7 16.1 11.5 15.8 16.4 23.1 18.8 25.4 18.6 21.8 24.2 21.4 23.2 25.9 22.0 5.4 21.0 17.9 12.0 24.0 19.7 11.8 23.2 24.9 26.9 14.0 12.8 16.9 15.0 16.5 15.9 23.8 22.6 29.8 20.4 19.9 34.7 26.8 15.3 13.4 17.0 22.7 13.7 28.1 6.6 18.9 6.0 22.6 16.5 0.0 19.7 29.6 17.4 18.3 17.3 20.2 20.4 38.1 20.3 17.8 20.0 7.9 31.4 16.3 16.9 15.4 20.5 20.0 21.1 14.0 31.1 13.9 24.9 6.5 14.4 21.8 37.3 22.8 21.3 22.0 26.4 23.0 SFRP1 "FRP, FRP-1, SARP2" ENSG00000104332 "Secreted frizzled related protein 1" Q8N474 8 41261958-41309497 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Cardiomyocytes: 175.8;Leydig cells: 535.6;Peritubular cells: 122.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "hTERT-RPE1: 270.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB008116, HPA064870" Approved Approved Nucleoli,Cytosol "Secreted in other tissues" Yes No 1600000 Nucleoli Cytosol "CAB008116: AB_2187070, HPA064870: AB_2685376" "unprognostic (1.23e-3)" "unprognostic (7.01e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-1)" "unprognostic (7.13e-2)" "prognostic favorable (1.55e-4)" "unprognostic (1.79e-1)" "unprognostic (2.69e-3)" "unprognostic (2.15e-2)" "unprognostic (4.67e-3)" "unprognostic (3.52e-3)" "unprognostic (4.74e-2)" "unprognostic (1.72e-2)" "unprognostic (1.75e-2)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (3.12e-4)" 20.1 3.4 4.6 2.4 7.5 0.3 73.2 10.8 5.6 58.4 6.1 15.2 8.0 3.0 35.6 19.3 9.7 25.9 15.5 43.9 7.8 2.5 30.6 1.5 1.8 0.9 4.5 6.7 12.5 1.5 0.6 0.7 9.9 24.1 12.8 7.8 19.3 73.2 27.1 1.9 20.8 5.4 21.4 2.8 5.0 11.0 11.1 13.7 0.0 3.3 18.4 5.1 10.9 41.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 6.3 0.1 5.7 0.3 1.2 10.9 57.4 16.6 15.8 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.8 4.4 23.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 1.0 21.4 1.6 1.6 270.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 17.1 0.0 0.0 0.0 1.3 0.0 35.3 0.0 0.3 1.5 0.4 0.0 3.3 23.2 0.0 0.1 0.1 0.0 1.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 7.5 10.8 5.6 7.8 2.5 4.5 6.7 24.1 13.7 0.0 0.0 0.0 104.7 10.0 1.5 175.8 0.0 0.0 1.2 59.3 2.0 0.7 68.0 3.1 4.8 6.7 0.0 0.0 0.0 55.3 47.0 19.9 0.0 0.0 1.7 1.6 0.0 15.4 0.0 13.0 535.6 1.4 94.5 0.0 0.0 51.5 0.1 0.0 122.4 3.5 1.5 0.0 4.1 1.6 20.6 4.8 0.7 0.0 0.0 8.5 SGF29 "CCDC101, FLJ32446, TDRD29" ENSG00000176476 "SAGA complex associated factor 29" Q96ES7 16 28553915-28591790 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 187.5;Late spermatids: 270.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052590, HPA053608" Enhanced Approved Nucleoplasm,Nucleoli Yes No Nucleoli Nucleoplasm "HPA052590: AB_2681875, HPA053608: AB_2682205" "unprognostic (1.38e-2)" "prognostic favorable (4.77e-4)" "unprognostic (1.73e-1)" "unprognostic (2.46e-3)" "unprognostic (2.80e-2)" "unprognostic (7.27e-3)" "unprognostic (1.48e-1)" "prognostic favorable (3.37e-4)" "unprognostic (1.98e-1)" "unprognostic (1.41e-1)" "prognostic favorable (2.99e-4)" "unprognostic (2.96e-1)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (1.76e-1)" "unprognostic (5.42e-3)" 11.1 11.4 7.9 11.8 12.5 9.9 15.5 20.9 11.0 19.5 17.1 10.6 16.9 11.6 21.4 10.2 9.0 17.6 11.1 10.7 7.9 6.8 9.8 12.9 11.1 17.2 16.5 7.1 31.5 17.7 8.6 9.4 8.4 10.8 13.1 6.9 12.1 14.8 20.0 36.1 12.2 13.4 21.4 13.4 11.6 13.5 35.6 14.4 17.6 19.5 9.0 10.4 17.1 25.1 25.4 27.6 18.8 18.2 19.5 36.1 20.4 7.0 12.0 9.2 6.0 6.4 6.3 16.8 4.8 5.4 12.6 11.9 13.8 6.4 21.3 12.0 3.7 7.6 8.3 7.0 8.4 3.6 6.8 13.3 13.2 7.4 18.3 15.6 11.8 14.9 6.7 11.5 7.5 7.6 6.8 4.7 13.6 11.1 10.9 4.4 23.6 13.4 23.2 12.7 5.2 11.7 21.0 6.0 18.5 6.3 10.7 14.9 6.9 7.4 14.2 7.9 3.7 11.7 9.8 3.3 8.7 7.4 5.0 8.3 12.7 18.4 12.4 6.2 20.1 7.0 5.0 18.2 18.8 22.3 15.6 26.9 22.2 31.2 27.2 18.3 25.4 36.1 27.8 5.6 19.5 12.5 27.6 29.6 20.4 7.9 12.5 20.9 11.0 7.9 6.8 16.5 7.1 10.8 14.4 14.9 11.8 6.7 16.2 0.0 6.1 0.0 5.1 12.0 13.6 17.4 13.7 15.2 8.3 9.9 187.5 3.6 9.3 0.0 11.3 10.4 9.5 6.7 5.8 14.3 12.7 0.0 3.5 6.2 12.9 270.5 28.4 12.1 0.0 11.8 9.2 11.2 11.3 12.2 20.5 18.8 13.9 19.4 0.0 8.4 19.2 0.0 17.6 13.1 14.0 11.1 SH2D7 LOC646892 ENSG00000183476 "SH2 domain containing 7" A6NKC9 15 78077808-78104909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 7 "testis: 37.1" "Group enriched" "Detected in some" 4 "Early spermatids: 17.9;Late spermatids: 23.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1;AN3-CA: 2.8;BEWO: 2.6;HEK 293: 2.0;SCLC-21H: 2.4;SH-SY5Y: 4.4;SuSa: 2.3" "Low region specificity" "Detected in all" "HPA051320, HPA058382, HPA076728" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA051320: AB_2681439, HPA058382: , HPA076728: " "unprognostic (1.22e-2)" "unprognostic (4.31e-2)" "unprognostic (2.24e-1)" "unprognostic (1.24e-2)" "unprognostic (2.53e-1)" "unprognostic (1.42e-1)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-3)" "unprognostic (4.73e-2)" "unprognostic (2.92e-1)" "unprognostic (2.32e-3)" "unprognostic (5.15e-3)" "unprognostic (1.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 0.1 0.2 0.6 0.5 0.4 0.0 0.1 0.5 0.5 0.1 4.3 0.1 0.1 5.0 0.1 0.1 0.1 0.0 1.0 0.2 0.4 0.4 0.1 0.1 0.6 0.1 0.3 0.1 0.1 0.3 0.0 0.2 0.3 0.1 0.2 0.5 0.2 0.2 0.1 0.1 0.1 4.2 0.1 0.3 0.1 0.3 37.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 2.1 2.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 1.5 0.1 0.0 1.1 1.4 0.0 0.0 0.4 2.4 4.4 0.4 0.6 0.2 2.3 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.5 0.5 0.4 0.4 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 2.5 0.0 0.0 0.0 SH3TC1 FLJ20356 ENSG00000125089 "SH3 domain and tetratricopeptide repeats 1" Q8TE82 4 8182072-8241803 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ito cells: 36.2;Kupffer cells: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 14.5" "Group enriched" "Detected in many" 5 "B-cells: 6.5;dendritic cells: 14.5;monocytes: 8.6" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 15.3;MOLT-4: 26.5;SK-MEL-30: 15.2;U-2197: 11.5" "Low region specificity" "Detected in many" "HPA038132, HPA056807" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA038132: AB_10673041, HPA056807: AB_2683239" "unprognostic (2.46e-1)" "unprognostic (2.43e-1)" "unprognostic (1.61e-3)" "unprognostic (5.46e-2)" "unprognostic (2.26e-2)" "unprognostic (1.63e-1)" "unprognostic (1.04e-1)" "unprognostic (8.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.25e-1)" "unprognostic (1.46e-2)" "unprognostic (2.59e-2)" "unprognostic (4.24e-2)" "unprognostic (2.46e-1)" "unprognostic (3.77e-3)" "unprognostic (1.15e-2)" "unprognostic (4.29e-2)" 16.8 4.2 3.7 12.7 7.6 7.5 8.5 0.9 4.0 5.7 3.2 8.6 3.3 1.9 3.2 7.9 9.7 3.9 10.0 4.5 6.6 3.5 19.9 11.2 10.1 14.2 7.4 1.0 2.8 8.6 1.1 3.3 5.8 7.2 5.9 2.4 6.4 5.9 6.0 2.0 3.3 5.6 4.1 9.6 17.0 9.6 1.7 5.8 24.4 5.6 3.8 14.5 9.9 6.3 6.5 14.5 1.0 8.6 0.4 2.0 2.6 2.2 3.5 0.1 0.0 0.0 0.4 2.6 0.2 0.2 0.3 0.5 1.8 1.3 3.1 3.0 0.0 0.5 1.3 0.0 6.6 0.0 8.1 0.1 0.0 2.8 2.9 2.6 0.0 0.4 0.1 8.2 0.1 6.7 0.2 15.3 2.0 0.4 4.3 0.3 2.5 26.5 2.1 0.1 1.3 2.9 1.7 0.9 0.9 0.3 0.4 0.2 1.4 1.0 0.3 15.2 1.0 0.0 0.5 6.2 0.0 1.8 11.5 0.2 0.1 0.6 2.7 0.1 1.2 2.0 0.0 7.5 1.0 0.7 6.9 0.7 4.2 1.5 0.9 6.2 6.5 0.7 0.6 0.2 0.4 8.6 14.5 2.0 2.6 3.7 7.6 0.9 4.0 6.6 3.5 7.4 1.0 7.2 5.8 0.0 8.0 7.4 10.1 0.7 0.8 2.8 7.6 1.4 3.4 24.4 0.0 1.8 6.6 3.2 0.5 6.9 0.2 0.0 4.8 2.7 1.7 4.0 17.3 7.3 19.3 22.3 1.2 36.2 27.9 1.0 0.6 18.1 0.0 5.4 0.9 18.4 7.4 2.9 0.7 12.5 0.6 0.0 2.1 0.0 0.0 0.5 2.5 6.9 1.2 15.7 SIPA1 SPA1 ENSG00000213445 "Signal-induced proliferation-associated 1" Q96FS4 11 65638097-65650930 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020833, HPA039867" Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" NA NA Nucleoli "Nucleoplasm, Golgi apparatus, Plasma membrane" "CAB020833: , HPA039867: AB_2676716" "unprognostic (6.10e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (1.35e-2)" "unprognostic (2.93e-1)" "unprognostic (2.32e-2)" "unprognostic (3.35e-2)" "unprognostic (1.09e-1)" "unprognostic (3.30e-2)" "unprognostic (6.44e-2)" "unprognostic (5.85e-2)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.60e-1)" "unprognostic (2.78e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-1)" 10.5 9.1 7.5 27.1 12.0 29.8 10.0 2.6 8.7 8.9 10.8 9.4 2.9 7.7 10.9 3.0 7.6 9.0 9.9 8.0 8.4 4.6 9.5 7.8 17.6 33.2 11.5 4.7 7.7 4.6 2.7 4.2 11.9 10.3 8.6 3.9 8.2 8.7 6.8 5.4 4.2 17.2 9.0 14.3 47.1 8.1 3.0 10.5 25.3 7.7 4.6 32.7 8.5 7.8 6.6 2.8 14.1 5.2 5.8 7.4 3.0 0.7 6.2 4.5 9.6 2.6 5.5 10.6 7.2 6.1 5.6 5.5 1.9 6.9 9.9 16.2 3.5 0.2 3.6 1.6 2.4 1.9 10.7 4.0 24.2 9.2 3.4 4.7 9.8 10.5 5.6 1.1 7.8 1.0 5.6 16.4 10.4 13.7 4.6 2.8 2.7 3.9 16.7 3.0 2.5 5.8 17.8 2.5 8.8 2.1 0.5 1.7 10.3 3.5 6.1 14.6 4.3 4.6 15.1 23.0 6.9 14.1 7.6 1.4 6.9 5.4 22.3 9.5 15.6 20.1 4.0 4.1 10.2 7.4 4.8 5.5 5.3 3.7 4.8 2.8 6.6 2.9 4.4 14.1 5.8 5.2 2.7 3.5 3.0 7.5 12.0 2.6 8.7 8.4 4.6 11.5 4.7 10.3 10.5 6.0 6.9 45.9 21.9 6.1 1.7 3.7 25.5 0.0 2.3 22.7 0.0 7.8 31.5 18.4 2.6 16.8 17.3 23.3 13.0 17.8 8.2 22.9 6.9 19.8 31.9 4.8 20.2 39.9 38.3 5.4 7.5 26.7 10.1 10.8 11.7 4.8 23.9 11.5 12.4 14.6 1.6 12.9 14.0 0.7 17.9 9.7 11.3 33.2 11.4 27.8 SIRT2 SIR2L ENSG00000068903 "Sirtuin 2" Q8IXJ6 19 38878555-38899862 "Cancer-related genes, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation" Transferase "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.6;skeletal muscle: 108.7" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 174.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004573, HPA011165" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "CAB004573: AB_2188600, HPA011165: AB_1856900" "unprognostic (2.15e-2)" "unprognostic (2.24e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (7.20e-7)" "unprognostic (3.75e-3)" "unprognostic (1.28e-2)" "unprognostic (2.85e-2)" "unprognostic (2.44e-3)" "unprognostic (2.73e-1)" "unprognostic (4.83e-2)" "unprognostic (2.97e-3)" "unprognostic (1.02e-1)" "unprognostic (1.90e-1)" "unprognostic (3.60e-2)" "unprognostic (1.19e-1)" "unprognostic (8.73e-2)" "unprognostic (1.70e-1)" 14.1 11.0 30.2 8.1 36.0 10.7 9.1 14.3 38.8 11.0 8.4 78.1 4.0 9.3 9.7 7.8 17.1 12.9 10.7 20.3 36.9 23.5 9.0 12.0 10.8 8.8 52.3 20.5 17.3 9.5 10.1 6.2 7.7 40.8 9.8 7.6 5.8 14.9 11.2 108.7 13.7 9.3 12.8 86.6 9.9 9.0 7.9 46.3 3.2 10.1 23.4 8.9 10.6 7.1 13.2 21.5 28.0 33.0 16.6 23.5 22.1 8.2 5.2 4.4 11.1 25.6 17.6 3.0 6.1 10.9 9.5 12.3 9.3 5.3 2.9 13.3 11.3 7.3 4.5 8.1 13.1 5.8 13.2 8.4 5.6 5.9 5.6 18.1 3.9 12.4 18.4 15.8 7.8 9.4 11.8 16.7 9.4 5.2 22.9 14.5 4.7 7.8 3.0 0.7 14.1 7.3 10.4 12.6 8.0 7.7 7.4 11.3 5.1 7.1 9.5 6.7 3.9 4.3 10.1 15.8 12.9 2.8 19.9 9.0 9.4 4.5 6.6 10.3 9.8 11.9 19.5 27.3 28.0 23.5 33.0 14.6 12.2 11.4 16.1 21.1 13.2 7.5 12.5 20.7 16.6 25.8 21.5 15.5 22.1 30.2 36.0 14.3 38.8 36.9 23.5 52.3 20.5 40.8 46.3 14.9 20.8 11.4 27.5 45.8 26.8 30.8 7.6 29.4 20.5 12.2 33.4 28.9 31.5 27.0 174.5 26.3 34.2 23.3 15.3 12.8 23.1 19.4 25.3 16.2 56.7 28.6 16.8 23.9 33.7 57.6 28.7 34.2 43.9 14.4 20.4 20.6 21.1 18.6 38.5 23.3 27.0 19.4 35.0 12.7 5.9 52.6 35.4 43.6 15.8 22.6 SIX1 DFNA23 ENSG00000126778 "SIX homeobox 1" Q15475 14 60643415-60658259 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0" "Cell type enhanced" "Detected in some" 19 "Basal glandular cells: 23.3;Ciliated cells: 65.6;Club cells: 33.0;Glandular cells: 24.0;Urothelial cells: 14.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "olfactory region: 1.2;pons and medulla: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 14.3;LHCN-M2: 53.4;RH-30: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001893, CAB058690" Enhanced Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "CAB058690: AB_2665581, HPA001893: AB_1079991" "unprognostic (3.62e-1)" "unprognostic (5.44e-2)" "unprognostic (5.09e-2)" "prognostic unfavorable (8.92e-6)" "unprognostic (1.33e-2)" "unprognostic (1.44e-2)" "unprognostic (2.04e-3)" "prognostic favorable (3.94e-4)" "unprognostic (1.40e-1)" "unprognostic (9.15e-2)" "unprognostic (6.45e-2)" "unprognostic (1.89e-1)" "unprognostic (3.06e-8)" "unprognostic (8.61e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" "unprognostic (3.86e-1)" 7.1 0.4 0.3 0.1 0.5 0.1 4.7 0.3 0.6 7.4 0.2 0.2 0.0 0.1 0.2 2.1 1.3 0.5 0.4 0.4 0.3 0.3 0.3 0.2 1.8 0.3 0.4 1.2 0.3 0.3 16.8 39.1 0.1 4.5 8.7 0.1 2.0 55.1 0.2 59.0 0.4 0.2 0.7 0.5 0.2 0.5 1.6 0.0 6.5 2.4 22.5 3.0 1.4 9.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 8.3 1.9 0.2 11.9 6.9 8.1 0.1 2.0 4.5 2.3 2.0 0.0 3.8 0.0 1.1 0.4 1.1 2.7 3.9 3.6 0.8 0.0 9.5 0.9 0.8 2.7 0.0 0.0 0.1 6.0 1.8 1.6 0.3 14.3 0.1 0.7 2.6 0.0 53.4 1.3 0.0 0.2 0.0 0.0 4.8 0.0 29.2 0.0 2.3 6.5 1.1 0.1 2.3 0.1 2.4 0.2 1.4 0.2 6.8 3.2 3.2 3.7 3.0 0.2 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.5 0.3 0.3 0.4 1.2 4.5 0.0 3.0 1.0 0.0 23.3 0.1 0.0 0.8 0.0 65.6 33.0 1.8 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.7 0.4 0.8 24.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 1.1 0.0 0.3 0.0 0.2 0.0 2.5 0.1 0.2 0.0 0.0 14.9 SLBP HBP ENSG00000163950 "Stem-loop binding protein" Q14493 4 1692800-1712555 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Spermatocytes: 268.0;Spermatogonia: 323.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019254, HPA061670" Supported Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA019254: AB_1856951, HPA061670: AB_2684581" "unprognostic (1.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.05e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (7.09e-3)" "prognostic unfavorable (2.29e-5)" "unprognostic (5.53e-2)" "unprognostic (1.94e-2)" "unprognostic (1.13e-2)" "unprognostic (9.81e-3)" "unprognostic (9.55e-3)" "unprognostic (4.58e-2)" "unprognostic (7.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.07e-2)" 19.8 18.1 26.9 30.4 28.0 60.7 27.5 23.8 30.0 19.3 19.3 14.2 20.7 16.3 20.4 21.9 25.0 19.0 15.8 17.9 25.1 26.5 23.7 21.2 18.7 43.9 19.9 24.0 23.1 17.8 13.0 19.5 27.7 16.0 20.0 21.3 17.9 24.7 21.2 15.1 24.7 17.0 20.5 17.1 26.1 18.2 50.6 12.4 52.4 24.9 17.7 42.8 23.7 26.6 24.4 24.1 45.3 29.8 19.8 36.1 30.4 29.4 12.1 17.5 18.4 15.5 17.7 18.2 25.9 22.2 31.5 31.9 25.0 34.4 38.9 15.5 21.4 37.2 18.1 35.1 23.5 37.0 15.9 19.0 48.8 15.1 25.1 19.2 45.1 23.8 12.2 18.9 23.9 15.9 18.3 17.9 26.1 34.9 38.5 38.5 10.6 69.4 41.1 21.8 31.1 21.6 52.3 28.6 24.6 30.3 22.4 19.9 15.3 22.0 14.3 15.3 24.7 23.7 29.8 15.1 26.5 15.2 27.9 40.3 22.4 40.7 93.0 24.8 38.7 26.0 9.3 29.8 21.8 23.6 22.3 21.4 24.4 30.8 33.2 24.1 18.0 26.5 25.1 45.3 19.8 19.8 19.1 36.1 30.4 26.9 28.0 23.8 30.0 25.1 26.5 19.9 24.0 16.0 12.4 14.9 16.8 53.9 86.5 93.4 17.7 7.1 25.5 8.1 7.9 34.9 23.6 121.4 91.2 43.6 64.1 31.8 21.2 23.3 27.3 39.1 59.3 64.3 23.1 26.1 70.1 23.8 34.4 29.4 34.0 32.9 40.9 44.4 62.4 61.3 27.5 27.6 30.6 23.0 41.4 37.4 11.4 12.9 49.1 268.0 323.2 92.5 37.4 59.9 37.5 71.2 SLC11A1 "LSH, NRAMP, NRAMP1" ENSG00000018280 "Solute carrier family 11 member 1" P49279 2 218382029-218396894 "Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.6;lymphoid tissue: 23.8" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 52.4;Hofbauer cells: 110.2;Kupffer cells: 163.4;Macrophages: 201.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0" "Group enriched" "Detected in many" 11 "dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9" "Cell line enhanced" "Detected in some" "HEL: 3.8;HMC-1: 3.7;NB-4: 3.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA029590, HPA050378, HPA068540" Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA029590: AB_10794613, HPA050378: , HPA068540: " "unprognostic (2.64e-1)" "unprognostic (3.05e-2)" "unprognostic (1.46e-2)" "unprognostic (2.34e-2)" "unprognostic (1.99e-2)" "unprognostic (3.83e-2)" "unprognostic (1.04e-3)" "unprognostic (2.06e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (7.29e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (2.58e-8)" "unprognostic (9.55e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-2)" "unprognostic (1.08e-2)" 13.5 4.7 4.3 14.9 13.3 11.6 2.6 0.6 9.3 1.7 1.8 4.6 0.0 1.3 1.3 2.1 1.4 4.1 3.0 6.5 15.0 2.6 2.1 3.2 37.6 19.9 17.1 0.7 2.4 3.3 1.2 1.9 6.2 11.3 1.7 1.0 1.7 2.0 1.2 2.0 1.0 1.2 4.6 18.1 23.8 1.7 2.4 10.3 0.0 1.8 0.2 1.0 7.1 1.3 0.4 2.4 6.0 7.9 0.2 0.4 2.6 0.3 0.7 0.0 0.4 0.1 0.1 0.9 0.0 0.0 0.1 0.2 1.0 2.1 0.2 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.7 0.1 3.8 0.6 0.7 0.1 0.0 3.7 0.3 0.1 0.0 0.2 0.3 0.0 1.2 1.0 0.7 0.1 1.3 0.2 3.1 0.0 0.6 0.2 0.2 0.6 0.4 0.1 0.3 0.8 0.2 0.5 0.4 0.4 0.2 0.3 1.1 0.3 0.7 0.4 0.2 0.0 0.3 0.3 0.7 0.2 0.4 0.4 0.3 7.9 0.6 0.4 5.8 0.3 0.1 0.2 0.2 2.4 0.4 0.4 0.3 6.0 0.2 7.0 0.2 0.2 2.6 4.3 13.3 0.6 9.3 15.0 2.6 17.1 0.7 11.3 10.3 20.8 52.4 3.0 3.9 0.8 3.6 6.3 5.1 17.4 22.7 8.7 0.0 1.6 8.3 0.8 1.2 4.7 1.2 0.0 1.8 7.2 2.4 5.7 24.3 4.7 110.2 1.6 1.2 8.6 163.4 0.4 2.0 201.4 1.7 1.0 4.0 7.6 0.6 0.9 0.7 6.8 3.0 19.4 5.0 0.5 1.7 0.9 6.8 1.7 2.2 2.7 SLC1A3 "EA6, EAAT1, GLAST" ENSG00000079215 "Solute carrier family 1 member 3" P43003 5 36606355-36688334 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 188.6" "Cell type enriched" "Detected in many" 9 "Muller glia cells: 579.8" "Cancer enriched" "Detected in all" 21 "glioma: 168.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4" "Group enriched" "Detected in many" 39 "dendritic cells: 3.4;monocytes: 4.3" "Cell line enhanced" "Detected in many" "AF22: 21.5;CACO-2: 34.7;HaCaT: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002573, HPA037467, HPA037468" Enhanced Supported Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371" "unprognostic (1.23e-1)" "unprognostic (2.15e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (7.70e-2)" "unprognostic (3.89e-3)" "unprognostic (2.36e-1)" "unprognostic (1.24e-1)" "unprognostic (2.84e-2)" "unprognostic (4.17e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.17e-2)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" 17.3 10.3 76.1 5.9 70.6 3.1 6.3 45.8 188.6 6.9 3.2 26.3 0.0 2.1 2.8 2.3 7.2 5.4 5.9 12.0 57.9 27.3 3.1 3.6 4.7 8.6 32.7 39.6 8.6 4.0 2.6 3.7 12.7 28.5 3.3 2.6 1.9 3.0 4.4 7.6 5.5 2.3 4.1 29.4 5.8 2.9 2.7 33.6 0.0 2.6 0.7 4.5 4.8 1.2 0.0 3.4 0.0 4.3 0.0 0.0 0.8 0.4 0.1 21.5 1.9 2.2 6.0 13.8 0.0 0.0 0.8 1.9 34.7 1.7 0.0 10.5 0.3 0.3 26.3 6.3 2.8 0.9 0.3 12.9 0.0 0.1 0.0 0.4 0.4 0.1 11.1 13.0 5.3 2.2 0.4 0.0 0.4 0.0 0.1 3.6 0.0 0.0 0.1 2.5 0.0 2.2 0.0 0.1 0.0 0.0 1.4 1.8 0.0 2.1 6.3 0.3 10.5 0.0 1.0 0.0 1.9 3.2 0.0 7.6 0.0 0.0 0.0 8.8 14.5 4.9 0.0 4.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.8 76.1 70.6 45.8 57.8 57.9 27.3 32.7 39.6 28.5 33.6 3.0 0.3 0.5 10.4 9.5 7.7 33.9 0.0 5.3 1.2 0.0 2.0 25.3 0.0 0.4 0.6 1.1 0.0 0.0 0.0 13.5 11.8 3.2 0.0 0.2 38.2 3.2 0.0 1.3 63.4 1.9 4.0 11.0 6.8 3.6 0.0 579.8 0.3 0.0 0.0 0.0 11.3 6.5 4.7 0.2 0.1 6.1 7.7 0.0 0.0 3.3 SLC30A3 ZNT3 ENSG00000115194 "Solute carrier family 30 member 3" Q99726 2 27253684-27275817 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 28.7;epididymis: 41.0;testis: 19.5" "Group enriched" "Detected in some" 18 "Cardiomyocytes: 8.1;Early spermatids: 13.1;Late spermatids: 29.1;Peritubular cells: 14.2;Spermatocytes: 18.7;Spermatogonia: 9.4" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 9 "amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 8.0;HAP1: 8.8;Hep G2: 11.7;REH: 19.0;RH-30: 9.9" "Group enriched" "Detected in many" 5 "amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6" "Group enriched" "Detected in many" 7 "amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9" "HPA060505, HPA067637, CAB079044" Enhanced Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Nucleoli, Cytosol" "CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875" "unprognostic (2.05e-4)" "unprognostic (1.17e-1)" "unprognostic (6.84e-4)" "unprognostic (5.26e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (1.43e-2)" "unprognostic (2.93e-2)" "unprognostic (2.64e-2)" "unprognostic (3.05e-1)" "unprognostic (2.20e-1)" "unprognostic (1.89e-1)" "unprognostic (4.65e-12)" "unprognostic (3.23e-2)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (2.63e-4)" 0.5 1.9 15.8 0.5 11.4 0.5 0.4 0.4 28.7 0.5 0.5 0.0 1.9 0.4 0.5 41.0 0.4 0.7 0.4 5.0 10.2 0.8 0.4 0.5 0.5 0.8 1.1 12.1 0.5 0.4 0.6 0.4 0.4 1.6 0.6 0.5 0.7 0.4 0.9 0.4 0.4 0.5 0.5 0.7 0.5 0.4 19.5 0.0 0.0 0.4 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 1.1 0.0 1.5 0.0 0.2 0.1 0.0 0.0 1.0 1.0 0.3 0.4 0.0 0.0 0.0 8.0 0.2 8.8 0.0 0.2 0.0 1.0 5.0 0.2 11.7 0.2 0.1 2.0 0.0 0.0 0.5 0.0 0.1 0.7 2.4 1.4 0.0 0.1 3.8 0.0 0.3 1.5 0.2 0.0 19.0 9.9 1.0 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.0 0.0 0.7 0.0 0.2 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 15.8 11.4 0.4 28.7 10.2 0.8 1.1 12.1 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 29.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.3 18.7 9.4 0.1 0.1 0.0 0.0 0.0 SLC35E2 KIAA0447 ENSG00000215790 "Solute carrier family 35 member E2" P0CK97 1 1724838-1745999 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 22.1;Ciliated cells: 10.7;Club cells: 11.4;Horizontal cells: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA006118, HPA062711" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA006118: , HPA062711: AB_2684844" "unprognostic (3.03e-1)" "unprognostic (2.56e-1)" "unprognostic (4.54e-3)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (1.28e-4)" "unprognostic (9.52e-4)" "unprognostic (6.57e-2)" "unprognostic (2.36e-1)" "unprognostic (1.28e-1)" "unprognostic (9.15e-3)" "unprognostic (4.86e-1)" "unprognostic (2.05e-1)" "unprognostic (2.83e-1)" "unprognostic (8.41e-2)" "unprognostic (2.43e-3)" "unprognostic (4.87e-4)" 3.0 4.1 8.0 5.2 5.1 0.6 3.0 9.8 6.2 4.0 3.0 2.9 1.6 4.9 6.0 10.5 4.5 5.8 7.6 3.0 5.0 3.5 2.5 2.4 4.8 11.6 4.4 4.7 5.5 3.5 6.9 5.9 3.5 4.0 3.6 5.4 3.6 9.1 1.6 4.7 6.4 4.8 3.7 3.7 6.8 6.2 6.2 5.5 5.5 3.5 3.8 4.3 4.3 7.7 5.0 5.2 6.4 3.4 3.1 6.5 3.2 1.6 1.6 5.4 11.5 11.2 11.0 3.6 7.4 15.3 7.0 9.0 4.6 15.1 4.9 1.3 1.7 1.7 7.5 1.4 2.9 7.6 6.8 1.7 6.4 7.5 1.2 2.3 1.3 7.2 8.8 3.7 1.2 6.3 5.8 2.1 9.2 2.1 2.2 1.3 1.2 1.9 3.2 1.0 0.9 1.9 3.7 5.0 1.0 7.4 5.3 15.2 3.1 2.2 9.2 8.8 1.3 17.9 3.6 9.6 7.3 1.5 2.2 0.4 3.0 0.4 1.6 5.2 3.9 1.2 6.4 3.4 2.1 5.5 2.6 6.5 4.5 4.8 5.3 1.5 5.0 5.5 4.8 4.0 3.1 1.6 5.2 4.5 3.2 8.0 5.1 9.8 6.2 5.0 3.5 4.4 4.7 4.0 5.5 26.8 22.1 0.0 0.5 0.5 5.1 0.0 2.5 10.7 11.4 0.0 2.0 0.8 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.4 1.0 0.4 2.3 0.8 0.6 12.7 0.0 1.8 0.6 0.0 2.8 0.3 0.0 0.0 0.7 1.2 0.0 0.0 3.2 0.0 3.9 0.0 0.0 0.7 1.3 1.5 0.2 4.9 1.2 0.4 SLC35F3 FLJ37712 ENSG00000183780 "Solute carrier family 35 member F3" Q8IY50 1 233904933-234324516 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell type enhanced" "Detected in some" 9 "Basal glandular cells: 2.4;Distal tubular cells: 3.3;Exocrine glandular cells: 3.0;Glandular cells: 1.7;Intestinal endocrine cells: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 49 "plasmacytoid DC: 7.1" "Lineage enriched" "Detected in single" 69 "dendritic cells: 7.1" "Cell line enriched" "Detected in some" 7 "HDLM-2: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051327, HPA061582" Uncertain Approved "Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" Nucleoli "HPA051327: AB_2681443, HPA061582: AB_2684563" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.26e-1)" "unprognostic (8.62e-2)" "unprognostic (2.69e-5)" "unprognostic (3.38e-2)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (3.86e-2)" "unprognostic (9.09e-2)" "unprognostic (1.57e-3)" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (3.62e-1)" "unprognostic (3.58e-1)" 0.8 3.5 4.6 1.3 26.0 0.7 6.8 25.1 16.7 1.4 0.8 0.5 0.0 0.8 1.0 2.5 1.6 1.7 0.8 0.6 5.4 4.6 1.6 0.6 1.2 2.4 4.8 6.6 0.6 3.6 4.6 2.8 0.7 4.1 2.0 0.8 0.0 6.6 1.1 1.1 0.8 0.9 1.1 4.8 1.0 2.5 1.1 4.3 0.5 1.9 0.3 1.9 0.8 0.6 0.0 7.1 0.0 0.1 0.0 0.0 0.0 1.4 3.9 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.1 0.3 0.0 3.6 0.0 49.4 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.8 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.4 0.0 0.0 0.0 3.6 0.0 2.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 7.1 0.0 0.0 4.6 26.0 25.1 11.6 5.4 4.6 4.8 6.6 4.1 4.3 0.0 0.0 0.0 2.4 0.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.8 0.6 0.0 0.0 0.0 3.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.7 1.3 0.1 0.0 0.0 0.0 0.0 SLC6A13 GAT2 ENSG00000010379 "Solute carrier family 6 member 13" Q9NSD5 12 220621-262873 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 77.6;retina: 95.9" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 261.2" "Cancer enriched" "Detected in some" 18 "renal cancer: 32.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 10.0;SuSa: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036449, HPA052726" Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Nucleoli, Cytosol" "HPA036449: AB_2675130, HPA052726: AB_2681927" "unprognostic (8.45e-3)" "unprognostic (4.20e-1)" "unprognostic (5.44e-2)" "unprognostic (1.64e-5)" "unprognostic (1.13e-1)" "unprognostic (8.02e-2)" "unprognostic (1.32e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (7.21e-4)" "unprognostic (2.93e-1)" "unprognostic (1.25e-3)" "unprognostic (3.79e-2)" "unprognostic (2.62e-1)" "unprognostic (6.23e-2)" "unprognostic (1.91e-1)" 0.6 0.5 3.0 0.4 5.8 0.5 0.5 2.1 5.8 0.5 0.5 2.5 0.0 1.8 0.5 0.9 0.4 4.2 0.5 1.0 3.1 2.4 77.6 13.2 0.9 0.5 3.4 4.1 0.5 0.4 0.4 1.0 0.5 4.8 0.5 0.5 95.9 0.5 0.5 0.6 0.6 0.8 0.4 5.7 0.5 0.5 1.1 2.1 0.0 4.9 0.0 0.5 0.5 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.3 0.0 0.0 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 1.3 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.4 0.4 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 10.0 0.1 0.1 0.0 0.1 0.0 0.9 3.7 0.0 0.0 0.3 0.2 1.0 0.0 0.4 1.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.3 3.0 5.8 2.1 5.8 3.1 2.4 3.4 4.1 4.8 2.1 0.0 1.1 0.5 0.0 0.0 0.2 1.3 0.0 1.4 0.0 17.4 2.0 0.0 41.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.7 0.0 0.0 0.0 0.6 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 261.2 0.8 0.0 0.0 0.5 0.5 0.0 0.2 0.0 0.0 0.0 SLC6A15 "FLJ10316, hv7-3, NTT73, SBAT1, V7-3" ENSG00000072041 "Solute carrier family 6 member 15" Q9H2J7 12 84859488-84913615 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 18.0;Horizontal cells: 11.1;Melanocytes: 30.4;Rod photoreceptor cells: 10.2" "Cancer enhanced" "Detected in some" "melanoma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 31.1;ASC TERT1: 19.2;hTERT-HME1: 43.9;SCLC-21H: 30.0;SK-MEL-30: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008609 Uncertain Approved Nucleoli,Vesicles NA NA Nucleoli Vesicles "HPA008609: AB_1857190" "unprognostic (1.01e-4)" "unprognostic (9.02e-2)" "unprognostic (1.27e-1)" "unprognostic (6.65e-6)" "unprognostic (1.25e-2)" "unprognostic (2.92e-1)" "unprognostic (7.65e-3)" "unprognostic (1.13e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "unprognostic (4.05e-2)" "unprognostic (7.69e-4)" "unprognostic (2.57e-2)" "unprognostic (3.80e-1)" "unprognostic (1.23e-2)" "unprognostic (2.63e-3)" 1.4 4.5 18.0 2.2 16.2 1.0 2.3 17.8 31.0 1.7 2.2 5.4 0.0 1.4 2.8 1.1 6.7 1.2 1.3 1.0 10.9 18.2 1.5 1.0 1.3 1.1 10.3 16.9 2.1 1.0 1.0 5.6 8.9 14.7 1.8 1.8 9.2 1.4 1.5 1.0 4.9 2.1 1.6 4.9 1.1 1.3 3.6 12.8 0.0 2.0 1.8 1.8 1.1 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 3.6 0.0 31.1 19.2 0.0 0.0 6.5 0.5 0.3 0.0 0.0 0.0 0.0 0.2 4.1 0.4 0.0 8.3 0.0 0.0 9.5 0.0 1.5 0.0 11.5 0.0 0.2 10.7 16.0 4.2 43.9 8.5 0.1 0.0 0.0 0.0 7.9 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 7.8 0.0 9.9 22.1 0.1 0.0 0.0 0.0 4.7 2.5 0.0 0.0 0.0 0.0 0.0 8.2 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.0 16.2 17.8 18.6 10.9 18.2 10.3 16.9 14.7 12.8 0.0 0.0 0.0 0.0 2.4 18.0 0.4 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 1.3 0.1 0.0 0.0 0.1 11.1 0.0 0.0 0.0 0.2 0.0 0.0 30.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 10.2 0.0 0.2 0.1 0.4 0.5 0.2 0.0 0.0 0.0 SLC7A10 asc-1 ENSG00000130876 "Solute carrier family 7 member 10" Q9NS82 19 33208664-33225850 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.9;brain: 13.6;breast: 15.6" "Group enriched" "Detected in some" 5 "Muller glia cells: 1.8;Spermatogonia: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 4.3;HHSteC: 2.6;HSkMC: 3.7;THP-1: 8.4;U-2 OS: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041884, HPA057036" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041884: AB_10794494, HPA057036: AB_2683317" "unprognostic (1.85e-2)" "unprognostic (1.69e-3)" "unprognostic (2.79e-2)" "unprognostic (1.79e-6)" "unprognostic (1.16e-1)" "unprognostic (2.08e-1)" "unprognostic (1.31e-1)" "unprognostic (4.98e-3)" "unprognostic (4.64e-2)" "unprognostic (1.96e-1)" "unprognostic (3.28e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-2)" "unprognostic (1.34e-3)" "unprognostic (8.91e-2)" "unprognostic (3.47e-1)" "unprognostic (2.18e-2)" 40.9 1.0 9.8 1.9 13.6 1.0 15.6 2.4 12.1 1.0 2.2 0.8 0.0 1.0 1.0 1.0 1.0 1.0 1.0 1.1 4.7 6.2 1.3 1.0 1.0 1.2 7.6 5.0 1.0 1.2 1.0 0.0 1.2 9.0 1.0 1.0 8.4 2.3 1.0 1.0 1.1 1.0 1.1 0.8 1.0 1.0 1.4 1.8 0.0 1.4 0.0 1.4 1.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 8.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 9.8 13.6 2.4 12.1 4.7 6.2 7.6 5.0 9.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.0 0.0 SMAD2 "JV18-1, MADH2, MADR2" ENSG00000175387 "SMAD family member 2" Q15796 18 47808957-47931146 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cone photoreceptor cells: 200.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025507, HPA067203, CAB073546" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "CAB025507: , CAB073546: , HPA067203: AB_2685803" "unprognostic (1.55e-1)" "unprognostic (2.49e-1)" "unprognostic (1.43e-2)" "unprognostic (9.82e-3)" "unprognostic (9.88e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.91e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-3)" "unprognostic (6.46e-2)" "unprognostic (4.91e-2)" "unprognostic (9.20e-3)" "unprognostic (2.68e-1)" "unprognostic (6.13e-2)" "unprognostic (3.20e-2)" "unprognostic (6.28e-2)" 38.5 39.2 29.0 26.2 25.9 19.6 31.4 19.5 28.9 28.8 34.2 29.4 28.9 21.5 26.6 26.3 33.5 28.8 25.7 31.1 26.1 27.1 26.4 20.9 28.3 23.8 30.9 24.3 36.6 28.1 25.7 24.4 34.8 28.6 27.8 29.8 31.7 29.7 28.7 33.9 28.0 26.4 34.6 35.4 34.1 26.3 29.2 26.2 60.7 46.1 23.6 31.5 35.1 35.7 12.0 21.8 28.9 24.7 24.5 25.9 19.7 22.2 32.0 19.5 18.9 31.2 38.2 22.3 24.3 29.2 25.4 29.7 12.2 21.4 34.6 17.5 30.8 35.6 24.6 21.9 27.1 34.1 37.6 11.2 29.4 48.3 19.8 36.4 40.8 30.1 28.2 35.0 21.7 50.3 29.6 28.0 28.2 13.6 29.0 31.2 14.5 28.0 19.6 9.6 1.1 7.6 20.5 28.5 23.6 57.0 38.4 18.1 21.2 29.2 20.1 23.8 19.9 15.2 27.2 31.3 37.7 21.8 10.2 17.6 28.5 27.3 30.2 26.1 27.9 27.5 28.9 22.6 25.0 16.9 24.7 21.2 12.0 23.1 20.9 21.8 9.4 25.8 19.8 22.7 24.5 20.8 15.5 25.9 19.7 29.0 25.9 19.5 28.9 26.1 27.1 30.9 24.3 28.6 26.2 41.7 29.7 22.0 39.2 48.3 44.4 40.0 40.8 30.8 45.5 73.3 200.3 37.8 33.2 31.7 53.8 44.7 32.0 46.7 38.2 33.2 34.3 51.4 20.8 22.6 38.9 33.4 49.0 57.7 52.1 97.0 38.6 38.2 49.0 44.1 42.5 37.9 37.5 24.6 50.2 32.1 82.1 32.3 35.9 26.3 39.6 54.1 58.1 38.1 35.7 55.8 SMC2 "CAP-E, hCAP-E, SMC2L1" ENSG00000136824 "Structural maintenance of chromosomes 2" O95347 9 104094260-104141417 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 56.1" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 96.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071309 Approved Supported Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA071309: AB_2686385" "unprognostic (1.51e-1)" "unprognostic (2.01e-3)" "unprognostic (2.26e-2)" "unprognostic (2.23e-2)" "unprognostic (3.04e-1)" "unprognostic (1.05e-1)" "unprognostic (5.57e-3)" "unprognostic (2.59e-3)" "unprognostic (1.47e-2)" "unprognostic (4.35e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (8.02e-3)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-2)" 7.4 6.1 6.6 10.1 10.5 15.2 6.1 8.1 9.1 7.9 7.5 4.0 5.1 7.0 6.1 5.2 11.4 5.1 3.6 7.1 6.5 6.8 8.6 5.7 5.5 14.2 8.2 5.2 6.0 4.1 5.2 6.5 7.5 10.7 5.2 8.5 3.0 5.9 4.7 4.2 6.8 6.9 5.4 8.6 13.7 5.9 12.3 8.7 56.1 7.2 12.9 14.7 6.1 6.3 8.9 5.1 12.0 8.3 8.0 7.4 2.8 18.3 14.2 16.0 14.8 3.4 5.0 15.0 17.0 8.1 15.3 12.9 12.3 14.3 35.2 8.3 8.7 13.2 31.2 23.1 11.0 20.7 22.3 9.7 21.2 22.7 7.9 0.9 12.8 21.4 3.2 2.3 20.7 8.4 5.2 10.8 22.7 17.0 29.0 13.8 8.9 33.3 6.6 13.8 14.9 11.2 22.3 45.9 13.2 6.5 6.7 15.1 11.7 20.3 9.5 5.0 7.0 19.1 8.7 8.6 18.6 19.6 25.7 21.2 10.6 35.7 20.6 12.1 18.8 22.5 12.0 2.8 2.8 6.2 7.1 7.0 8.5 5.7 6.2 3.0 8.9 6.7 7.4 0.4 8.0 8.3 5.1 6.9 2.8 6.6 10.5 8.1 9.1 6.5 6.8 8.2 5.2 10.7 8.7 23.8 11.0 20.1 9.5 24.3 34.1 38.9 7.6 10.7 14.8 15.7 7.9 30.9 29.9 16.5 27.3 15.5 6.5 0.0 17.9 78.9 14.2 5.9 21.9 6.8 37.8 27.0 4.7 19.6 12.1 20.4 17.3 20.0 6.8 27.1 11.4 14.5 14.2 7.0 11.7 13.3 18.4 12.9 17.5 56.4 96.0 20.3 21.6 14.9 24.7 6.7 SMG6 "C17orf31, EST1A, KIAA0732, SMG-6" ENSG00000070366 "SMG6, nonsense mediated mRNA decay factor" Q86US8 17 2059839-2303771 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042932 Approved Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA042932: AB_10964261" "unprognostic (5.22e-2)" "unprognostic (1.20e-1)" "unprognostic (5.30e-1)" "unprognostic (4.41e-2)" "unprognostic (1.33e-1)" "unprognostic (9.33e-3)" "unprognostic (1.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.75e-2)" "unprognostic (7.63e-2)" "unprognostic (4.78e-2)" "unprognostic (1.31e-1)" "prognostic favorable (1.30e-6)" "unprognostic (1.90e-2)" "unprognostic (2.67e-1)" "unprognostic (2.61e-1)" "unprognostic (3.08e-2)" 12.7 16.6 18.1 18.9 17.6 11.9 10.9 19.1 18.4 15.0 10.6 15.1 13.2 9.0 26.2 11.9 16.1 22.2 16.7 16.4 12.8 15.9 11.5 7.3 11.5 10.7 13.4 16.1 38.7 9.3 16.2 17.2 10.1 14.5 14.5 9.5 18.6 10.4 13.3 14.0 15.3 10.3 18.9 12.8 9.0 9.7 39.2 11.5 22.3 11.6 8.4 16.8 12.7 12.4 2.0 3.3 4.8 3.6 4.6 4.3 1.5 8.2 12.7 18.4 11.9 19.9 16.1 9.5 13.4 14.8 15.3 13.0 15.4 4.2 8.7 4.8 19.6 7.0 12.1 13.4 11.4 16.0 8.7 8.4 8.5 6.8 7.5 11.4 4.5 6.1 22.8 8.5 12.3 10.9 24.9 13.9 8.7 7.0 10.7 11.4 6.5 11.4 3.7 5.9 5.0 6.6 11.8 11.7 3.4 8.8 7.6 3.1 9.4 14.0 4.1 5.8 13.5 6.4 3.3 18.2 14.1 7.8 14.8 14.0 9.3 5.5 4.1 11.2 5.1 8.2 4.8 1.8 2.0 3.7 0.8 3.7 1.2 3.1 3.5 1.0 2.0 4.3 2.9 1.4 4.6 3.6 3.3 1.8 1.5 18.1 17.6 19.1 18.4 12.8 15.9 13.4 16.1 14.5 11.5 20.8 17.3 9.3 12.4 7.0 32.9 5.6 12.7 14.7 9.1 14.0 70.7 13.6 5.0 12.0 17.3 13.2 10.7 0.0 11.1 9.3 13.6 11.7 10.4 6.6 8.9 44.5 4.1 12.9 6.3 25.4 15.5 9.2 8.5 19.8 8.0 26.2 13.2 14.4 18.7 6.3 49.0 25.8 13.3 51.6 47.3 7.5 14.5 14.9 8.8 11.2 SMIM20 "C4orf52, MITRAC7, PNX" ENSG00000250317 "Small integral membrane protein 20" Q8N5G0 4 25861830-25929874 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016552 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA016552: AB_1859536" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" "unprognostic (1.78e-1)" "unprognostic (6.52e-3)" "unprognostic (1.55e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-3)" "unprognostic (7.01e-2)" "unprognostic (2.46e-1)" "unprognostic (1.02e-1)" "unprognostic (5.42e-2)" "unprognostic (2.86e-1)" "prognostic favorable (8.97e-5)" "unprognostic (5.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.53e-1)" "unprognostic (5.12e-3)" 14.9 20.5 21.8 15.6 26.7 7.1 25.0 11.4 28.0 12.9 16.4 8.3 12.8 24.1 13.7 46.4 11.9 15.1 22.5 33.7 17.9 16.2 27.1 22.7 18.5 26.0 19.2 14.3 19.5 50.0 8.7 10.0 9.5 22.8 13.6 16.1 11.3 20.4 15.7 51.3 6.9 23.8 24.0 22.6 12.7 18.8 17.7 13.5 9.3 21.3 15.3 14.5 14.5 15.9 27.1 21.4 13.3 20.3 18.1 31.1 18.2 12.9 10.9 14.6 14.1 16.2 35.4 19.6 12.7 15.4 10.9 14.0 9.6 23.1 21.4 22.1 14.0 22.7 3.8 17.0 16.2 15.3 12.1 13.5 12.3 7.9 18.3 27.6 14.6 8.2 25.0 32.6 13.9 21.2 21.4 8.4 14.5 19.7 7.0 13.4 8.3 15.8 24.9 27.6 17.3 16.3 13.1 19.1 13.7 24.3 9.5 18.9 17.6 8.1 5.7 27.9 16.8 11.8 20.9 13.9 11.9 14.1 13.3 16.1 13.8 11.3 22.4 18.0 15.6 15.0 13.3 18.2 8.4 15.7 20.3 20.5 27.1 22.7 19.7 20.5 26.8 31.1 24.7 9.2 18.1 15.2 21.4 23.2 18.2 21.8 26.7 11.4 28.0 17.9 16.2 19.2 14.3 22.8 13.5 8.9 35.3 39.7 30.7 19.5 7.0 54.2 58.6 29.4 35.2 34.9 7.9 53.4 111.0 55.9 8.3 17.8 60.0 0.0 54.3 51.6 39.2 34.0 10.4 52.1 61.7 1.6 18.6 19.0 49.0 18.9 34.8 47.0 42.2 36.1 53.7 55.6 48.1 35.1 45.3 134.2 16.1 71.1 36.2 42.9 40.5 16.9 36.6 25.9 63.5 25.3 SMKR1 ENSG00000240204 "Small lysine rich protein 1" H3BMG3 7 129502479-129512932 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "testis: 65.7" "Group enriched" "Detected in many" 36 "Early spermatids: 1715.8;Late spermatids: 4654.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 13 "B-cells: 2.9;NK-cells: 1.3;T-cells: 3.7" "Cell line enhanced" "Detected in many" "MCF7: 12.8;SCLC-21H: 22.5" "Low region specificity" "Detected in all" HPA078358 Approved Nucleoli NA NA Nucleoli "HPA078358: AB_2686883" "unprognostic (5.08e-2)" "unprognostic (1.72e-1)" "unprognostic (1.64e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (2.13e-1)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (9.24e-2)" "unprognostic (4.05e-2)" "unprognostic (2.00e-1)" "unprognostic (6.30e-2)" "unprognostic (1.72e-6)" "unprognostic (1.67e-2)" "unprognostic (1.11e-2)" "unprognostic (6.40e-2)" "unprognostic (3.67e-2)" 0.3 1.0 3.1 0.5 6.3 0.3 1.5 0.8 3.3 0.6 0.3 0.1 0.0 0.5 0.4 1.7 0.4 4.6 0.4 0.2 2.7 2.2 0.7 0.2 0.5 0.7 1.1 2.7 0.3 2.6 2.9 2.7 0.9 1.0 0.5 0.4 0.0 0.3 0.4 0.2 0.5 0.4 0.3 0.5 0.3 0.5 65.7 0.7 0.0 0.7 0.1 0.7 0.2 0.0 2.9 0.0 0.2 0.0 1.3 3.7 0.4 8.8 8.6 0.2 7.5 0.0 0.0 0.0 0.0 0.2 0.7 0.7 0.0 2.3 0.0 0.8 0.5 4.9 1.1 1.5 0.0 1.1 8.2 0.9 0.0 1.7 0.0 1.6 0.1 5.7 0.0 3.8 2.3 1.6 1.0 0.3 5.3 0.5 0.2 0.4 12.8 1.6 0.8 1.1 2.3 7.7 0.8 0.0 1.9 3.2 0.0 22.5 6.1 6.4 0.7 0.5 1.5 2.0 1.1 0.1 0.0 0.2 5.0 1.9 2.2 2.8 0.1 3.1 0.3 0.6 0.0 0.0 0.0 3.7 0.0 1.7 2.9 0.7 1.9 0.0 1.5 1.5 1.4 0.2 1.3 0.0 0.0 0.0 0.4 3.1 6.3 0.8 3.3 2.7 2.2 1.1 2.7 1.0 0.7 3.0 0.0 0.0 2.1 0.1 1.4 0.0 0.0 8.1 1.2 5.2 0.0 0.0 8.3 1.7 1715.8 0.1 0.0 0.0 5.3 0.2 0.6 1.0 0.0 0.0 0.1 0.0 8.6 0.6 0.0 4654.0 34.8 0.0 1.7 1.0 0.0 1.0 3.1 0.0 25.8 1.1 0.2 0.0 0.0 89.2 28.0 0.3 0.1 5.0 0.0 0.7 SMPDL3A "ASM3A, ASML3a, FLJ20177, yR36GH4.1" ENSG00000172594 "Sphingomyelin phosphodiesterase acid like 3A" Q92484 6 122789049-122809720 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 208.6;Proximal tubular cells: 122.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "basophil: 31.2" "Lineage enriched" "Detected in many" 10 "granulocytes: 31.2" "Cell line enhanced" "Detected in many" "ASC diff: 22.3;hTCEpi: 18.3;OE19: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030148 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted to blood" No No 22000000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA030148: AB_10601591" "unprognostic (2.60e-1)" "unprognostic (1.22e-1)" "prognostic favorable (6.11e-4)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (8.30e-3)" "unprognostic (3.37e-1)" "unprognostic (1.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.53e-1)" "unprognostic (1.39e-1)" "unprognostic (7.72e-2)" "unprognostic (2.27e-2)" "unprognostic (3.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.8 15.9 4.0 8.3 5.4 8.1 24.9 9.7 9.9 35.3 46.7 3.8 8.0 19.2 10.0 9.8 9.6 5.1 8.5 11.9 4.5 4.1 20.1 36.9 13.0 29.1 4.7 5.6 6.2 24.6 16.1 7.0 23.2 6.5 19.6 28.5 7.6 9.5 13.7 56.1 32.1 63.6 10.9 4.9 37.7 13.1 3.8 3.2 3.3 7.2 18.0 7.6 18.7 24.3 0.1 0.4 31.2 3.2 0.0 0.0 0.5 0.1 1.2 3.0 1.4 22.3 10.1 9.6 5.0 13.5 1.5 3.3 1.6 1.3 0.0 0.7 3.1 4.1 2.4 0.8 2.5 1.3 0.0 2.6 1.1 5.1 4.2 14.3 0.0 0.0 12.3 18.3 1.4 2.7 6.0 2.7 0.0 1.8 0.0 6.2 4.4 0.0 0.1 0.5 28.0 3.9 0.0 5.3 0.1 7.4 2.0 2.2 0.0 0.7 9.1 12.7 2.0 1.5 0.7 5.2 3.0 1.7 0.3 3.2 0.0 0.0 0.0 4.3 2.3 6.7 31.2 1.7 0.4 0.0 1.9 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.2 0.0 0.0 0.5 4.0 5.4 9.7 9.9 4.5 4.1 4.7 5.6 6.5 3.2 3.0 16.2 2.2 20.4 47.7 2.8 3.6 22.9 5.3 3.4 5.2 3.9 117.9 48.0 19.1 0.1 5.8 208.6 0.0 22.5 35.4 27.9 13.5 9.3 67.1 54.3 3.2 46.8 24.5 86.5 1.1 14.4 9.9 33.7 1.0 51.3 11.4 17.1 87.7 13.4 122.4 5.9 12.9 8.3 0.9 3.9 66.5 96.2 4.3 33.0 12.8 SNAPC1 "PTFgamma, SNAP43" ENSG00000023608 "Small nuclear RNA activating complex polypeptide 1" Q16533 14 61762357-61796428 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 120.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 41.4;hTERT-HME1: 41.6;U-2 OS: 55.1;U-251 MG: 38.0" "Low region specificity" "Detected in all" "HPA067076, HPA072276" Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA067076: AB_2732757, HPA072276: AB_2732199" "unprognostic (7.40e-2)" "unprognostic (5.04e-2)" "unprognostic (3.09e-2)" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.55e-2)" "unprognostic (1.68e-3)" "unprognostic (1.88e-1)" "unprognostic (4.01e-2)" "unprognostic (5.18e-2)" "unprognostic (1.58e-1)" "unprognostic (1.99e-1)" "unprognostic (2.47e-3)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.10e-1)" "unprognostic (2.26e-1)" 9.9 12.3 7.5 8.6 10.3 7.0 8.4 12.1 8.0 14.4 6.8 5.6 11.6 4.9 10.3 15.8 9.2 8.7 10.4 11.2 7.8 7.6 8.7 7.0 10.5 9.7 11.8 5.4 12.1 5.0 8.8 27.2 11.3 14.2 10.3 4.2 5.7 7.2 19.8 5.6 8.7 5.2 6.9 14.5 9.5 5.4 24.9 9.4 9.1 9.8 8.2 8.9 17.4 14.3 12.0 9.3 7.5 7.0 9.6 13.1 5.1 14.6 2.8 2.8 6.0 3.2 3.7 3.4 12.4 8.3 14.3 8.5 1.0 3.0 3.0 16.6 5.2 41.4 4.6 2.8 3.7 23.6 3.3 2.0 1.8 1.5 2.0 8.4 1.9 4.0 3.5 2.5 12.0 41.6 5.6 5.4 4.2 2.0 2.8 13.6 1.8 4.6 3.0 2.7 1.6 9.5 3.5 7.5 1.1 11.7 2.3 2.0 4.9 8.2 1.4 9.8 3.7 2.9 3.0 8.3 15.8 55.1 10.2 38.0 1.8 1.9 2.7 10.7 2.4 9.3 7.5 7.0 5.8 6.4 5.9 8.3 12.0 8.1 5.5 7.0 12.0 13.1 8.5 7.1 9.6 4.9 9.3 8.7 5.1 7.5 10.3 12.1 8.0 7.8 7.6 11.8 5.4 14.2 9.4 32.8 16.5 17.9 48.3 84.6 10.6 18.8 5.1 57.6 28.4 27.9 2.0 14.9 6.6 20.7 35.6 28.5 4.0 0.0 14.0 21.4 31.0 23.1 40.5 5.8 15.6 7.9 4.1 27.6 12.6 8.2 20.4 19.5 16.9 13.6 4.5 42.6 16.7 0.0 19.1 8.2 11.7 19.4 30.3 120.2 67.0 56.3 4.7 15.2 6.4 22.2 SNAPC3 "MGC132011, MGC33124, PTFbeta, SNAP50" ENSG00000164975 "Small nuclear RNA activating complex polypeptide 3" Q92966 9 15422704-15465953 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 98.3;Late spermatids: 162.5;Spermatocytes: 125.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053145, HPA066031" Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "HPA053145: AB_2682055, HPA066031: AB_2685600" "unprognostic (2.62e-1)" "unprognostic (4.26e-1)" "unprognostic (5.42e-3)" "unprognostic (2.09e-1)" "unprognostic (4.93e-3)" "unprognostic (6.08e-2)" "unprognostic (5.60e-3)" "unprognostic (4.15e-2)" "unprognostic (1.68e-2)" "unprognostic (1.67e-2)" "unprognostic (1.12e-2)" "unprognostic (2.64e-2)" "unprognostic (1.36e-3)" "unprognostic (3.07e-1)" "unprognostic (2.63e-1)" "unprognostic (4.38e-2)" "unprognostic (2.09e-2)" 9.8 18.5 18.7 10.3 21.1 4.6 10.4 26.3 21.2 17.9 13.2 10.4 10.3 11.6 16.5 15.5 12.6 10.8 10.8 17.5 18.0 14.0 12.3 8.6 10.0 11.2 15.2 16.3 17.4 11.1 12.8 18.4 16.7 21.8 13.3 14.6 9.6 10.5 11.3 19.3 13.7 14.2 12.8 15.2 12.8 10.5 14.7 15.9 11.9 11.3 6.8 10.8 12.9 15.1 12.2 7.7 5.0 21.2 5.0 8.2 5.5 3.9 5.1 10.8 4.1 8.7 9.1 6.3 6.2 2.8 3.7 4.4 2.4 1.7 2.8 2.4 3.9 5.2 2.4 5.7 2.9 4.6 13.1 6.7 10.1 10.8 3.3 4.3 2.2 7.8 5.9 5.9 2.6 3.0 15.7 6.8 6.7 2.8 4.6 8.4 1.2 2.7 7.2 3.4 3.0 13.5 5.5 1.3 1.5 6.4 2.4 11.6 8.2 2.1 1.9 1.4 9.9 4.6 4.6 5.6 6.2 2.5 2.6 7.9 6.1 7.3 3.5 4.0 3.0 2.8 3.4 10.1 5.0 5.7 16.7 5.5 9.9 5.7 5.1 7.7 12.2 8.2 7.9 1.2 5.0 21.2 6.3 7.9 5.5 18.7 21.1 26.3 21.2 18.0 14.0 15.2 16.3 21.8 15.9 17.9 11.0 17.8 12.4 8.5 19.2 37.1 5.1 13.4 5.7 19.2 29.5 10.6 11.6 16.6 98.3 16.4 21.6 0.0 8.2 10.8 16.4 10.3 17.3 12.4 13.8 33.4 14.5 19.0 22.1 162.5 31.4 10.0 18.6 17.2 14.1 15.1 11.3 27.7 28.7 24.2 17.8 12.9 21.7 125.8 27.9 10.5 8.1 17.1 16.2 10.2 SNAPIN "BLOC1S7, BORCS3, SNAPAP" ENSG00000143553 "SNAP associated protein" O95295 1 153658654-153661830 "Predicted intracellular proteins, Transporters" "Exocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046974 Approved Approved "Nucleoli,Golgi apparatus" NA NA 15000 "Golgi apparatus" Nucleoli "HPA046974: AB_10962506" "unprognostic (3.65e-1)" "unprognostic (1.67e-1)" "unprognostic (1.47e-1)" "unprognostic (5.66e-2)" "unprognostic (1.75e-1)" "unprognostic (2.06e-1)" "unprognostic (1.64e-3)" "unprognostic (1.54e-1)" "unprognostic (4.86e-2)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (5.42e-4)" "unprognostic (2.31e-1)" "unprognostic (4.73e-1)" "unprognostic (1.31e-3)" "unprognostic (4.89e-2)" 21.8 32.5 20.2 14.5 25.9 8.4 30.2 12.1 26.3 17.5 19.2 18.5 17.2 9.1 19.7 25.0 20.7 20.4 21.4 38.1 17.4 17.7 21.8 22.1 15.7 26.1 21.6 17.8 17.9 22.9 18.0 10.8 14.5 20.5 17.9 14.7 15.6 14.1 22.6 56.9 16.1 13.2 24.9 22.1 19.4 16.0 16.5 20.8 18.1 19.9 29.8 21.7 19.6 13.9 42.4 50.8 44.6 49.9 35.4 42.8 42.8 20.1 24.8 21.1 12.7 27.0 18.1 13.6 17.1 19.0 24.3 18.5 17.6 16.2 14.5 34.6 17.4 11.9 27.0 17.3 22.3 17.0 19.3 23.9 16.0 19.1 8.4 27.9 15.7 10.2 21.7 16.7 18.1 20.7 24.5 22.7 17.0 13.6 11.2 24.3 32.6 17.9 9.2 11.4 31.7 26.7 17.1 18.4 38.3 26.8 19.4 16.1 28.2 19.7 22.9 22.4 20.7 34.8 16.8 20.0 11.3 17.3 22.4 16.0 27.3 29.8 22.1 21.6 9.9 14.7 27.6 49.9 44.6 30.9 49.1 35.0 42.4 31.4 31.0 50.8 36.9 34.8 31.8 10.4 35.4 39.0 38.1 42.8 42.8 20.2 25.9 12.1 26.3 17.4 17.7 21.6 17.8 20.5 20.8 17.9 17.6 24.3 31.9 18.3 13.6 35.0 22.9 36.1 22.7 27.9 7.9 54.7 63.0 60.4 5.7 30.1 18.8 0.0 57.1 40.8 26.9 29.4 30.0 25.5 77.8 20.6 13.3 31.9 48.5 18.5 28.4 40.8 25.3 91.0 20.8 57.6 41.2 25.7 46.7 60.8 17.2 45.3 38.2 29.6 39.2 20.6 61.7 26.6 25.6 33.4 SNORC "ASCL830, C2orf82, UNQ830" ENSG00000182600 "Secondary ossification center associated regulator of chondrocyte maturation" Q6UX34 2 232857270-232878708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.9;breast: 19.6" "Group enriched" "Detected in some" 4 "Distal tubular cells: 5.0;Pancreatic endocrine cells: 9.1;Proximal tubular cells: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "basophil: 6.3" "Lineage enriched" "Detected in single" 18 "granulocytes: 6.3" "Cell line enriched" "Detected in some" 14 "Hep G2: 36.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA052824 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "HPA052824: AB_2681964" "unprognostic (4.58e-3)" "unprognostic (1.31e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (3.06e-1)" "unprognostic (4.71e-1)" "unprognostic (1.23e-3)" "unprognostic (3.52e-1)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (4.30e-7)" "unprognostic (1.83e-3)" "unprognostic (8.15e-2)" "unprognostic (1.58e-2)" "unprognostic (1.33e-2)" 1.4 1.5 4.8 0.8 6.4 1.5 19.6 2.8 9.0 0.3 2.4 9.3 0.0 2.7 0.7 2.0 0.3 0.4 0.3 0.4 8.8 7.8 1.2 2.1 1.3 1.7 11.9 7.0 0.5 4.2 0.7 0.3 0.9 9.1 3.0 1.1 0.0 3.2 0.6 2.8 10.8 2.0 0.6 27.9 1.4 1.3 6.2 7.4 0.0 0.9 0.0 0.5 0.5 0.0 0.0 0.0 6.3 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.9 0.6 1.0 1.5 0.1 0.0 0.2 0.4 0.0 0.1 0.0 0.4 0.1 0.3 0.3 0.0 0.0 0.0 0.4 1.3 0.3 0.2 36.4 0.5 0.0 1.1 0.0 0.9 0.2 0.5 0.4 1.0 0.4 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 1.4 0.2 0.3 0.2 0.0 0.5 0.1 0.5 0.2 0.0 1.3 0.6 0.0 1.6 0.5 0.1 0.5 0.5 0.4 2.4 2.5 0.1 0.0 0.8 0.2 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.4 2.8 9.0 8.8 7.8 11.9 7.0 9.1 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.5 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 SNRNP35 U1SNRNPBP ENSG00000184209 "Small nuclear ribonucleoprotein U11/U12 subunit 35" Q16560 12 123457641-123473154 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059145, HPA067031" Supported Supported Nucleoli NA NA Nucleoli "HPA059145: AB_2683926, HPA067031: AB_2685766" "unprognostic (3.80e-2)" "unprognostic (1.17e-2)" "unprognostic (6.16e-2)" "unprognostic (1.35e-3)" "unprognostic (6.78e-2)" "unprognostic (1.96e-1)" "unprognostic (7.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.75e-1)" "unprognostic (6.24e-2)" "unprognostic (2.56e-3)" "unprognostic (7.24e-2)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (7.10e-2)" "unprognostic (2.30e-2)" "unprognostic (1.31e-3)" 15.3 15.4 18.7 14.1 20.5 14.1 17.7 25.4 23.1 14.1 15.2 22.8 14.8 14.3 16.0 15.1 17.1 14.8 11.4 22.4 18.5 18.1 16.3 19.3 16.4 16.8 21.2 18.5 13.6 12.9 20.9 19.6 15.6 20.4 16.3 17.1 17.5 21.8 12.9 64.0 24.1 15.0 15.6 20.3 21.0 15.1 14.5 23.6 14.1 20.2 23.7 17.7 12.4 14.2 35.1 24.8 37.5 24.7 23.3 40.4 19.1 12.2 13.1 15.7 8.0 11.5 10.8 13.8 10.7 15.8 11.3 8.3 8.1 8.5 24.3 7.9 15.5 8.2 12.7 13.5 19.2 9.8 17.7 10.9 11.4 11.7 18.5 8.0 11.6 18.3 13.0 13.5 10.1 9.7 20.6 15.4 7.7 14.5 4.9 15.8 25.8 12.5 26.4 11.0 16.5 12.5 9.6 6.9 12.9 25.9 24.8 13.5 19.9 9.5 20.2 14.7 16.4 24.3 15.8 17.8 7.6 13.7 9.5 9.6 12.4 12.4 14.2 12.3 11.4 10.3 37.0 24.4 37.5 24.3 24.7 24.0 35.1 30.8 27.3 24.6 30.7 24.4 25.9 36.7 23.3 22.7 24.8 40.4 19.1 18.7 20.5 25.4 23.1 18.5 18.1 21.2 18.5 20.4 23.6 47.6 19.0 23.0 18.4 12.5 26.4 25.2 20.4 28.1 22.7 31.4 11.8 43.7 43.1 28.8 27.9 20.4 25.4 23.3 29.2 33.0 17.4 16.4 12.7 24.6 28.4 14.3 14.3 25.2 16.2 6.9 22.5 17.5 15.1 45.1 18.2 32.3 29.3 23.0 24.4 33.6 27.7 32.3 11.4 16.1 21.5 12.7 35.1 25.4 15.9 22.7 SNX10 ENSG00000086300 "Sorting nexin 10" Q9Y5X0 7 26291895-26374329 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;brain: 39.0;liver: 37.4" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 242.1;Hofbauer cells: 146.8;Kupffer cells: 156.1;Macrophages: 186.4;Muller glia cells: 262.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 67.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 27.2;U-937: 22.3;WM-115: 77.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015605, HPA064782" Approved Supported Nucleoplasm,Nucleoli,Microtubules NA NA "Nucleoplasm, Microtubules" Nucleoli "HPA015605: AB_1857342, HPA064782: AB_2685349" "unprognostic (6.42e-2)" "unprognostic (2.72e-3)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (6.92e-2)" "unprognostic (2.48e-3)" "unprognostic (4.51e-2)" "unprognostic (4.87e-1)" "unprognostic (9.36e-2)" "unprognostic (1.59e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (8.06e-5)" "unprognostic (1.12e-2)" "unprognostic (3.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.50e-1)" 17.7 8.7 20.2 18.6 17.9 20.9 6.7 13.2 39.0 2.9 3.3 2.1 0.1 2.5 5.4 0.8 1.8 1.9 5.2 1.3 22.2 32.7 21.3 37.4 22.4 18.0 27.8 20.8 1.0 5.0 0.6 3.0 8.9 36.2 2.2 3.9 1.8 1.4 1.5 0.9 1.0 3.6 5.4 15.4 22.1 2.3 3.0 2.1 3.8 1.9 0.1 13.6 6.3 1.8 16.3 20.1 67.6 30.9 9.0 5.6 11.6 13.9 1.3 0.0 2.6 0.0 0.0 15.2 0.0 1.0 0.0 0.0 0.1 4.7 6.1 11.0 0.0 9.6 0.4 3.5 0.9 0.0 8.4 3.3 0.6 0.1 9.2 0.0 13.0 2.3 0.1 1.4 0.0 1.1 0.0 0.2 7.9 0.3 0.0 0.0 2.4 5.4 13.7 4.0 0.1 1.3 0.0 0.0 0.3 27.2 3.0 6.0 1.8 3.0 2.2 15.8 5.0 4.0 18.6 0.0 0.0 3.3 0.0 3.4 4.7 3.7 4.1 0.1 22.3 77.5 8.2 29.2 0.7 4.0 30.9 3.8 16.3 2.8 3.4 20.1 14.5 1.5 2.6 67.6 9.0 30.1 7.4 5.6 11.6 20.2 17.9 13.2 39.0 22.2 32.7 27.8 20.8 36.2 2.1 3.0 17.1 49.9 1.0 4.7 17.7 1.6 20.4 1.4 7.9 22.7 2.0 11.6 242.1 51.3 0.9 5.6 2.6 23.3 23.5 64.7 3.6 2.8 31.1 90.6 146.8 33.4 9.1 2.5 156.1 0.7 1.1 186.4 8.5 49.5 2.5 262.3 22.1 0.0 0.0 123.2 20.4 0.0 3.3 1.6 28.0 2.6 24.0 38.8 9.7 0.9 SNX15 ENSG00000110025 "Sorting nexin 15" Q9NRS6 11 65027408-65040572 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "granulocytes: 8.1;Intestinal endocrine cells: 7.5;monocytes: 12.6;Undifferentiated cells: 6.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038955 Approved Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoli, Cytosol" "Vesicles, Plasma membrane" "HPA038955: AB_10672834" "unprognostic (2.00e-2)" "unprognostic (4.90e-2)" "unprognostic (3.93e-1)" "unprognostic (9.61e-4)" "unprognostic (2.79e-1)" "unprognostic (4.06e-3)" "unprognostic (4.45e-3)" "unprognostic (4.74e-2)" "unprognostic (1.09e-1)" "unprognostic (9.55e-2)" "unprognostic (8.93e-3)" "unprognostic (1.79e-2)" "unprognostic (8.84e-2)" "unprognostic (7.86e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.68e-4)" 17.9 13.6 17.1 12.7 18.3 11.6 23.5 25.7 21.9 13.2 22.7 16.7 9.5 19.7 14.2 8.9 15.9 11.4 13.9 15.1 16.2 14.3 15.7 9.8 14.1 14.7 16.3 14.5 18.3 17.7 13.7 8.4 9.5 13.4 15.1 11.6 11.2 15.6 15.4 25.2 17.2 20.4 15.0 17.6 11.3 13.5 7.6 15.8 12.4 14.4 10.1 11.5 14.9 12.5 7.7 8.0 10.9 18.3 3.2 7.1 5.7 17.4 12.9 8.4 8.2 10.2 7.5 4.7 1.7 7.9 13.8 12.7 10.2 13.7 17.8 9.9 10.0 17.4 9.8 9.8 8.7 3.8 26.8 8.1 8.9 10.6 17.0 11.0 4.6 14.4 6.3 13.1 14.6 8.5 7.7 8.2 13.1 15.0 11.4 7.2 10.5 16.3 20.7 9.1 6.8 12.8 13.5 5.0 19.2 10.2 3.8 15.2 11.5 14.9 13.5 12.9 4.0 13.7 10.7 16.1 14.0 13.5 14.1 7.4 12.3 21.1 17.0 13.7 7.3 4.8 7.8 11.3 10.9 6.9 13.6 5.6 7.7 7.1 6.1 8.0 6.1 5.2 4.7 1.6 3.2 18.3 5.5 6.7 5.7 17.1 18.3 25.7 21.9 16.2 14.3 16.3 14.5 13.4 15.8 0.0 3.5 0.0 0.0 0.9 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.3 0.0 4.7 0.0 0.4 4.2 0.0 2.7 0.4 0.4 0.0 8.1 0.0 0.9 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 12.6 3.1 0.2 3.5 5.1 0.4 0.5 0.4 0.0 0.3 0.0 0.0 0.4 0.3 1.0 6.0 0.0 SNX29 "FLJ12363, RUNDC2A" ENSG00000048471 "Sorting nexin 29" Q8TEQ0 16 11976737-12574289 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 333.8;Early spermatids: 117.2;Horizontal cells: 87.4;Late spermatids: 346.9;Rod photoreceptor cells: 256.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "naive B-cell: 19.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008889, HPA062810" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoli, Cytosol" "HPA008889: AB_1079856, HPA062810: " "unprognostic (2.50e-1)" "unprognostic (4.12e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (9.82e-3)" "unprognostic (2.29e-2)" "unprognostic (1.12e-1)" "unprognostic (5.38e-2)" "unprognostic (2.18e-2)" "unprognostic (7.44e-2)" "unprognostic (6.08e-2)" "prognostic favorable (1.38e-7)" "unprognostic (3.85e-3)" "unprognostic (4.54e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (1.03e-4)" 11.4 5.5 8.2 9.8 14.4 10.7 8.3 13.2 11.9 9.4 6.7 22.7 5.2 3.3 9.6 9.1 9.9 11.1 6.4 6.6 9.0 8.1 24.5 3.6 8.7 14.8 13.7 9.1 13.7 4.8 32.1 16.1 10.0 14.4 5.4 4.9 15.4 6.9 6.8 11.7 8.2 5.8 12.2 18.5 10.8 6.1 16.9 13.1 12.5 8.6 4.9 19.2 9.8 7.4 19.2 5.8 3.0 5.7 1.0 4.3 1.4 3.1 1.8 2.8 2.3 16.9 13.9 3.7 6.8 18.7 2.8 3.1 0.3 3.6 11.7 9.1 10.5 1.8 2.7 1.8 4.3 4.1 4.5 1.9 1.5 1.6 4.0 3.2 1.6 4.3 12.7 2.8 4.1 1.8 4.2 4.9 3.9 2.4 3.3 2.8 4.2 3.1 1.9 1.6 2.0 1.7 7.0 3.6 9.4 12.5 2.9 3.4 2.8 7.7 4.6 1.6 2.5 2.6 2.0 7.4 5.0 2.0 3.7 1.3 19.2 14.6 7.3 9.2 1.8 3.1 3.0 5.7 1.2 1.7 3.7 2.1 8.3 3.6 2.2 2.0 19.2 4.3 3.1 2.0 1.0 1.8 5.8 3.1 1.4 8.2 14.4 13.2 11.9 9.0 8.1 13.7 9.1 14.4 13.1 11.9 19.3 51.4 5.6 13.6 52.7 9.5 5.1 16.0 13.6 15.7 333.8 15.9 18.3 3.8 117.2 11.2 3.4 0.0 2.5 4.2 17.2 3.4 41.5 5.0 24.8 87.4 12.6 16.5 21.8 346.9 19.8 27.4 11.8 11.8 3.6 21.7 5.8 3.5 14.5 32.0 256.7 6.5 10.8 21.5 7.6 13.6 14.3 9.6 3.3 4.6 SNX30 ATG24A ENSG00000148158 "Sorting nexin family member 30" Q5VWJ9 9 112750838-112881671 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 65.1;Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019346 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA019346: AB_2286395" "unprognostic (1.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.08e-1)" "unprognostic (3.61e-1)" "unprognostic (3.61e-1)" "unprognostic (3.69e-1)" "unprognostic (8.05e-3)" "unprognostic (2.04e-3)" "unprognostic (4.48e-2)" "unprognostic (3.59e-3)" "unprognostic (3.39e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.01e-7)" "unprognostic (4.48e-3)" "unprognostic (1.18e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-2)" 4.9 4.4 12.2 7.7 12.6 8.3 7.7 18.1 18.5 10.9 11.1 25.6 3.6 7.9 6.4 4.1 5.3 3.8 5.4 3.4 14.2 12.0 23.7 5.2 23.4 8.8 14.8 12.8 6.9 5.2 6.9 6.3 5.1 14.7 4.1 11.7 4.9 7.1 4.3 2.6 5.7 8.9 7.5 20.3 7.4 4.7 12.7 11.8 2.3 3.1 2.6 8.7 5.4 4.6 0.7 4.2 1.5 5.1 0.8 1.7 1.6 6.0 3.8 6.6 5.2 8.3 7.6 5.5 5.2 10.9 4.4 4.2 13.5 1.4 10.1 4.4 13.4 7.9 7.2 7.9 3.1 6.9 3.2 3.7 3.1 3.4 5.4 6.0 3.1 5.6 6.2 4.3 6.8 5.1 11.2 3.8 2.6 4.8 5.8 5.9 4.2 2.0 3.6 7.2 9.8 4.0 4.3 15.4 2.6 8.6 10.6 9.8 3.1 6.8 9.4 13.0 7.0 7.0 5.6 4.2 6.6 7.0 19.3 4.4 15.1 13.9 4.8 8.5 2.9 12.8 0.0 5.1 1.5 0.8 2.0 1.7 0.0 0.8 1.0 4.2 0.7 0.7 0.6 0.7 0.8 2.1 0.7 1.6 1.6 12.2 12.6 18.1 18.5 14.2 12.0 14.8 12.8 14.7 11.8 6.0 65.1 0.0 1.9 7.2 5.7 3.8 5.1 1.4 9.1 5.2 9.8 0.4 5.0 2.1 5.3 3.0 12.4 46.7 2.8 1.6 5.7 3.1 6.9 5.9 11.9 7.9 4.6 12.3 19.7 6.3 5.2 12.5 20.3 1.0 9.7 2.6 3.4 17.3 7.4 33.2 2.7 0.0 1.4 5.5 10.5 9.7 0.3 3.8 8.6 5.4 SOGA1 "C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA" ENSG00000149639 "Suppressor of glucose, autophagy associated 1" O94964 20 36777442-36863686 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 55.5" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043992 Approved Approved Nucleoli,Cytosol "Secreted to blood" NA Yes "Nucleoli, Cytosol" "HPA043992: AB_2678762" "unprognostic (2.34e-2)" "unprognostic (1.35e-1)" "unprognostic (6.58e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.48e-1)" "unprognostic (2.27e-3)" "unprognostic (1.37e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (8.28e-5)" "unprognostic (1.09e-3)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.49e-4)" "unprognostic (6.99e-2)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (4.45e-3)" 6.2 11.4 10.8 4.5 10.6 1.4 6.0 55.5 12.5 11.3 8.3 20.5 7.2 2.5 8.8 5.3 7.2 9.4 9.9 6.7 9.9 7.5 4.7 1.3 6.1 3.0 12.7 8.9 12.6 3.7 11.5 4.4 7.9 8.7 10.7 3.9 6.7 4.4 12.3 2.9 11.0 4.6 14.1 7.9 5.3 5.3 14.8 14.7 0.9 16.0 4.7 4.1 8.0 10.5 1.0 2.1 1.4 0.7 0.7 0.2 0.2 7.5 10.3 12.5 13.5 7.3 6.7 3.3 6.6 7.2 9.5 5.6 4.1 1.2 3.3 2.5 11.6 8.2 10.2 10.0 6.2 10.0 0.5 2.0 5.4 9.6 5.4 3.8 1.2 5.3 3.8 7.6 9.0 6.4 4.1 6.1 3.7 3.8 0.7 10.3 7.3 3.8 2.8 3.2 0.8 8.0 9.0 11.7 1.3 5.5 2.3 15.0 9.4 13.8 15.2 4.4 5.8 19.3 8.1 9.3 23.8 4.6 11.6 14.4 1.4 0.3 3.4 10.1 1.6 15.0 1.4 0.7 0.2 0.1 0.4 0.2 1.0 0.1 0.1 0.4 1.0 0.2 0.2 1.4 0.7 0.3 2.1 0.1 0.2 10.8 10.6 55.5 12.0 9.9 7.5 12.7 8.9 8.7 14.7 0.0 2.6 1.4 4.8 11.2 18.8 12.1 0.0 2.7 7.9 19.2 35.3 12.5 1.7 3.4 0.4 10.5 1.7 0.0 1.3 8.6 11.0 5.2 10.4 0.2 8.5 22.3 5.8 9.8 5.3 1.5 11.2 6.0 5.0 1.0 1.3 19.4 1.8 0.0 17.7 1.2 3.7 12.9 11.3 0.7 1.0 14.1 2.7 1.0 2.5 2.5 SOSTDC1 "DAND7, DKFZp564D206, USAG1" ENSG00000171243 "Sclerostin domain containing 1" Q6X4U4 7 16461481-16530580 "Predicted secreted proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.1;retina: 74.8;stomach 1: 32.3" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 24.9;Horizontal cells: 28.6;Melanocytes: 30.4" "Cancer enhanced" "Detected in many" "renal cancer: 25.9" "Region enriched" "Detected in many" 9 "pons and medulla: 51.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.5;EFO-21: 11.2;HEL: 4.2;NTERA-2: 4.4;RPTEC TERT1: 20.8" "Group enriched" "Detected in many" 5 "basal ganglia: 9.4;hippocampal formation: 20.4;pons and medulla: 15.8;thalamus: 12.8" "Low region specificity" "Detected in many" HPA042856 Uncertain "Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA "Golgi apparatus" "Nucleoli, Nucleoli rim, Vesicles" "HPA042856: " "unprognostic (2.08e-2)" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.17e-3)" "unprognostic (5.59e-3)" "unprognostic (4.13e-2)" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (1.41e-2)" "prognostic favorable (8.69e-4)" "unprognostic (2.59e-1)" "unprognostic (2.62e-1)" "prognostic favorable (3.22e-5)" "unprognostic (7.01e-2)" "unprognostic (1.23e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (8.72e-4)" 0.4 0.4 2.0 1.4 1.9 0.0 9.5 0.5 5.8 2.6 5.9 7.0 0.2 6.1 2.5 2.4 2.7 2.7 0.4 3.7 3.5 1.6 12.8 0.2 22.0 0.1 0.7 5.3 0.6 1.1 0.0 2.9 0.0 51.1 1.1 8.4 74.8 12.5 6.4 0.3 13.7 4.8 0.5 1.0 0.2 32.3 1.9 0.0 0.0 4.7 3.1 4.9 1.0 3.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 11.2 0.0 0.0 0.2 0.4 0.0 0.0 0.1 2.2 4.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.3 0.1 0.0 0.0 0.7 0.8 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.0 1.9 0.5 5.8 3.5 1.6 0.7 5.3 51.1 0.0 0.0 0.0 0.0 4.5 4.9 0.4 1.0 0.0 0.0 3.4 14.0 0.0 0.0 24.9 0.0 14.4 0.2 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 28.6 2.4 0.6 0.0 9.4 6.6 0.0 30.4 0.0 0.0 15.0 0.2 0.0 2.5 14.4 0.4 0.0 0.4 2.7 0.9 6.4 0.0 0.0 2.1 0.3 SOX15 "SOX20, SOX26, SOX27" ENSG00000129194 "SRY-box 15" O60248 17 7588178-7590170 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 185.8;Suprabasal keratinocytes: 148.4;Urothelial cells: 76.9" "Cancer enhanced" "Detected in many" "testis cancer: 67.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 7.1;non-classical monocyte: 10.8" "Lineage enriched" "Detected in many" 4 "monocytes: 10.8" "Group enriched" "Detected in some" 7 "A-431: 41.8;HaCaT: 47.0;HBEC3-KT: 18.8;hTCEpi: 18.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA067196, HPA074049" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles" Yes NA Nucleoplasm "Nucleoli, Golgi apparatus, Vesicles" "HPA067196: AB_2685802, HPA074049: AB_2686656" "unprognostic (5.79e-3)" "unprognostic (6.65e-2)" "unprognostic (1.40e-2)" "unprognostic (2.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.60e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (5.00e-2)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (8.61e-3)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.95e-2)" "unprognostic (2.97e-1)" 1.0 0.8 4.6 1.0 4.1 2.1 1.3 7.2 5.0 7.5 2.6 1.1 1.0 0.7 4.4 1.7 62.7 3.7 1.0 2.9 3.1 4.1 1.3 1.0 1.5 1.0 2.6 1.0 7.0 1.0 0.1 2.0 2.0 3.5 4.1 0.6 1.4 3.4 7.0 1.9 30.0 1.0 1.6 1.4 1.0 0.7 1.3 1.0 1.8 1.0 59.0 38.7 3.6 7.8 0.0 2.4 0.2 10.8 0.0 0.0 0.5 41.8 1.0 0.6 0.3 0.0 0.1 3.2 0.5 0.1 0.3 0.6 0.8 0.2 0.1 0.4 0.0 0.1 47.0 0.0 18.8 0.1 1.1 1.3 0.1 0.5 0.1 0.0 0.1 0.9 0.0 18.6 0.2 4.2 1.3 0.0 0.8 0.9 0.3 0.0 0.3 0.2 0.5 1.3 0.1 0.2 0.5 0.6 0.3 0.8 0.2 0.3 0.7 0.5 0.1 0.2 1.9 0.3 0.3 0.5 0.4 0.8 0.5 1.4 0.3 0.5 0.6 1.5 0.6 1.1 0.2 2.4 0.0 0.0 7.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 10.8 1.2 0.0 0.5 4.6 4.1 7.2 4.4 3.1 4.1 2.6 1.0 3.5 1.0 0.0 0.0 0.0 39.1 185.8 11.0 2.8 0.0 10.7 5.7 1.8 13.7 0.3 1.7 0.0 0.1 1.6 0.2 0.0 0.4 1.5 6.1 15.1 0.0 0.0 0.4 9.5 1.2 1.8 2.7 0.6 29.1 1.1 25.3 1.8 0.0 33.2 0.3 0.0 34.6 0.0 6.2 32.3 8.9 0.4 8.7 148.4 0.9 0.0 0.2 76.9 SP5 ENSG00000204335 "Sp5 transcription factor" Q6BEB4 2 170715351-170718078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 10 "Cardiomyocytes: 2.8;Collecting duct cells: 1.8;Distal tubular cells: 3.3;Fibroblasts: 2.3;Mucus-secreting cells: 4.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "Hep G2: 51.7" "Region enhanced" "Detected in single" "cerebellum: 1.2" "Group enriched" "Detected in many" 4 "cerebellum: 5.3;hippocampal formation: 1.2;olfactory region: 5.8;thalamus: 3.6" HPA074123 Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA074123: AB_2686664" "unprognostic (1.16e-2)" "unprognostic (6.99e-2)" "unprognostic (3.41e-2)" "unprognostic (2.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.52e-3)" "unprognostic (1.45e-1)" "unprognostic (4.60e-2)" "unprognostic (4.77e-1)" "unprognostic (8.97e-3)" "unprognostic (1.79e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-8)" "unprognostic (8.05e-3)" "unprognostic (2.49e-1)" "unprognostic (2.41e-2)" "unprognostic (2.17e-1)" 8.7 1.8 0.5 2.5 0.6 0.1 7.4 1.6 1.0 11.4 3.9 1.4 3.2 3.1 7.2 3.0 1.9 3.0 5.1 0.8 0.6 1.4 0.8 5.9 4.6 3.1 0.2 0.8 1.5 0.5 0.1 0.1 2.1 0.4 7.2 1.0 3.8 2.1 0.9 0.7 6.6 3.1 3.1 0.1 0.2 7.3 2.4 0.0 0.2 0.1 0.8 6.5 3.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.9 0.0 0.0 0.2 0.0 0.2 0.6 0.1 0.0 0.0 1.5 0.1 0.2 0.0 51.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 1.6 1.0 0.6 1.4 0.2 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.7 0.0 2.8 0.0 0.0 0.0 1.8 0.0 0.9 3.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 2.3 0.1 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.2 0.0 0.9 0.0 SPATA17 IQCH ENSG00000162814 "Spermatogenesis associated 17" Q96L03 1 217631324-217871696 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 48.0" "Cell type enhanced" "Detected in many" 21 "Ciliated cells: 161.9;Early spermatids: 584.1;Late spermatids: 424.1;Spermatocytes: 138.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030099 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA030099: AB_2270988" "unprognostic (4.72e-2)" "unprognostic (7.58e-3)" "unprognostic (4.30e-2)" "unprognostic (3.66e-2)" "unprognostic (3.69e-2)" "unprognostic (2.41e-2)" "unprognostic (3.31e-3)" "unprognostic (3.25e-2)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (2.80e-2)" "unprognostic (3.24e-4)" "unprognostic (2.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.77e-3)" "unprognostic (1.82e-1)" 0.5 0.6 1.4 0.3 5.2 2.4 0.9 0.5 1.2 1.0 0.5 2.7 2.9 0.6 0.7 9.7 0.5 6.8 0.8 1.1 2.3 2.2 2.8 0.4 3.0 0.3 0.8 1.6 3.3 0.6 3.0 10.8 0.4 11.1 0.7 0.3 1.2 0.6 1.2 2.9 1.0 0.7 0.2 0.7 0.4 0.6 48.0 1.4 0.0 3.1 0.3 0.2 0.5 0.5 1.3 0.6 2.3 0.6 0.6 1.0 0.1 0.6 1.2 1.2 1.2 0.3 2.0 0.9 0.5 0.7 0.6 0.3 0.8 3.2 0.6 1.0 0.4 0.4 2.2 0.8 1.1 0.7 0.6 1.2 0.5 1.5 0.8 0.6 0.3 0.5 0.7 2.3 1.2 1.2 1.4 0.1 0.7 0.7 1.3 0.6 2.5 0.4 1.0 2.3 1.6 1.2 0.4 0.4 0.4 2.3 0.9 4.8 1.9 0.7 0.8 0.6 2.0 1.5 0.6 0.6 0.8 0.6 0.9 0.5 1.3 0.8 0.3 1.9 0.5 1.1 2.3 0.5 0.5 0.9 0.5 0.8 0.7 0.7 0.7 0.3 1.3 0.9 1.0 1.5 0.6 0.6 0.6 0.3 0.1 1.4 5.2 0.5 1.2 2.3 2.2 0.8 1.6 11.1 1.4 3.0 0.0 0.0 0.8 0.6 0.4 1.4 0.0 161.9 25.0 3.5 19.6 0.7 5.0 1.7 584.1 0.5 0.0 0.0 0.6 0.5 0.7 1.6 0.0 0.0 0.2 0.0 1.7 0.0 0.0 424.1 8.1 0.7 1.7 0.0 1.0 5.1 0.2 0.0 6.3 8.4 18.5 0.0 0.1 138.2 8.1 0.9 0.2 0.0 0.6 0.4 SPATA5L1 "FLJ12286, MGC5347" ENSG00000171763 "Spermatogenesis associated 5 like 1" Q9BVQ7 15 45402331-45421419 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043679 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA043679: AB_10964179" "unprognostic (6.22e-2)" "unprognostic (3.34e-2)" "unprognostic (7.03e-2)" "unprognostic (1.57e-2)" "unprognostic (9.67e-2)" "unprognostic (6.85e-2)" "unprognostic (2.46e-2)" "unprognostic (3.13e-2)" "unprognostic (3.69e-2)" "unprognostic (3.69e-1)" "unprognostic (4.97e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (5.40e-2)" "unprognostic (2.98e-2)" "unprognostic (2.55e-2)" "unprognostic (2.72e-2)" "unprognostic (4.80e-2)" 9.0 8.7 10.7 12.3 10.7 11.1 9.5 21.3 8.2 10.3 9.9 10.0 10.2 12.1 9.8 8.4 17.5 8.8 8.3 9.6 9.6 5.9 10.8 14.8 11.2 14.1 13.5 5.8 12.9 12.0 7.6 7.6 10.6 8.9 9.9 10.2 7.2 9.4 12.8 15.9 16.1 13.2 9.4 7.1 8.6 8.2 12.1 12.0 9.9 11.2 12.3 10.9 10.2 11.9 3.6 3.3 4.8 6.4 3.3 4.7 0.7 7.1 5.5 7.4 5.4 6.1 6.0 9.0 6.4 5.8 7.0 6.9 12.6 4.7 5.2 7.1 4.2 12.8 16.5 11.0 8.0 7.9 7.1 6.1 6.8 8.8 9.8 7.0 9.1 2.9 4.9 9.2 5.7 7.7 8.0 5.5 6.9 11.0 8.5 7.8 4.8 6.3 17.5 5.3 18.0 7.1 7.0 10.4 4.9 8.7 7.1 10.2 5.2 5.3 11.6 5.7 9.2 10.2 16.7 3.4 3.4 5.2 20.8 13.6 7.2 14.4 8.1 8.8 15.1 6.1 0.1 2.8 4.8 4.1 2.6 1.5 1.9 2.8 4.7 3.3 3.6 2.9 3.0 4.2 3.3 6.4 2.5 2.6 0.7 10.7 10.7 21.3 8.2 9.6 5.9 13.5 5.8 8.9 12.0 0.0 1.4 5.4 5.2 4.4 5.7 5.6 10.2 0.0 4.5 3.5 15.7 10.2 3.3 5.6 17.3 6.0 5.5 0.0 6.4 8.8 4.6 3.8 4.6 5.0 6.8 6.4 3.5 0.6 4.3 5.3 7.2 4.1 3.3 6.4 7.2 4.4 4.8 0.0 3.5 4.9 6.5 0.0 4.7 5.4 5.7 5.9 5.6 4.9 7.5 7.0 SPATS2L "DNAPTP6, SGNP" ENSG00000196141 "Spermatogenesis associated serine rich 2 like" Q9NUQ6 2 200305881-200482263 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 76.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055427, HPA066310" Uncertain Enhanced Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA055427: AB_2682813, HPA066310: AB_2685655" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" "unprognostic (9.35e-2)" "unprognostic (1.78e-2)" "unprognostic (4.39e-3)" "unprognostic (3.58e-2)" "unprognostic (2.17e-3)" "unprognostic (3.44e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (3.95e-1)" "unprognostic (7.84e-3)" "unprognostic (3.71e-2)" "unprognostic (5.67e-2)" "unprognostic (6.01e-2)" "unprognostic (2.99e-1)" 25.0 13.5 22.4 14.3 20.1 4.2 46.1 15.7 25.7 33.1 34.5 14.5 27.2 34.3 20.4 20.7 28.0 34.8 46.9 46.4 18.4 18.8 37.7 44.9 22.4 14.7 21.9 20.9 30.0 24.3 17.1 24.7 26.9 20.3 27.3 34.6 14.9 63.4 28.8 26.5 15.6 44.6 20.6 23.4 22.1 42.2 11.5 16.7 14.3 21.6 17.5 12.3 25.4 46.5 2.2 9.8 22.9 3.3 4.2 17.0 1.6 27.3 15.8 18.6 2.3 12.5 16.0 6.9 49.0 16.4 31.9 23.9 42.6 30.1 0.1 11.3 31.1 17.4 27.1 5.6 28.6 21.0 16.4 7.8 0.2 14.4 51.1 22.5 4.7 2.1 19.6 28.5 21.3 20.4 22.7 12.4 3.4 6.3 19.7 42.4 8.4 0.7 1.3 4.5 48.8 36.4 0.1 66.3 1.9 76.9 22.4 0.5 5.3 12.7 7.1 19.9 27.6 3.8 6.5 20.5 21.2 21.4 6.6 27.9 5.8 5.6 0.3 18.1 2.2 29.8 22.9 3.1 4.2 3.6 3.3 8.3 1.6 3.9 3.6 9.8 2.2 1.7 2.0 3.1 4.2 2.5 7.6 17.0 1.6 22.4 20.1 15.7 25.7 18.4 18.8 21.9 20.9 20.3 16.7 80.4 19.2 18.1 208.3 80.9 13.9 110.0 359.2 145.9 56.9 164.0 11.8 13.7 94.5 137.6 58.2 54.0 166.5 0.0 128.0 30.2 94.6 270.0 56.4 183.0 67.0 57.2 52.9 86.5 88.0 14.5 153.4 70.0 121.4 18.0 201.8 6.1 152.6 164.9 133.7 331.2 48.9 77.6 97.1 16.5 78.7 68.1 8.2 19.2 64.2 162.6 SPC24 "FLJ90806, SPBC24" ENSG00000161888 "SPC24, NDC80 kinetochore complex component" Q8NBT2 19 11131520-11155808 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.0" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA051234 Approved Supported Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA051234: AB_2681397" "unprognostic (1.57e-1)" "prognostic favorable (3.59e-4)" "unprognostic (6.79e-2)" "unprognostic (1.07e-3)" "unprognostic (4.04e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.21e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (6.12e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.62e-2)" "unprognostic (3.52e-2)" "unprognostic (2.25e-1)" "unprognostic (8.82e-2)" 2.8 3.2 1.1 9.0 1.0 19.4 3.8 0.4 1.9 2.8 4.0 0.8 0.9 3.5 2.2 2.8 8.4 1.4 2.4 8.2 1.0 0.4 1.8 2.6 4.2 4.9 0.6 1.0 1.1 1.0 0.1 1.0 5.9 0.6 1.4 3.5 0.8 2.4 1.5 2.7 3.2 4.4 6.7 0.7 5.5 4.0 13.3 0.7 58.0 0.9 12.8 12.2 2.3 3.2 1.9 1.3 7.2 1.4 4.2 3.7 0.7 26.2 9.9 13.7 11.1 1.9 3.6 6.2 15.4 5.7 14.6 16.6 10.4 9.0 20.8 17.6 6.8 8.5 14.3 10.6 11.0 10.8 11.0 9.1 28.0 23.0 15.4 0.4 19.6 12.5 0.7 0.4 10.4 4.8 3.8 12.8 23.0 14.9 43.9 10.1 17.3 26.7 11.9 9.6 7.3 16.0 21.4 21.0 6.7 4.3 8.7 14.3 10.3 13.5 8.4 3.6 6.8 8.3 7.1 12.1 13.8 14.7 18.5 18.4 26.8 13.8 20.0 10.2 19.4 11.2 4.1 1.4 1.5 1.4 1.2 1.2 1.9 2.3 3.4 0.5 1.9 2.7 1.7 7.2 4.2 1.3 1.3 3.7 0.7 1.1 1.0 0.4 1.9 1.0 0.4 0.6 1.0 0.6 0.7 0.0 0.3 0.0 0.8 1.0 0.0 7.0 2.5 0.0 1.2 5.2 5.9 3.0 0.0 0.2 0.1 0.1 0.7 70.0 0.0 13.5 4.0 0.3 5.7 0.0 11.2 0.0 2.4 2.5 2.8 1.7 0.6 1.3 0.0 0.0 1.1 0.9 0.2 0.0 0.4 0.4 0.3 0.0 0.3 6.5 10.1 0.3 1.7 2.2 2.9 0.4 SPDEF "bA375E1.3, PDEF" ENSG00000124664 "SAM pointed domain containing ETS transcription factor" O95238 6 34537802-34556333 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 55.8;salivary gland: 98.0" "Group enriched" "Detected in many" 6 "Glandular cells: 80.8;Mucus-secreting cells: 228.3" "Group enriched" "Detected in many" 10 "breast cancer: 103.4;endometrial cancer: 78.1;prostate cancer: 388.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MCF7: 68.7;OE19: 28.3;SK-BR-3: 47.5;T-47d: 38.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA055707 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA055707: AB_2682894" "unprognostic (2.98e-1)" "unprognostic (9.68e-2)" "unprognostic (2.84e-1)" "prognostic favorable (9.26e-9)" "unprognostic (1.57e-1)" "unprognostic (7.10e-3)" "unprognostic (2.56e-2)" "unprognostic (1.15e-1)" "unprognostic (1.63e-1)" "unprognostic (7.39e-3)" "unprognostic (3.48e-3)" "unprognostic (2.92e-1)" "unprognostic (6.16e-11)" "unprognostic (8.04e-2)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (1.12e-2)" 0.1 0.0 0.4 2.4 0.2 0.0 28.5 0.3 0.7 12.0 6.5 0.2 0.3 4.4 4.0 0.3 0.9 2.4 16.1 0.1 0.4 0.3 0.1 0.1 5.5 0.1 0.3 0.1 0.6 1.3 0.0 0.1 0.2 0.1 55.8 4.0 0.2 98.0 4.5 0.1 3.0 7.8 0.1 0.1 0.1 10.8 0.1 0.1 0.2 0.1 7.8 22.9 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.7 0.0 0.1 0.0 28.3 9.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 47.5 0.0 0.0 38.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.7 0.4 0.3 0.3 0.1 0.1 0.1 0.0 2.1 0.0 12.1 0.1 0.0 0.1 2.5 0.0 3.4 0.0 0.0 0.0 0.0 3.2 1.1 0.0 8.1 0.0 1.1 0.0 0.0 80.8 0.0 0.0 0.0 0.0 5.2 0.6 0.0 2.9 0.0 0.0 3.3 0.0 228.3 0.0 12.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 26.3 9.7 SPG11 "FLJ21439, KIAA1840" ENSG00000104133 "SPG11, spatacsin vesicle trafficking associated" Q96JI7 15 44562696-44663678 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040412, HPA040947" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA040412: AB_10795418, HPA040947: AB_10796232" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.98e-3)" "unprognostic (1.99e-1)" "unprognostic (9.31e-2)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (2.26e-3)" "unprognostic (2.58e-2)" "unprognostic (9.19e-2)" "prognostic favorable (6.28e-5)" "unprognostic (8.73e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.06e-2)" 23.8 24.6 16.6 26.4 22.2 25.8 23.4 21.2 21.2 20.8 26.0 31.7 25.8 17.9 18.6 28.1 22.9 19.0 20.2 19.3 16.1 15.2 22.0 25.1 22.6 26.9 26.3 15.6 20.5 25.5 33.4 25.9 15.7 22.1 22.3 21.6 18.7 22.7 26.6 19.0 31.8 26.2 21.5 22.1 39.2 22.8 22.1 23.1 35.8 30.9 12.6 26.0 23.0 19.4 12.8 7.1 13.6 13.0 6.7 8.3 3.8 8.0 5.5 14.1 13.7 22.0 21.7 10.1 8.5 10.9 8.3 10.7 6.6 7.9 5.9 10.6 11.3 14.4 18.5 9.7 13.0 8.2 17.8 5.9 13.6 13.0 10.0 15.5 13.6 12.6 16.5 14.9 6.8 19.7 13.1 11.7 10.5 17.3 15.4 11.7 7.0 6.0 12.5 7.4 24.9 7.5 8.0 11.8 6.5 17.7 21.1 9.2 10.8 9.3 14.8 7.9 12.1 14.1 18.6 12.8 11.1 5.5 13.7 10.2 15.3 13.5 11.9 11.4 18.0 11.3 6.0 8.8 12.3 7.8 10.2 8.3 10.9 6.5 5.8 6.9 12.8 5.4 6.4 13.6 6.7 13.0 7.1 6.6 3.8 16.6 22.2 21.2 21.2 16.1 15.2 26.3 15.6 22.1 23.1 41.7 17.4 28.3 13.4 8.2 22.1 15.9 17.8 44.2 29.6 26.2 45.2 13.6 5.0 16.4 24.2 10.8 26.7 0.0 14.7 8.5 12.9 17.8 26.5 19.5 17.6 15.9 19.3 23.9 45.3 24.1 16.4 30.5 13.5 84.8 28.1 15.6 16.1 17.3 13.1 14.6 21.7 6.5 8.9 40.8 24.7 9.7 7.8 23.0 25.1 17.9 SPIN4 "FLJ44984, TDRD28" ENSG00000186767 "Spindlin family member 4" Q56A73 X 63347228-63351344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 27.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA044559 Uncertain Approved Nucleoli,Cytosol NA Yes Cytosol Nucleoli "HPA044559: AB_10794171" "unprognostic (9.66e-2)" "unprognostic (2.00e-1)" "unprognostic (1.90e-1)" "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (3.12e-1)" "unprognostic (3.22e-4)" "unprognostic (3.30e-3)" "unprognostic (9.44e-3)" "unprognostic (8.62e-2)" "unprognostic (3.65e-3)" "unprognostic (9.39e-2)" "prognostic unfavorable (3.56e-6)" "unprognostic (1.74e-2)" "unprognostic (2.15e-1)" "unprognostic (2.57e-1)" "unprognostic (8.09e-2)" 3.9 3.2 4.2 5.1 4.4 13.8 13.7 2.3 5.4 5.1 5.9 6.7 2.0 3.5 6.7 4.7 16.8 3.9 3.5 3.2 4.7 6.1 3.3 2.4 16.8 7.6 4.5 2.3 6.6 4.2 4.8 4.7 12.3 5.2 7.2 6.9 4.8 27.4 2.9 1.2 3.5 4.9 5.8 5.2 5.9 3.9 3.4 3.5 11.2 5.6 6.4 11.8 4.3 8.2 1.2 1.4 3.7 2.1 6.0 1.5 0.8 16.0 4.1 9.6 7.8 2.1 3.0 6.9 8.0 3.4 4.7 5.7 2.7 16.0 0.0 3.5 3.7 5.4 5.4 12.3 5.8 8.6 6.9 3.9 20.6 5.5 2.5 0.9 17.8 16.1 1.4 2.0 7.8 4.2 2.3 5.1 3.6 6.2 20.1 10.7 5.4 5.9 9.6 9.9 2.6 6.0 8.3 20.7 4.4 3.4 4.3 0.0 5.3 14.4 4.2 1.5 20.8 9.1 8.5 2.2 9.5 10.7 15.7 5.0 4.4 5.1 10.6 5.0 14.7 5.6 1.7 1.8 3.7 1.5 2.1 0.7 1.2 0.8 0.9 1.4 1.1 0.5 1.0 0.0 6.0 1.7 0.0 0.5 0.8 4.2 4.4 2.3 5.4 4.7 6.1 4.5 2.3 5.2 3.5 0.0 1.3 0.5 1.3 3.0 5.2 1.2 0.0 4.0 2.3 3.5 2.0 5.5 1.7 0.6 0.0 2.7 1.7 0.0 1.2 5.8 3.1 2.6 9.2 0.8 2.2 1.6 6.4 8.6 1.3 0.0 2.8 1.7 5.0 0.0 7.2 1.2 1.3 7.0 3.2 1.0 2.4 0.0 1.6 0.0 0.2 5.5 2.7 3.2 6.0 4.7 SPOCD1 "FLJ25348, PPP1R146" ENSG00000134668 "SPOC domain containing 1" Q6ZMY3 1 31790422-31816051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.9;urinary bladder: 13.7" "Cell type enhanced" "Detected in some" 19 "Ductal cells: 9.9;Hofbauer cells: 13.9;Pancreatic endocrine cells: 18.9;Urothelial cells: 44.4" "Group enriched" "Detected in many" 7 "glioma: 13.9;urothelial cancer: 5.6" "Region enhanced" "Detected in many" "pons and medulla: 8.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.9;hTEC/SVTERT24-B: 19.7;RT4: 33.2;TIME: 17.3;U-87 MG: 32.7" "Low region specificity" "Detected in some" "HPA031713, HPA031714, HPA031715" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008" "unprognostic (7.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.85e-3)" "unprognostic (2.70e-3)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (2.15e-3)" "unprognostic (2.60e-2)" "unprognostic (3.51e-1)" "unprognostic (2.18e-1)" "unprognostic (3.01e-2)" "unprognostic (3.00e-1)" "unprognostic (0.00e+0)" "unprognostic (1.97e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "prognostic favorable (4.05e-5)" 28.9 0.5 1.8 5.1 1.6 0.3 1.6 0.4 3.9 2.0 0.7 1.5 0.1 1.6 2.4 2.8 0.3 2.1 1.6 0.4 1.2 1.6 0.5 0.2 12.9 0.9 2.6 0.3 1.8 0.1 0.1 1.6 3.5 8.2 1.8 0.9 1.8 0.1 0.3 0.4 0.1 0.9 2.4 3.1 1.9 1.1 11.9 0.6 0.1 0.4 0.8 0.2 13.7 2.1 0.0 0.0 1.9 0.1 0.0 0.0 7.3 10.7 0.3 0.0 0.0 0.2 1.5 0.5 14.1 18.9 13.7 9.2 0.2 0.6 0.1 1.9 15.9 5.6 1.4 0.0 0.2 4.3 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.2 6.9 0.2 19.7 0.6 11.1 9.3 0.7 0.2 0.2 8.1 0.0 0.1 0.0 0.2 0.1 0.3 0.0 1.4 0.0 0.0 33.2 0.0 0.0 0.3 0.0 0.9 0.4 8.2 0.0 17.3 14.5 1.4 9.3 5.3 0.0 0.1 0.0 32.7 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 1.8 1.6 0.4 0.6 1.2 1.6 2.6 0.3 8.2 0.6 0.0 5.9 0.0 4.0 0.1 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 9.9 0.2 0.1 0.0 0.0 8.9 0.5 0.4 1.7 1.1 0.0 13.9 0.0 1.7 0.6 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 18.9 0.0 0.4 0.0 0.0 0.0 1.4 0.0 4.3 0.0 0.2 0.0 0.0 44.4 SPON1 "f-spondin, KIAA0762" ENSG00000262655 "Spondin 1" Q9HCB6 11 13962689-14267884 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 40.2" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 163.5" "Cancer enhanced" "Detected in all" "ovarian cancer: 199.1" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 7.3" "Lineage enriched" "Detected in single" 74 "T-cells: 7.3" "Group enriched" "Detected in some" 35 "EFO-21: 42.0;RPTEC TERT1: 118.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038584, HPA077546" Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge" "Secreted to blood" Yes No 11500000 27000000 "Nucleoli, Microtubule ends" "Nucleoplasm, Actin filaments, Cytokinetic bridge" "HPA038584: AB_10697394, HPA077546: AB_2732351" "unprognostic (1.66e-1)" "unprognostic (1.03e-2)" "unprognostic (8.36e-2)" "unprognostic (8.72e-2)" "unprognostic (1.52e-1)" "unprognostic (3.76e-2)" "unprognostic (1.82e-1)" "unprognostic (8.20e-2)" "unprognostic (1.05e-1)" "unprognostic (5.93e-2)" "unprognostic (6.45e-2)" "unprognostic (1.07e-1)" "prognostic favorable (3.12e-4)" "unprognostic (7.22e-3)" "unprognostic (7.89e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (1.88e-4)" 16.8 5.1 8.3 5.2 12.5 0.0 3.3 4.8 10.7 15.7 9.7 7.6 0.0 9.6 12.0 4.6 5.3 20.3 40.2 4.9 7.2 5.4 0.1 8.1 0.7 5.1 8.8 12.0 0.8 0.0 2.0 12.3 7.5 7.2 15.0 8.5 0.9 2.5 0.0 1.6 12.4 15.7 3.2 1.8 3.9 0.8 5.7 0.0 0.8 0.6 0.0 15.6 9.9 0.0 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 118.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.3 0.0 1.3 0.7 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.9 10.4 12.6 0.0 8.9 1.2 2.5 1.4 0.0 0.0 2.0 2.6 3.3 3.3 1.3 1.0 19.8 0.0 1.8 3.1 18.3 5.0 2.3 0.0 1.6 1.6 16.0 3.7 0.3 1.2 4.0 0.0 0.0 0.0 18.6 163.5 4.5 10.5 28.3 0.8 29.7 6.5 5.4 0.2 0.6 0.0 4.1 5.0 35.1 8.0 SPRY3 HSPRY3 ENSG00000168939 "Sprouty RTK signaling antagonist 3" O43610 X 155767812-155782459 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 3.5;Cone photoreceptor cells: 3.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 8.6;EFO-21: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013505 Uncertain Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB013505: " "unprognostic (3.70e-2)" "unprognostic (4.39e-1)" "unprognostic (5.24e-2)" "unprognostic (3.37e-2)" "unprognostic (3.65e-1)" "unprognostic (1.20e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "unprognostic (3.68e-3)" "unprognostic (1.52e-4)" "unprognostic (1.21e-2)" "unprognostic (9.60e-2)" "unprognostic (5.26e-2)" "unprognostic (6.65e-2)" "unprognostic (1.86e-1)" "unprognostic (5.44e-2)" "unprognostic (3.49e-2)" 1.6 2.1 1.3 0.4 1.8 2.8 1.2 7.5 1.5 1.3 0.8 1.2 1.5 5.8 0.8 1.1 0.8 0.9 1.3 1.5 0.9 0.7 0.9 0.3 1.1 2.8 0.4 1.3 1.1 1.9 0.9 1.4 1.1 1.2 1.2 0.4 1.1 1.2 1.2 1.4 0.7 0.1 1.0 0.5 0.8 0.7 0.0 0.5 0.4 0.5 0.2 0.2 0.0 0.5 0.2 2.4 8.6 1.7 0.8 0.0 2.0 1.3 0.6 1.0 0.2 1.4 0.0 4.2 1.1 1.6 0.3 0.9 0.6 0.6 0.2 0.4 1.0 2.2 0.1 0.7 0.4 0.4 2.1 1.1 0.8 0.5 0.8 1.3 0.5 0.1 0.6 1.6 0.3 0.2 0.3 0.8 0.2 0.0 0.5 0.2 2.1 0.9 0.8 0.6 0.6 1.0 0.0 0.5 1.2 0.5 0.6 2.2 0.6 0.9 0.3 0.6 0.7 0.1 1.9 2.1 1.0 1.2 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.5 0.8 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.0 0.9 1.1 0.0 0.6 0.1 0.4 0.1 0.0 0.8 0.3 0.0 0.0 1.3 0.6 0.0 0.9 0.1 1.7 0.0 1.0 0.8 0.5 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.1 SPTBN4 "KIAA1642, SPTBN3" ENSG00000160460 "Spectrin beta, non-erythrocytic 4" Q9H254 19 40466241-40576464 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 36.3" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 55.4;Cone photoreceptor cells: 53.0;Horizontal cells: 69.9;Rod photoreceptor cells: 67.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 3.5;Karpas-707: 5.1;SCLC-21H: 8.0;SH-SY5Y: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054481 Enhanced Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA054481: AB_2682502" "unprognostic (1.97e-3)" "unprognostic (1.02e-1)" "unprognostic (5.65e-4)" "unprognostic (3.72e-4)" "unprognostic (7.79e-3)" "unprognostic (9.77e-2)" "unprognostic (2.62e-1)" "unprognostic (2.50e-2)" "unprognostic (3.19e-2)" "unprognostic (1.65e-1)" "unprognostic (1.78e-4)" "unprognostic (4.54e-1)" "unprognostic (2.55e-2)" "unprognostic (6.79e-2)" "unprognostic (1.42e-1)" "unprognostic (1.85e-2)" "unprognostic (2.02e-1)" 3.1 5.9 13.4 1.2 15.3 1.2 1.2 36.3 27.1 1.4 1.3 1.8 0.0 1.7 2.3 1.3 1.6 2.0 1.8 3.3 9.8 10.8 1.9 1.3 1.2 1.0 7.5 13.0 4.1 3.0 3.3 8.0 1.0 10.4 2.8 1.1 2.6 2.2 2.0 5.1 1.3 1.5 1.8 2.8 1.3 2.5 3.5 3.7 0.0 1.6 0.0 1.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.6 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.4 2.3 2.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 2.4 0.5 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.3 3.5 5.1 0.0 1.3 0.0 0.0 0.2 0.3 0.9 0.5 0.0 1.1 0.0 0.0 8.0 4.9 0.1 0.2 0.0 0.1 0.7 0.0 0.0 0.0 1.5 0.8 0.0 0.2 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 15.3 36.3 22.7 9.8 10.8 7.5 13.0 10.4 3.7 0.0 0.0 0.0 0.1 0.1 55.4 4.4 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.8 0.2 69.9 15.6 0.6 0.3 0.9 7.5 0.0 1.7 1.0 0.3 4.7 0.2 0.0 6.7 1.4 67.0 0.0 0.9 3.2 4.6 0.4 0.0 0.0 0.2 0.1 SPTY2D1 "DKFZp686I068, FLJ39441, Spt2" ENSG00000179119 "SPT2 chromatin protein domain containing 1" Q68D10 11 18606401-18634791 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039372, HPA040177, HPA047957" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224" "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (8.62e-2)" "unprognostic (2.16e-1)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.51e-2)" "unprognostic (5.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.59e-4)" "unprognostic (2.03e-1)" "prognostic favorable (2.07e-4)" "unprognostic (1.33e-2)" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (3.33e-1)" 14.0 12.7 6.2 9.7 9.2 33.6 11.9 10.9 10.9 13.7 10.9 6.9 9.9 8.3 11.9 8.6 15.5 12.5 12.2 9.9 5.8 6.5 14.9 25.1 9.7 8.7 6.0 6.8 16.7 16.9 13.6 14.0 15.3 8.5 12.5 9.7 7.9 13.3 13.9 16.3 12.5 13.7 9.3 7.6 15.0 11.0 7.1 5.5 17.7 12.8 8.0 13.3 12.5 11.8 2.7 3.4 7.8 5.7 7.3 8.7 3.3 8.2 8.1 6.5 9.1 10.9 11.4 10.0 12.2 13.4 10.2 12.3 7.2 3.6 18.5 6.9 11.5 8.0 8.6 10.8 9.6 14.7 9.7 10.1 7.4 4.9 6.6 10.5 15.6 14.8 9.4 10.0 6.5 13.3 7.4 11.2 11.1 10.3 29.5 11.3 8.9 10.4 6.2 5.9 16.2 9.1 9.6 18.1 7.9 10.7 11.9 6.3 8.9 10.9 12.7 8.5 8.9 7.9 6.7 9.8 10.0 8.5 19.4 7.4 10.3 12.7 14.5 11.9 8.7 8.4 7.8 4.1 5.8 5.7 5.7 8.7 2.6 5.6 5.7 3.4 2.7 5.2 5.6 6.0 7.3 5.4 2.9 6.0 3.3 6.2 9.2 10.9 10.9 5.8 6.5 6.0 6.8 8.5 5.5 23.8 45.0 23.8 18.6 49.6 12.8 23.6 12.7 61.6 34.2 26.2 9.8 12.3 14.9 21.5 1.6 21.9 22.7 0.0 21.7 19.7 31.0 20.1 56.6 25.6 14.3 11.1 42.5 21.5 27.0 1.7 17.5 31.7 15.1 13.6 24.2 13.8 21.6 22.1 13.1 12.6 11.2 32.3 23.0 10.7 14.2 58.1 23.0 35.5 18.6 29.3 SREK1IP1 "FLJ36754, P18SRP, SFRS12IP1" ENSG00000153006 "SREK1 interacting protein 1" Q8N9Q2 5 64718144-64768685 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 266.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045677, HPA062853" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045677: AB_10964635, HPA062853: AB_2684881" "unprognostic (1.19e-1)" "unprognostic (3.61e-1)" "unprognostic (2.17e-2)" "unprognostic (1.06e-1)" "unprognostic (1.51e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.51e-1)" "unprognostic (2.13e-1)" "unprognostic (8.60e-3)" "unprognostic (8.67e-2)" "unprognostic (1.20e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (2.67e-1)" "unprognostic (8.39e-2)" "unprognostic (3.85e-2)" "unprognostic (1.99e-1)" 16.3 12.1 12.2 10.9 16.5 8.3 13.8 13.9 12.8 17.0 16.1 4.1 10.8 8.6 12.5 12.4 25.3 10.8 11.6 13.1 12.3 10.7 18.0 13.1 13.2 12.1 10.6 9.5 14.6 11.7 10.8 20.5 20.2 11.9 15.5 10.4 4.7 10.3 15.0 15.7 18.7 15.2 12.6 15.5 19.0 10.9 11.7 11.5 19.2 13.9 17.9 12.3 24.1 14.6 4.0 8.2 3.8 4.1 4.1 4.7 2.1 7.0 3.6 9.2 7.0 8.3 13.7 5.5 10.7 8.6 7.3 9.8 6.7 7.7 7.3 11.0 8.5 7.0 4.6 8.3 16.1 12.9 8.7 10.1 8.0 6.7 5.9 8.5 8.5 8.1 9.0 15.3 10.2 13.3 7.8 10.8 9.2 7.0 4.5 8.6 2.5 15.1 8.6 4.7 1.9 4.9 7.3 7.5 11.6 12.5 5.6 4.0 5.9 6.7 4.8 10.2 6.7 6.1 16.5 10.9 5.4 3.2 6.4 11.0 6.7 11.3 6.5 10.2 13.4 7.2 3.8 4.1 1.7 4.5 3.0 4.7 3.9 4.6 4.2 3.4 4.0 4.5 4.7 1.6 4.1 1.9 8.2 4.0 2.1 12.2 16.5 13.9 12.8 12.3 10.7 10.6 9.5 11.9 11.5 44.7 36.1 35.8 47.3 72.7 50.8 26.2 76.5 41.5 43.3 82.0 29.5 62.3 76.3 67.8 266.8 54.7 61.7 46.7 64.6 64.7 50.4 43.7 52.0 85.5 55.9 92.2 58.6 78.5 70.9 129.9 88.6 70.4 37.1 46.9 60.5 43.1 140.5 64.5 68.2 63.3 36.0 64.7 57.4 32.7 40.7 90.8 40.7 54.9 45.7 82.3 SRP14 "ALURBP, MGC14326" ENSG00000140319 "Signal recognition particle 14" P37108 15 40035739-40039188 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053738, HPA065118" Approved Nucleoplasm,Nucleoli NA NA 400000 Nucleoli Nucleoplasm "HPA053738: , HPA065118: " "unprognostic (2.52e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-3)" "unprognostic (1.01e-2)" "unprognostic (1.04e-1)" "unprognostic (5.39e-3)" "unprognostic (2.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (7.99e-2)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "prognostic favorable (5.31e-4)" "unprognostic (2.20e-1)" "unprognostic (8.03e-3)" "unprognostic (1.41e-3)" "unprognostic (4.94e-2)" 63.0 81.2 100.0 46.0 102.8 85.9 75.4 65.4 91.3 87.8 62.6 67.9 54.7 50.7 83.0 115.7 75.6 87.8 64.2 114.2 80.7 95.4 107.2 79.6 52.2 60.8 103.5 86.3 99.1 59.1 69.6 82.3 68.8 84.3 84.1 65.0 61.0 71.3 66.4 107.5 44.4 65.7 67.2 86.5 67.5 56.0 43.4 68.9 58.7 98.9 56.6 65.0 80.9 72.7 78.7 151.5 111.2 69.3 63.6 96.4 135.1 24.2 30.4 73.8 55.1 55.3 50.1 36.0 44.7 47.4 38.8 39.9 54.7 20.8 20.4 46.6 54.2 62.1 39.3 58.6 46.5 36.8 48.6 41.9 48.6 97.1 64.0 42.4 43.2 39.7 52.1 53.3 32.1 39.4 73.9 65.2 55.9 50.8 37.4 62.0 36.8 63.8 51.0 40.2 94.1 55.2 43.9 33.7 34.3 83.7 72.4 53.8 48.0 45.1 44.8 29.3 47.6 61.6 80.2 56.1 45.2 30.7 42.6 32.6 30.5 85.1 50.5 43.9 47.2 41.8 76.2 69.3 111.2 68.5 62.5 66.4 78.7 77.7 76.3 74.5 66.1 75.4 72.8 60.7 63.6 56.5 151.5 96.4 135.1 100.0 102.8 65.4 91.3 80.7 95.4 103.5 86.3 84.3 68.9 428.8 342.1 635.3 745.6 592.5 436.3 765.2 639.5 717.4 483.4 943.9 117.8 766.6 2161.9 1141.2 204.6 898.5 667.3 467.2 948.8 912.5 754.8 783.4 543.5 639.1 894.6 328.9 532.2 609.5 565.3 236.1 962.8 751.5 749.0 1439.1 546.1 918.4 1056.2 782.0 927.8 1642.5 369.6 614.4 716.0 645.9 602.6 620.9 634.6 518.4 577.5 829.8 SRP54 ENSG00000100883 "Signal recognition particle 54" P61011 14 34981957-35029567 "Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrolase, Ribonucleoprotein, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 276.0;Late spermatids: 646.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048977, HPA062044" Approved Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA048977: AB_2680583, HPA062044: AB_2684668" "unprognostic (1.22e-3)" "unprognostic (6.04e-2)" "unprognostic (9.06e-2)" "unprognostic (1.72e-2)" "unprognostic (3.88e-1)" "unprognostic (2.67e-3)" "unprognostic (2.06e-3)" "unprognostic (6.44e-2)" "unprognostic (2.53e-1)" "unprognostic (1.88e-2)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.10e-3)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.50e-3)" 18.4 27.5 18.6 21.3 21.0 13.6 22.5 18.2 26.0 24.6 19.2 23.2 31.2 19.3 24.1 25.5 22.6 18.0 17.1 21.8 18.7 22.5 34.4 67.8 19.4 24.0 23.7 17.1 21.1 43.2 30.1 47.1 26.4 29.4 23.2 21.7 19.2 48.1 31.2 28.4 19.6 24.4 20.0 22.3 23.5 22.3 30.8 19.4 32.3 23.6 22.5 27.9 23.9 17.6 20.5 23.4 26.3 30.1 29.5 33.4 19.7 20.7 22.5 21.6 20.2 22.3 23.0 25.9 29.8 27.1 30.8 39.5 27.0 23.3 30.3 30.4 28.4 28.5 21.9 29.5 23.4 44.8 30.1 14.8 24.5 21.4 63.3 34.6 26.2 24.8 19.2 23.1 22.7 40.4 24.0 31.0 24.4 21.7 33.2 32.0 34.5 27.9 14.7 16.5 34.4 21.8 22.3 26.4 24.2 36.7 31.8 20.5 22.0 21.4 27.7 27.1 27.5 36.8 18.2 23.5 18.8 20.2 22.3 20.5 28.8 38.6 37.9 13.4 16.9 22.4 15.9 19.8 26.3 23.6 24.0 29.3 20.5 23.6 26.0 23.4 18.6 22.3 21.7 19.3 29.5 30.1 16.0 33.4 19.7 18.6 21.0 18.2 26.0 18.7 22.5 23.7 17.1 29.4 19.4 11.9 36.4 40.4 46.3 35.5 36.9 37.2 33.1 69.6 51.2 38.4 55.0 59.6 54.7 58.2 276.0 33.1 35.1 0.0 69.6 58.9 47.2 64.3 46.2 104.3 43.9 25.4 43.1 39.9 42.5 646.5 35.6 43.2 27.0 55.1 39.6 44.1 49.6 29.4 35.3 59.6 42.9 25.8 33.7 79.0 57.0 44.0 78.6 47.1 27.0 51.8 SRSF5 "HRS, SFRS5, SRP40" ENSG00000100650 "Serine and arginine rich splicing factor 5" Q13243 14 69726900-69772005 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043484, HPA056523" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA043484: AB_10797143, HPA056523: AB_2683164" "unprognostic (2.08e-3)" "prognostic favorable (7.91e-4)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.30e-3)" "unprognostic (1.07e-3)" "unprognostic (2.37e-2)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (1.00e-2)" 66.6 60.1 67.1 60.9 74.4 131.5 70.3 111.7 88.8 54.3 63.3 67.8 77.1 42.6 71.3 74.6 66.3 79.3 50.1 48.5 66.2 43.0 40.5 60.8 69.4 63.3 86.4 62.1 76.6 41.0 56.4 124.8 59.2 74.0 59.0 54.7 69.2 68.5 75.6 76.0 78.1 74.1 59.7 68.6 66.5 62.0 35.3 75.6 47.8 70.8 52.3 69.1 69.6 55.8 41.2 37.4 60.8 45.1 30.8 38.2 24.4 70.0 20.5 50.2 22.6 31.0 26.9 27.9 33.8 36.4 27.6 29.3 25.7 45.0 72.6 17.9 45.8 28.4 33.5 38.0 48.3 32.6 62.0 20.9 54.7 54.9 28.1 36.1 51.0 41.5 55.7 30.8 31.8 34.1 41.5 38.2 63.2 38.0 43.3 17.1 56.9 58.6 34.6 29.4 55.3 18.9 50.3 23.9 27.9 35.1 86.3 26.2 37.4 57.3 34.8 43.6 31.4 37.9 43.0 47.2 16.2 43.4 17.6 31.6 42.1 27.5 117.5 38.1 43.5 22.2 39.0 24.1 37.2 37.3 43.4 38.2 41.2 33.2 33.4 26.2 40.6 33.2 31.5 60.8 30.8 45.1 37.4 27.4 24.4 67.1 74.4 111.7 88.8 66.2 43.0 86.4 62.1 74.0 75.6 235.2 245.0 272.6 618.6 122.6 370.2 163.3 193.6 401.5 253.6 174.5 225.8 335.9 271.9 173.3 146.9 251.5 417.9 163.5 148.9 193.0 195.8 288.7 459.5 204.3 193.9 357.6 290.6 219.1 193.0 84.2 319.9 251.8 126.5 254.3 249.3 292.6 182.8 399.8 251.0 172.0 307.5 271.7 240.9 175.1 136.3 127.2 626.6 371.3 207.8 495.2 SRSF9 "SFRS9, SRp30c" ENSG00000111786 "Serine and arginine rich splicing factor 9" Q13242 12 120461668-120469793 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049849 Supported Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA049849: AB_2680911" "unprognostic (3.80e-1)" "unprognostic (3.84e-1)" "unprognostic (1.50e-1)" "unprognostic (1.75e-2)" "unprognostic (2.41e-1)" "unprognostic (2.50e-3)" "prognostic unfavorable (9.85e-7)" "unprognostic (9.65e-3)" "prognostic unfavorable (7.80e-4)" "unprognostic (2.31e-2)" "unprognostic (4.35e-1)" "unprognostic (1.19e-2)" "unprognostic (1.19e-3)" "unprognostic (9.57e-2)" "unprognostic (3.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" 25.8 50.7 29.5 37.9 28.5 33.8 31.2 24.9 30.6 31.5 36.4 21.7 35.5 29.8 26.7 37.4 53.6 32.6 42.3 20.7 26.7 27.9 37.2 42.5 27.2 41.4 31.6 25.3 37.1 68.5 34.9 36.5 49.3 27.9 33.1 35.8 29.3 33.9 30.4 17.0 32.4 31.0 25.1 23.8 39.6 33.0 52.5 25.0 53.1 43.7 36.8 51.0 26.5 35.7 22.1 18.7 28.8 15.4 15.7 14.8 5.1 55.7 39.0 59.9 38.5 27.4 27.6 64.1 38.3 34.5 49.3 42.4 46.8 26.3 54.4 44.9 32.1 26.8 33.4 53.9 54.5 54.4 40.7 55.4 46.4 26.2 45.6 35.4 57.1 42.4 29.1 35.2 42.8 37.3 52.9 44.8 35.6 58.2 16.5 42.3 78.0 56.3 111.5 75.0 37.9 34.1 62.9 25.1 52.5 42.6 71.2 53.2 38.0 44.9 23.9 44.3 40.8 72.1 50.4 39.0 36.7 43.5 27.5 41.4 50.7 38.0 68.0 38.6 43.1 38.2 12.3 10.7 28.8 14.8 11.7 11.2 22.1 11.7 13.0 13.9 17.7 11.5 12.8 12.2 15.7 15.4 18.7 11.9 5.1 29.5 28.5 24.9 30.6 26.7 27.9 31.6 25.3 27.9 25.0 23.8 30.4 155.5 203.9 235.3 77.2 1.3 147.7 20.1 26.1 153.5 27.5 301.6 414.4 172.1 51.9 119.1 86.4 23.3 135.5 354.8 182.5 290.8 33.4 118.4 178.0 68.3 138.9 108.1 103.3 17.4 115.3 184.7 190.6 190.2 126.0 96.8 139.8 80.7 145.6 272.7 44.3 51.8 162.7 260.2 249.1 273.9 397.6 97.9 129.8 332.4 SS18L2 KIAA-iso ENSG00000008324 "SS18 like 2" Q9UHA2 3 42581840-42595114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047377 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" Nucleoplasm "HPA047377: AB_2680020" "unprognostic (4.09e-3)" "unprognostic (1.90e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-1)" "unprognostic (1.57e-1)" "unprognostic (1.64e-2)" "prognostic favorable (7.03e-4)" "unprognostic (6.55e-2)" "unprognostic (4.51e-2)" "unprognostic (2.62e-2)" "unprognostic (2.94e-2)" "unprognostic (1.09e-3)" "unprognostic (1.44e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (2.24e-3)" 12.7 11.6 24.5 17.8 26.4 29.9 20.8 25.2 23.8 14.0 14.8 14.4 9.1 19.4 9.1 20.6 16.6 10.6 11.8 10.8 23.5 20.6 15.8 26.2 11.9 34.8 20.5 15.9 13.5 29.0 10.9 16.1 10.7 17.4 22.2 15.5 11.3 18.6 10.8 10.1 14.9 19.3 8.4 24.0 19.7 15.6 6.4 14.9 20.4 18.7 14.7 32.0 16.0 11.1 48.0 30.0 32.8 25.9 31.0 53.5 32.9 16.1 7.4 14.9 13.5 19.2 15.6 9.3 10.5 12.0 15.7 17.8 14.2 14.8 22.1 9.6 7.2 16.5 9.1 17.8 14.7 17.3 11.0 20.8 24.0 14.5 23.8 13.8 31.3 18.9 12.2 9.5 12.6 11.9 10.9 17.1 19.7 21.7 33.4 12.6 15.3 22.0 38.9 23.6 21.8 18.2 11.7 10.9 30.7 17.4 20.4 8.4 12.0 8.9 14.0 14.1 16.8 18.3 29.3 10.0 9.2 15.1 22.1 19.1 24.3 38.4 37.5 13.6 34.4 8.8 19.0 23.5 32.8 38.4 25.9 51.6 48.0 50.5 45.3 24.9 40.8 43.9 44.1 31.1 31.0 19.2 30.0 53.5 32.9 24.5 26.4 25.2 23.8 23.5 20.6 20.5 15.9 17.4 14.9 11.9 11.8 77.1 64.6 95.1 14.4 16.1 38.2 14.7 15.9 26.2 7.9 47.4 48.0 38.3 2.3 39.4 43.1 23.3 43.1 65.4 37.6 63.9 45.0 58.7 58.5 22.3 52.9 28.3 37.6 2.5 31.9 41.0 49.0 61.3 42.2 24.6 41.3 53.7 14.9 68.9 23.5 12.9 39.1 13.2 24.0 120.8 31.2 95.9 48.0 96.2 SSX1 CT5.1 ENSG00000126752 "SSX family member 1" Q16384 X 48255317-48267444 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 12.6" "Group enriched" "Detected in some" 12 "Sertoli cells: 6.5;Spermatocytes: 9.8;Spermatogonia: 22.6" "Cancer enhanced" "Detected in many" "liver cancer: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 28.8;Karpas-707: 41.8;U-2197: 9.7" HPA045683 Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" "unprognostic (2.25e-1)" "unprognostic (3.51e-3)" "unprognostic (2.36e-1)" "unprognostic (4.32e-3)" "unprognostic (3.38e-1)" "unprognostic (5.41e-2)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 9.7 0.0 0.0 2.0 0.0 2.4 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 9.8 22.6 0.0 0.0 0.0 0.0 0.0 SSX2 "CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX" ENSG00000241476 "SSX family member 2" Q16385 X 52696896-52707189 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 24.1" "Cell type enriched" "Detected in single" 28 "Spermatogonia: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 3.2;U-2197: 1.9" "HPA045683, CAB046020" Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "CAB046020: AB_2194010, HPA045683: AB_2679418" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.9 0.0 0.6 0.1 0.6 1.9 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 SSX2B CT5.2b ENSG00000268447 "SSX family member 2B" Q16385 X 52751132-52790305 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "testis: 13.5" "Cell type enriched" "Detected in single" 10 "Spermatogonia: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;HMC-1: 5.4;PC-3: 5.2;T-47d: 2.3;U-2197: 3.3" HPA045683 Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.9 0.0 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.6 0.5 0.1 0.0 0.0 0.2 0.0 5.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 2.3 0.0 1.0 0.0 0.5 3.3 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.4 0.0 0.0 0.0 0.0 0.0 SSX3 CT5.3 ENSG00000165584 "SSX family member 3" Q99909 X 48346428-48356707 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 18.0" "Cell type enriched" "Detected in some" 9 "Spermatogonia: 144.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "Karpas-707: 6.9" HPA045683 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" "unprognostic (1.86e-1)" "unprognostic (2.13e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 1.6 0.2 0.4 0.4 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.9 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 1.6 0.5 0.2 0.2 0.0 0.0 1.6 0.2 0.8 0.3 0.1 0.2 0.8 0.3 0.4 0.0 0.9 0.4 0.4 0.2 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.7 144.8 0.0 0.0 0.0 0.0 0.0 SSX4 CT5.4 ENSG00000268009 "SSX family member 4" O60224 X 48383516-48393347 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 3.6;Karpas-707: 8.8;U-266/70: 5.2;U-266/84: 9.5" HPA045683 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.8 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 5.2 9.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX4B OTTHUMT00000056510 ENSG00000269791 "SSX family member 4B" O60224 X 48402078-48411910 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 3.6;Karpas-707: 8.8;U-266/70: 5.2;U-266/84: 9.5" HPA045683 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.8 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 5.2 9.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX5 ENSG00000165583 "SSX family member 5" O60225 X 48186220-48196763 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.3;thyroid gland: 2.9" "Cell type enriched" "Detected in single" 14 "Spermatogonia: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "BEWO: 10.8" HPA045683 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" "unprognostic (1.20e-1)" "unprognostic (2.96e-1)" "unprognostic (1.23e-1)" 0.4 0.0 0.1 0.1 0.4 1.0 0.1 0.1 0.1 0.1 1.2 0.1 0.1 0.0 0.5 0.2 0.1 0.8 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.3 0.1 1.6 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.6 0.2 0.1 0.1 0.8 0.0 4.3 0.1 0.1 2.9 0.1 0.1 0.1 0.1 0.5 0.2 0.9 0.2 0.6 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.7 1.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.2 0.4 0.3 0.4 0.1 0.5 0.1 0.4 0.9 0.6 0.0 0.2 0.2 0.0 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.8 0.0 0.0 0.0 0.0 0.0 SSX7 ENSG00000187754 "SSX family member 7" Q7RTT5 X 52644090-52654900 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 1.7;HMC-1: 8.1;RT4: 4.3" HPA045683 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" "unprognostic (1.29e-1)" 0.1 0.2 0.2 0.4 0.1 0.7 0.1 0.1 1.0 0.1 0.2 0.6 0.2 0.0 1.5 0.3 0.5 0.1 0.1 0.2 0.1 0.1 0.5 0.3 0.1 0.8 0.1 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.1 1.5 0.1 0.0 0.1 0.6 0.4 1.0 0.4 0.0 0.2 0.1 0.0 0.2 1.0 0.7 0.3 0.4 0.0 0.4 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.1 0.1 0.6 0.3 1.7 0.7 0.3 0.0 0.0 8.1 0.0 0.2 0.2 0.0 0.3 0.1 0.4 0.2 1.4 0.1 1.0 0.7 0.2 0.0 0.2 0.0 0.4 0.5 0.0 0.0 4.3 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.5 0.3 0.1 0.0 0.0 0.3 0.4 0.6 0.1 0.0 0.1 0.1 0.1 0.5 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 STAG3 ENSG00000066923 "Stromal antigen 3" Q9UJ98 7 100177563-100221488 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Chromosome partition, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 85.4" "Cell type enhanced" "Detected in many" 10 "B-cells: 79.6;Spermatocytes: 87.4;Spermatogonia: 38.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 8 "memory B-cell: 4.8;naive B-cell: 7.6" "Lineage enriched" "Detected in single" 10 "B-cells: 7.6" "Group enriched" "Detected in some" 6 "BEWO: 27.0;HMC-1: 34.2;U-698: 9.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA049106, HPA058330" Enhanced Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA049106: AB_2680634, HPA058330: AB_2683681" "unprognostic (6.56e-4)" "prognostic favorable (8.45e-4)" "unprognostic (1.25e-2)" "unprognostic (7.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-3)" "unprognostic (3.59e-2)" "unprognostic (4.62e-2)" "unprognostic (1.12e-1)" "unprognostic (3.46e-1)" "unprognostic (3.31e-4)" "unprognostic (4.26e-4)" "unprognostic (7.48e-2)" "unprognostic (6.80e-2)" "unprognostic (2.72e-1)" "unprognostic (3.13e-2)" "unprognostic (5.07e-4)" 0.4 0.7 0.4 0.9 1.0 0.3 0.2 0.6 3.8 0.3 0.3 1.1 0.5 0.1 0.5 0.4 0.3 7.8 0.4 0.5 0.6 0.2 0.2 3.9 0.3 1.2 0.5 0.6 0.4 1.4 0.0 0.2 0.4 0.5 0.3 0.2 0.5 0.2 0.5 4.1 0.5 2.2 0.4 0.7 5.1 0.1 85.4 0.8 0.7 0.3 0.2 1.6 0.3 0.2 7.6 0.5 0.2 0.7 0.2 0.5 0.3 0.0 2.0 0.8 0.1 0.1 0.0 27.0 1.4 0.0 0.1 0.1 0.0 0.0 0.9 0.2 0.3 0.0 0.0 0.0 0.1 0.0 3.8 0.4 0.0 0.0 0.6 0.0 0.0 34.2 0.0 0.0 0.6 0.1 0.0 0.1 0.8 0.4 0.0 0.0 0.5 1.6 0.1 0.8 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.5 1.5 0.6 0.4 0.0 0.4 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 9.8 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.7 0.1 4.8 0.2 0.5 0.5 7.6 0.4 0.3 0.2 0.2 0.3 0.1 0.0 0.3 0.4 1.0 0.6 0.7 0.6 0.2 0.5 0.6 0.5 0.8 0.0 2.4 79.6 8.0 6.1 7.0 1.8 2.5 14.7 1.2 7.0 2.0 1.7 11.6 0.1 19.3 2.9 1.1 0.0 0.2 2.7 3.3 7.0 1.1 22.9 2.1 19.1 1.2 3.7 2.1 18.4 4.4 4.8 5.0 4.6 4.1 3.2 0.2 0.0 1.8 3.4 7.3 0.0 7.5 87.4 38.7 7.4 2.4 10.4 1.6 9.6 STEAP3 "dudlin-2, STMP3, TSAP6" ENSG00000115107 "STEAP3 metalloreductase" Q658P3 2 119223831-119265652 "Disease related genes, Predicted membrane proteins" "Apoptosis, Cell cycle, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "liver: 82.3;parathyroid gland: 47.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 30.8;Exocrine glandular cells: 31.3;Hepatocytes: 86.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 4.0;intermediate monocyte: 4.3;myeloid DC: 7.0;NK-cell: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;monocytes: 4.3;NK-cells: 2.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.1;U-87 MG: 46.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050510 Approved Approved Nucleoli,Cytosol NA NA 28000 Cytosol Nucleoli "HPA050510: AB_2681151" "unprognostic (6.51e-2)" "unprognostic (6.48e-2)" "unprognostic (4.89e-2)" "unprognostic (3.45e-2)" "unprognostic (1.94e-3)" "unprognostic (9.07e-2)" "unprognostic (1.99e-2)" "unprognostic (3.04e-1)" "unprognostic (9.75e-2)" "unprognostic (1.58e-3)" "unprognostic (5.08e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.82e-1)" "unprognostic (4.45e-1)" "unprognostic (9.37e-2)" "unprognostic (6.82e-2)" 8.1 2.8 2.5 1.2 4.2 5.1 9.2 3.0 2.2 6.4 6.1 3.0 3.7 7.9 1.3 3.1 5.1 4.0 2.8 6.6 2.9 1.4 3.4 82.3 3.9 4.9 3.9 0.4 5.2 9.0 47.4 5.1 4.3 6.1 4.8 2.4 2.1 12.6 9.1 10.9 3.0 9.8 0.9 6.4 1.0 6.7 1.5 3.2 0.2 3.3 6.9 4.0 4.2 3.7 0.8 7.0 0.7 4.3 2.1 0.2 1.5 6.4 7.7 0.0 2.6 3.8 36.1 6.8 2.0 2.2 4.1 3.7 5.8 8.8 0.0 15.6 11.6 29.3 10.9 3.4 6.8 4.6 0.0 11.0 12.5 7.0 11.5 9.5 3.1 2.4 21.4 12.0 24.2 8.7 28.1 3.5 0.0 6.1 1.3 11.5 6.1 0.0 1.8 10.6 9.9 16.1 0.0 4.5 5.5 5.0 16.3 13.0 2.4 5.7 19.8 1.5 1.6 3.9 4.1 15.0 25.5 14.9 5.4 11.1 0.0 0.0 0.0 46.7 7.9 5.2 0.0 4.0 0.7 0.2 4.3 0.0 0.8 0.0 0.0 7.0 0.2 0.0 0.0 0.1 2.1 0.6 0.3 0.0 1.5 2.5 4.2 3.0 2.2 2.9 1.4 3.9 0.4 6.1 3.2 0.0 6.4 0.5 6.8 1.8 0.1 5.5 5.1 30.8 10.3 0.0 0.0 25.8 0.0 7.9 0.2 2.9 10.9 0.0 31.3 3.0 4.3 4.8 3.5 86.3 11.1 0.0 1.7 0.6 3.8 0.0 1.7 6.4 0.0 0.0 4.6 0.0 17.9 7.8 7.1 0.5 0.0 6.5 2.1 0.2 0.0 1.3 19.8 0.0 9.1 8.1 STK24 "MST-3, MST3, MST3B, STE20, STK3" ENSG00000102572 "Serine/threonine kinase 24" Q9Y6E0 13 98445185-98577940 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026435, HPA026502" Enhanced Supported Nucleoli,Cytosol No No 2800000 "Nucleoli, Cytosol" "HPA026435: AB_1854151, HPA026502: AB_1854152" "unprognostic (3.49e-2)" "unprognostic (2.39e-2)" "unprognostic (1.78e-1)" "unprognostic (3.44e-2)" "unprognostic (2.86e-1)" "unprognostic (3.25e-2)" "unprognostic (9.67e-3)" "prognostic unfavorable (6.23e-6)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.81e-4)" "unprognostic (9.62e-2)" "prognostic favorable (6.91e-5)" "unprognostic (3.10e-2)" "unprognostic (4.49e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-2)" 28.6 14.2 15.0 29.7 16.9 19.1 34.8 12.2 21.0 36.3 37.4 12.1 23.0 31.9 24.6 26.5 68.4 20.4 41.3 30.0 14.7 12.8 30.5 14.2 23.9 31.2 10.6 10.1 20.0 20.6 12.4 13.9 38.4 14.7 28.3 28.8 36.8 30.8 21.6 18.8 60.6 67.9 34.8 9.2 31.7 30.2 22.1 7.6 38.2 28.2 41.6 48.5 39.2 45.4 8.1 11.2 11.4 13.4 1.5 13.7 6.7 36.0 11.3 20.0 18.5 30.8 18.5 28.5 16.9 23.8 23.7 23.2 33.0 49.1 25.7 8.6 21.1 14.9 32.7 18.5 37.3 22.7 64.1 9.5 27.5 14.4 18.9 43.6 27.6 19.5 11.9 59.6 18.6 54.9 25.1 20.4 20.3 9.9 17.8 15.5 15.7 20.6 11.4 17.9 49.1 8.5 26.1 12.3 13.9 22.9 32.6 11.7 16.8 10.7 17.3 22.8 31.9 20.8 26.9 27.4 15.1 11.0 12.3 19.4 17.4 9.1 9.6 23.5 16.7 24.8 5.8 13.4 6.1 6.1 10.6 7.2 6.6 11.4 8.7 11.2 8.1 7.8 6.1 11.4 1.5 12.7 7.5 13.7 6.7 15.0 16.9 12.2 21.0 14.7 12.8 10.6 10.1 14.7 7.6 11.9 24.3 29.0 62.3 63.0 20.3 2.8 68.8 34.8 44.3 64.6 53.0 35.6 21.6 29.9 2.5 26.3 110.9 0.0 47.8 36.3 36.7 53.4 18.4 22.9 24.7 9.5 40.9 27.0 68.7 3.4 24.7 40.1 54.0 16.2 70.9 22.1 67.8 59.4 28.7 31.9 11.4 38.8 29.0 1.8 3.6 71.8 16.7 21.8 51.8 117.9 STK33 ENSG00000130413 "Serine/threonine kinase 33" Q9BYT3 11 8391868-8594289 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 34.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 245.0;Late spermatids: 113.1;Rod photoreceptor cells: 83.4;Spermatocytes: 126.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 7.1;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 5 "B-cells: 7.1" "Cell line enhanced" "Detected in many" "Daudi: 14.0;hTERT-RPE1: 14.2;Karpas-707: 13.1;SCLC-21H: 14.7;U-251 MG: 14.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA015742, HPA056855" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA015742: AB_1857592, HPA056855: AB_2683257" "unprognostic (2.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (3.57e-1)" "unprognostic (1.40e-1)" "unprognostic (7.28e-2)" "unprognostic (3.85e-4)" "unprognostic (1.23e-1)" "unprognostic (8.06e-2)" "unprognostic (1.33e-3)" "unprognostic (9.46e-2)" "prognostic favorable (4.89e-6)" "unprognostic (2.39e-2)" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.90e-2)" 0.9 6.1 4.7 1.6 7.5 1.1 0.6 6.1 4.4 5.4 5.3 6.8 7.7 2.6 9.6 15.3 2.3 30.7 4.5 11.4 6.6 6.1 7.7 0.4 5.3 2.3 4.9 2.7 10.3 4.6 20.4 29.9 0.3 17.7 5.3 1.3 14.8 1.6 8.9 2.6 0.3 2.5 7.0 6.7 1.2 4.4 34.4 4.6 4.5 14.6 1.5 1.8 3.7 1.4 7.1 0.7 0.0 0.0 0.2 1.4 0.3 0.0 2.0 9.7 0.0 0.0 0.0 0.0 1.7 1.9 4.2 3.9 1.1 0.0 14.0 7.3 0.3 5.5 0.0 4.3 1.3 3.7 0.0 11.9 0.0 2.6 3.3 1.6 7.8 0.0 0.4 0.0 0.1 0.0 14.2 0.3 6.9 0.0 13.1 0.1 0.0 0.2 0.0 6.9 0.0 0.0 5.2 1.3 8.8 3.8 0.0 14.7 3.9 0.0 0.0 0.1 2.7 0.0 0.8 0.0 0.0 6.6 0.1 14.8 3.1 12.4 0.2 4.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 7.1 0.0 1.4 0.0 4.4 0.0 1.1 0.0 0.2 0.0 0.7 0.2 0.3 4.7 7.5 6.1 4.4 6.6 6.1 4.9 2.7 17.7 4.6 17.9 12.6 5.4 1.1 0.0 19.2 34.4 10.2 245.0 47.8 19.2 66.8 0.1 3.3 7.5 72.9 1.3 0.0 0.0 4.4 2.7 0.3 0.2 1.1 0.0 0.2 1.6 8.7 0.0 0.0 113.1 4.0 0.4 0.0 0.0 1.3 30.6 4.5 0.0 15.9 11.9 83.4 0.0 0.2 126.9 25.1 0.0 0.0 0.0 2.9 0.0 STON2 "STN2, STNB2" ENSG00000140022 "Stonin 2" Q8WXE9 14 81260656-81436465 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 23.2;Proximal tubular cells: 20.1;Urothelial cells: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;intermediate monocyte: 3.6" "Lineage enriched" "Detected in single" 4 "monocytes: 3.6" "Cell line enhanced" "Detected in many" "HEL: 43.7;HMC-1: 24.8;Karpas-707: 22.5;RT4: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003086 Enhanced Approved Nucleoli,Cytosol NA NA 9800 "Nucleoli, Cytosol" "HPA003086: AB_2302748" "unprognostic (5.28e-2)" "unprognostic (9.83e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.50e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.55e-2)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (3.30e-1)" "unprognostic (9.88e-2)" "unprognostic (9.19e-2)" "unprognostic (5.82e-3)" "unprognostic (1.37e-1)" "unprognostic (6.15e-2)" "unprognostic (1.44e-1)" 6.1 1.2 26.8 1.5 23.5 5.6 11.5 2.0 22.4 4.3 5.3 18.1 1.6 4.7 1.8 6.7 11.3 13.6 7.1 4.0 26.1 11.6 17.5 3.7 5.0 1.3 10.3 11.5 3.7 1.3 0.6 7.9 4.3 9.6 2.6 6.1 7.9 4.6 3.8 9.5 9.2 4.9 2.2 4.5 18.7 6.8 4.0 15.9 0.3 13.1 4.9 3.4 6.8 6.6 0.0 0.5 0.8 3.6 0.0 0.1 3.2 1.8 1.3 4.8 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.1 4.3 1.5 0.0 2.2 0.0 1.3 12.0 6.7 15.1 0.0 0.2 2.3 43.7 8.0 1.6 0.0 0.0 24.8 0.6 13.3 0.0 4.6 0.0 0.0 2.5 16.0 22.5 0.4 2.7 2.1 0.0 4.8 4.3 1.1 0.0 7.1 1.4 3.2 18.1 11.8 0.7 5.3 0.2 0.0 4.0 0.6 0.1 0.2 0.9 3.7 4.0 1.0 2.6 4.6 0.0 3.3 0.1 1.1 0.0 2.4 0.0 0.1 3.6 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.0 3.2 26.8 23.5 2.0 17.5 26.1 11.6 10.3 11.5 9.6 15.9 3.0 0.3 0.0 9.7 12.0 0.4 1.2 2.5 2.7 1.2 17.4 11.8 0.8 6.6 0.6 0.2 2.2 4.1 0.0 0.4 0.3 5.3 4.6 0.0 0.8 2.6 3.2 0.0 4.9 10.2 1.1 9.5 2.5 1.7 0.0 2.5 23.2 2.1 1.5 8.1 20.1 6.7 0.0 1.2 0.9 6.6 7.8 12.9 0.5 3.3 26.4 STX17 FLJ20651 ENSG00000136874 "Syntaxin 17" P56962 9 99906633-99970341 "Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001204 Approved Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA001204: AB_1080118" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (8.67e-2)" "unprognostic (2.93e-1)" "unprognostic (6.71e-2)" "unprognostic (1.88e-1)" "unprognostic (2.36e-1)" "unprognostic (1.70e-2)" "unprognostic (9.75e-2)" "unprognostic (1.62e-1)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.62e-5)" "unprognostic (9.48e-2)" "unprognostic (4.32e-2)" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" 15.1 15.8 13.5 16.4 16.3 13.6 16.1 10.8 17.8 19.4 18.5 14.2 29.3 13.4 21.7 25.2 19.9 12.0 14.9 14.5 13.8 13.2 14.3 26.0 13.2 11.9 15.4 14.2 18.2 17.8 25.5 37.1 17.6 14.1 18.2 14.6 16.3 20.6 28.7 28.5 20.6 18.9 20.4 19.1 13.3 15.0 12.0 10.4 17.0 21.8 18.3 15.9 18.8 17.8 7.4 4.9 15.5 8.1 14.3 10.4 4.5 10.7 9.8 10.0 12.0 11.4 11.6 19.9 8.2 12.2 9.3 8.0 12.2 14.4 21.0 8.2 8.7 15.0 12.3 8.3 11.5 7.5 18.3 6.8 13.5 12.9 7.4 13.3 19.8 4.9 11.4 13.4 10.0 15.2 9.8 10.8 18.2 18.7 11.7 7.0 13.1 11.8 5.4 8.8 14.0 7.9 10.1 17.7 9.6 12.3 12.5 5.8 10.3 16.6 12.7 8.1 6.7 12.6 5.5 8.5 6.2 8.8 10.0 6.6 16.6 20.2 4.2 8.7 8.3 6.7 15.5 4.2 7.3 7.4 4.5 10.3 7.4 9.1 8.2 4.9 5.9 10.4 9.8 4.3 14.3 8.1 3.1 4.9 4.5 13.5 16.3 10.8 17.8 13.8 13.2 15.4 14.2 14.1 10.4 14.9 21.7 14.5 18.1 9.4 14.0 16.9 10.2 24.1 22.7 22.7 19.6 20.4 24.9 15.8 40.4 13.7 9.7 0.0 17.1 15.8 11.1 23.3 25.4 23.1 9.2 9.5 24.2 20.9 8.3 24.8 23.9 15.1 8.5 27.1 15.7 20.3 14.1 15.9 17.0 15.7 12.9 38.8 13.9 25.9 16.6 10.7 22.9 16.6 13.1 12.9 SUB1 "p14, p15, PC4" ENSG00000113387 "SUB1 homolog, transcriptional regulator" P53999 5 32531633-32604079 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 165.5" "Low region specificity" "Detected in all" "HPA001311, CAB015351" Supported Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "CAB015351: AB_2197157, HPA001311: AB_1080123" "unprognostic (5.19e-2)" "unprognostic (1.58e-1)" "unprognostic (5.25e-2)" "unprognostic (1.71e-1)" "unprognostic (2.26e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (5.25e-6)" "unprognostic (8.31e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (3.46e-3)" "unprognostic (5.04e-2)" "unprognostic (1.95e-1)" "unprognostic (1.02e-3)" "unprognostic (2.12e-1)" "unprognostic (2.99e-1)" "unprognostic (2.43e-1)" "unprognostic (2.45e-1)" 54.4 40.8 64.1 50.9 69.8 87.6 52.3 28.2 82.4 48.9 44.4 21.5 23.2 36.2 36.8 36.3 52.7 27.4 31.3 46.9 79.3 53.5 54.7 60.7 36.3 58.4 45.8 57.5 30.7 26.9 26.5 49.0 47.0 51.6 34.5 46.0 17.4 32.3 29.1 39.6 26.8 47.5 33.2 39.6 67.2 38.7 28.1 29.8 72.4 42.2 54.2 54.6 39.8 29.7 61.1 69.4 92.0 24.6 25.9 59.5 49.2 22.1 18.3 36.4 34.1 22.2 39.5 22.9 38.7 28.2 35.1 32.4 26.5 35.0 11.2 27.0 26.7 35.9 15.1 30.5 31.7 47.3 46.8 28.1 37.7 44.7 50.2 31.5 65.6 51.6 27.6 27.5 37.2 26.7 19.4 26.2 43.1 43.7 165.5 30.9 19.7 61.9 104.8 24.0 26.3 37.6 27.5 47.6 71.7 34.8 20.1 19.8 16.4 60.0 28.3 27.5 24.0 31.3 61.0 27.1 38.0 41.3 32.0 29.1 64.8 111.6 19.6 35.0 71.3 23.1 92.0 23.9 54.9 31.5 24.6 28.4 61.1 41.4 41.2 46.8 35.1 32.9 37.6 29.2 25.9 21.9 69.4 59.5 49.2 64.1 69.8 28.2 82.4 79.3 53.5 45.8 57.5 51.6 29.8 134.0 164.3 396.8 516.1 519.5 114.4 178.2 247.1 151.3 121.7 294.8 41.2 431.0 855.4 544.4 65.7 278.7 291.1 256.9 284.6 652.5 391.4 435.3 302.3 359.4 432.3 81.0 269.9 203.1 322.6 51.2 222.1 419.5 501.0 571.7 258.1 146.4 357.5 396.3 323.9 714.8 66.1 200.5 303.1 377.2 414.8 494.2 699.8 467.7 329.5 537.0 SUMO1 "GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1" ENSG00000116030 "Small ubiquitin-like modifier 1" P63165 2 202206180-202238608 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004269, HPA056956" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear membrane" "Nucleoli, Nuclear bodies" "CAB004269: AB_628300, HPA056956: AB_2683285" "unprognostic (7.15e-2)" "unprognostic (2.34e-2)" "unprognostic (1.49e-1)" "unprognostic (2.52e-3)" "unprognostic (2.89e-1)" "unprognostic (9.56e-3)" "unprognostic (1.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.78e-3)" "prognostic favorable (7.93e-4)" "unprognostic (7.06e-3)" "unprognostic (1.16e-1)" "unprognostic (4.64e-3)" "unprognostic (1.31e-2)" "unprognostic (7.58e-2)" "unprognostic (2.82e-2)" "unprognostic (2.19e-1)" 27.1 37.8 44.4 21.6 37.9 41.8 31.6 47.7 49.2 26.9 29.7 19.9 27.2 26.2 24.7 33.4 26.9 24.7 26.6 28.3 38.0 39.6 43.5 62.6 24.6 28.7 34.6 40.6 23.4 29.8 26.6 28.7 30.4 32.3 28.8 31.2 21.6 35.6 24.5 42.4 21.6 33.2 27.6 29.6 25.1 26.4 28.7 27.1 32.2 38.4 28.1 33.6 26.9 23.1 74.8 63.0 77.0 63.7 65.8 89.0 94.0 33.7 17.1 62.4 33.1 34.8 37.2 27.9 35.9 45.4 44.8 59.5 36.8 43.0 23.1 33.4 41.4 41.9 24.7 51.1 49.9 70.5 21.6 39.2 42.7 33.6 43.2 25.2 48.1 40.7 28.6 48.3 35.1 26.8 42.2 41.7 46.2 39.3 37.6 47.9 28.7 60.5 80.0 75.0 34.8 36.4 39.2 35.0 40.7 54.3 28.1 43.4 47.4 29.3 28.5 48.0 70.7 25.6 46.1 29.2 33.1 33.4 30.3 31.7 32.8 64.7 58.6 36.9 34.3 29.0 56.6 63.7 77.0 51.1 62.6 53.5 74.8 63.7 59.8 63.0 58.4 60.2 62.8 73.6 65.8 62.8 52.9 89.0 94.0 44.4 37.9 47.7 49.2 38.0 39.6 34.6 40.6 32.3 27.1 104.2 49.5 141.2 176.9 375.0 93.7 54.1 96.8 83.0 78.5 179.7 60.9 228.3 407.8 216.2 44.0 153.6 150.3 46.7 152.2 246.7 239.6 215.1 91.1 181.0 182.5 82.6 136.7 118.4 134.8 20.6 120.3 156.9 200.8 294.0 123.6 118.9 175.8 178.5 120.2 378.6 73.5 109.9 205.0 172.2 119.7 371.1 175.4 191.9 139.7 207.2 SURF2 ENSG00000148291 "Surfeit 2" Q15527 9 133356552-133361169 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.1" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 358.5;Late spermatids: 675.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 43.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044340, HPA052213, HPA059710" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: " "unprognostic (1.53e-1)" "unprognostic (6.10e-3)" "unprognostic (1.24e-3)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (6.27e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (1.85e-1)" "unprognostic (5.46e-3)" "unprognostic (8.28e-2)" "unprognostic (1.07e-3)" "unprognostic (1.09e-2)" "unprognostic (3.15e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" 8.3 9.2 15.8 9.0 13.2 8.2 10.7 13.1 14.5 5.7 8.8 7.4 10.8 13.2 6.4 12.0 11.0 10.7 11.2 8.9 13.4 11.0 14.3 12.0 6.5 12.1 13.1 8.7 9.0 17.5 7.1 11.3 5.9 10.3 7.7 5.7 7.7 14.2 8.8 11.5 14.8 11.4 6.9 9.4 8.6 9.3 50.1 6.6 10.6 10.1 14.9 9.8 6.5 8.3 17.5 15.6 13.1 16.2 13.2 26.9 14.1 7.2 12.5 5.3 6.5 3.8 3.0 11.1 3.7 3.3 5.9 3.1 17.1 6.0 7.2 5.4 2.4 5.1 19.9 8.3 9.0 2.7 6.9 11.5 5.7 14.3 6.3 7.7 9.3 4.3 3.6 10.7 8.4 12.4 2.1 2.7 8.9 9.0 5.0 4.0 43.6 9.6 6.2 16.6 17.4 24.2 10.7 7.9 16.9 5.0 8.3 19.7 9.9 8.2 13.8 11.0 3.4 14.7 4.4 5.1 9.0 9.1 9.2 13.1 6.2 12.3 7.8 5.7 5.6 9.0 13.1 16.2 12.0 17.8 16.2 23.1 15.6 21.9 20.2 13.8 17.5 20.8 19.7 7.1 13.2 11.6 15.6 26.9 14.1 15.8 13.2 13.1 14.5 13.4 11.0 13.1 8.7 10.3 6.6 11.9 7.8 21.6 25.7 74.8 17.9 12.4 45.9 48.2 17.0 21.0 2.0 33.0 89.5 56.4 358.5 19.4 48.7 0.0 70.1 21.0 22.4 21.1 9.2 21.5 25.8 12.7 35.1 20.3 25.9 675.3 24.2 22.4 40.5 27.9 17.1 13.2 50.2 28.1 23.0 64.0 18.9 64.7 32.0 140.5 86.5 77.0 21.4 26.1 23.8 17.8 SURF6 "FLJ30322, RRP14" ENSG00000148296 "Surfeit 6" O75683 9 133328774-133336398 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023608, HPA074622" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA023608: AB_1857671, HPA074622: AB_2686703" "unprognostic (5.27e-3)" "unprognostic (8.67e-3)" "unprognostic (5.41e-3)" "unprognostic (3.69e-2)" "unprognostic (2.61e-1)" "unprognostic (3.20e-1)" "unprognostic (1.26e-3)" "unprognostic (3.60e-2)" "unprognostic (1.18e-1)" "unprognostic (9.37e-2)" "unprognostic (6.18e-3)" "unprognostic (9.32e-3)" "prognostic favorable (7.31e-5)" "unprognostic (1.50e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-1)" "unprognostic (2.66e-1)" 14.8 16.8 19.9 15.0 22.7 16.2 15.7 16.4 25.8 13.9 16.2 14.0 11.9 21.7 18.6 10.9 17.4 18.5 15.9 13.9 19.1 17.9 14.5 16.2 12.6 17.6 19.6 22.9 27.4 23.1 16.5 11.8 12.5 24.6 15.8 13.1 11.6 18.3 19.5 47.3 17.8 22.3 18.0 23.6 18.8 13.6 16.5 19.8 8.6 14.4 11.1 13.5 15.3 19.1 7.7 8.9 3.9 4.7 4.6 8.5 3.6 4.1 6.4 5.0 7.4 3.1 2.9 8.3 6.5 3.9 5.8 3.7 10.1 7.1 11.9 5.1 3.6 4.3 12.5 6.4 6.9 2.2 7.9 7.2 8.2 7.4 6.0 5.6 13.8 7.1 4.1 6.1 6.1 5.7 5.3 3.0 11.7 17.8 6.5 5.2 10.7 11.2 11.4 14.5 16.8 11.7 11.8 6.9 12.1 5.1 4.0 10.5 8.9 6.4 10.5 5.7 3.2 9.2 7.8 6.2 13.4 7.1 6.7 8.9 4.8 6.8 15.5 5.0 9.5 7.8 3.9 4.7 1.9 6.8 4.4 7.0 7.1 6.2 6.1 4.9 7.7 8.5 7.0 1.3 4.6 3.7 8.9 5.0 3.6 19.9 22.7 16.4 25.8 19.1 17.9 19.6 22.9 24.6 19.8 41.7 23.5 25.1 10.6 21.1 24.6 26.3 30.6 17.4 35.2 21.0 5.9 26.9 18.3 29.0 1.1 20.3 37.7 0.0 16.8 19.1 14.3 11.8 24.3 29.2 18.5 20.6 32.3 12.9 11.1 2.4 25.6 14.2 6.8 21.6 37.2 16.4 23.6 28.1 26.2 11.9 20.1 0.0 17.0 18.9 21.0 24.1 15.9 16.6 47.0 10.5 SUZ12 "CHET9, JJAZ1, KIAA0160" ENSG00000178691 "SUZ12 polycomb repressive complex 2 subunit" Q15022 17 31937018-32001045 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057436 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies" "HPA057436: AB_2683439" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (3.65e-3)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (7.31e-2)" "unprognostic (2.66e-3)" "unprognostic (8.05e-2)" "unprognostic (7.27e-2)" "unprognostic (3.06e-2)" "unprognostic (6.29e-2)" "unprognostic (8.70e-2)" "unprognostic (3.28e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (5.91e-2)" "unprognostic (1.31e-1)" 10.1 10.8 13.4 15.4 10.4 25.5 33.5 16.0 13.8 11.2 11.4 7.5 13.6 10.1 12.5 8.1 12.3 9.8 7.7 9.7 9.1 7.6 10.9 11.5 10.6 19.9 9.3 9.9 10.0 10.1 15.5 10.4 15.3 9.5 10.7 10.9 6.9 10.1 9.6 8.7 9.9 12.2 9.6 7.7 15.2 10.7 17.1 12.5 31.8 12.0 6.5 18.9 10.8 19.5 5.5 4.6 4.1 2.6 4.4 5.5 1.2 14.3 12.7 12.0 13.7 6.9 8.9 12.3 14.0 12.4 17.2 20.8 9.6 8.1 31.3 10.8 8.7 14.7 12.7 17.8 8.0 28.0 11.0 17.3 21.7 10.8 6.9 8.2 34.1 22.3 6.2 9.1 17.1 13.2 10.4 10.5 15.0 20.9 43.6 14.7 5.0 40.5 19.8 6.8 10.1 7.8 24.2 30.8 25.4 10.1 14.0 15.4 12.0 22.5 7.3 13.5 8.7 21.1 28.5 7.7 13.7 12.5 16.3 21.5 23.8 29.6 38.8 10.0 21.1 12.3 1.4 1.9 3.8 3.8 2.6 3.0 5.5 4.1 4.0 1.4 4.4 3.9 5.5 4.1 4.4 1.8 4.6 4.2 1.2 13.4 10.4 16.0 13.8 9.1 7.6 9.3 9.9 9.5 12.5 38.7 37.9 23.1 41.1 52.0 74.2 24.8 35.7 28.1 37.5 33.2 102.1 49.4 14.9 23.6 8.9 34.9 15.6 23.3 19.1 45.9 33.8 46.2 15.1 37.5 27.9 58.8 28.3 38.6 41.9 10.7 24.7 37.6 23.6 86.6 31.9 41.7 22.6 10.5 24.1 24.5 76.3 12.9 32.5 100.7 141.1 62.7 58.1 39.9 33.0 48.2 SYCE3 C22orf41 ENSG00000217442 "Synaptonemal complex central element protein 3" A1L190 22 50551112-50562905 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 61.5" "Group enriched" "Detected in many" 6 "Early spermatids: 349.3;Spermatocytes: 429.3;Spermatogonia: 109.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.8;Karpas-707: 7.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047813 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA047813: AB_2797234" "unprognostic (2.55e-1)" "unprognostic (2.52e-1)" "unprognostic (2.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.73e-2)" "unprognostic (2.22e-1)" "unprognostic (2.98e-3)" "unprognostic (1.68e-2)" "unprognostic (4.05e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.55e-2)" "unprognostic (5.20e-2)" 0.4 0.4 0.7 0.5 0.9 0.1 0.7 0.2 0.6 0.2 0.4 0.5 0.4 0.1 0.2 1.1 0.2 0.8 0.6 0.1 0.5 0.7 1.0 0.8 0.4 0.9 0.9 0.3 0.1 0.2 0.2 0.4 0.4 0.7 0.1 0.0 0.2 0.7 0.1 0.0 0.2 0.0 0.5 0.7 0.1 0.2 61.5 0.4 0.0 1.1 0.2 0.3 0.7 0.0 0.5 1.9 8.0 1.3 0.0 0.3 0.3 0.4 0.7 0.1 0.3 0.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 8.8 0.4 3.2 0.0 1.8 0.0 0.9 1.0 0.0 0.0 0.5 0.0 0.6 0.0 4.0 0.0 1.6 2.3 2.0 0.3 1.4 0.5 0.0 1.8 0.0 7.4 0.4 3.3 0.0 0.0 0.3 3.7 0.0 0.0 0.0 3.9 1.2 2.6 0.8 2.3 0.0 2.2 1.4 0.3 2.1 1.8 0.0 0.7 0.8 0.0 0.1 1.9 0.4 1.1 0.9 0.3 0.2 0.0 1.3 1.5 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 0.2 8.0 0.0 0.9 0.0 0.0 0.3 0.7 0.9 0.2 0.6 0.5 0.7 0.9 0.3 0.7 0.4 0.0 0.0 0.0 0.4 0.1 0.5 0.4 5.1 0.0 0.0 1.8 0.0 4.2 3.3 1.3 349.3 0.1 0.3 0.0 0.6 2.6 0.1 0.3 0.0 1.6 1.4 0.0 0.0 0.6 1.2 52.2 10.0 0.0 0.0 4.6 0.0 0.9 1.2 0.0 6.7 2.1 0.4 45.3 0.0 429.3 109.7 0.1 3.1 0.0 0.3 0.9 SYDE2 FLJ13815 ENSG00000097096 "Synapse defective Rho GTPase homolog 2" Q5VT97 1 85156873-85201046 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 1: 47.6;Cone photoreceptor cells: 51.1;Rod photoreceptor cells: 133.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 16.4;SK-BR-3: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027138, HPA058378" Uncertain Approved "Nucleoli,Nucleoli rim,Golgi apparatus" No No "Nucleoli, Nucleoli rim, Golgi apparatus" "HPA027138: AB_1857686, HPA058378: AB_2683696" "unprognostic (1.68e-1)" "unprognostic (8.90e-2)" "unprognostic (2.34e-2)" "unprognostic (3.43e-3)" "unprognostic (2.50e-1)" "unprognostic (6.98e-2)" "unprognostic (3.84e-3)" "unprognostic (6.47e-3)" "unprognostic (4.39e-2)" "unprognostic (1.85e-1)" "unprognostic (3.88e-2)" "unprognostic (4.05e-1)" "unprognostic (2.96e-3)" "unprognostic (1.57e-1)" "unprognostic (8.76e-2)" "unprognostic (7.51e-2)" "unprognostic (6.69e-2)" 2.5 1.8 1.1 2.6 1.7 0.6 3.8 0.6 2.2 3.5 11.4 0.5 2.0 2.5 3.8 2.6 5.6 2.3 7.7 5.4 2.8 0.9 4.7 6.4 9.1 3.4 0.9 2.4 3.3 9.9 8.4 5.1 5.0 0.9 5.0 2.6 7.2 3.9 2.5 2.4 1.9 9.2 13.3 0.9 1.0 6.0 3.3 1.0 0.6 5.2 1.0 0.8 6.0 9.6 0.3 0.1 1.4 0.1 0.3 0.7 0.2 2.2 0.7 0.7 0.8 2.5 0.8 16.4 2.5 1.6 1.5 2.4 4.3 0.8 0.0 0.8 1.6 3.0 4.3 8.1 1.1 2.4 0.9 2.3 2.0 1.7 1.5 3.0 1.3 0.5 1.1 1.3 1.2 1.1 1.0 0.3 1.5 2.5 0.0 1.2 3.1 1.3 0.2 4.2 1.7 0.9 0.0 4.4 0.5 1.2 5.7 0.1 0.0 1.8 8.9 2.6 3.9 2.0 1.8 0.3 1.9 4.3 0.0 2.5 0.0 0.3 0.9 0.2 0.9 1.7 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.3 0.7 0.3 1.4 0.3 0.0 0.1 0.0 0.2 1.1 1.7 0.6 2.2 2.8 0.9 0.9 2.4 0.9 1.0 47.6 7.7 0.0 8.1 7.3 4.6 21.2 2.5 2.7 10.3 1.8 51.1 7.9 6.6 1.6 2.4 1.8 3.3 0.0 4.0 3.8 5.4 4.5 1.1 6.0 1.3 0.0 18.5 3.1 0.3 0.9 2.0 1.4 18.6 2.8 3.3 6.4 3.2 0.0 2.5 4.6 133.9 0.0 2.0 11.5 7.2 4.0 2.2 2.2 3.7 3.8 TACSTD2 "EGP-1, GA733-1, M1S1, TROP2" ENSG00000184292 "Tumor associated calcium signal transducer 2" P09758 1 58575423-58577773 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Tumor antigen" "Amyloidosis, Corneal dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.9;salivary gland: 56.4" "Cell type enhanced" "Detected in many" 15 "Basal glandular cells: 5162.0;Glandular cells: 2977.4;Urothelial cells: 7434.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 12.4" "Group enriched" "Detected in many" 65 "dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2" "Cell line enhanced" "Detected in some" "A-431: 75.7;CAPAN-2: 102.7;HaCaT: 102.9;RT4: 35.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043104, HPA055067, CAB072852" Enhanced Supported "Nucleoli,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoli, Vesicles" "CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687" "unprognostic (1.80e-2)" "unprognostic (3.08e-1)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (5.70e-2)" "unprognostic (2.15e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (7.91e-2)" "prognostic favorable (3.99e-4)" "unprognostic (7.10e-2)" "unprognostic (2.55e-1)" "unprognostic (6.91e-3)" "unprognostic (2.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.7 17.1 0.0 0.0 23.1 0.0 0.0 1.7 2.6 103.9 2.7 0.9 0.0 0.0 0.0 10.4 0.0 8.0 0.0 0.0 0.0 9.0 0.0 0.0 1.5 15.7 0.0 56.4 12.6 0.0 42.1 0.0 0.0 0.0 0.0 7.3 0.0 0.1 20.6 17.7 36.1 0.0 3.7 12.4 3.2 0.0 0.0 1.8 75.7 0.0 0.0 0.1 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 102.7 0.0 9.9 6.4 0.0 102.9 0.0 18.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 1.1 0.0 4.3 0.0 0.0 0.1 0.0 16.3 0.0 0.1 0.0 16.7 0.1 0.0 0.0 0.0 13.8 35.5 0.0 0.0 3.3 27.4 0.1 0.3 17.9 0.1 4.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 12.4 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.8 321.6 110.2 1.3 5162.0 1324.0 0.0 0.3 287.9 277.1 312.8 1212.6 0.0 74.9 36.5 1546.3 0.0 14.3 0.4 0.0 1122.5 4.7 23.0 2977.4 8.1 0.6 7.6 0.0 0.0 0.6 0.3 0.0 0.0 32.3 108.0 54.1 2.9 0.0 1294.2 4.0 0.0 3.3 0.0 0.0 47.2 0.5 0.9 1339.0 65.6 0.0 0.9 7434.9 TAF13 "TAF2K, TAFII18" ENSG00000197780 "TATA-box binding protein associated factor 13" Q15543 1 109062486-109076002 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044492 Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA044492: AB_10962871" "unprognostic (8.54e-2)" "unprognostic (2.02e-2)" "unprognostic (2.82e-2)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.74e-6)" "unprognostic (1.73e-2)" "unprognostic (2.18e-1)" "prognostic favorable (2.42e-5)" "unprognostic (1.85e-1)" "unprognostic (6.78e-2)" "unprognostic (2.43e-1)" "unprognostic (2.11e-2)" "unprognostic (1.91e-1)" "unprognostic (7.61e-3)" "unprognostic (7.22e-3)" 23.5 13.4 24.6 14.3 23.4 27.7 14.7 14.0 33.7 18.0 16.6 19.5 15.3 10.0 13.9 14.7 22.1 9.9 18.0 19.2 25.3 26.9 22.3 21.0 11.5 8.6 32.2 22.6 6.6 15.9 14.6 21.2 21.0 35.8 16.9 18.2 7.7 14.5 11.7 40.9 13.0 12.8 22.2 36.1 7.7 14.0 10.3 20.7 4.1 18.2 16.6 14.8 16.4 11.0 1.3 3.0 7.9 4.6 0.5 2.3 0.8 20.6 5.4 8.3 12.1 24.0 22.5 13.8 49.1 20.8 20.0 20.3 8.6 4.7 7.9 18.8 32.6 11.9 8.7 14.6 17.7 30.2 13.5 3.3 7.9 13.2 8.9 19.0 13.9 12.1 20.0 21.3 33.5 18.3 10.8 17.1 7.3 15.1 7.7 27.0 11.9 7.3 3.8 16.6 9.6 11.3 5.7 15.0 3.1 23.6 18.0 8.7 10.8 24.1 15.6 17.7 15.5 5.3 9.9 22.3 33.1 12.6 23.3 26.8 9.4 23.7 10.6 35.2 7.4 49.1 2.6 4.6 3.7 1.7 3.3 1.5 1.2 1.1 1.7 1.5 1.3 1.1 1.6 7.9 0.5 2.8 3.0 2.3 0.8 24.6 23.4 14.0 33.7 25.3 26.9 32.2 22.6 35.8 20.7 17.9 21.1 8.2 9.3 62.4 4.5 57.2 10.2 16.0 26.1 7.0 0.0 15.5 11.6 14.4 29.0 19.7 31.6 23.3 18.1 26.6 20.6 18.8 13.9 35.8 16.4 6.4 30.6 24.5 29.7 2.9 8.6 18.4 13.5 12.6 26.1 10.8 24.9 20.1 12.0 26.2 7.5 6.5 26.2 9.8 15.7 72.0 45.9 7.7 10.5 25.9 TAF1B "RAF1B, RAFI63, SL1, TAFI63" ENSG00000115750 "TATA-box binding protein associated factor, RNA polymerase I subunit B" Q53T94 2 9843354-9934416 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071254 Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA071254: " "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "prognostic favorable (8.58e-5)" "unprognostic (1.44e-3)" "unprognostic (5.43e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.94e-7)" "unprognostic (9.17e-2)" "unprognostic (3.29e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (2.98e-1)" "prognostic favorable (8.55e-4)" "unprognostic (2.59e-1)" "unprognostic (2.49e-1)" "unprognostic (2.79e-2)" "unprognostic (1.49e-2)" 13.4 11.7 10.2 10.7 11.1 7.8 12.1 14.0 12.7 12.3 7.4 8.4 15.9 7.1 19.2 14.5 16.5 13.6 9.7 8.5 9.3 11.7 17.9 9.9 11.5 13.9 9.2 9.5 12.7 8.9 22.6 19.5 20.2 10.7 12.6 8.1 11.6 10.1 20.1 7.2 11.3 7.5 11.1 8.5 13.9 8.4 17.1 9.2 23.3 14.9 10.9 15.8 9.9 14.4 9.8 11.3 4.9 13.1 8.5 12.9 4.6 12.2 12.2 16.9 5.2 8.5 13.1 27.3 13.4 13.4 14.7 12.7 11.3 9.9 14.4 7.1 10.9 14.3 7.0 14.7 16.6 16.3 14.0 16.0 15.5 5.2 15.1 11.0 12.2 17.4 10.3 9.7 10.8 15.9 11.6 22.0 7.9 10.3 15.4 14.7 8.1 9.1 10.4 20.4 7.9 9.0 5.5 14.3 4.5 14.9 11.0 7.2 18.4 11.5 15.6 11.8 11.7 5.4 9.7 10.2 17.7 20.9 17.3 18.5 7.5 9.0 20.5 10.7 14.1 15.1 2.6 8.4 4.9 11.5 13.1 10.9 9.5 9.5 12.9 11.3 9.8 6.3 9.4 0.4 8.5 10.0 9.4 9.4 4.6 10.2 11.1 14.0 12.7 9.3 11.7 9.2 9.5 10.7 9.2 17.9 19.5 12.3 24.6 14.3 21.2 3.7 2.5 40.2 38.7 12.2 25.5 22.4 11.6 17.0 4.7 12.8 1.6 0.0 16.3 29.6 12.8 9.4 8.1 4.9 11.3 14.3 1.7 8.6 12.9 1.5 17.5 12.3 0.0 14.4 2.9 23.3 13.4 3.5 12.4 19.9 20.2 19.4 13.4 35.8 32.4 11.5 19.8 13.1 4.0 20.2 TAF1D "JOSD3, MGC5306, TAF(I)41" ENSG00000166012 "TATA-box binding protein associated factor, RNA polymerase I subunit D" Q9H5J8 11 93729948-93784391 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030703, HPA055935, HPA060385" Uncertain Supported "Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite" Yes No Nucleoplasm "Nucleoli, Mitotic spindle, Centriolar satellite" "HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271" "unprognostic (9.91e-3)" "unprognostic (4.38e-2)" "unprognostic (6.80e-2)" "unprognostic (1.71e-1)" "unprognostic (5.40e-3)" "unprognostic (6.46e-2)" "unprognostic (3.68e-3)" "unprognostic (9.70e-2)" "unprognostic (5.24e-3)" "unprognostic (3.55e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-2)" "prognostic unfavorable (3.17e-7)" "unprognostic (1.95e-1)" "unprognostic (2.51e-1)" "unprognostic (2.34e-1)" "unprognostic (6.37e-2)" 13.9 10.6 12.5 19.9 18.4 14.2 12.9 17.3 20.1 15.1 14.7 4.3 17.3 16.8 15.2 9.7 16.0 11.5 18.1 11.1 12.0 7.6 13.6 18.7 15.8 19.0 14.4 13.6 20.9 30.5 9.3 24.3 18.5 13.6 16.4 13.4 3.9 12.3 11.4 31.5 14.5 17.8 18.1 22.1 18.4 13.0 8.0 13.6 13.1 13.2 12.9 12.2 28.1 17.1 24.1 14.3 22.3 9.2 9.0 16.3 2.7 3.9 3.1 4.2 4.2 4.1 16.2 7.6 4.4 3.3 5.7 4.1 10.6 10.7 9.5 8.5 4.3 1.9 11.7 4.9 6.9 6.3 2.6 2.0 9.7 17.5 6.3 4.1 8.8 5.2 4.5 7.5 4.5 7.4 9.0 7.1 5.0 6.6 18.8 7.8 1.2 7.4 17.0 3.2 2.9 2.4 3.5 4.7 8.1 6.5 6.3 3.0 6.3 2.6 9.6 3.0 6.1 11.9 2.2 6.9 8.6 5.7 12.9 6.5 8.4 9.5 8.0 3.1 9.4 2.9 17.4 9.2 14.8 10.0 6.5 10.0 19.5 13.8 10.9 6.2 24.1 16.3 13.6 22.3 9.0 5.2 14.3 9.4 2.7 12.5 18.4 17.3 20.1 12.0 7.6 14.4 13.6 13.6 13.6 83.4 80.4 125.3 241.5 216.9 84.2 23.0 129.9 91.0 139.9 27.9 37.3 149.3 38.1 80.3 12.9 79.2 61.0 0.0 125.2 151.7 105.8 205.9 100.6 46.5 62.1 65.2 105.6 52.2 91.2 12.3 119.0 105.3 75.9 66.7 101.9 39.6 109.2 66.6 63.6 64.8 75.6 71.1 94.7 37.0 70.9 177.4 134.6 106.5 115.9 265.8 TANK "I-TRAF, TRAF2" ENSG00000136560 "TRAF family member associated NFKB activator" Q92844 2 161136908-161236221 "Predicted intracellular proteins" "DNA damage, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "monocytes: 219.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010345, HPA037675, HPA037676" Approved Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB010345: AB_2199871, HPA037675: AB_2675600, HPA037676: AB_2675601" "unprognostic (1.14e-2)" "unprognostic (9.68e-2)" "unprognostic (1.53e-1)" "unprognostic (5.27e-2)" "unprognostic (3.98e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.71e-1)" "unprognostic (2.98e-2)" "unprognostic (4.16e-2)" "unprognostic (1.06e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (2.78e-6)" "unprognostic (2.13e-2)" "unprognostic (2.00e-1)" "unprognostic (5.69e-3)" "unprognostic (2.30e-2)" 35.9 23.6 17.2 32.0 21.1 43.0 34.2 17.7 16.8 19.6 22.3 11.7 18.0 15.8 20.6 21.8 23.2 20.9 25.1 18.4 16.2 17.2 22.7 37.2 35.4 28.8 20.1 12.7 19.7 15.4 17.0 33.3 41.7 18.2 26.0 21.5 15.7 21.9 15.5 49.5 21.4 22.6 32.2 21.3 42.1 18.2 13.5 19.1 29.2 29.0 25.1 29.0 37.3 38.6 22.4 20.7 54.0 27.9 13.3 28.1 14.7 12.1 7.7 10.2 11.6 29.9 39.5 14.7 17.4 27.5 12.7 19.3 9.5 15.9 17.3 12.7 20.7 8.7 8.7 6.3 13.6 19.3 39.9 6.6 9.3 7.5 24.2 24.4 15.4 10.4 31.6 21.9 19.3 15.1 22.4 32.6 9.9 9.3 22.7 24.4 9.2 9.2 15.5 5.9 13.0 7.0 5.4 15.1 11.2 28.8 19.8 8.7 10.2 11.3 13.4 18.8 15.1 5.6 18.9 34.3 16.1 9.8 8.1 10.4 15.4 14.2 26.2 21.3 12.2 12.2 28.1 21.6 26.4 12.1 25.1 18.5 22.1 19.5 17.5 20.7 22.4 12.9 13.2 54.0 13.3 27.9 12.1 28.1 14.7 17.2 21.1 17.7 16.8 16.2 17.2 20.1 12.7 18.2 19.1 53.6 61.0 77.0 96.8 53.1 31.6 23.2 20.4 58.9 56.9 43.6 11.8 35.7 51.4 53.0 11.7 37.9 37.3 23.3 35.6 75.1 64.1 65.4 57.8 52.3 41.5 20.6 45.5 25.8 73.5 7.0 48.9 97.6 69.2 219.2 26.2 31.1 45.1 43.2 24.8 37.4 33.3 25.8 47.6 43.1 31.7 53.2 112.8 82.3 27.5 129.1 TAOK2 "KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2" ENSG00000149930 "TAO kinase 2" Q9UL54 16 29973641-29992261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ito cells: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010650 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA010650: AB_1080204" "unprognostic (7.30e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.51e-4)" "prognostic favorable (3.87e-5)" "unprognostic (8.46e-2)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.01e-2)" "unprognostic (1.60e-1)" "prognostic favorable (4.78e-4)" "unprognostic (3.85e-3)" "prognostic favorable (3.66e-4)" "unprognostic (7.42e-3)" "unprognostic (3.17e-1)" "unprognostic (7.47e-2)" "unprognostic (1.37e-1)" 27.8 24.1 26.2 15.1 26.7 12.3 17.7 29.2 30.6 13.5 13.6 21.5 11.8 18.5 16.8 13.0 12.4 14.1 15.1 17.6 25.0 18.2 13.9 10.4 23.0 14.4 22.1 22.7 15.8 16.3 26.2 18.7 22.5 20.7 13.6 9.6 15.0 17.1 15.9 22.8 20.0 19.3 14.8 14.9 26.3 16.0 21.2 20.2 14.0 15.9 9.8 11.5 12.8 18.0 2.6 3.3 4.8 2.8 2.0 3.2 2.0 11.2 21.5 11.8 18.6 13.9 9.3 18.1 20.7 11.1 14.0 13.1 17.2 15.1 12.2 17.6 14.9 9.4 17.6 10.7 10.4 7.6 18.9 22.7 13.1 21.7 17.2 10.1 12.9 25.3 10.9 9.1 14.9 6.0 9.8 23.4 11.7 11.8 12.4 13.3 20.8 15.0 18.3 11.4 8.4 14.5 27.7 17.1 11.3 8.8 10.6 13.9 11.2 11.8 15.8 6.2 7.9 19.8 14.6 32.6 24.2 11.2 17.1 11.9 18.1 11.6 11.5 14.8 14.8 17.6 1.3 2.8 1.5 2.9 2.7 3.1 2.0 2.9 2.6 1.8 2.6 1.6 1.4 4.8 2.0 1.4 3.3 3.2 2.0 26.2 26.7 29.2 30.6 25.0 18.2 22.1 22.7 20.7 20.2 8.9 11.5 2.2 4.2 9.5 13.3 8.1 5.1 4.0 7.9 8.7 37.3 6.7 1.7 7.6 3.1 27.6 23.3 0.0 10.2 4.8 9.3 5.8 3.5 9.7 8.4 9.5 12.6 44.2 12.4 2.1 11.5 5.5 6.8 4.6 14.9 8.7 12.7 14.2 12.0 6.4 19.2 6.5 7.6 21.1 17.2 8.4 10.1 9.2 13.3 5.7 TAS2R5 T2R5 ENSG00000127366 "Taste 2 receptor member 5" Q9NYW4 7 141790217-141791367 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 8.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 10.6" HPA053742 Approved "Nucleoplasm,Nucleoli,Cytoplasmic bodies" NA NA "Nucleoplasm, Nucleoli" "Cytoplasmic bodies" "HPA053742: " "unprognostic (5.48e-3)" "unprognostic (3.90e-3)" "unprognostic (6.07e-2)" "unprognostic (8.00e-3)" "unprognostic (7.56e-2)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.71e-1)" "unprognostic (2.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.13e-5)" "unprognostic (1.13e-2)" "unprognostic (8.29e-7)" "unprognostic (1.29e-1)" "unprognostic (3.28e-1)" "unprognostic (6.92e-2)" "unprognostic (1.39e-2)" 1.0 1.0 0.4 1.4 1.1 0.2 3.2 4.9 0.7 2.5 0.9 0.8 2.8 6.1 1.1 3.0 0.8 0.8 0.6 0.7 1.0 0.5 1.1 1.2 0.4 4.6 1.5 0.1 2.9 1.0 1.7 1.2 1.6 1.0 2.6 8.8 1.7 1.2 1.2 1.9 0.7 1.4 1.7 1.2 1.3 2.4 1.0 0.6 0.5 0.2 0.4 1.4 0.1 0.5 0.2 1.4 0.6 0.9 2.7 1.7 0.6 0.6 0.5 0.9 2.1 0.4 1.1 0.9 0.3 0.0 0.3 1.5 0.8 0.3 0.6 1.7 0.3 1.2 2.7 0.9 1.7 1.3 2.3 10.6 1.2 2.9 3.0 1.0 1.5 2.6 0.4 0.1 1.7 0.6 3.9 1.3 0.2 0.3 0.2 0.1 2.8 0.4 0.7 2.0 1.3 0.3 0.4 0.2 1.7 0.1 0.4 0.3 1.0 0.7 0.6 1.2 1.9 0.4 1.4 0.8 0.8 0.5 0.5 0.2 0.0 1.0 0.0 0.0 0.9 0.3 0.4 0.0 1.0 0.9 1.4 0.0 0.4 0.0 0.6 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D1 "KIAA1108, TBC, TBC1" ENSG00000065882 "TBC1 domain family member 1" Q86TI0 4 37891087-38139175 "Predicted intracellular proteins, Transporters" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Smooth muscle cells: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 78.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041816, HPA058158" Approved Approved Nucleoli NA NA Nucleoli "HPA041816: AB_10796784, HPA058158: " "unprognostic (3.77e-2)" "unprognostic (3.44e-1)" "unprognostic (1.14e-2)" "unprognostic (1.06e-1)" "unprognostic (5.18e-2)" "unprognostic (1.32e-1)" "unprognostic (1.01e-2)" "prognostic unfavorable (5.22e-4)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (1.22e-1)" "unprognostic (9.42e-2)" "prognostic favorable (1.47e-8)" "unprognostic (1.49e-2)" "unprognostic (1.14e-1)" "unprognostic (1.41e-2)" "unprognostic (1.21e-1)" 13.6 3.7 9.3 19.8 8.3 19.0 9.8 9.5 8.4 36.0 48.9 7.1 24.5 10.2 63.4 16.5 14.9 22.9 30.6 24.0 7.5 6.0 29.0 8.8 13.3 16.6 7.0 7.6 16.1 9.4 55.9 8.0 32.4 7.4 18.0 9.8 18.2 8.3 28.1 41.9 5.6 15.1 31.6 7.4 21.2 18.1 15.6 5.4 30.4 26.1 23.1 13.3 27.2 26.8 6.0 4.8 14.0 16.7 6.2 4.3 2.2 5.7 6.6 12.1 13.0 4.3 12.2 10.4 15.8 26.5 14.9 15.3 3.8 18.9 29.7 3.9 10.5 18.9 0.3 9.1 11.4 23.1 2.3 5.2 11.4 4.6 7.9 7.0 21.1 13.1 14.7 2.3 9.2 6.4 12.5 22.9 20.9 13.9 5.1 15.5 4.4 29.3 19.9 6.8 0.9 6.0 26.1 19.7 8.6 12.3 10.7 10.6 9.5 5.8 5.4 6.6 28.6 5.3 16.4 15.6 19.8 22.5 4.9 22.8 12.6 15.5 78.1 8.6 19.4 17.4 1.9 5.0 14.0 2.6 15.6 4.3 4.8 2.6 2.2 4.8 6.0 2.4 3.0 13.9 6.2 16.7 4.2 2.1 2.2 9.3 8.3 9.5 8.4 7.5 6.0 7.0 7.6 7.4 5.4 11.9 7.0 34.9 12.1 7.0 10.8 58.5 20.4 2.7 6.8 26.2 0.0 18.0 64.6 13.4 22.1 27.3 14.6 23.3 34.7 22.8 13.9 30.2 2.3 16.1 28.6 9.5 42.5 20.9 50.5 34.2 21.6 33.1 10.1 36.1 9.0 9.3 33.5 11.9 18.7 55.2 0.9 38.8 93.2 10.3 20.6 7.5 24.4 26.2 9.9 26.3 TBC1D13 FLJ10743 ENSG00000107021 "TBC1 domain family member 13" Q9NVG8 9 128787204-128810432 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "monocytes: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045865 Approved Approved Nucleoli No No Nucleoli "HPA045865: AB_10965700" "unprognostic (1.22e-1)" "unprognostic (1.32e-1)" "unprognostic (1.98e-3)" "unprognostic (1.98e-2)" "unprognostic (2.74e-1)" "unprognostic (3.75e-2)" "unprognostic (1.64e-3)" "unprognostic (2.16e-2)" "unprognostic (4.23e-2)" "unprognostic (4.29e-2)" "prognostic favorable (3.14e-6)" "unprognostic (1.82e-2)" "prognostic favorable (1.58e-7)" "unprognostic (1.72e-2)" "unprognostic (1.77e-1)" "unprognostic (8.33e-2)" "unprognostic (1.68e-1)" 12.5 17.4 23.0 8.3 20.8 12.1 10.1 12.0 24.7 9.8 10.7 17.3 8.4 11.7 13.3 14.2 8.4 14.7 10.9 13.4 17.8 18.5 26.0 8.9 10.5 11.0 13.9 12.7 19.3 11.3 30.2 9.7 9.5 14.9 11.6 8.2 12.5 16.9 14.3 16.6 11.6 13.0 12.6 8.7 12.0 11.2 8.1 13.3 8.6 14.1 7.6 11.2 11.2 8.5 5.0 9.0 15.7 2.8 3.4 5.6 3.4 6.3 15.2 16.0 16.0 20.8 10.1 15.6 15.2 13.1 15.8 10.3 16.5 8.5 10.6 10.6 18.0 15.8 17.2 9.7 12.1 9.4 8.4 11.1 11.4 17.8 15.1 12.9 17.1 23.3 14.1 14.4 13.7 8.3 14.1 20.3 11.4 17.5 7.2 18.8 13.6 10.3 10.2 15.2 17.6 23.0 11.7 14.8 24.1 11.6 8.3 16.2 11.3 21.2 13.6 8.9 16.3 14.5 16.1 16.0 19.9 12.5 16.1 12.3 9.3 11.9 10.5 14.5 10.3 14.2 15.7 2.7 4.6 4.9 2.8 4.9 5.0 3.8 4.7 3.1 4.0 3.3 5.6 2.2 3.4 2.1 9.0 2.8 3.4 23.0 20.8 12.0 24.7 17.8 18.5 13.9 12.7 14.9 13.3 3.0 7.0 4.2 2.6 2.1 8.3 8.9 0.0 4.0 3.4 15.7 9.8 4.3 8.3 5.6 1.3 9.5 7.8 0.0 8.6 4.1 5.7 2.8 8.1 11.6 14.2 6.4 5.2 16.0 8.6 2.3 8.6 4.1 0.0 87.4 6.1 6.7 6.8 7.0 7.1 24.8 5.8 6.5 3.5 5.1 9.3 2.8 2.1 5.0 6.0 2.0 TBCA ENSG00000171530 "Tubulin folding cofactor A" O75347 5 77691166-77868780 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 1097.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036487 Approved Supported Nucleoli,Microtubules NA NA 1000000 Microtubules Nucleoli "HPA036487: AB_10669794" "unprognostic (2.03e-2)" "unprognostic (2.12e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-2)" "unprognostic (2.06e-1)" "unprognostic (1.78e-2)" "unprognostic (4.95e-2)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (5.68e-2)" "unprognostic (4.67e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" "unprognostic (7.63e-2)" "unprognostic (2.66e-1)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" 40.5 77.3 50.0 32.5 66.7 41.2 108.9 46.8 86.9 33.0 35.7 22.1 34.1 31.8 37.5 78.5 44.4 43.0 27.1 76.7 69.2 56.5 57.7 85.1 59.8 69.6 51.0 50.8 62.3 80.7 24.0 57.9 36.7 77.9 39.1 33.2 30.6 37.3 36.8 43.4 24.6 31.0 62.4 117.9 30.3 38.9 31.2 29.0 26.7 39.8 35.2 40.7 33.3 35.4 53.6 63.1 20.9 39.2 30.9 57.8 34.8 60.2 42.0 77.2 76.1 34.4 49.0 42.2 51.3 44.1 55.9 64.4 57.5 66.6 93.3 94.1 28.8 81.9 37.5 47.7 65.5 55.4 43.4 76.4 44.3 45.2 63.2 50.4 38.3 37.0 49.1 51.7 39.8 61.6 55.3 47.8 77.4 46.1 58.5 50.3 53.5 80.5 92.0 47.4 17.0 38.6 54.5 64.5 99.7 54.1 54.0 74.5 48.5 49.3 34.9 92.2 69.7 49.5 97.1 44.5 28.8 32.0 50.6 80.4 48.4 46.6 81.4 65.6 66.2 57.1 13.9 34.9 18.2 35.9 36.7 40.4 53.6 43.0 42.4 42.4 49.0 41.3 52.0 20.9 30.9 39.2 63.1 57.8 34.8 50.0 66.7 46.8 86.9 69.2 56.5 51.0 50.8 77.9 29.0 142.9 126.0 317.1 216.5 187.4 175.0 82.6 310.8 251.6 117.2 287.9 55.0 354.5 608.5 336.6 34.6 194.4 208.5 233.6 337.0 312.3 228.2 275.0 154.8 1097.6 351.6 139.8 243.5 299.6 467.9 22.5 283.9 268.6 214.2 303.0 234.6 152.1 407.1 224.7 243.3 722.7 101.8 232.8 249.2 165.4 125.2 197.6 471.5 186.9 246.2 247.1 TBL1X "EBI, TBL1" ENSG00000101849 "Transducin beta like 1 X-linked" O60907 X 9463295-9741037 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Congenital hypothyroidism, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 65.3;Hepatocytes: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 17.3" "Low cell line specificity" "Detected in many" "CAB005363, HPA067703" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "CAB005363: AB_2240272, HPA067703: AB_2685892" "prognostic unfavorable (8.50e-4)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (2.89e-2)" "unprognostic (2.44e-1)" "unprognostic (1.40e-2)" "unprognostic (2.21e-3)" "unprognostic (3.09e-1)" "unprognostic (2.70e-1)" "unprognostic (3.27e-1)" "prognostic favorable (1.32e-4)" "unprognostic (2.66e-1)" "prognostic favorable (4.58e-4)" "unprognostic (6.71e-2)" "unprognostic (6.38e-2)" "unprognostic (3.40e-3)" "unprognostic (1.53e-1)" 6.5 7.1 10.1 6.0 12.3 4.5 8.1 3.3 8.1 21.4 7.9 13.2 18.0 2.1 33.0 26.4 8.3 12.4 6.7 5.2 8.6 9.0 12.5 11.0 5.2 9.5 7.6 6.0 13.8 11.3 21.0 24.3 14.5 7.5 24.7 4.1 9.8 5.5 33.0 4.9 5.8 4.2 22.4 9.0 5.7 7.0 9.9 8.5 14.7 9.4 3.4 7.1 15.3 24.5 3.2 3.1 17.3 4.2 0.3 3.1 1.7 0.0 13.5 8.6 22.9 8.0 8.4 8.5 5.2 11.6 10.0 10.5 10.1 9.3 14.3 0.3 10.3 4.3 3.1 18.8 4.0 14.6 5.9 9.2 9.0 16.5 11.8 11.3 3.2 32.3 7.4 4.7 10.4 5.5 5.4 9.2 7.9 15.7 25.0 5.7 11.4 7.8 12.1 17.1 6.4 14.5 17.6 6.8 17.6 13.5 7.6 11.0 5.0 12.5 3.1 7.4 23.6 6.1 7.0 13.3 3.5 8.7 0.3 2.0 15.3 11.8 11.4 12.9 7.8 3.3 4.4 4.2 4.9 2.1 2.6 1.7 2.0 1.6 1.9 3.1 3.2 3.1 2.8 17.3 0.3 1.7 0.3 2.5 1.7 10.1 12.3 3.3 8.1 8.6 9.0 7.6 6.0 7.5 8.5 0.0 5.0 15.2 9.4 5.8 11.5 9.5 22.9 12.0 6.8 29.6 21.6 65.3 11.6 9.9 0.8 9.4 2.6 0.0 6.7 2.4 10.0 18.9 10.5 59.7 10.0 6.4 21.9 11.6 32.3 1.7 13.3 19.9 5.0 10.8 4.8 38.8 8.5 3.5 26.9 17.0 22.7 0.0 25.9 1.4 17.9 10.8 37.6 10.7 4.7 22.3 TBL3 "SAZD, UTP13" ENSG00000183751 "Transducin beta like 3" Q12788 16 1972037-1982933 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 84.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042562, HPA055695" Enhanced Supported Enhanced Nucleoli NA NA Nucleoli "HPA042562: AB_10964911, HPA055695: AB_2682888" "unprognostic (1.96e-1)" "unprognostic (5.49e-3)" "unprognostic (8.49e-2)" "unprognostic (1.56e-1)" "unprognostic (4.67e-1)" "unprognostic (2.65e-1)" "unprognostic (2.97e-2)" "unprognostic (1.17e-1)" "unprognostic (3.78e-2)" "unprognostic (8.03e-2)" "unprognostic (2.14e-2)" "unprognostic (8.32e-2)" "prognostic favorable (7.33e-4)" "unprognostic (3.65e-2)" "unprognostic (1.87e-1)" "unprognostic (2.32e-1)" "unprognostic (3.77e-1)" 8.9 7.9 6.0 9.5 8.3 6.0 5.8 16.3 9.6 6.2 6.8 8.8 6.8 7.7 7.1 6.3 9.4 5.4 6.0 7.5 6.6 6.1 7.2 8.7 6.9 7.2 7.0 7.3 7.7 8.9 10.5 5.5 7.3 5.7 5.7 3.6 5.6 10.5 6.0 18.2 9.5 7.8 5.9 4.8 6.7 9.5 20.5 6.5 9.5 7.2 11.5 9.3 5.1 5.4 8.5 11.2 5.8 12.0 14.8 12.1 8.5 5.6 10.9 3.0 5.9 3.0 2.4 9.8 5.2 3.4 4.5 3.7 13.9 10.8 7.5 12.2 3.9 4.1 15.2 4.8 6.0 2.4 5.5 6.9 4.7 5.5 5.2 3.4 8.1 4.5 2.4 4.6 5.6 3.3 3.6 5.6 4.6 9.5 5.5 2.6 9.0 10.3 4.5 7.1 5.0 4.4 18.1 5.5 12.5 2.2 2.1 7.0 5.4 4.7 12.1 4.4 3.1 9.1 5.5 8.7 6.2 7.4 5.5 10.0 10.1 4.4 11.8 3.6 5.2 7.1 4.8 10.2 5.8 12.1 12.0 10.7 7.5 8.9 11.8 11.2 8.5 11.4 8.6 2.5 14.8 11.7 5.7 9.6 8.5 6.0 8.3 16.3 9.6 6.6 6.1 7.0 7.3 5.7 6.5 3.0 9.8 7.5 13.4 11.6 12.1 14.3 7.6 4.0 10.3 17.4 7.9 22.6 6.6 21.3 84.6 9.2 22.2 0.0 19.4 20.7 8.2 12.3 14.9 12.4 17.7 9.5 13.3 8.6 9.7 53.2 13.8 9.8 6.8 29.7 13.7 16.1 19.6 20.1 10.3 13.0 8.7 25.8 9.9 14.4 17.7 15.9 18.8 10.9 15.4 12.4 TBPL1 "STUD, TLF, TLP, TRF2" ENSG00000028839 "TATA-box binding protein like 1" P62380 6 133952170-133990432 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 221.6;Spermatocytes: 178.1;Syncytiotrophoblasts: 204.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071810, HPA071813" Enhanced Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA071810: AB_2686451, HPA071813: AB_2686452" "unprognostic (2.21e-3)" "unprognostic (1.95e-2)" "unprognostic (5.11e-2)" "unprognostic (6.67e-3)" "prognostic favorable (7.22e-4)" "unprognostic (5.16e-3)" "prognostic unfavorable (7.91e-5)" "unprognostic (1.19e-1)" "unprognostic (3.94e-2)" "unprognostic (4.66e-2)" "prognostic favorable (7.23e-4)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.14e-4)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.82e-1)" "unprognostic (8.16e-2)" 7.1 7.7 10.8 8.9 11.7 19.3 12.2 16.4 16.6 7.3 7.3 5.2 7.8 8.1 7.9 5.6 7.1 8.5 7.4 7.9 15.9 14.2 5.7 8.5 6.6 12.0 10.0 11.8 8.3 6.0 4.7 8.2 9.2 11.1 8.0 9.3 4.6 5.7 9.2 4.4 5.9 7.7 7.2 8.5 7.6 7.2 71.2 8.0 11.7 10.7 5.0 10.2 9.2 12.0 27.8 14.7 43.1 14.9 21.1 30.8 25.3 6.3 7.8 17.9 11.6 13.7 14.2 10.1 12.1 12.8 16.2 21.3 9.1 5.1 19.8 8.3 9.6 18.0 8.4 11.4 13.0 19.6 15.1 14.2 34.8 4.7 10.0 13.9 18.2 13.6 8.7 13.3 18.1 19.6 12.3 15.3 17.5 50.2 13.6 11.5 14.5 15.2 10.9 20.0 9.3 10.2 10.6 10.8 7.6 9.5 5.7 23.3 23.2 7.1 9.4 14.9 15.6 4.3 7.3 13.8 9.3 13.5 20.5 13.2 11.0 11.9 12.9 15.6 11.9 11.1 43.1 13.7 32.7 28.5 13.8 30.8 27.8 24.1 29.9 12.4 25.0 23.4 27.3 31.4 21.1 14.9 14.7 24.6 25.3 10.8 11.7 16.4 16.6 15.9 14.2 10.0 11.8 11.1 8.0 6.0 12.6 23.3 25.8 62.8 20.7 9.2 20.4 12.0 7.9 7.0 17.7 36.2 24.9 25.0 221.6 33.3 12.0 0.0 22.1 57.3 32.7 32.8 40.3 8.9 21.4 14.3 68.1 17.2 16.7 29.8 19.5 20.0 30.4 19.0 22.4 12.3 24.3 21.0 17.3 18.9 9.4 19.4 34.0 178.1 63.9 57.5 204.8 47.3 23.6 36.7 TCEA1 "GTF2S, SII, TCEA, TF2S, TFIIS" ENSG00000187735 "Transcription elongation factor A1" P23193 8 53966552-54022529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043786 Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA043786: AB_10959468" "unprognostic (5.35e-2)" "unprognostic (9.90e-2)" "unprognostic (2.39e-1)" "unprognostic (2.11e-3)" "unprognostic (3.34e-2)" "unprognostic (1.17e-1)" "unprognostic (3.72e-2)" "unprognostic (1.77e-1)" "unprognostic (4.14e-2)" "unprognostic (1.00e-2)" "unprognostic (1.56e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (3.75e-5)" "unprognostic (3.80e-3)" "unprognostic (1.10e-1)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" 26.7 25.3 30.7 40.5 31.5 29.6 31.1 26.1 27.4 26.0 28.3 21.9 26.6 20.3 27.3 20.9 27.5 23.6 24.7 21.4 27.8 24.2 26.5 56.8 22.3 39.2 29.7 17.6 28.5 38.4 32.2 28.7 21.1 27.1 31.3 22.5 20.6 25.4 25.4 21.8 22.8 22.4 38.9 36.8 30.0 26.1 17.3 31.3 39.9 54.6 18.6 46.9 39.6 37.3 60.0 31.9 20.5 17.8 25.2 40.1 17.8 27.3 27.7 24.8 25.5 17.6 21.9 17.8 21.7 25.5 25.7 28.7 15.8 22.9 67.2 24.7 24.9 27.4 21.1 31.3 19.9 37.5 38.4 15.7 50.8 13.5 23.3 55.3 19.9 21.9 15.7 53.8 24.2 106.8 21.3 21.9 23.2 32.2 58.4 23.3 13.0 41.1 13.9 40.3 44.5 8.3 31.9 8.7 12.0 35.4 18.7 23.3 16.9 17.9 15.8 58.3 24.2 22.8 22.3 19.4 18.9 17.4 21.2 19.5 36.1 22.6 45.5 33.3 22.8 26.6 18.1 17.8 20.5 30.1 16.8 28.6 60.0 31.4 27.7 22.1 44.4 28.0 29.1 6.4 25.2 15.6 31.9 40.1 17.8 30.7 31.5 26.1 27.4 27.8 24.2 29.7 17.6 27.1 31.3 83.4 82.6 150.6 116.2 120.3 70.8 20.7 79.0 139.2 124.0 94.2 84.4 99.1 142.6 96.9 85.2 85.7 52.6 93.5 95.8 104.8 89.7 121.1 94.9 140.5 76.9 54.0 83.7 48.5 68.2 129.1 124.8 89.2 111.3 118.2 83.8 139.0 101.0 71.9 124.8 130.8 97.6 77.6 122.7 77.9 84.3 131.6 93.7 107.1 78.7 109.8 TCF19 SC1 ENSG00000137310 "Transcription factor 19" Q9Y242 6 31158542-31167159 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.3" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 12.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 33.2;GAMG: 19.8;HEK 293: 18.7;JURKAT: 17.0;Karpas-707: 16.2;SCLC-21H: 20.6;U-138 MG: 20.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA065994 Approved Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA065994: " "unprognostic (1.41e-2)" "unprognostic (4.92e-2)" "unprognostic (4.00e-2)" "unprognostic (5.16e-3)" "unprognostic (1.99e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (5.66e-4)" "unprognostic (7.04e-2)" "unprognostic (1.35e-2)" "unprognostic (5.92e-2)" "unprognostic (1.74e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (3.54e-10)" "unprognostic (3.11e-2)" "unprognostic (1.05e-1)" "unprognostic (1.36e-2)" "unprognostic (1.21e-1)" 4.3 1.5 1.3 12.4 4.1 2.3 5.2 8.2 3.9 7.0 5.6 2.3 3.7 9.2 4.2 6.2 11.2 3.2 3.8 3.4 1.7 1.1 4.3 1.6 4.8 18.0 3.0 1.0 4.6 3.6 0.4 0.9 1.5 2.0 5.5 4.0 2.3 4.1 6.7 2.5 11.5 6.0 3.9 1.8 8.6 5.9 3.1 1.8 31.3 2.8 14.4 13.8 4.8 6.7 2.0 0.9 0.2 0.3 1.2 3.8 1.2 33.2 0.3 0.3 0.0 2.3 3.0 0.3 0.2 0.0 0.0 0.0 2.1 0.0 0.0 7.5 8.2 19.8 0.0 0.0 12.4 0.0 0.2 18.7 2.9 1.9 0.8 0.0 0.1 8.8 1.2 0.0 0.9 0.0 1.8 7.4 17.0 0.0 16.2 3.2 0.1 0.4 5.3 0.0 0.0 0.0 0.4 2.0 0.2 2.9 0.1 20.6 0.2 0.2 0.0 0.2 2.7 0.0 2.4 0.0 20.6 0.1 0.1 0.1 5.3 6.0 10.2 0.0 0.1 0.1 0.0 0.3 0.0 0.7 0.0 3.8 1.6 1.9 3.4 0.9 2.0 2.4 0.9 0.2 1.2 0.1 0.0 2.6 1.2 1.3 4.1 8.2 3.9 1.7 1.1 3.0 1.0 2.0 1.8 3.0 1.1 6.0 2.1 4.5 2.6 1.2 0.0 0.0 3.4 3.5 0.0 0.6 6.6 1.6 0.3 3.3 1.1 0.0 1.6 7.2 2.7 1.0 1.1 0.2 7.5 1.6 1.2 1.3 1.9 0.4 4.6 4.3 11.8 10.0 3.3 3.3 0.8 0.0 6.0 0.3 0.5 0.0 6.8 0.5 12.8 3.3 0.3 5.1 7.7 0.9 TCHHL1 "S100A17, THHL1" ENSG00000182898 "Trichohyalin like 1" Q5QJ38 1 152084144-152089064 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 1.7;skin 1: 3.8;tongue: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 59 "SK-BR-3: 10.7" "Not detected" "Not detected" "HPA042579, HPA063483" Enhanced Approved "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane, Nucleoli" "HPA042579: AB_10794283, HPA063483: AB_2685021" "unprognostic (8.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TENM2 "KIAA1127, ODZ2, Ten-M2" ENSG00000145934 "Teneurin transmembrane protein 2" Q9NT68 5 167284799-168264157 "Predicted membrane proteins" "Cell adhesion, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 15.1;heart muscle: 24.7" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 142.6;Horizontal cells: 114.4;Peritubular cells: 58.0" "Cancer enriched" "Detected in many" 6 "head and neck cancer: 15.4" "Region enhanced" "Detected in many" "cerebral cortex: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 26.7;HBEC3-KT: 17.5;HDLM-2: 17.1;U-138 MG: 31.3;U-2 OS: 27.2;U-251 MG: 20.0" "Low region specificity" "Detected in many" "HPA038018, HPA038420, HPA068691" Uncertain Approved Nucleoli No No Nucleoli "HPA038018: , HPA038420: AB_10674682, HPA068691: AB_2686019" "unprognostic (6.00e-2)" "unprognostic (1.50e-1)" "unprognostic (2.94e-2)" "unprognostic (9.16e-3)" "unprognostic (3.88e-3)" "unprognostic (3.81e-3)" "unprognostic (5.81e-2)" "unprognostic (2.41e-1)" "unprognostic (4.62e-2)" "unprognostic (2.10e-2)" "unprognostic (3.68e-3)" "unprognostic (4.34e-2)" "unprognostic (4.69e-5)" "unprognostic (3.47e-2)" "unprognostic (1.03e-1)" "unprognostic (5.16e-4)" "prognostic unfavorable (7.52e-4)" 0.2 0.4 2.5 0.0 3.5 0.0 1.8 0.5 15.1 0.6 0.3 0.0 0.0 0.3 0.2 0.4 1.4 0.2 0.3 24.7 6.5 0.9 2.7 1.2 0.3 0.0 0.5 1.7 0.7 0.2 0.0 0.4 0.0 2.3 2.2 0.0 0.2 0.3 1.0 0.2 2.3 0.2 0.0 0.6 0.2 0.3 1.2 0.4 0.0 0.4 0.0 0.9 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.7 0.0 0.0 0.0 0.0 26.7 0.7 0.0 0.0 17.5 0.3 17.1 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.3 3.1 0.1 2.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 4.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.0 1.5 0.0 0.0 31.3 27.2 0.0 20.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.5 0.5 15.1 6.5 0.9 0.5 1.7 2.3 0.4 0.0 0.0 0.0 0.7 13.2 9.5 142.6 0.0 0.0 1.2 0.0 17.7 0.0 0.0 2.5 20.1 1.3 0.1 0.0 0.2 0.0 0.7 1.1 1.1 4.2 0.1 114.4 0.0 0.0 0.0 13.2 4.0 0.0 1.7 0.0 0.3 2.1 0.0 0.0 58.0 0.0 1.6 0.0 1.7 0.9 1.1 1.5 0.0 0.0 0.0 0.1 TERB2 "C15orf43, MGC33951" ENSG00000167014 "Telomere repeat binding bouquet formation protein 2" Q8NHR7 15 44956702-44979229 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 51.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041780 Uncertain Nucleoplasm,Nucleoli No NA Nucleoli Nucleoplasm "HPA041780: AB_10796460" "unprognostic (1.42e-3)" "unprognostic (4.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX264 "FLJ13935, ZSIG11" ENSG00000164081 "Testis expressed 264" Q9Y6I9 3 51662693-51704323 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 310.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005002, HPA017739" Enhanced Approved Nucleoli,Cytosol "Secreted - unknown location" NA NA "Nucleoli, Cytosol" "CAB005002: AB_425976, HPA017739: AB_1857910" "unprognostic (2.80e-3)" "unprognostic (1.05e-2)" "unprognostic (2.69e-1)" "unprognostic (2.79e-3)" "unprognostic (8.11e-2)" "unprognostic (8.26e-3)" "unprognostic (2.05e-1)" "unprognostic (3.06e-3)" "unprognostic (2.30e-1)" "unprognostic (5.19e-2)" "prognostic favorable (5.67e-4)" "unprognostic (1.83e-1)" "prognostic favorable (7.95e-9)" "unprognostic (4.99e-2)" "unprognostic (3.65e-1)" "unprognostic (3.17e-1)" "unprognostic (4.67e-2)" 15.7 34.6 15.1 15.3 18.7 9.0 20.0 8.6 22.8 17.5 21.3 15.0 36.0 18.7 20.1 25.5 17.7 21.9 24.8 19.0 14.6 15.6 35.9 30.7 17.0 22.6 15.7 17.9 15.8 29.0 29.9 12.3 24.5 12.2 20.3 16.7 22.6 43.6 44.3 16.3 29.5 20.8 16.6 15.8 18.6 19.0 90.8 11.5 16.6 33.9 18.5 15.9 16.7 16.3 33.1 34.5 24.7 36.7 22.8 50.7 41.1 11.8 21.8 3.9 20.1 40.7 19.8 8.0 10.2 24.2 17.0 17.2 11.6 28.2 17.1 7.5 14.6 28.8 11.6 11.0 20.6 8.3 13.7 17.6 16.3 13.6 15.4 36.3 10.2 18.3 26.1 32.9 19.2 19.7 15.5 12.4 13.0 8.5 29.9 17.5 13.7 16.3 23.8 4.3 19.6 24.5 7.9 5.2 32.2 26.8 16.5 5.6 9.2 12.5 34.5 15.7 5.6 16.8 21.7 9.1 17.2 7.2 18.0 13.5 20.9 22.5 8.4 21.0 21.6 17.1 24.7 36.7 21.7 41.9 36.7 41.9 32.2 43.5 39.7 34.5 33.1 36.5 37.0 7.7 22.8 34.7 30.5 50.7 41.1 15.1 18.7 8.6 22.8 14.6 15.6 15.7 17.9 12.2 11.5 32.8 15.0 27.5 46.0 30.9 30.1 22.8 53.5 25.4 28.4 94.2 55.0 125.5 53.0 63.6 30.2 49.7 69.9 0.0 67.2 73.8 45.6 36.2 16.1 51.7 92.2 39.7 31.6 28.3 36.7 48.4 47.2 49.0 62.4 55.9 51.0 59.8 56.9 65.4 46.0 101.0 46.9 25.8 20.0 310.0 58.8 30.9 63.8 52.4 81.7 32.5 TFF3 "HITF, ITF" ENSG00000160180 "Trefoil factor 3" 21 42311667-42315651 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 230.9;thyroid gland: 258.3" "Cell type enriched" "Detected in many" 21 "Mucus-secreting cells: 36697.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 30 "eosinophil: 9.5" "Lineage enriched" "Detected in single" 63 "granulocytes: 9.5" "Cell line enhanced" "Detected in some" "MCF7: 28.4;OE19: 44.4;SCLC-21H: 8.7;T-47d: 13.3;TIME: 36.9" "Region enriched" "Detected in single" 20 "cerebellum: 1.7" "Not detected" "Not detected" "CAB020681, HPA035464" Enhanced Approved Nucleoplasm,Nucleoli "Secreted to blood" No NA 151000000 Nucleoplasm Nucleoli "CAB020681: , HPA035464: AB_2674636" "unprognostic (2.84e-2)" "unprognostic (3.61e-3)" "unprognostic (1.07e-1)" "prognostic favorable (5.60e-6)" "unprognostic (1.28e-1)" "unprognostic (2.35e-2)" "unprognostic (2.13e-1)" "unprognostic (5.03e-2)" "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (3.71e-1)" "unprognostic (6.90e-2)" "unprognostic (4.31e-2)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" "unprognostic (3.86e-2)" 2.2 1.2 0.2 16.8 0.2 0.0 4.3 0.2 0.2 45.1 66.3 0.2 0.5 40.8 2.8 1.2 5.1 8.0 230.9 0.7 0.2 0.3 1.0 0.6 12.6 0.6 0.4 0.2 2.0 4.8 0.0 0.5 0.5 0.2 3.6 63.3 0.3 54.8 0.7 0.6 1.6 70.6 1.5 0.5 5.0 1.1 0.4 0.2 0.3 258.3 14.4 72.6 1.1 1.6 0.0 0.0 9.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 28.4 0.0 0.5 0.1 44.4 4.3 0.0 3.2 0.3 0.0 0.0 8.7 0.1 0.0 0.8 0.0 0.0 13.3 0.0 36.9 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.4 0.2 0.2 0.2 14.9 22.3 0.9 17.0 37.0 0.0 13.4 1110.8 464.4 316.2 21.0 0.0 0.3 0.0 9.0 0.0 51.4 1768.3 0.0 62.1 0.6 20.3 103.0 60.8 0.9 1.9 4.8 740.8 82.9 2.6 0.8 2.3 2.5 91.1 0.0 36697.4 0.0 28.0 1779.2 7.4 0.0 0.0 0.0 6.1 0.3 0.3 33.8 0.7 1.0 1243.2 29.6 TGDS "SDR2E1, TDPGD" ENSG00000088451 "TDP-glucose 4,6-dehydratase" O95455 13 94574051-94596257 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039927, HPA040857" Approved Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoplasm "Nucleoli, Cytosol" "HPA039927: AB_10795238, HPA040857: AB_10794867" "unprognostic (4.07e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (2.87e-1)" "unprognostic (9.99e-2)" "unprognostic (1.96e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (5.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-2)" "unprognostic (1.09e-1)" 11.1 12.2 7.9 11.4 11.8 5.8 13.4 8.0 7.8 11.9 9.0 9.0 13.4 11.1 13.7 13.2 10.3 10.5 8.7 7.7 7.0 7.0 11.8 31.9 7.8 12.5 11.8 6.8 13.9 14.1 6.2 24.3 10.8 10.1 10.5 10.6 15.4 12.5 12.7 7.6 7.9 11.1 10.3 12.6 11.9 9.8 7.2 12.6 27.1 15.8 8.9 12.5 10.9 9.2 9.9 8.0 10.5 7.0 10.4 17.4 6.7 7.4 3.1 5.2 4.7 7.7 6.2 6.5 6.8 6.5 6.4 6.2 8.5 7.3 11.4 6.9 4.7 4.2 4.7 9.2 5.3 6.6 9.0 3.6 9.2 3.6 7.9 9.8 31.4 6.3 7.2 4.2 3.6 10.3 5.1 5.9 8.4 9.0 4.0 5.8 4.5 8.6 16.2 6.9 12.0 4.0 7.3 5.3 6.7 8.1 3.3 7.4 4.1 5.1 10.8 19.0 9.1 4.8 17.1 5.5 2.6 6.8 3.9 5.6 9.1 4.9 42.1 7.0 11.7 7.0 10.5 5.3 9.6 9.6 6.2 14.5 9.9 11.3 10.5 8.0 7.3 17.4 12.4 1.5 10.4 7.0 7.1 12.5 6.7 7.9 11.8 8.0 7.8 7.0 7.0 11.8 6.8 10.1 12.6 11.9 5.0 15.6 9.5 2.2 4.5 4.7 0.0 10.7 10.3 7.0 2.0 12.9 8.3 9.8 1.1 6.3 5.5 0.0 8.0 15.4 12.0 9.9 10.5 19.8 10.0 1.6 5.2 9.2 7.6 0.4 13.3 9.6 8.5 12.6 8.1 6.3 8.2 7.0 7.8 13.3 4.0 25.8 6.4 12.0 10.4 3.1 8.7 8.7 8.0 8.7 THAP3 ENSG00000041988 "THAP domain containing 3" Q8WTV1 1 6624866-6635586 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067114 Approved Approved Nucleoplasm,Nucleoli,Mitochondria No No Nucleoplasm "Nucleoli, Mitochondria" "HPA067114: AB_2685782" "unprognostic (1.82e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.89e-2)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (2.14e-3)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (4.63e-2)" "unprognostic (3.50e-3)" "unprognostic (4.30e-2)" "unprognostic (1.11e-2)" "unprognostic (4.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.67e-1)" "unprognostic (2.26e-3)" 14.2 17.2 16.4 11.4 16.8 12.9 31.4 21.5 20.3 16.5 16.6 13.8 11.8 12.0 15.2 13.6 11.8 16.3 11.9 19.0 16.0 14.5 17.2 17.3 10.8 15.5 18.1 14.1 23.7 28.8 12.1 14.2 11.4 17.6 17.0 7.2 11.5 24.8 16.7 20.9 14.2 11.4 12.7 13.0 15.3 12.0 11.9 16.3 11.6 22.6 9.0 12.9 17.2 21.6 22.2 18.0 10.6 14.7 17.0 22.0 15.0 9.9 9.4 8.6 12.4 14.3 12.9 8.3 9.0 11.8 24.0 15.0 12.6 6.3 8.8 12.2 9.9 8.9 7.9 13.6 8.0 8.4 15.1 22.3 10.1 12.6 11.2 17.9 7.1 10.5 12.0 10.3 15.1 13.3 14.7 10.3 15.5 10.2 11.4 8.8 6.9 12.4 16.2 7.4 11.7 16.0 11.9 10.5 12.7 10.7 2.4 11.4 12.9 11.0 15.2 20.8 7.5 9.7 12.9 9.3 12.8 7.7 8.7 14.0 12.9 13.7 11.6 10.8 15.4 7.2 10.2 14.7 10.6 20.1 11.7 20.2 17.1 19.7 20.8 18.0 22.2 22.0 18.5 9.0 17.0 9.1 16.4 19.3 15.0 16.4 16.8 21.5 20.3 16.0 14.5 18.1 14.1 17.6 16.3 0.0 6.9 9.8 10.6 12.5 10.9 5.6 7.6 14.7 3.4 8.7 5.9 12.9 16.6 9.6 5.3 14.0 11.6 23.3 9.0 15.6 14.6 13.0 5.7 10.0 13.4 4.8 7.5 10.4 13.2 2.3 17.3 8.3 10.1 22.6 7.7 9.8 9.8 8.4 21.9 15.1 6.9 12.9 20.6 8.1 16.0 12.9 13.7 9.2 11.5 13.7 THTPA THTPASE ENSG00000259431 "Thiamine triphosphatase" Q9BU02 14 23555988-23560271 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028876 Approved Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA028876: AB_10600731" "unprognostic (3.50e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (7.11e-2)" "unprognostic (2.25e-1)" "unprognostic (2.12e-1)" "unprognostic (4.13e-1)" "unprognostic (1.58e-3)" "unprognostic (1.98e-1)" "unprognostic (1.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.70e-9)" "unprognostic (3.47e-2)" "unprognostic (2.32e-1)" "unprognostic (3.62e-2)" "unprognostic (5.40e-2)" 14.9 19.5 27.7 12.2 23.3 7.6 12.9 16.4 24.3 12.3 14.0 20.7 15.9 15.7 13.3 18.4 10.1 17.7 16.8 16.3 23.3 17.4 16.3 12.1 10.7 10.7 21.9 13.3 15.4 12.7 25.0 12.4 7.6 16.1 18.8 12.3 17.1 18.0 23.5 21.9 7.4 11.7 13.7 19.5 11.3 11.6 18.8 14.3 14.1 15.9 12.3 11.2 9.9 7.9 14.3 17.0 11.1 14.4 6.9 11.6 8.7 2.7 17.1 8.4 9.1 19.3 10.9 4.6 8.0 7.1 7.9 7.9 3.5 11.3 5.2 7.0 9.6 9.0 8.5 8.8 10.0 5.9 10.9 9.6 7.0 12.1 9.3 9.8 6.4 6.4 14.8 7.4 12.1 8.9 16.7 9.5 8.4 5.3 11.4 11.5 8.2 10.1 2.6 3.0 14.6 14.6 6.9 5.7 9.4 13.9 5.4 16.2 7.7 7.9 16.2 4.6 5.2 10.8 3.1 7.4 5.2 5.5 10.7 4.7 13.5 8.2 2.9 5.4 2.9 8.0 11.1 14.4 7.3 9.6 10.6 9.5 9.6 6.9 7.5 13.2 14.3 11.6 9.9 1.5 6.9 13.4 17.0 5.4 8.7 27.7 23.3 16.4 24.3 23.3 17.4 21.9 13.3 16.1 14.3 6.0 6.9 15.9 5.8 0.0 27.6 0.0 10.2 5.3 6.8 7.0 7.9 9.0 46.4 13.0 16.7 2.9 8.4 0.0 10.7 4.4 7.2 8.5 23.1 7.6 15.9 7.9 5.8 8.0 10.0 16.8 10.6 8.2 0.0 11.8 6.4 18.8 8.1 8.6 7.1 24.6 9.4 12.9 0.1 19.6 8.7 0.0 5.6 6.4 8.5 5.4 THUMPD3 DKFZP434F091 ENSG00000134077 "THUMP domain containing 3" Q9BV44 3 9362842-9386791 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 224.3;Spermatocytes: 126.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036170, HPA036171" Approved Enhanced Nucleoli,Cytosol No No Cytosol Nucleoli "HPA036170: AB_10671836, HPA036171: AB_2674985" "unprognostic (2.13e-2)" "unprognostic (8.30e-2)" "unprognostic (1.74e-3)" "unprognostic (4.25e-2)" "unprognostic (2.66e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.25e-7)" "unprognostic (6.54e-2)" "unprognostic (1.09e-1)" "unprognostic (2.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "prognostic favorable (1.03e-4)" "unprognostic (1.41e-1)" "unprognostic (4.53e-2)" "unprognostic (4.05e-2)" "unprognostic (1.59e-2)" 17.4 17.2 13.3 12.9 14.8 22.2 14.2 13.4 19.6 15.2 14.4 13.8 12.5 12.8 14.0 15.8 16.5 12.3 10.9 19.3 12.3 13.9 20.7 23.9 11.1 13.5 18.3 11.0 14.3 14.8 22.2 27.8 14.4 23.2 15.9 15.1 14.0 16.1 14.9 29.4 13.4 14.9 12.3 15.8 14.5 12.5 42.8 14.8 22.3 18.2 17.5 13.2 16.2 11.7 13.9 15.4 12.5 19.3 11.7 22.3 10.1 12.8 17.5 12.2 6.4 16.1 15.6 49.2 15.7 12.9 16.0 12.2 13.1 13.6 13.2 12.3 14.2 25.6 8.5 22.3 16.0 16.3 14.7 13.0 16.5 17.7 11.4 15.8 21.0 12.0 12.5 18.2 18.9 19.7 13.0 10.5 21.5 25.9 19.2 21.1 18.2 24.8 9.0 23.5 14.4 17.0 15.8 21.0 18.8 10.5 19.5 5.1 16.5 13.0 9.4 13.9 13.2 15.1 13.6 7.4 15.4 13.3 18.5 17.2 24.6 57.2 42.5 18.7 19.7 22.0 10.6 13.2 12.5 16.2 17.4 21.1 12.3 14.1 16.8 15.0 13.9 22.3 16.8 2.7 11.7 19.3 15.4 13.2 10.1 13.3 14.8 13.4 19.6 12.3 13.9 18.3 11.0 23.2 14.8 23.8 17.9 6.7 21.7 9.5 20.8 43.1 20.4 16.0 29.6 21.0 15.7 29.0 44.7 33.1 224.3 13.1 8.7 0.0 25.5 25.1 18.7 25.5 26.7 23.1 24.1 36.5 2.9 11.6 15.1 105.0 19.0 17.7 11.8 17.2 15.2 28.6 27.1 3.5 24.4 25.2 34.6 6.5 13.4 126.9 51.4 11.3 23.0 15.2 18.8 18.0 TICAM1 "MGC35334, PRVTIRB, TICAM-1, TRIF" ENSG00000127666 "Toll like receptor adaptor molecule 1" Q8IUC6 19 4815932-4831704 "Disease related genes, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Urothelial cells: 129.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042460 Uncertain Uncertain "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA042460: AB_10806240" "unprognostic (2.09e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "prognostic favorable (4.81e-4)" "unprognostic (3.52e-2)" "unprognostic (2.88e-2)" "unprognostic (7.60e-3)" "prognostic unfavorable (3.48e-4)" "unprognostic (9.86e-2)" "unprognostic (1.59e-1)" "unprognostic (6.16e-2)" "unprognostic (2.82e-1)" "unprognostic (4.43e-2)" "unprognostic (2.30e-2)" "unprognostic (5.02e-2)" "unprognostic (3.53e-2)" "unprognostic (6.48e-2)" 10.5 6.9 7.3 9.4 9.5 18.2 9.4 5.9 15.8 10.2 15.4 7.0 3.4 20.3 8.3 5.2 35.6 8.0 11.4 7.7 5.9 5.4 11.0 15.2 14.1 9.0 6.4 6.1 8.0 14.8 4.2 7.8 6.8 7.1 8.2 5.2 6.1 11.8 5.7 15.3 15.8 21.3 5.2 6.5 11.6 15.2 2.8 6.5 4.4 8.5 12.1 21.7 9.3 13.3 5.3 5.0 7.8 9.1 1.5 3.1 5.4 21.3 4.2 0.0 3.7 3.2 4.1 2.0 7.0 7.3 5.7 6.4 4.3 7.7 14.6 4.0 8.1 5.7 14.6 2.0 7.4 2.2 15.6 3.9 3.6 8.5 4.1 9.0 1.3 9.5 6.6 9.3 7.1 5.2 4.4 5.9 5.1 7.8 3.1 3.1 8.0 3.6 0.7 0.6 3.8 16.9 8.1 0.9 9.5 5.1 6.7 2.9 5.5 4.3 13.1 7.2 0.0 5.9 3.0 11.6 7.0 4.8 17.6 10.6 12.7 11.1 10.1 8.1 5.0 5.3 7.8 5.3 2.3 2.6 7.8 2.4 5.3 2.6 3.0 5.0 4.0 1.7 1.0 1.6 1.5 9.1 3.6 3.1 5.4 7.3 9.5 5.9 15.8 5.9 5.4 6.4 6.1 7.1 6.5 6.0 11.1 7.8 63.8 61.6 0.7 2.1 17.8 4.0 9.1 5.2 0.0 5.3 6.6 27.1 0.0 10.5 58.5 0.0 15.3 9.5 9.3 51.3 10.4 12.5 12.1 1.6 28.0 11.1 8.6 0.0 3.4 18.8 13.5 23.4 15.2 0.8 36.4 38.6 4.9 7.0 0.2 6.5 8.9 0.3 1.1 62.2 2.9 7.9 11.0 129.1 TIFA "MGC20791, T2BP, T6BP, TIFAA" ENSG00000145365 "TRAF interacting protein with forkhead associated domain" Q96CG3 4 112274542-112285903 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 46.1;U-266/70: 28.9;U-698: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045889 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoplasm, Nucleoli" Cytosol "HPA045889: AB_10963785" "unprognostic (2.41e-2)" "unprognostic (2.47e-2)" "unprognostic (4.13e-2)" "unprognostic (3.23e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-3)" "unprognostic (1.05e-1)" "unprognostic (2.25e-1)" "unprognostic (2.48e-2)" "unprognostic (2.14e-2)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (6.44e-3)" "unprognostic (1.52e-1)" "unprognostic (2.56e-1)" "unprognostic (2.99e-1)" "unprognostic (8.49e-3)" 5.7 6.4 3.3 16.7 3.8 19.2 7.4 6.1 4.5 7.0 3.9 2.0 8.4 3.4 3.6 2.3 14.3 4.0 4.2 7.9 4.7 2.1 4.1 14.6 6.7 22.9 5.4 1.6 9.2 32.2 4.1 3.3 7.4 3.9 6.6 3.7 5.4 21.3 4.5 4.0 9.0 8.7 4.7 4.0 20.3 7.1 3.0 4.8 12.5 14.8 7.8 23.2 7.2 7.3 23.2 7.0 11.3 3.8 9.1 17.7 6.1 7.0 1.8 2.6 4.4 3.2 2.6 5.3 5.6 10.6 3.6 6.1 0.9 6.3 21.5 4.6 2.2 5.3 2.1 3.6 4.3 7.5 17.4 2.1 2.1 4.3 2.0 2.2 6.7 2.9 3.5 2.4 3.8 4.2 6.1 5.6 6.0 2.1 46.1 4.7 3.5 11.8 3.7 0.5 4.3 2.3 20.6 6.7 14.3 7.9 4.8 6.1 6.3 4.5 9.5 2.2 1.2 4.0 9.7 4.2 5.7 6.7 4.7 4.4 28.9 26.5 39.8 5.3 4.5 4.1 2.9 3.8 2.0 6.3 2.7 10.3 21.2 11.7 11.0 7.0 23.2 5.4 6.6 11.3 9.1 3.2 6.5 17.7 6.1 3.3 3.8 6.1 4.5 4.7 2.1 5.4 1.6 3.9 4.8 17.9 20.6 34.4 9.9 18.9 1.0 14.1 10.2 6.7 11.4 12.2 0.0 42.8 16.6 12.7 0.0 14.5 5.8 0.0 21.2 17.8 22.6 27.2 3.5 8.5 16.0 0.0 8.6 4.9 10.7 0.0 8.3 11.2 32.1 6.4 7.0 11.3 12.9 3.6 10.3 6.3 0.6 6.5 13.4 0.9 3.0 22.7 66.4 27.3 6.5 10.7 TLCD2 ENSG00000185561 "TLC domain containing 2" A6NGC4 17 1702790-1710438 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 59.3;Cone photoreceptor cells: 121.7;Enterocytes: 77.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 4.1;neutrophil: 2.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.1" "Cell line enhanced" "Detected in many" "ASC diff: 6.6;ASC TERT1: 7.7;HaCaT: 6.3;SiHa: 8.3;T-47d: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046063 Uncertain Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA046063: AB_2679520" "unprognostic (1.78e-1)" "unprognostic (6.71e-2)" "unprognostic (2.56e-2)" "unprognostic (1.20e-1)" "unprognostic (8.64e-3)" "unprognostic (1.64e-1)" "unprognostic (3.32e-1)" "unprognostic (4.04e-2)" "unprognostic (7.94e-2)" "unprognostic (7.74e-2)" "unprognostic (2.29e-3)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.36e-5)" "unprognostic (3.77e-2)" "unprognostic (2.82e-1)" "unprognostic (7.79e-2)" "unprognostic (4.44e-2)" 11.3 9.2 0.5 4.7 1.4 1.7 18.4 0.1 1.5 2.7 9.6 0.3 1.7 7.9 1.8 3.1 6.8 2.7 5.6 4.0 0.6 0.4 2.3 14.8 4.6 0.5 1.2 0.4 4.6 1.2 1.5 0.9 1.6 1.9 4.1 5.4 3.0 2.9 3.6 2.2 2.2 18.4 4.3 1.3 1.1 4.5 0.8 0.5 0.3 2.6 1.2 2.7 4.8 6.3 0.7 0.4 4.1 0.4 0.6 0.5 0.1 0.7 1.5 0.8 2.5 6.6 7.7 0.5 1.3 1.3 0.7 0.5 4.7 2.2 0.1 1.4 2.1 0.7 6.3 1.0 0.6 0.5 0.2 1.1 0.6 2.1 0.4 3.8 0.0 1.7 6.2 2.3 0.8 1.5 2.1 0.5 0.1 0.5 0.3 0.6 1.3 0.0 0.3 0.1 2.3 0.4 0.1 3.7 0.1 0.4 2.2 0.1 0.3 8.3 0.7 1.2 1.1 6.7 0.6 1.8 0.4 2.0 1.4 0.3 0.1 0.0 0.1 0.4 0.2 1.0 4.1 0.4 0.6 0.4 0.2 0.2 0.4 0.5 0.2 0.1 0.7 0.4 0.4 2.7 0.6 0.2 0.4 0.2 0.1 0.5 1.4 0.1 1.5 0.6 0.4 1.2 0.4 1.9 0.5 47.6 59.3 1.4 7.6 0.0 8.1 2.8 15.3 36.1 33.0 10.4 121.7 4.1 0.0 5.8 0.6 8.5 77.5 0.0 8.5 2.5 7.7 6.0 15.1 14.9 4.7 0.0 8.6 17.8 3.9 0.9 12.4 4.3 0.0 1.8 22.4 8.8 11.1 38.7 5.3 0.8 50.0 6.5 2.7 0.2 0.9 0.3 3.3 0.7 26.4 11.7 TLDC1 KIAA1609 ENSG00000140950 "TBC/LysM-associated domain containing 1" Q6P9B6 16 84476421-84554033 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 115.8;Rod photoreceptor cells: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041020 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA041020: AB_10794184" "unprognostic (8.35e-3)" "unprognostic (4.27e-2)" "unprognostic (1.48e-1)" "unprognostic (5.45e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-3)" "unprognostic (5.97e-4)" "prognostic unfavorable (1.03e-5)" "unprognostic (3.94e-1)" "unprognostic (2.85e-2)" "prognostic unfavorable (7.05e-5)" "unprognostic (2.92e-2)" "unprognostic (6.78e-3)" "unprognostic (9.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-2)" 5.5 4.9 7.6 7.1 10.7 1.8 7.3 8.1 11.5 8.1 7.1 6.3 5.2 6.0 14.0 8.8 24.4 6.9 6.5 4.7 6.3 4.5 7.6 5.1 6.4 6.1 5.0 9.4 8.7 5.2 11.3 4.4 15.8 10.7 7.8 7.8 12.9 7.7 6.1 4.5 11.0 9.3 10.7 4.0 5.4 6.8 8.1 3.4 8.3 7.6 6.5 10.0 10.4 12.1 3.3 2.7 13.6 3.5 3.1 8.7 2.6 14.7 10.4 9.1 4.9 4.2 7.4 4.3 10.9 9.8 11.3 3.3 5.9 17.9 2.0 5.9 21.0 8.3 16.5 2.5 29.3 14.9 1.1 2.2 1.6 5.1 5.1 5.2 1.2 5.1 5.1 12.7 10.5 13.9 9.2 4.7 5.9 2.7 2.5 7.6 3.5 1.1 1.2 2.8 7.7 3.6 4.5 2.3 0.7 10.0 8.3 3.0 2.1 9.9 7.1 4.9 10.0 10.2 2.0 11.5 7.9 3.6 4.2 4.5 2.0 3.5 5.4 4.7 0.6 2.7 13.6 3.1 4.4 3.8 2.7 3.7 3.3 6.8 5.5 2.7 2.7 7.6 4.7 3.1 3.1 3.5 0.8 8.7 2.6 7.6 10.7 8.1 11.5 6.3 4.5 5.0 9.4 10.7 3.4 3.0 4.5 2.7 8.9 2.1 14.1 3.3 5.1 8.1 6.8 12.2 115.8 28.9 5.0 15.5 1.4 5.8 13.6 0.0 7.5 8.8 5.1 7.2 4.7 1.5 7.3 4.8 2.9 5.5 4.8 1.2 7.5 2.7 3.3 10.8 4.5 8.1 14.4 7.0 5.3 6.1 65.7 0.0 5.1 4.6 3.9 3.0 39.4 3.2 4.8 20.0 TMA16 "C4orf43, FLJ11184" ENSG00000198498 "Translation machinery associated 16 homolog" Q96EY4 4 163494442-163520539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041571, HPA052688" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA041571: AB_10794381, HPA052688: AB_2681916" "unprognostic (6.02e-2)" "unprognostic (1.19e-1)" "unprognostic (4.63e-2)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (2.92e-3)" "prognostic unfavorable (2.70e-5)" "prognostic unfavorable (4.40e-4)" "unprognostic (2.30e-3)" "unprognostic (1.33e-2)" "unprognostic (1.17e-3)" "unprognostic (2.69e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (6.98e-2)" "unprognostic (2.30e-1)" "unprognostic (1.40e-2)" "unprognostic (2.56e-2)" 16.1 13.1 7.1 25.3 9.6 10.2 16.0 8.9 11.5 17.5 11.5 8.9 11.8 9.4 18.5 17.7 16.1 12.8 13.5 12.0 8.7 7.4 13.5 16.8 10.2 22.1 7.6 8.8 16.0 19.3 7.2 12.4 12.6 9.9 11.6 11.0 8.8 16.9 12.2 17.2 15.1 9.8 13.1 11.1 21.1 13.0 30.0 8.5 28.2 10.6 15.0 18.3 15.6 13.5 21.4 28.2 3.3 21.9 13.5 14.0 7.4 15.7 8.3 13.4 12.2 5.6 9.6 13.8 18.5 9.3 10.1 8.6 8.0 21.6 35.0 7.7 9.8 8.3 8.0 15.6 13.2 12.8 18.0 13.4 48.8 7.9 12.7 12.4 38.5 15.2 6.2 12.0 8.5 10.7 8.4 11.0 11.3 17.1 25.7 11.0 14.2 23.1 20.0 14.9 8.6 12.2 22.1 12.7 22.1 8.0 7.8 7.8 11.5 11.7 15.7 13.8 8.9 9.4 15.0 19.3 8.1 15.3 7.7 19.5 18.7 24.0 40.7 16.0 20.5 24.2 3.3 14.5 1.3 7.7 21.9 11.4 21.4 14.0 9.9 16.5 19.9 13.2 11.1 0.5 13.5 17.7 28.2 11.5 7.4 7.1 9.6 8.9 11.5 8.7 7.4 7.6 8.8 9.9 8.5 20.8 28.2 49.6 29.7 29.2 13.2 32.7 50.9 14.7 27.3 31.4 3.9 47.8 54.7 39.8 141.5 25.9 10.6 23.3 60.9 76.4 30.6 17.5 27.8 47.0 32.6 14.3 29.3 38.6 33.4 132.5 51.5 37.8 25.3 35.1 34.4 14.7 45.8 28.1 30.1 37.2 13.4 38.8 30.6 59.7 38.5 34.6 25.5 21.7 37.6 23.0 TMA7 "CCDC72, HSPC016" ENSG00000232112 "Translation machinery associated 7 homolog" Q9Y2S6 3 48440257-48444208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 204.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.10e-2)" "unprognostic (1.18e-2)" "unprognostic (2.06e-1)" "unprognostic (5.02e-2)" "unprognostic (3.55e-2)" "prognostic favorable (8.33e-4)" "unprognostic (1.14e-2)" "unprognostic (3.85e-3)" "unprognostic (1.92e-2)" "unprognostic (2.55e-2)" "unprognostic (1.14e-2)" "unprognostic (9.31e-3)" "unprognostic (3.13e-2)" "unprognostic (1.14e-1)" "unprognostic (8.64e-3)" 38.7 54.0 76.1 41.7 82.7 72.5 49.8 41.7 55.8 35.3 49.0 22.6 44.7 37.8 28.4 72.6 43.0 30.5 40.3 49.8 61.4 61.6 50.3 50.3 36.6 50.3 63.6 46.0 41.7 59.5 21.6 45.4 28.7 53.3 36.9 47.0 39.2 39.6 37.4 107.4 28.4 41.1 36.5 57.4 41.5 39.0 35.0 41.0 37.9 38.3 67.6 56.6 29.9 37.7 125.7 139.0 192.1 98.7 79.4 146.7 204.3 65.2 47.4 76.9 55.0 63.8 62.3 53.0 54.0 42.6 51.8 51.5 38.5 47.3 42.7 38.6 46.9 67.6 25.6 67.0 60.9 57.9 52.5 57.1 80.5 102.1 98.1 49.7 91.3 54.0 57.0 65.5 48.9 47.7 50.8 65.3 76.4 43.0 45.7 73.8 67.6 106.2 124.3 102.5 71.0 76.5 30.4 48.2 72.3 89.0 88.5 25.3 64.3 60.8 44.5 81.2 74.5 42.9 135.7 48.8 44.0 79.1 67.9 105.3 76.3 112.4 102.9 56.4 88.3 45.5 141.0 98.7 192.1 110.7 89.8 119.5 125.7 146.7 132.9 104.9 100.5 146.3 140.0 188.5 79.4 87.7 139.0 143.8 204.3 76.1 82.7 41.7 55.8 61.4 61.6 63.6 46.0 53.3 41.0 223.4 369.4 511.1 446.0 636.3 196.3 594.9 570.7 348.0 349.2 854.9 100.1 706.5 1455.6 502.0 547.1 428.3 899.7 443.9 893.2 693.8 535.7 516.2 437.2 865.9 741.4 112.8 610.5 535.9 636.7 794.0 598.9 617.4 737.2 776.3 895.2 244.7 727.5 821.9 436.7 886.4 223.1 349.3 415.1 507.5 743.5 785.4 368.1 657.2 795.4 485.3 TMEM108 "CT124, MGC3040" ENSG00000144868 "Transmembrane protein 108" Q6UXF1 3 133038391-133397792 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 25.6" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 96.2;Early spermatids: 57.1;Late spermatids: 29.1;Rod photoreceptor cells: 56.3" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 11.8;LHCN-M2: 6.6;SCLC-21H: 10.3;SH-SY5Y: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063350 Enhanced Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "Nucleoli, Vesicles" "HPA063350: AB_2684993" "unprognostic (4.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.00e-2)" "unprognostic (1.92e-2)" "unprognostic (3.07e-3)" "unprognostic (3.17e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.06e-4)" "unprognostic (2.08e-1)" "unprognostic (7.27e-4)" "unprognostic (1.11e-1)" "unprognostic (3.03e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-2)" "unprognostic (6.12e-2)" "unprognostic (1.36e-2)" 2.2 15.1 12.7 2.2 13.8 0.7 2.4 15.6 21.7 3.2 1.8 7.5 0.2 1.1 3.7 1.3 12.7 2.4 1.6 8.4 10.0 8.1 1.0 0.6 12.1 2.5 5.3 13.7 0.8 1.0 6.1 2.8 9.1 4.9 4.0 2.2 16.1 1.8 3.2 25.6 2.2 2.0 10.4 4.4 2.0 2.2 16.8 4.3 0.0 4.1 1.5 3.3 12.0 1.3 0.8 0.4 1.0 0.4 0.6 0.8 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.8 4.0 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.6 0.3 0.0 0.1 1.8 0.0 0.0 0.0 2.3 0.0 0.5 0.0 10.3 45.3 0.0 0.0 0.1 2.8 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.3 0.9 0.0 1.7 1.0 0.3 0.2 0.5 0.3 0.3 0.3 0.2 0.5 0.0 0.8 0.3 0.4 0.9 0.6 0.4 0.4 0.8 0.6 12.7 13.8 15.6 21.7 10.0 8.1 5.3 13.7 4.9 4.3 3.0 2.9 0.0 0.5 2.2 11.4 1.2 0.0 0.0 9.1 0.0 96.2 1.8 0.0 0.0 57.1 1.4 0.0 0.0 0.3 7.2 1.1 0.2 1.1 0.0 0.2 1.6 0.0 0.0 0.0 29.1 0.9 0.0 0.0 0.0 0.0 4.7 0.2 0.0 0.7 0.0 56.3 0.0 1.4 19.1 8.0 1.4 0.9 0.0 0.0 0.3 TMEM151A "MGC33486, TMEM151" ENSG00000179292 "Transmembrane protein 151A" Q8N4L1 11 66291870-66296664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 48.5" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 8.1;Cholangiocytes: 5.1;Horizontal cells: 14.3;Intestinal endocrine cells: 7.5" "Cancer enhanced" "Detected in some" "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041035 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA041035: AB_10794404" "unprognostic (1.20e-1)" "unprognostic (8.24e-3)" "unprognostic (4.80e-2)" "unprognostic (1.75e-2)" "unprognostic (3.44e-1)" "unprognostic (7.60e-2)" "unprognostic (9.48e-3)" "unprognostic (8.57e-2)" "unprognostic (8.73e-4)" "unprognostic (2.41e-3)" "unprognostic (2.02e-2)" "unprognostic (6.11e-3)" "unprognostic (1.69e-3)" "unprognostic (2.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.38e-2)" "unprognostic (2.67e-2)" 1.4 3.8 12.4 1.5 16.8 1.4 1.4 5.9 48.5 1.4 1.5 41.8 0.0 1.5 1.4 1.4 1.4 1.4 2.8 1.6 22.7 14.3 1.4 1.4 1.4 1.4 21.2 13.1 1.5 2.4 1.8 3.3 1.4 22.2 1.4 1.4 1.0 1.5 1.4 1.4 1.4 1.5 1.4 43.2 1.4 3.9 1.6 13.6 0.0 1.4 0.0 1.4 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.6 0.0 1.3 0.0 3.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.0 0.0 18.4 4.2 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.4 16.8 5.9 31.1 22.7 14.3 21.2 13.1 22.2 13.6 0.0 0.0 0.0 0.1 0.0 8.1 0.6 5.1 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 14.3 7.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 TMEM178B DKFZp547G036 ENSG00000261115 "Transmembrane protein 178B" H3BS89 7 141074232-141480380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;parathyroid gland: 20.6;pituitary gland: 18.5" "Group enriched" "Detected in some" 8 "Bipolar cells: 23.0;Cardiomyocytes: 39.1;Horizontal cells: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 7.1;HDLM-2: 6.4;NTERA-2: 6.0;RPTEC TERT1: 9.8;SCLC-21H: 7.7;WM-115: 10.4" HPA048771 Uncertain Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA048771: AB_2680517" "unprognostic (7.33e-3)" "unprognostic (2.02e-2)" "unprognostic (2.83e-2)" "unprognostic (7.79e-4)" "unprognostic (1.94e-1)" "unprognostic (1.49e-1)" "unprognostic (2.95e-1)" "unprognostic (1.69e-2)" "unprognostic (6.94e-2)" "unprognostic (2.21e-2)" "unprognostic (7.17e-4)" "unprognostic (1.05e-1)" "prognostic favorable (4.10e-4)" "unprognostic (2.02e-1)" "unprognostic (1.10e-1)" "unprognostic (5.35e-3)" "unprognostic (8.98e-2)" 0.9 1.7 5.2 0.7 7.4 0.1 0.7 3.2 13.4 0.5 0.8 1.0 2.3 0.1 1.1 0.6 1.8 0.3 0.7 11.6 4.8 5.8 2.9 0.6 0.4 1.5 4.9 1.0 0.2 2.6 20.6 18.5 0.1 1.8 2.8 0.4 0.5 4.4 0.8 4.5 0.2 1.2 1.3 2.4 0.8 0.5 0.8 0.4 1.0 9.5 0.1 3.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.6 0.3 1.8 0.1 2.8 0.8 1.0 0.0 0.0 2.2 2.4 0.2 0.5 0.0 7.1 0.0 2.3 6.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 5.1 0.1 0.0 0.0 6.0 0.0 0.0 0.4 1.1 3.0 9.8 2.8 7.7 4.7 0.1 0.3 1.0 1.5 1.0 0.0 0.0 0.1 1.2 3.2 0.0 0.1 0.0 0.0 0.5 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 7.4 3.2 9.6 4.8 5.8 4.9 1.0 1.8 0.4 0.0 0.0 0.0 0.4 0.5 23.0 39.1 0.0 0.0 0.0 1.8 2.0 0.0 1.7 0.0 0.8 0.1 0.0 0.0 0.3 0.0 0.2 3.1 0.0 0.0 0.1 28.6 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 3.8 1.2 0.0 0.7 2.8 1.6 0.0 0.8 0.5 0.7 0.1 0.2 0.0 0.0 1.6 TMEM187 "CXorf12, DXS9878E, ITBA1" ENSG00000177854 "Transmembrane protein 187" Q14656 X 153972327-153983195 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA038134 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA038134: AB_10669517" "unprognostic (1.51e-1)" "unprognostic (4.35e-2)" "unprognostic (1.41e-1)" "unprognostic (1.28e-1)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (8.94e-2)" "unprognostic (2.41e-1)" "unprognostic (3.09e-1)" "unprognostic (4.22e-2)" "unprognostic (5.33e-2)" "unprognostic (7.41e-2)" "prognostic favorable (9.14e-8)" "unprognostic (6.73e-2)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (7.04e-2)" 8.8 13.0 9.2 6.8 10.2 3.4 10.5 13.2 9.0 7.6 9.0 10.5 13.9 6.8 8.8 9.3 9.5 12.0 6.8 8.1 9.6 6.0 7.6 10.2 7.7 10.2 10.4 9.0 10.9 24.4 7.5 13.0 7.3 11.0 10.3 4.5 6.7 14.1 10.1 8.5 10.7 10.9 6.8 8.0 10.0 8.0 5.9 8.7 8.4 10.8 2.9 9.9 7.9 7.4 13.4 19.6 17.8 9.8 10.1 22.5 10.9 8.4 9.7 2.1 7.7 8.4 7.5 1.2 3.5 1.7 1.0 3.4 1.9 14.6 1.3 20.0 2.8 5.3 7.7 2.9 5.1 0.8 10.9 4.0 2.3 5.1 3.1 7.1 1.1 2.6 8.4 7.7 3.0 4.3 4.8 2.6 5.1 2.1 11.0 4.4 9.1 4.5 1.5 1.6 9.5 10.7 4.2 1.2 14.1 5.3 2.7 2.9 2.8 5.1 4.3 3.6 2.1 8.1 2.8 4.8 1.7 1.8 7.0 1.9 7.8 5.2 1.7 5.2 5.1 0.9 17.8 9.8 11.9 14.7 7.3 14.7 9.7 18.1 15.9 7.4 13.4 22.5 13.9 9.5 10.1 6.9 19.6 17.6 10.9 9.2 10.2 13.2 9.0 9.6 6.0 10.4 9.0 11.0 8.7 0.0 4.6 4.1 5.2 2.5 3.5 3.6 17.8 2.7 1.2 7.0 5.9 11.8 1.7 9.2 0.3 3.8 6.5 23.3 7.7 9.1 9.6 5.3 3.5 13.5 10.8 1.6 2.4 4.9 6.0 0.0 13.6 4.8 10.1 9.0 6.7 12.4 8.0 3.5 13.4 6.8 4.3 6.5 5.5 0.2 8.8 4.1 8.2 5.1 7.6 3.3 TMEM217 "C6orf128, dJ355M6.2" ENSG00000172738 "Transmembrane protein 217" Q8N7C4 6 37212180-37258155 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 20.1" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 13.1;Exocrine glandular cells: 13.9;Pancreatic endocrine cells: 14.4;Spermatocytes: 19.2;Urothelial cells: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HEL: 4.8;hTEC/SVTERT24-B: 3.4;HUVEC TERT2: 5.0;TIME: 13.1" "Not detected" "Not detected" "HPA045432, HPA071187" Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA045432: AB_2732519, HPA071187: AB_2732174" "unprognostic (7.78e-2)" "unprognostic (5.49e-2)" "unprognostic (2.22e-2)" "unprognostic (1.29e-2)" "unprognostic (7.79e-2)" "unprognostic (2.02e-1)" "unprognostic (6.77e-3)" "unprognostic (1.40e-2)" "unprognostic (3.51e-2)" "unprognostic (4.23e-4)" "unprognostic (8.22e-2)" "unprognostic (2.18e-1)" "unprognostic (5.62e-2)" "unprognostic (7.26e-2)" "unprognostic (1.33e-2)" "unprognostic (6.99e-2)" "unprognostic (1.59e-1)" 0.3 2.7 0.4 0.4 1.4 1.3 0.3 0.4 1.1 0.3 0.3 1.6 0.0 0.4 0.2 1.1 1.4 0.4 0.7 0.4 0.3 0.4 0.9 0.5 0.5 0.1 0.9 1.0 1.1 3.1 0.6 2.3 0.2 1.0 0.4 0.3 1.1 1.5 0.1 1.0 0.5 0.4 0.5 1.6 0.2 0.2 20.1 0.9 0.0 0.5 0.0 0.3 0.4 0.3 0.1 0.4 0.2 0.0 0.0 0.6 0.1 0.1 0.0 0.3 0.0 0.2 1.3 0.0 0.4 2.8 1.0 3.7 0.7 0.5 0.1 0.2 0.0 1.5 0.5 0.3 0.3 1.1 0.1 0.2 4.8 0.0 0.1 0.3 0.0 2.8 0.5 0.7 3.4 0.2 1.2 5.0 0.4 1.3 0.0 0.5 0.0 0.1 0.4 0.2 0.0 0.0 0.2 0.0 0.0 1.2 0.2 0.0 0.0 0.5 0.0 0.2 0.6 0.0 0.1 13.1 0.2 0.1 0.0 0.2 0.1 0.2 0.5 0.0 1.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.4 0.0 0.1 0.4 1.4 0.4 1.1 0.3 0.4 0.9 1.0 1.0 0.9 0.0 1.1 0.0 8.5 2.3 0.4 0.2 0.0 2.7 2.3 1.8 0.0 0.7 3.3 13.1 12.1 2.1 1.2 0.0 13.9 0.4 2.4 6.4 5.7 0.0 0.8 3.2 1.7 0.0 0.0 11.8 0.6 1.4 1.7 0.0 0.2 6.0 14.4 0.0 0.0 1.0 0.5 0.0 0.8 19.2 0.8 2.6 0.9 0.0 0.4 14.2 TMEM35B ZMYM6NB ENSG00000243749 "Transmembrane protein 35B" Q8NCS4 1 34981535-34985353 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 16 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 8.3;Ciliated cells: 28.1;Club cells: 11.4;granulocytes: 8.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 43.0;CAPAN-2: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051024 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051024: AB_2681316" "unprognostic (3.34e-3)" "unprognostic (2.77e-3)" "unprognostic (4.25e-1)" "unprognostic (2.12e-2)" "unprognostic (5.52e-2)" "unprognostic (2.08e-2)" "unprognostic (2.06e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "unprognostic (7.51e-3)" "unprognostic (2.32e-1)" "unprognostic (9.41e-2)" "unprognostic (2.03e-2)" "unprognostic (1.86e-1)" "unprognostic (5.49e-2)" "unprognostic (4.53e-3)" "unprognostic (1.07e-1)" 23.1 20.6 6.4 10.7 8.0 5.3 24.4 5.7 7.9 23.7 13.8 9.3 12.6 7.4 22.3 19.0 15.2 19.7 26.1 17.6 6.4 5.8 27.5 24.4 25.3 28.0 9.9 7.6 20.0 20.5 9.2 14.6 29.5 9.6 29.6 12.6 26.6 14.2 17.4 10.5 7.2 16.0 18.3 10.2 19.0 12.9 21.4 7.8 17.9 48.7 9.8 18.4 22.0 19.1 24.9 37.3 29.4 26.8 36.4 53.1 38.4 9.1 7.0 1.7 2.8 43.0 25.5 3.5 10.0 16.8 7.2 9.8 6.9 40.6 4.7 15.6 10.3 11.1 9.9 3.1 8.5 5.8 17.3 4.7 9.8 3.7 8.2 23.6 6.5 10.3 25.3 8.0 6.4 13.6 14.5 14.0 9.7 6.3 13.4 12.5 5.6 4.7 6.5 7.6 0.0 4.9 6.4 13.8 1.5 19.2 9.1 4.2 1.4 15.2 0.2 13.4 8.3 3.8 9.9 14.2 9.6 9.0 8.4 5.7 7.8 4.4 3.2 9.7 10.6 8.0 29.4 24.5 25.4 47.3 26.8 50.7 24.9 52.3 51.9 16.8 21.0 46.1 46.3 7.6 36.4 21.9 37.3 53.1 38.4 6.4 8.0 5.7 7.9 6.4 5.8 9.9 7.6 9.6 7.8 20.8 8.3 0.0 0.0 0.0 0.0 0.0 0.0 28.1 11.4 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 8.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TMEM42 MGC29956 ENSG00000169964 "Transmembrane protein 42" Q69YG0 3 44861869-44865670 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 73.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052569 Uncertain Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA052569: AB_2681871" "prognostic favorable (5.23e-4)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (3.73e-2)" "unprognostic (2.32e-1)" "unprognostic (7.93e-2)" "unprognostic (6.99e-3)" "unprognostic (1.64e-2)" "unprognostic (9.16e-2)" "unprognostic (9.23e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "prognostic favorable (1.10e-5)" "unprognostic (1.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" 11.1 14.6 18.6 5.7 26.1 4.6 13.4 7.8 17.3 12.7 8.5 17.7 8.5 6.1 10.4 25.9 7.2 16.8 8.9 10.2 18.4 19.7 12.9 19.1 9.7 9.3 19.1 14.1 17.1 17.5 12.7 16.5 8.9 16.4 12.7 8.5 8.5 10.9 12.7 16.6 8.6 6.2 9.2 19.8 8.7 9.9 20.0 15.5 11.6 17.1 6.5 9.1 7.5 8.7 13.9 11.8 4.2 10.2 9.1 15.9 9.2 4.1 4.2 1.2 2.4 16.1 12.7 0.1 3.4 4.8 4.2 4.2 0.9 8.2 2.8 6.7 6.6 1.9 2.8 0.3 5.2 4.2 4.4 0.0 1.7 5.4 4.4 17.1 2.0 0.1 13.1 13.4 4.3 9.7 9.0 7.1 7.2 0.1 5.8 6.3 3.2 1.7 3.4 2.3 5.0 1.9 1.5 0.7 0.6 9.1 1.6 1.3 1.7 4.1 1.4 1.6 4.2 3.0 3.5 4.6 3.7 0.4 5.4 3.7 2.0 1.5 0.8 7.4 2.4 1.6 3.7 8.6 4.2 7.8 7.7 8.2 13.9 11.6 7.2 10.6 11.9 15.9 12.6 1.6 9.1 10.2 11.8 9.2 9.2 18.6 26.1 7.8 17.3 18.4 19.7 19.1 14.1 16.4 15.5 20.8 4.8 10.7 14.4 5.5 8.0 10.1 15.3 16.0 4.5 31.4 2.0 17.6 11.6 15.3 56.7 9.3 5.2 0.0 8.9 11.3 14.2 14.8 3.5 15.3 19.8 17.5 11.5 11.6 13.3 73.6 25.3 10.3 6.8 9.0 9.1 20.9 11.7 8.4 18.4 17.0 15.9 6.5 6.9 36.1 19.3 7.9 8.1 13.1 11.8 6.2 TMPRSS15 "ENTK, MGC133046, PRSS7" ENSG00000154646 "Transmembrane serine protease 15" P98073 21 18269116-18485879 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 67 "intestine: 154.6" "Cell type enriched" "Detected in single" 11 "Early spermatids: 4.2" "Group enriched" "Detected in some" 12 "liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 20 "U-138 MG: 20.3;U-87 MG: 56.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "olfactory region: 9.3" "HPA015611, HPA034857, HPA072934" Enhanced Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214" "unprognostic (9.26e-2)" "unprognostic (4.14e-1)" "unprognostic (3.52e-1)" "unprognostic (8.33e-2)" "unprognostic (1.19e-1)" "unprognostic (7.20e-2)" "unprognostic (4.70e-2)" "unprognostic (6.35e-2)" "unprognostic (5.92e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 80.5 0.0 0.0 154.6 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 42.4 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.5 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.1 0.0 0.3 0.0 0.1 56.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 TMX1 "PDIA11, TMX, TXNDC, TXNDC1" ENSG00000139921 "Thioredoxin related transmembrane protein 1" Q9H3N1 14 51240162-51257546 "Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003085 Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA 740000 "Endoplasmic reticulum" Nucleoli "HPA003085: AB_1080424" "unprognostic (1.83e-1)" "unprognostic (7.42e-2)" "unprognostic (6.97e-3)" "unprognostic (1.49e-2)" "unprognostic (2.63e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.29e-6)" "unprognostic (3.70e-2)" "unprognostic (1.51e-1)" "unprognostic (6.84e-2)" "unprognostic (2.44e-3)" "unprognostic (5.07e-2)" "unprognostic (9.30e-2)" "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-1)" "unprognostic (3.21e-3)" 21.8 24.2 13.6 18.5 18.3 15.5 19.7 14.1 12.3 14.4 20.7 17.2 27.0 17.7 17.5 19.2 25.0 13.3 15.0 11.3 13.5 11.9 24.9 29.2 20.0 25.3 22.6 9.2 15.5 23.9 18.4 19.0 21.9 16.3 14.2 21.2 13.3 21.0 27.9 12.5 16.7 23.4 17.0 24.9 29.1 18.1 12.9 17.9 37.5 23.5 17.6 17.4 20.2 19.9 9.4 17.0 9.6 17.5 12.6 12.5 13.3 13.7 12.7 17.7 9.5 14.1 11.1 19.0 17.4 14.1 17.6 22.6 12.9 25.4 19.7 16.3 11.6 8.3 13.6 31.2 11.4 32.1 19.8 10.7 14.4 11.1 12.6 12.3 33.0 14.6 13.3 10.5 11.8 8.7 12.7 15.5 16.3 11.8 13.6 16.7 17.0 14.7 17.8 20.1 21.5 16.0 15.6 32.0 11.9 17.0 18.0 11.2 8.3 13.9 9.3 12.4 12.2 13.6 14.7 10.0 18.6 17.3 13.1 15.8 12.0 12.0 16.2 8.2 18.8 17.4 9.6 15.4 7.2 10.2 17.5 12.5 9.4 10.9 10.5 16.2 7.4 10.8 12.0 5.7 12.6 12.6 17.0 12.1 13.3 13.6 18.3 14.1 12.3 13.5 11.9 22.6 9.2 16.3 17.9 35.7 23.2 35.8 51.8 96.5 10.8 6.7 48.4 37.5 36.4 33.2 11.8 67.4 8.3 51.3 2.1 45.4 23.8 0.0 59.1 119.6 52.3 42.1 41.7 33.6 66.6 9.5 16.7 39.3 52.2 3.1 23.0 71.7 52.3 61.3 31.4 24.3 42.4 52.6 26.9 27.4 31.6 58.2 50.9 43.2 74.1 85.1 48.3 58.6 44.9 56.5 TNFAIP1 "B12, B61, BTBD34, EDP1, MGC2317" ENSG00000109079 "TNF alpha induced protein 1" Q13829 17 28335602-28347009 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Pancreatic endocrine cells: 88.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013333, HPA014641" Uncertain Approved Nucleoli NA NA Nucleoli "HPA013333: AB_1858160, HPA014641: AB_1858159" "unprognostic (4.42e-1)" "unprognostic (1.54e-2)" "unprognostic (4.32e-2)" "prognostic unfavorable (7.48e-5)" "unprognostic (2.29e-1)" "unprognostic (4.97e-3)" "unprognostic (3.21e-1)" "unprognostic (1.94e-1)" "unprognostic (2.64e-2)" "unprognostic (1.31e-2)" "unprognostic (8.27e-3)" "unprognostic (1.43e-2)" "unprognostic (4.21e-3)" "unprognostic (2.49e-2)" "unprognostic (2.04e-1)" "unprognostic (4.09e-1)" "unprognostic (7.02e-2)" 23.1 20.4 17.5 13.3 20.9 5.4 20.7 17.5 32.2 17.2 13.5 17.7 12.6 12.9 17.3 12.1 29.2 12.9 21.1 28.6 14.6 11.4 22.9 69.9 27.8 11.7 15.0 16.5 15.2 30.3 19.5 12.7 43.2 14.2 14.3 12.4 19.2 17.5 15.8 14.8 19.5 16.2 22.1 13.9 40.4 16.8 13.3 14.3 12.5 17.7 18.5 14.7 19.8 15.6 7.2 10.9 11.0 9.6 11.2 10.0 5.8 13.3 19.9 13.1 9.3 11.2 9.9 12.8 16.0 19.7 19.5 15.4 52.4 8.2 3.0 11.1 20.9 9.9 15.7 7.1 27.4 15.1 7.4 9.6 2.4 19.9 7.9 15.1 4.2 4.1 12.8 32.1 15.5 12.1 18.9 22.7 5.8 6.0 4.1 9.1 8.4 7.6 2.7 3.2 12.1 7.0 3.4 16.9 4.7 28.7 14.4 9.7 10.5 20.1 33.7 8.7 19.3 14.1 3.7 24.2 14.6 14.4 11.3 12.2 6.9 5.8 3.0 11.6 3.1 9.3 2.2 8.6 11.0 8.6 8.6 10.0 7.2 6.3 7.6 10.9 5.4 6.2 7.2 2.9 11.2 9.6 5.7 5.4 5.8 17.5 20.9 17.5 32.2 14.6 11.4 15.0 16.5 14.2 14.3 35.7 11.7 6.0 35.7 21.9 22.0 17.3 20.4 13.4 13.6 21.0 15.7 29.0 19.9 56.1 28.8 44.4 10.0 0.0 71.6 29.4 14.3 38.6 6.9 26.4 9.5 11.1 16.7 54.6 12.9 4.2 7.2 6.0 0.0 45.1 9.9 9.5 88.7 12.2 7.4 13.5 9.3 12.9 11.3 3.9 5.5 24.8 57.9 6.5 8.4 39.9 TNFRSF9 "4-1BB, CD137, ILA" ENSG00000049249 "TNF receptor superfamily member 9" Q07011 1 7915894-7943165 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 13.5;lymphoid tissue: 18.3" "Group enriched" "Detected in some" 4 "granulocytes: 62.3;monocytes: 53.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "memory CD8 T-cell: 8.0;neutrophil: 6.6;NK-cell: 4.1;T-reg: 13.5" "Group enriched" "Detected in many" 5 "granulocytes: 6.6;NK-cells: 4.1;T-cells: 13.5" "Cell line enriched" "Detected in some" 8 "HDLM-2: 47.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA071425 Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA071425: AB_2686394" "unprognostic (7.23e-2)" "unprognostic (1.72e-2)" "unprognostic (8.26e-3)" "unprognostic (1.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.04e-1)" "unprognostic (1.19e-4)" "unprognostic (9.47e-3)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (2.69e-8)" "unprognostic (1.64e-2)" "unprognostic (2.25e-2)" "unprognostic (1.19e-1)" "unprognostic (9.55e-2)" 0.8 1.0 0.3 11.0 0.3 1.9 0.5 0.2 0.3 0.4 0.5 0.1 0.1 0.6 0.3 0.1 0.6 0.8 1.6 1.8 0.3 1.0 0.7 0.7 2.1 10.8 0.3 0.1 0.3 0.6 0.0 0.5 0.2 0.5 0.4 0.7 0.3 2.1 0.1 0.3 0.5 2.3 0.1 0.3 7.9 0.7 0.5 0.1 18.3 0.7 0.9 17.5 1.4 0.4 0.5 1.1 6.6 1.5 4.1 13.5 1.1 1.2 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 1.0 0.4 0.1 0.4 0.0 0.8 0.2 0.0 0.2 0.5 47.0 0.1 0.2 0.2 0.0 0.9 0.0 0.5 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.7 0.0 0.2 0.2 0.2 1.6 0.1 0.2 0.1 0.1 0.1 5.8 0.2 0.0 1.1 1.5 0.2 1.5 0.4 0.2 0.2 1.0 8.0 1.1 0.5 0.3 1.6 6.6 4.1 0.1 0.3 13.5 1.1 0.3 0.3 0.2 0.3 0.3 1.0 0.3 0.1 0.5 0.1 0.0 1.7 0.0 0.4 0.2 0.0 0.3 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 1.0 0.0 0.4 0.3 62.3 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 1.8 5.0 53.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 12.9 0.0 0.3 TNNI1 ENSG00000159173 "Troponin I1, slow skeletal type" P19237 1 201403768-201429866 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 559.6" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 50.9" "Group enriched" "Detected in many" 5 "head and neck cancer: 9.6;prostate cancer: 3.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 9 "RH-30: 106.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA028190 Approved Uncertain Nucleoplasm,Nucleoli NA NA 25000 Nucleoplasm Nucleoli "HPA028190: AB_10600831" "unprognostic (2.82e-2)" "unprognostic (2.27e-1)" "unprognostic (2.91e-1)" "unprognostic (5.39e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (9.27e-4)" "unprognostic (1.93e-2)" "unprognostic (2.37e-1)" "unprognostic (4.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-2)" "unprognostic (1.05e-2)" "unprognostic (2.59e-2)" "unprognostic (3.52e-1)" "unprognostic (2.11e-1)" "unprognostic (1.71e-1)" 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 22.9 9.5 0.0 0.1 6.6 0.1 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 6.8 0.0 559.6 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 2.7 83.8 10.7 0.0 0.1 0.2 0.6 1.7 0.4 0.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 106.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.3 0.3 0.3 0.1 0.2 0.2 0.2 0.6 0.2 0.3 0.5 1.7 0.4 0.3 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 50.9 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 2.7 0.0 0.8 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 TNNT2 "CMD1D, CMH2, CMPD2" ENSG00000118194 "Troponin T2, cardiac type" P45379 1 201359008-201377762 "Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 241 "heart muscle: 679.2" "Cell type enriched" "Detected in many" 289 "Cardiomyocytes: 11884.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "RH-30: 189.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB015371, HPA015774, HPA017888" Enhanced Uncertain "Nucleoplasm,Nucleoli,Focal adhesion sites" No No 50000 "Nucleoplasm, Nucleoli" "Focal adhesion sites" "CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "unprognostic (2.33e-4)" "unprognostic (1.85e-1)" "unprognostic (7.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-2)" "unprognostic (5.50e-3)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (9.98e-2)" 0.1 0.3 0.1 0.1 0.7 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.2 679.2 0.9 0.0 1.9 0.0 0.7 0.3 0.1 1.1 0.1 0.3 0.0 0.2 0.7 0.1 0.7 0.0 0.0 0.2 0.1 2.0 1.3 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.4 0.5 0.0 0.0 189.8 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 10.5 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 2.1 0.9 0.0 0.1 1.1 0.1 0.0 3.0 4.0 0.0 1.1 3.1 1.0 11884.8 0.0 0.0 1.2 1.8 0.0 2.3 0.0 0.5 9.4 0.0 1.6 0.0 0.3 0.9 41.1 0.5 0.0 0.0 2.7 0.0 0.0 0.0 0.0 13.6 0.6 0.0 0.0 4.6 0.5 0.0 0.7 0.8 1.1 0.8 0.5 0.0 0.4 0.0 0.2 6.4 3.5 0.0 2.8 1.4 TNPO2 "FLJ12155, IPO3, KPNB2B, TRN2" ENSG00000105576 "Transportin 2" O14787 19 12699194-12724011 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 94.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046446, HPA071498" Approved Approved Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "CAB046446: AB_10603392, HPA071498: AB_2686405" "unprognostic (1.88e-1)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (7.16e-5)" "unprognostic (2.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.72e-2)" "unprognostic (6.75e-2)" "unprognostic (3.44e-1)" "unprognostic (1.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.63e-2)" "prognostic favorable (8.18e-4)" "unprognostic (2.76e-3)" "unprognostic (6.00e-2)" "unprognostic (3.50e-3)" "unprognostic (7.63e-2)" 21.7 19.8 37.1 16.0 35.7 17.8 13.5 33.1 44.7 17.9 13.9 23.2 12.7 13.4 20.7 20.9 22.9 22.4 15.9 20.0 31.1 24.9 14.3 10.1 13.7 16.6 24.8 36.6 32.9 16.0 26.6 19.1 16.1 22.2 16.8 15.9 18.2 15.1 20.0 15.2 36.6 12.5 23.3 25.2 15.3 12.9 24.1 20.9 14.9 17.8 9.9 17.8 18.9 14.7 1.6 4.3 2.6 1.2 0.4 3.3 0.7 17.6 13.5 20.8 26.5 12.7 16.8 13.5 20.4 13.5 29.6 20.9 18.4 9.6 12.0 16.0 17.2 8.3 23.6 36.8 20.2 16.5 14.8 29.5 18.5 21.2 22.3 14.3 32.6 17.8 14.9 16.0 19.6 20.9 19.2 13.8 24.4 28.7 11.5 16.3 30.6 27.3 22.5 24.1 13.1 40.8 26.3 16.2 22.0 17.5 12.9 51.0 25.3 16.6 21.1 10.1 14.7 14.7 11.6 13.8 45.5 12.0 24.3 29.9 22.9 22.0 20.5 13.5 29.7 16.1 0.6 0.9 0.3 2.1 0.8 3.0 1.5 1.5 1.7 1.2 1.6 2.7 3.3 2.6 0.4 1.2 4.3 0.5 0.7 37.1 35.7 33.1 42.1 31.1 24.9 24.8 36.6 22.2 20.9 6.0 19.9 11.8 8.5 27.5 38.9 15.9 17.8 6.7 9.1 21.0 94.2 9.1 5.0 8.3 9.5 17.5 10.5 0.0 7.3 5.6 14.7 12.6 3.5 15.3 8.9 54.0 22.0 18.4 11.3 15.4 28.7 9.5 8.5 10.8 17.0 24.7 13.1 5.8 30.4 14.6 32.2 6.5 17.8 24.7 10.0 36.3 12.1 11.5 15.0 8.0 TOP2A TOP2 ENSG00000131747 "DNA topoisomerase II alpha" P11388 17 40388516-40417950 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 146.3;testis: 36.8" "Group enriched" "Detected in many" 4 "Erythroid cells: 280.4;Spermatocytes: 527.8;Spermatogonia: 241.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002448, HPA006458, HPA026773" Enhanced Approved Supported Nucleoplasm,Nucleoli Yes Yes Nucleoplasm Nucleoli "CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "unprognostic (2.28e-3)" "unprognostic (9.42e-3)" "unprognostic (1.80e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.92e-6)" "prognostic unfavorable (4.99e-4)" "unprognostic (6.21e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.83e-5)" "unprognostic (5.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.46e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" 2.7 2.0 0.4 20.0 0.5 14.6 4.1 0.4 0.5 3.0 6.9 0.5 0.5 7.0 2.0 3.4 18.2 0.7 2.4 2.3 0.6 0.5 1.4 1.9 5.5 15.4 0.6 0.4 1.2 1.1 0.0 0.4 10.7 0.6 1.2 8.0 0.6 3.2 0.3 0.6 5.9 9.2 2.6 1.8 7.3 4.5 36.8 0.3 146.3 0.9 11.8 16.7 3.2 5.7 1.3 0.3 0.3 0.3 3.2 5.7 1.1 34.3 45.6 58.1 26.6 2.9 5.9 12.9 47.1 25.4 43.4 38.5 21.4 26.3 55.4 24.0 15.9 26.0 54.7 44.6 18.8 58.3 29.5 29.8 36.6 29.2 35.6 0.2 51.2 39.0 1.3 1.5 30.5 31.1 9.4 22.8 36.1 39.5 38.0 46.8 11.9 59.3 34.4 24.1 24.9 18.2 50.4 90.2 23.0 10.4 22.0 34.3 24.7 38.0 47.5 15.0 35.3 39.8 23.6 14.9 28.6 40.4 33.0 45.2 21.8 24.6 48.3 16.1 35.3 47.7 0.3 0.0 0.0 0.6 0.0 0.0 1.3 0.9 0.9 0.3 0.4 0.2 0.1 0.3 3.2 0.3 0.0 5.7 1.1 0.4 0.5 0.4 0.5 0.6 0.5 0.6 0.4 0.6 0.3 0.0 1.3 28.7 1.4 10.4 0.0 1.1 2.5 0.0 6.8 0.0 0.0 8.4 0.0 0.9 12.5 0.7 2.1 280.4 0.0 81.4 9.7 1.2 0.0 3.9 64.5 0.0 0.0 27.6 30.0 15.2 4.4 13.1 1.7 2.8 5.9 0.0 0.2 3.6 1.8 0.0 0.0 71.1 1.4 527.8 241.9 5.4 7.4 7.7 24.2 2.6 TOX4 "C14orf92, KIAA0737, LCP1" ENSG00000092203 "TOX high mobility group box family member 4" O94842 14 21476597-21499175 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017880, HPA027551" Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA017880: AB_1845573, HPA027551: AB_10601701" "unprognostic (9.56e-2)" "unprognostic (2.54e-2)" "unprognostic (2.81e-1)" "unprognostic (7.46e-2)" "unprognostic (9.30e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (3.46e-4)" "unprognostic (8.05e-3)" "unprognostic (2.58e-1)" "unprognostic (5.00e-2)" "unprognostic (3.23e-2)" "unprognostic (2.94e-1)" "prognostic favorable (8.38e-5)" "unprognostic (1.84e-1)" "unprognostic (2.48e-1)" "unprognostic (9.03e-2)" "unprognostic (2.48e-3)" 16.5 15.1 18.0 13.4 24.7 18.8 16.9 19.9 29.8 19.8 17.3 21.0 10.9 12.7 18.9 16.2 21.8 15.6 14.7 19.2 17.0 18.4 14.3 15.8 15.8 13.7 19.3 15.9 17.0 17.0 23.2 15.5 21.3 25.3 15.6 15.9 16.0 19.7 19.2 46.0 20.2 20.0 20.5 17.3 14.7 16.9 18.0 13.3 19.5 17.7 16.6 21.6 18.2 14.4 18.4 23.7 34.1 19.9 19.1 21.4 17.6 13.1 14.0 11.7 11.0 17.0 16.3 15.6 12.8 25.3 27.3 26.4 13.5 16.0 8.0 9.0 21.0 21.8 16.0 19.1 19.7 35.0 14.1 7.7 8.9 9.5 18.7 22.0 16.5 14.7 21.2 20.4 21.4 20.6 18.7 19.3 15.3 11.0 13.8 19.4 11.2 16.2 9.1 6.5 19.7 22.1 14.6 12.1 9.3 12.7 16.8 10.8 11.1 12.6 13.5 11.0 16.2 12.8 6.3 12.6 13.8 13.0 12.4 11.2 18.2 19.6 18.0 6.7 8.0 14.6 25.2 19.6 27.0 17.3 19.9 18.6 17.0 15.3 16.2 17.7 18.4 16.4 17.9 34.1 19.1 17.7 23.7 21.4 17.6 18.0 24.7 19.9 29.8 17.0 18.4 19.3 15.9 25.3 13.3 62.5 50.7 37.3 55.5 77.5 75.7 44.9 30.6 56.2 53.4 43.6 27.5 65.5 53.0 41.6 55.4 48.4 49.5 0.0 45.0 53.5 45.5 50.9 59.0 40.3 38.8 39.7 66.1 33.2 39.0 26.6 45.1 51.1 37.1 54.1 38.1 47.5 41.6 40.7 41.4 44.0 47.2 32.3 52.0 104.2 54.7 77.7 222.3 66.1 37.7 58.6 TP53TG5 "C20orf10, CLG01, dJ453C12.5" ENSG00000124251 "TP53 target 5" Q9Y2B4 20 45372563-45407889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 35.4" "Group enriched" "Detected in some" 98 "Early spermatids: 648.4;Late spermatids: 205.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 5.3" "Low region specificity" "Detected in all" "HPA041979, HPA058510, HPA077455" Enhanced Supported "Nucleoli,Nucleoli rim,Mitotic chromosome" NA NA "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA041979: AB_2677778, HPA058510: , HPA077455: " "unprognostic (2.86e-1)" "unprognostic (1.28e-1)" "unprognostic (2.18e-1)" "unprognostic (3.40e-3)" "unprognostic (1.70e-1)" "unprognostic (1.63e-3)" "unprognostic (2.29e-3)" "unprognostic (3.10e-3)" "unprognostic (9.26e-2)" "unprognostic (3.56e-2)" "unprognostic (1.72e-5)" "unprognostic (2.09e-2)" "unprognostic (7.46e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" "unprognostic (4.72e-4)" "unprognostic (1.41e-1)" 0.1 0.1 0.2 0.2 2.0 0.8 0.1 0.1 1.5 0.1 0.1 1.9 0.0 0.0 0.1 0.5 0.1 0.1 0.3 0.2 0.4 0.1 0.1 0.1 0.1 0.4 4.1 1.0 0.2 0.1 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.2 0.0 0.2 0.3 0.3 0.0 0.8 0.2 0.2 35.4 2.1 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.4 0.3 0.1 0.0 1.1 0.0 1.0 2.0 1.1 3.1 0.0 0.0 1.0 0.5 0.0 0.0 0.0 5.3 0.9 0.8 0.8 0.0 0.7 2.1 0.0 0.0 0.0 0.3 0.9 1.2 2.5 1.6 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.7 0.0 1.2 1.1 0.4 0.0 1.4 1.0 0.9 0.3 0.8 0.8 0.0 0.6 0.7 0.0 1.2 1.3 1.0 2.8 1.2 0.7 0.4 3.0 0.3 2.0 3.9 1.2 2.4 0.7 0.9 1.0 0.1 2.0 0.7 1.2 0.0 0.1 0.0 0.3 0.1 1.1 0.0 0.3 0.0 0.1 0.3 0.3 0.4 0.3 0.0 0.1 0.4 0.2 0.0 0.2 2.0 0.1 0.9 0.4 0.1 4.1 1.0 1.2 2.1 0.0 0.0 0.0 0.5 0.1 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 648.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 205.9 4.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 4.2 0.0 1.0 0.0 1.7 1.8 2.0 1.0 0.0 0.0 0.0 0.8 TPCN2 TPC2 ENSG00000162341 "Two pore segment channel 2" Q8NHX9 11 69048897-69162440 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Melanocytes: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 21.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA016561, HPA027080" Supported Approved Nucleoli NA NA Nucleoli "HPA016561: AB_1858207, HPA027080: AB_10600917" "unprognostic (1.29e-1)" "unprognostic (1.53e-2)" "unprognostic (1.39e-1)" "unprognostic (2.95e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.96e-4)" "unprognostic (7.60e-2)" "unprognostic (7.04e-2)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.49e-4)" "unprognostic (4.15e-2)" "unprognostic (1.89e-2)" "unprognostic (6.87e-2)" "unprognostic (2.22e-1)" "unprognostic (2.24e-3)" "unprognostic (5.01e-2)" "unprognostic (4.88e-2)" 11.0 6.2 6.3 8.7 11.1 9.2 9.4 14.5 14.0 18.0 18.0 9.2 11.3 15.0 22.4 12.4 11.2 13.8 12.1 7.5 6.2 4.9 11.6 15.7 8.7 10.4 6.0 7.7 12.1 6.8 6.4 7.2 7.1 8.8 13.1 7.4 20.7 8.1 17.8 8.1 16.1 13.7 15.6 6.0 10.9 11.4 8.5 4.9 6.4 7.3 7.4 10.1 11.0 11.2 2.0 7.5 7.1 9.9 6.9 3.2 3.6 3.4 8.9 2.7 4.2 2.6 2.1 11.7 3.9 4.7 4.7 2.8 7.6 10.9 4.5 5.6 4.8 3.7 8.0 2.2 4.4 1.4 2.8 2.3 6.1 9.5 2.5 2.5 4.3 8.3 3.3 2.3 2.4 2.5 1.9 3.2 7.4 2.9 21.1 2.9 8.1 3.6 10.3 3.2 10.1 3.2 3.4 2.2 5.5 4.7 5.6 2.4 3.2 4.5 10.2 15.7 4.1 6.6 5.7 2.9 3.2 4.7 5.9 3.6 5.5 2.3 2.3 5.2 4.6 6.7 4.3 9.8 2.9 1.0 9.8 0.9 2.0 2.1 2.1 7.5 1.5 1.7 2.0 7.1 6.9 9.9 3.2 3.2 3.6 6.3 11.1 14.5 14.0 6.2 4.9 6.0 7.7 8.8 4.9 8.9 1.0 7.5 2.1 3.5 1.5 3.2 7.6 0.0 1.2 12.2 2.0 2.3 14.9 6.0 16.2 2.9 6.2 23.3 7.6 3.7 3.5 1.2 2.3 12.9 10.5 0.0 0.0 6.2 15.4 1.7 5.8 7.4 33.7 4.6 2.9 2.5 3.7 3.5 6.3 9.6 4.2 6.5 5.9 1.9 3.8 3.0 1.6 2.6 3.4 1.4 TRA2A "AWMS1, htra-2-alpha, tra2a" ENSG00000164548 "Transformer 2 alpha homolog" Q13595 7 23504780-23532041 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054018 Uncertain Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoli "Nucleoplasm, Vesicles" "HPA054018: AB_2682344" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.24e-1)" "unprognostic (6.77e-3)" "unprognostic (8.05e-2)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.28e-2)" "unprognostic (2.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.87e-3)" "unprognostic (6.04e-2)" "prognostic unfavorable (1.79e-6)" "unprognostic (1.46e-2)" "unprognostic (1.52e-2)" "unprognostic (8.74e-2)" "unprognostic (1.36e-3)" 23.4 29.4 27.8 29.5 34.1 70.6 27.4 38.1 27.5 30.3 22.9 29.0 31.6 19.8 32.7 34.5 29.4 25.9 17.6 18.7 28.6 29.3 21.3 21.8 28.6 32.2 35.8 18.5 36.8 27.4 14.9 46.6 24.4 28.2 26.4 30.1 23.7 21.9 26.7 15.7 31.6 22.6 35.2 30.4 33.8 21.1 25.9 37.3 35.6 24.7 20.5 38.0 25.0 31.8 15.5 23.9 20.4 23.0 14.7 21.7 8.2 19.3 21.4 33.3 52.1 17.9 11.3 21.5 24.7 11.7 24.8 20.5 17.6 26.6 36.6 14.3 18.3 29.6 32.2 39.9 23.0 31.3 22.0 23.3 22.4 23.7 27.8 18.7 26.1 21.1 13.3 15.9 18.7 23.5 22.5 28.2 16.3 43.5 18.0 28.1 18.9 31.5 43.8 29.9 24.0 22.2 36.1 26.3 21.9 28.7 28.0 28.9 23.5 23.1 26.7 16.5 25.7 21.0 29.4 25.4 19.8 28.3 18.1 28.6 20.1 25.1 30.0 17.0 35.6 26.3 11.5 14.9 18.5 21.7 23.0 18.7 15.5 20.3 19.8 16.8 14.4 17.7 20.9 20.4 14.7 20.4 23.9 20.0 8.2 27.8 34.1 38.1 27.5 28.6 29.3 35.8 18.5 28.2 37.3 56.6 68.2 70.3 85.9 92.7 49.7 37.0 48.4 77.6 60.3 83.7 49.1 76.6 21.6 48.0 48.5 63.2 67.9 70.0 38.1 71.1 87.2 68.2 83.3 62.7 48.6 35.0 113.5 70.0 86.5 17.7 60.1 73.9 54.0 60.5 57.4 42.4 49.0 80.7 63.6 32.1 101.0 71.1 79.3 92.3 54.5 98.9 98.6 97.5 61.7 73.5 TRAF6 RNF85 ENSG00000175104 "TNF receptor associated factor 6" Q9Y4K3 11 36487027-36510272 "Enzymes, Predicted intracellular proteins" "DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004605, HPA019805, HPA020599" Approved Uncertain Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232" "unprognostic (2.48e-2)" "unprognostic (1.38e-1)" "unprognostic (2.83e-1)" "unprognostic (8.73e-2)" "unprognostic (1.71e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" "unprognostic (1.16e-2)" "unprognostic (9.22e-2)" "prognostic favorable (1.36e-4)" "unprognostic (2.82e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-2)" "unprognostic (1.07e-1)" 13.0 11.0 12.9 8.5 17.0 31.8 11.9 18.1 15.0 10.6 10.7 13.6 8.2 9.5 12.9 9.8 12.4 11.5 9.4 13.9 9.8 7.1 11.2 12.3 15.2 9.2 14.8 10.6 14.6 11.3 11.0 11.9 10.3 12.7 9.6 10.5 10.5 11.0 9.3 13.9 12.7 12.5 12.1 10.1 13.0 10.3 15.0 12.8 18.5 15.6 6.7 10.8 11.3 13.0 10.6 7.7 27.7 11.4 9.6 13.1 8.5 5.2 6.6 12.9 7.2 12.2 8.9 5.6 7.9 8.6 7.4 9.6 5.8 3.5 6.9 4.9 8.4 8.5 9.9 10.2 8.0 12.2 11.3 11.9 6.6 5.2 5.2 7.8 7.3 8.2 8.2 11.3 3.9 12.1 7.2 10.3 9.3 9.9 7.6 9.2 6.4 11.7 4.0 7.0 6.0 6.1 7.8 17.5 3.9 8.9 10.9 2.1 11.3 7.9 7.7 5.6 9.0 8.9 7.2 8.1 10.5 9.3 9.6 9.6 8.8 7.4 7.5 5.9 5.3 7.8 27.7 8.0 20.9 11.9 11.4 11.7 10.6 10.3 11.6 7.7 8.1 10.0 13.1 11.1 9.6 8.2 4.5 8.0 8.5 12.9 17.0 18.1 15.0 9.8 7.1 14.8 10.6 12.7 12.8 8.9 6.1 5.0 10.6 11.3 2.6 6.9 10.2 1.4 1.2 3.5 5.9 5.6 5.0 7.6 3.2 9.2 7.2 0.0 6.4 5.2 6.0 9.7 18.5 5.6 6.2 7.9 4.1 20.3 8.1 2.7 2.3 6.6 6.8 11.8 5.5 3.9 5.9 5.7 3.9 4.3 2.6 12.9 10.5 9.1 8.3 10.9 5.4 8.5 3.2 10.6 TRIM27 "RFP, RNF76" ENSG00000204713 "Tripartite motif containing 27" P14373 6 28903002-28923989 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048684, HPA053408" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA048684: AB_2680493, HPA053408: AB_2682139" "unprognostic (1.57e-1)" "unprognostic (1.48e-2)" "unprognostic (2.36e-1)" "unprognostic (1.14e-2)" "unprognostic (1.70e-2)" "unprognostic (2.56e-1)" "unprognostic (2.00e-3)" "unprognostic (1.17e-2)" "unprognostic (1.01e-2)" "unprognostic (1.12e-3)" "unprognostic (4.76e-3)" "unprognostic (1.16e-2)" "prognostic unfavorable (3.50e-6)" "unprognostic (1.27e-1)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "prognostic favorable (2.71e-4)" 11.5 10.6 8.8 25.5 9.7 7.9 9.3 10.1 12.2 11.2 10.2 8.7 20.2 23.8 12.1 13.2 7.8 12.1 11.4 8.1 8.2 9.6 10.1 22.5 10.4 17.4 12.6 8.3 14.7 31.0 7.4 13.9 13.7 10.6 13.7 4.6 7.7 17.0 25.2 12.2 9.7 19.4 9.2 8.4 18.6 18.5 9.2 9.2 16.7 12.5 7.9 12.1 9.9 11.8 12.5 12.5 13.8 13.9 11.2 15.9 13.8 3.3 2.3 1.0 6.1 0.8 1.7 0.7 4.6 1.1 1.4 1.7 1.7 1.4 7.7 8.0 1.3 3.0 7.4 1.1 2.7 0.1 3.0 13.1 11.0 0.5 2.3 1.3 4.6 1.7 1.3 1.7 1.2 0.5 0.1 1.2 8.0 10.6 3.3 0.4 1.3 6.4 2.4 0.0 2.1 7.4 9.1 7.0 14.3 1.1 1.1 3.3 13.1 5.6 3.4 7.4 0.3 3.3 3.6 4.0 3.5 7.1 6.3 2.7 12.2 14.6 12.2 1.8 11.7 5.2 12.6 13.8 8.8 12.7 13.9 15.9 12.5 12.6 14.4 12.5 10.5 11.8 12.1 13.8 11.2 12.1 9.8 10.4 13.8 8.8 9.7 10.1 12.2 8.2 9.6 12.6 8.3 10.6 9.2 14.9 21.9 30.9 26.1 25.2 11.0 14.9 30.6 24.1 19.4 27.9 15.7 41.3 18.3 35.7 9.4 29.1 15.7 23.3 37.7 49.1 24.4 31.4 20.8 36.5 36.4 7.9 26.5 25.2 23.8 4.4 22.2 24.5 8.5 25.2 24.4 9.8 42.8 19.5 17.3 24.1 13.1 19.4 21.1 5.1 11.2 17.1 38.1 26.2 24.4 24.0 TRIM34 RNF21 ENSG00000258659 "Tripartite motif containing 34" Q9BYJ4 11 5619764-5644398 "Predicted intracellular proteins" "Antiviral defense" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in single" 24 "Ciliated cells: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 16.5;SK-BR-3: 17.6" HPA077996 Approved Nucleoli,Centrosome NA NA Centrosome Nucleoli "HPA077996: AB_2686873" "unprognostic (8.66e-3)" "unprognostic (9.94e-2)" "unprognostic (1.53e-3)" "unprognostic (1.25e-1)" "unprognostic (2.71e-1)" "unprognostic (5.88e-2)" "unprognostic (9.68e-2)" "unprognostic (1.37e-1)" "unprognostic (1.70e-1)" "unprognostic (2.74e-1)" "unprognostic (9.16e-3)" "unprognostic (8.16e-2)" "unprognostic (1.79e-1)" "unprognostic (1.69e-1)" "unprognostic (3.91e-2)" "unprognostic (3.40e-1)" "unprognostic (6.76e-2)" 15.9 14.6 2.7 12.2 2.9 1.4 7.3 0.9 3.4 9.3 7.9 6.0 8.5 6.6 15.7 10.6 8.7 7.8 5.6 4.1 3.6 2.2 7.1 4.4 7.9 11.7 2.6 3.9 11.4 5.5 4.5 5.5 8.7 4.7 9.5 6.8 7.8 10.2 6.3 2.0 6.2 14.2 5.8 6.2 16.6 6.1 4.6 4.3 12.5 7.0 5.0 14.3 10.0 7.8 12.8 15.9 15.2 15.9 5.9 9.5 7.8 2.3 1.3 0.5 0.2 5.3 8.3 16.5 3.5 10.2 9.1 8.9 1.0 8.1 8.1 1.6 4.7 6.8 3.7 0.3 7.5 4.6 10.6 0.3 4.3 0.4 0.4 2.4 4.7 3.0 8.7 6.5 4.6 1.5 7.1 11.6 7.2 0.2 0.6 4.3 1.0 4.2 2.7 0.0 3.2 0.7 6.3 0.3 0.5 5.4 6.2 0.0 0.0 0.1 17.6 2.6 1.6 3.1 2.3 9.3 2.4 0.5 0.9 1.3 0.9 1.1 3.1 6.8 0.6 1.2 8.7 14.3 3.6 5.6 15.9 6.1 12.6 5.4 6.9 15.9 12.8 6.8 5.7 15.2 5.9 13.5 8.1 9.5 7.8 2.7 2.9 0.9 3.4 3.6 2.2 2.6 3.9 4.7 4.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 TRIM41 "MGC1127, RINCK" ENSG00000146063 "Tripartite motif containing 41" Q8WV44 5 181222499-181235809 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 39.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024204 Approved Supported "Nucleoli,Nuclear bodies" NA NA "Nucleoli, Nuclear bodies" "HPA024204: AB_1858299" "unprognostic (1.13e-1)" "unprognostic (7.05e-2)" "unprognostic (1.23e-2)" "unprognostic (7.93e-2)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (9.56e-2)" "unprognostic (7.24e-2)" "unprognostic (8.66e-2)" "unprognostic (6.87e-2)" "unprognostic (2.21e-3)" "unprognostic (2.07e-1)" "unprognostic (5.17e-3)" "unprognostic (2.45e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (2.68e-2)" 10.0 8.3 25.5 9.4 24.3 9.3 5.4 7.3 17.0 6.9 6.5 19.8 8.8 11.2 6.1 8.3 7.3 8.4 7.0 9.8 26.9 20.4 10.7 7.6 6.9 6.0 37.3 12.5 5.9 12.3 18.8 7.6 7.3 17.0 7.0 4.0 7.8 8.3 8.4 30.0 9.0 9.0 5.3 43.7 7.5 9.5 19.1 18.3 10.6 11.3 7.2 7.2 5.8 5.2 2.2 2.4 3.9 2.3 1.9 4.3 1.4 4.6 12.3 4.6 7.6 5.4 5.4 10.8 6.9 3.7 5.1 4.8 10.3 7.1 7.9 11.3 4.7 9.5 8.9 4.7 16.5 2.8 39.0 15.1 9.0 12.1 5.8 5.2 6.6 6.2 4.7 8.5 6.3 2.3 4.9 2.9 12.3 11.2 9.9 2.8 16.8 9.9 7.4 4.3 3.5 5.9 9.4 7.0 10.3 2.9 7.5 7.1 6.7 6.3 7.5 9.6 2.1 15.0 7.5 6.0 7.0 4.7 4.1 5.2 21.7 13.7 11.2 7.3 7.8 5.8 0.9 1.4 2.2 2.4 1.1 3.6 1.9 2.5 4.3 1.6 2.2 2.6 3.1 3.9 1.9 2.3 2.4 3.2 1.4 25.5 24.3 7.3 17.0 26.9 20.4 37.3 12.5 17.0 18.3 3.0 14.3 11.3 9.2 7.1 18.9 11.3 7.6 20.1 10.3 10.4 17.7 12.2 10.0 7.4 5.5 9.2 10.7 0.0 10.6 7.8 6.2 7.5 2.3 19.5 7.7 27.0 12.2 11.6 12.3 2.6 4.9 6.7 8.5 8.2 12.0 14.5 8.9 10.1 11.0 6.7 27.6 0.0 7.5 32.2 19.0 9.8 10.9 12.7 10.6 5.8 TRIM51 "SPRYD5, TRIM51A" ENSG00000124900 "Tripartite motif-containing 51" Q9BSJ1 11 55883297-55891810 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "blood: 11.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 50 "melanoma: 4.3" "Cell type enriched" "Detected in single" 111 "basophil: 11.0" "Lineage enriched" "Detected in single" 111 "granulocytes: 11.0" "Group enriched" "Detected in some" 124 "SK-MEL-30: 36.0;WM-115: 9.2" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA044988: AB_2679171, HPA077883: AB_2732362" "unprognostic (9.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM52 RNF102 ENSG00000183718 "Tripartite motif containing 52" Q96A61 5 181254417-181261139 "Predicted intracellular proteins" "Antiviral defense, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA054565, HPA056819" Approved Approved "Nucleoli,Intermediate filaments" NA NA Nucleoli "Intermediate filaments" "HPA054565: AB_2682525, HPA056819: AB_2683245" "unprognostic (1.21e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-2)" "unprognostic (5.23e-1)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (3.98e-2)" "unprognostic (7.37e-2)" "unprognostic (2.71e-1)" "unprognostic (2.24e-3)" "unprognostic (7.48e-3)" "prognostic unfavorable (3.46e-4)" "unprognostic (2.96e-1)" "unprognostic (6.41e-2)" "unprognostic (1.33e-2)" "prognostic favorable (4.07e-4)" 9.2 13.0 17.8 15.3 19.7 10.9 11.5 42.3 24.2 10.9 10.9 9.8 15.4 11.8 12.1 14.3 6.6 10.3 8.2 9.1 15.0 10.5 11.2 9.7 11.0 18.8 18.0 12.0 17.7 14.6 15.3 19.4 8.6 16.2 13.8 10.2 8.1 14.0 15.6 9.8 14.5 12.6 8.3 14.0 16.9 11.3 11.7 20.8 15.3 16.8 5.0 13.9 10.3 15.1 5.4 2.7 5.6 2.5 5.5 11.2 3.7 3.6 4.2 6.8 8.8 12.4 7.9 6.1 4.0 3.5 3.9 3.4 6.0 6.7 7.9 4.4 4.3 10.6 6.7 3.7 5.3 4.6 13.4 7.8 3.0 15.9 5.1 3.0 9.2 7.0 7.9 4.5 4.2 2.4 6.4 4.6 11.7 3.2 18.6 4.0 6.9 5.0 8.4 2.4 4.1 5.5 6.0 3.7 5.4 3.2 4.8 7.8 6.3 5.7 4.1 3.6 6.3 7.7 6.3 5.6 7.9 4.1 3.7 3.7 13.7 6.7 5.4 8.9 8.1 3.0 5.0 2.5 5.6 8.4 2.2 9.3 5.4 9.0 9.2 2.0 4.2 11.2 8.9 2.6 5.5 2.0 2.7 5.9 3.7 17.8 19.7 42.3 24.2 15.0 10.5 18.0 12.0 16.2 20.8 17.9 20.5 8.3 5.9 7.8 26.6 6.6 7.6 16.0 23.9 7.0 37.3 3.1 3.3 3.0 24.4 10.1 6.7 0.0 2.2 1.0 9.3 5.3 17.3 2.6 3.6 27.0 8.6 8.6 6.2 3.6 11.8 8.7 5.0 3.6 6.8 19.8 2.1 5.9 8.9 2.8 42.6 0.0 14.8 14.9 6.4 5.4 3.5 10.2 7.5 3.4 TRIM6-TRIM34 ENSG00000258588 "TRIM6-TRIM34 readthrough" 11 5596725-5644398 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "kidney: 30.3;salivary gland: 9.5;testis: 8.0" "Cell type enriched" "Detected in single" 9 "Ciliated cells: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "A549: 10.1" HPA077996 Uncertain Nucleoli,Centrosome NA NA Centrosome Nucleoli "HPA077996: AB_2686873" 0.9 0.7 0.4 0.6 0.4 0.1 0.9 0.4 0.4 1.4 0.4 0.0 0.7 0.8 1.5 1.6 1.9 0.7 0.2 1.4 0.4 0.3 30.3 0.4 0.7 0.1 0.3 0.0 1.7 2.7 1.1 0.4 1.4 0.3 1.5 0.2 2.2 9.5 1.9 0.4 0.4 0.6 1.9 0.4 1.1 0.4 8.0 0.0 0.0 1.7 0.0 1.5 1.1 0.5 0.5 1.5 1.3 0.8 0.9 0.2 0.2 0.0 10.1 0.0 0.0 0.2 0.8 1.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 1.1 0.0 0.0 0.7 0.6 0.6 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 0.2 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.2 0.2 0.1 0.4 0.0 0.1 1.5 0.5 0.1 0.1 1.3 0.9 0.4 0.3 0.0 0.2 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM60 "FLJ35882, RNF129, RNF33" ENSG00000176979 "Tripartite motif containing 60" Q495X7 4 165031953-165041744 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "placenta: 5.0;testis: 6.6" "Cell type enhanced" "Detected in some" 11 "Cytotrophoblasts: 4.8;Extravillous trophoblasts: 8.2;Spermatocytes: 3.8;Spermatogonia: 6.4;Syncytiotrophoblasts: 4.7" "Cancer enriched" "Detected in single" 103 "testis cancer: 5.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "BEWO: 18.0" "Not detected" "Not detected" "HPA035809, HPA035810, HPA061496" Uncertain Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540" "unprognostic (1.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 1.1 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.4 0.1 0.2 1.1 0.2 0.3 0.0 0.5 0.3 0.2 1.1 0.1 0.1 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.5 0.0 1.4 0.0 0.0 0.0 4.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 8.2 0.2 0.2 0.0 0.8 0.4 0.0 0.0 0.0 2.2 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.3 0.0 0.0 3.8 6.4 0.3 4.7 0.5 0.0 0.0 TRMT10A "MGC27034, RG9MTD2, TRM10" ENSG00000145331 "TRNA methyltransferase 10A" Q8TBZ6 4 99546709-99564032 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 76.6;Spermatogonia: 51.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047601, HPA058241" Uncertain Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" NA NA "Nucleoplasm, Nucleoli, Actin filaments" Cytosol "HPA047601: AB_2680099, HPA058241: AB_2683651" "unprognostic (5.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.34e-1)" "unprognostic (1.96e-3)" "unprognostic (2.10e-1)" "unprognostic (5.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.59e-2)" "unprognostic (3.65e-2)" "unprognostic (1.57e-1)" "unprognostic (3.51e-1)" "unprognostic (7.49e-3)" "unprognostic (3.32e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (1.68e-2)" 7.0 8.9 6.5 7.5 8.9 3.3 13.1 6.1 8.7 4.6 6.0 9.3 7.5 7.3 5.5 7.2 9.2 10.1 6.1 5.0 7.9 6.7 9.1 16.8 4.9 7.4 9.2 6.1 6.6 12.4 6.7 12.2 10.0 9.7 7.4 6.9 2.5 7.3 4.7 9.3 6.5 10.4 5.1 10.5 7.0 7.6 16.7 10.1 10.7 10.8 5.1 8.0 7.2 10.8 8.8 10.0 9.2 7.6 5.8 7.1 4.0 6.7 4.8 9.3 4.8 5.5 7.8 6.7 8.2 3.2 5.8 4.3 3.9 8.4 9.3 3.2 4.8 5.2 3.9 10.8 5.2 8.9 11.8 4.8 6.4 4.1 6.4 5.3 16.2 6.9 4.9 13.4 5.8 12.7 3.4 5.8 8.5 14.7 8.4 4.9 7.8 13.6 3.3 5.5 12.1 4.6 7.9 8.9 5.9 7.8 5.5 5.8 5.1 4.5 24.9 8.2 8.1 8.1 7.0 4.2 5.9 6.1 4.8 9.3 5.8 9.8 8.5 4.5 9.5 4.1 4.0 7.6 3.7 3.8 7.1 3.1 6.3 6.5 6.4 10.0 8.8 6.7 6.2 9.2 5.8 6.2 5.6 7.1 4.0 6.5 8.9 6.1 8.7 7.9 6.7 9.2 6.1 9.7 10.1 3.0 9.3 6.0 5.1 7.2 4.6 5.9 12.7 20.1 4.5 10.4 3.9 14.6 36.5 11.9 34.0 6.7 10.7 0.0 16.6 14.7 5.4 5.0 8.1 24.2 7.1 4.8 6.9 9.2 7.9 11.7 6.1 4.7 5.0 5.4 9.8 7.8 14.8 11.0 7.1 17.0 5.9 12.9 7.1 76.6 51.2 8.3 14.6 4.8 9.6 5.9 TRMT1L C1orf25 ENSG00000121486 "TRNA methyltransferase 1 like" Q7Z2T5 1 185118098-185157072 "Predicted intracellular proteins" "Behavior, tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 83.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026728 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA026728: AB_1845641" "unprognostic (1.07e-2)" "unprognostic (1.31e-1)" "unprognostic (8.55e-3)" "unprognostic (2.96e-1)" "unprognostic (1.46e-2)" "unprognostic (8.95e-2)" "unprognostic (2.38e-1)" "unprognostic (4.41e-2)" "unprognostic (2.32e-1)" "unprognostic (2.46e-3)" "unprognostic (1.32e-1)" "unprognostic (8.75e-2)" "unprognostic (1.16e-2)" "unprognostic (7.44e-2)" "unprognostic (9.45e-2)" "unprognostic (7.87e-2)" "unprognostic (2.26e-1)" 7.6 12.9 9.4 10.1 12.8 5.9 8.9 14.2 11.3 10.5 10.0 9.6 9.6 9.6 9.3 11.3 10.5 12.6 8.2 13.2 10.3 10.6 15.3 16.0 10.3 11.1 11.2 9.1 13.7 8.3 18.0 26.9 9.7 11.9 11.7 8.5 5.2 7.6 10.0 27.4 5.5 8.7 8.5 12.4 12.8 8.4 29.4 12.8 16.5 12.4 7.6 13.0 11.8 12.2 16.2 12.1 19.0 15.8 11.0 12.7 8.1 7.8 14.5 10.0 7.5 14.8 13.6 14.2 7.6 6.9 10.4 11.0 13.1 15.2 8.6 19.1 5.2 16.0 10.2 16.8 10.0 10.3 10.2 7.3 8.2 11.0 13.3 10.3 12.1 13.7 6.5 13.6 10.6 10.8 11.1 11.4 11.7 21.6 11.9 12.4 6.6 9.2 7.1 16.5 16.2 3.0 10.9 14.4 13.7 10.0 8.8 8.9 7.9 14.8 14.5 10.3 23.9 14.8 6.8 11.0 9.6 7.7 6.6 10.2 19.1 25.6 13.7 6.3 10.8 9.2 16.8 9.8 19.0 7.4 13.4 7.9 11.7 9.7 8.9 12.1 16.2 12.2 9.5 11.1 11.0 15.8 5.1 12.7 8.1 9.4 12.8 14.2 11.3 10.3 10.6 11.2 9.1 11.9 12.8 11.9 10.4 9.8 7.8 2.4 8.7 25.8 10.2 45.5 15.9 15.7 7.9 13.5 23.2 9.3 32.0 7.0 7.9 0.0 5.3 9.1 7.4 5.4 8.1 20.2 11.2 3.2 5.8 8.6 13.7 15.5 11.5 12.8 1.7 18.0 7.9 9.5 6.6 10.5 11.3 18.8 8.2 0.0 5.2 83.9 26.0 2.0 9.5 7.5 7.1 4.7 TRMT5 "KIAA1393, TRM5" ENSG00000126814 "TRNA methyltransferase 5" Q32P41 14 60971451-60981358 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 162.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000943 Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA000943: AB_1080388" "unprognostic (1.58e-2)" "unprognostic (3.62e-2)" "unprognostic (6.63e-3)" "unprognostic (1.11e-2)" "unprognostic (7.70e-3)" "unprognostic (2.26e-2)" "unprognostic (7.82e-3)" "unprognostic (4.50e-2)" "unprognostic (3.95e-1)" "unprognostic (1.78e-1)" "unprognostic (1.47e-1)" "unprognostic (2.84e-2)" "unprognostic (1.60e-3)" "unprognostic (1.82e-1)" "unprognostic (1.97e-2)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" 15.8 10.1 7.9 13.8 12.1 5.4 12.9 9.3 11.8 10.9 8.6 5.7 11.9 7.5 12.0 10.9 11.1 10.0 6.7 6.8 7.7 7.1 12.5 13.9 6.6 7.3 6.7 8.3 17.1 11.1 15.9 13.1 10.8 9.0 10.6 8.1 4.8 11.5 9.9 14.8 9.7 7.4 9.2 6.3 8.6 8.1 24.9 5.9 12.4 10.4 12.1 7.2 13.3 9.0 7.2 7.4 0.9 7.5 2.0 6.0 3.7 28.9 7.4 10.9 15.2 9.7 14.5 11.9 10.9 8.4 11.7 9.4 5.4 17.4 14.9 12.2 7.9 8.8 13.4 13.7 15.8 15.4 14.7 6.9 10.9 5.0 6.0 15.8 19.3 6.1 11.4 15.3 10.6 15.8 10.4 10.2 13.0 14.2 5.4 17.1 10.9 9.9 9.7 10.0 11.3 12.3 3.2 25.3 12.6 9.9 9.9 13.4 13.3 12.1 12.2 9.7 9.9 20.4 11.6 9.6 13.6 16.5 9.6 10.4 3.3 6.1 7.0 9.5 4.2 12.6 0.1 4.6 0.9 3.5 7.5 5.0 7.2 5.2 5.2 4.2 4.9 5.6 5.1 0.4 2.0 7.5 7.4 6.0 3.7 7.9 12.1 9.3 11.8 7.7 7.1 6.7 8.3 9.0 5.9 6.0 7.5 8.3 16.7 5.7 5.0 7.1 0.0 18.7 25.0 10.4 3.9 11.0 1.7 7.1 162.4 8.6 2.9 0.0 6.5 11.6 7.7 5.7 5.8 5.9 9.5 3.2 5.2 11.6 6.1 35.3 10.3 8.2 6.8 4.6 7.3 10.4 7.2 3.5 7.1 8.8 4.5 12.9 6.2 10.9 10.9 3.8 16.0 4.6 7.1 10.7 TSEN15 C1orf19 ENSG00000198860 "TRNA splicing endonuclease subunit 15" Q8WW01 1 184051651-184123978 "Disease related genes, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029237 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA029237: AB_10671361" "unprognostic (4.54e-1)" "unprognostic (2.29e-1)" "unprognostic (2.05e-1)" "unprognostic (1.04e-2)" "unprognostic (8.72e-3)" "unprognostic (8.04e-3)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.82e-2)" "unprognostic (4.11e-2)" "prognostic favorable (4.59e-4)" "unprognostic (3.82e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.66e-10)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (2.93e-2)" "unprognostic (2.20e-1)" 14.2 17.5 20.6 13.2 22.1 16.2 17.3 14.0 34.0 16.4 16.8 25.4 7.8 11.2 16.7 24.5 12.7 13.9 12.3 17.2 22.1 19.0 12.8 14.2 15.9 16.3 27.6 16.6 15.0 19.2 13.0 13.4 16.0 20.7 16.3 11.8 13.2 13.9 14.5 31.8 13.7 10.3 15.0 34.5 13.4 13.9 12.4 24.2 20.8 19.4 15.4 15.2 13.7 12.5 14.0 20.2 15.9 14.2 28.2 21.9 17.6 22.7 7.6 9.9 12.2 8.3 7.9 28.2 10.9 19.6 16.5 16.3 7.1 9.9 14.8 12.0 12.2 10.1 10.5 10.7 9.2 16.9 21.7 6.8 6.7 5.7 9.4 15.3 26.4 9.4 5.4 17.9 7.2 15.1 6.7 9.2 25.6 14.9 41.5 14.6 11.0 26.3 13.4 21.2 27.1 8.6 16.7 16.5 31.3 10.5 7.6 10.3 15.2 14.3 11.4 27.6 10.9 14.4 16.6 4.7 11.0 24.8 7.5 17.4 56.5 38.6 22.6 10.5 14.8 23.9 15.9 9.8 13.5 20.4 14.2 17.6 14.0 19.3 20.9 20.2 10.4 15.0 20.4 1.8 28.2 13.0 18.1 21.9 17.6 20.6 22.1 14.0 34.0 22.1 19.0 27.6 16.6 20.7 24.2 44.7 7.2 17.1 10.6 9.8 8.6 28.6 10.2 6.7 14.8 12.2 3.9 38.5 46.4 27.7 1.2 12.0 3.3 0.0 36.4 40.6 19.8 10.9 31.2 33.9 27.3 3.2 6.4 17.8 13.1 1.7 20.1 20.1 32.1 24.4 7.9 13.0 30.5 3.5 18.4 51.8 12.1 12.9 20.6 40.8 50.7 11.5 18.9 35.9 10.2 9.5 TSG101 "TSG10, VPS23" ENSG00000074319 "Tumor susceptibility 101" Q99816 11 18468336-18527232 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004283, HPA006161" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA 14000 Cytosol "Nucleoli, Plasma membrane" "CAB004283: AB_671392, HPA006161: AB_1080408" "unprognostic (1.42e-1)" "unprognostic (7.91e-2)" "unprognostic (2.11e-1)" "unprognostic (6.77e-2)" "unprognostic (1.82e-1)" "unprognostic (2.72e-3)" "prognostic unfavorable (3.74e-6)" "unprognostic (5.67e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-2)" "unprognostic (4.15e-3)" "unprognostic (4.27e-2)" "prognostic favorable (5.52e-6)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" "unprognostic (4.02e-3)" "unprognostic (1.06e-1)" 24.7 30.5 18.4 14.2 25.5 23.5 27.6 22.7 25.9 22.5 23.1 23.7 21.6 20.5 25.8 27.7 34.3 23.9 18.4 31.8 17.7 20.6 33.4 29.0 20.1 23.4 21.6 21.4 23.2 39.5 33.2 23.5 38.5 24.6 21.9 28.4 19.4 25.4 22.4 44.5 27.3 25.7 23.1 21.7 20.5 23.0 33.7 20.2 27.5 32.3 37.1 25.5 24.2 25.5 20.5 18.2 42.3 29.2 14.3 22.0 22.2 14.4 23.8 21.1 14.6 25.0 26.2 19.7 22.4 30.3 27.5 27.2 16.3 7.6 19.5 13.8 25.0 29.6 22.2 21.0 20.3 30.5 27.4 25.7 12.1 12.6 24.0 32.2 18.1 20.9 22.6 41.4 14.3 39.0 29.0 22.5 18.9 19.6 16.6 33.2 26.0 11.4 19.7 13.0 31.3 24.2 10.3 21.4 16.2 18.4 20.6 15.1 27.0 21.5 18.1 28.6 22.1 18.0 18.2 12.1 18.5 11.3 38.4 16.6 10.7 20.5 15.5 19.0 10.1 23.5 42.3 19.5 40.7 14.9 21.7 15.0 20.5 14.4 15.9 18.2 18.0 15.4 16.4 34.5 14.3 29.2 15.4 22.0 22.2 18.4 25.5 22.7 25.9 17.7 20.6 21.6 21.4 24.6 20.2 59.6 51.0 42.1 71.0 37.8 39.6 60.3 56.0 107.1 37.5 41.8 23.6 165.8 106.1 92.2 31.6 49.6 64.6 46.7 89.0 89.6 50.5 62.3 42.8 34.8 70.2 35.0 59.1 46.6 42.2 12.6 52.0 49.4 54.0 107.4 58.3 78.3 101.0 58.3 40.7 95.2 33.9 45.3 45.3 142.6 153.8 42.3 247.6 44.5 43.7 75.7 TSPYL1 TSPYL ENSG00000189241 "TSPY like 1" Q9H0U9 6 116276578-116279903 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031970 Supported Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA031970: AB_2674092" "unprognostic (1.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.11e-2)" "unprognostic (9.99e-2)" "unprognostic (1.70e-1)" "unprognostic (3.54e-2)" "unprognostic (2.46e-1)" "unprognostic (1.04e-1)" "unprognostic (2.76e-1)" "unprognostic (9.18e-3)" "prognostic favorable (5.40e-4)" "unprognostic (5.12e-1)" "prognostic favorable (1.48e-13)" "unprognostic (1.61e-1)" "unprognostic (1.81e-1)" "unprognostic (2.34e-2)" "unprognostic (2.47e-1)" 14.0 34.1 38.3 9.8 67.2 18.5 14.4 49.1 64.5 15.2 12.8 9.8 20.1 14.7 13.9 21.4 15.4 20.3 12.9 21.4 34.6 36.6 31.5 23.5 12.9 11.8 21.8 49.8 22.9 17.6 41.3 17.2 9.7 31.1 27.1 11.3 13.3 17.2 22.6 61.6 11.2 12.9 17.1 11.5 15.6 15.3 12.9 12.2 9.8 25.0 15.5 15.2 14.6 12.9 30.7 24.6 52.9 29.4 17.4 36.2 17.0 13.2 13.0 16.8 30.6 29.8 19.7 14.1 21.3 21.3 19.6 22.5 16.8 9.7 28.4 26.8 24.6 17.6 23.5 13.2 36.4 21.0 11.5 34.4 11.4 19.3 30.4 18.9 18.7 6.9 23.0 28.5 20.1 19.6 20.4 18.6 12.6 20.1 22.1 27.2 29.1 12.4 11.0 8.3 12.7 12.2 11.5 14.5 15.5 33.8 25.9 14.8 14.6 17.7 23.8 10.2 19.9 31.3 23.3 22.4 13.2 11.8 10.6 23.0 12.1 13.1 15.6 21.8 12.2 8.5 52.9 17.8 27.2 24.2 27.7 36.2 25.9 31.7 26.7 14.3 30.7 31.3 30.4 13.5 17.4 29.4 24.6 23.7 17.0 38.3 67.2 49.1 64.5 34.6 36.6 21.8 49.8 31.1 12.2 32.8 41.6 47.2 90.2 147.6 76.3 93.6 53.5 20.1 39.8 99.5 25.5 48.1 131.0 34.9 24.0 35.6 43.4 0.0 38.5 23.1 50.3 71.7 31.1 71.3 35.6 36.5 71.6 63.3 55.3 16.8 69.9 47.1 82.7 28.9 56.9 82.6 40.7 56.1 89.8 169.2 50.8 129.4 74.1 48.1 24.5 141.5 49.9 52.4 55.2 61.6 TSPYL6 ENSG00000178021 "TSPY like 6" Q8N831 2 54253184-54256272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 41.1" "Group enriched" "Detected in some" 9 "Spermatocytes: 27.4;Spermatogonia: 22.4" "Cancer enriched" "Detected in single" 27 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 66 "K-562: 13.4" "HPA034699, HPA034700" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA034699: AB_2674288, HPA034700: AB_10670159" "unprognostic (8.21e-2)" "unprognostic (4.25e-1)" "unprognostic (1.06e-2)" "unprognostic (1.00e-1)" "unprognostic (5.54e-6)" "unprognostic (4.50e-2)" "unprognostic (1.77e-1)" "unprognostic (5.73e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 27.4 22.4 0.0 0.0 0.0 0.0 0.0 TSR2 "DT1P1A10, RP1-112K5.2, WGG1" ENSG00000158526 "TSR2, ribosome maturation factor" Q969E8 X 54440401-54445487 "Disease related genes, Predicted intracellular proteins" "rRNA processing" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030514 Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions, Cytosol" "HPA030514: AB_10603457" "unprognostic (1.05e-1)" "unprognostic (1.80e-2)" "unprognostic (1.77e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-2)" "unprognostic (5.91e-2)" "unprognostic (7.15e-3)" "unprognostic (8.29e-2)" "unprognostic (4.39e-1)" "unprognostic (1.31e-1)" "unprognostic (2.94e-2)" "unprognostic (6.19e-2)" "prognostic favorable (1.21e-6)" "unprognostic (2.27e-1)" "unprognostic (1.13e-1)" "unprognostic (7.93e-3)" "unprognostic (1.80e-3)" 20.8 25.0 52.9 13.8 53.1 15.3 19.2 27.6 44.3 18.2 17.2 30.8 16.9 13.9 18.4 33.9 16.2 21.1 14.8 22.2 45.3 46.2 26.5 23.7 17.5 14.9 53.8 34.4 22.9 17.2 30.7 19.0 19.8 31.0 20.8 20.6 19.0 16.6 25.4 35.5 17.2 14.7 19.7 54.3 18.1 16.5 8.4 27.5 10.2 23.9 10.8 22.0 17.7 16.8 39.6 15.4 28.7 21.2 24.7 41.4 21.1 20.3 26.1 19.1 17.4 17.3 12.5 17.1 20.2 16.5 18.9 16.2 24.6 22.3 22.3 14.0 17.7 33.7 21.1 46.7 28.0 25.2 29.0 23.1 18.2 19.5 19.2 10.7 31.4 19.0 11.6 15.4 26.3 27.2 14.9 13.1 18.8 18.5 16.7 19.2 37.4 23.9 24.8 30.4 18.4 29.7 21.5 35.6 18.9 20.1 18.1 24.2 16.8 38.5 19.3 21.4 34.7 39.2 11.0 17.9 13.9 24.5 29.1 17.2 17.9 27.0 26.7 20.4 25.0 20.8 24.5 15.3 28.7 35.1 20.5 28.8 38.7 33.3 31.8 13.9 39.6 41.4 31.7 9.4 24.7 21.2 15.4 35.5 21.1 52.9 53.1 27.6 44.3 45.3 46.2 53.8 34.4 31.0 27.5 23.8 23.8 40.1 37.8 29.1 55.8 44.8 22.9 45.5 39.8 33.2 25.5 86.7 106.1 35.8 0.8 36.5 26.0 0.0 28.8 60.7 42.6 34.1 43.9 22.9 39.7 54.0 17.4 23.4 12.3 2.1 32.2 27.9 38.8 70.3 30.8 56.3 30.9 28.6 42.5 51.9 48.8 45.3 43.4 12.2 43.7 27.7 63.5 41.1 28.8 29.1 TSSK3 "SPOGA3, STK22C" ENSG00000162526 "Testis specific serine kinase 3" Q96PN8 1 32351521-32364312 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 68.1" "Group enriched" "Detected in some" 52 "Early spermatids: 242.3;Late spermatids: 839.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA037516 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA037516: AB_2675517" "unprognostic (5.71e-2)" "unprognostic (1.42e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-1)" "unprognostic (7.69e-2)" "unprognostic (2.02e-4)" "unprognostic (2.06e-1)" "unprognostic (1.98e-3)" "unprognostic (2.05e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (9.20e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.68e-3)" 1.1 2.0 0.8 1.7 0.8 8.2 1.1 3.9 0.8 1.3 0.9 0.8 1.4 2.5 1.8 2.9 0.8 1.3 1.0 0.9 0.8 0.0 0.9 1.3 1.4 2.4 0.8 0.8 2.0 1.2 0.0 0.8 0.8 1.0 1.0 0.0 0.8 1.4 0.8 1.7 3.4 2.9 0.8 0.8 3.4 1.2 68.1 0.8 0.8 1.3 0.8 0.8 0.9 1.1 0.6 0.1 0.1 0.7 0.3 2.3 0.1 2.3 2.3 6.0 3.5 0.0 1.2 5.4 0.7 1.1 0.0 0.0 0.5 1.2 1.2 0.9 0.0 1.0 3.7 0.0 0.0 0.0 3.5 7.2 2.7 9.8 3.7 4.4 1.1 3.4 0.1 0.9 0.0 1.3 6.3 0.0 4.6 3.1 5.8 0.0 0.6 1.4 1.5 1.5 0.4 1.2 1.9 1.7 4.4 0.0 1.9 1.8 3.8 0.8 2.8 4.1 4.4 1.9 2.7 2.9 2.1 3.4 3.0 2.4 8.5 2.8 1.8 3.7 3.9 0.5 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.2 0.0 0.1 0.6 2.3 0.9 0.1 0.3 0.5 0.0 0.0 0.1 0.8 0.8 3.9 0.8 0.8 0.0 0.8 0.8 1.0 0.8 0.0 0.3 0.0 0.4 0.1 0.1 0.3 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.2 242.3 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 839.4 8.6 0.0 0.0 0.0 0.3 0.9 0.2 0.0 8.9 0.6 1.4 6.5 0.0 10.3 3.8 0.0 0.2 0.0 0.2 0.2 TTC27 FLJ20272 ENSG00000018699 "Tetratricopeptide repeat domain 27" Q6P3X3 2 32628032-32821051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031246 Approved Approved Nucleoli,Mitochondria No No 11000 Mitochondria Nucleoli "HPA031246: AB_10603139" "unprognostic (3.10e-2)" "unprognostic (8.84e-2)" "unprognostic (3.21e-3)" "unprognostic (6.28e-3)" "unprognostic (8.90e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.42e-5)" "unprognostic (7.68e-2)" "unprognostic (2.30e-1)" "unprognostic (2.13e-1)" "unprognostic (2.07e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.37e-1)" "unprognostic (2.96e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" 18.4 18.2 7.0 18.8 11.5 9.9 17.8 8.6 10.7 16.4 11.9 16.1 12.0 8.2 25.1 13.6 17.5 14.7 8.5 14.3 8.2 6.9 11.0 15.7 10.8 13.6 12.5 8.1 18.6 17.7 15.7 19.4 11.9 8.9 14.7 13.1 13.2 17.2 14.7 18.7 16.8 11.0 15.3 11.0 19.3 13.4 17.4 10.3 16.4 14.9 15.5 20.4 14.6 14.6 9.6 9.6 0.3 9.0 8.4 12.5 5.7 22.0 10.7 7.4 5.8 6.2 12.7 3.8 9.2 7.6 14.2 12.5 16.5 13.4 19.3 8.3 13.8 14.8 11.1 11.9 14.3 20.9 9.2 14.6 21.9 5.9 22.4 12.1 20.9 11.6 8.4 13.2 17.2 18.7 7.1 12.9 4.9 30.1 5.7 12.7 8.8 16.5 7.3 13.6 10.0 11.2 11.1 16.2 16.9 11.0 12.9 6.2 8.9 7.6 7.2 8.5 9.0 8.8 5.0 10.7 9.1 10.0 10.7 15.7 8.3 2.1 21.9 9.8 16.3 9.7 0.0 4.5 0.0 9.1 9.0 10.0 9.3 10.0 8.9 9.6 9.6 12.5 9.8 0.3 8.4 6.1 4.7 8.7 5.7 7.0 11.5 8.6 10.7 8.2 6.9 12.5 8.1 8.9 10.3 8.9 7.2 4.5 8.0 4.9 5.4 6.7 0.0 16.0 9.1 0.0 3.9 10.8 6.6 7.7 14.7 6.3 1.7 0.0 8.3 10.2 6.2 5.0 11.5 3.9 7.0 3.2 7.0 4.3 7.2 0.9 7.8 4.6 5.0 7.2 4.6 4.6 5.3 5.9 6.7 3.8 5.6 6.5 7.1 18.4 10.4 5.0 5.4 6.1 7.6 5.4 TTC28 KIAA1043 ENSG00000100154 "Tetratricopeptide repeat domain 28" Q96AY4 22 27978014-28679865 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 42.8" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003099 Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA003099: AB_1079195" "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-1)" "unprognostic (8.55e-3)" "unprognostic (4.83e-2)" "unprognostic (5.20e-2)" "unprognostic (2.25e-1)" "prognostic favorable (4.30e-4)" "unprognostic (3.91e-2)" "unprognostic (1.18e-2)" "unprognostic (5.40e-2)" "unprognostic (5.10e-2)" "prognostic favorable (5.65e-5)" "unprognostic (5.54e-3)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (4.36e-1)" 4.6 3.0 1.4 1.1 2.0 0.0 4.2 0.6 1.3 6.0 4.1 1.4 7.6 6.5 3.0 5.7 3.7 2.8 1.2 1.0 2.8 2.1 4.7 0.5 0.9 11.8 2.7 3.2 2.4 5.4 3.3 1.3 3.7 4.4 2.6 1.6 2.1 5.3 1.0 1.6 3.1 5.0 4.3 0.2 4.3 3.4 1.0 2.5 0.4 0.2 0.9 0.6 0.5 0.0 5.3 13.8 5.9 8.3 12.4 0.3 4.0 7.5 5.7 5.0 0.4 0.0 0.0 5.6 11.7 1.9 0.8 8.9 0.2 3.1 0.5 5.9 0.8 6.7 5.0 3.8 0.1 5.5 12.3 0.3 3.7 2.6 3.9 10.4 3.6 3.4 0.5 1.3 1.9 0.1 0.4 2.5 0.0 3.4 5.4 3.5 0.1 2.7 0.2 3.9 8.6 5.6 0.2 3.7 4.0 2.8 0.5 9.6 6.8 3.4 4.4 3.0 1.8 0.2 0.1 2.4 0.1 2.9 0.4 0.2 0.1 0.5 0.1 0.3 0.3 0.4 0.3 0.3 1.0 0.6 0.5 0.4 0.9 0.2 2.5 0.1 0.5 3.0 12.2 2.0 4.6 5.4 32.1 8.9 7.6 2.7 2.3 12.2 17.7 4.5 0.0 4.3 7.2 28.6 2.6 0.0 5.2 1.2 19.2 5.3 1.1 12.4 3.2 27.0 8.6 29.4 5.9 5.6 29.1 4.8 10.1 1.0 4.9 12.1 5.1 5.1 42.8 14.1 22.1 12.9 18.6 22.9 11.4 3.3 2.1 4.9 6.7 3.0 TTC3 "DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII" ENSG00000182670 "Tetratricopeptide repeat domain 3" P53804 21 37073226-37203112 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016810, HPA023964, HPA036304" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.37e-2)" "unprognostic (8.52e-2)" "unprognostic (9.29e-2)" "unprognostic (8.71e-2)" "unprognostic (1.61e-1)" "unprognostic (2.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (6.74e-2)" 22.9 22.1 34.0 18.7 36.5 12.0 23.4 39.2 40.0 34.9 20.6 15.9 26.7 13.0 21.6 33.3 15.3 19.5 19.0 21.5 29.1 16.5 21.4 17.0 15.4 14.3 17.7 27.5 34.5 25.8 27.4 50.4 15.2 34.7 28.9 19.9 16.1 24.5 25.4 21.6 16.1 16.8 21.6 21.7 13.6 21.3 19.5 19.9 19.7 35.4 11.1 15.1 23.3 18.9 10.6 12.8 4.8 5.7 9.1 18.6 3.8 21.7 7.8 36.3 6.8 35.0 51.1 12.6 24.0 29.9 10.8 14.7 10.2 11.0 18.8 8.4 40.2 10.1 7.2 10.9 14.8 15.3 19.9 7.8 38.0 11.6 13.4 12.8 21.2 12.3 26.4 9.1 11.0 9.8 21.8 16.0 16.7 22.8 22.1 20.3 16.8 20.6 5.5 10.3 14.5 13.2 27.6 17.4 9.9 12.6 16.9 27.7 21.1 29.8 17.1 15.4 8.7 19.4 8.3 20.9 15.5 6.2 19.0 9.0 22.2 15.9 18.8 25.6 21.2 11.7 2.9 4.4 4.8 9.1 4.8 13.6 9.5 10.6 12.3 7.9 10.6 18.6 11.3 0.7 9.1 5.7 12.8 7.2 3.8 34.0 36.5 39.2 40.0 29.1 16.5 17.7 27.5 34.7 19.9 116.1 118.5 109.7 81.2 58.5 344.6 127.3 56.0 75.0 101.2 71.5 214.0 39.6 140.9 74.9 160.4 67.6 60.1 0.0 65.5 79.7 132.8 164.9 62.4 80.5 56.3 311.4 182.6 102.5 80.0 149.3 194.5 74.4 200.8 61.3 133.8 187.6 72.0 84.2 245.4 81.7 228.9 51.8 103.8 264.1 280.4 54.8 44.1 76.7 118.3 90.4 TTF1 ENSG00000125482 "Transcription termination factor 1" Q15361 9 132375548-132406851 "Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" "DNA replication inhibitor, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054837 Supported Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA054837: AB_2682621" "unprognostic (7.07e-2)" "unprognostic (5.62e-3)" "unprognostic (9.12e-2)" "unprognostic (6.05e-2)" "unprognostic (1.66e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.07e-1)" "unprognostic (9.21e-3)" "unprognostic (3.08e-1)" "unprognostic (1.33e-1)" "unprognostic (6.95e-3)" "unprognostic (2.09e-2)" "unprognostic (5.93e-3)" "unprognostic (8.38e-2)" "unprognostic (3.44e-1)" "unprognostic (4.71e-2)" 10.3 6.6 9.9 12.6 14.6 18.0 12.5 15.0 13.4 10.3 12.1 8.5 13.8 6.2 11.9 12.1 8.5 9.6 6.8 16.6 9.8 8.5 8.3 6.2 8.9 12.2 10.4 11.3 11.8 8.7 8.7 15.4 8.3 14.1 13.4 8.8 6.8 9.0 10.1 18.0 9.3 8.6 9.5 13.5 9.7 8.7 11.6 12.7 15.1 16.9 7.0 12.3 13.4 11.5 12.3 10.2 19.4 6.3 7.3 9.1 3.0 7.4 7.1 10.1 9.2 5.7 7.3 9.2 8.4 6.5 9.8 7.2 7.3 8.3 12.3 7.1 6.2 11.2 18.0 11.2 6.5 10.6 7.9 7.8 5.6 10.7 5.5 5.6 15.0 9.2 4.4 7.7 8.5 6.3 7.8 8.4 20.4 11.2 10.8 7.6 11.2 34.6 9.1 18.6 13.3 11.0 22.1 14.0 14.6 7.8 6.1 9.0 15.4 11.8 9.0 6.0 10.1 11.0 8.0 8.0 16.1 9.9 13.5 9.8 5.1 14.4 15.0 9.1 12.3 15.3 11.3 5.4 10.3 6.5 5.2 8.3 11.2 8.2 7.4 3.3 12.3 9.1 6.9 19.4 7.3 6.3 10.2 8.4 3.0 9.9 14.6 15.0 13.4 9.8 8.5 10.4 11.3 14.1 12.7 23.8 16.3 52.5 19.7 8.8 26.4 37.0 20.4 24.1 13.6 17.4 56.9 21.3 16.6 23.7 13.3 29.0 11.8 46.7 18.3 18.6 14.6 18.1 22.0 7.3 16.3 28.6 11.6 25.8 18.6 5.6 21.9 22.5 1.7 22.6 13.5 19.1 21.2 20.3 24.4 12.9 53.5 25.8 18.4 48.9 61.5 7.4 21.1 34.9 16.6 19.5 TTK "CT96, MPH1, MPS1, MPS1L1" ENSG00000112742 "TTK protein kinase" P33981 6 80003887-80042527 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.3;testis: 31.7" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 19.9;Erythroid cells: 23.3;Spermatocytes: 63.4;Spermatogonia: 28.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 4.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010166, CAB013229" Enhanced Approved Nucleoli,Cytosol NA Yes "Nucleoli, Cytosol" "CAB010166: AB_632567, CAB013229: AB_2533230" "unprognostic (4.27e-2)" "unprognostic (8.71e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (1.44e-5)" "unprognostic (7.97e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (3.84e-10)" "unprognostic (1.56e-3)" "unprognostic (7.95e-2)" "unprognostic (2.02e-3)" "prognostic unfavorable (2.54e-4)" "unprognostic (1.54e-1)" "unprognostic (0.00e+0)" "unprognostic (3.51e-2)" "unprognostic (1.06e-1)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" 1.1 1.4 0.3 3.2 0.4 13.9 1.0 0.3 0.4 1.0 2.7 0.2 0.2 2.2 0.5 1.0 6.5 0.3 0.4 1.5 0.4 0.3 0.9 0.6 1.2 4.6 0.4 0.2 0.4 0.5 0.0 0.3 3.0 0.6 0.6 3.6 0.3 1.2 0.6 0.3 2.0 2.8 0.7 0.8 2.1 1.8 31.7 0.2 58.3 0.5 2.6 5.4 0.8 1.8 1.7 0.0 1.1 0.0 1.1 4.0 0.8 13.3 8.0 24.0 19.6 1.1 3.5 13.6 15.5 9.5 22.7 27.8 10.9 10.2 19.8 12.1 6.6 23.8 17.3 21.1 9.5 31.6 18.0 17.0 18.3 10.6 8.9 0.0 21.5 11.9 0.4 1.0 15.8 10.1 3.3 12.8 27.9 19.9 20.4 19.2 9.9 12.2 15.5 14.1 12.0 9.7 11.0 43.8 8.2 5.7 8.6 16.5 9.7 9.1 9.9 5.6 13.5 9.3 16.3 5.3 10.2 10.2 6.6 24.7 4.6 15.5 11.0 3.6 20.0 8.7 0.0 0.0 1.1 0.6 0.0 0.6 0.9 1.0 1.6 0.0 1.7 0.3 0.5 0.3 1.1 0.0 0.0 4.0 0.8 0.3 0.4 0.3 0.4 0.4 0.3 0.4 0.2 0.6 0.2 3.0 0.6 0.0 0.5 1.1 0.0 0.7 0.0 4.0 3.4 0.0 2.0 4.1 3.3 0.4 19.9 0.1 0.2 23.3 0.2 13.1 0.8 0.2 1.1 0.0 5.2 0.0 1.7 0.0 2.4 12.8 0.9 1.2 0.0 9.0 1.0 0.3 0.4 0.0 0.7 0.0 1.2 6.5 0.2 63.4 28.5 0.3 3.1 0.0 1.2 0.7 TTLL1 C22orf7 ENSG00000100271 "Tubulin tyrosine ligase like 1" O95922 22 43039644-43089428 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 24.1;Early spermatids: 30.7;Spermatogonia: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048392 Approved Approved Nucleoli,Mitochondria No No Nucleoli Mitochondria "HPA048392: AB_2680384" "unprognostic (1.02e-1)" "unprognostic (4.06e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.18e-3)" "unprognostic (4.27e-3)" "prognostic unfavorable (2.34e-5)" "unprognostic (8.22e-2)" "unprognostic (2.16e-2)" "unprognostic (3.29e-1)" "unprognostic (4.47e-3)" "unprognostic (1.82e-1)" "prognostic favorable (1.68e-4)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (2.03e-1)" "unprognostic (3.38e-2)" 4.0 7.3 16.5 3.6 12.0 2.9 6.8 12.8 16.6 7.6 4.6 8.8 0.9 2.5 7.1 12.5 5.7 14.6 5.7 12.5 13.9 12.6 6.1 2.1 5.3 4.9 9.2 14.1 8.3 4.2 8.5 9.8 3.9 13.2 7.7 4.6 6.8 4.7 6.0 4.4 5.8 2.9 5.9 10.0 4.5 5.4 14.0 8.4 4.7 10.3 1.8 4.8 5.4 4.6 4.7 10.4 7.0 6.5 9.9 14.1 6.2 0.8 1.5 12.8 9.7 14.5 12.9 0.6 4.3 4.8 2.5 4.2 0.1 1.9 0.9 3.1 7.9 1.5 0.6 1.1 1.1 2.5 1.1 2.1 1.3 0.7 1.2 10.4 3.2 1.7 10.6 16.6 1.6 4.1 10.7 8.2 10.9 0.3 8.3 9.2 4.2 3.0 5.2 1.7 3.4 0.9 7.4 7.2 0.7 4.6 1.1 3.2 6.1 3.4 1.7 11.8 6.9 5.1 5.4 7.8 2.7 1.8 6.2 0.6 2.9 0.8 0.3 6.8 5.9 4.8 5.2 5.9 7.0 13.0 6.5 12.2 3.1 11.4 14.1 10.4 4.7 9.7 12.2 1.7 9.9 4.9 6.7 6.9 6.2 16.5 12.0 12.8 16.6 13.9 12.6 9.2 14.1 13.2 8.4 0.0 2.4 0.5 2.5 2.1 5.3 4.0 2.5 24.1 4.5 1.8 5.9 2.5 13.3 5.5 30.7 3.3 0.5 0.0 4.2 1.2 5.1 3.2 1.1 0.4 4.3 4.8 0.0 6.7 2.1 14.5 3.7 2.3 8.5 4.6 2.6 5.5 4.4 7.0 5.6 5.7 10.1 6.5 1.4 8.6 37.7 2.4 0.6 2.9 1.5 1.3 TTLL2 "C6orf104, dJ366N23.3, NYD-TSPG" ENSG00000120440 "Tubulin tyrosine ligase like 2" Q9BWV7 6 167325086-167359503 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "testis: 54.1" "Group enriched" "Detected in some" 167 "Early spermatids: 407.9;Late spermatids: 161.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "CACO-2: 6.3" "Not detected" "Not detected" HPA027985 Approved "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane, Nucleoli" "HPA027985: AB_2211832" "unprognostic (5.98e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-1)" "unprognostic (6.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.79e-1)" "unprognostic (5.29e-2)" "unprognostic (9.47e-4)" "unprognostic (7.57e-2)" "unprognostic (2.63e-4)" "unprognostic (3.50e-2)" "unprognostic (2.39e-1)" "unprognostic (8.14e-3)" "unprognostic (1.94e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.8 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 407.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 161.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 TUB rd5 ENSG00000166402 "Tubby bipartite transcription factor" P50607 11 8019244-8106112 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Sensory transduction" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 39.3;Horizontal cells: 28.6;Rod photoreceptor cells: 51.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HAP1: 13.3;HEK 293: 18.2;HeLa: 24.3;SCLC-21H: 27.6;SH-SY5Y: 20.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017997, HPA049019" Enhanced Approved "Nucleoli,Centriolar satellite" "Intracellular and membrane" NA NA "Centriolar satellite" Nucleoli "HPA017997: AB_1858449, HPA049019: AB_2680601" "unprognostic (2.53e-1)" "unprognostic (7.23e-2)" "unprognostic (1.80e-2)" "unprognostic (4.06e-2)" "unprognostic (9.62e-2)" "unprognostic (1.47e-2)" "unprognostic (1.53e-2)" "unprognostic (2.53e-1)" "unprognostic (9.71e-2)" "unprognostic (5.08e-2)" "prognostic favorable (2.85e-4)" "unprognostic (4.18e-1)" "prognostic favorable (2.35e-5)" "unprognostic (8.37e-3)" "unprognostic (1.61e-1)" "unprognostic (1.41e-1)" "unprognostic (1.39e-2)" 5.0 18.3 18.9 2.8 16.1 0.7 4.5 12.4 36.4 18.2 4.2 6.3 2.8 2.5 24.3 10.7 3.6 20.8 5.5 10.2 20.5 17.9 11.7 1.0 3.4 2.2 25.1 22.6 17.9 5.1 11.0 18.4 4.6 17.7 8.7 2.9 11.3 5.6 9.0 3.1 6.5 2.4 12.0 9.2 2.1 2.4 5.1 9.1 0.5 10.5 2.9 1.3 5.2 8.7 0.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.9 7.1 8.8 6.7 2.3 0.0 4.8 1.2 5.2 6.8 0.0 0.0 0.0 0.4 6.4 2.4 0.0 13.3 1.0 4.5 0.0 18.2 0.0 24.3 2.9 1.1 0.0 0.2 3.5 1.2 2.3 0.0 0.4 0.4 8.2 0.0 0.0 2.4 0.6 0.0 0.0 4.9 0.0 0.0 6.6 0.1 0.0 0.0 0.2 27.6 20.6 3.4 0.0 1.3 3.2 0.8 0.1 0.0 2.9 6.9 0.4 2.0 0.0 0.0 0.0 2.5 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.2 1.2 0.0 0.7 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 18.9 16.1 12.4 36.4 20.5 17.9 25.1 22.6 17.7 9.1 0.0 0.0 0.0 1.7 0.7 14.6 2.2 0.0 6.7 1.2 0.0 39.3 0.1 5.0 0.1 3.3 0.5 0.0 0.0 0.0 0.3 6.2 0.7 1.1 0.0 0.2 28.6 1.7 1.8 0.0 3.7 13.6 0.0 1.7 0.0 0.0 11.7 0.0 0.0 13.8 6.3 51.9 0.0 1.3 1.5 1.1 0.6 0.0 0.0 0.0 0.1 TULP3 TUBL3 ENSG00000078246 "Tubby like protein 3" O75386 12 2877223-2941140 "Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015285, HPA018496" Uncertain Supported "Nucleoplasm,Nucleoli,Plasma membrane" "Secreted - unknown location" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA015285: AB_1858460, HPA018496: AB_2669889" "unprognostic (5.33e-2)" "unprognostic (1.57e-1)" "unprognostic (4.80e-2)" "prognostic favorable (2.99e-4)" "unprognostic (2.45e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (7.97e-5)" "unprognostic (2.44e-1)" "unprognostic (4.09e-2)" "unprognostic (1.73e-1)" "unprognostic (1.50e-1)" "unprognostic (3.37e-1)" "prognostic unfavorable (7.18e-4)" "unprognostic (7.52e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-2)" "unprognostic (3.19e-2)" 14.0 12.0 8.1 6.9 12.9 2.4 13.0 21.2 11.1 22.7 13.6 19.6 12.6 5.3 27.7 11.7 14.1 20.9 11.5 12.7 12.1 5.3 12.1 6.5 9.5 7.2 11.0 7.7 37.1 6.8 13.5 15.4 12.7 10.9 12.5 8.1 17.2 9.8 14.0 9.9 19.8 7.0 17.5 9.7 7.3 11.7 13.2 13.8 4.4 13.3 6.3 9.2 11.6 28.4 3.5 2.8 0.6 1.5 4.8 6.3 1.7 9.1 7.8 14.9 12.3 15.0 22.4 14.1 14.4 24.2 15.6 17.3 9.9 8.5 6.8 2.2 21.2 13.3 7.7 8.8 9.3 18.1 8.8 6.5 4.1 9.7 6.3 19.4 4.3 4.7 13.1 11.0 23.6 32.3 19.2 12.0 8.7 3.8 6.4 13.0 8.2 6.4 3.8 20.1 7.3 5.8 6.9 14.6 2.5 9.8 7.7 3.8 10.0 12.6 7.5 8.2 28.4 9.4 4.3 9.6 11.5 13.9 23.3 13.9 2.0 2.4 5.9 11.6 2.4 17.5 0.0 1.5 0.5 4.0 1.5 6.3 2.9 3.1 4.0 1.3 3.5 3.8 5.2 0.6 4.8 0.8 2.8 5.5 1.7 8.1 12.9 21.2 11.1 12.1 5.3 11.0 7.7 10.9 13.8 6.0 8.0 4.2 14.7 18.0 5.6 5.0 12.7 52.2 17.0 1.8 2.0 7.8 19.9 14.2 2.5 13.6 3.2 0.0 6.4 8.8 23.1 19.1 0.0 3.8 4.6 38.1 3.5 19.0 2.2 2.4 37.7 4.7 18.6 9.0 5.0 46.7 9.7 0.0 23.3 13.5 9.5 38.8 23.7 30.7 52.5 17.7 9.7 5.3 5.6 11.1 TWF1 "A6, PTK9" ENSG00000151239 "Twinfilin actin binding protein 1" Q12792 12 43793723-43806375 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018116 Approved Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA018116: AB_1855899" "unprognostic (3.06e-1)" "unprognostic (1.95e-2)" "prognostic favorable (8.29e-4)" "unprognostic (7.39e-3)" "unprognostic (2.35e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (5.19e-2)" "unprognostic (1.13e-2)" "unprognostic (7.30e-2)" "unprognostic (3.11e-3)" "unprognostic (2.51e-1)" "unprognostic (8.48e-2)" "unprognostic (1.03e-1)" "unprognostic (2.19e-1)" "unprognostic (2.95e-1)" "unprognostic (2.62e-1)" 14.2 15.8 15.1 11.0 15.8 11.8 20.4 7.8 13.5 17.9 19.7 8.5 33.1 20.5 13.3 15.4 39.5 13.8 14.8 6.7 14.9 11.9 17.6 31.3 12.6 13.7 16.1 9.6 15.7 21.0 8.8 23.5 14.0 14.6 14.6 20.5 4.6 14.8 32.1 3.5 10.7 24.1 16.0 15.7 10.0 16.9 9.7 12.7 7.1 25.0 19.1 9.6 18.3 19.4 7.8 5.4 10.1 5.2 14.7 8.7 4.1 26.4 19.8 10.3 12.5 27.0 31.3 25.2 37.4 30.7 30.3 23.0 31.7 37.3 7.2 34.8 35.6 17.7 18.1 14.1 26.5 43.2 2.4 16.5 6.6 16.8 15.0 22.1 7.6 8.6 21.3 21.7 31.4 35.2 38.6 26.4 3.6 7.2 8.1 47.0 14.1 3.6 5.2 6.2 0.0 32.6 3.1 11.6 8.1 40.1 33.3 7.7 11.5 31.0 28.3 26.8 15.1 26.4 7.6 25.3 37.5 24.9 29.9 30.9 7.1 7.0 9.8 34.4 19.7 14.1 10.1 3.3 6.7 6.7 4.9 7.6 7.8 8.1 8.3 5.4 3.9 8.1 8.7 5.4 14.7 5.2 3.4 8.0 4.1 15.1 15.8 7.8 13.5 14.9 11.9 16.1 9.6 14.6 12.7 11.9 26.0 17.9 26.8 37.1 20.9 5.7 38.2 29.4 34.2 33.2 19.6 35.6 34.9 42.9 10.5 29.2 58.0 0.0 69.1 48.1 27.0 50.2 4.7 27.9 23.2 19.1 43.1 22.1 27.4 8.5 24.7 18.4 33.7 17.2 45.0 29.0 57.9 63.2 30.1 49.4 29.6 25.8 45.3 10.2 22.2 44.7 71.1 15.4 50.2 53.7 TWIST2 "bHLHa39, Dermo-1, DERMO1" ENSG00000233608 "Twist family bHLH transcription factor 2" Q8WVJ9 2 238848032-238910543 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 34.6" "Group enriched" "Detected in many" 6 "Basal glandular cells: 14.2;Fibroblasts: 25.5;Leydig cells: 44.5;Peritubular cells: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 21 "eosinophil: 11.2" "Lineage enriched" "Detected in single" 52 "granulocytes: 11.2" "Cell line enhanced" "Detected in many" "ASC diff: 33.5;ASC TERT1: 21.3;BJ: 27.2;BJ hTERT+: 85.8;fHDF/TERT166: 38.9;U-2197: 33.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA062870 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA062870: AB_2684888" "unprognostic (1.62e-2)" "unprognostic (1.33e-1)" "unprognostic (3.45e-1)" "unprognostic (3.81e-2)" "unprognostic (2.53e-4)" "unprognostic (1.83e-2)" "unprognostic (4.06e-2)" "unprognostic (1.13e-2)" "unprognostic (2.75e-2)" "unprognostic (2.33e-1)" "unprognostic (2.24e-1)" "unprognostic (1.17e-1)" "unprognostic (2.40e-9)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (1.98e-2)" "unprognostic (4.48e-2)" 25.8 1.3 0.2 4.7 0.6 0.6 21.7 0.1 0.4 34.6 8.4 0.4 4.3 0.6 14.3 6.2 9.1 7.4 5.8 4.3 0.6 0.2 0.7 0.3 4.2 0.9 1.1 0.0 15.6 0.7 0.0 2.1 9.1 0.4 13.1 1.9 3.9 2.2 7.1 4.3 9.7 2.3 12.4 1.7 1.2 3.3 4.6 0.5 0.0 4.0 6.4 3.4 15.9 18.6 0.2 0.0 11.2 0.1 0.0 0.0 0.0 0.0 1.8 0.1 0.0 33.5 21.3 0.0 27.2 85.8 12.7 19.2 0.0 0.0 0.0 0.8 38.9 1.0 0.2 0.3 2.2 9.3 0.0 2.9 0.0 1.6 0.1 5.7 0.0 0.6 4.9 1.2 6.1 5.1 1.5 1.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.3 4.7 0.5 0.9 33.2 0.3 0.0 0.0 0.0 0.1 0.8 1.7 0.0 0.1 11.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.3 0.6 0.2 1.1 0.0 0.4 0.5 0.0 1.6 0.0 14.2 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.7 25.5 2.5 1.1 0.0 2.0 0.0 0.0 4.3 0.0 0.2 44.5 0.0 1.7 0.0 0.0 0.0 0.1 0.0 36.7 0.0 0.0 0.0 5.1 0.5 1.7 1.5 1.4 0.0 0.0 3.0 TYW1 "FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W" ENSG00000198874 "TRNA-yW synthesizing protein 1 homolog" Q9NV66 7 66995173-67239519 "Enzymes, Predicted membrane proteins" "tRNA processing" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723" "unprognostic (1.53e-1)" "unprognostic (5.49e-3)" "unprognostic (1.62e-1)" "unprognostic (3.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.20e-1)" "unprognostic (1.83e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (4.86e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-2)" "unprognostic (4.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (1.79e-2)" 15.4 19.1 10.2 12.3 15.4 11.9 15.1 14.9 15.3 18.8 12.9 21.2 18.2 14.1 22.7 15.3 12.0 15.5 10.8 12.9 10.8 9.8 15.2 17.7 11.1 15.5 14.1 10.8 19.4 23.9 22.9 28.0 13.2 14.5 14.9 16.5 17.8 15.3 14.7 26.2 14.4 12.8 14.0 13.9 15.1 12.6 13.7 13.4 19.7 19.0 13.6 23.3 15.3 15.2 9.6 8.3 3.6 9.1 11.2 11.8 5.3 10.6 13.6 8.3 17.2 12.5 8.7 9.7 11.4 8.7 9.0 8.5 15.5 13.9 18.5 17.5 10.5 12.7 12.6 17.2 14.0 13.1 14.5 13.2 8.0 11.3 10.5 12.4 18.4 10.6 8.9 14.2 12.2 18.8 7.1 8.2 13.5 21.0 11.2 10.3 10.5 11.6 15.5 14.6 18.0 12.2 13.2 11.6 23.3 12.2 10.8 12.8 12.7 13.7 26.6 11.4 16.6 18.1 13.1 9.6 10.4 7.4 8.2 15.5 11.3 15.9 22.3 8.5 17.4 14.3 2.0 7.0 3.6 8.6 7.8 11.7 8.5 9.4 9.8 8.3 9.6 11.5 11.8 2.0 11.2 9.1 6.6 6.8 5.3 10.2 15.4 14.9 15.3 10.8 9.8 14.1 10.8 14.5 13.4 6.0 15.4 4.5 4.9 9.3 9.0 8.1 10.2 9.4 4.5 10.4 3.9 16.5 0.0 6.6 5.5 6.7 4.7 0.0 6.0 10.7 7.7 4.9 33.5 12.5 6.9 3.2 4.6 6.7 4.3 3.1 7.8 8.9 8.5 10.0 12.1 7.7 6.1 3.5 7.8 2.1 11.7 19.4 7.1 17.0 22.7 14.8 12.7 8.5 9.7 2.8 TYW1B "LINC00069, MGC87315, NCRNA00069, RSAFD2" ENSG00000277149 "TRNA-yW synthesizing protein 1 homolog B" 7 72558744-72828198 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 8.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA013568: AB_2668852, HPA014118: AB_2668941, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723" "unprognostic (2.61e-1)" "unprognostic (3.54e-1)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (1.91e-2)" "unprognostic (6.22e-3)" "unprognostic (3.88e-2)" "unprognostic (1.64e-2)" "unprognostic (1.19e-2)" "unprognostic (8.96e-3)" "unprognostic (5.78e-2)" "unprognostic (2.90e-2)" "unprognostic (4.33e-4)" "unprognostic (1.02e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (5.90e-2)" 2.7 1.6 1.8 4.5 3.8 4.4 4.2 6.0 3.3 5.6 2.9 5.8 7.4 1.5 6.0 5.2 3.4 4.1 1.5 2.3 1.9 3.1 7.9 2.9 2.4 3.9 1.7 10.1 5.7 2.0 11.6 3.0 3.4 4.1 4.4 4.7 4.1 5.9 4.4 2.5 2.9 3.6 4.7 3.0 3.1 7.2 3.8 6.0 5.9 1.8 6.0 3.1 1.1 7.5 5.4 5.7 3.5 2.4 3.0 0.9 2.3 2.5 1.0 2.0 1.6 0.5 1.1 1.2 0.5 1.1 1.1 8.0 4.2 7.3 0.7 0.8 1.0 1.1 1.9 0.8 1.3 7.9 2.3 0.7 1.2 4.7 0.8 7.4 2.1 3.8 0.6 1.3 0.9 0.7 0.7 1.6 10.0 7.7 1.1 1.0 2.4 3.8 1.8 3.1 4.6 1.4 5.5 2.6 1.1 0.8 1.8 0.9 1.5 8.4 4.3 3.3 2.1 2.6 3.2 1.8 4.3 9.7 1.4 6.7 8.1 8.3 0.5 2.1 9.7 4.0 3.5 5.7 3.0 1.8 2.8 7.5 2.0 1.8 1.4 5.2 2.3 2.7 4.3 2.4 1.7 5.4 2.0 0.9 0.0 1.3 4.7 1.8 0.0 3.4 4.8 2.5 2.7 1.2 0.0 9.8 3.5 0.0 2.0 3.3 1.4 1.2 0.0 0.6 1.5 2.1 1.6 1.1 1.5 2.9 1.6 0.0 1.3 1.5 0.4 0.9 0.7 0.0 2.8 2.3 1.6 1.0 0.3 0.7 0.5 8.1 0.0 1.7 5.5 5.1 0.0 1.6 2.2 1.1 0.9 UBE2M "hUbc12, UBC12" ENSG00000130725 "Ubiquitin conjugating enzyme E2 M" P61081 19 58555712-58558960 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 134.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004993, HPA054551, HPA057800" Approved Enhanced "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.35e-2)" "unprognostic (1.77e-1)" "unprognostic (1.17e-3)" "unprognostic (3.90e-3)" "unprognostic (4.86e-2)" "unprognostic (1.09e-2)" "unprognostic (3.05e-3)" "unprognostic (1.96e-1)" "unprognostic (1.81e-1)" "unprognostic (8.63e-3)" "unprognostic (1.76e-1)" "unprognostic (5.85e-2)" "unprognostic (8.42e-3)" 18.1 26.0 51.8 16.3 38.9 32.1 13.6 28.4 52.4 15.2 20.4 17.0 20.5 17.8 17.3 19.6 24.9 19.3 17.4 43.2 35.1 33.9 19.6 19.1 16.5 18.1 32.1 30.5 19.4 20.2 25.9 22.8 32.0 26.4 18.4 16.7 15.0 20.9 22.6 61.9 19.2 15.9 19.2 19.8 18.5 17.9 31.8 16.1 32.7 22.2 21.2 19.9 18.2 23.5 3.8 7.6 10.9 4.3 1.8 3.8 2.1 21.5 39.3 19.9 18.9 10.6 12.7 14.5 22.5 19.8 16.3 14.1 23.7 16.8 22.7 17.0 15.9 32.7 14.1 22.1 22.2 12.3 25.8 134.3 33.0 25.3 15.4 26.0 29.8 26.2 13.6 17.4 24.8 29.5 17.9 19.6 21.5 16.0 28.7 21.6 22.1 23.8 27.1 12.6 25.2 34.4 22.2 16.6 29.2 18.8 27.2 35.1 28.7 19.5 23.9 21.0 7.6 14.3 27.4 14.6 51.1 10.4 16.0 39.8 34.8 52.5 24.3 32.5 26.5 33.3 6.8 4.3 4.1 3.5 2.8 2.7 3.4 3.8 3.7 3.1 3.8 3.7 2.5 10.9 1.8 2.7 7.6 3.1 2.1 51.8 38.9 28.4 52.4 35.1 33.9 32.1 30.5 26.4 16.1 6.0 15.4 10.4 28.7 35.8 101.5 34.7 17.8 12.0 6.8 17.4 19.6 18.8 6.6 15.3 18.8 19.0 45.1 23.3 26.0 17.2 20.9 42.6 19.6 28.7 30.5 103.3 39.5 20.3 27.6 27.8 16.1 18.1 33.7 11.8 28.6 85.9 31.9 25.4 13.1 25.9 58.3 25.8 25.5 26.4 7.9 49.7 43.8 15.2 31.9 47.5 UBE2R2 "CDC34B, FLJ20419, MGC10481, UBC3B" ENSG00000107341 "Ubiquitin conjugating enzyme E2 R2" Q712K3 9 33817567-33920404 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 295.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 21.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061000, HPA074334" Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA061000: AB_2684408, HPA074334: " "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (7.08e-2)" "unprognostic (1.53e-1)" "unprognostic (6.55e-2)" "unprognostic (5.15e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.82e-3)" "unprognostic (4.61e-3)" "unprognostic (3.05e-3)" "unprognostic (2.22e-2)" "unprognostic (4.19e-1)" "unprognostic (2.01e-2)" "unprognostic (4.18e-2)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (1.43e-1)" 26.1 19.7 29.4 19.7 26.8 13.9 39.3 23.7 32.3 25.6 24.1 27.9 16.3 28.0 26.1 18.4 25.3 22.3 21.8 29.2 25.5 20.3 22.1 34.5 23.0 27.1 30.5 23.2 29.8 44.5 15.7 13.9 24.6 21.6 21.0 21.4 19.3 18.7 20.8 56.1 28.1 25.7 28.5 24.2 21.6 20.8 34.5 29.6 36.7 19.5 22.5 25.7 35.8 30.5 3.3 4.2 21.9 11.6 5.0 2.1 2.4 16.5 18.1 35.0 15.2 19.3 31.5 10.8 14.7 20.5 17.3 17.3 14.5 12.4 14.1 6.0 20.5 12.6 7.4 18.3 16.8 19.0 23.2 9.7 12.2 20.0 18.4 27.5 14.4 13.3 26.7 25.0 14.1 26.8 27.7 29.0 17.0 11.4 15.2 17.1 9.6 27.1 38.0 19.9 14.2 15.1 25.3 10.6 7.3 18.3 12.5 16.4 19.7 17.2 15.4 11.0 23.2 13.5 17.6 21.7 16.7 15.2 11.5 13.6 9.7 9.1 19.8 15.9 8.4 35.9 12.4 7.5 4.1 2.0 7.5 1.3 3.1 1.9 1.6 4.2 3.3 1.9 1.7 21.9 5.0 11.6 2.6 2.1 2.4 29.4 26.8 23.7 32.3 25.5 20.3 30.5 23.2 21.6 29.6 20.8 30.7 29.5 39.6 93.8 61.0 106.8 56.0 22.7 25.0 21.0 13.7 52.6 13.3 43.8 295.7 77.1 60.6 23.3 59.7 65.2 54.0 68.4 12.7 72.1 68.5 57.2 69.2 77.3 105.2 195.4 62.2 81.9 33.7 49.5 57.3 87.1 69.4 38.6 71.5 49.6 30.1 58.2 41.9 90.2 66.2 105.3 69.2 30.5 49.0 79.7 UBE2T "FANCT, HSPC150" ENSG00000077152 "Ubiquitin conjugating enzyme E2 T" Q9NPD8 1 202331657-202341980 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.8" "Cell type enhanced" "Detected in many" 12 "Erythroid cells: 186.9;Extravillous trophoblasts: 82.9;Spermatocytes: 115.5;Spermatogonia: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002831 Approved Nucleoplasm,Nucleoli NA Yes Nucleoli Nucleoplasm "HPA002831: AB_1080445" "unprognostic (2.38e-3)" "unprognostic (6.37e-2)" "unprognostic (5.27e-2)" "unprognostic (5.19e-2)" "unprognostic (2.81e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (4.79e-6)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "prognostic favorable (6.90e-6)" "unprognostic (6.28e-3)" "unprognostic (2.85e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (5.37e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" 1.9 4.2 9.6 8.5 12.2 20.8 3.9 4.4 13.5 3.5 11.2 0.7 17.2 7.5 4.3 4.1 10.3 2.9 3.0 8.8 8.8 11.2 4.5 2.8 3.1 15.2 8.7 8.2 1.3 0.9 2.4 3.1 8.7 8.2 2.2 13.9 1.9 2.8 7.0 13.1 4.5 6.9 8.1 3.4 6.7 4.0 16.0 1.8 46.8 2.6 12.8 15.3 6.3 4.5 9.0 3.6 1.7 8.6 1.1 11.1 2.9 30.4 29.1 43.3 20.4 4.0 7.4 24.8 33.3 18.6 38.1 26.9 20.7 37.4 35.5 13.2 12.1 28.4 24.9 40.0 19.5 34.4 32.2 22.9 21.7 15.8 23.6 1.8 25.9 26.4 2.6 4.7 29.9 12.5 9.1 22.1 40.1 27.3 29.3 29.8 28.3 46.4 33.1 16.8 31.7 14.8 36.0 46.1 30.8 14.6 14.6 34.1 34.8 23.3 28.7 11.1 13.5 30.2 16.4 10.8 17.2 27.5 30.0 39.5 14.9 29.1 45.2 17.0 27.0 35.6 0.0 0.8 1.7 3.7 2.4 2.8 9.0 5.0 3.9 1.7 6.3 7.3 8.0 0.0 1.1 8.6 3.6 11.1 2.9 9.6 12.2 4.4 13.5 8.8 11.2 8.7 8.2 8.2 1.8 0.0 2.1 10.4 11.0 12.7 5.2 12.2 0.0 6.7 7.9 5.2 0.0 33.9 5.0 11.2 13.0 1.9 2.7 186.9 6.6 82.9 4.8 2.2 8.1 1.7 23.5 9.5 1.2 4.3 1.8 6.6 2.8 5.2 3.3 3.6 9.0 1.3 7.8 0.0 3.9 7.9 0.9 6.5 1.9 115.5 96.9 9.5 18.8 9.5 19.6 4.1 UBE2W "FLJ11011, UBC-16" ENSG00000104343 "Ubiquitin conjugating enzyme E2 W" Q96B02 8 73780097-73878910 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045161, HPA073181" Uncertain Approved Nucleoli NA NA Nucleoli "HPA045161: AB_10960706, HPA073181: AB_2686578" "unprognostic (5.36e-2)" "unprognostic (1.87e-1)" "unprognostic (7.52e-2)" "unprognostic (1.32e-3)" "unprognostic (3.17e-1)" "unprognostic (9.74e-2)" "unprognostic (3.09e-2)" "unprognostic (6.93e-3)" "unprognostic (1.83e-1)" "unprognostic (3.47e-1)" "unprognostic (1.33e-1)" "unprognostic (2.34e-1)" "unprognostic (5.01e-2)" "unprognostic (4.38e-2)" "unprognostic (9.31e-2)" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" 15.2 14.2 13.5 13.3 21.8 17.5 13.4 18.9 24.4 12.0 9.8 11.3 11.0 7.9 13.4 10.5 16.6 9.4 15.2 14.8 19.0 12.3 21.9 23.4 13.6 11.6 11.6 13.0 11.8 12.7 18.4 20.9 13.6 18.4 12.0 11.5 9.5 12.2 10.6 16.4 10.6 8.5 12.8 12.6 13.6 10.0 16.4 12.3 14.7 17.1 4.8 12.9 16.8 12.8 5.0 8.1 23.0 9.4 4.7 4.3 4.8 8.6 5.7 7.0 7.5 12.2 12.5 6.1 9.5 10.5 9.2 9.6 4.7 9.7 4.0 7.9 9.9 14.0 8.8 10.2 9.7 15.3 6.5 6.2 8.1 5.9 7.2 8.2 4.5 11.6 9.8 10.9 10.7 19.2 8.3 11.1 4.5 4.0 8.6 13.9 6.9 9.7 4.8 5.3 12.3 11.2 2.9 7.1 3.4 17.0 9.5 5.2 5.7 7.6 24.7 11.4 7.9 11.5 8.0 9.9 11.1 8.4 8.4 6.9 7.3 7.5 3.0 9.7 7.1 9.5 12.9 9.4 11.5 3.5 8.8 4.3 5.0 3.6 2.6 6.3 4.3 3.2 3.8 23.0 4.7 9.4 8.1 4.0 4.8 13.5 21.8 18.9 24.4 19.0 12.3 11.6 13.0 18.4 12.3 14.9 12.3 22.7 24.3 49.1 33.4 20.4 20.4 9.4 11.4 50.6 15.7 15.8 43.1 21.3 107.9 29.2 13.4 116.8 15.1 16.5 23.4 29.3 20.7 25.1 35.4 39.7 22.3 20.3 43.6 45.7 19.0 46.1 40.5 76.7 12.2 23.6 17.3 14.0 17.7 41.3 27.1 19.4 60.9 31.4 29.8 56.3 46.1 34.9 12.5 36.9 UBFD1 "FLJ38870, FLJ42145, UBPH" ENSG00000103353 "Ubiquitin family domain containing 1" O14562 16 23557362-23574389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051746 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA051746: AB_2681587" "unprognostic (2.70e-2)" "unprognostic (1.84e-1)" "unprognostic (9.45e-3)" "unprognostic (2.31e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-2)" "unprognostic (2.86e-3)" "unprognostic (1.63e-1)" "unprognostic (2.17e-1)" "unprognostic (3.86e-1)" "unprognostic (8.28e-2)" "unprognostic (8.06e-2)" "unprognostic (6.20e-3)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "unprognostic (3.13e-1)" "unprognostic (1.46e-1)" 10.2 16.2 11.9 8.9 13.0 7.1 10.0 23.1 19.5 11.7 9.2 9.4 15.2 6.1 16.4 14.9 9.6 13.9 11.8 21.2 11.3 17.6 12.3 15.4 7.6 8.7 13.0 11.8 14.5 17.5 28.5 17.2 16.5 13.6 12.5 9.4 12.3 12.3 12.6 52.8 7.6 7.0 14.6 7.4 9.1 8.1 27.6 7.0 16.2 16.4 11.1 11.7 10.9 12.9 2.8 4.1 1.0 1.9 3.0 4.0 1.1 6.5 14.8 21.1 15.2 24.2 30.2 19.8 20.2 16.6 16.1 15.2 11.2 11.2 14.5 31.6 24.7 10.9 9.0 33.2 13.4 20.8 24.0 19.6 7.5 13.4 24.4 12.9 7.9 14.6 21.5 10.1 15.7 14.8 24.9 15.5 11.8 19.1 8.0 17.7 13.6 11.2 14.3 50.3 10.7 6.6 20.5 13.0 11.9 15.1 5.5 21.0 19.2 6.7 13.1 11.8 21.1 17.9 11.7 16.4 9.1 10.5 9.8 10.5 12.0 12.0 8.8 16.6 9.5 13.7 0.0 1.3 1.0 4.0 1.9 2.3 1.6 2.8 3.9 3.0 2.8 1.7 2.3 0.0 3.0 1.0 4.1 2.3 1.1 11.9 13.0 23.1 19.5 11.3 17.6 13.0 11.8 13.6 7.0 6.0 1.6 3.0 8.4 7.8 11.4 31.3 10.2 5.3 3.4 19.2 21.6 16.4 13.3 11.9 38.7 10.5 5.5 0.0 9.9 21.4 13.5 12.6 0.0 16.6 11.5 6.4 6.9 4.3 7.5 54.1 17.3 4.3 10.1 10.8 9.3 10.8 9.0 7.6 9.2 13.6 14.1 25.8 8.2 20.4 22.5 12.4 30.1 5.3 8.6 10.7 UBLCP1 "CPUB1, MGC10067" ENSG00000164332 "Ubiquitin like domain containing CTD phosphatase 1" Q8WVY7 5 159263081-159286040 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039615 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA039615: AB_10674425" "unprognostic (1.25e-1)" "unprognostic (3.10e-1)" "unprognostic (6.04e-3)" "unprognostic (3.45e-2)" "unprognostic (7.08e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (4.46e-5)" "unprognostic (4.01e-1)" "unprognostic (2.14e-2)" "unprognostic (1.98e-1)" "unprognostic (1.91e-2)" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (1.87e-1)" "unprognostic (1.18e-1)" "unprognostic (6.39e-2)" "unprognostic (2.51e-2)" 17.1 16.0 16.7 18.4 19.7 16.7 16.3 20.2 33.0 18.5 12.5 12.2 11.4 9.8 22.5 13.1 22.2 14.7 14.5 13.1 20.9 19.1 17.5 14.4 17.8 24.1 19.7 22.7 16.8 12.6 18.0 23.9 19.6 36.7 14.7 14.7 10.9 15.4 17.6 15.3 14.2 13.8 19.5 20.4 22.2 13.3 24.2 15.4 26.8 14.4 16.1 30.1 18.8 16.8 11.9 10.8 21.9 13.9 25.5 19.2 8.2 14.6 10.7 22.2 24.1 23.1 21.4 13.1 16.0 24.5 16.5 22.0 8.7 10.2 13.1 17.7 20.0 23.7 11.2 13.7 30.8 28.8 26.2 13.5 10.1 9.4 7.9 29.2 22.8 15.9 18.9 28.9 14.9 29.9 13.2 15.6 13.9 13.8 17.8 22.9 4.7 12.3 6.9 15.4 7.3 6.5 15.7 21.8 15.3 16.3 11.3 11.8 15.7 16.2 10.8 37.7 14.0 11.4 15.2 16.7 17.0 14.2 8.8 20.2 14.3 14.3 20.0 18.0 15.8 25.1 21.9 6.5 16.1 16.6 13.5 18.6 11.9 15.8 17.3 8.5 10.9 18.5 19.2 19.4 25.5 13.9 10.8 16.9 8.2 16.7 19.7 20.2 33.0 20.9 19.1 19.7 22.7 36.7 15.4 11.9 38.2 22.7 8.2 14.2 9.9 12.2 10.2 34.8 30.7 14.0 3.9 27.7 29.9 18.9 3.4 20.0 9.5 46.7 21.7 14.9 21.7 11.4 43.9 14.0 33.1 19.1 10.3 30.7 42.1 2.2 19.0 27.8 16.9 25.2 14.0 17.9 18.8 8.6 23.3 23.8 13.4 19.4 14.4 70.2 48.5 18.1 14.9 21.7 13.9 7.9 UBR3 "DKFZp434P117, FLJ37422, KIAA2024, ZNF650" ENSG00000144357 "Ubiquitin protein ligase E3 component n-recognin 3 (putative)" Q6ZT12 2 169827458-170084131 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.3" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 97.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035390 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA035390: AB_10670699" "unprognostic (1.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.59e-2)" "unprognostic (1.27e-1)" "unprognostic (2.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.26e-1)" "unprognostic (3.19e-2)" "unprognostic (5.56e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (2.18e-1)" 11.9 15.5 10.9 6.1 18.3 5.4 9.6 15.5 18.9 9.9 10.0 9.8 9.1 6.7 11.5 7.1 10.7 8.1 7.8 23.1 10.3 7.2 12.9 16.9 9.2 5.6 11.9 14.0 8.9 9.8 20.9 14.9 7.2 14.7 11.2 7.3 8.0 11.1 9.2 76.3 11.5 8.4 9.6 10.2 6.9 9.2 7.9 11.4 6.3 14.9 10.9 6.0 12.8 8.7 2.0 2.8 1.9 2.1 2.4 4.3 1.2 8.9 7.6 8.1 10.7 16.2 12.9 6.8 16.2 9.4 9.4 7.6 11.7 5.7 10.2 14.1 12.6 7.6 11.9 9.7 8.2 11.7 10.5 8.3 37.1 8.1 12.3 8.1 12.2 12.0 7.7 7.7 12.3 8.2 7.5 9.2 5.1 19.3 11.1 16.0 8.4 7.9 6.0 6.3 9.1 6.4 7.6 13.3 10.8 6.8 12.7 16.0 8.7 11.4 10.5 6.5 6.8 6.9 6.9 11.7 14.2 5.7 11.1 10.2 9.0 7.0 9.4 11.7 7.2 7.8 0.0 2.1 1.7 3.2 1.8 4.2 2.0 1.9 2.7 2.8 1.2 3.3 4.3 1.9 2.4 1.6 2.4 3.1 1.2 10.9 18.3 15.5 18.6 10.3 7.2 11.9 14.0 14.7 11.4 41.7 21.1 7.5 11.4 23.0 40.4 97.6 15.3 9.4 19.4 12.2 76.6 14.8 3.3 8.0 6.6 23.7 13.4 23.3 9.5 6.8 18.3 22.3 16.1 32.7 8.9 60.4 16.0 31.9 21.5 7.4 23.9 16.8 15.1 4.6 12.5 63.3 9.4 14.0 18.0 10.2 53.7 25.8 26.4 13.0 7.6 25.3 19.2 13.1 9.9 12.3 UBXN11 "SOC, SOCI, UBXD5" ENSG00000158062 "UBX domain protein 11" Q5T124 1 26281328-26318363 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 103.4;Late spermatids: 252.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 32.4;intermediate monocyte: 28.1;myeloid DC: 16.6;non-classical monocyte: 22.5" "Group enriched" "Detected in all" 4 "dendritic cells: 16.6;monocytes: 32.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028600, HPA031357" Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA028600: AB_10604001, HPA031357: AB_2673840" "unprognostic (1.78e-3)" "prognostic favorable (2.54e-5)" "unprognostic (8.18e-2)" "prognostic favorable (1.90e-4)" "unprognostic (2.53e-1)" "prognostic favorable (4.90e-4)" "prognostic unfavorable (5.90e-6)" "unprognostic (8.41e-2)" "unprognostic (2.70e-1)" "unprognostic (4.41e-2)" "unprognostic (1.79e-3)" "unprognostic (1.89e-2)" "unprognostic (5.59e-3)" "unprognostic (5.00e-2)" "unprognostic (2.20e-1)" "unprognostic (3.25e-1)" "unprognostic (1.31e-2)" 5.4 7.6 16.6 10.2 25.7 18.9 5.6 7.0 21.5 8.6 4.6 7.9 9.0 4.2 6.7 23.8 4.3 35.4 8.4 5.9 17.0 15.0 9.3 3.7 12.0 8.2 9.8 12.3 9.7 8.2 8.4 18.3 5.2 12.7 5.4 3.5 13.6 8.3 8.3 6.2 6.0 4.4 5.0 5.6 11.7 4.8 27.4 8.5 6.2 15.7 2.7 5.7 6.1 3.9 5.3 16.6 2.4 32.4 1.9 5.7 13.2 17.4 7.9 3.9 7.9 2.9 2.2 13.7 3.9 6.1 10.8 7.9 3.1 15.5 10.2 5.9 2.4 7.2 9.5 2.4 6.3 2.8 5.1 9.3 1.7 11.2 7.5 5.1 7.4 3.5 3.3 6.8 18.2 4.6 3.4 3.0 7.5 6.6 7.1 3.6 7.8 4.2 3.6 7.9 4.9 6.1 8.7 2.9 9.2 6.0 2.6 18.7 4.4 9.6 9.1 6.7 2.1 7.0 7.2 2.8 6.3 9.5 9.3 5.7 6.7 19.0 11.6 7.7 10.3 5.1 0.7 32.4 1.5 3.4 28.1 4.1 4.4 5.0 3.9 16.6 5.3 5.7 3.6 2.4 1.9 22.5 2.5 4.1 13.2 16.6 25.7 7.0 21.5 17.0 15.0 9.8 12.3 12.7 8.5 0.0 1.4 9.1 13.3 19.1 9.8 1.1 7.6 17.4 7.9 22.7 21.6 7.5 11.6 11.5 103.4 4.4 1.7 0.0 7.5 17.4 10.8 8.6 10.3 2.4 19.7 22.3 8.6 7.4 69.6 252.6 11.8 30.3 10.1 3.6 4.3 12.1 6.8 2.9 9.6 21.2 50.8 19.4 7.8 13.9 22.6 11.7 6.1 13.1 5.6 11.0 UBXN8 "D8S2298E, REP8, UBXD6" ENSG00000104691 "UBX domain protein 8" O00124 8 30732247-30767006 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 30.6" "Group enriched" "Detected in many" 4 "Early spermatids: 162.1;Hepatocytes: 56.2;Late spermatids: 132.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017725, HPA077538" Enhanced Supported "Nucleoplasm,Nucleoli,Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "Nucleoplasm, Nucleoli" "HPA017725: AB_1847462, HPA077538: AB_2686844" "unprognostic (3.00e-2)" "unprognostic (2.30e-1)" "prognostic favorable (6.13e-4)" "unprognostic (7.71e-2)" "unprognostic (2.24e-1)" "unprognostic (1.03e-1)" "unprognostic (2.41e-1)" "unprognostic (1.84e-2)" "unprognostic (1.90e-1)" "unprognostic (5.13e-2)" "unprognostic (1.58e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.25e-5)" "unprognostic (2.49e-1)" "unprognostic (1.96e-1)" "unprognostic (1.51e-1)" "unprognostic (6.88e-2)" 5.0 5.3 3.9 1.4 4.8 1.4 4.3 1.5 9.2 3.0 3.5 4.0 6.7 3.1 3.8 14.3 4.1 3.6 3.8 2.8 5.7 8.2 21.5 2.1 3.9 7.6 4.0 30.6 10.3 6.2 3.5 6.2 6.2 4.8 4.7 1.6 1.8 6.1 1.7 4.1 2.9 2.9 7.1 5.7 3.3 11.5 6.1 0.9 9.1 2.8 2.3 2.9 3.7 6.0 8.2 1.0 6.1 3.3 8.4 3.4 7.6 7.7 5.6 5.8 9.1 12.2 6.3 13.7 8.0 7.5 9.2 12.2 2.8 12.2 11.3 11.1 12.4 6.8 1.1 7.6 11.6 6.4 12.5 34.3 6.3 14.9 13.7 7.8 19.4 9.6 7.9 12.0 5.9 6.4 6.5 5.6 33.5 9.2 16.5 7.2 7.9 6.0 10.8 22.8 5.8 9.5 5.4 8.5 12.8 10.0 3.2 8.1 3.8 11.3 24.7 7.0 8.4 13.6 8.3 8.5 3.7 3.8 12.7 4.0 12.5 9.2 7.6 12.6 12.1 0.0 6.0 0.7 8.4 6.1 7.3 6.0 4.5 8.0 6.7 2.9 4.4 7.4 1.0 3.3 3.0 8.2 4.3 3.4 3.0 8.0 3.0 4.1 0.0 1.9 3.2 15.3 1.4 5.7 14.0 19.6 20.6 6.6 7.1 162.1 6.2 6.3 0.0 4.5 16.0 9.4 4.1 13.9 56.2 19.0 11.1 8.2 27.0 14.2 132.0 13.3 6.9 0.0 10.0 6.4 6.6 3.9 3.5 9.2 22.0 1.8 6.5 3.9 14.1 20.4 0.0 12.7 7.2 10.0 2.4 UCHL5 "CGI-70, INO80R, UCH37" ENSG00000116750 "Ubiquitin C-terminal hydrolase L5" Q9Y5K5 1 193012250-193060080 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005908, HPA006069" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA005908: AB_1858585, HPA006069: " "unprognostic (3.66e-2)" "unprognostic (3.84e-3)" "unprognostic (5.17e-2)" "unprognostic (5.98e-2)" "unprognostic (1.20e-2)" "unprognostic (1.20e-1)" "unprognostic (3.50e-2)" "unprognostic (7.41e-2)" "unprognostic (1.96e-2)" "unprognostic (1.04e-3)" "unprognostic (3.44e-3)" "unprognostic (6.92e-2)" "unprognostic (6.41e-3)" "unprognostic (1.51e-1)" "unprognostic (7.15e-2)" "prognostic unfavorable (7.10e-5)" "unprognostic (4.33e-2)" 15.7 18.3 20.1 16.1 26.2 16.0 18.2 30.1 34.8 10.9 17.7 11.5 12.6 19.0 12.5 14.7 26.1 10.7 11.9 22.0 21.6 20.6 21.6 28.3 12.4 19.9 21.3 29.4 13.4 24.8 15.6 16.2 17.8 33.3 17.8 18.8 10.3 19.3 12.9 29.1 16.7 18.0 13.9 20.1 17.3 14.0 9.9 17.5 20.0 15.1 19.1 23.0 14.8 14.8 22.5 20.8 23.8 21.1 35.6 30.9 20.9 33.6 18.7 16.2 16.6 9.5 9.6 19.3 19.8 10.1 19.0 16.5 17.7 22.9 26.4 19.2 11.0 11.5 20.9 21.6 25.6 25.2 27.2 15.5 31.3 24.2 23.4 15.2 49.1 17.6 8.9 11.4 27.3 24.2 8.7 18.7 26.6 68.6 21.6 16.1 27.2 36.1 18.2 15.0 23.1 11.8 21.0 18.2 51.4 17.7 19.8 16.5 20.3 17.8 25.8 27.6 17.9 21.0 24.8 12.2 17.8 5.4 18.0 31.5 16.8 26.0 29.8 10.7 30.6 30.3 23.8 16.5 19.0 28.3 19.5 30.9 22.5 25.9 26.9 19.4 18.0 28.2 30.5 10.0 35.6 21.1 20.8 24.8 20.9 20.1 26.2 30.1 34.8 21.6 20.6 21.3 29.4 33.3 17.5 8.9 24.6 13.7 12.3 21.6 18.3 68.2 15.3 26.8 29.6 26.2 41.2 31.3 38.1 21.6 1.8 20.4 19.5 0.0 24.6 27.1 16.4 17.3 53.3 22.2 24.8 23.8 10.4 18.4 20.3 3.4 13.8 24.5 16.9 19.8 18.3 25.7 20.3 7.0 16.3 30.8 41.8 19.4 17.0 14.0 16.8 26.2 21.1 27.7 20.6 10.5 UCK1 "FLJ12255, URK1" ENSG00000130717 "Uridine-cytidine kinase 1" Q9HA47 9 131523801-131531268 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050969, HPA070526" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA050969: AB_2681294, HPA070526: " "unprognostic (2.20e-1)" "prognostic favorable (3.19e-4)" "unprognostic (1.16e-2)" "unprognostic (1.74e-3)" "unprognostic (7.29e-2)" "unprognostic (1.43e-1)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (1.36e-3)" "unprognostic (1.54e-1)" "prognostic favorable (2.21e-7)" "unprognostic (5.11e-2)" "unprognostic (3.29e-2)" "unprognostic (1.74e-1)" "unprognostic (1.07e-1)" 13.2 15.9 21.7 13.7 22.5 13.7 15.6 29.9 23.2 15.0 15.6 17.3 20.8 11.4 12.2 19.3 14.5 17.6 16.5 21.0 19.6 18.4 18.3 26.7 12.7 12.9 20.4 19.1 21.3 24.0 17.6 14.4 16.4 14.8 14.9 9.2 17.6 24.1 18.3 30.0 12.0 12.2 14.8 19.9 12.1 13.4 15.7 15.6 12.5 18.5 10.8 11.5 13.6 9.4 7.9 6.6 9.4 7.8 6.8 13.5 6.1 7.0 15.7 18.2 23.3 12.9 9.2 15.5 11.5 17.0 20.0 15.2 15.6 6.5 7.7 7.0 13.8 15.6 13.8 16.9 14.7 8.6 14.1 15.7 7.2 23.6 9.8 18.5 11.8 10.7 10.3 13.9 16.1 11.7 12.1 12.2 19.2 9.0 5.9 14.6 28.2 16.0 6.0 21.5 13.9 15.7 15.4 28.1 12.9 12.8 6.7 24.6 15.5 16.6 12.7 17.9 8.7 24.8 7.0 8.9 22.2 11.3 13.7 11.2 12.2 15.6 9.8 11.0 8.3 15.4 2.3 6.2 9.4 8.5 7.8 11.3 7.9 10.1 7.6 5.7 7.9 13.5 6.8 4.1 6.8 2.7 6.6 12.3 6.1 21.7 22.5 29.9 23.2 19.6 18.4 20.4 19.1 14.8 15.6 14.9 5.3 14.9 10.3 12.7 17.5 12.9 7.6 0.0 3.4 14.0 7.9 26.0 24.9 19.6 15.1 13.4 17.0 0.0 22.9 12.0 15.5 11.2 2.3 19.4 22.3 25.4 11.6 11.1 11.1 20.2 16.4 8.2 15.1 27.1 11.8 17.7 15.6 11.6 18.7 23.7 10.2 19.4 18.9 29.3 29.4 10.9 21.5 9.6 11.8 7.1 UFD1 UFD1L ENSG00000070010 "Ubiquitin recognition factor in ER associated degradation 1" Q92890 22 19449910-19479215 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 105.1;Ductal cells: 98.8;Exocrine glandular cells: 123.6;monocytes: 132.6;Pancreatic endocrine cells: 115.9;Syncytiotrophoblasts: 142.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 131.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030286, HPA030287" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA030286: , HPA030287: AB_10601830" "unprognostic (2.52e-1)" "unprognostic (5.41e-2)" "unprognostic (1.95e-3)" "unprognostic (7.61e-2)" "unprognostic (3.50e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-3)" "unprognostic (8.82e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.50e-8)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" 27.8 28.0 22.7 24.3 38.0 38.7 23.9 25.3 30.4 21.1 28.9 23.3 24.7 21.7 32.8 40.3 31.6 21.3 21.7 35.6 21.9 22.9 28.0 46.6 24.6 34.8 44.3 15.9 22.4 34.7 22.5 22.6 31.6 33.0 21.7 27.7 21.9 26.7 24.4 57.9 27.3 24.7 28.3 39.7 26.7 26.2 31.8 29.9 37.8 27.8 26.9 31.7 23.9 23.7 27.7 35.3 53.5 42.8 31.1 67.6 37.5 31.8 23.2 19.8 30.0 16.3 11.5 15.2 26.4 26.4 36.5 33.8 25.7 13.9 22.3 20.5 22.1 16.8 27.7 23.2 23.1 31.8 41.0 24.5 23.5 16.4 20.3 15.5 37.2 32.1 10.5 23.8 31.1 15.3 10.7 29.2 11.8 131.8 43.0 22.2 46.3 23.9 22.8 14.2 40.2 19.7 29.1 46.9 8.6 22.4 30.1 16.3 18.3 20.7 22.5 20.7 21.6 13.5 17.9 31.7 30.8 41.9 25.6 28.3 18.4 36.6 29.0 25.9 19.0 28.1 39.8 29.0 47.8 36.1 42.8 34.7 27.7 41.6 37.3 25.5 23.9 35.9 35.1 53.5 31.1 41.1 35.3 67.6 37.5 22.7 38.0 25.3 30.4 21.9 22.9 44.3 15.9 33.0 29.9 23.8 34.6 0.0 0.0 0.0 0.0 0.0 0.0 50.9 30.7 26.2 0.0 105.1 71.3 98.8 0.0 0.0 0.0 0.0 123.6 90.9 0.0 0.0 25.6 0.0 79.3 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 132.6 0.0 0.0 115.9 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 142.5 0.0 0.0 0.0 UPF3B "HUPF3B, MRX62, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X" ENSG00000125351 "UPF3B, regulator of nonsense mediated mRNA decay" Q9BZI7 X 119805311-119852998 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001592, HPA001800, HPA001882" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No Cytosol "Nucleoplasm, Nucleoli" "HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474" "unprognostic (1.79e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" "unprognostic (3.64e-3)" "unprognostic (8.58e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.52e-6)" "unprognostic (6.61e-2)" "prognostic unfavorable (5.39e-4)" "unprognostic (5.74e-2)" "unprognostic (4.51e-2)" "unprognostic (8.63e-3)" "prognostic unfavorable (1.44e-7)" "unprognostic (8.67e-2)" "unprognostic (1.04e-1)" "unprognostic (2.34e-1)" "unprognostic (8.95e-2)" 9.7 10.3 19.4 11.5 21.9 14.5 10.8 34.1 24.0 10.2 13.0 9.3 12.8 14.2 14.6 13.5 13.0 8.8 8.4 7.8 16.9 17.5 10.0 12.4 9.0 17.2 16.5 21.7 14.8 8.7 14.3 26.7 10.5 17.2 12.4 13.2 9.1 9.7 14.4 14.5 18.6 11.1 14.2 21.7 12.9 9.9 15.0 21.0 9.9 12.5 11.5 18.3 12.6 12.9 17.5 10.0 7.1 5.9 7.9 8.1 2.7 11.9 7.2 15.1 12.2 6.9 4.5 9.7 11.5 6.5 9.0 8.0 13.5 8.6 21.5 9.8 4.8 12.9 11.4 19.5 6.9 11.5 12.2 14.3 19.9 24.0 7.1 7.9 21.5 9.9 3.9 5.3 15.4 18.8 8.2 8.3 12.9 19.2 18.0 7.5 14.5 15.1 27.0 29.1 15.3 19.8 14.8 17.3 15.8 7.3 6.0 20.1 13.9 23.5 9.5 17.2 16.4 5.0 12.6 7.2 9.4 7.2 15.0 24.3 9.9 11.0 29.1 7.5 31.7 10.9 7.1 5.3 6.8 7.5 5.1 5.7 13.8 7.0 5.9 3.8 17.5 7.6 8.1 5.9 7.9 5.9 10.0 7.8 2.7 19.4 21.9 34.1 24.0 16.9 17.5 16.5 21.7 17.2 21.0 29.8 25.5 28.9 28.2 33.5 47.9 17.1 15.3 42.8 47.8 24.4 53.0 33.2 5.0 27.3 107.2 24.5 27.1 0.0 22.8 39.7 29.2 18.5 57.7 19.2 25.4 27.0 26.6 20.3 15.4 17.6 28.1 32.2 23.6 49.5 21.8 39.5 18.6 31.7 30.8 12.4 94.7 12.9 36.2 32.2 32.4 33.2 53.8 34.8 32.2 21.3 URB2 "KIAA0133, NET10, NPA2" ENSG00000135763 "URB2 ribosome biogenesis 2 homolog (S. cerevisiae)" Q14146 1 229626234-229660199 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 27.5;Rod photoreceptor cells: 17.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008902, HPA046788" Uncertain Enhanced Nucleoli NA NA Nucleoli "HPA008902: AB_2213805, HPA046788: AB_2679807" "unprognostic (1.26e-1)" "unprognostic (4.03e-3)" "unprognostic (2.16e-2)" "unprognostic (3.63e-2)" "unprognostic (1.79e-1)" "unprognostic (2.48e-1)" "unprognostic (5.53e-3)" "unprognostic (1.67e-1)" "unprognostic (1.02e-1)" "unprognostic (1.17e-1)" "unprognostic (1.59e-1)" "unprognostic (2.61e-2)" "unprognostic (1.62e-3)" "unprognostic (7.81e-2)" "unprognostic (2.72e-1)" "unprognostic (1.69e-2)" "unprognostic (1.45e-1)" 9.8 6.2 7.0 7.2 7.8 7.6 6.5 5.8 11.0 4.7 5.0 9.5 2.9 4.3 7.4 3.8 8.0 6.9 5.2 4.9 5.3 3.7 4.3 10.4 4.9 12.0 8.2 7.7 7.2 13.7 6.5 9.9 6.5 8.0 5.0 4.9 6.4 5.8 3.8 14.0 5.8 5.3 6.6 5.8 8.4 5.8 15.6 7.2 10.3 4.6 6.2 9.0 5.5 4.8 2.7 2.7 0.5 3.9 1.9 5.6 2.9 7.3 11.1 7.2 9.6 4.6 3.8 22.1 5.9 3.6 9.1 6.9 11.0 5.8 15.2 6.8 4.1 4.8 10.2 17.8 7.2 8.4 7.4 17.0 9.5 9.3 6.4 4.3 13.8 8.2 3.7 5.3 9.0 7.1 2.3 4.3 9.0 20.0 7.1 5.6 5.8 15.4 6.8 24.2 13.1 7.4 17.3 10.3 15.2 4.1 9.3 10.8 13.3 6.9 7.3 5.8 2.6 8.2 7.9 4.7 7.5 9.5 9.5 16.7 7.9 7.6 22.9 4.0 10.4 13.6 0.2 1.9 0.5 3.0 3.9 5.6 2.0 2.8 3.6 2.7 2.7 4.3 3.3 0.2 1.9 1.3 1.6 3.1 2.9 7.0 7.8 5.8 11.0 5.3 3.7 8.2 7.7 8.0 7.2 0.0 0.6 1.9 4.7 9.0 6.8 2.4 2.5 0.0 2.3 5.2 27.5 4.2 0.0 2.3 0.3 5.5 0.9 0.0 2.4 8.6 2.7 4.3 0.0 2.9 2.5 3.2 6.3 4.3 1.8 0.8 2.0 2.4 5.0 2.8 1.8 2.7 2.3 0.0 3.2 1.6 17.2 0.0 3.0 5.2 2.9 8.0 2.7 0.0 3.0 3.1 USF3 KIAA2018 ENSG00000176542 "Upstream transcription factor family member 3" Q68DE3 3 113648385-113696646 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029243, HPA029245" Uncertain Uncertain Nucleoplasm,Nucleoli,Centrosome NA NA "Nucleoplasm, Nucleoli" Centrosome "HPA029243: AB_10611114, HPA029245: AB_10600443" "unprognostic (2.80e-2)" "unprognostic (2.80e-1)" "unprognostic (4.21e-2)" "unprognostic (7.80e-2)" "unprognostic (2.25e-2)" "unprognostic (1.96e-2)" "unprognostic (3.53e-1)" "unprognostic (2.62e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (8.74e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (3.28e-1)" "unprognostic (5.55e-2)" 9.0 5.1 8.8 11.0 7.3 13.8 11.4 13.9 7.5 7.2 12.2 5.3 5.4 4.8 5.8 13.3 7.0 6.3 5.3 8.1 7.6 5.5 12.7 24.0 6.1 9.2 6.3 5.6 6.9 10.8 14.4 8.9 4.9 6.5 6.2 6.7 6.4 8.3 5.4 28.7 11.4 14.7 8.3 11.2 12.0 7.3 4.8 6.9 13.3 7.1 11.5 8.9 6.1 6.0 5.9 5.1 6.9 3.7 2.6 3.1 1.4 5.2 4.0 5.0 4.7 12.1 4.7 3.4 2.1 3.4 2.1 2.0 3.7 2.2 9.3 3.9 5.4 3.4 3.3 5.3 4.2 4.0 2.8 2.2 6.6 2.5 6.1 3.6 12.1 7.4 6.7 7.7 3.9 4.4 3.2 5.0 7.1 3.1 5.0 4.4 7.4 6.7 6.7 3.6 7.1 4.1 2.9 3.9 3.7 7.5 7.4 2.4 3.6 5.1 2.9 6.1 3.6 3.9 9.0 6.8 3.3 7.2 1.8 3.0 5.8 3.2 11.1 3.8 5.1 2.4 4.1 2.4 3.5 3.1 2.8 2.3 2.2 2.2 2.3 1.7 5.9 2.7 2.8 6.9 2.6 3.7 5.1 1.1 1.4 8.8 7.3 13.9 7.5 7.6 5.5 6.3 5.6 6.5 6.9 20.8 10.8 4.8 9.6 0.0 20.4 0.0 10.2 22.7 11.4 24.4 13.7 6.7 21.6 7.4 4.6 10.8 9.7 0.0 10.3 3.1 5.4 14.9 4.7 36.5 6.7 12.7 5.8 20.3 16.4 9.1 12.0 10.4 0.0 3.6 13.2 11.3 10.2 16.5 13.1 18.7 17.2 6.5 0.0 9.5 3.9 0.0 12.1 13.4 13.3 17.8 USP36 "FLJ12851, KIAA1453" ENSG00000055483 "Ubiquitin specific peptidase 36" Q9P275 17 78787381-78841441 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012082, HPA012395, HPA052860" Uncertain Supported Enhanced "Nucleoli,Nucleoli rim,Nuclear speckles" NA NA "Nucleoli, Nucleoli rim" "Nuclear speckles" "HPA012082: AB_1858682, HPA012395: , HPA052860: AB_2681974" "unprognostic (1.94e-2)" "unprognostic (2.80e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.18e-5)" "unprognostic (9.35e-2)" "unprognostic (1.98e-1)" "unprognostic (2.50e-3)" "unprognostic (1.35e-1)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "unprognostic (1.68e-2)" "unprognostic (2.78e-2)" "unprognostic (1.31e-2)" "unprognostic (1.45e-1)" "unprognostic (1.81e-1)" "unprognostic (4.03e-3)" "unprognostic (1.78e-1)" 26.3 23.4 12.9 21.3 16.0 36.5 28.1 28.3 17.4 17.2 16.4 25.4 19.2 12.3 25.1 22.2 14.6 18.0 21.9 17.4 10.4 11.2 15.9 16.4 20.0 17.2 17.5 16.0 41.3 33.6 19.6 30.0 23.4 14.6 21.0 15.1 20.4 21.8 45.5 19.5 29.3 15.1 25.2 14.5 18.2 17.3 20.8 13.7 12.8 19.3 11.2 22.2 24.6 18.1 6.7 12.4 8.9 5.3 5.6 8.8 2.5 16.0 19.4 5.7 10.6 12.3 13.7 11.0 13.2 13.4 12.7 8.6 18.8 8.1 20.5 6.7 11.7 13.8 11.8 13.4 9.8 22.8 4.9 20.3 18.7 28.3 19.6 12.7 20.5 10.3 11.9 16.3 18.1 40.6 9.8 11.0 9.3 14.9 21.7 10.4 12.3 18.6 20.8 8.8 12.0 15.6 14.4 12.6 13.8 8.0 17.0 16.9 10.3 9.5 44.3 24.0 13.0 11.4 13.1 9.3 30.1 14.0 17.5 23.3 16.1 6.3 25.3 11.8 16.0 9.4 8.9 3.9 3.1 7.6 5.3 8.8 6.4 7.2 6.4 2.3 6.7 8.0 7.7 5.7 5.6 3.3 12.4 4.8 2.5 12.9 16.0 28.3 17.4 10.4 11.2 17.5 16.0 14.6 13.7 11.9 41.5 16.3 21.0 45.9 31.4 13.5 15.3 12.0 26.1 14.0 31.4 6.9 5.0 8.7 12.1 20.4 6.8 0.0 8.3 8.9 25.9 22.8 19.7 12.4 34.2 25.4 17.7 12.3 20.6 6.1 10.9 34.8 28.7 10.8 13.6 17.3 10.7 8.6 11.7 4.1 32.5 6.5 22.7 14.2 10.6 37.9 10.8 30.5 14.0 20.4 USP37 KIAA1594 ENSG00000135913 "Ubiquitin specific peptidase 37" Q86T82 2 218450251-218568361 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 117.3;Late spermatids: 116.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045160 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045160: AB_10795620" "unprognostic (7.00e-2)" "unprognostic (2.29e-1)" "unprognostic (8.83e-2)" "unprognostic (9.19e-4)" "unprognostic (1.83e-1)" "prognostic favorable (2.85e-4)" "unprognostic (2.18e-2)" "unprognostic (1.14e-1)" "unprognostic (9.66e-3)" "unprognostic (1.17e-1)" "unprognostic (3.78e-3)" "unprognostic (1.11e-1)" "unprognostic (3.82e-2)" "unprognostic (3.26e-1)" "unprognostic (2.87e-1)" "unprognostic (6.69e-2)" "unprognostic (6.41e-3)" 10.4 8.4 9.2 9.7 10.5 19.2 9.0 16.2 10.0 8.3 6.6 10.4 8.0 5.8 9.6 15.8 8.2 7.8 7.0 6.9 7.4 5.5 6.1 7.4 8.1 10.5 8.7 7.8 15.3 6.9 10.7 17.1 8.5 8.7 7.3 7.0 7.4 9.7 9.6 11.1 9.9 7.2 8.1 10.2 7.0 6.6 22.2 10.5 13.4 9.8 5.4 9.4 10.5 9.1 7.4 6.1 7.4 4.8 5.9 9.0 2.5 7.4 5.4 11.5 8.8 3.0 3.7 9.8 5.7 4.1 9.9 11.2 10.2 5.9 6.8 6.2 4.4 7.6 7.1 12.5 6.3 10.9 9.2 6.6 18.3 11.0 6.7 3.4 11.9 9.2 2.0 3.8 10.4 7.5 3.6 4.2 11.9 13.2 13.1 6.2 5.5 15.3 8.2 9.8 4.8 4.7 12.4 17.2 6.2 3.4 8.8 12.6 6.8 9.1 4.5 5.7 11.5 5.2 8.4 5.4 11.2 9.8 6.2 7.4 8.9 7.9 13.9 6.0 8.8 7.6 6.5 4.2 7.4 7.0 4.8 7.3 5.4 5.8 5.9 4.4 7.4 9.0 5.7 3.5 5.9 4.4 6.1 7.3 2.5 9.2 10.5 16.2 10.0 7.4 5.5 8.7 7.8 8.7 10.5 0.0 8.3 11.5 5.5 17.3 16.4 3.3 2.5 10.7 10.3 7.0 25.5 6.1 0.0 4.6 117.3 9.0 5.1 0.0 2.0 5.4 9.3 10.2 4.7 10.2 6.5 14.3 9.9 11.6 8.1 116.2 9.2 13.7 20.3 5.4 8.1 9.9 4.6 6.8 9.2 3.6 21.1 6.5 10.3 40.0 12.8 18.1 6.1 17.9 7.0 5.8 USP46 FLJ12552 ENSG00000109189 "Ubiquitin specific peptidase 46" P62068 4 52590972-52659335 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Behavior, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 123.5;Early spermatids: 151.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007288, CAB076369, CAB076370" Uncertain Approved "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "CAB076369: AB_2665642, CAB076370: AB_2665643, HPA007288: AB_1080531" "unprognostic (1.15e-2)" "unprognostic (1.64e-1)" "unprognostic (1.19e-1)" "unprognostic (1.61e-2)" "unprognostic (1.31e-1)" "unprognostic (1.41e-1)" "unprognostic (1.53e-3)" "unprognostic (1.59e-1)" "unprognostic (2.45e-2)" "unprognostic (1.80e-2)" "unprognostic (2.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.05e-1)" "unprognostic (1.45e-1)" "unprognostic (3.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.28e-1)" 4.7 9.5 26.0 3.5 20.9 2.8 7.0 23.7 29.4 8.9 4.2 12.8 5.2 4.8 7.2 6.2 12.4 7.8 5.8 28.9 21.9 19.0 10.8 3.1 4.4 3.7 19.1 13.9 12.3 5.6 12.2 5.3 10.6 12.7 7.7 4.6 5.3 8.0 7.8 13.7 8.0 4.5 5.5 18.9 3.5 6.3 12.2 15.0 1.0 10.0 4.3 5.8 7.3 5.7 1.4 4.4 2.0 1.4 1.2 3.9 1.0 5.4 3.8 12.5 9.2 13.6 17.1 13.8 8.9 7.2 6.6 5.6 7.7 4.2 3.6 10.5 8.8 9.3 3.2 21.7 10.3 12.1 3.1 7.6 5.6 3.7 8.6 13.6 7.3 6.5 14.5 9.7 6.8 6.4 12.9 9.8 5.1 5.5 5.1 13.9 4.9 3.1 3.9 9.2 6.0 4.7 8.0 9.1 0.7 14.2 10.0 7.5 9.0 4.3 14.9 8.5 12.5 5.4 5.5 9.0 6.5 14.2 7.6 13.3 5.2 2.4 2.9 10.0 4.5 8.0 2.0 1.4 0.3 2.3 1.2 1.7 1.4 3.9 2.0 2.8 1.2 0.9 0.8 0.3 1.2 0.9 4.4 1.2 1.0 26.0 20.9 23.7 24.3 21.9 19.0 19.1 13.9 12.7 15.0 6.0 4.5 1.9 9.8 4.7 123.5 42.3 12.7 24.1 11.4 14.0 3.9 10.5 18.3 10.3 151.7 8.4 3.8 0.0 10.5 10.9 10.3 17.3 0.0 5.7 5.0 33.4 4.1 7.4 7.6 24.3 26.7 4.4 8.5 14.4 5.6 21.3 9.7 7.6 33.9 12.6 7.9 6.5 8.3 3.0 11.5 7.2 6.4 4.4 6.0 15.9 UTP14A "NY-CO-16, SDCCAG16, Utp14" ENSG00000156697 "UTP14A, small subunit processome component" Q9BVJ6 X 129906121-129929761 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047217, HPA054023" Uncertain Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (6.75e-2)" "unprognostic (2.20e-1)" "unprognostic (1.10e-1)" "unprognostic (7.84e-3)" "unprognostic (2.95e-1)" "prognostic unfavorable (7.67e-4)" "unprognostic (3.00e-3)" "unprognostic (8.24e-2)" "unprognostic (4.09e-3)" "unprognostic (2.81e-1)" "unprognostic (2.28e-2)" "unprognostic (6.99e-3)" "prognostic unfavorable (8.12e-8)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (5.06e-2)" "unprognostic (9.99e-2)" 15.1 11.4 8.2 13.3 11.2 10.2 15.8 12.7 13.8 13.3 13.4 8.4 8.5 8.5 17.6 13.9 16.9 13.9 9.0 10.0 7.1 7.2 13.2 14.9 10.7 14.8 7.6 9.8 17.4 22.7 13.1 13.8 12.5 10.6 13.5 14.7 8.6 13.2 10.6 19.6 11.8 11.0 15.3 7.7 16.1 13.3 4.3 7.7 20.7 12.4 16.3 19.5 16.0 13.5 11.1 11.8 16.2 14.3 15.5 14.6 7.7 14.3 16.0 8.6 22.6 14.5 14.8 14.5 15.9 12.2 16.0 12.8 16.3 14.2 34.0 32.1 11.5 17.5 18.4 34.4 17.3 19.7 11.3 17.1 19.4 13.7 12.3 16.4 27.4 14.9 18.1 15.3 21.7 23.0 10.4 12.6 12.7 19.3 10.7 13.8 23.6 19.7 20.9 17.9 27.4 18.0 15.5 13.0 23.3 11.1 11.0 9.0 23.8 9.0 16.7 18.8 11.9 9.0 16.0 10.9 7.1 9.2 19.7 30.5 13.4 15.5 30.3 10.7 34.1 15.9 16.2 8.0 4.0 12.7 14.3 14.6 11.1 10.7 11.8 11.8 10.9 13.5 12.4 1.0 15.5 12.0 9.4 14.4 7.7 8.2 11.2 12.7 13.8 7.1 7.2 7.6 9.8 10.6 7.7 11.9 10.4 11.5 13.1 7.4 5.4 8.1 15.3 12.0 29.6 0.0 3.9 19.7 11.6 16.5 0.3 7.4 2.9 0.0 10.9 16.6 8.7 7.6 13.9 4.0 12.0 1.6 7.5 6.2 7.8 0.2 5.8 9.4 5.0 17.2 7.3 6.0 12.1 10.2 6.7 6.7 4.4 12.9 10.8 1.4 2.4 6.9 34.0 10.2 10.1 9.5 UTP14C "2700066J21Rik, KIAA0266" ENSG00000253797 "UTP14C, small subunit processome component" Q5TAP6 13 52024691-52033600 "Predicted intracellular proteins" "Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047217, HPA054023" Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (7.89e-2)" "unprognostic (5.98e-2)" "unprognostic (4.47e-1)" "unprognostic (1.25e-1)" "unprognostic (2.33e-3)" "unprognostic (2.51e-1)" "unprognostic (2.02e-1)" "unprognostic (3.30e-1)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (7.35e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.46e-5)" "unprognostic (2.44e-2)" "unprognostic (3.43e-1)" "unprognostic (1.74e-1)" "unprognostic (3.04e-2)" 4.8 4.8 5.3 3.4 5.9 0.5 6.2 6.6 5.9 6.8 5.3 4.6 6.7 4.6 3.6 5.2 3.9 5.5 5.1 5.2 8.0 7.9 4.5 3.5 5.5 6.1 5.8 8.9 4.8 6.6 7.1 5.9 5.7 5.5 5.3 2.9 4.5 5.3 6.2 4.4 5.7 2.3 9.1 3.8 4.6 4.2 4.1 5.8 6.7 4.8 3.5 6.8 3.1 4.2 6.8 14.1 11.1 14.5 10.5 10.9 12.3 9.6 8.3 7.7 6.7 9.0 10.5 3.3 11.6 10.5 10.0 12.4 6.8 11.0 10.7 8.8 20.2 4.8 6.5 9.9 17.9 14.0 9.2 13.0 6.4 12.4 10.9 6.8 12.5 11.6 5.3 12.4 3.1 10.9 10.0 12.8 19.5 4.9 10.7 9.9 4.5 14.1 6.9 4.6 9.5 7.3 11.0 8.4 13.5 9.8 14.2 10.3 7.7 8.0 8.6 8.4 5.4 7.8 12.7 4.1 6.7 14.4 6.7 3.7 5.4 4.6 4.8 3.9 3.0 4.9 3.7 4.4 4.1 6.8 6.7 2.4 3.5 3.9 5.8 5.2 3.1 6.0 17.4 11.2 5.0 5.3 13.0 18.5 20.4 12.0 13.6 15.7 3.9 8.5 0.0 6.0 0.3 10.6 10.8 0.0 6.6 8.1 10.8 11.1 11.5 28.1 7.9 23.8 17.9 12.3 14.8 0.0 9.8 6.7 8.5 2.8 15.1 13.6 6.8 14.0 13.4 5.0 10.6 6.5 7.6 6.6 12.2 7.3 5.8 6.9 12.7 5.4 UTP15 "FLJ12787, FLJ23637, NET21" ENSG00000164338 "UTP15, small subunit processome component" Q8TED0 5 73565443-73583377 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044697 Approved "Nucleoli,Endoplasmic reticulum" No No "Nucleoli, Endoplasmic reticulum" "HPA044697: AB_2679050" "unprognostic (8.96e-2)" "unprognostic (1.19e-1)" "unprognostic (1.87e-3)" "unprognostic (8.36e-2)" "unprognostic (1.78e-1)" "unprognostic (5.80e-2)" "unprognostic (1.39e-2)" "unprognostic (5.74e-2)" "unprognostic (2.12e-1)" "unprognostic (4.16e-3)" "unprognostic (1.02e-1)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (9.66e-2)" "unprognostic (7.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.22e-1)" 17.1 11.8 6.5 9.4 11.7 38.6 13.2 8.7 12.5 7.5 8.6 10.4 9.3 7.0 11.3 8.7 13.6 10.4 6.7 8.8 12.9 5.6 9.3 12.9 10.2 12.1 11.0 8.0 11.0 9.7 11.8 16.4 8.8 12.5 10.1 10.9 7.5 10.9 6.6 14.5 18.3 10.7 9.9 10.3 11.4 11.9 10.1 10.0 11.4 10.3 13.2 12.8 9.5 9.4 8.3 9.0 4.6 8.0 8.8 10.8 5.4 10.7 11.6 7.9 23.7 6.9 8.2 15.0 12.8 7.4 14.5 16.1 13.0 14.4 24.2 13.0 8.6 16.8 9.0 13.5 23.8 22.5 11.8 9.8 11.1 12.3 10.6 8.5 10.1 9.1 8.3 10.8 16.4 18.5 4.3 10.0 10.5 17.0 13.4 12.3 13.5 15.3 7.2 10.7 3.8 6.7 12.3 12.1 23.4 8.7 14.7 8.1 8.7 11.5 9.5 13.4 7.0 12.1 7.5 8.1 8.6 11.9 10.1 24.9 9.8 13.0 31.2 13.6 17.4 12.5 2.5 7.0 4.6 9.7 8.0 9.7 8.3 9.8 10.6 9.0 7.2 10.5 10.8 3.8 8.8 7.3 6.5 7.9 5.4 6.5 11.7 8.7 12.5 12.9 5.6 11.0 8.0 12.5 10.0 0.0 5.3 2.9 10.8 13.1 3.9 6.4 2.5 0.0 4.5 5.2 5.9 6.8 3.3 8.1 3.5 4.9 2.3 0.0 6.8 7.3 4.9 5.6 6.9 6.7 6.0 1.6 2.4 3.1 7.3 2.2 2.8 4.3 6.8 1.8 3.6 3.5 5.7 3.5 4.9 4.9 4.4 6.5 8.5 6.3 13.6 14.9 5.5 4.4 6.0 9.0 UTP18 "CGI-48, WDR50" ENSG00000011260 "UTP18, small subunit processome component" Q9Y5J1 17 51260528-51297936 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 146.3;Late spermatids: 145.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052378 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear membrane" "HPA052378: AB_2681805" "unprognostic (1.36e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.33e-4)" "unprognostic (2.62e-2)" "unprognostic (2.55e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.47e-2)" "unprognostic (8.37e-3)" "unprognostic (1.10e-2)" "unprognostic (8.82e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-3)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.72e-3)" "unprognostic (1.93e-2)" 15.6 16.1 14.4 18.0 20.5 26.9 20.2 23.3 20.9 15.0 13.6 14.5 12.4 13.6 13.0 13.4 17.7 14.0 11.1 8.9 14.2 13.9 17.1 16.9 14.0 22.9 17.0 20.5 19.4 18.1 17.3 19.4 28.3 16.1 13.1 15.0 12.8 14.9 11.9 19.1 25.7 13.0 10.2 14.4 22.0 13.5 42.5 16.9 21.6 19.1 15.6 25.3 15.2 17.9 26.1 26.4 12.4 22.9 17.4 28.1 24.9 26.5 26.4 16.8 15.4 11.1 16.7 43.9 14.7 12.2 25.8 24.9 16.5 14.9 33.7 21.1 10.9 27.6 14.5 27.3 15.7 38.5 22.0 35.6 35.4 16.0 28.7 15.2 37.4 17.4 10.6 12.2 21.9 17.8 13.1 15.4 16.8 28.7 15.5 19.4 16.4 33.5 25.5 24.1 37.9 28.0 30.5 38.3 26.4 18.8 17.7 18.8 23.8 17.1 20.4 33.4 21.9 25.1 19.1 13.4 26.6 22.3 21.9 30.5 30.1 55.4 39.0 16.5 26.1 19.0 6.8 22.9 12.4 20.5 21.6 24.9 26.1 25.8 24.7 26.4 24.4 28.1 26.2 4.0 17.4 21.1 16.6 25.7 24.9 14.4 20.5 23.3 20.9 14.2 13.9 17.0 20.5 16.1 16.9 14.9 25.5 32.0 48.3 53.3 16.3 3.9 17.8 48.2 22.7 14.0 13.7 61.4 33.2 24.4 146.3 25.4 10.5 0.0 40.8 58.4 26.5 24.1 31.1 16.6 54.8 9.5 15.4 8.6 38.6 145.5 24.7 35.4 21.9 38.7 19.4 20.6 29.1 17.8 20.8 29.8 10.3 12.9 16.5 115.2 106.7 46.0 66.6 27.7 22.5 46.3 UTP20 "1A6/DRIM, DRIM" ENSG00000120800 "UTP20, small subunit processome component" O75691 12 101280109-101386616 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049341 Supported "Nucleoli,Plasma membrane" No No Nucleoli "Plasma membrane" "HPA049341: AB_2680720" "unprognostic (3.04e-2)" "unprognostic (1.22e-1)" "unprognostic (3.92e-2)" "unprognostic (1.51e-2)" "unprognostic (1.39e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.15e-5)" "unprognostic (8.34e-2)" "unprognostic (4.30e-2)" "unprognostic (8.15e-3)" "unprognostic (2.81e-1)" "unprognostic (2.22e-2)" "prognostic favorable (8.87e-4)" "unprognostic (2.88e-1)" "unprognostic (3.44e-1)" "unprognostic (8.30e-2)" "unprognostic (6.92e-3)" 14.7 11.9 8.4 10.7 9.7 8.3 15.3 8.4 9.6 14.1 8.0 11.8 7.0 5.0 12.5 8.4 10.9 10.3 5.8 8.3 6.7 5.8 8.0 12.0 12.0 17.8 9.0 6.3 16.3 14.2 17.9 9.5 9.7 8.2 8.8 10.1 9.9 13.8 8.5 13.1 10.8 8.0 9.4 7.1 11.3 8.6 12.6 9.7 11.9 9.8 11.0 12.9 9.4 13.8 3.1 2.8 0.1 1.1 2.0 2.8 0.6 4.5 11.3 8.6 4.0 7.7 9.1 10.6 7.9 6.2 12.6 7.0 13.0 3.3 12.1 4.2 8.7 9.5 9.5 19.0 8.1 16.4 5.4 7.7 12.8 6.1 9.7 4.3 21.2 5.9 5.9 4.2 17.4 6.0 4.8 8.6 6.2 20.1 2.5 9.1 5.9 9.2 6.0 22.6 6.3 11.9 10.5 14.1 9.4 5.3 13.8 9.9 6.7 14.7 9.3 8.9 7.4 9.8 4.7 9.7 14.9 7.3 10.3 15.2 4.6 6.8 20.3 8.1 9.7 22.8 0.1 0.8 0.1 1.9 1.1 1.9 3.1 2.1 2.4 1.4 2.4 2.3 2.8 0.1 2.0 0.7 2.8 1.8 0.6 8.4 9.7 8.4 9.6 6.7 5.8 9.0 6.3 8.2 9.7 8.9 6.9 6.5 7.6 9.0 9.5 9.8 7.6 8.1 14.8 3.5 9.8 6.7 5.0 5.6 1.3 9.0 1.3 0.0 9.7 7.0 7.8 8.4 12.7 6.7 5.1 20.6 6.3 7.4 6.3 0.9 8.9 3.8 3.3 1.0 4.4 3.4 6.1 0.0 7.8 2.3 8.0 6.5 6.2 15.6 22.4 9.7 2.4 5.7 8.0 7.5 UTP23 "C8orf53, MGC14595" ENSG00000147679 "UTP23, small subunit processome component" Q9BRU9 8 116766503-116849463 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044418 Uncertain Approved Nucleoli NA NA Nucleoli "HPA044418: AB_10961139" "prognostic unfavorable (5.18e-5)" "unprognostic (2.30e-2)" "unprognostic (3.34e-1)" "unprognostic (1.18e-2)" "unprognostic (2.64e-1)" "unprognostic (7.23e-2)" "unprognostic (9.45e-3)" "unprognostic (7.73e-2)" "unprognostic (7.78e-2)" "unprognostic (1.77e-1)" "unprognostic (1.34e-2)" "unprognostic (8.62e-2)" "unprognostic (1.75e-2)" "unprognostic (5.78e-2)" "unprognostic (2.03e-1)" "unprognostic (7.15e-3)" "unprognostic (9.27e-2)" 14.5 11.9 16.9 13.1 21.4 39.5 13.6 25.2 20.0 12.3 12.3 9.3 9.3 8.5 15.6 10.1 11.4 12.9 10.5 11.6 14.4 10.0 9.7 11.6 12.4 18.8 15.4 15.5 20.0 12.7 9.7 15.8 12.8 13.3 13.8 8.3 6.8 11.7 13.4 11.7 11.3 11.5 12.7 13.0 13.2 11.0 8.9 16.2 13.1 16.4 8.7 12.0 13.7 13.7 27.4 23.3 24.2 21.7 16.3 33.3 15.9 10.9 11.9 6.5 5.9 9.3 11.5 4.9 10.8 6.3 7.2 7.9 12.4 7.3 16.2 10.6 5.2 6.8 7.9 8.9 5.8 9.5 16.0 17.3 20.1 9.1 8.2 9.2 10.1 9.6 9.0 7.1 7.1 9.6 5.0 7.7 13.0 13.0 12.4 7.5 20.0 24.5 6.0 5.8 18.0 22.4 13.8 7.0 14.0 4.4 10.1 12.0 9.5 7.0 28.4 9.9 3.7 12.7 7.6 8.6 7.8 10.7 17.9 14.5 15.0 22.8 19.9 9.8 13.1 8.7 24.2 16.3 20.6 26.8 16.8 23.2 27.4 24.4 21.1 14.1 27.3 33.3 23.2 16.2 16.3 21.7 23.3 26.4 15.9 16.9 21.4 25.2 20.0 14.4 10.0 15.4 15.5 13.3 16.2 38.7 31.5 28.3 17.9 19.5 21.6 21.0 10.2 24.1 29.6 7.0 5.9 25.2 23.2 14.5 5.4 22.0 6.9 23.3 18.0 16.2 23.5 11.4 40.5 11.5 14.8 15.9 11.5 25.8 9.1 3.1 26.7 15.6 10.1 15.4 13.7 24.6 10.8 10.5 26.9 13.4 22.2 12.9 18.0 38.8 22.6 14.2 16.6 17.8 14.5 15.5 UTP3 "CRLZ1, DKFZp761F222, FLJ23256, SAS10" ENSG00000132467 "UTP3, small subunit processome component" Q9NQZ2 4 70688479-70690551 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035655, HPA041453" Approved Supported Nucleoli,Vesicles NA NA Nucleoli Vesicles "HPA035655: AB_10601832, HPA041453: AB_2677488" "unprognostic (2.44e-2)" "unprognostic (9.70e-2)" "unprognostic (7.36e-3)" "unprognostic (2.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.90e-2)" "unprognostic (6.79e-3)" "unprognostic (2.13e-1)" "unprognostic (3.50e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (4.44e-3)" "prognostic favorable (3.16e-4)" "unprognostic (4.45e-2)" "unprognostic (7.95e-2)" "unprognostic (2.24e-1)" "unprognostic (2.24e-2)" 19.9 23.4 17.6 21.3 17.9 14.5 17.1 20.1 20.3 15.7 16.1 12.1 12.1 14.3 19.4 14.2 23.5 19.4 13.3 18.9 17.0 12.1 24.5 27.5 16.4 26.7 15.5 16.2 17.2 17.0 16.4 21.2 22.9 18.4 14.5 15.2 9.9 16.0 16.7 18.1 20.1 22.8 18.2 14.7 38.7 19.5 11.5 20.3 33.3 16.5 21.6 27.2 15.5 17.6 7.3 13.6 6.3 12.7 6.5 8.6 5.2 12.3 12.1 16.2 13.5 23.1 17.5 13.9 25.7 16.6 14.7 14.4 15.7 16.5 54.4 16.2 21.9 16.9 10.4 23.7 35.2 21.5 16.8 13.6 20.7 16.2 16.8 25.1 31.2 18.4 23.7 21.2 18.0 17.8 16.4 19.7 16.0 23.6 18.4 23.8 25.5 28.9 17.5 11.3 25.5 17.7 12.4 22.4 22.2 26.6 20.0 13.7 18.7 10.9 25.0 15.9 18.6 13.7 12.6 21.9 15.1 25.6 14.3 16.4 26.9 19.8 39.6 18.4 15.4 13.1 6.3 11.1 5.5 7.0 12.7 7.3 7.3 5.8 7.8 13.5 6.8 8.6 7.2 0.9 6.5 10.8 13.6 7.0 5.2 17.6 17.9 20.1 20.3 17.0 12.1 15.5 16.2 18.4 20.3 53.6 50.4 14.5 40.4 20.4 18.4 17.9 10.2 60.2 61.4 12.2 5.9 22.5 16.6 25.7 0.7 22.8 13.4 23.3 25.9 12.8 18.2 14.0 28.8 23.7 19.4 15.9 14.5 19.6 29.5 1.5 16.1 25.1 11.8 14.4 12.3 26.4 20.3 8.6 23.7 25.4 21.9 12.9 25.5 11.6 9.3 22.3 18.1 21.8 12.7 31.6 UTP6 "C17orf40, HCA66" ENSG00000108651 "UTP6, small subunit processome component" Q9NYH9 17 31860899-31901765 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025936, HPA055806" Supported Enhanced "Nucleoli,Mitotic chromosome" Yes No Nucleoli "Mitotic chromosome" "HPA025936: AB_1845588, HPA055806: AB_2682930" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (5.61e-3)" "unprognostic (2.54e-1)" "unprognostic (4.96e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (1.86e-5)" "unprognostic (5.68e-2)" "unprognostic (9.78e-3)" "unprognostic (5.50e-2)" "unprognostic (2.79e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (1.63e-1)" "unprognostic (2.87e-1)" "unprognostic (3.96e-2)" "unprognostic (4.76e-2)" 19.3 17.9 18.7 16.9 19.3 19.0 26.4 28.7 19.3 17.7 19.5 18.0 12.5 10.8 23.4 30.4 15.7 13.3 10.7 13.0 19.5 17.0 16.7 20.7 15.4 23.3 16.2 16.1 19.5 17.0 14.1 26.0 21.4 16.2 19.9 15.9 15.0 15.9 15.0 17.0 25.3 15.2 17.0 18.8 23.1 16.4 18.5 19.1 23.2 17.1 18.5 28.1 16.0 15.5 15.4 19.7 13.1 10.9 5.7 8.0 7.0 8.5 5.6 7.9 4.5 8.2 5.4 9.6 7.4 4.2 11.3 8.7 20.1 4.5 12.9 9.3 6.8 10.9 11.2 11.1 9.2 10.4 3.3 16.8 8.0 12.6 18.2 9.0 12.3 8.3 8.3 9.2 11.0 8.1 10.2 7.2 8.5 14.1 7.4 9.0 7.0 11.4 32.8 10.4 10.6 8.8 12.0 11.3 12.6 11.6 7.9 5.2 7.9 7.8 5.6 12.4 12.8 13.6 23.0 7.5 17.0 12.8 8.9 14.8 8.3 14.8 18.7 11.6 8.5 9.1 10.6 10.8 6.7 7.6 10.9 7.3 12.7 8.0 8.0 13.6 15.4 7.1 8.0 13.1 5.7 9.7 19.7 7.7 7.0 18.7 19.3 28.7 19.3 19.5 17.0 16.2 16.1 16.2 19.1 17.9 22.4 27.9 22.9 22.9 16.2 12.5 7.6 30.8 30.7 5.2 7.9 36.3 8.3 22.3 20.6 18.0 9.1 0.0 20.7 41.1 23.1 22.0 35.7 14.4 32.5 11.1 5.2 12.9 20.5 3.6 17.3 29.1 8.5 44.1 14.6 17.8 22.2 7.0 15.9 15.0 16.0 6.5 23.1 62.6 62.6 22.7 32.0 13.3 15.3 27.6 UTY "KDM6AL, KDM6C" ENSG00000183878 "Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked" O14607 Y 13248379-13480673 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 14.9;U-266/84: 11.4;U-698: 14.9" "HPA000568, HPA001165" Supported Approved "Nucleoplasm,Nucleoli,Nucleoli rim" "Intracellular and membrane" NA NA Nucleoplasm "Nucleoli, Nucleoli rim" "HPA000568: AB_1858705, HPA001165: AB_1080541" "unprognostic (7.52e-2)" "unprognostic (6.60e-2)" "unprognostic (4.04e-6)" "unprognostic (6.47e-2)" "unprognostic (9.34e-2)" "unprognostic (2.00e-2)" "unprognostic (9.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (1.41e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.46e-2)" 5.3 5.1 3.0 15.4 10.3 9.0 5.1 6.1 11.0 0.4 8.4 18.0 18.4 4.3 0.4 16.5 7.2 0.4 6.5 4.7 3.5 3.4 5.0 6.9 11.9 19.0 3.3 0.0 0.5 15.1 0.4 6.3 5.9 13.0 14.0 10.6 16.8 10.9 16.1 9.3 7.4 10.1 18.6 4.8 17.4 5.7 6.7 0.0 37.7 6.3 10.3 22.0 7.2 0.0 6.1 4.8 6.6 3.8 9.9 6.7 1.3 0.0 1.8 0.0 0.0 0.0 0.0 6.6 3.3 5.7 3.7 5.7 0.0 0.0 9.0 0.0 3.8 0.0 0.0 0.0 0.0 5.3 4.9 0.0 14.9 0.1 0.0 4.9 0.0 0.0 6.0 5.9 0.0 0.0 0.0 0.0 3.1 0.0 0.0 4.1 0.0 5.1 0.1 0.0 0.0 0.0 0.0 2.4 4.0 4.1 6.1 3.7 0.0 0.0 0.0 10.7 6.8 0.0 3.2 4.3 6.6 0.0 0.0 2.3 10.2 11.4 14.9 0.6 0.0 0.0 1.8 2.8 5.8 4.7 3.4 6.7 5.0 4.6 3.6 3.0 6.1 6.5 4.7 6.6 9.9 3.8 4.8 5.3 1.3 3.0 10.3 6.1 11.0 3.5 3.4 3.3 0.0 13.0 0.0 14.9 22.3 25.2 17.2 10.1 30.4 5.2 2.5 10.7 13.6 17.4 60.9 8.5 0.0 2.9 0.3 7.7 1.0 0.0 0.0 2.7 7.6 12.2 15.1 0.0 2.4 35.0 1.7 8.6 13.3 0.9 10.0 15.3 8.5 10.8 0.0 18.3 2.5 0.0 11.0 1.3 38.6 0.0 6.2 1.8 5.9 13.4 11.1 21.3 0.0 16.0 VASN SLITL2 ENSG00000168140 Vasorin Q6EMK4 16 4371848-4383528 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 108.9;Peritubular cells: 57.3;Sertoli cells: 97.0;Smooth muscle cells: 96.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 12 "U-2197: 126.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011246, HPA016992" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted - unknown location" NA Yes 2400000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA011246: AB_1858720, HPA016992: AB_2732418" "unprognostic (2.20e-1)" "unprognostic (2.75e-1)" "unprognostic (9.22e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.35e-3)" "unprognostic (8.91e-3)" "unprognostic (3.15e-3)" "unprognostic (5.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.82e-3)" "unprognostic (4.23e-2)" "unprognostic (4.95e-3)" "unprognostic (5.27e-2)" 22.4 10.2 4.9 7.7 6.7 3.8 28.6 1.6 6.5 19.9 5.1 5.6 6.4 5.1 14.3 13.6 16.2 9.9 10.2 12.9 4.4 1.8 21.6 14.1 17.2 5.2 2.7 2.9 21.0 9.8 1.7 5.9 30.2 4.8 12.9 2.0 33.6 7.9 13.1 7.0 16.0 4.0 9.4 3.6 7.9 6.5 14.7 3.5 0.0 15.2 5.5 8.2 16.6 19.0 0.3 0.2 0.4 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 2.8 3.2 1.2 5.3 5.2 1.6 2.7 0.3 0.6 0.0 1.9 3.5 0.2 0.0 0.0 0.1 0.2 1.2 0.1 0.1 1.5 1.6 10.2 0.0 0.0 3.3 0.0 4.0 0.1 2.7 0.0 0.0 0.2 0.0 0.2 1.8 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.1 0.9 2.5 4.2 0.0 0.2 0.9 0.2 0.0 4.9 1.3 126.7 0.6 0.0 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 6.7 1.6 6.5 4.4 1.8 2.7 2.9 4.8 3.5 6.0 12.5 0.9 6.0 8.5 0.0 12.9 35.7 1.4 3.4 22.7 0.0 3.0 6.6 10.3 1.0 3.3 0.2 0.0 2.6 6.4 108.9 7.4 3.5 12.9 2.8 0.0 0.0 4.9 0.3 1.8 46.3 1.2 13.5 0.0 0.4 16.3 17.4 0.0 57.3 12.5 0.7 97.0 96.8 0.5 5.1 6.6 8.4 1.8 0.2 3.3 VEPH1 "FLJ12604, KIAA1692" ENSG00000197415 "Ventricular zone expressed PH domain containing 1" Q14D04 3 157259742-157533619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 38.1;pituitary gland: 70.3" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 247.1;Alveolar cells type 2: 124.4;Early spermatids: 67.1;Late spermatids: 63.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 2.2;pons and medulla: 5.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.5;hTERT-RPE1: 26.3;HUVEC TERT2: 65.1;TIME: 38.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026645 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA026645: AB_1858741" "unprognostic (4.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-1)" "unprognostic (5.17e-2)" "unprognostic (3.30e-3)" "unprognostic (2.87e-3)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (1.75e-3)" "unprognostic (3.57e-3)" "unprognostic (1.99e-2)" "prognostic favorable (7.75e-9)" "unprognostic (2.03e-1)" "unprognostic (2.57e-1)" "unprognostic (1.15e-4)" "unprognostic (7.49e-2)" 0.5 16.0 0.3 0.2 0.3 1.1 1.4 2.2 3.5 1.9 0.4 0.7 2.0 0.2 0.4 12.1 0.2 3.4 1.1 0.4 0.8 0.5 20.7 0.6 38.1 0.1 0.7 0.1 1.1 8.6 0.7 70.3 1.6 5.5 1.2 0.3 17.7 6.9 4.9 0.2 0.7 0.2 0.1 0.3 2.3 0.6 1.7 0.2 0.1 1.1 0.5 0.6 0.5 0.8 0.0 0.0 1.5 0.7 0.0 0.0 5.1 1.8 0.2 4.3 0.0 2.5 9.4 0.0 11.0 24.5 3.3 4.8 0.3 1.7 0.0 4.3 11.8 0.5 0.0 0.1 0.2 18.3 0.0 0.0 1.8 0.2 0.0 0.8 0.0 0.0 2.7 0.1 14.0 2.8 26.3 65.1 0.0 0.6 0.0 8.9 0.2 0.0 0.0 1.7 0.5 1.6 0.0 0.3 0.0 1.6 0.9 0.1 0.0 0.3 0.5 4.3 0.0 18.9 0.0 38.7 13.1 0.4 4.5 15.1 0.0 0.0 0.0 10.5 0.0 3.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.1 0.3 0.3 2.2 0.4 0.8 0.5 0.7 0.1 5.5 0.2 247.1 124.4 0.0 0.2 1.5 0.0 0.3 12.7 14.7 26.1 29.6 2.0 1.6 39.7 5.5 67.1 0.0 0.0 0.0 8.7 0.1 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 63.8 1.4 0.4 27.0 1.0 0.2 0.8 2.0 2.8 0.4 24.1 0.3 0.0 0.0 0.3 0.6 0.4 0.0 0.0 0.6 0.1 VGLL3 VGL-3 ENSG00000206538 "Vestigial like family member 3" A8MV65 3 86876388-86991119 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "placenta: 195.7" "Group enriched" "Detected in many" 4 "Early spermatids: 105.6;Extravillous trophoblasts: 167.0;Late spermatids: 52.5;Leydig cells: 122.6;Peritubular cells: 140.4;Syncytiotrophoblasts: 67.5" "Cancer enhanced" "Detected in many" "prostate cancer: 7.9" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "U-2197: 106.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054983 Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA054983: AB_2682663" "unprognostic (9.08e-2)" "unprognostic (4.47e-3)" "unprognostic (5.97e-2)" "unprognostic (1.54e-1)" "unprognostic (2.98e-2)" "unprognostic (1.13e-1)" "unprognostic (2.77e-2)" "unprognostic (3.86e-2)" "unprognostic (1.38e-2)" "unprognostic (4.94e-2)" "unprognostic (3.70e-2)" "unprognostic (3.44e-2)" "unprognostic (2.73e-8)" "unprognostic (3.85e-3)" "unprognostic (1.27e-1)" "unprognostic (5.42e-3)" "unprognostic (1.05e-1)" 22.5 1.0 0.5 3.4 0.5 0.2 8.6 0.2 0.3 6.3 6.2 0.4 3.3 0.6 8.2 7.8 6.1 5.2 6.8 4.3 1.0 0.7 1.8 0.6 16.1 3.6 0.6 0.3 10.6 2.7 0.7 0.4 195.7 0.8 8.0 1.6 2.8 1.9 3.1 7.5 4.0 2.1 11.9 0.8 2.4 2.9 8.0 0.3 0.1 3.4 1.9 1.0 12.2 9.2 1.1 0.6 2.3 0.5 0.8 0.7 0.1 1.5 2.6 14.2 0.0 19.0 23.8 0.2 9.8 6.9 8.4 10.5 3.0 0.6 0.0 0.0 15.3 0.9 1.3 0.9 0.9 11.6 5.5 0.0 0.7 0.9 0.0 8.7 0.1 0.0 18.1 1.5 12.3 5.5 4.5 1.2 0.0 0.0 0.0 10.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 18.9 0.1 0.0 1.6 0.0 0.0 4.2 0.1 0.0 0.5 0.0 0.0 0.5 18.7 2.7 106.2 0.3 0.0 0.0 0.0 3.4 0.0 0.7 2.3 0.5 0.7 0.4 0.3 0.4 0.5 0.5 0.3 0.2 1.1 0.6 0.7 2.0 0.8 0.4 0.6 0.5 0.1 0.5 0.5 0.2 0.3 1.0 0.7 0.6 0.3 0.8 0.3 3.0 2.1 0.0 7.4 7.1 0.0 0.7 0.0 5.3 4.5 10.4 0.0 20.7 0.0 10.3 105.6 1.5 0.0 0.0 2.1 167.0 26.2 18.3 0.0 0.0 6.7 0.0 0.0 4.3 0.0 52.5 122.6 2.4 3.3 0.0 0.0 15.8 8.4 0.0 140.4 0.0 0.3 12.9 17.8 1.4 1.0 4.5 67.5 0.0 0.0 3.7 VMP1 "EPG3, TANGO5, TMEM49" ENSG00000062716 "Vacuole membrane protein 1" Q96GC9 17 59707192-59842255 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "blood: 193.2" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 872.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 193.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 193.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030773, HPA064780" Approved Approved "Nucleoli,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoli "HPA030773: AB_10602248, HPA064780: AB_2685348" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (3.14e-2)" "unprognostic (3.17e-1)" "prognostic unfavorable (8.02e-4)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" "unprognostic (2.98e-1)" "unprognostic (8.43e-2)" "unprognostic (4.21e-2)" "prognostic unfavorable (2.77e-8)" "unprognostic (1.88e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-2)" "unprognostic (7.96e-3)" 22.0 37.8 20.4 21.9 24.9 13.0 18.6 20.0 28.7 18.2 32.0 27.8 16.7 40.5 18.3 15.4 22.9 14.4 25.2 19.6 21.7 22.3 22.9 43.0 22.4 20.1 23.1 15.6 16.5 22.9 19.0 20.1 27.9 29.8 17.3 29.3 20.0 17.8 13.9 19.8 19.2 39.7 14.3 26.4 36.6 19.0 17.6 16.2 14.4 18.1 12.5 16.8 19.5 17.6 3.3 10.9 193.2 39.9 3.8 4.1 24.7 20.3 41.0 13.3 20.5 28.5 17.5 21.4 32.4 23.1 20.2 27.2 26.8 29.3 11.7 48.4 21.9 22.1 25.3 15.4 18.6 25.2 30.0 19.3 15.0 23.5 28.2 27.8 17.0 18.4 26.8 15.9 26.0 22.1 16.2 21.4 10.0 19.6 20.7 20.9 56.0 15.8 8.9 15.0 42.3 21.1 8.7 23.4 24.1 25.0 23.8 9.6 21.7 18.5 15.7 21.5 19.1 32.5 14.6 30.2 27.2 26.0 21.6 26.7 32.2 36.9 16.3 30.0 10.4 27.4 7.0 35.1 4.4 3.8 24.4 4.0 3.3 3.7 4.0 10.9 2.8 3.5 3.8 193.2 3.8 39.9 3.6 4.1 24.7 20.4 24.9 20.0 28.7 21.7 22.3 23.1 15.6 29.8 16.2 83.4 125.2 71.3 872.7 143.1 32.8 26.9 112.1 278.4 247.9 261.7 55.0 83.1 19.9 167.6 5.2 128.4 394.9 0.0 118.5 105.1 178.7 606.4 129.6 93.2 107.6 27.0 298.1 52.2 269.6 8.8 33.1 306.0 123.2 55.9 173.1 46.7 132.9 326.1 33.2 57.2 44.2 90.5 178.6 63.8 38.3 113.3 147.0 90.6 149.1 526.3 VPS51 "ANG2, ANG3, C11orf2, C11orf3, FFR" ENSG00000149823 "VPS51, GARP complex subunit" Q9UID3 11 65089324-65111860 "Predicted intracellular proteins" "Lipid transport, Protein transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039650, HPA061447" Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoli "HPA039650: AB_10673147, HPA061447: AB_2684521" "unprognostic (2.36e-2)" "unprognostic (7.58e-2)" "unprognostic (8.35e-2)" "unprognostic (1.56e-1)" "unprognostic (2.11e-2)" "unprognostic (1.64e-1)" "unprognostic (9.72e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (2.03e-3)" "unprognostic (1.56e-1)" "prognostic favorable (2.41e-9)" "unprognostic (7.77e-3)" "unprognostic (4.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.18e-1)" 22.1 19.5 17.5 19.4 24.3 30.3 21.7 29.8 33.8 23.4 30.9 16.9 22.4 31.2 27.7 15.5 22.9 20.9 25.0 27.7 15.9 13.0 18.5 24.7 16.6 35.0 14.5 19.2 53.2 77.6 22.9 14.5 21.7 15.9 22.0 15.7 17.2 54.2 18.4 39.4 32.0 27.7 24.4 13.2 20.5 30.3 17.5 12.6 36.5 34.7 24.4 21.9 24.6 22.4 15.6 14.8 9.9 10.5 21.8 19.8 10.5 21.8 24.2 11.9 14.5 5.3 13.2 22.2 8.6 17.7 17.6 13.1 17.5 29.0 38.2 24.8 16.7 9.1 18.8 12.5 19.4 6.4 22.2 18.9 22.8 24.6 16.8 17.4 24.6 20.9 22.7 13.3 13.0 10.8 14.0 19.3 17.9 23.1 27.5 7.1 29.8 32.9 24.6 19.2 9.9 18.5 20.6 5.7 46.1 12.0 24.6 19.8 27.2 6.4 36.8 21.5 7.4 30.0 12.3 15.6 11.9 10.5 14.8 12.3 35.1 27.2 21.4 13.3 8.9 8.5 7.0 10.0 9.9 13.3 10.5 15.5 15.3 18.5 19.8 14.8 15.6 16.9 14.7 6.3 21.8 10.3 13.4 11.9 10.5 17.5 24.3 29.8 33.8 15.9 13.0 14.5 19.2 15.9 12.6 17.9 45.0 65.3 52.1 43.6 62.1 5.6 35.7 5.3 12.5 29.6 27.5 63.6 53.0 43.3 65.8 40.2 144.6 0.0 103.8 66.7 40.9 44.2 38.0 45.2 39.6 63.5 91.9 45.4 49.7 145.2 49.5 26.5 47.2 65.9 97.4 47.8 56.6 144.0 51.2 58.6 41.1 25.8 45.3 35.7 31.3 47.9 96.5 55.8 135.4 40.9 VSIG4 Z39IG ENSG00000155659 "V-set and immunoglobulin domain containing 4" Q9Y279 X 66021738-66040125 "Plasma proteins, Predicted membrane proteins" "Complement alternate pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 31 "Hofbauer cells: 772.9;Kupffer cells: 436.3;Macrophages: 389.0" "Cancer enhanced" "Detected in all" "glioma: 88.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 26 "classical monocyte: 13.9;intermediate monocyte: 8.1;myeloid DC: 13.1" "Group enriched" "Detected in many" 30 "dendritic cells: 13.1;monocytes: 13.9" "Cell line enhanced" "Detected in some" "BEWO: 1.2;HMC-1: 1.1;NB-4: 3.1;SH-SY5Y: 1.1;U-937: 2.7" "Low region specificity" "Detected in many" "HPA003903, CAB026000" Enhanced Uncertain "Nucleoli,Plasma membrane,Cytosol" NA NA 41000000 "Plasma membrane, Cytosol" Nucleoli "CAB026000: , HPA003903: AB_1858776" "unprognostic (6.87e-3)" "unprognostic (4.79e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (3.19e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (9.37e-3)" "unprognostic (1.24e-1)" "unprognostic (3.10e-1)" "unprognostic (1.37e-3)" "unprognostic (1.06e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (1.95e-6)" "unprognostic (3.70e-2)" "unprognostic (5.45e-2)" "unprognostic (3.37e-2)" "unprognostic (3.47e-2)" 67.1 28.1 15.9 17.6 16.6 2.6 19.0 1.8 10.4 6.3 18.0 5.6 1.0 9.2 6.1 14.2 9.3 28.7 15.5 15.9 11.5 3.5 18.5 22.9 61.4 37.0 17.9 3.4 8.2 8.2 3.7 7.9 52.4 12.0 10.9 12.6 8.1 11.3 4.0 10.5 4.0 14.6 39.9 16.7 28.5 9.4 13.5 17.8 0.0 10.7 1.7 1.8 14.4 9.0 0.1 13.1 0.4 13.9 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.0 0.0 0.1 3.1 0.2 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.8 2.7 0.0 0.0 13.9 0.0 0.0 8.1 0.0 0.0 0.0 0.2 13.1 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 3.3 15.9 16.6 1.8 10.1 11.5 3.5 17.9 3.4 12.0 17.8 3.0 17.3 3.0 0.1 2.1 0.0 0.8 7.6 8.1 5.7 0.0 0.0 4.4 0.0 0.0 5.8 1.9 0.0 0.0 0.0 3.7 3.8 0.2 3.5 2.4 772.9 0.0 0.0 5.5 436.3 13.2 1.4 389.0 3.3 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 6.5 0.2 0.2 0.9 1.5 10.3 0.0 0.0 0.2 VWA5A "BCSC-1, LOH11CR2A" ENSG00000110002 "Von Willebrand factor A domain containing 5A" O00534 11 124115362-124147721 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 15 "granulocytes: 538.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 25.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 28.2;HEL: 20.3;HHSteC: 15.8;HUVEC TERT2: 18.7;RPTEC TERT1: 20.6" "Low region specificity" "Detected in all" "HPA037813, HPA037814, HPA061500" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542" "unprognostic (2.69e-1)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (8.49e-3)" "unprognostic (2.48e-1)" "unprognostic (8.18e-2)" "unprognostic (4.88e-2)" "unprognostic (1.18e-1)" "unprognostic (5.15e-2)" "unprognostic (4.53e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.55e-5)" "unprognostic (4.54e-2)" "unprognostic (7.21e-2)" "unprognostic (2.16e-1)" "unprognostic (4.65e-1)" 14.8 20.2 13.8 7.5 13.4 1.6 16.0 2.3 9.3 15.5 23.9 7.5 10.0 16.7 16.6 17.0 12.6 9.9 19.9 6.5 14.1 24.6 16.0 4.3 19.4 6.8 12.5 6.6 9.6 15.3 5.5 34.2 25.9 15.2 22.5 28.4 10.3 31.2 13.2 3.0 17.9 24.0 13.6 15.0 6.0 17.8 6.3 7.6 3.9 13.7 7.1 9.8 14.9 11.8 4.5 4.8 25.6 5.3 4.3 7.5 3.6 0.0 0.2 3.6 0.2 3.9 3.6 1.3 0.5 0.2 0.3 0.1 0.2 28.2 0.0 3.5 0.6 4.9 0.1 0.7 6.4 0.0 9.6 0.0 20.3 5.1 0.6 15.8 0.2 9.5 10.7 0.7 0.6 2.1 1.4 18.7 2.7 1.1 3.5 1.1 0.1 0.4 0.3 5.7 0.0 0.7 0.0 12.6 0.1 20.6 0.2 3.2 0.3 0.5 0.2 1.0 8.7 2.5 0.9 0.5 0.1 2.7 0.1 0.0 1.3 1.1 0.0 11.7 0.4 0.2 25.6 4.8 0.5 2.9 3.3 0.7 4.5 3.2 1.7 4.8 2.3 4.1 2.6 0.3 4.3 5.3 2.6 7.5 3.6 13.8 13.4 2.3 9.3 14.1 24.6 12.5 6.6 15.2 7.6 8.9 36.5 0.8 11.6 15.2 2.9 2.4 7.6 25.4 14.8 31.4 2.0 7.8 8.3 19.7 32.8 3.6 25.8 0.0 25.0 2.1 7.8 8.4 538.2 2.4 29.2 30.2 14.5 1.8 5.6 3.6 2.6 6.0 5.0 2.8 22.5 12.0 20.8 17.3 0.4 11.5 1.1 0.0 3.8 0.2 2.3 10.9 1.6 4.9 22.5 14.0 WASHC2A "bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824" ENSG00000099290 "WASH complex subunit 2A" Q641Q2 10 50067888-50133506 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 35.7;Ciliated cells: 76.3;Club cells: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (2.46e-1)" "unprognostic (1.11e-3)" "unprognostic (8.82e-2)" "unprognostic (3.28e-1)" "unprognostic (2.75e-1)" "unprognostic (6.51e-3)" "prognostic unfavorable (6.75e-5)" "unprognostic (4.60e-2)" "unprognostic (2.85e-2)" "unprognostic (2.37e-2)" "unprognostic (9.04e-2)" "unprognostic (2.73e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-1)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (4.40e-2)" 24.0 21.0 15.8 31.4 19.3 24.7 27.1 22.5 18.3 19.1 21.2 16.2 12.6 19.4 22.8 15.3 15.7 15.5 14.4 42.9 17.6 13.9 26.1 12.1 20.7 20.2 15.3 15.8 22.5 14.0 21.2 27.0 17.7 22.0 16.7 23.0 13.1 17.5 16.5 15.5 19.2 21.3 16.8 14.6 27.4 16.2 9.4 14.8 27.0 21.4 9.8 20.2 18.4 27.4 6.6 9.0 11.7 13.9 9.0 12.5 8.8 11.1 5.4 9.2 10.8 37.6 21.0 7.5 13.1 27.8 19.5 20.8 12.5 16.7 9.8 8.2 19.5 18.3 12.2 13.3 11.0 19.3 9.4 9.7 7.0 10.8 12.5 26.2 11.9 12.2 21.6 13.9 21.3 13.5 20.5 14.7 8.4 11.3 9.9 23.4 7.9 6.5 19.5 7.5 7.1 25.5 10.0 13.4 5.8 13.4 12.8 3.2 9.9 12.2 11.3 17.4 14.2 14.0 8.2 21.5 10.0 8.4 28.1 10.7 10.3 20.3 8.4 21.9 21.9 4.0 1.2 10.7 11.7 12.0 13.9 12.5 6.6 10.2 11.0 9.0 6.5 10.2 7.4 5.1 9.0 8.2 5.3 10.4 8.8 15.8 19.3 22.5 18.3 17.6 13.9 15.3 15.8 22.0 14.8 35.7 22.0 0.0 0.0 0.0 0.0 0.0 0.0 76.3 42.1 14.0 0.0 6.6 0.0 14.2 0.0 0.0 0.0 0.0 13.5 5.7 0.0 0.0 14.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 10.0 0.0 0.0 12.2 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 WASHC2C "Em:AC012044.3, FAM21C, KIAA0592" ENSG00000172661 "WASH complex subunit 2C" Q9Y4E1 10 45727200-45792961 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 26.2;Ciliated cells: 45.5;Collecting duct cells: 22.7;granulocytes: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (7.50e-2)" "unprognostic (2.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-2)" "unprognostic (5.98e-3)" "prognostic unfavorable (1.35e-5)" "prognostic favorable (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.00e-3)" "unprognostic (1.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-2)" 17.2 15.8 10.0 33.6 15.7 30.1 27.2 24.9 17.1 16.7 15.8 10.7 15.9 12.2 18.3 17.0 12.3 13.2 13.6 23.2 14.2 10.2 20.6 12.8 17.3 14.8 16.0 8.4 20.2 10.1 22.7 16.5 13.4 16.2 13.4 18.5 13.0 15.3 24.0 17.1 14.8 17.0 15.8 14.0 15.5 12.5 10.1 15.3 19.4 14.9 13.2 14.6 19.3 14.8 10.7 11.4 17.2 20.3 12.2 13.4 11.6 11.2 12.2 9.9 11.3 25.9 23.0 6.0 13.3 21.9 15.7 15.2 7.4 11.1 9.3 9.1 19.6 15.0 10.3 11.1 6.1 15.9 8.7 9.2 9.6 15.2 5.7 27.5 9.6 12.0 21.7 14.8 17.0 12.8 15.5 16.2 7.9 15.3 7.4 19.3 5.9 6.4 16.7 7.2 6.8 1.9 8.1 14.6 4.8 11.7 17.8 4.8 10.9 15.4 7.8 18.6 10.6 10.5 9.7 27.2 8.2 8.8 21.7 8.9 10.5 16.2 9.3 11.6 23.2 4.3 12.5 16.9 11.0 13.0 18.2 12.5 10.7 10.8 13.4 11.4 9.6 10.8 9.7 17.2 12.2 20.3 8.4 10.1 11.6 10.0 15.7 24.9 17.1 14.2 10.2 16.0 8.4 16.2 15.3 32.8 26.2 0.0 0.0 0.0 0.0 0.0 0.0 45.5 21.6 22.7 0.0 6.2 3.3 10.9 0.0 0.0 0.0 0.0 12.1 5.4 0.0 0.0 27.9 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 18.0 0.0 0.0 10.6 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 WASL "N-WASP, NWASP, WASPB" ENSG00000106299 "Wiskott-Aldrich syndrome like" O00401 7 123681935-123749067 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 212.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 45.1;U-2197: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005399, HPA005750" Supported Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB005399: AB_2288632, HPA005750: AB_1854729" "unprognostic (1.91e-1)" "unprognostic (3.60e-2)" "unprognostic (8.19e-2)" "unprognostic (1.83e-1)" "unprognostic (3.20e-1)" "unprognostic (4.61e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.30e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.30e-5)" "unprognostic (7.32e-2)" "prognostic favorable (4.51e-8)" "unprognostic (9.49e-2)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.14e-1)" 17.9 19.3 25.6 11.6 29.5 3.8 20.7 21.0 39.3 23.7 31.2 17.0 8.9 27.4 21.0 14.6 22.5 14.8 21.7 15.4 35.2 22.5 33.3 34.5 15.3 5.5 18.8 23.0 27.8 21.9 36.7 16.9 25.4 28.6 19.9 28.8 18.0 16.9 19.5 21.6 14.4 30.2 18.2 16.6 12.1 22.0 17.3 15.0 10.0 26.7 12.0 9.7 23.7 21.1 4.6 4.5 4.9 6.2 6.2 4.3 1.5 10.9 8.1 8.9 7.6 14.1 14.6 11.6 7.6 12.8 5.6 7.3 6.6 13.9 1.1 6.1 11.5 12.1 8.3 16.5 8.4 8.8 1.9 6.6 0.9 6.7 7.1 15.3 1.4 0.9 11.7 15.8 8.3 14.3 12.8 9.7 1.1 4.8 2.1 13.4 6.6 1.8 1.9 16.7 11.7 7.4 1.1 7.2 2.4 11.9 45.1 11.0 16.2 10.5 31.6 20.5 14.5 6.1 1.4 11.0 15.2 4.3 42.8 7.4 2.4 0.8 2.4 13.1 1.2 12.1 4.9 4.1 1.8 4.3 4.1 3.6 4.6 2.8 2.6 3.5 3.2 3.6 3.8 1.8 6.2 6.2 4.5 1.4 1.5 25.6 29.5 21.0 39.3 35.2 22.5 18.8 23.0 28.6 15.0 80.4 46.6 7.8 37.8 53.7 27.6 63.7 61.1 45.5 51.2 50.6 19.6 36.7 44.7 43.5 16.7 34.6 105.1 0.0 46.9 46.1 45.8 67.4 3.5 49.7 11.1 25.4 65.3 56.4 14.8 6.2 44.5 13.4 28.7 14.4 96.1 57.1 59.0 118.1 60.8 80.1 28.9 19.4 43.2 15.5 19.8 59.7 68.0 7.5 56.6 212.0 WDCP "C2orf44, FLJ21945" ENSG00000163026 "WD repeat and coiled coil containing" Q9H6R7 2 24029340-24049575 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 12 "Collecting duct cells: 8.7;Distal tubular cells: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041054 Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA041054: AB_10796566" "unprognostic (1.07e-1)" "unprognostic (3.19e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.32e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (5.14e-8)" "unprognostic (7.69e-2)" "unprognostic (9.01e-3)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (5.19e-2)" "unprognostic (2.76e-3)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (7.76e-2)" "unprognostic (3.00e-1)" 11.7 9.6 8.3 7.6 9.4 2.4 9.2 14.6 9.8 9.6 9.3 11.5 8.4 5.3 10.7 8.0 7.4 7.2 5.6 6.8 7.1 6.9 7.5 8.9 5.4 12.4 8.3 4.8 11.6 7.7 11.2 9.4 8.5 8.7 8.7 6.2 7.8 7.1 12.9 13.8 5.9 7.5 7.4 8.0 9.4 7.0 12.5 9.2 17.9 8.9 5.5 13.7 9.4 6.4 4.9 4.3 1.5 3.8 5.0 7.8 4.2 7.3 11.4 12.6 8.7 8.6 6.9 4.5 9.0 4.8 9.4 9.0 10.3 3.4 19.4 3.9 4.6 7.9 5.4 17.8 6.1 9.8 11.6 10.2 11.8 5.7 10.7 5.9 10.7 8.2 4.1 4.8 9.6 4.8 4.9 8.8 11.3 16.3 5.4 9.8 3.3 13.9 6.4 15.1 7.4 8.9 15.4 21.2 7.8 4.4 3.6 9.7 13.4 4.4 4.3 5.5 9.2 3.3 4.8 8.4 7.6 8.4 4.5 8.1 8.9 11.2 27.4 4.8 11.5 5.9 0.0 2.4 1.5 7.5 3.8 7.8 4.9 5.0 5.5 4.3 4.7 6.8 7.5 0.7 5.0 2.6 1.6 7.1 4.2 8.3 9.4 14.6 9.8 7.1 6.9 8.3 4.8 8.7 9.2 3.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 8.7 0.0 2.6 6.6 2.1 0.0 0.0 0.0 0.0 1.7 2.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 WDFY3 "ALFY, KIAA0993, ZFYVE25" ENSG00000163625 "WD repeat and FYVE domain containing 3" Q8IZQ1 4 84669610-84966391 "Disease related genes, Predicted intracellular proteins" Autophagy "Developmental protein" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.3" "Group enriched" "Detected in many" 23 "dendritic cells: 1.1;granulocytes: 4.3;monocytes: 1.5" "Cell line enhanced" "Detected in many" "TIME: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042734, HPA048572" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoli, Plasma membrane" "HPA042734: AB_2678135, HPA048572: AB_2680447" "unprognostic (7.14e-2)" "unprognostic (6.02e-2)" "unprognostic (7.68e-2)" "unprognostic (1.60e-1)" "unprognostic (1.84e-2)" "unprognostic (2.48e-1)" "unprognostic (2.86e-2)" "unprognostic (3.36e-1)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "prognostic favorable (3.64e-5)" "prognostic unfavorable (9.35e-4)" "unprognostic (2.79e-1)" "unprognostic (4.41e-2)" "unprognostic (4.95e-2)" 10.1 15.2 17.2 7.5 18.7 13.1 9.0 17.9 18.6 9.6 8.3 17.6 4.8 3.6 11.5 6.9 9.4 9.3 9.0 7.3 17.3 6.5 21.3 5.8 7.9 2.4 22.8 9.5 14.7 9.0 24.0 14.6 11.8 17.0 9.2 5.9 8.6 9.8 8.1 13.7 10.9 5.6 8.7 14.8 7.5 7.8 8.0 21.4 0.4 12.1 3.2 2.6 14.2 6.6 0.0 1.1 4.3 1.5 0.0 0.0 0.3 6.5 4.5 8.1 4.5 14.5 11.4 5.1 6.3 6.7 6.6 6.0 5.0 5.4 0.0 6.5 10.4 7.0 3.3 8.7 6.9 8.4 4.5 2.7 4.1 4.9 3.0 5.5 3.2 7.8 8.3 6.3 8.6 8.7 8.0 20.9 3.4 4.1 20.0 12.0 4.7 3.1 0.7 4.2 6.3 2.2 4.6 6.5 0.9 11.4 8.6 9.6 4.5 7.7 8.6 4.3 8.1 4.4 8.0 31.7 8.7 8.7 4.8 7.9 0.0 0.0 0.0 5.9 2.8 9.5 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.3 0.0 0.5 0.0 0.0 0.3 17.2 18.7 17.9 18.6 17.3 6.5 22.8 9.5 17.0 21.4 17.9 11.7 1.5 8.3 13.1 41.7 15.5 15.3 10.7 12.5 15.7 33.4 9.5 1.7 8.5 6.7 16.9 4.6 0.0 6.2 5.5 12.3 13.0 0.0 7.6 17.1 27.0 8.7 22.1 39.6 7.7 17.0 17.4 6.8 5.4 7.0 26.8 8.9 5.8 23.0 14.9 41.9 25.8 15.6 7.4 7.8 14.1 12.1 0.5 6.6 10.0 WDR12 "FLJ10881, YTM1" ENSG00000138442 "WD repeat domain 12" Q9GZL7 2 202874782-203014798 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036389 Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA036389: AB_10670716" "unprognostic (1.08e-2)" "unprognostic (3.59e-1)" "unprognostic (8.17e-2)" "unprognostic (3.59e-3)" "unprognostic (1.24e-2)" "unprognostic (9.40e-3)" "prognostic unfavorable (2.57e-6)" "unprognostic (1.52e-1)" "unprognostic (6.14e-2)" "unprognostic (4.78e-2)" "unprognostic (4.58e-2)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (5.21e-2)" "unprognostic (2.66e-1)" "unprognostic (9.69e-3)" "unprognostic (4.48e-2)" 5.8 9.7 7.2 5.5 16.1 6.7 7.6 11.5 15.2 5.9 6.2 6.5 3.7 8.9 7.1 7.0 8.0 6.7 5.0 8.4 6.8 8.6 11.1 8.7 4.2 6.4 7.4 8.9 7.3 5.7 6.7 8.0 6.6 12.6 4.9 8.7 6.7 5.4 5.2 11.0 7.7 6.0 7.4 6.2 5.3 5.6 17.1 8.2 9.6 7.1 5.1 7.5 5.8 5.6 5.4 6.9 3.6 5.0 3.6 5.9 3.0 4.4 4.7 5.4 10.1 10.2 8.8 9.8 6.7 5.4 8.4 8.1 11.8 6.2 8.0 6.2 5.4 7.4 5.6 14.6 10.8 13.4 4.0 9.0 13.6 7.5 13.9 6.6 17.7 8.4 7.9 7.8 9.9 19.7 5.6 8.7 8.8 21.3 5.3 9.1 5.1 12.1 10.4 12.3 5.9 11.9 8.8 8.4 12.6 9.1 5.3 9.5 8.3 5.3 7.0 8.2 9.8 4.1 11.7 6.9 7.5 6.1 6.2 7.4 7.0 10.4 13.5 7.4 12.1 7.4 3.6 4.7 2.0 4.2 5.0 5.9 5.3 4.0 4.3 6.0 5.4 5.2 5.0 2.1 3.6 4.5 6.9 4.3 3.0 7.2 16.1 11.5 15.2 6.8 8.6 7.4 8.9 12.6 8.2 8.9 16.3 6.0 16.7 18.2 9.1 22.5 10.2 17.4 17.0 5.2 2.0 21.5 13.3 14.9 8.1 10.6 10.0 0.0 9.1 29.0 15.4 7.7 15.0 13.6 15.8 14.3 5.2 8.0 9.1 6.6 15.8 9.5 1.7 8.2 9.1 5.8 12.6 3.5 14.5 29.9 7.8 12.9 15.1 35.1 32.6 15.2 18.0 10.2 17.2 16.0 WDR3 "DIP2, FLJ12796, UTP12" ENSG00000065183 "WD repeat domain 3" Q9UNX4 1 117929720-117966542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027509, HPA054354, HPA072915" Enhanced Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: " "unprognostic (6.77e-2)" "unprognostic (4.53e-3)" "unprognostic (1.50e-1)" "unprognostic (2.46e-3)" "unprognostic (1.91e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (8.82e-4)" "unprognostic (8.90e-3)" "unprognostic (7.47e-2)" "unprognostic (5.29e-2)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (8.65e-2)" 12.5 13.5 7.7 10.6 10.7 3.3 12.2 8.4 9.7 10.5 7.7 6.8 9.7 7.3 12.6 6.5 13.3 10.5 4.6 8.7 7.1 6.4 8.5 14.8 7.3 15.5 6.9 6.2 12.1 21.4 16.3 14.8 8.4 8.3 8.4 10.8 6.6 9.8 8.1 25.4 10.5 6.8 11.7 6.2 8.5 9.3 14.9 6.9 15.2 11.1 9.5 15.2 10.2 9.1 8.7 11.9 0.5 6.6 7.9 12.4 6.3 15.2 9.7 9.7 14.8 10.6 8.7 11.2 10.7 7.0 12.5 11.0 10.2 5.1 18.1 14.7 7.9 8.0 10.3 24.1 12.3 19.9 14.9 12.5 17.0 10.4 8.2 8.7 31.8 9.0 8.5 8.9 15.8 24.0 7.4 11.9 12.8 20.7 8.9 10.9 8.8 15.1 7.3 35.0 13.4 15.6 14.5 33.7 13.8 6.2 10.2 15.0 13.7 12.2 15.1 17.3 14.1 6.0 13.3 10.5 9.4 15.0 17.1 23.9 13.1 15.3 28.4 13.8 20.6 24.2 0.1 6.0 0.5 8.8 6.1 11.4 8.7 8.0 10.3 11.9 7.9 12.4 11.3 0.5 7.9 6.6 6.6 10.7 6.3 7.7 10.7 8.4 9.7 7.1 6.4 6.9 6.2 8.3 6.9 8.9 11.0 9.2 10.8 18.5 9.6 14.0 5.1 25.4 33.0 7.0 5.9 9.2 8.3 8.4 28.6 11.7 2.7 0.0 11.8 7.5 9.5 8.9 15.1 25.5 7.2 14.3 3.5 11.6 6.3 34.2 11.5 7.4 10.1 2.8 5.1 6.5 10.6 3.5 11.0 6.0 6.4 12.9 14.6 25.9 60.1 19.6 4.2 5.7 9.4 7.7 WDR36 "GLC1G, TA-WDRP, UTP21" ENSG00000134987 "WD repeat domain 36" Q8NI36 5 111091716-111130502 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Sensory transduction, Vision" "Disease mutation, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037796, HPA037797" Supported Supported Nucleoli NA NA Nucleoli "HPA037796: AB_2675673, HPA037797: AB_10672725" "unprognostic (2.14e-1)" "unprognostic (4.56e-2)" "unprognostic (1.45e-2)" "unprognostic (2.81e-1)" "unprognostic (2.60e-1)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (1.64e-1)" "unprognostic (9.79e-2)" "unprognostic (7.10e-3)" "unprognostic (3.09e-1)" "unprognostic (1.92e-1)" "unprognostic (5.31e-2)" "unprognostic (1.12e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (4.91e-2)" 30.6 12.3 8.2 15.4 12.2 17.5 15.2 14.5 14.6 15.9 12.2 9.3 10.2 9.6 19.0 11.8 18.4 13.9 11.5 11.7 8.2 9.7 14.8 24.6 12.4 18.7 8.8 11.1 20.6 15.0 14.8 19.1 15.3 13.5 15.0 12.8 9.3 13.6 11.0 17.0 15.2 13.7 14.5 8.9 21.7 12.2 11.3 9.4 24.3 16.7 12.9 18.4 13.8 14.7 6.7 9.9 2.5 10.1 6.0 9.4 6.4 10.1 11.5 8.1 21.1 12.7 17.8 13.5 8.6 8.8 12.9 19.1 13.3 12.1 30.6 11.2 6.9 16.6 11.2 16.6 20.0 22.6 10.9 9.2 16.8 11.3 10.3 13.3 15.3 30.9 10.2 11.0 22.6 22.6 19.5 15.0 12.1 20.1 15.6 13.8 8.5 20.1 11.7 10.4 9.0 10.2 16.5 18.8 23.8 8.9 13.4 14.4 10.9 11.5 8.3 12.6 9.6 9.6 10.3 10.5 16.8 11.1 12.4 17.7 12.7 11.8 33.0 12.9 20.5 13.5 0.2 6.4 2.5 7.8 8.6 9.2 6.7 6.7 8.7 9.9 5.9 9.4 7.8 0.4 6.0 10.1 4.3 9.0 6.4 8.2 12.2 14.5 14.6 8.2 9.7 8.8 11.1 13.5 9.4 17.9 14.4 16.0 8.0 54.3 8.4 13.3 17.8 14.7 25.0 15.7 5.9 8.0 6.6 9.3 5.0 17.3 5.2 0.0 11.7 8.0 12.8 8.7 13.9 27.2 12.8 11.1 5.8 15.4 17.7 2.6 8.1 12.6 20.3 16.2 13.4 5.6 7.9 7.0 10.6 9.8 8.3 19.4 11.3 16.9 14.5 50.6 4.5 9.6 11.5 8.8 WDR55 "FLJ20195, FLJ21702" ENSG00000120314 "WD repeat domain 55" Q9H6Y2 5 140664676-140674124 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043470, HPA048143, HPA075133" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: " "prognostic unfavorable (1.51e-4)" "unprognostic (1.35e-1)" "unprognostic (7.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.88e-6)" "unprognostic (9.96e-2)" "unprognostic (2.78e-1)" "unprognostic (3.05e-1)" "unprognostic (4.00e-2)" "unprognostic (1.02e-2)" "unprognostic (1.19e-3)" "unprognostic (1.37e-1)" "unprognostic (2.14e-1)" "unprognostic (3.70e-1)" "unprognostic (2.51e-2)" 17.9 12.4 7.6 17.8 8.8 18.1 12.9 13.0 12.7 9.5 16.6 11.4 16.9 14.9 12.0 11.0 18.8 10.9 20.2 9.6 7.7 9.1 15.3 29.9 12.7 15.0 12.6 8.5 12.0 16.2 11.4 13.2 13.9 10.6 12.8 17.5 8.9 16.7 14.8 18.2 15.8 20.8 11.1 8.9 18.8 14.9 8.0 8.5 12.5 12.0 14.0 21.4 13.5 11.0 10.4 11.3 10.4 18.9 11.3 14.3 10.2 7.9 10.9 5.3 21.3 8.3 6.7 14.9 7.9 9.8 8.5 9.7 18.7 10.9 7.5 10.7 10.3 15.3 9.9 7.2 13.9 6.6 6.9 5.9 8.5 9.0 7.6 8.0 8.9 16.1 7.9 8.1 11.6 6.2 5.8 9.0 8.4 5.9 5.9 9.3 11.3 8.2 8.0 5.6 11.4 9.6 7.0 7.7 7.0 10.1 12.0 5.2 7.0 10.9 31.9 12.1 6.8 22.6 9.6 8.0 11.1 5.8 12.7 10.7 9.8 7.6 5.9 14.3 11.9 6.5 6.9 11.7 8.6 13.9 18.9 14.3 10.4 12.9 11.8 11.3 8.8 10.5 10.7 10.4 11.3 15.4 8.4 14.1 10.2 7.6 8.8 13.0 12.7 7.7 9.1 12.6 8.5 10.6 8.5 8.9 18.4 22.6 8.8 12.9 12.9 4.5 5.1 17.4 18.2 17.4 11.8 19.4 18.3 17.5 20.3 9.5 24.1 0.0 24.4 36.3 12.9 11.7 19.6 13.5 18.9 22.3 14.3 8.6 12.4 6.8 8.9 18.9 8.5 26.2 17.8 5.6 23.0 28.1 7.1 15.6 7.8 12.9 12.3 7.1 9.6 11.7 19.5 20.0 19.8 12.9 WDR74 FLJ10439 ENSG00000133316 "WD repeat domain 74" Q6RFH5 11 62832342-62841809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.4" "Group enriched" "Detected in many" 4 "Club cells: 168.4;Early spermatids: 612.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037795, HPA038419" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037795: AB_10671380, HPA038419: AB_2676006" "unprognostic (5.52e-2)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (4.35e-2)" "unprognostic (3.47e-2)" "unprognostic (3.97e-3)" "unprognostic (6.58e-2)" "unprognostic (1.67e-2)" "unprognostic (1.62e-2)" "unprognostic (2.46e-2)" "unprognostic (8.20e-3)" "unprognostic (1.29e-3)" "unprognostic (2.77e-2)" "unprognostic (6.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-1)" 14.2 13.2 12.6 19.7 13.8 77.4 14.2 14.6 21.5 12.5 12.5 10.9 8.7 10.8 14.1 10.2 16.1 15.1 12.8 12.6 12.2 11.9 15.5 19.7 10.0 18.1 15.4 16.5 17.4 20.6 9.4 8.0 11.9 13.6 12.5 11.2 8.0 16.5 9.8 42.1 19.8 10.6 11.5 9.5 18.0 13.4 23.5 16.6 16.0 20.0 19.1 16.0 12.4 14.0 39.1 44.8 15.9 34.8 26.8 16.7 11.9 16.4 19.8 7.7 12.8 6.4 8.8 24.0 9.2 10.0 20.1 13.4 28.9 20.2 28.9 26.3 7.6 16.2 22.0 23.7 18.4 15.8 18.4 17.5 14.6 21.8 25.0 18.8 28.9 9.6 8.5 20.7 12.8 42.6 6.6 9.8 21.1 31.8 8.6 9.1 31.6 27.6 46.0 31.5 18.9 26.3 28.2 13.3 50.4 14.2 9.4 17.2 19.4 10.7 22.0 29.7 7.8 15.5 22.4 7.0 11.8 14.2 26.3 23.1 21.4 29.7 35.1 13.0 17.7 15.3 8.7 34.8 3.2 11.7 16.9 14.7 18.6 12.1 11.0 29.2 39.1 16.7 14.8 15.9 26.8 11.3 44.8 13.7 11.9 12.6 13.8 14.6 21.5 12.2 11.9 15.4 16.5 13.6 16.6 35.7 64.8 46.3 33.6 92.8 13.9 1.4 33.1 44.2 168.4 15.7 15.7 47.5 36.5 39.1 612.8 32.3 22.2 0.0 34.8 40.2 35.6 20.1 41.7 28.4 34.0 3.2 39.4 17.8 30.3 74.1 30.5 38.9 28.7 18.0 28.7 13.4 36.2 26.6 20.1 37.0 11.0 19.4 37.3 14.7 27.4 95.5 29.1 57.9 38.1 31.5 WDSUB1 "FLJ36175, UBOX6, WDSAM1" ENSG00000196151 "WD repeat, sterile alpha motif and U-box domain containing 1" Q8N9V3 2 159235793-159286799 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036840, HPA058172" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA036840: AB_10670926, HPA058172: AB_2683628" "unprognostic (1.37e-2)" "prognostic favorable (3.35e-4)" "unprognostic (2.56e-1)" "unprognostic (7.33e-3)" "unprognostic (3.44e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.76e-3)" "unprognostic (4.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" "unprognostic (6.75e-2)" "unprognostic (3.46e-3)" "unprognostic (8.49e-2)" "unprognostic (1.72e-1)" "unprognostic (1.00e-2)" "unprognostic (2.87e-2)" 10.3 14.2 9.7 6.6 12.7 10.9 14.8 18.9 14.0 10.3 8.5 8.9 10.6 5.8 9.8 22.1 11.1 11.8 9.9 11.5 9.7 10.6 27.7 8.2 10.7 16.1 11.5 7.0 16.4 15.5 19.4 23.8 15.7 9.2 11.3 9.2 16.0 11.8 8.7 7.7 8.2 7.7 9.9 9.5 10.5 9.0 7.7 10.2 8.5 22.2 6.1 9.2 10.0 15.0 9.8 10.3 2.8 9.3 16.2 13.0 6.2 6.1 4.6 4.2 6.6 7.6 8.8 14.2 4.8 9.5 8.8 15.5 9.9 10.0 8.2 5.1 7.2 15.1 3.7 11.7 4.4 12.4 3.2 9.7 8.4 5.3 10.0 9.3 7.1 11.7 5.1 16.4 10.8 8.9 16.9 7.2 10.9 11.1 6.2 8.3 6.3 5.1 13.2 5.7 10.4 9.9 8.0 6.2 4.4 10.1 8.9 7.8 5.1 5.0 6.5 11.2 20.4 5.0 12.6 3.0 6.3 4.6 8.8 4.6 3.2 5.3 7.6 11.1 8.9 3.9 2.7 9.3 2.8 13.0 7.0 9.8 9.8 5.2 8.1 10.3 8.9 6.3 7.4 0.6 16.2 6.3 9.7 2.6 6.2 9.7 12.7 18.9 14.0 9.7 10.6 11.5 7.0 9.2 10.2 11.9 5.0 6.7 7.4 4.7 6.4 10.7 10.2 17.4 9.1 19.2 2.0 20.1 29.9 7.2 3.0 6.6 5.1 0.0 3.1 7.7 8.8 6.6 11.5 1.7 15.4 4.8 5.2 6.2 13.9 2.1 11.8 9.5 5.0 3.6 5.5 6.0 4.7 9.0 10.6 17.4 8.9 0.0 7.1 10.5 20.2 5.5 19.2 10.1 7.0 5.1 WEE1 WEE1A ENSG00000166483 "WEE1 G2 checkpoint kinase" P30291 11 9573681-9593457 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal glandular cells: 165.0;Suprabasal keratinocytes: 167.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004619, HPA068845" Approved Approved Nucleoli No No Nucleoli "CAB004619: AB_628447, HPA068845: AB_2686048" "unprognostic (6.04e-2)" "unprognostic (1.90e-3)" "unprognostic (1.09e-2)" "unprognostic (9.29e-2)" "unprognostic (1.26e-1)" "unprognostic (1.39e-2)" "unprognostic (3.79e-3)" "unprognostic (2.48e-2)" "unprognostic (1.22e-1)" "unprognostic (1.79e-2)" "unprognostic (3.21e-3)" "unprognostic (3.73e-1)" "prognostic unfavorable (5.19e-4)" "unprognostic (1.07e-1)" "unprognostic (3.06e-1)" "unprognostic (2.08e-1)" "unprognostic (3.80e-1)" 6.9 3.5 2.0 26.1 2.1 6.6 27.4 5.3 1.6 12.8 18.0 2.5 15.4 3.7 21.9 14.3 22.1 12.4 20.2 23.0 2.0 2.2 6.8 19.3 10.2 10.9 1.8 1.2 11.1 4.4 4.9 6.1 42.7 4.7 17.0 4.7 5.9 12.8 17.8 12.0 33.3 10.4 22.9 2.4 8.0 12.5 28.3 2.0 35.9 12.0 26.8 26.4 19.8 14.7 8.5 0.1 6.4 0.0 2.1 7.8 0.6 14.4 5.6 21.5 11.9 18.9 9.5 42.6 17.9 13.8 10.0 10.0 10.2 17.8 33.9 6.7 7.8 9.4 17.5 14.7 6.9 12.8 12.1 12.0 13.3 9.0 6.8 2.0 20.1 13.3 3.1 7.5 4.7 16.6 10.4 6.2 13.2 21.6 23.6 17.4 3.4 20.5 10.9 32.4 10.0 6.4 19.8 16.9 7.3 7.9 30.5 8.1 10.6 12.1 14.3 8.7 26.8 9.0 9.6 7.1 18.1 12.6 7.3 14.2 5.5 16.5 44.8 7.7 11.1 12.6 0.0 0.0 6.4 2.0 0.0 0.2 8.5 2.0 3.3 0.1 3.6 0.1 1.6 0.1 2.1 0.0 0.1 7.8 0.6 2.0 2.1 5.3 1.6 2.0 2.2 1.8 1.2 4.7 2.0 47.6 26.9 13.5 165.0 156.6 1.8 53.3 66.2 49.5 56.9 40.1 0.0 78.4 11.6 22.0 18.2 13.0 34.2 23.3 11.8 154.6 38.6 75.9 6.9 86.3 14.7 1.6 58.5 9.2 1.6 29.5 10.9 8.4 16.9 2.8 32.0 9.3 20.6 25.7 10.3 6.7 4.4 6.5 22.1 42.6 52.9 167.1 114.8 13.1 37.4 55.3 XDH "XO, XOR" ENSG00000158125 "Xanthine dehydrogenase" P47989 2 31334321-31414715 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 78.6;liver: 32.5" "Group enriched" "Detected in many" 5 "Enterocytes: 95.3;Hepatocytes: 35.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 6.2;HBEC3-KT: 15.3;hTERT-HME1: 24.5;U-251 MG: 6.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA062641, HPA069323" Supported Uncertain Nucleoplasm,Nucleoli "Intracellular and membrane" No No Nucleoplasm Nucleoli "HPA062641: AB_2684816, HPA069323: AB_2686121" "unprognostic (8.58e-2)" "unprognostic (4.07e-2)" "unprognostic (1.34e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-2)" "unprognostic (7.06e-2)" "unprognostic (4.38e-3)" "unprognostic (7.48e-3)" "unprognostic (3.55e-1)" "unprognostic (3.60e-2)" "unprognostic (3.95e-3)" "unprognostic (3.51e-2)" "unprognostic (1.24e-6)" "unprognostic (2.25e-1)" "unprognostic (5.25e-2)" "unprognostic (2.54e-1)" "prognostic favorable (8.73e-6)" 0.2 0.2 0.2 2.4 0.2 0.0 17.8 0.2 0.2 2.6 17.9 0.1 0.0 20.1 0.3 6.3 9.3 0.2 1.8 0.2 0.1 0.2 0.4 32.5 0.2 0.0 0.2 0.0 0.2 0.4 0.0 1.5 3.7 0.1 1.2 4.2 0.1 20.9 0.0 0.7 1.0 78.6 0.1 0.2 0.2 1.3 0.2 0.0 0.2 0.3 2.4 6.1 1.8 1.1 0.7 0.3 1.0 0.6 0.7 0.5 0.0 1.5 0.3 0.0 0.0 0.0 0.1 0.1 6.2 3.6 0.7 1.1 0.2 1.7 0.0 1.2 0.2 0.6 3.2 0.0 15.3 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.4 0.9 24.5 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.3 0.9 0.1 0.0 1.1 3.3 4.5 3.9 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 3.0 1.9 0.1 6.7 2.0 0.1 0.0 0.2 0.0 0.0 0.5 0.6 0.2 0.2 0.2 0.4 0.1 0.3 0.3 0.0 0.7 0.2 0.5 1.0 0.7 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.0 0.1 0.0 0.0 3.7 0.0 2.6 0.5 0.3 0.3 2.5 0.0 2.3 0.0 0.0 0.1 0.0 2.4 0.2 0.0 95.3 0.0 7.2 0.5 0.0 0.5 0.0 35.8 0.0 0.0 11.3 1.8 1.6 0.0 0.0 0.0 0.0 0.0 5.2 0.1 8.8 7.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.1 0.3 0.0 12.8 14.2 XPO6 "FLJ22519, KIAA0370, RANBP20" ENSG00000169180 "Exportin 6" Q96QU8 16 28097979-28211920 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 7 "neutrophil: 56.4" "Lineage enriched" "Detected in all" 9 "granulocytes: 56.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038246 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" No No "Nucleoplasm, Nucleoli" "Plasma membrane, Cytosol" "HPA038246: AB_10674550" "unprognostic (1.17e-1)" "unprognostic (5.43e-2)" "unprognostic (1.07e-1)" "unprognostic (3.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.68e-4)" "unprognostic (2.22e-1)" "unprognostic (1.41e-1)" "unprognostic (1.31e-2)" "unprognostic (4.48e-1)" "unprognostic (1.40e-1)" "unprognostic (1.01e-3)" "unprognostic (2.10e-1)" "unprognostic (5.36e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (8.80e-4)" 18.4 14.1 24.3 32.0 25.0 47.9 17.7 16.0 30.6 12.4 17.7 30.4 9.9 13.4 13.5 12.0 16.8 14.1 14.9 9.6 27.5 23.9 13.3 19.1 20.6 54.6 25.6 16.9 15.3 13.2 22.0 18.0 25.9 21.7 14.1 17.0 16.3 19.4 13.1 8.3 18.8 18.3 16.3 23.8 50.4 14.8 28.9 19.8 37.1 18.0 7.8 31.8 17.2 13.2 5.2 2.6 56.4 4.4 2.7 6.5 2.0 28.5 20.5 18.1 19.4 12.6 20.0 20.8 35.4 32.0 41.4 42.0 28.7 20.5 20.3 30.5 32.1 21.1 18.7 42.9 27.1 50.4 45.7 26.6 22.2 28.9 32.0 29.7 31.0 25.0 15.7 20.2 36.8 36.5 17.8 23.8 20.7 40.4 10.3 28.0 32.0 37.2 36.9 30.6 13.9 19.6 34.9 21.5 33.6 15.4 14.6 35.3 19.2 17.5 29.2 15.5 21.0 21.0 20.5 25.1 35.0 23.5 29.8 29.4 24.0 30.3 30.1 26.7 32.3 29.5 4.7 2.7 8.4 4.1 3.0 4.4 5.2 4.7 4.4 2.0 3.9 5.2 6.5 56.4 2.7 4.4 2.6 3.8 2.0 24.3 25.0 16.0 30.6 27.5 23.9 25.6 16.9 21.7 19.8 8.9 13.9 21.7 8.2 16.6 23.8 6.6 2.5 9.4 10.3 22.7 29.5 9.8 6.6 13.3 27.6 10.6 14.7 0.0 16.4 13.9 12.4 15.6 2.3 14.0 19.9 20.6 22.7 8.6 23.4 30.6 10.0 14.7 6.8 27.1 21.5 8.3 18.1 14.0 8.1 5.0 26.3 6.5 11.3 29.5 29.2 18.6 7.0 20.8 17.0 12.6 XRN2 ENSG00000088930 "5'-3' exoribonuclease 2" Q9H0D6 20 21303304-21389827 "Predicted intracellular proteins" "mRNA processing, Transcription, Transcription regulation, Transcription termination" "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047118, HPA050485" Supported Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA047118: AB_2679941, HPA050485: AB_2681141" "unprognostic (9.38e-2)" "unprognostic (4.70e-2)" "unprognostic (2.07e-2)" "unprognostic (3.09e-2)" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.54e-5)" "unprognostic (7.26e-2)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.09e-2)" "unprognostic (1.40e-1)" "unprognostic (1.99e-3)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (1.63e-2)" "unprognostic (1.31e-1)" 42.9 35.1 12.5 24.5 17.7 38.3 30.4 18.0 16.4 26.8 22.8 18.6 23.3 14.4 38.6 25.2 22.1 30.6 21.8 19.3 13.7 10.3 31.4 35.3 27.5 33.4 17.4 12.1 32.1 26.4 30.0 35.3 26.5 15.9 25.7 20.1 19.1 27.6 25.0 36.8 23.0 21.6 24.1 18.6 40.9 23.2 27.4 18.3 41.1 31.3 20.4 30.6 33.1 21.7 16.0 30.6 35.0 33.9 21.7 24.6 23.8 27.4 32.7 36.1 27.6 27.0 33.3 35.8 25.3 33.1 33.8 39.5 21.8 31.6 27.1 15.1 26.5 46.1 32.7 40.6 42.6 43.5 12.2 20.5 35.0 12.3 41.1 23.8 31.4 30.5 31.5 21.6 37.2 32.7 30.2 29.0 26.1 28.0 23.3 31.3 21.5 46.2 20.8 28.1 26.8 22.1 34.0 61.4 23.1 28.8 29.2 28.0 36.4 29.5 36.4 27.1 29.2 20.4 37.5 26.7 34.0 25.5 7.7 31.9 20.6 26.4 29.1 13.1 14.7 25.6 15.1 33.9 23.8 18.6 27.2 24.6 16.0 20.4 20.2 30.6 15.1 21.8 21.0 35.0 21.7 32.7 13.2 24.0 23.8 12.5 17.7 18.0 16.4 13.7 10.3 17.4 12.1 15.9 18.3 56.6 105.5 63.6 78.1 56.4 39.0 48.7 53.5 108.4 109.2 38.4 39.3 93.9 23.2 104.4 113.2 77.5 32.5 0.0 104.1 85.7 61.2 59.6 79.9 61.8 93.6 47.7 57.1 43.0 136.4 16.3 53.5 87.6 57.3 76.7 45.4 69.3 88.3 45.9 52.3 62.6 44.7 58.2 72.1 99.1 113.5 58.7 88.0 62.3 54.7 73.2 YAP1 YAP65 ENSG00000137693 "Yes associated protein 1" P46937 11 102110461-102233423 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009370, HPA038885, CAB069915, HPA070359" Enhanced Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "CAB009370: AB_2273277, CAB069915: AB_922796, HPA038885: AB_2676255, HPA070359: AB_2732154" "unprognostic (9.56e-2)" "unprognostic (6.75e-2)" "unprognostic (2.08e-1)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.28e-1)" "unprognostic (2.66e-3)" "unprognostic (3.73e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (9.26e-2)" "unprognostic (4.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.77e-1)" "unprognostic (1.04e-1)" "unprognostic (1.29e-2)" 27.1 15.8 11.6 12.1 10.0 0.0 34.9 7.0 9.5 37.5 21.3 7.0 40.1 9.8 51.7 33.3 36.9 25.5 34.6 18.8 12.5 6.0 17.3 32.1 26.2 7.6 9.3 6.1 41.1 8.9 18.9 6.4 34.0 15.0 34.8 11.4 21.7 22.2 35.2 27.8 23.4 15.1 58.2 17.2 7.6 18.2 15.6 9.7 2.6 34.0 25.7 12.6 42.3 41.1 0.1 0.0 0.0 0.0 0.0 0.3 0.2 11.7 11.0 30.7 15.0 33.6 32.1 25.7 27.7 31.7 27.0 22.3 27.4 28.6 0.0 22.9 36.2 20.1 20.8 15.2 39.5 28.7 3.4 5.4 0.0 15.0 18.6 25.7 0.0 0.5 25.6 26.0 29.6 48.3 30.2 8.4 1.4 0.0 0.0 30.5 5.6 0.5 0.0 14.5 28.3 10.5 0.0 17.3 0.0 19.9 21.0 0.1 1.0 32.6 12.3 9.2 29.4 22.2 0.1 9.2 38.5 15.1 19.3 11.6 0.0 0.0 0.1 11.2 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 11.6 10.0 7.0 9.5 12.5 6.0 9.3 6.1 15.0 9.7 32.8 51.8 1.7 40.6 101.0 0.3 34.4 76.5 24.1 35.2 87.2 0.0 79.0 10.0 28.8 3.9 26.3 16.2 0.0 15.8 14.7 61.4 50.8 0.0 36.0 9.2 0.0 7.0 24.5 1.3 2.7 35.1 2.3 42.2 1.8 13.7 26.2 23.1 20.9 38.2 20.0 1.0 38.8 48.4 2.7 0.9 107.6 51.5 0.0 24.7 55.2 Z82206.1 ENSG00000225528 22 39960397-39964718 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "blood: 8.1;bone marrow: 4.1;lymphoid tissue: 2.3" "Group enriched" "Detected in some" 5 "Distal tubular cells: 6.6;granulocytes: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 4.0;JURKAT: 3.2;K-562: 16.1;MOLT-4: 2.7" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (8.48e-4)" "unprognostic (2.95e-6)" "unprognostic (3.67e-1)" "unprognostic (5.90e-2)" "unprognostic (4.27e-1)" "unprognostic (6.95e-3)" "unprognostic (3.74e-1)" "unprognostic (5.41e-4)" "unprognostic (2.33e-1)" "unprognostic (2.13e-2)" "unprognostic (1.18e-3)" "unprognostic (8.77e-2)" "unprognostic (6.53e-5)" "unprognostic (1.89e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (6.58e-3)" 0.0 0.0 0.5 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.1 0.0 0.0 1.1 0.3 3.6 3.0 5.7 2.2 2.2 8.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 16.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.8 4.4 5.2 2.2 4.5 3.6 6.5 5.7 2.7 3.2 6.7 8.1 4.3 2.2 1.9 3.0 4.2 7.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZBED9 "Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452" ENSG00000232040 "Zinc finger BED-type containing 9" Q6R2W3 6 28570535-28616212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 13.2;testis: 17.6" "Group enriched" "Detected in many" 4 "Early spermatids: 17.9;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 7.8;hTCEpi: 7.1;K-562: 12.5;U-266/84: 6.0" HPA007246 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoli "Nucleoplasm, Golgi apparatus" "HPA007246: AB_1080727" "unprognostic (1.01e-1)" "unprognostic (5.16e-5)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (3.96e-2)" "unprognostic (9.46e-3)" "unprognostic (3.40e-1)" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (2.34e-3)" "unprognostic (8.21e-3)" "unprognostic (4.31e-1)" "unprognostic (2.42e-2)" "unprognostic (1.14e-2)" "unprognostic (7.66e-3)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 0.8 1.8 2.6 0.4 7.2 0.4 2.3 9.5 4.7 2.3 1.1 0.3 9.3 0.7 1.6 7.5 1.0 3.1 0.7 1.2 2.4 2.3 2.3 3.2 1.9 0.5 1.3 2.9 4.1 3.4 3.2 6.9 3.0 3.5 3.4 1.5 0.8 2.4 13.2 0.5 0.7 0.8 1.1 0.8 0.6 1.0 17.6 0.7 0.0 4.1 0.0 0.6 1.4 1.2 0.5 0.7 1.1 0.7 0.4 1.4 0.2 1.8 1.8 1.9 0.0 0.0 0.0 2.3 0.4 0.0 0.4 1.2 0.0 1.2 0.0 7.8 0.1 3.8 1.0 0.0 2.1 0.4 0.0 5.2 0.5 1.2 1.8 1.3 0.0 0.0 1.1 7.1 0.1 3.5 1.1 0.0 0.0 12.5 0.0 0.1 1.4 0.0 0.1 1.8 0.0 0.9 0.7 0.8 0.1 2.0 2.2 2.0 4.9 0.0 2.0 0.0 2.8 0.0 0.6 0.0 0.0 2.2 0.0 1.2 0.0 6.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.3 0.4 0.1 0.2 0.4 0.4 0.2 0.5 1.4 1.0 1.1 0.4 0.7 0.7 0.1 0.2 2.6 7.2 9.5 4.7 2.4 2.3 1.3 2.9 3.5 0.7 0.0 2.7 0.0 0.8 0.0 1.6 1.6 5.1 1.4 1.2 0.0 2.0 2.0 1.7 1.7 17.9 0.0 0.4 0.0 1.2 1.1 0.4 1.1 0.0 1.6 0.3 0.0 1.2 0.0 0.0 3.2 2.3 0.0 0.0 0.0 1.4 1.1 0.6 0.0 0.0 0.7 1.1 0.0 0.0 27.7 2.9 0.0 0.8 0.0 0.9 0.6 ZBTB14 "ZFP161, ZNF478" ENSG00000198081 "Zinc finger and BTB domain containing 14" O43829 18 5289019-5297053 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050758, HPA070819" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA050758: AB_2681226, HPA070819: AB_2686316" "unprognostic (5.28e-2)" "unprognostic (4.37e-2)" "unprognostic (4.25e-2)" "unprognostic (2.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-2)" "unprognostic (2.95e-2)" "unprognostic (8.64e-2)" "unprognostic (1.19e-3)" "unprognostic (4.72e-3)" "unprognostic (3.25e-2)" "unprognostic (1.49e-1)" "unprognostic (3.70e-2)" "unprognostic (2.03e-1)" "unprognostic (2.53e-1)" "unprognostic (3.73e-1)" "unprognostic (2.90e-2)" 11.2 9.1 13.1 11.6 13.4 6.8 10.8 24.3 12.8 8.7 8.7 10.7 10.8 7.2 12.5 14.9 10.8 9.3 10.3 7.1 13.1 10.2 9.8 11.3 11.0 19.5 14.5 7.6 14.2 12.1 12.8 8.7 8.5 7.3 9.8 8.7 10.3 9.8 11.1 6.9 11.8 12.7 7.5 16.4 17.4 9.8 10.8 8.2 30.8 15.9 7.0 18.1 11.2 11.8 10.1 8.6 14.3 8.2 7.5 13.4 7.6 7.1 9.5 12.5 9.2 9.4 12.4 8.3 7.1 10.6 10.1 8.9 9.1 9.4 25.1 6.3 8.6 11.6 6.7 9.1 10.7 10.2 4.9 4.9 9.9 8.7 8.3 6.6 12.4 12.0 9.9 9.1 7.0 6.6 10.9 15.6 18.2 6.3 8.3 10.2 7.8 18.6 8.3 11.0 8.9 4.9 11.1 8.0 7.2 8.5 8.8 11.1 10.9 10.9 7.2 11.5 13.0 8.6 14.3 8.7 13.1 10.9 10.1 10.6 5.3 5.3 15.5 13.8 10.7 11.5 10.9 5.7 14.3 9.9 8.2 9.9 8.3 12.7 11.4 8.6 10.1 13.4 12.7 1.3 7.5 7.3 6.5 7.9 7.6 13.1 13.4 24.3 12.8 13.1 10.2 14.5 7.6 7.3 8.2 6.0 4.1 11.1 1.3 2.2 6.5 2.8 2.5 1.4 1.2 5.2 0.0 4.0 5.0 4.2 0.8 6.3 4.0 0.0 2.9 4.9 4.5 2.5 16.1 5.7 6.2 4.8 1.2 9.2 5.9 1.7 5.5 5.2 1.7 4.6 5.1 8.2 3.2 4.2 5.3 4.0 5.8 0.0 4.1 0.7 11.7 2.6 1.8 4.4 4.4 0.6 ZBTB43 "FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B" ENSG00000169155 "Zinc finger and BTB domain containing 43" O43298 9 126805006-126838210 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 51.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016825 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA016825: AB_1858959" "unprognostic (1.18e-1)" "unprognostic (2.66e-1)" "unprognostic (7.02e-2)" "unprognostic (9.11e-2)" "unprognostic (5.69e-2)" "unprognostic (3.41e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-2)" "unprognostic (6.87e-2)" "unprognostic (3.72e-2)" "unprognostic (5.14e-1)" "unprognostic (5.41e-3)" "prognostic favorable (8.73e-4)" "unprognostic (6.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" "unprognostic (7.13e-2)" 6.6 6.2 7.8 4.9 12.1 51.7 6.6 10.6 13.6 5.8 5.6 9.5 3.0 5.6 6.6 5.2 10.3 5.3 5.9 9.5 7.9 5.7 5.1 9.0 9.3 6.0 8.6 7.1 7.1 5.9 9.6 9.3 8.2 8.1 5.1 6.6 7.5 7.4 4.4 34.7 14.6 6.7 6.0 8.5 5.7 7.4 15.7 9.3 5.3 6.2 7.1 10.1 5.5 7.0 6.1 5.2 10.6 6.3 9.0 10.7 4.3 4.6 3.6 6.5 6.0 5.6 7.9 6.8 6.6 6.1 4.9 4.4 8.7 3.2 6.5 3.1 6.2 9.9 13.5 5.8 6.1 6.1 6.1 3.8 4.5 10.6 3.7 7.5 6.2 8.5 9.6 15.5 7.9 19.9 4.7 3.7 5.4 7.7 15.1 7.2 5.0 5.4 4.0 5.9 5.0 6.2 4.7 21.1 5.2 5.4 5.4 5.8 5.4 6.7 6.4 5.8 6.2 5.9 4.0 3.5 5.9 5.7 6.6 5.3 16.2 11.5 2.5 7.4 5.3 4.8 10.6 6.3 5.3 10.7 6.3 10.2 6.1 5.8 6.2 5.2 5.1 6.4 7.3 3.5 9.0 4.8 2.8 8.2 4.3 7.8 12.1 10.6 13.6 7.9 5.7 8.6 7.1 8.1 9.3 32.8 40.1 29.9 62.2 75.4 37.7 33.5 22.9 20.1 46.6 26.2 102.1 15.5 1.7 27.3 73.1 17.3 40.0 0.0 16.1 10.4 25.7 47.1 30.1 22.9 13.6 25.4 10.9 17.2 14.6 30.4 16.4 26.4 23.6 11.8 16.6 33.0 31.3 14.2 13.4 5.8 56.4 12.9 25.9 42.1 61.8 102.6 43.5 20.1 18.1 123.4 ZC3H14 "FLJ11806, NY-REN-37, UKp68" ENSG00000100722 "Zinc finger CCCH-type containing 14" Q6PJT7 14 88562909-88627596 "Disease related genes, Predicted intracellular proteins" RNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.1" "Group enriched" "Detected in many" 5 "Early spermatids: 961.1;Late spermatids: 410.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049798, HPA053510" Enhanced Enhanced "Nucleoli,Nucleoli rim,Nuclear speckles" NA NA "Nuclear speckles" "Nucleoli, Nucleoli rim" "HPA049798: AB_2680888, HPA053510: AB_2682174" "unprognostic (5.80e-3)" "unprognostic (2.25e-1)" "unprognostic (1.35e-2)" "unprognostic (7.39e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-1)" "unprognostic (6.47e-3)" "unprognostic (9.57e-2)" "unprognostic (7.21e-3)" "unprognostic (2.77e-3)" "unprognostic (4.83e-2)" "unprognostic (1.50e-2)" "prognostic favorable (7.08e-4)" "unprognostic (2.09e-1)" "unprognostic (8.23e-2)" "unprognostic (3.71e-1)" "unprognostic (4.25e-2)" 13.5 12.6 16.2 10.8 16.4 9.7 13.3 23.4 19.6 14.0 15.3 14.3 17.5 10.6 17.2 15.5 12.4 15.8 10.4 12.3 14.8 8.4 15.2 24.9 13.9 9.1 16.1 16.3 17.1 19.4 19.3 24.1 14.8 16.0 14.9 16.6 11.3 18.0 16.3 15.4 13.6 15.2 14.8 11.2 9.4 12.7 73.1 14.1 9.3 19.4 8.2 11.4 16.2 12.8 13.3 17.4 21.7 21.1 18.5 17.7 13.3 16.4 31.8 29.2 23.1 23.2 22.5 29.6 25.3 23.0 36.0 31.8 22.6 26.0 23.0 18.3 25.7 19.8 20.3 20.6 23.6 49.1 19.4 15.5 11.2 22.7 18.4 23.3 24.6 14.7 18.0 27.8 28.1 28.2 24.6 23.4 21.1 21.9 10.6 32.5 35.1 22.2 13.6 18.6 25.9 28.1 19.4 37.3 10.0 24.3 29.7 21.9 19.6 31.6 36.2 17.7 25.2 33.0 16.1 17.2 43.8 26.8 18.4 25.1 13.6 11.8 25.7 21.5 12.0 20.0 12.9 16.0 21.7 15.9 20.0 17.7 13.3 15.5 17.5 17.4 12.0 14.7 14.7 2.9 18.5 21.1 9.5 13.2 13.3 16.2 16.4 23.4 19.6 14.8 8.4 16.1 16.3 16.0 14.1 113.2 41.2 16.2 22.0 20.1 59.3 19.0 25.5 75.0 46.6 19.2 72.6 40.8 29.9 22.1 961.1 18.2 22.3 0.0 19.9 23.4 21.3 22.4 43.9 29.7 17.6 62.0 30.5 23.4 10.4 410.4 36.5 14.0 5.0 13.6 27.9 35.0 19.9 14.0 44.6 24.5 76.1 12.9 27.6 125.8 76.6 17.2 34.0 17.5 29.2 13.6 ZCCHC11 "KIAA0191, PAPD3, TUT4" ENSG00000134744 "Zinc finger CCHC-type containing 11" Q5TAX3 1 52408282-52553487 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 229.7;Horizontal cells: 198.6;Rod photoreceptor cells: 193.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027412, HPA027973" Supported Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA027412: AB_1852281, HPA027973: AB_10603242" "unprognostic (2.74e-2)" "unprognostic (1.67e-2)" "unprognostic (1.19e-2)" "unprognostic (3.48e-2)" "unprognostic (1.36e-2)" "unprognostic (1.85e-3)" "prognostic unfavorable (9.00e-4)" "unprognostic (2.64e-1)" "unprognostic (5.05e-2)" "unprognostic (3.84e-1)" "unprognostic (6.57e-3)" "unprognostic (3.11e-2)" "unprognostic (5.35e-3)" "unprognostic (2.26e-1)" "unprognostic (1.67e-1)" "unprognostic (7.08e-2)" "unprognostic (2.33e-1)" 13.8 19.1 18.4 25.6 19.0 20.5 18.7 50.9 21.3 22.4 13.3 11.8 16.1 7.7 22.1 22.0 11.5 16.8 14.0 13.5 17.8 16.5 14.2 17.7 13.3 27.4 15.4 14.6 28.3 17.6 34.4 56.0 18.8 16.3 16.1 10.5 12.1 12.6 20.6 44.6 28.1 17.1 20.3 26.6 20.9 12.3 24.9 21.1 31.9 23.9 14.6 25.1 18.3 17.0 23.2 26.0 26.7 4.3 10.3 15.0 2.2 10.3 9.8 24.2 16.3 9.5 12.2 16.8 9.2 13.5 13.4 15.6 10.1 5.4 22.1 10.9 12.8 21.8 8.6 18.1 9.8 17.2 18.0 16.5 23.3 12.7 21.0 15.8 25.2 13.3 14.4 21.7 14.4 17.9 17.1 9.3 15.5 18.9 11.1 11.2 0.1 25.1 18.0 17.5 5.3 12.5 22.3 24.6 17.3 14.5 8.6 13.0 12.9 14.2 6.1 13.8 28.7 8.4 13.2 7.8 10.5 14.2 9.6 11.2 24.3 31.9 31.8 6.9 13.8 7.6 26.7 4.3 13.8 11.8 1.7 8.8 19.1 12.4 9.5 2.1 23.2 15.0 9.9 16.2 10.3 1.4 26.0 9.3 2.2 18.4 19.0 50.9 21.3 17.8 16.5 15.4 14.6 16.3 21.1 56.6 47.0 71.8 47.7 40.9 133.4 0.0 45.9 66.9 56.9 0.0 229.7 39.6 0.0 0.0 48.0 31.6 5.9 0.0 0.0 15.9 34.0 45.0 55.6 29.2 14.9 198.6 35.3 38.1 14.9 22.9 59.2 16.4 16.9 0.0 15.8 50.0 0.0 12.2 57.3 0.0 193.4 19.4 28.8 108.0 77.6 44.5 30.9 55.4 16.1 36.0 ZCCHC2 "C18orf49, FLJ20222, FLJ20281, KIAA1744" ENSG00000141664 "Zinc finger CCHC-type containing 2" Q9C0B9 18 62523007-62587709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 99.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 114.5;Late spermatids: 110.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040943 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "HPA040943: AB_10795496" "unprognostic (9.32e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (2.84e-3)" "unprognostic (1.40e-1)" "unprognostic (4.07e-2)" "unprognostic (4.79e-2)" "unprognostic (2.60e-1)" "unprognostic (1.93e-1)" "unprognostic (8.25e-2)" "unprognostic (2.32e-2)" "unprognostic (1.30e-1)" "unprognostic (5.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.72e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 12.6 5.0 6.8 7.0 7.5 22.8 16.0 8.0 6.8 7.5 8.5 6.0 5.3 6.8 6.9 7.1 6.5 7.4 9.0 8.5 5.3 5.7 5.8 23.0 10.1 7.6 8.1 5.7 8.8 6.3 7.8 8.5 8.2 5.5 8.1 5.8 4.5 99.1 5.9 16.8 11.3 7.5 7.6 5.6 8.9 6.5 13.4 8.9 10.8 7.8 4.3 6.4 11.0 19.3 1.6 1.0 4.9 1.6 0.6 2.0 0.4 6.0 5.2 4.5 8.9 13.8 5.9 8.6 3.4 5.2 8.3 8.3 2.8 3.7 17.0 4.6 5.7 6.8 10.2 14.5 7.6 3.4 11.7 6.8 4.4 12.1 19.0 4.7 8.5 6.5 5.8 9.9 5.2 9.8 6.0 15.5 7.7 4.7 5.7 2.7 4.9 5.5 3.6 2.9 4.4 5.2 7.4 4.8 0.1 5.7 6.1 5.7 3.5 5.8 13.1 5.1 8.5 4.6 6.8 6.6 8.1 5.6 3.2 4.9 2.2 4.3 7.3 6.1 3.6 3.0 0.0 1.0 2.4 1.7 1.6 1.2 0.5 1.1 1.5 0.3 1.6 2.0 1.3 4.9 0.6 0.3 1.0 1.2 0.4 6.8 7.5 8.0 6.8 5.3 5.7 8.1 5.7 5.5 8.9 23.8 19.7 4.2 13.1 23.7 27.6 18.8 15.3 9.4 14.8 15.7 51.1 6.3 3.3 5.4 114.5 20.9 7.7 0.0 5.3 10.1 7.6 13.8 2.3 28.0 12.5 41.3 12.1 17.8 39.8 110.8 7.5 21.1 6.8 4.6 13.2 9.2 4.8 10.5 7.4 4.3 19.1 6.5 15.3 11.5 6.6 16.2 5.7 7.5 10.3 10.5 ZCCHC7 "AIR1, FLJ22611" ENSG00000147905 "Zinc finger CCHC-type containing 7" Q8N3Z6 9 37120539-37358149 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020600, HPA021088, HPA029522" Uncertain Enhanced Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029" "unprognostic (1.19e-3)" "unprognostic (1.21e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (7.21e-3)" "unprognostic (2.78e-1)" "unprognostic (4.27e-3)" "unprognostic (3.18e-2)" "unprognostic (8.00e-3)" "unprognostic (1.29e-2)" "unprognostic (7.87e-2)" "unprognostic (1.83e-1)" "unprognostic (4.58e-2)" "unprognostic (8.23e-2)" "unprognostic (2.33e-1)" "unprognostic (1.04e-2)" "unprognostic (5.49e-2)" 15.2 12.7 9.9 28.4 11.3 16.2 16.8 16.5 12.1 16.1 13.4 10.2 20.0 11.3 19.2 14.9 11.5 13.1 12.4 10.2 10.1 10.3 10.0 11.1 10.9 27.5 11.8 8.4 21.9 19.8 8.6 30.7 10.2 11.2 13.5 14.2 9.8 14.3 19.2 9.9 12.7 13.9 14.0 11.8 18.4 11.8 14.3 12.4 19.9 16.1 12.3 29.3 19.2 12.9 29.7 7.5 10.9 8.5 10.1 11.4 5.2 7.4 5.0 7.0 7.5 7.3 11.4 6.5 7.3 8.5 5.7 7.8 5.0 3.6 26.4 4.0 5.7 6.7 3.1 6.7 6.9 8.2 12.1 4.7 7.5 8.2 4.3 11.4 12.9 7.5 7.8 10.8 5.9 23.3 10.9 6.5 9.8 20.6 9.2 5.1 3.5 9.9 7.2 7.4 8.1 7.5 48.0 4.7 6.7 7.1 2.9 7.9 5.7 5.2 6.3 6.7 7.2 4.5 8.4 5.8 4.2 5.3 6.0 4.4 3.1 5.8 31.5 6.8 8.4 7.7 4.7 4.4 10.9 7.8 5.0 7.7 18.1 8.9 8.8 4.0 29.7 11.4 10.4 8.8 10.1 8.5 7.5 7.4 5.2 9.9 11.3 16.5 12.1 10.1 10.3 11.8 8.4 11.2 12.4 32.8 14.4 78.3 25.6 25.1 15.3 9.3 5.1 24.1 20.5 5.2 9.8 13.5 23.2 14.0 40.8 19.1 9.7 0.0 13.7 21.8 25.2 22.7 23.1 10.6 14.4 11.1 18.3 15.4 13.0 15.6 25.0 16.4 15.1 9.0 19.9 18.5 12.5 14.4 18.4 15.4 23.6 6.5 21.7 45.1 42.1 28.5 15.6 27.7 19.5 19.2 ZCCHC9 "DKFZp761J139, PPP1R41" ENSG00000131732 "Zinc finger CCHC-type containing 9" Q8N567 5 81301590-81313297 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038404 Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA038404: AB_10672744" "unprognostic (1.55e-1)" "unprognostic (2.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.43e-2)" "unprognostic (1.57e-2)" "unprognostic (1.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.91e-2)" "unprognostic (1.10e-1)" "unprognostic (3.31e-1)" "unprognostic (3.58e-2)" "unprognostic (2.68e-2)" "unprognostic (5.20e-3)" "unprognostic (1.60e-1)" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.06e-1)" 14.4 12.9 11.7 16.1 10.5 8.9 15.2 14.3 11.5 21.1 19.7 7.4 14.5 13.9 18.4 16.4 21.4 13.9 14.3 11.9 10.0 10.7 23.0 36.3 10.7 16.2 11.1 10.1 19.6 13.8 10.9 22.6 23.0 10.4 23.1 14.6 13.6 12.2 18.1 14.4 15.2 27.7 22.5 12.2 18.0 14.5 14.8 10.0 17.9 19.6 19.1 16.4 26.8 23.5 14.9 17.5 12.8 16.2 11.6 19.1 7.3 10.3 7.3 18.1 9.5 15.7 14.9 24.4 15.6 18.6 12.1 16.9 16.1 14.3 9.6 6.5 7.8 20.9 7.7 14.3 14.3 19.3 21.5 13.5 9.9 8.2 18.9 18.5 12.5 8.2 11.5 12.5 10.3 25.8 9.4 10.1 10.6 16.5 9.4 12.4 14.1 20.7 18.9 13.1 5.8 9.4 12.4 23.3 14.1 9.4 10.4 8.8 8.4 12.4 7.5 55.7 13.7 9.3 20.3 6.9 7.6 9.3 13.5 17.0 13.5 13.9 14.7 13.4 18.3 16.2 12.8 12.3 11.9 12.8 16.2 16.3 14.9 17.2 15.5 14.8 13.2 16.7 17.1 12.0 11.6 14.0 17.5 19.1 7.3 11.7 10.5 14.3 11.5 10.0 10.7 11.1 10.1 10.4 10.0 8.9 15.2 18.2 10.8 8.0 16.3 10.0 38.2 34.8 18.2 29.6 13.7 24.6 26.6 18.8 41.9 12.3 15.4 0.0 17.9 44.7 16.4 11.3 12.7 47.4 31.3 25.4 7.5 32.5 16.7 12.8 30.2 22.3 3.3 32.5 18.1 18.2 22.3 18.7 27.3 37.0 28.3 19.4 24.8 64.6 31.5 8.2 19.2 17.5 18.1 11.4 ZDHHC14 "FLJ20984, NEW1CP" ENSG00000175048 "Zinc finger DHHC-type containing 14" Q8IZN3 6 157381133-157678146 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Horizontal cells: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 33.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063754 Approved Approved Nucleoli,Mitochondria NA NA Nucleoli Mitochondria "HPA063754: AB_2685113" "unprognostic (1.66e-2)" "unprognostic (1.27e-2)" "unprognostic (1.58e-2)" "unprognostic (3.98e-2)" "unprognostic (1.59e-1)" "unprognostic (6.78e-3)" "unprognostic (1.84e-1)" "unprognostic (6.02e-2)" "unprognostic (2.87e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.93e-4)" "unprognostic (3.94e-2)" "unprognostic (5.01e-3)" "unprognostic (1.89e-1)" "unprognostic (7.95e-2)" "unprognostic (4.43e-1)" "unprognostic (2.63e-1)" 6.4 3.9 9.0 4.4 10.8 4.8 3.6 15.6 16.2 7.4 5.3 22.1 2.9 6.2 22.6 2.6 4.2 4.8 5.3 11.1 10.6 8.8 6.9 8.7 6.4 4.8 15.8 7.1 3.3 5.7 12.7 3.7 5.1 15.3 7.9 4.0 9.1 4.6 3.8 4.7 3.3 8.6 13.7 22.0 6.4 8.1 6.3 11.8 0.7 3.8 1.5 5.7 5.3 5.0 1.5 4.2 0.0 0.1 0.4 0.9 0.4 1.7 1.8 0.6 2.6 1.4 1.1 5.9 2.7 2.5 1.9 1.7 2.2 1.3 4.3 0.9 2.2 3.7 0.9 1.5 1.5 1.8 33.4 2.1 8.4 0.7 1.0 1.9 1.1 1.9 0.7 1.6 2.0 0.8 1.7 2.9 1.9 6.7 3.2 1.1 1.1 0.7 2.8 1.1 3.4 2.2 0.1 0.3 2.5 4.0 0.7 4.3 1.3 3.2 2.1 2.3 1.2 0.3 1.3 4.0 2.9 2.1 5.7 3.5 0.7 0.8 0.6 1.0 3.0 3.2 0.0 0.1 0.0 0.5 0.0 0.9 1.5 0.4 0.4 0.0 0.8 0.0 0.3 0.0 0.4 0.0 4.2 0.0 0.4 9.0 10.8 15.6 16.2 10.6 8.8 15.8 7.1 15.3 11.8 3.0 0.0 2.7 2.3 11.4 14.5 14.4 15.3 0.0 1.2 7.0 5.9 8.9 10.0 5.2 7.8 10.5 6.6 0.0 2.8 1.8 7.9 14.3 0.0 21.2 9.2 116.0 2.4 24.5 12.1 4.0 7.5 3.6 10.1 1.8 12.2 4.8 2.5 9.9 9.6 3.3 5.7 0.0 7.2 2.4 4.1 7.3 17.6 5.0 9.7 2.4 ZEB1 "AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a" ENSG00000148516 "Zinc finger E-box binding homeobox 1" P37275 10 31318495-31529814 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 99.5;Early spermatids: 98.1;Endothelial cells: 105.0;Late spermatids: 111.0;Peritubular cells: 95.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 47.1;RH-30: 27.8;TIME: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027524, CAB058686, CAB079943" Enhanced Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977" "unprognostic (1.54e-1)" "unprognostic (3.08e-1)" "unprognostic (3.42e-2)" "unprognostic (1.04e-1)" "unprognostic (4.85e-2)" "unprognostic (7.40e-2)" "unprognostic (1.34e-2)" "unprognostic (5.59e-2)" "unprognostic (1.30e-1)" "unprognostic (2.96e-2)" "unprognostic (3.48e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (7.34e-6)" "unprognostic (5.59e-3)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" "unprognostic (1.66e-2)" 18.8 7.4 14.4 13.9 14.4 6.1 11.4 15.5 24.1 31.3 31.2 7.1 8.0 4.9 32.9 14.1 17.3 12.0 16.0 27.9 12.9 14.7 5.9 8.1 12.5 7.0 13.7 11.9 11.5 3.4 2.7 9.3 13.3 13.1 20.4 11.0 4.8 5.9 24.2 36.2 5.1 8.3 40.4 20.4 6.6 14.8 7.3 14.9 22.6 8.3 18.7 8.0 53.1 20.7 5.4 3.8 11.5 0.0 7.2 10.2 2.2 0.0 6.1 15.4 15.0 21.6 47.1 0.0 13.4 18.7 2.5 4.9 0.0 0.0 4.3 6.4 16.2 3.6 0.0 6.5 0.0 4.6 8.2 3.2 0.0 3.6 2.7 18.0 3.4 0.1 21.8 0.0 8.0 8.1 8.2 23.7 3.6 3.0 5.7 16.7 0.0 11.9 1.8 0.9 0.0 3.1 4.3 27.8 1.7 4.4 0.0 0.4 5.7 4.6 0.0 0.0 3.0 0.0 2.3 36.2 15.2 3.6 3.4 6.4 2.8 2.3 5.1 4.3 0.0 1.7 5.1 0.0 6.6 3.6 0.0 4.8 5.4 4.5 2.3 1.5 4.7 10.2 4.5 11.5 7.2 0.0 3.8 5.8 2.2 14.4 14.4 15.5 11.9 12.9 14.7 13.7 11.9 13.1 14.9 0.0 11.4 18.0 2.5 10.0 38.8 99.5 2.5 1.4 5.7 1.8 43.2 0.2 0.0 1.8 98.1 105.0 0.0 0.0 2.2 0.4 37.0 2.6 1.1 11.3 1.2 9.5 0.0 44.8 5.3 111.0 28.4 5.0 25.3 17.2 0.0 3.1 1.9 0.0 95.8 1.4 39.7 77.6 47.8 16.3 15.3 7.5 0.6 14.9 0.0 3.7 ZEB2 "KIAA0569, SIP-1, SIP1, ZFHX1B" ENSG00000169554 "Zinc finger E-box binding homeobox 2" O60315 2 144364364-144524583 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.6" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 626.1;Kupffer cells: 357.2;Macrophages: 271.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 39.1;THP-1: 46.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003456 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA003456: AB_10603840" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.42e-1)" "unprognostic (4.12e-1)" "unprognostic (4.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.77e-2)" "unprognostic (5.83e-2)" "unprognostic (7.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.04e-5)" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (7.45e-2)" "unprognostic (1.32e-2)" 30.2 23.7 48.0 27.8 42.4 55.5 16.6 6.7 36.6 29.4 12.3 72.9 3.4 11.3 15.6 11.1 14.4 11.1 22.6 22.5 52.5 28.8 9.9 11.6 20.7 19.6 54.4 26.4 37.5 3.6 5.0 3.1 31.5 37.6 10.9 16.3 15.7 5.7 12.5 9.6 7.7 12.8 17.2 76.6 32.6 9.3 8.2 38.7 1.9 8.3 7.5 12.4 21.5 14.8 5.0 12.7 9.7 21.6 3.6 10.7 7.4 0.4 0.5 22.5 0.0 26.9 13.7 0.0 9.2 9.4 10.4 10.1 0.0 0.2 1.7 0.0 10.0 2.8 0.1 3.8 0.0 13.0 9.6 2.6 39.1 1.6 0.0 6.1 6.7 31.1 11.2 0.2 12.9 6.2 8.8 7.8 0.0 10.9 1.1 12.2 0.0 0.0 20.5 3.2 0.0 0.5 11.5 15.5 0.0 0.1 0.2 0.2 5.9 1.1 0.0 24.3 7.5 0.0 46.5 12.1 12.0 0.2 23.3 2.9 12.7 0.0 1.9 17.9 20.2 32.2 9.7 21.6 5.7 10.7 20.8 1.0 4.4 1.4 5.3 12.7 5.0 1.1 4.0 7.5 3.6 19.5 10.2 0.3 7.4 48.0 42.4 6.7 35.6 52.5 28.8 54.4 26.4 37.6 38.7 6.0 25.8 45.8 1.2 22.0 178.1 50.1 2.5 6.7 18.2 5.2 3.9 1.3 1.7 0.6 2.0 23.8 0.0 23.3 0.7 1.6 146.0 1.5 150.5 2.1 126.8 626.1 0.0 81.0 357.2 4.0 111.7 271.2 97.8 46.9 0.0 84.2 0.2 0.0 62.6 7.3 8.6 181.1 167.0 2.3 7.0 17.1 3.9 99.2 0.0 2.0 ZFAND2B AIRAPL ENSG00000158552 "Zinc finger AN1-type containing 2B" Q8WV99 2 219195237-219209651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 133.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035159, HPA035160" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA035159: AB_2674499, HPA035160: AB_10670697" "unprognostic (3.71e-1)" "unprognostic (5.49e-3)" "unprognostic (2.77e-3)" "unprognostic (2.59e-1)" "unprognostic (2.97e-1)" "unprognostic (6.85e-3)" "unprognostic (1.40e-2)" "unprognostic (2.27e-1)" "unprognostic (7.36e-2)" "unprognostic (1.20e-1)" "prognostic favorable (9.38e-4)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.69e-3)" "unprognostic (1.32e-1)" "unprognostic (6.21e-2)" "unprognostic (7.02e-2)" 13.4 12.9 16.4 14.6 16.9 23.8 13.5 22.3 24.6 14.8 30.0 20.2 15.9 30.5 15.3 14.2 22.2 13.1 22.2 11.6 16.2 13.3 20.0 28.5 15.2 27.3 18.8 17.9 14.1 29.1 18.6 18.0 22.2 15.6 14.7 18.5 11.3 17.3 14.2 15.9 23.4 34.7 24.5 17.5 22.6 21.8 9.5 13.9 23.0 30.0 12.9 19.3 14.7 16.6 29.1 20.5 36.6 27.8 30.7 32.5 25.4 10.6 7.3 8.3 11.7 8.9 9.4 11.6 10.8 12.7 15.6 15.5 16.3 9.1 8.6 11.5 18.4 12.7 7.4 7.7 13.7 12.5 13.3 12.0 19.8 12.0 14.1 18.2 10.5 22.9 7.7 30.2 15.3 36.6 8.8 10.4 19.1 11.5 24.6 15.2 18.4 17.3 22.1 4.3 14.8 8.4 10.8 5.0 14.8 14.7 9.0 18.2 8.2 5.2 8.8 12.0 9.8 7.5 22.3 11.0 15.7 14.8 18.1 15.3 10.2 3.3 15.5 15.4 20.8 12.2 17.7 21.7 28.6 32.1 27.8 28.0 25.4 29.3 31.3 16.4 29.1 26.7 32.5 36.6 30.7 21.9 20.5 30.2 25.4 16.4 16.9 22.3 24.6 16.2 13.3 18.8 17.9 15.6 13.9 20.8 26.3 36.4 21.1 24.2 13.5 11.1 25.5 8.1 9.1 19.2 13.7 22.5 48.0 34.1 3.4 27.0 133.2 0.0 57.4 20.0 23.7 23.5 32.3 35.5 29.9 7.9 38.6 14.7 29.1 5.5 29.7 26.7 33.7 13.6 57.3 20.9 46.6 94.7 28.0 57.5 14.9 25.8 33.0 5.7 13.0 31.6 42.9 46.7 47.7 24.8 ZFP41 "FLJ00028, FLJ38705, ZNF753" ENSG00000181638 "ZFP41 zinc finger protein" 8 143246821-143262705 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 7.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: AB_2683082" "unprognostic (9.16e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-1)" "unprognostic (1.47e-2)" "unprognostic (1.10e-1)" "unprognostic (1.45e-2)" "prognostic unfavorable (3.46e-5)" "unprognostic (4.92e-2)" "unprognostic (7.18e-2)" "unprognostic (3.53e-2)" "unprognostic (4.16e-3)" "unprognostic (2.98e-1)" "unprognostic (1.55e-2)" "unprognostic (6.89e-2)" "unprognostic (1.59e-1)" "unprognostic (3.44e-2)" "unprognostic (3.20e-1)" 7.8 6.6 10.3 6.5 9.0 4.1 5.6 12.6 13.7 8.0 8.8 10.7 6.5 9.4 12.5 6.8 5.7 9.2 5.6 6.3 10.8 14.3 6.5 5.8 6.3 6.7 10.7 7.4 13.1 9.1 11.4 10.2 3.5 9.6 7.7 4.5 8.9 12.6 9.1 8.1 12.1 9.1 7.3 7.4 8.5 7.2 10.6 8.6 4.6 8.0 4.6 6.7 6.7 10.0 0.9 3.7 0.1 0.9 0.7 2.2 0.8 7.1 11.4 5.0 6.6 5.8 4.5 5.9 4.3 2.4 8.5 5.8 5.6 6.0 4.0 6.5 5.6 8.7 5.9 5.4 5.7 4.2 6.3 6.6 5.0 5.5 4.4 8.1 2.0 3.1 4.7 8.1 5.5 8.1 5.9 4.0 2.9 10.6 3.9 4.0 12.8 5.3 2.2 7.4 8.8 11.3 2.8 4.1 1.4 3.7 6.5 6.3 8.7 12.2 3.4 6.4 4.5 8.5 3.9 4.2 6.5 11.6 5.0 6.9 6.3 4.8 1.9 5.7 4.8 8.4 0.0 0.6 0.1 1.3 0.9 2.2 0.4 1.1 0.9 0.5 0.9 1.9 1.2 0.0 0.7 0.1 3.7 0.9 0.8 10.3 9.0 12.6 13.7 10.8 14.3 10.7 7.4 9.6 8.6 0.0 1.3 1.3 0.6 1.0 1.4 2.8 2.5 4.0 1.2 3.5 5.9 0.2 1.7 1.6 1.3 0.7 2.7 0.0 0.8 0.9 1.1 0.4 0.0 3.9 1.0 6.4 2.9 1.8 2.2 1.4 1.1 0.9 1.7 0.0 3.2 2.7 1.2 4.3 2.1 1.1 2.2 0.0 1.1 7.7 3.4 0.3 0.2 0.0 2.9 0.3 ZFP91 "PZF, ZNF757" ENSG00000186660 "ZFP91 zinc finger protein" Q96JP5 11 58579111-58621042 "Enzymes, Predicted intracellular proteins, Transcription factors" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 181.7;Late spermatids: 146.8;Spermatocytes: 142.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024037, CAB025417, HPA065325" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "CAB025417: , HPA024037: AB_1859051, HPA065325: AB_2685468" "unprognostic (6.10e-2)" "unprognostic (5.01e-2)" "unprognostic (3.33e-3)" "unprognostic (9.19e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-1)" "unprognostic (2.33e-2)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.36e-2)" "prognostic unfavorable (3.74e-6)" "unprognostic (3.16e-1)" "unprognostic (1.75e-3)" "unprognostic (3.12e-2)" "unprognostic (2.61e-1)" "unprognostic (2.23e-1)" "unprognostic (2.00e-3)" 17.1 14.7 20.1 13.6 25.6 32.0 14.9 24.4 21.7 15.3 18.1 23.2 15.8 16.2 16.3 11.8 16.3 13.6 13.8 26.5 20.3 15.4 16.3 19.4 15.0 14.4 20.8 18.1 14.9 14.3 26.7 17.0 14.2 19.7 13.1 21.9 11.2 14.5 15.5 33.8 17.5 19.6 16.9 21.6 15.0 13.9 71.0 19.4 15.7 16.8 14.6 15.9 17.8 21.4 4.6 7.0 5.4 5.0 3.7 5.4 2.8 24.8 14.3 16.8 17.0 16.1 19.5 9.2 20.6 38.7 23.8 20.4 7.8 26.3 29.8 20.4 25.9 23.8 22.2 17.0 21.8 31.4 15.8 9.6 19.6 14.5 8.4 18.3 24.7 32.4 17.0 21.5 33.5 39.3 19.8 23.6 20.2 19.4 28.3 30.6 8.3 21.3 13.7 8.8 14.4 13.9 16.6 28.4 19.7 17.5 24.0 18.0 14.4 26.2 24.1 33.5 9.5 26.9 18.6 26.4 30.2 20.8 45.3 22.8 16.4 12.1 24.7 26.6 13.9 30.7 3.9 5.0 3.5 5.4 4.5 3.0 4.5 3.3 3.3 4.9 4.6 3.6 4.6 5.4 3.7 4.2 7.0 2.6 2.8 20.1 25.6 24.4 21.7 20.3 15.4 20.8 18.1 19.7 19.4 23.8 34.8 33.2 21.5 53.3 28.8 39.5 48.4 25.4 21.6 17.4 15.7 10.3 11.6 19.8 181.7 27.0 27.7 46.7 27.1 10.5 32.9 25.9 48.6 41.4 14.5 33.4 24.2 25.8 36.8 146.8 28.4 27.0 21.9 20.8 30.4 19.8 24.5 11.5 25.5 19.1 19.0 19.4 20.6 142.7 40.2 58.2 11.6 21.8 37.2 34.3 ZFX ZNF926 ENSG00000005889 "Zinc finger protein, X-linked" P17010 X 24149173-24216255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA001748, HPA003877, HPA071863" Supported Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: AB_2686463" "unprognostic (2.60e-1)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "unprognostic (4.64e-2)" "unprognostic (1.66e-1)" "unprognostic (2.78e-1)" "unprognostic (1.81e-2)" "unprognostic (1.56e-1)" "unprognostic (2.77e-2)" "unprognostic (1.90e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-1)" "unprognostic (9.22e-3)" "unprognostic (2.39e-1)" "unprognostic (4.27e-2)" "unprognostic (1.93e-1)" "unprognostic (5.95e-2)" 20.3 8.8 10.8 8.2 11.7 25.9 23.5 22.1 12.6 18.5 12.2 7.2 8.4 6.6 18.5 11.0 10.6 15.8 7.2 17.8 10.1 6.6 16.6 11.3 9.7 12.7 13.1 9.6 20.2 11.8 20.2 17.9 23.2 10.4 16.4 6.5 7.0 9.4 13.1 24.1 8.9 11.8 15.7 11.3 12.4 10.1 5.4 14.7 16.4 13.9 8.9 10.6 12.5 25.3 11.9 9.6 16.6 10.3 9.9 10.7 7.0 8.0 10.9 11.3 13.1 15.3 10.7 5.9 7.6 7.2 8.8 9.2 6.7 6.0 9.3 10.3 11.7 19.3 10.3 12.9 14.1 11.8 9.0 16.0 8.2 33.8 3.9 6.4 10.8 14.5 9.3 4.5 17.1 22.3 9.5 11.0 5.6 9.7 10.1 6.3 4.4 7.7 8.0 6.5 3.5 8.4 10.6 9.0 8.1 5.2 13.0 6.0 9.0 23.0 9.2 7.4 7.8 5.8 5.7 10.8 7.8 4.6 10.8 5.3 5.7 7.5 9.3 6.1 4.6 9.0 11.2 8.7 13.5 10.6 10.3 10.7 8.4 9.9 10.6 9.6 11.9 9.9 9.4 16.6 9.9 9.4 6.9 5.7 7.0 10.8 11.7 22.1 12.6 10.1 6.6 13.1 9.6 10.4 14.7 17.9 11.8 18.4 16.0 19.6 19.3 13.7 22.9 16.0 22.7 7.0 19.6 46.1 5.0 13.6 1.5 25.5 11.9 23.3 13.8 10.2 28.3 17.9 27.6 20.7 15.1 14.3 19.7 27.6 25.3 3.1 33.1 20.1 28.7 19.8 15.1 15.6 11.6 14.2 33.6 9.4 19.1 32.3 26.9 9.3 25.2 18.2 17.3 22.5 15.1 15.4 ZFY ZNF911 ENSG00000067646 "Zinc finger protein, Y-linked" P08048 Y 2935281-2982506 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 59.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA001748, HPA071863" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA001748: AB_1080650, HPA071863: AB_2686463" "unprognostic (1.07e-1)" "unprognostic (7.43e-2)" "prognostic favorable (3.58e-5)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (2.75e-2)" "unprognostic (2.94e-2)" "unprognostic (1.04e-1)" "unprognostic (8.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.91e-1)" "unprognostic (2.54e-2)" 4.1 2.9 2.8 6.8 4.3 9.6 3.4 6.8 5.3 0.0 5.4 2.8 14.1 3.2 0.0 9.1 7.2 0.0 7.0 6.1 3.0 3.0 2.7 13.1 10.1 10.9 2.6 0.0 0.0 10.0 0.1 3.3 5.8 4.5 10.6 8.0 3.5 15.8 10.2 7.0 2.9 6.3 5.8 3.3 9.1 4.7 10.5 0.0 12.6 7.2 5.7 5.8 6.1 0.0 5.8 5.9 4.7 4.7 6.2 7.0 2.7 0.0 3.6 0.0 0.0 0.0 0.0 6.5 9.1 8.8 7.8 7.6 0.0 0.0 7.0 0.0 9.5 0.0 0.0 0.0 0.0 10.5 10.5 0.0 12.9 0.1 4.6 6.9 0.0 0.0 7.6 6.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 8.8 0.0 5.3 0.0 2.9 0.0 0.0 0.0 5.7 2.7 5.3 11.9 6.2 0.0 0.0 0.0 9.1 4.3 0.0 4.2 7.9 7.6 0.0 0.0 4.6 4.9 0.0 11.8 1.0 0.0 0.0 0.0 4.7 4.7 5.0 3.9 7.0 4.3 5.5 2.8 5.9 5.8 6.3 3.0 3.2 6.2 3.3 4.3 3.1 2.7 2.8 4.3 6.8 5.3 3.0 3.0 2.6 0.0 4.5 0.0 8.9 8.0 16.9 9.6 9.8 11.8 5.9 5.1 8.1 13.6 1.8 7.9 4.4 0.0 2.7 28.3 7.3 0.0 0.0 0.0 1.2 7.8 7.9 6.9 0.5 2.6 12.7 1.7 8.0 5.0 59.3 9.2 8.5 3.3 3.6 0.0 11.2 2.1 0.0 10.3 2.9 7.8 12.9 7.6 19.0 3.8 8.3 3.1 11.4 0.0 10.5 ZMAT4 FLJ13842 ENSG00000165061 "Zinc finger matrin-type 4" Q9H898 8 40530590-40897833 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.5;brain: 21.6;thyroid gland: 29.1" "Group enriched" "Detected in some" 5 "Early spermatids: 18.2;Late spermatids: 39.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 115 "NK-cell: 11.5" "Lineage enriched" "Detected in single" 115 "NK-cells: 11.5" "Group enriched" "Detected in some" 5 "AF22: 21.1;U-2197: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA069813, HPA071585" Enhanced Approved Nucleoplasm,Nucleoli No NA "Nucleoplasm, Nucleoli" "HPA069813: AB_2686206, HPA071585: AB_2686423" "unprognostic (1.25e-2)" "unprognostic (9.29e-2)" "unprognostic (2.80e-1)" "unprognostic (2.83e-3)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (1.07e-1)" "unprognostic (9.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-2)" "unprognostic (4.46e-4)" "unprognostic (5.44e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.79e-3)" 0.8 2.0 4.4 0.9 15.3 0.8 0.9 0.6 20.4 3.3 1.0 0.9 0.0 0.7 1.4 1.0 0.7 0.9 1.0 1.5 6.1 4.0 1.2 0.7 0.8 0.9 3.3 7.8 1.6 0.7 0.7 5.3 1.0 21.6 1.6 1.2 1.4 0.8 1.5 0.7 0.7 0.8 0.8 1.0 1.3 1.0 2.9 3.9 0.0 29.1 0.0 0.9 0.8 0.2 0.0 0.0 0.0 0.0 11.5 0.0 0.1 0.0 1.2 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.2 0.0 0.0 0.2 0.0 0.0 1.2 0.3 0.0 0.0 0.0 1.8 3.4 0.0 0.0 0.0 0.6 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.1 4.4 15.3 0.6 20.4 6.1 4.0 3.3 7.8 21.6 3.9 0.0 0.0 0.0 0.2 0.0 6.0 0.4 2.5 0.0 0.0 0.0 5.9 0.0 1.7 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 39.7 2.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.1 0.0 1.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 ZMYM4 "KIAA0425, MYM, ZNF198L3, ZNF262" ENSG00000146463 "Zinc finger MYM-type containing 4" Q5VZL5 1 35268967-35422058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051301, HPA054802" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA051301: AB_2681431, HPA054802: AB_2682605" "unprognostic (8.95e-2)" "unprognostic (6.80e-2)" "unprognostic (1.51e-2)" "unprognostic (1.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (9.75e-9)" "unprognostic (9.76e-2)" "unprognostic (4.35e-3)" "unprognostic (4.44e-2)" "unprognostic (6.70e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.18e-1)" "unprognostic (2.04e-1)" "unprognostic (9.18e-2)" "unprognostic (2.21e-1)" 16.6 15.9 17.9 17.3 22.1 13.6 19.7 28.1 24.7 22.0 14.8 17.1 18.3 10.2 19.8 18.2 15.0 17.9 15.7 13.1 17.6 19.0 15.8 14.4 14.1 15.0 15.8 14.6 27.0 15.7 26.1 22.6 19.6 22.2 21.0 13.6 18.2 18.0 26.8 15.9 12.9 12.5 16.6 15.2 16.0 15.4 36.3 13.6 26.7 21.6 13.0 18.8 17.2 14.7 4.2 9.8 3.5 8.2 9.6 4.4 2.5 12.8 10.4 32.1 16.2 9.4 20.4 11.8 15.3 23.1 18.7 24.4 11.2 12.9 23.9 9.4 19.1 9.1 8.3 22.2 11.3 27.0 13.5 15.4 29.2 12.2 9.5 17.0 25.0 13.2 15.4 10.1 18.1 17.2 15.6 20.7 13.3 31.8 6.6 22.6 7.7 21.1 13.9 26.7 6.7 10.0 23.7 20.6 11.6 13.4 17.0 18.5 18.0 18.4 13.5 20.9 21.1 10.9 19.0 24.9 17.4 18.1 7.6 16.4 7.2 13.4 18.4 12.6 19.1 16.6 2.4 5.0 3.5 4.3 7.1 4.4 4.2 4.2 3.8 4.8 3.7 4.1 3.9 1.0 9.6 8.2 9.8 3.1 2.5 17.9 22.1 28.1 24.7 17.6 19.0 15.8 14.6 22.2 13.6 11.9 15.0 11.0 16.2 10.2 27.2 29.5 35.7 22.7 22.7 26.2 29.5 12.4 5.0 19.4 48.6 21.1 5.3 0.0 20.5 10.2 15.8 19.3 13.9 16.1 11.2 22.3 21.5 17.2 18.4 69.6 24.5 13.7 5.0 13.6 13.8 20.1 18.6 9.0 21.5 9.1 33.8 19.4 15.5 22.9 10.4 9.9 11.8 11.7 12.2 24.5 ZNF106 "SH3BP3, ZFP106, ZNF474" ENSG00000103994 "Zinc finger protein 106" Q9H2Y7 15 42412823-42491123 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 64.8;skeletal muscle: 111.1" "Cell type enriched" "Detected in all" 9 "Cardiomyocytes: 1626.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 48.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054267 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA054267: AB_2682431" "unprognostic (2.15e-2)" "unprognostic (3.31e-1)" "unprognostic (7.10e-2)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" "unprognostic (2.49e-1)" "unprognostic (3.96e-1)" "unprognostic (1.33e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-3)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-1)" "unprognostic (4.09e-3)" 14.9 5.4 8.8 6.6 10.4 9.0 10.3 6.3 9.1 7.1 7.8 4.5 4.5 3.9 7.4 6.3 12.7 5.4 6.1 64.8 9.2 6.3 6.4 3.7 7.8 6.0 7.6 6.4 6.6 4.4 8.4 7.1 5.0 11.9 7.8 5.6 11.3 6.0 5.7 111.1 4.3 5.9 10.9 8.0 6.3 6.0 5.7 7.2 3.4 5.7 46.9 6.8 7.0 17.7 8.3 10.8 48.5 19.6 3.9 5.1 4.5 14.4 8.4 14.7 16.2 37.2 32.8 9.0 11.8 11.2 10.3 11.0 19.7 4.2 9.7 10.5 14.4 11.8 16.6 15.2 12.0 15.8 15.7 7.3 18.6 19.6 7.0 10.7 22.2 11.1 24.7 8.1 15.7 17.5 9.2 16.5 12.2 22.0 1.3 16.7 5.7 8.5 5.4 6.2 11.4 8.6 8.1 26.7 5.3 5.4 16.3 9.4 5.0 23.8 11.2 13.2 12.0 10.3 14.5 24.9 11.1 17.1 14.7 17.2 8.1 15.6 36.4 9.9 17.8 19.2 19.9 19.6 7.6 5.1 15.9 4.5 6.7 4.2 4.2 10.5 8.3 3.8 3.4 48.5 3.9 18.5 10.8 3.8 4.5 8.8 10.4 6.3 9.1 9.2 6.3 7.6 6.4 11.9 7.2 125.0 90.2 37.8 49.6 34.2 58.0 1626.8 56.0 188.7 61.4 27.9 90.3 31.5 34.9 37.0 133.3 49.8 30.9 23.3 36.8 30.7 62.9 79.6 42.8 32.7 46.8 33.4 38.7 57.1 104.1 80.0 34.8 64.4 62.4 28.9 28.5 43.3 51.2 23.0 87.0 34.8 75.4 45.3 46.4 55.4 37.4 26.1 25.6 29.4 33.7 64.4 ZNF121 "D19S204, ZHC32, ZNF20" ENSG00000197961 "Zinc finger protein 121" P58317 19 9560353-9584533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA054961 Uncertain Approved Nucleoplasm,Nucleoli,Centrosome NA NA "Nucleoplasm, Centrosome" Nucleoli "HPA054961: AB_2682651" "unprognostic (3.06e-1)" "unprognostic (9.38e-3)" "unprognostic (9.51e-2)" "unprognostic (7.49e-2)" "unprognostic (3.07e-2)" "unprognostic (3.91e-3)" "unprognostic (3.68e-2)" "unprognostic (1.76e-1)" "unprognostic (6.80e-3)" "prognostic favorable (6.59e-5)" "unprognostic (9.36e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (1.01e-4)" "unprognostic (8.75e-3)" "unprognostic (2.83e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.75e-5)" 13.8 8.9 10.4 11.0 12.3 21.0 14.0 16.1 11.8 10.6 8.9 6.2 12.5 6.7 9.4 10.0 16.5 12.4 7.6 10.3 10.3 5.0 9.2 13.2 14.6 13.0 13.6 6.3 13.8 12.5 22.3 20.2 8.3 11.0 11.8 10.6 5.3 14.1 13.7 9.4 18.6 12.3 12.3 14.8 12.4 11.1 6.2 13.0 12.2 11.3 10.4 12.1 15.8 12.7 6.0 4.6 2.9 4.5 7.1 6.8 1.8 7.7 5.0 6.0 12.5 2.8 3.3 9.3 2.7 2.4 4.0 5.0 8.7 3.4 8.8 7.7 2.1 2.2 7.7 12.2 7.1 5.7 4.2 19.8 27.5 12.3 7.7 3.5 13.6 13.8 4.5 6.3 4.0 10.5 3.6 2.9 9.7 9.8 15.0 2.9 6.5 10.1 31.3 14.8 3.1 8.7 6.5 8.2 6.1 3.9 33.0 10.7 5.4 5.3 5.2 3.1 12.5 4.3 4.4 4.2 12.8 7.2 4.4 6.9 16.0 8.7 10.4 3.5 8.0 4.4 2.9 3.6 2.1 5.5 4.4 6.8 4.0 4.9 5.1 4.1 6.0 6.1 6.8 2.8 7.1 4.5 4.6 4.3 1.8 10.4 12.3 16.1 11.8 10.3 5.0 13.6 6.3 11.0 13.0 6.0 8.0 14.1 29.6 20.0 6.5 9.7 7.6 10.7 17.0 8.7 11.8 10.7 6.6 9.0 1.1 7.1 3.3 23.3 4.7 9.4 7.3 18.2 14.0 9.6 4.6 6.4 13.1 9.2 8.9 0.4 5.8 9.2 8.5 1.8 9.2 2.5 9.4 3.5 7.8 4.2 7.0 6.5 6.6 5.4 11.3 27.7 8.8 13.8 12.3 32.8 ZNF136 pHZ-20 ENSG00000196646 "Zinc finger protein 136" P52737 19 12163064-12189881 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA054120 Approved Nucleoli NA NA Nucleoli "HPA054120: AB_2682389" "unprognostic (1.40e-1)" "unprognostic (5.90e-2)" "unprognostic (3.38e-2)" "unprognostic (1.17e-1)" "unprognostic (6.22e-2)" "unprognostic (4.68e-3)" "unprognostic (2.36e-1)" "unprognostic (9.39e-3)" "unprognostic (5.97e-3)" "unprognostic (1.71e-1)" "unprognostic (4.33e-2)" "unprognostic (5.46e-3)" "prognostic favorable (4.75e-5)" "unprognostic (3.44e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-2)" 12.6 10.8 7.2 15.3 11.0 20.5 13.0 19.6 12.4 13.2 9.5 7.1 10.5 4.5 13.3 13.0 5.9 11.6 8.2 8.0 7.3 7.2 9.4 6.0 11.1 12.7 7.5 11.3 19.0 7.5 13.0 16.8 10.6 10.2 13.0 8.6 8.3 10.1 8.9 9.9 10.4 9.4 12.9 12.5 11.7 10.0 10.2 6.8 16.0 14.4 3.6 10.7 12.6 11.3 9.7 5.1 13.5 4.1 8.7 10.0 4.0 2.1 1.2 7.4 7.7 4.1 4.7 4.5 4.0 4.4 3.9 4.1 1.4 0.7 10.1 5.3 2.9 3.7 2.2 3.5 2.4 5.0 5.0 4.6 5.7 3.7 2.5 3.1 12.1 10.3 5.0 4.4 3.7 4.6 5.7 2.8 8.6 4.2 16.3 4.9 3.0 8.3 4.8 8.7 0.7 4.5 6.6 9.4 3.9 4.2 7.7 7.7 7.2 5.1 1.2 4.2 6.4 3.2 6.3 5.7 9.7 3.3 4.0 3.5 11.1 19.2 11.5 3.6 4.6 5.0 13.5 3.9 9.0 7.9 3.7 9.4 9.0 8.9 8.5 4.2 9.7 10.0 8.4 11.6 8.7 4.1 5.1 5.9 4.0 7.2 11.0 19.6 12.4 7.3 7.2 7.5 11.3 10.2 6.8 6.0 6.5 14.5 9.8 4.8 18.5 2.4 12.7 2.7 11.4 8.7 17.7 6.5 5.0 5.4 1.7 6.9 3.9 23.3 3.4 5.8 7.7 7.8 8.1 2.4 4.9 19.1 9.8 8.6 5.3 0.9 12.4 6.9 1.7 10.8 5.3 12.8 4.2 5.1 13.8 3.4 15.2 6.5 11.3 19.4 28.6 2.8 8.2 10.0 4.3 9.8 ZNF146 OZF ENSG00000167635 "Zinc finger protein 146" Q15072 19 36214602-36238774 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003358 Supported Supported Nucleoli NA NA Nucleoli "HPA003358: AB_1080674" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (5.35e-3)" "unprognostic (2.11e-3)" "unprognostic (1.82e-2)" "unprognostic (1.15e-1)" "unprognostic (1.42e-3)" "unprognostic (2.87e-2)" "unprognostic (1.35e-2)" "unprognostic (1.27e-1)" "unprognostic (3.95e-3)" "unprognostic (2.53e-2)" "unprognostic (1.72e-2)" "unprognostic (7.84e-2)" "unprognostic (1.17e-1)" "unprognostic (2.51e-2)" "unprognostic (1.92e-1)" 20.6 17.2 24.5 23.5 40.4 8.6 33.0 25.7 27.9 28.9 20.7 28.4 23.5 17.9 30.0 18.2 22.3 23.0 18.0 21.5 25.6 20.0 21.1 25.0 18.1 25.0 46.4 23.7 33.7 20.3 32.5 45.2 25.1 32.0 25.2 25.5 13.4 19.6 23.9 38.3 21.1 17.7 26.2 30.9 19.9 19.2 9.9 36.3 33.6 27.1 24.0 28.3 25.8 20.5 13.7 9.8 5.9 14.6 10.2 18.3 10.3 21.7 30.4 26.1 25.0 19.3 21.7 13.9 19.3 17.9 18.7 18.6 13.7 16.0 21.2 31.2 17.8 12.2 10.2 33.0 22.5 33.9 32.8 18.4 35.5 11.7 16.5 22.5 55.7 24.6 17.6 35.0 18.0 51.4 19.7 23.1 23.2 37.6 23.4 22.4 14.2 25.8 13.2 35.2 38.4 18.6 30.0 26.2 18.1 22.7 21.5 33.1 20.9 23.8 30.2 20.4 28.0 13.4 28.6 17.5 21.1 25.3 16.5 33.7 16.4 19.3 30.3 14.8 27.7 26.8 4.9 8.2 5.9 12.2 9.9 17.4 13.7 14.1 12.2 9.8 12.1 18.3 16.6 2.0 10.2 14.6 4.9 12.1 10.3 24.5 40.4 25.7 27.9 25.6 20.0 46.4 23.7 32.0 36.3 41.7 25.3 20.4 25.2 20.9 10.1 40.2 22.9 30.8 33.0 19.2 9.8 29.2 29.9 24.6 14.9 20.6 8.5 0.0 15.6 40.2 22.4 23.6 19.7 17.3 16.6 11.1 13.9 20.3 18.6 13.5 23.3 13.5 10.1 10.0 23.8 9.1 20.1 5.8 18.0 16.5 9.4 6.5 35.3 7.7 12.4 26.1 19.7 21.8 24.5 24.3 ZNF16 KOX9 ENSG00000170631 "Zinc finger protein 16" P17020 8 144930358-144950888 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, Transcription, Transcription regulation" "Activator, DNA-binding, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035782, HPA061835" Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA035782: AB_10603243, HPA061835: AB_2684621" "unprognostic (4.11e-2)" "unprognostic (1.51e-2)" "unprognostic (6.87e-2)" "unprognostic (2.45e-1)" "unprognostic (2.69e-1)" "prognostic favorable (2.39e-4)" "unprognostic (7.53e-3)" "unprognostic (1.10e-1)" "unprognostic (1.24e-1)" "unprognostic (8.50e-2)" "unprognostic (1.45e-1)" "unprognostic (2.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.70e-2)" "unprognostic (2.96e-1)" "unprognostic (9.75e-2)" "unprognostic (4.17e-3)" 8.1 6.0 8.9 7.1 9.0 3.4 9.7 8.1 10.1 9.7 10.1 7.8 7.1 7.2 13.8 11.1 9.4 11.2 13.3 6.5 7.5 4.9 8.5 5.9 5.7 5.0 6.4 7.5 17.4 12.1 15.9 7.0 6.0 6.5 8.9 7.3 7.7 7.4 9.2 12.4 14.0 10.8 10.3 4.9 6.4 7.7 10.9 5.3 6.7 10.8 5.3 6.8 9.1 10.1 5.6 6.4 3.5 4.0 12.2 7.8 4.1 4.9 4.4 8.7 4.8 7.5 10.5 6.3 4.5 10.0 9.1 8.3 3.3 5.1 7.9 6.0 5.8 4.9 4.0 6.1 10.0 8.3 3.3 5.1 9.0 4.9 4.9 12.5 3.3 5.3 12.8 10.1 5.8 15.3 9.1 5.0 6.0 6.1 5.3 7.2 6.7 6.5 3.3 5.4 7.6 10.0 8.2 5.1 5.0 7.7 7.5 7.3 5.4 9.5 5.8 7.7 7.0 10.8 6.1 5.3 4.1 8.8 4.8 5.0 3.9 3.2 7.2 4.8 4.5 6.5 3.5 4.0 2.7 6.9 3.7 7.8 4.1 5.5 6.3 6.4 5.6 5.6 5.1 0.5 12.2 3.7 3.5 7.2 4.1 8.9 9.0 8.1 10.1 7.5 4.9 6.4 7.5 6.5 5.3 3.0 4.1 0.0 5.7 2.4 10.8 3.6 7.6 2.7 0.0 8.7 11.8 4.6 1.7 5.6 8.1 3.1 4.5 0.0 3.8 2.9 3.8 3.2 6.9 3.4 3.1 6.4 4.1 6.2 3.2 1.9 5.8 2.6 1.7 4.6 4.7 6.0 3.5 3.5 6.0 3.6 23.7 0.0 2.0 14.0 12.4 4.0 4.6 5.3 4.9 4.7 ZNF275 ENSG00000063587 "Zinc finger protein 275" Q9NSD4 X 153334155-153360110 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 38.6" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 25.5;Peritubular cells: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 36.2;U-698: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000566 Approved Approved Nucleoli NA NA Nucleoli "HPA000566: AB_1080700" "unprognostic (6.96e-2)" "unprognostic (8.97e-2)" "unprognostic (3.10e-2)" "unprognostic (1.11e-3)" "unprognostic (5.25e-2)" "unprognostic (1.45e-1)" "unprognostic (9.59e-2)" "unprognostic (9.37e-2)" "unprognostic (2.80e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.64e-1)" "unprognostic (4.33e-2)" "unprognostic (2.69e-1)" "unprognostic (1.95e-1)" "unprognostic (3.74e-2)" "unprognostic (1.14e-2)" 6.5 38.6 5.9 3.4 5.9 2.2 11.5 5.9 6.9 5.8 3.5 7.0 20.4 2.8 5.9 12.6 2.5 5.4 4.9 3.0 6.8 6.9 3.8 8.5 3.3 7.0 8.8 5.3 30.3 8.5 5.8 6.9 2.1 6.2 5.1 3.2 3.8 6.3 27.9 3.1 2.5 4.5 5.6 10.7 6.8 4.1 10.5 6.5 3.9 4.7 1.7 5.3 4.0 2.6 4.5 2.7 0.7 1.7 2.8 5.0 2.0 6.0 2.7 5.3 3.7 6.1 6.0 2.6 4.2 7.0 2.7 4.1 2.8 1.4 10.4 8.7 7.9 4.0 1.0 6.0 3.8 4.0 2.4 4.8 3.3 2.6 3.9 8.2 4.2 3.1 7.1 2.7 2.3 4.3 4.4 3.3 5.7 5.1 0.0 4.8 4.4 4.9 3.5 2.4 5.9 4.3 6.0 5.6 3.6 2.0 4.0 2.7 3.7 2.1 0.2 5.1 3.4 1.0 7.5 3.5 4.1 4.9 6.8 5.4 36.2 9.6 20.7 3.7 8.5 2.8 0.7 1.7 0.2 3.7 1.5 4.4 4.5 3.4 3.3 1.6 4.4 5.0 4.2 0.1 2.8 1.4 2.7 4.6 2.0 5.9 5.9 5.9 6.5 6.8 6.9 8.8 5.3 6.2 6.5 0.0 5.8 5.2 3.4 3.0 6.6 4.7 10.2 1.4 2.3 8.7 11.8 1.3 6.6 2.6 1.2 4.1 1.6 0.0 4.4 3.4 7.2 4.9 2.3 25.5 2.2 0.0 0.0 8.0 5.3 2.0 13.3 3.1 3.3 1.0 6.2 6.3 4.4 2.9 37.1 6.5 2.2 12.9 11.4 3.3 3.4 1.9 0.7 3.8 5.0 1.7 ZNF276 "CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477" ENSG00000158805 "Zinc finger protein 276" Q8N554 16 89720400-89740903 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021309, HPA022255" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "HPA021309: AB_1859024, HPA022255: AB_1859025" "unprognostic (1.45e-2)" "unprognostic (7.05e-2)" "unprognostic (1.17e-2)" "unprognostic (8.25e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-3)" "unprognostic (1.27e-1)" "unprognostic (3.70e-2)" "unprognostic (1.92e-1)" "unprognostic (7.85e-2)" "unprognostic (1.59e-2)" "unprognostic (1.36e-3)" "prognostic unfavorable (3.37e-4)" "unprognostic (2.65e-2)" "unprognostic (4.14e-1)" "unprognostic (1.26e-1)" "unprognostic (1.62e-3)" 9.7 9.8 9.0 18.6 13.1 25.5 7.9 20.2 12.3 10.8 11.1 30.6 9.4 16.0 9.0 8.4 14.5 11.4 9.5 6.7 9.8 7.3 8.4 10.1 9.6 21.7 21.3 11.2 13.5 10.9 11.0 11.6 7.4 12.6 10.2 8.8 8.1 11.3 11.4 11.4 18.5 15.3 6.8 9.9 22.2 12.2 6.4 18.4 11.1 10.1 8.1 15.1 9.5 10.3 2.9 2.0 4.5 1.9 5.0 10.1 2.4 5.0 4.3 3.5 9.1 2.8 3.9 6.1 3.5 2.1 3.2 1.2 5.5 5.4 6.7 4.4 3.7 1.6 9.4 4.4 3.9 2.4 4.1 23.5 6.0 8.0 2.1 5.5 5.8 7.9 5.4 5.2 4.3 3.6 3.2 4.9 6.0 11.0 5.7 1.5 7.1 7.3 13.3 2.6 5.0 9.6 11.8 3.8 4.5 4.0 3.0 9.5 8.0 7.6 6.9 4.2 2.2 9.3 8.4 5.5 5.4 7.3 4.2 3.0 20.8 6.7 3.5 4.3 9.7 5.3 4.3 1.7 2.8 10.1 1.9 4.8 2.0 5.5 7.6 1.8 2.9 5.6 7.2 4.5 5.0 1.2 2.0 4.0 2.4 9.0 13.1 20.2 11.3 9.8 7.3 21.3 11.2 12.6 18.4 8.9 14.1 17.5 7.4 10.2 13.9 2.0 5.1 4.0 10.3 10.4 19.6 4.0 1.7 7.1 1.6 10.0 16.3 0.0 5.8 3.4 6.9 7.2 11.6 9.8 8.0 6.4 6.9 20.3 10.5 1.3 10.6 15.3 8.5 5.4 11.8 12.3 6.8 11.5 9.9 2.4 23.5 12.9 5.6 15.1 10.6 14.1 3.3 34.9 14.0 8.9 ZNF286A "KIAA1874, ZNF286" ENSG00000187607 "Zinc finger protein 286A" Q9HBT8 17 15699577-15720787 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SuSa: 49.4" HPA021594 Approved Nucleoli No No Nucleoli "HPA021594: AB_2670768" "unprognostic (2.09e-2)" "unprognostic (1.51e-2)" "unprognostic (2.05e-1)" "unprognostic (1.91e-2)" "unprognostic (1.24e-1)" "unprognostic (8.83e-2)" "unprognostic (2.47e-4)" "unprognostic (4.66e-2)" "unprognostic (9.68e-2)" "unprognostic (1.67e-2)" "unprognostic (2.29e-4)" "unprognostic (5.60e-2)" "unprognostic (1.66e-3)" "unprognostic (4.95e-2)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (4.94e-2)" 3.7 5.9 6.6 5.5 9.5 2.0 6.0 8.2 7.8 9.7 5.3 6.5 10.0 2.5 11.3 10.0 7.6 6.6 6.6 11.5 7.6 6.5 6.1 3.2 3.5 7.0 8.7 4.7 14.3 2.9 9.8 15.9 4.0 9.4 7.1 3.5 7.1 4.7 8.3 3.8 4.0 3.5 8.4 10.7 4.5 3.4 14.2 9.0 5.2 8.0 3.8 6.0 6.9 6.0 6.4 2.7 1.0 3.6 6.0 9.8 2.5 13.4 15.2 22.2 10.7 6.5 9.4 7.1 6.3 5.5 10.5 8.4 9.1 4.8 12.0 5.2 5.3 9.0 11.9 15.7 7.4 13.1 8.8 12.2 8.2 15.6 7.8 6.4 4.0 4.0 8.8 4.7 9.9 10.0 12.2 13.8 20.2 7.1 2.4 14.7 3.7 17.6 3.7 20.5 8.0 3.6 13.2 32.3 5.9 7.6 5.2 7.0 15.9 13.7 5.9 4.8 49.4 5.5 2.4 6.1 6.6 7.0 5.7 9.5 5.3 8.3 0.0 8.0 0.1 7.3 0.8 1.6 1.0 6.9 1.9 7.1 4.0 7.9 7.0 2.5 6.4 9.2 9.8 1.0 6.0 3.6 2.7 9.5 2.5 6.6 9.5 8.2 7.8 7.6 6.5 8.7 4.7 9.4 9.0 17.9 0.0 4.9 4.1 6.3 2.1 3.6 2.5 2.7 6.8 1.8 2.0 1.2 1.7 3.4 10.2 3.0 0.2 0.0 1.4 1.5 3.3 2.9 3.5 0.5 1.1 3.2 5.2 1.8 0.6 8.2 4.6 1.1 1.7 1.0 2.0 1.3 3.4 0.8 4.9 2.1 1.6 0.0 3.5 10.5 5.4 4.8 1.0 2.5 1.2 4.1 ZNF300 ENSG00000145908 "Zinc finger protein 300" Q96RE9 5 150894392-150904983 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 7.0;Spermatocytes: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 3.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.2;HeLa: 18.9" "HPA028975, HPA051777" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" NA NA Nucleoplasm "Nucleoli, Nucleoli rim, Nuclear bodies" "HPA028975: AB_2672851, HPA051777: AB_2681606" "unprognostic (5.06e-2)" "unprognostic (1.05e-2)" "unprognostic (8.41e-2)" "unprognostic (2.31e-1)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.15e-1)" "unprognostic (6.23e-3)" "unprognostic (4.21e-2)" "unprognostic (3.23e-1)" "unprognostic (8.62e-2)" "unprognostic (6.85e-3)" "prognostic unfavorable (3.21e-6)" "unprognostic (3.62e-3)" "unprognostic (2.99e-1)" "unprognostic (3.46e-1)" "unprognostic (1.50e-2)" 4.5 1.3 4.8 4.0 12.0 3.6 7.2 12.5 6.4 7.4 4.3 5.4 4.1 4.1 11.7 5.3 7.5 5.4 5.4 4.0 7.5 3.2 7.3 1.5 3.0 4.4 8.2 2.4 16.6 7.3 1.0 7.3 2.4 7.4 7.0 4.4 3.6 3.8 3.9 1.5 6.9 5.8 6.4 9.2 5.1 7.1 14.9 9.1 1.5 9.3 2.7 4.4 5.5 6.2 3.8 1.2 1.1 1.5 1.7 1.0 0.8 1.2 2.8 17.2 0.0 1.5 3.6 0.0 4.2 3.3 3.7 5.4 1.4 2.1 0.0 3.7 3.5 11.2 2.5 0.0 9.7 5.8 0.0 5.6 0.0 18.9 2.2 3.1 0.1 0.0 5.5 3.0 7.7 9.1 5.3 6.3 0.1 0.0 9.2 3.7 0.0 0.0 0.8 16.5 0.0 0.0 0.0 2.5 4.9 2.7 3.1 9.7 16.1 9.9 8.6 5.7 10.9 5.7 0.0 2.7 5.0 2.1 3.6 7.6 0.3 0.1 0.0 0.5 0.1 10.3 0.0 0.6 1.1 0.7 1.5 0.1 0.9 1.0 0.0 1.2 3.8 0.7 0.4 0.2 1.7 0.1 0.1 0.0 0.8 4.8 12.0 12.5 6.4 7.5 3.2 8.2 2.4 7.4 9.1 0.0 0.3 0.0 2.5 1.3 3.6 0.4 0.0 0.0 2.3 7.0 0.0 0.7 1.7 2.1 1.3 2.1 0.4 0.0 1.4 1.9 3.0 2.0 0.0 0.2 0.4 0.0 2.9 0.6 0.6 0.5 2.3 0.7 0.0 1.8 0.7 3.9 1.4 0.0 1.1 1.1 4.6 6.5 1.7 6.6 3.8 1.9 0.7 1.3 1.2 2.6 ZNF324B FLJ45850 ENSG00000249471 "Zinc finger protein 324B" Q6AW86 19 58451604-58457833 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "NK-cell: 8.3" "Lineage enriched" "Detected in many" 6 "NK-cells: 8.3" "Cell line enhanced" "Detected in many" "HEK 293: 29.4" HPA023400 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA023400: AB_1859195" "unprognostic (2.75e-1)" "unprognostic (2.36e-2)" "unprognostic (2.27e-1)" "unprognostic (1.35e-1)" "unprognostic (2.19e-1)" "unprognostic (5.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.47e-3)" "unprognostic (2.65e-1)" "unprognostic (3.21e-1)" "prognostic favorable (2.83e-4)" "unprognostic (5.58e-2)" "unprognostic (2.43e-1)" "unprognostic (9.50e-2)" "unprognostic (1.40e-1)" "unprognostic (1.56e-3)" "unprognostic (2.94e-2)" 7.4 6.2 6.9 8.3 12.4 5.0 9.0 11.4 12.6 8.7 5.9 7.6 9.8 5.9 8.5 5.0 8.4 9.0 6.8 4.7 6.6 5.5 6.2 6.6 7.3 6.8 9.1 7.0 10.2 10.1 8.0 8.4 4.8 8.8 7.5 6.1 8.4 8.9 8.5 8.2 11.2 6.0 7.4 5.3 10.3 8.0 11.3 9.3 9.4 8.0 6.0 6.4 9.3 6.9 1.1 0.6 1.3 1.0 8.3 1.3 0.7 4.3 7.2 4.0 6.6 2.8 2.5 2.9 3.9 2.9 3.2 2.3 2.5 1.9 5.9 2.5 2.3 3.3 3.6 5.2 3.6 2.5 6.0 29.4 5.1 5.4 1.0 2.9 8.3 7.6 2.5 3.6 3.6 3.1 2.1 2.3 5.3 7.3 3.6 3.3 2.8 6.1 2.0 2.2 5.1 4.1 5.8 5.2 3.5 2.1 8.7 9.5 5.4 3.7 6.0 0.9 2.9 2.2 2.4 2.6 7.7 2.0 4.1 6.3 7.8 7.0 4.4 3.0 3.6 2.9 0.0 1.0 0.1 1.3 0.6 0.9 0.5 0.6 0.9 0.6 1.1 1.3 0.9 1.3 8.3 0.4 0.6 0.4 0.7 6.9 12.4 11.4 12.6 6.6 5.5 9.1 7.0 8.8 9.3 0.0 0.3 0.5 0.9 0.7 3.0 0.8 0.0 2.7 3.4 1.8 21.6 0.8 0.0 2.0 0.7 0.7 1.1 0.0 1.4 0.7 1.1 0.6 0.0 1.0 0.8 4.8 0.0 1.3 1.9 1.3 2.8 0.4 0.0 1.8 0.8 1.5 1.5 0.0 2.5 0.8 5.8 6.5 1.1 3.1 1.9 0.9 0.6 1.5 1.1 0.9 ZNF330 "HSA6591, NOA36" ENSG00000109445 "Zinc finger protein 330" Q9Y3S2 4 141220887-141234697 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 80.7" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 163.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015705, HPA056325" Uncertain Supported Nucleoli NA NA Nucleoli "HPA015705: AB_1859199, HPA056325: AB_2683101" "unprognostic (1.90e-1)" "unprognostic (4.65e-2)" "unprognostic (3.66e-1)" "unprognostic (1.35e-2)" "unprognostic (4.12e-1)" "unprognostic (5.93e-2)" "unprognostic (2.37e-1)" "unprognostic (2.32e-3)" "unprognostic (4.49e-3)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (3.66e-6)" "prognostic favorable (7.27e-6)" "unprognostic (3.24e-1)" "unprognostic (4.60e-2)" "unprognostic (2.02e-2)" "unprognostic (1.30e-2)" 21.7 15.9 8.9 12.2 13.7 16.2 13.8 17.5 11.2 14.9 17.4 9.8 14.2 9.5 19.0 15.6 13.6 14.0 10.5 80.7 9.0 9.5 14.9 26.7 15.2 13.4 13.7 8.6 14.9 16.5 13.2 15.1 10.4 12.7 12.2 12.3 22.3 44.9 11.4 34.7 10.9 12.6 18.9 14.1 16.0 14.2 14.2 13.3 14.3 23.5 15.4 13.5 18.7 16.0 16.3 21.9 12.2 20.8 14.6 19.3 11.8 7.7 9.6 11.6 9.2 20.9 18.9 16.4 21.0 12.1 13.5 12.8 12.9 15.0 33.4 12.9 13.2 7.6 6.3 20.5 13.6 20.8 15.4 13.4 15.5 14.8 18.1 22.4 38.9 12.5 18.9 16.0 12.7 18.6 16.5 14.1 20.7 31.4 22.8 17.2 17.6 30.1 18.3 10.3 24.1 18.3 24.6 16.7 21.1 14.5 8.7 20.3 9.4 7.3 16.9 20.6 13.7 8.4 10.7 15.0 17.3 11.7 10.4 14.9 38.2 27.4 31.7 14.5 24.4 12.3 9.7 20.8 12.2 12.9 17.5 17.8 16.3 16.4 16.6 21.9 13.4 18.0 16.2 3.2 14.6 13.5 15.0 19.3 11.8 8.9 13.7 17.5 11.2 9.0 9.5 13.7 8.6 12.7 13.3 50.6 29.6 27.4 41.1 43.7 64.5 140.4 22.9 20.1 23.9 8.7 13.7 30.9 49.7 27.5 163.4 28.7 21.1 23.3 44.0 30.7 29.8 28.9 23.0 63.5 61.1 15.9 16.1 33.7 48.2 40.5 36.2 41.2 43.9 17.2 22.7 29.8 35.0 24.6 26.9 67.2 23.1 12.9 36.8 47.3 16.1 45.0 28.7 24.9 26.0 54.1 ZNF354A "EZNF, HKL1, KID-1, KID1, TCF17" ENSG00000169131 "Zinc finger protein 354A" O60765 5 178694605-178730702 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052043 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA052043: AB_2681706" "unprognostic (2.79e-1)" "unprognostic (3.44e-2)" "unprognostic (7.06e-3)" "unprognostic (1.78e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (3.25e-2)" "unprognostic (1.41e-1)" "unprognostic (7.66e-3)" "prognostic favorable (8.28e-4)" "unprognostic (4.06e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (8.71e-2)" "unprognostic (4.13e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" 14.0 7.0 13.0 12.1 13.6 14.2 14.2 13.3 14.4 12.6 15.0 6.7 11.4 7.1 13.7 13.3 10.4 11.7 9.8 14.5 13.2 9.3 18.0 6.2 10.8 12.7 16.7 16.1 10.9 15.0 11.7 14.1 14.0 13.4 13.3 10.0 7.1 8.8 15.1 11.9 12.3 10.6 13.6 12.9 17.1 10.4 14.0 14.4 13.1 15.1 8.6 14.2 17.0 25.1 5.7 5.3 15.0 5.8 6.0 6.4 3.6 4.3 3.4 7.1 18.8 12.4 10.1 29.4 5.0 6.7 7.0 7.5 5.0 7.3 5.8 6.6 4.5 12.9 8.6 2.6 21.3 10.8 7.7 8.1 1.7 4.2 0.6 9.4 0.0 4.9 7.9 13.7 6.1 12.5 9.0 6.6 7.9 1.4 0.0 10.1 8.7 8.7 5.8 6.2 4.0 8.8 6.5 1.2 3.6 6.5 4.4 7.8 8.5 6.3 7.2 9.7 9.8 5.9 8.5 5.1 7.9 5.2 4.5 4.2 1.9 4.0 3.6 0.2 1.3 9.9 4.4 5.8 14.5 5.1 3.8 6.4 5.7 4.6 5.7 5.3 3.6 5.3 3.8 15.0 6.0 3.9 1.9 4.1 3.6 13.0 13.6 13.3 14.4 13.2 9.3 16.7 16.1 13.4 14.4 11.9 6.1 3.2 10.0 4.4 8.9 5.5 0.0 12.0 10.3 7.0 13.7 10.6 11.6 9.8 9.2 8.0 2.1 0.0 6.6 10.6 6.1 5.3 5.8 0.8 8.0 6.4 4.6 6.2 8.2 3.2 6.4 7.8 10.1 3.6 2.2 7.4 6.7 0.0 9.9 13.5 9.7 6.5 9.2 22.3 9.8 4.8 10.2 10.9 4.3 6.9 ZNF362 "FLJ25476, lin-29, RN" ENSG00000160094 "Zinc finger protein 362" Q5T0B9 1 33256545-33300719 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059239 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA059239: AB_2683955" "unprognostic (8.31e-3)" "unprognostic (2.61e-1)" "unprognostic (2.23e-2)" "unprognostic (6.90e-3)" "unprognostic (1.08e-1)" "unprognostic (2.34e-2)" "unprognostic (4.02e-3)" "unprognostic (2.02e-2)" "unprognostic (7.74e-2)" "unprognostic (1.82e-1)" "unprognostic (9.25e-2)" "unprognostic (1.52e-1)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (2.67e-1)" "unprognostic (5.83e-2)" "unprognostic (2.66e-1)" 21.6 14.0 18.1 12.0 17.2 8.9 21.7 24.5 30.5 18.6 17.3 13.8 9.6 11.0 23.7 23.8 14.2 20.1 20.7 28.0 15.4 13.8 16.8 8.8 18.7 26.3 12.8 15.6 23.3 19.9 16.4 19.1 17.9 12.3 20.4 8.8 27.4 22.8 21.7 26.1 23.5 11.6 28.1 13.1 22.6 14.0 8.5 10.3 17.9 17.4 14.1 15.3 20.1 15.4 6.0 8.3 6.0 4.6 4.2 4.7 2.5 3.3 5.4 23.7 9.4 6.3 4.4 15.6 4.7 5.5 5.8 6.2 5.6 11.4 1.7 10.3 5.9 1.8 11.3 5.5 2.6 2.4 10.0 5.0 8.5 3.3 6.8 5.6 4.0 6.9 9.4 6.6 2.5 2.2 5.9 7.9 11.3 0.9 2.9 4.4 8.1 13.0 6.7 14.1 2.0 5.1 21.3 5.6 0.7 4.6 5.4 8.4 25.4 13.3 4.2 20.9 10.6 4.1 10.4 11.4 3.5 4.8 8.3 3.1 8.9 8.2 1.8 2.8 3.6 10.4 3.8 4.6 6.0 4.7 4.1 3.4 3.0 3.5 4.1 3.3 6.0 3.1 2.9 3.5 4.2 4.5 8.3 2.6 2.5 18.1 17.2 24.5 30.5 15.4 13.8 12.8 15.6 12.3 10.3 8.9 11.3 1.9 4.0 9.0 12.3 19.4 7.6 1.4 9.1 10.4 0.0 9.4 1.7 5.5 0.9 10.5 3.1 0.0 6.5 5.7 9.7 2.2 9.3 6.6 8.7 7.9 1.7 19.6 14.5 5.4 12.7 6.1 8.5 1.0 4.0 7.7 3.7 8.5 20.1 9.9 4.5 6.5 11.3 0.9 2.5 8.3 3.0 4.9 6.9 1.3 ZNF397 "MGC13250, ZNF47, ZSCAN15" ENSG00000186812 "Zinc finger protein 397" Q8NF99 18 35241030-35267133 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026087 Uncertain Approved "Nucleoli,Plasma membrane,Microtubules,Cytosol" NA NA "Nucleoli, Plasma membrane, Cytosol" Microtubules "HPA026087: AB_1859243" "unprognostic (1.97e-1)" "unprognostic (2.82e-2)" "unprognostic (2.12e-1)" "unprognostic (3.09e-1)" "unprognostic (6.35e-2)" "unprognostic (1.15e-2)" "unprognostic (1.74e-3)" "unprognostic (1.45e-2)" "unprognostic (1.48e-2)" "unprognostic (3.28e-2)" "prognostic favorable (9.44e-4)" "unprognostic (2.46e-2)" "unprognostic (2.17e-3)" "unprognostic (3.83e-2)" "unprognostic (4.44e-2)" "unprognostic (1.06e-1)" "unprognostic (2.09e-3)" 15.1 17.7 20.3 16.8 31.1 5.7 20.6 23.9 26.4 16.2 15.0 27.9 16.7 13.3 22.7 16.5 13.4 15.2 12.9 14.6 20.2 13.8 14.9 12.7 13.6 18.8 34.8 19.3 23.6 17.1 25.3 24.8 14.7 25.6 18.4 18.0 13.8 17.5 16.3 15.0 17.2 15.9 18.9 30.5 19.0 16.7 11.9 35.1 22.0 20.2 8.3 19.2 17.3 16.8 13.3 8.1 12.4 9.4 4.8 9.4 2.2 2.9 5.8 13.8 12.5 15.3 13.0 6.6 6.1 6.1 3.0 4.0 2.1 4.2 15.1 5.5 4.8 4.2 8.1 8.9 6.6 4.3 9.5 5.5 0.6 7.6 6.1 5.1 7.2 5.5 5.8 9.0 3.6 10.6 10.9 1.9 11.7 8.8 10.6 7.8 6.4 12.1 5.6 11.9 2.3 2.3 12.8 4.0 10.7 6.3 7.9 15.0 12.9 9.9 5.3 5.9 12.6 9.2 5.4 3.0 10.2 5.7 3.4 2.7 17.2 6.4 8.8 9.0 5.1 9.6 9.4 5.1 8.4 6.6 8.0 4.8 10.3 6.3 5.3 3.6 13.3 9.4 6.5 12.4 4.8 9.4 8.1 3.2 2.2 20.3 31.1 23.9 26.4 20.2 13.8 34.8 19.3 25.6 35.1 32.8 16.0 27.0 17.0 3.7 46.9 14.4 12.7 21.4 22.7 14.0 33.4 18.5 11.6 16.1 39.6 17.9 14.2 0.0 9.5 11.4 15.4 13.7 11.5 11.3 9.2 31.8 29.7 25.2 15.6 39.9 17.3 10.9 8.5 14.4 12.0 27.7 9.7 16.5 21.2 8.6 46.3 32.3 7.2 26.0 19.1 4.0 12.2 15.2 13.4 9.7 ZNF404 ENSG00000176222 "Zinc finger protein 404" Q494X3 19 43872363-43901385 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 6 "Alveolar cells type 2: 5.6;granulocytes: 6.9;Horizontal cells: 4.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 8.6;U-2 OS: 31.2" "Low region specificity" "Detected in all" "HPA032014, HPA063607" Uncertain Supported "Nucleoli,Nucleoli rim,Intermediate filaments" NA Yes "Nucleoli, Nucleoli rim" "Intermediate filaments" "HPA032014: AB_10602591, HPA063607: AB_2732705" "unprognostic (3.76e-3)" "unprognostic (3.41e-1)" "unprognostic (1.11e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-2)" "unprognostic (2.82e-1)" "unprognostic (1.64e-2)" "unprognostic (2.68e-2)" "unprognostic (7.47e-2)" "unprognostic (1.26e-1)" "unprognostic (2.03e-5)" "unprognostic (1.46e-2)" "unprognostic (3.79e-3)" "unprognostic (2.89e-2)" "unprognostic (1.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.80e-3)" 0.9 2.2 4.6 0.7 4.8 0.1 2.6 5.8 4.8 1.5 2.5 0.2 2.0 10.9 1.2 3.7 2.2 6.0 4.6 4.4 1.5 1.0 1.8 3.1 6.0 7.5 0.8 2.6 8.2 2.6 4.6 1.6 2.6 2.2 1.5 2.9 1.0 1.8 7.0 3.9 1.9 3.4 2.6 1.2 1.5 1.1 1.9 0.9 1.9 0.4 2.1 1.9 0.6 2.3 0.3 2.4 0.3 6.0 8.6 1.4 3.2 1.6 2.0 2.8 0.2 0.8 0.0 3.4 1.5 0.0 0.3 0.4 1.6 2.8 0.3 2.3 0.8 0.0 0.9 2.2 0.2 0.6 5.1 3.9 1.5 1.4 7.0 1.7 0.0 0.1 0.0 1.9 0.2 0.0 0.0 1.9 0.1 0.5 0.0 1.3 0.4 2.0 1.5 1.3 1.0 1.3 0.6 1.6 4.5 0.1 0.9 0.7 2.9 31.2 2.6 1.8 4.1 5.3 0.0 4.1 0.0 1.6 0.0 0.3 1.9 0.7 0.0 0.8 0.9 1.4 0.0 0.4 1.9 1.9 1.5 0.0 2.1 0.4 0.9 1.3 0.6 0.0 5.6 0.0 0.5 0.0 3.7 4.0 0.0 1.4 0.0 0.0 0.0 1.2 0.0 0.5 0.9 0.4 0.2 0.0 0.2 1.0 0.8 0.6 6.9 0.0 0.6 4.8 2.4 1.3 0.3 0.0 0.9 0.1 0.0 0.0 0.6 3.5 0.2 0.0 3.2 0.3 2.5 0.0 1.0 1.6 1.9 0.0 0.8 0.0 0.8 0.6 ZNF428 "C19orf37, MGC51082, Zfp428" ENSG00000131116 "Zinc finger protein 428" Q96B54 19 43607219-43619874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042596, HPA048072" Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA042596: AB_2678070, HPA048072: AB_2680249" "unprognostic (2.45e-3)" "unprognostic (5.51e-2)" "unprognostic (6.68e-3)" "unprognostic (6.31e-2)" "unprognostic (1.60e-1)" "unprognostic (1.12e-1)" "unprognostic (3.22e-2)" "unprognostic (2.32e-2)" "unprognostic (2.53e-1)" "unprognostic (6.67e-2)" "prognostic favorable (3.60e-5)" "unprognostic (3.85e-1)" "unprognostic (5.59e-2)" "unprognostic (1.85e-1)" "unprognostic (2.30e-2)" "unprognostic (4.00e-1)" "unprognostic (2.74e-2)" 18.8 31.2 36.8 15.8 37.6 18.9 9.2 25.9 48.8 13.7 14.2 14.4 8.8 17.0 18.8 14.9 8.8 13.0 18.4 19.9 31.3 28.7 17.4 15.5 13.1 15.5 27.0 31.1 19.2 19.4 9.8 19.2 12.7 18.0 20.1 6.3 14.8 21.7 13.2 37.7 6.6 13.7 17.2 22.2 16.8 16.6 19.7 17.0 17.8 16.6 8.7 8.9 10.0 11.4 7.8 7.1 9.4 3.2 3.1 8.5 1.0 11.2 9.0 14.1 23.3 5.4 4.0 6.6 8.5 3.9 6.0 6.3 5.5 7.5 19.0 19.5 6.5 3.8 2.8 5.6 1.6 2.0 15.9 23.9 20.7 9.4 9.3 10.6 16.2 17.2 7.3 3.6 5.3 2.8 6.2 8.4 13.6 21.6 12.0 6.2 11.9 40.0 29.1 9.4 5.0 6.3 39.9 6.5 13.9 7.2 6.8 27.1 31.6 12.3 7.6 19.0 3.9 4.6 23.3 16.5 7.2 20.5 6.8 13.0 13.4 16.1 33.2 10.4 16.6 15.8 2.5 2.5 9.4 7.8 1.4 4.4 5.2 7.1 7.4 2.7 7.8 8.5 3.7 1.3 3.1 3.2 7.1 4.1 1.0 36.8 37.6 25.9 48.8 31.3 28.7 27.0 31.1 18.0 17.0 0.0 3.8 39.5 61.1 28.5 98.9 17.9 63.7 4.0 3.4 62.8 13.7 115.0 126.0 77.7 112.3 58.4 31.5 0.0 69.0 37.8 99.2 49.9 36.8 47.0 89.6 54.0 155.7 74.9 36.5 48.8 82.3 46.8 108.0 43.3 49.3 108.0 64.6 46.0 85.2 176.5 53.3 71.1 93.7 20.4 56.9 22.6 46.1 73.0 46.0 41.6 ZNF444 "EZF2, FLJ11137, ZSCAN17" ENSG00000167685 "Zinc finger protein 444" Q8N0Y2 19 56132599-56160893 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056895, HPA065203" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA056895: AB_2683267, HPA065203: AB_2685431" "unprognostic (1.58e-1)" "unprognostic (3.34e-1)" "unprognostic (5.00e-2)" "unprognostic (1.23e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (1.32e-2)" "unprognostic (2.01e-2)" "unprognostic (1.56e-1)" "unprognostic (7.29e-2)" "unprognostic (1.35e-3)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.61e-4)" "unprognostic (4.70e-2)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "prognostic favorable (1.87e-4)" 9.4 13.4 15.0 7.1 21.0 3.7 8.3 14.9 20.1 9.0 14.8 12.8 14.3 13.6 10.5 9.9 6.6 11.9 11.2 10.5 13.5 13.3 9.9 37.4 10.9 6.1 12.3 11.0 12.5 25.3 8.5 12.2 12.5 8.0 14.3 5.3 10.4 14.1 25.6 17.2 11.5 11.3 7.5 10.3 8.6 17.2 9.2 10.4 28.1 16.6 2.8 8.2 10.4 6.8 4.3 3.5 3.5 1.7 3.7 7.1 1.8 4.7 9.1 8.4 7.3 3.6 3.7 5.5 6.1 4.0 5.2 5.7 10.0 5.4 8.4 5.4 3.5 2.6 4.4 5.2 4.1 2.2 7.3 51.5 8.2 6.1 18.0 5.9 3.6 7.7 4.3 3.8 4.2 3.3 7.9 4.6 10.5 10.6 3.7 3.6 6.2 11.8 10.3 9.1 9.5 16.7 13.8 5.4 4.4 5.7 4.4 9.0 12.4 3.1 10.3 4.5 4.8 10.2 6.7 6.0 9.4 8.1 2.0 6.6 9.1 7.7 6.3 5.9 5.0 6.1 3.1 1.7 3.5 4.1 1.4 4.5 2.0 6.9 6.9 2.1 4.3 7.1 4.6 0.2 3.7 1.0 3.5 4.2 1.8 15.0 21.0 14.9 20.1 13.5 13.3 12.3 11.0 8.0 10.4 3.0 14.9 10.2 14.2 2.7 16.7 11.4 33.1 13.4 9.1 10.4 7.9 16.2 8.3 23.1 26.9 15.8 12.8 0.0 19.3 7.9 9.2 13.8 10.3 34.7 9.4 19.1 28.2 19.6 5.3 28.6 11.2 3.9 15.1 19.8 24.4 16.6 21.0 10.5 11.3 18.8 13.6 25.8 13.2 10.4 19.8 4.5 10.4 13.1 19.3 8.9 ZNF461 "GIOT-1, MGC33911" ENSG00000197808 "Zinc finger protein 461" Q8TAF7 19 36637192-36666853 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 31.6;Club cells: 21.6;granulocytes: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021139 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA021139: AB_10961418" "unprognostic (8.37e-3)" "unprognostic (2.23e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (3.64e-4)" "unprognostic (2.08e-2)" "unprognostic (6.32e-2)" "unprognostic (5.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-3)" "unprognostic (2.11e-1)" "unprognostic (7.01e-3)" "unprognostic (2.43e-2)" "unprognostic (1.51e-1)" "unprognostic (4.21e-2)" "unprognostic (4.54e-2)" "unprognostic (5.86e-2)" "unprognostic (5.11e-3)" 6.0 8.7 8.1 5.6 12.3 6.3 7.2 13.5 12.0 7.1 5.9 8.5 4.7 1.5 10.2 7.1 5.2 7.6 5.8 5.0 6.9 7.5 6.8 5.1 5.4 6.9 7.0 8.6 10.8 4.0 7.9 12.1 8.7 8.7 6.7 4.7 5.7 4.8 6.3 4.1 5.9 5.4 8.5 7.4 7.9 5.4 8.1 9.2 5.9 10.6 3.1 7.6 6.2 7.3 3.3 2.3 1.0 2.3 2.2 6.2 1.6 2.9 5.3 4.0 5.1 2.8 6.3 2.5 3.1 3.5 4.9 6.8 0.9 1.3 0.4 6.7 4.4 4.8 0.5 2.8 3.4 5.3 5.4 4.0 4.6 0.7 2.0 4.5 3.9 5.6 3.9 6.2 1.6 4.4 5.8 3.0 2.5 0.2 0.4 4.9 3.1 6.1 1.0 2.3 0.4 2.0 0.4 3.9 0.9 1.5 6.7 4.7 6.7 0.3 2.3 4.2 4.3 2.5 1.5 3.0 3.0 3.8 1.9 3.8 8.8 13.0 1.6 0.0 0.8 3.8 0.0 0.8 1.0 2.5 2.3 3.1 2.8 4.1 6.2 2.3 3.3 3.1 2.2 0.1 2.2 0.4 0.7 3.5 1.6 8.1 12.3 13.5 12.0 6.9 7.5 7.0 8.6 8.7 9.2 26.8 31.6 1.3 1.7 3.0 5.5 1.6 5.1 14.7 21.6 3.5 0.0 2.4 1.7 1.2 17.7 3.4 0.2 0.0 0.8 2.4 3.0 1.7 31.3 1.0 1.5 3.2 2.9 4.3 2.2 4.1 0.9 1.9 0.0 0.0 1.0 1.9 0.7 0.0 1.8 1.5 3.2 0.0 3.1 7.7 4.2 3.0 2.4 4.3 1.2 1.5 ZNF483 "KIAA1962, ZKSCAN16, ZSCAN48" ENSG00000173258 "Zinc finger protein 483" Q8TF39 9 111525159-111577844 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.3;pituitary gland: 40.4" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 44.0;Horizontal cells: 33.4;Muller glia cells: 21.7;Rod photoreceptor cells: 22.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055041 Approved Nucleoli NA NA Nucleoli "HPA055041: AB_2682681" "unprognostic (4.33e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (2.34e-1)" "unprognostic (4.11e-2)" "unprognostic (5.95e-3)" "unprognostic (9.18e-5)" "unprognostic (2.02e-1)" "unprognostic (9.50e-2)" "unprognostic (4.44e-3)" "unprognostic (5.49e-2)" "unprognostic (5.19e-4)" "unprognostic (7.19e-3)" "unprognostic (1.74e-1)" "unprognostic (4.30e-2)" "unprognostic (6.17e-2)" 3.2 10.1 13.9 2.1 30.5 7.7 5.6 35.9 36.3 6.1 4.0 8.6 2.9 2.0 10.0 11.9 2.4 7.0 4.9 4.7 18.1 7.3 5.1 2.5 3.9 3.4 9.5 23.0 12.6 4.3 13.6 40.4 1.8 24.4 7.2 2.4 5.9 3.2 7.7 2.3 3.5 2.9 5.5 9.8 4.8 3.9 11.8 10.3 0.0 12.5 0.0 3.1 4.7 4.8 2.5 1.0 4.6 1.0 2.1 6.5 1.5 0.3 3.2 3.2 4.8 0.4 0.6 1.0 0.4 1.6 3.2 3.0 0.4 1.5 0.5 0.5 1.3 2.4 0.9 1.5 1.7 1.9 0.2 1.9 1.7 4.5 2.6 0.9 0.6 0.4 1.2 0.6 1.7 0.9 2.4 2.9 2.1 1.3 0.9 0.7 3.0 0.2 0.8 11.8 1.5 1.1 0.3 4.9 0.4 1.2 1.3 6.9 3.3 1.2 0.6 0.8 3.0 1.9 0.4 0.5 1.0 1.6 1.5 2.2 0.7 1.9 0.4 1.1 0.5 0.7 4.6 1.0 0.6 4.8 0.5 2.7 1.5 3.3 2.3 0.3 2.5 5.9 6.5 3.4 2.1 0.7 1.0 1.6 1.5 13.9 30.5 35.9 36.3 18.1 7.3 9.5 23.0 24.4 10.3 0.0 7.5 0.0 4.4 0.7 44.0 2.9 0.0 1.4 6.8 7.0 19.6 0.9 5.0 0.8 17.5 1.8 0.2 0.0 1.8 0.5 3.1 3.3 0.0 2.1 0.3 33.4 2.9 0.6 0.0 6.7 4.4 1.0 1.7 0.0 0.0 21.7 0.9 0.0 9.6 0.0 22.6 6.5 2.3 7.5 2.7 1.3 0.6 0.0 0.1 3.0 ZNF507 KIAA1084 ENSG00000168813 "Zinc finger protein 507" Q8TCN5 19 32345594-32387667 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030964, HPA049728" Uncertain Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA030964: AB_10670562, HPA049728: AB_2680864" "unprognostic (3.39e-1)" "unprognostic (3.78e-2)" "unprognostic (6.84e-2)" "unprognostic (2.61e-2)" "unprognostic (2.21e-2)" "unprognostic (1.74e-2)" "unprognostic (1.41e-3)" "unprognostic (1.20e-1)" "unprognostic (3.24e-2)" "unprognostic (4.28e-3)" "unprognostic (7.24e-2)" "unprognostic (7.44e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-1)" "unprognostic (1.89e-1)" "unprognostic (2.97e-2)" "unprognostic (1.46e-2)" 10.9 8.7 11.3 16.0 13.1 13.5 12.0 18.4 16.4 12.0 11.4 9.0 10.2 10.0 12.4 9.8 9.6 12.2 10.3 10.1 9.4 8.1 9.0 11.1 8.2 10.5 12.3 10.3 18.6 10.9 13.6 15.7 16.9 11.1 10.7 9.9 6.8 11.0 9.6 21.0 8.6 14.7 11.9 12.9 9.6 9.7 28.3 13.0 17.1 18.7 10.0 10.5 11.0 20.1 4.0 0.4 2.3 1.4 2.0 4.7 1.4 9.3 18.6 13.8 8.6 9.1 14.3 11.2 8.4 8.2 7.7 8.7 10.7 7.3 13.8 10.4 8.0 8.4 5.4 20.1 10.4 14.9 10.7 18.3 14.2 8.9 7.2 10.9 11.8 7.8 9.0 8.0 9.9 16.1 8.0 10.3 11.6 20.8 11.2 8.1 5.8 12.7 3.9 14.8 13.8 5.9 13.2 16.1 5.6 4.7 10.4 11.4 9.9 11.1 7.5 9.1 11.5 5.9 8.5 11.0 12.4 13.3 7.2 10.8 10.9 12.6 14.3 8.7 8.7 11.1 0.4 0.1 2.3 4.1 0.0 4.7 2.5 3.1 2.8 0.0 4.0 4.2 3.4 2.0 2.0 1.4 0.4 2.4 1.4 11.3 13.1 18.4 16.4 9.4 8.1 12.3 10.3 11.1 13.0 8.9 15.3 7.3 5.9 2.5 19.9 12.6 2.5 22.7 11.4 0.0 13.7 8.0 1.7 5.1 13.1 6.3 8.1 0.0 4.8 4.4 5.7 9.3 3.5 9.6 2.9 55.6 8.6 12.9 0.3 8.2 8.6 1.1 1.7 0.0 14.3 19.5 4.9 10.5 6.7 3.5 25.0 0.0 7.2 20.4 16.2 2.4 7.3 8.7 11.2 6.8 ZNF519 "FLJ36809, HsT2362" ENSG00000175322 "Zinc finger protein 519" Q8TB69 18 14057457-14132490 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 14.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA028982 Uncertain Approved Nucleoli NA NA Nucleoli "HPA028982: AB_10610705" "unprognostic (1.85e-2)" "unprognostic (4.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.15e-3)" "unprognostic (1.90e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (3.43e-1)" "unprognostic (2.31e-2)" "unprognostic (1.18e-1)" "unprognostic (6.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.16e-5)" "unprognostic (1.40e-2)" "unprognostic (1.58e-1)" "unprognostic (2.38e-1)" "unprognostic (3.65e-4)" 1.8 1.4 2.8 1.9 7.6 1.4 2.8 13.7 14.4 5.7 4.6 0.7 0.8 1.2 7.0 2.6 3.4 4.5 1.8 1.9 3.4 1.6 0.8 1.0 2.7 6.6 1.7 4.0 8.7 1.2 1.1 1.5 1.2 3.0 2.6 2.6 2.0 1.6 2.7 1.0 2.0 2.1 6.0 2.1 2.2 1.4 3.0 2.5 1.1 2.0 0.9 1.9 4.3 3.8 1.7 0.1 0.0 0.6 0.5 3.5 0.7 1.3 0.3 6.0 6.3 0.8 1.2 1.6 1.6 0.9 3.5 3.2 2.7 1.2 3.1 1.7 1.2 1.6 1.0 4.9 1.2 4.1 1.9 3.3 5.5 1.8 1.1 0.2 11.3 2.4 0.6 1.6 2.9 1.2 1.0 0.6 4.7 2.7 4.7 2.0 1.8 6.9 4.4 2.7 3.5 1.4 7.4 5.8 3.9 0.9 1.9 9.3 2.5 2.3 0.8 1.8 4.0 0.7 3.1 0.4 5.7 7.6 2.5 1.8 1.8 1.2 4.5 1.8 4.4 4.7 0.0 0.3 0.0 1.1 0.6 1.8 1.7 1.4 1.5 0.1 0.8 3.5 2.2 0.0 0.5 0.5 0.1 2.0 0.7 2.8 7.6 13.7 14.4 3.4 1.6 1.7 4.0 3.0 2.5 6.0 7.4 4.2 2.4 1.8 14.4 4.4 2.5 2.7 1.2 0.0 2.0 2.3 1.7 2.0 0.7 2.1 0.1 0.0 1.7 3.5 3.9 1.2 3.5 0.8 1.5 3.2 1.2 3.7 2.4 1.1 6.1 1.8 1.7 1.0 1.3 5.0 0.8 0.0 8.5 0.6 6.8 0.0 2.2 6.9 11.5 1.1 0.7 4.4 2.5 1.4 ZNF554 FLJ34817 ENSG00000172006 "Zinc finger protein 554" Q86TJ5 19 2819874-2835773 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060247, HPA063358" Uncertain Enhanced Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA060247: AB_2684230, HPA063358: AB_2684995" "unprognostic (3.81e-1)" "unprognostic (1.89e-3)" "unprognostic (1.84e-1)" "unprognostic (3.58e-3)" "unprognostic (5.05e-2)" "unprognostic (7.36e-5)" "unprognostic (1.65e-1)" "prognostic favorable (9.31e-4)" "unprognostic (1.82e-1)" "unprognostic (3.37e-3)" "prognostic favorable (4.69e-4)" "unprognostic (1.57e-1)" "prognostic favorable (1.99e-5)" "unprognostic (1.75e-1)" "unprognostic (9.91e-3)" "unprognostic (1.79e-2)" "prognostic favorable (5.00e-4)" 4.1 4.4 7.9 2.0 9.1 1.9 5.1 12.2 14.1 6.0 4.6 7.7 5.6 6.1 6.8 4.5 4.0 6.4 5.6 7.3 8.2 8.4 6.6 8.6 5.0 3.9 6.2 6.9 8.2 5.0 9.8 8.4 25.9 6.0 5.7 4.3 7.7 7.6 5.4 8.9 7.4 4.7 5.6 4.2 3.7 4.2 4.0 6.5 5.1 7.9 4.7 6.0 4.5 4.1 2.3 3.6 0.6 0.6 1.8 1.8 0.7 3.7 0.1 3.3 3.6 2.3 3.0 4.2 2.4 2.6 5.0 2.3 0.3 1.0 3.5 2.3 1.9 3.8 1.8 0.3 1.9 0.7 0.0 1.7 1.0 1.2 1.5 1.8 0.5 0.8 2.4 4.4 1.4 2.0 3.0 0.4 4.4 3.6 2.0 1.6 0.7 1.7 0.4 1.6 1.2 1.1 1.9 2.2 0.9 3.2 3.0 3.0 5.4 2.7 0.5 4.0 4.2 1.4 1.8 0.0 0.4 1.0 1.4 0.9 6.6 7.3 0.7 1.9 1.7 1.0 0.2 0.3 0.6 0.4 0.1 1.5 0.8 0.7 0.9 0.0 2.3 1.8 0.3 0.2 1.8 0.6 3.6 0.3 0.7 7.9 9.1 12.2 11.2 8.2 8.4 6.2 6.9 6.0 6.5 11.9 15.1 0.9 2.6 1.1 4.1 2.8 2.5 8.1 6.8 0.0 7.9 1.9 3.3 2.0 0.4 2.5 3.8 0.0 1.2 1.0 2.0 2.5 0.0 1.9 1.3 3.2 3.5 2.5 1.0 0.2 2.8 2.0 0.0 1.0 1.7 4.6 1.7 0.0 2.5 2.1 4.7 0.0 1.5 4.4 10.4 1.3 7.3 4.5 2.2 1.5 ZNF57 ZNF424 ENSG00000171970 "Zinc finger protein 57" Q68EA5 19 2900898-2918476 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 74.9;Late spermatids: 28.7;Suprabasal keratinocytes: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA061915 Approved Nucleoli NA NA Nucleoli "HPA061915: AB_2684635" "unprognostic (3.59e-2)" "unprognostic (1.53e-3)" "unprognostic (1.91e-2)" "unprognostic (8.86e-3)" "unprognostic (3.32e-2)" "unprognostic (3.07e-2)" "unprognostic (7.66e-2)" "prognostic favorable (6.26e-4)" "unprognostic (1.35e-1)" "unprognostic (4.04e-2)" "prognostic favorable (7.72e-4)" "unprognostic (2.34e-3)" "prognostic favorable (4.11e-9)" "unprognostic (6.26e-3)" "unprognostic (2.82e-2)" "unprognostic (7.35e-2)" "unprognostic (6.49e-3)" 3.6 2.9 3.6 3.2 4.7 4.0 7.3 17.2 5.7 6.2 15.7 2.3 5.1 7.8 5.6 4.2 11.0 4.7 4.0 4.2 3.3 2.7 9.2 3.9 4.9 2.9 2.6 3.2 5.4 7.4 3.9 4.1 5.8 4.2 6.1 10.1 3.6 5.5 8.7 7.4 18.6 18.5 2.1 2.4 3.6 11.7 26.4 3.9 2.9 5.4 7.0 6.6 5.0 7.9 4.9 3.6 1.4 5.8 6.3 8.4 4.1 6.7 3.2 4.4 6.4 4.3 3.7 7.4 2.9 2.3 4.6 4.8 6.5 2.6 5.7 3.7 2.3 6.7 7.9 7.0 9.9 5.8 0.0 3.6 3.3 3.7 8.6 3.3 0.0 6.3 2.9 11.1 4.1 8.8 3.8 3.5 13.8 5.8 0.1 3.6 6.8 8.6 3.7 2.9 8.0 5.6 8.0 13.5 1.3 6.3 11.1 2.2 3.3 4.2 7.9 2.7 6.5 4.9 5.5 2.7 3.2 3.1 7.3 4.0 1.2 6.5 2.8 2.6 0.9 2.5 0.0 3.3 1.4 6.5 5.8 5.4 4.9 7.1 6.7 3.6 4.9 8.4 7.4 1.2 6.3 3.1 3.4 7.1 4.1 3.6 4.7 17.2 5.7 3.3 2.7 2.6 3.2 4.2 3.9 0.0 4.0 0.0 17.8 19.1 1.9 2.5 2.5 4.0 10.3 0.0 5.9 3.6 3.3 2.8 74.9 1.4 11.8 0.0 2.0 3.4 2.5 3.4 0.0 1.6 1.9 1.6 0.0 1.8 1.0 28.7 2.3 1.9 5.0 1.8 5.0 1.6 1.4 7.0 2.8 2.4 2.6 0.0 3.9 4.1 11.5 25.1 5.5 0.0 6.0 8.9 ZNF571 HSPC059 ENSG00000180479 "Zinc finger protein 571" Q7Z3V5 19 37554782-37594790 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.8" "Cell type enhanced" "Detected in many" 4 "granulocytes: 15.0;Rod photoreceptor cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA054762 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA054762: " "unprognostic (1.16e-1)" "unprognostic (3.01e-2)" "unprognostic (3.92e-2)" "unprognostic (1.19e-1)" "unprognostic (5.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.19e-1)" "unprognostic (9.03e-4)" "unprognostic (5.77e-2)" "unprognostic (9.82e-2)" "unprognostic (1.22e-3)" "unprognostic (3.90e-2)" "unprognostic (2.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.62e-1)" "unprognostic (4.89e-2)" "unprognostic (2.71e-4)" 6.5 6.7 8.6 3.2 12.9 6.1 12.5 12.5 12.8 5.9 4.2 9.8 4.4 2.3 6.7 8.7 3.9 6.0 4.5 4.2 10.4 7.2 6.4 4.2 4.1 4.4 15.3 9.4 8.5 3.8 11.5 12.2 4.8 13.4 7.1 3.4 5.1 3.6 4.5 3.5 7.1 3.7 7.7 14.3 4.8 3.5 8.5 15.8 3.7 61.8 3.3 5.0 6.6 5.3 9.4 4.1 4.9 1.3 3.7 8.4 3.2 1.8 1.0 6.3 9.1 4.7 4.8 2.0 2.7 4.4 6.6 8.2 1.9 1.7 9.6 8.6 2.8 4.6 2.4 2.0 2.9 11.0 2.1 7.9 5.1 2.7 1.1 5.4 1.9 5.8 2.6 5.3 6.3 5.8 4.7 1.3 8.7 2.4 0.8 5.3 1.7 9.6 2.1 15.8 2.9 3.5 4.8 3.0 5.1 9.1 11.6 13.6 9.5 6.4 2.1 3.2 13.2 9.7 1.3 0.8 3.0 3.9 3.3 6.9 7.7 15.8 13.2 0.5 0.8 6.6 1.8 0.8 4.9 6.7 1.3 6.1 8.7 6.3 6.5 2.7 9.4 7.8 8.4 1.5 3.7 1.2 4.1 4.2 3.2 8.6 12.9 12.5 12.8 10.4 7.2 15.3 9.4 13.4 15.8 0.0 1.3 4.5 1.1 1.5 9.3 1.1 2.5 4.0 5.7 5.2 9.8 1.8 3.3 1.7 10.5 2.5 0.8 0.0 1.4 1.3 2.3 1.7 15.0 0.8 1.4 12.7 1.2 2.5 1.3 2.5 4.0 1.3 5.0 0.0 2.1 4.5 0.8 0.0 2.5 2.6 16.6 12.9 1.7 7.2 5.7 2.3 1.0 6.2 1.3 0.5 ZNF577 MGC4400 ENSG00000161551 "Zinc finger protein 577" Q9BSK1 19 51804816-51890950 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 33.2;Early spermatids: 47.8;Late spermatids: 35.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041499, HPA046761" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041499: AB_2677516, HPA046761: AB_2679791" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (5.69e-2)" "unprognostic (4.17e-1)" "unprognostic (8.21e-2)" "unprognostic (1.45e-3)" "unprognostic (1.48e-1)" "unprognostic (1.64e-2)" "unprognostic (3.01e-3)" "unprognostic (1.18e-1)" "unprognostic (1.04e-1)" "unprognostic (6.51e-3)" "unprognostic (2.81e-3)" "unprognostic (2.72e-2)" "unprognostic (2.70e-1)" "unprognostic (7.02e-2)" "prognostic favorable (2.03e-4)" 7.9 6.8 13.4 5.8 15.5 4.2 13.9 14.6 12.1 10.2 10.9 9.9 15.5 5.1 12.3 11.1 6.3 10.0 8.9 8.0 14.8 5.6 11.0 5.5 6.8 5.6 7.6 8.7 27.2 7.1 17.4 7.5 10.1 9.9 17.4 7.6 17.2 12.9 16.1 9.4 22.3 8.1 14.4 11.0 10.1 7.1 22.5 14.9 3.8 16.3 5.2 6.3 8.8 10.2 9.4 3.2 7.1 4.0 4.6 4.6 1.8 1.2 0.1 6.6 8.1 11.4 12.4 0.0 7.7 2.9 3.0 6.1 0.8 1.0 1.3 0.8 3.5 4.4 2.1 2.6 1.6 1.6 0.0 7.6 12.7 0.1 1.1 8.8 2.8 4.3 9.6 5.0 4.4 1.3 9.5 1.5 0.0 2.7 0.0 3.8 0.0 7.8 3.6 7.6 0.0 0.2 3.4 3.3 2.3 4.9 2.9 2.7 1.4 1.9 0.9 6.5 7.0 1.3 3.1 1.0 5.5 7.7 1.6 2.7 5.4 0.0 1.7 1.5 0.5 8.9 7.1 2.6 5.7 1.7 4.0 4.6 9.4 3.0 3.6 2.8 5.1 3.8 2.4 1.2 4.6 3.0 3.2 1.4 1.8 13.4 15.5 14.6 12.1 14.8 5.6 7.6 8.7 9.9 14.9 0.0 1.6 6.7 3.0 3.9 11.1 7.8 5.1 1.4 1.2 17.4 9.8 6.0 33.2 3.1 47.8 6.0 2.7 0.0 1.0 4.5 5.5 6.1 4.7 1.5 4.7 6.4 2.9 4.3 2.4 35.6 7.5 5.1 0.0 5.4 5.0 14.0 1.2 0.0 12.0 4.2 9.3 0.0 6.6 10.7 14.4 4.5 3.8 2.5 4.2 2.1 ZNF583 FLJ31030 ENSG00000198440 "Zinc finger protein 583" Q96ND8 19 56397966-56436035 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 53.6;Late spermatids: 29.3;Spermatocytes: 25.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 14.0" "Low region specificity" "Detected in all" "HPA023805, HPA023957" Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA023805: AB_2671318, HPA023957: AB_2671383" "unprognostic (9.89e-3)" "unprognostic (5.52e-3)" "unprognostic (8.14e-2)" "unprognostic (2.89e-2)" "unprognostic (1.15e-1)" "unprognostic (6.69e-3)" "unprognostic (1.49e-1)" "unprognostic (1.85e-1)" "unprognostic (2.31e-2)" "unprognostic (1.79e-2)" "unprognostic (8.43e-3)" "unprognostic (5.00e-2)" "unprognostic (9.54e-5)" "unprognostic (2.30e-2)" "unprognostic (1.16e-1)" "unprognostic (2.37e-2)" "unprognostic (2.54e-2)" 7.2 5.9 7.9 3.9 9.3 2.3 4.7 11.6 12.4 5.6 4.6 5.6 3.7 3.2 6.1 5.5 3.6 5.8 5.4 5.0 7.7 7.3 6.6 5.9 6.6 4.5 7.5 6.3 11.2 5.9 7.3 8.4 4.7 8.3 6.0 3.5 3.3 2.6 4.7 4.8 2.1 3.1 6.2 7.6 5.4 3.9 15.8 7.6 5.0 7.9 2.1 4.1 4.4 5.7 6.3 3.5 9.4 4.7 9.2 7.4 2.8 0.0 2.0 4.7 0.0 3.3 2.7 0.0 5.8 5.9 2.7 2.2 0.2 0.6 4.3 2.9 5.3 5.0 0.3 1.9 1.8 2.9 2.0 10.2 5.7 0.0 1.0 3.8 4.7 5.2 3.7 2.9 3.9 1.9 4.0 2.6 4.5 2.1 1.6 8.8 0.0 5.8 1.6 1.2 0.0 1.9 2.9 8.9 3.2 2.1 4.2 2.7 4.1 0.0 0.5 1.5 2.5 2.9 6.1 1.8 14.0 3.8 2.7 11.4 6.0 11.0 6.8 0.3 1.3 4.9 9.4 2.2 4.7 4.9 3.2 7.2 6.3 4.0 4.5 2.5 5.5 7.4 4.4 1.0 9.2 4.7 3.5 4.9 2.8 7.9 9.3 11.6 12.4 7.7 7.3 7.5 6.3 8.3 7.6 3.0 1.0 3.2 3.1 1.5 16.1 4.4 0.0 1.4 0.0 1.8 5.9 1.4 8.3 5.1 53.6 5.5 0.4 0.0 2.4 0.4 5.0 2.5 10.4 1.6 3.4 9.5 0.0 6.2 4.0 29.3 6.4 3.5 3.3 1.8 1.5 10.2 2.3 1.5 12.7 4.8 14.3 6.5 5.3 25.1 12.8 1.5 0.9 8.5 1.7 1.4 ZNF593 ZT86 ENSG00000142684 "Zinc finger protein 593" O00488 1 26169871-26170873 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 59.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054363, HPA059387" Supported Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA054363: AB_2682462, HPA059387: AB_2684001" "unprognostic (1.23e-2)" "unprognostic (8.97e-2)" "unprognostic (7.13e-2)" "unprognostic (7.42e-2)" "unprognostic (9.37e-2)" "unprognostic (5.92e-2)" "unprognostic (1.63e-2)" "unprognostic (8.96e-2)" "unprognostic (5.06e-1)" "unprognostic (1.76e-2)" "unprognostic (1.78e-1)" "unprognostic (1.08e-1)" "unprognostic (4.46e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" "unprognostic (4.79e-2)" 11.7 11.5 9.4 10.7 9.4 15.7 18.3 7.2 12.1 9.0 11.7 7.0 12.1 11.4 8.7 9.0 10.9 8.4 11.3 14.5 8.9 10.0 13.5 30.8 7.7 16.8 10.0 7.0 11.6 36.2 9.7 9.3 12.7 10.9 10.4 5.8 5.9 15.9 12.0 59.3 9.8 11.0 6.5 7.3 13.0 15.2 9.3 8.3 5.4 15.1 17.2 9.2 10.6 10.1 23.5 26.8 0.7 25.0 16.1 21.7 14.1 20.1 11.1 3.8 13.4 3.7 4.9 20.2 9.0 4.6 10.5 10.1 17.0 12.2 23.6 16.6 5.6 8.4 13.2 12.9 11.7 3.8 14.1 41.4 16.0 9.1 25.7 16.1 22.1 14.1 8.8 11.5 11.6 12.2 4.4 8.8 5.8 24.0 9.1 6.2 15.4 9.0 41.1 15.1 19.5 39.5 11.3 6.7 23.8 7.5 8.9 10.1 11.0 10.9 27.4 34.2 3.3 11.3 12.5 9.1 10.1 11.9 21.1 16.8 18.0 18.2 25.5 11.8 45.9 12.9 0.1 15.7 0.2 14.2 25.0 13.3 23.5 20.1 14.0 21.7 22.7 15.0 14.3 0.7 16.1 25.0 26.8 21.7 14.1 9.4 9.4 7.2 12.1 8.9 10.0 10.0 7.0 10.9 8.3 11.9 63.0 48.3 137.4 152.1 16.6 5.9 58.6 21.4 40.9 57.6 2.0 93.3 87.9 89.4 5.0 36.0 55.3 23.3 126.2 135.2 54.6 99.4 51.7 184.5 69.6 3.2 105.3 38.6 55.7 10.0 30.0 42.5 47.2 47.7 71.1 18.5 122.6 60.4 21.9 148.8 11.7 12.9 55.6 33.0 56.3 147.0 186.2 28.8 68.1 152.9 ZNF596 ENSG00000172748 "Zinc finger protein 596" Q8TC21 8 232137-264703 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 35.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 14.0" "Low region specificity" "Detected in all" HPA055463 Uncertain Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA055463: AB_2682821" "unprognostic (3.30e-1)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.90e-1)" "unprognostic (9.07e-3)" "unprognostic (9.68e-3)" "unprognostic (2.10e-3)" "unprognostic (1.74e-1)" "unprognostic (4.84e-1)" "unprognostic (1.70e-5)" "unprognostic (6.37e-2)" "unprognostic (1.20e-1)" "unprognostic (3.10e-2)" "unprognostic (2.39e-1)" "unprognostic (3.51e-1)" "unprognostic (4.53e-1)" 4.9 6.2 6.3 9.9 7.4 2.6 8.5 18.2 10.1 6.7 4.4 8.3 8.3 4.3 10.4 11.9 4.7 6.7 6.3 5.1 7.5 7.0 6.1 5.3 4.8 5.3 6.8 7.3 7.8 7.1 13.5 10.9 5.5 6.2 6.1 5.3 6.6 4.2 9.4 10.2 6.7 4.1 7.7 7.8 6.8 5.4 22.4 7.8 7.4 9.2 4.2 4.4 4.5 4.8 6.8 4.4 6.4 5.0 2.9 7.3 2.6 1.8 1.1 5.5 14.0 2.9 2.7 4.6 4.2 1.9 1.7 2.9 1.4 2.3 1.8 1.4 3.4 2.3 3.6 1.5 3.3 2.1 1.4 2.1 3.9 3.4 1.3 3.2 1.7 1.9 6.2 0.5 1.9 3.0 2.7 1.3 6.1 2.4 6.0 9.8 5.9 4.3 1.6 2.9 3.6 1.3 2.0 1.2 3.3 5.5 3.3 3.1 8.3 2.8 1.4 2.0 2.9 4.2 5.1 3.3 4.1 1.2 0.3 1.8 2.1 5.3 2.2 4.9 1.5 2.6 6.4 2.8 4.5 4.8 2.3 6.7 6.4 5.2 4.2 3.6 6.8 6.2 7.3 3.1 2.9 5.0 4.4 5.6 2.6 6.3 7.4 18.2 10.1 7.5 7.0 6.8 7.3 6.2 7.8 3.0 2.4 0.0 0.7 0.3 8.1 2.8 0.0 5.3 2.3 1.8 2.0 1.8 3.3 1.5 35.2 2.2 1.0 0.0 1.5 1.2 1.1 0.6 4.7 0.9 0.9 11.1 0.0 3.1 0.6 11.0 3.7 0.5 0.0 0.0 1.5 4.0 1.1 0.0 1.1 1.6 8.5 0.0 0.9 10.2 3.9 0.4 1.3 0.8 1.2 0.1 ZNF597 "FLJ33071, HIT-4" ENSG00000167981 "Zinc finger protein 597" Q96LX8 16 3432422-3443542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 23.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 11.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001556 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA001556: AB_1080740" "unprognostic (1.98e-1)" "unprognostic (8.07e-2)" "unprognostic (1.03e-1)" "unprognostic (9.15e-3)" "unprognostic (2.88e-1)" "unprognostic (6.16e-2)" "unprognostic (1.84e-2)" "unprognostic (5.56e-2)" "unprognostic (3.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.34e-1)" "unprognostic (8.75e-3)" "unprognostic (4.73e-2)" "unprognostic (7.26e-2)" "unprognostic (4.58e-1)" "unprognostic (2.89e-1)" "unprognostic (5.99e-3)" 6.7 6.7 4.5 4.6 8.5 5.0 5.9 5.2 8.7 4.7 4.2 7.3 2.4 3.8 5.6 6.8 4.0 5.9 6.0 5.4 4.8 4.4 5.2 5.4 7.4 6.1 4.5 4.5 7.2 5.2 4.5 7.7 7.9 8.9 4.8 3.2 5.8 4.6 4.9 3.6 4.4 5.1 4.1 4.6 5.4 4.8 13.2 5.4 5.4 6.4 2.6 5.6 5.7 4.6 1.4 1.1 11.3 2.2 0.9 2.2 0.8 0.0 1.8 2.3 5.4 1.7 2.6 8.7 2.6 3.2 2.5 3.2 0.0 3.3 4.4 2.5 2.9 1.9 1.4 5.1 2.3 3.3 2.6 2.0 7.5 4.8 3.1 2.5 4.4 4.5 3.3 3.7 2.8 3.2 2.5 6.8 2.4 1.6 2.9 2.9 1.4 3.1 4.7 7.3 1.9 0.0 2.0 6.7 3.0 2.1 7.1 2.9 4.1 5.1 2.7 1.9 6.4 2.3 6.7 4.4 4.2 2.2 0.0 2.5 3.8 4.0 0.5 0.0 2.6 2.5 3.8 1.1 11.3 1.3 2.2 2.2 1.4 1.0 1.1 1.1 1.1 1.9 1.4 0.3 0.9 1.0 0.5 1.6 0.8 4.5 8.5 5.2 8.7 4.8 4.4 4.5 4.5 8.9 5.4 23.8 1.6 2.7 1.6 0.1 1.9 1.4 0.0 1.4 9.1 1.8 0.0 1.0 0.0 0.9 3.8 2.2 0.7 0.0 0.9 1.6 1.0 2.1 3.5 1.0 1.0 0.0 2.4 3.1 1.5 3.3 1.1 0.9 0.0 2.8 1.6 1.5 1.6 0.0 2.1 1.2 3.2 6.5 1.0 4.2 6.9 0.4 1.3 0.7 2.3 1.8 ZNF615 FLJ33710 ENSG00000197619 "Zinc finger protein 615" Q8N8J6 19 51991332-52008230 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA052422 Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA052422: AB_2681825" "unprognostic (2.20e-1)" "unprognostic (4.66e-2)" "unprognostic (4.56e-1)" "unprognostic (2.64e-1)" "unprognostic (4.08e-3)" "unprognostic (7.28e-2)" "unprognostic (5.23e-2)" "unprognostic (3.68e-1)" "unprognostic (4.44e-3)" "unprognostic (2.44e-2)" "unprognostic (4.41e-2)" "unprognostic (4.80e-2)" "unprognostic (1.77e-1)" "unprognostic (8.16e-3)" "unprognostic (3.03e-1)" "unprognostic (1.82e-1)" "prognostic favorable (2.98e-4)" 10.2 7.4 11.9 6.0 16.4 7.5 10.1 20.7 12.2 8.2 8.8 7.3 6.9 5.2 12.0 7.8 6.5 9.8 7.6 8.5 8.5 7.1 9.5 6.1 7.6 6.2 11.7 9.8 15.7 7.5 16.6 17.8 8.3 9.9 26.9 5.8 8.0 7.7 11.0 7.2 7.2 6.0 9.6 12.8 7.9 6.7 5.5 13.6 7.3 11.7 3.8 6.1 11.1 8.8 4.7 4.8 6.9 4.4 12.0 7.8 3.8 1.3 5.2 5.8 11.8 10.6 7.7 4.4 3.9 6.6 5.4 5.6 1.1 1.4 2.1 2.2 4.7 3.4 1.4 4.0 2.5 5.0 0.3 8.9 6.7 5.2 3.9 8.3 0.0 4.0 6.5 2.8 8.5 9.1 10.0 2.9 2.1 0.0 0.0 4.1 0.4 0.0 3.5 6.0 0.2 8.8 4.2 9.1 3.7 3.7 9.1 5.2 4.5 4.8 4.5 3.2 6.4 6.5 3.3 5.2 5.1 5.9 3.3 2.8 4.0 10.4 2.6 3.0 0.0 8.2 6.9 3.0 5.8 3.7 4.4 7.8 3.9 6.6 5.3 4.8 4.7 6.6 4.3 4.1 12.0 2.7 2.9 5.7 3.8 11.9 16.4 20.7 12.2 8.5 7.1 11.7 9.8 9.9 13.6 6.0 4.5 3.2 1.9 2.5 7.1 5.9 2.5 4.0 1.2 3.5 5.9 3.2 3.3 1.6 0.9 2.9 1.1 0.0 1.0 2.2 3.8 5.2 0.0 1.9 2.6 3.2 8.6 3.7 3.3 0.9 2.3 3.2 6.8 1.8 2.6 3.0 1.3 3.7 3.9 2.4 6.2 6.5 5.7 2.6 2.1 3.4 4.2 4.4 2.1 1.8 ZNF622 "MGC17552, MGC2485, ZPR9" ENSG00000173545 "Zinc finger protein 622" Q969S3 5 16451519-16465792 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036514, HPA036515" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Nucleoli" "HPA036514: AB_2675167, HPA036515: AB_10672224" "unprognostic (6.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.00e-2)" "unprognostic (6.53e-2)" "unprognostic (8.24e-3)" "unprognostic (4.71e-3)" "unprognostic (1.06e-1)" "unprognostic (1.71e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (8.69e-2)" "unprognostic (5.93e-2)" "unprognostic (2.19e-1)" "unprognostic (7.42e-2)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" 14.3 10.8 18.3 12.1 19.4 28.8 14.8 20.5 20.3 12.6 19.5 14.5 9.5 15.5 14.4 16.9 13.6 13.2 12.3 38.6 13.8 14.6 14.8 18.8 12.8 14.5 16.8 15.5 15.1 45.9 12.5 15.0 16.0 17.2 13.1 19.8 10.9 17.5 12.8 29.0 18.6 19.6 12.6 12.8 12.4 15.9 14.1 17.3 14.0 16.7 11.9 15.4 13.7 14.9 50.4 45.6 55.4 45.9 39.1 56.9 47.2 11.0 24.3 7.6 15.7 18.7 16.0 27.7 20.0 15.2 16.3 20.9 28.8 10.3 13.0 27.1 15.8 22.0 14.7 12.2 15.6 13.2 17.5 16.6 11.9 43.1 20.6 26.9 23.0 14.3 24.6 19.8 15.2 14.4 12.7 11.4 7.8 16.0 12.9 17.9 18.7 12.0 22.5 13.4 10.5 24.1 9.5 9.3 11.1 15.1 16.7 10.6 11.9 27.9 21.0 32.4 13.9 11.6 17.9 15.5 18.3 13.9 17.7 12.6 18.7 16.7 18.2 15.9 20.0 12.7 45.2 41.6 52.9 49.1 43.4 51.2 50.4 49.5 53.7 45.6 47.0 56.9 47.7 55.4 39.1 45.9 37.0 50.1 47.2 18.3 19.4 20.5 20.3 13.8 14.6 16.8 15.5 17.2 17.3 20.8 24.5 31.7 36.6 53.9 21.6 68.8 12.7 22.7 19.4 14.0 9.8 53.3 23.2 49.8 98.2 21.5 74.9 0.0 58.2 46.3 35.5 23.5 50.8 21.9 45.1 15.9 94.5 9.8 15.4 46.0 16.7 31.7 32.1 49.5 33.2 20.1 47.9 129.6 18.7 30.7 15.9 19.4 31.6 40.3 26.2 37.8 34.0 30.9 34.7 29.6 ZNF627 FLJ90365 ENSG00000198551 "Zinc finger protein 627" Q7L945 19 11559374-11619135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA049770, HPA073463" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA049770: AB_2680871, HPA073463: AB_2686606" "unprognostic (1.81e-1)" "unprognostic (9.89e-2)" "unprognostic (1.64e-2)" "unprognostic (3.14e-2)" "unprognostic (7.89e-3)" "prognostic favorable (8.12e-4)" "unprognostic (2.81e-1)" "unprognostic (1.00e-1)" "unprognostic (1.83e-3)" "unprognostic (3.17e-2)" "unprognostic (2.03e-1)" "unprognostic (1.67e-2)" "prognostic favorable (6.93e-7)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-1)" "unprognostic (6.39e-3)" 10.3 8.4 9.9 10.1 11.1 10.5 17.5 15.6 12.8 13.8 9.2 11.1 15.4 8.1 16.7 14.6 7.9 19.4 10.1 8.4 9.2 10.0 15.4 11.0 9.6 10.3 12.3 10.0 20.9 19.7 9.3 17.8 9.8 10.3 13.4 11.0 12.5 11.6 14.8 7.7 10.1 8.5 14.1 9.6 9.9 9.2 12.1 11.8 17.4 19.9 7.8 11.3 11.9 13.8 10.2 8.0 13.4 5.6 7.9 8.9 4.8 4.7 3.9 12.8 15.7 5.8 6.1 7.2 7.0 8.3 8.0 8.2 3.2 3.3 3.5 7.1 5.5 4.1 4.3 5.1 6.9 9.1 6.3 2.3 9.9 2.5 6.2 10.9 5.6 5.7 7.3 9.9 5.5 12.2 12.5 8.8 9.0 9.3 5.1 10.6 9.8 9.0 5.6 9.4 3.2 8.6 10.0 9.6 4.8 9.1 7.5 17.7 12.8 9.2 5.2 9.8 11.4 9.1 15.9 7.8 8.7 4.0 4.9 4.9 7.2 7.0 3.9 4.0 9.3 7.1 13.4 4.9 7.8 5.4 5.6 6.4 10.2 6.6 6.6 8.0 6.9 8.9 7.9 2.6 7.9 5.3 3.1 3.6 4.8 9.9 11.1 15.6 12.8 9.2 10.0 12.3 10.0 10.3 11.8 11.9 5.1 11.9 3.2 1.1 4.7 11.5 10.2 9.4 1.2 8.7 3.9 4.3 14.9 4.7 6.0 3.2 3.2 0.0 2.1 3.5 3.3 4.2 1.1 5.3 2.8 6.4 5.1 4.3 5.7 2.4 4.9 2.1 0.0 3.6 3.8 5.5 4.0 3.5 4.9 6.0 5.6 0.0 4.1 14.4 3.9 2.4 3.9 3.2 3.7 2.6 ZNF668 FLJ13479 ENSG00000167394 "Zinc finger protein 668" Q96K58 16 31060843-31074320 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043048 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA043048: AB_10962503" "unprognostic (2.71e-2)" "unprognostic (4.95e-2)" "unprognostic (6.42e-2)" "unprognostic (1.48e-1)" "unprognostic (3.27e-1)" "unprognostic (7.20e-3)" "unprognostic (6.73e-5)" "unprognostic (4.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-1)" "unprognostic (7.71e-3)" "prognostic unfavorable (6.24e-4)" "unprognostic (1.72e-3)" "unprognostic (2.00e-1)" "unprognostic (2.23e-1)" "unprognostic (4.83e-3)" "unprognostic (7.25e-2)" 7.1 8.2 8.2 8.9 10.0 18.5 5.9 11.1 15.4 8.3 10.2 6.6 5.1 11.8 9.4 5.6 8.0 6.1 9.6 5.1 8.6 7.4 5.9 6.9 7.3 8.6 7.6 5.2 5.7 10.6 4.6 6.7 10.1 9.2 8.1 4.2 4.9 7.2 7.6 12.6 9.0 10.3 9.5 6.5 8.6 8.8 10.0 6.1 16.9 5.4 8.8 7.5 6.6 6.5 5.6 7.3 8.6 4.8 8.4 13.9 5.4 3.6 12.6 2.8 7.0 3.0 3.1 9.7 10.4 7.6 5.2 4.4 5.7 5.1 5.9 8.4 6.1 3.3 6.7 1.9 5.6 1.3 7.5 8.2 3.6 7.8 9.1 3.7 5.7 9.1 3.8 2.3 9.0 1.8 1.7 3.8 6.5 6.8 3.7 9.5 12.4 12.0 12.3 10.1 2.6 10.7 16.0 21.3 8.6 2.8 8.1 9.9 11.7 6.6 9.3 3.2 1.1 7.1 8.3 6.4 13.1 5.4 9.9 4.5 6.2 10.2 8.3 8.7 6.0 8.4 7.6 4.8 8.6 13.9 4.7 9.2 5.6 4.1 8.4 7.3 4.4 4.5 5.6 1.7 8.4 3.8 3.9 4.3 5.4 8.2 10.0 11.1 15.4 8.6 7.4 7.6 5.2 9.2 6.1 0.0 5.1 2.2 2.6 7.4 2.9 0.5 5.1 1.4 2.3 0.0 0.0 5.4 6.6 8.2 31.1 3.1 6.3 0.0 4.1 9.5 6.0 2.2 4.6 1.8 6.0 11.1 4.6 3.7 3.2 12.7 5.8 4.4 3.3 4.6 3.8 4.8 6.4 4.2 14.2 4.7 1.9 0.0 2.5 2.9 13.3 7.8 5.8 6.4 4.7 1.7 ZNF678 MGC42493 ENSG00000181450 "Zinc finger protein 678" Q5SXM1 1 227563543-227677443 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA028507 Uncertain Approved Nucleoli,Mitochondria,Cytosol Yes No "Mitochondria, Cytosol" Nucleoli "HPA028507: AB_10603567" "unprognostic (1.76e-2)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (4.42e-3)" "unprognostic (3.92e-2)" "unprognostic (4.64e-2)" "unprognostic (1.59e-2)" "unprognostic (2.19e-2)" "unprognostic (2.50e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-6)" "unprognostic (1.39e-1)" "unprognostic (4.18e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-4)" 9.0 7.6 8.2 6.6 16.2 7.1 8.8 19.4 10.8 9.3 7.2 6.7 7.1 5.4 9.2 6.2 6.1 7.7 7.4 7.4 8.9 6.3 6.4 5.3 7.8 9.8 12.7 8.2 9.9 12.6 7.2 19.4 9.7 8.9 10.6 10.8 4.6 7.6 6.3 6.2 5.2 6.6 7.5 14.2 9.5 7.6 8.7 15.5 12.0 12.7 5.1 9.1 8.2 9.4 6.6 3.2 7.1 1.1 2.2 3.2 1.5 2.0 3.2 11.9 13.5 1.5 3.4 7.2 2.7 2.7 4.1 4.4 2.6 2.6 8.3 7.2 1.2 2.2 4.0 7.0 1.8 6.8 3.5 13.4 3.9 2.5 1.6 2.7 6.6 10.6 3.0 3.4 2.5 5.3 3.1 3.9 9.3 9.9 13.1 4.5 1.7 9.1 2.3 10.4 3.0 5.4 7.1 7.7 3.2 3.0 6.5 5.1 9.9 4.1 4.9 2.0 6.1 6.8 8.4 2.5 5.1 4.9 4.6 5.6 4.2 9.6 9.1 2.1 1.2 5.3 7.1 1.1 1.3 2.5 0.3 3.0 6.6 2.5 1.4 2.1 4.5 2.2 3.2 0.2 2.2 0.7 3.2 2.7 1.5 8.2 16.2 19.4 10.8 8.9 6.3 12.7 8.2 8.9 15.5 3.0 5.3 4.7 3.6 2.1 11.6 3.6 5.1 5.3 4.5 3.5 3.9 1.8 1.7 3.3 0.6 4.7 1.5 0.0 4.4 2.1 3.4 5.6 3.5 1.6 1.4 1.6 9.2 3.7 3.7 0.2 6.9 2.2 0.0 1.8 3.9 4.2 2.9 4.5 2.5 1.1 6.7 0.0 2.1 7.2 10.0 0.5 1.1 7.5 2.6 3.4 ZNF691 Zfp691 ENSG00000164011 "Zinc finger protein 691" Q5VV52 1 42846573-42852477 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062527 Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA062527: AB_2684791" "unprognostic (4.34e-2)" "unprognostic (4.05e-2)" "unprognostic (1.09e-1)" "unprognostic (4.32e-2)" "unprognostic (4.86e-2)" "unprognostic (5.50e-2)" "prognostic unfavorable (7.33e-6)" "unprognostic (1.40e-3)" "unprognostic (2.65e-3)" "unprognostic (5.12e-2)" "prognostic favorable (6.25e-5)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" 7.8 14.6 13.6 11.2 15.5 2.9 15.6 10.8 14.4 12.9 12.6 18.3 14.1 8.8 16.9 21.8 9.1 14.2 8.4 11.4 11.9 9.8 14.2 24.1 9.9 16.0 12.2 12.1 18.6 13.4 19.2 17.3 12.7 12.3 16.8 10.2 12.3 15.2 18.5 10.9 12.8 10.6 13.5 11.9 17.7 10.8 13.9 14.8 17.9 19.3 6.4 16.8 11.8 10.0 20.5 12.5 18.2 11.2 18.4 19.3 12.8 4.5 6.3 12.8 10.5 11.6 8.9 1.6 5.4 6.5 8.8 8.8 4.4 6.6 11.1 8.4 5.0 4.4 8.0 12.3 7.1 7.6 19.8 12.4 11.6 17.3 7.9 8.6 4.4 2.5 7.7 8.7 11.0 9.1 10.8 8.9 11.0 11.2 4.8 8.6 3.6 13.2 5.9 19.1 4.9 4.7 9.0 16.1 7.6 8.2 4.3 9.2 9.2 5.5 10.0 9.3 20.0 5.5 15.2 4.6 8.8 9.3 4.9 5.8 11.7 9.2 3.2 6.2 5.4 7.4 18.2 11.2 16.0 12.2 9.7 15.7 15.9 16.4 16.4 11.1 20.5 15.8 15.7 6.3 18.4 10.0 12.5 19.3 12.8 13.6 15.5 10.8 14.4 11.9 9.8 12.2 12.1 12.3 14.8 6.0 2.4 3.0 2.1 1.5 2.4 5.7 5.1 4.0 2.3 5.2 3.9 5.4 6.6 3.9 3.0 3.6 1.7 0.0 3.3 4.4 4.0 2.4 4.7 6.4 6.4 1.6 2.9 6.2 3.3 2.5 6.6 3.5 1.7 3.6 2.7 5.2 2.4 2.9 6.7 6.8 4.2 0.0 3.9 9.1 6.4 0.6 2.7 6.4 2.3 1.0 ZNF692 "AREBP, FLJ20531, Zfp692" ENSG00000171163 "Zinc finger protein 692" Q9BU19 1 248850006-248859144 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059337, HPA062792" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA059337: AB_2683984, HPA062792: AB_2684869" "unprognostic (4.86e-2)" "unprognostic (9.51e-2)" "unprognostic (1.64e-3)" "unprognostic (1.05e-2)" "unprognostic (1.90e-1)" "unprognostic (6.72e-3)" "unprognostic (2.85e-3)" "unprognostic (5.66e-3)" "unprognostic (1.25e-1)" "unprognostic (4.50e-2)" "prognostic favorable (4.09e-4)" "unprognostic (5.65e-3)" "prognostic unfavorable (7.72e-9)" "unprognostic (5.32e-2)" "unprognostic (2.07e-2)" "unprognostic (1.59e-1)" "prognostic favorable (8.35e-5)" 5.6 8.7 15.3 7.9 25.0 11.1 10.7 27.7 22.3 11.6 8.1 16.5 17.8 8.3 13.6 15.1 9.7 13.1 9.4 7.4 20.1 11.6 9.7 8.6 6.9 9.8 30.4 14.3 17.2 12.2 18.4 13.8 8.1 21.2 14.9 7.0 7.7 21.9 11.1 11.5 19.6 8.9 9.2 18.3 10.0 8.7 22.9 25.7 6.6 11.3 9.2 7.8 9.1 8.8 4.6 4.4 4.8 2.1 10.6 6.4 2.8 4.8 5.1 4.3 10.7 3.7 1.9 18.7 4.1 1.4 4.7 3.0 5.8 7.0 6.0 8.5 2.0 1.9 7.0 6.5 6.2 3.4 8.9 4.4 7.1 10.9 1.6 2.8 7.9 5.7 2.4 8.0 4.8 12.8 4.7 4.3 8.0 14.6 4.4 2.1 3.4 4.0 16.3 8.8 12.4 11.1 13.7 2.8 12.0 9.0 3.6 8.5 6.3 4.5 7.8 8.4 1.7 9.5 13.0 3.0 2.1 3.5 2.3 5.6 12.4 7.8 3.8 4.6 10.5 3.5 0.0 2.1 1.9 5.7 1.6 4.9 4.6 4.5 6.0 4.4 3.8 6.4 4.6 4.8 10.6 1.4 3.5 4.7 2.8 15.3 25.0 27.7 22.3 20.1 11.6 30.4 14.3 21.2 25.7 8.9 7.5 8.0 10.6 8.5 14.0 3.0 10.2 8.1 2.3 10.4 21.6 10.2 5.0 6.3 8.0 6.3 8.8 23.3 3.4 9.1 6.6 13.7 5.7 5.9 5.7 11.1 7.9 1.8 6.9 5.8 9.5 5.4 15.1 6.4 9.4 8.4 6.1 5.8 6.7 3.1 13.8 0.0 4.9 31.1 15.6 6.9 5.1 10.2 11.7 8.5 ZNF696 FLJ14129 ENSG00000185730 "Zinc finger protein 696" Q9H7X3 8 143289676-143298061 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057855, HPA072473" Uncertain Approved Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA057855: AB_2683545, HPA072473: AB_2686524" "unprognostic (3.23e-2)" "prognostic unfavorable (6.63e-5)" "unprognostic (3.62e-2)" "prognostic unfavorable (3.52e-5)" "unprognostic (2.58e-1)" "unprognostic (7.86e-2)" "unprognostic (2.76e-3)" "unprognostic (8.82e-2)" "unprognostic (3.16e-1)" "unprognostic (3.02e-1)" "prognostic favorable (1.41e-4)" "unprognostic (6.57e-2)" "unprognostic (8.22e-2)" "unprognostic (7.99e-2)" "unprognostic (2.86e-1)" "unprognostic (3.42e-3)" "unprognostic (8.09e-3)" 8.5 6.9 10.3 8.1 10.6 6.3 6.9 13.9 13.7 5.6 5.4 9.8 5.4 13.5 8.8 4.8 5.0 6.6 7.1 5.2 10.4 10.3 7.2 8.1 7.6 8.6 12.6 7.2 9.8 13.7 8.6 6.7 5.5 10.6 7.5 4.1 7.2 11.9 5.1 7.7 13.3 8.0 10.7 8.9 8.3 6.5 6.9 12.8 6.5 7.5 3.0 6.6 7.2 5.2 6.4 6.4 2.3 3.3 5.3 7.5 3.3 6.3 5.9 5.7 6.8 2.5 1.7 12.4 5.0 1.6 3.6 2.1 3.4 5.0 0.4 7.0 1.7 2.0 4.5 6.6 2.7 3.2 7.1 14.4 8.5 5.6 5.1 2.5 3.4 10.9 1.5 4.5 2.4 5.0 2.3 1.7 5.1 17.6 3.9 2.1 12.7 3.7 7.0 8.1 6.9 15.1 7.8 3.6 6.2 1.9 4.6 9.7 13.6 7.6 4.9 6.2 3.9 8.0 6.2 3.6 4.9 11.2 4.3 8.8 8.1 5.4 7.9 3.3 7.0 5.7 1.1 3.3 2.3 5.3 1.9 5.8 4.2 4.0 5.9 3.7 6.4 7.5 6.2 1.4 5.3 2.9 6.4 1.3 3.3 10.3 10.6 13.9 13.5 10.4 10.3 12.6 7.2 10.6 12.8 0.0 0.0 0.0 2.1 2.6 4.3 2.4 0.0 0.0 0.0 3.5 5.9 1.2 3.3 2.3 0.6 2.1 2.0 0.0 1.8 2.1 1.5 1.2 0.0 2.1 1.1 3.2 0.0 1.8 0.0 1.6 3.7 0.0 1.7 1.0 0.9 2.5 1.6 0.0 1.1 1.9 3.4 6.5 1.6 2.1 5.9 1.8 0.3 1.5 1.9 0.7 ZNF71 "Cos26, EZFIT" ENSG00000197951 "Zinc finger protein 71" Q9NQZ8 19 56595264-56626481 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 20.3" "Low region specificity" "Detected in all" HPA018124 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA018124: AB_1848339" "unprognostic (1.93e-2)" "unprognostic (7.95e-2)" "unprognostic (1.32e-1)" "unprognostic (1.96e-2)" "unprognostic (7.72e-2)" "unprognostic (5.03e-2)" "unprognostic (5.06e-3)" "unprognostic (1.27e-1)" "unprognostic (2.09e-1)" "unprognostic (1.39e-1)" "unprognostic (1.12e-3)" "unprognostic (1.90e-3)" "unprognostic (3.91e-2)" "unprognostic (4.34e-2)" "unprognostic (1.08e-1)" "unprognostic (2.05e-1)" "unprognostic (6.97e-3)" 11.8 6.4 12.9 6.9 8.7 3.5 11.7 12.0 12.5 7.9 9.9 10.2 6.5 6.7 12.3 6.6 8.6 8.7 7.0 10.5 9.3 8.0 6.4 3.4 9.6 10.6 7.7 10.2 12.3 8.8 7.6 8.5 8.0 9.3 8.7 5.0 6.4 8.9 10.5 10.6 7.4 6.0 16.6 8.5 10.2 7.0 8.7 8.2 9.8 7.5 5.9 6.2 10.0 10.7 7.0 4.9 6.8 4.2 9.0 8.3 4.2 3.4 6.6 9.8 8.1 4.1 3.6 6.3 4.0 3.8 2.8 4.0 1.2 1.0 2.9 3.7 3.4 3.3 1.2 2.2 3.1 2.4 0.0 20.3 4.4 0.9 2.6 3.4 5.5 4.3 4.1 3.3 2.8 1.8 4.3 4.5 7.3 2.6 0.0 3.0 0.0 11.3 2.1 7.6 0.0 6.5 4.2 6.1 2.4 2.0 3.9 8.7 10.6 2.8 3.7 4.0 4.0 2.1 5.7 5.9 9.4 5.3 2.2 6.4 2.8 3.5 4.5 3.1 3.3 2.5 2.9 3.2 6.8 7.7 2.0 8.3 6.5 6.4 7.3 4.9 7.0 7.2 7.4 1.3 9.0 4.2 3.7 6.6 4.2 12.9 8.7 12.0 12.5 9.3 8.0 7.7 10.2 9.3 8.2 3.0 1.7 2.2 2.5 2.6 7.8 3.2 2.5 0.0 1.2 7.0 3.9 4.5 3.3 8.7 2.2 6.0 0.7 0.0 4.3 5.2 5.3 1.9 0.0 0.6 5.1 11.1 2.4 3.1 1.6 3.1 5.8 3.9 3.3 5.4 1.7 3.2 5.5 2.3 5.3 4.6 7.7 0.0 4.1 2.1 8.0 3.8 1.3 5.4 2.4 1.0 ZNF713 FLJ39963 ENSG00000178665 "Zinc finger protein 713" Q8N859 7 55887475-55942225 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 13.4;Early spermatids: 14.3;Late spermatids: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 10.2" "Low region specificity" "Detected in all" "HPA059425, HPA062887" Uncertain Approved Nucleoli NA NA Nucleoli "HPA059425: AB_2684013, HPA062887: AB_2684894" "unprognostic (5.27e-2)" "unprognostic (2.50e-1)" "unprognostic (1.66e-1)" "unprognostic (4.97e-2)" "unprognostic (1.36e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-3)" "unprognostic (1.46e-1)" "unprognostic (7.07e-2)" "unprognostic (4.63e-2)" "unprognostic (2.77e-3)" "unprognostic (7.78e-2)" "unprognostic (4.80e-2)" "unprognostic (8.00e-2)" "unprognostic (8.16e-3)" "unprognostic (1.34e-1)" "unprognostic (1.63e-3)" 2.0 2.7 7.0 2.6 9.7 4.1 4.0 5.6 9.3 3.8 2.2 10.6 2.7 2.7 5.5 3.5 1.7 7.1 2.9 2.4 7.8 6.1 3.9 1.7 2.6 1.7 13.4 4.8 5.6 3.2 4.2 8.1 2.2 7.3 4.1 1.9 2.6 2.4 2.9 4.7 3.1 1.9 3.7 9.8 2.5 4.0 9.4 10.6 6.9 4.9 0.4 1.8 2.1 2.0 2.2 1.7 6.9 1.3 1.4 1.0 0.4 1.8 1.2 7.4 6.7 0.9 1.0 2.6 0.8 0.5 1.0 1.4 0.7 2.4 3.1 2.7 0.6 2.1 0.7 1.8 0.6 1.4 1.7 2.9 0.7 2.5 1.9 1.2 3.7 2.0 1.7 1.5 0.5 1.4 1.7 1.8 3.4 2.0 1.4 1.2 1.6 3.7 2.2 5.0 1.9 1.4 3.1 1.8 0.4 3.6 3.3 8.6 10.2 4.3 1.2 1.2 4.1 2.8 3.3 1.9 0.9 3.6 0.7 1.2 1.6 2.2 1.4 0.6 2.1 6.3 3.7 1.3 3.3 0.9 1.0 0.6 1.3 0.7 0.6 0.4 2.2 0.9 1.0 6.9 1.4 1.0 1.7 0.4 0.4 7.0 9.7 5.6 9.3 7.8 6.1 13.4 4.8 7.3 10.6 0.0 3.0 0.0 2.8 1.1 2.8 1.5 5.1 13.4 4.5 0.0 9.8 1.0 0.0 1.0 14.3 1.4 0.3 0.0 1.2 1.0 1.4 1.6 1.1 0.0 0.4 7.9 0.0 1.3 2.1 12.1 0.6 1.8 0.0 0.0 1.0 5.8 1.3 0.0 2.5 0.5 2.7 6.5 1.4 6.0 6.1 1.6 1.7 1.3 0.9 2.2 ZNF77 pT1 ENSG00000175691 "Zinc finger protein 77" Q15935 19 2933218-2944971 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023397 Uncertain Approved Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "HPA023397: AB_1859447" "unprognostic (1.17e-2)" "prognostic favorable (8.49e-4)" "unprognostic (2.18e-1)" "prognostic favorable (6.65e-5)" "unprognostic (2.01e-3)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "prognostic favorable (6.79e-6)" "unprognostic (2.06e-1)" "unprognostic (5.03e-2)" "unprognostic (3.93e-3)" "unprognostic (2.65e-3)" "unprognostic (3.20e-3)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (1.84e-2)" "unprognostic (1.79e-3)" 6.3 6.6 6.6 5.4 8.9 5.6 13.2 18.2 9.8 8.4 6.1 8.4 9.9 4.1 8.5 8.5 7.5 7.3 4.2 7.4 5.9 5.8 6.4 6.3 12.7 6.6 7.0 7.8 9.7 8.2 8.2 8.2 8.2 6.5 6.9 6.4 8.9 11.4 6.7 6.1 8.3 6.1 8.7 5.5 6.8 8.1 8.3 4.3 9.6 8.8 4.0 9.3 6.4 6.7 5.5 3.7 1.3 3.1 3.9 6.2 3.3 4.7 2.2 10.8 6.3 2.3 3.0 4.9 2.9 4.3 5.8 6.9 7.3 1.9 5.3 2.4 3.2 3.2 3.8 7.0 4.7 9.8 0.4 5.1 6.4 3.4 8.1 5.7 0.2 5.3 4.6 6.5 4.5 6.7 7.2 8.0 10.5 8.4 0.0 3.9 5.2 7.8 4.6 2.4 4.1 3.1 8.9 8.3 3.7 4.6 7.4 4.4 8.3 4.4 4.2 5.0 5.5 4.0 11.1 3.8 2.4 3.1 6.8 5.2 5.5 5.3 2.5 6.2 0.1 4.4 0.0 2.7 1.3 5.5 2.6 6.2 5.5 5.8 5.9 3.7 5.3 4.5 6.2 0.2 3.9 3.1 3.0 2.8 3.3 6.6 8.9 18.2 9.8 5.9 5.8 7.0 7.8 6.5 4.3 3.0 3.8 0.0 4.2 10.3 2.8 2.0 0.0 2.7 4.5 1.8 2.0 2.9 0.0 1.8 1.6 2.1 1.3 0.0 1.5 2.6 2.2 2.0 2.3 1.5 1.5 0.0 6.9 3.1 0.6 0.0 2.6 1.6 1.7 0.0 2.2 3.0 2.0 1.9 1.4 1.0 5.5 0.0 2.1 10.0 7.3 9.5 5.1 1.9 3.1 1.8 ZNF771 DSC43 ENSG00000179965 "Zinc finger protein 771" Q7L3S4 16 30407297-30431108 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 27.0;REH: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030730, HPA046672, HPA059398" Uncertain Enhanced Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA030730: AB_2673583, HPA046672: AB_2679745, HPA059398: AB_2684002" "unprognostic (8.21e-2)" "unprognostic (1.61e-1)" "unprognostic (9.21e-2)" "unprognostic (2.41e-1)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-2)" "unprognostic (3.12e-5)" "unprognostic (3.53e-2)" "unprognostic (3.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.38e-1)" "unprognostic (2.57e-1)" "unprognostic (9.99e-3)" 6.6 6.7 15.3 5.0 14.5 4.0 5.3 10.7 18.3 6.6 6.1 4.9 6.6 4.5 10.4 7.2 4.6 7.5 6.1 4.6 13.4 10.6 9.2 8.6 4.1 3.3 8.8 16.9 10.8 7.3 8.1 6.2 2.4 8.8 10.1 5.4 4.0 4.9 12.3 18.2 6.1 4.3 9.6 5.1 3.6 4.8 3.7 8.1 1.9 5.4 3.5 4.2 6.8 5.6 6.6 3.7 1.9 2.5 1.8 6.2 2.7 3.1 3.6 5.0 4.1 7.2 3.0 3.8 4.7 2.3 3.0 3.1 1.6 1.6 3.8 8.0 2.3 3.7 2.4 5.2 2.1 3.1 1.3 27.0 3.2 2.4 4.8 3.7 1.6 3.8 4.6 1.6 3.7 2.3 3.1 3.0 4.0 7.7 2.3 2.5 5.7 3.8 5.2 4.0 1.9 2.9 17.3 3.7 2.4 1.7 1.3 7.9 5.0 2.5 2.2 3.0 2.7 2.9 1.8 2.7 5.0 6.0 2.9 3.3 3.5 3.7 1.9 3.3 3.5 3.2 1.0 1.1 0.7 3.6 2.5 4.9 2.7 4.3 4.2 2.8 6.6 6.2 3.7 1.9 1.8 0.5 3.7 4.4 2.7 15.3 14.5 10.7 18.3 13.4 10.6 8.8 16.9 8.8 8.1 3.0 0.3 2.2 10.4 4.5 11.2 6.3 15.3 0.0 1.2 5.2 9.8 4.8 28.2 6.4 1.3 5.8 5.3 0.0 3.7 2.6 9.4 8.8 1.1 16.3 2.9 11.1 4.1 14.7 0.6 1.5 23.3 2.8 5.0 1.0 8.1 15.1 3.6 4.2 28.0 23.6 7.1 12.9 8.9 1.1 1.6 5.8 3.0 3.9 9.8 3.4 ZNF787 ENSG00000142409 "Zinc finger protein 787" 19 56087366-56121280 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 52.1;Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035140 Supported Approved Nucleoplasm,Nucleoli,Mitochondria NA NA Nucleoplasm "Nucleoli, Mitochondria" "HPA035140: AB_10602358" "unprognostic (1.97e-2)" "unprognostic (5.86e-2)" "unprognostic (8.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.54e-1)" "unprognostic (4.83e-2)" "unprognostic (1.26e-1)" "unprognostic (1.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.86e-1)" "unprognostic (1.10e-1)" "unprognostic (1.96e-3)" 7.4 8.0 4.3 7.8 5.2 18.8 7.1 4.7 7.0 8.0 9.8 5.1 8.5 12.8 5.8 6.5 9.8 8.7 8.7 10.2 4.0 4.3 6.4 18.0 6.9 7.7 4.8 4.0 8.7 13.9 3.3 6.6 4.8 4.6 10.0 3.9 7.9 9.6 7.2 28.2 9.3 10.5 6.8 3.1 14.9 11.0 6.8 4.6 4.8 10.0 8.2 5.7 8.7 10.1 3.0 5.5 4.9 2.1 1.2 1.6 0.7 12.0 11.9 3.9 8.1 1.1 2.5 10.1 6.2 2.4 4.3 4.8 7.0 7.5 8.6 0.4 2.6 3.8 9.5 2.4 5.0 1.9 11.4 43.9 13.7 6.0 10.5 6.3 13.1 12.0 3.3 5.0 3.5 6.2 2.6 3.1 4.9 16.3 9.7 2.5 7.6 8.1 16.5 12.3 11.1 22.4 10.2 5.7 10.9 4.3 8.0 14.9 14.4 6.6 13.0 11.5 2.3 8.0 18.6 6.7 16.1 11.5 6.7 17.1 20.6 15.1 8.3 9.3 8.8 7.5 1.7 2.1 2.6 1.2 1.5 1.6 2.3 0.8 1.0 2.2 3.0 1.3 0.7 4.9 1.2 1.4 5.5 1.3 0.7 4.3 5.2 4.7 7.0 4.0 4.3 4.8 4.0 4.6 4.6 11.9 2.4 6.7 8.9 5.5 52.1 9.0 12.7 0.0 4.5 10.4 104.1 2.9 1.7 5.9 1.5 6.7 15.4 0.0 14.2 4.0 5.0 8.6 5.7 28.4 7.5 33.4 8.7 12.9 6.5 2.9 4.6 6.8 1.7 4.6 17.1 29.5 12.9 15.3 4.2 3.7 60.0 6.5 6.2 2.5 7.9 6.4 1.6 3.2 16.9 11.7 ZNF790 "FLJ20350, MGC62100" ENSG00000197863 "Zinc finger protein 790" Q6PG37 19 36817428-36850787 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 72.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA056134, HPA060288" Uncertain Approved Nucleoli NA NA Nucleoli "HPA056134: AB_2683049, HPA060288: AB_2797260" "unprognostic (1.14e-1)" "unprognostic (3.79e-2)" "unprognostic (3.87e-1)" "prognostic unfavorable (7.66e-4)" "unprognostic (1.55e-1)" "unprognostic (5.10e-2)" "unprognostic (1.05e-1)" "unprognostic (1.03e-2)" "unprognostic (5.07e-2)" "unprognostic (4.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.58e-2)" "unprognostic (1.48e-2)" "unprognostic (5.54e-2)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" "unprognostic (2.85e-2)" 6.6 8.9 9.3 9.9 15.9 3.2 7.2 21.5 14.8 7.6 6.4 12.5 7.1 6.4 7.7 7.7 7.5 6.1 8.1 8.8 10.8 7.9 10.3 13.8 6.1 7.9 14.2 7.2 7.8 7.3 11.6 14.5 6.0 13.1 6.8 4.5 7.4 5.7 7.3 7.3 15.6 6.1 6.1 11.4 7.4 7.9 20.4 15.9 8.5 13.2 4.9 6.8 7.7 7.9 9.7 6.8 6.8 6.2 6.7 9.0 3.0 0.0 0.7 6.4 11.6 4.5 4.8 4.1 4.5 6.1 3.6 6.5 0.0 1.4 1.4 9.1 3.3 4.5 1.7 5.0 4.1 3.3 10.4 4.5 7.4 0.7 1.7 3.8 3.3 5.6 6.1 3.4 3.1 0.0 4.3 6.1 5.8 0.2 0.1 8.0 3.5 8.4 2.6 4.3 0.0 0.8 1.5 5.3 5.6 3.9 8.4 8.0 7.3 4.2 0.1 2.5 7.6 5.2 6.2 6.7 5.0 3.8 4.5 5.9 9.1 12.7 5.2 0.0 0.2 4.0 6.0 3.7 6.8 5.9 6.2 6.1 9.0 8.4 8.3 6.8 9.7 9.0 7.4 1.3 6.7 2.2 5.6 6.8 3.0 9.3 15.9 21.5 14.8 10.8 7.9 14.2 7.2 13.1 15.9 3.0 0.6 5.9 3.0 1.5 23.7 3.4 7.6 1.4 1.2 7.0 29.5 5.5 5.0 4.1 72.8 6.6 5.1 0.0 4.5 3.0 3.3 3.0 4.6 5.5 3.7 11.1 2.4 5.5 3.7 24.9 7.8 3.2 3.3 4.6 2.7 10.1 3.8 3.1 4.6 8.1 25.0 0.0 5.0 5.6 1.6 3.6 4.9 7.5 2.3 7.2 ZNF793 ENSG00000188227 "Zinc finger protein 793" Q6ZN11 19 37506939-37548762 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 29.5;Early spermatids: 32.2;Horizontal cells: 46.1;Rod photoreceptor cells: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.5;RT4: 9.8;U-266/70: 17.0;U-266/84: 11.3" HPA034781 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA034781: AB_10602784" "unprognostic (4.80e-2)" "unprognostic (4.70e-2)" "unprognostic (3.26e-1)" "unprognostic (7.13e-2)" "unprognostic (4.08e-2)" "unprognostic (5.72e-2)" "unprognostic (1.05e-2)" "unprognostic (3.80e-2)" "unprognostic (2.22e-1)" "unprognostic (2.69e-3)" "unprognostic (4.16e-3)" "unprognostic (1.03e-4)" "unprognostic (4.94e-3)" "unprognostic (1.38e-1)" "unprognostic (4.62e-1)" "unprognostic (1.24e-2)" "unprognostic (8.12e-3)" 3.1 7.7 12.5 4.9 11.9 2.1 6.4 22.1 14.0 6.4 4.2 12.8 4.6 3.0 9.3 6.9 5.2 6.7 4.6 6.8 10.3 8.0 6.2 1.1 3.3 5.6 8.3 10.0 14.1 4.0 15.7 18.4 4.5 11.2 7.5 6.0 8.1 3.6 5.8 3.7 10.7 3.6 6.1 10.1 5.6 5.3 12.3 9.6 2.1 11.0 3.2 4.9 4.9 5.7 4.0 2.1 7.2 1.6 4.0 2.8 1.4 0.1 0.2 4.2 11.5 0.9 0.9 0.2 3.3 0.2 0.7 0.3 0.2 1.3 2.9 5.5 1.7 1.0 0.4 0.3 2.9 0.3 0.8 4.2 0.3 0.4 0.3 2.1 0.2 2.6 3.4 2.6 0.6 0.1 0.3 0.1 0.3 0.1 0.5 0.5 3.2 0.3 0.4 6.9 0.0 0.3 0.1 0.1 0.6 2.9 9.8 3.1 6.7 0.2 0.2 0.0 8.1 6.4 0.3 0.4 0.1 1.8 0.3 3.3 17.0 11.3 0.3 0.0 0.2 0.5 7.2 1.6 1.2 1.5 0.6 2.3 2.0 2.8 2.5 1.2 4.0 1.9 2.4 4.2 4.0 0.6 2.1 2.2 1.4 12.5 11.9 22.1 14.0 10.3 8.0 8.3 10.0 11.2 9.6 3.0 7.2 0.8 3.4 3.0 28.0 7.3 12.7 6.7 5.7 12.2 29.5 4.8 3.3 3.1 32.2 6.3 1.4 0.0 1.3 3.6 3.1 2.6 2.3 0.4 0.8 46.1 8.6 6.2 0.0 7.7 4.6 2.0 0.0 1.8 3.4 16.2 1.6 0.0 9.6 1.5 33.5 0.0 5.1 5.4 6.4 2.9 1.6 4.3 3.4 1.4 ZNF800 ENSG00000048405 "Zinc finger protein 800" Q2TB10 7 127346790-127431924 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023090, HPA052194" Approved Supported "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA023090: AB_1859457, HPA052194: AB_2681757" "unprognostic (2.93e-2)" "unprognostic (1.10e-1)" "unprognostic (2.27e-1)" "unprognostic (3.34e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-2)" "unprognostic (6.19e-2)" "unprognostic (2.45e-2)" "unprognostic (1.23e-3)" "unprognostic (1.37e-1)" "unprognostic (9.43e-2)" "unprognostic (8.99e-2)" "unprognostic (7.04e-2)" "unprognostic (1.32e-1)" "unprognostic (1.08e-1)" "unprognostic (2.53e-2)" "unprognostic (8.96e-3)" 17.5 11.2 10.8 14.4 11.7 61.7 18.7 18.6 12.7 11.9 11.9 6.3 12.8 10.3 14.6 10.4 15.4 13.5 11.6 9.5 10.2 5.9 8.9 14.4 16.5 20.7 13.5 9.2 15.2 15.3 16.2 18.6 10.8 12.6 10.5 10.5 7.1 15.1 16.1 14.9 22.7 14.8 11.5 15.7 15.2 13.1 19.1 12.8 22.4 12.7 10.9 13.8 14.4 15.5 14.2 12.0 16.9 6.8 18.9 17.2 5.9 9.1 4.8 5.7 9.8 8.2 11.0 5.4 8.9 10.5 9.2 8.9 4.4 8.8 15.6 5.5 8.4 9.9 6.7 9.2 9.5 12.7 13.7 5.4 10.0 4.9 4.1 10.3 13.7 19.3 9.3 8.8 10.1 13.7 7.7 9.7 9.7 12.4 16.1 9.9 7.0 15.2 9.9 4.7 8.5 6.4 9.5 7.9 10.3 6.7 11.6 8.1 8.5 8.8 34.9 11.3 8.1 4.1 9.4 10.4 15.5 4.9 10.2 10.4 19.4 8.5 22.6 11.5 12.5 12.8 16.9 6.8 10.1 13.3 6.3 14.0 12.0 10.0 13.5 7.0 14.2 16.4 17.2 6.0 18.9 6.6 12.0 13.8 5.9 10.8 11.7 18.6 12.7 10.2 5.9 13.5 9.2 12.6 12.8 35.7 19.7 27.4 41.3 39.8 25.9 12.6 15.3 16.0 21.6 12.2 21.6 9.7 10.0 20.7 27.0 23.3 24.9 23.3 16.7 8.6 17.5 40.1 28.8 12.9 12.9 73.1 15.5 23.4 26.2 8.6 25.0 26.7 27.0 27.9 22.6 16.6 19.9 25.9 29.7 10.5 26.1 25.8 25.8 97.4 48.6 41.9 18.4 33.8 20.0 57.6 ZNF837 ENSG00000152475 "Zinc finger protein 837" Q96EG3 19 58367618-58381060 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 13.4" HPA042833 Uncertain Approved Nucleoli NA NA Nucleoli "HPA042833: AB_10806373" "unprognostic (2.61e-1)" "unprognostic (7.62e-2)" "unprognostic (1.33e-1)" "prognostic favorable (1.27e-4)" "unprognostic (1.07e-1)" "unprognostic (7.33e-3)" "unprognostic (1.02e-2)" "unprognostic (2.75e-1)" "unprognostic (9.06e-2)" "unprognostic (1.92e-2)" "unprognostic (2.37e-3)" "unprognostic (6.02e-2)" "prognostic favorable (1.76e-5)" "unprognostic (2.35e-3)" "unprognostic (9.74e-2)" "unprognostic (1.90e-2)" "unprognostic (1.07e-2)" 3.7 3.3 4.2 2.2 5.4 1.1 2.3 1.0 6.1 3.1 2.5 2.9 1.2 4.6 3.6 4.4 3.1 5.2 3.0 1.4 2.0 1.7 5.3 10.8 3.7 2.1 1.6 0.9 4.3 5.1 2.7 4.1 3.7 2.1 3.8 1.0 2.9 4.6 2.5 1.3 5.7 6.1 1.1 1.4 4.7 4.9 2.6 1.2 9.4 7.1 1.3 5.1 2.3 2.2 0.9 0.5 0.1 0.3 0.0 1.7 0.4 2.0 1.0 1.3 1.5 0.2 0.5 2.3 2.0 0.4 0.1 0.2 0.5 2.1 2.5 1.8 0.0 0.8 0.6 0.1 0.1 0.1 1.3 13.4 1.1 0.3 0.1 0.5 0.8 0.7 0.8 0.4 0.2 0.1 0.5 0.2 3.2 1.5 0.7 0.2 2.7 5.8 2.3 3.5 0.8 3.4 5.0 0.6 2.4 0.3 1.5 4.0 5.2 1.5 1.3 2.3 0.2 1.6 1.1 0.5 3.0 0.1 0.8 0.7 3.2 2.4 2.2 1.9 0.4 0.8 0.0 0.3 0.0 1.3 0.0 1.4 0.5 1.6 0.0 0.4 0.9 1.7 0.2 0.1 0.0 0.0 0.5 0.7 0.4 4.2 5.4 1.0 6.1 2.0 1.7 1.6 0.9 2.1 1.2 3.0 2.6 5.2 0.8 0.8 1.3 1.3 0.0 0.0 1.2 3.5 0.0 1.5 6.6 3.7 3.7 1.0 2.6 0.0 4.6 0.9 0.8 1.8 0.0 3.4 0.9 1.6 1.2 2.5 0.3 0.4 1.7 0.1 3.3 4.6 2.6 2.0 2.5 3.1 1.1 4.4 0.5 0.0 1.9 2.1 5.9 1.5 1.8 0.8 2.1 0.9 ZNF853 DKFZp434J1015 ENSG00000236609 "Zinc finger protein 853" P0CG23 7 6615617-6624290 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 28.9" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 13.0;Muller glia cells: 10.9;Rod photoreceptor cells: 9.1;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 3.1" "Group enriched" "Detected in many" 5 "granulocytes: 3.1;NK-cells: 1.1;T-cells: 1.5" "Cell line enhanced" "Detected in many" "AN3-CA: 14.8;SH-SY5Y: 22.1;U-2 OS: 14.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067690 Approved Approved Nucleoli NA NA Nucleoli "HPA067690: AB_2685888" "unprognostic (1.35e-3)" "unprognostic (2.63e-1)" "unprognostic (7.17e-2)" "unprognostic (8.77e-2)" "unprognostic (2.76e-1)" "unprognostic (1.96e-1)" "unprognostic (1.17e-1)" "unprognostic (3.54e-1)" "unprognostic (2.26e-2)" "unprognostic (5.06e-2)" "unprognostic (1.87e-3)" "unprognostic (9.28e-2)" "prognostic favorable (2.30e-6)" "unprognostic (4.41e-3)" "unprognostic (4.95e-2)" "unprognostic (2.30e-3)" "unprognostic (4.01e-2)" 3.7 3.9 16.6 2.9 14.4 1.0 4.6 4.5 13.5 7.8 7.7 10.4 2.8 1.8 9.4 5.9 5.6 11.8 5.8 12.3 16.1 15.5 3.3 0.9 4.5 4.3 14.8 9.1 15.6 10.6 7.3 4.5 3.7 11.9 7.6 2.5 6.0 6.7 11.5 28.9 2.4 2.7 8.5 10.1 4.3 3.6 3.0 9.9 2.6 9.9 2.7 2.7 6.5 11.7 0.3 0.4 3.1 0.0 1.1 1.5 0.3 0.0 1.2 3.5 14.8 0.1 0.0 0.1 0.3 0.0 1.6 0.3 2.6 0.6 0.0 5.8 0.0 0.5 0.0 5.3 0.1 1.5 0.0 1.9 0.4 0.0 2.7 2.1 0.0 0.1 0.5 0.5 0.2 0.0 1.5 0.0 1.2 2.2 0.0 0.9 0.1 0.3 1.9 5.5 0.0 0.0 1.6 5.8 0.1 1.1 5.5 4.7 22.1 0.0 0.2 0.9 3.0 0.8 3.1 0.0 1.1 14.8 0.0 1.3 0.3 0.1 0.0 0.0 0.0 5.7 0.0 0.0 3.1 1.2 0.0 1.5 0.3 0.8 1.4 0.0 0.3 0.2 1.4 0.0 1.1 0.0 0.4 0.0 0.3 16.6 14.4 4.5 12.4 16.1 15.5 14.8 9.1 11.9 9.9 0.0 0.0 0.0 1.5 0.5 13.0 8.5 0.0 4.0 1.2 7.0 5.9 0.0 0.0 0.5 1.5 1.5 0.0 0.0 0.6 0.0 2.3 1.1 0.0 0.0 0.1 4.8 1.7 1.8 0.0 1.7 4.9 0.0 3.3 0.0 0.0 10.9 0.4 0.0 8.1 0.2 9.1 12.9 1.4 0.5 0.7 0.3 0.2 0.8 0.0 0.7 ZNF860 ENSG00000197385 "Zinc finger protein 860" A6NHJ4 3 31981771-31991628 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.2" "Cell type enhanced" "Detected in some" 9 "B-cells: 3.4;Ciliated cells: 6.7;Club cells: 4.5;Intestinal endocrine cells: 3.4;Syncytiotrophoblasts: 3.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 61 "memory B-cell: 9.1;naive B-cell: 6.4" "Lineage enriched" "Detected in single" 71 "B-cells: 9.1" "Cell line enriched" "Detected in many" 4 "BEWO: 31.9" HPA063386 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA063386: AB_2684999" "unprognostic (1.19e-1)" "unprognostic (2.46e-2)" "unprognostic (2.88e-1)" "unprognostic (1.64e-2)" "unprognostic (1.51e-1)" "unprognostic (8.01e-2)" "unprognostic (1.23e-2)" "unprognostic (1.94e-2)" "unprognostic (3.15e-1)" "unprognostic (4.15e-3)" "unprognostic (1.51e-2)" "unprognostic (6.38e-2)" "unprognostic (1.30e-4)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.74e-2)" "unprognostic (3.75e-3)" 2.0 1.0 0.7 11.2 1.0 0.1 2.8 0.8 1.5 4.3 1.1 0.0 1.7 0.3 4.1 4.9 6.2 1.9 3.6 1.3 0.6 1.6 7.2 0.4 3.7 8.3 1.6 0.6 1.8 0.6 0.1 5.5 8.1 1.1 6.0 1.6 1.6 5.6 2.6 0.4 2.3 3.7 6.7 0.5 9.6 1.1 2.2 0.0 0.5 1.8 4.2 20.2 6.4 3.6 9.1 0.0 0.1 0.0 0.0 0.0 0.2 2.1 0.7 0.0 1.6 0.0 0.0 31.9 0.2 0.1 0.2 0.2 2.1 2.5 2.3 2.3 0.0 1.0 1.9 0.7 3.1 0.2 0.0 0.3 0.0 3.2 1.0 0.0 0.0 0.0 0.1 1.4 0.2 6.1 0.2 0.6 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.8 5.6 3.4 0.0 0.0 0.1 7.2 0.9 0.2 0.0 0.5 3.8 0.0 1.6 2.9 0.0 1.2 0.2 2.6 0.0 0.2 0.0 0.0 3.6 0.3 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 1.0 0.8 1.5 0.6 1.6 1.6 0.6 1.1 0.0 0.0 0.0 3.4 0.4 0.8 0.2 0.6 0.0 6.7 4.5 0.0 0.0 1.4 0.0 0.0 0.0 1.1 0.0 0.0 0.5 3.0 0.5 0.9 0.0 0.0 0.3 0.0 3.4 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.4 1.1 0.0 0.0 0.3 0.1 0.1 0.3 3.5 0.0 0.3 0.6 ZNF865 ENSG00000261221 "Zinc finger protein 865" P0CJ78 19 55605405-55617269 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.2" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068079 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA068079: AB_2685947" "unprognostic (3.98e-3)" "unprognostic (2.46e-1)" "unprognostic (4.72e-3)" "unprognostic (8.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.20e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "unprognostic (1.16e-1)" "unprognostic (2.30e-2)" "unprognostic (1.05e-2)" "unprognostic (8.85e-2)" "unprognostic (1.40e-2)" "unprognostic (3.62e-2)" "unprognostic (2.12e-1)" "unprognostic (1.54e-1)" "unprognostic (9.41e-3)" 12.1 7.5 8.3 11.0 10.5 11.1 8.2 12.3 15.1 8.0 10.0 9.7 6.6 11.0 11.5 6.8 6.2 8.7 7.0 12.2 7.3 5.8 8.3 6.7 8.7 13.3 7.4 8.5 10.3 11.2 9.9 9.5 6.1 7.4 9.9 4.8 8.1 12.1 7.7 56.2 11.1 10.4 7.4 7.3 16.0 12.2 4.7 7.9 14.0 9.5 8.0 9.1 9.3 9.9 1.2 0.5 1.4 0.1 0.1 0.6 0.1 6.4 5.3 2.3 3.7 2.5 1.9 6.3 4.6 2.6 2.5 2.4 1.7 4.2 7.5 5.4 3.4 1.3 5.4 1.4 2.8 1.0 7.4 17.6 4.3 3.2 2.2 4.0 4.9 8.4 2.9 4.5 3.1 1.9 2.3 1.7 4.7 8.2 5.1 1.6 3.0 7.7 5.3 5.2 3.7 9.2 12.0 3.6 4.7 2.9 4.4 5.5 8.9 6.4 3.9 3.9 1.2 3.1 7.7 5.0 3.9 9.3 3.5 5.8 10.8 9.3 3.9 4.8 3.8 6.2 0.0 0.0 1.4 0.3 0.1 0.2 1.2 0.2 0.1 0.1 0.2 0.1 0.6 0.8 0.1 0.1 0.5 0.0 0.1 8.3 10.5 12.3 15.1 7.3 5.8 7.4 8.5 7.4 7.9 0.0 0.0 1.9 1.0 3.7 3.7 18.6 2.5 0.0 0.0 14.0 0.0 2.1 5.0 3.1 1.9 5.2 5.2 0.0 3.8 2.7 3.8 1.2 0.0 5.4 4.0 9.5 5.8 6.7 5.4 3.2 4.9 4.2 5.0 1.8 6.3 3.9 4.7 0.0 9.6 3.6 3.2 6.5 4.1 1.2 1.4 3.8 2.2 4.8 5.7 0.9 ZNF878 ENSG00000257446 "Zinc finger protein 878" C9JN71 19 12043805-12052939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Cytotrophoblasts: 1.1;Spermatogonia: 1.5;Syncytiotrophoblasts: 1.0" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 6.4" HPA052735 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA052735: AB_2681932" "unprognostic (3.27e-2)" "unprognostic (1.76e-1)" "unprognostic (2.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.79e-2)" "unprognostic (1.56e-2)" "unprognostic (3.00e-4)" "unprognostic (1.42e-1)" "unprognostic (7.43e-3)" "unprognostic (2.80e-1)" "unprognostic (6.67e-2)" "unprognostic (8.75e-2)" "unprognostic (3.02e-1)" "unprognostic (7.65e-3)" "unprognostic (6.82e-2)" "unprognostic (4.04e-1)" "unprognostic (3.62e-2)" 1.1 1.4 0.4 1.5 3.1 5.8 0.8 2.5 2.4 1.5 1.2 0.4 0.0 0.6 1.8 1.2 1.4 1.2 1.4 0.7 1.9 0.5 7.7 2.5 1.5 1.4 4.4 0.3 2.4 5.0 0.8 2.4 5.1 7.4 1.4 1.2 0.4 3.2 0.3 0.5 1.0 1.3 1.4 1.9 1.3 1.2 4.6 2.2 1.7 1.4 0.0 1.3 1.2 1.7 0.3 0.1 0.5 0.0 1.5 0.5 0.1 3.0 0.0 1.7 6.4 0.1 0.0 3.8 1.0 0.5 1.3 1.7 2.5 0.4 1.4 1.5 0.4 1.8 0.8 0.6 0.9 1.2 0.0 0.9 1.8 0.0 3.5 0.0 1.2 3.3 0.2 0.0 0.7 0.0 0.1 0.0 3.9 0.0 0.0 1.3 0.0 2.9 1.7 3.6 0.0 0.5 2.4 3.3 0.0 2.2 2.2 1.7 0.3 0.0 0.1 0.3 3.5 3.3 3.9 0.0 1.9 1.4 1.5 1.8 1.2 3.8 0.3 0.0 0.6 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.5 0.1 0.0 1.5 0.0 0.0 0.0 0.1 0.4 3.1 2.5 2.4 1.9 0.5 4.4 0.3 7.4 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.0 0.0 0.0 0.0 ZSCAN1 "FLJ33779, ZNF915" ENSG00000152467 "Zinc finger and SCAN domain containing 1" Q8NBB4 19 58034032-58054631 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.7;epididymis: 16.4;pituitary gland: 15.8" "Group enriched" "Detected in some" 4 "Distal tubular cells: 10.0;Early spermatids: 20.0;Late spermatids: 14.4;Muller glia cells: 5.8;Spermatocytes: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;HMC-1: 4.4;NTERA-2: 4.5;T-47d: 6.5" HPA007938 Uncertain Approved Nucleoli NA NA Nucleoli "HPA007938: AB_1080768" "unprognostic (1.60e-3)" "unprognostic (2.44e-1)" "unprognostic (2.21e-1)" "unprognostic (3.58e-1)" "unprognostic (1.49e-1)" "unprognostic (1.82e-2)" "unprognostic (1.97e-2)" "unprognostic (1.29e-1)" "unprognostic (3.34e-1)" "prognostic favorable (7.36e-4)" "unprognostic (1.41e-2)" "unprognostic (3.81e-2)" "unprognostic (1.26e-2)" "unprognostic (1.09e-2)" "unprognostic (1.32e-1)" "unprognostic (2.47e-2)" "unprognostic (3.60e-1)" 0.9 2.2 7.0 0.7 9.5 0.9 3.2 4.0 13.7 2.2 0.8 6.5 1.0 0.8 1.7 16.4 0.8 4.3 1.3 1.6 6.3 9.7 2.8 0.7 1.4 0.8 6.0 6.7 0.9 2.1 7.3 15.8 1.3 8.2 3.7 0.7 3.4 1.6 3.0 0.8 0.8 1.0 1.1 3.7 0.9 1.0 13.3 2.4 0.9 8.1 0.0 0.7 1.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.0 1.6 0.1 0.0 0.0 0.0 6.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 1.3 0.0 0.0 0.0 0.9 6.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 9.5 4.0 13.7 6.3 9.7 6.0 6.7 8.2 2.4 0.0 0.0 0.0 0.3 0.0 2.8 0.6 0.0 0.0 0.0 1.8 2.0 0.0 10.0 0.8 20.0 0.4 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 14.4 0.9 0.0 1.7 0.0 0.0 5.8 0.4 0.0 0.0 0.0 2.1 0.0 0.3 17.0 3.1 0.0 0.0 0.0 0.0 0.4 ZSCAN26 "SRE-ZBP, ZNF187" ENSG00000197062 "Zinc finger and SCAN domain containing 26" Q16670 6 28267010-28278224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027521 Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA027521: AB_2672314" "unprognostic (1.07e-1)" "unprognostic (4.10e-1)" "unprognostic (1.95e-1)" "unprognostic (3.31e-2)" "unprognostic (1.38e-3)" "unprognostic (4.60e-3)" "prognostic unfavorable (7.81e-5)" "unprognostic (1.00e-2)" "unprognostic (1.16e-2)" "unprognostic (1.04e-2)" "unprognostic (2.49e-3)" "unprognostic (9.01e-2)" "prognostic unfavorable (6.79e-5)" "unprognostic (4.45e-2)" "unprognostic (1.44e-1)" "unprognostic (3.10e-1)" "prognostic favorable (1.68e-4)" 4.4 5.4 7.4 4.8 10.5 2.5 8.3 17.7 11.4 8.4 4.3 10.5 7.3 4.2 10.5 7.4 4.9 7.9 6.7 6.3 8.1 5.1 3.6 5.2 4.9 7.3 11.5 18.7 4.0 8.9 7.8 4.6 9.6 7.7 5.0 5.7 4.5 10.7 6.4 4.9 4.4 8.9 6.6 7.6 4.9 2.9 9.6 4.0 7.6 2.0 6.1 5.8 4.6 15.2 9.6 10.7 6.2 16.1 16.3 9.6 5.6 4.8 13.7 11.7 14.9 14.3 3.1 11.2 11.2 14.8 15.3 3.5 4.1 3.2 17.4 7.1 11.1 4.3 6.3 8.2 16.3 6.8 6.8 8.5 6.7 7.5 10.3 7.0 5.5 11.9 7.8 11.3 10.3 19.1 14.9 5.0 7.0 6.8 11.6 4.7 7.4 9.6 4.0 3.0 7.3 7.5 11.9 5.4 12.5 5.8 9.9 7.7 6.9 2.9 9.3 11.6 4.8 4.8 9.7 11.9 8.7 4.2 13.6 7.2 9.6 6.2 4.3 7.9 10.3 10.5 6.2 10.7 13.4 4.8 15.8 13.4 13.1 14.4 9.6 15.2 16.3 13.5 4.4 16.1 4.0 4.5 11.8 9.6 0.0 3.5 10.4 2.8 0.0 8.6 8.7 0.0 2.7 11.4 0.0 3.9 3.8 3.3 4.2 3.2 6.8 2.6 0.0 4.4 2.7 3.5 3.0 5.8 1.5 5.0 1.6 6.4 4.3 5.0 1.7 8.3 1.9 0.0 1.0 2.3 11.7 3.0 4.0 12.4 4.9 9.7 19.4 2.7 5.5 8.1 0.0 1.1 7.5 2.7 0.9 ZXDC "FLJ13861, MGC11349" ENSG00000070476 "ZXD family zinc finger C" Q2QGD7 3 126437601-126475919 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049593 Approved Nucleoli Yes No Nucleoli "HPA049593: AB_2680828" "unprognostic (3.06e-1)" "unprognostic (2.00e-2)" "unprognostic (2.65e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (3.06e-2)" "unprognostic (5.97e-2)" "unprognostic (4.34e-2)" "unprognostic (3.37e-2)" "unprognostic (2.67e-2)" "unprognostic (1.06e-1)" "unprognostic (8.13e-2)" "unprognostic (2.98e-1)" "unprognostic (4.66e-2)" "unprognostic (1.12e-3)" 13.4 9.7 11.5 8.5 13.1 44.5 12.6 15.9 11.7 12.1 10.6 16.0 12.3 6.9 14.4 12.0 11.9 12.3 10.3 8.5 10.5 5.7 10.2 14.9 10.6 9.9 17.4 7.9 15.7 19.3 19.2 11.9 9.9 10.9 12.4 7.6 13.4 13.2 9.7 28.9 18.0 10.2 10.0 10.5 11.0 9.8 9.0 13.2 14.1 11.6 8.5 9.1 14.5 12.3 1.0 2.2 2.5 7.6 0.8 1.1 0.4 14.1 7.3 9.2 8.6 10.0 7.9 16.3 6.5 7.2 9.5 8.5 10.9 6.2 10.6 11.0 5.8 8.8 11.7 12.2 7.5 7.5 5.6 10.3 8.2 8.4 7.1 10.7 12.6 13.5 6.2 14.7 5.8 10.5 9.4 9.6 12.6 8.8 14.2 7.9 8.3 12.1 7.0 13.0 9.3 7.4 13.1 6.2 13.3 6.7 10.3 16.7 9.3 12.4 9.2 17.1 6.3 12.4 11.2 9.7 8.8 11.4 13.1 7.8 11.8 5.5 14.0 9.6 9.9 9.6 2.4 0.8 1.6 1.1 0.4 0.4 0.3 0.8 0.8 1.4 1.0 1.1 1.0 2.5 0.8 7.6 2.2 0.5 0.4 11.5 13.1 15.9 11.7 10.5 5.7 17.4 7.9 10.9 13.2 23.8 14.1 2.7 7.3 5.6 28.6 3.4 15.3 6.7 9.1 5.2 43.2 6.2 6.6 4.4 1.5 6.8 7.7 0.0 5.2 2.0 3.8 5.0 2.3 11.3 5.1 12.7 3.5 7.4 4.3 0.2 6.9 6.2 1.7 1.8 5.9 24.0 4.0 4.9 7.1 6.9 27.2 0.0 4.7 3.2 7.7 3.8 5.3 5.0 6.3 5.3